Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" AAAS ENSG00000094914 "Aladin WD repeat nucleoporin" Q9NRG9 12 53307456-53324864 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040086 Approved Approved "Nuclear membrane,Centrosome,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nuclear membrane" "Centrosome, Cytosol" "HPA040086: AB_10805602" "unprognostic (1.53e-1)" "unprognostic (1.24e-1)" "unprognostic (1.83e-1)" "unprognostic (1.81e-2)" "unprognostic (1.76e-1)" "unprognostic (2.64e-1)" "unprognostic (1.51e-3)" "unprognostic (1.70e-1)" "unprognostic (4.34e-1)" "unprognostic (1.00e-2)" "unprognostic (1.57e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.93e-4)" "unprognostic (1.95e-1)" "unprognostic (9.82e-2)" "unprognostic (2.53e-1)" "unprognostic (7.44e-2)" 17.0 36.3 12.3 13.8 15.0 19.1 17.1 15.2 15.6 20.3 15.1 19.1 12.3 19.1 7.2 19.3 19.9 9.4 22.7 12.9 13.7 21.7 24.6 14.0 17.6 14.3 14.1 19.2 23.9 18.0 24.8 17.4 14.8 18.4 15.1 12.3 18.5 11.7 22.6 17.3 17.7 16.8 13.7 22.2 21.6 27.3 14.0 25.2 19.4 18.5 21.6 17.8 17.9 17.2 26.1 77.3 63.2 38.0 28.6 32.2 38.9 29.8 31.3 72.6 42.1 54.0 56.7 62.2 47.4 37.3 41.9 37.6 106.4 78.8 42.1 41.0 68.1 49.7 29.9 40.7 26.4 45.5 37.9 28.1 39.4 48.9 44.6 40.4 56.6 56.2 67.6 70.6 30.4 72.8 71.2 46.1 40.0 27.7 53.1 72.1 39.3 69.4 38.2 17.5 32.8 41.3 20.2 46.9 21.0 40.2 61.2 38.8 25.5 34.9 51.1 27.4 32.9 32.5 43.5 54.7 25.6 39.6 40.5 1.0 17.7 10.7 18.4 20.2 20.8 20.0 15.9 16.8 18.8 21.8 21.7 21.4 1.1 10.5 22.5 22.6 17.4 15.2 12.3 15.0 15.2 15.6 12.9 13.7 14.3 14.1 14.8 13.7 14.0 17.2 11.7 12.8 7.8 17.9 15.1 7.4 19.0 26.2 10.2 11.8 13.2 13.0 8.2 17.2 15.4 14.7 16.7 58.4 13.7 9.3 13.7 20.4 12.5 11.9 12.9 11.7 8.4 41.2 7.3 18.3 49.5 14.9 13.3 8.9 8.2 13.1 11.0 12.0 28.5 1.7 6.6 13.1 18.3 12.4 9.3 26.2 17.7 10.6 10.6 5.6 11.6 18.0 15.5 6.6 11.4 8.9 11.0 12.8 20.8 8.1 11.2 18.5 12.6 15.5 19.7 11.0 39.7 34.2 40.5 13.1 7.4 36.5 11.4 14.9 17.2 13.0 AAMP ENSG00000127837 "Angio associated migratory cell protein" Q13685 2 218264129-218270178 "Plasma proteins, Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017717, HPA031868" Approved Supported Microtubules,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Microtubules Cytosol "CAB017717: , HPA031868: AB_2674078" "unprognostic (1.57e-1)" "unprognostic (6.12e-2)" "unprognostic (8.11e-3)" "prognostic unfavorable (1.62e-4)" "unprognostic (1.39e-2)" "unprognostic (5.04e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (8.94e-2)" "unprognostic (7.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" "unprognostic (4.22e-2)" "unprognostic (5.51e-2)" "unprognostic (1.23e-3)" "unprognostic (5.26e-2)" "unprognostic (1.92e-1)" "unprognostic (9.09e-2)" 66.5 66.4 65.0 46.2 66.1 27.5 65.2 67.1 80.1 62.6 63.2 76.3 62.8 61.7 43.8 75.1 60.8 56.1 65.4 65.7 67.2 60.2 77.5 46.6 47.8 69.2 66.6 79.8 70.7 72.7 62.1 54.9 66.4 58.0 58.0 38.4 66.9 58.7 90.4 76.6 61.7 50.7 67.5 53.0 86.9 53.8 67.1 54.0 66.6 62.0 52.6 70.0 57.4 70.3 126.1 104.6 75.1 102.2 111.9 75.7 146.0 89.6 136.3 167.1 124.5 226.2 100.1 64.6 121.8 112.6 158.8 94.3 150.7 133.4 129.3 103.5 200.9 147.4 108.2 237.4 158.9 139.3 92.4 97.8 152.7 172.2 149.7 99.7 97.6 124.3 202.6 82.4 108.9 198.0 112.4 234.9 121.0 182.4 75.4 90.6 97.5 105.8 100.3 160.5 96.2 92.9 59.4 128.7 134.7 119.1 99.1 104.6 84.7 110.2 82.3 81.2 106.8 105.7 198.1 108.4 111.0 88.6 77.4 75.9 166.2 60.3 101.1 209.2 105.1 100.3 90.1 94.9 191.4 105.7 111.1 100.7 26.2 114.9 210.6 114.1 109.3 179.4 65.0 66.1 67.1 80.1 65.7 67.2 69.2 66.6 66.4 67.5 67.1 70.3 57.8 41.7 35.2 11.4 50.4 90.5 86.1 122.9 66.0 47.7 50.7 45.2 35.5 41.5 74.0 42.3 12.5 160.0 42.2 74.3 103.7 95.7 3.5 33.5 46.4 50.6 75.5 34.0 11.5 95.4 130.3 63.4 80.5 38.2 34.8 57.6 42.5 46.2 91.9 63.9 12.9 89.9 93.6 37.0 65.3 8.8 83.3 38.5 62.2 5.6 64.8 80.2 41.2 8.0 10.5 86.6 72.0 74.9 51.2 116.0 99.5 85.3 47.4 37.1 65.7 38.4 86.5 72.0 53.3 70.2 97.3 202.6 44.4 62.5 103.5 119.9 AAR2 "bA234K24.2, C20orf4" ENSG00000131043 "AAR2 splicing factor" Q9Y312 20 36236131-36270918 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034220, HPA048645" Uncertain Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "CAB034220: AB_1564205, HPA048645: AB_2680475" "unprognostic (1.73e-1)" "unprognostic (1.30e-1)" "unprognostic (3.92e-2)" "unprognostic (1.01e-2)" "unprognostic (1.56e-1)" "unprognostic (7.54e-3)" "prognostic unfavorable (1.83e-6)" "unprognostic (5.09e-2)" "unprognostic (6.84e-2)" "unprognostic (6.38e-2)" "unprognostic (3.79e-1)" "unprognostic (3.31e-1)" "unprognostic (4.61e-3)" "unprognostic (4.58e-2)" "unprognostic (5.85e-2)" "unprognostic (1.25e-1)" "unprognostic (6.17e-2)" 22.3 26.8 14.5 14.3 15.8 22.3 21.6 15.8 15.5 19.8 19.1 27.5 15.1 25.6 25.0 17.8 23.2 16.5 18.8 14.3 14.7 20.9 23.5 19.2 17.5 15.9 15.2 22.6 18.6 25.5 10.0 17.5 15.9 19.9 17.3 7.5 18.1 21.1 23.4 25.9 18.9 27.9 15.5 18.1 23.0 16.4 15.4 26.2 17.9 20.7 19.9 25.8 16.2 17.2 26.9 30.7 28.8 33.2 48.9 32.4 22.9 25.4 33.7 58.1 45.7 69.2 35.0 18.2 35.6 36.9 44.8 36.6 46.6 48.2 35.8 17.0 28.2 57.9 19.3 43.3 36.9 39.5 27.9 39.6 68.7 41.5 31.5 29.4 36.3 36.0 36.8 34.3 32.4 32.0 56.0 48.9 25.1 39.1 49.5 30.7 48.3 42.4 33.0 19.6 33.2 36.1 37.8 100.7 32.8 26.2 57.1 42.8 26.6 54.9 34.3 33.0 32.2 31.1 42.3 34.6 39.9 26.3 29.7 60.6 46.2 41.6 43.0 49.4 43.2 32.5 40.0 41.4 49.1 35.5 50.0 43.0 8.9 58.4 58.1 39.8 50.2 57.4 14.5 15.8 15.8 15.5 14.3 14.7 15.9 15.2 15.9 15.5 15.4 17.2 11.7 6.4 12.5 4.6 10.8 5.7 10.6 11.8 6.8 4.4 10.3 9.5 6.8 11.5 8.4 9.2 8.4 21.3 10.9 7.1 11.7 19.7 2.8 6.9 8.9 11.9 11.4 14.7 6.3 21.0 14.3 12.7 6.6 6.6 15.9 10.8 11.4 11.8 15.0 15.2 7.1 10.5 12.2 15.0 2.5 3.1 11.1 8.5 10.6 3.7 12.3 6.1 14.4 5.0 9.9 17.3 7.6 15.1 7.5 11.3 8.4 8.0 11.1 3.5 6.6 9.8 13.9 17.0 14.5 9.0 7.5 18.6 7.9 15.3 8.7 8.9 AARS1 "AARS, AlaRS, CMT2N" ENSG00000090861 "Alanyl-tRNA synthetase 1" P49588 16 70251983-70289707 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Epilepsy, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 25.1;Cytotrophoblasts: 63.0;Extravillous trophoblasts: 29.9;Hofbauer cells: 27.1;Syncytiotrophoblasts: 52.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034261, HPA040870, HPA044223" Supported Supported Cytosol NA NA 620000 "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 47: Cytotrophoblasts - Unknown function" Cytosol "CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862" "unprognostic (1.98e-2)" "unprognostic (6.87e-2)" "unprognostic (8.02e-2)" "unprognostic (5.72e-2)" "unprognostic (3.58e-1)" "unprognostic (2.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.36e-1)" "unprognostic (1.99e-1)" "unprognostic (1.76e-1)" "unprognostic (8.33e-2)" "unprognostic (2.92e-1)" "unprognostic (3.42e-2)" "unprognostic (3.75e-2)" "unprognostic (2.05e-3)" "unprognostic (8.22e-2)" "unprognostic (3.83e-3)" 43.7 54.7 60.1 33.4 64.3 7.9 41.4 73.3 88.6 42.1 49.2 48.9 26.0 49.8 49.6 29.5 40.4 22.3 47.9 62.8 71.7 43.6 72.0 45.3 30.0 78.6 68.6 37.3 75.8 74.9 50.1 35.6 84.9 40.0 26.2 59.3 53.3 47.2 62.4 28.8 32.7 47.8 66.3 38.3 51.8 23.8 74.8 36.4 66.6 39.7 35.5 45.9 32.8 83.9 123.7 192.8 52.9 205.7 127.3 115.0 125.7 97.7 135.3 119.7 151.8 162.5 163.2 140.4 127.2 99.3 90.8 137.2 160.5 133.1 170.7 63.2 54.7 135.6 78.0 152.2 348.0 74.4 77.2 133.9 193.8 228.1 508.4 91.4 120.3 209.3 176.0 173.4 91.3 282.0 89.4 85.0 104.3 160.0 108.5 170.4 36.1 317.0 84.7 60.3 67.9 57.3 269.5 62.3 246.1 75.8 197.7 181.3 75.2 85.2 82.9 84.9 78.8 233.8 174.2 258.2 155.4 124.9 175.9 6.5 7.8 2.7 11.9 13.2 13.0 12.8 9.7 11.7 11.9 9.1 11.2 12.2 0.1 22.7 14.1 7.0 8.0 12.6 60.1 64.3 73.3 88.6 62.8 71.7 78.6 68.6 84.9 66.3 74.8 83.9 6.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 63.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 29.9 4.5 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 52.0 0.2 0.0 0.0 0.0 AARSD1 MGC2744 ENSG00000266967 "Alanyl-tRNA synthetase domain containing 1" Q9BTE6 17 42950526-42964498 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 68.2;Spermatocytes: 44.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021408, HPA022869, HPA023714" Supported Approved "Nuclear membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nuclear membrane, Cytosol" "HPA021408: AB_1844410, HPA022869: AB_1844411, HPA023714: AB_1844412" "unprognostic (2.85e-3)" "unprognostic (9.78e-2)" "unprognostic (1.67e-1)" "unprognostic (8.53e-2)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (3.58e-2)" "unprognostic (7.41e-2)" "unprognostic (1.38e-2)" "unprognostic (1.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.67e-6)" "unprognostic (2.20e-1)" "unprognostic (2.51e-1)" "unprognostic (3.73e-2)" "unprognostic (4.69e-3)" 18.2 19.6 18.1 13.7 20.2 16.5 20.3 17.9 21.4 19.9 17.2 20.4 12.8 20.7 21.1 18.6 20.3 13.5 34.4 19.5 19.8 20.5 24.4 13.7 17.4 19.3 18.1 26.0 25.5 24.7 20.5 14.6 19.7 18.1 17.4 13.5 20.5 18.4 68.9 15.6 13.7 23.2 17.7 14.2 20.5 72.3 18.8 19.3 21.4 60.5 20.7 19.6 17.6 20.3 38.7 52.4 39.6 39.8 47.0 44.8 30.5 41.2 34.5 46.9 31.1 45.8 32.0 104.3 2.0 43.2 28.7 32.1 55.2 62.2 53.7 35.1 43.7 41.4 57.6 25.3 61.6 81.6 22.2 40.8 33.1 32.6 81.5 32.2 38.3 46.4 76.3 21.3 45.0 22.0 81.8 58.3 27.6 53.5 26.3 53.3 80.8 107.0 46.7 35.8 51.1 32.0 20.0 20.5 54.0 43.0 54.8 68.4 37.3 48.4 43.4 24.9 58.6 33.6 46.3 64.7 31.7 50.1 52.7 4.1 19.0 1.5 20.5 27.3 27.1 27.2 21.4 24.4 29.9 31.2 26.9 26.3 0.6 25.4 24.5 33.3 22.6 17.8 18.1 20.2 17.9 21.4 19.5 19.8 19.3 18.1 19.7 17.7 18.8 20.3 6.3 12.8 8.2 0.0 22.6 8.3 11.7 10.6 26.2 22.1 8.4 8.0 0.7 4.3 13.2 14.7 33.3 8.7 6.9 11.9 3.9 7.2 68.2 7.5 7.0 7.1 12.0 14.7 0.0 6.1 8.7 12.4 12.8 5.3 5.1 11.1 7.5 4.2 5.0 15.2 0.0 6.7 22.4 4.1 6.4 26.9 13.1 6.8 3.6 0.0 6.1 5.5 17.5 0.0 0.0 4.3 4.5 10.9 21.7 9.6 4.5 4.9 9.6 16.2 0.0 7.2 15.0 44.5 21.4 17.4 4.5 2.7 17.7 13.7 10.0 6.7 ABCC4 "EST170205, MOAT-B, MOATB, MRP4" ENSG00000125257 "ATP binding cassette subfamily C member 4" O15439 13 95019835-95301475 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters" Transport Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 41.1" "Cell type enhanced" "Detected in many" "Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3" "Cancer enriched" "Detected in all" 8 "prostate cancer: 90.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002476 Enhanced Supported "Nucleoli,Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" "Nucleoli, Golgi apparatus" "HPA002476: AB_1844434" "unprognostic (8.77e-2)" "unprognostic (1.94e-2)" "unprognostic (1.48e-1)" "prognostic unfavorable (9.89e-4)" "unprognostic (2.83e-2)" "unprognostic (1.23e-1)" "unprognostic (7.45e-3)" "unprognostic (2.40e-2)" "unprognostic (9.96e-2)" "unprognostic (2.60e-2)" "unprognostic (1.28e-1)" "unprognostic (2.55e-2)" "prognostic favorable (2.25e-10)" "unprognostic (7.44e-3)" "unprognostic (1.67e-1)" "unprognostic (5.55e-2)" "unprognostic (2.35e-2)" 2.2 1.3 2.5 6.1 2.3 4.1 6.9 2.5 2.5 4.9 7.2 9.2 4.9 3.4 18.8 2.0 10.2 6.1 2.0 2.3 5.4 18.0 1.3 7.6 3.9 4.3 3.7 3.7 3.3 22.5 1.4 2.1 4.6 41.1 8.5 0.9 1.5 5.5 5.3 2.9 5.4 6.3 4.9 4.1 5.2 4.7 3.2 3.9 7.7 1.7 6.3 15.4 1.8 5.1 18.5 31.7 5.3 9.4 9.5 12.3 1.3 14.4 14.3 12.6 10.9 43.8 13.2 10.2 9.3 19.5 9.0 24.0 7.9 7.1 15.8 30.7 12.1 245.7 8.8 8.8 19.2 28.6 256.3 9.4 3.2 9.1 18.5 17.9 16.4 11.3 25.8 0.4 17.1 5.9 5.4 4.6 6.2 22.3 7.9 7.7 14.3 26.9 69.3 40.4 12.5 9.3 4.8 1.2 10.1 5.9 0.0 15.1 27.0 13.3 8.6 11.2 17.3 0.1 0.0 4.0 25.4 16.0 6.6 0.2 0.5 0.2 1.3 0.6 1.1 1.4 1.0 1.5 1.8 1.6 0.6 1.5 0.3 1.9 2.3 0.3 1.5 1.3 2.5 2.3 2.5 2.5 2.3 5.4 4.3 3.7 4.6 4.9 3.2 5.1 4.6 9.6 32.7 28.4 5.8 4.2 7.0 7.3 4.0 0.1 0.6 0.6 4.5 8.6 9.1 23.9 22.9 0.1 2.0 2.7 0.0 6.9 3.8 4.2 11.3 19.8 0.0 51.3 13.6 3.1 0.4 5.7 6.1 6.0 53.9 9.5 2.9 0.6 4.5 0.0 10.3 4.0 0.0 2.5 8.1 2.0 6.8 10.7 1.8 203.3 13.5 0.5 4.1 16.1 2.5 2.9 8.3 1.9 8.3 27.1 0.5 26.4 4.7 0.8 0.0 8.2 3.1 0.9 8.3 3.4 7.5 0.3 6.4 17.3 9.2 4.5 ABCE1 "OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I" ENSG00000164163 "ATP binding cassette subfamily E member 1" P61221 4 145098288-145129524 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Translation regulation" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012476, HPA036846" Approved Enhanced Cytosol No No 380000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "CAB012476: , HPA036846: AB_2675346" "unprognostic (2.22e-3)" "unprognostic (8.11e-3)" "prognostic favorable (8.69e-4)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (5.51e-3)" "prognostic unfavorable (6.29e-4)" "unprognostic (5.68e-3)" "unprognostic (6.77e-2)" "unprognostic (1.34e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.56e-2)" "unprognostic (1.38e-3)" "unprognostic (2.85e-1)" "unprognostic (2.40e-1)" "unprognostic (2.08e-2)" "unprognostic (2.21e-1)" 30.0 21.5 11.2 33.6 12.5 27.2 33.1 13.7 16.0 20.7 10.7 22.7 20.2 24.4 16.0 35.1 22.5 22.4 24.9 12.5 14.3 23.8 39.7 18.5 40.5 12.6 11.2 29.1 29.4 27.0 10.0 28.7 14.4 19.4 27.7 14.4 24.1 16.9 28.0 25.2 17.7 28.9 13.8 26.4 20.1 26.5 11.8 34.2 26.9 30.3 42.1 40.5 15.9 18.1 117.1 61.2 89.5 62.2 74.6 107.5 89.4 124.6 86.4 145.1 101.3 95.5 105.9 187.6 39.3 109.2 77.7 75.4 132.5 157.7 193.1 108.6 82.9 106.9 44.0 80.6 98.3 244.3 81.3 80.0 108.4 153.8 213.7 74.8 157.4 139.1 219.5 136.1 156.3 70.4 234.5 82.2 74.8 177.5 142.9 124.0 107.9 135.7 108.1 79.9 111.1 55.1 74.7 124.6 89.5 66.7 74.2 98.1 105.3 143.3 89.4 101.3 152.5 120.6 209.6 199.5 87.7 214.6 163.7 2.2 10.0 0.9 12.3 13.1 25.4 13.2 15.4 16.0 19.5 13.0 21.0 18.1 0.8 16.4 13.4 10.9 18.5 14.8 11.2 12.5 13.7 16.0 12.5 14.3 12.6 11.2 14.4 13.8 11.8 18.1 56.4 25.6 18.7 15.3 55.9 59.9 109.0 38.7 45.5 37.2 35.0 30.6 24.0 17.2 45.4 25.8 20.9 39.4 44.4 9.8 39.2 39.4 40.1 29.0 61.8 53.7 20.4 47.5 24.2 28.2 45.1 50.6 35.7 23.4 32.9 50.3 21.4 32.9 41.5 42.1 27.8 22.5 24.4 22.4 40.3 15.4 46.9 34.6 19.6 12.2 33.2 18.1 33.0 18.1 37.5 39.1 10.3 34.6 58.3 112.2 8.0 39.8 28.5 34.9 32.9 71.7 47.5 92.4 79.4 65.5 59.5 26.5 47.2 98.4 36.6 72.2 ABCF2 "ABC28, EST133090, HUSSY-18, M-ABC1" ENSG00000033050 "ATP binding cassette subfamily F member 2" Q9UG63 7 151211484-151227205 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 55.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA020091, CAB020682, HPA021815, HPA030388" Approved Enhanced Cytosol NA NA 51000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558" "unprognostic (6.80e-2)" "unprognostic (4.23e-1)" "unprognostic (1.38e-1)" "unprognostic (9.07e-2)" "unprognostic (1.41e-2)" "unprognostic (1.49e-1)" "prognostic unfavorable (9.52e-6)" "unprognostic (1.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.73e-1)" "unprognostic (6.31e-2)" "unprognostic (5.58e-2)" "unprognostic (9.93e-2)" "unprognostic (1.16e-2)" "unprognostic (1.95e-1)" "unprognostic (6.07e-2)" "unprognostic (7.84e-3)" 19.0 18.8 16.1 11.1 16.2 7.6 14.8 15.1 19.5 13.8 14.2 18.8 6.0 16.6 12.1 19.2 14.4 8.9 27.9 16.0 16.7 20.2 12.3 14.6 11.6 18.0 16.5 15.0 15.0 14.3 17.0 10.3 17.3 16.1 10.8 10.8 14.2 10.2 61.2 16.3 13.4 14.1 16.2 15.6 16.6 18.7 16.5 11.5 13.8 20.2 15.2 19.5 13.9 16.9 33.0 50.3 18.8 66.0 36.6 31.1 25.1 40.6 33.0 49.9 42.1 47.9 22.1 57.4 34.3 42.8 40.9 25.2 58.9 47.8 49.5 28.1 48.8 23.1 26.3 27.4 43.3 58.0 35.7 42.3 39.6 54.6 34.4 21.2 40.7 32.5 68.4 22.9 43.2 80.1 60.4 70.3 46.8 37.6 54.5 40.3 30.1 50.5 35.4 24.0 32.9 31.0 39.5 37.5 26.8 19.5 16.2 29.0 40.7 31.7 12.8 39.6 61.7 46.9 54.5 42.7 43.5 56.4 60.3 7.9 11.3 3.8 13.8 13.3 19.5 11.9 14.2 13.7 13.1 13.1 13.3 13.8 1.6 14.5 15.1 9.8 15.8 14.7 16.1 16.2 15.1 19.5 16.0 16.7 18.0 16.5 17.3 16.2 16.5 16.9 4.7 0.0 0.5 10.1 15.9 27.1 25.9 22.5 14.2 17.4 0.3 0.6 23.5 7.2 9.5 0.0 8.4 29.5 10.0 28.4 0.0 0.0 47.0 0.1 0.1 12.8 6.7 18.3 12.6 0.0 28.8 13.8 16.3 0.0 10.2 0.0 12.5 12.9 20.7 10.1 12.6 9.1 12.2 10.4 11.5 55.9 10.5 6.7 19.6 7.5 6.2 14.1 14.4 7.1 10.4 0.0 18.9 14.7 14.0 29.8 15.7 0.0 6.6 16.9 13.1 25.7 15.1 31.0 12.4 21.5 25.1 32.3 10.9 0.1 15.1 19.6 ABCF3 EST201864 ENSG00000161204 "ATP binding cassette subfamily F member 3" Q9NUQ8 3 184186023-184194012 "Predicted intracellular proteins, Transporters" "Antiviral defense" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036332 Approved Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 6: T47d - Mammary gland" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Nucleoli "HPA036332: AB_10603571" "unprognostic (1.70e-2)" "unprognostic (1.16e-1)" "unprognostic (3.10e-2)" "unprognostic (3.81e-2)" "unprognostic (4.11e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (4.16e-5)" "unprognostic (5.18e-2)" "unprognostic (5.97e-2)" "unprognostic (2.67e-1)" "unprognostic (1.01e-1)" "unprognostic (5.52e-2)" "unprognostic (1.85e-2)" "unprognostic (3.72e-2)" "unprognostic (1.44e-1)" "unprognostic (1.94e-2)" "unprognostic (6.53e-2)" 16.1 56.1 10.9 13.3 10.9 16.8 15.8 11.8 13.4 18.2 9.6 15.5 15.7 15.5 12.3 20.0 17.0 12.7 28.5 10.9 12.7 19.2 22.7 14.4 17.0 13.9 12.3 20.0 23.6 43.5 21.0 16.4 12.8 16.2 13.6 14.2 26.9 19.6 46.8 19.6 16.3 12.4 9.2 17.8 17.5 16.5 12.4 14.6 17.9 41.3 16.1 17.1 17.6 11.6 49.9 30.2 16.9 32.8 48.1 26.9 33.3 35.2 39.1 46.7 36.5 52.0 19.3 29.8 69.5 38.1 54.9 46.4 26.5 37.1 24.1 38.4 25.5 25.7 26.6 30.8 40.4 29.2 25.2 39.7 33.5 33.1 32.7 27.4 33.8 25.7 24.1 34.9 33.5 60.0 28.7 18.8 25.7 51.1 41.2 28.5 28.1 50.4 25.4 29.6 29.1 16.9 36.5 69.1 33.8 18.3 93.7 25.3 33.5 24.9 27.1 39.5 53.1 39.2 40.5 38.2 38.8 28.7 31.3 8.1 29.1 22.7 32.9 30.4 34.7 23.6 29.0 27.5 25.6 23.8 36.0 29.5 14.6 24.0 32.4 15.8 27.2 37.2 10.9 10.9 11.8 13.4 10.9 12.7 13.9 12.3 12.8 9.2 12.4 11.6 10.2 9.6 2.0 6.2 17.4 14.5 10.0 29.8 9.6 16.7 10.8 6.7 11.6 17.2 19.7 14.7 14.6 36.9 16.2 19.8 29.4 22.5 9.5 11.2 12.0 11.6 11.4 8.6 7.1 22.4 25.5 12.5 13.3 12.0 9.5 16.0 16.8 20.0 21.6 20.2 9.9 13.4 30.5 9.4 6.9 10.2 12.5 12.9 16.0 3.7 22.8 14.7 17.5 6.6 7.3 20.5 9.8 11.7 19.4 9.0 28.6 37.3 14.4 22.3 6.6 11.9 9.5 12.8 17.1 14.5 10.2 43.8 16.6 18.1 14.7 11.7 AC000120.2 ENSG00000285772 "Novel protein" 7 92112159-92179511 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 3.7;testis: 7.4" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 16.0;Alveolar cells type 2: 25.3;Club cells: 5.6;Respiratory ciliated cells: 2.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.0;HeLa: 1.6;Karpas-707: 1.5;U-266/70: 1.4" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: U-266 - Adaptive immune response" "Cluster 11: Alveolar cells - Smell perception" 0.3 0.4 0.3 0.2 0.8 0.2 2.5 0.7 1.0 0.0 0.1 0.1 0.0 0.4 0.8 0.1 0.0 0.8 0.0 0.6 0.4 0.3 0.0 0.5 0.2 2.3 0.7 0.0 1.4 0.1 0.4 2.0 0.1 0.0 0.0 0.0 0.2 0.2 0.3 0.1 0.0 1.5 0.2 0.4 7.4 0.3 0.2 1.0 0.0 0.2 0.1 3.7 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.2 0.7 0.3 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.3 0.0 0.7 1.0 0.1 1.6 0.4 0.0 0.7 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.5 0.4 0.3 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.6 0.0 0.0 0.3 0.0 0.0 0.0 0.9 0.2 0.0 1.4 0.2 0.4 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.0 0.1 0.1 0.3 0.1 0.1 0.2 0.3 0.8 0.7 1.0 0.6 0.4 2.3 0.7 2.0 1.5 0.3 3.7 0.0 16.0 25.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC005702.1 ENSG00000267318 "Novel protein" 17 59940908-59973101 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "skeletal muscle: 25.0;tongue: 23.0" "Group enriched" "Detected in some" 8 "Alveolar cells type 2: 1.7;Club cells: 1.8;Respiratory ciliated cells: 1.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/84: 22.5" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 16: U-266 - Nucleosome" "Cluster 11: Alveolar cells - Smell perception" 8.0 3.4 1.3 0.7 1.5 0.9 4.3 2.1 2.6 0.8 1.0 2.3 1.7 0.2 7.7 0.9 1.3 1.3 7.0 1.3 1.6 4.7 10.5 1.3 1.1 1.9 2.3 0.6 0.5 2.0 0.2 0.6 2.2 1.3 2.3 1.9 1.2 0.3 25.0 2.3 1.4 0.7 1.6 0.9 1.2 6.2 1.5 0.7 0.5 23.0 0.9 1.3 0.1 1.6 0.7 1.2 0.5 2.0 1.3 0.2 2.3 0.7 0.3 1.0 1.3 0.3 7.4 0.7 4.1 0.8 1.4 0.1 1.4 1.3 1.2 5.2 1.1 3.4 0.5 0.9 1.8 0.8 6.8 1.8 0.6 1.6 1.4 0.1 0.0 0.6 0.9 2.8 0.7 8.2 0.5 0.4 0.0 4.6 0.9 1.1 2.2 0.8 0.2 0.3 0.1 0.5 1.5 1.3 2.8 0.5 4.5 3.2 0.0 1.6 2.1 1.1 1.3 6.1 22.5 4.7 1.0 2.5 0.9 0.0 0.5 2.0 1.0 1.3 2.7 1.5 1.7 1.5 0.7 0.4 1.2 1.9 0.1 2.4 4.2 0.9 4.4 0.8 1.3 1.5 2.1 2.6 1.3 1.6 1.9 2.3 2.2 1.6 1.5 1.6 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 AC023055.1 ENSG00000257390 "Novel protein" 12 55757275-55827546 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 9 "testis: 8.9" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 6.4;Alveolar cells type 2: 6.3;granulocytes: 2.5;Respiratory ciliated cells: 3.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "SK-MEL-30: 3.0" "HPA017653, HPA030902, HPA030903" Uncertain Approved "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 74: Testis - Spermatogenesis" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 11: Alveolar cells - Smell perception" "Nuclear speckles" "Cytoplasmic bodies" "HPA017653: AB_1847799, HPA030902: AB_10669872, HPA030903: AB_10964180" "unprognostic (8.84e-4)" "unprognostic (2.25e-1)" "unprognostic (8.19e-2)" "unprognostic (1.16e-1)" "unprognostic (1.60e-1)" "unprognostic (7.17e-2)" "unprognostic (1.55e-3)" "unprognostic (1.86e-1)" "unprognostic (6.30e-2)" "unprognostic (3.79e-2)" "unprognostic (3.05e-2)" "unprognostic (2.16e-2)" "unprognostic (1.16e-5)" "unprognostic (6.36e-2)" "unprognostic (1.71e-1)" "unprognostic (1.22e-1)" "unprognostic (4.37e-3)" 0.4 0.1 0.0 0.1 0.2 0.5 0.1 0.1 0.2 0.0 0.2 0.1 0.2 0.0 0.3 0.2 0.1 0.4 0.2 0.1 0.1 0.3 0.2 0.1 0.4 0.3 0.2 0.0 0.1 0.3 0.0 0.0 0.3 0.2 0.3 0.9 0.1 0.1 0.2 0.2 0.4 0.0 0.0 0.1 0.2 8.9 0.7 0.0 0.0 0.0 0.2 0.3 0.1 0.3 0.1 0.0 1.2 1.7 1.1 0.0 1.3 0.8 0.6 0.1 0.5 0.5 0.4 1.3 0.2 0.7 0.4 0.7 1.0 1.2 0.5 0.0 1.2 0.9 0.3 0.5 0.5 1.4 1.0 0.2 0.0 0.5 0.2 0.0 0.1 0.7 0.6 0.0 0.2 0.0 0.7 1.0 1.9 1.4 0.0 1.1 1.4 0.8 0.7 0.6 1.6 0.5 0.5 2.1 3.0 0.5 0.4 0.4 0.0 0.0 0.1 0.2 0.3 0.0 1.1 0.9 0.3 0.2 0.2 1.2 0.4 1.4 1.1 0.8 0.7 1.9 1.3 0.7 1.1 1.3 0.9 1.3 0.2 1.8 2.0 0.6 1.8 1.4 0.0 0.2 0.1 0.2 0.1 0.1 0.3 0.2 0.3 0.0 0.7 0.3 0.1 6.4 6.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 1.3 0.0 0.0 0.1 0.5 0.0 0.0 0.3 0.0 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.3 2.5 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 AC069544.1 ENSG00000284024 "Zinc finger and SCAN domain containing 29" 10 14838302-14846999 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Breast glandular cells: 1.8;Breast myoepithelial cells: 1.5;Endometrial ciliated cells: 1.2;Endometrial stromal cells: 1.8;Glandular and luminal cells: 1.2;Granulosa cells: 2.3;Proximal tubular cells: 1.3;Theca cells: 4.3" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" 4.3 4.1 2.8 6.2 2.7 8.9 6.8 6.8 4.5 5.5 1.7 5.9 5.4 5.9 3.4 6.7 3.7 6.1 3.6 3.8 3.3 3.0 3.8 3.1 8.4 2.5 2.2 7.3 5.9 5.3 3.6 7.9 2.5 5.3 6.3 10.1 3.8 4.3 2.4 7.6 5.2 4.4 2.2 5.8 6.5 6.8 2.8 9.7 5.3 4.3 7.2 6.3 2.9 3.8 13.9 9.7 15.3 14.9 9.1 7.8 15.1 12.6 5.6 15.7 20.3 16.5 10.0 21.5 6.1 7.9 8.4 14.5 24.1 12.5 20.2 11.9 14.3 22.0 20.1 10.8 11.1 8.9 13.3 5.8 10.2 25.0 11.1 7.4 9.9 13.2 25.1 16.8 18.7 12.8 18.2 8.0 13.5 8.0 6.1 15.8 13.2 14.3 8.8 6.4 12.1 14.6 11.8 13.9 12.6 9.7 9.9 10.2 8.1 16.0 16.9 18.2 12.8 9.9 12.9 19.9 8.3 13.5 7.5 2.9 1.6 1.9 1.8 2.0 2.0 2.1 1.7 1.7 1.6 2.2 2.0 2.5 1.6 3.5 2.9 2.2 1.8 1.7 2.8 2.7 6.8 4.5 3.8 3.3 2.5 2.2 2.5 2.2 2.8 3.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.7 0.0 1.2 1.8 0.3 0.0 0.0 0.0 0.5 0.0 0.3 0.0 1.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 4.3 0.0 0.0 AC093512.2 ENSG00000285043 "Uncharaterized LOC112694756" 16 30053090-30070420 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 6 "tongue: 94.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: U-698-M & Daudi - Adaptive immune response" 1.5 1.5 7.5 2.0 8.8 3.4 7.9 6.5 10.3 5.4 9.7 2.3 0.6 1.8 1.1 1.6 4.3 2.3 6.7 9.7 8.0 1.3 0.6 3.2 3.1 7.3 8.4 2.8 1.4 3.0 2.2 7.8 3.1 1.1 2.4 2.3 8.1 17.1 1.3 0.7 2.6 7.5 2.6 2.0 5.2 7.6 9.6 5.6 94.4 3.6 3.7 6.7 7.5 17.6 3.5 11.3 2.6 9.0 2.8 7.5 12.6 9.8 38.2 7.5 9.4 45.6 11.0 12.5 3.3 11.9 25.4 20.2 6.7 8.2 16.4 11.3 15.5 13.1 20.1 19.9 4.2 9.0 0.9 19.3 21.7 8.0 14.0 7.2 2.4 12.9 24.3 9.3 9.6 15.4 3.9 3.2 12.6 14.4 7.2 42.0 27.0 1.6 11.0 9.1 2.0 3.4 2.8 1.1 9.5 7.6 3.3 14.3 4.3 6.8 10.1 13.2 10.7 14.3 14.0 21.1 6.6 0.1 6.3 0.1 4.8 2.6 6.6 6.5 6.3 5.1 6.2 5.7 7.4 5.8 0.8 4.5 2.5 5.3 5.3 15.3 7.5 8.8 6.5 10.3 9.7 8.0 7.3 8.4 7.8 7.5 7.6 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACBD6 MGC2404 ENSG00000230124 "Acyl-CoA binding domain containing 6" Q9BR61 1 180269653-180502954 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028179, HPA028457" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA028179: AB_10601788, HPA028457: " "unprognostic (3.12e-1)" "unprognostic (4.38e-2)" "unprognostic (1.66e-1)" "unprognostic (7.66e-2)" "unprognostic (1.48e-1)" "unprognostic (1.66e-1)" "unprognostic (2.93e-3)" "unprognostic (1.75e-2)" "unprognostic (2.03e-2)" "unprognostic (2.73e-2)" "unprognostic (7.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.02e-7)" "unprognostic (1.26e-1)" "unprognostic (1.74e-1)" "unprognostic (1.21e-1)" "unprognostic (2.51e-1)" 19.5 19.0 11.5 15.0 11.3 25.9 18.4 14.9 13.8 20.5 10.7 21.1 15.2 21.5 15.1 15.1 17.7 17.7 22.3 10.6 12.3 17.7 15.5 15.2 19.0 10.7 10.5 24.7 19.5 25.0 14.4 28.2 10.7 16.4 13.6 7.2 17.3 17.4 24.0 20.7 13.8 18.5 10.3 17.8 15.4 33.0 11.1 20.5 20.0 20.6 18.1 19.5 17.3 13.5 69.4 56.4 47.6 33.2 33.9 57.4 91.1 31.3 69.7 57.6 52.0 80.1 52.8 60.0 62.2 35.3 27.5 47.0 36.2 62.7 38.3 44.5 56.8 48.3 51.9 48.2 82.2 85.5 41.2 51.1 89.5 35.9 59.0 52.4 66.2 49.9 74.5 48.9 48.4 70.7 68.1 84.1 47.8 53.2 20.3 67.3 38.0 119.4 51.4 40.8 68.0 86.0 44.4 74.6 44.9 48.6 75.6 65.4 50.4 40.8 45.3 49.5 71.0 88.1 55.7 137.4 43.4 50.7 47.7 3.1 13.1 4.4 13.6 20.0 15.4 18.1 11.6 11.8 22.0 11.6 13.9 16.3 0.9 27.3 16.3 17.7 11.7 12.2 11.5 11.3 14.9 13.8 10.6 12.3 10.7 10.5 10.7 10.3 11.1 13.5 31.5 32.1 33.0 60.4 32.7 21.3 29.9 38.7 42.7 64.2 23.6 33.3 42.3 21.5 35.4 16.5 39.6 165.0 38.7 3.8 41.1 43.7 106.9 22.2 38.0 31.9 19.4 25.0 124.9 41.6 41.7 35.6 19.9 23.3 20.2 52.2 23.9 13.4 44.6 52.2 118.1 15.7 34.6 17.8 18.6 59.2 51.3 25.0 37.4 60.9 30.0 37.8 26.8 98.0 109.3 36.2 12.9 50.8 48.4 27.2 19.6 51.2 27.4 6.6 59.2 38.4 53.4 143.6 64.6 40.5 22.4 84.4 29.4 63.2 19.2 24.8 ACO2 ACONM ENSG00000100412 "Aconitase 2" Q99798 22 41447830-41529273 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Lyase "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 567.7;skeletal muscle: 660.4;tongue: 695.8" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 374.2;Proximal tubular cells: 285.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001097 Enhanced Approved Approved Mitochondria NA NA 2000000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA001097: AB_1078092" "unprognostic (1.95e-1)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (3.06e-2)" "unprognostic (6.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.99e-2)" "unprognostic (6.54e-2)" "unprognostic (1.20e-2)" "unprognostic (7.32e-2)" "unprognostic (1.64e-2)" "unprognostic (6.07e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.46e-2)" "unprognostic (9.60e-2)" "unprognostic (6.45e-2)" "unprognostic (1.12e-2)" 88.8 81.6 154.2 38.6 152.2 32.0 52.4 153.0 190.0 39.5 160.1 94.4 162.9 42.0 26.1 60.4 53.6 36.5 567.7 155.2 153.1 138.9 73.9 40.7 40.5 146.1 145.3 30.8 53.8 233.8 33.6 30.5 147.8 41.2 69.6 46.9 72.0 49.5 660.4 45.5 158.5 43.7 152.5 44.7 110.2 35.1 186.3 38.0 53.7 695.8 43.3 52.5 42.4 159.6 47.2 55.8 56.5 116.3 101.2 69.8 78.7 43.7 60.9 79.0 71.9 81.2 63.5 115.7 72.2 70.6 60.3 109.8 108.8 88.3 42.8 75.8 80.2 51.0 73.7 95.0 86.7 147.8 77.8 120.8 64.4 78.9 83.2 61.7 81.2 61.5 72.9 118.4 65.4 91.7 73.7 47.9 37.0 282.6 115.1 102.3 37.8 162.1 106.8 97.3 37.8 33.9 112.2 128.7 82.0 44.9 74.9 74.7 55.5 60.0 68.7 50.2 45.0 64.7 92.1 80.6 102.0 64.0 66.5 10.3 52.9 18.1 32.0 76.4 29.3 49.4 25.5 34.9 69.0 46.4 29.2 30.8 9.0 39.4 97.1 24.0 41.2 58.6 154.2 152.2 153.0 190.0 155.2 153.1 146.1 145.3 147.8 152.5 186.3 159.6 26.3 25.6 31.8 45.4 49.4 18.7 54.5 102.7 31.3 60.6 28.0 23.2 9.1 64.3 63.5 60.7 81.3 100.3 33.3 190.8 131.0 58.3 14.5 37.2 17.7 26.1 53.2 30.3 28.8 42.6 60.0 24.0 77.5 37.1 40.6 56.7 20.7 64.6 91.5 53.8 34.0 99.1 89.5 35.5 26.4 8.9 24.2 39.2 35.6 7.5 68.3 73.9 34.0 12.1 20.9 43.9 103.5 27.8 63.2 34.4 374.2 285.7 59.2 73.5 59.2 28.6 38.4 26.4 38.2 35.8 16.1 193.2 30.7 54.4 113.6 64.9 ACSL5 "ACS2, ACS5, FACL5" ENSG00000197142 "Acyl-CoA synthetase long chain family member 5" Q9ULC5 10 112374018-112428380 "Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 217.8;intestine: 418.0;liver: 165.5" "Cell type enhanced" "Detected in many" "Distal enterocytes: 164.9;Endometrial ciliated cells: 159.9;Glandular and luminal cells: 292.3;Proximal enterocytes: 462.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 87.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 138.8;RT4: 143.3;U-937: 70.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007162, CAB035986, CAB062546" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 9: Intestine - Unknown function" "Cluster 15: RT4 - Unknown function" "Cluster 44: Endometrium - Transcription" Mitochondria Nucleoplasm "CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761" "unprognostic (5.75e-3)" "unprognostic (2.06e-1)" "unprognostic (3.08e-2)" "prognostic favorable (1.13e-4)" "unprognostic (2.45e-1)" "unprognostic (2.13e-2)" "unprognostic (4.92e-2)" "unprognostic (5.90e-2)" "unprognostic (1.67e-1)" "unprognostic (4.06e-2)" "unprognostic (4.18e-3)" "unprognostic (7.40e-2)" "unprognostic (5.25e-3)" "unprognostic (2.11e-1)" "unprognostic (1.10e-1)" "unprognostic (5.92e-3)" "unprognostic (1.08e-3)" 23.8 4.2 13.1 29.0 12.6 16.2 21.3 13.0 15.5 51.4 10.4 111.7 358.9 30.3 217.8 7.9 45.0 21.5 9.4 12.1 13.4 9.0 165.5 35.6 28.0 14.4 13.1 17.0 5.5 2.2 2.6 8.6 14.9 12.3 116.6 1.5 5.5 20.3 3.9 3.4 418.0 15.5 14.0 25.7 44.2 9.6 15.3 16.4 7.2 8.8 28.0 76.3 7.6 13.2 38.6 0.9 0.7 0.1 2.5 0.4 3.3 1.1 7.3 0.3 0.6 34.8 138.8 46.7 8.4 1.9 6.8 0.3 0.0 0.2 0.8 39.4 0.0 36.5 1.3 60.9 8.8 57.3 59.2 5.9 0.0 0.8 0.0 2.7 2.8 0.0 0.1 20.6 0.1 0.0 0.1 26.3 0.1 32.2 1.3 12.9 0.2 28.6 3.8 143.3 0.1 0.9 55.8 21.0 0.1 0.1 0.1 31.7 40.5 0.5 0.4 2.2 2.5 14.8 0.1 22.6 1.2 70.5 0.1 27.4 15.1 27.5 25.2 27.9 24.9 16.3 20.4 27.8 31.1 13.1 13.8 21.4 3.9 26.1 27.7 9.8 41.5 21.1 13.1 12.6 13.0 15.5 12.1 13.4 14.4 13.1 14.9 14.0 15.3 13.2 23.4 12.8 51.3 0.0 20.1 3.8 10.3 10.7 8.6 0.1 7.0 4.6 1.7 12.8 23.6 0.0 4.2 1.8 10.5 164.9 0.0 13.3 92.6 159.9 37.6 24.7 40.8 10.7 1.3 6.4 2.6 5.7 41.8 292.3 17.2 0.5 16.1 88.6 18.9 0.0 1.1 79.0 0.0 22.4 57.8 42.6 15.8 24.9 3.6 17.8 11.5 0.1 16.5 1.0 1.0 48.0 122.4 12.0 20.3 7.1 462.5 0.2 8.2 1.2 0.0 0.8 3.3 4.0 1.9 3.3 1.7 0.7 24.0 6.4 103.3 50.0 ACTL6A "Actl6, Arp4, BAF53A, INO80K" ENSG00000136518 "Actin like 6A" O96019 3 179562886-179588407 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 243.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012188, HPA018671, HPA063149" Supported Enhanced Nucleoplasm,Cytosol NA NA 18000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: " "unprognostic (2.13e-1)" "unprognostic (5.33e-2)" "unprognostic (1.54e-2)" "unprognostic (2.24e-3)" "unprognostic (7.79e-3)" "unprognostic (1.51e-2)" "prognostic unfavorable (1.89e-5)" "unprognostic (3.36e-2)" "unprognostic (1.09e-3)" "unprognostic (2.13e-2)" "prognostic unfavorable (5.44e-5)" "unprognostic (1.03e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (4.21e-2)" "unprognostic (1.96e-1)" "unprognostic (4.21e-3)" "unprognostic (5.20e-2)" 19.7 20.4 8.3 23.5 9.8 17.8 33.0 10.1 12.4 24.6 11.0 31.1 24.7 27.6 25.9 25.3 25.0 15.6 18.6 7.9 9.5 22.3 21.8 19.0 32.0 10.4 9.8 31.9 20.6 24.3 13.1 23.5 10.8 21.3 37.8 16.3 21.3 21.4 12.3 26.8 23.8 26.3 9.4 19.9 22.3 62.5 8.9 46.0 20.5 13.9 41.4 24.8 20.7 11.9 196.4 59.5 142.2 75.7 53.4 58.0 111.7 78.1 60.2 142.3 119.8 126.6 94.8 154.0 136.8 73.5 164.7 88.7 126.3 95.7 174.6 156.7 105.0 125.5 58.2 101.9 61.0 157.4 75.2 40.7 96.1 91.5 76.6 44.5 82.5 90.7 100.1 85.1 103.6 135.6 140.1 96.8 127.6 178.0 129.5 128.7 118.0 284.4 113.4 76.2 116.9 83.2 119.1 118.5 125.2 71.2 231.5 128.8 62.5 101.0 87.1 104.1 237.8 54.6 86.5 231.3 55.6 165.0 113.5 5.7 19.3 14.7 24.5 25.5 32.4 29.2 27.8 28.5 34.1 24.1 30.2 31.3 2.6 26.7 30.1 19.3 39.1 24.3 8.3 9.8 10.1 12.4 7.9 9.5 10.4 9.8 10.8 9.4 8.9 11.9 31.1 22.4 23.1 6.2 27.1 47.2 48.0 60.4 29.0 6.1 24.5 23.9 6.7 30.0 38.1 27.6 8.4 51.2 21.6 13.4 35.2 51.1 53.5 27.1 28.8 26.7 30.5 62.3 2.8 44.7 67.5 28.1 23.4 20.8 14.5 31.0 13.6 16.8 34.9 0.0 3.8 26.7 48.8 17.1 18.7 17.7 32.3 15.4 30.2 3.7 27.1 16.7 18.6 6.6 19.0 38.8 18.8 30.1 25.8 45.4 18.2 25.8 35.6 14.9 26.3 25.0 49.0 243.2 92.1 42.7 45.9 30.6 21.6 35.1 40.4 38.5 ACY1 ENSG00000243989 "Aminoacylase 1" Q03154 3 51983340-51989197 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 9 "intestine: 181.5;kidney: 449.9;liver: 274.9" "Cell type enhanced" "Detected in many" "Distal enterocytes: 31.6;Gastric mucus-secreting cells: 32.6;Proximal enterocytes: 144.8;Proximal tubular cells: 92.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 128.0" "CAB003695, HPA036174, HPA036175" Enhanced NA NA 23000000 "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: AB_2674989" "unprognostic (4.28e-2)" "unprognostic (1.89e-1)" "unprognostic (2.10e-1)" "unprognostic (2.48e-3)" "unprognostic (3.15e-1)" "unprognostic (6.51e-2)" "unprognostic (2.82e-2)" "unprognostic (1.47e-1)" "unprognostic (1.05e-2)" "unprognostic (6.08e-2)" "unprognostic (2.36e-2)" "unprognostic (2.70e-2)" "prognostic favorable (2.93e-4)" "unprognostic (3.57e-1)" "unprognostic (3.75e-1)" "unprognostic (7.88e-2)" "prognostic favorable (6.77e-4)" 19.2 24.0 5.6 7.3 5.7 8.8 20.7 6.4 7.3 13.9 11.6 30.6 181.5 4.3 21.8 10.7 13.0 10.7 14.5 5.1 6.0 449.9 274.9 9.2 7.2 6.5 5.9 4.8 8.7 28.2 4.7 9.7 6.6 14.3 30.5 1.9 16.4 11.1 20.2 8.2 138.2 6.9 6.7 8.1 23.6 3.2 6.1 5.1 21.0 34.6 9.2 12.5 7.1 6.6 15.9 26.2 13.2 34.1 28.9 39.4 40.5 12.6 28.2 29.4 14.9 41.2 67.9 7.2 12.2 22.0 13.2 20.0 14.7 81.2 11.5 21.8 10.7 25.3 13.9 128.0 49.7 19.8 21.0 48.0 67.2 25.4 69.1 25.8 11.5 14.6 47.1 23.9 29.9 35.2 0.6 38.9 23.4 92.1 39.3 8.0 14.1 63.5 74.5 50.8 16.9 18.2 12.6 62.6 29.5 7.5 42.3 27.9 7.1 22.0 21.9 24.8 18.8 61.7 16.9 12.1 28.1 42.9 29.0 9.1 15.7 0.4 10.7 15.1 5.7 7.4 2.6 4.5 21.2 6.1 4.1 4.7 0.0 20.4 6.4 2.8 3.8 9.7 5.6 5.7 6.4 7.3 5.1 6.0 6.5 5.9 6.6 6.7 6.1 6.6 0.5 3.2 3.2 0.0 4.9 0.6 1.0 1.9 17.1 0.2 2.7 1.3 0.2 1.5 2.5 5.5 0.0 3.9 0.3 31.6 9.8 16.6 0.2 0.2 0.9 0.9 2.4 15.8 0.0 8.3 4.5 4.3 32.6 0.6 7.0 0.2 1.1 13.1 1.9 0.0 0.0 11.2 4.1 1.9 0.3 0.8 0.6 4.2 0.0 0.0 9.3 0.8 1.0 0.0 0.0 16.4 23.3 0.0 14.9 0.6 144.8 92.0 1.7 1.1 0.0 0.6 2.0 0.1 0.2 18.5 0.4 4.1 2.6 1.0 14.5 0.4 ACYP1 ENSG00000119640 "Acylphosphatase 1" P07311 14 75053237-75069483 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 137.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034944 Approved Approved Nucleoplasm,Cytosol NA NA 89000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Nucleoplasm "HPA034944: AB_10669898" "prognostic favorable (1.17e-4)" "unprognostic (3.83e-3)" "unprognostic (1.92e-1)" "unprognostic (5.90e-2)" "unprognostic (1.26e-1)" "unprognostic (1.85e-1)" "prognostic unfavorable (6.14e-7)" "unprognostic (5.48e-2)" "unprognostic (4.40e-1)" "unprognostic (1.64e-2)" "unprognostic (1.37e-3)" "unprognostic (3.56e-2)" "unprognostic (4.74e-2)" "unprognostic (6.69e-3)" "unprognostic (9.39e-2)" "unprognostic (1.07e-1)" "unprognostic (5.32e-3)" 13.7 38.4 46.2 15.2 48.6 21.1 22.1 49.9 65.5 17.3 50.8 21.5 15.6 14.4 36.7 20.8 29.6 10.2 17.0 45.0 54.0 29.1 9.6 19.7 27.7 50.7 49.7 13.6 12.4 21.1 36.5 15.3 51.8 17.3 26.9 44.0 15.8 15.0 34.0 35.0 21.1 15.6 46.6 16.5 19.3 26.9 50.4 39.7 30.1 21.1 28.1 16.1 17.6 56.0 78.9 43.1 60.9 37.4 24.5 26.6 32.6 44.7 17.2 45.5 63.5 42.8 86.9 86.5 26.4 18.2 25.7 68.1 39.9 19.1 73.8 127.8 49.3 57.6 123.6 32.1 14.3 36.6 56.8 14.9 27.7 61.5 30.0 28.8 60.0 80.9 45.2 103.0 60.0 52.3 82.7 67.7 18.6 67.6 40.8 64.7 80.8 41.2 62.2 39.0 112.0 44.5 29.5 20.8 74.2 29.1 44.5 35.4 27.3 29.5 55.6 61.3 48.4 23.8 52.4 94.6 46.1 42.5 32.8 5.3 2.8 17.5 10.9 6.2 12.7 13.7 18.3 12.9 5.1 14.1 15.4 14.5 1.2 14.0 10.5 10.3 24.6 6.7 46.2 48.6 49.9 65.5 45.0 54.0 50.7 49.7 51.8 46.6 50.4 56.0 18.5 6.4 9.1 17.0 18.2 28.7 44.4 54.1 30.1 38.6 20.8 24.0 21.2 31.5 28.9 66.2 12.5 27.3 18.7 24.5 39.2 20.6 31.6 89.2 18.4 26.5 30.1 47.5 17.8 18.7 33.7 22.7 13.7 17.8 12.0 19.8 10.4 5.7 22.3 43.7 25.0 25.2 73.2 6.6 11.7 11.0 16.8 12.3 39.2 15.9 10.1 23.2 16.5 16.1 44.4 20.2 20.6 16.6 16.9 20.2 16.7 22.3 137.9 32.4 26.3 11.1 31.5 89.8 14.1 23.8 24.0 13.7 22.3 20.4 33.8 34.4 AFG1L "AFG1, LACE1" ENSG00000135537 "AFG1 like ATPase" Q8WV93 6 108294991-108526796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030154, HPA030155, HPA030659" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 43: THP-1 - Innate immune response" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" "HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415" "unprognostic (9.76e-5)" "unprognostic (1.72e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-1)" "unprognostic (7.04e-2)" "unprognostic (2.57e-1)" "unprognostic (5.53e-2)" "unprognostic (2.35e-3)" "unprognostic (1.48e-1)" "unprognostic (2.73e-2)" "unprognostic (9.61e-2)" "unprognostic (8.40e-8)" "unprognostic (2.03e-2)" "unprognostic (2.03e-1)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 1.8 2.1 2.2 1.3 2.7 2.1 2.2 2.0 3.3 1.7 2.7 2.6 4.2 1.5 1.9 1.6 2.2 1.5 4.6 1.7 1.9 5.0 3.7 1.7 1.8 1.8 2.0 1.7 2.1 5.4 1.5 2.2 2.0 1.6 3.1 3.1 1.8 1.7 3.7 1.2 3.0 1.7 1.7 2.0 2.8 10.7 2.7 2.3 3.0 4.0 2.1 1.7 1.1 3.2 2.7 1.4 3.4 6.1 3.5 5.1 3.3 3.0 4.4 4.8 4.7 5.7 3.3 4.8 3.8 4.7 5.8 1.5 4.4 4.5 5.4 2.8 2.6 5.7 1.8 6.6 3.5 5.3 2.7 4.7 3.6 3.6 5.8 3.1 2.6 3.5 5.9 2.2 4.5 2.6 0.9 4.8 2.2 4.6 2.8 3.3 4.6 2.8 6.1 2.9 3.7 3.2 2.4 3.5 6.4 4.5 2.8 9.8 3.2 2.9 0.7 2.6 3.4 1.5 2.6 3.7 3.6 6.0 4.5 0.0 1.6 2.8 1.0 1.2 1.3 2.5 1.5 1.9 1.4 3.4 2.1 1.4 0.4 2.4 4.3 1.6 2.3 0.7 2.2 2.7 2.0 3.3 1.7 1.9 1.8 2.0 2.0 1.7 2.7 3.2 2.4 0.0 4.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.0 2.2 0.0 0.0 5.0 3.7 0.0 6.4 1.1 0.0 9.8 3.1 0.0 2.6 2.6 2.2 0.0 0.0 0.0 3.8 4.6 1.2 0.0 1.8 2.5 5.1 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.4 0.0 0.0 6.3 5.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 5.2 0.9 4.5 0.0 0.0 AIFM1 "AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8" ENSG00000156709 "Apoptosis inducing factor mitochondria associated 1" O95831 X 130124666-130165879 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "DNA-binding, Oxidoreductase" "Charcot-Marie-Tooth disease, Deafness, Disease variant, Dwarfism, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 165.4;Proximal tubular cells: 326.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003764, HPA030611" Enhanced Supported Mitochondria NA NA 230000 "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "CAB003764: AB_289587, HPA030611: AB_2673549" "unprognostic (3.00e-3)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.22e-1)" "unprognostic (2.10e-2)" "unprognostic (3.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.14e-2)" "unprognostic (1.43e-1)" "unprognostic (3.11e-2)" "unprognostic (2.54e-3)" "unprognostic (2.81e-3)" "prognostic favorable (4.42e-10)" "unprognostic (1.76e-2)" "unprognostic (1.14e-1)" "unprognostic (5.04e-2)" "unprognostic (2.11e-2)" 21.0 65.2 10.5 17.6 11.2 11.8 17.8 11.9 12.8 15.7 24.7 34.3 52.9 15.3 8.9 20.8 22.1 10.1 107.7 10.9 11.6 97.3 110.6 13.9 16.2 11.3 11.0 11.9 27.8 29.7 16.2 10.3 11.4 14.8 15.9 8.5 18.6 7.6 68.9 15.2 29.9 10.1 11.2 20.3 41.2 30.3 12.1 18.5 14.7 25.2 11.0 18.4 13.4 11.6 52.8 95.4 22.6 85.2 24.1 14.6 50.0 28.6 19.0 33.5 25.2 55.8 36.4 105.0 113.3 17.5 39.3 47.2 61.3 33.3 12.7 48.2 73.4 61.6 59.1 68.9 34.0 51.5 63.5 26.1 21.7 34.5 22.0 12.1 27.2 83.4 62.6 50.7 13.1 96.7 57.6 74.5 24.4 53.6 65.1 55.6 31.7 132.7 60.8 36.6 46.0 28.2 35.5 68.0 67.5 13.2 46.0 40.8 31.7 20.5 20.4 63.9 58.7 24.2 45.0 47.5 25.3 86.4 33.4 4.1 21.0 14.1 11.8 26.6 13.1 14.6 12.8 14.6 31.7 10.3 12.7 12.6 2.4 20.7 24.8 14.7 17.9 12.4 10.5 11.2 11.9 12.8 10.9 11.6 11.3 11.0 11.4 11.2 12.1 11.6 12.6 16.0 20.1 17.0 17.1 8.7 8.2 25.0 9.1 19.3 13.0 8.3 165.4 22.8 21.2 40.5 22.9 58.0 14.2 31.6 92.0 24.9 1.8 36.7 17.3 11.5 9.6 26.3 10.8 20.5 29.0 16.4 27.0 50.4 10.8 33.1 14.3 92.3 38.0 15.2 12.1 24.0 34.6 14.4 7.4 4.9 17.4 16.8 10.6 8.4 16.6 17.2 20.6 8.0 19.6 18.0 18.9 17.3 19.2 7.9 45.6 326.1 21.3 48.1 6.6 11.3 39.3 10.2 32.0 17.1 6.8 39.7 15.8 45.9 37.2 9.8 AKAP8 "AKAP95, DKFZp586B1222" ENSG00000105127 "A-kinase anchoring protein 8" O43823 19 15353385-15379815 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004776 Supported Supported Nucleoplasm NA NA 10000 "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA004776: AB_1078122" "unprognostic (9.04e-3)" "unprognostic (3.67e-3)" "unprognostic (1.03e-1)" "unprognostic (4.17e-2)" "unprognostic (8.03e-2)" "unprognostic (1.77e-2)" "unprognostic (4.13e-2)" "unprognostic (3.17e-2)" "unprognostic (3.34e-3)" "unprognostic (1.27e-1)" "unprognostic (2.82e-1)" "unprognostic (1.78e-3)" "unprognostic (5.04e-3)" "unprognostic (1.22e-2)" "unprognostic (3.57e-1)" "unprognostic (6.06e-2)" "unprognostic (3.83e-2)" 13.6 10.4 0.1 1.5 0.1 3.1 12.3 0.2 1.0 10.2 0.1 11.7 5.4 12.3 0.0 11.6 11.0 0.0 10.0 0.1 0.1 8.8 12.5 10.3 0.3 0.1 0.1 10.9 10.5 1.5 7.5 0.4 0.1 9.5 0.1 0.3 11.2 1.1 23.0 14.6 12.8 0.4 0.0 13.3 10.7 7.4 0.1 1.8 10.1 2.5 0.2 10.7 10.2 0.1 18.2 12.2 8.4 5.6 2.6 2.3 12.2 10.1 7.1 7.2 7.2 19.4 10.6 19.9 10.2 8.9 6.8 8.5 5.1 12.3 0.4 17.9 12.8 21.1 11.7 18.8 4.3 28.0 8.0 4.5 2.7 7.8 0.0 0.6 7.3 11.5 15.1 6.4 2.3 23.7 15.1 5.7 17.8 9.7 15.8 12.1 12.3 16.8 0.0 22.5 10.5 11.4 13.0 9.9 8.9 1.5 4.3 2.2 18.8 12.4 10.1 7.0 21.0 12.9 12.8 21.0 9.8 10.4 11.5 0.0 4.4 0.9 4.4 4.6 4.7 3.8 4.0 4.8 6.5 4.2 2.9 3.6 0.3 4.1 6.3 4.4 5.6 3.0 0.1 0.1 0.2 1.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 25.6 12.8 28.1 17.0 24.6 19.2 21.0 14.5 19.9 14.7 16.0 14.7 18.0 10.0 22.3 12.9 27.1 30.0 25.9 26.0 5.9 18.9 3.6 22.8 24.1 20.9 10.8 28.2 14.4 21.6 23.9 17.6 20.9 39.9 30.4 14.3 10.4 13.8 13.1 21.9 14.0 21.9 2.0 13.5 16.1 2.7 19.0 19.8 12.4 10.3 21.3 16.5 12.3 12.1 15.3 18.6 13.1 13.9 25.6 16.7 14.8 9.7 22.1 19.5 6.6 26.3 22.5 19.6 23.2 21.3 16.1 40.2 25.6 15.4 22.6 20.9 ALDH1B1 "ALDH5, ALDHX" ENSG00000137124 "Aldehyde dehydrogenase 1 family member B1" P30837 9 38392702-38398661 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 172.7;smooth muscle: 128.0" "Cell type enhanced" "Detected in many" "Cholangiocytes: 85.8;Ductal cells: 64.1;Hepatocytes: 128.1;Proximal tubular cells: 165.0;Theca cells: 91.7;Undifferentiated cells: 71.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 183.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021037, HPA077080" Enhanced Supported Nucleoplasm,Mitochondria,Cytosol NA NA 500000 "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "Nucleoplasm, Cytosol" "HPA021037: AB_1844724, HPA077080: " "unprognostic (4.16e-1)" "unprognostic (1.98e-2)" "unprognostic (5.84e-2)" "unprognostic (1.55e-3)" "unprognostic (2.47e-2)" "unprognostic (4.48e-3)" "unprognostic (2.84e-3)" "unprognostic (2.70e-2)" "unprognostic (1.91e-1)" "unprognostic (1.35e-1)" "unprognostic (2.09e-1)" "unprognostic (1.00e-1)" "prognostic favorable (2.05e-4)" "unprognostic (1.04e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (1.17e-5)" "unprognostic (2.89e-2)" 21.2 10.4 3.2 31.4 3.2 2.9 8.9 4.1 4.0 8.5 6.4 61.5 22.9 57.7 5.7 32.7 34.9 29.0 14.7 2.7 4.8 59.2 172.7 7.3 5.1 3.5 3.3 12.6 11.3 8.5 2.5 5.2 4.3 36.9 35.5 1.5 11.1 54.5 55.8 6.3 24.8 128.0 3.4 7.2 28.2 8.3 4.0 5.1 15.4 35.9 5.6 85.1 10.5 4.1 72.2 65.5 19.8 31.8 27.6 32.5 15.8 33.6 16.9 27.8 28.3 44.2 13.7 45.2 19.7 47.4 42.0 10.0 66.0 71.4 27.4 50.8 28.5 22.4 44.7 132.2 20.0 36.0 24.0 39.0 15.3 22.6 19.5 56.6 26.8 10.6 65.6 42.8 42.8 27.3 0.1 14.4 59.1 183.3 29.0 14.9 119.9 34.5 25.1 31.7 43.3 19.9 25.7 16.7 19.4 20.6 15.9 27.9 18.2 31.9 52.4 26.9 42.5 6.5 13.2 17.8 16.4 36.0 22.1 0.3 4.2 0.2 6.7 9.2 9.6 5.5 6.5 6.1 9.5 2.6 5.1 6.2 1.0 8.0 11.9 1.2 5.0 5.3 3.2 3.2 4.1 4.0 2.7 4.8 3.5 3.3 4.3 3.4 4.0 4.1 3.3 9.6 1.7 0.0 3.7 1.0 5.7 9.4 2.2 1.2 3.7 4.2 6.6 85.8 3.8 16.5 2.1 2.0 1.2 12.8 17.6 64.1 0.6 2.3 6.4 4.7 15.6 12.8 0.5 6.9 46.6 6.6 8.2 3.4 8.9 12.8 8.9 128.1 7.2 0.0 1.1 25.5 6.1 4.1 2.4 2.2 6.5 4.2 0.0 0.0 5.5 2.1 0.0 0.5 0.5 15.0 7.7 6.8 3.7 6.1 10.3 165.0 0.3 0.7 0.0 6.0 16.1 0.6 0.8 2.1 1.0 1.8 3.3 91.7 71.7 2.8 ALG11 "CDG1P, KIAA0266" ENSG00000253710 "ALG11 alpha-1,2-mannosyltransferase" Q2TAA5 13 52012391-52079232 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047214 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 59: Non-specific - Transcription" "HPA047214: AB_10961640" "unprognostic (9.21e-2)" "unprognostic (1.31e-3)" "unprognostic (2.02e-1)" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (3.04e-2)" "unprognostic (9.15e-3)" "unprognostic (1.69e-1)" "unprognostic (2.28e-1)" "unprognostic (8.97e-3)" "unprognostic (8.89e-3)" "unprognostic (7.47e-2)" "unprognostic (2.30e-4)" "unprognostic (1.87e-2)" "unprognostic (1.60e-1)" "unprognostic (6.03e-2)" "unprognostic (9.71e-3)" 10.1 9.5 7.4 8.3 8.4 4.1 12.1 9.5 9.7 12.1 1.9 11.0 10.1 11.0 9.4 7.5 10.8 8.9 10.4 7.5 4.8 14.6 19.2 9.1 8.1 4.8 4.0 11.6 8.6 17.2 2.4 12.7 4.6 12.1 11.8 9.0 10.9 10.9 6.5 7.2 9.7 11.4 2.9 10.1 11.6 6.2 4.7 9.5 16.8 8.8 8.6 8.7 2.5 9.6 6.7 10.5 17.8 15.2 18.6 13.3 14.2 17.7 16.3 12.9 10.3 8.5 14.5 16.2 4.2 18.4 15.8 15.3 18.2 12.0 17.0 16.7 12.9 31.0 8.8 11.4 14.1 28.3 31.0 12.9 17.8 10.1 18.4 14.1 11.5 18.5 17.8 10.4 19.4 5.7 14.7 9.7 19.2 28.8 7.5 15.2 11.9 8.9 16.7 10.8 6.9 15.2 11.9 17.1 11.9 15.0 11.9 20.8 17.8 10.4 11.5 13.6 11.8 9.1 13.5 17.7 6.4 11.7 18.0 13.2 5.4 7.2 7.7 4.5 7.6 5.1 7.0 6.6 6.9 7.1 8.9 8.9 2.2 7.3 12.0 9.8 7.2 4.9 7.4 8.4 9.5 9.7 7.5 4.8 4.8 4.0 4.6 2.9 4.7 9.6 5.3 19.2 8.2 5.5 7.1 2.4 3.2 7.8 8.0 6.8 4.2 3.2 7.5 5.7 9.3 3.7 6.2 3.4 6.2 2.1 1.9 2.9 0.9 5.1 7.3 5.2 3.0 12.6 9.3 2.2 3.9 8.2 9.7 5.4 3.8 6.5 6.1 4.0 2.5 5.0 8.1 2.7 6.1 2.2 3.1 0.5 3.4 3.5 1.8 5.6 2.6 2.8 11.3 13.0 8.9 2.7 1.7 1.2 14.0 2.6 3.5 1.7 13.5 7.5 0.0 4.2 6.4 4.8 3.5 7.8 2.4 4.8 7.2 3.7 2.1 4.0 ALKBH3 DEPC-1 ENSG00000166199 "AlkB homolog 3, alpha-ketoglutarate dependent dioxygenase" Q96Q83 11 43880811-43920274 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 90.9;Late spermatids: 103.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA009674, HPA046489" Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 34: Spermatids - Unknown function" Nucleoplasm Mitochondria "HPA009674: AB_1850460, HPA046489: AB_2679671" "unprognostic (3.53e-1)" "unprognostic (2.41e-1)" "unprognostic (7.43e-3)" "unprognostic (4.70e-2)" "unprognostic (6.94e-3)" "unprognostic (1.89e-1)" "unprognostic (7.71e-2)" "unprognostic (5.42e-2)" "unprognostic (8.56e-2)" "unprognostic (4.62e-1)" "unprognostic (5.87e-2)" "unprognostic (7.02e-2)" "unprognostic (2.09e-2)" "unprognostic (1.22e-1)" "unprognostic (2.31e-1)" "unprognostic (2.76e-1)" "unprognostic (1.35e-2)" 20.6 15.7 14.6 9.1 16.0 7.9 20.6 18.3 20.9 21.3 15.7 18.3 10.9 20.5 24.7 18.5 19.5 9.2 15.3 15.3 15.4 16.7 18.5 13.2 13.8 15.5 15.2 22.9 23.6 16.9 18.2 7.3 15.3 21.9 12.8 17.0 19.3 13.5 35.2 23.4 15.9 13.6 15.3 19.6 20.0 20.4 15.2 15.9 15.3 25.8 14.6 19.2 19.9 17.6 15.8 26.0 10.7 0.0 20.3 26.1 0.0 19.5 42.0 36.9 34.7 10.7 12.0 2.6 12.2 28.7 20.5 21.3 14.6 32.3 33.1 0.0 49.6 23.7 17.1 27.4 51.9 44.5 30.5 27.8 55.7 17.0 81.4 15.2 26.5 44.7 33.9 25.9 18.3 18.4 38.6 21.9 20.6 16.2 38.5 11.6 23.8 30.3 21.3 23.2 20.3 16.1 15.7 22.6 37.1 9.7 32.9 26.3 20.6 21.6 12.5 35.7 28.0 23.1 25.1 26.3 31.3 18.3 17.6 34.4 16.4 9.4 19.8 18.4 19.3 18.6 20.9 18.2 23.5 21.8 24.8 22.9 2.9 24.6 29.4 20.9 21.3 17.4 14.6 16.0 18.3 20.9 15.3 15.4 15.5 15.2 15.3 15.3 15.2 17.6 12.0 16.0 10.9 15.0 12.6 10.3 8.8 16.5 10.8 11.5 10.9 12.8 6.8 14.3 13.3 16.5 4.2 3.4 13.7 9.8 31.3 24.6 90.9 6.3 7.3 14.6 9.5 9.9 15.8 32.6 4.6 14.0 10.2 4.8 7.6 12.5 13.2 12.9 19.0 10.1 15.8 11.3 6.1 11.2 7.0 103.3 16.1 13.1 17.8 3.7 14.1 20.4 22.6 13.0 16.1 27.7 8.6 10.5 12.4 9.3 15.5 17.1 14.0 13.0 6.6 9.9 15.3 29.3 12.6 20.6 7.1 2.2 12.7 15.7 12.5 8.3 ALKBH4 FLJ20013 ENSG00000160993 "AlkB homolog 4, lysine demethylase" Q9NXW9 7 102456238-102464863 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Actin-binding, Chromatin regulator, Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051422 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "HPA051422: AB_2681480" "unprognostic (1.18e-2)" "unprognostic (7.35e-2)" "unprognostic (3.50e-2)" "unprognostic (1.75e-2)" "unprognostic (4.14e-3)" "unprognostic (3.83e-2)" "unprognostic (2.71e-3)" "unprognostic (6.04e-3)" "unprognostic (1.34e-1)" "unprognostic (7.25e-3)" "unprognostic (3.20e-3)" "unprognostic (1.10e-1)" "prognostic favorable (3.09e-4)" "unprognostic (1.44e-2)" "unprognostic (2.04e-1)" "unprognostic (2.23e-1)" "unprognostic (5.44e-2)" 3.4 5.2 8.3 2.9 9.0 5.0 3.6 10.0 9.4 4.3 7.6 3.9 3.9 4.6 3.5 4.2 3.8 2.3 4.2 8.7 8.8 5.0 4.9 2.7 4.3 8.5 8.5 4.0 5.0 6.9 5.1 2.9 8.8 4.1 2.6 2.3 5.0 3.2 4.3 4.9 5.0 2.9 8.6 7.1 4.3 2.7 8.9 4.4 5.8 4.3 3.3 3.7 3.8 9.2 5.4 7.2 5.9 13.9 4.0 4.5 6.5 4.0 6.9 8.4 7.9 8.2 7.1 6.3 6.6 5.7 7.4 4.3 7.6 5.6 6.2 6.3 15.9 6.3 3.3 6.0 6.2 5.6 5.9 6.8 7.6 6.5 2.9 7.2 5.5 10.1 11.2 7.5 5.2 19.6 15.7 17.5 9.0 10.2 10.9 9.3 6.2 11.2 7.0 5.8 7.3 10.9 5.0 15.1 5.6 7.4 6.3 6.6 1.8 8.9 10.2 13.8 8.8 10.2 8.4 11.7 5.2 7.6 9.4 3.7 5.4 3.0 6.1 4.8 6.4 5.2 4.7 8.0 5.4 4.6 4.7 6.1 1.6 9.2 9.8 6.9 4.9 3.4 8.3 9.0 10.0 9.4 8.7 8.8 8.5 8.5 8.8 8.6 8.9 9.2 10.2 6.4 5.8 2.3 7.0 8.3 4.3 12.9 5.2 16.6 8.1 11.7 2.2 11.5 5.9 9.2 4.2 25.6 9.2 7.3 25.4 16.3 1.3 6.8 12.2 10.5 6.1 19.6 5.2 14.9 15.4 10.8 7.7 10.0 3.8 11.7 10.4 9.1 15.3 28.6 6.2 8.1 10.2 12.0 5.8 1.9 14.0 7.2 3.6 2.8 14.6 13.4 25.7 2.0 4.5 11.8 10.6 21.4 8.3 6.3 12.0 18.8 4.6 10.2 0.0 7.6 9.5 11.9 16.9 9.5 7.4 11.1 8.7 17.7 10.1 1.8 AMDHD1 MGC35366 ENSG00000139344 "Amidohydrolase domain containing 1" Q96NU7 12 95943331-95968720 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Histidine metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 60.7;skeletal muscle: 27.3" "Cell type enriched" "Detected in many" 4 "Hepatocytes: 132.5" "Cancer enriched" "Detected in many" 14 "liver cancer: 23.4" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 46.6;HMC-1: 47.7;Karpas-707: 61.2;SiHa: 40.5;SK-BR-3: 46.1;U-266/70: 49.1;U-266/84: 62.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA039720, HPA040149" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" No NA 1400000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 15: Hepatocytes - Hemostasis" Cytosol "Nucleoplasm, Plasma membrane" "HPA039720: AB_10672967, HPA040149: " "unprognostic (4.81e-2)" "unprognostic (2.91e-1)" "unprognostic (1.53e-1)" "unprognostic (2.09e-2)" "unprognostic (1.80e-2)" "unprognostic (2.88e-2)" "unprognostic (2.33e-2)" "unprognostic (6.62e-3)" "unprognostic (1.06e-1)" "unprognostic (7.01e-2)" "unprognostic (3.35e-3)" "unprognostic (1.17e-1)" "unprognostic (4.63e-3)" "unprognostic (3.98e-2)" "unprognostic (1.70e-1)" "unprognostic (4.08e-3)" "unprognostic (2.61e-1)" 1.8 11.7 8.2 6.5 11.2 6.1 0.4 5.5 11.8 0.3 6.9 1.4 5.1 3.0 0.4 2.6 0.7 1.7 1.7 7.6 6.9 5.8 60.7 2.3 4.4 15.5 8.6 1.4 3.3 0.7 0.5 2.0 9.5 2.8 0.2 1.8 2.0 0.2 27.3 5.8 5.0 0.6 2.7 5.9 4.8 13.1 8.0 0.6 0.9 0.9 0.4 0.3 0.2 15.4 46.6 9.5 0.8 5.8 0.0 0.0 10.0 1.5 0.5 0.7 1.4 3.9 5.8 4.0 4.2 0.0 2.6 8.2 0.3 0.0 0.3 16.0 1.7 4.2 7.9 9.4 0.0 5.9 47.7 0.0 0.4 0.8 0.1 0.2 0.3 3.9 2.7 61.2 0.0 6.8 3.7 10.8 4.4 1.8 2.2 7.8 0.3 5.3 0.0 4.3 4.9 6.9 40.5 46.1 5.2 0.2 4.6 8.4 0.0 5.8 19.1 8.0 5.4 49.1 62.8 6.3 3.8 12.2 6.9 0.2 0.6 1.7 0.5 0.6 0.4 0.6 0.2 0.6 0.5 0.3 0.3 0.4 0.4 2.3 1.8 0.2 0.1 0.5 8.2 11.2 5.5 11.8 7.6 6.9 15.5 8.6 9.5 2.7 8.0 15.4 1.1 0.0 0.5 0.3 2.0 0.4 0.2 0.0 0.0 0.1 1.1 1.0 0.6 1.5 0.6 3.7 0.0 0.9 1.7 0.0 3.9 0.2 0.9 0.1 0.0 0.8 1.8 8.0 0.7 1.1 0.1 0.1 0.0 0.0 0.0 0.2 8.6 132.5 4.4 1.7 0.3 0.1 0.0 5.7 1.3 0.1 0.3 1.8 3.6 0.0 0.7 1.8 2.1 4.0 2.0 0.2 0.0 0.0 0.7 0.0 0.4 31.0 0.0 0.0 0.0 0.8 0.0 1.5 1.9 0.0 0.3 0.3 1.4 0.3 0.4 0.1 AMMECR1 ENSG00000101935 "AMMECR nuclear protein 1" Q9Y4X0 X 110194186-110440318 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Alport syndrome, Deafness, Disease variant, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 83.1;Excitatory neurons: 92.8;Inhibitory neurons: 108.7;Rod photoreceptor cells: 87.3;Syncytiotrophoblasts: 86.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000590, HPA051762" Uncertain Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm Mitochondria "HPA000590: AB_2666037, HPA051762: AB_2681596" "unprognostic (7.77e-2)" "unprognostic (1.93e-1)" "unprognostic (2.06e-1)" "unprognostic (5.17e-2)" "unprognostic (1.25e-1)" "unprognostic (6.87e-2)" "unprognostic (1.66e-3)" "unprognostic (6.55e-2)" "unprognostic (5.98e-2)" "prognostic favorable (6.62e-5)" "unprognostic (3.61e-2)" "unprognostic (3.96e-2)" "unprognostic (2.43e-3)" "unprognostic (3.33e-1)" "unprognostic (1.02e-1)" "prognostic favorable (8.44e-4)" "unprognostic (7.82e-2)" 3.6 2.9 1.7 3.7 1.7 13.4 3.4 1.8 2.0 2.9 8.5 3.7 3.1 2.3 2.1 7.9 3.3 2.3 1.1 1.5 1.7 3.4 3.3 2.8 4.2 1.3 1.3 5.5 2.0 2.2 2.0 7.0 1.2 2.2 3.9 14.5 2.8 1.9 1.3 7.4 3.3 2.9 1.0 3.7 3.7 1.6 1.7 4.5 2.4 1.7 5.7 4.8 4.5 1.5 20.3 9.8 7.1 3.4 7.9 11.8 7.8 13.8 12.3 11.1 16.2 15.9 14.4 12.0 6.4 18.4 9.0 9.5 22.7 15.7 11.3 8.4 10.1 16.7 21.7 3.3 19.9 13.5 6.7 6.6 27.3 12.7 22.6 6.0 8.9 5.9 47.1 34.8 8.5 17.2 6.5 4.8 32.6 17.4 19.1 13.7 7.6 21.2 18.8 16.8 11.3 5.3 23.2 22.7 19.9 8.5 5.6 13.3 4.1 7.6 4.6 22.8 12.6 7.1 8.6 18.9 11.6 27.5 25.9 0.6 0.9 0.8 1.6 0.6 2.1 1.6 3.2 2.6 1.5 2.2 2.1 1.9 0.4 0.6 2.7 0.6 2.3 1.0 1.7 1.7 1.8 2.0 1.5 1.7 1.3 1.3 1.2 1.0 1.7 1.5 4.4 0.0 9.8 17.9 11.5 9.6 3.9 10.5 5.7 35.3 7.5 4.4 4.2 8.6 8.9 3.7 52.1 27.2 9.5 8.9 23.5 9.2 0.5 10.5 7.7 9.6 15.0 83.1 92.8 12.0 9.9 12.8 13.7 13.4 2.5 14.4 19.6 8.4 7.1 1.7 108.7 11.2 12.2 7.6 3.1 2.1 12.8 7.3 3.6 21.5 9.4 7.1 14.4 35.7 19.2 11.5 3.7 17.3 8.0 9.1 10.3 10.2 10.4 87.3 13.1 6.7 8.4 2.2 6.9 17.4 26.7 86.5 13.0 34.7 10.5 15.7 ANGEL1 "Ccr4e, KIAA0759" ENSG00000013523 "Angel homolog 1" Q9UNK9 14 76786009-76826246 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 64.3;Late spermatids: 75.1;Oligodendrocyte precursor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000948 Uncertain Approved Nucleoplasm "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA000948: AB_2227189" "unprognostic (4.81e-2)" "unprognostic (2.37e-2)" "unprognostic (2.67e-1)" "unprognostic (2.46e-3)" "unprognostic (1.42e-1)" "unprognostic (3.15e-1)" "unprognostic (7.33e-2)" "prognostic favorable (3.43e-4)" "unprognostic (9.24e-2)" "unprognostic (1.01e-1)" "prognostic favorable (5.46e-4)" "unprognostic (3.03e-1)" "unprognostic (6.92e-3)" "unprognostic (1.42e-1)" "unprognostic (2.22e-1)" "unprognostic (1.53e-1)" "unprognostic (6.32e-2)" 11.3 18.5 18.3 11.8 19.7 6.8 12.7 16.7 21.2 12.8 15.6 10.0 9.2 14.8 23.8 7.0 12.2 11.4 15.7 19.2 21.1 11.6 19.3 14.0 12.2 22.5 19.6 19.3 50.8 17.2 21.1 10.4 21.5 9.3 10.9 26.4 15.8 8.4 12.2 6.4 10.3 12.3 18.1 29.3 15.8 52.4 20.1 8.1 13.7 9.8 10.9 9.5 8.5 23.8 13.1 14.0 15.2 13.6 12.2 11.1 14.1 7.7 11.0 7.8 9.9 13.5 18.2 23.8 11.1 6.7 10.6 16.2 14.6 13.7 13.1 10.1 13.1 14.8 9.7 10.3 7.9 7.8 8.7 11.8 16.8 7.3 14.5 11.3 20.0 24.8 14.5 6.2 8.2 25.3 14.0 11.6 17.5 20.7 18.4 17.0 10.4 14.1 11.8 18.4 21.5 9.6 11.6 15.8 7.1 13.8 31.1 8.4 9.6 9.1 8.0 6.9 6.4 15.9 12.9 14.7 7.7 13.7 11.8 0.8 4.8 1.6 5.9 5.5 7.2 6.8 5.3 5.6 7.5 5.5 7.5 5.6 1.4 5.5 7.1 4.9 4.5 5.9 18.3 19.7 16.7 21.2 19.2 21.1 22.5 19.6 21.5 18.1 20.1 23.8 7.4 6.4 10.5 17.6 4.7 1.1 1.8 1.5 2.2 2.4 5.7 5.0 6.7 5.7 2.2 3.7 10.4 1.5 1.5 2.1 0.0 3.3 64.3 3.7 3.9 10.0 4.2 4.2 18.3 3.2 2.8 4.3 1.5 3.3 1.3 15.9 7.1 9.5 7.2 0.0 19.7 4.4 4.1 5.7 2.0 75.1 2.1 5.5 1.8 23.4 1.4 4.9 1.0 64.8 30.2 2.5 1.0 4.9 8.9 3.4 1.7 1.3 1.4 8.9 6.6 5.1 2.4 15.9 4.9 2.8 0.4 1.2 3.0 12.9 4.6 1.5 ANKRD13C "dJ677H15.3, DKFZP566D1346" ENSG00000118454 "Ankyrin repeat domain 13C" Q8N6S4 1 70258999-70354734 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 98.5;Inhibitory neurons: 91.0;Oligodendrocytes: 103.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (1.34e-2)" "unprognostic (7.20e-2)" "unprognostic (3.05e-3)" "unprognostic (3.11e-1)" "unprognostic (1.28e-2)" "unprognostic (1.91e-2)" "unprognostic (6.38e-3)" "unprognostic (6.59e-2)" "unprognostic (3.48e-2)" "unprognostic (2.41e-1)" "unprognostic (2.28e-2)" "unprognostic (3.17e-2)" "unprognostic (1.47e-3)" "unprognostic (1.57e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-1)" "unprognostic (7.42e-2)" 9.8 8.7 5.3 8.3 6.2 5.7 7.8 8.9 7.8 7.8 1.5 8.7 7.6 9.1 5.9 7.1 6.3 7.1 5.4 6.1 5.2 9.1 7.5 7.4 9.4 3.8 4.1 9.6 8.5 9.0 4.7 7.4 3.8 8.3 8.7 13.3 7.2 6.4 9.1 9.9 8.2 8.4 4.1 8.3 8.3 4.3 4.4 9.0 8.5 8.6 8.2 8.4 6.7 6.8 18.4 8.5 14.1 14.7 17.1 22.8 5.6 16.9 19.8 14.5 14.5 11.5 10.1 15.7 16.0 19.9 14.3 12.0 13.8 10.0 17.1 22.6 15.8 17.0 19.5 10.7 18.0 18.8 8.7 19.6 11.1 16.7 15.2 12.9 14.0 8.4 14.4 22.2 14.4 8.3 11.1 8.3 15.2 8.4 16.2 11.5 17.8 10.9 20.5 11.9 11.1 11.1 21.7 26.6 23.7 13.5 14.0 12.5 17.8 22.6 14.4 34.9 20.6 21.4 28.8 12.9 19.5 14.6 19.2 14.6 7.0 8.6 8.8 9.1 12.4 9.8 11.1 11.0 10.6 8.5 10.3 9.7 0.7 8.4 8.0 5.6 14.0 9.1 5.3 6.2 8.9 7.8 6.1 5.2 3.8 4.1 3.8 4.1 4.4 6.8 15.1 28.9 15.1 40.1 17.0 16.2 11.4 7.9 15.9 19.3 10.6 7.5 12.3 5.7 14.1 11.0 31.3 8.9 17.0 12.9 13.7 10.0 1.7 11.9 20.3 13.2 12.5 5.5 98.5 10.5 10.9 18.7 20.4 15.1 3.8 9.4 12.5 7.2 10.3 6.7 91.0 9.5 12.2 12.9 7.8 2.1 11.8 11.7 17.8 43.1 10.5 10.9 13.4 64.8 103.6 13.0 10.6 11.3 16.6 14.9 5.9 13.2 15.7 23.5 0.0 18.3 17.7 8.5 6.2 13.3 12.1 13.1 20.3 18.0 10.3 15.9 ANKZF1 "FLJ10415, Vms1, ZNF744" ENSG00000163516 "Ankyrin repeat and zinc finger peptidyl tRNA hydrolase 1" Q9H8Y5 2 219229783-219236679 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035208 Approved Approved "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA035208: AB_10602229" "unprognostic (5.23e-2)" "unprognostic (2.23e-1)" "unprognostic (1.12e-3)" "unprognostic (8.27e-2)" "unprognostic (3.38e-1)" "unprognostic (7.95e-3)" "prognostic unfavorable (3.09e-5)" "unprognostic (3.87e-2)" "unprognostic (9.68e-3)" "unprognostic (7.82e-3)" "unprognostic (1.24e-2)" "unprognostic (3.26e-3)" "prognostic unfavorable (2.01e-6)" "unprognostic (1.49e-2)" "unprognostic (1.62e-1)" "unprognostic (3.35e-1)" "unprognostic (2.88e-3)" 9.1 9.2 7.8 8.8 8.6 7.8 10.8 9.9 9.8 13.8 9.6 13.1 9.6 10.1 3.2 15.2 13.5 6.1 14.1 7.9 8.0 13.9 14.4 10.7 13.7 10.1 8.5 16.0 15.6 6.4 12.5 5.9 9.3 15.1 5.2 8.2 15.3 5.6 16.9 17.3 15.2 4.6 7.9 18.1 14.2 7.9 8.7 11.9 11.9 8.1 8.3 12.4 15.0 10.5 31.6 6.1 8.1 11.8 10.6 8.8 32.5 10.1 10.0 13.6 17.2 14.9 13.2 6.6 18.0 4.3 15.3 22.7 10.5 17.5 10.0 13.9 11.0 14.6 19.1 13.9 10.6 9.6 13.7 8.9 33.1 10.1 15.9 22.6 9.4 17.0 24.8 14.9 6.9 13.6 14.1 24.1 13.5 13.7 10.9 14.3 9.9 21.4 7.6 7.9 10.3 10.5 11.9 23.9 19.8 19.5 6.4 23.7 10.3 11.4 8.7 10.1 13.3 31.6 19.9 12.9 19.4 13.8 5.1 9.9 9.1 11.0 16.1 9.0 17.4 13.0 16.3 16.2 9.4 13.3 19.0 18.0 12.3 24.4 14.0 9.8 17.1 13.6 7.8 8.6 9.9 9.8 7.9 8.0 10.1 8.5 9.3 7.9 8.7 10.5 10.2 16.0 17.2 24.2 28.0 9.3 14.5 28.9 9.6 39.8 14.4 13.6 9.2 11.5 24.8 12.9 31.3 10.5 32.7 17.3 13.7 20.5 4.4 28.2 9.7 11.8 9.6 19.6 19.0 12.6 27.2 8.9 17.9 13.0 21.6 21.4 8.6 13.1 7.7 32.0 21.0 19.1 20.3 8.2 5.3 4.0 23.9 10.9 10.6 6.5 15.6 18.0 43.3 13.6 25.3 14.2 16.0 16.6 17.7 13.6 25.2 16.5 65.1 55.4 6.6 13.2 12.8 10.1 17.0 8.3 9.9 11.6 30.0 21.3 17.6 11.1 AP1G2 G2AD ENSG00000213983 "Adaptor related protein complex 1 subunit gamma 2" O75843 14 23559565-23568070 "Predicted intracellular proteins" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 108.3;RT4: 151.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA004106 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA004106: AB_1078172" "unprognostic (1.94e-3)" "unprognostic (2.49e-1)" "unprognostic (2.56e-2)" "unprognostic (2.73e-2)" "unprognostic (7.34e-2)" "unprognostic (6.61e-2)" "unprognostic (6.61e-2)" "unprognostic (6.28e-3)" "unprognostic (1.16e-1)" "unprognostic (8.65e-3)" "unprognostic (8.85e-2)" "unprognostic (8.40e-2)" "prognostic unfavorable (1.79e-4)" "unprognostic (1.30e-2)" "unprognostic (3.22e-1)" "unprognostic (2.06e-1)" "unprognostic (1.02e-3)" 15.3 18.0 31.3 23.3 35.5 30.5 20.0 34.0 40.5 22.5 27.8 27.2 28.7 11.7 14.3 35.5 19.8 18.2 6.1 32.8 30.7 26.7 15.1 18.9 39.1 29.7 28.7 23.0 36.2 24.9 67.4 12.9 29.9 33.8 23.0 9.8 29.7 15.9 2.2 45.2 37.5 10.3 27.5 45.7 35.2 7.5 30.2 30.1 27.2 1.6 42.9 26.3 26.2 30.1 29.1 30.4 0.8 3.1 4.5 7.2 45.5 3.5 8.3 10.3 13.5 28.6 64.8 53.8 15.6 2.8 0.1 53.5 16.2 45.4 7.0 30.0 9.2 20.8 14.5 67.7 16.9 31.6 108.3 20.9 66.0 7.0 24.1 11.2 6.1 37.5 9.2 22.3 4.4 70.8 26.3 28.8 6.9 59.2 11.1 38.9 0.2 16.7 41.3 151.2 8.2 11.5 15.0 68.0 5.6 17.9 40.4 7.8 5.3 2.7 20.2 2.6 0.2 16.2 9.2 21.3 1.2 21.3 3.3 40.6 25.4 43.8 29.5 35.2 28.0 30.7 31.5 31.5 42.5 28.1 25.4 24.8 10.2 38.7 37.0 22.2 42.2 35.6 31.3 35.5 34.0 40.5 32.8 30.7 29.7 28.7 29.9 27.5 30.2 30.1 9.1 19.2 21.7 6.2 31.4 13.5 18.9 33.1 29.0 31.1 23.7 21.8 0.5 17.2 38.2 12.9 2.1 22.8 23.7 38.7 5.9 30.4 1.1 9.7 4.7 9.7 32.4 9.9 21.5 29.4 24.1 7.1 64.2 15.6 31.7 22.0 6.4 2.5 15.2 72.3 15.7 29.4 42.7 15.2 21.0 1.2 9.3 15.1 10.6 6.5 27.5 8.6 12.3 4.0 4.7 26.6 53.1 6.0 14.0 11.0 33.1 9.6 24.3 6.2 0.0 1.6 5.0 5.8 3.9 16.4 9.8 24.5 30.9 13.9 34.6 23.3 APEH "D3F15S2, D3S48E, DNF15S2" ENSG00000164062 "Acylaminoacyl-peptide hydrolase" P13798 3 49674014-49683971 "Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029700, HPA029701, HPA029702, HPA029703" Enhanced Enhanced Cytosol No No 2300000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348" "unprognostic (4.93e-2)" "unprognostic (5.42e-2)" "unprognostic (6.04e-3)" "unprognostic (2.71e-1)" "unprognostic (9.32e-2)" "unprognostic (8.20e-2)" "unprognostic (3.65e-2)" "unprognostic (2.48e-1)" "unprognostic (5.89e-2)" "unprognostic (8.03e-2)" "unprognostic (3.21e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.32e-10)" "unprognostic (2.11e-2)" "unprognostic (1.12e-1)" "unprognostic (4.34e-2)" "unprognostic (7.67e-2)" 21.7 43.6 18.0 30.7 18.0 42.3 26.8 17.9 22.8 24.8 27.7 48.5 48.6 19.7 24.7 40.2 33.7 22.3 40.6 17.7 19.9 65.8 63.3 26.8 35.2 19.2 21.3 24.6 34.8 63.0 38.3 31.9 24.3 31.0 51.7 12.9 34.0 29.5 103.8 32.8 35.1 28.1 16.8 27.2 35.5 18.7 20.0 37.3 48.6 103.9 43.4 35.0 21.2 16.7 101.2 79.2 84.2 110.8 71.3 48.3 113.6 64.2 79.3 87.4 91.2 130.1 101.7 127.1 70.0 71.7 78.9 89.8 95.1 143.4 64.2 61.9 41.0 138.8 123.4 105.1 72.0 145.5 204.7 55.0 106.5 49.2 101.4 85.5 78.7 86.4 86.6 59.8 86.0 90.8 105.3 76.6 50.4 140.5 75.3 38.4 72.8 165.1 169.9 226.7 40.4 71.2 72.4 166.7 78.9 61.0 112.1 77.2 36.1 53.8 93.0 83.6 86.8 69.8 54.5 77.7 91.7 104.1 78.7 57.9 43.0 52.8 44.8 47.6 34.8 33.3 36.3 41.9 43.6 27.6 37.9 37.4 13.6 39.0 47.6 35.1 50.4 51.9 18.0 18.0 17.9 22.8 17.7 19.9 19.2 21.3 24.3 16.8 20.0 16.7 5.4 41.7 25.3 7.5 20.1 8.7 23.3 50.2 11.4 6.8 20.8 15.9 46.8 30.0 39.4 27.6 12.5 83.7 16.5 83.2 43.0 44.4 6.4 16.6 13.8 9.0 26.5 43.8 4.8 34.7 64.8 16.4 41.8 20.5 23.5 20.0 13.2 74.7 51.1 8.4 4.7 47.1 63.1 35.9 11.9 10.9 15.2 23.2 21.4 2.8 26.8 30.4 27.8 3.0 2.0 39.0 35.8 13.5 39.4 18.0 85.4 80.7 19.4 11.1 13.1 10.6 25.2 33.2 28.5 30.6 9.2 62.1 23.9 28.5 74.0 23.7 APIP "APIP2, CGI-29, Mmrp19" ENSG00000149089 "APAF1 interacting protein" Q96GX9 11 34853094-34916379 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Amino-acid biosynthesis, Apoptosis, Methionine biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 187.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021188, HPA024131" Approved Approved Nucleoplasm,Cytosol NA NA 52000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 30: Mammary glandular cells - Lactation" Nucleoplasm Cytosol "HPA021188: AB_10610977, HPA024131: AB_10602171" "unprognostic (2.80e-1)" "unprognostic (7.68e-2)" "unprognostic (5.30e-2)" "unprognostic (3.68e-3)" "unprognostic (4.22e-2)" "unprognostic (1.76e-1)" "prognostic unfavorable (1.99e-4)" "unprognostic (2.74e-2)" "unprognostic (3.84e-2)" "unprognostic (9.16e-2)" "unprognostic (2.45e-2)" "unprognostic (1.68e-1)" "unprognostic (1.51e-1)" "unprognostic (3.23e-1)" "unprognostic (5.48e-2)" "unprognostic (7.44e-2)" "unprognostic (1.58e-2)" 30.4 25.4 14.7 20.7 17.1 14.4 20.7 17.3 17.1 18.0 14.2 19.9 13.6 15.0 15.0 13.8 17.2 18.5 20.0 13.9 16.3 27.0 19.4 21.2 20.2 18.7 16.4 12.3 17.2 15.8 9.1 13.3 18.4 16.8 19.5 16.8 31.7 23.6 65.6 10.0 16.3 12.3 17.1 15.5 18.8 10.7 16.0 31.3 24.6 38.3 16.3 19.1 9.6 20.9 25.1 27.3 33.5 8.3 27.7 26.8 14.5 36.8 38.0 38.9 44.4 15.6 21.3 77.1 21.7 15.5 40.3 28.8 56.1 24.9 53.3 49.9 56.3 39.5 27.8 42.6 41.2 111.3 28.9 23.6 20.6 22.1 40.7 19.1 29.8 49.8 94.2 45.2 27.6 24.2 59.7 57.7 25.1 39.6 61.7 36.4 89.1 29.6 46.8 36.3 28.5 13.6 45.0 37.2 50.2 17.4 38.9 34.3 24.1 29.2 26.9 68.1 9.0 43.9 36.1 89.4 32.2 27.3 37.2 11.3 27.3 25.4 17.2 30.0 21.3 24.5 21.1 18.8 42.7 24.3 21.4 18.3 6.7 31.4 36.8 27.2 27.2 18.4 14.7 17.1 17.3 17.1 13.9 16.3 18.7 16.4 18.4 17.1 16.0 20.9 24.7 35.3 30.1 42.4 27.9 25.0 37.5 62.7 19.4 28.8 73.8 36.2 23.1 37.1 63.0 18.4 4.2 37.2 25.5 49.5 187.9 30.2 8.0 33.4 23.9 22.8 35.5 42.5 28.4 32.4 23.4 24.4 29.6 24.8 20.3 22.0 21.0 26.0 76.5 18.5 35.2 41.3 87.5 47.1 31.8 8.3 23.9 47.6 21.4 17.8 59.4 23.1 25.7 51.3 108.8 25.4 28.4 24.8 44.2 33.0 35.0 101.7 56.8 21.6 39.5 37.8 30.1 32.4 22.3 31.4 26.3 26.4 25.8 27.1 50.1 50.4 APOOL "AAIR8193, CXorf33, FAM121A, Mic27, MICOS27, UNQ8193" ENSG00000155008 "Apolipoprotein O like" Q6UXV4 X 85003877-85093316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000612 Approved Approved Mitochondria "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "HPA000612: AB_1078594" "prognostic unfavorable (2.68e-5)" "unprognostic (2.72e-2)" "unprognostic (6.16e-2)" "unprognostic (5.71e-3)" "unprognostic (4.27e-3)" "unprognostic (1.47e-1)" "unprognostic (2.73e-1)" "unprognostic (2.22e-2)" "unprognostic (8.35e-2)" "unprognostic (1.10e-1)" "unprognostic (2.77e-1)" "unprognostic (8.20e-2)" "prognostic favorable (1.35e-12)" "unprognostic (2.67e-2)" "unprognostic (5.65e-2)" "unprognostic (7.11e-2)" "unprognostic (7.51e-2)" 5.9 6.5 2.8 3.7 3.2 3.7 6.6 3.6 5.2 4.3 5.4 5.9 5.9 4.4 4.7 6.2 5.1 4.0 11.5 4.2 3.9 11.2 14.5 4.3 3.3 4.5 4.3 4.1 6.0 11.6 3.2 4.1 4.6 5.9 6.5 6.8 5.8 4.4 17.8 6.7 4.6 5.9 2.9 3.5 6.8 2.2 4.6 3.6 8.3 17.9 3.5 4.2 4.0 4.3 11.4 6.5 6.0 8.2 16.9 11.7 6.4 7.4 6.9 6.2 6.0 7.0 6.3 8.3 6.9 8.4 11.7 8.8 18.3 7.0 9.3 8.4 8.0 8.8 10.2 7.2 11.0 17.5 9.1 11.8 11.8 10.4 18.4 7.2 8.8 10.7 15.2 10.7 10.8 6.1 7.2 7.1 4.9 6.8 12.1 7.9 14.6 8.6 7.8 8.3 0.6 9.8 14.1 12.7 8.8 6.4 7.7 8.3 9.2 8.5 8.3 17.5 8.6 6.9 24.4 7.1 10.9 12.4 7.3 2.4 2.0 0.6 1.9 2.8 1.7 2.1 1.7 1.4 2.1 1.9 2.1 2.0 0.4 1.2 2.5 2.6 1.0 1.0 2.8 3.2 3.6 5.2 4.2 3.9 4.5 4.3 4.6 2.9 4.6 4.3 16.7 16.0 19.1 25.8 10.7 5.6 13.3 5.3 6.2 26.7 16.8 11.9 45.4 15.7 7.7 20.2 14.6 15.3 9.3 10.6 13.7 18.1 0.2 17.0 15.4 13.0 37.1 14.9 32.3 14.0 11.3 13.9 17.3 17.4 21.5 18.3 15.0 51.6 12.0 21.9 26.2 15.3 4.1 15.2 2.3 0.8 13.7 11.4 0.0 21.5 9.5 13.6 8.2 30.2 36.2 17.5 14.6 15.4 8.7 19.6 15.6 43.7 7.6 16.8 19.7 19.3 16.9 3.1 8.2 11.5 3.4 19.4 6.6 16.8 15.4 17.8 APTX "AOA, AOA1, AXA1, EAOH, EOAHA, FLJ20157" ENSG00000137074 Aprataxin Q7Z2E3 9 32886601-33025130 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Hydrolase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064930 Supported Supported Nucleoplasm,Nucleoli No No "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nucleoli" "HPA064930: AB_2685386" "unprognostic (9.18e-2)" "unprognostic (2.65e-2)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (4.04e-1)" "unprognostic (8.16e-2)" "unprognostic (2.26e-2)" "unprognostic (1.00e-1)" "unprognostic (1.32e-2)" "unprognostic (2.78e-3)" "unprognostic (3.48e-3)" "unprognostic (3.49e-2)" "prognostic favorable (6.01e-5)" "unprognostic (7.87e-2)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.50e-2)" 9.7 14.8 14.6 7.0 14.8 11.0 10.4 14.8 20.2 9.1 13.9 10.2 8.6 8.6 7.6 14.7 8.9 4.9 9.9 14.8 15.0 13.6 15.6 9.3 8.1 14.7 14.6 8.5 9.6 12.1 7.6 7.8 15.0 9.6 11.2 8.0 9.0 6.6 9.8 15.3 8.3 8.6 14.2 8.9 9.7 14.7 15.2 9.3 7.0 6.9 11.0 10.4 9.6 15.0 36.2 26.1 18.4 17.1 19.0 17.4 25.6 24.8 26.0 28.7 31.5 35.1 12.7 27.8 14.6 21.1 18.4 19.4 33.7 32.8 35.1 39.2 11.2 17.9 32.5 37.8 24.4 29.4 15.1 23.8 36.3 32.5 37.9 16.9 26.8 20.2 27.0 24.2 26.0 15.6 24.4 43.2 33.5 24.4 29.0 21.2 14.4 21.5 25.2 21.2 15.6 11.1 21.4 18.0 15.5 17.9 23.0 11.4 17.7 16.2 21.1 29.9 25.0 11.1 21.2 27.5 23.4 23.8 13.2 3.3 14.7 13.4 12.2 15.6 15.2 16.3 12.8 14.6 17.6 16.1 16.0 12.1 5.9 23.1 21.7 15.2 17.3 16.1 14.6 14.8 14.8 20.2 14.8 15.0 14.7 14.6 15.0 14.2 15.2 15.0 14.8 19.2 29.0 31.3 16.9 16.7 23.1 32.9 22.2 15.2 17.9 17.0 14.9 21.5 23.1 9.2 10.4 27.7 15.1 12.6 29.4 25.3 55.6 19.7 18.3 13.3 16.8 20.0 27.3 28.2 27.7 15.6 19.4 18.1 16.5 17.8 8.9 21.4 18.8 13.5 29.0 15.3 34.6 14.7 9.9 48.7 13.4 15.0 14.2 15.9 19.3 18.3 15.5 23.6 43.0 31.9 6.8 10.5 28.3 24.0 13.9 31.7 25.4 16.6 13.1 13.5 20.2 42.2 26.9 25.8 21.2 27.9 15.9 20.5 16.3 23.1 ARAP2 "CENTD1, PARX" ENSG00000047365 "ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2" Q8WZ64 4 35948221-36244514 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 39.9;brain: 92.8" "Cell type enhanced" "Detected in many" "Astrocytes: 285.4;Late spermatids: 167.5;Oligodendrocytes: 781.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 13.7;hTCEpi: 12.7;MOLT-4: 12.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035925 Approved Approved "Actin filaments,Focal adhesion sites" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Focal adhesion sites" "Actin filaments" "HPA035925: AB_10672075" "unprognostic (2.97e-2)" "unprognostic (8.62e-2)" "unprognostic (3.43e-3)" "unprognostic (1.04e-1)" "unprognostic (8.86e-2)" "unprognostic (2.72e-3)" "unprognostic (1.09e-1)" "unprognostic (3.78e-3)" "unprognostic (2.04e-1)" "unprognostic (2.45e-2)" "unprognostic (2.72e-3)" "unprognostic (2.96e-1)" "unprognostic (4.48e-2)" "unprognostic (4.54e-2)" "unprognostic (3.43e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-2)" 4.5 2.2 28.9 10.0 70.4 39.9 5.1 19.9 39.5 3.5 0.0 5.3 8.9 3.3 3.8 13.1 3.3 9.3 1.5 24.5 21.5 3.7 9.4 13.4 15.7 34.1 38.8 1.5 7.0 5.4 2.9 3.5 32.6 2.2 5.6 1.4 4.6 2.9 0.7 16.1 8.9 4.3 18.3 11.5 6.1 6.2 32.1 24.6 23.2 0.8 11.0 9.9 6.3 92.8 8.6 0.7 0.8 0.3 0.0 0.0 4.2 0.0 0.0 0.0 0.0 4.2 13.7 4.1 3.2 0.4 0.0 3.2 1.3 6.7 0.0 0.0 7.6 0.1 2.9 0.2 1.6 5.5 0.0 0.4 12.7 0.0 2.7 4.9 0.0 11.1 0.2 0.7 0.0 3.6 12.8 4.5 1.0 6.0 2.6 6.5 0.0 4.7 9.3 8.7 7.3 0.0 0.4 2.1 2.7 0.4 5.6 1.6 0.0 2.3 7.5 0.0 1.1 0.0 0.0 8.0 0.9 6.1 1.9 0.0 0.5 0.0 3.8 1.8 3.5 1.8 2.1 2.7 0.3 0.9 0.7 1.9 0.4 6.7 4.7 1.2 1.1 0.6 28.9 70.4 19.9 39.5 24.5 21.5 34.1 38.8 32.6 18.3 32.1 92.8 18.6 153.8 23.3 285.4 46.1 39.1 32.9 13.5 21.6 0.8 11.2 7.0 2.1 17.2 33.2 7.3 0.0 0.2 100.4 15.5 7.9 7.9 123.6 31.4 3.0 15.8 3.0 8.6 140.8 10.0 0.4 9.4 20.4 50.0 9.5 5.9 3.3 4.2 8.7 0.0 29.9 11.3 6.1 33.2 24.9 167.5 2.8 35.1 5.4 40.3 26.7 5.4 95.8 161.4 781.2 21.5 23.3 0.7 43.0 30.0 17.4 5.8 18.0 1.2 0.0 8.1 3.6 4.2 3.0 37.0 67.5 0.8 90.7 0.1 6.9 44.1 ARMC6 MGC19595 ENSG00000105676 "Armadillo repeat containing 6" Q6NXE6 19 19033575-19060311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 110.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041420, HPA041681" Supported Enhanced Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 2: Hepatocytes - Metabolism" Cytosol "HPA041420: AB_2677469, HPA041681: AB_10793928" "unprognostic (2.01e-2)" "unprognostic (3.34e-2)" "unprognostic (1.62e-1)" "unprognostic (1.63e-1)" "unprognostic (2.11e-2)" "unprognostic (1.65e-2)" "unprognostic (3.55e-2)" "unprognostic (2.43e-1)" "unprognostic (8.98e-2)" "unprognostic (2.36e-1)" "unprognostic (7.04e-3)" "unprognostic (1.05e-1)" "unprognostic (1.11e-1)" "unprognostic (6.37e-2)" "unprognostic (1.70e-1)" "unprognostic (3.73e-2)" "unprognostic (1.40e-1)" 11.9 16.6 20.4 11.4 20.4 16.7 11.7 21.6 27.8 13.9 19.8 12.4 10.0 14.7 6.1 18.7 11.7 6.9 17.9 21.2 21.7 16.9 110.5 11.9 15.8 22.9 21.2 12.0 11.2 11.9 17.8 8.8 22.7 15.6 8.9 7.7 13.3 8.0 21.3 12.7 12.3 9.1 19.5 17.8 12.3 24.0 20.3 23.2 19.4 18.2 12.4 14.4 12.6 20.8 64.1 42.8 30.7 38.0 14.5 24.7 39.7 40.3 23.5 64.5 47.7 59.8 56.0 96.3 63.8 34.1 23.8 31.8 73.7 47.8 35.5 20.4 104.0 48.5 39.0 49.0 32.0 87.1 54.3 31.2 44.9 44.0 30.7 14.5 41.6 56.3 86.4 36.0 36.0 78.0 93.2 70.5 71.5 71.9 86.8 76.3 27.7 68.9 31.9 42.6 70.5 30.6 32.4 41.1 33.9 20.7 35.0 54.1 27.2 33.0 28.8 47.3 83.8 27.5 53.2 93.2 27.3 117.1 44.0 10.6 19.0 5.3 22.1 20.3 16.6 13.4 12.0 19.3 28.3 15.1 15.7 18.0 3.8 30.6 16.7 18.2 23.4 18.3 20.4 20.4 21.6 27.8 21.2 21.7 22.9 21.2 22.7 19.5 20.3 20.8 7.1 0.0 5.9 4.6 10.7 6.6 6.8 9.2 9.1 14.1 11.5 11.4 5.9 17.2 8.9 12.9 12.5 20.5 21.3 12.3 7.9 16.0 25.5 6.3 11.8 10.2 15.0 13.7 4.0 10.7 20.3 10.7 12.2 9.6 1.3 11.1 8.2 52.4 20.7 5.0 5.0 10.9 6.1 15.6 6.0 47.9 10.2 9.2 5.4 0.0 14.9 16.4 20.6 5.0 5.5 10.8 10.8 8.2 10.3 12.4 10.4 12.3 4.5 17.9 13.1 7.4 9.1 22.0 31.0 10.0 10.1 13.0 10.3 16.5 17.3 5.5 ATAD3A FLJ10709 ENSG00000197785 "ATPase family AAA domain containing 3A" Q9NVI7 1 1512162-1534685 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058968, HPA064867, HPA065305" Approved Enhanced Mitochondria NA NA 27000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 39: CACO-2 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459" "unprognostic (8.42e-2)" "unprognostic (1.67e-1)" "unprognostic (3.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.50e-1)" "unprognostic (8.74e-2)" "prognostic unfavorable (5.90e-5)" "unprognostic (6.62e-2)" "unprognostic (9.53e-2)" "unprognostic (5.81e-2)" "unprognostic (4.09e-2)" "unprognostic (7.66e-2)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" "unprognostic (3.09e-1)" "unprognostic (6.25e-2)" "unprognostic (1.87e-3)" 10.9 13.6 8.3 12.3 8.4 18.1 10.7 8.5 11.1 10.6 9.7 11.2 11.4 12.8 2.0 17.2 10.4 4.4 15.5 9.0 7.7 10.6 18.5 10.0 10.4 8.4 8.2 8.4 19.5 5.2 14.6 6.6 8.0 9.5 3.0 2.0 13.4 5.5 28.8 14.3 9.8 3.8 7.5 11.7 12.9 9.3 8.2 6.2 9.6 8.3 4.7 11.4 10.7 8.3 79.2 47.9 18.0 49.3 8.3 10.6 45.6 62.9 16.8 52.7 32.1 127.2 52.8 45.9 41.5 24.9 19.7 65.8 27.5 36.5 9.2 42.7 110.3 75.0 131.9 97.0 17.3 112.5 42.7 12.8 11.2 44.2 16.2 6.1 23.2 44.2 120.1 27.3 19.7 64.5 83.1 95.2 40.9 25.9 91.5 88.5 35.7 91.9 14.7 40.3 91.8 35.3 39.8 58.1 53.0 5.9 24.8 55.7 32.6 52.5 45.0 85.8 79.2 45.6 52.6 172.7 54.2 160.5 25.4 0.5 1.8 0.6 1.5 1.5 1.0 1.4 1.5 1.7 2.2 1.5 1.3 0.6 0.1 2.5 3.4 2.2 1.5 1.1 8.3 8.4 8.5 11.1 9.0 7.7 8.4 8.2 8.0 7.5 8.2 8.3 8.5 3.2 9.0 10.7 11.7 20.4 11.2 5.9 8.0 10.5 11.6 8.3 9.5 8.6 6.4 7.3 6.2 21.6 10.0 18.8 7.9 22.5 9.5 14.7 9.3 11.8 13.8 28.4 8.8 21.3 43.4 10.4 13.7 8.7 8.9 21.9 4.6 12.5 22.4 23.5 8.3 19.6 14.2 7.5 12.5 10.1 5.6 7.7 16.0 6.5 5.9 10.9 6.2 4.5 6.1 25.3 5.2 7.9 27.5 38.3 13.8 12.8 7.9 9.4 0.0 9.4 14.8 5.8 20.1 17.4 24.3 19.7 7.7 35.6 27.7 15.7 ATG16L1 "APG16L, ATG16A, ATG16L, FLJ10035, WDR30" ENSG00000085978 "Autophagy related 16 like 1" Q676U5 2 233210051-233295674 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012577, HPA063900" Supported Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 5: NTERA-2 - Transcription" "Cluster 44: Endometrium - Transcription" Cytosol "HPA012577: AB_1845155, HPA063900: AB_2685146" "unprognostic (1.24e-1)" "unprognostic (1.07e-1)" "unprognostic (3.57e-2)" "unprognostic (2.22e-3)" "unprognostic (1.89e-1)" "unprognostic (4.49e-1)" "prognostic unfavorable (1.48e-5)" "unprognostic (2.51e-1)" "unprognostic (1.80e-1)" "unprognostic (1.85e-2)" "unprognostic (6.66e-3)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.70e-4)" "unprognostic (3.93e-2)" "unprognostic (1.41e-1)" "unprognostic (2.41e-1)" "unprognostic (2.08e-1)" 7.6 7.8 7.0 3.8 7.5 14.3 8.8 7.9 8.4 8.1 12.8 11.1 5.0 9.6 5.5 11.6 7.1 3.3 10.7 7.3 6.6 9.2 15.1 7.6 5.8 6.5 6.3 8.5 8.6 5.3 5.5 4.0 6.9 12.1 5.2 5.6 11.5 4.3 19.9 17.2 11.1 5.2 6.3 11.5 11.1 13.5 6.5 5.9 11.2 6.1 5.2 11.5 8.2 7.7 13.3 12.2 4.9 8.5 12.4 8.0 14.0 11.4 9.3 9.6 8.9 8.9 9.7 3.1 3.7 8.9 14.3 7.7 9.8 6.4 9.8 6.2 7.7 7.1 9.1 14.6 9.1 5.6 9.0 5.3 9.1 11.5 8.7 7.2 9.0 4.7 7.6 2.9 10.2 9.3 6.7 11.2 19.1 14.1 17.6 4.8 10.3 2.6 9.9 8.4 8.8 6.5 7.8 8.5 8.5 7.4 5.3 7.1 10.7 6.2 5.4 9.6 10.3 6.5 3.9 6.1 10.5 5.7 10.2 0.0 1.7 2.9 4.8 1.4 3.7 2.0 3.1 4.4 1.4 2.2 3.5 3.5 1.2 4.1 4.7 0.7 3.8 2.1 7.0 7.5 7.9 8.4 7.3 6.6 6.5 6.3 6.9 6.3 6.5 7.7 6.1 6.4 8.2 5.2 7.4 9.1 4.6 5.2 3.4 8.4 12.0 6.6 5.6 7.2 11.6 5.5 4.2 4.6 20.9 13.9 5.9 8.3 1.2 16.4 10.9 6.4 9.0 3.8 31.0 6.7 6.2 5.2 8.2 31.8 9.5 6.4 6.1 10.2 5.6 1.7 25.6 5.1 6.1 6.3 5.7 1.7 4.1 5.1 10.6 8.4 6.6 7.1 4.1 11.6 21.4 16.8 8.0 3.8 8.1 7.1 9.2 5.6 11.5 19.5 6.6 5.8 6.9 11.0 17.6 7.3 13.2 3.7 19.2 5.1 8.4 6.0 ATG4B "APG4B, AUTL1, DKFZp586D1822, KIAA0943" ENSG00000168397 "Autophagy related 4B cysteine peptidase" Q9Y4P1 2 241637213-241673857 "Enzymes, Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037195, HPA069803" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "CAB037195: AB_1078237, HPA069803: AB_2686200" "unprognostic (1.51e-1)" "unprognostic (8.80e-2)" "prognostic unfavorable (6.85e-4)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "unprognostic (2.67e-3)" "unprognostic (1.07e-3)" "unprognostic (1.06e-1)" "unprognostic (1.61e-1)" "unprognostic (1.58e-1)" "unprognostic (1.15e-3)" "unprognostic (3.02e-2)" "prognostic unfavorable (2.79e-4)" "unprognostic (2.60e-1)" "unprognostic (6.63e-2)" "unprognostic (1.66e-1)" "prognostic favorable (9.64e-4)" 12.0 17.5 21.4 8.1 21.7 14.7 13.2 20.9 24.7 18.0 20.1 19.7 11.4 16.8 5.3 16.2 16.8 7.6 18.4 21.6 23.0 19.7 18.0 12.4 13.2 23.0 21.4 16.5 16.4 12.1 21.5 7.2 23.6 22.6 5.4 8.5 14.4 9.6 18.7 16.7 18.3 6.7 20.7 19.9 16.1 19.7 22.4 16.1 18.7 7.6 7.8 16.3 14.6 21.5 8.8 15.6 16.9 13.5 15.8 10.5 29.5 23.8 9.8 16.5 12.4 15.0 9.8 7.4 7.2 11.8 10.5 16.5 16.0 20.3 3.8 18.8 31.8 19.6 14.1 40.2 20.1 13.6 12.0 13.8 15.0 9.0 7.1 16.8 11.0 44.3 23.4 5.1 8.6 32.6 33.4 36.9 30.9 23.8 25.9 51.3 25.1 16.2 11.4 14.9 26.2 21.3 17.5 13.9 27.8 14.1 15.5 24.6 15.4 7.1 12.0 14.8 13.3 21.1 17.0 34.6 18.8 21.4 17.6 3.9 17.9 19.2 18.5 15.6 15.9 15.8 14.2 15.6 20.4 16.5 18.0 12.8 12.8 11.8 18.9 17.0 20.4 16.8 21.4 21.7 20.9 24.7 21.6 23.0 23.0 21.4 23.6 20.7 22.4 21.5 23.2 32.1 33.8 41.1 25.6 24.3 27.2 41.3 25.0 22.2 24.4 21.8 16.2 25.8 29.9 27.6 33.3 35.8 33.5 61.8 19.6 37.5 18.1 28.6 21.9 25.3 35.9 31.8 38.5 40.2 28.5 22.6 40.8 43.3 19.0 36.5 20.3 27.9 33.4 42.1 33.8 36.4 42.7 28.5 34.5 25.9 22.1 30.7 28.4 31.9 51.2 24.5 41.2 20.1 41.0 41.5 41.5 24.8 28.6 35.6 70.5 25.1 26.7 26.8 19.7 22.7 22.8 58.3 63.3 19.9 25.4 53.9 29.4 27.6 35.6 32.5 ATP1B1 ATP1B ENSG00000143153 "ATPase Na+/K+ transporting subunit beta 1" P05026 1 169105697-169132722 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 1337.8" "Cell type enhanced" "Detected in all" "Collecting duct cells: 1723.3;Proximal tubular cells: 1070.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "basophil: 13.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 919.7;RPTEC TERT1: 513.0;SH-SY5Y: 382.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012911 Enhanced NA NA 2100000 "Cluster 27: Non-specific - Gene expression" "Cluster 7: Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA012911: AB_1845173" "unprognostic (4.20e-2)" "unprognostic (3.08e-1)" "unprognostic (1.13e-1)" "unprognostic (1.85e-2)" "unprognostic (1.95e-1)" "unprognostic (5.34e-2)" "unprognostic (2.22e-1)" "unprognostic (1.69e-1)" "unprognostic (3.24e-1)" "unprognostic (6.80e-2)" "unprognostic (1.66e-1)" "unprognostic (1.35e-1)" "prognostic favorable (7.08e-7)" "unprognostic (1.11e-1)" "unprognostic (5.48e-2)" "unprognostic (1.97e-3)" "unprognostic (9.39e-2)" 12.4 146.9 197.7 48.0 216.2 4.4 79.4 370.0 451.1 37.5 369.3 246.1 336.6 108.8 64.3 159.8 48.8 178.7 160.5 326.4 332.1 1337.8 180.1 92.6 8.5 558.7 264.3 58.1 178.5 732.7 79.8 44.1 540.2 48.6 201.1 99.3 314.1 72.6 342.9 67.0 284.4 96.6 248.8 52.6 402.1 46.3 375.1 19.2 330.2 337.8 84.0 101.2 52.1 382.2 89.7 215.8 73.3 56.3 15.9 3.3 23.8 45.3 33.1 41.7 43.3 276.8 183.5 0.1 158.3 35.1 50.8 102.4 38.1 83.2 45.1 1.1 16.6 5.7 152.6 138.9 26.6 4.0 7.5 9.1 21.1 31.8 42.5 79.7 40.5 6.6 1.3 1.4 52.6 38.0 7.9 16.0 28.1 919.7 47.4 1.3 89.3 15.6 513.0 118.6 54.3 382.5 263.1 271.3 12.5 85.4 55.7 9.8 92.0 35.2 90.4 60.9 159.3 4.8 6.8 2.0 42.0 13.9 47.9 13.2 1.0 0.2 2.7 3.2 1.5 1.5 3.3 1.3 9.3 0.2 1.0 1.1 0.3 6.2 1.1 0.4 10.1 1.4 197.7 216.2 370.0 451.1 326.4 332.1 558.7 264.3 540.2 248.8 375.1 382.2 14.4 240.4 251.5 79.0 18.4 52.5 156.5 490.4 153.1 86.9 274.2 166.5 147.3 664.8 425.7 1723.3 14.6 4.8 21.0 817.1 923.4 629.9 3.8 199.6 11.6 18.6 160.9 6.9 344.7 591.9 9.0 78.7 353.7 190.6 23.4 89.0 45.7 273.3 385.3 580.5 602.3 296.7 370.2 99.5 676.1 9.0 89.8 101.5 247.3 81.5 27.1 23.4 1.0 94.5 514.7 377.9 666.4 149.0 16.9 84.4 646.8 1070.2 332.5 64.9 6.6 93.6 32.5 10.6 66.9 142.8 31.7 9.9 48.2 111.8 436.0 322.8 ATP2A2 "ATP2B, DAR, SERCA2" ENSG00000174437 "ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2" P16615 12 110280756-110351093 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Disease variant, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 12 "heart muscle: 1005.8;skeletal muscle: 2856.8;tongue: 2768.8" "Cell type enriched" "Detected in all" 7 "Cardiomyocytes: 2119.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062605 Enhanced NA NA 2500000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 15: RT4 - Unknown function" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA062605: AB_2684805" "unprognostic (4.81e-2)" "unprognostic (2.16e-2)" "unprognostic (1.87e-1)" "unprognostic (3.41e-3)" "unprognostic (2.50e-1)" "unprognostic (3.98e-3)" "unprognostic (1.91e-2)" "unprognostic (6.20e-2)" "unprognostic (4.69e-2)" "unprognostic (2.42e-1)" "unprognostic (1.20e-2)" "unprognostic (1.00e-1)" "unprognostic (3.47e-2)" "unprognostic (1.36e-3)" "unprognostic (2.26e-1)" "unprognostic (5.62e-2)" "unprognostic (9.93e-2)" 60.4 49.6 26.2 57.8 34.6 46.0 34.1 36.0 28.0 43.4 23.2 64.2 47.5 46.6 39.0 181.2 67.0 60.5 1005.8 39.0 28.8 34.4 54.7 49.0 36.0 32.5 46.3 42.0 38.1 56.1 24.5 55.4 29.8 93.4 69.0 19.1 92.2 70.0 2856.8 46.5 56.4 74.4 29.8 30.5 47.2 74.1 57.6 36.2 73.3 2768.8 48.1 90.9 57.9 36.1 129.7 305.7 135.4 106.5 95.3 111.7 185.1 154.9 197.2 163.6 102.1 229.1 131.3 155.4 129.2 165.4 115.4 185.0 215.9 264.4 157.3 130.0 127.2 148.0 115.6 121.5 164.7 151.1 130.6 130.3 170.7 202.3 190.1 165.4 134.9 82.6 162.9 74.9 118.6 131.3 76.0 53.2 139.7 126.6 134.8 96.8 130.2 128.6 59.5 279.2 138.2 101.5 207.8 151.1 87.0 113.9 213.7 95.6 159.8 147.8 69.3 93.9 127.4 140.6 189.5 169.0 152.3 70.9 168.8 0.0 0.6 0.0 0.5 1.3 0.2 0.1 0.3 0.2 0.5 0.2 0.3 0.3 0.0 0.3 0.6 0.5 0.3 0.2 26.2 34.6 36.0 28.0 39.0 28.8 32.5 46.3 29.8 29.8 57.6 36.1 48.9 44.8 57.5 85.5 26.3 114.5 95.2 134.5 68.9 63.6 70.2 64.6 2119.9 41.5 103.5 51.5 64.6 33.4 37.4 155.1 1.9 43.7 14.8 291.6 90.8 59.7 137.3 14.1 161.0 71.0 37.6 104.2 49.5 258.1 45.0 47.3 40.7 122.2 64.3 84.1 146.1 109.6 65.1 54.6 64.9 13.4 30.4 65.3 67.6 63.7 33.8 27.5 15.5 119.6 96.4 98.0 89.4 83.1 56.8 117.4 78.0 25.3 176.4 42.9 52.6 88.0 110.2 80.3 47.7 142.3 109.0 30.6 32.7 40.0 97.7 126.4 ATXN2 "ATX2, SCA2, TNRC13" ENSG00000204842 "Ataxin 2" Q99700 12 111443485-111599676 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 209.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018295, HPA020339, HPA021146" Enhanced Enhanced Cytosol NA NA 9600 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132" "unprognostic (3.08e-1)" "unprognostic (1.52e-1)" "unprognostic (1.29e-1)" "unprognostic (7.82e-2)" "unprognostic (1.55e-1)" "unprognostic (3.53e-1)" "prognostic unfavorable (2.66e-4)" "unprognostic (2.34e-1)" "unprognostic (2.77e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (4.58e-1)" "unprognostic (5.28e-2)" "unprognostic (1.81e-1)" "unprognostic (2.58e-1)" "unprognostic (3.00e-1)" "unprognostic (3.40e-2)" 19.6 23.5 20.5 11.2 21.9 8.0 17.5 22.8 30.3 21.6 20.8 22.8 11.2 21.7 13.9 14.2 20.4 12.0 22.2 20.5 29.9 17.5 20.1 19.7 9.5 25.2 26.0 25.9 13.8 18.6 21.9 16.3 24.5 19.4 11.6 15.7 14.5 15.6 25.8 15.6 14.9 18.3 18.6 14.1 16.3 23.2 22.7 12.8 17.1 20.8 8.9 19.6 18.3 25.8 31.0 38.0 30.3 38.2 35.9 29.0 29.4 35.8 25.9 28.8 23.4 25.2 25.7 25.8 14.2 47.7 23.8 25.5 45.0 18.2 36.0 23.3 33.9 38.2 22.8 42.4 49.7 27.1 21.4 32.4 20.1 38.0 42.6 48.0 27.8 20.2 46.8 13.1 37.2 24.7 23.2 24.2 30.1 19.4 24.6 21.8 18.6 19.2 30.1 34.5 28.7 25.2 38.5 49.3 24.7 29.1 30.9 16.5 34.9 36.9 21.6 30.4 20.6 23.4 30.0 22.5 19.0 20.9 23.5 4.5 3.6 5.8 3.9 3.4 5.2 5.1 4.9 5.3 5.0 2.7 4.1 3.6 3.5 5.6 6.4 2.7 2.2 2.8 20.5 21.9 22.8 30.3 20.5 29.9 25.2 26.0 24.5 18.6 22.7 25.8 43.0 80.1 72.6 175.3 26.7 35.3 34.3 18.4 35.9 101.0 33.6 26.3 36.6 30.0 36.6 36.8 135.5 32.5 28.9 25.6 3.9 26.0 11.1 87.2 72.2 43.9 41.4 34.9 146.7 25.3 25.4 40.0 23.9 50.3 23.5 67.2 63.5 38.1 24.5 65.6 171.8 26.7 24.4 35.9 35.9 11.9 65.6 30.6 32.0 106.8 35.1 32.6 48.4 128.7 209.6 32.6 16.0 47.4 24.2 43.0 22.7 16.9 56.0 90.4 32.9 41.5 46.6 78.0 70.7 25.7 35.2 46.9 27.4 68.7 31.5 42.2 B3GALT6 beta3GalT6 ENSG00000176022 "Beta-1,3-galactosyltransferase 6" Q96L58 1 1232237-1235041 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Disease variant, Dwarfism, Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 69.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 52: Non-specific - Transcription" "unprognostic (9.76e-2)" "unprognostic (6.97e-2)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-1)" "unprognostic (4.62e-2)" "unprognostic (2.65e-3)" "unprognostic (1.86e-1)" "unprognostic (1.37e-1)" "unprognostic (2.66e-1)" "unprognostic (3.08e-2)" "unprognostic (2.40e-2)" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (3.28e-1)" "unprognostic (9.89e-2)" 8.7 8.7 8.9 5.6 9.0 1.8 8.4 7.3 9.9 7.6 7.3 6.5 3.9 10.7 3.8 7.2 7.7 3.7 10.1 9.5 10.1 9.9 13.5 6.8 6.2 10.4 9.3 7.0 11.9 7.8 9.3 5.2 8.8 8.0 3.0 2.4 6.4 4.2 9.3 9.2 6.5 4.8 8.3 10.3 7.8 5.4 9.0 5.8 7.7 4.8 3.7 7.6 6.3 9.3 20.4 10.2 17.0 17.9 16.8 11.3 13.2 21.2 17.9 17.4 14.1 9.1 20.3 15.1 12.4 12.7 15.2 17.9 7.4 11.4 10.6 26.8 28.2 28.2 10.1 8.7 17.3 17.6 17.1 10.6 8.3 11.6 11.3 10.5 13.3 17.2 20.0 13.2 18.0 11.6 24.0 31.6 21.9 21.2 37.9 22.8 6.7 12.5 17.4 6.1 69.6 28.6 15.8 18.4 11.4 9.9 15.4 24.9 14.4 17.9 7.9 11.3 30.9 8.2 7.6 14.0 14.1 38.9 20.8 1.3 1.2 0.4 1.6 1.6 2.8 1.4 1.6 1.9 1.7 2.3 1.4 1.7 0.6 2.9 2.0 2.3 0.7 1.0 8.9 9.0 7.3 9.9 9.5 10.1 10.4 9.3 8.8 8.3 9.0 9.3 15.6 12.8 9.9 3.9 13.7 8.4 31.1 3.8 2.2 13.1 15.4 17.5 8.4 11.5 3.4 12.9 4.2 1.7 20.9 3.8 7.9 8.1 0.6 7.6 16.0 12.5 6.0 5.9 3.8 12.7 3.4 10.8 5.1 9.4 0.0 24.7 11.4 13.6 7.3 20.2 5.0 3.7 4.1 12.2 10.3 2.2 2.8 10.5 1.8 1.9 6.9 11.0 18.6 5.5 3.8 11.9 1.0 4.1 9.6 24.5 1.6 10.9 3.0 9.4 0.0 13.6 10.8 1.7 4.1 3.7 12.6 1.4 11.1 33.2 5.3 14.8 BAHD1 KIAA0945 ENSG00000140320 "Bromo adjacent homology domain containing 1" Q8TBE0 15 40439721-40468236 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041196 Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA041196: AB_10803999" "prognostic unfavorable (1.55e-4)" "unprognostic (4.08e-1)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (1.35e-2)" "unprognostic (1.04e-1)" "unprognostic (7.19e-2)" "unprognostic (1.12e-2)" "unprognostic (2.06e-2)" "unprognostic (2.00e-2)" "unprognostic (3.49e-3)" "unprognostic (4.81e-2)" "prognostic favorable (1.29e-10)" "unprognostic (4.95e-2)" "unprognostic (1.15e-1)" "unprognostic (1.70e-1)" "unprognostic (1.11e-1)" 9.6 21.9 10.8 8.0 11.5 8.1 9.2 8.6 10.5 11.0 9.9 12.3 9.1 12.5 10.2 12.0 13.6 6.3 14.3 11.9 9.8 14.2 11.6 12.5 9.8 10.3 9.5 21.4 13.8 13.0 13.3 8.7 9.4 10.3 5.8 5.2 12.6 10.2 12.6 11.0 12.0 7.2 9.1 12.6 12.7 18.6 10.9 11.6 16.5 7.6 9.1 12.3 9.1 10.1 16.9 8.5 14.7 24.5 11.7 9.1 32.0 13.3 9.5 14.4 14.0 23.1 7.9 12.5 17.6 12.0 17.6 32.6 24.2 10.1 8.0 24.2 15.2 32.9 13.2 11.5 11.1 14.4 24.0 12.0 10.2 8.8 8.7 12.8 12.5 15.8 32.8 10.4 8.6 16.0 16.2 21.8 14.6 19.7 15.6 27.3 16.6 10.4 15.9 19.7 23.0 13.9 8.2 42.8 9.7 9.1 34.4 23.1 14.8 15.6 17.4 22.4 14.1 15.5 18.4 14.2 16.3 22.1 10.7 0.6 0.3 1.4 1.3 0.6 0.6 0.5 0.9 0.7 0.3 0.7 1.2 1.0 0.3 1.4 1.2 0.6 0.3 0.4 10.8 11.5 8.6 10.5 11.9 9.8 10.3 9.5 9.4 9.1 10.9 10.1 9.7 19.2 7.0 7.8 4.9 8.3 3.7 4.1 6.8 3.9 11.4 9.4 11.7 5.7 7.7 11.0 2.1 5.5 5.6 20.7 1.9 5.4 1.0 6.1 4.9 8.4 7.8 2.5 10.3 7.4 7.3 4.7 2.0 8.4 8.9 5.6 9.7 12.0 5.7 16.8 8.1 7.4 2.0 12.0 4.6 2.7 10.2 5.4 0.0 7.5 6.7 5.2 10.3 9.0 8.9 6.7 8.9 5.7 1.6 5.3 11.6 5.0 5.0 4.7 6.6 6.1 5.5 6.3 10.9 6.9 7.7 4.1 5.8 7.6 8.0 4.9 BBS1 FLJ23590 ENSG00000174483 "Bardet-Biedl syndrome 1" Q8NFJ9 11 66510606-66533613 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Olfaction, Protein transport, Sensory transduction, Transport, Vision" "Bardet-Biedl syndrome, Ciliopathy, Disease variant, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 19.9;Excitatory neurons: 28.5;Inhibitory neurons: 28.4;Microglial cells: 14.0;Oligodendrocyte precursor cells: 13.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA058283 Uncertain Uncertain Midbody Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Midbody "HPA058283: AB_2683667" "unprognostic (1.06e-1)" "unprognostic (1.05e-1)" "unprognostic (1.73e-1)" "unprognostic (1.14e-1)" "unprognostic (1.56e-1)" "unprognostic (1.08e-3)" "unprognostic (1.40e-2)" "unprognostic (6.68e-2)" "unprognostic (1.72e-2)" "unprognostic (2.76e-1)" "unprognostic (1.19e-3)" "unprognostic (2.61e-2)" "unprognostic (6.05e-2)" "unprognostic (3.04e-1)" "unprognostic (2.20e-1)" "unprognostic (2.38e-1)" "unprognostic (4.87e-4)" 10.5 15.2 11.5 4.9 13.0 2.9 11.9 10.8 17.8 18.9 13.9 18.0 6.5 20.7 17.7 9.0 28.0 12.6 10.1 11.6 12.7 24.2 7.0 10.4 5.1 10.2 13.5 27.5 13.5 38.0 17.9 8.2 10.1 15.8 7.3 21.4 16.8 22.0 8.1 9.6 9.4 14.1 10.5 6.0 13.8 10.5 13.3 8.0 27.1 8.2 5.0 15.4 10.9 10.7 5.7 6.0 13.7 5.4 24.9 17.2 6.3 4.8 9.6 6.3 6.0 9.5 10.1 0.8 10.0 11.5 5.6 10.6 10.1 10.6 6.8 5.2 5.8 2.5 8.9 5.3 11.7 4.7 1.8 17.7 9.7 9.7 7.1 17.8 8.9 8.5 5.5 4.3 7.8 5.1 3.7 4.1 10.4 18.0 10.5 9.2 9.0 7.4 19.3 6.4 14.0 9.3 8.1 8.7 18.6 6.6 18.7 2.5 8.7 5.0 5.7 6.0 1.6 3.1 1.5 1.4 16.3 1.3 5.4 0.0 1.5 0.2 1.8 1.6 2.6 2.2 2.5 2.0 1.2 1.1 1.7 2.2 0.9 3.1 3.0 0.5 0.8 1.9 11.5 13.0 10.8 17.8 11.6 12.7 10.2 13.5 10.1 10.5 13.3 10.7 0.5 0.0 2.2 19.9 2.5 0.5 1.3 1.6 0.6 3.9 0.9 1.0 0.5 1.5 1.1 0.0 8.4 1.6 0.5 0.6 0.0 0.8 4.1 2.3 1.8 1.3 1.2 3.0 28.5 0.4 0.6 3.1 7.1 0.9 0.0 2.9 0.7 0.3 0.6 0.0 28.4 0.7 2.0 0.9 0.7 2.6 0.9 0.5 0.0 14.0 0.8 1.7 1.0 13.6 9.0 0.4 0.5 1.5 2.5 0.8 0.4 1.7 9.2 10.8 0.0 1.5 1.6 4.9 2.6 2.2 1.0 1.0 1.4 2.0 0.9 0.9 BCL7B ENSG00000106635 "BAF chromatin remodeling complex subunit BCL7B" Q9BQE9 7 73536356-73557690 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Differentiation, Wnt signaling pathway" "Allergen, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049943, HPA058069" Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA049943: AB_2680963, HPA058069: AB_2683594" "unprognostic (2.79e-2)" "unprognostic (2.87e-1)" "unprognostic (1.93e-2)" "unprognostic (1.04e-1)" "unprognostic (3.54e-3)" "unprognostic (1.12e-1)" "unprognostic (2.91e-2)" "unprognostic (4.84e-2)" "unprognostic (1.35e-1)" "unprognostic (2.73e-1)" "unprognostic (5.37e-2)" "unprognostic (9.43e-2)" "prognostic favorable (4.38e-4)" "unprognostic (4.09e-1)" "unprognostic (3.55e-1)" "unprognostic (5.41e-2)" "unprognostic (1.32e-1)" 35.6 23.8 34.9 18.7 35.0 90.0 18.5 28.1 43.5 16.3 28.3 32.6 21.8 15.5 17.4 27.5 16.6 22.5 49.5 36.5 34.1 21.9 25.1 27.4 24.4 30.6 31.2 9.0 25.6 30.3 20.9 21.7 29.7 17.8 16.4 17.7 16.0 23.5 66.0 11.1 23.6 29.8 28.3 23.0 20.6 20.5 33.4 22.4 22.1 55.8 19.4 33.4 11.4 34.3 67.8 46.9 26.7 47.8 21.5 34.0 27.1 56.1 58.9 58.0 52.9 52.0 73.8 56.7 14.0 58.7 84.7 30.4 19.4 45.7 42.7 73.9 27.5 31.5 28.7 28.0 61.3 54.3 85.3 22.8 45.0 59.5 58.7 23.9 38.4 31.7 50.6 65.0 41.6 79.5 93.0 71.2 46.5 43.0 67.7 49.2 28.6 67.6 46.5 51.8 59.7 57.9 49.6 85.0 62.3 11.3 53.0 73.3 39.6 69.8 44.7 47.9 84.1 37.0 35.9 105.2 68.7 82.8 89.0 13.7 13.3 19.7 11.4 15.8 13.8 11.7 13.1 15.3 13.5 17.6 13.7 11.1 6.5 21.2 20.3 15.9 11.4 8.3 34.9 35.0 28.1 43.5 36.5 34.1 30.6 31.2 29.7 28.3 33.4 34.3 50.4 32.1 20.7 6.8 59.8 64.6 81.9 18.7 39.3 27.5 37.4 32.1 29.5 24.3 17.5 16.5 6.2 72.5 55.9 63.3 54.8 46.7 8.0 35.4 16.8 37.3 34.6 17.9 10.3 45.8 43.6 30.4 21.9 31.6 32.4 21.5 34.2 18.1 51.0 42.1 8.8 40.6 32.6 37.5 46.4 6.7 25.7 48.3 32.0 6.5 41.1 32.4 62.8 6.0 10.0 67.9 58.3 30.5 35.7 61.6 50.4 47.0 15.7 21.8 46.0 52.4 46.7 64.1 71.6 28.7 57.7 101.8 58.3 27.3 37.6 74.1 BCOR "FLJ20285, KIAA1575" ENSG00000183337 "BCL6 corepressor" Q6W2J9 X 40049815-40177329 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes, Disease variant, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA056308, HPA073591" Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 44: Endometrium - Transcription" Nucleoplasm "HPA056308: AB_2683095, HPA073591: AB_2732227" "unprognostic (2.75e-2)" "unprognostic (2.83e-1)" "unprognostic (2.45e-1)" "unprognostic (9.26e-2)" "unprognostic (1.55e-1)" "unprognostic (9.80e-3)" "prognostic unfavorable (1.30e-5)" "unprognostic (3.82e-3)" "unprognostic (6.86e-2)" "unprognostic (1.86e-1)" "unprognostic (4.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.91e-3)" "unprognostic (6.83e-2)" "unprognostic (9.57e-2)" "unprognostic (2.63e-1)" "unprognostic (1.55e-1)" 10.2 14.0 2.4 8.3 3.8 22.2 10.0 3.0 3.7 11.5 3.8 14.7 8.8 11.0 5.4 14.4 10.9 7.5 14.0 1.9 2.9 12.9 14.6 12.3 15.0 4.5 3.3 20.0 13.9 14.0 12.0 12.3 2.8 12.5 6.8 14.2 11.9 8.4 20.6 14.7 11.2 8.7 2.0 10.7 12.2 9.0 3.8 25.8 15.6 7.2 12.5 10.9 11.4 5.1 35.5 21.9 45.1 50.5 4.7 3.3 7.8 11.4 18.6 14.4 11.7 8.9 13.5 31.3 13.3 21.7 8.9 31.0 70.8 9.3 12.0 56.0 67.4 36.2 31.8 31.7 7.6 28.7 19.3 5.6 12.0 16.7 7.0 20.0 19.8 20.2 94.7 74.3 14.8 17.9 65.8 27.2 43.4 14.2 33.9 32.3 47.5 36.2 17.3 20.8 32.5 57.6 25.5 20.5 15.5 18.9 22.8 51.5 16.8 15.5 18.5 23.1 12.8 39.1 36.1 33.8 13.1 23.5 24.6 4.6 3.1 2.1 3.8 3.6 2.7 1.9 2.5 2.4 4.5 2.5 2.1 2.3 0.5 3.3 3.9 1.4 2.7 8.8 2.4 3.8 3.0 3.7 1.9 2.9 4.5 3.3 2.8 2.0 3.8 5.1 20.3 22.4 24.5 24.2 16.8 14.7 4.7 8.0 33.6 35.7 10.4 13.1 9.2 10.0 5.9 11.0 12.5 4.5 20.6 6.4 1.9 5.4 2.1 24.1 8.6 15.9 16.3 20.4 21.6 10.5 6.3 11.9 11.7 25.6 24.6 12.8 16.4 10.7 7.5 15.2 20.4 11.4 10.2 8.4 25.6 2.4 10.5 11.5 5.4 27.2 12.0 7.6 7.2 27.6 31.3 6.4 3.9 7.9 16.9 7.6 6.5 4.1 7.1 23.8 0.0 16.4 17.4 2.0 13.2 21.0 13.9 2.1 21.1 6.4 8.8 2.8 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376327-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 202.2;Inhibitory neurons: 190.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 82: Adipose tissue - ECM organization" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA017385: AB_1845397, HPA049014: AB_2680599" "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.5 21.6 8.2 10.9 14.1 2.2 13.2 3.2 16.8 22.6 0.3 13.6 8.5 20.0 11.3 12.4 14.9 17.3 21.5 16.0 14.8 17.4 15.6 29.1 7.2 6.2 7.7 16.8 10.4 17.5 8.5 34.0 10.0 17.1 13.0 26.7 11.0 13.9 10.9 10.9 8.6 24.3 3.9 13.1 11.7 11.3 10.6 9.0 18.2 23.1 9.4 20.6 12.4 5.9 13.3 12.3 12.6 19.7 34.2 31.9 23.8 27.2 28.3 23.6 23.9 10.8 19.6 4.7 30.7 58.2 19.9 24.5 16.8 21.4 41.6 13.8 11.2 14.2 12.6 16.8 22.7 4.0 10.7 24.2 21.5 17.1 22.8 40.6 73.9 5.6 9.3 22.5 33.8 24.8 3.4 3.6 6.9 6.6 11.1 9.1 24.3 7.1 21.3 27.9 12.6 12.7 28.9 17.7 32.7 32.0 13.2 9.5 75.9 48.0 24.4 16.3 16.7 3.1 4.1 1.3 11.3 9.0 13.9 0.1 0.6 0.2 0.9 0.5 0.6 0.3 0.3 0.5 0.6 0.4 0.7 0.3 0.1 0.3 0.9 0.7 1.0 0.3 8.2 14.1 3.2 16.8 16.0 14.8 6.2 7.7 10.0 3.9 10.6 5.9 116.9 105.8 40.3 104.5 15.2 33.4 18.0 34.9 13.6 54.3 29.2 29.7 55.5 15.7 38.8 20.2 81.3 16.9 17.8 25.2 1.9 27.2 2.8 23.1 54.5 152.2 25.1 6.9 202.2 28.1 22.6 47.7 16.8 36.4 23.5 155.1 143.1 19.9 18.7 35.3 190.2 16.3 20.3 24.2 31.7 4.6 33.8 23.5 42.7 170.5 20.2 39.9 16.5 152.8 55.1 46.8 21.1 42.9 9.5 23.9 16.4 12.4 28.0 31.7 65.7 48.8 62.4 33.2 25.0 21.2 35.9 20.0 13.1 0.8 15.5 24.8 BMS1 "BMS1L, KIAA0187" ENSG00000165733 "BMS1 ribosome biogenesis factor" Q14692 10 42782795-42834937 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036589, HPA043081" Uncertain Enhanced "Nucleoplasm,Nucleoli,Mitotic chromosome" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli, Mitotic chromosome" "HPA036589: AB_10601460, HPA043081: AB_2678305" "unprognostic (1.46e-2)" "unprognostic (4.31e-1)" "unprognostic (7.09e-2)" "unprognostic (3.56e-2)" "unprognostic (3.11e-2)" "unprognostic (7.25e-3)" "prognostic unfavorable (1.06e-6)" "unprognostic (1.47e-1)" "unprognostic (1.20e-1)" "unprognostic (1.89e-2)" "unprognostic (3.81e-3)" "unprognostic (1.32e-2)" "unprognostic (2.16e-3)" "unprognostic (7.03e-2)" "unprognostic (1.80e-1)" "unprognostic (3.43e-1)" "unprognostic (4.82e-2)" 8.1 8.3 6.5 8.9 7.2 10.7 8.5 8.6 8.2 8.2 8.5 7.7 6.3 8.2 6.8 9.6 7.3 5.1 9.0 6.1 7.8 8.1 8.1 7.6 10.0 7.4 7.8 8.4 8.8 11.4 7.6 8.2 7.7 7.3 7.9 6.5 8.8 6.9 17.7 10.2 7.8 7.7 6.5 8.7 7.4 8.1 7.0 9.6 7.2 13.4 10.8 10.1 8.3 7.2 32.0 26.7 25.3 29.0 18.8 15.5 24.5 26.1 27.5 30.3 25.9 37.1 24.4 16.9 18.1 22.7 17.0 27.3 42.0 33.8 39.4 24.7 29.3 22.7 20.7 31.9 16.2 61.7 20.4 13.9 16.9 32.7 31.5 16.9 23.2 19.4 40.4 17.7 21.8 27.1 34.6 20.3 32.3 22.0 28.0 31.3 26.7 18.1 16.8 27.7 19.3 20.4 22.9 25.1 21.7 26.2 30.6 17.6 28.3 14.0 50.7 28.4 43.2 14.1 18.7 48.5 20.5 44.9 11.0 3.8 4.6 2.7 7.2 8.2 8.5 8.7 8.9 7.9 7.5 6.1 9.6 8.3 0.6 6.1 7.1 3.9 6.9 5.3 6.5 7.2 8.6 8.2 6.1 7.8 7.4 7.8 7.7 6.5 7.0 7.2 25.6 32.1 33.1 19.6 29.7 22.9 33.9 28.4 14.2 20.7 18.8 17.1 48.0 20.0 37.4 23.9 10.4 27.7 23.6 10.2 21.5 32.3 14.6 28.8 34.5 31.3 16.8 19.5 31.4 34.9 30.0 26.4 16.3 30.0 22.1 36.8 21.4 18.6 19.7 21.9 28.8 11.5 22.4 15.3 22.6 12.1 23.6 19.9 33.8 10.3 35.2 12.8 24.7 20.1 24.0 38.2 8.9 16.6 31.3 32.2 8.8 30.1 49.5 28.7 19.7 35.3 31.4 40.3 56.1 17.1 25.4 24.9 25.3 33.5 18.7 41.4 BNIP1 "Nip1, SEC20" ENSG00000113734 "BCL2 interacting protein 1" Q12981 5 173144442-173164387 "Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, ER-Golgi transport, Host-virus interaction, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008009, HPA008149" Supported Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 55: Plasma cells - Humoral immune response" "Endoplasmic reticulum" "HPA008009: AB_1078291, HPA008149: AB_2667993" "unprognostic (2.11e-1)" "unprognostic (1.72e-1)" "unprognostic (5.89e-2)" "unprognostic (3.08e-1)" "unprognostic (2.57e-1)" "unprognostic (2.94e-2)" "unprognostic (2.71e-2)" "unprognostic (1.50e-1)" "unprognostic (7.38e-2)" "unprognostic (2.70e-2)" "unprognostic (1.84e-2)" "unprognostic (2.28e-1)" "unprognostic (4.40e-3)" "unprognostic (2.10e-1)" "unprognostic (2.13e-1)" "unprognostic (5.61e-2)" "unprognostic (3.07e-2)" 9.5 13.0 14.2 6.6 14.2 34.2 11.3 14.5 16.6 8.3 13.3 9.6 8.7 8.3 12.0 10.2 8.9 7.7 11.6 14.2 15.6 12.4 12.6 8.9 10.3 14.9 14.9 8.6 19.3 10.9 12.3 11.3 15.1 9.1 11.0 12.3 8.8 7.0 13.5 8.8 7.9 9.1 14.0 10.1 10.7 14.9 15.3 11.9 10.9 15.8 9.7 10.3 7.8 15.1 18.2 15.9 18.6 23.2 11.2 26.1 20.7 15.0 23.5 31.4 31.3 27.6 24.3 19.4 17.3 22.5 32.7 14.0 24.4 42.6 31.7 31.8 19.5 17.4 10.6 14.6 29.7 28.1 20.9 14.7 21.1 29.0 36.3 14.8 24.2 27.8 17.1 22.8 25.8 42.3 31.3 24.7 8.2 22.0 18.8 20.4 15.0 23.8 18.0 10.9 23.5 14.6 13.3 16.7 33.5 12.9 28.3 22.1 19.4 26.8 20.0 23.4 30.7 17.3 21.8 30.1 24.8 28.5 17.8 0.1 10.1 4.4 16.9 11.4 14.2 10.5 14.5 12.2 12.6 11.6 12.1 11.9 0.4 11.9 9.8 15.6 14.0 10.1 14.2 14.2 14.5 16.6 14.2 15.6 14.9 14.9 15.1 14.0 15.3 15.1 9.3 3.2 11.4 2.9 10.9 11.6 10.0 13.4 5.2 13.5 9.4 9.5 5.8 7.2 9.7 5.5 4.2 24.2 15.4 7.4 27.4 14.7 3.4 11.5 11.6 9.1 7.2 2.5 3.9 12.3 20.2 9.0 10.7 14.0 1.3 12.6 6.1 6.7 15.6 10.1 4.7 13.7 2.0 7.1 4.9 6.6 8.7 7.9 3.6 4.7 10.1 12.4 13.4 5.5 8.3 8.8 7.4 11.7 10.8 12.4 9.5 15.7 9.8 11.2 0.0 6.1 9.0 32.4 11.3 10.8 10.9 30.1 11.5 14.0 11.5 9.4 BOLA2-SMG1P6 ENSG00000261740 "BOLA2-SMG1P6 readthrough" 16 29443230-29454651 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 21.8;Exocrine glandular cells: 27.3;granulocytes: 18.9;Pancreatic endocrine cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 16: Pancreatic endocrine cells - Mixed function" "unprognostic (2.14e-2)" "unprognostic (2.14e-1)" "unprognostic (2.19e-1)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (4.45e-2)" "unprognostic (3.08e-3)" "unprognostic (7.50e-2)" "unprognostic (9.88e-2)" "unprognostic (2.64e-1)" "unprognostic (8.79e-3)" "unprognostic (2.30e-1)" "unprognostic (3.82e-3)" "unprognostic (9.90e-2)" "unprognostic (5.75e-2)" "unprognostic (1.07e-2)" "unprognostic (9.64e-2)" 11.0 11.7 6.5 8.9 7.0 20.0 8.9 7.5 8.6 7.7 7.2 13.6 8.9 5.1 1.6 13.8 7.1 4.8 15.8 7.1 7.7 15.0 10.2 7.1 14.0 7.1 7.0 5.2 10.9 14.5 6.8 6.0 7.4 6.0 12.8 4.1 9.9 3.0 14.3 9.7 10.2 6.7 7.3 11.5 10.0 8.9 7.0 9.9 5.8 11.0 9.8 8.6 8.8 7.4 17.5 38.1 44.9 18.9 14.7 16.5 25.7 41.3 29.8 31.7 28.5 8.9 37.6 25.8 58.1 25.5 33.5 32.4 12.1 31.6 45.8 28.3 36.4 17.2 21.2 57.9 34.8 44.6 27.4 22.5 26.4 35.3 39.4 17.9 28.0 102.9 51.6 28.5 34.0 57.9 33.5 73.7 78.3 64.0 52.3 35.6 27.8 68.3 37.4 13.4 30.0 57.3 11.1 51.0 57.5 0.5 29.9 68.2 17.8 16.0 16.3 22.2 27.6 34.7 45.6 61.4 31.9 33.7 40.0 1.8 13.9 8.3 13.1 20.7 13.3 14.9 12.1 10.0 21.4 10.8 9.2 13.5 1.8 8.2 28.0 23.8 22.4 11.8 6.5 7.0 7.5 8.6 7.1 7.7 7.1 7.0 7.4 7.3 7.0 7.4 1.9 9.6 9.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.0 2.2 0.0 0.0 8.6 0.0 0.0 3.4 2.7 0.0 3.9 21.8 0.0 1.7 1.8 4.8 0.0 0.0 0.0 27.3 3.0 2.4 0.0 1.9 18.9 0.7 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 9.8 0.0 0.0 0.0 0.0 45.1 0.0 0.0 0.4 0.0 0.0 5.5 5.8 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 2.2 3.7 0.4 0.0 0.0 BPNT2 "FLJ20421, gPAPP, IMPA3, IMPAD1" ENSG00000104331 "3'(2'), 5'-bisphosphate nucleotidase 2" Q9NX62 8 56957931-56993867 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 22.6;Cardiomyocytes: 53.8;Cytotrophoblasts: 18.0;dendritic cells: 16.2;Extravillous trophoblasts: 91.8;Hofbauer cells: 26.6;Syncytiotrophoblasts: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009411 Supported Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 480000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 24: Non-specific - Transcription regulation" "Golgi apparatus" "Nucleoplasm, Cytosol" "HPA009411: AB_1079138" "unprognostic (1.62e-2)" "unprognostic (7.89e-3)" "unprognostic (6.58e-2)" "unprognostic (6.42e-2)" "unprognostic (2.00e-1)" "unprognostic (8.59e-2)" "unprognostic (1.88e-1)" "unprognostic (1.67e-2)" "unprognostic (2.09e-1)" "unprognostic (4.53e-2)" "unprognostic (4.24e-3)" "unprognostic (1.41e-1)" "unprognostic (1.43e-2)" "unprognostic (1.68e-3)" "unprognostic (2.89e-1)" "unprognostic (1.68e-1)" "unprognostic (1.05e-1)" 37.6 37.3 14.8 16.1 19.9 12.4 19.3 19.2 19.8 25.5 8.9 17.4 13.3 21.9 16.2 19.1 13.4 16.5 29.4 16.0 17.9 23.4 36.2 17.2 12.3 17.2 17.6 11.8 19.6 35.6 13.7 24.9 17.7 31.0 17.6 19.7 21.9 23.6 37.4 14.3 12.7 25.7 15.3 15.5 16.9 16.5 18.0 15.4 27.1 30.1 13.3 22.4 12.2 29.3 42.4 34.5 26.0 26.9 78.2 53.3 35.7 62.9 60.9 44.1 38.3 17.4 29.2 26.3 47.0 67.3 31.2 33.7 31.8 42.5 65.0 36.4 22.7 51.4 23.0 31.2 48.5 33.0 35.1 43.2 41.6 39.7 63.9 40.8 59.5 24.3 22.5 46.1 48.9 22.1 40.6 19.8 19.2 48.1 12.7 27.9 23.4 29.7 46.0 24.9 10.1 28.1 35.3 42.9 36.3 27.1 38.4 23.9 50.1 59.3 34.2 59.2 45.8 47.5 42.5 27.8 81.0 27.0 37.3 1.8 0.9 0.5 0.9 0.6 0.7 0.7 0.6 0.5 0.7 0.9 0.6 1.1 2.5 3.2 2.6 1.0 0.4 0.3 14.8 19.9 19.2 19.8 16.0 17.9 17.2 17.6 17.7 15.3 18.0 29.3 22.6 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 0.0 18.0 16.2 0.0 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 0.0 91.8 14.4 0.0 0.0 0.0 0.0 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 33.8 1.8 0.0 0.0 0.0 BSCL2 "GNG3LG, seipin, SPG17" ENSG00000168000 "BSCL2 lipid droplet biogenesis associated, seipin" Q96G97 11 62690275-62709845 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Lipid degradation, Lipid metabolism" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 292.1;pituitary gland: 237.0" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 35.9;Late spermatids: 53.1;Plasma cells: 86.3;Spermatocytes: 32.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 242.1;RPMI-8226: 176.1;SCLC-21H: 181.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042394 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA042394: AB_10794047" "unprognostic (7.78e-2)" "unprognostic (8.74e-2)" "unprognostic (1.24e-1)" "unprognostic (8.17e-2)" "unprognostic (3.08e-2)" "unprognostic (2.01e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (9.30e-2)" "unprognostic (4.44e-2)" "unprognostic (5.13e-3)" "unprognostic (2.41e-1)" "prognostic favorable (7.55e-5)" "unprognostic (3.56e-1)" "unprognostic (1.69e-1)" "unprognostic (1.70e-1)" "unprognostic (1.96e-1)" 24.9 88.1 126.6 7.4 133.2 12.0 26.2 75.0 155.6 38.2 85.4 24.3 10.8 28.4 156.7 24.1 63.7 21.5 18.7 134.9 292.1 50.8 39.3 26.7 15.3 138.1 139.0 32.7 79.4 61.7 237.0 10.0 203.4 35.4 13.3 52.6 66.1 30.3 30.9 25.1 17.2 13.7 83.1 16.2 37.1 190.3 169.3 14.4 37.9 15.5 8.9 17.5 26.1 89.9 18.0 61.7 49.6 83.8 130.8 41.5 7.2 7.2 34.4 13.6 14.5 9.6 26.3 11.9 16.5 25.2 11.8 62.1 5.2 21.8 7.0 30.7 5.0 10.9 33.4 7.8 27.7 9.7 13.5 27.8 16.6 26.9 10.9 19.7 10.8 33.0 7.8 242.1 19.8 44.0 11.4 21.8 132.4 13.9 13.0 21.3 4.2 176.1 65.0 2.4 181.2 29.4 28.2 13.9 25.3 5.7 41.3 15.3 6.5 16.5 3.7 24.5 4.2 32.2 72.5 16.6 82.4 3.2 14.5 26.6 59.2 34.6 24.7 46.2 27.4 27.5 25.5 26.1 42.4 29.7 25.7 27.0 14.2 41.0 40.3 54.3 33.1 43.3 126.6 133.2 75.0 155.6 134.9 292.1 138.1 139.0 203.4 83.1 169.3 89.9 0.8 16.0 5.6 0.0 7.1 1.7 1.0 1.4 35.9 2.5 3.6 2.2 0.2 1.5 1.6 3.7 0.0 2.4 0.9 1.7 3.9 2.0 25.5 4.8 1.5 2.9 0.0 8.8 0.0 1.1 1.9 9.2 20.4 1.5 2.5 0.7 1.4 2.1 1.9 3.3 0.0 1.6 6.1 2.5 3.1 53.1 2.5 6.2 12.4 0.0 0.7 0.8 1.0 0.0 0.0 0.5 1.6 3.0 86.3 0.9 2.5 6.0 23.9 1.2 6.6 1.2 4.1 32.6 18.1 24.7 4.0 1.5 6.5 0.7 1.2 0.5 C11orf49 "FLJ22210, MGC4707" ENSG00000149179 "Chromosome 11 open reading frame 49" Q9H6J7 11 46936689-47164385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 140.0;Excitatory neurons: 140.8;Inhibitory neurons: 112.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040051, HPA040280" Uncertain Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 88: Choroid plexus - Transmembrane transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles" "HPA040051: AB_10795412, HPA040280: AB_10795363" "unprognostic (3.11e-2)" "unprognostic (3.01e-1)" "unprognostic (2.15e-1)" "unprognostic (1.06e-2)" "unprognostic (6.65e-2)" "unprognostic (7.76e-2)" "prognostic unfavorable (2.18e-5)" "unprognostic (1.27e-1)" "unprognostic (2.76e-1)" "unprognostic (1.72e-1)" "unprognostic (2.14e-2)" "unprognostic (1.55e-1)" "unprognostic (1.54e-2)" "unprognostic (1.36e-1)" "unprognostic (1.11e-1)" "unprognostic (1.07e-1)" "unprognostic (5.34e-3)" 8.1 13.4 52.4 6.2 51.6 3.3 10.0 45.9 54.7 15.6 46.1 14.3 11.2 16.8 14.1 9.7 32.5 9.6 12.3 52.4 53.3 15.7 3.9 12.1 6.3 47.0 53.9 14.9 12.7 22.6 30.3 6.8 49.2 12.4 11.4 21.8 11.0 13.2 7.3 31.6 11.9 12.8 46.2 7.0 15.4 20.2 53.7 13.7 16.1 6.4 7.2 11.9 11.4 45.5 10.9 30.6 37.9 27.9 17.8 25.7 9.5 11.7 26.9 24.6 29.9 6.9 17.0 9.1 12.3 24.4 29.7 14.8 18.8 28.7 20.9 18.1 27.2 12.2 36.6 12.6 30.5 14.6 16.2 17.5 19.1 11.2 16.4 47.0 27.6 22.1 10.3 11.7 18.2 22.8 23.0 16.2 14.3 26.5 16.4 8.2 9.5 10.1 43.3 11.7 25.5 36.5 13.4 14.9 14.7 19.7 25.0 8.5 6.5 13.8 11.0 22.0 17.7 10.4 9.2 7.5 33.7 3.0 17.5 12.7 10.2 9.0 19.2 13.7 23.0 24.1 18.1 22.7 24.6 17.6 19.1 20.3 0.3 25.2 10.3 21.8 19.0 18.3 52.4 51.6 45.9 54.7 52.4 53.3 47.0 53.9 49.2 46.2 53.7 45.5 6.6 9.6 26.7 140.0 9.9 13.0 16.4 30.6 12.0 22.9 12.0 13.0 9.4 12.8 24.0 23.9 18.8 19.4 5.6 18.3 46.9 30.2 53.2 42.8 20.4 10.2 19.2 8.0 140.8 20.4 13.4 18.0 25.5 14.1 16.4 23.3 8.6 2.4 9.9 37.0 112.7 12.8 22.4 3.3 7.0 35.8 12.8 6.2 12.4 41.2 10.9 45.0 7.2 93.0 71.9 16.2 21.2 20.3 5.8 8.1 22.1 33.4 66.7 53.1 6.6 12.2 13.5 63.3 7.6 10.5 18.0 10.0 10.8 32.6 13.7 12.1 C12orf4 ENSG00000047621 "Chromosome 12 open reading frame 4" Q9NQ89 12 4487735-4538508 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037871 Uncertain Approved "Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Nuclear bodies" "HPA037871: AB_10670531" "unprognostic (5.88e-2)" "unprognostic (2.81e-1)" "unprognostic (5.64e-2)" "unprognostic (2.51e-2)" "unprognostic (3.07e-2)" "unprognostic (6.69e-2)" "unprognostic (2.96e-3)" "unprognostic (8.59e-2)" "unprognostic (6.85e-2)" "unprognostic (2.75e-2)" "unprognostic (2.26e-2)" "unprognostic (5.93e-2)" "unprognostic (1.26e-2)" "unprognostic (7.83e-2)" "unprognostic (2.74e-1)" "unprognostic (5.02e-2)" "unprognostic (3.92e-1)" 7.5 5.4 6.6 8.9 7.6 9.2 7.3 7.7 9.1 6.6 5.6 7.0 4.3 6.6 5.3 7.1 5.5 6.5 7.4 7.8 6.0 6.0 5.9 6.7 10.1 5.6 6.3 5.3 4.7 6.2 4.7 9.6 6.0 7.4 8.1 10.0 4.9 6.6 10.5 5.9 5.1 9.4 5.9 7.9 5.7 9.2 7.0 9.2 7.9 10.8 10.2 8.6 5.0 7.6 14.6 11.0 13.4 15.9 13.1 19.5 28.4 27.6 11.4 24.9 30.3 19.5 11.8 12.4 5.6 17.9 20.5 10.6 19.0 15.9 33.6 37.1 13.0 21.5 10.3 9.6 19.0 18.7 19.4 17.4 8.8 29.9 33.4 15.6 14.4 15.1 12.8 20.9 23.5 7.0 14.9 7.9 19.8 12.6 10.4 16.0 21.1 7.9 15.3 15.1 5.3 10.4 18.9 13.6 11.9 36.4 5.7 15.9 15.0 21.6 19.9 23.8 29.3 4.8 6.8 30.2 16.0 15.1 20.4 0.0 7.5 2.8 4.2 12.7 4.6 4.7 4.1 4.3 6.6 5.2 4.5 4.0 2.4 4.4 15.1 6.9 6.9 4.3 6.6 7.6 7.7 9.1 7.8 6.0 5.6 6.3 6.0 5.9 7.0 7.6 9.8 16.0 12.0 21.5 9.2 2.9 3.0 5.5 7.4 11.8 5.2 5.3 14.3 2.8 8.9 3.7 29.2 7.4 11.4 5.2 3.9 7.6 40.9 7.3 11.8 8.2 6.0 16.0 43.0 8.2 8.5 8.1 1.5 4.4 1.3 9.7 7.5 5.4 28.2 8.4 32.4 5.3 4.1 13.3 4.7 29.9 8.1 11.4 1.8 30.0 8.5 6.8 8.2 32.6 39.2 8.3 3.2 6.8 15.5 2.2 4.6 5.4 8.6 12.3 6.6 9.7 9.6 22.0 16.2 6.4 3.3 6.2 8.2 8.0 6.0 1.9 C4orf46 "LOC201725, RCDG1" ENSG00000205208 "Chromosome 4 open reading frame 46" Q504U0 4 158666675-158672255 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 49.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047287, HPA052670" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA047287: AB_2680011, HPA052670: " "unprognostic (2.71e-1)" "unprognostic (2.38e-1)" "unprognostic (1.41e-2)" "unprognostic (2.57e-1)" "unprognostic (2.26e-1)" "unprognostic (6.10e-2)" "unprognostic (6.27e-5)" "unprognostic (1.60e-1)" "unprognostic (4.71e-2)" "unprognostic (4.20e-2)" "unprognostic (1.35e-1)" "unprognostic (5.29e-2)" "unprognostic (4.56e-2)" "unprognostic (5.15e-2)" "unprognostic (1.19e-1)" "unprognostic (5.69e-2)" "unprognostic (9.06e-3)" 2.5 2.4 1.9 4.1 2.4 14.5 2.9 2.4 2.8 2.7 1.3 3.3 3.0 5.0 2.1 2.9 2.4 2.8 3.7 1.9 1.9 1.9 1.5 2.6 6.0 2.3 2.2 4.2 2.4 1.7 1.1 4.5 2.3 2.4 4.2 9.4 1.7 2.2 2.1 2.9 2.8 4.0 2.1 3.2 2.6 12.8 2.0 10.2 4.3 6.0 5.4 2.6 2.0 2.9 16.6 9.9 23.7 35.0 10.3 10.6 11.8 27.5 18.9 31.5 27.4 8.9 14.6 29.3 4.3 14.0 11.6 9.0 20.6 14.2 40.3 40.5 10.7 44.5 10.4 11.9 3.5 33.9 23.7 6.2 5.0 25.6 11.2 10.4 22.7 29.3 19.7 72.1 43.2 8.9 65.8 29.7 16.3 10.6 13.0 47.0 13.5 13.0 9.6 8.1 12.8 38.5 12.1 10.9 10.1 11.9 9.3 26.9 12.0 48.0 22.1 27.0 23.2 16.5 22.3 37.0 12.1 29.8 18.9 2.4 1.9 1.7 1.9 1.6 1.4 1.7 1.5 1.9 2.1 1.4 2.1 2.3 0.6 3.4 2.2 1.8 1.8 1.3 1.9 2.4 2.4 2.8 1.9 1.9 2.3 2.2 2.3 2.1 2.0 2.9 10.3 3.2 1.8 1.3 7.8 24.1 5.1 5.8 14.2 7.5 6.5 5.2 7.6 1.5 3.2 1.8 4.2 9.8 8.2 2.9 7.9 3.6 0.8 7.6 10.8 6.9 7.7 11.2 1.2 3.0 11.8 14.5 4.6 15.0 7.0 8.7 5.0 2.0 9.7 10.1 1.8 5.1 6.1 10.3 25.8 1.8 4.7 7.6 19.6 0.0 18.9 6.5 5.2 1.0 6.2 3.8 3.1 6.0 18.1 6.6 3.2 2.8 3.3 28.2 6.6 7.7 10.6 49.1 15.2 30.1 15.6 3.3 9.6 2.5 5.8 7.2 C8orf33 FLJ20989 ENSG00000182307 "Chromosome 8 open reading frame 33" Q9H7E9 8 145052465-145066685 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 180.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024812, HPA026104" Approved Uncertain "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Plasma membrane" "HPA024812: AB_10599490, HPA026104: AB_10600875" "prognostic unfavorable (2.77e-4)" "unprognostic (6.51e-3)" "unprognostic (1.85e-1)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (8.95e-4)" "unprognostic (4.75e-2)" "unprognostic (3.51e-1)" "unprognostic (2.45e-2)" "unprognostic (5.17e-2)" "unprognostic (2.71e-1)" "unprognostic (1.05e-1)" "unprognostic (5.29e-2)" "unprognostic (1.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" 16.5 42.1 32.3 13.1 32.1 18.2 24.8 33.5 41.7 17.7 28.3 21.7 13.1 20.4 27.1 19.5 22.8 16.5 22.3 32.0 33.1 18.7 17.1 15.0 18.2 33.3 34.3 40.7 20.8 34.0 5.6 21.1 32.8 18.8 33.4 24.6 16.4 24.2 16.9 17.4 10.2 19.6 32.4 12.2 11.5 13.1 32.7 19.3 33.2 26.0 18.4 18.8 8.9 33.3 28.3 32.7 45.8 22.7 51.3 35.5 17.2 16.6 41.7 42.0 23.3 9.2 39.2 30.3 55.3 40.5 19.5 22.4 67.5 41.2 45.3 15.0 48.4 38.1 32.1 11.5 53.1 30.6 15.1 41.0 60.4 43.0 96.8 34.5 28.1 44.9 75.4 26.3 46.1 42.4 86.3 12.3 31.8 89.1 55.2 51.2 14.9 46.6 44.1 16.3 44.1 39.1 44.3 39.3 39.0 26.1 41.1 29.1 13.8 27.5 37.3 24.2 37.8 21.7 16.9 72.2 65.9 47.0 55.1 1.0 13.7 8.7 16.3 17.4 18.4 13.4 16.2 17.8 19.6 13.3 21.3 15.6 1.4 28.2 16.0 18.4 12.6 16.3 32.3 32.1 33.5 41.7 32.0 33.1 33.3 34.3 32.8 32.4 32.7 33.3 67.8 28.9 27.2 4.9 34.8 44.4 32.8 31.9 24.5 48.3 52.8 47.9 18.4 45.8 33.8 25.8 31.3 36.9 45.3 180.5 62.6 79.5 5.6 49.9 55.1 50.2 35.3 17.5 5.7 64.9 40.2 41.7 20.9 53.0 21.5 58.5 37.1 66.8 28.7 50.5 6.0 36.4 14.2 21.5 21.2 5.6 37.9 23.0 16.0 7.5 32.3 61.2 45.3 4.0 6.0 55.3 37.7 38.7 20.4 48.1 22.1 66.1 26.6 54.5 26.3 32.8 37.9 26.2 34.8 25.4 42.9 24.9 23.6 94.9 53.0 28.5 C8orf82 MGC70857 ENSG00000213563 "Chromosome 8 open reading frame 82" Q6P1X6 8 144525733-144529132 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 138.9;Proximal tubular cells: 99.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "PC-3: 46.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB034331 Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "CAB034331: AB_1565393" "unprognostic (3.56e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (1.63e-2)" "unprognostic (8.60e-2)" "unprognostic (6.31e-3)" "unprognostic (1.95e-1)" "unprognostic (4.57e-2)" "unprognostic (3.82e-1)" "unprognostic (1.22e-1)" "unprognostic (3.61e-1)" "unprognostic (4.09e-2)" "prognostic favorable (1.70e-5)" "unprognostic (5.72e-3)" "unprognostic (3.51e-1)" "unprognostic (1.41e-1)" "unprognostic (1.87e-3)" 10.6 14.6 9.0 4.5 8.6 2.8 11.4 11.1 10.5 14.7 4.2 14.1 11.1 11.8 2.6 16.7 11.9 3.8 17.0 8.2 7.5 16.2 35.6 8.6 3.8 9.4 8.1 15.1 13.2 6.6 12.2 3.3 8.6 26.3 3.8 4.6 11.6 5.5 12.0 9.1 11.7 2.8 7.2 9.9 12.3 7.4 8.4 4.5 12.6 3.5 2.4 15.0 11.8 11.5 6.8 16.8 9.8 7.9 4.0 3.4 8.2 7.2 3.9 3.9 3.9 8.3 11.2 11.9 11.4 4.5 3.3 8.1 2.2 2.5 1.4 9.0 25.7 23.0 10.4 15.6 4.2 3.5 10.8 5.1 5.5 2.5 2.5 6.4 2.7 6.6 19.1 5.9 2.9 35.7 8.9 14.2 5.3 10.1 46.6 9.9 3.3 5.8 6.1 10.1 33.3 27.3 11.0 7.8 7.1 3.3 14.3 7.1 14.6 7.5 28.7 8.4 5.3 4.2 2.8 9.8 9.9 4.3 7.3 0.1 0.3 0.3 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.2 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.0 9.0 8.6 11.1 10.5 8.2 7.5 9.4 8.1 8.6 7.2 8.4 11.5 12.2 3.2 6.9 0.3 12.9 15.9 49.6 1.9 23.3 30.4 39.6 38.6 17.9 18.6 1.9 16.5 14.6 33.4 13.0 46.3 138.9 5.8 16.8 10.3 22.1 12.3 34.2 14.9 0.1 7.7 35.1 18.5 19.4 26.0 5.7 16.3 9.7 69.8 18.6 28.6 0.1 31.9 2.0 16.1 16.1 21.4 24.2 15.2 33.8 0.0 7.5 28.0 13.4 0.0 0.1 6.7 22.1 20.3 16.3 55.6 35.4 99.1 0.4 35.8 32.9 21.1 23.0 24.4 18.8 36.9 20.9 25.2 13.1 34.5 34.6 43.3 CALU ENSG00000128595 Calumenin O43852 7 128739292-128773400 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Extravillous trophoblasts: 504.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 2467.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006018 Supported Supported "Endoplasmic reticulum" "Intracellular and membrane" NA NA 21000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" "HPA006018: AB_1845934" "unprognostic (7.22e-3)" "unprognostic (1.16e-3)" "unprognostic (3.16e-1)" "unprognostic (8.86e-2)" "unprognostic (1.27e-1)" "unprognostic (9.52e-3)" "prognostic unfavorable (1.80e-4)" "unprognostic (1.05e-3)" "unprognostic (1.95e-1)" "unprognostic (1.38e-1)" "unprognostic (2.75e-3)" "unprognostic (2.31e-1)" "prognostic unfavorable (1.30e-11)" "unprognostic (3.80e-3)" "unprognostic (1.66e-1)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.60e-5)" 115.8 56.6 20.6 137.9 22.7 22.8 66.2 22.8 28.5 133.5 54.7 97.5 37.6 113.6 61.1 60.4 57.1 92.7 236.9 24.5 23.5 45.1 74.2 68.5 38.8 24.1 22.2 54.8 52.6 85.0 28.8 211.8 24.2 113.0 81.3 19.6 67.7 150.1 82.1 29.9 40.0 328.4 22.3 47.5 62.5 39.8 33.2 31.0 77.1 117.1 45.2 160.1 48.2 26.6 257.8 207.4 486.6 152.7 1348.5 1229.5 270.9 1821.7 1378.1 577.5 770.7 238.6 388.3 100.0 351.5 2467.8 850.4 144.9 258.2 318.2 826.5 80.6 138.2 136.6 283.7 295.0 657.1 187.2 254.3 930.5 223.6 868.3 370.6 904.4 537.3 116.4 237.9 172.8 1131.8 141.0 130.2 95.5 305.2 247.0 197.3 122.9 333.3 164.5 243.5 132.7 44.3 238.2 595.4 481.5 753.1 932.2 106.2 145.6 799.8 1706.6 234.2 1350.8 754.6 306.8 385.7 224.8 1478.6 223.6 1857.2 21.7 38.8 23.5 28.3 41.4 27.9 23.7 19.5 22.0 33.4 16.6 17.1 20.0 4.5 26.2 35.7 32.9 23.4 31.2 20.6 22.7 22.8 28.5 24.5 23.5 24.1 22.2 24.2 22.3 33.2 26.6 67.3 22.4 38.5 25.5 29.9 81.3 68.1 82.0 31.3 28.2 51.7 42.7 247.0 25.8 62.7 25.8 18.8 116.8 25.0 14.4 17.6 69.5 11.4 37.5 186.3 104.0 19.7 42.3 37.7 60.5 504.7 198.8 37.2 72.8 59.6 62.6 113.2 54.2 136.9 28.6 47.0 55.9 22.4 58.9 70.7 9.3 100.3 44.6 120.9 27.2 26.3 32.4 21.6 31.2 32.2 71.5 11.4 118.8 140.9 110.6 12.6 17.7 57.2 12.8 59.2 64.9 162.8 27.1 41.9 30.9 76.9 243.0 30.9 69.7 26.1 90.5 CAPRIN1 "caprin-1, GPIAP1, M11S1, RNG105" ENSG00000135387 "Cell cycle associated protein 1" Q14444 11 34051731-34102610 "Predicted intracellular proteins" Differentiation "Protein synthesis inhibitor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 483.0;Late spermatids: 289.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018126, HPA063617" Approved Enhanced Cytosol NA NA 43000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Cytosol "HPA018126: AB_1849929, HPA063617: AB_2685062" "unprognostic (3.79e-1)" "unprognostic (3.85e-2)" "unprognostic (3.51e-3)" "unprognostic (1.12e-1)" "unprognostic (2.28e-1)" "unprognostic (1.97e-2)" "prognostic unfavorable (8.67e-8)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" "unprognostic (1.13e-1)" "unprognostic (1.93e-3)" "unprognostic (2.90e-1)" "unprognostic (2.87e-2)" "unprognostic (2.55e-1)" "unprognostic (1.37e-2)" "unprognostic (1.22e-1)" "unprognostic (1.22e-1)" 45.2 30.6 26.1 42.2 28.6 70.3 56.8 25.0 30.9 56.8 21.8 48.8 46.0 52.7 30.5 47.1 61.8 41.7 44.9 28.7 28.3 49.9 39.9 43.3 42.9 26.1 26.7 60.5 47.5 59.9 21.6 53.8 27.3 45.7 60.5 58.7 38.6 53.5 45.3 30.3 41.1 66.2 32.3 40.1 42.1 123.0 26.9 77.6 53.3 54.0 62.6 58.9 31.8 36.7 134.7 168.8 245.6 137.2 180.9 182.5 117.5 168.0 175.8 202.4 188.2 154.9 80.8 211.1 104.9 213.9 169.4 173.1 311.9 204.3 244.9 134.7 155.5 174.1 153.3 131.9 109.4 282.0 122.8 164.0 109.2 129.1 236.3 174.7 204.2 153.7 228.1 103.6 211.3 114.5 243.7 55.8 114.8 155.3 150.6 191.8 339.2 93.7 120.4 263.1 155.5 147.7 202.6 101.1 88.8 150.5 183.5 104.4 205.3 172.7 116.4 167.9 190.8 110.9 175.5 238.7 117.2 116.3 191.7 25.0 33.3 13.9 18.8 39.7 27.3 19.4 20.9 23.2 39.0 17.8 21.6 21.1 13.5 30.7 43.4 18.2 28.1 31.0 26.1 28.6 25.0 30.9 28.7 28.3 26.1 26.7 27.3 32.3 26.9 36.7 42.1 35.3 43.5 37.9 46.0 77.8 45.5 51.5 68.9 38.1 63.7 43.9 55.4 24.3 37.2 64.4 18.8 46.7 47.2 46.0 31.3 56.6 483.0 90.0 116.5 52.1 71.8 79.0 37.4 60.1 60.2 54.6 65.7 132.2 17.1 63.1 39.7 46.1 57.2 25.2 38.8 51.1 54.9 75.8 72.3 289.3 47.8 57.9 39.2 37.5 57.0 36.7 35.0 44.2 53.1 71.3 40.4 72.6 83.0 72.7 42.9 47.4 49.5 32.3 39.5 40.4 64.3 201.7 74.8 93.2 72.9 45.8 46.5 53.9 65.5 77.7 CAST ENSG00000153113 Calpastatin P20810 5 96525267-96779595 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 858.4;Early spermatids: 979.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009491, HPA036881, HPA036882, HPA075906" Enhanced Enhanced "Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA 17000000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 34: Spermatids - Unknown function" "Endoplasmic reticulum, Cytosol" "Plasma membrane" "CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: " "unprognostic (2.17e-1)" "unprognostic (1.39e-1)" "unprognostic (2.44e-2)" "unprognostic (1.91e-2)" "unprognostic (4.68e-2)" "unprognostic (1.45e-1)" "unprognostic (3.79e-1)" "unprognostic (4.53e-3)" "unprognostic (1.94e-2)" "unprognostic (6.11e-3)" "prognostic unfavorable (9.27e-5)" "unprognostic (2.66e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (1.20e-5)" "unprognostic (1.16e-1)" "unprognostic (2.79e-1)" "prognostic unfavorable (4.98e-4)" 144.4 68.4 32.3 86.1 36.3 119.1 104.1 35.0 40.8 147.2 55.5 160.1 120.5 83.8 49.0 342.8 79.7 78.7 303.7 30.7 42.2 82.0 116.8 112.1 52.9 46.7 43.2 83.1 56.1 111.7 51.2 116.1 44.4 100.2 148.2 17.1 130.0 78.7 317.3 157.4 137.2 92.2 38.3 64.1 100.5 98.8 39.1 43.1 97.9 166.4 104.3 129.4 216.4 41.7 300.3 239.7 42.6 112.1 240.1 390.1 145.4 220.9 288.8 169.1 215.8 60.4 189.6 44.1 189.8 286.1 263.1 465.6 81.3 283.5 202.8 292.4 78.5 65.9 251.0 71.1 172.9 38.9 100.1 201.8 254.8 239.6 375.0 222.9 194.8 33.5 51.7 144.5 196.4 98.0 17.9 2.0 35.4 85.0 89.9 18.2 141.9 78.3 327.1 114.1 179.6 45.0 222.6 118.2 142.5 94.0 77.4 39.5 263.9 239.0 94.6 154.9 211.4 51.2 140.4 22.1 264.7 21.8 67.5 10.5 156.6 24.1 75.6 85.3 74.1 79.4 68.2 76.9 107.5 79.1 34.8 45.7 38.2 61.6 109.8 28.8 79.2 108.1 32.3 36.3 35.0 40.8 30.7 42.2 46.7 43.2 44.4 38.3 39.1 41.7 251.6 403.8 221.4 58.1 153.8 239.6 439.8 223.6 169.0 39.4 133.6 84.5 858.4 163.0 277.0 108.5 18.8 181.2 227.1 484.0 133.1 263.6 979.7 348.0 213.4 188.5 142.1 229.3 60.2 249.7 96.2 259.0 153.4 327.8 177.1 71.8 138.8 169.3 113.7 13.5 53.0 253.9 103.7 209.4 259.1 414.4 172.1 243.8 131.6 63.7 354.4 36.9 293.6 33.2 70.2 325.1 346.8 146.3 126.3 314.7 302.9 152.3 379.0 19.5 92.1 267.8 175.0 23.6 17.9 348.9 251.7 140.8 207.7 69.8 221.2 548.5 CCDC137 MGC16597 ENSG00000185298 "Coiled-coil domain containing 137" Q6PK04 17 81666737-81673904 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052637, HPA053914" Uncertain Enhanced "Nucleoli,Mitotic chromosome" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Mitotic chromosome" "HPA052637: AB_2681894, HPA053914: AB_2682306" "unprognostic (3.04e-1)" "unprognostic (5.82e-2)" "unprognostic (1.76e-1)" "unprognostic (3.07e-2)" "unprognostic (1.68e-2)" "unprognostic (2.24e-1)" "prognostic unfavorable (1.35e-7)" "prognostic unfavorable (8.32e-4)" "unprognostic (2.21e-2)" "unprognostic (8.33e-3)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (1.16e-7)" "unprognostic (4.26e-2)" "unprognostic (2.01e-1)" "unprognostic (3.93e-1)" "unprognostic (1.39e-1)" 8.2 9.5 13.8 12.3 13.7 17.7 7.6 13.5 17.5 10.7 14.2 9.3 11.4 7.5 5.5 23.1 7.8 6.1 6.5 13.7 13.8 10.2 10.8 7.7 16.3 14.4 14.3 6.7 8.2 7.0 6.2 7.7 14.7 11.7 5.8 2.8 9.9 6.4 7.7 22.8 10.7 6.0 13.4 15.6 8.8 10.4 14.5 11.8 7.8 4.5 11.5 9.8 13.8 14.3 38.0 62.8 21.5 35.3 13.9 13.1 35.2 41.6 19.7 53.0 30.6 55.1 22.8 33.8 22.4 21.2 36.6 47.9 34.5 43.8 30.6 19.4 51.7 51.6 30.1 48.0 20.7 46.6 37.5 19.8 26.3 47.6 26.3 14.6 37.4 41.1 53.3 19.1 28.3 34.5 45.7 56.6 46.9 32.9 59.8 55.4 34.6 24.1 19.8 29.6 45.1 57.7 41.1 87.8 37.1 28.9 58.8 48.3 27.8 82.0 53.5 34.9 65.9 53.1 28.7 36.8 30.8 42.9 48.8 2.2 7.7 11.7 11.5 9.6 6.3 10.4 8.7 8.8 7.5 13.2 9.2 8.8 3.3 13.1 11.9 12.9 9.8 5.9 13.8 13.7 13.5 17.5 13.7 13.8 14.4 14.3 14.7 13.4 14.5 14.3 17.9 22.4 17.0 5.9 29.8 31.7 22.8 19.7 74.6 6.8 17.4 13.7 6.7 15.7 20.9 12.9 2.1 25.7 31.5 19.7 19.6 25.2 1.7 26.5 32.9 20.3 7.2 37.5 4.5 21.4 41.0 16.5 29.0 29.4 19.6 28.1 15.4 11.8 24.3 18.5 4.6 17.0 14.2 12.9 11.5 1.7 13.7 16.8 16.0 4.7 24.2 13.8 37.0 4.0 5.0 35.2 16.0 13.5 25.7 40.0 12.4 15.9 21.6 9.1 6.6 13.7 22.3 30.8 44.9 57.0 34.4 20.8 29.7 22.8 22.4 24.2 CCDC142 FLJ14397 ENSG00000135637 "Coiled-coil domain containing 142" Q17RM4 2 74471986-74483408 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 28.3;Respiratory ciliated cells: 31.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA056946 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" "HPA056946: AB_2683282" "unprognostic (2.00e-1)" "unprognostic (3.25e-2)" "unprognostic (3.93e-2)" "prognostic unfavorable (1.87e-4)" "unprognostic (1.73e-1)" "unprognostic (1.69e-3)" "prognostic unfavorable (4.46e-4)" "unprognostic (9.05e-2)" "unprognostic (5.15e-2)" "unprognostic (2.44e-2)" "unprognostic (5.65e-3)" "unprognostic (8.94e-3)" "prognostic unfavorable (3.71e-7)" "unprognostic (1.31e-1)" "unprognostic (1.46e-1)" "unprognostic (3.27e-2)" "unprognostic (5.31e-3)" 1.9 2.6 3.0 2.4 2.9 1.5 1.9 5.6 3.5 2.7 3.6 2.8 4.4 2.6 1.3 2.4 2.4 1.2 1.8 2.8 2.6 2.2 4.6 1.8 2.6 3.5 2.7 2.6 2.2 2.7 2.9 1.2 3.1 2.8 1.9 1.3 2.4 2.0 1.5 2.6 3.3 1.5 2.3 3.3 2.4 3.2 3.1 2.5 2.4 1.2 2.2 2.3 2.0 4.1 2.7 2.1 4.3 3.4 2.8 2.7 7.5 4.0 2.4 3.2 2.4 6.3 3.8 3.2 2.6 2.5 3.9 4.8 2.8 3.1 2.1 4.5 8.9 5.6 7.7 4.6 1.2 3.6 4.2 1.9 2.1 5.0 2.1 4.1 2.5 3.8 2.6 2.2 3.0 2.3 4.8 3.6 4.1 4.7 5.3 5.7 7.8 2.9 1.9 3.9 5.5 3.4 3.1 6.4 3.5 3.1 4.3 2.5 2.1 6.3 4.0 4.4 4.9 6.6 3.1 3.2 2.9 1.9 3.7 6.3 3.0 5.9 5.1 1.8 4.1 3.3 2.9 3.6 1.6 5.3 4.6 3.8 2.4 4.7 3.8 2.9 1.4 1.1 3.0 2.9 5.6 3.5 2.8 2.6 3.5 2.7 3.1 2.3 3.1 4.1 2.5 9.6 28.3 3.3 6.1 3.2 2.4 1.4 1.8 16.4 2.8 2.0 4.1 2.8 16.2 0.0 18.8 3.1 6.1 6.2 1.9 2.7 1.1 1.3 4.2 5.6 6.0 4.8 3.3 2.0 2.2 6.7 4.1 1.8 18.3 8.6 6.8 2.1 2.0 5.0 3.6 5.3 0.0 3.3 3.0 0.4 7.5 5.8 0.0 5.6 4.2 11.5 16.5 2.5 2.4 1.5 5.7 6.0 4.6 1.7 14.0 1.3 31.2 22.9 0.0 6.1 4.0 8.1 5.0 1.2 3.0 1.9 7.7 5.9 6.3 2.0 CCDC43 FLJ31795 ENSG00000180329 "Coiled-coil domain containing 43" Q96MW1 17 44673069-44689779 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 73.5" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023078, HPA023391" Enhanced Enhanced Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA023078: , HPA023391: AB_1846146" "unprognostic (6.05e-2)" "unprognostic (8.91e-2)" "unprognostic (8.75e-3)" "unprognostic (3.58e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (3.42e-5)" "prognostic unfavorable (1.33e-4)" "unprognostic (1.89e-1)" "unprognostic (1.14e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (2.08e-1)" "unprognostic (1.63e-2)" "unprognostic (1.13e-1)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.11e-1)" 9.6 10.2 9.5 11.4 10.3 20.8 12.5 11.5 14.3 9.3 8.1 12.1 11.7 10.0 10.9 12.0 9.3 7.5 20.4 10.6 10.3 14.2 9.5 9.7 13.5 9.5 9.0 8.1 9.6 15.4 4.8 14.0 10.2 12.0 14.9 18.5 8.9 8.9 73.5 11.3 9.7 10.8 9.8 9.8 11.2 9.5 10.4 13.8 13.5 42.7 14.6 11.8 8.1 11.5 24.9 29.3 27.2 24.1 18.2 26.7 49.8 37.1 21.8 35.7 34.9 39.7 26.0 43.1 28.0 30.4 25.5 19.2 45.3 42.9 51.5 53.1 52.5 38.8 48.8 59.0 32.5 54.8 28.0 24.1 42.7 37.2 50.2 24.4 35.1 34.8 41.6 29.3 36.6 31.0 53.7 38.8 28.2 23.5 37.1 34.5 68.2 37.6 36.7 16.0 27.3 26.9 27.2 21.6 39.5 40.7 55.2 36.6 30.6 43.9 32.5 26.6 50.0 29.5 40.1 49.4 32.1 31.4 32.2 11.6 15.7 11.0 11.9 18.4 11.0 9.1 11.3 13.7 17.5 11.3 11.0 12.0 3.2 16.4 12.5 12.4 15.1 10.2 9.5 10.3 11.5 14.3 10.6 10.3 9.5 9.0 10.2 9.8 10.4 11.5 24.4 12.8 21.0 6.8 19.1 13.3 10.8 20.0 13.1 24.4 15.2 15.7 41.1 17.2 21.5 9.2 10.4 41.1 13.4 10.7 39.2 21.6 0.9 23.4 27.1 23.9 18.0 15.4 10.5 24.5 46.7 17.1 13.7 24.0 32.4 19.9 20.0 15.5 30.6 21.9 8.2 17.1 8.2 18.8 16.0 3.5 14.0 19.2 21.4 1.0 24.6 19.6 9.2 6.6 6.5 21.0 12.4 12.8 26.9 12.9 15.0 36.8 19.8 25.4 6.6 23.4 17.5 3.6 12.4 24.8 11.2 25.3 16.7 22.6 22.6 8.7 CCDC77 MGC13183 ENSG00000120647 "Coiled-coil domain containing 77" Q9BR77 12 389273-442642 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 24.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038854 Approved Approved "Nuclear membrane" NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 5: NTERA-2 - Transcription" "Cluster 12: Non-specific - Cell cycle regulation" "Nuclear membrane" "HPA038854: AB_10673121" "unprognostic (3.25e-1)" "unprognostic (2.32e-1)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (7.26e-3)" "unprognostic (2.34e-1)" "prognostic unfavorable (8.11e-7)" "unprognostic (2.54e-2)" "unprognostic (3.41e-3)" "unprognostic (2.89e-1)" "unprognostic (3.82e-1)" "unprognostic (2.62e-1)" "unprognostic (4.11e-3)" "unprognostic (1.27e-2)" "unprognostic (1.08e-1)" "unprognostic (3.19e-2)" "unprognostic (4.41e-3)" 3.4 5.0 3.1 6.2 4.9 4.6 4.5 3.1 4.9 3.6 1.8 4.1 4.6 5.0 2.2 4.1 3.8 3.2 3.1 3.9 4.6 3.8 3.4 3.9 6.8 4.5 4.1 5.2 2.5 2.3 2.4 3.6 4.3 3.5 4.7 3.4 3.0 2.6 4.7 5.2 3.6 3.4 2.8 4.8 3.3 12.5 3.9 9.7 4.0 3.2 6.2 3.1 3.6 7.7 10.0 13.2 28.7 18.9 9.5 8.1 29.4 24.7 11.6 23.3 37.4 13.4 17.1 23.8 5.9 9.8 13.6 13.6 20.5 7.2 25.0 52.0 20.1 26.9 26.5 17.8 5.5 22.2 12.9 6.5 4.3 21.9 13.5 14.0 15.6 22.7 22.4 24.2 23.9 6.0 21.6 15.7 57.0 13.8 9.9 24.4 51.8 14.7 8.7 7.3 8.2 21.1 24.5 9.4 12.9 42.4 7.4 16.7 14.8 11.6 22.5 20.6 29.0 6.8 13.9 29.8 15.7 22.0 20.3 2.5 4.5 3.9 4.7 6.4 4.9 5.9 4.3 5.2 4.8 8.1 3.0 4.5 3.4 6.2 8.1 5.2 3.3 3.1 3.1 4.9 3.1 4.9 3.9 4.6 4.5 4.1 4.3 2.8 3.9 7.7 4.6 0.0 6.2 2.6 9.4 4.1 3.6 3.5 3.4 3.1 4.1 4.4 3.7 2.8 4.4 3.7 6.2 6.8 8.6 2.9 7.9 3.2 24.2 5.6 5.5 4.4 2.4 5.0 8.1 2.0 8.0 4.7 6.6 4.5 7.0 8.1 3.6 2.3 5.5 1.7 7.9 4.5 8.2 6.6 2.9 15.3 4.1 5.5 1.8 3.7 6.0 6.5 8.2 8.0 13.7 2.0 5.9 4.5 7.0 2.6 2.0 3.4 5.4 5.5 6.6 7.4 4.3 22.3 18.0 6.7 3.8 5.6 6.6 4.4 4.1 2.2 CCT6A "CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20" ENSG00000146731 "Chaperonin containing TCP1 subunit 6A" P40227 7 56051685-56063989 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 1612.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042996, HPA045576, HPA049949" Supported Approved Cytosol NA NA 3600000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA042996: AB_2678261, HPA045576: AB_2679372, HPA049949: AB_2680968" "prognostic unfavorable (4.04e-4)" "unprognostic (5.32e-3)" "unprognostic (1.34e-1)" "unprognostic (2.81e-1)" "unprognostic (3.02e-1)" "prognostic unfavorable (8.45e-4)" "prognostic unfavorable (9.00e-10)" "unprognostic (1.19e-2)" "unprognostic (3.17e-1)" "unprognostic (1.67e-2)" "unprognostic (3.24e-2)" "unprognostic (4.82e-2)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.35e-1)" "unprognostic (1.20e-1)" "unprognostic (1.78e-1)" "unprognostic (9.44e-3)" 58.5 58.8 48.3 66.6 50.5 67.0 59.7 52.6 71.1 43.5 55.9 52.6 53.2 52.0 38.2 68.1 50.9 39.8 56.7 50.2 56.4 72.5 53.3 41.1 69.6 52.5 52.9 42.1 60.8 69.4 39.1 56.4 53.9 44.9 60.1 46.5 45.5 49.4 124.3 58.0 51.8 61.4 53.2 46.1 52.2 49.5 53.5 61.3 49.7 85.5 81.1 72.1 47.6 55.3 1612.6 357.8 211.6 322.5 145.7 181.6 243.2 293.0 165.4 284.4 227.7 407.0 196.7 487.8 222.9 192.1 511.6 333.2 438.2 339.2 390.0 276.8 328.1 306.1 337.0 363.8 157.3 444.1 240.5 157.1 191.1 287.8 284.4 224.8 283.7 221.2 682.0 121.2 325.5 199.2 346.4 392.7 449.3 356.6 466.8 315.1 213.9 284.8 321.6 302.3 280.3 282.0 259.2 440.7 272.6 321.8 324.6 341.6 238.6 194.1 372.4 651.4 617.1 146.7 321.5 596.7 194.4 389.0 658.4 21.0 69.9 34.0 57.8 87.7 77.3 65.9 59.7 63.3 96.5 50.4 59.8 64.8 8.4 77.7 103.0 54.0 68.3 81.2 48.3 50.5 52.6 71.1 50.2 56.4 52.5 52.9 53.9 53.2 53.5 55.3 94.6 89.8 106.4 13.1 83.3 108.8 201.4 175.3 91.6 60.2 77.4 83.2 114.0 65.8 187.7 47.8 27.1 199.6 93.4 56.6 88.0 263.1 22.5 209.6 121.0 129.4 102.1 163.4 19.3 274.2 264.8 97.0 88.2 133.8 131.7 123.4 71.0 66.7 148.2 38.7 23.7 94.2 124.1 83.5 79.2 19.5 70.5 104.0 58.7 19.7 206.9 80.7 80.3 18.1 22.7 245.6 66.7 90.7 106.4 184.8 65.2 146.4 190.3 60.8 59.2 99.1 136.3 115.0 219.8 160.9 109.7 199.9 91.8 189.7 138.6 145.9 CD99L2 "CD99B, MIC2L1" ENSG00000102181 "CD99 molecule like 2" Q8TCZ2 X 150766336-150898816 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 179.1" "Cell type enhanced" "Detected in many" "Excitatory neurons: 49.1;Horizontal cells: 52.2;Inhibitory neurons: 57.2;Oligodendrocytes: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038782, HPA038783, HPA061400" Enhanced Supported "Plasma membrane" NA NA 1200000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Plasma membrane" "HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: AB_2732660" "unprognostic (2.10e-2)" "unprognostic (2.62e-3)" "unprognostic (3.12e-3)" "unprognostic (6.03e-3)" "unprognostic (1.22e-1)" "unprognostic (2.66e-1)" "unprognostic (5.56e-2)" "prognostic favorable (4.96e-4)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "prognostic favorable (2.74e-5)" "unprognostic (5.50e-2)" "unprognostic (5.13e-2)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (9.23e-2)" "prognostic unfavorable (8.74e-4)" 46.1 28.1 68.5 14.8 69.5 7.3 29.7 71.0 99.6 33.4 26.8 40.1 10.0 39.9 24.5 14.5 30.5 19.2 61.6 69.9 80.4 24.9 47.3 25.2 13.2 104.7 77.9 38.9 18.7 14.6 23.8 21.5 107.2 25.8 10.6 43.4 14.8 32.6 179.1 13.4 19.2 32.4 71.5 26.9 21.8 11.2 91.6 14.5 16.8 99.2 10.7 29.4 21.0 80.2 8.1 79.8 29.5 36.9 153.3 95.2 8.7 65.2 76.1 32.3 46.3 5.5 10.2 29.3 154.0 114.6 24.2 13.0 40.4 44.4 26.6 68.5 31.9 12.7 17.8 8.2 41.2 21.4 23.3 90.3 14.5 24.0 45.4 50.3 38.6 22.4 8.9 74.9 41.1 17.3 18.9 31.1 12.4 6.9 42.7 18.8 24.2 40.5 31.7 5.4 38.9 19.9 25.8 21.9 29.6 21.6 6.2 36.6 45.8 47.5 14.4 62.2 48.0 62.6 112.3 28.3 59.6 42.3 36.4 7.3 8.6 5.9 6.2 7.6 5.4 4.5 5.8 6.3 8.1 4.8 5.5 6.0 2.1 7.2 12.5 5.8 4.4 7.0 68.5 69.5 71.0 99.6 69.9 80.4 104.7 77.9 107.2 71.5 91.6 80.2 14.1 16.0 7.8 21.5 8.2 3.1 2.3 3.6 4.6 26.8 3.7 3.2 42.8 11.5 6.4 12.9 18.8 10.1 7.4 2.0 5.9 4.4 0.3 5.6 10.1 13.8 8.4 6.5 49.1 5.3 3.9 15.9 7.1 3.6 7.6 12.6 17.2 26.6 10.2 52.2 57.2 2.9 8.2 16.4 6.8 2.8 20.8 8.6 10.6 23.4 8.1 18.2 2.1 21.6 60.7 3.6 3.1 30.1 12.5 3.4 5.3 11.3 5.0 18.7 0.0 15.9 12.0 2.8 4.9 3.3 1.3 13.5 6.4 11.8 3.3 1.3 CDC37 P50CDC37 ENSG00000105401 "Cell division cycle 37, HSP90 cochaperone" Q16543 19 10391133-10420121 "Cancer-related genes, Predicted intracellular proteins, Transporters" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003928, CAB004214" Supported Supported Cytosol NA NA 610000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 24: NB-4 - Immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Cytosol "CAB004214: AB_627232, HPA003928: AB_1846373" "unprognostic (2.40e-1)" "unprognostic (1.06e-1)" "unprognostic (1.27e-1)" "unprognostic (2.33e-2)" "unprognostic (2.46e-3)" "unprognostic (6.21e-2)" "unprognostic (1.37e-1)" "unprognostic (7.90e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-3)" "unprognostic (1.96e-2)" "unprognostic (1.82e-2)" "unprognostic (1.84e-2)" "prognostic favorable (2.33e-4)" "unprognostic (5.80e-2)" "unprognostic (1.23e-1)" "unprognostic (3.02e-2)" 149.9 93.6 82.2 81.3 84.6 89.5 130.6 75.0 104.2 111.4 72.1 109.9 58.1 110.0 34.2 125.7 98.5 39.8 186.0 86.3 85.8 123.2 102.2 129.9 66.5 85.9 85.8 105.9 100.3 59.3 74.6 62.7 88.1 105.0 48.2 34.6 96.6 52.2 313.2 100.9 96.3 50.2 75.7 137.5 102.8 77.5 82.5 69.3 100.8 222.6 52.4 110.3 103.0 87.8 279.2 181.2 95.5 137.5 128.8 111.8 122.9 322.8 144.6 198.3 168.8 209.1 106.7 165.3 254.7 198.3 117.2 169.9 130.6 208.7 136.4 133.6 387.2 313.9 147.2 300.9 202.5 183.9 137.9 136.9 112.5 231.8 104.0 113.5 258.1 142.2 248.2 193.8 156.1 265.3 184.3 450.2 234.6 175.5 317.8 181.0 128.3 190.3 185.1 178.2 111.5 161.9 151.5 158.1 143.1 72.7 108.4 195.7 290.0 230.8 133.9 319.9 262.2 261.3 276.5 204.4 181.4 294.1 191.2 77.2 110.8 97.1 114.4 107.9 103.1 73.2 91.8 103.5 105.2 62.9 70.0 81.8 60.2 101.1 112.6 89.4 106.8 145.6 82.2 84.6 75.0 104.2 86.3 85.8 85.9 85.8 88.1 75.7 82.5 87.8 420.1 54.5 95.5 51.6 163.7 148.6 119.3 149.0 127.5 78.0 85.0 75.8 71.3 75.8 114.8 64.4 39.6 188.9 166.1 192.3 101.8 199.8 119.0 88.2 120.5 267.5 81.3 89.8 35.0 199.0 430.2 108.3 226.8 126.4 134.3 90.8 172.1 45.3 210.2 89.2 24.6 181.3 105.8 83.9 313.8 253.8 106.2 165.6 138.7 29.0 165.1 75.8 135.9 21.1 32.5 297.6 183.5 103.4 170.5 120.1 117.9 89.7 78.2 84.4 78.9 94.4 138.6 72.4 73.5 138.1 133.7 242.4 164.2 123.0 186.1 156.1 CDCA8 "BOR, DasraB, FLJ12042, MESRGP" ENSG00000134690 "Cell division cycle associated 8" Q53HL2 1 37692481-37709719 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 33.5;lymphoid tissue: 38.8;testis: 22.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 34.1;Extravillous trophoblasts: 26.0;Spermatocytes: 76.8;Spermatogonia: 42.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA028120, HPA028258, HPA028783, CAB040294" Enhanced Supported "Nucleoplasm,Nucleoli,Cytokinetic bridge" Yes Yes "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli "Nucleoplasm, Cytokinetic bridge" "CAB040294: , HPA028120: AB_10670556, HPA028258: AB_10669864, HPA028783: AB_10671092" "unprognostic (8.36e-2)" "unprognostic (2.00e-1)" "unprognostic (8.39e-2)" "unprognostic (7.75e-3)" "unprognostic (2.34e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (4.93e-10)" "unprognostic (4.30e-3)" "prognostic unfavorable (6.04e-4)" "unprognostic (3.00e-1)" "prognostic unfavorable (8.32e-4)" "unprognostic (3.78e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (6.39e-3)" "unprognostic (2.99e-1)" "unprognostic (3.18e-1)" "unprognostic (1.67e-1)" 1.0 1.1 0.7 7.9 1.0 33.5 2.0 0.2 0.9 1.7 0.0 9.4 8.3 1.3 1.8 9.2 1.0 1.1 0.6 0.5 0.4 0.8 1.3 1.5 19.5 0.6 0.4 0.6 0.8 0.5 0.6 4.4 0.5 0.7 11.3 1.9 1.8 0.5 0.3 6.3 7.3 2.8 0.3 4.9 4.9 22.5 0.6 38.8 0.6 0.5 22.7 2.0 2.9 0.7 108.5 45.5 84.4 62.1 3.6 7.0 57.2 79.6 39.5 137.2 96.6 71.9 78.8 130.2 31.5 50.5 54.5 59.4 97.8 52.4 141.9 86.8 44.9 116.8 49.2 57.3 0.8 113.8 58.4 2.8 3.8 77.1 67.3 15.3 60.9 91.1 100.7 135.6 99.1 47.7 106.1 68.9 98.8 61.7 62.8 102.2 115.6 74.4 31.0 43.8 75.4 33.3 87.5 40.6 52.4 71.7 60.1 42.4 37.3 67.8 70.6 39.2 126.0 91.4 128.1 176.3 31.6 104.7 79.6 0.0 0.7 1.3 1.5 1.6 2.8 1.7 3.6 2.2 0.7 1.4 1.1 2.3 3.0 4.1 3.9 1.2 5.9 1.7 0.7 1.0 0.2 0.9 0.5 0.4 0.6 0.4 0.5 0.3 0.6 0.7 0.8 0.0 0.5 1.3 4.8 3.3 0.8 2.4 1.8 1.3 1.9 1.5 0.7 2.8 0.4 0.0 0.0 17.1 1.9 12.4 0.0 1.2 1.0 1.7 1.6 1.9 3.6 34.1 1.2 0.6 26.0 2.9 6.6 2.5 0.0 12.0 3.6 1.0 11.6 1.7 0.9 8.2 2.0 3.5 1.9 2.8 1.5 3.7 1.8 0.0 1.6 0.1 2.1 0.5 0.9 2.4 4.0 1.2 15.8 1.3 1.9 0.6 4.7 1.0 19.7 0.2 6.3 76.8 42.0 17.1 2.7 2.9 5.5 1.2 13.2 1.2 CDK10 PISSLRE ENSG00000185324 "Cyclin dependent kinase 10" Q15131 16 89680737-89696354 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007451, HPA059634, HPA067060" Uncertain Supported "Nucleoplasm,Midbody,Midbody ring" Yes Yes "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Midbody, Midbody ring" "HPA007451: AB_2732400, HPA059634: AB_2684090, HPA067060: AB_2685772" "unprognostic (7.89e-2)" "unprognostic (8.08e-2)" "unprognostic (3.74e-3)" "unprognostic (9.87e-2)" "unprognostic (1.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.53e-1)" "unprognostic (9.06e-2)" "unprognostic (2.99e-1)" "unprognostic (2.13e-1)" "prognostic favorable (2.69e-4)" "unprognostic (2.58e-2)" "unprognostic (2.93e-1)" "unprognostic (3.32e-2)" "unprognostic (1.79e-1)" "unprognostic (6.88e-2)" "prognostic favorable (3.63e-4)" 30.1 38.5 20.2 10.4 20.4 19.5 26.7 20.3 32.8 49.3 22.0 38.2 22.7 25.9 8.7 35.3 36.3 8.6 27.3 21.0 19.5 52.9 77.0 31.0 14.7 18.6 18.7 43.2 49.2 13.5 55.5 12.5 19.6 39.1 11.3 7.6 24.8 7.5 33.8 32.1 36.1 8.2 17.0 37.5 38.5 17.0 18.4 10.8 54.5 4.1 7.0 32.3 36.5 19.1 27.5 17.8 13.9 5.8 5.7 11.0 14.2 22.3 12.6 15.2 4.9 13.1 21.2 23.9 9.8 19.3 9.1 15.5 5.8 30.8 9.3 5.3 14.1 9.7 21.0 1.7 23.4 15.8 17.1 13.3 10.7 9.3 15.3 10.3 27.0 16.1 25.5 3.2 17.7 36.6 19.5 45.0 28.5 29.7 13.1 26.5 19.0 34.1 27.9 21.2 10.1 29.6 28.0 13.0 6.8 15.2 30.3 25.0 24.1 9.1 26.6 10.1 15.4 11.7 6.4 7.5 16.4 25.0 15.5 5.1 14.0 4.2 14.8 19.7 12.8 7.8 13.2 10.7 18.1 9.0 15.1 12.6 1.5 20.4 15.4 12.4 11.6 11.4 20.2 20.4 20.3 32.8 21.0 19.5 18.6 18.7 19.6 17.0 18.4 19.1 28.2 12.8 26.6 35.3 21.2 15.4 24.2 26.9 23.3 17.2 24.5 25.1 6.5 38.6 20.0 27.6 25.0 28.6 26.7 44.8 43.0 28.6 6.1 20.7 21.9 23.0 67.7 15.4 44.5 12.5 19.8 19.6 85.1 16.9 9.5 40.3 21.8 41.1 18.8 18.5 33.3 49.4 26.4 17.4 16.0 8.8 23.9 17.0 19.6 17.8 15.5 8.5 26.8 24.6 20.0 13.6 41.5 12.4 20.8 30.7 58.3 53.7 28.1 32.3 6.6 11.4 16.3 27.3 28.7 22.4 15.5 27.9 22.0 54.8 58.2 22.9 CDK5RAP1 "C20orf34, C42, CGI-05, HSPC167" ENSG00000101391 "CDK5 regulatory subunit associated protein 1" Q96SZ6 20 33358839-33401561 "Enzymes, Predicted intracellular proteins" "tRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Ionocytes: 128.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 116.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066301 Approved "Nuclear speckles,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" Mitochondria "HPA066301: AB_2685653" "unprognostic (2.86e-1)" "unprognostic (7.19e-2)" "unprognostic (1.31e-1)" "unprognostic (1.66e-3)" "unprognostic (2.25e-1)" "unprognostic (6.49e-2)" "unprognostic (7.68e-3)" "unprognostic (2.18e-2)" "unprognostic (5.10e-1)" "unprognostic (2.36e-1)" "unprognostic (5.90e-3)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.51e-2)" "unprognostic (8.13e-2)" "unprognostic (1.28e-1)" "unprognostic (4.87e-1)" "unprognostic (1.06e-1)" 9.1 8.4 4.9 10.7 5.7 18.6 10.5 4.9 5.3 8.4 6.3 9.0 8.9 9.8 11.5 9.3 9.2 6.2 12.0 5.7 4.3 9.0 11.1 9.0 12.7 4.5 4.4 8.6 7.6 11.2 7.2 10.3 4.1 8.4 12.2 15.9 10.6 8.7 20.9 12.6 9.5 10.8 3.9 10.3 9.7 9.3 4.6 11.3 11.9 22.8 15.2 8.7 7.9 4.9 27.0 27.6 18.6 17.1 17.4 13.4 40.7 15.8 22.5 45.0 46.9 116.5 23.9 47.3 21.0 17.2 29.0 39.1 31.8 45.1 34.8 8.9 17.3 57.1 30.8 45.1 20.3 36.6 17.4 17.5 18.9 30.2 35.9 11.4 24.9 13.6 36.7 19.3 20.0 26.6 37.8 27.5 14.1 30.2 40.1 27.8 42.4 36.1 24.5 23.6 25.2 14.3 50.5 24.4 33.0 20.9 34.7 17.4 18.4 33.3 27.3 23.1 27.4 16.6 20.1 34.8 19.8 39.3 15.9 4.5 17.3 11.8 18.5 22.3 22.2 21.4 18.3 18.0 19.1 14.1 16.2 14.0 0.9 21.6 18.4 13.4 17.3 15.1 4.9 5.7 4.9 5.3 5.7 4.3 4.5 4.4 4.1 3.9 4.6 4.9 13.2 16.0 20.0 26.8 18.6 12.1 10.3 21.1 10.8 25.6 9.3 8.9 15.7 11.5 18.6 7.3 27.1 31.4 18.2 7.4 13.7 17.6 2.9 10.1 10.3 11.4 12.6 12.2 36.7 18.3 18.5 10.4 13.3 14.6 29.8 15.6 6.1 15.6 17.5 11.8 25.4 8.6 128.1 10.1 12.6 2.8 13.1 13.5 10.6 10.3 15.2 16.5 19.6 16.1 26.6 13.0 9.0 10.5 19.3 8.3 13.8 15.3 20.9 39.9 19.7 14.8 15.3 32.6 23.6 8.5 10.4 16.0 22.3 16.1 12.6 8.9 CDKAL1 FLJ20342 ENSG00000145996 "CDK5 regulatory subunit associated protein 1 like 1" Q5VV42 6 20534457-21232404 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "tRNA processing" Transferase "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Astrocytes: 133.2;Excitatory neurons: 159.5;Inhibitory neurons: 134.1;Microglial cells: 198.6;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 255.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 5 "SCLC-21H: 188.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (9.64e-2)" "unprognostic (7.23e-3)" "unprognostic (8.40e-2)" "prognostic unfavorable (1.03e-4)" "unprognostic (1.05e-1)" "unprognostic (1.51e-2)" "unprognostic (3.47e-2)" "unprognostic (4.25e-3)" "unprognostic (6.72e-3)" "unprognostic (1.61e-3)" "unprognostic (1.42e-1)" "unprognostic (3.73e-2)" "unprognostic (5.79e-3)" "unprognostic (3.11e-2)" "unprognostic (1.75e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" 5.6 4.0 3.6 5.8 5.7 9.5 6.9 7.2 4.3 6.6 5.8 5.2 4.6 8.1 5.8 4.9 6.8 6.3 4.7 3.5 4.9 5.6 5.4 5.5 8.2 6.5 4.9 8.5 5.7 6.5 4.0 6.6 6.5 5.5 6.5 5.3 5.9 4.9 14.0 7.4 5.1 6.4 4.8 7.2 5.8 6.7 4.9 9.6 9.4 9.5 8.6 5.7 5.1 9.0 8.7 5.3 12.1 15.6 6.7 9.0 12.8 9.0 8.2 13.0 17.1 9.8 7.7 20.7 22.0 7.7 14.1 8.6 16.5 9.1 17.3 37.3 9.1 17.7 9.1 13.3 8.7 17.6 11.7 8.2 9.4 12.5 11.5 8.0 12.0 12.6 23.3 8.2 9.7 7.3 22.4 21.0 8.5 8.9 5.8 13.1 16.1 19.5 16.6 9.9 188.5 11.1 10.0 16.0 13.2 10.2 11.7 8.8 11.7 15.2 10.4 6.1 16.8 12.9 36.8 17.7 5.5 9.9 26.0 1.5 3.3 3.1 6.4 5.3 5.3 7.0 6.3 6.5 4.4 6.4 7.7 7.1 1.5 10.3 11.2 4.6 7.4 3.5 3.6 5.7 7.2 4.3 3.5 4.9 6.5 4.9 6.5 4.8 4.9 9.0 13.9 6.4 4.6 133.2 19.5 10.5 10.9 5.2 9.1 8.7 8.7 6.0 9.0 4.3 8.1 7.3 6.2 9.4 12.2 4.6 11.7 8.3 15.4 16.9 13.6 12.2 33.4 6.7 159.5 7.8 10.0 9.4 13.3 18.5 13.3 12.5 8.2 6.4 7.1 11.8 134.1 8.5 14.2 6.1 7.6 6.3 8.7 9.5 3.6 198.6 13.2 6.0 10.3 198.5 255.4 8.8 5.8 4.5 20.8 4.1 5.4 10.7 4.7 10.8 6.6 14.2 9.7 13.3 11.8 9.5 10.5 9.0 17.4 5.0 7.1 6.3 CDPF1 "C22orf40, LOC150383" ENSG00000205643 "Cysteine rich DPF motif domain containing 1" Q6NVV7 22 46244011-46250311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018823 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" Cytosol Nucleoplasm "HPA018823: AB_1853018" "unprognostic (1.98e-2)" "unprognostic (5.06e-3)" "unprognostic (1.42e-2)" "prognostic favorable (3.13e-5)" "unprognostic (2.20e-1)" "unprognostic (1.51e-1)" "unprognostic (1.85e-3)" "unprognostic (1.83e-3)" "unprognostic (2.09e-1)" "unprognostic (2.56e-3)" "unprognostic (4.69e-3)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.04e-1)" "unprognostic (2.73e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-1)" 6.2 9.5 7.1 4.1 7.3 2.6 6.1 6.9 8.6 8.1 6.7 10.3 4.2 7.8 2.9 4.9 7.2 4.0 8.6 6.9 6.8 7.9 7.5 4.6 6.3 7.6 7.1 7.7 6.7 6.2 6.4 3.8 7.0 8.9 2.8 2.6 6.7 5.1 7.9 5.0 6.3 4.8 6.7 9.1 6.7 3.2 7.1 7.4 8.0 5.8 4.0 7.7 5.7 7.4 5.5 7.2 6.5 9.8 4.7 6.9 6.7 3.3 4.5 6.6 6.3 1.8 7.0 5.1 4.0 2.7 5.3 7.7 3.8 2.8 3.9 7.3 10.3 3.1 5.2 6.3 7.0 9.3 4.3 7.4 7.8 5.8 7.4 7.5 5.8 13.0 5.2 6.9 6.2 3.8 12.1 5.8 5.2 8.0 6.7 8.9 4.3 11.7 5.8 2.1 3.1 7.8 4.2 7.8 9.4 3.8 8.9 5.1 3.7 10.7 7.4 5.9 4.7 7.9 4.0 5.9 5.8 6.3 11.1 1.4 6.4 10.5 10.4 9.1 9.9 6.9 10.0 9.0 6.3 8.3 11.3 8.5 1.6 10.0 9.9 10.9 8.7 8.0 7.1 7.3 6.9 8.6 6.9 6.8 7.6 7.1 7.0 6.7 7.1 7.4 6.9 6.4 3.9 1.0 7.1 1.8 2.9 8.1 1.2 4.5 4.7 6.7 6.1 5.7 4.0 7.3 0.0 12.8 4.5 1.3 7.9 10.7 1.0 2.5 3.3 8.9 4.2 3.4 1.1 11.2 10.0 5.8 3.1 1.9 14.5 6.9 6.8 4.8 9.3 0.0 1.8 3.7 6.1 5.0 2.0 1.2 5.0 4.2 5.4 0.0 8.1 5.7 19.6 1.5 2.5 8.3 1.4 7.9 3.8 5.1 3.4 8.1 6.9 5.4 13.1 4.5 6.5 4.3 8.1 3.1 2.0 4.5 6.1 9.1 5.3 2.1 CENPS "APITD1, CENP-S, FAAP16, MHF1" ENSG00000175279 "Centromere protein S" Q8N2Z9 1 10430433-10442808 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Mitosis" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.6" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 23.7;Distal tubular cells: 37.2;Proximal tubular cells: 86.1;Respiratory ciliated cells: 27.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 32: U-937 - Innate immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "unprognostic (2.64e-1)" "prognostic favorable (1.24e-4)" "unprognostic (3.06e-3)" "unprognostic (2.21e-1)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (4.72e-3)" "unprognostic (3.79e-1)" "unprognostic (1.26e-3)" "unprognostic (2.95e-2)" "unprognostic (4.37e-2)" "unprognostic (1.78e-1)" "unprognostic (7.04e-3)" "unprognostic (4.23e-2)" "unprognostic (4.66e-2)" "unprognostic (1.87e-1)" "unprognostic (9.21e-2)" 3.5 8.9 4.7 5.8 4.7 9.1 5.1 4.3 6.4 5.7 5.8 6.8 12.5 4.6 12.3 7.4 9.9 7.6 4.5 4.5 4.5 28.0 8.3 5.1 6.4 4.5 4.5 4.0 7.9 14.5 14.1 4.5 4.3 6.5 7.4 8.8 6.8 4.8 3.6 4.4 9.6 4.2 4.4 3.9 6.3 48.6 4.8 9.5 12.0 3.7 6.4 5.6 4.2 4.4 38.9 25.1 17.4 25.2 13.6 11.3 9.1 21.2 22.4 27.8 21.4 11.5 26.4 29.3 19.3 19.0 15.6 29.5 16.1 24.0 30.0 25.1 17.4 17.2 21.0 24.2 8.7 58.5 21.5 7.0 12.0 29.5 18.3 10.8 16.6 31.2 24.3 24.9 27.0 29.6 27.7 35.1 24.5 33.0 26.6 29.7 19.9 34.5 34.1 13.6 22.0 20.1 23.1 25.4 25.7 14.4 30.9 31.6 9.9 29.2 35.6 26.6 37.1 6.6 16.8 35.5 27.3 65.4 38.5 0.0 1.4 0.8 2.8 2.3 3.8 6.9 4.1 3.1 1.8 6.1 4.5 3.8 0.8 2.1 6.0 5.0 4.5 1.8 4.7 4.7 4.3 6.4 4.5 4.5 4.5 4.5 4.3 4.4 4.8 4.4 2.5 6.4 13.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 8.6 6.5 0.0 0.0 8.1 5.5 0.0 23.7 2.3 0.0 37.2 16.5 0.0 15.0 3.7 3.6 0.0 0.0 0.0 10.9 12.0 3.5 0.0 3.6 3.8 7.4 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 10.3 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.5 0.0 0.0 86.1 27.7 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 6.7 2.0 9.3 0.0 0.0 CFAP410 "A2, C21orf2, LRRC76, YF5" ENSG00000160226 "Cilia and flagella associated protein 410" O43822 21 44328944-44339402 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, DNA damage" "Ciliopathy, Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 30.8;Extravillous trophoblasts: 15.7;Hofbauer cells: 35.5;Syncytiotrophoblasts: 32.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030283, HPA030284, CAB034126, CAB034128" Supported Supported Vesicles,Mitochondria,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" Mitochondria "Vesicles, Cytosol" "CAB034126: AB_1564257, CAB034128: AB_1564259, HPA030283: , HPA030284: AB_10602700" "unprognostic (1.84e-1)" "unprognostic (1.56e-1)" "unprognostic (3.14e-2)" "unprognostic (1.29e-2)" "unprognostic (2.11e-3)" "unprognostic (1.36e-1)" "unprognostic (6.58e-2)" "unprognostic (1.13e-2)" "unprognostic (9.73e-2)" "unprognostic (2.77e-1)" "prognostic favorable (1.32e-4)" "unprognostic (1.49e-1)" "prognostic favorable (4.08e-4)" "unprognostic (2.98e-1)" "unprognostic (2.79e-1)" "unprognostic (1.32e-2)" "unprognostic (1.06e-1)" 19.8 22.2 14.5 5.1 14.6 11.4 19.5 13.8 18.6 22.9 12.7 21.1 6.5 23.4 2.3 12.5 26.3 3.8 19.9 14.9 14.5 26.0 26.8 18.5 6.6 16.5 16.8 22.3 24.0 7.5 34.4 3.3 14.5 26.3 1.4 10.0 18.6 5.0 16.1 17.9 19.2 2.4 13.9 20.9 20.7 30.9 18.5 4.2 32.8 4.9 2.3 19.2 14.8 16.2 12.9 5.2 4.9 6.3 3.2 2.0 19.3 6.4 3.7 2.5 1.3 9.4 3.7 9.1 12.5 2.2 5.1 6.0 0.9 1.2 0.6 14.2 12.9 9.5 4.3 11.2 4.1 10.2 9.8 2.9 2.2 1.0 2.2 4.4 1.6 6.7 11.6 15.1 1.6 15.5 11.2 25.0 12.2 6.4 7.8 28.6 6.3 20.3 2.9 18.0 12.9 12.2 8.9 2.1 11.0 2.9 9.3 22.0 7.5 5.4 6.9 5.8 4.9 25.1 14.2 6.4 13.2 20.4 9.9 1.7 10.2 1.6 9.4 12.6 11.3 16.6 10.0 13.2 10.5 11.6 11.3 11.1 1.3 17.3 9.5 31.3 6.1 7.6 14.5 14.6 13.8 18.6 14.9 14.5 16.5 16.8 14.5 13.9 18.5 16.2 5.5 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 30.8 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 15.7 7.4 0.0 0.0 0.0 0.0 0.0 0.0 35.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 32.7 1.1 0.0 0.0 0.0 CHCHD3 "FLJ20420, Mic19, MICOS19, MINOS3, PPP1R22" ENSG00000106554 "Coiled-coil-helix-coiled-coil-helix domain containing 3" Q9NX63 7 132784870-133082090 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "heart muscle: 125.6;skeletal muscle: 351.7;tongue: 243.0" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 210.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042935 Enhanced Supported Mitochondria NA NA 13000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "HPA042935: AB_10794538" "unprognostic (1.53e-1)" "unprognostic (2.50e-1)" "unprognostic (4.15e-2)" "unprognostic (3.00e-3)" "unprognostic (5.69e-2)" "unprognostic (4.75e-3)" "prognostic unfavorable (3.25e-4)" "unprognostic (1.39e-2)" "unprognostic (1.28e-1)" "unprognostic (1.18e-1)" "unprognostic (1.69e-3)" "unprognostic (2.04e-1)" "prognostic favorable (1.15e-4)" "unprognostic (4.98e-2)" "unprognostic (1.20e-1)" "unprognostic (2.57e-1)" "unprognostic (8.03e-2)" 40.4 33.3 18.0 29.0 19.4 51.5 32.8 21.7 25.4 25.5 22.2 45.5 56.7 28.0 19.2 28.3 25.5 22.5 125.6 20.1 19.3 54.8 32.1 26.4 30.3 19.6 19.0 27.2 26.6 59.7 17.2 30.2 19.2 25.4 49.7 40.3 24.3 28.6 351.7 20.8 42.2 37.1 17.7 21.9 31.6 16.8 18.2 42.5 35.6 243.0 29.8 31.8 23.0 21.5 102.0 103.8 99.7 138.9 70.6 64.9 60.2 97.0 90.3 106.7 117.4 121.0 108.9 83.1 37.6 61.1 237.1 69.1 117.0 82.7 148.7 113.4 111.8 85.9 101.9 70.7 139.3 194.7 62.1 59.0 55.8 146.9 151.7 53.2 75.9 107.6 186.1 74.2 100.1 134.3 284.0 169.9 165.1 160.3 117.2 140.6 146.2 119.8 103.9 83.1 127.4 158.8 80.5 62.4 186.7 67.6 52.5 116.2 63.5 101.8 44.3 162.0 176.7 71.3 100.4 206.6 161.1 163.9 146.6 42.3 43.7 33.2 30.5 62.8 28.9 38.5 27.6 29.6 57.9 23.2 23.9 26.9 6.4 45.2 52.1 49.5 41.9 34.0 18.0 19.4 21.7 25.4 20.1 19.3 19.6 19.0 19.2 17.7 18.2 21.5 32.0 25.6 26.2 103.8 36.5 34.9 28.7 56.9 31.9 26.5 29.0 25.7 138.8 38.6 36.2 14.7 22.9 69.7 29.0 40.4 125.2 61.5 99.6 27.8 33.6 34.3 35.9 64.3 201.3 60.7 79.5 38.9 32.6 22.4 34.2 34.6 17.2 20.7 78.4 15.2 210.5 48.9 30.5 27.3 44.4 103.4 31.4 38.3 37.4 100.2 49.7 34.2 37.0 161.4 143.5 50.1 31.0 35.3 46.5 44.4 50.7 88.8 29.6 27.0 32.9 43.4 53.5 20.9 29.2 37.0 40.3 68.4 34.0 55.8 73.1 42.6 CHCHD4 "FLJ31709, MIA40, TIMM40" ENSG00000163528 "Coiled-coil-helix-coiled-coil-helix domain containing 4" Q8N4Q1 3 14112077-14124870 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 84.1;Proximal tubular cells: 62.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA034688, HPA063727" Uncertain Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA034688: AB_10696361, HPA063727: AB_2685103" "unprognostic (3.89e-3)" "unprognostic (8.82e-2)" "unprognostic (1.50e-2)" "unprognostic (7.34e-2)" "unprognostic (1.11e-2)" "unprognostic (9.12e-2)" "unprognostic (2.63e-3)" "unprognostic (1.02e-1)" "unprognostic (1.82e-1)" "unprognostic (5.55e-2)" "unprognostic (3.59e-2)" "unprognostic (1.43e-1)" "prognostic favorable (8.63e-5)" "unprognostic (1.53e-1)" "unprognostic (2.34e-1)" "unprognostic (9.65e-2)" "unprognostic (7.85e-3)" 12.2 14.0 12.3 8.6 12.9 3.3 11.5 12.8 16.4 9.8 13.3 19.5 14.6 8.9 10.1 12.4 9.6 5.8 25.8 12.4 14.4 20.9 18.8 7.6 8.9 13.0 13.8 10.4 11.1 22.9 9.6 8.5 13.0 10.8 15.5 11.4 10.1 11.8 34.1 10.3 11.5 8.8 12.5 10.3 13.6 8.7 12.7 9.4 9.6 29.0 12.7 15.1 9.9 13.3 19.1 39.2 19.8 19.8 16.9 18.9 57.5 20.3 18.7 24.4 21.4 23.3 15.3 40.9 19.4 15.5 24.7 15.3 41.5 41.8 29.8 25.7 41.6 47.9 28.5 31.3 28.2 32.5 19.9 16.6 43.5 40.0 63.5 17.3 27.7 32.4 50.6 35.6 26.3 40.7 41.0 19.6 30.6 59.5 52.1 29.3 19.9 87.5 27.8 20.7 16.3 20.1 22.6 72.2 30.1 17.0 34.6 32.8 10.0 22.3 16.2 27.8 37.4 19.8 56.1 40.6 21.9 49.5 16.6 12.0 15.6 10.7 7.8 24.0 14.0 15.0 13.2 12.1 25.7 22.0 16.8 11.5 6.9 21.8 24.8 10.5 16.3 11.6 12.3 12.9 12.8 16.4 12.4 14.4 13.0 13.8 13.0 12.5 12.7 13.3 6.7 16.0 8.6 2.9 10.6 9.4 14.5 17.9 13.1 7.9 13.3 11.4 24.5 11.5 8.8 9.2 0.0 21.6 3.5 12.2 84.1 18.8 2.6 6.7 8.3 9.0 4.9 20.8 3.2 13.4 22.3 8.9 5.6 5.4 10.8 7.6 3.9 20.4 21.0 5.0 3.8 13.3 16.2 10.0 6.6 5.3 11.5 9.7 8.8 1.9 11.4 9.9 15.5 2.5 3.5 13.1 10.0 10.1 13.2 25.3 22.4 62.2 5.9 7.2 6.6 9.9 11.8 24.7 40.4 20.8 11.8 13.0 7.3 12.0 17.9 11.6 CHD3 "Mi-2a, Mi2-ALPHA, ZFH" ENSG00000170004 "Chromodomain helicase DNA binding protein 3" Q12873 17 7884796-7912760 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Helicase, Hydrolase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043368, HPA076524" Supported Supported "Nucleoplasm,Nucleoli,Centriolar satellite" No No "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 20: HeLa - Mitochondria" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Nucleoli" "Centriolar satellite" "HPA043368: AB_2678448, HPA076524: AB_2686804" "unprognostic (1.77e-2)" "unprognostic (8.01e-2)" "prognostic unfavorable (2.43e-4)" "prognostic favorable (7.68e-5)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.11e-1)" "unprognostic (2.83e-2)" "unprognostic (5.25e-3)" "prognostic favorable (8.36e-4)" "unprognostic (9.11e-2)" "unprognostic (8.31e-2)" "unprognostic (3.98e-2)" "unprognostic (1.50e-1)" "unprognostic (8.90e-3)" "unprognostic (2.20e-3)" 28.2 29.3 19.9 35.0 27.9 42.7 28.4 0.0 39.9 71.6 0.0 55.3 16.7 63.9 31.2 35.1 56.8 27.8 21.2 35.8 7.0 38.3 5.7 32.4 41.3 4.9 2.4 60.0 34.8 44.7 47.7 16.6 1.1 68.7 22.1 19.0 40.3 38.0 8.0 32.7 34.6 45.0 3.1 31.5 36.3 20.9 8.0 58.2 44.9 9.1 36.7 41.2 42.8 21.4 44.9 108.7 61.6 81.2 72.2 60.9 32.8 51.7 66.1 40.8 43.5 21.1 36.7 122.8 38.3 73.0 34.0 59.6 117.7 52.5 53.0 65.5 67.2 62.7 148.5 2.7 38.3 17.8 112.1 79.2 27.5 55.4 36.9 108.7 76.9 54.1 41.5 2.0 38.8 42.6 48.2 19.6 9.8 45.3 40.3 137.8 82.1 19.3 40.0 107.7 41.9 56.3 126.4 47.9 24.6 16.9 55.7 27.1 99.7 89.4 68.8 22.3 72.5 8.8 1.6 68.3 46.1 47.4 77.6 1.7 2.6 3.3 4.1 1.4 3.6 1.1 4.2 4.0 1.3 1.2 4.6 3.1 2.8 3.2 3.2 3.0 2.5 2.5 19.9 27.9 0.0 39.9 35.8 7.0 4.9 2.4 1.1 3.1 8.0 21.4 20.9 32.1 63.2 10.4 19.6 36.6 47.6 21.1 65.4 60.7 43.8 34.2 14.3 17.2 35.2 80.9 8.4 16.8 57.3 39.8 17.6 22.9 11.3 48.6 51.9 29.4 56.8 19.1 20.6 23.4 20.5 39.9 31.1 70.7 39.9 59.7 22.9 2.7 9.0 45.4 25.2 17.0 12.2 24.7 34.7 18.5 44.4 26.7 8.8 6.5 43.7 12.4 59.8 12.1 2.5 20.9 10.8 57.2 17.4 55.5 10.9 9.7 24.8 17.3 26.3 31.8 43.5 25.5 46.8 52.8 20.5 16.4 62.9 52.0 30.3 60.3 CHRNB1 CHRNB ENSG00000170175 "Cholinergic receptor nicotinic beta 1 subunit" P11230 17 7445061-7457710 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 158.4;tongue: 57.7" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 39.0;Skeletal myocytes: 47.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 34.6;RH-30: 71.0" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "HPA005822, CAB011200" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 47: Cytotrophoblasts - Unknown function" "CAB011200: AB_262151, HPA005822: AB_1079484" "unprognostic (2.89e-2)" "unprognostic (3.43e-1)" "unprognostic (1.08e-1)" "unprognostic (2.67e-2)" "unprognostic (4.19e-2)" "unprognostic (1.60e-1)" "unprognostic (1.84e-1)" "unprognostic (1.09e-1)" "unprognostic (3.15e-2)" "unprognostic (3.56e-1)" "unprognostic (4.35e-1)" "unprognostic (1.70e-1)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" "unprognostic (2.49e-1)" "unprognostic (1.90e-1)" "unprognostic (1.59e-1)" 7.0 30.6 6.9 2.4 7.8 9.1 6.7 7.3 7.5 7.5 8.8 6.3 2.9 6.6 5.1 7.0 5.4 1.9 11.5 6.9 6.9 10.7 16.5 5.1 3.6 7.5 7.0 5.4 16.5 9.1 6.7 6.7 7.3 5.1 2.5 3.2 10.7 3.0 158.4 8.1 5.5 3.2 7.3 7.9 5.2 3.2 7.1 6.5 13.0 57.7 3.9 5.5 7.2 8.1 1.6 2.2 3.8 4.5 6.0 4.0 8.6 1.1 3.8 5.6 4.6 1.3 2.0 6.2 4.0 2.5 2.0 13.6 1.4 25.1 2.0 7.6 4.8 3.5 2.3 8.1 2.6 2.2 8.6 8.8 6.8 3.4 11.0 9.3 3.8 12.0 4.6 3.4 34.6 1.0 6.7 4.1 2.7 1.5 1.1 4.4 71.0 15.8 15.3 1.2 0.6 11.1 2.4 4.0 4.7 5.9 3.9 3.0 3.6 2.3 6.4 1.7 5.0 8.1 9.6 1.7 2.1 4.9 2.1 9.9 5.4 13.6 7.9 6.3 6.1 6.7 8.7 8.0 7.0 7.0 7.0 9.2 1.7 11.0 10.4 5.2 7.9 6.1 6.9 7.8 7.3 7.5 6.9 6.9 7.5 7.0 7.3 7.3 7.1 8.1 8.8 0.0 4.8 4.6 8.9 6.4 3.8 12.6 6.2 3.9 9.3 11.2 9.8 4.3 7.2 9.2 2.1 39.0 17.7 5.2 23.5 16.1 2.2 5.1 7.1 10.1 2.4 3.4 1.4 13.4 9.4 8.1 3.6 7.1 13.3 5.8 10.4 10.8 12.6 15.2 1.5 4.8 14.2 7.2 8.7 2.1 21.8 7.9 12.4 1.0 17.0 14.0 29.9 1.0 5.6 17.3 4.9 17.0 5.8 4.1 10.2 15.5 9.5 7.1 0.0 47.3 8.1 2.8 2.8 6.1 6.5 30.4 11.2 12.1 5.9 3.8 CIBAR1 "FAM92A, FAM92A1, FLJ38979" ENSG00000188343 "CBY1 interacting BAR domain containing 1" A1XBS5 8 93698561-93731527 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 110.2" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 13.3;Extravillous trophoblasts: 14.1;Fibroblasts: 8.4;Hofbauer cells: 6.4;Syncytiotrophoblasts: 3.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "myeloid DC: 2.9" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034760, HPA058942" Enhanced Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 33: Fibroblasts - ECM organization" Mitochondria "HPA034760: AB_10599947, HPA058942: AB_2732628" "unprognostic (2.65e-3)" "unprognostic (6.81e-2)" "unprognostic (2.48e-3)" "unprognostic (2.44e-1)" "unprognostic (1.62e-2)" "unprognostic (2.93e-1)" "unprognostic (3.56e-1)" "unprognostic (3.13e-1)" "unprognostic (1.20e-1)" "unprognostic (2.14e-1)" "unprognostic (2.28e-3)" "unprognostic (1.97e-1)" "unprognostic (1.71e-1)" "unprognostic (6.85e-3)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (3.07e-2)" 14.3 23.9 17.5 5.6 18.8 3.5 10.9 18.6 25.0 16.5 22.9 14.2 3.2 16.0 26.2 5.0 13.1 14.1 25.3 17.8 16.2 20.2 18.5 9.9 5.7 13.4 14.5 18.0 21.1 21.5 20.8 10.1 13.3 12.1 5.9 14.1 5.7 11.6 10.3 6.6 7.7 15.0 12.9 5.7 9.8 110.2 17.1 5.0 14.5 11.1 3.1 14.6 9.3 17.4 37.8 20.0 52.9 54.6 55.8 78.9 14.0 34.2 49.8 45.2 43.5 3.5 8.6 3.2 42.7 50.7 52.0 26.6 54.0 32.5 41.0 1.2 29.5 21.5 20.8 18.7 64.1 1.0 5.5 50.4 14.3 44.3 36.0 64.9 49.0 18.1 13.4 1.7 35.8 14.2 23.8 4.1 22.2 0.8 1.1 2.3 39.7 0.8 35.3 8.7 15.3 18.7 24.4 0.5 41.6 23.7 8.2 11.8 27.2 44.2 17.4 46.3 28.0 2.6 2.7 1.2 38.8 3.0 15.8 0.1 1.7 0.0 0.1 1.2 0.2 0.4 0.4 0.1 2.9 0.0 0.1 0.3 0.0 1.3 0.1 0.3 0.8 0.5 17.5 18.8 18.6 25.0 17.8 16.2 13.4 14.5 13.3 12.9 17.1 17.4 2.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 14.1 8.4 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 CKAP5 "ch-TOG, KIAA0097, TOG, TOGp" ENSG00000175216 "Cytoskeleton associated protein 5" Q14008 11 46743048-46846308 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 119.7;Spermatocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039377, HPA040375" Supported Approved "Nucleoli,Nucleoli rim,Plasma membrane,Centrosome" NA Yes 360000 "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Centrosome" "Nucleoli, Nucleoli rim" "HPA039377: AB_10805477, HPA040375: AB_10794739" "unprognostic (8.00e-2)" "unprognostic (7.35e-2)" "unprognostic (2.35e-1)" "unprognostic (4.12e-2)" "unprognostic (1.91e-1)" "unprognostic (2.08e-2)" "prognostic unfavorable (1.03e-6)" "unprognostic (6.09e-2)" "unprognostic (1.12e-2)" "unprognostic (2.21e-2)" "unprognostic (4.30e-3)" "unprognostic (3.77e-2)" "unprognostic (2.03e-1)" "unprognostic (2.71e-1)" "unprognostic (1.12e-1)" "unprognostic (3.48e-1)" "unprognostic (4.69e-2)" 12.8 30.7 15.9 15.1 19.5 25.9 14.9 30.8 24.3 11.7 5.2 18.5 12.6 15.7 12.2 13.0 11.5 12.2 21.3 21.4 18.0 11.5 45.5 10.4 18.4 21.0 17.4 27.8 9.0 21.2 12.5 17.3 22.9 15.9 17.2 57.0 9.1 13.2 37.8 13.7 12.3 19.3 17.5 11.9 16.1 33.0 20.2 36.4 9.6 28.8 18.5 13.5 10.8 24.6 104.7 95.8 212.6 90.8 48.7 73.0 48.3 117.1 69.4 107.8 114.6 76.8 33.3 104.5 41.0 76.0 117.0 116.2 144.0 62.7 134.3 102.0 107.6 176.6 80.2 78.4 35.0 139.6 76.7 37.0 34.0 60.3 125.6 56.1 79.3 97.9 129.5 103.8 89.2 71.2 127.9 39.2 114.7 78.8 73.0 131.2 210.0 98.3 34.7 63.3 96.8 83.9 149.8 56.9 57.3 88.9 103.9 39.1 64.0 106.2 92.9 180.8 176.2 59.2 137.3 158.6 66.5 64.9 105.9 4.6 4.2 4.6 6.1 6.2 5.9 6.5 4.5 6.9 6.1 6.2 5.4 5.8 0.7 8.6 6.2 3.9 5.6 3.1 15.9 19.5 30.8 24.3 21.4 18.0 21.0 17.4 22.9 17.5 20.2 24.6 13.4 25.6 23.6 32.3 17.4 8.5 11.0 17.9 16.5 19.3 11.6 12.3 65.2 12.8 18.8 9.2 37.5 19.4 11.2 13.3 9.8 12.2 119.7 19.7 21.0 16.5 12.1 32.6 61.9 7.8 15.0 27.8 29.0 18.8 37.9 55.5 11.7 8.1 18.7 13.5 63.1 16.9 16.2 17.6 5.6 50.7 19.6 19.6 7.2 30.9 16.5 16.2 16.5 32.6 51.7 13.7 15.2 29.0 26.4 14.2 9.1 9.3 30.7 25.6 19.7 18.0 21.4 107.4 59.3 24.3 11.6 11.5 16.1 83.3 19.8 9.7 CLASP2 KIAA0627 ENSG00000163539 "Cytoplasmic linker associated protein 2" O75122 3 33496245-33718356 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 176.6;retina: 126.4" "Cell type enhanced" "Detected in all" "Astrocytes: 294.5;Excitatory neurons: 514.2;Inhibitory neurons: 526.3;Oligodendrocyte precursor cells: 739.9;Oligodendrocytes: 1315.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067071 Supported "Golgi apparatus,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Golgi apparatus" Cytosol "HPA067071: AB_2685775" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (7.24e-3)" "unprognostic (5.46e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (1.27e-2)" "unprognostic (4.51e-2)" "unprognostic (1.40e-1)" "unprognostic (1.36e-2)" "unprognostic (2.60e-3)" "unprognostic (3.25e-2)" "prognostic favorable (1.48e-6)" "unprognostic (1.23e-1)" "unprognostic (2.55e-1)" "unprognostic (1.07e-2)" "unprognostic (5.72e-2)" 14.0 25.1 43.4 12.1 84.1 12.3 15.8 100.7 79.1 21.4 0.0 16.9 9.9 20.5 11.3 17.9 16.0 17.7 40.4 44.8 57.5 18.1 10.8 15.3 15.4 69.0 49.9 27.3 11.5 17.7 33.3 15.6 85.9 16.6 13.1 126.4 8.8 20.7 64.9 13.0 11.0 19.4 67.8 14.5 11.2 11.8 60.0 16.1 14.1 63.4 15.9 14.5 11.5 176.6 13.5 29.4 32.9 27.8 20.9 20.4 23.6 24.8 23.2 28.5 30.6 17.2 13.8 44.4 14.1 19.6 18.3 11.5 43.0 19.7 34.4 36.0 30.5 43.7 24.6 15.4 9.9 43.6 35.8 12.7 19.3 30.9 29.2 16.5 28.0 27.0 43.3 24.8 31.1 7.6 32.5 18.6 24.5 13.5 18.4 34.5 30.9 24.1 17.9 15.2 27.4 46.4 28.7 22.1 24.7 26.5 20.9 38.1 27.0 22.3 19.4 16.9 27.7 17.3 34.6 36.5 20.2 29.6 28.8 3.7 4.6 2.6 3.3 4.5 5.1 6.1 2.9 3.2 6.5 3.7 3.9 3.6 0.9 9.1 7.0 6.1 3.5 4.8 43.4 84.1 100.7 79.1 44.8 57.5 69.0 49.9 85.9 67.8 60.0 176.6 19.7 6.4 11.7 294.5 29.9 21.0 8.6 8.8 18.8 103.3 26.0 13.8 37.4 15.7 12.7 14.7 156.4 12.3 36.2 9.9 1.9 6.4 2.8 20.8 15.6 16.1 14.4 12.2 514.2 7.0 8.1 19.2 26.5 27.9 12.0 17.8 16.1 13.9 15.0 92.5 526.3 8.8 8.2 32.3 26.6 2.9 14.3 26.0 16.0 128.4 19.5 32.0 22.6 739.9 1315.9 8.0 5.6 13.5 28.8 12.3 6.1 12.2 13.8 120.6 6.6 34.2 22.9 11.1 14.4 19.3 30.7 12.9 25.6 15.5 11.2 8.8 CLCC1 MCLC ENSG00000121940 "Chloride channel CLIC like 1" Q96S66 1 108927361-108963504 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009087, HPA013210" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 17: WM-115 - Nervous system development" "Cluster 47: Cytotrophoblasts - Unknown function" "Endoplasmic reticulum" "HPA009087: AB_1078532, HPA013210: AB_1846895" "unprognostic (2.95e-1)" "unprognostic (1.09e-1)" "prognostic favorable (1.33e-5)" "unprognostic (4.32e-2)" "unprognostic (2.55e-1)" "unprognostic (1.48e-1)" "unprognostic (2.40e-2)" "unprognostic (1.45e-1)" "unprognostic (5.30e-2)" "unprognostic (9.23e-2)" "unprognostic (1.14e-1)" "unprognostic (1.36e-1)" "unprognostic (7.50e-2)" "unprognostic (1.74e-1)" "unprognostic (2.04e-1)" "unprognostic (4.68e-3)" "unprognostic (9.65e-2)" 14.6 16.5 10.1 11.4 14.3 6.1 16.3 10.6 11.7 17.0 7.8 15.4 13.2 17.0 24.3 9.9 15.1 14.0 18.3 10.7 11.5 11.0 22.2 13.0 10.5 12.8 10.9 18.6 24.8 21.3 18.3 17.7 12.1 20.2 13.2 11.8 22.3 20.0 27.2 10.3 12.7 14.9 11.0 11.5 16.1 7.6 11.8 5.2 21.9 24.8 10.8 15.2 13.4 16.0 44.2 22.3 25.1 45.8 36.7 33.9 35.6 43.8 34.2 30.1 34.2 22.6 21.0 10.8 43.7 33.3 18.5 17.1 23.9 16.1 39.4 38.0 23.2 30.4 24.7 23.5 28.9 28.7 28.2 25.2 21.9 33.2 25.7 28.3 27.1 12.1 38.6 47.7 22.1 18.9 2.3 10.1 21.5 16.6 19.8 24.5 13.1 31.2 24.3 30.5 15.9 22.7 46.9 49.6 38.9 18.9 15.9 19.7 26.7 38.3 27.7 35.1 38.4 32.1 33.3 17.1 44.7 21.8 82.5 4.1 5.6 6.1 5.6 8.4 6.1 6.1 4.5 4.4 5.6 3.2 4.9 4.5 1.4 4.7 12.4 6.4 6.8 4.4 10.1 14.3 10.6 11.7 10.7 11.5 12.8 10.9 12.1 11.0 11.8 16.0 13.3 25.6 20.9 26.8 11.8 3.7 14.0 11.7 1.8 12.3 11.8 9.1 5.9 20.0 18.0 11.0 29.2 28.7 9.0 7.1 0.0 18.6 6.7 8.1 21.3 10.9 3.6 5.9 25.0 21.1 12.8 19.5 10.7 13.5 12.0 16.3 9.7 22.3 13.1 21.9 30.3 9.0 16.2 6.7 5.1 2.8 19.9 9.3 8.8 14.0 12.0 11.4 3.1 35.7 39.3 17.7 3.8 18.8 17.7 17.7 7.2 5.0 14.9 18.9 19.7 18.6 10.7 5.5 5.4 6.4 6.3 18.5 8.4 12.5 9.8 9.9 CLNS1A "CLCI, ICln" ENSG00000074201 "Chloride nucleotide-sensitive channel 1A" P54105 11 77514936-77637794 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017840, HPA031707, HPA031708, HPA032045" Approved Supported Nucleoplasm,Microtubules,Cytosol No No 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 32: Non-specific - Translation" Cytosol "Nucleoplasm, Microtubules" "CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123" "unprognostic (1.30e-1)" "unprognostic (3.26e-1)" "unprognostic (5.16e-2)" "unprognostic (1.30e-2)" "unprognostic (5.12e-3)" "unprognostic (5.09e-2)" "unprognostic (9.63e-2)" "unprognostic (5.56e-2)" "unprognostic (2.06e-3)" "unprognostic (5.56e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.07e-4)" "unprognostic (2.05e-1)" "unprognostic (9.19e-2)" "unprognostic (5.99e-3)" "unprognostic (1.17e-1)" 53.1 88.7 86.1 63.1 91.8 72.3 79.9 89.3 92.7 62.2 82.0 72.7 49.7 63.5 99.6 85.3 74.8 53.2 76.4 79.9 94.1 59.6 105.6 45.7 99.5 88.0 86.6 103.3 90.0 60.2 54.0 65.6 89.8 61.2 77.5 97.0 58.2 57.5 98.4 54.0 53.6 56.8 90.5 61.9 65.7 45.7 87.9 102.8 79.0 100.7 105.4 74.6 61.0 94.8 138.4 134.7 216.6 160.7 157.1 224.8 86.8 119.1 181.3 189.0 168.9 326.5 190.0 308.6 194.5 144.6 148.1 162.8 263.0 245.6 227.2 178.6 160.1 301.9 161.7 188.8 132.5 451.8 134.1 182.9 278.9 165.9 311.7 185.5 217.4 187.1 404.8 91.9 186.6 205.0 299.2 364.5 205.7 458.8 243.9 161.5 419.8 332.7 136.7 191.9 219.0 250.1 158.2 177.7 112.1 155.2 241.8 195.8 144.4 138.7 171.2 274.4 116.8 184.3 276.6 330.1 55.0 166.9 114.4 48.1 100.6 39.1 61.1 107.1 68.9 96.5 76.1 66.3 138.7 99.5 91.1 77.8 7.1 101.2 93.6 85.3 72.8 105.7 86.1 91.8 89.3 92.7 79.9 94.1 88.0 86.6 89.8 90.5 87.9 94.8 47.9 16.0 20.3 14.7 91.6 82.7 107.0 248.2 116.7 67.2 75.4 78.6 71.6 71.4 102.6 58.8 50.1 132.9 70.0 27.4 84.1 76.4 17.0 45.1 57.4 53.1 31.8 123.6 21.7 87.5 145.9 72.5 43.8 34.5 78.0 117.0 57.5 62.2 91.1 58.9 24.3 65.3 87.5 108.7 99.3 13.6 87.7 74.9 76.5 10.3 153.8 221.9 57.7 17.6 24.9 65.4 54.3 68.4 64.8 108.2 79.3 97.6 71.6 60.3 52.6 61.8 54.5 116.0 109.4 128.0 86.1 80.6 69.2 126.7 112.5 103.9 CLOCK "bHLHe8, KAT13D, KIAA0334" ENSG00000134852 "Clock circadian regulator" O15516 4 55427903-55546909 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Transcription factors" "Biological rhythms, DNA damage, Transcription, Transcription regulation" "Activator, Acyltransferase, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001867, HPA027565" Supported Enhanced Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA001867: AB_1078537, HPA027565: AB_1846975" "unprognostic (1.30e-2)" "unprognostic (9.02e-2)" "unprognostic (4.25e-3)" "unprognostic (2.48e-1)" "unprognostic (3.94e-2)" "unprognostic (2.00e-2)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (4.52e-2)" "unprognostic (4.32e-2)" "unprognostic (3.01e-2)" "unprognostic (5.96e-2)" "unprognostic (4.07e-2)" "unprognostic (8.31e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "unprognostic (7.16e-2)" 5.5 6.1 3.7 4.2 4.2 1.3 5.9 8.9 5.4 8.0 5.5 5.1 4.9 6.9 5.7 9.2 5.3 4.3 7.5 4.7 5.3 6.5 5.5 4.6 2.9 2.8 3.7 6.2 5.1 10.3 5.5 5.5 3.3 6.2 5.7 11.6 4.6 6.1 9.8 6.8 5.6 7.1 3.8 4.5 6.9 14.1 3.8 3.0 10.1 9.2 3.7 5.6 6.8 5.0 20.0 9.1 7.5 11.6 11.8 11.5 3.6 18.7 16.4 12.9 12.7 5.1 14.8 5.1 9.9 22.8 10.3 15.9 9.5 15.4 23.2 6.9 3.1 4.4 9.4 6.7 10.3 7.0 4.7 6.7 15.8 18.8 18.7 10.4 13.1 4.6 10.1 10.1 21.3 10.6 4.0 4.1 5.0 16.3 9.4 2.5 8.7 3.3 11.0 10.9 7.6 6.2 13.5 16.7 8.9 6.2 5.7 4.2 17.1 18.4 19.5 6.0 26.6 9.1 7.5 3.1 15.6 5.8 14.6 0.0 0.7 0.2 0.7 0.7 1.3 0.4 0.9 0.8 1.1 0.7 0.4 0.6 0.2 0.9 0.7 0.5 0.9 0.4 3.7 4.2 8.9 5.4 4.7 5.3 2.8 3.7 3.3 3.8 3.8 5.0 32.2 41.7 27.7 49.3 15.2 31.1 21.8 28.5 27.9 63.4 21.5 14.9 55.2 14.3 27.4 14.7 43.8 11.3 11.9 21.5 1.9 13.6 34.5 34.2 39.9 32.1 39.7 3.8 95.9 16.5 6.8 28.0 25.0 32.0 3.8 16.6 28.9 27.7 11.6 33.7 114.6 18.5 18.3 17.0 26.1 16.9 23.9 16.9 10.6 70.3 14.0 26.7 19.6 82.0 93.1 28.3 13.2 36.1 18.5 34.0 29.6 19.7 25.2 41.4 13.1 36.5 28.2 64.9 72.5 55.1 37.5 5.2 14.0 21.7 15.6 51.6 CLTC "CLTCL2, Hc" ENSG00000141367 "Clathrin heavy chain" Q00610 17 59619689-59696956 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Autophagy, Cell cycle, Cell division, Mitosis" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010389, CAB011571, CAB017155, HPA059143" Approved Enhanced "Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol" Yes No 14000000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" "Vesicles, Endosomes, Lysosomes" "Mitotic spindle, Cytosol" "CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924" "unprognostic (1.56e-1)" "prognostic unfavorable (7.35e-4)" "prognostic favorable (7.65e-4)" "unprognostic (1.03e-1)" "unprognostic (2.62e-1)" "unprognostic (5.23e-3)" "prognostic unfavorable (5.54e-4)" "unprognostic (1.11e-1)" "unprognostic (6.43e-2)" "unprognostic (1.09e-1)" "unprognostic (3.34e-2)" "unprognostic (2.69e-1)" "unprognostic (1.49e-1)" "unprognostic (1.18e-1)" "unprognostic (9.22e-2)" "unprognostic (1.10e-1)" "prognostic unfavorable (2.02e-4)" 105.4 95.2 42.1 89.7 54.9 96.3 81.6 67.3 103.9 92.3 36.7 121.7 74.1 83.1 126.4 82.1 67.8 88.9 90.7 60.7 65.1 125.5 117.7 82.1 75.5 95.5 52.4 73.2 56.8 186.8 51.6 139.6 95.2 97.8 128.3 163.6 68.6 104.2 88.4 81.3 73.3 121.0 43.8 78.8 91.2 71.3 68.2 76.0 114.1 83.9 86.8 101.1 51.6 55.0 293.3 426.1 207.6 207.0 345.8 280.5 240.0 305.7 321.7 268.2 278.9 264.7 175.2 200.6 340.1 436.4 296.9 186.2 313.6 255.1 356.2 214.4 166.8 328.2 248.8 414.0 262.3 228.5 182.3 266.9 154.6 408.0 262.3 211.4 302.0 99.9 334.4 280.4 429.1 511.1 135.6 65.1 179.6 263.3 248.2 118.7 343.6 244.9 297.5 404.1 184.1 216.7 188.3 122.9 180.4 270.5 290.3 142.3 385.6 492.4 287.9 237.0 317.8 213.3 320.3 181.4 357.7 151.6 305.3 16.6 33.1 21.3 17.5 36.3 21.7 13.7 16.1 19.2 36.5 12.9 13.4 15.0 19.9 18.9 32.5 22.8 22.1 23.3 42.1 54.9 67.3 103.9 60.7 65.1 95.5 52.4 95.2 43.8 68.2 55.0 62.6 99.3 107.9 80.3 46.3 63.9 44.4 75.6 28.5 91.9 58.5 34.7 77.9 71.4 103.3 77.3 60.5 109.1 60.7 184.0 27.4 76.2 23.3 95.5 95.6 79.7 120.6 115.9 137.7 97.7 47.7 84.5 99.4 106.1 68.4 75.5 120.7 185.4 182.5 85.8 135.9 120.7 77.3 195.0 93.2 77.2 74.0 128.3 53.4 79.6 102.8 53.9 38.1 73.4 124.2 106.2 76.1 93.6 83.0 86.3 102.7 132.4 128.0 65.2 78.9 66.0 82.8 52.7 38.0 60.5 79.3 107.9 45.9 81.3 127.8 91.6 CMAS ENSG00000111726 "Cytidine monophosphate N-acetylneuraminic acid synthetase" Q8NFW8 12 22046218-22065674 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 532.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039905 Supported Uncertain Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 36: HEL - Hemostasis" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Cytosol Nucleoli "HPA039905: AB_10795237" "unprognostic (5.54e-2)" "unprognostic (4.10e-2)" "unprognostic (4.25e-1)" "unprognostic (5.39e-3)" "unprognostic (1.94e-2)" "unprognostic (3.99e-2)" "unprognostic (2.30e-2)" "unprognostic (4.17e-3)" "unprognostic (1.53e-2)" "unprognostic (1.01e-1)" "unprognostic (4.44e-1)" "unprognostic (7.53e-2)" "prognostic unfavorable (7.19e-4)" "unprognostic (2.27e-1)" "unprognostic (1.91e-2)" "unprognostic (3.65e-1)" "unprognostic (2.03e-1)" 19.7 57.0 46.6 23.2 51.1 47.9 32.9 40.3 57.8 29.2 35.8 77.8 66.2 23.5 69.0 71.6 21.8 24.4 42.6 51.2 57.3 28.9 72.2 18.1 24.2 43.8 57.1 25.3 42.5 79.4 30.0 34.0 57.1 36.7 71.9 24.8 32.6 26.7 44.0 29.3 63.6 27.7 41.8 20.1 29.7 69.9 49.0 19.8 23.8 41.1 26.1 24.2 40.3 44.0 63.4 50.2 59.5 29.3 47.0 57.5 88.8 43.2 46.2 45.0 47.2 114.1 72.0 56.5 41.3 37.3 83.9 50.9 35.8 60.1 60.7 75.0 45.4 169.1 38.8 57.2 43.2 45.4 85.5 38.5 56.4 58.1 86.3 61.5 61.3 58.7 108.8 28.1 80.9 83.8 52.0 105.3 147.5 69.4 69.5 36.2 63.6 53.7 56.0 67.8 23.8 42.0 34.2 59.6 51.9 120.2 82.3 62.0 45.5 51.2 42.4 46.2 81.1 19.4 26.0 74.9 83.6 34.6 54.3 22.7 27.3 32.1 20.4 29.7 26.1 19.0 26.9 27.0 31.5 18.2 24.2 24.6 2.8 36.9 27.4 20.2 33.8 25.5 46.6 51.1 40.3 57.8 51.2 57.3 43.8 57.1 57.1 41.8 49.0 44.0 21.5 12.8 17.5 12.4 19.2 29.2 76.8 117.2 14.8 38.3 31.9 21.2 72.7 41.5 102.3 23.9 4.2 175.2 17.8 158.1 76.3 56.6 12.4 17.2 19.6 36.8 41.6 153.9 38.7 83.6 141.3 41.7 21.9 20.0 22.8 28.2 34.2 63.6 66.2 35.3 29.2 118.2 93.6 29.8 22.0 19.0 25.4 32.5 44.4 8.4 45.3 33.4 26.8 16.6 25.5 79.7 156.2 27.8 16.7 112.3 133.6 87.0 82.5 20.4 19.7 30.4 42.3 112.2 97.1 52.3 44.5 532.6 24.6 63.0 90.8 190.6 CMTR1 "FTSJD2, ISG95, KIAA0082, MTr1" ENSG00000137200 "Cap methyltransferase 1" Q8N1G2 6 37433219-37482827 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA capping, mRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 253.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029954, HPA029979, HPA029980" Enhanced Enhanced Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094" "unprognostic (1.33e-1)" "unprognostic (2.12e-2)" "unprognostic (6.43e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (1.00e-1)" "unprognostic (3.72e-1)" "unprognostic (1.68e-2)" "unprognostic (6.43e-3)" "unprognostic (2.95e-2)" "unprognostic (9.17e-2)" "unprognostic (5.24e-3)" "unprognostic (1.50e-3)" "unprognostic (3.00e-3)" "unprognostic (3.27e-2)" "unprognostic (9.72e-2)" "unprognostic (2.54e-1)" "unprognostic (1.14e-2)" 20.1 22.1 21.0 19.2 21.2 30.9 19.5 20.3 22.9 23.6 18.6 26.8 18.1 23.1 17.4 16.9 22.4 15.1 25.1 20.7 22.0 19.4 21.8 20.4 25.3 21.5 21.0 28.0 22.1 27.5 26.0 24.9 20.3 21.9 15.2 28.5 21.7 18.4 30.1 23.2 23.2 20.4 20.2 28.8 21.9 62.9 23.5 30.9 20.3 23.4 25.6 21.6 20.0 20.2 23.5 21.9 31.0 50.7 34.2 31.1 37.4 27.5 37.7 68.1 75.9 33.3 15.3 48.6 30.5 40.7 63.8 25.7 39.7 28.4 51.7 33.8 35.2 26.8 26.8 37.2 26.3 38.9 17.6 27.1 20.9 37.6 26.7 35.7 32.2 44.3 60.6 34.5 36.3 38.5 49.8 34.6 15.6 15.7 20.7 39.0 36.7 28.1 22.0 28.2 34.2 25.6 30.8 23.4 40.2 22.1 39.8 29.7 30.0 40.7 30.3 16.3 31.1 39.3 21.8 253.0 16.0 40.1 45.6 4.2 5.4 3.5 4.9 7.1 4.1 5.5 4.3 5.2 5.1 3.8 4.7 3.9 3.3 5.6 5.5 4.2 6.1 4.6 21.0 21.2 20.3 22.9 20.7 22.0 21.5 21.0 20.3 20.2 23.5 20.2 11.3 9.6 9.2 5.9 12.0 3.6 3.9 4.0 8.6 14.2 6.3 5.5 10.4 8.6 11.5 7.3 33.3 18.0 15.4 5.3 0.0 4.5 20.2 7.7 15.4 9.6 8.4 6.5 15.1 8.5 8.0 8.8 11.7 8.9 3.8 24.9 7.9 10.1 7.5 11.8 13.9 8.4 4.1 7.5 2.3 11.3 7.8 9.5 3.6 14.0 11.5 8.8 7.2 10.6 14.2 8.5 3.3 6.8 12.4 4.3 4.7 4.0 11.2 11.9 6.6 8.5 13.5 16.8 10.6 5.8 4.7 20.8 11.5 22.0 6.9 3.6 CNDP2 "CN2, CPGL, FLJ10830, HsT2298, PEPA" ENSG00000133313 "Carnosine dipeptidase 2" Q96KP4 18 74495816-74523454 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 334.7;Proximal enterocytes: 629.1;Proximal tubular cells: 487.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 458.7;RPMI-8226: 616.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026196, HPA036898, HPA036899" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 2600000 "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Cytosol" "CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371" "unprognostic (2.81e-2)" "unprognostic (9.96e-2)" "unprognostic (3.28e-1)" "unprognostic (1.19e-3)" "unprognostic (2.57e-2)" "unprognostic (5.06e-2)" "unprognostic (2.84e-2)" "unprognostic (5.35e-2)" "unprognostic (1.49e-1)" "unprognostic (9.31e-2)" "unprognostic (1.56e-3)" "unprognostic (1.15e-1)" "prognostic favorable (3.50e-6)" "unprognostic (2.37e-3)" "unprognostic (4.65e-3)" "unprognostic (1.51e-1)" "unprognostic (1.34e-1)" 54.8 40.7 125.3 75.0 147.0 25.1 60.4 139.4 156.9 136.8 113.0 83.6 190.1 44.2 122.8 78.4 140.8 94.4 63.7 123.7 133.2 327.3 261.1 82.3 86.3 143.1 137.4 34.4 100.7 58.5 48.0 75.4 144.7 122.5 79.5 42.1 57.4 101.7 26.6 47.0 255.0 37.9 140.4 137.0 103.5 20.9 143.9 52.5 159.1 22.4 82.2 94.5 47.4 157.6 64.6 85.0 60.5 57.4 72.2 42.5 252.3 66.0 61.7 88.3 87.4 49.6 67.1 80.3 81.4 72.1 69.0 95.0 92.7 124.9 62.7 121.3 36.7 80.2 42.1 79.6 104.6 158.7 119.3 64.5 93.9 76.4 136.6 50.1 78.3 94.6 86.3 458.7 59.1 71.6 84.9 75.6 91.0 42.4 50.3 91.3 69.4 616.6 346.1 264.1 65.3 34.2 51.6 360.2 91.6 143.0 151.5 64.0 82.5 93.9 79.5 21.2 45.2 85.5 380.6 108.1 63.6 113.8 80.2 37.1 115.4 49.0 77.6 166.3 84.4 102.4 61.6 72.2 185.1 110.5 65.5 72.4 15.9 124.6 174.1 161.3 94.5 135.7 125.3 147.0 139.4 156.9 123.7 133.2 143.1 137.4 144.7 140.4 143.9 157.6 39.2 73.7 62.7 16.6 55.7 9.2 40.3 48.6 12.5 33.6 76.5 36.4 26.9 77.2 56.8 119.5 16.7 157.9 47.8 99.0 187.9 168.1 3.3 187.7 49.7 49.6 65.3 23.3 8.8 154.7 130.9 23.5 63.7 334.7 12.0 34.0 40.0 119.8 216.3 43.7 10.8 82.9 75.3 122.9 24.9 4.1 18.6 79.0 17.8 13.1 90.8 86.6 55.6 15.6 51.7 108.9 103.5 16.6 44.4 65.2 629.1 487.6 73.3 31.6 13.1 15.2 22.3 8.3 7.2 27.1 9.7 109.0 38.2 32.8 99.8 53.8 CNOT6 "CCR4, Ccr4a, KIAA1194" ENSG00000113300 "CCR4-NOT transcription complex subunit 6" Q9ULM6 5 180494379-180578358 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044568 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA044568: AB_10797257" "unprognostic (9.41e-3)" "unprognostic (1.40e-1)" "unprognostic (2.03e-3)" "unprognostic (2.55e-1)" "unprognostic (1.41e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (3.61e-7)" "unprognostic (1.31e-1)" "unprognostic (1.10e-2)" "unprognostic (1.85e-2)" "unprognostic (2.50e-2)" "unprognostic (2.35e-2)" "unprognostic (1.79e-2)" "unprognostic (1.25e-1)" "unprognostic (1.26e-1)" "unprognostic (4.03e-2)" "unprognostic (3.57e-2)" 6.6 6.5 8.7 12.0 9.1 11.9 9.5 16.1 8.8 8.0 10.1 10.0 12.1 9.2 8.6 11.5 9.4 7.3 6.2 7.9 9.3 10.0 5.1 9.7 11.4 8.9 8.7 9.4 6.6 8.7 5.6 11.8 7.9 9.4 11.5 17.5 7.1 7.4 5.2 9.3 11.9 8.1 8.4 10.0 10.1 13.5 9.2 19.7 9.0 7.4 14.0 11.4 8.0 9.4 24.9 29.6 59.2 47.5 9.6 10.9 61.0 17.9 12.0 23.2 27.5 36.1 35.7 26.2 26.5 11.8 32.2 25.5 50.0 59.4 27.1 77.5 25.2 28.6 38.4 23.4 14.3 33.6 20.1 9.3 28.1 17.1 36.1 21.6 28.6 30.2 30.9 24.5 21.8 51.1 43.0 20.2 17.5 25.0 13.9 39.1 29.6 18.6 25.6 48.5 43.0 36.4 30.1 39.7 26.2 28.7 49.9 33.5 31.4 24.5 28.1 18.0 32.0 16.0 30.9 27.4 23.4 45.3 20.6 0.7 0.8 1.2 1.2 1.4 1.3 0.6 1.0 0.7 0.8 0.7 1.4 1.4 0.8 0.7 2.3 0.8 0.8 0.6 8.7 9.1 16.1 8.8 7.9 9.3 8.9 8.7 7.9 8.4 9.2 9.4 12.4 28.9 13.4 16.3 11.9 21.7 6.4 12.9 15.9 18.0 19.5 11.7 11.4 14.3 12.4 11.0 22.9 9.4 21.9 17.1 1.9 11.0 6.4 32.3 22.3 13.2 14.5 27.8 27.2 9.3 12.8 11.8 11.2 21.1 2.5 29.7 13.6 5.7 12.5 18.5 24.9 13.8 6.1 16.2 15.4 9.3 13.1 14.4 10.6 18.7 20.1 13.5 26.8 30.2 33.4 17.6 8.4 18.8 15.5 17.3 12.1 13.1 20.2 17.5 26.3 11.7 13.1 38.6 48.7 23.2 22.3 11.5 16.2 12.8 16.5 19.9 CNOT9 "CAF40, CT129, RCD1, RCD1+, RQCD1" ENSG00000144580 "CCR4-NOT transcription complex subunit 9" Q92600 2 218568580-218597080 "Predicted intracellular proteins" "RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046622 Approved Approved "Cytoplasmic bodies" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Cytoplasmic bodies" "HPA046622: AB_10962694" "unprognostic (7.70e-2)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.58e-2)" "unprognostic (1.34e-1)" "unprognostic (1.30e-2)" "prognostic unfavorable (8.41e-9)" "unprognostic (8.08e-3)" "unprognostic (1.91e-3)" "unprognostic (1.53e-2)" "unprognostic (7.02e-2)" "unprognostic (6.89e-2)" "prognostic unfavorable (4.69e-9)" "unprognostic (1.87e-2)" "unprognostic (2.38e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 17.2 21.9 18.3 26.0 19.7 40.2 16.6 20.8 19.4 17.8 18.9 17.7 18.1 17.6 19.4 21.4 18.8 16.1 20.1 18.7 19.4 16.3 21.0 18.2 31.3 18.6 19.2 18.7 15.8 21.0 25.2 18.0 18.6 18.4 22.6 26.1 15.1 15.0 22.4 20.5 17.3 20.2 19.4 22.6 17.1 27.0 18.9 33.6 15.4 17.1 36.2 21.8 17.6 22.1 49.9 38.2 62.2 82.2 35.2 33.8 79.8 55.5 57.4 69.6 67.4 68.2 40.4 55.4 33.7 64.3 60.9 57.2 88.1 61.6 81.4 79.8 55.6 110.6 72.1 81.1 48.9 120.2 61.7 31.0 48.5 73.1 74.2 32.7 53.1 74.0 67.1 121.1 56.3 40.0 117.2 72.8 94.5 38.4 60.4 97.8 88.7 57.1 37.1 71.5 79.2 64.8 54.5 47.5 52.2 59.1 38.1 66.5 43.2 75.5 55.8 55.3 69.0 57.6 62.6 128.3 53.7 73.1 55.0 36.9 25.6 29.1 41.5 31.7 36.4 29.9 34.0 35.4 30.4 26.6 31.8 35.0 10.5 35.5 34.0 35.1 30.8 37.9 18.3 19.7 20.8 19.4 18.7 19.4 18.6 19.2 18.6 19.4 18.9 22.1 22.1 22.4 20.7 0.0 10.0 0.0 0.0 0.0 0.0 0.0 20.4 15.1 0.0 0.0 9.9 12.9 0.0 28.4 27.1 0.0 27.4 21.2 0.0 32.2 21.2 10.3 0.0 0.0 0.0 20.7 40.7 10.9 0.0 22.4 16.4 18.9 0.0 0.0 28.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.3 0.0 0.0 20.7 0.0 0.0 0.0 0.0 25.6 0.0 0.0 7.0 0.0 0.0 16.1 10.2 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 28.3 11.0 16.9 0.0 0.0 COG2 LDLC ENSG00000135775 "Component of oligomeric golgi complex 2" Q14746 1 230642481-230693982 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 71.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076994 Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 21: OE19 - Mitochondria" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "HPA076994: AB_2686823" "unprognostic (2.21e-1)" "unprognostic (7.35e-2)" "prognostic favorable (9.76e-4)" "unprognostic (2.91e-1)" "unprognostic (1.32e-3)" "unprognostic (3.59e-1)" "unprognostic (1.08e-1)" "unprognostic (4.06e-1)" "unprognostic (2.18e-1)" "unprognostic (5.87e-2)" "unprognostic (6.83e-3)" "unprognostic (1.08e-1)" "unprognostic (2.73e-2)" "unprognostic (2.61e-1)" "unprognostic (4.44e-2)" "unprognostic (2.18e-2)" "unprognostic (5.62e-2)" 10.1 22.0 10.7 11.0 11.8 9.1 12.9 14.7 13.1 13.1 13.5 19.0 13.5 10.0 13.8 8.9 14.2 10.9 17.2 10.0 10.9 16.6 9.9 10.0 16.3 11.0 11.2 10.0 14.1 71.2 8.5 8.9 10.9 12.1 22.7 10.9 12.8 10.9 20.1 11.8 13.3 11.7 11.1 15.1 14.4 10.9 11.5 16.6 15.0 19.9 16.2 11.1 9.1 12.4 15.6 18.0 21.1 20.4 20.6 16.0 30.7 13.2 20.4 21.4 18.6 24.2 23.2 47.6 20.2 18.1 13.8 22.8 20.1 23.6 20.3 38.8 39.8 16.8 17.0 24.9 25.4 43.6 25.1 21.7 25.6 13.6 19.5 13.7 18.0 29.1 29.5 25.8 17.4 12.5 39.7 21.2 30.5 47.1 33.1 33.8 33.8 56.7 22.1 22.8 21.7 29.7 15.5 27.9 30.5 9.4 33.6 41.9 15.3 10.3 9.5 12.8 25.9 31.7 28.3 37.7 17.2 17.7 22.1 18.7 15.7 20.5 16.0 19.4 18.5 13.9 15.1 15.5 18.1 15.2 21.6 19.0 0.8 22.9 29.4 9.1 13.5 18.2 10.7 11.8 14.7 13.1 10.0 10.9 11.0 11.2 10.9 11.1 11.5 12.4 12.5 22.4 19.5 22.9 21.0 5.2 6.1 7.8 8.6 16.1 12.3 10.8 25.9 20.0 15.1 12.9 29.2 13.1 19.6 19.8 27.4 18.7 19.3 17.6 15.2 10.7 18.6 14.9 22.3 23.3 11.8 10.8 15.8 10.7 23.4 14.2 11.0 14.1 14.0 25.2 20.5 37.1 12.2 20.1 6.0 6.4 11.5 12.3 7.2 17.8 19.0 20.5 21.6 23.1 22.6 18.0 12.8 14.7 13.0 9.0 15.2 20.3 28.9 42.9 13.1 13.9 13.3 23.3 25.2 10.0 4.8 9.2 18.4 21.0 21.6 6.0 COG5 "GOLTC1, GTC90" ENSG00000164597 "Component of oligomeric golgi complex 5" Q9UP83 7 107201372-107564261 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 124.4;Excitatory neurons: 147.0;Inhibitory neurons: 196.1;Microglial cells: 147.1;Oligodendrocyte precursor cells: 136.7;Oligodendrocytes: 183.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020300, HPA041583" Uncertain Enhanced "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 18: U-2197 - ECM organization" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Golgi apparatus" Nucleoplasm "HPA020300: AB_2081406, HPA041583: AB_2677564" "unprognostic (3.10e-1)" "unprognostic (1.95e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.11e-1)" "prognostic unfavorable (3.77e-4)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (3.40e-3)" "unprognostic (1.94e-1)" "unprognostic (2.06e-1)" "unprognostic (3.91e-3)" "unprognostic (8.73e-2)" "unprognostic (3.90e-2)" "prognostic unfavorable (1.48e-4)" "unprognostic (1.15e-1)" 11.4 12.1 6.7 9.5 7.7 14.2 10.8 7.7 8.5 20.4 8.1 12.0 9.3 17.1 10.0 12.8 9.0 12.9 19.7 7.1 7.5 9.7 6.8 10.2 9.5 7.0 7.5 12.4 14.7 19.4 10.2 10.5 7.6 17.8 12.4 11.8 22.8 11.0 14.0 12.9 10.1 14.4 6.3 9.0 11.7 8.6 7.5 6.2 20.3 15.4 10.4 10.5 16.7 9.4 39.3 14.9 16.1 15.1 14.7 16.2 12.6 27.0 28.2 11.7 20.5 12.0 17.5 7.9 14.9 27.0 26.5 15.5 10.7 16.0 18.2 23.5 9.6 8.7 9.9 15.1 17.4 18.8 19.0 15.4 15.3 20.4 24.0 32.1 31.7 17.1 16.6 25.1 21.5 18.5 19.2 17.8 5.9 30.0 19.1 6.8 13.6 18.6 13.6 17.9 7.6 21.8 16.6 27.2 31.2 23.8 6.2 12.2 36.6 12.6 16.0 39.7 17.2 16.3 16.9 17.3 24.2 21.0 33.9 9.4 6.6 7.5 6.1 7.6 8.4 6.0 7.7 6.9 5.4 5.8 6.4 6.4 3.4 5.1 9.3 3.7 6.5 5.9 6.7 7.7 7.7 8.5 7.1 7.5 7.0 7.5 7.6 6.3 7.5 9.4 14.8 3.2 15.5 124.4 21.7 12.2 15.0 11.1 24.5 23.2 10.0 7.7 27.6 7.2 16.5 14.7 33.3 10.2 16.5 15.8 1.9 10.5 22.6 11.8 21.8 11.0 10.3 5.9 147.0 10.9 8.5 14.4 14.8 19.8 3.8 12.3 9.7 5.8 11.3 11.8 196.1 36.2 18.3 14.8 12.3 22.1 11.8 15.3 12.4 147.1 15.7 9.0 11.3 136.7 183.2 10.8 10.1 12.4 20.7 20.6 14.5 6.5 16.3 17.4 26.3 15.4 10.2 18.2 14.0 19.0 13.4 10.5 18.9 7.5 14.9 16.1 COG7 ENSG00000168434 "Component of oligomeric golgi complex 7" P83436 16 23388493-23453189 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Congenital disorder of glycosylation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040758, HPA041824, HPA064645" Uncertain Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 26: Pituitary gland - Hormone signaling" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Golgi apparatus" "HPA040758: AB_2677120, HPA041824: , HPA064645: AB_2685311" "unprognostic (1.72e-1)" "unprognostic (1.02e-2)" "unprognostic (8.21e-2)" "prognostic favorable (6.95e-4)" "unprognostic (3.71e-1)" "unprognostic (2.15e-1)" "unprognostic (5.95e-2)" "unprognostic (2.70e-2)" "unprognostic (3.10e-1)" "unprognostic (4.15e-1)" "unprognostic (6.07e-3)" "unprognostic (1.58e-1)" "prognostic favorable (3.14e-4)" "unprognostic (3.77e-1)" "unprognostic (1.30e-1)" "unprognostic (1.05e-1)" "unprognostic (1.14e-1)" 8.7 13.1 9.2 7.2 8.7 9.8 10.3 7.5 10.0 14.9 16.7 13.2 8.3 10.9 11.2 12.1 15.0 8.4 10.0 8.6 8.6 12.7 9.5 10.0 6.8 8.8 9.4 13.4 10.2 16.3 23.8 7.5 9.1 16.2 11.8 13.8 13.4 10.4 9.8 12.2 10.5 8.6 7.4 9.8 12.7 10.0 8.8 8.1 14.6 6.4 7.2 11.4 12.2 10.7 10.2 19.5 11.9 13.5 10.4 16.9 10.8 11.2 14.1 12.9 12.9 8.3 17.6 4.8 11.6 17.8 8.2 15.2 10.8 13.8 9.8 15.7 16.3 5.0 15.3 22.2 11.0 13.9 14.2 11.0 11.0 9.9 10.4 16.0 15.2 15.7 12.2 13.6 10.5 29.9 9.3 10.2 10.7 15.7 9.3 18.7 10.3 17.3 14.0 10.0 7.2 9.2 12.6 14.2 9.7 8.9 21.0 17.8 10.7 14.3 7.5 13.4 8.2 12.4 14.1 6.5 19.1 8.1 14.0 8.4 6.7 7.3 6.0 7.7 7.6 3.9 5.5 5.7 8.0 4.6 5.6 8.5 1.6 5.6 10.0 5.7 7.0 4.9 9.2 8.7 7.5 10.0 8.6 8.6 8.8 9.4 9.1 7.4 8.8 10.7 8.0 25.6 16.9 30.3 6.2 6.6 10.1 13.7 10.2 10.1 12.0 12.2 7.2 8.6 19.9 12.9 31.3 12.5 5.5 19.4 1.9 12.0 5.0 24.4 10.8 7.7 19.2 10.8 39.7 13.8 7.6 9.8 27.5 14.2 8.2 13.1 6.1 6.0 6.4 11.8 39.8 19.3 8.2 4.0 2.3 3.6 9.9 7.7 8.8 19.7 4.4 9.2 5.2 45.8 40.6 12.9 11.3 12.4 7.2 9.3 11.6 8.7 39.1 22.4 13.1 10.1 8.6 16.5 13.3 9.1 5.4 11.8 8.9 7.2 15.9 10.7 COPS2 "ALIEN, CSN2, TRIP15" ENSG00000166200 "COP9 signalosome subunit 2" P61201 15 49106068-49155661 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016867, HPA018271, HPA061071" Approved Supported "Vesicles,Cytokinetic bridge" Yes No 190000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 18: U-2197 - ECM organization" "Cluster 10: Non-specific - Unknown function" Vesicles "Cytokinetic bridge" "HPA016867: AB_1858336, HPA018271: AB_1858335, HPA061071: AB_2684424" "unprognostic (3.47e-1)" "unprognostic (2.28e-2)" "unprognostic (1.66e-1)" "unprognostic (7.20e-2)" "unprognostic (1.86e-1)" "unprognostic (7.84e-3)" "unprognostic (1.04e-1)" "unprognostic (6.77e-2)" "unprognostic (2.49e-2)" "unprognostic (6.09e-2)" "unprognostic (3.86e-3)" "unprognostic (1.42e-1)" "unprognostic (4.35e-3)" "unprognostic (1.02e-1)" "unprognostic (1.97e-1)" "unprognostic (5.62e-2)" "unprognostic (1.10e-3)" 61.7 43.4 24.8 34.4 28.5 124.5 67.0 35.0 36.8 61.9 25.3 43.2 43.3 58.4 44.0 63.2 43.2 53.7 61.5 26.1 30.4 60.8 57.6 35.0 45.5 30.9 27.7 76.7 54.0 65.7 26.4 45.0 32.8 45.2 41.6 32.2 40.0 47.0 92.6 35.5 37.2 56.5 35.2 32.0 36.4 51.0 27.5 49.6 61.8 112.1 48.8 59.0 35.3 41.7 92.0 53.1 111.6 94.4 134.2 189.9 76.7 157.3 149.8 135.4 123.5 113.0 49.1 151.1 105.2 152.2 108.7 131.9 160.3 130.9 148.0 103.3 64.5 141.0 105.4 91.7 102.6 134.7 70.7 161.2 104.3 110.4 193.3 149.3 144.0 82.5 184.4 78.8 149.3 49.5 72.3 67.3 72.6 128.4 68.9 78.2 105.2 227.7 143.5 136.5 108.4 78.6 90.7 96.4 127.8 129.4 95.6 133.3 93.4 132.1 71.0 249.6 167.9 71.0 196.3 191.0 123.4 215.1 109.4 11.7 17.9 12.2 13.1 23.5 24.4 14.6 19.7 19.2 21.0 13.9 24.8 16.2 7.4 16.6 22.9 13.3 28.4 16.0 24.8 28.5 35.0 36.8 26.1 30.4 30.9 27.7 32.8 35.2 27.5 41.7 72.8 76.9 56.1 14.4 50.0 87.1 57.1 90.8 80.8 23.2 47.6 59.3 104.3 27.1 69.8 23.9 10.4 56.1 48.2 18.5 54.8 40.3 28.2 56.7 91.6 53.6 20.8 50.1 35.2 29.9 71.0 79.6 36.2 94.0 52.6 39.3 46.1 32.5 43.9 33.7 36.1 25.1 32.6 47.5 44.9 21.6 55.3 46.1 35.6 19.7 49.3 24.8 27.8 21.6 48.7 35.9 21.6 53.4 63.5 53.0 41.0 84.8 47.4 19.7 19.7 74.6 109.0 93.1 43.3 63.2 98.9 131.9 54.0 58.6 34.6 64.4 COPS7B CSN7B ENSG00000144524 "COP9 signalosome subunit 7B" Q9H9Q2 2 231781671-231809254 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034675, HPA034676" Uncertain Supported Nucleoplasm NA NA 44000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA034675: AB_10696360, HPA034676: AB_2674274" "unprognostic (3.21e-1)" "unprognostic (1.59e-1)" "unprognostic (6.25e-3)" "unprognostic (3.59e-3)" "unprognostic (3.50e-1)" "unprognostic (4.77e-2)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.19e-1)" "unprognostic (4.81e-2)" "unprognostic (1.89e-1)" "unprognostic (5.77e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.50e-6)" "unprognostic (2.37e-2)" "unprognostic (1.39e-1)" "unprognostic (6.64e-2)" "unprognostic (1.55e-3)" 10.8 15.6 16.5 11.3 17.6 11.7 11.3 16.3 26.3 16.7 14.3 15.1 6.9 14.2 10.6 12.7 15.1 8.1 10.8 17.0 16.4 11.9 14.6 11.6 17.8 16.0 17.4 13.8 11.5 19.8 15.5 15.0 17.3 14.9 15.1 9.4 14.1 14.9 13.6 17.0 13.3 16.7 16.2 17.5 15.9 20.5 16.8 22.9 13.9 12.8 22.3 13.9 13.8 18.4 24.8 20.9 31.7 33.5 22.1 27.8 33.9 19.8 18.6 31.5 37.3 35.9 26.6 23.4 21.2 24.3 38.1 19.5 45.6 36.1 46.8 40.3 42.3 46.2 17.9 51.4 23.8 49.1 25.0 19.4 36.2 35.2 25.8 28.6 36.4 58.2 51.7 18.6 30.2 31.8 49.7 40.0 48.5 24.8 22.0 54.6 38.8 25.6 24.2 21.1 34.2 28.5 18.6 15.8 35.4 44.9 20.1 39.6 23.6 22.9 22.1 26.8 27.7 29.9 26.9 65.0 22.0 34.2 23.4 12.6 8.4 4.6 12.3 9.9 12.1 13.3 9.6 11.4 12.5 13.3 13.1 9.4 1.8 15.8 13.7 9.8 10.5 11.5 16.5 17.6 16.3 26.3 17.0 16.4 16.0 17.4 17.3 16.2 16.8 18.4 10.6 16.0 11.3 28.1 17.1 12.4 12.2 24.0 18.2 13.8 16.7 16.5 6.7 10.0 15.2 16.5 10.4 24.2 19.7 8.6 13.7 14.1 54.6 10.7 10.1 11.1 23.3 7.6 14.8 9.3 20.5 12.3 9.7 9.0 5.7 18.1 14.6 7.9 15.1 13.5 14.3 15.7 18.3 12.7 9.7 14.9 18.0 10.1 12.4 14.0 18.6 9.5 35.0 18.1 17.8 13.7 9.5 20.3 13.5 12.5 10.4 9.9 11.4 18.3 13.1 8.3 13.5 43.3 61.4 16.5 8.1 17.8 16.5 21.1 14.3 12.1 CPSF1 CPSF160 ENSG00000071894 "Cleavage and polyadenylation specific factor 1" Q10570 8 144393229-144409335 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065167, HPA068906" Enhanced Nucleoplasm No No "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA065167: AB_2685426, HPA068906: AB_2686055" "unprognostic (6.37e-2)" "unprognostic (7.72e-2)" "unprognostic (2.41e-2)" "unprognostic (1.21e-1)" "unprognostic (2.93e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (1.05e-1)" "unprognostic (2.00e-3)" "unprognostic (6.45e-2)" "unprognostic (7.54e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.54e-5)" "unprognostic (2.40e-1)" "unprognostic (1.91e-1)" "unprognostic (7.90e-2)" "unprognostic (9.66e-3)" 39.1 52.0 16.2 11.0 16.6 20.4 45.5 15.9 23.3 53.5 16.2 54.8 27.4 48.8 3.8 49.2 49.1 9.0 44.9 15.9 14.9 52.2 76.3 43.3 12.3 16.8 14.9 56.6 88.6 6.1 78.0 6.8 17.1 61.7 4.2 5.2 49.6 7.6 41.0 55.3 68.1 5.7 14.6 70.5 68.9 132.0 15.6 15.0 52.9 5.2 6.8 41.2 44.0 16.2 21.4 29.4 26.3 27.7 13.8 11.0 25.7 19.6 12.4 15.8 16.3 29.8 27.0 24.6 18.7 14.8 10.7 19.1 14.9 16.7 4.4 22.2 43.0 48.3 37.4 48.6 11.7 18.6 28.8 12.1 6.9 14.5 8.5 9.5 21.2 40.1 41.1 20.4 8.0 90.7 48.8 38.6 15.9 17.9 41.0 34.7 10.6 19.9 17.0 31.1 21.3 21.1 25.4 15.7 14.8 7.4 27.9 20.5 18.4 10.8 41.3 23.9 22.3 12.1 10.2 23.3 14.6 31.0 13.1 3.8 5.1 3.3 4.8 6.1 5.1 4.0 5.2 5.1 5.7 4.8 4.5 4.3 0.9 4.0 6.2 2.6 6.7 4.2 16.2 16.6 15.9 23.3 15.9 14.9 16.8 14.9 17.1 14.6 15.6 16.2 10.1 16.0 22.5 10.1 9.5 10.1 4.0 6.6 6.2 9.6 15.1 16.9 8.3 20.0 10.7 9.2 12.5 10.1 14.5 26.4 1.9 9.5 19.5 9.6 7.8 11.7 13.1 15.8 9.4 11.5 11.5 10.7 21.9 11.8 14.0 20.7 8.9 8.1 15.1 8.4 6.9 28.6 8.2 12.4 12.4 40.4 14.0 11.7 14.2 3.7 11.9 5.0 10.3 5.5 6.5 10.5 8.8 16.1 17.9 4.1 24.0 6.2 11.7 14.4 6.6 7.7 9.0 36.5 23.1 12.2 12.4 7.3 11.5 7.6 30.3 4.3 CPSF2 "CPSF100, KIAA1367" ENSG00000165934 "Cleavage and polyadenylation specific factor 2" Q9P2I0 14 92121969-92172145 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024238 Supported Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Vesicles "HPA024238: AB_1847200" "unprognostic (2.31e-1)" "unprognostic (9.80e-2)" "unprognostic (3.73e-2)" "unprognostic (1.77e-2)" "unprognostic (4.95e-2)" "unprognostic (2.14e-2)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.34e-1)" "unprognostic (2.94e-1)" "unprognostic (1.78e-2)" "unprognostic (2.33e-2)" "unprognostic (6.68e-2)" "unprognostic (8.78e-3)" "unprognostic (2.44e-1)" "unprognostic (2.91e-1)" "unprognostic (8.75e-2)" "unprognostic (4.90e-2)" 14.8 14.5 7.3 24.9 9.7 11.5 11.8 9.3 10.1 13.7 13.0 16.1 14.7 15.0 15.0 18.3 11.7 15.0 13.1 6.8 8.9 13.6 19.7 14.7 21.0 9.5 9.2 12.6 14.9 18.2 10.7 16.7 10.6 15.6 16.8 13.9 13.6 14.1 27.1 11.1 14.4 17.8 8.5 18.6 17.4 26.0 8.5 27.3 18.3 25.6 24.8 16.6 12.3 12.2 48.1 46.9 47.0 48.6 23.9 21.1 69.5 60.7 59.0 55.1 54.3 41.4 64.9 51.3 38.9 65.1 37.2 69.2 65.2 55.2 79.2 83.3 22.4 75.4 46.1 39.5 70.5 76.3 60.6 34.7 46.2 52.5 93.8 36.5 52.2 54.5 68.8 62.9 62.1 69.6 88.3 26.8 53.3 76.8 42.3 86.0 72.7 45.9 37.5 67.1 51.7 34.7 71.7 39.9 51.1 41.9 82.9 47.4 56.3 43.9 27.7 33.4 52.4 37.6 66.2 103.0 53.0 58.9 69.7 16.6 12.9 9.3 7.8 11.7 10.4 7.6 6.9 8.4 11.3 4.0 6.1 8.6 4.4 11.1 9.8 7.3 12.1 9.5 7.3 9.7 9.3 10.1 6.8 8.9 9.5 9.2 10.6 8.5 8.5 12.2 14.2 28.9 31.8 23.2 22.9 10.3 15.2 15.1 15.9 12.7 13.4 9.5 27.1 10.0 25.5 7.3 29.2 24.0 19.8 14.6 13.7 18.0 28.2 24.3 30.0 22.9 13.8 33.0 13.6 24.0 22.7 20.0 17.3 16.8 30.4 26.2 20.7 27.2 24.8 11.8 17.5 17.3 12.2 32.9 8.8 11.2 19.0 31.1 3.6 19.7 41.2 16.9 27.8 18.6 27.9 23.8 14.0 23.0 35.4 29.9 12.5 16.3 34.1 22.7 32.9 19.6 23.2 61.7 41.3 27.2 12.8 25.3 22.8 26.6 18.2 20.2 CPSF3 "CPSF-73, CPSF73, YSH1" ENSG00000119203 "Cleavage and polyadenylation specific factor 3" Q9UKF6 2 9423651-9473101 "Predicted intracellular proteins" "mRNA processing" "Endonuclease, Hydrolase, Nuclease, Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 187.6;Spermatocytes: 151.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034657 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "HPA034657: AB_10669728" "unprognostic (9.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.73e-2)" "unprognostic (1.89e-2)" "unprognostic (2.56e-1)" "unprognostic (1.48e-1)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.30e-1)" "unprognostic (6.82e-2)" "unprognostic (8.45e-3)" "unprognostic (7.39e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (3.93e-5)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (3.64e-1)" "unprognostic (1.10e-2)" 14.2 15.0 10.5 18.4 11.9 23.4 16.9 11.7 13.5 14.5 12.2 17.1 13.9 13.2 23.4 16.2 14.4 11.3 11.1 10.2 11.3 15.6 19.9 12.9 26.3 11.6 10.8 10.4 12.7 14.3 10.6 16.2 12.1 12.7 19.4 11.6 11.5 13.3 15.0 19.2 13.2 16.8 11.4 15.4 13.8 50.9 12.1 32.2 16.4 12.4 30.5 16.4 11.5 13.5 35.7 79.2 85.1 74.4 46.6 54.6 89.2 56.2 60.3 67.2 63.7 100.6 64.5 112.2 51.8 49.3 61.0 61.6 96.0 66.6 81.5 73.9 70.5 95.6 37.7 94.5 40.1 92.8 61.0 49.0 44.6 84.6 61.3 38.2 55.9 71.9 117.0 46.9 64.1 78.7 96.2 121.0 125.9 89.2 54.9 92.6 107.2 94.2 59.9 52.4 46.4 110.7 55.0 41.5 63.5 71.5 40.7 63.1 42.5 53.3 46.1 54.3 70.8 56.1 80.5 118.9 62.3 95.0 57.9 32.9 34.4 23.1 22.2 39.9 23.3 25.3 20.3 23.3 50.1 23.6 20.9 22.6 5.8 38.0 38.4 33.2 36.7 30.5 10.5 11.9 11.7 13.5 10.2 11.3 11.6 10.8 12.1 11.4 12.1 13.5 7.1 6.4 12.7 3.9 15.7 10.5 10.5 26.4 8.6 12.2 7.2 6.5 11.1 8.6 19.5 5.5 8.4 39.5 19.7 9.0 19.6 22.5 187.6 14.6 15.7 11.8 12.6 36.2 9.8 22.5 43.4 13.1 8.6 14.0 8.2 19.9 6.8 14.2 26.1 21.9 9.6 11.9 26.4 20.1 9.5 33.9 11.1 20.6 19.6 10.3 36.3 18.2 16.5 8.5 13.7 16.4 7.4 12.4 15.7 6.5 9.7 18.7 18.0 20.1 6.6 12.3 38.0 151.4 43.2 16.1 8.8 27.2 13.1 26.1 15.1 8.7 CRELD1 "AVSD2, CIRRIN" ENSG00000163703 "Cysteine rich with EGF like domains 1" Q96HD1 3 9933816-9945406 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Isomerase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 110.3;hTERT-RPE1: 77.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026964 Uncertain Approved Nucleoli,Cytosol "Intracellular and membrane" NA NA 19000000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Cytosol Nucleoli "HPA026964: AB_10602210" "unprognostic (3.06e-2)" "unprognostic (1.08e-1)" "unprognostic (2.69e-3)" "unprognostic (1.23e-1)" "prognostic unfavorable (8.07e-4)" "unprognostic (3.03e-1)" "unprognostic (3.59e-1)" "unprognostic (2.85e-2)" "unprognostic (1.24e-2)" "unprognostic (1.19e-1)" "unprognostic (1.92e-2)" "unprognostic (4.59e-2)" "unprognostic (1.14e-2)" "unprognostic (6.31e-2)" "unprognostic (9.51e-2)" "unprognostic (2.89e-1)" "unprognostic (3.78e-2)" 32.7 37.3 63.6 11.4 63.5 9.3 24.8 69.1 94.4 27.7 59.1 57.5 14.0 31.3 17.0 18.0 34.9 16.5 73.2 63.9 65.7 43.0 57.1 27.5 12.4 64.7 63.0 32.5 27.6 22.7 70.9 17.9 66.3 47.6 12.1 16.4 26.3 34.5 48.9 20.1 25.9 22.2 58.6 28.6 35.6 23.6 65.5 10.5 67.6 26.4 9.2 33.6 24.4 68.2 6.4 8.1 19.3 8.8 30.1 17.6 110.3 26.7 8.0 6.1 11.7 11.1 20.7 8.4 57.6 17.7 27.7 4.5 10.4 17.6 4.9 15.2 9.2 7.3 15.2 28.2 68.7 3.3 29.3 21.7 32.3 15.2 13.6 77.2 28.8 11.1 9.5 10.4 6.1 15.5 3.6 19.3 5.7 30.1 6.6 4.8 3.1 21.6 25.9 9.9 6.9 26.7 12.6 10.3 24.3 27.5 27.9 17.0 21.7 12.1 19.5 16.2 6.3 10.7 14.2 15.2 27.3 7.8 13.0 12.3 10.2 9.3 11.9 9.8 12.2 7.9 8.9 11.5 6.9 8.7 11.3 10.4 1.8 13.8 12.9 12.3 7.2 9.5 63.6 63.5 69.1 94.4 63.9 65.7 64.7 63.0 66.3 58.6 65.5 68.2 24.7 19.2 17.5 43.4 14.1 9.7 26.2 48.5 15.9 21.5 17.5 15.0 41.9 31.5 24.0 16.5 16.7 23.7 15.1 10.9 7.9 19.6 6.8 10.3 7.0 20.2 27.0 7.8 38.0 4.4 11.5 20.1 19.4 12.9 21.0 18.8 19.2 14.9 20.6 32.0 37.1 19.1 38.7 8.8 9.0 10.1 32.0 10.0 12.4 15.0 13.9 18.3 27.8 14.6 21.7 8.7 20.4 26.4 15.3 31.4 18.8 11.1 13.2 15.8 26.3 11.0 17.1 68.0 26.5 9.6 12.4 22.2 15.4 11.2 15.4 20.2 CRY2 ENSG00000121671 "Cryptochrome circadian regulator 2" Q49AN0 11 45847118-45883248 "Predicted intracellular proteins" "Biological rhythms, Sensory transduction, Transcription, Transcription regulation" "Photoreceptor protein, Receptor, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Bipolar cells: 141.9;Horizontal cells: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037577 Supported Supported "Nuclear speckles,Cytosol" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Nuclear speckles" Cytosol "HPA037577: AB_10672497" "unprognostic (1.67e-1)" "unprognostic (9.35e-2)" "prognostic unfavorable (1.67e-4)" "unprognostic (1.31e-2)" "unprognostic (9.16e-2)" "unprognostic (3.09e-2)" "prognostic favorable (6.82e-5)" "unprognostic (1.48e-3)" "unprognostic (1.67e-1)" "unprognostic (5.07e-2)" "prognostic favorable (4.39e-4)" "unprognostic (1.01e-1)" "prognostic favorable (6.44e-15)" "unprognostic (8.13e-3)" "unprognostic (1.89e-1)" "unprognostic (4.24e-2)" "unprognostic (2.24e-1)" 31.8 22.3 33.3 8.9 35.3 29.4 27.1 36.4 36.9 24.4 22.8 26.5 10.8 23.3 16.9 15.9 29.1 17.4 60.0 36.6 29.3 22.5 62.7 22.9 10.4 27.4 31.5 38.7 34.7 22.4 30.8 13.5 28.5 25.3 9.9 52.8 21.7 22.1 96.7 50.4 16.7 17.1 28.8 14.0 24.6 34.4 35.2 12.6 34.0 64.8 10.3 26.0 18.4 31.4 1.4 4.2 6.3 7.5 16.7 8.4 13.8 5.0 8.9 6.2 4.5 6.8 3.3 9.8 3.8 10.5 5.9 8.5 6.0 5.2 4.3 9.8 5.5 6.4 8.2 9.4 6.4 8.0 8.5 9.9 7.5 4.8 7.6 7.0 4.4 7.5 12.7 16.2 5.6 5.3 6.8 9.4 17.1 17.8 5.0 11.5 9.1 4.6 4.5 7.8 10.1 3.8 8.3 7.5 4.5 8.0 10.0 5.5 5.5 8.7 5.3 13.5 3.6 15.0 10.8 7.9 5.3 3.5 5.3 4.1 3.5 5.4 5.7 4.8 4.7 5.0 5.5 6.1 3.6 4.6 6.6 6.9 1.8 7.5 8.0 2.6 4.9 5.3 33.3 35.3 36.4 36.9 36.6 29.3 27.4 31.5 28.5 28.8 35.2 31.4 11.7 12.8 18.2 48.0 12.6 17.0 9.7 5.1 8.0 141.9 10.6 8.6 34.7 14.3 11.6 7.3 27.1 8.0 10.0 17.2 29.4 5.4 24.2 28.1 7.5 9.2 7.1 3.0 30.3 4.7 5.6 19.8 12.8 15.4 14.7 10.8 8.6 47.3 3.6 101.0 26.0 7.4 6.1 8.5 12.5 8.7 31.4 7.2 16.0 10.3 6.2 34.4 10.3 13.0 13.6 6.0 6.0 39.9 8.5 11.6 10.5 11.6 23.8 27.5 19.7 14.5 14.6 29.1 15.0 4.4 17.5 9.3 9.1 8.4 6.0 9.8 CSTF1 ENSG00000101138 "Cleavage stimulation factor subunit 1" Q05048 20 56392371-56406362 "Predicted intracellular proteins" "mRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019270, HPA047275, HPA065000" Supported Enhanced Nucleoplasm NA NA 210000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400" "unprognostic (2.51e-1)" "unprognostic (1.74e-1)" "unprognostic (1.54e-3)" "unprognostic (1.13e-3)" "unprognostic (1.02e-1)" "unprognostic (1.50e-1)" "unprognostic (8.57e-3)" "unprognostic (3.08e-2)" "unprognostic (2.23e-1)" "unprognostic (2.62e-1)" "unprognostic (1.03e-1)" "unprognostic (4.05e-2)" "unprognostic (3.91e-2)" "unprognostic (2.87e-1)" "unprognostic (2.67e-1)" "unprognostic (1.29e-1)" "unprognostic (3.60e-1)" 6.3 6.4 4.1 8.1 4.7 5.1 11.1 6.1 5.0 7.3 5.0 7.9 5.3 8.2 8.0 8.8 9.5 7.7 8.0 4.5 4.4 9.6 10.9 8.5 12.4 4.3 4.1 11.8 10.0 11.4 4.8 9.4 4.8 8.5 8.0 14.9 10.3 7.0 9.4 8.4 5.9 8.8 3.9 7.6 7.8 17.6 5.6 14.3 10.0 14.7 14.4 8.9 5.7 6.1 18.9 17.4 22.1 15.6 22.6 20.2 23.7 25.2 27.8 49.2 36.7 37.6 26.9 39.1 26.7 19.1 31.5 31.2 35.7 43.4 57.8 12.4 12.6 38.1 29.3 23.3 13.4 32.2 23.6 19.4 24.5 27.6 23.8 19.1 30.2 24.3 32.6 18.5 30.2 44.6 36.2 17.0 20.3 37.2 23.2 26.5 47.7 34.6 23.9 19.3 24.5 17.0 34.5 93.1 25.6 25.3 37.1 22.9 17.1 39.9 25.3 16.9 24.9 13.0 21.5 42.0 32.0 21.3 19.4 11.4 16.9 13.6 20.7 14.6 26.0 21.1 25.9 23.4 21.5 24.3 28.4 24.9 13.3 31.2 13.1 23.7 33.3 20.4 4.1 4.7 6.1 5.0 4.5 4.4 4.3 4.1 4.8 3.9 5.6 6.1 8.4 9.6 13.1 4.2 11.6 9.2 10.8 29.3 12.5 9.2 9.9 8.3 8.9 14.3 16.8 18.4 14.6 30.9 11.5 7.3 19.6 17.9 25.9 7.1 9.4 13.3 4.9 21.0 4.2 14.7 21.1 12.1 9.7 6.0 17.7 12.6 11.7 22.6 15.3 5.0 4.2 9.4 14.2 16.7 7.8 7.5 13.7 8.4 5.4 9.4 18.4 14.2 12.3 5.5 6.7 11.9 11.8 12.8 10.8 12.3 8.5 21.1 12.9 14.7 19.7 11.1 9.9 84.3 30.5 11.3 8.8 21.1 14.9 16.7 9.8 8.8 CSTF2 CstF-64 ENSG00000101811 "Cleavage stimulation factor subunit 2" P33240 X 100820359-100841520 "Plasma proteins, Predicted intracellular proteins" "mRNA processing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000427, CAB004680" Supported Enhanced "Nucleoplasm,Nuclear bodies" NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "Nuclear bodies" "CAB004680: AB_425385, HPA000427: AB_1078580" "unprognostic (2.02e-2)" "unprognostic (8.70e-3)" "unprognostic (3.50e-1)" "unprognostic (3.43e-1)" "unprognostic (7.00e-2)" "unprognostic (1.09e-2)" "prognostic unfavorable (8.23e-6)" "unprognostic (2.02e-1)" "unprognostic (4.82e-2)" "unprognostic (2.08e-3)" "unprognostic (5.98e-3)" "unprognostic (2.75e-1)" "prognostic favorable (1.12e-4)" "unprognostic (1.75e-2)" "unprognostic (2.90e-2)" "unprognostic (8.75e-2)" "unprognostic (2.89e-1)" 6.3 7.2 5.7 9.9 6.0 10.5 7.7 6.7 6.3 7.0 5.0 12.0 8.6 7.5 8.2 19.2 8.1 6.4 6.1 5.9 6.4 8.0 5.3 6.3 12.5 5.4 5.4 7.1 4.7 8.9 5.3 7.2 5.3 7.5 13.1 8.5 7.9 8.4 4.5 8.4 8.2 7.6 5.3 7.0 6.6 12.7 6.6 12.0 6.7 5.1 19.9 10.0 8.4 6.3 36.0 41.7 27.5 24.9 14.7 11.4 37.2 29.6 24.0 47.6 68.0 45.4 32.1 35.6 35.2 19.1 61.2 35.1 64.2 35.3 57.2 36.5 39.9 32.8 38.8 29.8 19.4 46.9 33.8 11.3 16.5 49.8 32.6 12.7 29.0 31.3 56.2 33.7 29.2 41.9 38.4 31.8 76.8 55.7 39.9 35.8 46.3 42.3 17.5 34.4 24.1 30.4 49.1 20.5 20.4 27.6 20.5 20.3 25.8 26.2 42.3 38.1 37.8 22.8 52.3 45.9 22.5 48.6 32.4 20.0 16.1 11.1 23.4 18.9 17.9 17.4 21.1 21.8 23.3 16.9 19.0 17.8 2.6 23.9 25.8 16.7 24.2 15.3 5.7 6.0 6.7 6.3 5.9 6.4 5.4 5.4 5.3 5.3 6.6 6.3 4.1 3.2 1.1 3.9 8.2 4.2 4.6 20.7 9.6 2.2 3.1 3.0 4.9 2.8 12.9 0.0 2.1 16.7 3.6 5.9 5.9 12.5 13.3 6.3 4.9 4.6 4.2 12.8 10.4 8.3 18.4 4.3 6.1 4.3 3.8 5.5 2.5 1.5 10.8 3.3 10.8 3.7 14.2 2.5 3.7 2.4 4.7 4.3 1.8 1.0 5.9 4.5 4.1 7.1 5.7 15.4 6.7 4.1 6.2 2.0 5.4 4.0 9.9 2.9 6.6 2.7 5.7 18.8 25.5 14.4 4.1 7.7 7.1 5.0 6.4 5.0 CTPS2 ENSG00000047230 "CTP synthase 2" Q9NRF8 X 16587999-16712936 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Pyrimidine biosynthesis" Ligase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017437, HPA075930" Approved Approved Mitochondria,Cytosol NA NA 40000 "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Mitochondria, Cytosol" "HPA017437: AB_1847326, HPA075930: " "unprognostic (1.40e-1)" "unprognostic (6.69e-2)" "unprognostic (3.37e-2)" "unprognostic (7.38e-2)" "unprognostic (1.05e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (6.57e-3)" "unprognostic (8.52e-2)" "unprognostic (4.31e-3)" "unprognostic (4.43e-1)" "unprognostic (1.89e-2)" "unprognostic (7.22e-2)" "unprognostic (6.04e-2)" "unprognostic (8.93e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.56e-4)" 5.5 7.0 5.6 4.3 7.2 6.9 10.4 7.6 6.3 9.5 6.0 8.1 12.3 10.3 6.7 5.1 9.0 6.8 4.4 5.1 6.8 6.0 7.5 6.5 6.6 8.0 6.3 13.2 9.2 12.1 4.0 6.6 8.0 9.5 9.5 9.9 7.4 7.0 4.3 7.1 10.3 7.4 6.5 4.4 8.3 2.0 6.3 6.1 6.8 4.6 8.2 6.2 6.2 9.4 13.7 12.6 20.3 16.9 10.1 7.6 0.2 7.3 6.2 12.1 11.0 13.0 14.2 0.4 23.2 7.9 11.0 11.0 28.9 13.9 14.3 0.1 18.9 7.9 17.0 19.2 5.3 5.7 0.2 8.4 4.7 11.3 9.5 13.6 16.5 0.3 11.1 0.5 11.2 18.9 0.2 4.6 34.7 5.2 14.6 0.3 11.6 4.4 13.3 15.5 12.5 22.8 23.5 1.8 14.2 21.9 32.8 16.2 10.3 6.2 3.3 16.5 6.6 0.3 0.2 45.6 5.0 4.9 7.0 0.1 0.6 0.5 0.4 0.3 0.9 0.6 0.8 0.5 1.3 0.5 0.6 0.6 0.0 1.7 2.7 0.9 0.9 0.6 5.6 7.2 7.6 6.3 5.1 6.8 8.0 6.3 8.0 6.5 6.3 9.4 6.7 9.6 6.7 13.4 3.4 3.2 6.0 4.8 4.6 5.4 8.0 6.5 6.0 8.6 8.9 5.5 0.0 3.5 4.4 5.5 3.9 9.8 4.0 7.2 6.4 5.4 11.3 3.8 10.4 9.4 7.9 5.9 6.1 9.0 6.3 9.1 6.8 7.9 5.3 6.7 18.2 7.5 4.1 4.4 2.7 8.6 9.0 3.3 8.8 24.4 6.0 4.4 1.0 26.2 35.5 11.3 9.0 4.1 4.0 3.9 19.2 3.0 6.1 5.1 6.6 4.1 6.6 0.1 0.3 3.7 3.8 1.5 2.7 4.3 8.8 5.8 CTU2 "C16orf84, NCS2" ENSG00000174177 "Cytosolic thiouridylase subunit 2" Q2VPK5 16 88706483-88715396 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" "Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041135, HPA041894" Uncertain Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA041135: AB_10794543, HPA041894: AB_10796463" "unprognostic (4.19e-1)" "unprognostic (3.62e-2)" "unprognostic (5.19e-2)" "unprognostic (5.77e-2)" "unprognostic (3.00e-2)" "unprognostic (5.96e-2)" "prognostic unfavorable (5.68e-4)" "unprognostic (4.83e-2)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (1.19e-3)" "unprognostic (2.90e-2)" "unprognostic (1.25e-2)" "unprognostic (3.03e-2)" "unprognostic (5.83e-2)" "unprognostic (1.13e-1)" "unprognostic (1.74e-1)" 9.7 9.6 8.8 5.0 8.7 6.2 8.8 7.9 13.8 10.2 6.5 9.9 4.2 11.6 2.0 8.7 9.5 3.5 11.8 9.1 7.5 9.7 12.5 7.9 6.1 9.6 8.1 10.5 11.3 3.6 11.3 3.2 8.5 8.8 1.6 1.4 8.0 3.7 19.1 8.7 7.6 3.4 7.5 9.4 9.6 10.9 8.2 4.0 10.3 5.4 3.4 9.9 8.1 10.5 14.9 22.9 8.8 19.4 7.3 7.5 21.8 15.2 11.4 16.6 8.1 27.2 14.0 21.7 19.8 9.8 7.8 14.7 14.8 14.9 4.5 6.8 44.6 14.9 9.8 27.8 12.4 15.1 10.8 8.5 10.8 13.1 13.9 6.0 14.1 13.1 56.5 6.3 6.3 40.0 42.0 34.9 13.7 12.9 36.9 33.0 6.6 23.4 5.8 5.8 29.0 14.0 24.2 4.6 9.7 5.3 13.8 15.6 15.9 17.5 22.1 19.2 16.8 19.4 10.5 61.7 15.1 32.1 19.6 1.1 5.5 0.0 7.3 6.9 6.0 5.5 6.6 7.3 6.8 5.8 6.4 5.5 0.4 7.5 6.0 6.4 4.1 4.2 8.8 8.7 7.9 13.8 9.1 7.5 9.6 8.1 8.5 7.5 8.2 10.5 6.5 0.0 4.4 2.3 10.0 13.8 12.2 7.8 5.2 12.5 7.3 7.2 2.5 10.0 7.8 1.8 6.2 11.0 15.7 8.4 11.7 8.8 12.1 4.0 7.1 6.6 5.4 3.8 2.9 13.6 16.2 8.6 11.2 4.9 0.0 9.9 3.6 6.7 9.9 13.5 2.3 7.1 4.1 1.9 4.0 7.0 8.1 6.7 5.4 1.0 5.0 4.4 7.2 0.5 2.7 8.9 8.2 9.8 15.5 17.2 9.6 7.8 4.7 8.7 0.0 8.9 11.1 25.6 25.7 6.5 10.7 8.1 9.5 10.8 10.5 8.9 CUL1 ENSG00000055130 "Cullin 1" Q13616 7 148697914-148801110 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 466.3;Late spermatids: 567.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002676, HPA064584" Supported Supported Nucleoplasm,Nucleoli NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Nucleoli "CAB002676: , HPA064584: AB_2685294" "unprognostic (3.59e-2)" "unprognostic (1.23e-1)" "unprognostic (5.23e-1)" "unprognostic (1.19e-1)" "unprognostic (5.06e-3)" "unprognostic (9.45e-2)" "unprognostic (1.41e-2)" "unprognostic (8.23e-2)" "unprognostic (2.40e-2)" "unprognostic (3.65e-2)" "unprognostic (3.40e-2)" "unprognostic (2.84e-2)" "unprognostic (2.18e-2)" "unprognostic (3.88e-2)" "unprognostic (1.48e-1)" "unprognostic (2.40e-1)" "unprognostic (7.24e-3)" 33.2 27.3 19.6 29.4 20.9 15.5 30.2 20.4 26.5 28.1 22.2 38.9 23.0 29.8 28.8 30.6 29.4 23.2 35.9 22.1 23.0 21.6 45.1 26.3 39.0 20.4 21.2 30.9 20.6 36.3 25.6 32.7 20.4 27.3 24.5 52.1 26.1 30.1 88.8 28.8 27.3 32.2 21.8 30.0 29.7 95.1 21.3 30.3 27.4 74.6 35.6 34.9 26.6 21.7 79.9 61.6 59.5 93.6 46.6 51.6 72.8 64.8 77.7 65.8 61.4 64.5 53.9 109.6 49.5 65.9 104.4 52.5 87.0 59.9 76.4 72.8 71.9 65.2 39.6 64.5 50.5 74.8 58.9 40.0 58.5 45.9 46.0 59.9 71.3 52.8 100.8 78.2 72.2 76.4 64.1 81.0 111.6 68.6 58.8 78.7 52.3 106.3 54.2 55.4 83.3 61.0 74.5 92.3 51.4 69.9 29.0 57.5 56.6 44.1 15.4 87.7 75.8 70.4 54.2 96.7 94.3 82.5 66.2 15.5 17.0 14.1 16.5 18.3 21.8 17.3 18.9 21.2 26.6 15.0 22.4 18.5 1.4 27.9 18.5 6.7 18.5 20.0 19.6 20.9 20.4 26.5 22.1 23.0 20.4 21.2 20.4 21.8 21.3 21.7 24.0 35.3 40.9 41.4 26.0 27.9 31.1 19.5 22.2 33.4 13.8 17.5 29.2 12.8 32.2 9.2 29.2 66.6 19.1 12.0 17.6 28.1 466.3 20.4 23.4 25.1 15.6 23.1 76.3 26.2 77.1 29.9 19.4 21.9 23.4 31.6 18.5 41.5 29.8 21.9 89.5 19.7 22.4 18.5 16.8 567.7 21.8 25.7 28.4 60.9 51.7 32.7 37.0 52.8 74.3 28.5 15.0 30.5 25.3 29.8 11.7 13.5 33.6 48.9 32.9 30.3 38.9 59.6 34.0 20.6 25.4 73.2 26.5 24.1 18.8 21.7 CUL2 ENSG00000108094 "Cullin 2" Q13617 10 35008551-35090642 "Cancer-related genes, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 319.6;Late spermatids: 181.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002677, HPA024578" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "CAB002677: , HPA024578: AB_1847338" "unprognostic (8.11e-3)" "unprognostic (1.12e-1)" "unprognostic (9.77e-2)" "unprognostic (1.17e-2)" "unprognostic (1.53e-2)" "unprognostic (1.59e-2)" "prognostic unfavorable (8.24e-6)" "unprognostic (2.18e-1)" "unprognostic (1.34e-1)" "unprognostic (1.20e-1)" "unprognostic (4.70e-2)" "unprognostic (6.94e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (2.26e-2)" "unprognostic (2.31e-1)" "unprognostic (3.70e-1)" "unprognostic (2.29e-1)" 15.3 13.3 10.5 16.2 11.7 20.1 15.5 11.9 13.1 13.0 9.8 14.7 14.5 14.8 10.4 16.8 11.0 12.0 19.2 12.2 12.2 14.3 21.0 13.4 19.8 10.8 11.2 12.7 13.4 22.1 8.8 18.8 11.4 15.3 15.2 13.2 11.5 15.7 45.2 13.4 13.9 19.1 11.5 15.0 14.0 35.8 12.3 18.2 16.2 37.6 20.8 17.0 10.1 12.2 50.4 29.2 37.7 32.5 42.0 46.0 39.8 57.8 32.1 56.1 56.2 38.7 47.0 39.9 31.0 61.6 41.1 45.3 55.4 53.4 63.9 46.9 35.9 51.8 29.0 34.8 46.0 28.6 32.6 44.5 43.7 61.6 21.4 43.3 63.6 41.5 60.5 35.2 62.2 34.4 47.7 15.9 13.8 34.4 117.3 39.4 61.0 25.0 51.3 38.9 18.4 24.4 32.4 40.3 47.0 41.6 30.7 32.4 58.6 34.5 38.3 59.6 38.4 14.7 21.2 47.4 66.4 63.2 24.8 12.8 9.9 11.6 12.3 14.9 17.4 10.9 13.5 14.6 12.6 12.6 16.1 15.2 4.8 13.3 15.3 5.7 17.8 8.5 10.5 11.7 11.9 13.1 12.2 12.2 10.8 11.2 11.4 11.5 12.3 12.2 24.8 22.4 12.6 21.9 23.0 12.0 8.6 13.1 9.6 13.1 12.0 12.4 26.4 5.7 20.7 9.2 10.4 24.7 27.8 9.9 15.6 18.4 319.6 17.5 25.4 22.3 10.7 9.4 39.7 17.8 20.1 15.7 9.2 20.5 20.3 19.2 16.4 18.2 20.1 23.5 35.6 10.6 14.2 17.2 12.3 181.0 14.0 20.3 10.6 27.2 23.0 16.0 27.8 30.7 41.7 17.5 6.9 11.7 17.3 8.3 15.2 15.0 19.9 13.7 0.0 16.1 26.9 40.1 32.8 14.4 13.1 37.1 25.3 23.0 13.1 9.9 CUL4A ENSG00000139842 "Cullin 4A" Q13619 13 113208193-113267108 "Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 171.7" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058979 Approved Nucleoplasm NA NA 44000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 43: THP-1 - Innate immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA058979: AB_2683868" "unprognostic (3.01e-1)" "unprognostic (5.93e-3)" "unprognostic (6.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (2.53e-2)" "unprognostic (6.41e-3)" "unprognostic (6.77e-2)" "unprognostic (1.45e-1)" "unprognostic (9.66e-2)" "unprognostic (3.52e-2)" "unprognostic (5.16e-3)" "unprognostic (3.57e-3)" "prognostic favorable (2.84e-4)" "unprognostic (2.95e-1)" "unprognostic (3.91e-2)" "unprognostic (3.48e-1)" 39.3 34.6 17.0 26.0 19.4 63.3 34.3 19.2 17.2 30.9 29.7 33.0 26.9 30.8 24.2 36.9 29.1 24.4 63.1 16.2 20.2 30.3 40.5 30.8 33.0 23.2 21.0 28.6 36.6 33.9 25.3 30.2 21.9 33.6 29.8 21.0 37.1 25.1 171.7 47.7 31.4 25.3 19.4 31.4 34.2 47.2 19.5 26.1 31.5 125.7 31.1 32.2 32.4 23.2 106.9 50.9 50.7 43.9 60.2 67.0 65.5 104.9 79.0 88.9 68.5 93.0 85.8 129.7 44.7 92.7 87.3 67.4 76.9 58.3 82.4 57.2 77.1 85.8 109.3 74.8 72.1 134.2 56.8 48.1 70.3 52.5 82.2 59.3 60.3 47.8 88.2 24.8 89.7 51.4 67.7 123.3 47.9 149.3 53.5 70.9 52.2 59.7 61.5 47.8 73.7 43.5 54.3 118.6 53.9 43.6 84.6 141.7 83.2 42.7 90.0 47.2 59.9 65.3 49.8 113.0 93.7 108.2 69.0 12.9 20.0 18.1 27.6 29.1 25.7 17.1 27.1 31.2 17.4 16.5 23.5 27.9 5.9 16.2 30.4 13.5 19.9 25.8 17.0 19.4 19.2 17.2 16.2 20.2 23.2 21.0 21.9 19.4 19.5 23.2 27.8 28.9 36.1 46.7 28.2 46.4 30.9 24.9 52.9 14.4 35.5 27.2 140.3 31.5 24.4 35.0 10.4 32.3 25.0 29.2 25.4 28.3 61.6 28.7 28.0 30.0 23.9 73.8 46.1 37.2 40.5 33.0 36.7 41.7 11.4 26.1 23.6 56.9 30.4 28.6 41.0 34.2 24.4 40.9 30.5 118.2 35.8 31.0 39.2 37.5 28.5 13.0 28.8 43.2 66.1 39.8 25.3 31.6 38.0 54.0 22.2 26.9 26.4 18.1 32.9 30.5 30.9 65.3 38.1 53.8 60.0 39.7 32.5 25.2 32.3 45.6 CWF19L1 "FLJ10998, hDrn1" ENSG00000095485 "CWF19 like cell cycle control factor 1" Q69YN2 10 100232298-100267680 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA036889, HPA036890" Uncertain Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Golgi apparatus" "HPA036889: AB_10670928, HPA036890: AB_10696789" "unprognostic (2.76e-2)" "unprognostic (1.10e-2)" "unprognostic (1.16e-1)" "unprognostic (1.39e-1)" "unprognostic (3.66e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.90e-4)" "unprognostic (3.04e-1)" "unprognostic (9.17e-3)" "unprognostic (3.61e-1)" "unprognostic (2.70e-2)" "unprognostic (6.50e-3)" "unprognostic (5.61e-3)" "unprognostic (6.16e-2)" "unprognostic (2.60e-2)" "unprognostic (1.18e-1)" "unprognostic (1.10e-1)" 8.1 6.9 5.9 11.4 6.3 18.8 11.6 7.5 7.6 7.9 5.1 7.2 6.8 8.2 5.7 6.9 8.7 6.7 7.4 5.9 6.5 7.8 8.2 7.5 16.4 6.0 5.8 10.3 8.0 9.0 6.1 9.0 6.3 6.8 8.6 10.3 8.6 6.5 10.1 11.2 8.1 9.3 6.3 11.8 6.6 14.3 6.0 14.8 8.1 10.2 16.9 8.5 6.6 8.4 29.1 18.8 18.7 29.2 9.1 10.8 20.7 17.2 23.8 37.5 30.6 21.5 22.6 30.5 19.4 16.6 16.3 27.9 42.2 24.9 39.6 19.4 20.8 17.5 15.8 20.6 15.8 44.7 19.6 15.2 10.4 28.0 26.2 14.2 26.6 30.8 20.7 26.8 21.9 18.3 36.2 32.4 14.7 15.0 23.2 12.6 29.2 21.2 15.0 16.5 9.4 16.8 20.6 10.3 26.0 12.6 37.3 19.1 18.6 15.8 21.5 18.3 32.8 23.9 29.6 17.9 20.1 39.1 11.4 10.0 17.0 22.7 12.8 15.9 16.3 14.0 13.3 14.4 14.9 13.0 14.9 15.0 9.6 18.1 14.7 6.8 17.7 13.8 5.9 6.3 7.5 7.6 5.9 6.5 6.0 5.8 6.3 6.3 6.0 8.4 8.0 19.2 10.8 14.0 16.2 4.5 7.7 6.8 4.6 9.5 4.8 3.9 8.0 5.7 11.3 5.5 4.2 10.4 13.5 4.3 7.9 6.0 23.6 6.8 6.4 8.3 4.2 11.2 26.8 7.7 11.0 6.7 4.6 6.3 17.7 8.3 7.5 5.9 9.5 10.1 24.3 4.2 10.2 13.1 5.7 5.3 6.8 11.3 8.8 14.0 15.5 5.1 19.6 18.6 24.0 7.2 6.7 4.1 11.3 5.3 4.5 6.2 12.5 12.3 0.0 8.4 6.9 18.4 12.2 5.8 7.7 10.9 12.8 6.7 5.3 4.4 DAZAP1 MGC19907 ENSG00000071626 "DAZ associated protein 1" Q96EP5 19 1407569-1435687 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004201, HPA004631" Enhanced Enhanced Nucleoplasm,Cytosol NA NA 1600000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA004201: AB_1078627, HPA004631: AB_1078626" "unprognostic (1.50e-1)" "unprognostic (3.19e-2)" "unprognostic (7.69e-2)" "unprognostic (2.29e-1)" "unprognostic (7.31e-3)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.86e-4)" "unprognostic (1.83e-1)" "unprognostic (2.30e-1)" "unprognostic (6.13e-2)" "unprognostic (1.09e-1)" "unprognostic (8.11e-3)" "unprognostic (2.72e-3)" "unprognostic (2.40e-3)" "unprognostic (8.30e-2)" "unprognostic (1.65e-1)" "unprognostic (2.21e-3)" 44.2 34.7 20.5 55.9 21.4 69.3 37.2 22.8 23.5 31.9 23.1 45.1 45.3 33.5 10.5 64.7 32.1 13.3 55.0 19.7 20.7 40.6 51.2 37.0 49.8 23.6 21.2 32.3 48.0 20.3 22.6 22.2 22.3 33.0 23.6 20.1 32.4 17.1 65.2 42.3 46.9 19.5 18.2 49.3 39.0 77.5 25.2 47.7 32.1 21.4 34.4 42.2 36.7 27.0 275.7 98.0 64.3 117.9 27.8 33.5 183.9 120.7 59.6 95.7 78.2 98.0 132.3 320.8 72.1 58.7 47.4 151.2 84.9 114.5 80.7 225.9 135.2 165.4 95.2 101.3 64.3 203.1 136.1 33.7 73.8 65.4 119.0 41.1 85.0 133.7 251.5 164.1 60.6 111.9 357.5 178.3 198.7 99.6 97.1 254.3 102.4 199.3 72.9 91.7 127.3 114.2 79.9 124.0 149.3 83.1 113.1 266.8 93.7 79.0 107.5 139.7 267.9 192.9 212.2 256.0 95.6 194.4 123.8 1.5 2.3 1.9 2.7 3.4 2.9 3.1 2.4 2.9 2.2 2.1 2.4 2.6 1.0 3.0 2.4 2.7 2.7 1.3 20.5 21.4 22.8 23.5 19.7 20.7 23.6 21.2 22.3 18.2 25.2 27.0 57.1 9.6 27.6 29.7 50.3 69.3 90.9 37.6 34.1 55.7 46.9 33.3 40.0 38.6 28.8 25.8 35.5 43.5 68.7 60.0 23.5 44.4 49.8 26.3 37.0 45.0 33.0 96.6 17.1 55.1 108.6 39.7 46.9 34.0 26.6 58.0 36.0 41.6 47.7 26.9 16.8 71.6 28.5 49.2 54.9 65.7 28.0 50.3 40.9 16.9 36.0 35.1 34.0 18.6 45.2 63.5 49.4 23.7 73.6 110.3 50.4 48.2 23.5 45.4 26.3 50.5 58.9 111.6 41.0 67.0 74.9 69.0 53.0 41.8 81.5 107.9 DCAF1 "KIAA0800, MGC102804, VPRBP" ENSG00000145041 "DDB1 and CUL4 associated factor 1" Q9Y4B6 3 51395867-51500002 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway" "Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.4" "Cell type enhanced" "Detected in many" "Glandular and luminal cells: 17.9;Granulosa cells: 13.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036142, HPA052445, HPA053203" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "Nucleoli fibrillar center" "HPA036142: AB_10669666, HPA052445: AB_2681835, HPA053203: AB_2682080" "unprognostic (7.51e-2)" "unprognostic (3.19e-1)" "unprognostic (3.71e-3)" "unprognostic (1.26e-1)" "unprognostic (5.15e-2)" "unprognostic (9.75e-2)" "unprognostic (2.58e-2)" "unprognostic (1.24e-1)" "unprognostic (8.75e-2)" "unprognostic (2.15e-1)" "unprognostic (2.89e-2)" "unprognostic (2.21e-2)" "prognostic favorable (7.45e-5)" "unprognostic (5.49e-2)" "unprognostic (5.00e-1)" "unprognostic (6.81e-2)" "unprognostic (1.64e-1)" 11.4 11.3 7.6 11.7 8.8 15.9 11.2 11.2 9.4 9.4 9.8 11.0 7.9 10.3 9.4 10.6 8.9 7.4 9.5 7.8 9.3 11.0 11.5 10.0 14.8 8.4 8.8 10.3 10.4 18.9 8.6 10.3 8.6 9.7 10.9 19.7 11.3 9.6 27.9 13.5 11.4 9.2 8.0 11.3 10.3 53.4 8.5 18.6 14.6 16.1 15.9 11.2 10.0 9.0 19.9 23.9 22.8 20.7 20.1 15.9 21.6 21.8 16.2 23.1 22.5 26.4 18.8 48.1 11.7 17.2 35.3 17.1 43.3 19.5 29.6 33.7 21.5 41.2 32.4 22.8 14.7 54.4 28.7 10.6 22.2 29.8 21.6 15.0 18.2 26.1 24.5 30.3 18.3 20.3 41.8 22.0 24.0 23.5 26.0 17.5 24.4 32.0 18.0 30.5 11.8 21.0 24.1 22.0 13.2 16.7 15.0 22.8 22.9 18.8 25.1 31.4 33.9 20.5 29.7 48.2 21.9 36.6 15.7 2.5 3.0 2.4 6.5 3.3 7.4 5.1 5.6 5.6 4.8 4.9 6.0 5.1 0.7 5.8 5.0 3.8 6.7 4.9 7.6 8.8 11.2 9.4 7.8 9.3 8.4 8.8 8.6 8.0 8.5 9.0 11.1 3.2 10.6 0.0 3.6 0.0 0.0 0.0 0.0 0.0 11.3 9.4 0.0 0.0 6.8 3.7 0.0 7.6 9.7 0.0 1.9 7.0 0.0 11.2 10.3 5.6 0.0 0.0 0.0 6.7 5.7 3.0 0.0 17.9 6.3 13.1 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 2.6 0.0 0.0 0.0 0.0 7.5 0.0 0.0 2.8 0.0 0.0 6.1 5.1 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 10.5 5.0 7.4 0.0 0.0 DCAF10 "FLJ23201, MGC10765, WDR32" ENSG00000122741 "DDB1 and CUL4 associated factor 10" Q5QP82 9 37800554-37867666 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 182.4;Late spermatids: 325.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024160 Uncertain Approved "Nucleoli fibrillar center" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoli fibrillar center" "HPA024160: AB_1858802" "unprognostic (2.16e-2)" "unprognostic (2.74e-2)" "unprognostic (1.14e-2)" "unprognostic (1.09e-1)" "unprognostic (4.46e-2)" "unprognostic (2.21e-1)" "unprognostic (1.44e-2)" "unprognostic (1.77e-1)" "unprognostic (4.50e-3)" "unprognostic (2.54e-3)" "unprognostic (2.01e-1)" "unprognostic (1.17e-1)" "prognostic favorable (1.02e-6)" "unprognostic (1.01e-1)" "unprognostic (5.42e-2)" "unprognostic (1.08e-1)" "unprognostic (9.05e-2)" 7.0 11.2 3.3 4.5 3.7 6.1 7.7 5.1 4.1 7.0 5.1 8.0 5.4 7.5 7.6 7.8 6.5 4.5 5.6 3.5 3.5 8.5 11.4 5.5 5.1 3.1 3.4 7.1 8.4 14.1 5.5 6.2 3.1 7.0 6.4 7.2 7.3 7.0 9.9 7.2 5.5 7.5 3.3 5.2 6.4 17.6 3.5 5.2 9.0 5.7 5.2 7.4 6.8 3.7 11.7 5.7 7.1 6.1 12.2 16.4 7.1 9.6 10.6 5.8 7.3 2.2 4.4 12.2 4.0 12.7 6.6 4.5 6.7 7.9 8.3 9.4 5.3 5.6 9.8 4.1 21.0 7.4 4.2 14.9 17.4 6.4 26.0 13.2 10.3 7.8 17.9 5.9 10.7 4.9 7.1 3.9 6.1 18.2 4.0 6.6 3.4 6.2 11.1 5.9 6.8 9.5 9.1 11.9 8.5 8.5 8.1 16.1 11.1 6.1 3.7 8.1 6.7 5.4 9.2 6.8 10.2 8.1 8.8 0.3 0.3 0.5 0.5 0.3 0.4 0.4 0.4 0.5 0.2 0.6 0.6 0.5 0.7 0.6 0.8 0.3 0.3 0.1 3.3 3.7 5.1 4.1 3.5 3.5 3.1 3.4 3.1 3.3 3.5 3.7 21.4 16.0 28.7 54.2 21.4 40.8 28.3 24.6 28.5 28.6 26.9 17.5 16.5 17.2 27.4 12.9 25.0 17.8 15.9 21.8 9.8 22.7 182.4 18.9 26.8 26.8 19.2 41.9 89.9 21.9 17.1 26.5 21.4 23.9 5.1 35.7 23.6 43.0 15.3 25.2 90.2 20.7 24.4 15.5 23.3 325.7 28.0 16.4 26.6 38.4 19.3 23.4 22.6 82.4 80.6 22.9 16.1 38.4 18.3 42.4 20.5 28.7 18.3 27.3 39.5 32.5 24.0 100.9 11.3 31.7 52.4 22.8 17.7 40.4 25.2 30.1 DCAF8 "FLJ35857, H326, WDR42A" ENSG00000132716 "DDB1 and CUL4 associated factor 8" Q5TAQ9 1 160215715-160262549 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027218, HPA027381" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA027218: AB_10602586, HPA027381: AB_1858808" "unprognostic (3.47e-1)" "unprognostic (1.86e-1)" "unprognostic (4.39e-3)" "unprognostic (1.02e-2)" "unprognostic (2.25e-1)" "unprognostic (1.87e-2)" "unprognostic (3.29e-1)" "unprognostic (1.87e-2)" "unprognostic (3.13e-2)" "unprognostic (9.34e-3)" "prognostic favorable (4.71e-4)" "unprognostic (5.42e-2)" "prognostic unfavorable (3.74e-5)" "unprognostic (3.30e-1)" "unprognostic (7.42e-2)" "unprognostic (3.98e-1)" "unprognostic (1.56e-3)" 63.3 62.6 35.3 47.0 43.3 54.6 60.6 47.7 52.8 55.8 47.1 72.0 56.6 60.4 76.2 50.2 58.9 53.5 85.1 33.7 41.8 55.8 103.4 50.9 60.5 39.2 37.3 62.2 80.2 85.7 66.3 45.1 37.0 53.6 40.6 106.7 60.6 53.2 219.7 67.2 61.8 44.0 32.6 65.6 67.3 40.7 41.1 67.5 77.9 118.3 51.1 61.1 49.8 53.0 54.2 62.5 72.0 64.8 86.3 65.5 63.7 62.7 81.8 49.5 42.2 69.8 89.6 56.3 112.1 67.2 34.6 64.8 34.6 57.4 31.0 134.9 69.0 63.4 99.7 54.1 69.3 52.9 80.3 74.6 58.9 44.2 60.8 55.3 73.5 73.1 60.6 98.4 46.0 50.0 71.7 54.5 52.7 70.1 62.6 69.2 41.8 115.5 57.7 87.6 49.0 47.3 101.8 113.1 68.2 68.9 104.9 82.0 95.1 60.7 31.5 38.6 58.7 169.8 124.9 94.3 68.7 49.6 51.2 32.9 21.5 22.0 31.5 19.7 29.6 28.5 27.0 29.2 17.5 30.4 29.4 27.0 24.9 30.4 28.4 22.0 30.4 19.2 35.3 43.3 47.7 52.8 33.7 41.8 39.2 37.3 37.0 32.6 41.1 53.0 21.4 57.7 54.9 57.5 35.4 18.4 16.3 17.3 38.7 44.6 27.5 21.8 54.2 30.0 30.5 25.8 64.6 30.9 26.4 20.4 62.6 23.9 3.6 26.6 18.9 26.4 25.1 48.4 53.7 21.6 21.0 28.9 35.2 21.4 34.1 21.2 21.4 77.6 23.8 40.4 49.5 19.2 20.3 29.8 18.9 4.3 28.0 24.2 14.2 39.4 27.6 38.1 18.6 58.8 93.1 19.2 13.6 32.7 45.3 16.3 29.0 38.1 40.5 60.5 13.1 29.5 26.6 28.0 20.4 35.1 24.2 44.3 36.5 25.6 18.8 12.5 DCP1A "HSA275986, SMAD4IP1, SMIF" ENSG00000272886 "Decapping mRNA 1A" Q9NPI6 3 53283429-53347586 "Plasma proteins, Predicted intracellular proteins, Transporters" "Nonsense-mediated mRNA decay" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013202 Approved Supported "Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "Cytoplasmic bodies" "HPA013202: AB_1857287" "unprognostic (2.10e-1)" "unprognostic (7.61e-2)" "prognostic favorable (9.01e-4)" "unprognostic (9.79e-3)" "unprognostic (7.68e-2)" "unprognostic (4.44e-2)" "prognostic unfavorable (3.25e-5)" "unprognostic (2.90e-1)" "unprognostic (1.42e-1)" "unprognostic (3.24e-2)" "unprognostic (1.86e-1)" "unprognostic (8.37e-2)" "unprognostic (7.33e-3)" "unprognostic (9.14e-2)" "unprognostic (3.40e-2)" "unprognostic (1.52e-1)" "unprognostic (2.95e-1)" 9.3 8.2 4.3 8.7 4.9 29.9 8.9 11.3 6.8 8.5 5.5 8.5 6.1 11.7 5.8 7.9 9.1 8.2 8.0 4.6 4.9 6.0 6.4 7.7 10.3 4.6 4.6 14.9 6.3 10.3 6.3 10.2 4.8 7.9 8.4 8.6 6.1 6.9 9.5 7.4 7.3 10.4 4.1 9.2 6.8 8.2 5.2 14.2 8.7 9.5 9.8 9.0 7.0 6.3 8.3 8.3 19.4 15.8 13.1 13.5 26.3 9.5 12.5 20.5 19.0 24.7 14.5 18.9 3.7 12.0 12.3 6.8 25.3 9.7 17.8 16.9 11.3 18.5 11.8 12.9 11.4 23.0 24.6 10.7 9.4 18.5 15.0 12.6 15.1 13.2 16.4 20.2 10.1 5.0 30.6 11.2 13.1 8.6 12.1 14.0 12.9 13.2 8.6 18.2 10.1 16.7 16.3 10.7 14.3 14.4 7.0 17.8 16.3 9.8 14.1 10.3 14.5 12.9 11.9 21.9 12.0 12.8 17.8 46.9 25.0 43.0 41.0 25.5 50.4 38.9 41.4 47.8 27.1 48.7 49.6 46.8 26.0 54.3 52.3 31.4 30.9 38.5 4.3 4.9 11.3 6.8 4.6 4.9 4.6 4.6 4.8 4.1 5.2 6.3 28.6 28.9 30.7 26.4 43.6 57.5 48.5 32.4 48.9 27.5 32.7 25.5 26.4 15.7 24.7 7.3 47.9 41.1 34.5 25.5 3.9 29.2 10.8 21.5 33.4 33.5 51.8 20.2 43.4 35.1 52.3 33.6 18.3 34.0 36.8 34.8 24.7 13.2 19.9 28.6 40.5 27.6 24.4 27.6 48.9 26.3 24.8 29.2 10.6 20.6 35.2 18.3 30.9 40.7 44.2 45.0 19.6 25.9 31.8 48.4 22.3 13.5 14.2 30.3 13.1 39.2 32.5 12.8 19.1 27.4 41.2 64.0 39.1 27.7 27.9 62.1 DCTN5 "MGC3248, p25" ENSG00000166847 "Dynactin subunit 5" Q9BTE1 16 23641466-23677472 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042003, HPA063710" Approved Approved "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA042003: AB_10796468, HPA063710: AB_2685101" "unprognostic (5.90e-3)" "unprognostic (3.38e-1)" "unprognostic (1.77e-1)" "unprognostic (2.61e-2)" "unprognostic (3.22e-2)" "unprognostic (1.28e-2)" "prognostic unfavorable (4.02e-4)" "unprognostic (1.18e-1)" "unprognostic (1.25e-1)" "unprognostic (6.36e-2)" "unprognostic (6.78e-2)" "unprognostic (9.28e-2)" "prognostic favorable (4.48e-4)" "unprognostic (1.17e-1)" "unprognostic (1.61e-1)" "unprognostic (1.59e-2)" "unprognostic (9.55e-2)" 13.9 11.3 14.6 18.1 18.1 41.5 14.2 10.4 18.3 13.6 3.8 19.2 20.8 14.8 12.0 25.2 13.6 14.2 14.7 17.2 13.0 21.0 10.7 14.0 22.1 11.4 13.6 12.0 15.9 19.8 8.5 20.9 11.1 14.1 24.9 21.5 12.8 14.0 13.9 14.1 22.2 21.7 11.4 15.1 16.7 20.6 12.8 20.9 18.8 14.2 32.2 20.6 10.9 12.9 30.0 58.5 56.0 46.9 39.0 28.9 39.2 51.9 32.1 32.9 39.3 66.5 40.3 42.1 41.2 54.8 34.6 30.6 93.4 50.2 40.5 48.1 37.1 51.9 67.2 93.9 26.5 63.7 38.4 24.3 35.3 40.5 42.8 36.5 52.8 52.0 100.7 31.6 53.3 82.4 49.4 18.4 66.3 43.3 25.5 59.8 48.6 45.9 26.2 62.6 46.8 48.5 45.6 36.7 30.5 49.0 51.2 53.2 71.8 44.0 20.0 34.9 36.6 42.6 68.6 66.2 42.0 31.4 48.8 14.3 16.6 20.3 15.5 14.0 17.1 13.9 14.2 17.0 17.5 10.5 12.0 14.3 7.3 22.0 22.0 12.4 19.0 17.2 14.6 18.1 10.4 18.3 17.2 13.0 11.4 13.6 11.1 11.4 12.8 12.9 19.7 16.0 26.2 12.1 19.1 14.7 14.5 12.9 22.8 52.1 15.5 14.5 27.1 15.7 15.6 20.2 91.8 32.9 16.1 36.2 11.7 23.8 23.2 11.9 22.4 22.5 22.1 27.6 13.4 25.2 36.3 16.3 20.9 20.8 27.8 37.3 17.2 14.2 28.4 52.2 13.2 18.9 12.2 19.1 11.4 23.4 13.1 17.1 7.2 6.5 34.4 32.3 30.9 11.1 12.0 45.7 19.4 18.0 17.4 14.4 31.9 23.3 11.2 45.0 13.1 22.4 18.1 70.4 30.6 20.9 14.2 48.2 18.7 17.9 26.2 22.0 DDB1 ENSG00000167986 "Damage specific DNA binding protein 1" Q16531 11 61299451-61342596 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 352.3;Rod photoreceptor cells: 451.4;Syncytiotrophoblasts: 389.4;Theca cells: 303.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032821, HPA045174, HPA068456" Approved Enhanced Nucleoplasm NA NA 440000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992" "unprognostic (3.45e-1)" "unprognostic (8.38e-2)" "prognostic favorable (7.09e-4)" "unprognostic (1.21e-1)" "unprognostic (6.56e-2)" "unprognostic (1.19e-2)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" "unprognostic (9.74e-3)" "unprognostic (1.09e-1)" "unprognostic (7.42e-3)" "unprognostic (3.11e-1)" "prognostic favorable (1.51e-8)" "unprognostic (3.44e-1)" "unprognostic (1.58e-1)" "unprognostic (7.30e-2)" "unprognostic (1.25e-3)" 52.8 164.8 30.2 44.0 32.5 47.2 59.0 29.5 30.2 61.3 42.5 50.0 53.2 48.0 79.7 49.7 78.3 39.9 65.1 31.9 36.4 64.8 55.9 43.1 47.0 31.8 33.5 89.3 42.5 232.1 44.5 129.7 36.9 56.6 52.3 162.5 54.1 70.9 133.1 60.6 49.9 61.9 31.9 41.9 44.4 69.1 33.5 81.2 65.0 125.1 66.6 58.6 39.2 36.1 160.3 168.1 159.0 142.2 151.4 139.2 237.8 140.9 193.6 174.4 129.2 188.7 130.7 237.6 126.8 203.4 107.4 141.4 245.5 177.5 188.0 115.7 131.3 128.0 144.3 192.0 109.4 182.7 112.6 169.1 121.7 174.0 146.2 123.5 195.7 86.0 278.4 119.9 158.9 194.7 238.4 77.4 214.5 104.3 146.3 197.9 198.5 254.3 119.7 177.3 140.3 143.0 154.6 183.8 145.9 144.8 226.0 85.6 150.9 120.9 113.6 138.2 106.4 139.5 157.0 194.7 134.9 103.7 121.1 38.4 43.6 36.5 46.7 47.1 61.1 35.8 42.0 47.3 60.5 30.5 37.8 43.3 4.6 46.4 45.3 34.2 49.6 54.6 30.2 32.5 29.5 30.2 31.9 36.4 31.8 33.5 36.9 31.9 33.5 36.1 34.2 28.9 69.9 46.4 48.8 52.6 53.6 61.1 51.2 87.0 52.0 39.9 105.6 34.3 54.5 53.3 352.3 283.5 57.5 45.0 17.6 43.9 15.7 46.6 40.8 48.1 74.2 102.3 27.8 42.4 130.1 50.6 46.4 51.3 30.9 102.7 45.0 67.4 75.5 87.5 31.6 55.4 44.7 45.3 33.5 18.8 85.1 38.3 42.7 30.0 61.1 64.4 71.1 24.1 31.0 52.6 36.4 62.1 65.4 55.7 63.2 46.7 64.4 451.4 32.9 51.5 44.5 114.0 120.9 52.3 59.8 389.4 46.0 303.8 60.0 57.1 DDX11 "CHL1, CHLR1, KRG2, WABS" ENSG00000013573 "DEAD/H-box helicase 11" Q96FC9 12 31073860-31104799 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 25.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA065197 Supported Supported Nucleoplasm,Nucleoli No Yes "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 5: NTERA-2 - Transcription" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "HPA065197: AB_2685430" "unprognostic (6.10e-2)" "unprognostic (1.48e-2)" "unprognostic (1.02e-1)" "unprognostic (5.09e-2)" "unprognostic (1.45e-1)" "unprognostic (2.79e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (4.87e-2)" "unprognostic (3.89e-3)" "unprognostic (3.53e-1)" "unprognostic (5.66e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (5.23e-8)" "unprognostic (1.89e-2)" "unprognostic (3.64e-2)" "unprognostic (1.02e-1)" "unprognostic (8.03e-3)" 5.9 6.4 6.0 10.2 6.8 29.2 7.2 6.9 7.3 10.7 7.1 9.6 8.0 7.5 4.3 9.5 8.0 5.9 5.3 6.0 6.1 9.2 9.3 6.1 13.2 6.9 6.4 11.0 17.5 5.8 9.4 5.4 6.9 10.0 10.1 6.6 8.6 5.3 10.6 16.7 13.4 3.6 6.1 13.8 9.6 8.8 6.7 24.0 8.0 6.6 11.1 6.9 9.8 6.9 36.5 35.0 42.2 34.5 5.8 11.0 58.7 21.8 10.4 25.2 28.5 44.1 58.6 49.2 23.9 10.8 23.6 35.0 31.7 28.9 21.3 43.4 66.6 47.4 71.0 25.4 2.1 37.4 35.0 11.9 13.0 32.6 24.8 16.9 12.6 55.2 26.6 103.3 17.6 30.9 64.5 60.7 84.0 39.9 19.5 55.0 53.3 66.2 13.3 38.5 30.2 21.7 23.4 33.2 10.4 65.0 27.3 25.5 8.2 22.0 42.1 42.2 40.0 39.4 29.6 95.3 24.6 32.5 20.3 0.0 1.3 0.8 2.0 1.2 1.5 2.5 1.9 1.5 1.5 2.6 2.0 2.6 0.5 2.2 4.4 2.4 2.0 1.3 6.0 6.8 6.9 7.3 6.0 6.1 6.9 6.4 6.9 6.1 6.7 6.9 10.1 3.2 9.5 1.6 9.0 6.0 4.0 6.0 2.2 9.4 8.3 7.1 2.5 4.3 6.0 0.0 14.6 7.6 8.8 7.8 0.0 2.0 1.7 5.5 8.9 5.4 0.0 15.3 2.5 3.3 7.5 5.7 9.7 7.4 5.7 15.6 6.1 7.7 5.2 8.4 3.6 6.5 10.2 4.1 5.4 1.3 7.2 4.4 7.2 3.7 3.5 2.7 4.1 1.5 1.7 3.2 2.7 4.5 17.2 6.0 2.3 1.4 6.7 25.8 0.0 4.9 4.8 5.3 18.0 5.5 6.5 2.6 8.4 4.1 9.5 5.1 DDX28 "FLJ11282, MDDX28" ENSG00000182810 "DEAD-box helicase 28" Q9NUL7 16 68020916-68023232 "Enzymes, Predicted intracellular proteins" "Ribosome biogenesis" "Helicase, Hydrolase, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 99.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041911, HPA053585" Approved Supported Nucleoli,Mitochondria,Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Mitochondria, Cytosol" Nucleoli "HPA041911: AB_10794161, HPA053585: AB_2682200" "unprognostic (8.11e-2)" "unprognostic (1.18e-1)" "unprognostic (6.10e-3)" "unprognostic (8.03e-2)" "unprognostic (1.58e-1)" "unprognostic (8.69e-2)" "unprognostic (8.46e-2)" "unprognostic (9.58e-2)" "unprognostic (2.19e-1)" "unprognostic (7.63e-2)" "unprognostic (8.14e-3)" "unprognostic (8.53e-2)" "prognostic favorable (2.07e-10)" "unprognostic (1.58e-2)" "unprognostic (6.21e-2)" "unprognostic (2.23e-1)" "unprognostic (2.47e-1)" 5.8 10.0 3.9 4.8 4.1 16.8 5.6 4.0 4.3 3.9 4.0 5.7 3.9 6.0 5.1 8.2 5.0 2.8 8.3 4.1 4.7 6.4 8.7 4.3 7.7 4.0 3.9 5.5 5.6 7.0 3.6 4.7 4.3 3.5 4.3 1.6 5.0 3.5 15.4 9.7 7.0 3.7 4.0 9.0 6.3 9.7 4.1 5.6 4.0 7.7 6.4 5.5 4.3 4.1 10.2 14.7 7.1 8.5 9.5 5.3 16.5 6.9 9.8 16.4 11.6 14.4 15.5 37.6 10.2 8.3 9.0 17.9 10.1 16.1 9.6 5.1 16.7 13.6 7.4 14.9 12.8 21.7 14.1 10.3 17.2 13.5 12.4 5.7 9.2 24.9 24.5 5.7 7.4 22.4 22.9 30.0 17.2 10.2 10.7 22.1 6.6 40.3 11.6 11.4 14.8 9.9 27.6 7.8 15.3 8.0 14.9 23.1 7.0 7.3 6.3 10.6 11.2 12.8 16.9 36.7 9.0 16.4 10.1 24.0 22.3 27.4 17.0 22.4 18.7 14.3 15.6 18.5 20.8 19.0 24.2 18.2 7.2 21.5 23.4 10.2 16.0 20.8 3.9 4.1 4.0 4.3 4.1 4.7 4.0 3.9 4.3 4.0 4.1 4.1 4.4 6.4 6.8 0.7 10.9 9.2 14.2 11.7 8.0 5.6 4.8 4.3 4.1 8.6 8.3 3.7 0.0 27.9 4.0 2.9 13.7 12.0 6.6 5.4 4.4 5.7 4.8 9.5 0.9 9.7 12.5 4.4 5.1 5.4 3.8 8.0 6.8 11.6 17.1 3.3 1.0 3.5 6.1 8.5 3.1 4.0 5.0 6.8 7.2 0.0 13.3 7.5 25.7 0.5 1.4 7.4 4.2 3.4 4.2 5.7 2.0 19.7 5.3 4.3 13.1 4.4 9.4 22.7 14.1 6.7 10.7 99.9 7.6 12.5 6.1 8.8 DDX41 "ABS, MGC8828" ENSG00000183258 "DEAD-box helicase 41" Q9UJV9 5 177511577-177516961 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017911, HPA048803" Supported Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Nucleoli "HPA017911: AB_1847558, HPA048803: AB_2680527" "unprognostic (2.52e-1)" "unprognostic (1.51e-1)" "unprognostic (7.57e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-1)" "unprognostic (2.61e-2)" "unprognostic (4.21e-3)" "unprognostic (2.60e-2)" "unprognostic (1.92e-1)" "unprognostic (1.25e-1)" "unprognostic (2.89e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (2.21e-6)" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-1)" "unprognostic (1.75e-1)" 26.5 29.0 15.1 28.7 16.1 22.3 25.4 13.1 21.9 26.1 13.7 26.5 24.8 25.2 16.8 33.7 30.6 18.3 18.9 17.8 14.2 26.8 27.1 24.5 24.7 15.8 13.7 28.6 23.5 31.2 18.0 22.8 16.0 22.3 19.3 14.6 28.7 19.1 43.4 35.0 28.7 20.1 12.8 26.7 26.7 17.9 16.2 24.3 29.0 20.3 25.0 24.8 27.6 16.4 62.1 71.4 42.4 44.9 43.4 45.2 125.1 58.4 35.1 47.1 36.1 107.7 61.3 67.2 83.3 57.6 67.6 47.8 57.2 128.5 33.2 175.4 68.0 90.5 70.8 66.5 52.5 89.3 82.3 48.7 47.0 45.3 59.0 43.5 53.4 68.1 72.3 50.0 55.6 135.5 80.6 45.9 62.0 59.0 61.3 72.7 48.1 86.2 50.5 78.8 45.0 41.9 64.6 83.2 56.5 27.1 54.6 110.2 51.3 74.4 42.8 43.6 87.6 49.6 75.9 120.1 81.3 100.1 47.0 14.3 31.4 22.3 18.3 28.5 23.5 17.0 18.3 16.8 27.2 14.4 14.6 18.8 9.2 25.8 31.4 11.2 18.8 25.6 15.1 16.1 13.1 21.9 17.8 14.2 15.8 13.7 16.0 12.8 16.2 16.4 17.0 25.6 17.8 7.8 20.6 21.0 22.9 37.9 18.2 16.9 17.5 16.5 9.0 25.8 24.3 9.2 2.1 46.6 22.9 22.9 41.1 42.1 11.2 16.1 16.5 22.3 11.4 25.2 6.0 39.6 63.2 17.6 17.3 19.2 29.8 21.3 16.1 18.0 48.8 8.4 6.4 27.0 18.3 23.5 15.4 22.9 14.9 22.2 12.4 4.7 34.6 23.9 20.6 5.0 3.9 33.5 23.9 21.1 23.2 19.0 29.5 40.1 20.5 10.3 13.1 14.5 29.0 24.5 26.7 26.2 20.3 37.5 19.0 25.6 31.0 22.7 DDX42 "RHELP, RNAHP, SF3b125, SF3B8" ENSG00000198231 "DEAD-box helicase 42" Q86XP3 17 63773603-63819317 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023447, HPA023571, HPA025941" Approved Enhanced "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles" "HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562" "unprognostic (3.46e-1)" "unprognostic (7.11e-2)" "unprognostic (8.44e-2)" "unprognostic (1.29e-1)" "unprognostic (2.49e-2)" "unprognostic (3.17e-2)" "prognostic unfavorable (2.84e-4)" "unprognostic (1.06e-1)" "unprognostic (4.73e-2)" "unprognostic (1.90e-1)" "unprognostic (2.54e-2)" "unprognostic (1.34e-2)" "prognostic unfavorable (9.26e-4)" "unprognostic (3.02e-1)" "unprognostic (2.42e-1)" "unprognostic (7.35e-2)" "unprognostic (1.55e-2)" 43.5 32.6 27.4 30.5 29.4 37.3 42.7 26.2 29.7 38.5 21.6 42.9 31.3 42.4 39.0 32.6 44.0 30.2 35.3 25.8 30.8 30.0 34.8 35.8 40.6 29.9 30.1 54.7 54.4 39.9 29.2 36.5 28.9 39.3 36.4 39.3 47.3 40.7 59.2 39.6 33.5 43.1 29.0 37.2 37.1 39.8 30.7 40.1 34.2 42.7 47.1 39.5 30.6 26.5 87.4 89.9 79.2 81.3 78.2 62.7 85.0 83.4 74.6 74.7 72.9 84.7 55.9 120.8 32.0 94.3 62.4 68.2 90.3 74.3 98.5 35.9 59.1 91.0 92.0 104.2 77.1 106.9 59.7 80.3 69.2 67.9 81.6 63.5 75.2 61.6 103.2 49.7 77.0 71.3 102.8 59.3 75.8 69.4 47.4 88.7 135.8 62.3 68.2 101.3 49.5 93.9 63.2 112.3 74.1 110.7 77.2 87.1 80.5 109.9 67.0 45.3 99.4 55.6 47.9 109.5 56.4 58.1 58.9 1.9 2.2 6.9 3.7 2.2 4.2 2.8 3.0 3.7 2.9 5.3 3.6 3.7 2.0 4.5 4.3 1.8 2.1 1.9 27.4 29.4 26.2 29.7 25.8 30.8 29.9 30.1 28.9 29.0 30.7 26.5 41.5 80.1 60.4 24.2 34.7 31.2 24.4 24.5 48.9 40.9 37.0 38.0 49.5 30.0 49.0 36.8 37.5 33.3 29.3 27.0 13.7 30.4 9.2 64.9 68.0 41.8 40.7 33.0 33.6 27.1 24.4 42.2 32.1 72.0 30.4 82.1 30.0 34.5 23.2 50.5 30.3 37.8 28.5 32.7 26.1 12.7 48.7 29.6 14.2 21.5 55.5 46.6 32.0 18.1 26.7 41.1 25.3 50.4 36.7 39.0 26.5 23.5 65.5 46.7 39.5 63.2 51.8 68.5 63.1 52.7 29.7 27.4 32.7 71.3 33.8 32.4 DDX47 "DKFZp564O176, FLJ30012, HQ0256, RRP3" ENSG00000213782 "DEAD-box helicase 47" Q9H0S4 12 12813316-12829981 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Apoptosis, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Ductal cells: 22.6;Exocrine glandular cells: 17.8;Pancreatic endocrine cells: 19.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014855 Approved Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA014855: AB_1847567" "unprognostic (3.14e-2)" "unprognostic (1.21e-1)" "unprognostic (2.11e-1)" "unprognostic (1.75e-2)" "unprognostic (2.38e-1)" "unprognostic (4.91e-2)" "unprognostic (5.84e-4)" "unprognostic (1.96e-1)" "unprognostic (1.11e-2)" "unprognostic (1.13e-3)" "unprognostic (2.79e-1)" "unprognostic (3.49e-3)" "unprognostic (6.55e-9)" "unprognostic (1.68e-1)" "unprognostic (1.27e-1)" "unprognostic (3.24e-1)" "unprognostic (8.20e-6)" 28.8 24.1 23.2 22.7 23.7 41.2 32.1 24.6 30.8 27.8 24.5 29.3 18.2 30.8 22.3 29.1 29.8 19.9 23.0 22.6 24.0 32.1 37.8 24.8 32.7 23.8 23.6 35.6 30.8 36.5 17.5 28.9 24.1 26.4 26.3 16.9 24.5 29.0 44.6 30.5 21.7 33.4 24.4 23.4 29.3 23.1 23.2 35.5 33.3 41.7 39.8 47.6 25.5 25.2 161.7 68.3 65.6 53.7 63.1 61.7 111.8 67.8 77.0 141.0 131.0 104.1 101.0 82.4 25.9 92.2 87.4 102.6 95.2 78.0 157.7 117.2 68.1 75.5 45.3 59.7 53.5 87.0 46.5 60.0 72.4 84.0 68.8 110.7 110.4 63.9 74.3 18.2 78.3 57.7 71.0 60.1 288.7 74.4 41.4 77.7 127.2 50.0 86.5 114.2 28.6 72.5 82.3 52.1 69.2 161.4 21.4 64.9 49.9 56.5 136.5 36.8 103.4 25.2 49.1 148.1 60.2 44.9 66.8 10.5 32.9 8.4 46.6 43.8 55.5 48.0 40.9 43.2 56.8 44.9 53.0 51.5 3.8 40.6 44.4 33.3 43.4 35.8 23.2 23.7 24.6 30.8 22.6 24.0 23.8 23.6 24.1 24.4 23.2 25.2 5.1 3.2 8.2 9.1 8.4 2.2 2.7 2.4 14.2 0.6 1.4 1.0 0.1 0.0 8.5 0.0 0.0 1.7 2.3 3.2 1.9 22.6 0.1 3.0 4.1 4.3 4.8 3.4 8.2 17.8 1.9 3.2 4.6 5.7 12.0 0.9 1.1 0.9 0.9 0.0 9.4 4.2 2.0 1.0 1.6 0.4 0.6 2.5 0.0 12.2 9.7 0.9 2.1 8.0 12.6 19.0 4.2 0.4 12.3 1.9 2.8 1.1 6.3 1.6 6.6 1.6 3.4 0.7 0.7 9.0 1.8 1.4 6.2 0.6 6.5 2.8 DGCR8 "C22orf12, DGCRK6, Gy1, pasha" ENSG00000128191 "DGCR8 microprocessor complex subunit" Q8WYQ5 22 20080232-20111877 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.3;Rod photoreceptor cells: 60.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "K-562: 78.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076916, HPA079351" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies, Cytosol" "HPA076916: , HPA079351: " "unprognostic (2.57e-1)" "unprognostic (1.12e-1)" "unprognostic (1.97e-1)" "unprognostic (1.81e-1)" "unprognostic (8.34e-2)" "unprognostic (2.75e-3)" "prognostic unfavorable (1.08e-4)" "unprognostic (2.34e-1)" "unprognostic (5.72e-3)" "unprognostic (2.83e-1)" "unprognostic (1.09e-3)" "unprognostic (2.62e-2)" "prognostic unfavorable (5.67e-4)" "unprognostic (1.02e-2)" "unprognostic (4.20e-1)" "unprognostic (4.68e-2)" "unprognostic (2.26e-2)" 5.2 4.4 5.3 6.1 5.2 7.7 4.8 9.4 5.6 6.8 5.0 7.0 5.0 8.5 3.6 7.1 6.9 4.7 5.2 5.3 4.6 4.7 4.5 5.3 6.3 5.1 5.1 8.4 6.2 6.4 5.2 11.6 5.6 5.5 5.0 6.5 7.2 5.6 14.8 7.5 6.7 6.0 4.7 5.9 6.1 15.2 5.3 9.5 6.0 9.3 5.9 6.8 5.7 6.2 22.7 15.7 20.1 11.9 7.7 12.4 25.5 21.3 12.6 14.1 9.9 17.0 11.3 20.1 11.6 20.0 9.4 21.4 18.4 17.8 12.2 19.7 27.4 21.7 17.4 14.0 20.3 40.7 17.5 10.0 21.6 14.8 10.7 12.9 12.6 12.1 78.7 14.1 16.5 14.6 24.7 12.1 19.4 16.5 11.8 29.0 21.2 6.8 8.5 20.9 22.3 14.3 19.4 11.3 13.0 12.0 10.9 17.2 18.8 20.5 17.1 13.0 21.9 7.8 11.5 19.9 15.3 18.2 20.3 0.0 1.1 0.6 2.0 0.9 1.5 0.7 0.9 2.1 1.3 0.6 0.9 1.2 0.2 1.6 3.6 1.5 1.2 1.5 5.3 5.2 9.4 5.6 5.3 4.6 5.1 5.1 5.6 4.7 5.3 6.2 8.1 6.4 7.9 11.8 6.0 9.6 5.2 6.8 10.2 37.1 9.1 8.0 4.2 11.5 7.3 5.5 39.6 13.6 6.9 9.6 0.0 6.1 61.3 5.5 8.3 10.2 7.3 10.3 12.4 10.2 11.2 7.3 12.8 7.3 3.8 19.2 9.7 14.4 5.3 43.7 12.7 10.3 4.1 8.4 6.5 39.2 18.3 5.0 5.4 6.5 7.2 10.9 11.3 9.5 14.0 10.9 5.8 10.5 9.3 8.6 6.2 3.4 8.1 60.7 6.6 9.7 8.1 25.2 17.5 10.4 9.2 13.5 9.3 15.1 9.7 5.6 DHX36 "DDX36, KIAA1488, MLEL1, RHAU" ENSG00000174953 "DEAH-box helicase 36" Q9H2U1 3 154272546-154324487 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Antiviral defense, Differentiation, Immunity, Innate immunity, Transcription, Transcription regulation, Translation regulation, Transport" "Activator, Developmental protein, DNA-binding, Helicase, Hydrolase, Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 547.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035398, HPA035399" Approved Supported Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Nucleoplasm "Mitochondria, Cytosol" "HPA035398: , HPA035399: AB_10670115" "unprognostic (8.04e-2)" "unprognostic (1.46e-1)" "unprognostic (1.86e-1)" "unprognostic (3.50e-3)" "unprognostic (2.67e-2)" "unprognostic (3.22e-1)" "unprognostic (8.80e-3)" "unprognostic (1.03e-1)" "unprognostic (7.51e-2)" "unprognostic (1.26e-1)" "unprognostic (3.94e-2)" "unprognostic (3.90e-2)" "unprognostic (2.72e-1)" "unprognostic (5.09e-2)" "unprognostic (5.27e-1)" "unprognostic (4.96e-2)" "unprognostic (1.37e-1)" 17.7 14.4 5.6 17.3 8.6 16.3 16.4 8.9 7.3 13.9 6.3 12.0 12.6 18.3 11.6 14.8 14.4 15.5 16.9 5.6 8.1 18.6 20.0 13.7 21.7 7.0 7.5 19.0 16.0 29.1 14.9 19.0 7.2 17.3 13.7 17.0 11.7 16.4 58.9 12.0 12.8 17.1 6.9 15.2 16.0 34.4 6.9 21.7 23.1 31.6 20.5 17.2 11.0 10.0 63.8 42.6 56.6 32.7 26.1 36.3 28.1 40.6 40.5 45.2 53.5 43.7 49.7 61.3 64.0 35.8 41.7 40.1 53.8 34.4 70.6 59.3 35.6 44.5 34.8 25.0 44.2 62.7 37.4 41.3 28.5 48.6 59.1 24.5 39.4 37.3 42.6 34.3 42.2 31.0 52.2 13.7 75.4 33.6 40.5 53.4 47.6 88.8 32.1 44.4 52.7 56.1 42.3 44.4 59.7 38.3 45.5 31.5 44.9 47.1 29.6 44.6 82.1 63.6 43.9 87.5 38.1 32.2 51.1 1.2 1.5 1.8 3.7 1.5 2.3 2.6 3.2 2.5 1.3 3.1 2.9 3.1 0.6 2.6 3.5 3.3 3.1 0.6 5.6 8.6 8.9 7.3 5.6 8.1 7.0 7.5 7.2 6.9 6.9 10.0 95.6 57.7 92.9 45.4 123.6 92.9 146.6 56.6 81.4 152.2 61.8 62.6 60.8 67.2 83.5 60.7 129.3 138.0 179.3 43.8 39.2 71.2 547.0 73.4 147.9 82.0 92.0 68.5 53.5 62.8 69.9 97.6 66.8 104.2 103.8 86.7 72.8 80.5 62.0 154.8 60.2 57.4 73.2 73.7 85.2 335.5 110.6 83.0 53.4 37.5 88.5 86.4 113.3 59.3 55.4 66.5 49.9 121.5 97.6 132.2 40.4 54.4 52.3 128.6 78.9 130.6 88.8 197.4 135.1 65.3 83.1 370.1 152.0 114.2 58.1 128.4 DHX57 DDX57 ENSG00000163214 "DExH-box helicase 57" Q6P158 2 38797729-38875934 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Early spermatids: 136.3;Late spermatids: 352.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036160 Uncertain Approved "Nucleoli,Intermediate filaments,Microtubules,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments, Microtubules" "Nucleoli, Cytosol" "HPA036160: AB_10670711" "unprognostic (6.78e-2)" "unprognostic (3.08e-1)" "unprognostic (3.49e-2)" "unprognostic (2.03e-3)" "unprognostic (3.25e-2)" "unprognostic (3.43e-1)" "prognostic unfavorable (3.32e-6)" "unprognostic (1.75e-2)" "unprognostic (2.74e-1)" "unprognostic (1.45e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.55e-2)" "unprognostic (1.47e-1)" "unprognostic (3.88e-2)" "unprognostic (7.03e-3)" "unprognostic (1.77e-1)" 6.1 9.2 6.6 5.2 6.9 4.8 6.5 6.4 8.8 8.1 6.9 7.1 2.2 7.7 10.3 5.4 6.6 4.2 5.3 7.1 7.2 6.8 5.3 4.9 6.2 5.8 6.5 7.8 7.0 9.7 10.0 5.8 6.0 6.2 5.5 8.5 5.6 6.3 9.1 7.1 5.2 7.3 6.0 5.9 5.7 23.4 6.6 6.7 7.2 5.5 6.3 7.4 6.2 6.5 23.4 19.3 21.0 15.8 13.5 16.6 16.2 15.5 15.9 15.2 14.7 15.7 7.2 7.1 15.6 16.9 17.1 11.8 23.6 18.2 24.9 28.0 18.4 13.3 11.5 21.3 12.2 14.5 7.3 16.0 10.8 20.0 12.5 10.8 20.7 5.2 17.8 9.5 16.7 17.7 14.7 12.9 25.1 10.1 11.4 7.0 27.7 13.9 14.2 8.6 16.8 24.8 15.8 16.4 17.4 14.7 11.7 8.0 15.4 15.1 16.5 10.9 17.7 9.3 12.2 2.8 11.4 10.1 10.2 1.6 6.3 1.2 2.8 4.5 3.6 3.8 2.3 2.1 3.2 4.6 2.9 1.7 0.4 2.3 5.6 1.2 2.5 2.9 6.6 6.9 6.4 8.8 7.1 7.2 5.8 6.5 6.0 6.0 6.6 6.5 6.2 3.2 10.9 24.2 8.8 2.7 2.7 5.9 6.2 24.7 5.2 7.6 6.2 10.0 10.9 23.9 56.3 7.2 4.7 2.5 0.0 7.7 136.3 18.0 13.4 6.3 11.9 8.2 36.7 7.6 6.7 9.3 7.1 6.2 10.8 19.4 9.7 6.2 7.0 18.5 38.0 5.7 4.1 11.7 3.8 352.8 15.8 8.5 1.8 25.3 23.9 9.5 8.2 33.2 20.9 8.5 3.1 13.9 8.1 2.0 2.1 6.0 27.3 27.7 0.0 8.8 6.0 19.3 9.8 5.3 2.6 2.9 7.9 14.7 5.0 2.2 DHX9 "DDX9, LKP, RHA" ENSG00000135829 "DExH-box helicase 9" Q08211 1 182839347-182887982 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport" "Activator, DNA-binding, Helicase, Hydrolase, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011819, HPA028050, HPA055684" Supported Supported Nucleoplasm,Nucleoli NA NA 360000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoplasm Nucleoli "CAB011819: AB_777725, HPA028050: AB_10603564, HPA055684: AB_2682885" "unprognostic (8.14e-2)" "unprognostic (9.32e-2)" "unprognostic (1.84e-2)" "unprognostic (4.80e-2)" "unprognostic (1.58e-1)" "unprognostic (7.40e-2)" "prognostic unfavorable (3.17e-4)" "unprognostic (9.98e-2)" "prognostic unfavorable (6.04e-4)" "unprognostic (2.76e-1)" "unprognostic (2.88e-2)" "unprognostic (5.53e-2)" "unprognostic (7.51e-2)" "unprognostic (1.43e-1)" "unprognostic (1.70e-1)" "unprognostic (3.17e-1)" "unprognostic (1.99e-1)" 38.7 30.5 13.6 47.4 15.8 131.4 53.2 19.0 19.7 43.7 17.0 40.2 32.6 49.4 33.0 32.2 45.9 31.1 28.5 13.1 16.0 49.9 36.9 38.6 56.9 15.2 13.6 52.8 30.5 68.2 21.1 44.6 16.3 39.6 47.1 66.5 32.5 44.3 30.3 31.1 36.3 50.8 16.6 40.9 34.5 50.4 14.6 88.7 48.0 37.7 70.2 54.0 30.0 25.5 165.7 158.8 223.0 122.3 113.7 87.8 219.2 143.5 130.3 203.6 137.0 175.8 124.2 264.3 133.7 129.6 121.7 138.8 342.6 155.2 225.7 108.3 169.5 176.4 121.0 119.6 62.5 258.3 115.0 78.6 75.8 200.4 53.4 91.6 161.7 132.9 281.8 91.9 165.1 142.3 263.6 61.1 282.8 173.9 96.8 236.0 208.0 151.0 127.0 187.8 160.0 183.2 203.2 125.0 83.2 186.4 148.4 140.9 127.6 125.3 138.8 128.9 195.9 93.6 167.2 305.0 79.0 137.0 174.5 7.7 21.3 16.1 23.4 22.5 26.2 20.5 19.8 21.1 29.9 16.6 21.6 23.7 8.0 20.0 19.7 14.2 20.1 21.2 13.6 15.8 19.0 19.7 13.1 16.0 15.2 13.6 16.3 16.6 14.6 25.5 43.6 41.7 74.1 59.1 54.5 53.7 61.2 42.7 38.7 59.6 43.3 38.9 43.9 30.0 60.8 51.5 52.1 50.9 70.2 38.6 19.6 49.0 26.8 79.2 67.4 50.7 53.8 74.5 49.4 50.8 47.5 48.0 37.8 109.8 44.9 67.7 36.0 28.0 40.8 28.6 55.5 40.9 30.5 35.4 35.1 45.8 60.3 44.7 30.2 55.3 55.9 42.7 42.2 55.3 70.3 52.3 28.0 47.0 52.4 48.3 35.4 38.0 67.7 77.1 39.5 73.9 54.1 69.9 68.2 51.7 47.2 49.5 59.2 60.9 54.4 55.4 DIS3L "DIS3L1, FLJ38088, KIAA1955, MGC4562" ENSG00000166938 "DIS3 like exosome 3'-5' exoribonuclease" Q8TF46 15 66293217-66333898 "Predicted intracellular proteins" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041805 Approved Supported "Plasma membrane,Centrosome,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" Centrosome "HPA041805: AB_10796783" "unprognostic (2.57e-1)" "unprognostic (5.37e-2)" "unprognostic (1.12e-1)" "unprognostic (3.99e-2)" "unprognostic (3.16e-1)" "unprognostic (1.40e-1)" "unprognostic (1.68e-1)" "unprognostic (2.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.28e-2)" "unprognostic (1.59e-3)" "unprognostic (1.86e-1)" "unprognostic (3.42e-3)" "unprognostic (2.66e-1)" "unprognostic (6.18e-2)" "unprognostic (9.58e-2)" "unprognostic (3.40e-1)" 11.0 11.8 7.9 6.2 9.8 7.6 9.3 8.9 8.6 10.3 7.7 11.1 5.1 11.1 9.5 7.5 9.6 5.5 12.7 8.0 9.1 8.3 11.0 5.9 7.6 8.7 9.4 11.1 12.8 15.8 10.0 5.4 9.6 8.7 6.0 11.4 8.9 9.0 23.2 7.4 7.7 8.8 8.8 8.7 9.0 9.8 8.9 7.8 11.0 28.3 7.2 9.6 8.1 12.2 14.0 32.6 10.6 14.1 12.2 16.4 12.4 9.5 11.1 14.3 13.2 17.6 10.1 51.6 10.3 13.4 14.9 23.3 25.7 9.2 9.2 12.0 24.1 26.7 25.1 20.1 9.5 27.7 10.1 6.9 9.7 4.5 14.8 9.7 13.1 17.7 18.6 12.6 14.4 12.3 13.8 17.3 15.4 12.7 20.0 18.3 42.1 30.0 5.7 18.9 17.1 15.7 22.3 7.6 11.4 10.0 10.6 21.8 14.4 18.7 16.8 7.4 18.7 10.1 36.9 24.0 6.4 35.9 7.8 8.5 5.1 4.3 7.6 6.1 10.2 6.5 7.7 10.0 8.5 7.8 8.8 7.3 0.6 11.7 13.2 6.7 8.0 6.7 7.9 9.8 8.9 8.6 8.0 9.1 8.7 9.4 9.6 8.8 8.9 12.2 7.1 6.4 16.2 22.5 14.6 4.2 5.5 4.0 17.1 15.6 9.4 7.6 30.3 15.7 7.1 3.7 4.2 17.0 9.6 5.0 5.9 6.5 7.1 8.3 14.6 10.2 3.0 24.2 11.4 3.5 4.5 12.4 10.7 7.3 16.5 25.1 7.1 19.2 9.6 10.1 17.2 10.6 8.2 12.3 7.8 9.9 19.9 10.1 1.8 13.1 14.4 17.7 12.3 22.6 23.1 3.3 5.1 20.3 18.4 4.8 5.4 9.8 8.1 23.2 19.7 9.5 10.1 28.5 17.2 12.1 5.4 3.7 16.0 16.5 14.0 3.8 DKC1 "Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101" ENSG00000130826 "Dyskerin pseudouridine synthase 1" O60832 X 154762742-154777689 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Isomerase, Ribonucleoprotein, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 707.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000166, HPA000447, HPA001022, CAB033086" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 34000 "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli fibrillar center" Nucleoplasm "CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: AB_2666175" "unprognostic (9.87e-3)" "unprognostic (1.14e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (2.86e-1)" "prognostic unfavorable (2.94e-4)" "prognostic unfavorable (1.39e-5)" "unprognostic (7.02e-2)" "prognostic unfavorable (9.13e-4)" "unprognostic (2.53e-2)" "unprognostic (2.35e-2)" "unprognostic (2.63e-2)" "prognostic unfavorable (1.46e-9)" "unprognostic (5.28e-2)" "unprognostic (1.47e-1)" "unprognostic (4.04e-1)" "unprognostic (2.55e-1)" 23.5 20.4 17.1 29.9 18.1 68.8 35.3 18.3 20.5 21.3 18.9 28.5 24.2 23.2 22.3 36.4 24.4 15.3 19.4 17.0 18.4 21.7 22.6 16.5 40.2 17.9 18.2 30.8 32.6 26.5 17.6 23.2 18.8 22.2 34.8 19.8 22.0 18.9 31.2 30.6 21.3 22.8 18.0 25.7 21.5 25.3 18.1 39.4 27.8 23.2 47.8 36.8 23.8 19.7 236.5 129.3 77.4 111.4 47.2 48.2 114.9 87.2 60.5 127.2 118.9 164.3 114.2 447.2 221.3 74.7 119.4 123.5 239.6 144.8 189.3 108.8 132.9 223.4 131.1 143.3 66.9 304.6 131.2 46.3 135.6 141.1 320.8 46.6 89.7 146.2 210.1 108.0 88.0 137.7 201.5 233.7 130.2 234.0 158.8 177.1 174.1 230.3 80.4 132.0 170.0 84.4 77.8 133.3 122.7 75.0 68.1 120.8 70.8 91.4 138.2 119.3 292.6 199.8 290.5 707.7 62.2 316.5 102.0 10.8 25.0 33.1 38.6 30.1 48.8 44.2 31.1 41.6 35.5 31.3 40.7 39.1 7.4 41.2 31.2 25.5 26.5 30.3 17.1 18.1 18.3 20.5 17.0 18.4 17.9 18.2 18.8 18.0 18.1 19.7 21.6 25.6 32.3 5.9 47.6 99.7 76.2 45.4 60.3 31.6 39.2 34.0 32.0 25.8 35.2 25.8 14.6 56.6 34.8 17.7 41.1 62.8 2.7 22.4 39.8 39.7 34.1 84.1 6.4 45.3 74.8 36.4 23.0 24.1 56.8 70.0 13.6 26.0 44.5 23.5 7.1 35.9 54.9 21.6 36.4 7.9 25.7 25.8 49.8 7.5 36.4 34.8 29.9 7.5 7.7 47.3 14.8 28.6 45.1 131.2 9.5 25.6 26.7 28.5 13.1 37.8 42.6 41.0 87.2 69.9 98.3 34.2 35.9 59.6 49.9 57.9 DMAC2L "ATP5S, ATPW, HSU79253" ENSG00000125375 "Distal membrane arm assembly complex 2 like" Q99766 14 50312324-50335558 "Predicted intracellular proteins" "ATP synthesis, Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 60.5;Cytotrophoblasts: 36.6;Extravillous trophoblasts: 24.6;Hofbauer cells: 28.5;Syncytiotrophoblasts: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062690 Approved Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 2: Karpas-707 - Immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Mitochondria" "HPA062690: AB_2684836" "unprognostic (2.24e-2)" "unprognostic (3.44e-3)" "unprognostic (7.85e-2)" "unprognostic (1.71e-1)" "unprognostic (8.53e-3)" "unprognostic (2.92e-2)" "unprognostic (2.21e-1)" "prognostic favorable (5.53e-4)" "unprognostic (5.73e-2)" "unprognostic (2.98e-1)" "unprognostic (1.02e-3)" "unprognostic (1.91e-1)" "prognostic favorable (2.37e-8)" "unprognostic (5.64e-2)" "unprognostic (1.67e-1)" "unprognostic (1.72e-1)" "unprognostic (2.95e-1)" 8.0 5.6 3.9 5.5 6.2 13.5 8.6 4.1 5.7 6.9 3.0 6.8 10.3 6.3 7.1 10.0 5.2 6.9 10.0 3.4 4.3 8.0 7.5 5.4 8.6 5.4 4.9 4.7 10.8 8.8 3.8 3.7 5.1 6.2 6.3 10.1 6.7 5.0 15.7 10.8 7.3 3.8 4.7 5.9 6.3 15.4 4.2 6.3 12.9 8.9 7.6 7.2 4.2 9.7 18.8 6.7 8.5 5.6 7.2 11.8 18.8 5.9 8.5 11.4 13.3 9.5 10.4 21.1 5.9 8.8 5.4 10.9 2.3 6.3 6.8 10.9 5.0 9.1 5.4 22.5 5.6 20.6 17.6 12.0 11.3 3.5 6.5 3.0 8.9 14.3 5.4 25.9 8.0 14.2 5.2 7.7 6.2 14.0 7.7 10.2 9.6 8.7 9.1 20.4 11.2 9.1 6.9 14.5 13.4 3.1 18.6 10.4 4.2 11.3 15.4 5.3 7.4 13.2 12.4 12.2 3.4 10.2 10.4 20.5 13.1 19.8 14.3 15.6 12.4 19.3 11.7 13.5 9.9 17.1 13.8 15.4 2.5 12.3 20.4 19.0 14.5 12.5 3.9 6.2 4.1 5.7 3.4 4.3 5.4 4.9 5.1 4.7 4.2 9.7 9.4 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.5 0.0 0.0 0.0 0.0 36.6 12.5 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 24.6 6.3 0.0 0.0 0.0 0.0 0.0 0.0 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 41.7 1.9 0.0 0.0 0.0 DNAJC11 FLJ10737 ENSG00000007923 "DnaJ heat shock protein family (Hsp40) member C11" Q9NVH1 1 6634168-6701924 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023707, HPA028705" Uncertain Supported Mitochondria No No "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Mitochondria "HPA023707: , HPA028705: AB_10603662" "unprognostic (3.74e-2)" "unprognostic (3.19e-2)" "unprognostic (4.06e-2)" "unprognostic (6.05e-3)" "unprognostic (9.55e-2)" "unprognostic (6.65e-2)" "unprognostic (4.38e-3)" "unprognostic (6.10e-2)" "unprognostic (6.34e-2)" "unprognostic (2.89e-1)" "unprognostic (1.45e-1)" "unprognostic (1.34e-1)" "prognostic favorable (2.63e-5)" "unprognostic (6.30e-2)" "unprognostic (1.76e-1)" "unprognostic (9.77e-2)" "unprognostic (1.04e-1)" 16.9 28.3 15.8 19.1 16.3 14.5 16.3 14.5 20.0 15.2 11.9 28.6 27.2 17.2 12.7 24.2 15.5 12.5 37.2 17.7 15.1 54.5 28.8 13.6 19.0 17.9 16.5 18.7 19.0 24.5 12.7 17.7 18.1 15.4 31.7 16.5 17.1 13.8 44.0 20.3 23.3 17.6 13.5 23.3 21.7 16.5 17.8 15.4 14.6 35.9 18.5 18.6 16.2 17.7 44.5 41.5 47.6 44.3 40.5 28.6 44.7 42.6 36.5 82.7 58.9 51.2 61.7 70.0 41.2 49.2 35.3 58.1 82.9 69.1 72.1 40.0 57.6 71.0 84.1 51.4 40.7 85.4 37.6 42.3 19.0 74.8 48.7 29.2 39.6 52.2 92.6 29.7 42.3 35.5 53.6 45.1 49.9 60.2 71.9 60.0 41.7 50.9 53.0 37.3 64.9 46.0 49.3 98.2 55.4 39.9 39.1 44.6 40.5 48.9 26.1 40.9 51.7 34.5 40.7 91.2 48.1 93.5 25.0 10.2 9.6 3.4 8.7 12.8 8.8 7.5 6.2 9.4 12.1 8.4 6.6 5.2 0.3 10.0 14.4 5.3 7.6 9.2 15.8 16.3 14.5 20.0 17.7 15.1 17.9 16.5 18.1 13.5 17.8 17.7 11.9 9.6 11.8 17.3 9.7 19.6 4.4 9.1 4.6 18.5 8.6 9.8 9.7 2.8 9.7 12.9 29.2 21.4 5.3 33.4 35.2 14.2 14.9 8.6 13.1 9.3 14.6 25.2 28.6 13.7 22.8 10.3 23.0 10.5 5.1 27.4 5.0 14.1 16.7 20.2 35.8 22.9 14.2 8.2 24.2 9.3 8.1 9.6 28.4 18.7 8.4 11.8 6.2 15.6 23.3 11.1 19.6 4.5 13.3 6.5 37.2 32.4 12.0 17.7 6.6 11.8 13.7 17.0 11.6 14.5 18.3 23.8 8.9 24.9 36.4 5.3 DNAJC17 FLJ10634 ENSG00000104129 "DnaJ heat shock protein family (Hsp40) member C17" Q9NVM6 15 40765161-40807478 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chaperone, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040914, HPA041187" Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Nucleoplasm "HPA040914: AB_10794072, HPA041187: AB_10794192" "unprognostic (9.79e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (5.89e-4)" "unprognostic (1.66e-3)" "unprognostic (1.46e-1)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "unprognostic (1.40e-1)" "unprognostic (3.65e-1)" "unprognostic (2.84e-1)" "unprognostic (1.94e-1)" "unprognostic (5.98e-2)" "unprognostic (5.37e-2)" "unprognostic (2.72e-1)" "unprognostic (4.78e-1)" "unprognostic (2.64e-2)" "unprognostic (6.58e-2)" 13.2 11.1 6.9 9.9 6.7 6.3 13.4 9.3 9.3 12.5 4.6 13.8 8.2 14.6 9.6 12.5 14.2 10.1 8.8 6.5 6.4 12.0 14.8 11.1 13.6 6.5 6.5 17.1 9.8 16.8 8.9 13.9 6.6 9.7 11.4 5.4 9.2 11.2 8.0 12.2 10.8 12.7 5.8 12.2 10.6 4.5 6.7 16.2 11.8 11.2 16.8 10.9 10.7 7.3 10.8 9.6 23.8 23.1 10.5 26.2 10.1 19.9 19.5 32.7 26.7 7.7 15.1 16.6 21.5 23.9 15.0 22.2 24.4 32.6 28.9 30.8 15.3 28.1 19.2 7.6 29.8 14.7 24.0 26.2 20.6 25.8 46.2 18.2 30.5 28.0 20.0 8.6 25.3 13.6 21.5 19.7 8.6 25.3 14.1 15.7 19.8 8.6 33.2 19.5 15.0 9.6 14.4 13.4 10.2 16.8 17.0 29.1 30.0 18.5 16.0 21.0 17.1 9.6 31.0 36.5 11.9 37.1 15.9 30.0 21.5 28.9 24.5 28.6 17.6 19.8 21.2 23.7 24.3 19.4 22.4 21.8 7.9 13.3 17.0 19.8 39.2 14.1 6.9 6.7 9.3 9.3 6.5 6.4 6.5 6.5 6.6 5.8 6.7 7.3 26.6 12.8 16.4 9.4 16.5 5.6 19.2 40.6 8.6 15.0 24.3 14.7 5.8 22.8 33.2 25.8 12.5 25.1 15.5 17.5 19.6 18.9 3.2 13.4 15.8 16.2 7.8 9.4 13.0 17.5 15.8 14.7 12.8 16.9 22.1 13.6 19.6 14.4 22.5 13.5 15.0 16.1 20.3 10.3 10.6 2.0 15.2 13.1 7.2 12.2 13.0 8.5 36.0 11.6 16.1 16.9 24.6 16.1 9.9 12.8 30.6 27.2 20.2 10.4 0.0 14.5 22.6 5.6 4.7 16.3 5.3 17.2 16.7 16.6 16.9 20.6 DNM1L "DRP1, DVLP, DYMPLE, HDYNIV, VPS1" ENSG00000087470 "Dynamin 1 like" O00429 12 32679200-32745650 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Biological rhythms, Endocytosis, Necrosis" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009952, HPA039324" Approved Enhanced Vesicles,Cytosol NA NA 2000000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol Vesicles "CAB009952: AB_2093533, HPA039324: AB_2676443" "unprognostic (2.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.10e-3)" "unprognostic (1.12e-1)" "unprognostic (5.09e-1)" "unprognostic (4.06e-2)" "prognostic unfavorable (6.27e-6)" "unprognostic (8.68e-2)" "unprognostic (2.25e-2)" "unprognostic (1.04e-2)" "unprognostic (1.71e-1)" "unprognostic (2.63e-1)" "unprognostic (4.06e-1)" "unprognostic (1.00e-1)" "unprognostic (8.17e-2)" "unprognostic (7.48e-2)" "unprognostic (1.57e-2)" 23.2 23.2 25.3 23.5 27.5 40.0 21.1 27.7 32.3 18.4 15.7 24.0 18.6 23.6 23.9 28.6 19.8 17.5 38.9 28.4 26.1 27.9 14.2 16.7 20.9 22.5 22.0 20.0 13.5 40.5 25.3 23.9 23.6 27.0 22.7 44.9 16.0 28.7 43.8 18.3 16.8 32.0 22.2 18.8 17.3 36.0 21.6 21.4 22.4 57.2 24.8 29.9 18.5 26.6 66.8 62.3 64.3 68.3 51.2 52.7 123.2 72.0 55.4 67.2 61.7 80.6 48.0 87.3 50.0 65.8 66.9 57.8 69.2 80.3 79.3 46.6 57.6 102.3 57.2 48.2 41.7 72.5 50.1 48.6 37.4 70.7 66.1 63.5 81.1 41.4 74.4 37.5 75.3 21.7 29.1 61.7 138.2 41.0 30.8 48.6 125.0 61.5 56.5 79.1 57.1 59.3 76.3 51.8 56.7 129.4 59.7 49.0 74.0 57.3 54.4 135.3 68.2 26.1 75.8 86.3 55.6 47.0 43.5 7.4 10.0 3.2 5.6 15.6 6.9 7.0 6.2 6.1 18.8 6.0 7.3 8.4 1.8 8.1 15.6 5.6 7.3 7.9 25.3 27.5 27.7 32.3 28.4 26.1 22.5 22.0 23.6 22.2 21.6 26.6 42.5 38.5 38.4 82.6 36.0 30.0 34.7 28.0 44.3 80.9 32.5 29.2 82.8 20.0 33.3 25.8 131.3 30.0 53.8 26.7 31.3 34.8 63.9 38.8 55.8 42.0 30.5 28.4 139.4 25.1 63.7 41.0 23.9 59.4 50.7 48.8 26.4 16.0 30.8 126.2 150.0 24.9 34.6 27.5 30.7 78.0 26.8 43.3 14.2 44.0 45.6 59.0 34.0 99.5 121.7 45.7 14.4 30.5 48.5 42.8 11.4 23.3 22.8 164.8 19.7 55.0 55.5 79.3 52.3 39.6 27.6 36.0 42.2 26.0 31.5 36.4 DOCK10 "KIAA0694, ZIZ3" ENSG00000135905 "Dedicator of cytokinesis 10" Q96BY6 2 224765090-225042468 "Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 83.1;lymphoid tissue: 32.1" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 1806.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 45.5;GAMG: 73.4;HDLM-2: 52.7;TIME: 48.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058106 Enhanced Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "HPA058106: AB_2683606" "unprognostic (6.95e-2)" "unprognostic (1.41e-2)" "unprognostic (1.05e-2)" "unprognostic (2.03e-2)" "unprognostic (1.14e-1)" "unprognostic (1.55e-3)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (3.44e-2)" "unprognostic (3.80e-1)" "unprognostic (3.22e-3)" "unprognostic (3.39e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.99e-2)" "unprognostic (2.54e-1)" "unprognostic (7.72e-2)" 4.5 8.2 22.6 18.8 49.2 10.2 3.8 33.7 33.4 8.7 9.7 6.3 4.1 3.2 1.1 3.2 2.4 6.3 1.6 28.7 35.1 3.2 5.5 7.6 27.8 45.5 38.4 17.7 1.7 2.0 1.0 2.3 48.9 1.6 6.5 5.7 2.5 1.7 1.2 5.0 12.5 4.3 32.0 29.8 6.7 2.2 37.9 32.1 2.7 0.8 19.9 6.4 4.4 83.1 0.0 21.4 6.7 0.0 8.5 17.9 0.0 45.5 36.8 21.3 15.8 0.0 0.0 0.6 0.1 28.9 73.4 0.5 0.0 0.1 16.9 52.7 0.0 0.6 4.5 0.0 0.3 4.4 2.1 4.3 0.4 31.0 12.0 8.3 21.4 7.0 0.1 42.1 36.4 2.1 8.0 6.1 2.6 0.0 5.0 10.5 9.8 6.2 1.1 0.1 0.4 5.5 0.0 0.0 4.8 1.2 1.4 20.0 48.2 22.8 5.7 10.9 15.6 0.0 0.0 0.0 32.2 29.6 10.1 3.0 3.3 0.2 6.5 9.2 6.6 7.2 10.9 9.1 6.9 4.5 10.5 9.3 0.1 14.3 11.8 2.8 8.4 4.5 22.6 49.2 33.7 33.4 28.7 35.1 45.5 38.4 48.9 32.0 37.9 83.1 3.7 3.2 9.1 4.2 47.1 4.7 0.6 0.3 8.0 7.9 0.8 4.3 1.2 0.0 2.5 5.5 0.0 0.3 39.5 0.8 1.9 0.1 3.2 0.2 2.3 3.2 2.4 5.5 8.0 0.0 0.2 4.9 5.1 0.5 36.7 64.0 2.5 1.4 30.6 97.6 244.2 3.8 0.0 54.2 39.7 2.8 0.6 51.0 8.8 201.4 38.3 1.2 38.1 400.6 1806.0 0.2 0.3 0.0 43.5 0.5 0.2 0.3 2.6 1.8 13.1 2.5 18.9 0.3 1.1 2.1 4.1 0.8 75.1 31.4 2.5 0.7 DOLK "DK1, KIAA1094, TMEM15" ENSG00000175283 "Dolichol kinase" Q9UPQ8 9 128945530-128947603 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Kinase, Transferase" "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 33.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA066767, HPA068706" Supported Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" Cytosol "HPA066767: AB_2732751, HPA068706: AB_2732118" "unprognostic (6.35e-2)" "unprognostic (2.69e-1)" "unprognostic (2.63e-1)" "unprognostic (1.30e-3)" "unprognostic (3.55e-1)" "unprognostic (2.81e-3)" "unprognostic (8.90e-3)" "unprognostic (3.26e-1)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (8.83e-3)" "unprognostic (1.83e-2)" "prognostic favorable (5.53e-4)" "unprognostic (3.20e-2)" "unprognostic (1.06e-1)" "prognostic favorable (6.88e-5)" "unprognostic (6.13e-3)" 9.6 14.3 6.6 6.3 6.3 1.5 7.8 6.7 6.7 7.4 8.6 7.5 7.6 9.3 13.5 8.6 8.9 7.9 10.5 6.5 7.1 9.1 10.5 9.1 6.8 6.9 7.6 6.7 14.5 16.8 5.9 9.3 7.3 10.0 6.6 4.4 12.0 10.0 6.7 9.9 7.5 9.4 6.5 8.0 10.6 14.5 7.6 5.1 7.8 7.1 6.6 8.6 5.9 6.8 11.7 42.5 14.8 22.0 42.6 22.2 20.0 23.7 38.1 28.5 21.0 33.7 17.9 6.4 12.3 34.6 40.3 80.3 20.3 29.6 14.7 10.7 17.8 8.0 27.4 24.5 43.0 8.8 13.5 31.1 27.0 30.8 16.8 16.7 28.1 9.1 19.7 10.0 31.3 56.9 7.3 7.3 19.0 33.0 26.0 7.2 19.5 25.1 25.7 17.3 13.5 15.1 31.4 25.6 14.1 13.7 44.8 11.4 23.6 25.6 9.2 32.5 19.8 9.4 25.0 6.4 24.2 8.0 19.9 2.7 15.4 6.9 11.2 15.3 10.1 11.8 9.9 12.3 16.6 12.5 12.8 13.2 2.2 13.0 21.2 9.3 16.8 10.5 6.6 6.3 6.7 6.7 6.5 7.1 6.9 7.6 7.3 6.5 7.6 6.8 8.5 6.4 4.1 2.9 2.6 1.8 3.6 13.9 4.6 9.1 4.4 4.3 3.5 10.0 10.9 7.3 8.4 25.6 3.5 5.2 0.0 15.7 15.1 5.9 7.2 9.2 1.2 3.6 1.2 14.2 16.4 8.1 5.1 3.6 1.3 7.5 16.1 9.2 13.5 5.0 2.2 3.5 12.2 5.2 2.7 3.7 12.2 2.9 3.6 1.9 2.8 10.7 5.2 2.5 1.7 11.1 7.5 6.0 1.5 4.4 7.5 9.0 11.4 7.1 0.0 7.0 15.7 33.8 15.1 3.3 1.3 18.2 2.3 15.8 5.7 2.1 DPH5 CGI-30 ENSG00000117543 "Diphthamide biosynthesis 5" Q9H2P9 1 100989623-101026088 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046439, HPA076234" Approved Approved "Nucleoli,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Golgi apparatus" Nucleoli "HPA046439: AB_2679667, HPA076234: AB_2797274" "unprognostic (1.31e-1)" "unprognostic (3.37e-2)" "unprognostic (1.98e-2)" "unprognostic (7.82e-2)" "unprognostic (1.22e-2)" "unprognostic (2.23e-1)" "unprognostic (2.81e-2)" "unprognostic (3.57e-2)" "unprognostic (8.59e-2)" "unprognostic (8.12e-2)" "unprognostic (1.37e-2)" "unprognostic (2.56e-1)" "unprognostic (1.58e-2)" "unprognostic (2.15e-1)" "unprognostic (7.09e-2)" "unprognostic (1.88e-1)" "unprognostic (9.00e-2)" 12.5 23.2 17.2 8.4 17.8 10.7 28.8 17.3 22.5 23.2 18.3 14.6 7.1 17.2 23.8 13.7 26.2 11.6 23.5 17.4 18.7 19.5 25.3 10.1 18.1 17.8 18.0 49.8 31.4 20.0 15.5 12.3 17.8 15.0 17.5 8.8 11.9 17.1 20.8 15.0 11.2 19.7 17.6 15.4 14.1 9.8 19.0 29.0 20.7 25.0 25.4 14.7 13.3 18.0 28.1 30.1 40.1 37.0 48.3 154.7 34.9 24.9 42.9 41.0 34.5 35.3 7.7 46.0 33.2 22.2 23.1 20.0 47.5 41.1 62.6 20.0 35.8 22.1 26.7 71.4 84.1 33.4 13.8 97.1 63.9 38.8 118.6 67.4 64.8 33.4 62.6 16.7 70.3 26.3 40.7 36.7 31.5 15.2 46.4 37.8 51.1 32.6 50.0 25.7 44.2 22.2 13.7 36.2 114.0 29.6 27.3 18.3 25.1 23.0 28.7 28.8 34.4 20.0 24.1 31.9 31.5 29.6 7.9 5.7 7.5 4.6 16.1 8.9 21.7 19.2 17.9 17.7 13.6 15.1 24.0 20.9 2.7 24.7 10.6 9.8 12.8 10.2 17.2 17.8 17.3 22.5 17.4 18.7 17.8 18.0 17.8 17.6 19.0 18.0 8.1 6.4 14.6 17.0 30.3 15.8 17.0 24.2 19.9 5.3 18.7 12.3 23.8 21.5 12.7 7.3 0.0 26.2 10.1 4.7 23.5 14.0 1.8 14.2 19.6 11.2 10.2 17.7 12.0 18.4 27.8 13.5 5.6 8.2 25.4 29.0 12.1 29.3 18.9 1.7 14.6 15.0 22.4 28.4 13.1 3.0 27.1 14.0 12.4 8.4 27.7 16.5 27.8 27.2 28.3 8.9 12.9 13.9 10.3 10.8 8.1 30.9 16.8 6.5 6.6 16.6 12.5 15.7 17.6 17.0 18.0 13.0 19.4 33.4 23.7 11.3 DPP3 ENSG00000254986 "Dipeptidyl peptidase 3" Q9NY33 11 66480013-66509657 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035780, HPA035781" Approved Supported Cytosol NA NA 3200000 "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol "HPA035780: AB_2674778, HPA035781: AB_10669529" "unprognostic (5.74e-2)" "unprognostic (1.16e-3)" "unprognostic (2.62e-3)" "unprognostic (4.77e-2)" "unprognostic (1.99e-1)" "unprognostic (5.44e-3)" "unprognostic (1.67e-3)" "unprognostic (1.25e-3)" "unprognostic (1.73e-2)" "unprognostic (9.87e-2)" "unprognostic (1.02e-2)" "unprognostic (3.87e-1)" "unprognostic (5.85e-2)" "prognostic favorable (1.34e-4)" "unprognostic (1.81e-2)" "unprognostic (3.43e-1)" "unprognostic (5.66e-2)" 11.6 17.5 8.2 21.4 9.1 20.7 11.2 10.2 10.4 11.0 5.4 30.2 24.8 11.7 7.8 23.5 9.8 14.5 10.3 8.4 8.9 17.1 18.6 14.3 21.8 10.2 8.8 6.8 17.3 11.9 8.7 14.3 10.8 14.4 26.3 15.9 18.8 12.9 26.5 13.6 20.5 16.2 8.6 15.4 19.2 9.8 10.2 18.6 11.7 7.4 23.3 17.3 13.5 9.9 84.1 71.6 32.5 36.3 26.4 28.3 50.4 46.5 61.8 61.4 40.7 90.8 68.4 48.7 154.0 52.9 52.2 73.6 52.1 57.0 39.4 92.5 23.8 63.1 32.1 54.2 40.7 77.6 101.1 40.5 54.5 46.2 22.8 26.5 47.8 50.1 45.1 28.2 56.7 95.3 91.0 78.7 55.5 82.0 43.2 63.1 32.7 79.6 52.6 71.7 61.1 52.2 39.7 45.6 62.5 30.3 70.8 44.7 50.1 36.5 39.4 40.7 46.2 23.3 46.6 56.6 48.5 36.5 45.9 20.7 18.8 21.3 21.4 40.0 13.3 11.5 15.8 17.7 32.3 11.1 9.4 13.9 3.2 30.8 27.9 22.5 29.6 17.7 8.2 9.1 10.2 10.4 8.4 8.9 10.2 8.8 10.8 8.6 10.2 9.9 5.8 16.0 13.2 6.8 11.6 6.0 17.4 34.8 8.6 11.4 7.1 3.8 3.0 10.0 27.0 23.9 10.4 46.9 11.5 41.6 13.7 45.6 24.6 8.7 6.2 10.5 18.6 3.4 3.4 61.3 34.2 7.4 29.0 11.5 1.3 9.9 3.6 14.7 37.4 6.7 4.0 19.5 63.1 7.9 9.0 7.0 2.1 10.8 16.0 3.7 31.3 21.6 18.6 4.5 5.6 40.8 25.2 5.3 15.7 11.0 26.4 28.7 17.3 72.9 13.1 4.4 16.2 8.8 20.7 14.4 6.0 36.0 13.1 20.1 29.5 19.5 DRG2 ENSG00000108591 "Developmentally regulated GTP binding protein 2" P55039 17 18087892-18107970 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007716 Approved Supported Nucleoplasm,Vesicles,Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 12: NES - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" "Vesicles, Cytosol" Nucleoplasm "HPA007716: AB_1078705" "unprognostic (7.47e-2)" "unprognostic (1.29e-1)" "unprognostic (4.78e-2)" "prognostic favorable (1.56e-4)" "unprognostic (1.26e-3)" "unprognostic (7.86e-2)" "unprognostic (8.85e-2)" "unprognostic (5.72e-2)" "unprognostic (8.49e-2)" "unprognostic (1.25e-1)" "unprognostic (2.88e-3)" "prognostic unfavorable (7.34e-4)" "unprognostic (3.10e-1)" "unprognostic (2.18e-1)" "unprognostic (1.49e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" 19.3 19.1 14.2 12.8 14.8 15.9 19.6 14.8 15.0 21.6 13.6 19.4 14.8 22.3 12.9 21.6 19.8 12.6 19.8 14.9 15.7 18.5 16.6 15.7 18.4 15.2 15.4 22.5 19.6 15.8 17.8 12.3 16.1 20.1 10.0 5.2 17.0 15.2 36.6 20.3 17.4 13.7 15.4 19.8 17.9 8.9 14.9 16.0 18.4 16.5 14.9 20.0 18.3 16.5 37.1 51.1 17.4 17.3 31.1 31.7 33.1 24.8 24.7 40.0 37.0 55.5 21.8 35.5 31.8 29.4 21.2 38.9 28.5 35.1 27.4 32.1 74.2 16.0 26.5 31.5 33.4 14.3 24.2 36.4 30.5 39.1 33.0 22.9 38.5 46.8 27.6 13.7 23.6 42.5 38.7 25.8 12.9 51.4 36.1 41.5 41.8 66.7 24.3 21.6 9.9 28.0 25.2 15.2 31.9 102.8 30.0 21.4 29.2 19.6 18.3 23.0 42.8 15.5 19.4 20.1 27.9 26.2 36.6 17.7 21.1 23.6 24.6 23.3 20.2 14.9 17.8 20.0 24.6 17.7 16.9 18.7 2.8 28.2 30.5 13.8 24.9 19.3 14.2 14.8 14.8 15.0 14.9 15.7 15.2 15.4 16.1 15.4 14.9 16.5 23.8 0.0 12.4 8.5 19.5 16.7 19.9 21.2 11.4 14.9 18.8 23.0 3.9 24.3 13.2 7.3 2.1 37.5 26.3 20.1 29.4 29.4 7.3 12.8 19.3 20.8 21.6 10.1 11.9 27.1 40.8 19.4 17.9 12.9 12.0 32.6 16.4 19.4 32.2 6.7 10.0 19.7 16.2 21.4 12.2 14.2 21.5 18.0 12.4 8.4 23.9 19.6 23.7 4.0 8.0 24.8 16.2 24.5 22.9 17.4 31.4 31.8 9.3 13.4 6.6 22.0 21.7 12.1 13.0 18.2 11.6 39.3 21.9 33.9 24.5 14.4 DROSHA "Etohi2, HSA242976, RN3, RNASE3L, RNASEN" ENSG00000113360 "Drosha ribonuclease III" Q9NRR4 5 31400494-31532196 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Ribosome biogenesis, RNA-mediated gene silencing" "Endonuclease, Hydrolase, Nuclease, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocyte precursor cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031150 Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm Cytosol "HPA031150: AB_2673761" "unprognostic (8.37e-3)" "unprognostic (1.81e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (6.79e-4)" "unprognostic (5.40e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.11e-1)" "unprognostic (4.08e-2)" "unprognostic (9.08e-2)" "unprognostic (1.86e-1)" "unprognostic (5.43e-2)" "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.39e-1)" "unprognostic (6.94e-2)" "unprognostic (2.32e-2)" 12.3 11.3 2.6 15.9 3.8 11.6 11.5 9.4 8.0 13.3 4.2 13.8 13.6 15.9 20.4 11.4 14.5 11.7 13.0 2.0 8.1 12.3 9.7 10.9 16.0 1.1 2.9 20.5 14.4 15.2 4.5 13.8 2.3 13.6 15.6 27.2 12.5 13.2 22.2 13.5 12.2 13.8 0.2 12.5 13.2 11.1 5.2 24.5 15.5 19.6 17.1 12.2 3.9 4.9 38.7 47.3 51.8 70.8 27.0 32.8 74.2 50.0 24.4 45.6 33.9 50.6 49.0 43.3 55.9 36.9 52.7 33.0 63.5 37.8 50.4 40.9 44.6 52.9 157.8 37.0 24.3 59.2 151.6 25.8 26.0 50.7 24.2 34.6 39.5 45.3 68.9 19.7 40.5 38.5 58.3 44.8 49.1 31.2 37.9 52.2 98.9 31.1 25.7 43.2 26.9 35.6 127.1 51.4 30.0 46.0 47.4 34.1 33.9 43.7 50.3 39.0 48.0 35.8 63.5 47.1 30.3 65.9 42.9 0.9 1.2 1.5 2.2 1.3 2.4 1.8 2.4 2.7 2.5 2.0 2.7 2.0 0.3 2.5 2.5 3.0 2.5 1.6 2.6 3.8 9.4 8.0 2.0 8.1 1.1 2.9 2.3 0.2 5.2 4.9 6.2 12.8 14.3 45.4 7.1 3.6 5.0 7.0 10.8 19.4 7.1 6.0 23.4 5.7 12.8 5.5 0.0 8.5 11.4 12.9 3.9 7.8 3.5 12.3 11.6 9.0 11.4 8.0 43.4 8.1 7.6 12.7 8.6 13.6 9.5 20.4 10.0 7.2 7.8 6.7 45.8 8.5 14.2 6.3 3.0 8.2 10.8 6.0 1.8 34.7 8.4 10.2 9.2 74.9 43.9 9.3 10.2 13.2 8.8 6.1 7.3 5.1 16.8 18.8 6.6 10.4 11.6 7.1 10.9 8.8 3.4 4.9 8.3 13.9 11.7 5.9 DUS1L "DUS1, PP3111" ENSG00000169718 "Dihydrouridine synthase 1 like" Q6P1R4 17 82057506-82065887 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023384 Uncertain Approved "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "HPA023384: AB_1847879" "unprognostic (4.42e-2)" "unprognostic (2.19e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-2)" "unprognostic (1.73e-3)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (5.17e-2)" "unprognostic (1.10e-1)" "unprognostic (4.16e-3)" "unprognostic (5.23e-3)" "unprognostic (3.13e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (4.17e-2)" "unprognostic (8.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.70e-3)" 83.3 86.7 38.2 51.1 38.0 94.2 89.0 35.2 49.7 85.3 40.6 101.3 66.6 74.0 23.0 117.8 81.8 27.0 93.1 38.4 34.9 90.4 174.3 80.5 64.8 40.4 36.4 82.3 148.3 32.0 99.7 27.0 37.0 118.8 29.8 16.9 105.8 30.4 144.3 127.1 107.2 18.9 35.2 131.3 119.4 93.6 38.5 37.7 93.6 27.3 33.3 87.9 85.0 38.6 169.4 109.0 37.7 44.3 28.9 28.4 115.0 57.5 26.8 56.5 40.2 99.7 77.9 133.7 65.3 33.0 39.8 112.0 46.1 60.9 21.9 54.6 263.1 89.2 167.3 178.8 65.3 138.8 101.0 43.1 75.1 37.3 46.4 27.0 64.1 124.8 147.1 69.4 28.5 268.6 192.9 114.9 43.7 87.6 151.7 143.7 43.1 151.7 42.3 114.3 193.9 118.7 45.2 192.6 127.1 35.8 112.3 133.1 49.1 91.7 89.0 79.3 150.1 164.5 48.9 113.0 58.8 102.2 65.0 3.0 3.5 5.0 4.0 3.9 6.0 3.9 4.0 5.0 3.6 3.3 6.5 5.6 1.2 5.9 5.3 7.9 7.6 2.0 38.2 38.0 35.2 49.7 38.4 34.9 40.4 36.4 37.0 35.2 38.5 38.6 36.8 28.9 19.1 17.6 30.0 22.0 20.0 10.0 10.8 28.3 78.3 69.8 21.3 24.3 15.0 11.0 29.2 16.1 60.1 65.2 7.9 12.1 87.2 30.5 28.4 21.0 43.2 21.7 15.9 39.1 19.1 19.1 37.2 37.6 3.8 46.3 13.9 77.8 21.0 18.5 15.8 58.1 8.2 26.8 14.3 146.2 14.3 27.0 10.6 10.3 19.2 17.8 27.8 10.1 18.2 32.0 32.2 13.5 33.7 40.9 32.4 24.5 15.3 47.8 13.1 18.0 23.9 43.3 9.6 23.3 28.4 15.6 28.4 52.2 75.4 37.5 DUS3L "DUS3, FLJ13896" ENSG00000141994 "Dihydrouridine synthase 3 like" Q96G46 19 5784832-5791225 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 55.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041854, HPA041944, HPA062846" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA041854: AB_10794493, HPA041944: AB_10794163, HPA062846: AB_2684879" "unprognostic (1.25e-2)" "unprognostic (7.27e-2)" "unprognostic (1.75e-1)" "unprognostic (9.64e-3)" "unprognostic (6.08e-2)" "unprognostic (6.98e-3)" "unprognostic (1.25e-1)" "unprognostic (1.87e-1)" "unprognostic (4.19e-1)" "unprognostic (3.55e-2)" "unprognostic (7.35e-3)" "unprognostic (4.25e-3)" "unprognostic (7.73e-3)" "unprognostic (1.09e-1)" "unprognostic (1.10e-1)" "unprognostic (1.17e-1)" "unprognostic (2.89e-2)" 14.5 15.3 7.1 8.4 7.4 20.7 15.6 6.8 10.2 16.9 7.2 15.4 11.4 16.3 1.6 20.6 17.1 4.1 13.4 7.0 6.6 16.7 25.2 11.7 9.5 8.9 7.3 18.2 24.1 3.9 13.7 5.4 7.3 18.9 2.8 3.0 17.7 5.0 16.7 24.6 18.4 2.8 7.0 19.6 16.9 40.2 7.7 8.1 18.6 3.7 3.7 15.5 16.8 9.4 29.9 28.3 8.1 29.0 2.3 3.7 26.9 9.8 5.7 9.9 7.6 44.4 13.9 30.2 36.1 3.9 11.5 18.9 7.3 9.5 1.5 22.7 63.6 20.3 15.4 16.9 14.2 45.0 56.2 8.6 10.0 11.3 7.8 1.3 6.8 19.8 53.2 0.0 5.4 38.0 38.8 45.9 28.4 10.7 76.9 19.4 17.0 38.1 4.2 20.7 27.9 28.6 10.3 17.0 19.7 1.9 12.1 36.1 9.4 14.3 25.2 43.1 42.6 83.4 66.9 29.3 13.9 46.1 16.4 8.3 20.1 5.8 21.5 30.2 24.7 15.2 16.4 20.3 29.8 19.0 21.2 21.5 2.2 27.9 25.3 30.9 20.1 16.3 7.1 7.4 6.8 10.2 7.0 6.6 8.9 7.3 7.3 7.0 7.7 9.4 7.2 9.6 10.0 2.6 19.9 14.7 19.3 16.7 25.6 6.6 7.7 10.2 3.0 7.2 9.7 1.8 12.5 18.3 9.3 14.4 7.9 12.4 48.8 6.7 8.3 9.2 7.7 25.2 4.2 22.4 17.7 10.9 18.3 8.2 35.5 7.7 4.6 7.5 14.8 11.8 5.0 12.8 4.1 7.2 9.1 10.9 12.8 10.6 5.4 1.9 6.9 4.3 14.4 1.5 4.8 12.0 10.3 6.4 12.3 8.6 12.8 7.2 6.2 11.1 19.7 15.8 9.8 55.0 10.7 16.1 12.8 21.8 13.5 9.8 15.9 12.7 DYM "DMC, FLJ20071, SMC" ENSG00000141627 Dymeclin Q7RTS9 18 49036387-49461347 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Astrocytes: 113.6;Early spermatids: 353.4;Excitatory neurons: 173.2;Inhibitory neurons: 204.1;Late spermatids: 176.1;Microglial cells: 149.9;Oligodendrocyte precursor cells: 167.9;Oligodendrocytes: 299.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043551, HPA049187" Approved Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Golgi apparatus" "HPA043551: AB_2678547, HPA049187: AB_2680668" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (3.12e-3)" "unprognostic (1.33e-2)" "unprognostic (1.95e-1)" "unprognostic (1.59e-1)" "unprognostic (1.85e-3)" "unprognostic (1.77e-1)" "unprognostic (1.72e-1)" "unprognostic (8.30e-3)" "unprognostic (2.53e-2)" "unprognostic (2.58e-2)" "prognostic favorable (2.76e-5)" "unprognostic (3.89e-1)" "unprognostic (1.69e-1)" "unprognostic (4.26e-3)" "prognostic unfavorable (5.26e-5)" 17.9 19.2 17.3 14.8 19.6 24.0 23.3 24.9 20.4 24.9 24.4 20.7 15.8 19.8 20.2 25.3 18.6 17.7 21.1 16.7 20.4 21.1 19.7 15.7 17.0 22.8 21.1 29.4 80.7 28.6 9.9 14.6 24.5 20.6 16.8 36.0 36.6 22.0 49.6 18.2 14.1 25.1 19.0 12.7 16.6 44.0 19.1 33.0 32.6 46.0 20.7 23.2 22.3 23.9 32.9 19.8 30.6 47.0 56.9 63.9 24.1 32.2 42.1 37.7 36.8 14.6 20.7 102.1 27.8 60.1 27.9 41.0 48.1 42.1 46.0 38.6 24.7 23.8 16.9 43.4 56.7 83.5 41.5 50.1 49.1 44.1 112.7 63.3 59.0 51.6 25.7 60.5 30.4 35.0 56.5 35.5 9.8 27.1 15.2 29.2 39.2 48.3 34.8 37.2 56.5 36.5 21.9 26.1 30.2 34.5 36.7 29.8 32.6 35.6 16.9 15.5 18.9 67.8 52.7 57.4 19.1 51.6 40.5 20.9 26.9 32.7 20.2 23.4 27.2 17.0 19.3 18.7 29.2 13.9 19.6 15.2 11.9 30.6 20.6 8.4 21.4 21.4 17.3 19.6 24.9 20.4 16.7 20.4 22.8 21.1 24.5 19.0 19.1 23.9 16.0 6.4 6.9 113.6 29.1 11.6 20.4 8.1 29.0 20.1 17.9 15.4 24.5 17.2 8.4 3.7 6.2 19.5 17.4 10.5 13.7 18.1 353.4 11.6 17.2 16.3 16.2 17.9 173.2 20.3 22.2 20.6 17.3 14.8 16.5 23.3 14.3 11.5 16.7 21.9 204.1 15.1 6.1 23.0 15.1 176.1 27.7 20.5 3.6 149.9 19.7 16.1 24.7 167.9 299.4 14.7 11.4 27.1 23.8 25.0 16.1 22.5 13.4 24.9 13.1 22.4 15.4 49.8 16.2 19.4 11.4 35.2 21.6 18.1 16.2 20.2 ECI2 "ACBD2, DRS1, HCA88, PECI" ENSG00000198721 "Enoyl-CoA delta isomerase 2" O75521 6 4115693-4135597 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 422.7" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 293.6;Distal tubular cells: 428.4;Proximal tubular cells: 577.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022130, HPA031626" Enhanced Enhanced Peroxisomes,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Peroxisomes, Mitochondria" "HPA022130: AB_1855176, HPA031626: AB_2673965" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (1.71e-2)" "unprognostic (1.04e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.85e-4)" "unprognostic (1.17e-3)" "unprognostic (4.97e-2)" "unprognostic (9.49e-2)" "unprognostic (3.95e-3)" "unprognostic (3.17e-2)" "unprognostic (5.75e-2)" "prognostic favorable (2.04e-6)" "unprognostic (1.40e-1)" "unprognostic (1.23e-1)" "unprognostic (8.45e-2)" "unprognostic (1.34e-1)" 53.6 123.6 43.9 21.0 47.7 21.5 65.0 46.5 63.7 60.0 50.5 53.3 64.0 44.9 102.1 26.7 49.2 40.1 150.9 42.4 47.8 236.0 422.7 28.6 20.0 45.0 45.6 71.4 159.8 53.2 52.6 37.7 44.2 45.2 55.4 31.8 29.9 36.3 198.4 22.7 59.6 35.5 45.3 30.1 103.5 30.9 49.0 33.5 37.0 236.4 21.8 31.6 26.8 45.5 82.8 45.1 72.8 161.0 89.7 131.4 8.8 114.0 116.7 122.1 107.7 34.0 12.4 3.6 139.6 126.0 111.0 41.6 83.6 67.4 179.5 30.4 95.8 44.0 59.7 186.8 51.3 40.4 20.7 90.6 40.6 106.2 58.4 166.0 262.9 136.2 146.2 31.1 118.6 33.4 113.9 100.7 49.5 8.1 158.7 108.8 90.8 1.5 67.2 16.8 1.8 33.7 6.8 48.2 107.6 131.0 109.8 18.9 268.6 92.4 49.8 82.7 69.8 46.8 88.7 8.4 47.9 34.7 73.0 19.2 36.4 17.4 41.5 28.4 57.1 45.8 48.8 58.3 58.9 51.9 59.8 59.2 1.2 66.0 43.3 45.3 57.9 41.1 43.9 47.7 46.5 63.7 42.4 47.8 45.0 45.6 44.2 45.3 49.0 45.5 61.0 28.9 25.2 17.0 24.4 18.2 48.6 50.3 22.2 14.3 33.3 41.0 165.8 78.6 40.1 36.8 12.5 293.6 29.3 32.0 428.4 53.2 63.1 60.8 43.1 48.0 52.1 77.6 10.7 175.5 29.0 55.2 34.7 57.0 23.4 68.6 53.9 162.2 64.3 18.5 11.9 41.6 20.3 22.0 19.2 50.6 63.3 23.5 35.6 14.0 34.7 77.7 21.6 8.5 18.2 80.4 37.5 50.8 28.3 24.7 120.6 577.0 83.6 46.4 26.3 46.8 33.9 46.5 35.6 24.9 12.8 101.9 41.2 224.0 60.8 22.3 EDC4 "Ge-1, HEDLS, RCD-8" ENSG00000038358 "Enhancer of mRNA decapping 4" Q6P2E9 16 67873052-67884499 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 24.8;Excitatory neurons: 14.2;Gastric mucus-secreting cells: 15.3;Inhibitory neurons: 12.6;Oligodendrocytes: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041164, HPA043038" Supported Enhanced "Nucleoplasm,Cytoplasmic bodies" NA NA 9700 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Cytoplasmic bodies" Nucleoplasm "HPA041164: AB_2677339, HPA043038: AB_2678281" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (8.53e-2)" "unprognostic (1.01e-1)" "unprognostic (1.63e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (7.61e-4)" "unprognostic (1.47e-2)" "unprognostic (2.87e-1)" "unprognostic (7.93e-2)" "unprognostic (3.75e-3)" "unprognostic (1.10e-2)" "unprognostic (2.44e-2)" "unprognostic (1.48e-1)" "unprognostic (3.13e-2)" "unprognostic (7.69e-3)" "unprognostic (1.17e-1)" 10.1 11.8 36.3 11.9 36.2 24.4 10.6 36.0 42.2 11.6 34.0 15.5 13.7 12.9 9.6 12.1 13.2 12.1 17.0 34.7 34.8 12.2 10.9 10.8 16.3 34.3 34.5 15.8 18.1 13.6 14.0 10.8 34.4 11.3 11.2 8.5 11.3 10.2 21.9 16.1 14.1 9.7 33.0 13.7 15.8 18.3 34.1 20.6 10.9 11.3 16.0 13.1 10.5 37.0 23.8 33.6 22.0 19.9 19.6 14.8 43.6 21.1 17.8 42.4 33.9 55.2 22.4 38.2 22.6 29.1 17.9 32.4 43.1 17.2 21.3 14.8 54.6 27.2 21.9 29.5 23.7 33.2 29.8 20.3 23.2 42.7 19.8 24.9 32.8 28.3 48.2 7.1 25.4 36.5 44.9 83.6 21.8 15.9 18.4 66.1 26.1 42.3 17.0 17.7 38.5 20.8 56.0 15.9 15.8 17.3 29.4 45.2 21.5 17.7 24.7 16.3 28.6 34.9 22.2 94.7 13.6 39.4 16.3 0.7 5.8 4.2 8.9 6.2 7.9 5.6 7.6 8.4 6.0 4.1 7.5 5.4 2.6 8.3 10.9 4.2 11.2 6.6 36.3 36.2 36.0 42.2 34.7 34.8 34.3 34.5 34.4 33.0 34.1 37.0 0.6 22.4 24.8 8.5 4.8 0.0 0.3 0.2 7.4 1.2 0.3 0.4 1.5 0.0 3.2 0.0 4.2 0.2 1.1 1.6 0.0 0.4 0.0 1.0 1.1 2.1 1.2 8.8 14.2 0.0 0.4 2.6 15.3 1.3 3.8 0.8 1.4 0.2 0.4 0.0 12.6 0.4 0.0 0.3 0.3 0.2 0.3 4.5 0.0 11.2 0.0 0.7 1.0 8.5 13.6 0.3 1.2 0.0 8.3 0.2 2.0 0.1 4.4 1.2 6.6 1.0 0.9 0.2 0.2 8.3 0.1 0.0 5.5 0.8 0.4 0.1 EEF1AKMT3 "DKFZP586D0919, FAM119B, METTL21B" ENSG00000123427 "EEF1A lysine methyltransferase 3" Q96AZ1 12 57771492-57782541 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Breast glandular cells: 14.9;Breast myoepithelial cells: 7.6;Exocrine glandular cells: 12.7;monocytes: 8.8;Proximal tubular cells: 16.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in all" 7 "RH-30: 152.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA043020, HPA045492" Uncertain Approved "Nucleoplasm,Mitotic chromosome,Centrosome" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 7: Non-specific - Mitochondria" Centrosome "Nucleoplasm, Mitotic chromosome" "HPA043020: AB_2678274, HPA045492: " "unprognostic (2.00e-1)" "unprognostic (6.52e-2)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (2.01e-1)" "unprognostic (1.55e-3)" "unprognostic (1.06e-1)" "unprognostic (7.34e-3)" "unprognostic (7.52e-3)" "unprognostic (1.66e-1)" "unprognostic (2.32e-1)" "unprognostic (1.54e-3)" "unprognostic (5.77e-2)" "unprognostic (1.33e-1)" "unprognostic (1.34e-2)" "unprognostic (1.23e-1)" 7.5 6.2 2.5 3.6 2.3 2.6 9.2 4.1 2.7 10.5 2.6 5.6 3.9 9.3 9.6 5.6 8.4 5.4 3.7 2.4 1.8 11.6 6.5 5.3 3.6 2.6 2.4 11.4 21.7 6.4 3.7 4.6 2.7 8.2 4.6 3.7 19.4 8.7 2.9 7.3 3.8 7.6 2.1 4.0 7.2 4.2 2.4 1.9 10.1 3.1 3.1 6.3 7.3 3.1 5.4 11.0 4.6 5.9 12.8 12.0 4.0 5.8 10.9 8.9 9.0 5.6 9.5 3.1 7.4 7.6 7.2 5.2 3.7 3.3 9.3 4.0 5.6 14.9 6.6 9.2 11.3 3.7 6.6 12.6 8.7 9.3 9.8 15.2 9.7 13.2 8.9 22.6 5.4 3.8 4.7 11.0 3.4 4.3 8.0 8.5 152.1 10.0 6.0 5.3 4.4 6.0 10.0 7.5 6.2 4.1 11.9 10.0 9.5 13.7 7.7 5.8 6.4 5.7 2.3 3.8 11.3 15.4 10.0 0.4 3.0 0.1 1.8 1.1 7.8 0.5 3.5 2.2 3.1 0.4 1.7 1.4 0.7 1.5 4.6 1.5 2.2 2.3 2.5 2.3 4.1 2.7 2.4 1.8 2.6 2.4 2.7 2.1 2.4 3.1 3.9 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 14.9 7.6 0.0 0.0 1.8 1.8 0.0 3.4 1.3 0.0 5.9 5.5 0.0 2.0 6.0 1.9 0.0 0.0 0.0 12.7 4.9 3.4 0.0 2.5 2.5 5.4 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 8.8 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.1 0.0 0.0 16.4 1.5 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 1.6 0.5 4.7 0.0 0.0 EEF1AKNMT "CGI-01, DFNM1, FEAT, KIAA0859, METTL13" ENSG00000010165 "EEF1A lysine and N-terminal methyltransferase" Q8N6R0 1 171781660-171814023 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 8.1;Cytotrophoblasts: 16.9;Extravillous trophoblasts: 22.3;Hofbauer cells: 17.5;Syncytiotrophoblasts: 9.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044498, HPA053705" Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA044498: AB_10960884, HPA053705: AB_2682235" "unprognostic (1.05e-2)" "unprognostic (3.68e-2)" "unprognostic (8.30e-2)" "unprognostic (2.76e-1)" "unprognostic (3.78e-1)" "unprognostic (4.40e-1)" "prognostic unfavorable (5.68e-4)" "unprognostic (1.86e-1)" "unprognostic (3.12e-1)" "unprognostic (8.83e-2)" "unprognostic (1.16e-1)" "unprognostic (3.65e-1)" "unprognostic (4.12e-1)" "unprognostic (6.86e-3)" "unprognostic (7.49e-2)" "unprognostic (3.01e-1)" "unprognostic (1.13e-1)" 10.5 12.6 8.0 11.3 8.6 8.2 11.1 9.4 8.3 10.5 8.2 10.7 12.1 10.2 18.6 9.8 12.1 7.1 9.4 7.8 8.4 10.0 10.4 9.6 13.8 9.1 8.3 11.0 10.0 10.6 5.4 9.0 8.3 9.4 11.4 6.2 10.2 10.4 16.4 11.2 11.2 11.5 8.7 11.3 10.0 13.0 8.9 13.2 9.3 13.1 14.2 10.1 8.5 9.2 27.3 63.3 16.7 17.2 23.1 20.7 44.7 33.5 26.2 39.5 30.7 48.2 27.5 49.5 39.3 22.9 26.0 27.3 51.3 26.8 31.2 32.4 29.1 34.3 33.0 21.3 17.0 46.2 33.4 18.5 24.5 41.1 17.7 18.1 23.9 26.6 69.7 16.6 30.3 20.7 36.9 31.3 63.6 54.0 84.1 33.3 21.9 45.8 22.7 27.7 27.3 37.5 25.3 56.8 31.0 40.3 42.0 39.8 19.8 26.6 24.4 27.6 40.0 42.7 51.2 56.7 20.2 31.5 24.5 1.6 8.0 3.0 8.3 7.7 9.6 8.4 8.3 7.1 7.7 6.1 7.4 10.0 2.3 10.5 7.1 8.9 6.7 7.5 8.0 8.6 9.4 8.3 7.8 8.4 9.1 8.3 8.3 8.7 8.9 9.2 1.6 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 16.9 1.9 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 22.3 3.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 9.6 0.3 0.0 0.0 0.0 EIF2A EIF-2A ENSG00000144895 "Eukaryotic translation initiation factor 2A" Q9BY44 3 150546678-150586016 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036256 Approved Uncertain Mitochondria,Cytosol No No 16000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Mitochondria Cytosol "HPA036256: AB_10611961" "unprognostic (1.72e-1)" "unprognostic (2.09e-2)" "unprognostic (2.71e-3)" "unprognostic (3.36e-2)" "unprognostic (3.96e-3)" "unprognostic (7.05e-3)" "prognostic unfavorable (2.36e-5)" "unprognostic (2.11e-1)" "unprognostic (7.92e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.57e-6)" "unprognostic (6.30e-2)" "unprognostic (3.08e-2)" "unprognostic (3.78e-1)" "unprognostic (1.13e-1)" "unprognostic (1.48e-1)" "unprognostic (3.39e-1)" 57.0 54.0 14.5 47.8 18.5 86.8 103.4 27.2 25.4 63.9 21.9 57.8 65.5 69.7 46.9 64.7 62.7 55.8 72.3 16.6 18.4 72.2 75.2 47.7 68.4 17.1 15.3 94.9 107.2 62.8 32.8 52.4 18.5 52.8 70.8 52.3 77.2 47.0 87.3 74.0 55.3 68.4 18.1 47.4 59.7 24.3 15.1 68.7 92.1 76.7 83.4 67.5 43.4 22.8 158.0 69.4 76.6 79.9 100.8 234.3 105.0 97.3 158.0 134.1 143.0 202.5 168.9 212.0 142.4 134.3 160.1 125.1 149.9 152.9 193.5 81.3 91.6 129.4 76.1 130.9 101.1 155.0 113.0 151.4 153.6 97.2 221.9 200.7 180.3 112.3 109.8 116.5 105.5 121.3 109.6 70.6 108.4 161.3 98.7 97.5 101.1 238.8 119.9 116.9 93.7 102.1 62.6 88.0 144.5 91.6 130.9 127.3 99.9 76.3 69.3 109.2 186.6 194.9 119.6 195.0 96.4 130.5 39.5 23.6 47.2 10.4 27.9 49.5 46.1 36.2 40.6 35.7 54.2 34.7 51.5 41.6 3.7 46.1 56.9 26.5 37.0 44.4 14.5 18.5 27.2 25.4 16.6 18.4 17.1 15.3 18.5 18.1 15.1 22.8 77.7 35.3 67.1 14.4 91.4 140.1 157.3 109.8 109.3 30.6 86.0 76.5 102.4 58.6 69.2 35.0 27.1 84.1 85.7 43.1 137.0 76.1 21.5 39.6 64.3 67.5 56.8 80.3 30.4 108.3 113.6 63.8 64.7 51.4 75.5 45.0 60.0 30.6 62.4 23.5 33.1 81.7 54.9 96.4 82.8 6.6 61.5 72.7 69.4 19.7 97.4 37.2 73.2 32.6 34.7 64.0 57.7 56.4 112.1 79.6 77.0 138.4 41.7 31.2 78.9 95.4 77.9 40.4 41.9 102.3 122.9 120.3 95.0 55.1 99.0 130.4 EIF2B3 "EIF-2B, EIF2Bgamma" ENSG00000070785 "Eukaryotic translation initiation factor 2B subunit gamma" Q9NR50 1 44850522-44986722 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024213, HPA024218, HPA024219" Supported Supported Vesicles,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Vesicles, Cytosol" "HPA024213: AB_1848067, HPA024218: AB_1848068, HPA024219: AB_1848069" "unprognostic (2.12e-2)" "unprognostic (7.49e-2)" "unprognostic (4.37e-3)" "unprognostic (5.14e-2)" "unprognostic (1.57e-2)" "unprognostic (4.45e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (4.55e-2)" "unprognostic (1.14e-2)" "unprognostic (7.22e-2)" "unprognostic (2.16e-1)" "unprognostic (1.36e-1)" "unprognostic (5.38e-2)" "unprognostic (6.98e-2)" "unprognostic (7.80e-2)" "unprognostic (5.69e-3)" "unprognostic (2.73e-2)" 23.6 27.2 11.4 11.6 10.9 10.9 21.9 13.2 15.6 18.7 10.1 17.5 8.6 17.0 12.5 17.4 16.3 9.6 40.6 11.2 11.6 15.4 24.7 13.5 14.3 11.9 12.1 18.2 16.9 30.0 15.8 9.7 12.8 15.0 13.4 19.0 25.1 13.7 77.0 17.6 10.7 19.4 11.0 14.9 14.2 19.3 11.2 13.3 12.5 48.0 14.5 17.7 17.1 14.0 35.4 26.9 30.9 25.5 36.3 43.1 36.2 56.1 42.2 56.5 52.9 39.0 20.7 90.6 39.9 43.2 45.0 20.6 65.3 48.6 69.5 32.5 58.1 44.3 29.3 38.4 46.2 71.2 24.3 29.3 25.8 61.0 69.9 26.5 52.8 30.1 106.1 31.6 62.3 23.1 69.7 30.2 42.0 38.8 52.7 54.7 51.3 65.7 28.7 15.7 53.2 20.5 55.1 63.8 37.4 40.7 24.7 32.8 28.3 35.9 42.9 53.4 73.7 31.6 37.9 68.9 27.9 59.5 43.1 1.6 23.4 3.9 18.6 37.2 22.8 14.8 18.3 21.1 37.0 18.9 22.9 23.6 2.1 25.5 33.1 25.3 17.6 21.4 11.4 10.9 13.2 15.6 11.2 11.6 11.9 12.1 12.8 11.0 11.2 14.0 13.9 6.4 22.0 24.8 15.8 13.8 19.0 33.0 10.8 15.1 15.8 16.8 79.2 15.7 24.9 5.5 20.9 25.1 12.1 4.5 29.4 18.9 26.1 17.0 23.0 14.4 3.6 15.3 39.9 15.8 22.6 22.6 13.7 11.5 25.9 21.1 3.9 22.6 24.8 21.9 44.5 7.0 20.3 10.7 11.2 11.3 26.4 15.4 17.8 26.2 30.1 21.7 10.3 29.1 35.7 13.7 6.9 25.2 22.6 17.1 5.7 23.1 34.2 21.8 26.3 19.7 45.4 45.5 23.6 17.1 14.9 14.9 13.5 40.4 9.4 13.9 EIF3A "EIF3, eIF3-p170, eIF3-theta, EIF3S10, KIAA0139, TIF32" ENSG00000107581 "Eukaryotic translation initiation factor 3 subunit A" Q14152 10 119033670-119080823 "Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Initiation factor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038315, HPA038316" Enhanced Supported Nucleoplasm,Cytosol Yes No 110000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 32: U-937 - Innate immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA038315: AB_10672588, HPA038316: AB_10673168" "unprognostic (8.15e-2)" "unprognostic (2.09e-2)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (4.53e-3)" "unprognostic (3.19e-1)" "unprognostic (1.47e-1)" "unprognostic (2.16e-1)" "unprognostic (1.84e-1)" "unprognostic (9.38e-2)" "unprognostic (3.84e-3)" "unprognostic (9.07e-2)" "unprognostic (5.48e-3)" "unprognostic (8.07e-2)" "unprognostic (1.20e-1)" "unprognostic (9.07e-2)" "unprognostic (1.89e-2)" 83.0 53.2 27.5 73.7 30.9 120.7 62.5 28.4 31.8 48.8 38.0 62.9 65.8 60.1 34.9 69.3 44.8 50.1 69.0 25.7 33.7 58.1 77.9 49.5 75.1 34.8 30.0 61.7 155.1 70.2 24.4 57.0 35.4 55.5 63.9 31.6 73.3 46.3 178.2 69.9 60.0 62.8 31.6 57.4 72.8 44.8 32.4 78.3 70.3 89.8 74.6 76.4 51.8 32.4 258.5 190.9 154.0 211.6 163.6 235.0 119.4 228.9 235.9 144.0 143.7 181.2 165.5 300.2 83.2 190.3 113.3 252.0 202.5 175.7 203.5 166.1 166.3 258.3 143.6 203.2 186.2 382.3 183.9 204.6 193.0 212.7 362.8 240.7 165.7 119.8 269.7 191.9 188.7 152.5 159.4 179.8 147.8 99.4 96.3 162.1 332.1 143.7 137.0 213.9 71.6 151.3 180.2 166.9 244.9 132.0 107.2 241.1 245.6 138.7 128.0 147.1 335.8 164.9 194.0 286.9 147.2 368.2 97.6 49.0 38.2 23.9 27.4 41.8 31.7 25.6 33.1 25.2 36.1 24.7 22.6 24.7 10.0 26.6 58.1 20.5 50.9 28.3 27.5 30.9 28.4 31.8 25.7 33.7 34.8 30.0 35.4 31.6 32.4 32.4 122.1 233.9 323.8 24.5 147.3 304.2 279.1 129.0 203.7 60.1 155.8 133.7 320.7 111.5 198.5 64.4 62.6 169.1 181.1 130.2 27.4 157.2 199.4 230.3 248.6 145.3 141.2 270.0 32.7 185.4 159.5 152.5 159.0 371.8 145.4 132.6 74.3 184.5 126.3 43.7 34.9 168.2 87.5 200.3 169.0 119.1 108.7 196.5 147.7 29.0 235.9 78.2 135.9 24.6 38.9 192.8 105.4 117.8 258.6 253.6 98.5 58.7 158.3 54.1 59.2 209.7 221.6 158.0 112.9 255.3 363.8 252.3 171.1 145.0 227.7 302.3 EIF3C "eIF3-p110, EIF3S8" ENSG00000184110 "Eukaryotic translation initiation factor 3 subunit C" Q99613 16 28688558-28735727 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 67.3;Alveolar cells type 2: 101.4;Cardiomyocytes: 157.0;Club cells: 91.1;Respiratory ciliated cells: 168.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB034045, HPA047097, HPA049495, HPA050112" Supported Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 49: Ciliated cells - Cilium organization" Cytosol "CAB034045: AB_1122487, HPA047097: AB_2679930, HPA049495: AB_2680793, HPA050112: AB_2681020" "unprognostic (2.42e-1)" "unprognostic (2.69e-2)" "unprognostic (2.07e-1)" "unprognostic (2.18e-1)" "unprognostic (5.84e-2)" "unprognostic (1.23e-1)" "unprognostic (1.85e-2)" "unprognostic (5.75e-2)" "unprognostic (7.23e-2)" "unprognostic (1.40e-1)" "unprognostic (3.90e-2)" "unprognostic (6.54e-3)" "unprognostic (3.53e-3)" "unprognostic (2.25e-1)" "unprognostic (1.48e-1)" "unprognostic (6.42e-2)" "unprognostic (1.10e-3)" 174.0 99.7 86.7 113.5 94.3 149.8 185.7 77.4 92.6 136.9 83.2 189.7 148.6 138.0 51.7 159.7 185.9 86.7 135.3 98.1 89.2 172.8 143.1 104.6 124.8 87.4 91.6 236.4 219.6 227.9 86.8 122.8 92.8 115.2 166.1 94.8 187.6 112.9 360.1 188.3 145.0 149.0 80.2 116.2 124.4 140.8 84.2 91.0 175.7 291.9 189.0 144.8 104.2 89.3 182.1 321.5 419.3 481.5 368.0 453.1 627.7 444.1 380.9 587.7 425.4 620.6 333.9 461.7 556.7 322.2 366.5 214.5 361.4 618.1 650.0 188.4 376.0 518.9 466.8 860.4 471.9 791.3 344.6 521.4 367.4 370.4 582.8 253.6 679.5 439.3 595.7 394.5 314.5 783.0 622.0 299.2 652.8 304.0 491.2 638.8 612.7 447.0 317.8 406.4 379.1 573.2 396.8 531.0 478.0 263.3 551.6 356.6 570.3 372.3 370.1 180.4 299.9 325.8 279.0 860.7 378.7 320.4 398.7 54.5 198.1 90.2 122.0 204.0 140.6 114.3 131.8 129.1 213.2 113.9 127.4 120.5 14.3 163.8 220.5 98.3 147.2 267.3 86.7 94.3 77.4 92.6 98.1 89.2 87.4 91.6 92.8 80.2 84.2 89.3 5.0 67.3 101.4 1.0 9.6 11.9 10.0 3.9 15.4 7.0 5.3 3.0 157.0 5.7 91.1 5.5 41.7 3.7 6.2 4.6 1.9 3.3 2.8 8.7 7.7 16.0 6.0 17.5 1.4 3.5 3.1 33.2 10.2 12.9 39.1 7.3 7.9 4.8 3.1 0.0 1.5 5.9 2.0 5.0 8.4 3.5 6.5 12.6 5.4 5.6 3.9 1.9 2.1 4.5 1.0 4.1 5.2 5.3 21.4 5.7 7.1 5.2 168.1 16.2 0.0 6.9 18.5 3.9 4.6 16.9 13.8 5.6 11.2 6.1 6.3 8.8 EIF4G1 "EIF4F, EIF4G, p220, PARK18" ENSG00000114867 "Eukaryotic translation initiation factor 4 gamma 1" Q04637 3 184314495-184335358 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis, Translation regulation" "Initiation factor, RNA-binding, Translational shunt" "Cancer-related genes, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 348.3" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB014774, HPA028487, HPA043866" Approved Enhanced Cytosol NA NA 330000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705" "unprognostic (4.14e-3)" "unprognostic (2.10e-2)" "unprognostic (6.01e-2)" "unprognostic (3.01e-2)" "unprognostic (2.25e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (7.99e-4)" "unprognostic (4.27e-3)" "unprognostic (2.35e-1)" "unprognostic (1.54e-1)" "unprognostic (1.55e-3)" "unprognostic (7.06e-3)" "unprognostic (2.42e-1)" "unprognostic (7.15e-2)" "unprognostic (2.45e-1)" "unprognostic (1.31e-1)" "unprognostic (2.33e-3)" 86.2 91.8 24.8 75.7 22.2 84.0 69.0 17.9 22.2 66.6 34.1 81.8 62.0 71.3 32.7 126.8 59.6 50.9 90.8 23.3 29.8 53.9 113.0 74.2 55.7 38.5 36.1 57.5 96.2 99.3 57.4 59.4 32.4 62.2 56.5 22.3 93.1 59.2 348.3 116.7 67.2 74.7 24.4 58.2 79.9 64.8 37.4 49.1 71.3 177.0 63.2 76.0 85.3 16.6 559.0 232.3 173.1 205.7 196.9 192.5 322.5 298.6 204.1 315.4 238.8 486.5 173.7 348.4 381.9 367.6 358.5 292.7 322.6 365.8 230.5 375.1 345.8 321.3 226.1 206.4 173.4 321.4 212.2 199.6 206.8 292.4 268.8 152.8 278.3 128.8 239.6 267.2 205.7 403.4 219.7 105.3 368.9 241.3 180.8 221.7 183.4 281.9 156.8 331.8 197.7 174.6 258.1 415.6 187.6 144.6 445.2 206.5 364.1 227.2 228.9 297.3 567.9 203.8 263.2 629.0 260.5 271.4 258.3 8.3 16.0 6.7 11.7 14.4 10.8 7.7 7.8 9.6 12.8 9.2 6.9 7.6 5.6 8.7 21.0 18.1 6.0 12.7 24.8 22.2 17.9 22.2 23.3 29.8 38.5 36.1 32.4 24.4 37.4 16.6 63.9 76.9 72.6 23.8 41.7 59.1 78.2 58.0 70.6 24.2 69.3 46.2 109.4 50.1 72.3 62.5 14.6 64.0 37.6 135.5 13.7 98.8 151.6 53.0 67.1 69.3 55.7 82.7 10.8 135.3 74.8 64.5 75.4 85.6 48.0 163.8 43.5 152.8 66.8 21.9 12.9 97.2 50.8 40.8 39.9 202.7 73.0 48.9 33.8 14.0 53.0 23.2 30.9 4.0 10.1 149.0 69.0 56.1 112.9 96.8 77.0 45.4 51.4 23.2 78.9 81.6 78.9 24.8 41.4 120.7 91.8 79.6 46.0 94.8 108.4 95.6 ELP2 "FLJ10879, STATIP1, StIP" ENSG00000134759 "Elongator acetyltransferase complex subunit 2" Q6IA86 18 36129444-36180557 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Transcription, Transcription regulation, tRNA processing" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002996, CAB020835" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 31: Spermatids - Spermatogenesis" Cytosol Nucleoplasm "CAB020835: , HPA002996: AB_1857552" "unprognostic (5.51e-2)" "unprognostic (1.29e-1)" "prognostic favorable (5.41e-4)" "unprognostic (6.66e-3)" "unprognostic (4.33e-2)" "unprognostic (4.54e-1)" "unprognostic (2.23e-1)" "unprognostic (5.89e-2)" "unprognostic (1.92e-1)" "unprognostic (6.74e-3)" "unprognostic (7.31e-3)" "unprognostic (7.07e-2)" "unprognostic (8.04e-2)" "unprognostic (1.91e-1)" "unprognostic (3.05e-2)" "unprognostic (1.14e-1)" "unprognostic (8.97e-2)" 17.7 20.7 12.1 12.3 13.2 13.2 35.3 12.4 11.9 23.5 12.3 19.1 15.2 27.3 31.0 15.9 28.8 20.3 23.6 11.4 14.2 18.9 46.2 16.6 19.9 12.1 12.1 48.6 24.4 24.8 20.7 20.8 12.6 29.4 16.2 21.2 19.1 26.3 32.4 21.5 14.0 22.5 12.2 16.7 16.5 22.2 13.4 23.6 21.8 32.3 23.3 22.5 16.9 16.0 23.7 16.7 30.8 27.8 42.7 63.9 33.9 47.9 69.3 39.6 52.5 17.6 21.5 49.6 32.6 40.4 26.5 32.9 39.7 35.8 55.8 22.6 21.1 19.2 27.4 31.0 46.6 63.0 19.6 52.3 40.2 39.4 63.6 59.5 45.0 33.8 32.9 25.4 42.4 28.4 30.6 27.0 36.7 18.2 12.6 48.7 37.0 34.9 35.7 54.4 24.2 46.3 45.1 17.6 73.0 44.0 22.5 31.2 26.8 35.6 20.5 13.2 24.8 30.4 25.6 46.2 30.0 33.2 31.3 22.0 12.1 10.0 12.6 17.6 17.9 20.0 17.0 15.0 17.6 16.3 21.5 18.9 2.2 22.2 24.8 17.5 18.4 14.0 12.1 13.2 12.4 11.9 11.4 14.2 12.1 12.1 12.6 12.2 13.4 16.0 25.0 48.1 28.8 34.3 46.3 32.9 49.4 33.8 39.9 50.1 42.1 28.6 48.5 22.8 29.2 35.0 43.8 39.5 45.9 10.9 29.4 26.4 55.0 29.9 33.1 29.4 24.7 21.7 61.7 22.2 42.3 39.2 17.3 29.5 36.7 39.9 24.7 75.3 22.8 33.7 60.7 20.3 20.3 28.0 24.8 90.4 43.5 20.8 23.2 34.7 39.1 26.9 41.2 52.3 77.4 18.7 12.1 36.5 34.2 60.9 24.3 19.0 36.5 45.4 6.6 40.8 30.6 40.0 33.2 25.0 36.7 39.8 39.7 28.0 26.9 50.7 ELP3 "FLJ10422, KAT9" ENSG00000134014 "Elongator acetyltransferase complex subunit 3" Q9H9T3 8 28089673-28191156 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation, tRNA processing" "Acyltransferase, RNA-binding, Transferase, tRNA-binding" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 74.3;Glandular and luminal cells: 125.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025297, HPA025812" Uncertain Enhanced Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 44: Endometrium - Transcription" Cytosol "HPA025297: , HPA025812: AB_10601369" "unprognostic (1.29e-2)" "unprognostic (1.26e-2)" "prognostic favorable (9.25e-4)" "unprognostic (3.49e-3)" "unprognostic (5.73e-2)" "unprognostic (1.10e-1)" "unprognostic (6.95e-2)" "unprognostic (2.07e-2)" "unprognostic (7.66e-2)" "unprognostic (1.22e-2)" "unprognostic (3.89e-1)" "unprognostic (3.46e-2)" "prognostic favorable (1.31e-5)" "unprognostic (2.29e-1)" "unprognostic (1.94e-1)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" 13.6 13.0 17.3 11.0 19.0 6.6 16.6 19.0 20.3 26.1 14.1 13.8 9.7 22.6 11.3 12.2 16.1 15.4 16.3 19.2 19.8 17.5 21.0 12.1 16.3 18.2 17.4 16.1 10.9 16.8 11.6 12.0 18.5 13.4 15.6 12.4 9.8 19.2 27.9 12.0 11.1 14.9 18.0 13.7 10.7 14.2 20.1 14.6 18.3 26.5 19.5 13.6 10.6 19.6 34.5 36.3 26.1 21.7 28.9 27.8 17.6 17.7 26.6 31.9 31.2 23.9 14.7 60.0 24.6 27.7 31.3 21.5 26.3 34.3 41.2 11.2 12.4 38.0 21.9 41.3 27.7 21.4 27.5 32.7 48.4 24.4 36.5 26.2 32.4 41.3 46.2 34.8 32.9 20.9 47.3 30.1 28.9 29.5 12.0 34.4 24.4 24.2 33.8 25.5 13.6 25.5 18.1 14.4 28.4 21.3 29.2 24.2 25.7 23.6 35.2 26.8 26.5 14.4 25.9 45.2 26.7 24.7 26.8 20.2 16.1 12.9 25.0 22.2 28.7 17.9 21.8 26.0 18.3 21.2 18.7 22.1 3.8 25.0 27.0 17.3 23.5 19.1 17.3 19.0 19.0 20.3 19.2 19.8 18.2 17.4 18.5 18.0 20.1 19.6 8.8 3.2 12.7 26.4 14.4 2.7 7.1 10.2 10.8 8.5 6.8 8.9 16.6 7.2 11.1 7.3 22.9 15.1 12.5 6.3 7.9 12.5 7.4 74.3 25.0 10.1 1.2 9.4 32.2 9.9 14.8 9.5 9.7 125.2 8.2 12.8 10.4 19.0 14.9 15.2 38.7 7.0 0.0 13.2 4.0 4.8 8.4 9.6 1.8 31.9 9.6 8.7 24.7 49.3 45.9 9.3 11.3 10.1 11.0 7.6 9.9 13.1 10.6 12.2 0.0 9.5 8.4 20.2 17.7 6.9 2.4 10.4 13.7 15.6 10.5 5.4 EMC1 KIAA0090 ENSG00000127463 "ER membrane protein complex subunit 1" Q8N766 1 19215660-19251527 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 63.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048904 Approved NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 46: Photoreceptor cells - Phototransduction" "HPA048904: AB_2680552" "unprognostic (9.46e-3)" "unprognostic (1.91e-3)" "unprognostic (1.75e-2)" "unprognostic (4.11e-3)" "unprognostic (2.05e-1)" "unprognostic (5.31e-3)" "prognostic unfavorable (8.56e-6)" "unprognostic (5.98e-2)" "unprognostic (1.69e-1)" "unprognostic (1.08e-1)" "unprognostic (4.96e-2)" "unprognostic (2.50e-1)" "unprognostic (3.02e-2)" "unprognostic (1.61e-1)" "unprognostic (1.54e-1)" "unprognostic (6.19e-2)" "prognostic unfavorable (1.43e-4)" 15.4 11.2 10.1 11.7 11.6 9.2 11.1 11.7 14.0 12.2 2.1 12.8 8.7 12.2 13.1 10.7 12.0 8.2 12.5 11.8 16.0 10.8 15.5 12.0 9.0 8.3 9.5 14.1 10.6 16.3 10.0 24.0 11.3 13.2 14.1 51.9 10.7 11.0 19.9 11.6 9.1 18.9 5.1 9.7 11.0 13.1 12.4 9.4 14.0 14.3 10.5 11.7 9.8 8.8 41.1 36.5 40.3 105.4 63.6 49.3 78.3 65.1 60.8 88.3 86.8 38.4 92.5 36.5 84.1 100.6 57.1 45.4 56.7 73.0 102.1 31.0 29.6 44.0 46.3 45.5 46.2 56.9 50.7 52.7 46.4 104.6 86.2 82.2 75.6 31.2 55.1 53.7 69.1 23.5 23.3 27.9 24.4 47.2 33.9 34.4 49.7 64.2 35.8 18.8 49.6 33.9 71.5 37.0 54.6 47.2 40.5 35.3 67.3 79.5 51.7 61.2 75.2 29.7 67.0 46.3 75.4 73.5 108.4 5.2 12.7 3.1 8.1 9.6 9.0 6.2 8.1 9.2 12.6 7.0 8.0 8.0 0.5 21.7 12.8 6.1 6.2 9.1 10.1 11.6 11.7 14.0 11.8 16.0 8.3 9.5 11.3 5.1 12.4 8.8 13.0 16.0 14.6 8.1 12.4 11.6 10.1 16.9 8.0 20.3 11.2 11.7 15.7 11.5 10.5 22.0 10.4 40.4 9.9 11.4 0.0 14.3 1.2 10.0 18.0 16.1 19.7 6.9 12.9 8.5 41.0 19.2 9.7 15.0 8.2 23.2 14.3 25.6 19.4 15.2 14.5 11.4 14.2 12.3 7.3 2.6 14.9 11.5 10.6 8.4 12.0 19.0 4.1 15.1 10.9 10.6 9.4 14.3 14.5 10.3 6.4 9.0 7.8 63.4 6.6 20.1 13.5 12.9 19.3 13.0 9.2 36.0 8.9 18.6 12.7 6.7 EML2 "ELP70, EMAP-2, EMAP2" ENSG00000125746 "EMAP like 2" O95834 19 45606994-45645602 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 153.1;Syncytiotrophoblasts: 101.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012757 Approved Approved Vesicles NA NA 180000 "Cluster 27: Non-specific - Gene expression" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 30: Epithelial cell lines - Translation" "Cluster 46: Photoreceptor cells - Phototransduction" Vesicles "HPA012757: AB_1848145" "unprognostic (1.10e-1)" "unprognostic (1.36e-1)" "unprognostic (1.61e-3)" "unprognostic (2.12e-1)" "unprognostic (1.81e-3)" "unprognostic (1.13e-1)" "unprognostic (1.69e-2)" "unprognostic (1.16e-1)" "unprognostic (1.85e-1)" "unprognostic (3.05e-3)" "unprognostic (3.72e-1)" "unprognostic (2.75e-3)" "unprognostic (1.77e-1)" "unprognostic (2.85e-2)" "unprognostic (9.44e-2)" "unprognostic (7.48e-2)" "unprognostic (7.03e-2)" 11.2 32.7 23.2 13.6 41.7 14.1 12.9 43.2 37.6 16.4 9.7 21.3 11.5 9.1 6.8 40.2 12.0 10.9 20.4 19.5 36.1 17.5 7.9 13.6 13.4 57.6 35.4 5.2 21.1 55.1 14.3 19.8 52.8 15.8 14.4 49.0 29.0 18.3 5.7 38.6 11.9 7.1 27.9 12.9 18.9 3.5 40.3 16.5 20.9 4.9 12.5 19.5 24.9 57.9 47.6 16.2 3.2 1.1 25.0 13.6 17.4 29.2 37.0 12.6 14.8 6.2 39.5 14.6 17.0 15.4 4.0 39.7 6.0 57.4 4.0 56.7 15.0 5.7 19.5 12.4 47.1 18.5 13.4 21.1 74.5 15.1 74.1 10.5 9.4 28.0 18.3 38.5 10.0 49.9 10.3 4.2 1.9 75.7 14.3 2.3 5.6 18.9 33.3 61.2 17.8 3.3 16.4 32.0 22.1 17.0 18.7 18.9 15.1 0.0 5.4 4.8 0.3 66.2 43.9 7.9 20.4 20.9 38.7 7.8 3.7 5.7 6.5 4.8 5.1 5.5 4.4 6.7 4.4 2.2 2.9 3.9 1.0 2.6 5.2 6.4 5.8 3.9 23.2 41.7 43.2 37.6 19.5 36.1 57.6 35.4 52.8 27.9 40.3 57.9 10.6 3.2 13.1 8.5 15.7 18.6 42.9 40.3 27.3 32.2 13.2 14.2 9.0 14.3 25.5 35.0 14.6 66.4 24.5 34.1 37.2 16.8 72.1 28.6 9.0 13.8 17.5 5.5 29.7 20.8 20.4 7.6 38.7 20.1 19.1 6.7 20.3 6.4 15.8 28.6 46.0 32.6 26.4 8.8 9.6 27.0 4.1 8.7 19.6 5.6 13.1 16.4 12.3 15.1 68.0 17.9 29.1 7.2 25.0 23.7 11.0 7.5 40.7 153.1 0.0 6.8 16.4 3.5 6.1 29.6 14.3 101.0 23.2 39.1 31.9 41.9 EPRS1 "EARS, EPRS, GLUPRORS, PARS, QARS, QPRS" ENSG00000136628 "Glutamyl-prolyl-tRNA synthetase 1" P07814 1 219968600-220046530 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding" "Disease variant, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 22.3;Cardiomyocytes: 84.7;Cytotrophoblasts: 40.8;Extravillous trophoblasts: 59.3;Hofbauer cells: 42.6;Syncytiotrophoblasts: 36.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026490, HPA030052" Enhanced Enhanced Cytosol NA NA 360000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA026490: AB_1855979, HPA030052: AB_10601466" "prognostic unfavorable (7.25e-4)" "unprognostic (1.19e-2)" "unprognostic (3.94e-2)" "unprognostic (2.60e-2)" "unprognostic (7.98e-3)" "unprognostic (1.12e-2)" "unprognostic (3.41e-3)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.30e-1)" "unprognostic (7.13e-2)" "unprognostic (5.12e-2)" "unprognostic (2.32e-2)" "unprognostic (2.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.62e-4)" 28.8 24.7 18.1 34.4 19.6 26.6 35.7 22.8 24.8 30.5 17.6 36.1 27.7 25.6 25.2 30.6 26.2 20.6 31.8 17.7 21.8 31.6 27.9 24.3 36.5 21.6 20.5 34.7 49.0 54.5 22.5 23.8 22.9 23.6 39.0 43.8 83.4 26.4 52.2 28.9 29.7 32.5 22.4 27.4 35.9 20.5 21.7 34.8 43.0 55.9 42.5 30.4 18.6 27.8 125.9 78.4 55.7 152.3 114.9 126.7 138.0 160.1 111.7 102.1 113.4 93.3 98.1 239.3 86.7 170.4 41.3 130.3 140.9 129.4 136.2 117.9 88.9 130.2 97.6 80.2 125.1 217.6 106.7 92.1 161.7 130.3 161.6 84.8 113.4 113.2 228.0 182.9 100.8 61.8 94.7 53.1 107.4 146.8 159.6 98.5 98.0 236.2 92.8 54.4 128.6 101.3 93.7 152.6 166.5 78.9 141.2 235.1 101.1 48.3 88.1 149.6 151.1 122.8 150.1 197.1 111.4 153.9 156.4 8.8 17.8 10.0 19.7 24.6 27.8 21.0 19.7 22.1 23.2 18.5 22.0 22.9 0.6 22.5 22.1 7.6 20.8 17.2 18.1 19.6 22.8 24.8 17.7 21.8 21.6 20.5 22.9 22.4 21.7 27.8 22.3 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 84.7 0.0 0.0 0.0 0.0 40.8 14.1 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 59.3 17.1 0.0 0.0 0.0 0.0 0.0 0.0 42.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 0.0 36.5 2.6 0.0 0.0 0.0 EPS15 "AF-1P, MLLT5" ENSG00000085832 "Epidermal growth factor receptor pathway substrate 15" P42566 1 51354263-51519266 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Host-virus interaction, Protein transport, Transport" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 314.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008451, CAB010164, HPA061431" Approved Enhanced Vesicles,Cytosol "Intracellular and membrane" NA NA 65000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Vesicles, Cytosol" "CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662" "unprognostic (1.45e-2)" "prognostic unfavorable (6.44e-4)" "unprognostic (1.05e-2)" "unprognostic (7.72e-3)" "unprognostic (3.99e-1)" "unprognostic (1.42e-1)" "unprognostic (4.96e-3)" "unprognostic (9.26e-2)" "unprognostic (4.13e-2)" "unprognostic (5.80e-2)" "unprognostic (1.17e-1)" "unprognostic (1.41e-1)" "unprognostic (5.36e-2)" "unprognostic (8.73e-3)" "unprognostic (2.13e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-1)" 31.9 35.1 40.3 25.5 48.2 20.7 25.6 38.8 55.7 23.9 25.7 19.1 15.8 22.8 17.6 21.0 18.3 26.1 26.5 43.9 39.1 24.5 26.4 26.9 46.0 38.6 44.1 28.8 14.7 29.0 15.5 31.5 40.7 26.7 20.5 23.4 16.7 20.9 47.6 24.2 17.7 24.3 40.1 34.1 21.3 46.9 45.0 27.6 25.3 40.5 45.6 22.8 20.9 57.2 35.4 10.4 22.0 20.8 49.6 49.2 54.5 24.2 37.9 19.4 28.4 14.4 19.2 71.8 24.3 38.1 39.5 32.7 28.7 23.1 29.1 81.8 18.0 64.1 16.9 17.1 46.7 36.9 56.4 40.3 21.0 34.0 45.7 33.5 36.5 25.2 40.4 31.7 29.8 17.5 29.9 19.8 30.2 24.6 16.7 24.1 33.3 15.9 25.5 43.2 15.0 20.9 28.8 50.4 42.1 60.2 20.5 25.7 51.1 18.0 19.1 36.3 20.5 37.6 41.0 47.6 26.6 41.0 16.1 18.8 10.4 12.1 9.4 10.7 14.2 15.6 11.2 14.9 10.8 9.0 6.6 9.6 7.8 10.8 13.0 7.1 19.0 8.7 40.3 48.2 38.8 55.7 43.9 39.1 38.6 44.1 40.7 40.1 45.0 57.2 51.5 35.3 41.0 142.4 78.3 43.0 32.1 16.4 30.1 18.1 28.2 15.6 59.8 24.3 22.7 44.1 31.3 22.8 65.0 28.5 19.6 15.2 27.0 22.1 50.1 43.3 28.8 81.0 77.1 19.0 18.9 52.5 41.3 35.6 24.6 36.0 61.4 37.7 83.4 28.6 60.6 30.7 12.2 80.9 61.9 61.7 65.9 67.0 103.2 110.5 57.6 38.4 27.8 29.7 314.1 23.3 19.8 48.2 78.4 62.1 20.7 28.1 31.9 26.6 39.5 45.1 38.0 74.4 44.5 33.8 51.0 28.5 74.3 28.5 21.4 50.8 ERCC2 "EM9, MAG, MGC102762, MGC126218, MGC126219, XPD" ENSG00000104884 "ERCC excision repair 2, TFIIH core complex helicase subunit" P18074 19 45349837-45370918 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 34.1;Spermatocytes: 30.5;Theca cells: 29.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005375, HPA038057, HPA069266" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" Nucleoplasm Cytosol "CAB005375: AB_2100152, HPA038057: AB_2675810, HPA069266: AB_2686104" "unprognostic (1.10e-1)" "unprognostic (5.48e-1)" "unprognostic (5.08e-2)" "unprognostic (9.92e-3)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.67e-3)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (1.06e-1)" "prognostic favorable (3.26e-4)" "unprognostic (3.36e-2)" "unprognostic (2.44e-3)" "unprognostic (1.94e-1)" "unprognostic (5.47e-1)" "unprognostic (8.99e-2)" "unprognostic (3.45e-2)" 6.8 13.0 10.5 6.9 10.3 4.8 6.5 8.4 11.7 7.5 8.4 7.5 4.9 9.7 3.2 6.3 8.0 4.1 7.0 10.8 9.3 7.6 9.0 5.8 5.8 10.6 9.9 7.8 7.7 7.7 9.7 4.5 9.6 6.7 4.0 3.1 7.3 6.7 11.7 7.2 6.6 6.9 8.1 8.1 7.5 13.9 10.1 5.3 8.4 6.3 5.2 7.5 5.9 8.9 28.0 13.3 27.1 38.4 16.3 19.4 15.2 38.8 27.4 50.2 40.2 32.6 18.6 10.0 21.6 39.9 19.1 14.0 19.1 32.9 18.5 24.4 31.8 16.9 26.8 35.4 33.3 27.1 28.4 22.4 5.6 55.8 31.9 28.2 29.1 28.8 41.8 10.9 34.8 14.7 16.1 17.9 12.7 27.2 24.6 30.3 19.4 8.3 14.0 24.9 15.8 17.1 34.2 23.9 13.6 20.6 22.8 35.4 37.9 46.4 25.3 19.9 88.0 24.9 15.8 14.2 13.8 16.4 21.2 0.0 17.2 6.5 9.1 18.0 11.9 9.1 8.9 8.9 21.8 6.5 8.2 8.7 0.5 15.6 14.9 10.4 9.8 12.1 10.5 10.3 8.4 11.7 10.8 9.3 10.6 9.9 9.6 8.1 10.1 8.9 4.2 6.4 3.4 6.2 5.8 6.2 5.5 8.6 4.6 0.0 6.1 4.3 6.7 8.6 8.7 5.5 0.0 10.5 4.1 5.9 13.7 10.7 4.7 3.3 4.5 5.5 7.2 5.5 2.9 8.2 12.1 6.8 6.1 3.8 0.0 34.1 7.9 12.3 11.5 0.0 3.1 8.5 4.1 8.2 4.2 2.8 6.5 6.3 3.6 1.0 4.2 0.0 5.2 5.0 1.4 8.1 3.1 7.9 7.5 4.2 4.1 13.0 7.5 0.0 0.0 3.5 9.9 30.5 13.1 5.1 5.7 4.8 4.7 29.1 8.8 3.2 ERCC5 "ERCM2, XPGC" ENSG00000134899 "ERCC excision repair 5, endonuclease" P28715 13 102845831-102875995 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "DNA-binding, Endonuclease, Hydrolase, Nuclease" "Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 60.7;Gastric mucus-secreting cells: 44.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045845, HPA050374" Supported Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 9: Intestine - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" Nucleoplasm "HPA045845: AB_2679471, HPA050374: AB_2681106" "unprognostic (1.28e-3)" "unprognostic (1.32e-3)" "unprognostic (1.86e-2)" "unprognostic (9.28e-3)" "unprognostic (6.19e-2)" "unprognostic (8.73e-2)" "unprognostic (1.23e-1)" "unprognostic (8.72e-2)" "unprognostic (2.52e-1)" "unprognostic (2.55e-1)" "unprognostic (7.77e-3)" "unprognostic (5.76e-3)" "prognostic unfavorable (2.96e-6)" "unprognostic (3.56e-2)" "unprognostic (1.56e-1)" "unprognostic (1.67e-1)" "prognostic favorable (6.82e-4)" 14.1 11.1 7.8 10.9 8.6 16.3 14.5 8.9 11.8 12.2 10.5 14.5 20.1 9.2 13.4 10.7 9.7 10.8 9.8 8.1 8.2 12.6 21.8 12.8 15.2 8.5 8.2 12.5 11.3 12.3 3.7 11.3 8.5 11.7 14.3 12.6 10.5 10.8 9.5 13.2 17.1 9.6 8.0 15.2 16.3 7.0 8.4 21.3 13.5 10.8 16.5 11.2 3.9 8.4 21.5 10.5 15.4 7.4 34.4 30.5 8.9 24.5 31.1 13.6 16.7 10.8 37.9 19.3 10.4 23.4 9.4 23.8 14.3 19.6 10.1 19.4 9.7 16.6 23.7 13.3 15.9 50.9 26.3 26.1 19.2 15.7 25.6 19.6 23.1 23.4 9.5 16.5 23.9 8.0 18.7 23.5 7.7 30.2 9.9 14.9 10.9 17.9 19.3 15.7 9.0 14.1 12.6 25.0 8.8 13.6 13.9 43.4 21.4 7.5 5.5 3.7 13.1 16.1 5.0 9.4 41.3 20.7 10.9 19.2 11.9 20.4 16.2 15.0 14.6 8.9 17.1 19.8 14.3 8.8 18.4 18.2 3.5 20.5 21.1 7.4 20.7 17.7 7.8 8.6 8.9 11.8 8.1 8.2 8.5 8.2 8.5 8.0 8.4 8.4 2.2 3.2 9.5 0.0 22.2 7.1 4.7 11.5 16.5 0.0 2.0 2.0 28.6 14.3 14.0 0.0 0.0 9.6 7.3 17.6 0.0 1.6 60.7 2.4 4.8 8.6 4.9 24.8 0.0 1.2 7.5 11.0 44.9 2.1 19.0 1.7 13.2 21.2 10.5 0.0 0.0 22.3 10.2 17.2 6.5 28.3 22.1 14.0 7.2 0.0 12.6 0.0 19.6 0.0 0.0 1.7 16.7 15.8 21.5 4.0 26.6 1.5 11.4 0.0 19.7 10.6 6.7 11.6 6.3 19.1 7.0 5.7 31.3 1.7 18.2 5.0 ESF1 "bA526K24.1, C20orf6" ENSG00000089048 "ESF1 nucleolar pre-rRNA processing protein homolog" Q9H501 20 13714322-13784919 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047083, HPA050396" Supported Approved Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 78: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli" "HPA047083: AB_2679924, HPA050396: AB_2681111" "unprognostic (2.81e-1)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (1.31e-2)" "unprognostic (4.83e-3)" "unprognostic (1.01e-2)" "prognostic unfavorable (7.81e-9)" "unprognostic (2.52e-2)" "unprognostic (3.17e-2)" "unprognostic (1.78e-1)" "unprognostic (4.17e-3)" "unprognostic (3.91e-2)" "unprognostic (7.34e-2)" "unprognostic (2.16e-2)" "unprognostic (2.02e-1)" "unprognostic (1.60e-2)" "unprognostic (1.57e-1)" 12.0 9.6 11.2 9.6 12.4 7.9 10.8 11.5 13.3 8.6 8.7 8.3 7.5 10.2 10.3 9.1 6.9 8.5 9.5 9.8 12.4 9.7 13.9 6.6 10.8 12.8 12.3 12.5 6.5 10.0 5.3 11.3 14.2 9.5 9.8 9.0 6.2 7.3 12.6 10.8 6.8 8.8 12.8 9.9 7.8 14.1 12.6 9.7 10.5 12.2 9.7 12.3 7.1 13.4 30.4 24.3 24.1 13.0 18.8 23.3 14.9 28.9 18.5 21.5 19.4 26.0 29.2 38.4 15.1 14.5 40.2 45.9 36.0 30.3 41.4 11.1 18.1 49.5 10.2 64.2 25.4 59.4 13.2 18.7 23.0 33.1 28.2 16.0 17.0 18.7 70.9 17.9 27.1 22.6 46.7 39.8 25.9 27.0 17.1 30.6 61.1 30.4 16.7 22.3 25.9 16.2 23.8 41.8 42.4 22.1 20.5 27.3 23.2 36.2 24.2 25.7 59.1 17.9 43.4 45.7 14.7 27.2 33.2 2.7 8.7 2.7 10.5 11.1 12.3 18.2 12.2 11.6 8.9 17.4 14.9 13.8 0.5 15.1 14.0 19.3 10.0 4.6 11.2 12.4 11.5 13.3 9.8 12.4 12.8 12.3 14.2 12.8 12.6 13.4 71.5 22.4 45.0 36.6 60.4 61.8 63.8 50.5 44.3 92.8 31.4 53.2 61.7 50.1 47.6 33.1 45.9 47.8 55.3 53.8 33.2 55.0 80.5 35.3 61.4 50.8 48.5 34.5 56.2 42.1 39.2 48.5 32.6 34.0 26.0 55.4 45.0 51.5 45.1 95.9 59.7 49.7 28.5 35.3 22.4 30.2 65.3 35.3 26.6 34.7 57.6 58.0 33.0 53.8 63.6 56.0 48.8 73.7 26.8 62.8 47.6 38.4 34.6 81.9 32.9 117.0 78.0 210.4 175.5 31.5 53.6 41.5 40.8 71.9 61.5 42.2 ETAA1 ETAA16 ENSG00000143971 "ETAA1 activator of ATR kinase" Q9NY74 2 67397322-67412089 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035048, HPA035049" Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "HPA035048: AB_10670300, HPA035049: AB_2674430" "unprognostic (1.23e-1)" "unprognostic (2.56e-1)" "unprognostic (5.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (3.39e-2)" "unprognostic (6.47e-2)" "unprognostic (5.53e-2)" "unprognostic (1.12e-2)" "unprognostic (8.33e-2)" "unprognostic (9.89e-2)" "unprognostic (1.87e-1)" "unprognostic (8.52e-3)" "unprognostic (9.85e-2)" "unprognostic (7.88e-2)" "unprognostic (5.01e-2)" "unprognostic (1.14e-2)" 4.7 11.1 2.7 4.3 3.1 3.9 7.1 4.0 3.3 6.7 3.9 5.0 3.6 6.9 6.2 5.9 6.6 4.3 3.9 2.4 2.7 6.1 5.3 5.4 6.5 2.9 2.8 7.3 8.2 6.1 3.3 4.2 2.9 5.0 4.4 5.7 6.2 3.9 3.5 6.2 5.5 5.1 2.7 5.5 5.2 4.6 2.8 6.3 6.3 3.1 5.0 5.1 6.6 3.5 7.9 5.9 10.2 9.0 7.6 10.4 8.0 8.2 10.8 8.7 8.3 4.8 9.3 14.8 4.4 6.8 12.1 9.5 8.9 10.0 12.3 8.6 6.8 8.1 14.7 7.1 7.2 8.3 7.4 8.3 13.8 6.4 9.7 13.7 13.8 11.8 6.8 6.1 12.0 3.5 12.3 9.0 10.3 12.7 6.3 8.6 16.0 6.8 10.5 5.1 8.5 16.7 8.4 7.6 8.0 9.9 6.6 4.0 9.6 11.6 8.9 5.6 9.8 6.8 6.5 11.6 10.9 8.6 9.0 1.3 1.1 0.9 2.2 1.8 2.4 3.5 2.0 1.3 1.4 3.6 2.7 2.4 0.1 2.0 2.6 2.0 3.2 1.3 2.7 3.1 4.0 3.3 2.4 2.7 2.9 2.8 2.9 2.7 2.8 3.5 7.7 22.4 21.0 10.4 7.6 2.4 7.9 8.3 6.8 5.1 8.8 8.4 10.1 15.7 9.1 12.9 0.0 6.6 9.1 3.5 11.7 17.8 0.6 15.0 15.0 7.8 10.7 13.7 6.3 18.4 6.3 10.9 6.6 11.1 6.3 15.4 10.4 8.9 4.8 5.0 6.6 7.1 2.0 5.1 1.5 1.9 12.2 4.8 1.8 2.8 9.4 6.5 15.5 15.1 13.6 20.4 4.7 13.2 7.0 8.0 5.9 15.0 16.6 4.6 0.0 8.9 7.3 12.7 8.2 7.9 2.6 2.1 7.2 14.1 7.0 6.1 ETF1 "ERF, ERF1, RF1, SUP45L1, TB3-1" ENSG00000120705 "Eukaryotic translation termination factor 1" P62495 5 138506095-138543236 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 456.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011686, HPA037511" Approved NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 34: Spermatids - Unknown function" "CAB011686: AB_732263, HPA037511: AB_2675516" "unprognostic (2.56e-2)" "unprognostic (9.99e-2)" "prognostic favorable (9.33e-5)" "unprognostic (1.63e-1)" "unprognostic (3.45e-1)" "unprognostic (1.40e-2)" "prognostic unfavorable (6.35e-4)" "unprognostic (1.65e-2)" "unprognostic (2.33e-1)" "unprognostic (2.44e-1)" "unprognostic (9.19e-2)" "unprognostic (1.23e-1)" "unprognostic (3.58e-1)" "unprognostic (2.10e-1)" "unprognostic (1.11e-1)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.63e-2)" 68.3 46.5 26.9 47.1 27.3 169.5 51.9 26.7 31.3 37.4 34.0 46.2 33.7 41.7 36.7 88.2 33.9 49.1 48.3 29.4 30.0 46.2 58.9 56.8 40.3 28.6 29.2 29.4 48.4 54.6 33.0 59.8 28.4 39.1 45.6 27.3 37.7 46.3 98.1 61.1 33.6 51.6 28.8 31.1 41.6 59.1 29.7 35.5 49.1 74.2 57.8 70.1 39.5 29.3 137.9 132.2 92.0 151.4 120.5 112.5 161.4 148.1 152.2 172.4 199.7 321.5 123.3 171.6 125.1 151.2 243.6 112.4 218.0 277.2 258.0 96.7 117.2 137.2 142.9 128.8 162.0 117.3 110.5 117.8 158.5 176.4 231.2 90.4 141.4 110.4 180.1 101.9 179.0 102.9 146.3 104.4 113.5 104.8 75.8 123.5 152.2 139.7 119.0 191.7 119.6 120.6 164.8 110.8 264.0 238.4 129.6 138.3 117.4 136.1 78.2 108.9 218.4 211.9 215.0 249.2 122.2 173.4 131.1 17.7 22.9 14.4 17.0 27.1 19.7 17.2 17.5 19.7 23.8 10.8 12.3 16.3 15.1 16.7 25.6 16.9 19.9 17.1 26.9 27.3 26.7 31.3 29.4 30.0 28.6 29.2 28.4 28.8 29.7 29.3 54.8 160.3 62.4 14.4 57.2 209.3 179.0 70.4 85.4 16.1 78.9 63.6 63.3 41.5 77.9 57.0 14.6 118.0 80.0 51.0 62.6 77.9 456.1 110.3 74.9 54.1 39.9 63.7 18.6 75.0 90.1 68.5 44.4 128.4 54.5 32.1 26.0 50.8 76.5 25.2 18.1 47.4 26.4 62.5 146.6 178.4 23.3 116.1 72.9 13.1 71.4 25.6 34.0 10.1 17.8 91.3 39.6 27.1 64.2 109.2 36.9 54.5 72.1 19.9 59.2 118.4 79.8 46.3 52.7 98.1 202.0 285.5 67.6 40.5 58.9 181.5 EXOC2 "FLJ11026, SEC5L1, Sec5p" ENSG00000112685 "Exocyst complex component 2" Q96KP1 6 485154-693139 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 75.8;Inhibitory neurons: 80.1;Microglial cells: 68.4;Oligodendrocytes: 73.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032093 Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Vesicles "HPA032093: AB_10611964" "unprognostic (1.61e-1)" "unprognostic (4.69e-1)" "unprognostic (1.52e-1)" "unprognostic (9.32e-2)" "unprognostic (1.91e-2)" "unprognostic (2.48e-1)" "unprognostic (1.82e-3)" "unprognostic (1.34e-1)" "unprognostic (1.29e-1)" "unprognostic (1.30e-1)" "unprognostic (5.32e-2)" "unprognostic (2.02e-1)" "unprognostic (8.79e-2)" "unprognostic (1.39e-1)" "unprognostic (1.43e-1)" "unprognostic (1.38e-2)" "unprognostic (2.20e-1)" 10.2 8.3 11.0 11.5 11.7 6.6 10.9 11.4 11.2 10.1 11.6 9.1 8.6 8.7 5.2 12.2 6.5 8.9 11.6 11.2 11.5 9.3 10.3 11.3 13.4 11.6 11.6 7.8 6.6 11.6 8.2 18.0 12.5 7.9 10.0 13.4 8.0 7.9 10.1 11.8 9.3 9.2 11.0 13.1 8.9 16.1 11.3 18.6 14.2 10.4 14.1 10.8 9.1 14.4 21.0 15.2 26.0 28.5 23.2 20.8 15.7 18.5 21.5 21.7 25.8 20.4 11.0 15.5 44.0 22.3 32.7 17.7 29.2 32.2 25.7 48.4 30.9 19.8 18.5 20.4 29.1 21.2 18.8 18.1 25.9 15.5 18.0 21.4 36.9 30.0 39.4 11.1 27.3 18.1 28.6 20.6 26.4 18.6 15.1 26.6 22.5 31.3 19.5 22.4 25.4 14.9 14.8 9.0 29.1 48.4 23.2 12.9 54.1 19.6 14.1 24.6 17.4 27.2 56.8 16.4 19.8 17.4 61.0 11.6 9.0 10.2 17.1 11.0 20.9 13.5 17.2 18.3 14.1 14.5 16.2 15.7 2.8 14.8 17.7 11.1 21.1 14.4 11.0 11.7 11.4 11.2 11.2 11.5 11.6 11.6 12.5 11.0 11.3 14.4 12.6 3.2 14.5 35.6 15.9 4.8 3.8 6.2 6.2 9.0 10.1 9.3 8.6 2.8 6.5 5.5 8.4 16.0 18.5 6.1 7.9 6.2 11.0 7.3 7.0 11.1 2.4 8.2 75.8 5.1 7.1 7.6 6.1 8.2 5.1 11.8 8.6 8.2 10.0 8.4 80.1 6.8 12.2 9.0 5.8 3.8 6.8 8.7 5.4 68.4 10.8 4.6 13.4 49.3 73.4 6.9 5.1 9.1 11.3 6.4 4.1 8.2 9.0 9.3 0.0 7.3 8.9 21.8 17.5 9.9 7.7 12.9 18.3 7.4 5.9 6.0 EXOC4 "KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p" ENSG00000131558 "Exocyst complex component 4" Q96A65 7 133253073-134066589 "Plasma proteins, Predicted intracellular proteins, Transporters" "Exocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031443, HPA031444" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" NA NA 10000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 46: Photoreceptor cells - Phototransduction" "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "HPA031443: AB_10602496, HPA031444: AB_2673886" "unprognostic (1.70e-1)" "unprognostic (1.62e-2)" "unprognostic (2.05e-1)" "unprognostic (5.09e-2)" "unprognostic (1.03e-1)" "unprognostic (4.06e-3)" "unprognostic (8.63e-2)" "unprognostic (2.33e-1)" "unprognostic (4.40e-1)" "unprognostic (2.04e-1)" "prognostic unfavorable (6.19e-4)" "unprognostic (9.78e-3)" "prognostic favorable (6.85e-5)" "unprognostic (5.91e-2)" "unprognostic (2.18e-1)" "unprognostic (3.37e-1)" "unprognostic (3.35e-2)" 20.7 21.1 18.7 13.8 20.2 13.8 21.4 19.3 20.3 22.6 24.3 19.7 13.1 21.5 13.6 24.4 27.3 17.8 15.3 20.9 19.4 17.7 17.8 17.7 16.4 18.4 20.3 30.6 27.3 27.3 16.9 19.6 19.9 18.3 21.5 53.1 16.3 20.5 68.4 25.4 13.5 23.9 18.8 21.0 17.3 18.7 19.1 28.1 26.4 38.5 20.3 21.1 18.6 20.8 40.1 32.2 43.3 43.3 49.7 51.6 15.0 28.6 47.2 25.4 33.2 18.8 54.7 29.8 20.1 54.1 36.9 24.7 23.7 38.8 41.8 45.6 28.2 24.0 31.5 19.9 54.7 32.0 25.1 50.4 47.6 36.3 66.5 55.7 43.5 38.6 35.1 28.8 47.7 26.1 58.5 35.2 32.8 47.5 29.8 25.7 38.7 54.2 40.7 35.2 33.9 53.2 43.0 39.1 46.3 48.9 25.8 29.3 47.9 28.1 14.6 30.0 31.5 45.0 29.4 28.1 82.9 36.4 43.8 10.3 12.0 7.2 11.2 12.9 10.0 8.3 11.6 11.9 16.3 8.1 9.4 9.6 4.0 19.6 11.4 7.2 12.9 11.2 18.7 20.2 19.3 20.3 20.9 19.4 18.4 20.3 19.9 18.8 19.1 20.8 22.9 22.4 22.3 238.6 27.3 18.9 16.3 16.6 25.6 39.9 16.8 15.4 30.9 11.5 18.0 14.7 93.8 17.5 26.7 21.5 3.9 15.0 29.6 27.0 21.2 23.0 17.4 18.7 334.2 18.2 16.6 21.2 34.1 21.0 8.2 32.4 23.2 15.9 18.1 50.5 306.8 21.0 26.4 27.3 14.5 27.6 17.4 20.4 14.2 341.0 23.9 20.4 23.7 395.6 345.9 15.4 17.4 18.8 27.7 13.2 16.3 16.9 29.8 231.5 13.1 26.0 15.3 20.5 13.1 28.2 17.0 11.2 26.2 26.4 21.9 20.1 EXOSC10 "p2, p3, p4, PM-Scl, PM/Scl-100, PMSCL2, RRP6, Rrp6p" ENSG00000171824 "Exosome component 10" Q01780 1 11066618-11099869 "Predicted intracellular proteins" "Nonsense-mediated mRNA decay, rRNA processing" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028470, HPA028484, CAB037141" Supported Supported "Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoli, Nucleoli rim" "Nucleoplasm, Cytosol" "CAB037141: AB_532315, HPA028470: AB_10599180, HPA028484: AB_10611250" "unprognostic (1.23e-2)" "unprognostic (3.46e-2)" "unprognostic (1.85e-2)" "unprognostic (1.62e-1)" "unprognostic (6.88e-2)" "unprognostic (6.37e-2)" "prognostic unfavorable (2.49e-6)" "unprognostic (3.36e-1)" "unprognostic (4.66e-2)" "unprognostic (2.52e-1)" "unprognostic (5.49e-2)" "unprognostic (2.52e-2)" "unprognostic (7.68e-3)" "unprognostic (3.43e-1)" "unprognostic (9.03e-2)" "prognostic favorable (5.27e-4)" "unprognostic (1.33e-1)" 31.8 21.4 18.3 25.9 18.4 39.4 30.8 23.1 22.2 32.5 14.7 27.6 20.7 28.7 23.9 27.3 26.4 19.2 20.3 17.7 15.9 21.8 20.0 24.3 31.1 17.2 15.2 35.8 24.0 25.2 26.1 26.1 16.6 25.3 27.6 35.4 25.4 21.0 33.3 37.0 26.1 27.5 13.7 27.4 26.1 23.4 17.9 32.7 23.3 22.6 34.2 24.6 28.4 19.1 66.4 41.5 84.9 33.0 44.3 48.7 48.5 63.8 46.8 109.8 99.1 61.6 94.1 66.3 40.3 61.0 48.8 64.2 95.0 71.2 100.1 74.9 95.0 96.5 80.5 63.2 43.4 79.5 73.7 38.4 60.2 108.1 63.1 40.9 69.4 58.0 103.2 59.3 61.4 37.4 78.5 73.1 56.5 50.3 49.1 79.8 72.2 58.1 64.8 33.3 54.5 53.3 68.8 58.9 77.0 59.4 51.5 72.1 63.6 58.2 60.4 53.0 76.2 35.7 60.0 130.0 59.4 116.2 71.5 57.7 32.0 26.6 36.2 41.5 43.0 36.4 37.7 36.7 37.9 36.5 31.9 35.4 6.2 49.3 51.2 19.3 39.4 43.3 18.3 18.4 23.1 22.2 17.7 15.9 17.2 15.2 16.6 13.7 17.9 19.1 18.4 28.9 18.3 17.0 26.1 13.3 14.3 19.8 26.2 14.9 11.0 23.6 6.4 12.8 29.2 5.5 47.9 26.5 18.8 16.4 9.8 25.0 16.4 14.3 21.0 20.1 9.0 28.0 20.3 31.9 34.3 17.2 31.1 19.2 20.2 26.2 13.9 11.1 24.7 21.9 24.3 16.5 22.4 15.1 14.1 7.1 29.5 18.7 12.4 9.4 24.0 6.1 28.8 30.2 15.2 30.2 9.4 23.0 26.8 8.5 12.7 8.8 27.3 34.8 13.1 18.4 17.6 21.9 20.8 28.7 13.4 22.7 21.2 19.7 20.1 10.0 EXT2 SOTV ENSG00000151348 "Exostosin glycosyltransferase 2" Q93063 11 44095673-44251962 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease variant, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078409 Supported "Golgi apparatus" NA NA 39000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 33: Fibroblasts - ECM organization" "Golgi apparatus" "HPA078409: AB_2686884" "unprognostic (5.87e-2)" "unprognostic (3.05e-3)" "unprognostic (3.48e-2)" "unprognostic (3.94e-1)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.50e-4)" "unprognostic (1.77e-3)" "unprognostic (2.22e-2)" "unprognostic (1.97e-1)" "unprognostic (2.05e-1)" "unprognostic (1.74e-3)" "unprognostic (3.70e-2)" "prognostic unfavorable (5.36e-6)" "unprognostic (7.07e-3)" "unprognostic (2.97e-1)" "unprognostic (3.85e-1)" "unprognostic (1.36e-2)" 33.5 22.8 14.4 22.1 15.4 11.2 29.3 15.4 16.3 36.1 17.5 29.1 26.5 43.1 33.3 20.1 33.7 28.1 27.3 15.6 18.1 26.5 26.9 27.9 16.0 15.5 16.0 33.5 26.5 28.9 20.1 61.9 15.5 29.8 28.7 20.9 26.7 30.2 16.2 25.8 31.0 49.3 14.7 21.6 23.8 21.6 19.4 15.2 27.6 18.4 17.3 29.7 28.5 16.1 57.9 71.6 38.3 121.5 170.4 124.2 60.8 181.1 198.0 93.1 125.1 51.2 36.5 40.4 82.1 188.8 98.5 90.0 41.0 114.0 110.0 83.2 71.5 38.4 33.7 39.7 67.5 37.5 76.6 97.7 73.4 56.3 86.6 108.8 132.7 34.8 50.0 63.9 68.4 40.3 25.9 22.3 43.8 67.1 70.9 32.3 116.1 21.1 53.9 49.1 30.9 35.5 118.1 41.4 28.1 67.0 69.8 37.2 137.8 127.4 90.6 133.1 111.4 33.4 46.0 30.4 84.7 27.9 140.0 15.2 17.5 19.4 20.9 17.7 23.5 9.0 16.5 19.3 21.3 8.8 15.4 15.2 3.4 26.3 12.8 7.4 14.2 15.5 14.4 15.4 15.4 16.3 15.6 18.1 15.5 16.0 15.5 14.7 19.4 16.1 24.5 16.0 10.6 41.4 8.7 15.2 17.3 22.0 10.8 11.5 11.0 11.4 10.2 8.6 13.5 12.9 14.6 34.3 10.6 21.1 5.9 33.5 43.2 7.9 17.1 19.2 1.8 6.7 64.3 23.7 37.0 32.3 7.7 11.5 6.3 22.7 22.9 18.3 18.3 13.5 63.3 12.9 12.2 10.8 7.2 23.0 27.4 10.4 5.4 28.1 10.2 17.4 7.2 50.3 51.8 24.0 14.9 28.6 7.0 23.6 31.6 8.2 8.1 15.0 19.7 15.8 20.7 51.2 24.4 10.2 12.6 35.3 9.2 12.2 15.0 15.3 EZH2 "ENX-1, EZH1, KMT6, KMT6A" ENSG00000106462 "Enhancer of zeste 2 polycomb repressive complex 2 subunit" Q15910 7 148807383-148884321 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 47.9;lymphoid tissue: 43.0;testis: 27.8" "Cell type enhanced" "Detected in many" "Early spermatids: 109.3;Spermatocytes: 142.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009589, HPA029131" Enhanced Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB009589: , HPA029131: AB_2672920" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.57e-1)" "unprognostic (3.30e-3)" "unprognostic (1.33e-1)" "unprognostic (3.85e-3)" "prognostic unfavorable (2.11e-6)" "unprognostic (2.21e-2)" "prognostic unfavorable (1.96e-4)" "unprognostic (2.32e-3)" "unprognostic (1.58e-3)" "unprognostic (1.69e-3)" "prognostic unfavorable (8.18e-12)" "prognostic favorable (6.97e-4)" "unprognostic (1.83e-1)" "unprognostic (2.12e-1)" "unprognostic (6.67e-2)" 1.5 1.5 1.1 10.1 1.1 47.9 2.7 2.0 1.3 2.7 1.5 7.0 6.4 2.0 1.2 10.8 1.1 1.9 1.2 1.1 1.1 2.1 3.3 2.3 22.1 1.2 1.2 1.6 3.7 1.3 0.5 4.8 1.2 1.3 8.2 3.3 2.8 0.2 2.9 10.7 6.9 2.8 1.0 5.6 4.0 27.8 1.5 43.0 1.3 1.9 21.1 3.5 3.8 1.2 65.6 30.1 99.7 66.9 3.1 5.1 54.6 49.7 19.9 39.9 40.2 45.6 73.2 114.3 23.5 18.7 36.3 39.0 52.1 17.1 50.6 164.9 51.8 48.9 38.4 35.5 8.0 110.1 38.5 4.3 9.6 29.9 15.9 12.1 24.0 108.9 105.9 73.6 36.2 74.0 215.7 91.7 79.6 57.0 39.9 131.3 56.0 70.9 18.6 31.0 95.1 60.3 62.3 46.8 16.5 25.3 34.3 46.7 14.8 42.4 19.8 85.2 90.4 65.7 76.6 115.3 38.6 74.2 84.9 0.4 1.7 1.1 1.2 1.2 0.9 1.1 2.6 2.2 3.8 0.6 1.4 0.9 0.1 7.2 3.6 0.8 8.3 1.2 1.1 1.1 2.0 1.3 1.1 1.1 1.2 1.2 1.2 1.0 1.5 1.2 14.4 0.0 6.7 1.3 14.5 26.5 6.7 6.3 10.2 6.0 15.1 12.2 6.1 2.8 7.1 7.3 35.5 28.8 35.9 14.7 3.9 9.5 109.3 16.3 17.0 9.4 9.0 57.0 6.2 8.5 32.2 9.9 15.8 24.2 21.6 45.9 3.3 2.2 11.9 15.2 9.2 20.5 6.1 9.0 33.6 27.7 3.1 19.1 14.2 14.0 14.9 2.6 12.3 16.6 7.0 12.4 10.5 0.7 37.4 4.8 6.8 1.2 9.7 21.3 6.6 13.8 24.1 142.2 58.2 35.8 29.0 30.5 25.7 4.7 22.1 5.9 FAF2 "ETEA, KIAA0887, UBXD8, UBXN3B" ENSG00000113194 "Fas associated factor family member 2" Q96CS3 5 176447628-176510074 "Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065968, HPA071246, HPA073828" Approved Enhanced "Endoplasmic reticulum,Lipid droplets" NA NA 12000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 44: HDLM-2 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "Lipid droplets" "Endoplasmic reticulum" "HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636" "unprognostic (6.25e-3)" "unprognostic (9.61e-2)" "unprognostic (3.52e-3)" "unprognostic (1.02e-3)" "unprognostic (4.74e-2)" "unprognostic (4.47e-2)" "prognostic unfavorable (1.79e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (6.02e-2)" "unprognostic (2.68e-1)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (2.74e-3)" "unprognostic (9.03e-2)" "unprognostic (1.19e-1)" "unprognostic (1.56e-3)" "unprognostic (1.48e-1)" 15.5 19.7 13.5 15.0 14.1 21.7 17.5 15.0 17.0 16.9 18.1 16.8 15.0 18.6 17.5 16.7 17.3 14.6 11.4 14.0 14.9 14.7 21.0 15.4 16.3 13.5 14.4 20.0 16.2 24.9 14.7 16.7 14.6 18.2 19.2 22.6 16.4 14.7 11.6 19.4 14.7 18.8 13.3 14.9 14.5 21.0 14.7 23.1 19.5 12.8 18.7 18.0 13.1 13.5 36.9 41.1 39.9 44.4 55.4 43.9 54.6 47.2 53.8 52.7 56.6 53.9 64.9 32.1 52.0 50.2 95.6 55.5 57.8 119.6 72.3 128.7 31.8 21.1 40.7 26.4 56.3 46.2 26.4 58.1 51.6 64.5 53.2 34.0 44.3 35.8 30.7 42.6 50.8 61.2 40.6 24.2 32.4 39.8 34.4 39.5 34.7 35.9 44.7 48.0 35.3 37.7 57.5 49.4 52.9 34.1 58.1 36.2 49.9 71.9 38.8 40.1 63.8 36.2 41.6 41.2 45.4 32.5 64.2 9.0 6.8 4.7 6.8 5.6 8.3 4.9 5.6 7.3 8.0 4.8 7.1 6.4 5.6 9.2 12.1 5.3 9.8 5.7 13.5 14.1 15.0 17.0 14.0 14.9 13.5 14.4 14.6 13.3 14.7 13.5 26.4 28.9 54.5 26.8 19.6 5.4 34.4 49.7 16.5 46.3 18.6 18.7 13.4 15.7 44.9 18.4 45.9 34.8 19.2 17.6 11.7 34.0 12.1 24.6 41.0 29.0 19.9 17.5 29.0 37.2 40.8 32.6 23.4 27.6 32.2 32.6 28.2 24.3 22.5 15.2 34.2 15.1 34.6 16.1 8.0 5.6 30.4 17.9 12.4 14.0 23.3 39.6 26.8 31.7 36.1 59.1 12.0 31.2 22.0 32.3 17.3 9.3 41.3 29.9 26.3 36.3 36.6 59.8 51.3 16.6 8.5 57.9 18.4 43.2 17.1 29.0 FAM117B "ALS2CR13, FLJ38771" ENSG00000138439 "Family with sequence similarity 117 member B" Q6P1L5 2 202634969-202769757 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 45.8;Inhibitory neurons: 49.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003229, HPA028746" Uncertain Approved Nucleoplasm,Centrosome Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 41: Macrophages - Immune response" Nucleoplasm Centrosome "HPA003229: AB_2246696, HPA028746: AB_2672760" "unprognostic (1.39e-2)" "unprognostic (1.47e-1)" "unprognostic (1.53e-2)" "unprognostic (4.59e-2)" "unprognostic (1.07e-2)" "unprognostic (4.07e-3)" "unprognostic (1.55e-2)" "unprognostic (4.84e-2)" "unprognostic (6.21e-2)" "unprognostic (2.55e-2)" "unprognostic (8.40e-3)" "unprognostic (5.75e-1)" "unprognostic (6.01e-2)" "unprognostic (8.93e-2)" "unprognostic (3.18e-1)" "unprognostic (8.59e-2)" "unprognostic (1.37e-3)" 3.1 7.5 5.1 4.5 5.4 2.9 3.3 7.0 7.1 2.7 0.7 4.9 4.3 2.9 2.9 5.4 3.8 3.0 1.8 5.0 6.3 4.9 1.9 2.9 7.2 3.1 3.8 5.1 4.6 7.3 3.5 6.9 3.6 5.1 4.7 2.6 3.3 3.0 1.5 5.0 3.7 2.0 3.3 5.4 4.1 5.8 6.4 9.6 2.8 1.8 7.4 3.8 3.2 4.1 2.0 2.4 10.5 7.2 3.5 1.9 10.2 0.6 0.9 0.6 1.1 3.1 4.2 8.2 6.5 1.2 1.6 1.9 9.0 4.6 1.7 0.2 7.2 6.9 4.3 11.6 2.8 5.9 3.0 2.6 6.3 1.3 1.9 4.7 2.8 10.8 10.1 1.6 0.6 3.9 16.1 12.1 10.7 5.8 4.5 12.5 2.1 9.8 5.5 5.2 17.7 15.4 8.0 5.3 3.9 8.7 2.2 8.1 1.7 1.2 2.4 1.9 1.1 5.9 3.6 10.8 2.4 4.5 1.3 0.4 3.9 1.5 1.3 8.2 3.4 8.1 3.0 2.7 4.5 7.7 8.2 5.7 2.2 4.4 9.1 1.5 1.2 3.1 5.1 5.4 7.0 7.1 5.0 6.3 3.1 3.8 3.6 3.3 6.4 4.1 9.7 3.2 7.5 13.1 21.5 17.2 2.9 3.0 12.0 4.9 8.1 4.3 4.9 12.8 2.6 18.4 4.2 8.4 8.8 11.7 0.0 10.2 2.2 8.6 6.5 4.9 25.8 3.0 45.8 6.4 6.3 6.1 7.1 10.1 5.7 15.3 8.2 2.2 2.8 6.7 49.7 11.8 2.0 27.4 13.9 1.4 13.1 17.1 3.6 23.4 17.1 1.7 3.1 29.1 29.4 5.8 9.7 23.7 5.2 6.7 4.9 5.9 3.0 2.7 6.6 2.0 4.1 5.0 16.3 29.2 19.9 2.7 10.1 11.1 13.8 6.0 FAM135A "FLJ20176, KIAA1411" ENSG00000082269 "Family with sequence similarity 135 member A" Q9P2D6 6 70412941-70561174 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 29.8" "Cell type enhanced" "Detected in all" "Excitatory neurons: 170.1;Horizontal cells: 238.9;Inhibitory neurons: 172.8;Microglial cells: 132.1;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 121.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 31.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031743, HPA031744" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm Cytosol "HPA031743: AB_10600767, HPA031744: AB_10601101" "unprognostic (5.79e-2)" "unprognostic (1.64e-1)" "prognostic favorable (8.00e-4)" "unprognostic (1.59e-1)" "unprognostic (1.66e-2)" "unprognostic (1.08e-1)" "unprognostic (6.69e-4)" "unprognostic (4.08e-2)" "unprognostic (3.87e-2)" "unprognostic (1.58e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "prognostic favorable (3.46e-4)" "unprognostic (3.99e-1)" "unprognostic (2.75e-1)" "unprognostic (6.26e-2)" "unprognostic (2.65e-2)" 2.6 2.8 2.5 4.8 3.6 1.3 2.5 8.1 3.3 4.9 0.6 10.7 13.6 6.3 2.5 29.8 4.1 7.0 4.1 3.2 2.1 4.9 2.4 4.2 3.8 2.4 2.3 6.3 6.0 9.7 1.9 4.0 2.4 16.1 11.1 8.2 4.5 3.5 2.6 9.6 11.5 3.7 1.2 3.5 10.7 10.1 2.2 2.9 3.8 6.5 6.4 4.9 7.1 3.7 7.9 4.8 9.5 6.1 4.5 3.2 8.9 2.5 5.0 2.6 4.3 8.9 6.2 14.3 18.1 1.9 12.6 7.3 9.6 5.6 4.6 6.8 8.2 6.2 4.6 8.0 5.5 12.3 6.4 2.9 13.8 5.0 13.4 3.1 7.2 4.4 10.6 6.8 3.1 0.8 2.2 5.5 6.4 9.2 3.9 6.8 31.3 6.8 9.8 4.0 10.1 3.1 2.9 2.6 3.0 6.3 1.8 5.2 3.6 2.2 5.7 2.2 5.8 8.5 10.3 5.5 1.6 10.4 4.2 1.8 2.3 0.1 0.8 2.0 0.9 1.6 0.7 0.3 3.5 2.0 1.1 0.7 0.6 2.7 3.3 0.5 0.9 0.9 2.5 3.6 8.1 3.3 3.2 2.1 2.4 2.3 2.4 1.2 2.2 3.7 12.0 28.9 12.5 85.8 10.8 15.9 12.9 8.3 31.3 20.8 4.5 4.1 11.5 17.2 8.9 20.2 29.2 2.9 4.7 49.9 5.9 6.7 30.4 13.9 15.6 13.0 23.4 1.7 170.1 12.4 1.5 10.2 45.9 21.4 8.8 13.5 9.7 6.5 5.6 238.9 172.8 29.2 16.2 10.6 15.5 23.8 15.5 11.9 5.4 132.1 11.9 13.8 4.1 219.2 121.3 18.4 31.7 13.2 6.4 35.4 24.0 10.0 9.9 26.4 6.6 11.6 9.3 33.2 10.5 71.4 33.5 8.2 4.6 10.9 25.5 15.8 FAM162A "C3orf28, E2IG5" ENSG00000114023 "Family with sequence similarity 162 member A" Q96A26 3 122384176-122412334 "Predicted membrane proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 625.3;Distal tubular cells: 540.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035856, HPA075611" Approved Supported Mitochondria NA NA 19000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 21: OE19 - Mitochondria" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA035856: AB_10611965, HPA075611: " "unprognostic (1.17e-2)" "unprognostic (1.42e-1)" "unprognostic (5.64e-2)" "unprognostic (1.10e-1)" "unprognostic (3.99e-1)" "unprognostic (7.84e-2)" "unprognostic (1.01e-1)" "unprognostic (1.15e-1)" "unprognostic (5.91e-3)" "unprognostic (8.74e-2)" "unprognostic (1.95e-2)" "unprognostic (7.91e-3)" "unprognostic (4.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.06e-1)" "unprognostic (4.10e-2)" "prognostic favorable (3.93e-4)" 49.0 105.7 54.8 31.3 60.2 39.9 43.9 57.3 82.2 84.5 57.1 145.9 56.1 49.5 59.4 207.6 49.7 46.2 174.2 57.1 58.5 107.6 200.3 32.0 32.9 55.9 57.2 84.3 133.9 116.6 51.0 17.6 55.6 74.6 149.0 83.5 59.8 49.2 141.0 89.8 56.3 44.6 56.6 31.7 93.2 43.6 58.8 34.7 44.1 142.6 42.7 76.9 131.5 55.6 132.0 27.7 40.4 75.6 72.1 66.4 20.7 52.9 46.8 49.0 123.9 69.4 58.7 142.1 89.2 18.2 40.3 89.8 73.5 128.1 130.0 74.0 55.1 115.6 44.0 125.8 47.4 114.0 39.6 77.3 65.5 46.7 97.9 164.3 66.0 137.7 79.2 55.6 71.1 52.0 116.9 137.9 59.5 294.9 144.4 69.5 57.8 186.9 144.3 314.9 60.1 48.1 39.4 92.4 114.3 59.9 57.9 55.7 47.0 48.4 34.6 28.7 55.6 108.8 39.9 144.8 143.3 109.7 22.8 9.9 25.8 75.7 58.3 68.2 86.9 75.3 79.5 74.0 84.6 68.1 85.1 88.6 8.5 50.6 75.9 70.4 80.4 38.8 54.8 60.2 57.3 82.2 57.1 58.5 55.9 57.2 55.6 56.6 58.8 55.6 55.7 28.9 46.0 41.1 68.2 128.1 155.3 625.3 82.0 31.5 80.6 109.5 338.4 84.4 188.6 130.6 47.9 51.4 47.9 477.5 540.0 148.2 102.5 82.0 30.1 49.8 106.9 47.7 33.0 177.6 47.8 78.7 84.6 79.2 85.7 59.3 44.6 280.4 92.7 38.7 30.4 374.3 240.1 66.7 108.9 33.1 134.5 61.2 104.9 7.5 108.9 79.7 45.3 22.1 21.6 141.6 313.2 148.6 61.2 121.4 186.2 466.2 95.5 29.9 105.2 83.2 315.3 146.4 68.3 315.1 132.8 47.2 66.0 121.1 358.4 210.9 FAM168B "KIAA0280L, MANI" ENSG00000152102 "Family with sequence similarity 168 member B" A1KXE4 2 131047876-131093460 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043778, HPA061659" Enhanced NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA043778: AB_10964889, HPA061659: AB_2684577" "unprognostic (8.39e-2)" "unprognostic (4.13e-2)" "unprognostic (2.61e-1)" "unprognostic (3.26e-2)" "unprognostic (4.58e-2)" "unprognostic (6.90e-3)" "unprognostic (1.60e-2)" "unprognostic (2.10e-1)" "unprognostic (5.91e-2)" "unprognostic (1.88e-1)" "unprognostic (4.84e-2)" "unprognostic (1.88e-1)" "prognostic favorable (5.30e-5)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.30e-2)" "unprognostic (3.35e-3)" 41.5 33.7 55.5 26.8 67.7 46.2 32.1 49.8 60.1 35.4 32.6 54.2 26.3 51.4 26.5 34.4 37.9 23.7 43.4 57.5 52.1 38.4 30.9 27.6 27.8 51.4 53.6 46.9 30.1 46.7 20.3 29.4 54.0 37.5 31.9 48.6 28.1 46.8 69.9 29.9 34.3 40.8 54.7 24.2 36.3 26.8 60.1 38.5 36.2 52.9 31.3 47.6 28.0 55.8 74.1 47.6 98.2 67.7 82.2 62.4 74.0 75.2 54.9 46.3 39.7 88.1 40.0 78.6 61.1 79.8 31.8 57.1 83.8 83.8 66.2 64.8 62.3 72.1 49.8 67.4 83.0 84.8 58.6 63.6 82.4 94.5 81.0 62.3 65.5 72.3 70.3 28.9 72.2 53.4 68.0 55.3 61.6 60.2 57.5 85.0 82.5 70.2 63.7 84.0 71.3 100.0 58.2 58.8 80.1 46.0 52.4 79.2 70.8 77.3 78.9 58.0 73.9 67.9 81.2 98.1 65.9 49.3 70.7 2.5 2.2 4.3 4.4 1.5 4.0 3.0 3.6 3.7 2.0 3.0 4.7 3.4 2.1 2.5 3.4 3.3 3.2 2.8 55.5 67.7 49.8 60.1 57.5 52.1 51.4 53.6 54.0 54.7 60.1 55.8 24.4 35.3 27.4 25.1 19.0 22.8 18.3 24.5 16.5 32.2 28.6 23.6 51.4 24.3 21.6 35.0 37.5 27.0 22.5 38.8 5.9 24.8 12.3 28.0 21.6 22.8 31.8 13.3 47.9 30.8 24.8 23.8 19.4 29.0 19.0 34.7 22.1 39.8 20.1 30.3 52.2 29.8 14.2 25.1 16.0 11.1 29.2 19.2 24.9 28.1 20.9 27.0 14.4 18.6 38.8 38.0 25.3 49.7 25.1 33.3 27.3 26.8 19.5 42.3 13.1 27.5 27.4 18.2 22.8 20.0 25.1 38.3 19.0 23.2 36.7 31.0 FAM3A "2-19, DXS560S, XAP-7" ENSG00000071889 "FAM3 metabolism regulating signaling molecule A" P98173 X 154506159-154516242 "Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 116.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "EFO-21: 109.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025016, HPA035268, HPA056991" Uncertain Approved "Nucleoplasm,Nucleoli rim,Mitotic chromosome" "Secreted to blood" Yes No 15000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 38: EFO-21 - Unknown function" "Cluster 45: Enterocytes - Digestion" "Nucleoli rim" "Nucleoplasm, Mitotic chromosome" "CAB025016: , HPA035268: , HPA056991: AB_2683303" "unprognostic (1.60e-1)" "unprognostic (2.72e-2)" "prognostic unfavorable (1.76e-4)" "unprognostic (3.19e-2)" "unprognostic (4.73e-2)" "unprognostic (5.19e-2)" "unprognostic (2.54e-2)" "unprognostic (2.57e-2)" "unprognostic (2.53e-1)" "unprognostic (6.27e-2)" "unprognostic (3.42e-2)" "unprognostic (3.48e-2)" "unprognostic (1.31e-2)" "unprognostic (2.74e-1)" "unprognostic (1.41e-1)" "unprognostic (4.04e-1)" "unprognostic (9.71e-2)" 28.4 37.3 43.5 11.3 49.1 11.3 27.6 50.8 51.3 44.6 38.8 35.3 28.0 36.0 7.7 41.3 38.9 8.4 58.7 40.6 45.8 38.6 63.1 26.8 9.4 52.2 47.6 51.5 52.0 14.8 40.9 10.1 47.8 39.1 6.8 6.1 28.5 12.7 36.8 31.1 33.8 7.4 46.9 28.2 36.1 10.0 46.4 12.1 39.9 13.7 5.5 35.8 35.3 58.1 44.4 41.1 10.3 34.5 30.3 15.4 28.8 22.3 15.1 14.8 17.6 19.1 26.2 28.5 109.2 36.8 29.0 31.6 16.2 19.3 3.6 23.4 21.7 11.2 36.9 13.8 47.2 7.6 17.6 19.0 17.5 30.7 21.4 17.7 10.5 18.1 21.6 20.5 17.3 46.3 14.2 32.7 4.6 47.8 52.4 17.3 10.4 79.6 16.6 18.0 20.4 15.6 10.3 24.4 37.3 7.4 18.7 11.8 12.0 19.9 12.0 54.7 30.6 77.6 46.5 36.0 36.4 19.6 20.8 23.4 10.8 15.2 13.4 12.7 13.2 6.1 8.6 9.6 11.0 8.7 10.0 12.0 5.8 10.6 11.3 14.6 9.1 10.1 43.5 49.1 50.8 51.3 40.6 45.8 52.2 47.6 47.8 46.9 46.4 58.1 23.5 12.8 16.7 13.1 16.9 16.3 23.4 29.2 22.8 25.4 21.9 24.9 21.9 22.8 16.3 22.0 14.6 47.0 19.3 60.2 27.4 27.6 1.0 13.4 18.3 18.3 17.5 29.9 7.1 42.5 50.0 28.4 50.0 15.0 5.7 34.8 23.6 30.3 29.8 21.9 9.4 58.9 18.3 16.4 15.3 2.8 33.5 18.0 33.8 6.5 17.6 28.9 24.7 11.1 14.3 28.2 57.5 29.3 32.5 28.7 116.2 33.1 12.7 20.4 6.6 26.7 24.5 5.2 10.1 32.1 21.2 71.3 19.3 23.7 39.7 22.9 FARSA "CML33, FARSL, FARSLA" ENSG00000179115 "Phenylalanyl-tRNA synthetase subunit alpha" Q9Y285 19 12922479-12934037 "Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001911 Enhanced Approved Cytosol NA NA 55000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA001911: AB_1848427" "unprognostic (1.52e-1)" "prognostic favorable (8.23e-4)" "unprognostic (2.71e-1)" "prognostic unfavorable (9.22e-4)" "unprognostic (1.16e-2)" "unprognostic (1.28e-1)" "unprognostic (4.93e-3)" "unprognostic (5.76e-2)" "unprognostic (2.86e-1)" "unprognostic (1.24e-1)" "unprognostic (1.21e-1)" "unprognostic (1.45e-2)" "unprognostic (1.45e-3)" "prognostic favorable (8.32e-4)" "unprognostic (2.59e-1)" "unprognostic (8.25e-2)" "unprognostic (1.84e-2)" 26.4 32.5 30.1 29.4 32.2 31.6 25.0 28.1 40.0 21.8 19.4 29.1 26.2 24.3 12.1 39.2 24.0 16.4 37.4 33.4 32.7 29.1 40.6 20.7 36.0 32.6 31.8 23.1 36.3 30.4 32.1 22.5 33.4 25.5 17.1 14.7 30.4 21.7 57.0 33.3 26.5 17.7 24.3 32.0 30.6 22.6 30.6 33.0 25.5 30.6 25.4 30.6 25.6 31.1 135.7 125.6 49.3 106.9 33.4 31.4 88.9 93.6 60.8 133.0 103.9 154.2 56.1 148.7 147.1 54.1 53.9 101.9 121.0 108.4 48.1 87.9 183.7 117.0 106.8 124.2 108.4 227.7 147.8 43.4 78.7 102.8 82.1 43.8 73.1 148.7 179.6 30.6 56.7 181.5 273.4 283.5 154.2 83.4 210.6 139.5 51.2 191.4 70.5 78.7 153.8 141.4 64.2 109.2 69.0 23.0 85.9 137.5 71.3 108.0 47.8 165.6 180.6 199.6 186.5 156.8 97.7 203.4 114.1 66.6 111.0 86.3 87.1 119.0 108.2 88.2 85.1 81.4 120.4 94.5 85.4 82.3 7.0 118.0 92.8 97.0 87.6 130.2 30.1 32.2 28.1 40.0 33.4 32.7 32.6 31.8 33.4 24.3 30.6 31.1 15.0 9.6 21.4 9.1 24.7 25.4 28.0 63.4 20.5 25.1 18.8 18.5 25.7 14.3 35.4 23.9 10.4 87.5 17.5 26.7 58.7 55.4 5.8 16.0 18.6 20.0 22.8 61.8 12.1 46.4 78.7 18.4 27.5 15.8 23.5 26.3 21.0 25.8 62.9 18.5 12.8 32.6 69.2 23.5 21.2 9.4 19.0 19.7 33.8 1.9 45.5 23.6 25.7 8.5 7.5 47.0 26.3 13.2 40.9 32.6 30.4 55.7 22.3 17.1 6.6 16.5 24.3 20.2 41.9 26.3 29.5 96.7 22.5 28.9 44.7 26.8 FARSB "FARSLB, FRSB, PheHB" ENSG00000116120 "Phenylalanyl-tRNA synthetase subunit beta" Q9NSD9 2 222566899-222656092 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036677, HPA036678, HPA061398" Enhanced Supported Nucleoplasm,Cytosol NA NA 28000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Cytosol "HPA036677: AB_2675242, HPA036678: AB_10673504, HPA061398: AB_2684504" "unprognostic (9.95e-3)" "unprognostic (1.86e-3)" "unprognostic (7.02e-2)" "unprognostic (7.42e-3)" "unprognostic (1.90e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (6.45e-10)" "unprognostic (8.89e-3)" "unprognostic (4.51e-2)" "unprognostic (3.63e-2)" "unprognostic (5.25e-3)" "unprognostic (6.25e-2)" "prognostic unfavorable (3.21e-5)" "unprognostic (1.36e-1)" "unprognostic (4.38e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (1.25e-4)" 12.8 10.9 9.5 7.6 10.0 8.0 12.8 10.4 11.3 13.1 6.5 14.7 9.1 13.5 6.5 20.7 11.9 3.9 16.7 10.2 10.7 11.8 14.1 9.4 7.4 9.6 9.4 14.3 15.6 8.0 13.2 5.0 10.8 11.2 11.1 10.0 10.4 6.1 31.9 14.9 10.8 8.1 8.4 9.7 13.9 13.5 9.9 7.7 9.7 13.2 8.3 13.1 13.7 9.4 31.1 17.8 20.7 27.2 18.0 26.3 31.0 31.0 19.2 29.4 23.9 45.3 16.6 15.3 22.7 22.6 24.7 25.8 39.7 34.7 43.0 22.8 20.7 35.1 18.9 28.8 27.9 51.9 14.0 17.6 27.0 33.9 51.2 10.5 28.3 26.4 53.5 30.3 36.1 28.9 31.2 29.2 26.6 37.0 22.0 30.2 49.4 49.8 24.5 19.9 33.4 11.2 12.9 22.4 27.6 24.7 20.9 21.3 15.8 25.5 21.1 37.8 38.5 14.8 15.5 54.5 20.8 34.0 27.2 0.5 7.6 1.2 9.6 9.4 14.3 15.1 12.8 11.9 14.4 12.7 16.4 14.2 0.9 17.4 11.3 7.2 12.5 13.7 9.5 10.0 10.4 11.3 10.2 10.7 9.6 9.4 10.8 8.4 9.9 9.4 10.2 6.4 6.4 21.2 25.2 12.4 19.5 32.7 19.4 17.9 16.3 18.0 28.6 5.7 18.5 22.0 4.2 37.0 7.5 18.1 35.2 24.7 57.5 17.3 15.8 13.3 20.9 24.2 50.2 30.4 43.3 18.0 32.6 18.6 5.1 21.8 7.5 17.8 27.4 3.3 56.7 19.9 20.3 10.1 9.7 73.1 15.2 11.8 7.2 26.2 11.3 13.2 15.5 38.7 38.2 22.8 11.3 19.9 27.3 18.1 9.9 31.0 16.8 19.5 6.6 17.6 34.4 67.4 33.7 28.8 14.2 22.2 16.9 24.3 45.8 14.3 FASTKD2 KIAA0971 ENSG00000118246 "FAST kinase domains 2" Q9NYY8 2 206765357-206796189 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis" "RNA-binding, rRNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA067191 Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA067191: AB_2685801" "unprognostic (1.19e-1)" "unprognostic (2.45e-1)" "unprognostic (3.50e-3)" "unprognostic (1.36e-3)" "unprognostic (7.40e-2)" "unprognostic (2.69e-3)" "prognostic unfavorable (8.29e-4)" "unprognostic (1.69e-2)" "unprognostic (2.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.38e-3)" "unprognostic (1.48e-1)" "unprognostic (6.32e-2)" "unprognostic (4.87e-2)" "unprognostic (7.18e-2)" "unprognostic (1.03e-3)" "unprognostic (3.57e-2)" 14.4 14.0 5.2 12.4 5.9 11.4 17.3 4.8 6.2 12.8 7.5 15.0 14.9 15.8 8.8 15.9 12.9 11.5 24.9 5.7 5.3 17.4 27.2 11.8 14.3 5.8 4.5 15.7 11.6 18.4 6.9 13.0 6.5 13.3 17.0 11.2 11.2 11.1 31.5 11.8 12.5 15.7 4.4 11.2 13.3 12.0 4.9 13.1 17.8 36.6 17.2 20.4 9.6 4.8 30.2 27.0 24.7 28.1 27.2 32.7 46.2 34.3 29.0 57.3 32.4 48.3 32.0 37.4 37.5 35.5 66.7 40.0 30.7 47.4 50.4 11.7 19.8 29.4 25.6 46.6 33.1 64.3 26.5 35.2 48.8 43.8 47.2 29.1 39.3 27.2 56.4 18.6 42.8 25.3 27.3 27.4 44.0 28.2 51.2 23.7 38.1 38.8 39.4 49.7 36.0 22.9 26.6 44.7 41.3 36.8 20.9 33.4 30.8 35.0 31.5 24.4 36.3 18.5 32.9 48.0 40.6 29.2 29.5 9.6 21.4 5.2 19.2 21.4 21.5 20.1 21.3 20.2 31.0 17.3 28.0 25.2 1.4 31.2 16.5 14.6 18.7 20.5 5.2 5.9 4.8 6.2 5.7 5.3 5.8 4.5 6.5 4.4 4.9 4.8 17.8 28.9 11.4 19.6 20.3 23.7 33.7 28.8 32.5 18.9 11.1 12.2 23.2 7.2 22.8 12.9 22.9 28.2 15.1 6.7 9.8 19.2 30.9 14.5 23.1 14.6 7.3 11.6 41.9 15.1 22.4 21.2 27.5 14.9 5.1 17.5 9.3 17.6 14.8 6.7 40.3 10.5 12.2 7.9 9.4 8.0 9.6 10.8 5.4 25.3 12.9 9.3 8.2 26.2 23.2 12.1 8.2 13.9 20.0 13.7 8.8 12.7 15.9 22.8 13.1 19.3 17.4 37.5 12.8 24.5 21.5 25.7 18.4 18.6 13.1 22.6 FBXO21 "FBX21, KIAA0875" ENSG00000135108 "F-box protein 21" O94952 12 117141991-117190471 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 128.9" "Cell type enhanced" "Detected in all" "Peritubular cells: 222.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA062411, HPA071452" Approved Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA062411: AB_2684755, HPA071452: AB_2686398" "unprognostic (6.38e-2)" "unprognostic (4.43e-2)" "unprognostic (2.58e-2)" "unprognostic (9.00e-3)" "unprognostic (1.57e-1)" "unprognostic (8.89e-2)" "unprognostic (1.84e-1)" "unprognostic (1.37e-1)" "unprognostic (8.99e-2)" "unprognostic (7.01e-3)" "unprognostic (1.28e-2)" "unprognostic (9.44e-2)" "prognostic favorable (2.05e-8)" "unprognostic (1.69e-2)" "unprognostic (1.17e-1)" "unprognostic (2.01e-1)" "unprognostic (7.29e-2)" 12.2 40.9 21.7 10.7 23.0 8.5 17.5 22.2 24.7 18.5 25.7 15.6 16.5 25.0 110.8 15.4 128.9 17.0 31.1 27.2 29.7 53.7 27.5 17.5 13.7 17.5 18.7 60.3 30.7 24.8 20.2 19.5 17.2 26.5 14.6 24.3 16.5 29.3 23.8 16.9 14.3 19.5 20.4 15.2 18.7 42.2 30.2 13.7 28.3 28.5 14.1 16.2 13.8 23.5 20.3 47.3 29.2 16.2 23.5 24.4 33.4 26.6 28.6 24.3 19.7 30.8 14.0 26.5 25.7 27.3 18.2 27.0 34.7 26.6 29.1 15.0 31.2 1.3 24.9 25.0 21.3 8.7 9.0 24.1 25.1 19.5 31.0 39.7 34.4 23.0 10.7 8.6 21.2 33.0 25.0 6.3 43.7 30.9 30.6 29.3 42.5 27.8 24.4 47.7 57.6 34.9 66.4 17.3 14.5 23.3 40.6 3.5 26.8 16.1 20.7 19.1 17.4 15.0 16.6 34.4 23.5 13.5 23.1 1.2 7.0 4.5 11.6 12.2 12.1 10.4 12.0 12.1 9.7 14.3 13.6 12.6 0.6 11.4 12.7 6.6 13.6 8.8 21.7 23.0 22.2 24.7 27.2 29.7 17.5 18.7 17.2 20.4 30.2 23.5 28.5 32.1 35.4 44.1 44.0 37.2 49.1 29.5 40.5 44.3 32.3 26.7 65.4 42.9 39.6 51.5 41.7 58.3 26.3 16.4 45.0 62.5 37.2 108.6 38.3 46.2 39.0 12.0 50.7 50.5 38.0 44.3 24.5 113.1 3.8 57.0 60.0 38.9 15.6 74.0 51.4 23.7 54.9 22.3 17.2 60.4 99.7 17.3 23.2 23.4 18.4 54.1 16.5 41.7 67.5 36.9 16.4 222.3 23.4 48.8 19.0 95.4 29.9 34.1 105.2 35.3 40.6 21.6 43.9 33.9 45.3 65.5 34.1 44.2 27.2 38.3 FBXO28 "CENP-30, Fbx28, FLJ10766, KIAA0483" ENSG00000143756 "F-box protein 28" Q9NVF7 1 224114111-224162047 "Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003289 Approved Supported "Nucleoplasm,Focal adhesion sites" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 17: WM-115 - Nervous system development" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "Focal adhesion sites" "HPA003289: AB_2666879" "unprognostic (4.91e-2)" "unprognostic (5.57e-2)" "unprognostic (1.78e-2)" "unprognostic (1.03e-1)" "unprognostic (1.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.12e-1)" "unprognostic (8.25e-2)" "unprognostic (2.03e-1)" "unprognostic (7.09e-2)" "unprognostic (5.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.98e-3)" "unprognostic (9.46e-2)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (2.61e-1)" 10.9 7.5 6.5 8.3 7.3 8.9 12.3 8.8 10.5 10.9 7.4 10.3 8.5 10.0 7.9 12.4 8.2 9.5 8.1 7.6 9.1 13.6 17.4 8.9 10.5 8.5 7.4 11.3 7.6 13.7 4.4 9.0 8.8 10.0 10.6 8.3 7.9 8.5 12.5 21.1 7.7 9.8 8.0 8.9 8.5 7.8 7.8 10.9 9.8 14.2 10.6 11.5 9.0 8.9 24.6 10.6 16.2 17.4 16.6 19.0 26.7 24.3 19.7 16.0 15.2 14.9 18.7 11.8 24.4 22.3 10.3 20.9 24.2 23.4 27.4 17.0 27.0 15.0 12.8 10.7 20.7 28.3 18.8 18.6 27.7 23.2 41.9 18.8 27.1 15.0 24.8 16.4 29.1 8.1 14.9 14.4 38.6 32.3 22.8 15.7 23.1 22.3 30.2 16.1 26.2 28.1 25.1 38.0 27.4 16.9 20.2 28.2 31.2 19.8 15.0 25.0 46.1 17.8 22.3 18.0 24.5 13.7 39.3 7.4 6.5 11.8 5.8 6.0 7.2 8.9 5.9 6.8 7.8 9.0 5.9 6.6 4.2 8.6 6.9 3.5 8.8 4.6 6.5 7.3 8.8 10.5 7.6 9.1 8.5 7.4 8.8 8.0 7.8 8.9 15.0 6.4 10.6 22.5 16.8 34.3 25.5 11.3 9.6 20.5 14.7 11.7 11.4 7.2 13.5 11.0 22.9 14.2 12.3 17.2 9.8 13.2 30.3 15.9 13.0 16.4 18.5 17.4 48.8 11.5 13.1 12.7 7.1 22.9 14.0 12.6 14.3 23.4 13.9 18.5 43.8 12.7 14.2 17.7 16.3 14.8 13.1 16.8 28.4 34.7 16.4 12.6 7.2 45.8 43.7 17.7 12.2 13.2 15.4 21.5 12.0 22.8 11.5 18.6 13.1 14.9 12.7 24.7 26.8 17.2 39.1 23.0 18.9 10.9 14.6 30.7 FBXO34 "Fbx34, FLJ20725" ENSG00000178974 "F-box protein 34" Q9NWN3 14 55271344-55370053 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 165.2;Late spermatids: 219.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052592 Uncertain Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 24: Non-specific - Transcription regulation" "Nuclear speckles" "HPA052592: AB_2681877" "unprognostic (6.19e-2)" "unprognostic (1.73e-1)" "unprognostic (5.47e-2)" "unprognostic (6.35e-2)" "unprognostic (1.60e-1)" "unprognostic (1.44e-2)" "unprognostic (1.18e-1)" "unprognostic (9.87e-3)" "unprognostic (3.07e-2)" "unprognostic (1.67e-1)" "unprognostic (1.04e-2)" "unprognostic (1.30e-1)" "prognostic favorable (1.20e-13)" "unprognostic (4.49e-2)" "unprognostic (3.14e-1)" "unprognostic (2.04e-1)" "unprognostic (1.23e-1)" 9.0 7.9 7.8 11.9 10.7 17.2 12.6 6.5 14.9 12.3 7.1 27.3 14.4 11.0 15.9 33.5 15.0 13.3 13.1 14.4 6.2 18.3 12.0 15.2 12.8 4.6 5.8 11.6 10.5 11.6 6.5 10.0 4.7 12.9 26.8 16.0 17.5 11.6 31.2 12.2 15.1 11.7 4.9 13.9 18.1 24.8 6.7 17.0 22.7 44.7 15.8 16.4 16.1 7.5 30.1 17.2 13.5 12.3 17.3 14.1 14.8 14.9 25.4 22.1 25.5 15.7 37.8 24.0 12.1 12.9 14.4 29.0 17.5 15.0 28.3 14.8 10.2 25.2 10.4 9.7 13.4 30.5 23.8 11.5 21.6 15.4 15.4 17.2 17.0 25.8 19.9 18.8 14.3 20.2 24.0 21.6 8.0 26.3 13.3 25.5 33.1 13.4 20.3 34.2 14.9 16.2 18.0 17.9 14.8 16.3 21.5 19.5 13.0 19.3 24.9 10.5 11.8 9.1 8.2 27.1 13.7 16.4 11.3 9.4 11.2 2.5 9.9 7.5 11.8 7.0 10.1 10.8 11.1 7.0 8.8 9.3 6.1 13.2 14.0 5.1 6.9 8.7 7.8 10.7 6.5 14.9 14.4 6.2 4.6 5.8 4.7 4.9 6.7 7.5 16.2 22.4 31.6 22.9 27.3 21.0 32.9 18.5 15.9 36.7 15.6 12.7 21.5 7.2 32.5 18.4 22.9 13.9 57.8 63.7 17.6 22.8 165.2 27.1 17.4 24.1 26.4 52.8 109.1 30.3 4.7 14.7 31.1 28.9 17.2 21.1 9.3 7.8 9.9 37.0 75.5 30.0 30.5 13.5 24.3 219.1 23.0 27.8 12.4 46.9 12.6 14.1 24.7 35.2 20.7 18.0 35.3 16.6 27.4 31.2 20.0 17.0 34.5 32.4 6.6 24.2 19.3 34.1 16.3 20.7 24.3 27.0 44.1 11.4 29.3 63.2 FBXO5 "EMI1, FBX5, Fbxo31" ENSG00000112029 "F-box protein 5" Q9UKT4 6 152970519-152983579 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "bone marrow: 44.1;lymphoid tissue: 27.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 36.0;Extravillous trophoblasts: 30.5;Spermatocytes: 32.3;Spermatogonia: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB008106, HPA029048" Approved Supported Nucleoplasm NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB008106: AB_828450, HPA029048: AB_10602132" "unprognostic (1.22e-2)" "unprognostic (7.21e-2)" "unprognostic (4.61e-3)" "unprognostic (1.24e-2)" "unprognostic (5.92e-2)" "unprognostic (2.94e-2)" "unprognostic (2.43e-8)" "unprognostic (2.46e-2)" "unprognostic (1.55e-2)" "unprognostic (7.32e-2)" "unprognostic (2.89e-1)" "unprognostic (5.86e-2)" "unprognostic (1.25e-9)" "prognostic favorable (8.65e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-1)" 3.1 3.1 1.5 7.3 1.6 44.1 4.5 2.6 2.1 4.0 1.9 5.0 4.6 5.3 4.5 3.7 3.0 2.6 1.8 1.4 1.7 3.1 4.4 3.4 14.9 1.6 1.6 4.1 3.0 2.3 2.1 6.3 1.7 3.0 5.1 3.3 2.7 2.9 0.9 4.3 4.3 5.0 1.6 5.5 4.6 3.9 1.8 27.3 4.4 2.6 14.6 4.0 3.0 2.0 33.7 17.2 70.8 48.1 5.3 10.8 22.6 79.9 35.5 58.7 65.6 35.6 19.8 81.6 23.9 21.3 39.7 31.4 56.4 26.7 70.0 44.2 50.6 82.3 24.1 38.7 10.2 74.4 48.6 7.7 4.9 39.8 30.9 14.3 27.3 42.3 88.2 74.5 53.9 25.7 85.2 47.6 41.5 25.8 25.0 71.0 56.8 52.8 20.8 18.0 46.1 47.9 56.6 30.2 15.6 24.7 21.8 68.7 20.6 43.9 57.4 51.1 94.8 24.9 29.5 120.4 31.9 54.3 54.2 0.0 1.9 0.0 2.8 2.5 4.0 5.1 4.7 5.2 3.7 5.0 4.6 4.8 0.0 7.1 3.2 4.3 6.6 2.5 1.5 1.6 2.6 2.1 1.4 1.7 1.6 1.6 1.7 1.6 1.8 2.0 6.0 0.0 1.1 1.3 9.8 9.9 3.7 4.0 7.4 3.2 5.7 5.2 1.8 2.8 3.9 1.8 6.2 15.2 13.5 2.6 3.9 3.0 0.4 2.3 10.5 5.7 4.8 36.0 1.0 1.6 30.5 9.1 7.7 4.0 2.5 16.6 5.0 1.9 7.9 1.7 0.9 6.1 2.0 3.2 6.1 0.1 4.4 5.3 1.8 1.9 4.2 4.1 9.2 1.5 2.1 1.5 0.5 6.0 24.7 3.6 1.5 3.6 1.9 3.6 13.1 8.6 8.9 32.3 26.1 10.2 5.3 5.9 7.9 8.0 6.3 2.0 FDX2 "FDX1L, MGC19604" ENSG00000267673 "Ferredoxin 2" Q6P4F2 19 10310045-10316015 "Disease related genes, Predicted intracellular proteins" "Electron transport, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 29.4;Ductal cells: 38.5;Exocrine glandular cells: 30.3;Hofbauer cells: 37.0;monocytes: 31.6;Pancreatic endocrine cells: 30.2;Proximal tubular cells: 69.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "NB-4: 266.8" HPA043986 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 7: Non-specific - Mitochondria" "HPA043986: AB_10960282" "unprognostic (1.48e-2)" "unprognostic (3.76e-2)" "unprognostic (7.61e-3)" "unprognostic (3.83e-2)" "unprognostic (1.48e-1)" "unprognostic (9.03e-2)" "unprognostic (1.02e-3)" "unprognostic (9.70e-3)" "unprognostic (2.29e-1)" "unprognostic (1.42e-3)" "unprognostic (4.92e-2)" "unprognostic (3.73e-2)" "unprognostic (3.93e-2)" "unprognostic (3.14e-1)" "unprognostic (4.74e-2)" "unprognostic (1.66e-1)" "unprognostic (6.75e-2)" 16.1 27.2 58.1 9.1 59.5 4.9 15.1 53.8 79.8 15.4 55.1 20.5 7.7 16.3 13.2 14.4 13.6 9.8 23.3 60.7 60.6 32.1 28.2 14.1 11.2 54.9 57.9 15.3 20.0 29.9 28.8 9.3 58.7 20.2 6.8 4.4 14.0 16.0 24.6 12.6 11.5 13.3 52.3 15.2 17.4 12.1 57.8 8.7 24.4 22.1 7.9 19.5 13.9 61.9 34.9 28.4 19.4 33.4 40.2 31.7 20.2 32.2 51.0 53.6 44.5 41.4 24.5 26.2 59.2 45.9 37.7 26.5 32.3 61.1 20.7 28.6 46.0 38.3 30.0 30.5 58.4 18.7 12.3 28.9 42.6 45.2 44.4 25.9 32.9 30.0 47.2 20.4 61.2 56.2 35.1 266.8 33.8 32.7 52.2 26.3 16.0 39.0 62.1 36.4 42.5 25.7 40.0 46.7 36.6 13.1 39.3 13.7 23.2 73.9 18.6 76.7 48.2 44.9 73.2 42.1 68.6 41.2 39.3 0.0 9.1 0.0 10.8 19.6 14.7 19.7 10.9 14.0 20.9 14.1 13.6 15.6 1.7 24.4 19.0 15.4 15.5 7.7 58.1 59.5 53.8 79.8 60.7 60.6 54.9 57.9 58.7 52.3 57.8 61.9 11.3 9.6 10.9 0.0 2.1 0.0 0.0 0.0 0.0 0.0 18.9 18.7 0.0 0.0 4.3 11.0 0.0 14.1 3.5 0.0 29.4 38.5 0.0 5.7 5.1 4.9 0.0 0.0 0.0 30.3 19.5 5.7 0.0 4.3 2.5 5.5 0.0 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.5 0.0 0.0 31.6 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.9 0.0 0.0 69.9 5.8 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 7.9 2.1 5.7 0.0 0.0 FGD6 "FLJ11183, ZFYVE24" ENSG00000180263 "FYVE, RhoGEF and PH domain containing 6" Q6ZV73 12 95076749-95217482 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 109.0;Microglial cells: 90.9;Pancreatic endocrine cells: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 23.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007974 Approved Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 31: Skin - Epidermis development" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 64: Astrocytes - Nervous system maintenance" Vesicles "HPA007974: AB_1848520" "unprognostic (1.28e-2)" "unprognostic (2.67e-3)" "unprognostic (6.06e-2)" "unprognostic (5.56e-2)" "unprognostic (1.65e-1)" "unprognostic (4.70e-2)" "unprognostic (4.66e-2)" "unprognostic (1.35e-3)" "unprognostic (1.32e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.62e-5)" "prognostic unfavorable (9.83e-4)" "prognostic unfavorable (5.46e-6)" "unprognostic (1.01e-2)" "unprognostic (1.38e-1)" "unprognostic (3.33e-2)" "unprognostic (1.92e-1)" 1.8 3.3 3.3 5.1 5.3 1.5 2.9 0.3 5.2 3.3 4.0 4.5 1.3 3.4 1.2 3.3 1.9 4.9 3.6 3.2 0.4 3.3 3.1 5.2 5.5 2.0 1.7 4.5 3.4 1.2 1.1 4.3 0.3 3.3 4.2 2.2 2.2 4.0 1.6 7.8 3.5 3.5 1.8 3.3 1.8 3.0 2.9 2.5 5.2 1.3 9.7 3.3 3.5 1.6 22.5 20.1 18.2 2.0 1.9 1.8 9.5 3.1 4.4 1.1 1.8 7.7 15.0 23.8 5.1 2.0 1.3 8.9 3.3 18.7 2.6 2.5 2.0 1.1 3.2 3.8 2.5 2.5 0.2 7.5 8.4 2.2 22.1 7.3 11.9 3.2 5.1 0.4 0.6 1.2 2.0 0.5 7.5 2.8 6.9 5.5 3.6 1.9 12.8 7.1 3.0 4.9 9.0 4.6 0.4 9.1 2.1 0.2 16.4 0.7 2.0 0.9 2.4 2.2 5.3 6.7 0.9 1.6 1.4 0.2 1.6 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.9 1.4 0.1 0.0 0.1 0.1 2.0 0.0 0.0 0.6 3.3 5.3 0.3 5.2 3.2 0.4 2.0 1.7 0.3 1.8 2.9 1.6 12.4 16.0 17.0 109.0 3.9 48.6 21.9 18.6 29.0 3.8 11.0 10.5 22.2 10.0 14.0 9.2 4.2 4.5 1.5 26.5 0.0 22.6 1.7 10.9 17.3 22.3 12.5 1.7 23.9 21.9 8.8 7.3 6.6 22.1 1.3 10.6 16.4 5.2 11.7 1.7 22.4 15.5 10.2 16.1 11.8 3.1 12.5 11.0 1.8 90.9 12.6 1.9 1.0 4.0 4.1 78.1 17.0 10.5 3.5 19.3 14.9 5.2 12.0 9.7 0.0 3.5 6.1 4.8 16.0 28.3 24.9 43.8 1.7 4.9 5.5 30.7 FGGY FLJ10986 ENSG00000172456 "FGGY carbohydrate kinase domain containing" Q96C11 1 59296638-59810647 "Disease related genes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 77.1" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 191.7;Cholangiocytes: 343.1;Hepatocytes: 142.3" "Cancer enhanced" "Detected in all" "liver cancer: 13.9" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.9;RH-30: 28.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054971, HPA075137" Approved "Nucleoplasm,Nuclear bodies" NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 44: HDLM-2 - Immune response" "Cluster 11: Alveolar cells - Smell perception" Nucleoplasm "Nuclear bodies" "HPA054971: , HPA075137: " "unprognostic (4.15e-1)" "unprognostic (1.87e-1)" "unprognostic (2.31e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (2.20e-3)" "unprognostic (1.47e-3)" "unprognostic (1.80e-2)" "unprognostic (4.09e-1)" "unprognostic (2.78e-1)" "unprognostic (2.92e-1)" "unprognostic (1.47e-1)" "unprognostic (4.36e-3)" "unprognostic (7.22e-2)" "unprognostic (1.44e-1)" "unprognostic (2.70e-1)" "unprognostic (1.78e-1)" 4.2 14.6 10.5 2.0 12.8 2.3 6.6 21.8 10.2 6.3 4.5 7.1 7.1 4.7 36.5 5.5 9.9 5.4 11.3 7.4 12.1 19.1 77.1 4.7 3.3 12.9 13.4 4.8 12.0 10.5 9.7 3.0 12.9 7.8 6.7 9.6 7.5 10.3 41.8 5.7 8.1 4.2 9.3 2.8 6.1 4.2 16.5 4.1 7.7 17.1 3.6 7.0 5.2 12.7 4.8 1.4 9.2 3.9 4.7 16.6 0.8 4.1 6.8 2.3 3.4 0.0 3.8 5.4 13.0 11.0 4.1 2.0 1.6 11.9 4.9 42.9 1.1 3.8 2.9 8.6 12.3 2.3 2.4 23.2 10.2 5.0 7.9 10.0 4.6 6.0 2.7 3.4 15.3 5.2 3.0 3.2 5.8 13.0 5.3 6.5 28.3 2.1 12.9 8.8 7.2 3.2 5.6 3.3 12.0 8.0 2.8 2.3 4.7 4.0 2.6 4.7 2.8 7.5 2.9 4.6 12.9 9.2 3.8 1.5 1.3 1.4 3.0 1.3 2.7 5.1 1.4 3.8 2.2 3.6 2.7 4.3 2.2 2.9 3.4 1.1 2.8 1.8 10.5 12.8 21.8 10.2 7.4 12.1 12.9 13.4 12.9 9.3 16.5 12.7 3.7 54.5 191.7 83.2 7.9 20.9 23.8 45.2 14.2 10.1 33.1 66.9 29.9 343.1 40.4 12.9 12.5 9.3 3.7 4.2 17.6 62.6 14.0 33.2 7.5 6.9 2.4 12.2 20.4 42.5 4.5 7.6 7.1 20.4 10.1 5.3 5.3 142.3 11.4 8.4 33.7 11.3 22.4 8.8 7.6 11.4 1.8 6.7 35.6 17.8 11.2 12.2 3.1 39.2 36.0 17.7 7.7 3.0 3.4 19.1 14.9 47.9 91.2 16.4 0.0 31.4 8.9 4.6 11.5 13.5 31.5 4.5 5.1 5.9 17.1 35.5 FIGNL1 ENSG00000132436 "Fidgetin like 1" Q6PIW4 7 50444128-50542535 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 27.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA055542 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "HPA055542: AB_2682841" "unprognostic (4.62e-2)" "unprognostic (8.76e-2)" "unprognostic (3.99e-3)" "unprognostic (1.18e-2)" "unprognostic (1.18e-1)" "unprognostic (8.73e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.15e-1)" "prognostic unfavorable (4.82e-4)" "unprognostic (3.62e-2)" "unprognostic (3.11e-1)" "unprognostic (4.79e-2)" "prognostic unfavorable (9.54e-7)" "unprognostic (1.86e-1)" "unprognostic (6.32e-2)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" 4.5 4.1 4.0 8.4 4.9 8.7 8.8 6.2 5.3 5.4 1.6 6.2 6.8 8.5 4.7 9.0 4.8 4.5 3.9 4.3 4.2 3.5 4.7 3.3 10.3 4.4 3.9 11.3 2.7 3.8 2.5 5.2 4.9 5.9 6.4 9.7 3.8 4.4 6.5 8.6 6.3 9.9 3.9 7.7 4.2 7.2 4.4 10.2 3.7 8.0 13.3 3.6 4.9 5.7 12.9 25.8 33.0 36.1 7.4 13.3 21.1 43.8 22.3 46.0 50.9 40.6 28.5 49.1 22.9 13.1 38.3 43.6 35.3 21.9 73.0 42.0 26.5 21.8 53.7 14.2 4.5 52.5 33.4 6.1 10.7 30.4 15.6 7.3 48.8 22.1 51.5 30.0 35.3 19.1 32.1 38.8 30.2 48.6 30.4 29.8 28.5 17.9 14.3 32.7 37.6 29.2 16.3 35.5 16.6 15.4 34.8 17.4 19.0 0.1 19.2 55.9 36.4 50.5 56.5 38.1 14.7 47.2 73.4 0.0 1.1 0.8 1.7 2.0 3.0 3.4 2.0 3.4 1.2 4.0 3.0 2.9 0.6 3.8 6.1 1.2 4.1 1.5 4.0 4.9 6.2 5.3 4.3 4.2 4.4 3.9 4.9 3.9 4.4 5.7 3.4 0.0 0.5 3.9 7.8 4.1 1.9 3.2 8.6 10.8 4.3 3.9 17.2 2.8 2.3 1.8 6.2 7.0 6.0 1.7 3.9 3.0 1.1 3.3 5.6 4.4 0.0 17.9 11.0 1.2 9.8 5.7 2.6 6.0 2.5 21.3 3.9 2.1 4.6 10.1 7.6 1.3 4.1 2.9 4.2 1.4 11.5 2.9 3.6 4.7 4.4 6.0 7.2 6.6 11.1 2.3 2.8 9.4 8.6 0.7 1.5 2.2 0.8 14.9 0.0 6.0 4.3 27.6 20.4 7.7 3.0 1.4 5.5 9.9 4.0 1.2 FIZ1 "FLJ14768, ZNF798" ENSG00000179943 "FLT3 interacting zinc finger 1" Q96SL8 19 55591376-55601970 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074026 Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm "HPA074026: AB_2686653" "unprognostic (1.97e-2)" "unprognostic (6.59e-2)" "unprognostic (2.54e-2)" "unprognostic (1.01e-1)" "unprognostic (6.43e-2)" "unprognostic (8.33e-3)" "unprognostic (4.51e-3)" "unprognostic (8.69e-2)" "unprognostic (1.15e-1)" "unprognostic (1.30e-1)" "prognostic favorable (8.42e-4)" "unprognostic (7.02e-2)" "unprognostic (7.28e-2)" "unprognostic (1.87e-2)" "unprognostic (6.92e-2)" "unprognostic (3.03e-1)" "prognostic favorable (2.02e-4)" 7.6 8.4 23.3 5.8 23.6 4.0 8.1 21.8 24.6 10.3 18.1 12.3 6.3 12.4 7.6 9.2 9.1 3.5 13.1 21.2 21.3 12.3 9.7 6.8 5.3 22.7 22.6 10.0 13.0 10.3 11.9 5.3 21.1 11.4 5.1 11.7 9.4 6.7 12.7 8.6 9.3 6.2 20.9 9.4 11.7 6.5 23.9 8.3 11.9 7.8 5.9 10.8 8.2 22.0 10.8 22.7 14.9 10.6 8.5 6.0 17.0 8.6 5.8 9.6 7.5 12.2 11.4 18.5 8.0 5.4 5.3 10.2 10.3 10.8 9.3 14.6 26.9 14.0 16.0 10.8 8.5 12.3 12.9 7.3 17.7 8.2 10.0 9.1 4.8 11.3 17.8 8.4 7.1 9.1 22.3 9.0 16.5 12.6 15.2 22.4 14.1 10.0 9.6 18.8 20.1 22.9 13.9 9.7 9.7 8.6 10.0 15.0 7.8 9.2 15.0 3.8 11.3 22.1 36.0 12.2 12.7 11.4 10.0 0.0 0.4 0.0 0.2 0.7 0.2 0.6 0.6 0.3 0.2 0.3 0.2 0.4 0.4 0.5 0.3 0.9 0.2 0.2 23.3 23.6 21.8 24.6 21.2 21.3 22.7 22.6 21.1 20.9 23.9 22.0 6.4 9.6 1.1 3.3 3.1 3.3 3.4 1.5 4.0 13.5 7.1 7.4 5.3 7.2 3.0 5.5 4.2 3.7 3.9 7.5 0.0 4.1 0.8 5.1 5.3 4.8 10.1 1.7 2.7 4.0 3.7 4.3 5.1 5.2 0.0 9.5 3.3 5.9 4.5 13.5 2.7 5.3 0.0 4.4 1.2 1.5 3.1 3.3 0.0 2.8 2.6 10.0 2.1 2.0 3.0 5.3 3.7 3.4 2.0 3.9 5.0 4.8 5.4 13.6 0.0 4.6 3.8 2.5 2.5 2.6 2.3 3.4 2.3 5.0 5.7 3.2 FMC1-LUC7L2 C7orf55-LUC7L2 ENSG00000269955 "FMC1-LUC7L2 readthrough" 7 139341360-139422599 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "Cardiomyocytes: 26.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA045663, HPA051631" Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "HPA045663: AB_2679410, HPA051631: AB_2681558" "unprognostic (2.54e-1)" "unprognostic (5.27e-2)" "unprognostic (3.21e-2)" "unprognostic (1.33e-3)" "unprognostic (1.38e-1)" "unprognostic (2.46e-3)" "unprognostic (1.68e-2)" "unprognostic (4.48e-2)" "unprognostic (2.26e-1)" "unprognostic (1.76e-3)" "unprognostic (1.10e-1)" "unprognostic (3.12e-2)" "unprognostic (6.42e-3)" 16.8 17.7 2.4 8.8 4.4 6.4 16.1 3.8 9.8 15.8 3.7 20.2 11.0 21.8 1.1 13.4 18.2 2.7 21.9 2.3 3.9 15.0 19.3 14.8 6.2 4.9 3.0 20.4 12.3 12.3 14.1 6.9 4.1 15.3 4.0 13.9 18.1 8.6 56.9 13.3 16.0 6.7 3.5 12.7 16.5 11.7 3.2 14.1 24.7 30.5 4.9 17.7 14.9 4.6 32.6 46.2 55.1 31.7 23.3 16.2 20.8 25.2 17.0 29.9 23.8 36.5 35.8 36.5 44.3 18.6 40.1 25.5 59.7 21.3 9.4 25.2 6.3 48.6 45.9 27.8 21.7 60.2 38.2 12.7 15.3 28.8 18.4 16.9 20.9 19.1 62.1 47.4 18.7 45.6 88.9 3.2 44.5 44.2 9.7 57.5 41.6 48.5 4.8 22.3 45.7 47.5 33.9 26.4 33.8 10.4 20.2 25.1 24.0 21.5 20.2 22.5 38.8 44.4 40.3 70.5 39.9 37.8 40.1 14.6 15.7 22.3 22.2 16.1 21.3 22.2 21.3 23.0 22.8 23.0 23.9 21.7 5.6 24.6 20.4 17.9 25.8 16.4 2.4 4.4 3.8 9.8 2.3 3.9 4.9 3.0 4.1 3.5 3.2 4.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FP565260.1 ENSG00000275464 "Periodic tryptophan protein 2 homolog" 21 5130871-5154658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 2: 9.1;Ductal cells: 9.3;Exocrine glandular cells: 8.0;granulocytes: 5.1;Hofbauer cells: 6.3;Pancreatic endocrine cells: 8.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 102.4" HPA024573 Uncertain Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 2: Immune cells - Immune response" "Cluster 36: HEL - Hemostasis" "Cluster 1: Pancreatic cells - Digestion" Nucleoli Cytosol "HPA024573: AB_1855963" "unprognostic (3.37e-3)" "unprognostic (4.09e-2)" "unprognostic (4.43e-1)" "unprognostic (9.66e-3)" "unprognostic (2.58e-1)" "unprognostic (1.08e-1)" "unprognostic (1.16e-3)" "unprognostic (1.34e-1)" "unprognostic (2.30e-3)" "unprognostic (8.40e-3)" "unprognostic (5.16e-2)" "unprognostic (1.07e-2)" "unprognostic (9.34e-3)" "unprognostic (1.74e-2)" "unprognostic (5.76e-2)" "unprognostic (5.96e-2)" "unprognostic (1.11e-1)" 9.2 9.2 6.4 9.9 8.8 12.1 7.4 7.2 8.0 5.9 4.9 8.5 9.1 6.8 1.7 8.3 7.8 7.3 7.5 7.1 6.8 9.0 6.8 7.1 13.4 7.6 7.2 6.7 7.7 6.5 6.0 7.9 9.1 6.5 8.4 3.5 6.7 4.7 10.1 8.6 8.2 7.3 6.8 11.5 7.6 7.1 7.2 6.7 6.6 3.2 5.3 11.4 7.1 13.7 32.0 24.0 15.4 24.2 6.6 5.0 9.1 0.2 0.0 0.1 0.1 0.4 20.1 0.3 14.1 10.5 20.8 21.0 42.9 19.0 0.0 7.4 15.1 102.4 12.4 11.9 10.4 47.6 29.1 17.8 22.5 25.5 20.1 5.0 20.1 16.5 56.8 11.6 6.6 28.4 34.4 33.1 60.4 36.5 29.3 54.0 14.2 28.8 13.5 25.3 16.6 27.3 25.5 38.4 14.9 4.2 31.5 24.9 10.2 12.0 29.7 0.3 32.9 13.9 16.0 63.5 20.4 62.3 16.7 3.3 7.3 6.9 18.5 12.6 21.2 11.0 11.3 13.5 8.7 11.2 11.1 15.2 4.1 9.9 18.2 5.5 8.5 11.6 6.4 8.8 7.2 8.0 7.1 6.8 7.6 7.2 9.1 6.8 7.2 13.7 0.9 0.0 9.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.5 1.9 0.0 0.0 2.5 0.0 0.0 2.7 1.1 0.8 0.0 9.3 0.0 0.8 1.1 0.9 0.0 0.0 0.0 8.0 1.4 0.9 0.0 0.9 5.1 0.6 0.0 0.0 6.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 3.1 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 2.3 1.2 0.4 0.9 0.0 FTO "ALKBH9, KIAA1752, MGC5149" ENSG00000140718 "FTO alpha-ketoglutarate dependent dioxygenase" Q9C0B1 16 53701692-54158512 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase, Transferase" "Disease variant, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 173.3;Excitatory neurons: 226.1;Inhibitory neurons: 240.7;Oligodendrocyte precursor cells: 210.6;Oligodendrocytes: 282.5;Respiratory ciliated cells: 182.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017123, HPA041086, HPA068695" Enhanced Supported Vesicles,Cytosol No No 540000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol Vesicles "CAB017123: , HPA041086: AB_2677293, HPA068695: AB_2732117" "unprognostic (9.74e-2)" "unprognostic (2.49e-1)" "unprognostic (9.30e-2)" "unprognostic (1.24e-2)" "unprognostic (1.81e-1)" "unprognostic (2.09e-2)" "unprognostic (2.95e-2)" "unprognostic (1.41e-1)" "unprognostic (8.67e-2)" "unprognostic (1.02e-1)" "unprognostic (3.88e-2)" "unprognostic (6.80e-2)" "unprognostic (1.44e-1)" "unprognostic (5.81e-3)" "unprognostic (1.78e-1)" "unprognostic (4.30e-3)" "unprognostic (6.11e-3)" 24.4 33.6 31.8 12.5 36.6 8.2 36.3 30.1 37.7 25.8 31.0 22.2 7.7 26.9 21.4 17.2 25.3 21.6 27.1 35.2 39.5 25.0 17.4 36.8 15.0 29.2 31.3 27.2 20.7 40.6 26.2 20.1 31.9 20.0 14.1 38.4 18.9 23.9 33.1 21.4 12.5 29.9 30.5 16.4 15.0 8.3 33.8 17.0 27.5 23.0 14.8 21.9 18.5 43.9 15.1 26.8 35.0 35.9 67.3 50.4 11.5 35.6 32.2 29.3 8.5 16.8 19.3 34.4 38.2 46.3 16.6 21.7 32.4 34.9 42.5 16.0 25.5 15.5 33.6 31.7 46.2 12.5 17.1 55.9 36.5 26.6 32.5 36.6 44.1 25.1 15.2 8.4 48.1 11.8 28.0 19.2 18.1 15.5 17.5 42.2 52.9 32.3 44.6 12.3 43.0 29.7 40.4 23.6 10.8 33.7 31.1 29.3 42.4 36.4 23.9 19.8 22.1 15.9 13.9 35.0 33.9 22.9 28.7 14.9 17.9 9.7 25.6 22.7 32.4 17.6 24.4 25.9 23.8 17.4 22.5 24.4 2.9 26.4 16.5 9.5 26.6 23.1 31.8 36.6 30.1 37.7 35.2 39.5 29.2 31.3 31.9 30.5 33.8 43.9 15.1 80.1 62.0 173.3 10.3 12.4 10.0 8.6 13.6 22.8 69.1 39.5 22.3 15.7 54.4 7.3 12.5 9.3 10.2 4.8 7.9 9.0 39.1 11.0 18.3 17.4 6.6 9.7 226.1 5.7 7.4 23.1 9.7 9.9 25.9 16.8 11.0 13.8 9.2 16.8 240.7 6.6 10.2 9.0 13.2 69.9 14.3 11.8 10.6 134.0 5.5 19.6 10.3 210.6 282.5 5.5 5.0 15.1 18.7 6.0 4.5 15.8 182.7 14.1 13.1 21.6 16.8 3.5 3.4 11.0 9.1 5.1 12.9 17.8 6.3 7.9 GALE SDR1E1 ENSG00000117308 UDP-galactose-4-epimerase Q14376 1 23795599-23800781 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Galactose metabolism" Isomerase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "stomach 1: 122.4" "Cell type enhanced" "Detected in many" "Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070023 Approved "Golgi apparatus,Cytosol" NA NA 16000 "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Golgi apparatus, Cytosol" "HPA070023: " "unprognostic (1.65e-1)" "unprognostic (1.78e-1)" "unprognostic (5.25e-2)" "unprognostic (1.41e-2)" "unprognostic (3.03e-3)" "unprognostic (1.17e-2)" "unprognostic (3.19e-3)" "unprognostic (1.84e-1)" "unprognostic (1.59e-1)" "unprognostic (2.65e-1)" "unprognostic (1.56e-2)" "unprognostic (1.34e-1)" "unprognostic (2.25e-1)" "unprognostic (7.51e-2)" "unprognostic (2.12e-1)" "prognostic favorable (2.68e-4)" "unprognostic (1.41e-2)" 8.9 12.8 12.3 16.0 12.5 6.0 12.8 12.2 17.7 22.3 11.5 58.6 54.6 6.7 12.7 63.1 16.6 31.5 7.1 12.5 12.5 34.0 61.2 20.6 7.5 12.5 12.3 4.6 15.2 15.5 6.7 17.8 12.4 11.0 60.0 6.3 59.7 16.4 4.3 9.7 38.3 10.8 12.6 17.6 122.4 8.7 13.2 8.0 4.7 5.4 15.8 20.9 22.2 12.6 60.3 71.5 27.8 44.5 9.8 13.9 26.9 40.7 53.4 68.6 50.9 65.3 195.4 14.3 54.7 23.5 91.9 65.8 24.5 101.8 51.5 29.4 16.2 40.6 34.4 71.6 102.0 18.4 11.6 30.1 53.4 63.4 156.8 69.2 59.5 30.1 45.9 3.8 49.5 64.5 29.0 19.5 7.8 83.1 67.7 33.6 27.1 18.5 112.7 41.4 10.7 24.1 73.9 66.7 70.6 31.1 47.9 14.5 33.7 52.0 74.9 52.0 50.3 18.5 46.4 18.9 53.0 74.5 27.8 1.7 13.5 3.0 8.5 29.3 8.5 5.4 5.0 6.9 19.0 1.7 5.8 4.1 3.4 37.3 37.1 5.2 9.5 8.8 12.3 12.5 12.2 17.7 12.5 12.5 12.5 12.3 12.4 12.6 13.2 12.6 9.6 12.8 49.3 6.8 7.5 7.6 18.8 110.4 6.2 17.2 26.7 10.9 3.5 37.1 90.6 40.5 16.7 54.1 7.4 131.8 35.2 67.6 21.5 19.9 9.1 14.3 12.1 8.2 9.4 114.8 106.3 14.0 276.8 36.2 10.8 17.4 10.8 38.3 99.3 8.4 10.8 149.5 73.2 5.7 6.8 5.0 4.7 12.5 24.9 5.6 19.4 21.2 7.2 4.5 2.1 92.0 109.0 3.4 9.4 24.9 78.6 89.5 37.0 14.8 0.0 3.7 13.1 14.5 9.7 19.6 4.8 96.3 7.6 99.6 73.8 46.0 GAR1 NOLA1 ENSG00000109534 "GAR1 ribonucleoprotein" Q9NY12 4 109815510-109824740 "Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059098 Supported Approved "Nucleoplasm,Nucleoli fibrillar center" NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli fibrillar center" "HPA059098: AB_2683904" "unprognostic (9.72e-2)" "unprognostic (6.94e-2)" "unprognostic (3.04e-2)" "unprognostic (4.47e-2)" "unprognostic (2.40e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.01e-2)" "unprognostic (1.73e-1)" "unprognostic (4.17e-3)" "unprognostic (2.14e-2)" "unprognostic (2.45e-3)" "unprognostic (1.17e-1)" "unprognostic (5.11e-2)" "unprognostic (1.11e-1)" "unprognostic (6.49e-2)" "unprognostic (1.08e-3)" 14.7 16.4 10.0 13.5 10.1 31.7 15.9 9.8 13.0 12.3 10.1 16.0 11.3 13.7 11.4 23.0 13.3 6.4 12.7 10.0 10.3 20.1 16.5 9.6 13.5 10.1 10.1 15.5 14.7 9.3 11.8 11.5 10.3 12.2 15.2 7.1 13.2 8.0 12.2 23.2 13.2 11.7 9.9 15.5 12.9 15.1 10.3 13.8 10.7 6.6 16.0 16.3 13.5 10.6 45.7 65.5 34.3 49.7 19.3 26.8 34.1 47.1 24.1 35.3 30.1 100.6 60.2 103.5 27.5 38.9 39.5 22.2 68.8 47.7 66.5 31.2 68.3 57.7 57.1 113.1 46.6 150.8 35.2 27.0 49.5 48.6 37.6 27.9 44.5 48.1 146.8 34.6 50.0 121.7 78.5 115.4 59.5 78.4 68.7 58.0 57.2 41.2 55.3 79.3 51.2 55.7 26.3 80.6 46.2 29.5 25.1 48.4 39.3 38.5 51.1 27.2 61.4 42.0 70.7 132.2 26.3 69.7 43.2 7.5 4.0 2.9 6.1 6.7 6.5 8.4 5.9 6.2 6.3 7.9 6.7 6.2 0.7 7.3 6.3 6.8 6.8 2.6 10.0 10.1 9.8 13.0 10.0 10.3 10.1 10.1 10.3 9.9 10.3 10.6 25.2 3.2 17.0 4.6 29.0 57.9 40.9 42.7 27.3 11.9 36.3 37.2 13.8 14.3 33.1 16.5 14.6 69.9 23.4 18.5 25.4 49.2 1.3 54.0 39.9 30.9 18.6 62.1 6.6 53.8 65.8 24.7 30.1 36.9 19.0 38.1 18.2 19.6 35.8 5.0 6.3 40.7 10.2 13.3 17.2 4.3 22.1 16.0 17.8 5.6 16.1 39.2 17.5 5.5 7.4 49.5 22.7 18.8 24.7 68.5 14.5 40.4 35.6 9.3 6.6 35.2 27.7 45.0 38.3 40.2 60.0 87.8 24.8 44.6 46.1 40.6 GART "GARS-AIRS-GART, PGFT, PRGS" ENSG00000159131 "Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase" P22102 21 33503931-33543491 "Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Ligase, Multifunctional enzyme, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002119, HPA005779" Approved Approved Mitochondria,Cytosol NA NA 300000 "Cluster 27: Non-specific - Gene expression" "Cluster 3: T-cells - Adaptive immune response" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Mitochondria "HPA002119: AB_1849482, HPA005779: AB_1849484" "unprognostic (3.77e-2)" "unprognostic (2.25e-2)" "unprognostic (4.51e-3)" "unprognostic (1.72e-2)" "unprognostic (2.30e-2)" "prognostic unfavorable (5.05e-5)" "prognostic unfavorable (9.82e-5)" "unprognostic (2.50e-2)" "unprognostic (2.76e-3)" "unprognostic (2.92e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (1.98e-3)" "prognostic unfavorable (3.95e-6)" "unprognostic (1.36e-2)" "unprognostic (2.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.57e-1)" 24.1 20.3 9.2 24.2 12.2 18.8 24.3 11.3 11.9 16.4 10.1 23.2 22.1 18.3 17.1 24.8 21.8 15.9 20.7 8.6 10.5 21.0 29.7 16.0 30.3 11.0 10.3 19.0 22.3 19.9 12.8 26.1 11.7 17.0 29.1 20.9 16.8 16.7 29.1 17.4 19.4 26.3 11.3 20.0 19.7 29.3 10.9 34.4 20.8 21.9 38.6 32.2 16.5 14.0 132.2 61.5 90.3 98.8 61.1 64.2 100.3 82.6 70.8 96.8 101.5 117.7 108.9 174.8 48.5 55.6 124.9 67.9 189.0 130.4 138.3 91.3 111.7 265.2 68.5 78.6 85.2 148.6 66.3 57.3 86.5 113.3 162.5 48.1 91.5 138.4 312.4 108.5 84.9 63.6 158.2 100.0 194.4 186.3 71.8 131.1 166.6 246.7 74.7 69.4 93.1 84.1 116.9 89.1 107.1 81.0 113.0 93.9 68.7 64.9 76.9 56.1 90.9 106.8 159.6 193.0 67.1 171.3 96.2 9.0 24.0 16.3 25.9 33.9 31.4 29.7 25.2 27.1 31.6 24.5 26.4 26.2 10.6 43.9 30.6 23.2 34.1 22.8 9.2 12.2 11.3 11.9 8.6 10.5 11.0 10.3 11.7 11.3 10.9 14.0 21.1 19.2 19.8 17.3 30.1 46.0 50.3 34.1 38.1 18.5 18.6 17.3 19.3 11.5 28.0 14.7 35.5 41.2 21.8 12.4 23.5 28.4 21.7 23.3 36.9 21.9 13.1 40.3 19.1 24.2 37.4 27.2 21.4 23.4 7.6 31.8 16.1 18.0 23.6 5.0 21.1 17.1 22.4 17.0 12.0 6.6 17.4 17.0 12.4 10.3 19.8 13.3 22.6 17.6 19.3 31.5 12.7 18.0 22.7 54.3 16.4 14.3 17.8 28.5 13.1 23.0 23.9 57.2 27.6 34.4 45.9 25.6 21.2 55.0 24.1 46.6 GBP3 FLJ10961 ENSG00000117226 "Guanylate binding protein 3" Q9H0R5 1 89006679-89022894 "Predicted intracellular proteins" "Antiviral defense, Immunity" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 78.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 127.2;Pancreatic endocrine cells: 106.7;Proximal enterocytes: 133.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 80.9;BJ hTERT+ SV40 Large T+ RasG12V: 56.3;LHCN-M2: 71.3" HPA045657 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 9: Intestine - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA045657: AB_10961631" "unprognostic (1.14e-2)" "unprognostic (2.23e-1)" "unprognostic (6.30e-2)" "unprognostic (1.25e-1)" "unprognostic (4.06e-2)" "unprognostic (2.02e-1)" "unprognostic (2.18e-1)" "unprognostic (4.39e-2)" "unprognostic (3.47e-1)" "unprognostic (7.44e-2)" "unprognostic (4.42e-2)" "unprognostic (1.98e-1)" "unprognostic (1.86e-2)" "unprognostic (1.66e-2)" "unprognostic (9.70e-3)" "unprognostic (3.06e-2)" "unprognostic (5.06e-3)" 8.4 9.2 3.5 10.9 3.8 1.6 12.8 3.3 6.3 7.2 2.9 39.1 78.3 8.9 10.0 6.1 15.3 10.8 5.1 3.3 4.7 13.9 14.9 22.8 14.5 5.4 4.2 8.2 5.9 4.1 4.2 13.8 4.4 10.3 27.4 0.6 11.8 20.2 1.8 7.2 59.8 9.3 4.1 16.1 31.7 2.3 4.1 10.0 9.7 4.2 8.6 27.4 7.7 5.0 26.4 1.6 0.0 0.0 24.5 28.6 4.3 44.4 80.9 41.5 56.3 0.0 2.0 1.9 8.5 40.4 24.0 10.9 0.0 29.5 40.2 0.6 0.0 2.5 4.0 0.5 20.8 9.0 0.1 22.3 5.7 31.1 11.0 28.3 13.9 4.2 0.0 5.8 71.3 0.0 6.5 1.1 0.2 14.3 20.0 2.0 4.8 3.1 41.6 49.1 0.0 0.2 14.0 7.9 0.0 0.8 0.1 2.6 17.2 44.6 3.1 0.4 4.8 7.6 2.6 0.1 0.4 0.2 11.4 0.1 6.0 0.3 11.8 7.0 10.5 3.6 10.5 9.8 6.5 2.8 6.5 9.7 3.1 6.9 13.3 0.4 8.6 5.6 3.5 3.8 3.3 6.3 3.3 4.7 5.4 4.2 4.4 4.1 4.1 5.0 20.7 6.4 18.1 2.9 7.3 6.9 25.7 19.4 6.8 0.1 11.5 7.4 1.4 35.8 24.8 22.0 0.0 7.6 12.4 127.2 13.7 59.4 0.1 46.7 15.0 21.2 9.1 5.7 0.3 61.6 8.2 12.5 27.0 35.0 4.5 5.6 22.5 10.6 5.0 0.0 0.2 34.8 14.2 12.0 5.8 1.5 9.9 18.0 0.0 2.8 21.1 0.7 28.8 0.5 0.1 106.7 71.4 15.4 13.6 17.5 133.3 32.8 69.3 0.2 19.7 3.9 8.0 0.5 0.2 5.9 4.8 2.2 21.8 10.9 28.8 37.2 GBP4 Mpa2 ENSG00000162654 "Guanylate binding protein 4" Q96PP9 1 89181144-89198942 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 84.4;Endothelial cells: 81.2;Hepatic stellate cells: 92.4;Theca cells: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 12.1;HDLM-2: 9.9;HEL: 13.0;REH: 11.1;RT4: 18.3;U-266/70: 16.0" "HPA030101, HPA062039" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 15: RT4 - Unknown function" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Golgi apparatus" "Plasma membrane" "HPA030101: AB_10601654, HPA062039: " "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (1.02e-2)" "unprognostic (1.07e-3)" "unprognostic (3.22e-1)" "unprognostic (9.93e-3)" "unprognostic (5.65e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (1.22e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.02e-3)" 11.3 5.2 4.0 29.5 3.9 6.6 6.7 4.4 4.8 4.2 2.6 6.6 12.4 8.8 4.5 7.2 9.1 8.8 11.0 3.8 4.3 9.8 14.1 31.2 34.3 7.1 3.7 16.4 1.6 6.5 2.7 11.9 7.7 5.8 7.2 3.4 7.1 6.7 7.1 2.1 11.8 7.7 3.9 29.0 11.9 2.9 4.4 10.0 7.8 9.4 11.0 13.1 4.5 3.9 0.8 0.0 0.1 0.3 0.1 0.1 0.6 1.8 7.6 8.0 7.2 0.1 12.1 0.6 1.0 2.3 0.6 0.9 0.0 0.3 0.4 9.9 0.1 13.0 0.4 0.3 1.0 0.2 0.3 0.4 0.0 0.1 0.0 1.2 1.9 0.3 0.4 2.3 0.0 0.2 6.6 0.3 0.4 0.1 0.1 11.1 0.2 0.4 0.1 18.3 0.2 0.5 0.3 0.7 0.3 0.6 0.5 1.4 0.4 0.3 1.6 0.2 0.2 16.0 0.3 0.3 0.3 0.1 2.3 0.6 4.1 0.4 7.1 14.1 6.1 2.5 7.6 7.9 2.2 3.3 5.6 5.2 5.6 13.8 14.5 0.9 9.0 5.5 4.0 3.9 4.4 4.8 3.8 4.3 7.1 3.7 7.7 3.9 4.4 3.9 84.4 32.1 39.3 0.0 28.3 4.6 9.1 20.7 1.8 2.8 3.5 2.4 3.6 8.6 25.3 5.5 8.4 0.9 29.0 5.1 0.0 2.2 1.9 4.8 8.4 81.2 0.0 11.2 0.5 3.3 1.6 22.2 9.2 7.4 21.5 17.9 92.4 6.5 8.3 0.0 2.5 4.3 4.1 29.2 10.9 1.2 3.7 33.7 5.4 15.9 33.8 15.5 36.0 1.0 0.6 36.3 1.9 1.9 7.2 24.4 4.4 1.5 43.3 12.2 0.0 5.3 11.3 2.4 3.4 2.9 3.0 1.5 34.2 122.6 2.4 13.6 GCN1 "GCN1L, GCN1L1, KIAA0219" ENSG00000089154 "GCN1 activator of EIF2AK4" Q92616 12 120127202-120194715 "Plasma proteins, Predicted intracellular proteins" "Stress response, Translation regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018799, HPA019648, HPA024367" Enhanced Enhanced Cytosol NA NA 120000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 15: RT4 - Unknown function" "Cluster 59: Non-specific - Transcription" Cytosol "HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569" "unprognostic (7.36e-2)" "unprognostic (2.10e-3)" "unprognostic (3.17e-1)" "unprognostic (2.60e-1)" "unprognostic (1.26e-1)" "unprognostic (3.14e-2)" "prognostic unfavorable (1.87e-8)" "unprognostic (5.24e-2)" "unprognostic (1.59e-1)" "unprognostic (1.20e-2)" "unprognostic (2.07e-1)" "unprognostic (1.75e-1)" "unprognostic (6.35e-2)" "unprognostic (1.21e-1)" "unprognostic (2.34e-1)" "unprognostic (7.09e-3)" "unprognostic (1.43e-1)" 17.2 16.5 9.5 16.0 11.6 19.1 16.9 10.3 10.1 17.1 12.7 18.7 12.1 20.0 9.5 22.3 17.3 9.5 16.1 8.9 9.4 16.2 17.8 16.0 18.3 11.6 10.6 20.2 22.9 18.0 21.1 16.5 10.0 15.8 12.4 8.8 18.2 12.7 44.4 22.0 18.1 14.7 9.2 20.5 20.5 17.9 11.8 18.3 19.7 22.9 16.3 18.6 16.4 13.4 51.4 99.3 35.1 39.7 54.4 32.7 122.4 44.9 38.9 45.8 37.2 85.6 34.5 67.8 49.6 64.8 29.0 49.5 82.1 63.5 28.4 45.5 66.9 84.0 65.5 59.8 35.2 78.2 51.5 40.3 36.3 54.3 50.9 40.2 42.5 30.3 100.3 17.0 38.8 51.6 49.7 59.1 62.3 48.8 59.9 59.7 36.0 67.3 31.2 172.8 57.4 57.4 73.8 31.7 26.5 33.1 67.5 43.8 58.6 37.3 41.0 24.7 47.0 66.2 65.4 67.1 35.7 40.5 38.2 0.7 1.8 1.3 3.3 1.7 4.1 2.0 2.6 2.7 2.3 2.1 1.9 2.1 0.0 1.8 4.1 2.7 2.6 1.9 9.5 11.6 10.3 10.1 8.9 9.4 11.6 10.6 10.0 9.2 11.8 13.4 12.0 9.6 17.9 0.0 11.2 0.0 6.8 0.0 9.6 14.1 11.9 13.6 0.0 12.8 9.3 22.0 10.4 14.2 12.0 8.1 1.9 15.6 1.9 9.0 14.1 10.5 3.6 16.2 0.0 15.9 38.2 10.5 25.5 14.9 5.1 25.7 10.4 24.6 11.2 16.8 0.0 11.4 0.0 9.1 0.0 3.5 14.3 8.9 0.0 0.0 11.1 9.0 7.2 0.0 0.0 18.6 8.6 12.8 17.7 15.7 11.1 9.1 2.9 12.1 6.6 16.4 8.9 8.8 20.8 14.1 0.0 14.6 10.1 14.3 11.7 15.8 GEMIN4 "DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97" ENSG00000179409 "Gem nuclear organelle associated protein 4" P57678 17 744421-753999 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 148.3;Late spermatids: 157.2;Spermatocytes: 57.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065699, HPA067891" Uncertain Supported "Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA065699: AB_2685534, HPA067891: AB_2685918" "unprognostic (1.85e-1)" "unprognostic (3.36e-1)" "unprognostic (1.05e-1)" "unprognostic (3.92e-2)" "unprognostic (1.60e-1)" "unprognostic (7.41e-3)" "unprognostic (2.00e-2)" "unprognostic (7.95e-2)" "unprognostic (1.98e-2)" "unprognostic (1.63e-1)" "unprognostic (1.89e-2)" "unprognostic (8.67e-3)" "unprognostic (4.65e-2)" "unprognostic (1.88e-1)" "unprognostic (1.61e-1)" "unprognostic (4.74e-2)" "unprognostic (8.56e-3)" 12.4 7.7 3.0 8.2 3.0 15.5 12.3 10.5 6.2 13.4 5.9 9.5 8.0 12.1 5.7 14.8 12.3 13.0 11.2 2.9 3.3 4.9 8.6 9.8 13.6 2.3 2.4 15.6 9.7 6.3 5.7 6.6 2.6 14.4 6.3 3.4 11.7 8.2 13.9 38.9 9.8 8.5 2.1 10.0 14.5 48.9 3.1 13.2 15.6 10.1 12.3 11.8 12.4 2.6 44.8 77.8 25.5 38.3 15.8 19.9 31.7 25.0 17.4 44.4 39.1 44.5 23.6 77.9 32.5 21.6 23.6 55.4 48.3 47.0 35.3 29.6 72.3 28.0 40.9 25.1 11.3 30.1 36.8 19.3 23.3 36.5 25.6 15.4 25.3 44.9 39.6 31.7 24.0 31.7 49.8 17.0 24.7 37.4 33.0 53.1 12.1 36.6 18.9 32.5 26.4 21.4 25.7 26.1 11.7 18.2 27.8 21.7 20.2 27.3 24.6 35.6 61.4 5.3 12.4 44.8 23.5 41.9 31.8 1.6 7.0 0.3 7.9 9.6 13.6 11.8 8.6 8.4 9.3 12.3 10.1 10.2 0.9 8.7 11.6 5.2 6.0 10.0 3.0 3.0 10.5 6.2 2.9 3.3 2.3 2.4 2.6 2.1 3.1 2.6 2.9 16.0 6.7 1.3 8.5 20.4 14.3 6.6 9.1 2.9 4.6 4.7 38.4 4.3 8.5 0.0 0.0 8.4 4.4 3.1 3.9 7.5 148.3 2.6 3.9 5.8 1.2 3.0 1.2 6.4 8.3 6.4 7.7 2.9 1.3 11.1 4.6 5.2 5.4 5.0 1.5 7.0 8.2 3.9 5.7 157.2 11.5 2.6 5.4 1.0 4.8 2.4 2.1 0.0 0.5 8.4 1.8 6.8 4.3 7.4 2.3 2.2 4.4 1.4 0.0 6.2 6.4 57.0 11.2 8.7 16.1 4.0 3.2 7.4 8.7 9.8 GEMIN6 FLJ23459 ENSG00000152147 "Gem nuclear organelle associated protein 6" Q8WXD5 2 38751534-38785002 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 164.5;Spermatocytes: 87.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035726, HPA035727" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Nucleoplasm, Nuclear bodies" "HPA035726: AB_10669528, HPA035727: AB_2674753" "unprognostic (1.97e-2)" "unprognostic (3.83e-1)" "unprognostic (2.32e-1)" "unprognostic (1.31e-2)" "unprognostic (1.86e-1)" "unprognostic (2.10e-2)" "unprognostic (3.82e-3)" "unprognostic (3.10e-2)" "unprognostic (8.13e-2)" "unprognostic (3.53e-3)" "unprognostic (2.71e-1)" "unprognostic (1.20e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (2.47e-1)" "unprognostic (2.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.67e-2)" 6.5 10.1 7.7 7.7 8.2 3.6 8.3 8.2 10.9 6.7 8.2 6.9 9.0 6.5 10.3 7.1 9.0 5.5 6.0 7.7 7.6 12.5 13.8 5.3 10.8 7.7 7.8 9.8 6.8 7.5 6.2 7.4 8.1 5.6 8.5 6.1 6.1 5.2 13.1 5.4 7.8 8.7 7.4 7.9 7.2 19.6 8.0 8.1 6.7 7.0 12.4 7.7 5.8 10.5 38.8 31.2 21.3 24.9 27.3 23.8 36.4 32.4 16.1 28.1 23.3 33.1 18.1 52.8 36.3 16.8 39.4 18.1 33.5 31.6 40.7 45.5 42.3 34.4 17.9 54.4 18.7 29.0 17.2 16.3 22.9 37.6 18.5 19.2 29.9 14.1 35.9 17.9 28.4 27.4 35.1 37.0 36.6 45.4 37.0 24.1 37.6 28.9 25.8 13.4 26.6 41.9 8.3 31.1 25.3 24.7 16.0 9.8 16.4 27.1 34.6 21.4 49.1 36.7 77.4 50.6 21.8 43.0 27.7 3.1 24.3 7.8 19.6 28.6 21.7 32.4 20.3 20.3 24.0 29.5 24.4 25.5 3.6 26.3 26.6 17.7 31.3 22.4 7.7 8.2 8.2 10.9 7.7 7.6 7.7 7.8 8.1 7.4 8.0 10.5 11.8 12.8 24.0 1.0 18.7 8.3 10.3 31.5 7.4 6.9 13.9 21.1 9.1 14.3 22.3 11.0 4.2 29.7 7.5 7.5 29.4 22.2 164.5 28.6 21.3 14.9 1.2 18.5 1.7 17.8 37.8 16.1 16.8 8.3 12.6 19.0 16.8 33.5 26.4 11.8 1.8 10.7 6.1 19.5 15.5 29.0 20.5 15.0 10.6 1.9 23.4 9.2 15.5 1.5 1.2 19.1 11.4 11.3 13.3 10.7 21.2 68.5 32.6 7.9 19.7 10.7 15.7 87.8 18.3 16.1 11.5 7.3 12.5 30.5 17.7 7.7 GEMIN8 "FAM51A1, FLJ20514" ENSG00000046647 "Gem nuclear organelle associated protein 8" Q9NWZ8 X 14006726-14029893 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028613 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Cytosol" "HPA028613: AB_10602905" "unprognostic (7.10e-2)" "unprognostic (1.91e-3)" "unprognostic (1.83e-1)" "unprognostic (1.87e-3)" "unprognostic (2.58e-1)" "unprognostic (5.42e-2)" "prognostic unfavorable (7.78e-5)" "unprognostic (3.87e-3)" "unprognostic (3.29e-1)" "unprognostic (2.40e-2)" "unprognostic (5.52e-2)" "unprognostic (2.40e-1)" "unprognostic (4.74e-2)" "unprognostic (4.23e-2)" "unprognostic (2.07e-2)" "unprognostic (7.75e-2)" "prognostic favorable (7.73e-5)" 15.7 15.0 16.3 10.9 19.1 14.3 21.4 19.4 15.9 19.8 20.9 18.3 8.7 22.3 18.8 15.6 22.1 15.2 15.2 16.0 17.8 17.8 15.7 14.3 16.2 21.2 18.8 28.1 20.4 15.0 21.5 10.5 21.2 15.8 12.4 28.5 23.4 18.2 9.5 16.6 12.3 18.9 20.3 14.7 16.3 6.9 18.2 12.9 20.8 6.0 14.1 15.5 15.7 24.0 12.7 12.7 15.2 3.2 26.9 38.6 7.9 11.8 11.7 10.1 7.5 6.0 20.7 29.3 25.7 10.5 11.1 16.0 10.7 21.3 13.1 14.8 17.1 7.5 8.9 14.2 13.8 18.9 15.3 29.5 32.1 18.0 32.1 30.3 25.2 22.0 13.2 24.6 17.0 16.2 17.2 26.6 15.2 16.5 6.6 26.3 9.7 51.4 15.6 12.9 13.0 37.1 14.6 21.5 13.8 35.7 28.4 16.3 16.6 7.1 4.2 19.7 4.6 16.7 8.7 19.1 16.2 10.5 4.3 1.0 10.1 0.4 13.1 9.9 15.2 17.2 20.5 12.2 18.9 13.3 17.4 13.5 1.2 15.4 10.9 22.1 13.0 11.5 16.3 19.1 19.4 15.9 16.0 17.8 21.2 18.8 21.2 20.3 18.2 24.0 9.5 6.4 8.9 23.2 8.1 7.6 11.7 16.8 13.6 3.4 13.3 15.4 5.2 11.5 15.0 9.2 0.0 15.2 7.2 5.1 19.6 22.7 19.9 20.7 6.7 8.4 3.5 5.5 13.2 11.8 16.0 11.3 9.7 14.8 6.3 8.0 4.6 7.5 10.9 10.1 18.0 11.1 10.2 6.0 6.1 3.4 10.2 5.0 1.8 4.7 7.6 6.7 7.2 16.1 44.0 11.2 7.4 8.6 15.8 6.5 5.5 36.6 15.9 6.4 0.0 11.2 9.4 7.4 5.5 12.9 9.5 8.3 7.2 14.0 12.2 9.4 GHDC LGP1 ENSG00000167925 "GH3 domain containing" Q8N2G8 17 42188799-42194532 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 70.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031650 Uncertain "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "HPA031650: AB_10601014" "unprognostic (2.30e-2)" "unprognostic (1.63e-1)" "unprognostic (2.60e-1)" "prognostic favorable (3.21e-4)" "prognostic unfavorable (6.81e-5)" "unprognostic (5.13e-2)" "unprognostic (3.35e-2)" "unprognostic (2.56e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (5.20e-4)" "unprognostic (6.69e-3)" "unprognostic (5.18e-2)" "prognostic favorable (2.00e-6)" "unprognostic (2.08e-1)" "unprognostic (7.93e-2)" "unprognostic (9.66e-2)" "unprognostic (4.02e-2)" 15.7 32.9 14.3 10.1 15.2 11.8 15.8 15.1 16.2 18.6 15.2 15.3 15.8 15.1 11.0 8.8 15.9 10.6 12.3 13.9 15.8 24.5 18.6 15.9 13.2 18.3 15.7 22.2 26.4 12.8 16.7 9.3 16.7 20.7 5.3 3.8 24.1 14.2 7.8 9.8 19.4 5.3 15.0 32.2 19.5 5.9 15.5 7.4 26.8 5.7 6.5 15.5 13.3 16.3 7.5 26.1 1.8 20.5 6.8 6.0 16.1 9.9 7.7 5.0 6.5 8.4 35.4 11.4 34.9 9.2 6.1 0.6 5.8 0.2 1.2 18.8 21.1 17.3 11.9 18.0 17.7 13.9 70.4 9.1 5.3 13.7 4.2 6.1 7.8 6.9 16.8 50.0 2.6 9.2 9.0 27.1 4.4 28.1 0.0 8.7 9.5 49.8 13.8 6.0 4.0 13.9 0.3 46.1 34.4 0.4 31.8 22.0 6.7 23.3 9.2 20.4 4.7 37.3 31.3 7.7 19.7 17.3 9.6 0.8 3.2 1.8 2.3 3.0 1.0 2.5 1.5 2.3 2.7 4.1 1.5 1.8 1.6 1.1 4.1 2.4 1.4 2.6 14.3 15.2 15.1 16.2 13.9 15.8 18.3 15.7 16.7 15.0 15.5 16.3 16.2 0.0 9.6 4.9 9.9 2.9 9.3 8.8 2.2 7.6 8.8 7.1 2.1 14.3 6.7 16.5 6.2 13.1 8.7 5.1 3.9 12.9 1.0 5.6 8.5 12.6 13.8 4.6 2.6 19.3 11.6 10.0 6.1 8.9 13.3 6.5 28.5 15.3 27.9 8.4 4.3 10.7 8.2 25.5 5.4 1.3 11.5 12.6 8.8 2.8 9.3 16.2 13.4 1.0 3.5 10.3 4.8 13.9 4.7 6.5 25.6 16.5 7.8 5.5 0.0 12.8 6.3 2.8 0.5 2.2 1.8 7.3 9.5 15.9 9.4 5.4 GLOD4 "C17orf25, CGI-150, HC71" ENSG00000167699 "Glyoxalase domain containing 4" Q9HC38 17 757097-783390 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021623, HPA023246, HPA023248" Enhanced Approved Cytosol NA NA 3500000 "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA021623: AB_1844365, HPA023246: AB_1844366, HPA023248: AB_1844367" "unprognostic (2.82e-1)" "unprognostic (1.80e-1)" "unprognostic (1.33e-1)" "unprognostic (1.45e-2)" "unprognostic (1.99e-1)" "unprognostic (2.11e-1)" "unprognostic (2.88e-1)" "unprognostic (3.35e-1)" "unprognostic (3.13e-2)" "unprognostic (6.27e-2)" "unprognostic (4.86e-2)" "unprognostic (1.96e-2)" "prognostic favorable (2.18e-6)" "unprognostic (6.21e-3)" "unprognostic (1.33e-1)" "unprognostic (2.46e-1)" "unprognostic (3.02e-1)" 42.5 46.8 27.4 33.5 31.0 22.5 34.5 25.4 33.3 28.4 33.4 71.3 80.5 31.6 33.6 42.9 44.9 32.6 37.3 30.6 36.4 75.7 67.7 31.5 46.9 27.8 27.9 39.9 40.5 37.6 23.2 36.7 28.8 37.8 48.3 25.6 39.5 27.3 39.8 44.3 72.7 31.9 28.3 36.8 85.3 19.4 35.3 35.2 47.4 23.0 40.0 41.5 22.4 27.5 121.1 106.8 120.9 67.1 52.0 51.5 73.8 94.4 57.6 75.0 56.7 87.4 84.0 142.9 100.2 42.8 69.7 85.5 106.6 60.1 78.0 105.4 91.2 69.0 55.7 115.5 51.6 72.1 87.5 36.2 81.9 75.5 66.0 47.7 70.4 116.9 115.1 90.4 80.2 73.9 124.1 55.3 88.7 118.8 36.3 122.7 49.0 65.9 74.5 81.2 54.8 91.8 74.8 53.6 124.6 75.3 66.6 75.2 92.2 71.0 56.8 99.9 120.4 50.3 100.0 89.1 83.6 79.5 75.9 26.1 51.8 48.7 68.1 64.1 73.2 70.0 81.0 82.2 45.9 75.4 68.9 75.7 7.1 64.0 70.4 47.2 99.1 75.9 27.4 31.0 25.4 33.3 30.6 36.4 27.8 27.9 28.8 28.3 35.3 27.5 52.2 57.7 35.2 11.4 48.5 47.9 40.4 91.1 40.5 39.6 39.2 36.3 30.9 54.3 70.4 101.2 29.2 104.5 43.2 39.3 178.1 77.3 34.0 44.0 34.3 43.8 28.9 54.7 12.7 57.4 85.9 41.5 71.4 40.8 40.4 42.1 31.1 58.8 82.3 13.5 13.6 52.0 97.6 30.1 26.5 63.3 38.8 40.8 67.6 7.5 61.7 39.8 44.3 10.1 13.2 58.7 52.0 46.6 27.5 39.4 110.5 186.1 66.8 38.7 46.0 30.3 45.8 23.5 32.9 53.6 54.8 69.1 53.3 57.2 63.7 39.3 GMEB2 "KIAA1269, P79PIF, PIF79" ENSG00000101216 "Glucocorticoid modulatory element binding protein 2" Q9UKD1 20 63587602-63627101 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 29.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA009706, HPA067455" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 39: CACO-2 - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoplasm Cytosol "HPA009706: AB_1078996, HPA067455: AB_2685845" "unprognostic (4.55e-1)" "unprognostic (5.65e-2)" "unprognostic (3.16e-1)" "unprognostic (1.38e-3)" "unprognostic (1.36e-1)" "unprognostic (4.85e-2)" "unprognostic (2.77e-3)" "unprognostic (2.04e-1)" "unprognostic (5.47e-2)" "unprognostic (5.43e-2)" "unprognostic (2.01e-2)" "unprognostic (2.04e-2)" "unprognostic (6.86e-3)" "unprognostic (2.82e-2)" "unprognostic (3.84e-1)" "unprognostic (3.46e-1)" "unprognostic (2.29e-1)" 7.5 8.0 6.2 5.0 5.9 19.3 7.4 6.3 6.7 8.7 5.5 8.5 5.0 9.0 2.5 9.3 10.3 3.1 7.9 6.1 5.3 8.5 9.0 8.2 6.7 6.2 5.8 9.5 9.8 5.6 8.3 3.6 5.6 9.0 2.4 2.1 8.8 3.5 9.2 9.3 9.3 3.3 5.2 10.7 8.2 13.4 6.2 8.1 15.5 3.4 4.4 8.0 7.1 5.6 13.8 8.3 9.9 8.6 4.7 4.3 13.2 9.3 5.9 14.7 7.7 25.9 10.1 10.9 9.5 8.1 10.6 19.2 7.8 13.7 6.5 5.8 8.8 8.5 12.7 12.6 6.4 8.1 13.6 6.2 12.9 9.5 11.8 6.2 6.5 13.6 12.6 7.7 5.1 14.9 19.8 17.8 7.1 16.3 13.1 21.3 10.1 10.1 6.1 12.1 14.8 12.2 17.0 14.8 10.0 4.5 18.1 13.3 8.3 16.0 8.7 9.7 10.4 14.7 12.8 17.2 9.7 7.5 10.7 0.0 0.8 1.4 1.7 1.0 1.5 0.7 1.5 1.5 0.8 1.0 1.6 1.4 1.7 0.8 2.5 1.0 1.1 1.0 6.2 5.9 6.3 6.7 6.1 5.3 6.2 5.8 5.6 5.2 6.2 5.6 5.6 3.2 5.6 9.1 7.3 6.0 11.2 3.8 5.2 5.2 6.4 5.6 3.2 4.3 5.0 3.7 0.0 4.1 6.3 9.3 1.9 4.3 29.3 6.9 5.2 6.8 9.6 2.5 5.3 5.4 6.9 4.2 5.6 10.3 2.5 6.0 4.6 6.6 4.5 8.4 4.2 7.6 2.0 3.5 3.8 6.9 4.1 4.5 1.8 4.7 3.2 2.4 4.1 2.5 4.8 6.1 8.2 5.7 7.8 12.0 5.5 3.5 4.2 5.9 6.6 5.0 4.6 22.2 9.5 5.1 5.4 11.5 8.9 3.5 6.1 12.1 GNL2 "HUMAUANTIG, Ngp-1, Nog2, Nug2" ENSG00000134697 "G protein nucleolar 2" Q13823 1 37566816-37595937 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027163, HPA060026" Approved Enhanced "Nucleoli,Nucleoli rim" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Nucleoli rim" "HPA027163: AB_10601655, HPA060026: AB_2684191" "unprognostic (1.38e-2)" "unprognostic (5.23e-2)" "unprognostic (2.61e-1)" "unprognostic (9.49e-2)" "unprognostic (2.00e-1)" "unprognostic (1.16e-1)" "prognostic unfavorable (5.86e-9)" "unprognostic (2.28e-1)" "unprognostic (7.80e-2)" "prognostic favorable (7.89e-4)" "unprognostic (1.01e-2)" "unprognostic (8.19e-2)" "prognostic unfavorable (2.90e-11)" "unprognostic (3.36e-2)" "unprognostic (7.33e-3)" "unprognostic (3.37e-1)" "unprognostic (1.87e-1)" 27.8 22.4 11.1 24.8 12.1 49.9 30.4 12.5 13.5 21.7 13.1 22.8 17.8 22.8 24.4 26.4 20.1 19.4 21.6 10.9 12.1 19.2 31.6 22.7 26.5 13.0 12.0 20.4 20.8 20.9 19.3 23.5 12.7 18.2 25.5 11.7 23.2 14.2 50.6 29.5 18.7 24.4 12.1 19.6 21.9 30.2 13.5 26.1 16.0 29.0 32.7 35.2 21.2 14.1 66.5 33.5 63.9 66.4 49.8 57.1 102.9 98.6 68.5 89.3 90.4 92.6 75.2 107.8 62.7 73.5 50.8 60.6 105.1 80.5 121.1 62.6 83.5 108.4 66.4 74.5 66.5 143.3 73.7 36.2 72.6 122.4 144.3 42.7 65.2 47.1 146.8 74.6 87.3 58.2 77.7 85.9 165.8 48.2 65.9 81.8 114.7 121.8 75.0 70.7 76.9 71.1 74.2 73.4 73.1 93.8 52.7 82.5 53.0 59.1 83.9 127.2 138.6 69.9 67.8 185.8 68.3 113.2 77.3 23.2 28.1 24.4 22.5 36.3 26.0 28.1 21.0 24.6 39.8 21.1 21.9 21.2 2.8 33.5 35.3 29.0 28.2 21.7 11.1 12.1 12.5 13.5 10.9 12.1 13.0 12.0 12.7 12.1 13.5 14.1 18.5 16.0 48.1 6.5 29.7 63.3 84.3 37.2 27.3 8.8 17.5 14.5 21.9 12.8 63.3 7.3 10.4 37.2 27.8 18.2 27.4 52.9 54.0 27.2 31.0 28.1 17.3 17.7 6.4 62.3 49.4 40.8 23.9 29.7 48.1 29.5 11.0 18.3 32.0 6.7 5.3 27.3 24.4 17.9 29.6 13.5 23.9 27.7 8.8 8.4 31.7 21.1 25.7 3.5 5.7 51.5 21.9 19.2 32.4 68.3 15.7 18.8 54.4 9.6 0.0 44.8 34.8 46.7 45.6 29.5 52.8 46.1 28.3 20.6 27.5 56.5 GNPNAT1 "FLJ10607, Gpnat1" ENSG00000100522 "Glucosamine-phosphate N-acetyltransferase 1" Q96EK6 14 52775193-52791668 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 77.1" "Cell type enhanced" "Detected in all" "Hepatocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044647 Approved NA NA 72000 "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 21: OE19 - Mitochondria" "Cluster 55: Plasma cells - Humoral immune response" "HPA044647: AB_10795986" "unprognostic (4.55e-3)" "unprognostic (1.19e-2)" "unprognostic (4.47e-3)" "unprognostic (5.18e-3)" "unprognostic (4.23e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-1)" "unprognostic (3.19e-3)" "unprognostic (1.03e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (8.52e-5)" "unprognostic (5.82e-2)" "unprognostic (3.22e-3)" "unprognostic (2.16e-2)" "unprognostic (1.68e-1)" "unprognostic (1.31e-1)" "unprognostic (4.05e-2)" 21.5 7.3 4.8 11.1 5.5 3.9 16.8 6.9 6.1 14.6 5.0 18.4 15.0 9.2 9.5 8.5 8.4 11.4 5.4 5.9 5.8 13.6 77.1 6.0 7.3 4.9 4.7 9.3 25.4 8.0 5.8 10.5 5.4 15.5 22.0 5.6 19.3 7.0 11.2 6.7 14.1 10.7 4.9 5.5 19.7 15.3 5.1 5.8 8.5 7.3 8.5 13.8 6.1 6.2 99.8 37.6 30.5 34.7 32.0 73.8 49.9 63.6 41.4 53.5 54.8 43.4 59.1 56.3 34.6 64.2 26.2 40.0 59.2 64.0 92.9 32.4 31.1 38.1 36.2 55.1 46.2 42.7 19.5 29.9 53.1 92.9 99.5 27.7 62.1 35.3 36.7 13.4 70.8 85.6 52.0 21.9 31.8 129.1 67.6 34.7 14.4 33.9 51.2 51.3 30.6 42.8 54.1 70.5 46.6 20.8 83.4 14.6 70.1 55.2 56.9 97.6 50.0 14.0 28.4 24.4 26.1 27.4 32.8 6.4 1.7 0.1 5.0 2.1 6.0 4.6 5.2 4.6 4.0 5.1 5.9 4.7 0.6 5.5 5.0 2.4 6.8 3.1 4.8 5.5 6.9 6.1 5.9 5.8 4.9 4.7 5.4 4.9 5.1 6.2 14.1 16.0 12.1 5.2 10.7 19.2 33.7 19.1 10.2 9.6 23.6 16.3 3.6 18.6 18.5 12.9 4.2 23.3 10.6 13.4 33.2 40.3 43.8 16.0 25.5 17.7 5.4 13.3 16.5 37.6 74.8 25.8 32.6 39.5 7.0 16.5 12.1 89.4 15.5 3.3 10.8 61.0 10.2 6.0 9.3 11.8 19.6 8.6 7.2 8.4 5.4 5.3 18.6 9.0 9.0 45.9 14.0 18.0 13.8 42.0 8.0 16.1 13.0 6.4 19.7 18.3 24.7 71.2 7.2 22.3 21.3 12.2 10.6 13.7 30.1 38.1 GPATCH4 "DKFZP434F1735, FLJ20249, GPATC4" ENSG00000160818 "G-patch domain containing 4" 1 156594301-156601496 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028323, HPA054319" Approved Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA028323: AB_10601017, HPA054319: AB_2682447" "unprognostic (2.80e-2)" "unprognostic (4.61e-2)" "unprognostic (3.45e-1)" "unprognostic (1.28e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (2.40e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-3)" "unprognostic (9.60e-2)" "unprognostic (6.39e-3)" "prognostic unfavorable (3.70e-4)" "unprognostic (1.07e-1)" "unprognostic (1.71e-1)" "unprognostic (6.03e-2)" "unprognostic (6.80e-2)" 24.5 19.5 12.1 16.7 12.4 10.6 18.9 8.7 17.3 14.9 8.0 19.8 8.9 19.9 9.1 21.7 16.6 6.8 23.0 11.5 12.4 26.5 21.4 14.9 16.8 12.5 13.0 15.0 19.6 15.6 10.1 9.6 12.8 19.2 13.0 2.9 16.3 10.6 79.0 17.3 16.2 14.3 9.9 18.6 19.3 13.1 11.7 11.8 14.4 31.9 19.0 22.8 16.1 14.7 54.6 67.6 31.2 46.3 28.1 20.4 44.0 66.0 27.8 53.3 30.7 74.9 44.8 131.6 55.0 47.8 34.3 38.7 68.9 59.4 54.5 38.2 65.2 82.1 65.2 57.3 26.2 174.9 48.3 25.0 51.1 96.9 79.3 13.1 36.6 44.0 135.5 31.8 40.7 96.2 82.0 39.8 138.9 92.5 71.4 72.9 52.1 96.3 35.0 58.4 50.4 75.8 59.6 146.7 41.6 31.9 46.2 89.3 52.8 50.7 66.0 53.4 121.1 57.8 69.5 169.9 45.7 89.7 79.7 0.1 9.4 0.1 20.9 17.9 20.4 29.1 21.2 24.0 17.5 30.7 24.1 25.1 0.4 19.0 22.0 11.1 15.7 12.6 12.1 12.4 8.7 17.3 11.5 12.4 12.5 13.0 12.8 9.9 11.7 14.7 17.0 32.1 38.3 5.2 36.0 73.7 65.9 32.5 26.2 7.7 23.8 25.4 27.2 25.8 33.4 16.5 8.4 35.6 19.5 26.5 25.4 51.9 12.9 19.1 53.7 32.5 37.0 42.9 6.4 57.1 53.0 29.0 23.0 20.1 57.7 24.3 18.5 46.9 37.4 8.4 4.6 26.1 10.2 13.6 21.3 11.4 26.8 19.0 23.2 2.8 18.8 6.9 23.7 1.5 3.3 53.0 17.5 26.7 23.8 92.5 7.8 34.3 14.9 6.4 32.9 66.0 45.4 47.4 44.3 33.5 62.7 15.5 26.3 38.6 43.6 51.5 GPATCH8 "GPATC8, KIAA0553" ENSG00000186566 "G-patch domain containing 8" Q9UKJ3 17 44395281-44503430 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Excitatory neurons: 312.1;Inhibitory neurons: 287.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044380 Approved Approved "Nuclear speckles,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Nuclear speckles" Mitochondria "HPA044380: AB_10965696" "unprognostic (3.37e-1)" "unprognostic (5.90e-2)" "unprognostic (1.27e-1)" "unprognostic (1.37e-1)" "unprognostic (6.07e-3)" "unprognostic (2.13e-2)" "unprognostic (5.86e-3)" "unprognostic (2.25e-1)" "unprognostic (1.38e-1)" "unprognostic (6.84e-3)" "unprognostic (8.47e-2)" "unprognostic (6.99e-2)" "unprognostic (2.04e-2)" "unprognostic (1.50e-1)" "unprognostic (9.91e-2)" "unprognostic (7.58e-2)" "unprognostic (2.49e-1)" 10.5 9.2 12.0 11.3 13.3 18.3 11.0 15.0 14.0 10.6 9.3 8.9 11.1 14.5 11.8 9.4 11.1 8.8 8.9 11.8 12.5 9.0 7.0 10.7 15.7 12.9 12.9 17.3 8.0 14.4 0.4 13.1 12.7 9.5 10.4 30.1 9.3 10.2 33.4 15.5 11.0 12.5 12.1 13.1 8.8 10.8 13.0 20.8 11.0 13.8 15.4 9.8 0.8 13.5 22.0 12.8 22.8 18.9 17.5 20.2 23.1 16.7 21.1 18.3 19.2 19.0 13.9 31.1 10.9 23.7 15.8 16.7 23.3 19.3 27.2 25.7 20.8 26.5 15.5 22.5 20.9 25.7 20.3 22.9 20.5 20.9 27.2 18.4 20.2 19.4 20.1 18.7 16.8 10.0 33.7 9.9 16.0 12.5 16.2 27.1 25.8 21.7 16.0 10.6 15.9 19.3 16.6 10.6 20.9 27.0 13.9 17.3 22.5 18.0 12.6 19.3 23.4 20.1 17.9 29.2 16.8 14.1 19.3 8.2 6.1 4.9 9.4 6.0 8.7 8.6 8.2 7.8 6.5 7.1 7.5 7.3 4.6 10.3 13.6 8.0 4.1 5.2 12.0 13.3 15.0 14.0 11.8 12.5 12.9 12.9 12.7 12.1 13.0 13.5 38.8 22.4 32.5 148.5 64.6 48.7 53.1 52.0 47.8 72.7 28.8 22.7 40.5 30.0 46.0 25.8 123.0 42.4 76.6 25.2 9.8 32.8 19.6 38.7 63.3 38.8 38.8 50.1 312.1 24.5 39.3 48.4 23.9 56.5 42.4 44.6 44.3 19.4 23.0 146.4 287.3 20.3 36.7 36.2 42.3 7.6 63.0 38.6 23.2 108.7 42.5 43.5 161.7 172.9 204.1 34.7 24.7 43.2 58.1 45.3 30.2 14.6 29.8 125.3 52.6 68.6 51.2 93.1 74.2 33.7 46.9 53.4 69.8 43.1 25.4 56.8 GPR89A UNQ192 ENSG00000117262 "G protein-coupled receptor 89A" B7ZAQ6 1 145607988-145670650 "Predicted membrane proteins" "Ion transport, Protein transport, Transport" "Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA076096 Approved "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Endoplasmic reticulum" "HPA076096: AB_2686777" "unprognostic (1.19e-1)" "unprognostic (6.71e-2)" "unprognostic (2.44e-1)" "unprognostic (1.29e-1)" "unprognostic (3.51e-3)" "unprognostic (4.51e-2)" "unprognostic (1.99e-3)" "unprognostic (8.14e-2)" "unprognostic (4.61e-3)" "unprognostic (5.41e-2)" "unprognostic (1.96e-1)" "unprognostic (3.00e-2)" "unprognostic (1.02e-5)" "unprognostic (1.42e-1)" "unprognostic (3.70e-2)" "unprognostic (5.47e-2)" "unprognostic (1.21e-1)" 5.9 6.7 6.0 3.7 6.0 4.1 14.1 8.6 7.0 11.9 6.2 8.7 9.8 6.4 6.9 5.9 7.6 8.2 7.0 6.3 7.3 31.2 24.7 5.7 5.7 7.3 7.5 4.2 12.9 11.7 3.4 7.1 8.4 9.5 11.8 4.3 6.9 7.2 6.7 4.7 11.6 9.7 6.5 3.3 8.5 14.8 6.9 8.1 10.6 8.7 8.0 8.3 2.3 6.9 20.7 11.6 18.0 9.7 35.1 34.3 19.2 23.0 25.8 29.3 33.2 27.6 24.4 13.4 13.2 26.0 14.3 20.2 19.9 22.4 25.8 21.5 15.5 9.8 15.8 14.2 29.3 30.5 6.7 36.4 26.5 21.9 28.6 12.7 21.9 16.2 23.7 30.2 40.6 29.7 13.1 11.5 23.5 36.3 25.4 15.5 21.0 48.7 24.8 12.6 7.0 15.4 30.7 36.8 16.6 30.1 32.4 20.0 9.6 27.1 6.5 24.0 23.2 15.2 33.2 17.4 20.6 16.4 20.2 3.7 5.8 7.1 9.2 5.7 9.5 6.0 7.1 9.9 8.1 3.0 7.3 6.5 1.1 9.3 7.6 6.5 8.2 5.0 6.0 6.0 8.6 7.0 6.3 7.3 7.3 7.5 8.4 6.5 6.9 6.9 6.1 22.4 5.9 16.0 13.7 7.6 10.1 17.7 15.4 6.9 10.2 6.3 13.9 14.3 13.2 14.7 12.5 20.1 12.1 6.5 0.0 13.6 13.6 4.8 6.0 6.5 13.7 24.4 29.0 20.2 21.2 9.1 12.8 5.6 5.7 5.1 7.9 9.2 9.3 3.3 24.3 11.2 20.3 5.1 4.0 8.6 9.6 7.3 10.6 7.5 9.0 7.5 17.5 14.1 19.7 17.1 6.0 7.2 20.9 8.5 24.3 13.7 8.0 6.9 13.1 7.3 8.2 45.4 24.6 10.1 8.5 16.1 14.6 6.3 10.9 5.7 GRWD1 "GRWD, RRB1, WDR28" ENSG00000105447 "Glutamate rich WD repeat containing 1" Q9BQ67 19 48445841-48457022 "Predicted intracellular proteins" "DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042643, HPA055680" Approved Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim" No No "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim" Nucleoplasm "HPA042643: AB_10795510, HPA055680: AB_2682884" "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (4.99e-2)" "unprognostic (1.00e-1)" "unprognostic (3.46e-1)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.16e-4)" "unprognostic (1.71e-2)" "unprognostic (5.68e-2)" "unprognostic (2.69e-2)" "unprognostic (7.70e-2)" "unprognostic (2.83e-2)" "unprognostic (8.10e-2)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.02e-1)" "unprognostic (5.07e-2)" 16.0 13.7 6.3 14.0 5.8 14.0 14.4 7.0 6.9 13.7 7.2 11.5 13.1 16.1 4.2 18.2 13.0 8.6 13.6 6.2 6.7 13.0 16.3 10.9 16.0 6.9 7.4 13.7 18.6 13.0 8.6 11.4 7.4 12.2 6.5 3.7 12.7 8.9 28.4 17.5 10.9 8.6 5.6 14.1 13.8 7.4 8.7 11.5 11.8 14.5 10.6 14.6 13.5 7.3 58.3 148.9 25.0 47.3 20.2 19.8 21.6 44.9 20.8 62.2 51.8 84.0 42.4 83.4 37.8 28.7 35.0 48.8 62.7 67.9 24.9 63.8 86.5 78.2 48.6 60.4 23.0 71.9 47.8 23.8 37.0 58.9 29.4 14.3 31.5 43.8 107.3 50.1 27.0 59.1 75.1 180.1 68.1 63.8 43.2 92.9 28.3 58.5 26.4 70.4 56.2 32.1 51.3 71.0 22.4 15.4 34.6 36.5 35.2 57.9 49.1 25.9 107.1 50.6 126.8 78.3 19.7 64.8 69.0 0.3 24.8 3.3 41.5 40.7 46.4 44.4 37.1 41.0 40.9 44.8 42.6 40.3 2.0 41.6 32.4 29.7 36.3 37.4 6.3 5.8 7.0 6.9 6.2 6.7 6.9 7.4 7.4 5.6 8.7 7.3 17.3 3.2 17.5 1.0 26.8 46.3 31.7 18.6 23.3 13.4 16.0 13.7 7.1 14.3 14.3 12.9 0.0 41.4 15.1 14.4 23.5 29.0 3.8 13.1 20.5 19.1 19.2 28.8 1.6 18.2 39.7 18.1 13.3 14.3 19.7 16.8 13.6 18.5 24.4 21.9 3.9 14.5 14.2 11.1 14.3 19.4 17.1 11.4 28.4 2.8 25.3 6.1 19.6 3.0 2.6 22.4 6.5 12.4 28.5 24.2 6.8 18.8 16.8 15.7 19.7 22.7 20.4 9.4 34.3 20.5 40.6 35.0 17.9 26.3 17.1 24.0 GSPT1 "eRF3a, ETF3A, GST1" ENSG00000103342 "G1 to S phase transition 1" P15170 16 11868128-11916082 "Plasma proteins, Predicted intracellular proteins" "Nonsense-mediated mRNA decay, Protein biosynthesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052488, HPA074588" Approved Approved Vesicles,Cytosol NA NA 210000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol Vesicles "HPA052488: AB_2681849, HPA074588: " "unprognostic (4.13e-2)" "unprognostic (1.66e-1)" "prognostic favorable (2.10e-5)" "unprognostic (1.64e-1)" "unprognostic (2.05e-1)" "unprognostic (6.44e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (2.38e-1)" "unprognostic (2.31e-1)" "unprognostic (1.74e-1)" "unprognostic (1.41e-3)" "unprognostic (1.65e-1)" "prognostic favorable (3.06e-5)" "unprognostic (3.47e-1)" "unprognostic (1.19e-1)" "unprognostic (6.61e-3)" "unprognostic (3.13e-2)" 60.8 57.5 22.3 49.5 24.7 76.3 46.0 24.4 33.3 42.0 27.4 56.0 33.8 34.5 46.6 67.9 30.1 35.2 53.4 23.9 24.5 53.6 76.3 47.7 55.4 25.0 23.1 33.3 62.2 62.7 27.5 50.0 26.2 47.8 59.6 35.3 41.0 41.8 127.0 43.5 34.3 46.9 25.0 40.2 49.8 68.7 23.1 56.3 57.7 97.8 82.0 85.7 39.6 29.3 220.1 212.9 116.1 161.0 164.2 169.3 167.5 238.0 245.9 187.1 185.4 153.1 197.8 295.7 303.9 207.5 130.1 164.3 297.8 220.3 312.9 142.4 153.6 202.0 163.1 325.5 137.9 258.7 103.5 133.5 170.0 212.0 288.3 122.4 210.4 146.2 331.7 148.7 220.0 211.2 219.8 134.0 232.9 163.0 120.1 256.4 200.5 345.6 184.7 189.3 186.4 99.6 342.0 256.3 144.2 164.3 222.4 122.6 163.3 206.8 129.5 151.5 190.3 146.6 233.2 253.8 145.4 258.1 128.5 1.4 5.8 7.7 6.3 11.1 8.8 7.9 8.1 7.7 7.0 6.5 8.2 8.1 1.9 7.2 9.9 3.8 10.5 4.3 22.3 24.7 24.4 33.3 23.9 24.5 25.0 23.1 26.2 25.0 23.1 29.3 69.4 76.9 160.2 39.5 92.3 242.2 232.0 47.1 170.8 47.7 95.0 61.6 123.4 57.2 69.1 86.5 50.1 76.1 94.5 88.1 103.7 58.9 94.9 109.0 95.6 74.4 66.6 328.5 61.6 63.4 118.3 77.2 81.1 153.9 24.7 93.2 43.5 77.9 75.2 52.2 47.0 107.2 32.6 60.8 116.3 51.6 47.8 80.9 64.0 35.6 50.1 43.6 25.7 38.7 42.9 73.0 66.9 47.4 166.2 271.0 38.3 120.3 52.7 41.5 59.2 94.6 123.0 138.3 83.5 198.5 257.7 102.1 132.1 128.1 114.1 270.4 GTF2H3 "BTF2, P34, TFIIH" ENSG00000111358 "General transcription factor IIH subunit 3" Q13889 12 123633739-123662604 "Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004844, HPA053562" Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA004844: AB_2667265, HPA053562: AB_2682191" "unprognostic (1.07e-1)" "unprognostic (1.36e-1)" "unprognostic (6.02e-2)" "unprognostic (6.13e-3)" "unprognostic (2.29e-1)" "unprognostic (7.34e-2)" "prognostic unfavorable (6.72e-8)" "unprognostic (1.02e-1)" "unprognostic (1.22e-3)" "unprognostic (3.30e-1)" "unprognostic (1.37e-1)" "unprognostic (1.10e-1)" "unprognostic (5.68e-3)" "unprognostic (4.71e-2)" "unprognostic (1.22e-1)" "unprognostic (7.49e-2)" "unprognostic (2.80e-2)" 10.4 9.0 6.1 12.9 6.0 11.2 15.6 5.8 6.9 11.7 5.0 14.0 10.5 12.9 8.9 15.4 15.0 9.7 10.7 5.8 5.2 11.2 14.1 9.7 16.6 5.9 6.3 11.2 5.6 11.7 5.9 12.9 6.4 13.0 16.2 10.1 7.3 11.3 13.8 12.8 10.6 14.2 5.8 10.4 11.7 12.2 6.2 16.0 13.4 11.1 16.1 11.4 8.2 7.1 42.0 21.7 27.6 35.5 33.3 37.1 38.9 31.2 38.2 47.1 31.6 23.2 21.1 48.4 37.4 43.0 18.8 27.8 46.2 56.4 56.2 41.4 32.5 39.7 19.3 33.3 46.8 80.9 25.3 39.7 42.2 38.2 85.9 35.3 34.2 59.4 60.4 15.7 42.9 27.4 40.5 27.2 35.6 29.6 39.9 41.3 42.1 27.4 24.1 40.1 24.8 21.8 41.1 19.8 32.1 30.1 55.4 48.1 22.9 29.3 22.3 45.9 50.7 28.8 42.3 47.6 33.7 40.5 34.3 11.4 4.6 6.0 7.6 6.9 7.6 5.9 6.1 8.1 7.0 5.7 8.7 8.0 0.6 10.7 7.0 5.9 6.7 4.1 6.1 6.0 5.8 6.9 5.8 5.2 5.9 6.3 6.4 5.8 6.2 7.1 20.8 22.4 24.3 23.5 19.2 11.7 12.3 20.9 27.9 16.2 12.6 15.2 7.4 12.8 22.3 12.9 10.4 26.3 13.8 8.4 3.9 12.9 8.6 18.3 24.7 11.1 6.7 21.6 26.6 11.0 23.4 17.1 16.8 16.7 24.1 19.9 12.1 16.9 17.2 16.8 27.8 12.3 6.1 12.3 7.9 4.3 11.8 15.3 1.8 10.3 16.1 21.9 7.2 15.6 23.1 10.8 10.8 11.3 17.1 10.5 6.1 15.8 20.7 13.7 13.1 18.8 15.2 32.6 27.1 25.7 13.2 23.7 14.5 36.2 15.7 10.4 GYS1 "GSY, GYS" ENSG00000104812 "Glycogen synthase 1" P13807 19 48968130-48993310 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Glycogen biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "heart muscle: 118.5;skeletal muscle: 319.4;tongue: 201.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007793, HPA041598" Enhanced Approved Microtubules,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" "Microtubules, Cytosol" "CAB007793: AB_562291, HPA041598: AB_2677571" "unprognostic (3.37e-1)" "unprognostic (3.07e-1)" "unprognostic (1.02e-1)" "unprognostic (1.83e-1)" "unprognostic (1.92e-1)" "unprognostic (2.04e-2)" "unprognostic (6.83e-3)" "unprognostic (2.41e-2)" "unprognostic (1.12e-1)" "unprognostic (3.30e-2)" "unprognostic (1.30e-1)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.46e-4)" "unprognostic (4.04e-2)" "unprognostic (6.76e-2)" "unprognostic (5.87e-3)" "unprognostic (3.81e-2)" 32.4 26.3 17.9 16.2 18.8 46.0 23.7 26.4 23.3 17.1 22.2 21.7 15.3 18.8 8.9 38.2 18.7 10.1 118.5 19.7 17.6 21.8 14.9 16.0 15.5 22.2 20.9 19.7 13.6 15.7 15.5 11.3 19.6 27.4 14.7 19.2 22.2 15.5 319.4 20.7 19.9 16.7 16.4 18.5 23.2 6.1 20.2 14.7 15.9 201.6 14.4 24.3 23.2 18.3 67.3 26.3 19.0 26.3 43.2 16.9 37.6 45.5 31.7 46.8 54.3 25.8 21.3 28.0 27.0 44.7 12.4 46.6 32.0 57.7 40.6 17.4 46.5 23.1 33.3 23.1 24.3 25.4 15.9 41.8 27.2 30.2 25.4 40.5 39.8 28.8 16.4 36.1 59.4 25.4 31.8 21.9 10.2 29.0 29.8 26.6 33.2 27.5 46.7 70.6 11.8 16.4 40.5 52.1 10.4 25.2 27.7 26.1 31.0 57.1 22.0 26.1 50.5 29.8 33.1 13.5 58.3 22.2 13.1 7.7 9.4 6.6 7.0 5.3 8.6 5.2 6.0 6.5 13.4 3.9 4.7 4.4 3.7 10.6 8.0 7.2 8.6 7.1 17.9 18.8 26.4 23.3 19.7 17.6 22.2 20.9 19.6 16.4 20.2 18.3 3.5 0.0 14.2 21.9 5.9 5.1 3.7 11.7 11.4 4.2 7.3 5.5 67.9 2.8 5.8 0.0 16.7 7.6 6.8 13.2 0.0 8.1 0.3 6.9 8.9 7.1 7.2 4.8 14.7 6.9 31.7 5.0 12.8 11.9 4.5 6.7 9.7 5.2 8.3 0.0 16.6 9.2 4.1 7.0 5.7 0.7 5.3 7.2 7.2 4.7 9.8 3.3 10.3 8.5 6.9 11.8 8.2 5.7 9.7 5.4 9.2 6.0 6.2 11.7 0.0 5.0 7.3 1.3 2.9 15.3 4.1 4.0 5.2 3.8 11.7 3.3 H4C5 "H4/j, H4FJ, HIST1H4E" ENSG00000276966 "H4 clustered histone 5" P62805 6 26204552-26206038 "Disease related genes, Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 69.4" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 1.2;Cytotrophoblasts: 2.7;dendritic cells: 1.8;Extravillous trophoblasts: 1.6;Hofbauer cells: 4.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 69.4" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 6.1;U-266/70: 11.3" HPA042201 Supported NA NA 25000000 "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 29: U-266 - Adaptive immune response" "Cluster 24: Non-specific - Transcription regulation" "HPA042201: AB_2677898" "unprognostic (8.62e-2)" "unprognostic (4.86e-2)" "unprognostic (5.71e-3)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.57e-1)" "unprognostic (5.08e-3)" "unprognostic (7.99e-2)" "unprognostic (1.21e-1)" "unprognostic (6.57e-2)" "unprognostic (2.34e-3)" "unprognostic (4.34e-2)" "prognostic unfavorable (2.00e-6)" "unprognostic (1.28e-2)" "unprognostic (1.88e-1)" "unprognostic (1.40e-1)" "unprognostic (4.92e-2)" 0.8 0.5 12.1 0.4 14.5 2.1 0.8 69.4 14.4 3.8 0.5 1.9 0.9 0.5 0.8 2.6 2.7 0.2 1.1 10.8 8.1 3.1 1.0 1.0 0.5 3.9 3.2 2.8 0.5 0.2 2.2 0.5 6.9 7.5 0.5 1.5 1.3 0.3 0.0 1.9 0.9 0.2 15.2 1.5 1.6 2.0 7.2 1.9 1.5 0.0 0.4 0.6 3.6 16.8 1.1 0.7 1.3 3.1 0.5 0.0 0.7 1.1 0.3 0.5 0.4 0.4 1.1 0.4 1.5 0.3 0.7 1.9 0.7 0.1 0.7 0.9 0.8 0.3 1.5 0.7 0.0 0.5 1.2 0.3 0.0 0.4 0.3 0.3 0.4 1.0 2.3 2.6 0.1 0.4 6.1 2.8 1.3 0.5 1.0 2.7 1.4 2.7 0.5 0.4 3.7 0.9 0.8 1.3 0.4 0.4 1.2 0.5 0.5 1.5 2.1 0.4 0.9 11.3 4.7 1.7 0.3 1.1 1.1 2.7 2.1 1.8 2.0 1.8 2.9 2.5 3.0 2.0 3.1 5.4 3.2 2.6 2.6 2.3 5.5 2.7 2.0 1.2 12.1 14.5 69.4 14.4 10.8 8.1 3.9 3.2 6.9 15.2 7.2 16.8 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 HARS1 "HARS, HisRS, USH3B" ENSG00000170445 "Histidyl-tRNA synthetase 1" P12081 5 140673035-140691537 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cytotrophoblasts: 41.4;dendritic cells: 11.5;Extravillous trophoblasts: 48.6;Hofbauer cells: 35.7;Syncytiotrophoblasts: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036539 Approved Enhanced Cytosol NA NA 190000 "Cluster 27: Non-specific - Gene expression" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 39: CACO-2 - Unknown function" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA036539: AB_10669796" "unprognostic (9.35e-2)" "unprognostic (9.95e-2)" "unprognostic (1.62e-3)" "unprognostic (1.65e-2)" "unprognostic (2.33e-1)" "unprognostic (8.57e-2)" "prognostic unfavorable (1.96e-7)" "unprognostic (6.50e-2)" "unprognostic (1.46e-1)" "unprognostic (3.82e-2)" "unprognostic (1.28e-2)" "unprognostic (2.40e-1)" "unprognostic (3.46e-2)" "unprognostic (2.99e-1)" "unprognostic (1.25e-1)" "unprognostic (6.26e-2)" "unprognostic (1.36e-1)" 31.6 39.9 64.8 27.1 67.0 24.3 29.3 64.9 88.7 32.9 57.9 39.2 21.8 34.5 27.1 42.9 30.8 21.0 38.3 67.8 72.2 30.7 47.3 27.2 29.6 71.2 69.9 31.3 40.8 37.1 60.0 18.5 72.8 33.0 29.6 18.5 29.2 32.0 56.7 53.9 28.6 35.2 62.1 32.2 36.0 25.6 77.4 32.2 27.1 33.4 36.8 34.3 32.0 71.9 66.8 94.3 55.5 120.5 68.9 74.9 57.9 104.8 75.0 118.6 109.4 174.8 54.1 88.4 90.3 118.3 94.3 66.6 85.9 169.2 111.6 74.5 105.0 63.7 115.4 111.8 86.3 101.1 49.8 80.4 51.5 129.0 72.6 69.5 122.1 52.2 56.5 68.6 125.6 111.0 71.8 100.6 43.3 52.3 60.9 65.4 82.0 70.9 97.0 82.2 86.5 83.7 86.1 121.5 84.2 54.9 89.5 55.5 100.3 107.8 41.6 61.5 144.7 68.5 90.5 89.4 82.8 83.1 76.1 16.2 31.2 24.0 61.0 46.3 54.2 34.9 54.1 57.6 48.5 34.6 58.1 55.4 8.1 59.3 54.9 34.3 51.3 56.7 64.8 67.0 64.9 88.7 67.8 72.2 71.2 69.9 72.8 62.1 77.4 71.9 9.6 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 41.4 11.5 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 48.6 6.1 0.0 0.0 0.0 0.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 36.0 1.7 0.0 0.0 0.0 HCFC2 HCF-2 ENSG00000111727 "Host cell factor C2" Q9Y5Z7 12 104064531-104106524 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 250.3;Spermatocytes: 130.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006227 Approved Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Plasma membrane, Cytosol" "HPA006227: AB_1079042" "unprognostic (4.22e-3)" "unprognostic (1.22e-1)" "unprognostic (1.08e-1)" "unprognostic (7.66e-2)" "unprognostic (3.15e-2)" "unprognostic (2.11e-2)" "unprognostic (1.46e-1)" "unprognostic (1.07e-2)" "unprognostic (1.59e-1)" "unprognostic (1.43e-2)" "unprognostic (2.71e-2)" "unprognostic (4.54e-2)" "unprognostic (4.23e-3)" "unprognostic (1.16e-2)" "unprognostic (2.24e-1)" "unprognostic (1.19e-2)" "unprognostic (7.23e-2)" 6.3 6.7 3.8 3.6 5.2 2.7 5.1 4.4 5.4 7.4 2.0 9.2 5.2 7.9 5.0 6.2 5.3 5.7 5.1 3.7 4.2 5.7 7.3 4.7 4.6 4.9 5.0 7.8 6.0 6.7 4.1 6.4 4.8 7.2 4.3 8.0 4.5 9.4 9.7 4.4 5.0 7.2 4.7 5.1 5.2 9.5 4.6 5.2 6.9 11.2 3.7 5.9 6.0 6.6 2.0 2.3 2.3 2.0 12.7 12.5 1.7 9.1 4.1 6.8 3.9 1.1 0.9 2.1 3.1 7.1 2.5 2.2 2.9 1.6 7.3 3.5 2.8 2.1 2.3 1.0 8.5 1.7 3.3 7.8 4.3 4.2 3.5 9.8 5.3 3.1 2.5 4.2 12.3 1.8 3.1 4.0 0.5 1.3 4.7 2.5 7.6 1.3 3.1 1.4 3.3 2.5 4.4 3.2 3.5 1.5 5.0 1.9 8.0 10.7 1.4 5.6 3.1 5.3 1.7 1.8 5.1 2.3 4.4 0.4 0.6 0.9 0.8 1.1 0.9 0.5 0.7 0.9 0.7 0.5 0.8 0.9 0.1 0.8 1.8 0.4 0.9 0.5 3.8 5.2 4.4 5.4 3.7 4.2 4.9 5.0 4.8 4.7 4.6 6.6 19.3 12.8 14.1 18.9 10.0 8.0 6.6 5.4 8.6 19.6 6.1 5.0 12.5 1.5 9.6 5.5 20.9 5.0 8.8 7.4 9.8 6.2 250.3 7.9 18.5 14.4 8.4 7.4 31.8 3.3 5.0 16.0 6.6 6.5 17.1 9.8 15.7 11.5 7.4 23.5 33.9 4.7 8.2 11.4 5.7 59.4 21.8 8.6 7.2 16.9 9.3 13.7 7.2 30.7 45.6 3.1 6.0 27.8 12.2 2.7 7.7 8.6 10.4 22.2 13.1 18.7 17.4 130.9 16.4 8.5 7.2 10.8 11.3 17.9 3.8 3.3 HDAC2 "KDAC2, RPD3, YAF1" ENSG00000196591 "Histone deacetylase 2" Q92769 6 113933028-114011308 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005054, HPA011727" Supported Supported Nucleoplasm NA NA 25000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "CAB005054: AB_562295, HPA011727: AB_1850540" "prognostic unfavorable (7.07e-4)" "unprognostic (1.44e-1)" "unprognostic (2.67e-1)" "unprognostic (2.56e-2)" "unprognostic (2.61e-2)" "unprognostic (1.89e-2)" "prognostic unfavorable (5.39e-10)" "unprognostic (2.03e-1)" "unprognostic (2.63e-2)" "unprognostic (9.00e-2)" "unprognostic (2.01e-1)" "unprognostic (3.92e-1)" "unprognostic (1.84e-2)" "unprognostic (1.96e-1)" "unprognostic (2.42e-1)" "unprognostic (9.80e-2)" "unprognostic (3.51e-1)" 35.9 42.7 26.6 37.4 31.5 63.4 54.8 32.8 40.0 45.2 22.3 48.0 34.4 57.3 53.4 43.3 48.7 34.6 41.1 26.7 34.7 46.3 34.6 33.0 42.6 31.2 29.5 53.4 37.1 45.7 35.9 56.1 31.2 47.0 53.6 37.2 34.3 45.3 48.6 46.1 36.7 54.3 28.8 35.9 40.5 76.7 31.1 68.5 45.6 43.4 52.1 63.2 37.5 37.5 126.7 84.9 387.1 224.3 97.7 110.5 162.6 146.6 119.0 168.5 200.1 226.3 90.1 103.6 119.0 132.5 173.1 96.6 266.0 148.1 281.4 148.9 185.0 249.2 102.1 131.8 129.7 256.1 107.7 90.0 97.6 180.0 167.2 164.4 199.6 179.2 326.4 101.6 282.7 105.5 231.9 229.6 220.0 133.4 116.3 155.0 193.0 95.2 174.4 148.9 258.3 219.1 115.9 107.5 127.7 231.4 78.6 294.0 163.2 107.0 122.9 113.7 246.9 80.6 113.9 244.6 90.9 242.6 185.3 43.5 39.0 42.1 28.0 38.6 37.3 37.0 34.0 30.3 51.0 31.4 41.8 39.1 23.1 39.8 50.2 44.2 36.0 37.2 26.6 31.5 32.8 40.0 26.7 34.7 31.2 29.5 31.2 28.8 31.1 37.5 40.2 57.7 57.8 13.4 51.4 192.1 91.3 152.6 85.4 31.0 61.0 54.6 64.0 25.8 116.4 53.3 4.2 157.7 42.6 43.5 43.0 154.9 86.8 74.3 91.6 73.8 100.5 129.4 29.9 105.0 140.7 76.2 53.5 63.2 55.1 103.9 50.0 31.9 102.0 15.2 26.3 73.4 175.0 64.1 89.8 109.1 83.0 63.3 83.6 26.2 107.7 30.9 33.0 29.1 34.0 133.6 51.3 67.4 56.2 90.0 37.4 71.7 98.7 28.1 39.5 94.7 88.0 199.0 215.5 96.5 193.1 207.7 45.5 53.9 94.6 100.5 HDHD2 DKFZP564D1378 ENSG00000167220 "Haloacid dehalogenase like hydrolase domain containing 2" Q9H0R4 18 47107408-47150500 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040697, CAB045978, HPA059818" Approved Approved Vesicles NA NA 240000 "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 10: Non-specific - Unknown function" Vesicles "CAB045978: AB_11124418, HPA040697: AB_2677084, HPA059818: AB_2684132" "unprognostic (3.22e-1)" "unprognostic (6.32e-2)" "unprognostic (9.95e-2)" "unprognostic (7.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.58e-1)" "unprognostic (3.11e-1)" "unprognostic (1.24e-1)" "unprognostic (2.10e-2)" "unprognostic (5.35e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "prognostic favorable (3.52e-5)" "unprognostic (1.95e-1)" "unprognostic (1.61e-1)" "unprognostic (3.44e-1)" "unprognostic (1.17e-1)" 13.7 26.3 29.1 10.5 31.0 10.5 17.0 37.2 33.4 10.9 27.3 17.2 13.4 11.8 16.0 14.3 16.2 11.9 27.2 28.3 31.5 23.9 30.2 13.5 19.6 34.2 31.8 14.2 17.9 27.0 15.6 11.6 35.2 17.6 16.5 22.1 14.0 17.1 15.5 11.7 13.7 13.5 31.2 13.5 15.8 11.4 31.9 28.1 26.4 24.1 21.2 13.1 10.0 37.5 14.1 9.1 34.5 16.9 20.6 28.4 9.6 15.8 15.3 24.9 25.0 4.7 11.1 23.0 13.4 17.7 11.3 12.2 19.0 21.2 35.3 19.2 17.6 22.1 15.0 23.5 28.2 31.1 19.6 23.4 25.5 14.0 31.3 27.1 21.0 37.2 22.8 26.3 32.6 19.0 29.2 19.6 33.9 11.9 9.3 28.1 22.0 31.2 31.4 21.5 31.2 26.0 15.0 10.6 19.5 23.7 16.0 42.7 15.2 18.9 15.2 5.4 11.5 33.1 16.9 19.9 23.3 32.1 18.8 21.4 24.7 19.7 20.7 22.9 21.8 27.3 21.5 20.5 23.9 26.7 27.1 21.6 2.3 30.5 23.3 15.8 24.2 21.4 29.1 31.0 37.2 33.4 28.3 31.5 34.2 31.8 35.2 31.2 31.9 37.5 8.8 16.0 18.2 21.5 16.9 7.1 11.1 10.7 13.6 22.5 17.7 10.5 13.1 15.7 14.0 11.0 14.6 25.0 9.7 15.6 72.4 18.9 1.9 11.0 8.5 11.5 13.8 13.9 28.9 17.9 15.0 11.0 12.8 6.4 7.6 15.6 13.9 28.1 21.7 45.4 29.2 16.2 14.2 20.3 15.0 2.7 17.7 15.0 16.0 20.6 22.7 53.1 14.4 36.7 45.4 16.4 19.3 23.7 9.7 17.5 16.0 57.7 16.4 27.0 19.7 15.1 19.7 20.2 35.1 13.1 6.0 19.7 12.2 29.8 21.6 13.0 HIBADH NS5ATP1 ENSG00000106049 "3-hydroxyisobutyrate dehydrogenase" P31937 7 27525442-27662883 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Branched-chain amino acid catabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 543.9;Proximal tubular cells: 355.1;Syncytiotrophoblasts: 272.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019522, HPA021002" Enhanced NA NA 820000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" "HPA019522: AB_1850690, HPA021002: AB_1850692" "unprognostic (6.76e-2)" "unprognostic (1.09e-1)" "unprognostic (7.50e-2)" "unprognostic (9.79e-2)" "unprognostic (1.72e-1)" "unprognostic (2.28e-3)" "unprognostic (7.22e-3)" "unprognostic (3.14e-2)" "unprognostic (1.10e-1)" "unprognostic (1.06e-1)" "unprognostic (1.73e-1)" "unprognostic (2.05e-2)" "prognostic favorable (5.56e-11)" "unprognostic (2.49e-2)" "unprognostic (5.47e-2)" "unprognostic (3.38e-2)" "unprognostic (3.39e-2)" 62.1 79.0 15.0 11.9 18.0 7.6 56.5 18.8 18.4 37.2 27.6 33.8 35.0 35.3 11.6 20.4 41.6 28.4 66.7 13.2 18.2 160.5 197.9 20.4 15.1 16.1 17.0 33.4 34.2 97.4 14.1 47.4 16.9 44.7 34.5 31.5 45.4 42.4 117.4 13.1 32.0 37.2 15.6 18.0 34.0 26.4 17.4 21.2 54.5 203.2 14.8 33.5 18.0 17.5 74.0 46.8 31.0 50.1 89.1 109.8 29.3 44.8 83.8 46.3 52.8 27.6 85.2 29.9 38.4 81.4 79.4 67.1 34.5 66.5 67.3 20.9 34.6 14.6 73.0 114.3 73.8 22.4 16.1 101.2 54.1 34.8 120.6 112.1 61.7 35.3 59.7 29.2 117.2 31.2 21.4 34.7 30.0 110.4 56.0 21.2 31.2 33.1 106.5 43.6 28.6 31.7 93.8 173.5 77.9 76.4 75.0 48.6 40.3 28.6 49.5 47.1 31.2 51.8 39.7 17.8 41.2 67.8 85.1 5.3 17.3 8.2 16.7 22.8 22.5 18.2 18.4 19.3 19.3 16.4 24.0 19.8 3.0 22.9 22.0 9.1 13.2 17.4 15.0 18.0 18.8 18.4 13.2 18.2 16.1 17.0 16.9 15.6 17.4 17.5 17.3 9.6 6.4 56.2 14.1 21.3 43.6 51.9 17.1 15.8 58.8 28.2 105.8 58.6 37.7 47.8 4.2 181.1 8.1 23.3 543.9 35.8 58.5 22.8 28.5 21.5 15.6 33.2 64.4 29.1 138.9 44.6 43.3 27.3 2.5 12.0 25.4 149.8 53.7 23.5 85.9 28.9 40.7 28.3 10.0 62.3 44.7 18.5 65.8 51.5 11.0 34.1 8.2 147.2 131.6 28.0 24.1 36.9 20.1 46.1 58.4 355.1 50.8 11.9 46.0 31.6 35.4 35.0 44.3 22.4 15.5 272.4 15.2 77.3 38.8 47.3 HINFP "DKFZP434F162, HiNF-P, MIZF, ZNF743" ENSG00000172273 "Histone H4 transcription factor" Q9BQA5 11 119121580-119136059 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061008 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 36: HEL - Hemostasis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA061008: AB_2684414" "unprognostic (2.79e-1)" "unprognostic (2.63e-2)" "unprognostic (8.77e-2)" "unprognostic (8.41e-2)" "unprognostic (8.39e-2)" "unprognostic (7.44e-2)" "prognostic unfavorable (4.44e-8)" "unprognostic (4.17e-2)" "unprognostic (7.39e-2)" "unprognostic (3.78e-1)" "unprognostic (5.33e-2)" "unprognostic (2.95e-3)" "unprognostic (4.21e-2)" "unprognostic (1.19e-1)" "unprognostic (2.72e-1)" "prognostic favorable (5.26e-4)" "unprognostic (1.25e-2)" 5.1 4.8 8.4 4.6 9.8 4.6 5.2 12.4 9.9 6.2 7.8 7.5 6.9 5.7 4.4 5.5 7.1 3.8 5.5 8.5 7.7 6.7 4.3 5.1 6.8 8.6 7.8 6.8 7.1 6.0 5.2 4.3 8.6 5.7 7.1 11.0 6.6 5.1 9.2 8.6 7.1 5.8 6.7 7.1 6.7 6.6 9.4 11.5 6.2 8.1 7.0 6.5 5.5 11.9 5.9 9.4 10.3 9.6 8.4 5.7 9.3 4.5 7.1 10.1 11.1 17.0 12.9 7.6 15.7 6.3 11.2 13.7 18.0 4.5 6.7 16.9 8.9 39.1 6.8 5.8 9.9 11.7 9.0 8.0 16.0 10.6 9.2 11.7 8.1 14.1 15.7 12.9 5.7 11.5 14.7 10.5 9.1 10.7 8.6 14.5 11.4 8.7 6.8 5.5 14.6 7.1 7.7 11.3 6.3 10.0 15.4 13.3 6.1 8.9 3.5 6.0 5.5 6.1 6.8 8.3 3.3 10.0 6.8 12.8 12.9 9.3 10.0 10.2 11.2 10.0 12.3 11.9 16.5 12.5 16.3 10.0 8.0 17.2 6.9 7.9 16.6 10.4 8.4 9.8 12.4 9.9 8.5 7.7 8.6 7.8 8.6 6.7 9.4 11.9 7.9 0.0 8.8 12.4 11.0 14.4 7.4 10.3 10.8 19.1 12.6 8.6 5.5 8.6 9.2 9.2 35.5 7.4 13.8 17.6 5.9 9.4 9.4 8.3 8.7 10.3 8.4 7.8 16.6 11.0 8.0 7.5 7.1 8.2 5.1 11.3 12.1 4.5 5.4 15.2 16.2 9.7 4.1 7.2 9.5 3.4 8.4 7.2 8.8 4.7 18.1 9.6 12.3 7.5 9.1 9.3 10.3 6.4 12.4 8.6 15.5 5.6 9.5 29.5 0.0 7.4 9.2 38.6 31.8 7.7 16.3 8.3 11.6 12.4 10.7 6.5 HLCS HCS ENSG00000159267 "Holocarboxylase synthetase" P50747 21 36748626-36990236 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Ligase, Multifunctional enzyme" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 86.2;Inhibitory neurons: 99.7;Oligodendrocyte precursor cells: 79.9;Oligodendrocytes: 80.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017379 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 2: Karpas-707 - Immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Cytosol "HPA017379: AB_1850768" "prognostic unfavorable (7.72e-4)" "unprognostic (2.41e-1)" "unprognostic (3.93e-2)" "unprognostic (2.05e-1)" "unprognostic (2.75e-1)" "unprognostic (1.44e-2)" "unprognostic (5.08e-2)" "unprognostic (2.67e-1)" "unprognostic (1.54e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-1)" "unprognostic (7.44e-2)" "unprognostic (2.43e-1)" "unprognostic (2.55e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-3)" "unprognostic (3.02e-1)" 5.0 5.1 4.9 4.2 5.5 3.3 7.4 9.1 5.8 5.1 9.4 4.7 4.2 4.0 7.0 6.1 5.3 4.2 3.7 6.3 5.4 6.4 10.6 4.9 3.7 5.9 4.6 3.8 7.6 10.6 8.8 4.1 6.3 8.9 4.4 6.1 8.5 6.6 13.3 2.8 4.9 4.5 4.1 3.1 5.7 5.7 5.4 3.3 10.7 6.2 4.3 5.4 2.8 5.5 23.8 10.4 13.0 9.6 14.8 13.7 13.3 13.0 12.7 7.1 7.0 10.8 11.0 10.6 6.4 21.4 13.0 8.2 5.9 11.6 5.5 21.0 9.2 16.4 9.6 6.7 14.9 8.6 11.0 10.2 17.0 10.6 23.6 15.5 9.0 12.0 19.7 31.9 17.4 14.2 4.6 5.4 21.8 16.7 11.3 7.1 7.5 11.2 10.8 24.8 8.3 9.9 16.7 8.8 14.8 10.0 16.2 9.1 10.5 9.1 2.7 8.9 7.8 25.6 19.8 7.1 14.6 11.1 10.7 1.9 0.8 0.8 3.6 2.0 2.9 1.2 1.9 2.3 0.8 1.3 2.4 2.2 1.2 4.8 5.1 1.9 1.6 1.8 4.9 5.5 9.1 5.8 6.3 5.4 5.9 4.6 6.3 4.1 5.4 5.5 3.0 9.6 12.5 46.4 4.1 3.3 9.2 5.3 6.8 12.8 9.4 7.4 4.5 8.6 8.4 12.9 22.9 8.9 5.1 3.5 7.9 7.8 5.6 8.0 8.0 3.8 6.0 7.4 86.2 8.1 5.4 5.1 9.7 8.0 5.7 7.9 4.2 18.5 4.6 18.5 99.7 5.2 4.1 5.1 2.1 4.3 4.4 4.0 0.0 45.9 3.2 5.6 8.2 79.9 80.1 9.0 2.9 7.2 4.2 7.8 8.0 6.1 9.2 14.2 0.0 9.0 6.8 5.2 11.5 8.7 4.0 5.1 5.5 11.1 5.4 6.9 HMG20A "FLJ10739, HMGX1, HMGXB1" ENSG00000140382 "High mobility group 20A" Q9NP66 15 77420412-77485607 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 79.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008126 Supported Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA008126: AB_1079072" "unprognostic (2.04e-1)" "unprognostic (6.87e-2)" "unprognostic (2.88e-1)" "unprognostic (1.11e-1)" "unprognostic (2.56e-1)" "unprognostic (1.70e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (1.64e-1)" "unprognostic (1.14e-1)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (9.74e-3)" "unprognostic (3.40e-1)" "unprognostic (1.58e-1)" "unprognostic (1.50e-1)" "unprognostic (2.65e-1)" 12.2 18.2 14.5 15.9 14.2 10.2 14.2 15.1 17.6 15.2 7.8 15.4 12.4 20.3 13.6 13.4 13.2 15.5 25.1 14.4 14.8 14.0 24.9 15.7 25.2 11.5 12.9 22.2 13.0 18.1 9.7 21.8 11.3 11.6 17.0 26.0 13.5 13.9 27.2 13.4 14.2 15.7 12.0 35.8 13.6 21.3 15.0 31.6 15.0 26.4 22.1 14.4 10.8 16.6 17.8 29.8 53.8 38.4 22.4 28.4 21.6 23.2 34.6 27.2 29.5 18.6 26.7 30.2 26.4 27.0 21.0 23.8 76.6 29.3 27.6 27.1 38.4 62.3 26.6 24.5 33.4 46.1 35.7 31.9 20.9 24.2 26.8 36.3 54.9 38.9 47.8 24.6 25.1 14.1 36.8 32.1 39.0 15.8 14.2 48.0 52.1 34.2 31.1 30.7 21.1 45.3 37.5 22.6 70.6 51.2 22.3 48.3 33.8 32.3 28.4 15.2 28.4 33.2 75.7 59.9 24.1 66.3 38.4 9.2 20.8 16.9 29.1 21.2 34.4 31.3 22.9 27.3 27.8 27.3 30.8 27.3 3.4 49.2 26.1 21.1 23.7 24.9 14.5 14.2 15.1 17.6 14.4 14.8 11.5 12.9 11.3 12.0 15.0 16.6 14.6 12.8 11.5 39.2 18.1 8.8 5.3 10.0 13.6 20.6 13.0 12.3 47.2 14.3 10.7 11.0 25.0 13.7 12.9 12.2 5.9 9.9 25.9 10.4 21.1 16.8 18.0 15.4 60.1 8.0 9.5 17.2 13.7 10.0 12.7 16.5 22.9 32.4 16.6 38.7 56.9 15.6 6.1 28.6 11.9 79.5 12.8 13.0 14.2 29.0 22.1 14.3 19.6 64.3 71.1 9.0 10.8 13.9 13.3 6.0 8.4 10.6 4.9 20.6 19.7 13.4 13.2 28.2 17.0 11.3 7.4 13.8 16.4 25.5 13.8 5.5 HNRNPR "hnRNP-R, HNRPR" ENSG00000125944 "Heterogeneous nuclear ribonucleoprotein R" O43390 1 23303771-23344336 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011687, HPA026092" Supported Enhanced Nucleoplasm NA NA 470000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB011687: AB_2295532, HPA026092: AB_1850885" "unprognostic (1.86e-1)" "unprognostic (2.12e-1)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.92e-1)" "unprognostic (5.70e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (2.29e-2)" "unprognostic (1.67e-2)" "unprognostic (3.01e-1)" "unprognostic (1.15e-3)" "unprognostic (3.28e-2)" "unprognostic (7.65e-2)" "unprognostic (1.37e-1)" "unprognostic (4.95e-2)" "unprognostic (4.14e-2)" "unprognostic (4.12e-1)" 51.1 47.9 18.4 48.7 21.6 56.6 49.0 26.0 22.9 55.0 22.3 44.7 33.6 66.1 25.8 54.9 52.6 29.0 40.4 18.1 22.2 43.8 27.2 47.6 58.0 20.2 19.6 61.6 34.0 42.3 33.9 50.0 21.6 35.0 43.2 40.2 46.7 31.8 55.9 51.2 46.7 44.7 20.1 41.9 38.9 31.0 19.2 71.9 43.5 27.7 60.0 48.3 50.1 26.8 161.7 103.9 200.9 123.5 70.0 73.6 103.6 102.7 118.0 178.3 123.0 73.2 113.4 202.3 52.1 141.4 88.9 89.5 211.0 143.9 208.5 142.3 161.4 192.5 131.0 121.9 68.4 224.2 125.1 74.8 86.7 141.5 113.4 73.3 112.9 153.0 185.4 139.9 119.2 98.3 268.3 71.6 111.6 105.3 103.4 196.9 186.5 144.1 96.5 88.7 137.3 132.6 141.8 116.0 88.7 109.5 98.6 102.6 121.0 102.6 133.4 123.8 129.5 81.3 149.0 276.8 71.9 200.7 117.7 21.7 35.9 44.9 49.0 47.2 51.7 41.4 45.0 47.7 45.8 41.6 48.0 45.5 12.8 53.9 48.1 30.0 58.4 46.6 18.4 21.6 26.0 22.9 18.1 22.2 20.2 19.6 21.6 20.1 19.2 26.8 112.0 118.6 109.1 29.0 132.7 127.6 207.1 139.0 95.6 127.8 89.1 78.0 72.3 84.4 138.0 88.3 43.8 253.0 125.8 60.2 92.0 126.6 22.9 110.5 183.8 129.3 116.4 150.4 28.6 126.5 274.4 135.3 92.2 146.2 172.0 171.4 61.8 73.1 106.6 126.2 32.6 107.8 138.4 77.7 92.4 17.2 120.9 98.8 83.6 36.5 147.7 159.9 112.3 63.3 60.6 125.2 64.1 116.6 144.3 208.5 59.6 76.9 114.5 111.1 85.5 159.1 170.2 170.4 148.3 136.4 129.9 206.7 136.5 157.3 116.8 182.4 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3 biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129638-149173732 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease variant, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 115.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 57: B-cells - Immune response" "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: AB_2681943" "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 7.6 9.2 4.2 11.4 4.7 5.6 7.9 4.8 4.2 7.5 8.3 7.5 11.0 9.9 4.9 5.6 8.6 9.0 5.0 3.7 6.0 12.0 8.0 9.7 17.6 6.7 5.6 14.0 6.7 5.7 3.7 10.6 6.8 9.3 9.1 9.6 6.6 8.5 2.8 4.7 10.8 10.3 5.6 16.0 9.2 6.9 5.2 16.8 8.8 3.9 16.4 8.4 5.2 8.5 49.1 26.5 15.7 16.3 21.4 27.4 11.7 19.7 38.4 25.3 32.4 9.1 31.8 12.4 23.8 23.7 115.3 16.5 17.4 13.4 32.4 30.6 13.9 5.8 11.8 9.9 19.1 15.7 9.1 18.0 13.5 24.4 10.0 51.6 26.2 20.2 6.5 29.4 32.5 30.3 11.3 22.1 37.7 26.3 21.1 13.4 10.3 33.7 13.9 24.1 4.7 12.4 16.8 17.7 35.9 33.4 19.2 20.5 13.2 25.2 4.5 26.0 29.0 24.0 10.0 30.6 37.7 30.1 6.3 20.7 12.5 12.1 12.0 15.2 14.5 15.4 10.9 12.9 19.5 12.2 8.4 10.9 5.7 9.8 10.3 11.0 10.7 10.9 4.2 4.7 4.8 4.2 3.7 6.0 6.7 5.6 6.8 5.6 5.2 8.5 9.9 12.8 19.5 17.6 28.6 3.7 3.9 11.5 6.8 6.7 9.1 7.4 2.5 5.7 22.9 7.3 2.1 21.0 24.3 8.0 5.9 10.7 3.0 10.6 11.6 9.9 9.0 7.4 13.3 18.1 14.6 10.8 16.8 10.4 15.2 18.0 17.5 6.9 19.8 3.3 16.5 8.8 14.2 29.3 23.8 4.8 11.5 33.1 14.2 38.4 14.4 25.1 19.6 19.1 27.3 12.9 4.9 30.1 15.4 6.8 13.6 22.8 20.7 5.2 0.0 7.4 8.4 4.4 8.4 8.7 5.3 14.1 18.9 5.4 7.5 5.1 HRAS HRAS1 ENSG00000174775 "HRas proto-oncogene, GTPase" P01112 11 532242-537287 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins" Hydrolase "Cancer-related genes, Disease variant, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Suprabasal keratinocytes: 145.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "non-classical monocyte: 4.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002015, HPA049830, HPA070222" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Cytosol" "CAB002015: , HPA049830: AB_2680903, HPA070222: " "unprognostic (3.06e-2)" "unprognostic (2.98e-2)" "unprognostic (7.01e-2)" "unprognostic (3.08e-3)" "unprognostic (3.49e-3)" "unprognostic (3.87e-1)" "prognostic unfavorable (2.32e-4)" "unprognostic (1.07e-1)" "unprognostic (2.25e-1)" "unprognostic (1.50e-1)" "unprognostic (2.88e-3)" "unprognostic (9.85e-2)" "unprognostic (2.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.80e-1)" "unprognostic (1.58e-2)" "unprognostic (1.38e-1)" 28.1 24.6 64.6 3.5 67.2 2.9 27.0 62.1 86.8 30.4 58.3 34.3 2.8 23.6 12.5 80.1 18.9 3.6 56.8 64.4 64.6 33.8 21.8 27.1 4.3 65.6 65.3 20.0 20.5 13.1 38.2 9.0 66.9 38.3 6.9 10.2 27.3 12.3 59.0 69.9 19.5 8.9 64.2 20.6 24.2 16.5 64.8 9.2 20.5 25.2 10.2 34.5 44.2 65.4 59.0 105.6 44.2 25.6 22.2 17.5 39.6 49.9 25.1 64.5 29.5 62.4 29.7 20.4 10.9 63.2 60.7 43.7 46.0 114.1 19.3 19.5 108.4 6.6 43.7 56.1 38.5 13.9 12.0 28.3 118.0 42.0 51.5 19.6 31.5 34.3 29.7 32.3 40.9 110.6 34.0 50.5 26.5 39.9 94.5 31.6 40.7 18.2 47.0 33.2 87.6 43.7 25.5 55.4 17.9 31.5 43.3 14.8 35.4 47.3 44.7 16.4 39.7 20.3 17.7 15.4 39.1 17.0 38.3 0.0 0.5 0.6 0.8 0.7 0.4 0.3 0.9 0.8 0.7 2.0 0.9 0.3 0.0 0.1 4.0 0.9 1.5 0.2 64.6 67.2 62.1 86.8 64.4 64.6 65.6 65.3 66.9 64.2 64.8 65.4 51.3 12.8 10.7 9.1 18.0 131.2 101.7 25.4 82.0 46.0 38.8 75.7 25.2 22.8 11.2 35.0 18.8 78.8 21.5 72.2 74.3 35.2 1.6 36.1 28.6 32.0 29.3 11.2 9.8 37.4 63.4 25.9 33.6 34.1 2.5 26.8 22.9 17.4 39.9 48.8 10.6 26.5 4.1 11.7 38.4 7.9 17.1 21.3 64.0 10.3 12.8 50.8 11.3 4.0 12.3 48.2 30.9 23.0 26.5 61.2 30.8 54.6 20.0 37.6 32.9 20.3 40.3 5.4 21.4 118.1 145.9 78.1 22.0 18.8 26.2 106.4 HSF1 HSTF1 ENSG00000185122 "Heat shock transcription factor 1" Q00613 8 144291591-144314720 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport" "Activator, DNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 248.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004239, HPA008888" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "CAB004239: AB_627753, HPA008888: AB_1079088" "unprognostic (7.08e-2)" "unprognostic (1.89e-2)" "unprognostic (6.07e-2)" "prognostic unfavorable (8.93e-4)" "unprognostic (1.55e-1)" "unprognostic (5.63e-2)" "prognostic unfavorable (4.95e-4)" "unprognostic (5.69e-3)" "unprognostic (1.05e-1)" "unprognostic (4.35e-2)" "unprognostic (1.40e-2)" "unprognostic (1.47e-1)" "unprognostic (1.41e-1)" "unprognostic (1.07e-2)" "unprognostic (2.23e-1)" "unprognostic (2.13e-1)" "unprognostic (1.12e-1)" 51.7 55.7 20.0 14.7 19.2 18.0 47.9 18.2 24.0 48.6 17.0 70.6 14.1 51.7 7.4 48.1 52.1 12.4 133.5 18.6 19.1 50.2 46.0 49.5 14.5 22.3 21.4 57.3 68.7 18.7 48.1 17.0 20.2 53.2 10.8 7.6 39.8 17.1 125.1 49.2 39.7 15.3 18.6 42.8 57.8 107.8 21.7 14.7 45.7 32.2 12.6 58.7 46.2 18.0 40.8 53.8 22.9 19.6 37.6 35.0 37.9 29.7 26.6 28.8 25.0 36.3 34.6 46.7 42.5 41.5 28.2 28.9 35.2 42.7 18.3 29.9 40.7 58.4 51.8 50.1 59.1 17.1 43.4 34.2 39.3 40.6 74.2 30.6 39.4 41.9 39.6 27.1 29.4 82.0 58.0 26.2 29.4 52.6 154.2 37.2 19.9 59.2 20.6 40.5 34.3 27.9 45.4 35.9 52.8 23.8 40.5 34.5 40.2 29.5 66.3 46.8 49.5 18.8 15.4 39.9 41.8 31.4 28.8 14.2 23.2 26.3 16.7 24.9 17.2 19.2 17.8 21.1 24.6 17.3 17.1 15.9 9.7 16.3 32.2 12.6 22.9 19.2 20.0 19.2 18.2 24.0 18.6 19.1 22.3 21.4 20.2 18.6 21.7 18.0 46.5 6.4 11.2 8.5 40.4 51.4 73.8 53.8 39.9 67.8 37.0 30.5 46.4 22.8 34.7 29.5 62.6 69.9 38.2 43.3 150.6 39.2 248.7 35.1 20.5 44.4 40.9 120.8 12.1 41.1 80.6 34.7 44.9 34.6 37.5 51.1 40.7 63.8 49.5 69.0 14.7 36.8 42.7 25.7 45.6 106.7 37.3 32.7 33.8 12.2 59.7 24.9 34.0 6.0 12.9 45.3 49.3 42.9 40.4 76.6 63.8 34.9 25.9 33.1 59.2 41.3 39.2 84.4 47.7 36.3 45.5 111.0 39.0 105.9 45.8 76.4 HSP90AB1 "HSPC2, HSPCB" ENSG00000096384 "Heat shock protein 90 alpha family class B member 1" P08238 6 44246166-44253888 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Stress response" Chaperone "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 4755.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005230, HPA055729, HPA072606, HPA074351" Enhanced Supported Cytosol "Intracellular and membrane" NA Yes 63000000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" Cytosol "CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252" "unprognostic (6.12e-3)" "unprognostic (2.96e-3)" "unprognostic (4.72e-2)" "unprognostic (9.24e-2)" "unprognostic (4.20e-1)" "unprognostic (1.15e-3)" "unprognostic (1.76e-3)" "unprognostic (2.74e-1)" "unprognostic (7.97e-2)" "prognostic favorable (4.03e-4)" "unprognostic (1.31e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (9.94e-4)" "unprognostic (3.02e-1)" "unprognostic (9.53e-2)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" 584.8 719.5 647.1 368.9 700.4 466.4 507.6 675.2 1529.5 581.3 651.0 425.3 215.8 594.2 540.1 463.8 708.5 332.5 783.8 699.9 811.5 494.6 396.5 526.9 427.7 707.0 738.2 1204.8 722.9 606.0 574.8 451.9 764.3 471.2 389.8 339.5 410.2 491.9 1379.0 483.7 332.6 526.8 655.1 346.0 538.8 251.6 745.8 362.1 456.8 998.8 571.4 525.0 509.4 818.8 2393.2 1495.7 1298.1 1606.0 871.2 904.4 1355.3 1049.1 1021.8 1898.3 1325.5 2254.5 708.0 3029.2 1106.3 1099.8 1928.1 1349.9 3197.5 1563.4 2326.7 1010.5 1292.5 2359.3 793.9 2978.8 628.9 2386.2 1563.2 842.6 1034.9 1495.5 1277.7 1658.4 1847.6 1533.9 3210.4 1095.1 1309.8 2404.3 2003.1 1432.6 1519.7 4378.9 1129.7 1900.7 1325.9 1658.7 1287.7 1422.1 1891.1 1154.8 816.3 1164.8 1526.2 1751.5 1518.6 1178.2 1169.0 1124.0 1875.7 931.1 2440.0 1255.6 2125.8 5370.7 1221.7 1720.8 1312.1 65.9 231.7 52.8 343.7 341.0 577.8 544.0 380.3 395.0 375.1 473.1 509.3 494.0 27.3 434.9 349.0 232.1 326.8 678.5 647.1 700.4 675.2 1529.5 699.9 811.5 707.0 738.2 764.3 655.1 745.8 818.8 1165.2 897.4 678.2 70.5 906.4 1059.3 4755.7 862.6 1331.1 329.3 938.9 1418.3 1407.0 519.0 942.6 366.0 227.2 1104.3 629.3 538.6 729.8 1011.1 185.5 1385.8 1359.6 1070.6 567.4 775.9 103.5 688.9 1107.1 1247.3 616.2 1444.8 1003.4 761.3 360.5 360.3 807.5 339.9 151.0 578.2 518.8 314.5 1262.5 198.4 686.0 896.7 736.4 76.8 573.3 326.1 200.8 69.9 127.4 811.7 504.8 611.2 725.0 1810.6 361.5 664.8 1219.1 262.1 348.4 1512.7 1437.2 266.1 694.1 1232.8 923.5 1123.3 1265.6 1350.0 739.6 2408.7 HSPA9 "GRP75, HSPA9B, mot-2, mthsp75, PBP74" ENSG00000113013 "Heat shock protein family A (Hsp70) member 9" P38646 5 138553756-138575675 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" Chaperone "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000898, CAB005219" Supported Supported Mitochondria NA NA 3600000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB005219: AB_647720, HPA000898: AB_1079032" "prognostic unfavorable (2.93e-4)" "unprognostic (1.86e-1)" "prognostic favorable (4.53e-4)" "unprognostic (3.73e-2)" "unprognostic (2.33e-1)" "unprognostic (9.06e-2)" "unprognostic (2.05e-2)" "unprognostic (1.10e-1)" "unprognostic (9.85e-2)" "unprognostic (2.53e-1)" "unprognostic (2.74e-1)" "unprognostic (1.31e-1)" "unprognostic (8.78e-3)" "unprognostic (1.02e-1)" "unprognostic (2.15e-1)" "unprognostic (3.27e-2)" "unprognostic (2.29e-1)" 88.6 226.3 10.3 51.5 15.1 98.8 72.4 25.4 26.0 60.3 28.8 80.3 61.2 67.0 33.9 87.8 56.5 38.3 179.5 10.9 19.6 112.1 194.2 62.5 43.6 19.6 20.7 80.0 79.8 169.4 71.4 46.5 23.8 56.4 56.5 48.8 78.9 46.7 288.9 77.5 64.3 44.2 21.6 54.7 91.8 50.1 17.8 44.6 91.3 193.6 55.7 73.8 65.6 29.1 196.0 276.6 111.4 231.0 138.1 94.3 274.7 198.3 196.7 255.4 268.6 579.4 194.4 419.3 263.7 150.8 382.0 158.6 334.0 314.1 298.2 219.7 177.9 230.5 209.0 270.4 360.4 229.0 201.3 142.6 317.7 299.5 494.8 78.7 128.0 167.8 280.4 297.5 134.7 220.6 206.7 82.9 182.5 191.6 173.3 252.1 188.8 302.4 192.8 267.4 150.1 112.4 242.5 338.5 630.7 269.0 230.5 200.5 117.7 204.1 126.5 174.9 313.5 324.6 300.5 378.6 249.6 301.4 202.6 11.8 31.3 10.7 39.8 34.9 46.2 31.7 30.6 36.8 42.0 22.4 34.1 33.9 4.3 28.3 38.8 17.9 31.3 53.6 10.3 15.1 25.4 26.0 10.9 19.6 19.6 20.7 23.8 21.6 17.8 29.1 63.0 99.3 123.8 43.1 101.7 87.8 228.6 157.2 84.8 88.2 83.4 63.8 337.3 70.1 153.8 99.3 83.4 194.7 114.7 80.8 223.0 151.4 12.1 90.1 98.4 83.1 73.0 75.1 41.1 106.1 132.9 109.6 73.9 126.6 167.8 86.1 43.5 175.9 133.9 99.3 48.4 95.4 148.5 54.1 76.4 12.6 67.4 100.1 83.6 25.3 92.3 92.5 43.3 27.6 43.3 93.8 66.0 72.6 102.3 131.1 85.8 231.3 119.7 89.3 46.0 134.3 136.2 52.5 91.4 93.2 73.9 175.5 130.7 157.9 150.7 141.2 HSPH1 "HSP105A, HSP105B, KIAA0201, NY-CO-25" ENSG00000120694 "Heat shock protein family H (Hsp110) member 1" Q92598 13 31134973-31162388 "Cancer-related genes, Predicted intracellular proteins" "Stress response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "brain: 1251.1" "Cell type enhanced" "Detected in all" "Basal prostatic cells: 1316.2" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 6 "cerebral cortex: 1251.1" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002060, HPA028675, HPA031569" Uncertain Enhanced Nucleoplasm,Cytosol No Yes 1300000 "Cluster 27: Non-specific - Gene expression" "Cluster 10: Brain - Neuronal signaling" "Cluster 21: OE19 - Mitochondria" "Cluster 22: Epithelial cell types - Mixed function" Cytosol Nucleoplasm "CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938" "unprognostic (1.10e-2)" "unprognostic (4.94e-2)" "unprognostic (5.44e-2)" "unprognostic (1.36e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (1.41e-5)" "unprognostic (5.03e-2)" "unprognostic (1.38e-1)" "unprognostic (1.74e-1)" "unprognostic (1.53e-1)" "unprognostic (3.13e-1)" "unprognostic (7.45e-3)" "unprognostic (9.61e-2)" "unprognostic (2.58e-1)" "unprognostic (2.04e-1)" "unprognostic (7.89e-2)" 52.2 42.1 175.9 23.5 193.6 20.7 27.9 175.2 1251.1 25.0 182.5 29.3 11.3 25.9 37.6 35.8 54.8 32.3 57.3 184.9 189.3 73.5 47.6 66.6 34.9 172.7 180.7 56.3 28.6 30.3 63.8 37.8 180.9 28.4 25.3 26.7 20.1 29.3 36.6 21.7 20.4 28.0 177.2 32.3 53.1 67.8 190.2 37.4 32.2 32.6 45.1 58.8 35.4 227.4 69.9 130.7 105.1 10.2 99.1 56.0 70.0 117.8 104.6 179.0 82.8 154.9 105.4 179.6 71.9 82.4 253.7 131.2 411.7 104.8 229.2 141.6 51.7 155.7 69.3 137.2 32.3 109.1 118.8 35.5 236.5 119.6 68.3 93.0 105.4 62.0 132.7 27.8 127.4 94.7 158.1 124.2 150.3 338.6 96.6 122.5 85.8 58.9 135.0 83.5 108.5 90.1 107.4 104.0 56.6 160.6 35.0 104.7 64.4 61.3 77.4 89.2 132.4 21.8 76.0 150.6 51.0 129.8 104.7 1.4 5.0 2.7 7.6 12.2 9.4 11.1 9.7 11.8 8.4 10.6 14.7 13.8 0.5 16.7 19.6 6.6 7.0 7.7 175.9 193.6 175.2 1251.1 184.9 189.3 172.7 180.7 180.9 177.2 190.2 227.4 171.1 131.4 87.7 36.6 130.8 214.6 1316.2 44.7 175.2 38.7 152.2 143.3 163.6 40.0 123.3 46.0 417.0 23.2 78.9 153.2 29.4 49.8 100.0 346.1 140.1 132.3 227.7 58.9 121.0 35.9 64.2 249.6 94.3 250.6 248.6 61.7 26.4 25.7 90.6 30.3 77.7 159.0 65.1 38.6 452.1 36.5 33.8 281.3 163.7 55.3 42.6 28.2 26.8 30.7 53.2 45.5 154.0 39.1 142.0 426.3 18.2 31.6 290.5 79.0 39.5 98.1 153.1 161.3 164.6 151.1 143.3 42.5 363.8 58.5 166.1 511.8 HTT "HD, IT15" ENSG00000197386 Huntingtin P42858 4 3041363-3243960 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 181.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002756, HPA026114" Uncertain Supported Nucleoplasm,Cytosol NA NA 36000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm Cytosol "CAB002756: , HPA026114: AB_1851330" "unprognostic (2.05e-1)" "unprognostic (1.09e-1)" "unprognostic (8.79e-3)" "unprognostic (1.08e-1)" "unprognostic (1.66e-1)" "prognostic favorable (3.26e-4)" "unprognostic (1.52e-2)" "unprognostic (8.33e-2)" "unprognostic (8.06e-2)" "unprognostic (2.15e-1)" "unprognostic (1.87e-2)" "unprognostic (6.04e-2)" "prognostic favorable (2.41e-12)" "unprognostic (9.46e-3)" "unprognostic (1.99e-1)" "unprognostic (6.53e-2)" "unprognostic (3.84e-2)" 8.3 9.3 10.5 8.2 11.7 8.1 7.6 7.8 14.2 6.1 8.2 8.1 6.0 7.1 8.3 10.4 6.7 5.1 7.1 15.7 3.5 7.9 8.9 10.1 11.5 8.7 5.2 7.2 21.3 12.3 9.0 6.9 7.8 7.0 6.5 10.3 7.2 5.8 15.3 15.1 9.7 5.8 3.0 11.5 8.9 10.1 6.8 11.3 9.1 12.4 8.8 7.3 7.0 11.0 19.5 14.2 17.6 10.3 30.9 20.2 17.7 9.0 10.4 13.0 12.6 17.3 12.2 28.6 8.9 20.9 21.6 10.7 20.6 15.3 12.0 7.8 15.4 27.4 18.0 18.8 7.5 17.7 37.9 11.1 9.5 25.4 10.7 9.3 14.3 13.0 17.7 9.9 11.4 17.9 22.4 17.1 21.2 9.7 20.7 17.7 16.9 5.7 14.2 18.1 18.5 13.9 15.0 5.7 14.6 12.9 16.1 10.8 20.6 16.8 11.1 12.4 19.0 7.6 8.8 22.9 13.4 16.4 13.3 0.0 0.7 0.9 1.0 1.1 0.7 0.8 0.8 1.3 1.1 0.6 0.4 0.7 0.1 0.9 1.5 0.7 1.2 0.7 10.5 11.7 7.8 14.2 15.7 3.5 8.7 5.2 7.8 3.0 6.8 11.0 15.8 25.6 14.8 41.1 20.7 13.8 8.0 12.4 9.1 48.1 20.4 15.4 10.4 17.2 14.6 14.7 181.4 11.8 26.1 22.4 5.9 12.0 9.4 23.1 20.8 17.2 18.5 18.5 88.8 17.5 11.7 13.9 20.9 25.3 11.4 54.9 22.1 17.1 26.7 45.4 75.1 13.3 4.1 23.4 15.4 10.3 16.1 25.4 8.8 40.3 18.2 20.8 24.7 59.8 52.4 20.0 21.2 11.7 15.3 15.7 20.9 12.2 12.0 50.7 13.1 19.2 13.6 13.0 21.3 21.9 20.0 8.3 19.5 16.8 20.9 11.6 HUWE1 "Ib772, KIAA0312, UREB1" ENSG00000086758 "HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1" Q7Z6Z7 X 53532096-53686728 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway" "DNA-binding, Transferase" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Granulosa cells: 507.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002548, CAB022718" Approved Enhanced Nucleoplasm,Cytosol NA NA 73000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Nucleoplasm, Cytosol" "CAB022718: , HPA002548: AB_1080489" "unprognostic (4.73e-2)" "unprognostic (9.06e-2)" "unprognostic (1.31e-1)" "unprognostic (1.59e-2)" "unprognostic (6.64e-2)" "unprognostic (3.16e-2)" "unprognostic (1.33e-2)" "unprognostic (2.21e-1)" "unprognostic (3.56e-1)" "unprognostic (5.51e-2)" "unprognostic (1.33e-1)" "unprognostic (8.89e-2)" "unprognostic (8.10e-3)" "unprognostic (2.17e-1)" "unprognostic (1.32e-1)" "unprognostic (3.67e-2)" "unprognostic (2.45e-1)" 37.7 46.1 55.6 21.1 57.4 26.7 37.4 57.6 69.6 39.8 42.0 49.4 17.6 45.6 52.6 48.4 40.7 18.5 57.1 62.6 61.3 45.2 41.8 36.1 26.6 58.7 67.8 54.0 45.9 43.2 54.2 24.0 73.2 38.4 22.7 40.0 38.9 28.6 101.0 59.3 40.2 28.8 49.1 42.5 45.5 43.0 65.1 41.2 42.9 58.1 30.3 44.6 40.2 57.2 166.8 100.4 64.0 45.4 109.2 64.8 78.5 48.8 62.6 50.2 52.3 77.0 52.2 86.6 32.3 89.4 90.4 77.8 145.6 81.8 68.3 125.6 64.6 69.1 91.9 60.5 100.2 104.5 40.6 62.4 59.8 120.8 137.6 49.7 88.3 66.4 70.3 54.5 66.3 102.4 57.0 58.2 87.7 45.4 71.3 52.0 87.9 52.8 84.0 113.3 53.1 38.4 137.7 60.5 44.1 118.7 87.0 50.1 113.8 46.0 65.8 66.5 62.9 47.3 50.2 73.1 49.2 100.1 67.6 2.8 2.3 4.3 3.3 1.9 4.0 2.4 3.1 3.5 3.3 2.4 2.2 2.2 1.9 3.5 3.8 3.5 2.9 1.9 55.6 57.4 57.6 69.6 62.6 61.3 58.7 67.8 73.2 49.1 65.1 57.2 41.4 51.3 46.1 70.2 41.9 30.1 32.6 30.4 44.9 57.8 37.0 35.6 110.4 37.1 35.4 40.5 50.1 31.0 40.0 29.2 1.9 42.8 28.6 45.6 59.8 38.3 47.6 47.7 94.4 35.4 34.8 38.6 57.1 69.6 22.1 507.7 32.9 48.1 24.8 82.4 85.8 28.1 18.3 31.4 30.8 32.8 28.3 34.1 26.6 59.0 43.7 22.6 35.0 83.9 95.3 49.3 20.5 39.1 50.9 44.1 27.1 14.7 35.7 33.3 13.1 69.6 56.4 34.5 44.6 53.3 41.6 37.9 46.7 114.1 31.7 42.0 IBTK "BTBD26, BTKI, DKFZP564B116" ENSG00000005700 "Inhibitor of Bruton tyrosine kinase" Q9P2D0 6 82169986-82247754 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 190.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023826, HPA048438" Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA023826: AB_1851378, HPA048438: AB_2680392" "unprognostic (3.13e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (2.72e-2)" "unprognostic (1.75e-2)" "unprognostic (2.48e-1)" "unprognostic (2.78e-1)" "unprognostic (5.93e-2)" "unprognostic (1.97e-2)" "unprognostic (6.18e-2)" "unprognostic (1.90e-2)" "unprognostic (8.81e-2)" "unprognostic (3.02e-2)" "unprognostic (1.08e-2)" "unprognostic (7.33e-2)" "unprognostic (1.09e-1)" "unprognostic (7.27e-2)" "unprognostic (9.78e-2)" 7.3 14.3 2.5 8.1 3.3 3.7 7.9 3.2 2.6 8.9 3.1 8.6 8.4 8.0 4.8 8.3 7.6 6.0 10.0 2.0 2.7 10.3 22.2 7.0 6.7 2.8 3.4 8.8 11.0 12.3 4.8 6.3 3.0 7.7 10.4 8.5 8.9 7.4 21.4 4.1 8.4 7.4 3.5 6.5 11.5 4.0 3.1 7.2 10.3 20.9 7.2 8.6 5.9 3.5 8.3 17.0 12.2 10.3 14.4 19.8 5.5 19.3 21.1 15.5 16.6 9.0 9.6 16.4 11.9 22.8 20.5 8.8 9.8 10.8 18.5 22.5 7.3 17.6 8.8 14.1 20.2 20.7 10.3 17.1 17.6 14.8 36.8 14.5 15.7 11.4 16.4 10.0 16.7 12.7 7.2 6.7 5.5 13.0 9.1 10.2 25.7 6.5 23.2 18.9 8.2 9.0 13.0 16.1 10.3 10.8 15.1 12.5 12.6 9.0 6.7 11.3 15.6 10.3 17.1 7.5 9.9 13.4 11.9 1.3 1.2 1.0 1.8 1.1 2.4 1.6 1.8 1.6 1.9 1.0 1.7 1.6 0.0 1.0 2.3 1.4 2.7 0.8 2.5 3.3 3.2 2.6 2.0 2.7 2.8 3.4 3.0 3.5 3.1 3.5 26.1 41.7 47.6 46.4 33.5 13.6 42.8 19.4 15.4 55.6 27.4 19.0 64.9 40.0 41.2 38.6 54.2 23.9 25.9 62.2 15.6 37.5 4.2 37.4 28.1 27.3 38.9 37.4 102.6 51.6 16.4 34.1 117.8 57.0 36.8 38.1 21.8 77.0 26.7 52.2 97.9 49.3 6.1 33.4 26.1 4.1 25.7 36.1 23.2 44.0 43.6 32.7 25.7 80.9 190.0 52.1 55.5 21.1 68.2 53.4 31.1 28.3 42.1 39.2 26.3 42.0 29.1 21.2 22.9 41.1 11.6 9.4 29.8 67.0 41.9 64.4 ICA1L "ALS2CR14, ALS2CR15" ENSG00000163596 "Islet cell autoantigen 1 like" Q8NDH6 2 202773150-202871766 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 171.7;Inhibitory neurons: 114.3;Oligodendrocyte precursor cells: 93.5;Rod photoreceptor cells: 84.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042507 Approved Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 58: Brain - Synaptic function" "Cluster 28: BEWO - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Mitochondria "HPA042507: AB_10797016" "unprognostic (4.14e-3)" "unprognostic (3.60e-3)" "unprognostic (5.15e-2)" "unprognostic (5.63e-3)" "unprognostic (1.96e-1)" "unprognostic (2.36e-1)" "unprognostic (1.38e-1)" "unprognostic (8.05e-4)" "unprognostic (1.66e-1)" "unprognostic (9.60e-2)" "unprognostic (4.50e-4)" "unprognostic (4.15e-1)" "unprognostic (8.15e-3)" "unprognostic (2.97e-2)" "unprognostic (1.74e-1)" "unprognostic (9.79e-2)" "unprognostic (1.58e-3)" 3.8 4.8 9.8 1.3 12.0 3.9 3.5 23.2 20.6 7.1 7.4 6.8 1.5 7.5 5.7 2.6 9.5 3.6 4.9 13.4 13.7 3.2 0.5 2.2 1.5 3.7 5.5 8.1 2.7 7.1 15.7 5.2 1.6 5.5 1.6 17.5 1.9 6.1 5.1 1.9 2.0 4.6 3.3 1.4 3.7 8.3 9.9 2.7 5.1 6.7 1.2 5.4 3.4 8.7 1.5 1.2 2.9 8.4 2.7 5.0 21.8 2.9 3.8 1.6 2.3 1.4 0.6 1.7 0.8 3.5 4.6 0.8 4.0 1.4 2.1 1.5 3.1 3.6 1.8 1.8 1.5 4.4 2.1 1.9 2.4 1.7 1.4 4.9 2.4 5.6 2.8 1.6 2.5 0.7 3.6 6.0 8.4 0.5 3.1 4.3 4.4 0.7 1.6 3.9 7.8 7.5 4.5 0.2 1.9 2.4 1.0 3.4 1.6 7.0 1.8 1.5 4.4 5.5 8.9 4.5 4.0 1.4 1.3 1.2 1.1 0.6 0.9 1.2 0.7 1.3 0.8 0.7 1.6 2.3 1.1 1.6 1.5 2.3 2.1 1.1 0.7 0.7 9.8 12.0 23.2 20.6 13.4 13.7 3.7 5.5 1.6 3.3 9.9 8.7 13.0 9.6 10.0 62.0 10.5 2.0 4.4 2.9 1.2 58.7 4.1 2.8 15.2 1.5 8.7 18.4 60.5 16.3 5.7 1.0 0.0 5.3 28.7 40.9 17.0 5.8 19.2 2.5 171.7 4.9 37.7 12.0 3.6 9.9 6.3 17.4 5.7 1.1 3.6 16.8 114.3 2.1 4.1 5.3 9.7 40.2 31.7 5.2 7.2 15.9 3.8 22.1 17.5 93.5 42.7 3.4 0.6 46.3 2.1 5.2 1.9 3.7 36.7 84.1 0.0 10.0 6.3 34.1 8.8 1.9 2.3 7.5 7.3 6.0 1.7 2.7 IDE ENSG00000119912 "Insulin degrading enzyme" P14735 10 92451684-92574096 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Host-virus interaction" "Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063478 Approved "Secreted in other tissues" NA NA 310000 "Cluster 27: Non-specific - Gene expression" "Cluster 31: Skin - Epidermis development" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA063478: AB_2685020" "unprognostic (1.70e-1)" "unprognostic (6.40e-2)" "prognostic favorable (3.69e-4)" "prognostic favorable (3.53e-4)" "unprognostic (2.54e-1)" "unprognostic (1.78e-1)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (8.88e-2)" "unprognostic (2.57e-1)" "unprognostic (6.58e-2)" "unprognostic (7.79e-2)" "unprognostic (6.81e-2)" "unprognostic (9.24e-3)" "unprognostic (6.13e-2)" "unprognostic (3.89e-2)" "unprognostic (3.91e-1)" 6.7 10.1 3.4 2.8 3.6 3.5 6.1 3.7 4.2 8.1 5.9 8.6 3.3 7.4 9.7 9.8 6.5 2.9 11.7 3.4 3.7 5.9 11.4 5.9 3.4 3.8 3.7 5.4 12.3 9.5 4.7 2.7 3.9 9.1 3.8 10.3 7.8 4.2 28.8 36.4 6.8 3.7 3.6 6.3 8.2 25.8 3.6 2.4 6.7 9.7 4.1 8.9 7.9 3.8 12.1 22.9 6.2 15.1 10.5 5.8 8.5 10.4 13.3 6.1 5.2 19.4 9.5 12.5 16.4 14.3 7.2 16.3 14.6 10.0 3.9 14.7 8.8 5.1 13.7 25.9 11.5 14.9 6.5 5.4 6.6 9.1 14.0 7.8 8.6 3.3 10.0 8.1 5.4 18.0 6.6 8.8 10.2 10.4 5.2 10.2 10.8 9.0 10.9 19.3 2.2 5.6 14.3 6.4 6.7 6.8 12.6 6.3 15.3 4.4 8.2 5.0 10.4 11.2 12.2 14.5 6.9 10.9 4.4 0.3 3.5 1.4 2.0 4.2 2.2 2.9 2.6 2.9 4.6 2.1 1.9 2.0 0.0 3.7 5.9 1.3 3.9 2.3 3.4 3.6 3.7 4.2 3.4 3.7 3.8 3.7 3.9 3.6 3.6 3.8 12.9 9.6 14.1 20.9 11.1 5.2 6.1 10.5 5.2 15.0 8.7 4.3 45.7 7.2 10.6 7.3 47.9 11.2 10.0 14.0 1.9 14.0 46.4 14.9 19.3 10.8 10.8 19.6 43.3 20.2 5.7 9.1 22.4 16.5 1.3 9.9 11.7 24.1 11.9 6.7 42.6 12.7 18.3 16.6 5.4 12.0 6.5 12.5 8.8 23.4 7.8 7.8 4.1 20.6 24.0 16.5 5.7 10.1 24.2 12.2 9.0 10.7 23.3 26.9 6.6 7.6 13.2 51.5 11.0 19.6 16.3 3.8 8.5 9.8 9.8 9.6 IFT52 "C20orf9, CGI-53, dJ1028D15.1, NGD2, NGD5" ENSG00000101052 "Intraflagellar transport 52" Q9Y366 20 43590937-43647299 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 78.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063367, HPA067423" Enhanced Approved "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 49: Ciliated cells - Cilium organization" "Plasma membrane" "HPA063367: , HPA067423: AB_2685837" "unprognostic (2.88e-1)" "unprognostic (2.44e-2)" "unprognostic (6.82e-2)" "unprognostic (5.18e-3)" "unprognostic (7.39e-2)" "unprognostic (1.26e-1)" "prognostic unfavorable (3.30e-6)" "unprognostic (8.36e-2)" "unprognostic (1.25e-1)" "unprognostic (2.00e-1)" "unprognostic (2.98e-2)" "unprognostic (2.28e-2)" "unprognostic (3.43e-2)" "unprognostic (7.51e-2)" "prognostic favorable (3.33e-4)" "unprognostic (2.37e-1)" "unprognostic (7.40e-2)" 23.5 15.1 12.2 11.7 12.6 29.1 26.1 12.4 15.2 29.3 14.3 16.3 9.2 27.4 29.0 14.8 38.0 19.0 11.8 12.5 13.5 20.5 7.8 16.9 18.3 12.3 12.8 39.2 15.7 22.5 16.5 17.5 12.8 17.5 17.8 15.1 13.6 23.8 4.7 15.5 11.2 24.3 13.3 15.7 12.2 31.8 14.1 22.8 31.3 9.0 18.9 19.5 18.0 14.2 33.9 25.4 50.3 35.8 41.9 46.4 23.9 20.8 46.1 53.6 51.6 70.5 33.7 18.8 32.8 42.6 43.4 27.7 21.3 37.3 58.6 15.6 20.0 24.8 16.2 65.9 51.4 33.4 16.4 37.8 40.2 34.9 27.0 39.0 42.7 41.4 21.3 26.1 39.9 34.0 46.4 51.5 28.4 22.2 24.9 48.6 57.5 27.8 41.8 32.9 38.8 45.3 63.6 46.7 52.2 25.3 21.8 45.1 26.9 47.3 35.1 26.3 31.1 25.3 26.9 32.8 56.8 24.0 34.8 8.0 22.0 16.8 18.4 20.9 15.0 17.5 14.7 17.5 28.4 15.3 15.4 16.0 6.3 17.4 26.2 21.5 18.6 17.3 12.2 12.6 12.4 15.2 12.5 13.5 12.3 12.8 12.8 13.3 14.1 14.2 21.1 6.4 13.1 11.4 13.7 13.0 12.8 22.4 12.0 11.5 14.1 19.2 2.9 11.5 13.2 7.3 0.0 19.9 16.0 14.8 19.6 26.1 78.4 32.1 19.4 18.1 9.5 23.4 20.5 22.2 19.7 25.3 8.2 10.5 14.5 26.7 23.2 2.6 19.4 8.4 22.5 11.0 14.2 18.2 13.9 20.9 28.6 13.3 17.8 12.2 21.3 22.6 18.6 14.6 25.7 14.8 10.1 38.4 13.5 5.9 5.5 18.3 49.0 12.8 13.1 23.9 24.8 57.3 18.5 12.2 14.9 9.6 12.1 30.4 10.3 10.5 IMMT "HMP, Mic60, MICOS60, MINOS2, P87, P89" ENSG00000132305 "Inner membrane mitochondrial protein" Q16891 2 86143932-86195472 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 288.9" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 223.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022439, HPA036164, HPA036165" Supported Enhanced Mitochondria NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980" "unprognostic (3.83e-3)" "unprognostic (1.56e-1)" "unprognostic (1.95e-2)" "prognostic unfavorable (1.06e-4)" "unprognostic (1.40e-1)" "unprognostic (2.45e-2)" "prognostic unfavorable (2.03e-4)" "unprognostic (5.66e-2)" "unprognostic (1.53e-1)" "unprognostic (8.10e-2)" "unprognostic (7.35e-2)" "unprognostic (2.21e-1)" "prognostic favorable (3.51e-6)" "unprognostic (2.06e-3)" "unprognostic (6.35e-2)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" 41.3 82.4 30.3 34.9 31.8 40.3 36.5 33.1 39.0 30.2 41.9 57.4 57.4 35.0 27.6 43.4 30.9 27.1 174.8 31.9 34.5 80.9 65.0 32.5 44.3 35.3 34.2 28.1 48.5 90.2 36.0 36.7 35.1 29.4 58.1 42.4 37.9 35.1 200.9 38.0 46.6 38.9 29.8 44.8 56.0 49.2 32.6 52.3 35.5 288.9 47.1 41.5 33.8 32.8 115.6 111.2 99.2 45.6 93.7 88.3 101.5 80.5 85.6 108.0 98.7 160.7 89.1 175.7 78.9 87.7 87.7 83.4 128.9 118.4 131.8 71.4 105.9 139.0 65.6 192.0 95.7 135.9 91.1 100.6 84.0 101.7 119.5 67.2 124.7 99.7 138.4 96.7 105.1 99.0 135.6 140.8 117.8 175.1 88.2 89.9 211.2 158.7 122.5 128.3 119.3 89.0 82.9 124.0 126.3 77.4 70.7 94.6 93.6 76.0 83.6 112.0 101.8 76.6 104.1 119.9 86.9 158.8 94.4 12.1 29.2 12.2 23.5 34.0 20.7 15.9 20.6 19.3 32.9 13.7 18.3 22.3 3.8 20.8 33.2 17.2 23.2 25.4 30.3 31.8 33.1 39.0 31.9 34.5 35.3 34.2 35.1 29.8 32.6 32.8 29.3 54.5 49.2 31.3 42.1 23.3 34.9 51.6 30.1 40.9 21.6 19.7 223.0 24.3 57.3 40.5 33.3 94.9 49.6 57.9 133.1 59.9 152.4 26.5 34.0 38.3 56.0 76.1 41.6 52.8 73.9 36.3 39.8 26.8 48.0 55.6 35.7 64.2 70.9 23.5 46.5 46.2 38.7 49.4 28.3 158.9 27.7 48.9 17.8 26.2 80.6 30.2 52.5 29.1 44.1 43.3 36.3 36.9 56.4 28.6 59.8 92.6 41.8 42.5 6.6 39.7 58.2 100.7 54.6 41.1 24.9 98.5 45.6 118.6 68.0 33.6 INO80E "CCDC95, FLJ90652" ENSG00000169592 "INO80 complex subunit E" Q8NBZ0 16 29995715-30005793 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043146 Approved Supported "Nucleoplasm,Nucleoli rim" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 14: REH - Unknown function" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Nucleoli rim" "HPA043146: AB_10794923" "unprognostic (5.61e-2)" "unprognostic (3.50e-2)" "unprognostic (3.46e-2)" "unprognostic (2.75e-2)" "unprognostic (3.38e-1)" "unprognostic (5.73e-2)" "unprognostic (7.14e-2)" "unprognostic (1.90e-2)" "unprognostic (1.31e-1)" "unprognostic (2.56e-1)" "unprognostic (1.13e-2)" "unprognostic (3.41e-2)" "unprognostic (2.02e-2)" "unprognostic (4.74e-3)" "unprognostic (5.21e-2)" "unprognostic (2.55e-1)" "unprognostic (3.98e-3)" 25.9 22.7 36.6 22.1 39.0 33.1 26.4 38.8 43.1 31.6 29.1 35.3 19.9 30.8 29.2 29.7 40.8 24.8 25.3 35.7 36.3 21.9 26.4 28.7 32.9 40.3 38.9 38.0 25.5 39.9 23.2 24.8 38.0 24.1 36.5 13.4 32.4 34.7 30.9 27.6 24.0 40.3 37.1 26.5 24.8 27.8 38.3 42.5 33.3 29.7 46.8 30.8 25.5 42.5 79.1 95.1 59.6 88.0 54.0 45.6 55.0 66.9 75.2 95.4 93.8 54.7 85.7 101.6 100.4 75.3 63.0 52.9 73.8 109.8 80.0 106.7 88.8 50.2 57.7 79.0 63.5 66.4 59.5 53.5 89.1 112.1 87.6 54.9 115.4 137.5 64.4 55.6 89.9 114.7 142.0 87.2 120.3 55.4 55.1 176.9 72.6 104.7 73.2 39.5 90.8 111.3 36.8 65.1 83.7 48.9 80.8 53.0 62.5 68.0 48.3 58.7 84.6 58.9 120.2 92.9 77.3 96.2 97.9 1.5 6.1 5.1 4.3 4.1 3.6 4.5 3.4 5.0 4.9 3.3 3.2 3.3 3.0 3.5 6.8 5.1 5.2 21.4 36.6 39.0 38.8 43.1 35.7 36.3 40.3 38.9 38.0 37.1 38.3 42.5 32.8 38.5 19.6 15.0 27.6 14.8 19.1 34.0 37.0 15.1 23.5 22.6 0.8 22.8 24.1 20.2 20.9 36.9 27.6 32.9 33.2 29.3 1.9 17.1 13.3 25.4 35.2 14.9 6.6 39.3 40.1 20.2 45.9 19.2 15.8 16.4 23.9 18.9 27.8 8.4 6.9 28.4 32.6 22.4 15.0 5.2 26.1 24.0 19.6 14.0 25.2 20.4 29.9 9.0 14.4 38.0 39.7 27.8 35.2 12.4 48.2 29.8 19.7 20.9 26.3 17.3 23.1 44.4 23.3 33.6 17.2 18.1 30.9 13.9 31.6 12.4 INPP4A INPP4 ENSG00000040933 "Inositol polyphosphate-4-phosphatase type I A" Q96PE3 2 98444854-98594392 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 150.5;Inhibitory neurons: 124.4;Microglial cells: 73.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "Karpas-707: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001628 Approved Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 2: Karpas-707 - Immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Nuclear membrane" "HPA001628: AB_10961254" "unprognostic (3.45e-1)" "unprognostic (2.39e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (3.70e-6)" "unprognostic (1.58e-1)" "unprognostic (3.10e-2)" "unprognostic (1.15e-3)" "unprognostic (9.44e-2)" "unprognostic (1.37e-2)" "unprognostic (1.23e-1)" "unprognostic (9.65e-2)" "unprognostic (3.70e-2)" "unprognostic (2.90e-2)" "unprognostic (4.89e-2)" "unprognostic (1.20e-1)" "unprognostic (1.08e-2)" "unprognostic (1.97e-2)" 8.7 8.2 15.9 13.2 19.5 12.7 6.1 18.8 22.0 7.0 1.0 11.3 7.3 7.5 5.2 7.7 6.6 9.9 10.5 15.9 9.9 5.2 4.1 9.6 17.2 9.2 3.5 7.0 6.6 8.9 7.7 8.1 9.2 6.0 7.9 10.7 5.6 6.3 8.4 4.1 8.8 9.8 4.7 16.7 7.3 5.9 5.9 20.3 5.9 11.6 12.5 10.8 5.5 10.1 12.7 11.0 18.2 14.8 10.4 11.1 19.2 10.0 9.4 10.9 11.3 14.6 11.5 7.8 13.3 15.4 14.0 12.6 12.6 11.1 8.5 27.7 10.9 9.5 9.7 6.5 8.8 17.3 34.3 9.9 9.9 10.6 9.0 9.5 15.1 44.9 8.5 67.4 8.3 16.2 26.3 16.8 17.6 7.4 11.3 12.0 12.5 51.9 5.6 41.6 12.8 15.7 12.1 10.1 9.5 18.7 4.8 13.8 14.3 12.7 17.9 10.1 7.5 50.2 31.1 5.8 10.5 16.2 11.5 1.1 1.0 2.3 2.8 2.2 3.3 0.4 1.6 1.8 1.1 0.1 2.2 2.5 1.1 3.2 3.4 3.3 0.9 1.0 15.9 19.5 18.8 22.0 15.9 9.9 9.2 3.5 9.2 4.7 5.9 10.1 14.6 6.4 13.1 50.9 11.2 8.0 6.4 2.8 9.1 49.7 5.3 4.2 12.6 2.8 7.8 5.5 8.4 10.2 64.6 4.1 3.9 4.0 13.5 6.2 9.1 14.2 5.4 7.2 150.5 1.5 8.7 9.9 6.6 6.3 0.0 22.4 14.3 3.4 10.5 33.7 124.4 5.6 4.1 36.4 18.4 10.9 9.3 25.3 10.6 73.1 26.8 8.4 71.1 55.8 26.1 3.8 2.5 12.0 48.6 5.9 1.2 3.3 5.1 14.1 6.6 9.9 12.4 8.6 14.0 5.2 6.1 9.4 48.3 9.4 3.6 6.8 INTS10 "C8orf35, FLJ10569, INT10" ENSG00000104613 "Integrator complex subunit 10" Q9NVR2 8 19817391-19852083 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039129, HPA050570" Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Cytosol Nucleoplasm "HPA039129: AB_10794424, HPA050570: AB_2681180" "unprognostic (9.11e-2)" "unprognostic (8.41e-3)" "prognostic favorable (4.00e-4)" "prognostic favorable (1.22e-4)" "unprognostic (4.54e-2)" "unprognostic (9.79e-3)" "unprognostic (1.15e-1)" "unprognostic (1.14e-3)" "unprognostic (3.41e-1)" "unprognostic (1.38e-1)" "unprognostic (1.67e-2)" "unprognostic (2.62e-1)" "unprognostic (8.58e-3)" "unprognostic (1.34e-3)" "unprognostic (1.08e-1)" "unprognostic (2.34e-2)" "unprognostic (1.33e-1)" 27.7 24.0 42.2 24.6 44.1 34.3 29.1 44.2 57.6 27.5 40.3 28.5 26.6 22.5 20.3 26.6 38.7 21.5 21.7 44.4 43.2 29.9 47.6 24.2 30.5 43.0 42.3 25.3 42.6 28.3 18.7 23.0 42.9 29.2 27.3 37.2 30.4 20.0 25.6 31.8 24.1 26.1 42.1 22.7 25.0 15.2 43.7 29.2 43.7 18.6 33.2 24.6 18.0 45.1 40.0 57.3 32.5 42.1 48.7 53.3 41.5 29.5 50.6 40.3 38.4 33.6 19.7 113.9 47.9 33.1 43.9 42.3 39.5 38.5 44.8 22.4 40.0 51.7 62.6 63.2 35.0 45.2 34.2 42.3 58.9 29.8 46.5 24.8 40.2 65.4 66.3 88.2 28.4 33.9 86.7 53.4 42.6 92.9 32.2 43.7 35.9 73.1 52.8 60.7 32.2 26.1 41.1 51.0 37.1 29.1 26.2 43.6 29.2 25.5 35.0 59.1 39.5 24.7 30.5 81.5 51.4 64.4 41.1 10.0 23.7 14.5 19.6 21.4 30.8 26.5 25.6 25.2 30.9 21.7 28.1 25.1 7.7 27.7 18.6 27.1 31.8 20.2 42.2 44.1 44.2 57.6 44.4 43.2 43.0 42.3 42.9 42.1 43.7 45.1 25.5 16.0 51.1 74.4 40.3 37.6 40.9 29.3 43.3 60.2 28.3 20.3 22.5 37.1 39.1 20.2 52.1 33.7 41.5 22.9 35.2 43.6 53.9 78.8 23.1 33.0 20.4 27.3 88.8 40.0 49.2 34.1 25.5 33.4 35.5 63.6 35.3 61.0 42.4 70.7 61.0 34.3 22.4 34.0 25.5 31.9 34.8 35.6 17.8 37.5 37.8 33.9 45.3 80.9 74.9 33.1 27.4 35.0 48.6 53.4 33.9 37.5 70.0 99.0 13.1 29.1 32.5 8.3 32.3 50.8 45.0 22.3 40.6 41.2 42.0 32.7 INTS11 "CPSF3L, CPSF73L, FLJ20542, INT11, RC-68" ENSG00000127054 "Integrator complex subunit 11" Q5TA45 1 1311585-1324687 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 77.3;Ductal cells: 56.4;Extravillous trophoblasts: 63.9;Syncytiotrophoblasts: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028379, HPA029025" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 25: RPMI-8226 - Immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol Nucleoplasm "HPA028379: AB_10599598, HPA029025: AB_10600425" "unprognostic (7.54e-2)" "unprognostic (2.14e-3)" "unprognostic (2.33e-2)" "unprognostic (2.56e-1)" "unprognostic (2.99e-2)" "unprognostic (9.34e-2)" "prognostic unfavorable (7.44e-4)" "unprognostic (3.97e-1)" "unprognostic (1.71e-1)" "unprognostic (2.75e-2)" "unprognostic (1.33e-2)" "unprognostic (3.08e-2)" "unprognostic (1.72e-2)" "unprognostic (1.27e-1)" "unprognostic (2.76e-3)" "unprognostic (5.14e-2)" "unprognostic (5.62e-3)" 39.7 40.8 26.0 24.0 28.6 29.0 39.0 37.2 40.1 64.7 27.7 70.6 32.8 66.6 26.4 43.9 61.1 24.1 54.9 27.2 28.4 40.4 45.7 35.6 31.8 30.3 27.2 63.6 53.6 28.9 40.0 28.2 30.6 52.9 20.8 13.0 38.3 27.6 90.3 47.2 44.9 26.7 24.5 45.4 52.4 76.0 28.0 29.6 40.7 44.2 25.1 67.5 50.6 33.6 58.4 56.2 31.5 62.1 52.4 41.7 34.1 31.2 49.9 67.6 50.1 53.2 71.0 63.2 43.6 60.7 40.6 41.4 46.3 67.7 29.9 60.3 60.5 49.8 79.7 70.2 80.2 39.1 52.5 72.1 35.9 61.7 91.7 38.2 71.7 59.7 59.5 56.3 34.2 50.8 77.6 52.1 39.1 53.6 60.1 61.0 30.8 93.1 47.6 31.3 45.0 42.1 31.9 83.8 91.7 23.4 45.5 57.0 54.5 43.6 39.6 50.8 40.0 87.3 101.8 85.1 60.4 68.7 22.0 66.5 69.6 48.0 65.2 82.1 68.9 50.3 56.4 59.8 81.2 44.0 52.2 50.2 33.2 64.8 101.7 52.9 78.7 81.0 26.0 28.6 37.2 40.1 27.2 28.4 30.3 27.2 30.6 24.5 28.0 33.6 36.4 38.5 33.7 0.0 9.5 0.0 0.0 0.0 0.0 0.0 32.6 33.9 0.0 0.0 13.0 18.4 0.0 77.3 24.1 0.0 31.3 56.4 0.0 27.1 27.2 14.0 0.0 0.0 0.0 53.9 63.9 18.7 0.0 23.2 10.1 40.4 0.0 0.0 42.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 36.2 0.0 0.0 0.0 0.0 54.8 0.0 0.0 6.8 0.0 0.0 34.4 14.6 0.0 0.0 0.0 17.6 0.0 0.0 0.0 0.0 77.0 12.7 49.8 0.0 0.0 INTS9 "CPSF2L, FLJ10871, RC-74" ENSG00000104299 "Integrator complex subunit 9" Q9NV88 8 28767661-28890242 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 28.7;Excitatory neurons: 29.5;Inhibitory neurons: 31.3;Oligodendrocyte precursor cells: 32.2;Oligodendrocytes: 39.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051615, HPA066822" Enhanced Nucleoplasm Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA051615: AB_2681552, HPA066822: AB_2685729" "unprognostic (2.19e-2)" "unprognostic (1.45e-2)" "unprognostic (1.79e-2)" "prognostic favorable (9.45e-4)" "unprognostic (2.46e-1)" "unprognostic (1.56e-3)" "unprognostic (6.91e-3)" "prognostic favorable (7.71e-4)" "unprognostic (3.64e-2)" "unprognostic (5.01e-2)" "unprognostic (4.72e-2)" "unprognostic (2.48e-3)" "prognostic favorable (1.91e-5)" "unprognostic (2.51e-2)" "unprognostic (2.73e-1)" "unprognostic (1.32e-1)" "unprognostic (1.52e-1)" 8.6 22.0 7.9 11.1 8.9 6.8 8.3 8.7 9.4 9.1 10.5 8.8 6.9 9.2 11.3 11.1 9.7 6.7 12.2 7.9 8.6 10.7 5.9 8.8 14.6 8.5 8.8 8.2 9.7 9.5 12.5 7.9 8.6 9.1 9.3 10.5 8.9 7.2 11.6 9.9 9.6 9.0 8.6 15.7 9.4 12.8 8.9 17.5 10.6 6.9 17.9 11.0 8.7 9.4 24.7 17.0 20.1 21.4 24.3 11.3 8.8 11.1 15.1 19.0 20.9 11.9 13.4 24.4 15.2 11.4 17.0 20.1 39.2 22.7 26.1 10.3 16.1 24.4 9.5 21.0 17.6 12.3 18.2 13.0 16.0 22.9 16.3 10.2 23.8 34.5 52.2 13.7 12.8 13.5 57.5 22.3 27.4 28.8 10.9 36.5 23.3 12.8 13.4 16.8 14.4 26.4 11.5 14.8 20.5 16.0 14.4 13.8 14.1 10.9 27.6 18.7 14.2 7.0 5.3 29.8 16.8 20.3 15.8 17.0 20.6 19.0 17.3 23.0 16.1 18.0 15.1 19.3 29.1 19.5 13.4 14.5 8.3 25.1 17.4 15.4 20.3 12.0 7.9 8.9 8.7 9.4 7.9 8.6 8.5 8.8 8.6 8.6 8.9 9.4 3.6 6.4 4.2 28.7 10.9 2.3 2.4 4.7 1.8 2.1 2.7 2.3 5.8 5.7 3.7 3.7 6.2 7.7 6.1 2.8 1.9 3.7 8.3 4.8 6.2 4.6 6.0 4.2 29.5 5.1 4.8 4.7 9.2 5.9 0.0 6.7 3.9 2.5 7.5 1.7 31.3 3.6 4.1 3.8 6.1 4.1 7.8 4.1 3.6 23.4 5.4 2.4 4.1 32.2 39.9 4.9 1.7 4.5 4.3 1.9 3.3 4.3 3.4 6.1 0.0 4.2 4.0 5.1 3.5 7.7 3.0 4.8 5.4 11.2 3.5 1.7 INVS NPHP2 ENSG00000119509 Inversin Q9Y283 9 100099243-100302175 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Wnt signaling pathway" "Calmodulin-binding, Developmental protein" "Ciliopathy, Disease variant, Nephronophthisis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Astrocytes: 132.9;Excitatory neurons: 144.8;Inhibitory neurons: 142.8;Microglial cells: 112.4;Oligodendrocyte precursor cells: 144.3;Oligodendrocytes: 233.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049994 Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA049994: " "unprognostic (3.84e-3)" "unprognostic (3.11e-2)" "unprognostic (1.74e-1)" "unprognostic (2.86e-2)" "unprognostic (6.73e-2)" "prognostic unfavorable (6.35e-4)" "unprognostic (3.53e-3)" "unprognostic (2.93e-3)" "unprognostic (1.99e-1)" "unprognostic (6.46e-2)" "unprognostic (1.15e-1)" "unprognostic (3.56e-2)" "unprognostic (1.34e-3)" "unprognostic (1.61e-1)" "unprognostic (2.65e-1)" "unprognostic (6.37e-2)" "unprognostic (1.83e-1)" 6.2 6.1 4.2 4.3 7.5 4.6 5.0 7.1 5.4 7.3 7.0 5.6 4.0 7.0 6.3 4.3 5.7 5.4 4.8 4.1 5.6 8.7 9.4 5.2 5.8 6.5 5.5 9.7 4.7 9.7 6.7 5.9 7.1 6.1 4.6 11.8 4.3 5.1 3.6 3.5 4.7 6.1 4.4 5.2 4.4 6.6 6.2 7.8 6.6 4.2 5.7 5.3 5.9 11.6 7.4 13.2 11.0 11.7 13.3 10.7 9.2 8.6 9.0 7.5 6.1 6.7 4.5 17.3 4.9 10.0 13.7 11.1 8.8 11.3 6.1 13.3 6.0 13.0 12.4 7.3 10.0 13.1 10.4 11.2 13.1 7.8 15.8 10.1 13.7 11.7 11.4 10.4 7.8 6.4 10.4 5.1 6.4 13.5 7.6 9.3 19.3 3.9 7.0 6.9 10.0 7.9 9.7 5.8 9.9 8.9 4.1 7.2 10.2 8.7 6.3 9.0 6.5 10.5 13.2 3.5 9.2 5.4 4.8 0.0 1.2 1.9 2.2 0.8 1.9 2.6 1.9 1.2 1.7 2.5 2.4 2.4 0.1 2.5 2.1 1.7 1.2 1.3 4.2 7.5 7.1 5.4 4.1 5.6 6.5 5.5 7.1 4.4 6.2 11.6 5.8 3.2 4.1 132.9 7.1 1.8 7.0 1.5 12.0 4.8 1.7 2.4 2.9 7.2 2.7 0.0 8.4 4.4 5.4 1.4 3.9 2.7 21.5 3.2 7.8 4.8 1.2 6.5 144.8 1.1 3.9 6.0 8.6 3.3 1.3 7.8 1.1 4.0 3.6 6.7 142.8 1.5 2.0 2.2 1.0 35.6 4.7 4.0 0.0 112.4 2.6 2.5 9.2 144.3 233.9 1.5 2.0 3.4 7.4 2.9 2.7 5.8 0.7 5.8 0.0 6.4 4.4 11.0 4.7 5.0 1.6 3.4 6.3 5.3 1.3 4.1 IPO4 "FLJ23338, Imp4" ENSG00000196497 "Importin 4" Q8TEX9 14 24180219-24188869 "Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 40.4" "Group enriched" "Detected in many" 4 "Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039043, HPA064572" Uncertain Approved Cytosol NA NA 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA039043: AB_10673233, HPA064572: AB_2685291" "unprognostic (2.43e-2)" "unprognostic (1.15e-1)" "unprognostic (6.03e-2)" "unprognostic (1.00e-1)" "unprognostic (1.64e-1)" "unprognostic (5.93e-2)" "prognostic unfavorable (8.08e-6)" "unprognostic (9.45e-2)" "unprognostic (2.60e-1)" "unprognostic (5.13e-2)" "unprognostic (6.75e-2)" "unprognostic (9.28e-2)" "prognostic unfavorable (3.20e-4)" "unprognostic (8.59e-4)" "unprognostic (5.45e-2)" "unprognostic (2.18e-1)" "unprognostic (2.15e-2)" 8.9 13.2 1.6 4.7 1.4 4.2 8.0 1.5 1.6 6.9 4.4 7.2 3.2 7.7 2.0 14.0 8.0 1.1 7.8 1.3 2.1 14.1 14.7 6.7 2.8 1.6 1.4 6.9 27.7 2.6 9.4 2.5 1.8 6.8 1.4 0.3 8.7 3.6 21.0 10.7 5.9 1.9 1.4 7.3 8.6 40.4 1.6 2.1 7.0 1.0 1.8 8.7 7.0 2.0 21.9 49.2 6.0 36.0 4.1 8.6 28.4 14.8 6.3 23.5 12.5 39.2 22.4 31.3 16.1 10.6 12.2 25.6 20.4 28.8 2.6 12.1 29.8 20.4 18.6 77.0 8.7 45.4 18.1 7.5 12.3 24.3 6.0 5.3 11.8 15.8 37.5 8.5 15.0 76.6 21.8 21.2 29.1 28.5 41.7 24.4 17.3 23.2 12.6 25.7 29.3 21.1 19.7 31.8 13.9 2.9 27.1 14.7 12.4 22.9 30.8 21.0 32.4 19.8 27.1 34.2 10.8 19.3 31.8 0.0 1.1 0.4 3.3 1.9 3.8 1.8 2.8 2.7 2.4 2.6 2.3 2.9 0.0 2.7 2.4 3.2 1.7 1.9 1.6 1.4 1.5 1.6 1.3 2.1 1.6 1.4 1.8 1.4 1.6 2.0 3.5 0.0 7.9 0.7 4.9 5.9 3.8 5.0 4.6 0.8 11.1 9.7 1.6 8.6 8.7 5.5 4.2 12.1 5.5 3.1 0.0 13.3 80.5 8.3 3.9 5.6 4.2 3.4 1.3 11.0 11.1 4.5 1.1 5.0 0.0 3.1 2.9 5.8 7.9 1.7 1.1 5.9 2.0 2.2 2.6 118.0 5.0 1.3 0.0 0.0 1.7 1.6 2.1 1.0 0.8 6.8 2.5 5.7 2.9 6.1 0.7 11.7 15.1 2.7 6.6 7.0 4.7 52.1 18.8 3.9 6.3 5.9 3.1 6.1 10.4 2.7 IPO7 "Imp7, RANBP7" ENSG00000205339 "Importin 7" O95373 11 9384652-9448127 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019002, HPA056590" Approved Approved Supported Nucleoplasm,Cytosol NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Cytosol" "HPA019002: AB_1856059, HPA056590: AB_2683180" "unprognostic (1.92e-1)" "prognostic unfavorable (4.98e-4)" "unprognostic (9.50e-2)" "unprognostic (1.27e-1)" "unprognostic (3.68e-1)" "unprognostic (1.60e-2)" "prognostic unfavorable (6.57e-4)" "unprognostic (1.19e-2)" "unprognostic (7.60e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (8.38e-6)" "unprognostic (3.06e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.08e-2)" "unprognostic (2.17e-1)" "unprognostic (3.90e-3)" 37.9 29.1 24.1 31.3 25.7 22.7 40.4 27.3 30.7 35.7 27.5 34.6 27.2 33.9 29.2 37.9 31.3 31.8 50.4 23.2 28.0 41.4 38.5 28.9 30.1 27.6 27.4 33.1 33.8 38.9 13.0 41.1 27.3 32.1 34.1 47.8 33.3 33.2 110.3 25.3 26.0 43.4 26.8 22.9 25.6 12.7 27.4 31.8 54.0 93.4 34.8 51.8 22.8 29.9 148.7 110.8 130.6 104.4 129.4 165.7 104.4 176.0 112.4 127.1 136.4 99.1 132.6 138.1 62.5 136.3 115.5 113.5 187.5 136.7 210.7 66.3 154.5 114.3 118.8 100.1 80.7 177.0 83.3 106.7 144.8 84.0 195.6 129.5 152.8 46.7 174.7 80.5 167.9 60.3 107.5 86.3 129.0 136.3 130.2 111.4 205.5 63.0 105.3 137.5 51.7 101.5 78.6 153.5 129.1 103.2 70.7 87.6 120.9 155.6 107.4 162.0 190.9 23.2 95.3 93.6 102.0 93.6 86.4 0.1 1.5 0.3 1.4 2.6 2.7 1.9 1.5 2.0 3.2 1.4 1.9 1.7 0.7 3.5 3.8 1.4 1.5 1.0 24.1 25.7 27.3 30.7 23.2 28.0 27.6 27.4 27.3 26.8 27.4 29.9 41.3 67.3 71.5 19.6 46.4 144.0 103.3 44.8 68.9 40.1 65.5 42.4 131.9 25.8 59.7 35.0 58.4 52.8 39.7 27.2 33.2 34.2 4.6 55.9 92.5 55.7 31.1 50.9 43.9 42.2 63.8 58.0 47.4 99.5 37.9 56.5 25.0 46.8 35.3 35.3 49.7 38.8 32.6 48.0 92.2 7.1 28.0 56.6 39.2 17.8 39.2 31.8 13.4 28.1 44.9 45.5 32.9 35.7 47.6 150.6 26.5 45.7 48.4 39.8 13.1 96.2 71.0 21.6 19.8 82.2 147.9 36.7 37.7 49.0 50.9 127.4 ISOC2 FLJ23469 ENSG00000063241 "Isochorismatase domain containing 2" Q96AB3 19 55452985-55462343 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 284.3" "Cell type enhanced" "Detected in all" "Hepatocytes: 272.2;Proximal tubular cells: 479.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEK 293: 270.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043142 Enhanced Approved Mitochondria,Cytosol NA NA 220000 "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria Cytosol "HPA043142: AB_10794653" "unprognostic (2.74e-1)" "unprognostic (8.38e-3)" "unprognostic (7.34e-2)" "unprognostic (3.09e-2)" "unprognostic (1.35e-1)" "unprognostic (1.08e-1)" "unprognostic (1.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-1)" "unprognostic (3.09e-1)" "unprognostic (5.82e-2)" "unprognostic (8.59e-2)" "unprognostic (9.90e-3)" "unprognostic (2.24e-1)" "unprognostic (2.42e-1)" "unprognostic (9.20e-2)" "unprognostic (2.09e-2)" 50.4 55.6 39.7 20.0 41.2 21.4 38.3 42.7 52.4 25.4 48.1 62.1 36.2 28.4 8.1 52.2 25.8 17.2 69.5 39.5 43.9 101.4 284.3 26.4 19.2 46.6 44.4 23.3 44.4 39.9 46.3 9.3 43.7 40.9 16.3 3.3 41.8 28.7 95.7 37.6 37.2 16.8 42.6 50.8 41.4 65.6 42.1 9.9 39.1 49.0 14.0 41.6 30.3 44.4 52.8 78.1 20.1 55.6 13.6 28.4 67.7 37.9 36.7 45.7 46.4 40.0 88.2 98.6 66.2 42.2 44.0 51.1 39.7 46.6 14.6 38.9 270.2 57.6 17.8 128.0 55.6 63.2 163.5 42.5 44.2 29.4 22.0 20.4 42.4 39.3 93.6 61.1 28.9 101.9 0.3 73.6 32.4 113.2 217.9 72.1 44.4 126.0 75.0 47.7 24.7 70.5 35.5 75.3 41.4 11.9 63.8 109.4 32.4 34.0 48.5 38.8 44.7 78.7 73.0 78.7 52.2 79.4 58.3 0.7 16.0 0.9 12.7 33.8 12.6 18.7 11.6 16.2 29.5 12.6 11.5 11.8 0.7 24.3 27.8 24.1 15.2 15.0 39.7 41.2 42.7 52.4 39.5 43.9 46.6 44.4 43.7 42.6 42.1 44.4 25.4 6.4 6.3 5.5 38.0 59.5 65.3 148.8 32.5 12.5 51.7 56.5 20.8 48.6 50.3 62.5 2.1 32.5 19.1 200.1 162.4 65.1 44.5 37.8 39.0 36.9 71.3 46.9 3.5 68.1 105.5 44.2 63.7 25.1 45.2 43.2 28.5 272.2 96.0 13.5 5.4 225.4 87.5 44.5 50.6 43.6 38.8 39.0 62.2 2.8 28.0 53.1 21.6 6.6 12.8 56.4 125.8 30.9 80.5 128.7 253.7 479.9 26.1 10.0 26.3 32.0 39.0 183.8 16.4 69.6 68.6 21.6 19.4 123.4 190.7 74.8 ITFG2 "FGGAP1, MDS028" ENSG00000111203 "Integrin alpha FG-GAP repeat containing 2" Q969R8 12 2812622-2859791 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038664, HPA038665" Uncertain Uncertain "Endoplasmic reticulum" NA No "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA038664: AB_10672722, HPA038665: AB_2676138" "unprognostic (5.70e-2)" "unprognostic (2.74e-1)" "unprognostic (1.73e-2)" "unprognostic (2.96e-1)" "unprognostic (2.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.47e-2)" "unprognostic (3.64e-2)" "unprognostic (1.60e-2)" "unprognostic (4.36e-2)" "unprognostic (5.05e-3)" "unprognostic (8.40e-2)" "unprognostic (2.60e-1)" "unprognostic (4.24e-1)" "unprognostic (5.89e-1)" "unprognostic (4.35e-2)" "unprognostic (7.43e-2)" 12.8 15.6 6.0 11.4 8.1 14.4 14.0 10.2 8.1 17.7 10.7 14.2 12.4 18.7 14.5 13.1 17.1 8.9 12.1 5.9 9.2 16.4 12.2 15.0 15.9 7.7 7.9 28.9 22.1 28.1 14.1 14.5 8.1 13.9 15.0 8.1 17.9 15.6 8.3 11.7 14.5 13.4 6.2 19.6 16.1 5.1 8.0 18.1 26.7 9.7 15.8 14.7 14.9 11.8 7.3 10.6 11.9 9.7 10.2 11.6 11.0 15.9 9.0 18.9 13.8 22.7 17.6 16.5 4.4 15.0 9.4 9.1 18.5 15.9 14.1 14.7 10.6 23.1 12.7 9.1 18.8 21.7 12.0 15.7 18.4 17.3 26.4 15.5 13.1 15.6 12.8 17.3 10.9 21.9 31.3 12.6 24.6 16.5 8.0 15.6 13.3 9.5 11.3 12.3 5.7 18.3 19.5 17.1 7.2 16.2 10.6 9.9 13.4 12.4 7.4 12.0 30.8 2.2 1.4 25.0 8.0 12.4 12.8 4.0 16.6 8.4 19.2 22.2 18.0 25.8 14.7 19.0 19.6 24.2 19.8 18.6 1.9 23.4 35.6 14.6 13.2 16.5 6.0 8.1 10.2 8.1 5.9 9.2 7.7 7.9 8.1 6.2 8.0 11.8 11.1 12.8 17.9 12.7 35.9 3.3 9.8 9.3 10.2 39.8 16.5 15.6 17.1 18.6 12.1 12.9 64.6 28.1 27.6 13.0 11.7 9.2 46.3 13.0 19.1 10.5 9.5 17.9 13.6 7.2 8.9 15.0 23.0 13.2 6.3 18.7 12.1 11.3 13.4 32.0 15.2 15.2 8.2 12.0 5.1 12.1 16.8 11.0 1.8 8.4 16.8 10.0 42.2 10.1 25.8 7.2 14.4 13.2 19.6 9.1 20.5 6.1 8.7 56.0 6.6 11.7 16.9 13.2 20.0 14.3 4.0 17.4 24.3 22.2 19.5 5.9 JMJD7 ENSG00000243789 "Jumonji domain containing 7" P0C870 15 41828092-41837581 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Monooxygenase, Oxidoreductase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 3.2;Alveolar cells type 2: 5.2;Basal squamous epithelial cells: 1.8;Gastric mucus-secreting cells: 2.0;Squamous epithelial cells: 3.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 31.2;RT4: 43.5" "Low region specificity" "Detected in all" HPA005726 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Cytosol "HPA005726: AB_1852017" "unprognostic (2.92e-1)" "unprognostic (7.99e-2)" "unprognostic (1.47e-2)" "unprognostic (2.30e-2)" "unprognostic (9.46e-2)" "unprognostic (1.03e-1)" "unprognostic (1.59e-1)" "unprognostic (1.78e-2)" "unprognostic (2.11e-2)" "unprognostic (1.77e-1)" "unprognostic (2.42e-1)" "unprognostic (8.74e-3)" "unprognostic (3.13e-1)" "unprognostic (7.25e-2)" "unprognostic (1.06e-1)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" 6.7 8.4 6.3 4.2 6.2 8.2 9.0 19.9 9.5 13.6 8.0 7.3 4.8 6.5 3.1 35.4 8.6 6.5 11.2 5.8 6.3 10.1 10.3 10.8 7.3 5.8 5.2 11.6 15.9 9.0 9.8 3.0 7.0 14.5 3.0 1.9 21.9 6.8 7.7 33.3 8.0 2.9 5.1 7.9 11.5 6.7 5.9 5.6 15.6 6.6 6.6 11.4 21.0 7.0 7.9 7.5 9.3 2.6 2.5 1.7 5.8 3.1 6.6 5.1 4.1 10.5 5.9 1.0 6.4 2.0 5.3 19.6 4.3 15.6 1.6 7.7 4.6 10.5 10.4 6.5 4.1 5.1 11.0 1.1 13.6 3.4 7.2 4.7 5.8 9.9 7.0 6.2 3.7 10.8 6.6 4.9 4.0 31.2 4.8 2.9 6.3 7.6 11.5 43.5 9.9 3.5 2.6 13.5 4.3 2.7 26.2 5.4 5.4 3.7 8.3 8.0 6.1 10.2 3.7 3.2 4.9 12.4 5.7 6.1 14.8 10.8 14.1 15.8 14.8 7.2 15.7 18.6 10.6 11.1 19.7 15.6 3.9 13.0 15.8 6.7 16.7 12.6 6.3 6.2 19.9 9.5 5.8 6.3 5.8 5.2 7.0 5.1 5.9 7.0 0.1 3.2 5.2 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.1 0.0 0.8 0.0 0.2 0.0 0.2 2.0 0.1 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 3.4 0.1 0.0 0.6 0.0 0.0 0.0 KARS1 "DFNB89, KARS, KARS2" ENSG00000065427 "Lysyl-tRNA synthetase 1" Q15046 16 75627474-75648643 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, Transferase" "Charcot-Marie-Tooth disease, Deafness, Disease variant, Neurodegeneration, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 7 "Cardiomyocytes: 90.7;Cytotrophoblasts: 122.7;Extravillous trophoblasts: 143.3;Hofbauer cells: 89.5;Syncytiotrophoblasts: 110.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041345, HPA041550" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 82000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Plasma membrane" "HPA041345: AB_10795589, HPA041550: AB_10794520" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-2)" "unprognostic (1.02e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (8.84e-6)" "unprognostic (6.24e-3)" "unprognostic (8.97e-3)" "unprognostic (1.18e-1)" "unprognostic (9.11e-3)" "unprognostic (8.71e-3)" "unprognostic (8.46e-2)" "unprognostic (7.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" 68.5 49.6 45.5 71.6 47.3 86.1 83.0 46.9 63.2 60.3 50.6 75.8 62.4 53.9 75.1 72.5 69.5 50.4 96.0 45.6 48.3 72.2 76.8 53.1 88.3 46.9 47.5 74.9 86.5 76.7 51.5 62.2 46.8 55.2 85.6 69.6 79.6 60.6 213.4 67.3 62.6 69.6 46.8 57.6 66.2 98.9 47.4 96.6 65.3 186.8 107.8 92.1 55.0 48.1 164.2 187.0 133.5 185.4 140.1 140.3 262.4 135.0 164.9 290.2 217.0 332.8 209.0 292.4 145.4 180.8 138.4 229.4 272.0 246.7 314.4 86.0 139.8 161.4 153.1 348.5 255.8 245.5 174.1 166.4 173.8 257.4 414.6 147.7 240.0 253.5 273.4 68.5 222.5 378.0 254.1 262.2 284.3 238.4 135.9 329.2 120.0 358.4 235.4 136.3 200.2 162.9 339.5 122.8 152.2 144.8 166.1 229.2 133.8 159.8 164.9 123.6 196.7 145.1 178.6 696.6 139.5 206.5 199.7 88.6 112.7 130.0 110.7 155.7 202.6 109.5 137.1 132.0 135.7 91.6 126.6 117.1 24.9 127.6 163.1 85.7 155.5 160.5 45.5 47.3 46.9 63.2 45.6 48.3 46.9 47.5 46.8 46.8 47.4 48.1 14.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.7 0.0 0.0 0.0 0.0 122.7 10.1 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 143.3 14.4 0.0 0.0 0.0 0.0 0.0 0.0 89.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 110.0 2.1 0.0 0.0 0.0 KAT14 "ATAC2, CRP2BP, CSRP2BP, dJ717M23.1, PRO1194" ENSG00000149474 "Lysine acetyltransferase 14" Q9H8E8 20 18137228-18188387 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 17.5;Extravillous trophoblasts: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068443 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA068443: AB_2685990" "unprognostic (4.02e-2)" "unprognostic (1.17e-1)" "unprognostic (8.60e-2)" "unprognostic (9.38e-2)" "unprognostic (3.98e-1)" "unprognostic (1.90e-2)" "unprognostic (3.37e-2)" "unprognostic (3.21e-1)" "unprognostic (4.04e-1)" "unprognostic (2.29e-1)" "unprognostic (7.15e-3)" "unprognostic (1.96e-2)" "prognostic favorable (4.64e-5)" "unprognostic (4.51e-1)" "unprognostic (4.51e-1)" "unprognostic (1.57e-1)" "unprognostic (1.45e-1)" 6.4 8.4 8.9 4.5 9.5 2.0 7.9 8.9 9.9 7.6 7.6 9.8 8.8 7.8 10.5 7.1 9.4 5.2 7.3 9.8 9.0 9.0 8.3 4.7 7.4 8.0 8.3 10.8 8.0 10.3 7.9 8.3 7.9 7.5 8.8 7.2 7.9 8.0 20.8 9.9 8.5 7.7 8.3 7.7 11.2 8.6 10.3 11.3 8.3 16.6 7.8 8.8 7.4 9.3 8.9 12.9 10.1 9.7 13.4 11.2 87.5 8.4 12.1 11.2 11.1 46.7 11.8 20.7 5.1 7.0 15.9 10.8 10.3 8.9 8.9 8.0 4.1 13.0 3.6 7.4 11.0 12.4 8.5 9.2 16.1 6.7 12.7 10.0 9.1 16.9 7.4 10.6 11.1 10.7 22.1 7.0 14.9 20.4 12.2 11.1 25.1 8.2 10.7 5.3 13.8 8.7 10.8 24.8 13.8 9.2 10.4 11.1 7.7 10.5 4.1 7.4 6.3 9.2 19.0 11.1 3.4 6.0 11.3 0.6 5.7 1.8 9.1 5.7 10.8 7.9 9.2 10.8 8.5 9.8 12.9 10.0 0.5 10.7 11.1 5.9 5.9 8.4 8.9 9.5 8.9 9.9 9.8 9.0 8.0 8.3 7.9 8.3 10.3 9.3 3.1 9.6 6.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 4.3 3.9 0.0 0.0 4.3 1.8 0.0 17.5 1.6 0.0 1.9 4.5 0.0 6.9 5.8 2.1 0.0 0.0 0.0 6.4 38.2 2.3 0.0 5.8 3.8 8.3 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.3 0.0 0.0 6.9 4.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 4.1 1.6 7.9 0.0 0.0 KATNA1 ENSG00000186625 "Katanin catalytic subunit A1" O75449 6 149594873-149648972 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036207 Approved Supported "Nucleoplasm,Centriolar satellite" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Centriolar satellite" Nucleoplasm "HPA036207: AB_10672238" "unprognostic (1.57e-1)" "unprognostic (2.41e-2)" "unprognostic (2.95e-2)" "unprognostic (3.57e-2)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.57e-7)" "unprognostic (9.78e-2)" "unprognostic (8.89e-2)" "unprognostic (7.40e-2)" "unprognostic (2.70e-2)" "unprognostic (4.50e-2)" "unprognostic (3.92e-2)" "unprognostic (2.10e-1)" "unprognostic (3.37e-1)" "unprognostic (1.74e-3)" "unprognostic (8.85e-2)" 12.9 8.2 7.2 10.3 8.4 19.2 12.6 9.6 9.1 13.3 12.3 13.1 8.5 13.3 9.8 12.5 11.8 9.7 11.6 7.0 7.9 13.2 9.0 11.2 14.1 8.2 7.9 19.5 9.5 7.3 7.4 12.7 8.4 9.9 9.9 16.8 9.7 10.9 23.0 12.3 10.0 12.4 7.9 11.8 10.1 45.1 7.8 17.0 11.2 14.3 15.8 12.0 12.7 9.6 22.5 8.3 18.6 42.1 22.9 32.7 28.9 28.7 24.3 29.4 37.2 17.9 11.4 33.7 16.9 28.4 20.4 17.1 34.5 18.5 37.8 30.4 33.8 42.7 17.6 27.9 31.0 60.0 16.4 22.8 22.5 33.3 27.3 27.3 27.8 44.4 46.1 20.7 26.2 32.0 41.2 40.4 19.1 26.2 15.1 30.5 33.3 15.2 21.6 11.6 13.7 20.7 48.9 15.0 22.2 24.3 14.4 61.6 23.7 14.6 23.4 39.2 33.9 20.4 20.3 43.9 19.8 42.7 26.4 39.8 20.4 29.1 25.9 28.5 22.2 27.7 25.2 25.8 26.1 18.3 21.4 20.9 8.7 18.2 25.6 22.3 34.0 20.5 7.2 8.4 9.6 9.1 7.0 7.9 8.2 7.9 8.4 7.9 7.8 9.6 27.6 16.0 11.3 11.8 20.2 29.3 35.7 23.0 12.5 9.1 17.3 26.9 15.5 10.0 15.0 14.7 29.2 23.6 31.4 12.1 17.6 19.5 416.6 23.2 21.6 19.3 6.0 27.4 8.6 12.4 19.4 25.9 11.7 19.3 20.3 23.9 10.0 7.7 17.4 13.5 9.4 9.7 24.4 12.5 19.4 194.2 21.1 17.3 10.6 7.5 22.1 12.2 27.8 13.6 16.3 15.9 12.5 16.6 9.0 19.4 9.7 20.9 23.8 36.1 6.6 40.0 28.5 109.3 58.8 17.7 28.7 25.6 25.6 17.7 12.1 15.4 KIAA1191 "FLJ21022, p33MONOX, p60MONOX" ENSG00000122203 KIAA1191 Q96A73 5 176346062-176361807 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 304.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044701, HPA048145" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 7: Kidney - Transmembrane transport" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm "HPA044701: AB_2679053, HPA048145: AB_2680283" "unprognostic (7.59e-3)" "unprognostic (1.08e-1)" "unprognostic (3.85e-2)" "unprognostic (4.94e-2)" "unprognostic (2.27e-2)" "unprognostic (1.32e-2)" "unprognostic (2.46e-1)" "unprognostic (1.48e-2)" "unprognostic (4.39e-1)" "unprognostic (7.10e-2)" "unprognostic (8.93e-2)" "unprognostic (1.73e-1)" "prognostic favorable (9.94e-5)" "unprognostic (5.02e-3)" "unprognostic (1.69e-1)" "unprognostic (2.52e-1)" "unprognostic (1.73e-2)" 41.7 44.3 40.6 26.7 43.8 30.8 46.0 33.4 43.2 50.9 44.3 46.3 49.6 49.4 52.5 61.2 66.8 42.9 86.7 45.1 47.4 199.3 70.4 47.9 29.2 39.1 39.6 90.0 57.3 87.0 33.1 38.2 45.1 55.2 44.5 58.6 72.3 64.8 70.9 44.2 51.0 55.1 32.7 34.0 62.0 12.8 46.3 36.6 60.8 63.2 37.5 49.7 34.3 33.9 61.5 63.4 105.1 142.7 95.6 72.8 82.6 86.8 86.2 96.6 106.1 118.2 60.2 24.0 111.9 105.5 145.2 53.8 67.6 157.6 113.1 125.0 81.4 27.9 41.4 63.1 111.0 24.0 47.2 73.9 115.2 83.2 70.8 109.6 120.7 39.1 43.1 51.2 108.6 81.7 34.7 14.5 47.1 65.6 81.2 25.2 66.1 21.1 92.6 60.0 82.8 91.6 92.3 45.7 103.6 94.6 66.9 27.1 106.5 88.4 40.2 65.7 107.5 33.7 49.7 27.7 69.0 46.5 71.3 33.8 23.8 32.9 28.7 28.6 32.1 25.1 27.3 27.6 23.1 18.3 28.4 29.7 10.4 27.4 29.0 18.2 40.2 28.6 40.6 43.8 33.4 43.2 45.1 47.4 39.1 39.6 45.1 32.7 46.3 33.9 26.8 54.5 41.0 16.6 31.3 34.0 40.6 29.1 39.3 31.3 40.8 35.6 61.2 34.3 35.9 33.1 25.0 25.0 35.8 38.7 93.9 37.2 2.5 27.5 24.5 30.2 43.2 17.4 19.6 27.4 13.7 29.6 28.1 35.6 17.7 20.6 26.0 45.8 15.8 48.8 22.7 28.3 30.5 21.4 27.1 7.9 31.1 19.8 21.4 12.2 29.5 33.5 13.4 12.5 16.0 37.9 37.5 38.4 28.6 45.0 50.1 304.3 35.1 30.8 13.1 23.8 26.0 7.2 6.0 38.7 31.7 33.4 30.3 20.0 30.6 47.5 KIAA1586 ENSG00000168116 KIAA1586 Q9HCI6 6 57046532-57055239 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 87.0;Erythroid cells: 74.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA036370 Approved Approved "Nucleoplasm,Nuclear membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "HPA036370: AB_10672219" "unprognostic (7.17e-2)" "unprognostic (3.05e-1)" "unprognostic (1.79e-1)" "unprognostic (1.29e-2)" "unprognostic (2.50e-2)" "unprognostic (1.03e-1)" "unprognostic (3.51e-2)" "unprognostic (1.08e-1)" "unprognostic (2.46e-2)" "unprognostic (4.96e-3)" "unprognostic (2.62e-2)" "unprognostic (1.55e-1)" "unprognostic (1.36e-3)" "unprognostic (5.64e-2)" "unprognostic (8.25e-2)" "unprognostic (1.54e-2)" "unprognostic (1.07e-1)" 4.1 4.8 2.0 3.6 2.4 8.6 5.4 9.4 3.7 4.6 0.0 2.9 2.1 6.1 3.7 3.3 2.8 4.6 3.5 2.3 3.0 3.6 4.9 2.7 4.6 2.9 2.4 7.6 2.8 5.2 3.7 9.4 2.8 5.2 2.6 4.0 2.7 3.6 1.6 2.5 2.4 4.4 1.4 4.5 2.1 8.0 2.8 5.9 5.7 3.4 3.9 4.8 2.6 2.6 8.6 3.5 21.9 25.1 8.5 13.7 12.0 14.1 11.6 12.0 14.4 5.9 2.7 3.4 11.4 10.4 10.6 4.2 16.7 8.3 16.4 10.7 12.7 35.9 8.0 13.3 11.1 29.0 12.7 10.1 5.9 10.6 11.7 8.5 11.5 9.1 49.9 2.7 14.4 6.8 14.0 17.5 14.2 3.0 5.0 12.8 16.0 8.4 8.0 17.6 18.5 16.8 9.3 3.0 10.6 15.1 7.2 26.0 9.4 18.6 7.7 17.9 10.2 10.9 15.4 16.8 11.5 21.0 7.7 0.2 2.5 2.0 2.3 2.0 2.7 3.7 3.4 3.0 3.9 3.1 4.2 3.6 0.1 5.3 2.0 4.0 4.4 1.9 2.0 2.4 9.4 3.7 2.3 3.0 2.9 2.4 2.8 1.4 2.8 2.6 15.4 9.6 6.3 10.4 8.8 10.5 4.5 13.0 13.1 15.4 7.4 11.7 23.1 1.5 7.8 7.3 2.1 43.3 11.7 1.0 11.7 7.0 87.0 4.6 29.6 12.5 5.4 74.9 32.4 5.4 33.2 21.4 3.1 3.2 13.3 30.5 8.2 4.0 12.5 10.1 32.7 2.4 6.1 6.6 7.1 21.9 12.8 8.9 3.6 12.2 9.7 9.6 15.5 23.6 24.4 2.8 0.9 14.7 13.0 2.3 0.7 14.6 8.4 8.2 19.7 19.5 17.6 23.4 17.9 8.7 4.4 10.7 10.6 29.5 3.2 1.6 KIFBP "DKFZP586B0923, KBP, KIAA1279, KIF1BP, TTC20" ENSG00000198954 "Kinesin family binding protein" Q96EK5 10 68988803-69043544 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Hirschsprung disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 9.5;Cardiomyocytes: 40.7;Cytotrophoblasts: 21.7;Extravillous trophoblasts: 19.5;Fibroblasts: 8.7;Hofbauer cells: 16.7;Syncytiotrophoblasts: 8.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035538, HPA035539" Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" "HPA035538: AB_10601130, HPA035539: AB_2674676" "unprognostic (4.28e-2)" "unprognostic (1.80e-1)" "unprognostic (9.64e-2)" "unprognostic (4.19e-1)" "unprognostic (1.96e-1)" "unprognostic (2.13e-3)" "unprognostic (4.23e-3)" "unprognostic (3.72e-2)" "unprognostic (3.52e-2)" "unprognostic (7.74e-2)" "unprognostic (6.23e-3)" "unprognostic (8.74e-2)" "prognostic favorable (2.60e-4)" "unprognostic (5.19e-2)" "unprognostic (9.45e-2)" "unprognostic (1.75e-1)" "unprognostic (1.04e-1)" 19.9 22.1 21.3 6.7 24.4 1.3 11.2 24.4 32.5 14.0 19.7 11.9 6.4 12.5 15.9 12.2 11.8 12.6 37.3 24.6 23.8 19.5 13.8 9.9 6.7 23.9 22.2 12.3 8.5 33.8 13.6 14.8 24.5 16.6 10.3 25.7 9.8 17.3 30.4 8.7 8.1 15.3 25.7 7.5 11.4 16.2 22.7 7.6 19.2 43.3 9.2 15.2 9.3 28.1 49.1 36.9 33.3 36.1 48.3 42.5 0.2 63.2 58.0 63.4 71.9 40.4 24.7 0.1 20.7 57.3 39.5 40.2 57.0 37.9 63.6 27.5 48.8 9.5 22.0 24.0 32.4 13.3 11.5 26.4 30.4 42.3 37.7 60.5 46.6 15.1 13.1 14.0 78.4 23.3 13.0 15.8 20.7 25.4 84.1 15.5 27.7 7.2 67.4 12.4 25.0 18.1 36.0 48.9 34.8 32.2 60.3 10.2 46.3 28.0 25.7 24.6 64.0 2.8 0.3 9.0 35.9 19.8 15.7 1.8 4.3 2.4 7.3 7.5 8.8 5.1 8.4 7.2 5.5 4.1 9.6 7.8 1.6 6.9 12.9 2.8 8.0 5.0 21.3 24.4 24.4 32.5 24.6 23.8 23.9 22.2 24.5 25.7 22.7 28.1 9.5 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.7 0.0 0.0 0.0 0.0 21.7 3.5 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 19.5 8.7 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 8.3 0.9 0.0 0.0 0.0 KLHDC4 DKFZp434G0522 ENSG00000104731 "Kelch domain containing 4" Q8TBB5 16 87696485-87765992 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 61.6;Late spermatids: 79.9;NK-cells: 77.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 112.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041665 Approved Approved "Nucleoli,Mitotic chromosome" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoli "Mitotic chromosome" "HPA041665: AB_10796352" "unprognostic (2.96e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-3)" "unprognostic (3.54e-1)" "unprognostic (2.94e-1)" "unprognostic (2.26e-2)" "unprognostic (7.61e-3)" "unprognostic (6.40e-2)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "prognostic favorable (1.14e-4)" "unprognostic (3.84e-2)" "unprognostic (2.73e-2)" "unprognostic (1.54e-1)" "unprognostic (4.56e-2)" "unprognostic (3.88e-1)" "prognostic favorable (1.69e-4)" 10.6 10.8 7.6 11.6 7.2 13.3 10.7 11.7 9.0 11.8 5.2 14.0 8.9 11.6 4.4 11.9 12.0 6.7 8.9 7.8 7.7 14.0 14.6 11.4 16.1 7.6 7.0 12.2 18.4 10.3 13.1 5.4 7.4 13.2 10.9 6.2 11.8 7.8 12.5 11.9 13.7 7.1 6.3 19.8 14.0 12.5 7.3 15.6 13.1 6.4 13.4 11.5 12.9 7.1 16.6 29.7 14.8 22.8 6.0 7.9 23.3 15.1 14.5 24.8 11.6 43.9 23.3 25.6 19.6 12.1 8.8 26.6 23.1 20.0 18.0 4.2 24.9 15.0 20.6 29.4 14.9 14.3 14.8 3.6 10.7 21.9 25.0 12.4 20.8 42.5 48.3 13.4 17.1 72.0 32.7 40.3 25.5 18.9 21.8 31.3 17.3 15.3 15.0 19.2 22.5 21.4 31.9 16.4 7.8 12.6 25.8 22.0 13.4 13.1 23.3 7.1 29.5 63.2 23.4 112.0 13.2 35.2 9.7 0.0 7.8 5.9 18.3 10.8 16.2 7.8 7.2 14.1 6.0 7.7 7.3 11.3 0.6 25.7 16.0 8.0 6.8 8.7 7.6 7.2 11.7 9.0 7.8 7.7 7.6 7.0 7.4 6.3 7.3 7.1 8.4 0.0 16.8 11.1 14.7 4.6 10.9 6.8 12.5 17.8 12.7 9.9 9.9 14.3 14.2 9.2 27.1 14.4 36.1 16.5 11.7 12.3 61.6 8.9 6.0 8.8 24.0 16.0 9.1 16.7 9.4 9.0 19.4 11.4 3.8 17.7 12.1 13.3 13.3 11.8 10.1 15.9 8.2 13.3 6.1 79.9 6.5 9.9 8.8 7.5 10.2 6.5 77.2 7.1 9.2 13.1 9.3 7.5 35.9 15.1 13.8 25.1 9.0 18.0 0.0 16.7 8.5 22.8 11.8 8.6 6.7 11.9 25.5 11.6 21.8 16.5 KLHL25 "ENC-2, ENC2, FLJ12587" ENSG00000183655 "Kelch like family member 25" Q9H0H3 15 85759326-85794925 "Predicted intracellular proteins" "Translation regulation, Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 13.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 3.8" "Group enriched" "Detected in many" 4 "monocytes: 3.8;NK-cells: 2.5;T-cells: 1.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "cerebral cortex: 29.1;hippocampal formation: 16.3" HPA023450 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA023450: AB_1852583" "unprognostic (1.18e-1)" "unprognostic (1.06e-2)" "unprognostic (2.78e-2)" "unprognostic (1.99e-2)" "unprognostic (1.30e-1)" "unprognostic (1.42e-1)" "unprognostic (2.94e-2)" "unprognostic (8.98e-2)" "unprognostic (6.60e-2)" "unprognostic (9.29e-3)" "unprognostic (4.25e-2)" "unprognostic (5.18e-2)" "unprognostic (2.22e-2)" "unprognostic (3.57e-2)" "unprognostic (1.80e-1)" "unprognostic (2.08e-1)" "unprognostic (2.66e-2)" 6.5 2.4 5.6 2.6 7.6 0.5 5.4 5.8 7.5 4.3 4.3 3.8 4.7 6.6 3.1 5.7 4.0 2.2 3.9 6.0 7.6 3.7 15.1 4.3 1.9 5.4 8.2 3.3 1.6 2.2 3.6 1.1 6.9 4.6 1.1 0.8 3.6 3.1 6.5 9.3 3.4 2.8 4.7 1.6 5.0 10.5 7.6 2.0 2.4 3.0 1.3 3.7 5.0 6.7 2.7 8.1 11.6 5.7 2.3 1.2 6.0 3.4 1.6 4.6 3.5 10.9 4.4 1.7 1.7 2.8 2.9 6.6 12.5 6.4 1.0 1.7 5.8 0.5 3.5 8.4 2.7 0.5 2.0 2.4 2.1 4.5 1.5 2.0 2.5 5.8 0.7 1.5 2.0 5.0 4.3 2.6 10.5 4.6 4.2 8.7 6.9 2.8 1.7 5.6 16.1 11.1 4.9 5.6 2.2 4.7 10.2 0.6 2.1 4.9 8.9 3.2 6.2 1.6 3.7 1.7 2.2 3.0 2.8 0.0 0.1 0.2 1.0 1.2 0.5 0.0 1.0 0.7 0.2 0.2 1.7 1.1 0.0 2.5 3.8 0.6 0.9 0.5 5.6 7.6 5.8 7.5 6.0 7.6 5.4 8.2 6.9 4.7 7.6 6.7 0.8 0.0 1.9 3.6 1.2 2.7 4.0 2.1 0.0 3.3 4.0 2.8 4.3 1.5 1.5 0.0 0.0 1.0 3.6 6.3 1.9 2.3 13.0 3.0 3.6 1.8 10.7 0.0 7.7 2.7 1.5 2.4 8.6 3.2 0.0 2.0 2.2 12.4 0.8 13.5 4.1 7.6 4.1 1.3 2.7 4.6 0.9 1.4 7.2 1.0 0.6 2.7 2.1 6.0 0.9 5.3 3.1 1.5 1.3 2.7 2.7 2.1 2.1 1.1 6.6 2.9 2.9 3.3 4.1 4.4 4.7 1.8 4.0 1.4 5.2 4.3 KPNA6 "FLJ11249, IPOA7, KPNA7, MGC17918" ENSG00000025800 "Karyopherin subunit alpha 6" O60684 1 32108056-32176563 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 294.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018863 Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 29: Early spermatids - Spermatogenesis" Cytosol Nucleoplasm "HPA018863: AB_1852632" "unprognostic (8.58e-2)" "unprognostic (1.13e-1)" "unprognostic (1.95e-1)" "unprognostic (3.30e-2)" "unprognostic (8.35e-2)" "unprognostic (7.34e-2)" "prognostic unfavorable (9.28e-5)" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.51e-2)" "unprognostic (3.18e-1)" "unprognostic (5.32e-2)" "unprognostic (1.73e-2)" "unprognostic (1.35e-1)" "unprognostic (1.76e-1)" "unprognostic (1.80e-1)" "unprognostic (1.57e-2)" 14.2 15.4 12.8 11.0 13.9 20.5 13.1 12.4 15.1 15.4 12.7 17.7 8.8 17.1 12.8 18.8 14.2 8.8 22.0 13.8 17.2 13.8 15.8 15.1 11.1 15.7 16.3 13.4 13.4 24.6 14.3 16.6 18.2 13.9 13.0 17.1 13.4 14.3 39.3 18.5 12.5 17.8 12.0 12.0 14.8 20.2 14.6 12.8 13.5 23.7 14.8 15.6 15.6 14.5 32.0 24.8 21.6 28.0 32.5 28.4 25.3 25.2 29.5 36.0 34.5 27.8 33.9 26.5 29.1 45.6 21.6 26.7 33.5 38.5 45.6 27.0 18.4 27.4 36.4 22.6 28.7 30.4 21.5 28.9 35.8 44.6 42.3 30.3 38.1 20.5 27.0 23.7 34.4 17.5 24.6 17.3 50.5 20.6 18.3 24.5 31.0 21.7 31.4 28.9 20.7 17.4 45.8 27.1 25.0 52.6 19.2 15.9 44.5 33.1 22.7 43.8 36.6 16.9 20.7 20.3 36.3 27.8 32.4 3.2 7.4 7.2 7.7 9.1 7.5 5.3 6.5 6.0 6.0 6.1 7.4 7.2 4.2 3.8 9.9 6.7 7.3 5.3 12.8 13.9 12.4 15.1 13.8 17.2 15.7 16.3 18.2 12.0 14.6 14.5 27.9 41.7 41.5 33.0 36.1 63.6 36.9 37.6 22.2 48.6 44.7 26.7 32.7 37.1 32.4 29.5 58.4 45.4 42.4 29.5 17.6 36.2 294.2 41.0 44.6 40.4 46.1 52.8 62.5 31.6 41.6 35.7 25.5 49.3 13.9 31.3 36.0 77.3 30.4 52.2 58.4 36.0 24.4 36.8 44.8 65.2 34.2 29.3 24.9 30.0 41.4 29.0 47.4 40.7 54.3 46.1 26.4 40.6 24.1 56.7 25.3 33.2 48.2 44.7 32.9 53.1 36.7 78.7 56.2 31.2 85.1 135.7 31.7 31.8 35.6 59.0 KRBA1 KIAA1862 ENSG00000133619 "KRAB-A domain containing 1" A5PL33 7 149714781-149734575 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 40.2" "Cell type enhanced" "Detected in many" "Muller glia cells: 11.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021237, HPA050448" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 5: Muller glia cells - Visual perception" Nucleoplasm Cytosol "HPA021237: AB_2134145, HPA050448: AB_2681129" "unprognostic (2.19e-2)" "unprognostic (9.01e-2)" "unprognostic (8.06e-2)" "unprognostic (7.48e-3)" "unprognostic (6.75e-3)" "unprognostic (5.59e-2)" "unprognostic (1.01e-5)" "unprognostic (3.41e-2)" "unprognostic (1.51e-2)" "unprognostic (1.42e-1)" "prognostic favorable (2.77e-4)" "unprognostic (2.55e-1)" "unprognostic (6.33e-3)" "unprognostic (9.62e-2)" "unprognostic (4.29e-2)" "unprognostic (1.47e-1)" "unprognostic (9.31e-2)" 4.1 6.0 6.0 5.0 6.7 3.9 5.4 4.3 10.1 9.2 1.8 9.0 1.5 9.6 2.3 5.7 7.0 4.3 40.2 6.5 4.2 7.6 2.6 4.7 4.6 7.6 4.7 8.9 7.6 6.0 25.2 2.3 4.8 8.9 1.3 4.9 12.9 5.6 6.3 6.9 5.3 6.4 2.6 6.8 7.4 6.8 5.6 3.9 6.1 4.1 3.7 8.1 7.5 7.1 8.0 4.9 9.5 20.0 4.2 4.1 8.3 4.2 5.1 6.6 7.5 0.5 2.1 2.4 8.6 5.3 13.3 7.8 7.2 14.0 3.3 11.1 13.7 4.4 7.5 4.7 5.2 0.0 12.0 9.2 6.5 4.6 2.5 7.8 6.1 13.0 18.4 2.5 3.4 3.2 11.7 6.8 11.4 3.7 4.7 12.2 3.8 1.3 5.1 6.3 7.5 12.7 6.4 18.3 4.5 4.3 3.2 6.8 6.2 8.0 3.4 0.0 5.8 11.7 4.1 10.7 4.7 7.6 8.5 0.0 0.7 0.1 1.4 0.7 0.9 0.6 0.7 0.8 1.0 1.3 1.2 1.0 0.5 0.1 1.6 1.4 1.6 0.7 6.0 6.7 4.3 10.1 6.5 4.2 7.6 4.7 4.8 2.6 5.6 7.1 2.0 0.0 3.2 9.4 1.9 1.8 2.6 2.7 4.6 7.9 4.4 3.9 10.3 5.7 1.6 3.7 4.2 1.2 4.8 0.0 0.0 4.9 0.6 0.8 2.0 1.6 0.0 0.4 6.9 2.7 2.3 3.0 2.6 0.9 0.0 6.3 1.4 1.2 5.2 8.4 6.5 0.1 0.0 2.8 0.9 1.2 4.1 1.8 0.0 1.9 1.6 11.7 2.1 5.5 3.3 1.3 0.0 3.4 1.1 3.0 0.0 1.8 1.6 4.2 6.6 2.8 2.2 1.8 3.5 1.2 1.8 1.2 2.8 3.0 0.1 1.9 KYAT1 "CCBL1, GTK, KATI" ENSG00000171097 "Kynurenine aminotransferase 1" Q16773 9 128832942-128882494 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "Granulosa cells: 45.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA021176, HPA021177, HPA027736" Approved Supported Cytosol NA NA 22000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 20: HeLa - Mitochondria" "Cluster 40: Granulosa cells - Unknown function" Cytosol "HPA021176: AB_1846120, HPA021177: AB_1846119, HPA027736: AB_10611818" "unprognostic (6.51e-2)" "unprognostic (8.67e-3)" "unprognostic (1.05e-2)" "unprognostic (5.98e-3)" "unprognostic (2.15e-2)" "unprognostic (5.44e-2)" "unprognostic (2.91e-2)" "unprognostic (1.12e-2)" "unprognostic (2.47e-1)" "unprognostic (8.60e-3)" "unprognostic (1.43e-1)" "unprognostic (3.65e-2)" "unprognostic (3.10e-2)" "unprognostic (5.79e-2)" "unprognostic (2.03e-1)" "unprognostic (1.08e-1)" "unprognostic (1.98e-1)" 3.5 4.7 12.3 3.6 13.3 2.3 4.0 13.0 15.5 7.2 10.6 4.7 2.5 5.8 2.9 5.3 6.4 2.7 10.3 12.1 11.8 7.8 12.7 3.6 5.0 13.2 12.3 6.2 3.1 5.5 8.7 2.5 12.8 7.4 1.3 7.5 4.2 4.3 12.6 7.7 4.2 3.1 12.3 5.4 4.9 5.6 12.9 8.9 6.1 8.7 4.8 7.2 6.7 18.0 4.8 9.8 9.3 10.6 6.9 11.4 3.0 5.5 8.0 6.2 8.0 3.9 9.7 8.3 2.9 4.6 7.0 14.9 13.9 11.1 9.3 10.0 7.3 5.7 27.7 9.6 7.7 5.0 1.9 4.5 7.1 7.1 7.7 21.8 11.3 22.7 8.2 9.0 8.5 3.1 14.0 3.4 15.2 18.3 7.6 16.4 6.4 18.9 8.7 1.7 10.5 7.4 9.9 2.9 6.2 12.8 6.6 1.6 7.0 4.6 7.9 7.1 5.0 15.2 11.0 11.6 9.6 8.3 3.2 0.1 1.4 2.9 5.1 1.8 4.5 7.7 5.7 6.0 5.5 3.3 5.9 6.7 0.9 3.3 2.9 2.4 7.0 3.3 12.3 13.3 13.0 15.5 12.1 11.8 13.2 12.3 12.8 12.3 12.9 18.0 2.6 0.0 1.5 0.0 1.5 0.0 0.0 0.0 0.0 0.0 2.0 1.5 0.0 0.0 0.6 0.0 0.0 5.0 0.9 0.0 3.9 1.6 0.0 2.6 3.3 0.7 0.0 0.0 0.0 0.2 2.4 0.7 0.0 4.2 0.0 45.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 0.0 0.0 7.3 2.9 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 2.1 1.3 1.3 0.0 0.0 KYAT3 "CCBL2, KAT3, KATIII, RBM1, RP11-82K18.3" ENSG00000137944 "Kynurenine aminotransferase 3" Q6YP21 1 88935773-88992953 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Aminotransferase, Lyase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 70.7;Exocrine glandular cells: 38.2;Extravillous trophoblasts: 39.9;Proximal tubular cells: 35.6;Syncytiotrophoblasts: 83.5;Theca cells: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026538, HPA027168" Enhanced Approved "Nucleoli,Cytokinetic bridge,Cytosol" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 7: Non-specific - Mitochondria" Cytosol "Nucleoli, Cytokinetic bridge" "HPA026538: AB_1852076, HPA027168: AB_1852078" "prognostic favorable (3.19e-5)" "unprognostic (3.36e-3)" "unprognostic (1.88e-2)" "unprognostic (1.62e-1)" "unprognostic (2.01e-2)" "prognostic favorable (1.86e-4)" "unprognostic (2.61e-1)" "unprognostic (3.61e-3)" "unprognostic (2.11e-1)" "prognostic favorable (2.80e-4)" "unprognostic (1.04e-1)" "unprognostic (3.17e-1)" "prognostic favorable (5.02e-6)" "unprognostic (1.17e-1)" "unprognostic (1.06e-1)" "unprognostic (2.51e-1)" "unprognostic (2.78e-1)" 19.3 22.5 8.3 16.0 9.3 13.4 29.8 10.0 12.2 18.0 12.3 19.9 22.6 21.3 21.7 26.5 18.3 20.0 11.3 9.4 9.5 30.5 27.4 15.4 22.1 8.5 9.5 25.7 30.0 33.4 15.2 22.7 9.2 21.1 21.7 11.0 20.5 22.1 10.6 18.8 17.4 15.7 8.7 17.6 22.7 9.9 8.7 21.6 26.2 10.0 23.7 24.6 14.9 8.9 55.1 11.1 52.2 18.0 19.1 51.2 46.4 31.7 57.2 39.8 49.4 15.6 18.9 35.6 23.8 23.8 27.3 15.7 15.6 25.6 57.7 22.7 21.3 32.4 9.8 26.8 61.8 45.6 8.5 44.9 25.2 29.0 50.1 26.8 37.0 41.0 41.5 19.0 37.9 17.8 48.0 21.6 31.0 42.5 10.3 49.3 36.2 19.2 87.0 49.2 38.9 45.6 44.4 60.0 29.1 31.8 33.3 13.9 27.7 17.5 11.4 55.5 23.1 23.7 13.6 23.6 8.4 19.5 14.7 8.3 12.1 7.5 8.0 7.7 11.1 8.6 10.6 9.5 16.3 8.9 10.6 9.3 8.8 11.3 10.2 5.9 16.3 8.3 8.3 9.3 10.0 12.2 9.4 9.5 8.5 9.5 9.2 8.7 8.7 8.9 10.6 12.8 11.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 16.0 13.7 0.0 0.0 8.1 12.9 0.0 70.7 13.1 0.0 25.4 34.4 0.0 12.7 14.1 4.6 0.0 0.0 0.0 38.2 39.9 10.1 0.0 14.3 5.1 17.5 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 32.0 0.0 0.0 0.0 0.0 25.2 0.0 0.0 1.8 0.0 0.0 35.6 3.6 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 83.5 7.6 43.3 0.0 0.0 L3MBTL2 "dJ756G23.3, DKFZP761I141, H-l(3)mbt-l" ENSG00000100395 "L3MBTL histone methyl-lysine binding protein 2" Q969R5 22 41205282-41231271 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000815 Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA000815: AB_1079220" "unprognostic (2.42e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.98e-2)" "prognostic favorable (4.37e-4)" "unprognostic (3.48e-1)" "unprognostic (1.19e-2)" "unprognostic (4.16e-3)" "unprognostic (1.03e-2)" "unprognostic (2.19e-1)" "unprognostic (2.26e-1)" "unprognostic (7.95e-3)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.07e-3)" "unprognostic (1.81e-1)" "unprognostic (2.70e-2)" "unprognostic (2.19e-1)" 9.8 14.6 15.8 12.3 16.6 11.0 10.5 14.7 16.8 12.8 12.6 13.5 8.6 13.2 12.1 12.1 19.4 9.5 13.2 15.4 16.3 14.2 16.6 11.8 17.7 16.3 16.4 14.0 11.0 17.0 16.4 9.5 17.0 14.2 10.2 10.0 13.0 13.8 11.9 13.7 11.6 13.9 14.7 15.5 12.7 14.9 16.6 15.0 12.2 9.0 18.0 13.9 10.4 24.3 21.3 20.8 17.6 35.6 20.9 15.6 20.6 19.8 22.7 37.7 31.1 13.7 15.0 34.6 15.7 26.7 22.6 20.3 40.9 26.3 23.9 42.3 52.8 14.4 35.7 32.9 22.1 65.8 31.4 21.4 10.2 29.6 27.8 16.4 27.2 26.1 24.9 27.5 18.1 37.4 33.4 22.4 23.9 75.6 23.8 34.1 14.3 39.9 19.0 20.9 14.3 10.0 35.5 25.3 21.4 17.0 16.9 36.0 21.6 20.2 19.1 16.2 22.2 22.6 43.1 28.6 23.3 29.7 26.3 10.0 13.4 10.7 21.4 16.6 19.6 15.7 16.7 17.1 17.0 11.0 20.0 18.9 2.1 21.2 18.6 12.9 18.4 21.6 15.8 16.6 14.7 16.8 15.4 16.3 16.3 16.4 17.0 14.7 16.6 24.3 9.4 16.0 19.6 7.5 12.2 2.7 5.1 8.0 2.8 24.7 9.0 8.9 10.2 15.7 17.1 11.0 16.7 17.7 15.8 9.6 11.7 9.9 13.9 14.8 9.1 9.3 15.0 10.5 9.9 7.9 17.4 9.3 13.7 8.0 11.4 12.0 7.9 14.2 13.0 16.8 10.8 8.7 22.4 11.1 4.6 30.0 7.2 11.6 3.6 3.7 11.2 13.7 12.3 9.5 8.1 7.6 5.8 9.4 13.3 6.9 7.3 8.7 22.6 15.0 6.6 9.4 13.4 21.5 14.4 6.7 3.8 17.1 13.9 17.5 9.4 6.2 LARP1 "KIAA0731, Lar1, LARP, Lhp1, MGC19556" ENSG00000155506 "La ribonucleoprotein 1, translational regulator" Q6PKG0 5 154712843-154817605 "Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis, Translation regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015222, HPA051397, HPA054819" Approved Supported "Nucleoplasm,Endoplasmic reticulum,Cytosol" NA NA 12000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nucleoplasm, Endoplasmic reticulum, Cytosol" "CAB015222: , HPA051397: AB_2681467, HPA054819: AB_2682612" "unprognostic (1.44e-3)" "unprognostic (1.21e-1)" "unprognostic (7.69e-2)" "unprognostic (1.76e-3)" "unprognostic (3.95e-2)" "unprognostic (3.08e-3)" "unprognostic (2.72e-2)" "unprognostic (3.34e-3)" "unprognostic (4.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.70e-1)" "unprognostic (6.83e-2)" "unprognostic (2.07e-1)" "unprognostic (2.20e-1)" "unprognostic (1.22e-1)" "unprognostic (1.45e-2)" "unprognostic (1.83e-1)" 42.5 50.0 30.9 36.5 28.4 37.0 36.4 12.2 44.8 38.4 15.8 38.4 33.8 43.6 37.4 51.6 39.9 29.3 48.6 34.3 25.8 40.0 36.7 34.8 41.1 26.7 40.3 45.0 103.0 70.3 39.8 37.9 47.2 31.3 34.6 32.1 57.4 32.9 78.8 45.4 37.7 38.7 5.4 35.7 44.0 38.2 27.6 42.1 53.8 46.4 44.8 38.0 40.0 37.4 93.3 140.3 107.6 124.1 93.3 73.1 103.1 99.0 101.8 114.7 110.0 218.1 116.8 252.2 128.0 127.5 168.5 92.9 196.1 185.9 135.7 83.4 94.1 187.1 143.8 106.1 117.6 250.6 81.2 91.2 108.4 144.5 185.2 66.4 103.9 114.0 149.2 180.2 111.9 102.9 156.5 100.0 107.3 89.8 60.5 158.8 97.5 120.5 74.1 120.7 180.7 93.5 132.2 215.4 112.3 112.9 126.0 119.0 130.4 140.3 83.0 106.2 170.3 136.8 126.0 219.5 92.1 134.8 99.1 2.2 2.4 0.7 2.6 3.0 3.3 2.5 3.0 3.0 2.4 3.3 2.5 2.6 1.4 5.9 5.6 3.9 2.1 1.7 30.9 28.4 12.2 44.8 34.3 25.8 26.7 40.3 47.2 5.4 27.6 37.4 37.6 44.8 33.8 67.9 37.2 78.3 39.7 38.0 34.7 64.4 45.1 33.0 104.4 50.1 33.7 40.5 37.5 43.7 35.3 45.1 29.4 42.2 14.4 70.1 70.6 48.8 43.9 73.4 72.0 82.5 35.2 46.2 46.9 65.5 17.2 63.2 47.8 66.9 57.9 87.5 92.5 49.6 18.3 53.3 42.6 12.1 69.6 43.6 37.4 46.9 49.1 26.5 33.0 47.7 69.5 62.1 37.7 80.1 47.3 75.2 53.0 50.1 46.5 38.7 13.1 63.6 39.4 56.2 40.5 54.6 84.5 23.9 34.6 71.6 68.8 53.6 LARP4 PP13296 ENSG00000161813 "La ribonucleoprotein 4" Q71RC2 12 50392383-50480004 "Predicted intracellular proteins" "Protein biosynthesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039306, HPA039673" Approved Enhanced "Nucleoli fibrillar center,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" Cytosol "Nucleoli fibrillar center" "HPA039306: AB_10805362, HPA039673: AB_10795110" "unprognostic (4.41e-3)" "unprognostic (4.11e-2)" "unprognostic (2.01e-2)" "unprognostic (8.50e-2)" "unprognostic (3.13e-1)" "unprognostic (1.17e-1)" "unprognostic (1.57e-1)" "unprognostic (1.18e-1)" "unprognostic (6.40e-2)" "unprognostic (9.93e-3)" "unprognostic (9.08e-2)" "unprognostic (8.94e-2)" "unprognostic (8.51e-3)" "unprognostic (1.91e-2)" "unprognostic (3.14e-1)" "unprognostic (9.06e-2)" "unprognostic (3.99e-3)" 17.4 27.7 9.5 16.2 12.6 14.0 14.6 16.4 10.8 14.1 23.8 15.3 16.7 10.5 11.7 18.9 9.3 12.9 16.3 8.8 13.9 29.0 62.1 13.5 15.6 13.2 14.4 9.4 16.5 21.8 8.8 18.3 14.0 13.9 14.4 20.3 15.9 11.3 26.4 11.2 13.1 11.7 12.2 12.5 17.2 14.9 13.0 15.9 20.0 37.0 15.5 21.5 9.0 17.3 43.9 61.0 40.1 29.6 36.6 30.2 67.9 52.9 31.5 51.3 40.8 120.5 50.2 102.9 63.9 33.2 47.5 41.1 88.2 36.1 67.3 64.3 35.9 83.9 56.1 43.6 34.0 93.9 47.5 27.6 33.9 60.9 65.1 33.9 45.9 37.2 122.8 47.4 48.0 39.3 77.7 31.6 58.2 28.5 52.9 56.6 63.6 61.0 27.8 65.1 47.2 27.7 94.0 48.3 54.9 37.0 42.1 37.4 66.9 34.0 50.2 39.7 50.4 45.9 134.7 90.3 47.0 37.9 28.9 8.2 8.7 6.0 8.1 9.6 7.5 8.6 7.0 4.5 11.7 8.6 8.2 6.7 4.4 8.2 12.1 10.0 7.6 7.7 9.5 12.6 16.4 10.8 8.8 13.9 13.2 14.4 14.0 12.2 13.0 17.3 35.9 48.1 44.7 31.0 26.8 71.0 33.8 23.1 59.7 41.0 34.0 25.1 47.8 22.8 27.7 29.5 87.6 27.4 22.0 29.1 9.8 19.7 8.6 52.9 50.4 28.6 24.0 33.0 38.9 24.0 17.3 31.0 38.7 57.5 19.7 27.9 21.0 129.0 27.3 18.5 45.5 25.8 20.3 33.0 26.6 25.4 14.9 23.0 26.6 24.4 27.6 18.4 13.4 26.7 40.4 27.0 16.1 19.2 56.4 44.3 20.3 54.7 33.0 54.0 6.6 42.2 36.8 37.4 42.5 52.2 74.3 34.2 22.0 34.4 27.5 33.2 LATS1 WARTS ENSG00000131023 "Large tumor suppressor kinase 1" O95835 6 149658153-149718105 "Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031804 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" "HPA031804: AB_10601688" "unprognostic (4.02e-3)" "unprognostic (3.80e-3)" "unprognostic (1.28e-2)" "unprognostic (1.00e-1)" "unprognostic (4.40e-2)" "unprognostic (2.09e-1)" "unprognostic (6.15e-3)" "unprognostic (1.29e-2)" "unprognostic (9.67e-2)" "unprognostic (1.02e-2)" "unprognostic (1.74e-1)" "unprognostic (1.52e-1)" "unprognostic (5.62e-2)" "unprognostic (1.92e-1)" "unprognostic (8.43e-2)" "unprognostic (2.63e-1)" "unprognostic (2.65e-1)" 8.1 8.0 4.8 8.6 4.9 15.4 9.2 11.0 7.0 10.1 5.5 7.3 7.2 12.1 7.4 8.2 9.7 7.7 5.6 5.2 4.6 7.7 7.8 9.1 9.8 4.7 4.3 15.6 6.8 11.7 5.2 8.8 5.0 11.0 8.5 11.0 8.7 7.7 6.4 9.1 7.7 10.7 4.3 10.2 7.7 6.2 5.1 11.7 8.9 8.1 8.4 9.0 7.2 7.6 8.7 6.8 13.7 19.8 12.9 16.6 10.7 11.3 11.4 11.8 11.7 11.1 7.3 14.0 11.1 15.7 9.4 11.8 18.3 12.0 18.5 12.9 14.7 28.1 8.2 9.9 11.9 26.5 19.8 11.3 19.1 13.5 22.7 12.2 14.8 12.1 35.3 13.9 11.9 10.4 13.8 11.0 8.5 8.0 6.5 13.6 16.4 6.5 11.0 12.2 9.3 14.7 16.1 11.5 8.4 9.3 12.0 22.9 18.7 9.5 14.8 11.4 18.2 11.6 13.5 15.8 8.7 14.8 14.3 8.2 3.0 4.8 5.9 5.3 5.3 3.8 4.5 5.0 3.3 4.7 3.8 5.1 2.0 3.0 8.9 2.8 4.8 2.4 4.8 4.9 11.0 7.0 5.2 4.6 4.7 4.3 5.0 4.3 5.1 7.6 21.1 12.8 21.3 33.0 21.9 16.3 11.2 9.7 27.9 20.3 15.2 10.2 9.6 12.8 12.5 7.3 18.8 8.5 18.7 15.3 1.9 7.5 23.0 14.1 23.4 16.2 16.8 17.7 51.4 6.6 11.4 19.7 20.9 17.1 14.0 19.8 21.0 13.3 11.0 13.5 48.0 12.6 6.1 14.7 11.6 6.9 13.7 16.6 14.2 32.8 15.0 10.7 10.3 54.8 64.0 9.9 11.5 25.9 21.9 15.4 13.6 6.6 12.8 22.0 19.7 28.8 15.1 8.8 9.6 18.8 18.0 13.1 23.3 13.8 11.7 11.8 LEO1 ENSG00000166477 "LEO1 homolog, Paf1/RNA polymerase II complex component" Q8WVC0 15 51938025-51971778 "Predicted intracellular proteins" "Transcription, Transcription regulation, Wnt signaling pathway" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 7 "granulocytes: 272.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040741, HPA040941" Enhanced Enhanced "Nucleoplasm,Nucleoli fibrillar center,Centrosome" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 60: Granulocytes - Receptor signaling" "Nucleoplasm, Nucleoli fibrillar center" Centrosome "HPA040741: AB_10794859, HPA040941: AB_10805832" "unprognostic (2.76e-2)" "unprognostic (2.14e-2)" "unprognostic (2.44e-1)" "unprognostic (1.81e-3)" "unprognostic (2.85e-2)" "unprognostic (1.03e-1)" "unprognostic (1.09e-2)" "unprognostic (1.04e-2)" "unprognostic (1.83e-2)" "unprognostic (2.10e-1)" "unprognostic (1.20e-1)" "unprognostic (1.02e-2)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (8.48e-2)" "unprognostic (2.10e-2)" "unprognostic (1.08e-1)" 10.2 11.4 8.1 13.8 8.8 9.0 15.5 14.7 12.9 11.6 6.4 17.0 13.3 10.4 10.0 19.8 8.7 13.2 8.1 8.0 10.0 13.7 22.2 9.7 18.0 8.0 8.1 8.5 8.1 18.8 9.1 12.1 7.7 12.3 19.2 12.0 18.5 8.6 13.9 20.8 14.5 11.7 6.9 10.5 13.2 9.3 8.3 22.1 11.1 11.7 17.9 19.3 14.0 10.0 28.0 63.9 40.3 32.6 40.7 35.0 28.8 44.4 36.6 37.3 33.9 44.3 17.9 56.2 25.3 45.8 41.3 53.2 54.2 39.6 35.8 37.5 24.5 88.5 50.6 78.5 32.0 80.7 118.2 37.9 30.5 29.2 37.6 35.2 37.0 46.5 54.6 30.1 44.9 118.7 43.0 61.1 17.4 82.6 27.0 47.6 69.7 58.9 32.8 77.0 28.5 43.4 33.9 51.5 36.5 43.8 42.8 72.6 44.4 36.8 25.5 34.3 53.7 23.4 78.2 50.7 32.2 113.1 40.0 11.5 14.5 15.7 27.4 23.3 25.7 18.7 27.2 22.3 23.8 16.4 27.9 25.2 3.3 30.9 26.0 17.8 31.7 16.3 8.1 8.8 14.7 12.9 8.0 10.0 8.0 8.1 7.7 6.9 8.3 10.0 16.2 35.3 24.6 10.1 15.2 26.1 16.8 33.4 18.2 38.2 11.8 10.2 21.2 17.2 37.0 7.3 10.4 24.9 24.8 24.6 15.6 26.3 2.4 19.5 38.8 18.0 7.7 12.4 16.5 24.2 26.7 19.9 15.8 29.8 272.8 16.2 10.0 18.0 19.5 26.9 16.9 17.9 26.4 14.8 6.0 2.7 8.1 13.0 3.6 5.6 12.8 23.1 22.6 13.0 13.3 18.2 14.7 13.5 11.0 9.0 20.5 23.3 31.4 23.2 6.6 18.5 29.3 21.5 11.0 19.5 24.7 17.6 25.0 23.8 17.0 21.2 LIG3 "LIG2, LIG3alpha" ENSG00000005156 "DNA ligase 3" P49916 17 34980512-35009743 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 80.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006723 Supported Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 3: HMC-1 - Innate immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA006723: AB_1847781" "unprognostic (6.05e-3)" "unprognostic (2.98e-1)" "unprognostic (1.24e-1)" "unprognostic (2.83e-1)" "unprognostic (1.57e-1)" "unprognostic (8.76e-2)" "unprognostic (2.40e-2)" "unprognostic (2.78e-1)" "unprognostic (2.25e-1)" "unprognostic (1.02e-2)" "unprognostic (8.77e-3)" "unprognostic (1.31e-1)" "unprognostic (6.67e-3)" "unprognostic (3.39e-1)" "unprognostic (3.28e-1)" "unprognostic (3.29e-2)" "unprognostic (4.71e-2)" 4.9 6.4 3.2 7.3 3.3 7.1 8.7 3.8 4.4 7.9 4.7 8.2 5.9 12.5 6.4 8.9 11.9 5.3 7.6 3.4 1.9 6.6 6.3 5.2 7.2 2.2 2.0 11.5 8.7 13.7 6.6 8.3 1.8 11.1 9.0 7.2 10.6 9.0 10.6 8.4 6.7 10.2 1.0 7.6 6.6 21.1 2.1 13.9 10.1 9.3 8.5 8.9 7.2 3.1 16.6 32.6 38.3 33.9 7.4 9.3 29.2 15.7 11.4 20.9 20.8 15.8 8.8 27.0 12.7 20.6 20.5 15.2 43.9 20.3 26.7 12.8 29.4 28.4 14.6 23.2 11.7 44.9 48.1 7.0 17.5 15.5 24.0 10.3 25.6 40.8 45.3 30.2 15.2 18.6 56.7 14.1 36.8 20.6 13.7 30.4 35.2 28.6 10.2 17.7 31.2 22.3 23.6 19.0 15.2 55.9 34.5 22.3 12.3 13.5 16.8 16.8 25.6 27.0 31.5 35.1 9.7 20.9 26.5 0.6 3.4 4.2 4.6 5.1 6.7 3.7 3.1 4.1 8.4 3.0 4.1 3.0 0.3 9.3 2.8 4.9 2.1 3.9 3.2 3.3 3.8 4.4 3.4 1.9 2.2 2.0 1.8 1.0 2.1 3.1 7.6 3.2 10.3 1.6 8.0 5.0 10.5 3.6 12.0 18.2 10.0 7.5 10.1 10.0 9.2 12.9 16.7 14.6 11.9 7.0 9.8 6.7 41.8 18.5 11.9 8.5 6.7 8.2 5.0 6.0 17.8 7.3 16.8 15.8 9.5 16.7 3.6 8.9 7.9 16.8 5.2 7.9 8.2 5.3 2.7 80.0 7.2 6.7 3.6 2.8 6.4 7.6 16.5 4.0 5.8 3.6 7.5 7.9 15.4 11.6 6.8 6.5 5.3 17.7 6.6 11.8 7.0 32.7 13.2 11.2 5.3 21.6 8.9 10.8 9.5 10.2 LNPEP "CAP, IRAP, P-LAP, PLAP" ENSG00000113441 "Leucyl and cystinyl aminopeptidase" Q9UIQ6 5 96935394-97037513 "Enzymes, Predicted membrane proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "NK-cells: 257.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043642 Approved "Intracellular and membrane" NA NA 9800000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 63: NK-cells & T-cells - Immune response" "HPA043642: AB_10964137" "unprognostic (1.52e-1)" "unprognostic (5.39e-2)" "unprognostic (7.78e-2)" "unprognostic (1.53e-2)" "unprognostic (6.38e-2)" "unprognostic (6.59e-3)" "unprognostic (6.83e-2)" "unprognostic (2.11e-1)" "unprognostic (1.11e-1)" "unprognostic (3.54e-3)" "unprognostic (6.24e-2)" "unprognostic (2.08e-1)" "unprognostic (3.28e-1)" "unprognostic (4.13e-3)" "unprognostic (1.46e-1)" "unprognostic (1.69e-1)" "unprognostic (1.17e-1)" 11.4 4.4 8.4 12.2 10.6 16.2 8.2 17.9 8.6 6.8 4.0 8.1 5.2 6.5 5.1 9.0 5.7 5.1 12.0 8.5 10.0 8.3 4.3 7.7 19.4 10.0 9.4 8.8 4.9 15.3 5.8 9.1 10.7 8.8 7.9 9.4 6.0 8.5 11.2 16.4 8.2 7.7 8.6 12.5 7.9 4.1 9.2 17.8 8.4 12.7 18.7 7.0 7.0 10.3 10.7 11.9 5.4 5.6 32.5 15.4 6.2 10.5 13.8 12.0 18.1 9.9 16.4 52.2 19.1 14.1 33.7 13.4 6.8 20.1 12.5 18.2 3.8 12.9 8.2 7.3 8.4 15.5 16.9 12.0 12.5 17.5 13.3 13.6 12.8 11.6 5.6 32.7 13.9 9.6 18.1 10.9 1.1 3.4 6.2 12.7 19.8 7.9 44.9 21.2 10.2 2.7 12.8 11.4 6.4 5.2 34.1 20.2 26.6 17.6 9.6 13.9 16.3 7.3 17.4 45.6 16.1 14.5 8.2 4.3 2.6 3.6 5.9 4.2 5.0 2.3 4.4 4.6 2.8 3.1 4.2 4.7 3.1 9.0 11.2 2.6 4.2 3.6 8.4 10.6 17.9 8.6 8.5 10.0 10.0 9.4 10.7 8.6 9.2 10.3 43.4 35.3 41.3 52.2 91.0 59.4 21.3 28.4 37.5 58.9 24.9 18.8 80.8 22.8 27.2 36.8 125.1 12.3 108.4 20.7 5.9 15.4 3.6 21.4 28.9 33.6 25.7 38.9 47.5 14.4 24.3 36.6 30.1 28.9 25.9 29.3 30.7 16.7 16.2 23.5 50.9 29.6 22.4 49.3 35.9 5.3 32.9 52.0 21.4 45.9 59.7 33.6 257.5 49.3 73.9 21.5 17.5 46.6 44.9 27.4 16.6 10.7 25.8 38.4 26.3 46.8 36.6 29.4 27.5 44.4 47.2 27.4 97.3 31.1 25.6 23.2 LNX1 "LNX, MPDZ, PDZRN2" ENSG00000072201 "Ligand of numb-protein X 1" Q8TBB1 4 53459301-53701405 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Adipocytes: 77.5;Early spermatids: 171.7;Excitatory neurons: 123.8;Glandular and luminal cells: 83.0" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 9 "amygdala: 2.7;basal ganglia: 6.0;cerebral cortex: 10.3;hippocampal formation: 7.5;white matter: 3.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "OE19: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002235, HPA071091" Approved Supported "Cell Junctions,Cytosol" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" "Cell Junctions" Cytosol "HPA002235: AB_1079261, HPA071091: AB_2686344" "unprognostic (4.95e-2)" "unprognostic (1.74e-2)" "unprognostic (2.00e-2)" "unprognostic (3.16e-2)" "unprognostic (2.79e-1)" "unprognostic (2.31e-1)" "unprognostic (1.31e-1)" "unprognostic (5.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.06e-1)" "unprognostic (5.18e-2)" "unprognostic (8.56e-2)" "prognostic favorable (3.08e-7)" "unprognostic (2.67e-1)" "unprognostic (5.49e-2)" "unprognostic (6.81e-2)" "unprognostic (3.05e-2)" 21.9 2.5 2.7 2.1 6.0 1.0 14.3 0.1 10.3 6.1 0.0 6.7 9.4 4.2 0.6 24.4 6.4 5.5 8.7 7.5 0.1 10.6 4.4 2.7 2.1 0.0 0.1 2.1 16.3 11.9 4.3 24.6 0.4 5.9 6.9 3.8 25.1 7.2 5.9 11.8 9.0 3.0 0.0 0.9 9.5 4.4 0.6 3.3 17.9 12.0 4.1 4.3 7.9 3.1 1.4 0.5 1.6 0.9 2.7 5.8 8.0 1.2 0.6 0.0 0.0 2.9 8.9 1.7 1.1 4.3 0.4 1.4 0.0 0.2 0.0 0.4 4.6 2.2 1.5 1.5 1.3 2.4 0.7 4.4 0.2 0.3 0.0 1.9 2.7 0.8 1.9 0.8 6.4 4.5 2.2 1.7 4.3 17.7 0.7 1.2 0.6 0.7 5.6 8.2 2.2 2.1 0.6 10.8 0.9 9.1 5.7 1.1 7.8 10.0 2.6 3.1 1.6 3.6 0.5 1.1 8.7 2.0 1.5 0.3 0.0 0.0 0.1 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.2 0.2 0.0 0.7 0.4 0.2 0.2 0.0 2.7 6.0 0.1 10.3 7.5 0.1 0.0 0.1 0.4 0.0 0.6 3.1 77.5 0.0 3.9 4.9 1.7 8.2 18.0 14.5 24.5 7.5 13.3 7.1 1.6 12.8 15.5 7.3 6.2 30.6 1.5 18.5 19.6 13.7 171.7 37.7 7.6 16.0 13.8 3.6 123.8 11.7 22.1 4.8 14.3 83.0 2.5 1.5 2.9 6.2 2.5 42.1 42.2 13.4 14.2 0.3 2.1 47.9 4.4 1.3 5.4 11.2 0.4 2.2 2.1 43.7 4.0 12.3 26.5 8.6 0.9 8.5 14.5 2.9 17.9 5.8 0.0 10.0 2.2 0.9 2.6 32.2 11.9 14.9 1.9 1.4 14.2 15.2 LONP2 "LONP, LONPL, MGC4840" ENSG00000102910 "Lon peptidase 2, peroxisomal" Q86WA8 16 48244300-48363122 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008862 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 52: Non-specific - Transcription" "HPA008862: AB_2137156" "unprognostic (8.08e-3)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.75e-2)" "unprognostic (2.33e-2)" "unprognostic (6.08e-2)" "unprognostic (1.60e-2)" "unprognostic (7.59e-3)" "unprognostic (2.13e-1)" "unprognostic (2.36e-1)" "unprognostic (3.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.40e-1)" "prognostic favorable (6.71e-7)" "unprognostic (6.53e-2)" "unprognostic (1.49e-1)" "unprognostic (5.60e-2)" "unprognostic (1.33e-1)" 21.8 19.2 20.4 14.8 22.8 13.5 46.0 23.0 24.7 19.5 27.9 16.7 20.3 19.3 25.9 16.8 22.2 14.8 22.4 23.0 21.2 20.1 86.9 14.6 15.6 20.5 19.8 24.4 22.1 38.2 25.3 13.9 21.8 29.6 18.7 39.0 20.9 22.2 23.7 17.9 18.4 20.9 21.3 17.3 20.0 9.1 20.4 17.1 32.6 22.5 16.4 19.3 16.0 23.5 24.3 33.1 18.3 25.5 42.1 34.6 30.9 30.4 23.1 28.0 12.8 17.3 12.4 11.0 29.2 30.9 14.1 29.8 33.4 33.6 38.7 18.0 21.7 16.1 20.1 38.2 25.8 27.5 20.7 32.2 36.6 26.2 24.4 33.8 21.1 20.7 27.6 12.6 29.2 22.4 26.5 13.6 13.7 22.8 32.5 34.0 33.1 35.1 31.7 16.1 28.6 17.7 34.6 38.1 31.6 22.8 17.6 20.5 28.3 28.7 16.9 25.2 23.7 25.6 22.8 18.0 33.7 18.5 21.3 6.8 11.6 8.0 10.6 12.0 11.7 10.5 12.9 11.2 11.4 11.7 12.3 11.4 4.4 8.4 12.7 8.5 10.7 10.7 20.4 22.8 23.0 24.7 23.0 21.2 20.5 19.8 21.8 21.3 20.4 23.5 33.0 57.7 66.3 70.8 44.6 34.9 43.1 38.3 40.5 104.5 51.0 39.1 62.7 75.8 52.0 27.6 85.5 40.1 37.9 31.9 13.7 35.0 30.8 43.7 48.2 34.2 49.7 23.4 97.2 30.7 29.0 43.3 39.8 53.6 30.4 65.2 42.5 194.6 30.5 85.8 95.4 36.8 38.7 53.8 42.7 10.1 59.0 38.3 39.2 60.0 45.1 63.9 32.0 73.9 87.6 31.3 38.9 54.5 41.5 52.3 40.9 30.0 56.3 141.7 39.5 67.2 42.5 22.0 17.0 36.7 36.8 64.0 39.8 41.4 41.2 45.8 LRRC40 FLJ20331 ENSG00000066557 "Leucine rich repeat containing 40" Q9H9A6 1 70144805-70205579 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026564 Approved Approved Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoli "HPA026564: AB_2250054" "unprognostic (9.39e-2)" "unprognostic (1.01e-1)" "prognostic favorable (4.54e-4)" "unprognostic (6.42e-2)" "unprognostic (6.65e-3)" "unprognostic (3.94e-2)" "unprognostic (7.69e-3)" "unprognostic (9.90e-2)" "unprognostic (3.40e-2)" "unprognostic (3.77e-1)" "unprognostic (1.45e-2)" "unprognostic (2.50e-2)" "unprognostic (8.64e-2)" "unprognostic (5.11e-3)" "unprognostic (1.95e-1)" "unprognostic (5.88e-2)" "unprognostic (2.12e-1)" 9.7 8.4 5.7 9.0 6.6 16.3 11.0 8.3 8.4 7.7 2.3 9.0 14.6 10.3 6.5 9.5 5.4 8.4 11.7 7.0 6.3 14.1 23.6 8.2 13.2 4.6 4.8 8.3 7.1 6.8 3.5 12.0 5.1 8.6 9.7 9.9 5.6 6.9 7.4 7.7 13.5 11.2 5.3 9.3 6.9 11.9 5.3 14.0 8.2 10.0 12.6 9.8 5.1 6.8 26.4 10.9 42.1 33.3 15.1 16.6 25.4 25.0 18.2 37.0 45.4 16.0 14.5 35.4 21.4 19.6 36.6 19.0 100.0 22.3 50.2 28.5 20.0 26.8 18.6 25.9 19.0 35.4 6.2 13.8 12.7 24.7 24.6 17.1 21.7 22.2 33.6 16.7 31.7 6.8 42.8 27.4 55.5 17.3 22.5 33.8 43.5 22.9 34.1 16.0 21.5 21.7 30.2 29.9 28.6 29.6 14.3 19.8 27.2 26.0 20.8 39.7 28.7 14.0 14.4 57.2 21.0 36.6 27.3 5.4 4.6 5.5 5.5 6.0 7.3 7.2 5.8 5.3 6.0 6.7 6.8 5.8 0.7 7.6 5.8 4.6 7.8 4.5 5.7 6.6 8.3 8.4 7.0 6.3 4.6 4.8 5.1 5.3 5.3 6.8 13.9 12.8 12.6 22.2 15.1 12.9 7.8 10.5 17.1 16.4 6.9 6.0 10.4 8.6 9.2 14.7 6.2 16.9 23.2 6.9 11.7 12.7 1.3 6.0 12.1 11.3 23.3 17.2 41.1 8.9 13.3 12.7 5.1 10.8 15.2 11.3 13.2 21.4 11.9 15.2 40.1 6.5 20.3 11.7 12.1 3.0 10.2 9.4 5.4 15.9 13.4 7.6 8.2 22.6 30.9 9.2 4.1 10.1 11.7 5.1 13.2 24.1 6.4 12.5 19.7 12.9 12.9 25.1 28.3 11.7 11.1 7.3 15.8 10.4 8.1 5.0 LRRC41 MUF1 ENSG00000132128 "Leucine rich repeat containing 41" Q15345 1 46261196-46303616 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 133.1;Syncytiotrophoblasts: 142.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051941 Uncertain Approved "Nucleoplasm,Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 44: Endometrium - Transcription" "Nuclear bodies" Nucleoplasm "HPA051941: AB_2681669" "unprognostic (1.57e-2)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.80e-3)" "unprognostic (2.23e-2)" "unprognostic (2.11e-1)" "unprognostic (1.16e-2)" "prognostic unfavorable (1.66e-9)" "unprognostic (6.09e-2)" "unprognostic (2.96e-2)" "unprognostic (3.38e-2)" "unprognostic (5.34e-2)" "unprognostic (2.34e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (8.11e-2)" "unprognostic (1.80e-1)" "unprognostic (6.31e-2)" "unprognostic (1.73e-2)" 37.7 43.5 30.4 19.1 31.1 20.0 36.7 29.1 32.7 45.0 28.0 41.4 22.7 50.7 29.0 44.3 45.9 30.9 36.7 31.7 31.4 33.4 36.0 33.7 20.7 31.9 30.2 48.5 41.6 44.1 44.3 34.0 29.8 43.3 19.8 19.4 37.6 41.4 55.3 43.3 29.4 35.4 30.4 28.5 35.1 32.7 30.9 29.9 38.7 33.2 22.7 44.8 39.5 32.6 42.2 30.2 51.1 55.8 67.7 84.0 48.1 42.7 78.6 60.8 40.6 25.7 13.7 26.7 55.5 102.0 81.4 32.0 50.5 60.5 30.7 32.5 54.7 43.5 34.3 37.7 94.6 27.1 22.1 103.8 80.1 56.9 68.2 87.0 78.6 49.3 43.7 26.7 67.5 26.8 36.2 36.0 76.9 27.4 29.3 29.6 26.4 43.4 68.4 50.9 47.4 54.0 57.8 56.6 69.5 78.3 33.5 80.9 52.4 53.0 23.9 44.8 41.5 43.5 21.8 11.8 49.7 20.6 37.6 30.6 32.7 15.5 21.1 30.8 22.6 18.7 22.9 24.0 46.4 22.0 24.9 19.3 3.3 32.7 21.7 26.4 24.4 30.2 30.4 31.1 29.1 32.7 31.7 31.4 31.9 30.2 29.8 30.4 30.9 32.6 19.0 19.2 22.7 17.0 17.9 28.4 36.6 40.4 17.1 23.7 28.6 24.8 11.3 28.6 32.0 35.0 25.0 83.1 20.2 27.4 39.2 42.0 28.2 57.5 36.2 22.0 36.6 24.0 19.8 30.0 48.7 34.8 23.9 133.1 7.0 42.4 25.7 28.0 36.5 47.1 21.1 30.4 30.5 20.6 22.8 19.3 34.8 20.7 10.6 11.2 23.5 25.4 20.6 18.6 22.3 30.1 24.2 33.1 26.5 36.7 38.0 32.7 23.4 27.4 39.5 40.4 32.1 46.6 45.8 21.2 29.0 142.6 18.8 37.7 30.0 34.7 LSG1 FLJ11301 ENSG00000041802 "Large 60S subunit nuclear export GTPase 1" Q9H089 3 194640791-194672463 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037704, HPA037705" Approved Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 60: Granulocytes - Receptor signaling" "Nuclear bodies, Cytosol" Nucleoplasm "HPA037704: AB_10672912, HPA037705: AB_2675621" "unprognostic (5.72e-3)" "unprognostic (9.38e-3)" "unprognostic (2.63e-1)" "unprognostic (1.23e-2)" "unprognostic (3.74e-2)" "unprognostic (3.03e-1)" "prognostic unfavorable (3.21e-7)" "unprognostic (4.63e-2)" "unprognostic (1.59e-1)" "unprognostic (2.07e-1)" "unprognostic (1.60e-2)" "unprognostic (4.86e-3)" "unprognostic (1.42e-1)" "unprognostic (3.00e-2)" "unprognostic (2.70e-1)" "unprognostic (6.77e-2)" "unprognostic (2.07e-1)" 14.9 12.8 13.2 15.8 13.8 28.1 15.8 13.9 15.9 12.8 14.0 15.1 17.2 15.2 19.8 15.9 14.5 12.6 14.0 13.1 14.5 16.6 21.7 12.8 18.7 14.7 16.4 14.2 15.5 16.8 11.1 17.2 15.8 14.6 18.1 14.0 13.8 13.9 23.0 19.3 14.9 14.5 14.0 15.4 13.6 14.4 14.4 17.2 15.5 18.9 21.3 18.2 14.3 15.4 55.6 36.0 21.2 35.3 32.3 17.8 43.1 31.0 30.1 42.9 37.6 47.9 25.1 43.1 93.5 29.4 75.5 39.5 68.2 35.0 52.1 56.3 32.5 46.8 38.4 27.6 22.9 51.1 42.4 17.3 31.5 44.4 41.7 16.0 47.1 29.4 39.5 46.2 36.0 76.6 46.3 30.8 57.7 73.5 65.6 56.2 35.0 49.3 23.7 46.9 40.5 27.9 39.9 38.2 40.0 39.7 90.3 32.9 36.5 32.4 37.3 46.2 66.6 50.6 71.1 97.7 26.2 64.7 52.4 3.5 10.1 13.6 15.3 13.2 17.1 16.6 12.5 13.9 17.2 14.3 14.4 12.9 1.3 21.0 8.9 9.0 15.4 10.6 13.2 13.8 13.9 15.9 13.1 14.5 14.7 16.4 15.8 14.0 14.4 15.4 25.0 19.2 29.6 10.4 22.5 16.2 13.4 8.9 25.0 18.3 12.1 11.9 17.2 18.6 27.9 9.2 12.5 25.1 21.2 14.0 5.9 23.3 12.0 22.1 24.5 23.7 7.8 16.2 10.5 22.4 19.4 17.7 21.9 24.0 53.7 21.9 11.7 14.0 13.0 15.2 8.3 14.2 12.2 4.4 10.2 8.9 15.5 15.5 12.4 8.4 14.0 18.2 12.3 12.5 12.2 19.7 8.0 14.7 23.8 11.5 10.8 9.7 34.3 18.6 19.7 22.1 14.6 26.4 35.7 30.5 16.1 28.5 24.0 23.2 17.6 9.0 LTV1 "C6orf93, dJ468K18.4, FLJ14909" ENSG00000135521 "LTV1 ribosome biogenesis factor" Q96GA3 6 143843338-143863812 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030159, HPA030160, HPA030161" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 39: Non-specific - Basic cellular processes" Cytosol Nucleoplasm "HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001" "unprognostic (2.26e-2)" "unprognostic (1.52e-1)" "unprognostic (3.88e-2)" "unprognostic (5.45e-2)" "unprognostic (1.11e-1)" "unprognostic (1.99e-2)" "prognostic unfavorable (4.95e-5)" "unprognostic (7.09e-2)" "unprognostic (2.16e-1)" "unprognostic (1.55e-2)" "unprognostic (1.26e-1)" "unprognostic (4.70e-2)" "prognostic unfavorable (6.01e-13)" "unprognostic (2.94e-1)" "unprognostic (6.83e-2)" "unprognostic (8.62e-3)" "unprognostic (1.41e-1)" 26.3 22.6 12.2 22.4 13.2 52.5 24.1 13.4 16.3 18.8 12.9 20.3 15.7 22.2 15.6 23.3 19.4 12.4 18.7 12.6 13.7 18.5 24.6 19.0 26.2 13.0 12.9 21.2 23.5 14.1 14.0 19.6 13.0 17.5 20.5 10.3 18.0 17.4 36.9 29.3 20.0 21.0 12.6 22.2 20.6 20.7 13.5 16.8 17.0 18.5 25.6 23.1 19.4 14.7 42.5 39.0 45.3 101.4 32.9 39.7 52.5 64.5 47.2 69.7 55.2 63.6 21.6 88.7 50.6 58.7 76.5 46.8 76.3 63.2 96.8 51.2 74.4 175.8 45.1 98.4 57.9 219.0 97.8 45.1 45.5 77.7 84.4 28.7 49.0 51.1 170.3 57.2 54.4 71.7 75.2 92.8 53.6 48.5 42.5 64.1 85.6 40.1 51.9 58.1 40.0 48.2 65.8 53.8 62.3 41.1 30.2 138.1 44.7 44.4 51.6 100.0 120.0 70.9 93.6 118.9 44.5 112.3 63.8 2.0 16.7 7.3 18.9 21.8 20.6 28.6 19.6 20.5 25.3 24.5 21.5 24.9 0.5 36.0 19.5 30.7 18.7 14.2 12.2 13.2 13.4 16.3 12.6 13.7 13.0 12.9 13.0 12.6 13.5 14.7 19.8 6.4 34.1 9.1 22.1 25.6 22.3 28.8 13.1 9.9 10.8 15.7 25.6 10.0 28.3 7.3 2.1 25.5 22.1 9.0 13.7 29.4 25.0 11.5 29.0 20.6 19.7 18.3 13.7 28.7 30.5 27.6 12.8 14.0 24.7 17.6 11.4 18.0 27.9 11.8 14.2 13.3 38.7 13.1 14.8 10.7 25.7 17.0 5.4 10.3 33.6 9.9 23.7 13.6 13.7 29.9 10.4 27.4 17.6 21.9 6.9 17.3 24.1 10.2 6.6 29.0 24.5 57.5 62.5 18.9 32.1 16.3 16.2 57.8 19.7 16.3 MAGT1 "DKFZp564K142, IAP, MRX95, OST3B, SLC58A1" ENSG00000102158 "Magnesium transporter 1" Q9H0U3 X 77825747-77895593 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Congenital disorder of glycosylation, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 145.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049851 Approved "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 55: Plasma cells - Humoral immune response" "HPA049851: AB_2680913" "prognostic unfavorable (1.30e-4)" "unprognostic (3.32e-1)" "unprognostic (6.47e-2)" "unprognostic (1.16e-1)" "unprognostic (2.39e-1)" "unprognostic (3.81e-3)" "unprognostic (1.07e-1)" "unprognostic (2.47e-2)" "prognostic unfavorable (8.98e-4)" "unprognostic (2.03e-2)" "prognostic unfavorable (3.55e-4)" "unprognostic (1.03e-1)" "unprognostic (1.60e-2)" "unprognostic (5.56e-3)" "unprognostic (1.14e-1)" "unprognostic (6.25e-3)" "unprognostic (1.66e-1)" 25.3 22.6 12.9 24.2 19.4 20.8 36.5 17.2 17.4 39.4 14.4 28.3 25.7 27.5 53.7 25.6 25.9 25.1 37.5 13.0 16.4 41.9 71.2 26.8 22.5 20.9 18.5 23.6 31.9 38.4 18.5 36.4 21.9 33.5 27.0 5.2 34.6 28.0 17.1 18.3 26.2 24.3 16.6 23.5 29.4 11.3 17.9 21.0 78.0 21.9 23.5 29.1 18.2 27.0 62.5 34.1 41.7 48.8 75.0 49.3 64.8 66.9 67.4 51.7 56.5 45.6 99.5 45.6 90.9 71.7 53.3 56.4 88.4 50.8 80.0 32.3 55.4 30.6 46.2 42.5 66.6 64.9 31.1 45.3 43.5 64.6 56.7 55.1 74.0 31.2 36.5 123.2 64.7 40.4 36.2 23.9 56.1 64.6 41.3 43.3 72.5 84.7 61.9 45.8 14.1 26.3 91.6 64.8 58.0 43.6 43.8 35.3 75.2 45.6 51.1 71.7 33.2 44.8 103.1 58.1 49.7 60.5 61.0 15.3 12.9 13.7 17.2 19.7 18.4 12.5 15.6 16.6 11.1 10.7 14.9 17.7 11.0 18.6 21.0 22.2 12.8 15.7 12.9 19.4 17.2 17.4 13.0 16.4 20.9 18.5 21.9 16.6 17.9 27.0 50.2 41.7 53.6 9.8 37.3 33.0 55.3 51.6 24.5 5.2 39.1 25.1 53.4 42.9 51.6 40.5 4.2 33.3 43.4 44.8 3.9 35.3 2.2 23.7 38.9 40.7 22.7 33.0 6.1 34.9 59.3 43.7 33.1 58.0 30.4 24.5 43.2 145.6 42.3 1.7 6.3 39.6 32.6 49.8 46.1 2.5 30.7 45.1 33.8 15.9 33.9 17.1 18.6 13.6 28.0 36.2 37.2 27.1 87.4 65.4 31.2 32.0 20.7 5.2 19.7 38.7 31.2 6.6 16.7 36.5 45.6 81.3 36.0 31.2 26.0 69.4 MAK16 "MAK16L, RBM13" ENSG00000198042 "MAK16 homolog" Q9BXY0 8 33485182-33501262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044417, HPA050574" Uncertain Approved Nucleoli,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli, Vesicles" "HPA044417: AB_2678935, HPA050574: AB_2681181" "unprognostic (2.10e-1)" "unprognostic (1.74e-1)" "unprognostic (8.48e-3)" "unprognostic (2.28e-2)" "unprognostic (1.72e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.00e-4)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "unprognostic (4.00e-2)" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (8.04e-2)" "unprognostic (1.20e-1)" "unprognostic (6.74e-2)" "unprognostic (1.47e-1)" 9.9 6.2 4.7 9.3 4.8 9.2 8.9 5.1 5.7 6.6 4.1 5.7 5.4 7.2 5.1 8.0 5.9 6.5 7.0 4.5 6.4 7.2 9.0 5.6 11.1 5.3 6.3 7.5 9.3 5.9 4.5 7.8 5.8 6.1 6.5 4.0 5.6 5.6 8.4 7.4 5.0 7.7 5.3 6.5 5.4 5.6 5.5 8.8 8.5 8.0 10.8 12.2 5.1 6.0 14.1 19.3 13.2 30.6 15.2 18.1 19.9 25.0 16.2 26.4 24.6 28.5 12.0 49.7 23.8 22.1 22.5 18.3 45.6 27.8 35.0 10.8 12.3 46.9 13.2 25.6 22.9 19.3 27.4 19.1 24.8 34.8 40.4 9.4 19.6 33.5 59.5 27.5 22.0 16.1 68.9 22.4 71.4 34.4 13.2 23.9 20.1 22.2 22.2 23.7 33.6 26.7 15.5 21.1 30.4 16.2 14.7 19.5 17.8 24.9 19.3 32.6 28.9 13.8 16.4 50.4 15.3 39.7 27.0 0.0 2.4 0.6 3.2 5.0 3.6 2.0 3.2 2.8 2.9 2.5 4.0 4.3 0.4 4.4 7.9 3.0 2.6 2.3 4.7 4.8 5.1 5.7 4.5 6.4 5.3 6.3 5.8 5.3 5.5 6.0 12.8 16.0 9.7 3.6 12.8 15.6 15.2 5.6 13.1 5.1 7.9 9.0 12.9 10.0 11.3 9.2 2.1 11.5 7.8 3.9 7.9 10.6 1.8 9.8 19.8 12.7 1.8 15.8 5.8 7.8 15.8 15.8 8.2 10.5 9.5 10.8 5.3 7.3 8.7 10.1 6.0 6.7 6.1 5.3 4.7 1.3 9.0 7.8 1.8 2.8 7.7 2.9 10.3 7.1 4.7 11.5 5.0 7.5 12.1 15.3 4.1 10.2 10.5 5.1 6.6 17.6 14.4 13.8 19.2 12.7 14.9 7.5 9.9 13.8 7.4 12.3 MAN1B1 "ERManI, MANA-ER, MRT15" ENSG00000177239 "Mannosidase alpha class 1B member 1" Q9UKM7 9 137086985-137109183 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Glycosidase, Hydrolase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051516 Approved Uncertain Vesicles NA NA 940000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Vesicles "HPA051516: AB_2681518" "unprognostic (1.21e-2)" "unprognostic (4.66e-1)" "unprognostic (1.25e-3)" "unprognostic (4.67e-3)" "unprognostic (2.27e-1)" "unprognostic (3.70e-3)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.59e-1)" "unprognostic (6.67e-2)" "unprognostic (1.79e-2)" "unprognostic (5.93e-3)" "unprognostic (1.75e-1)" "unprognostic (3.55e-2)" "unprognostic (2.28e-1)" "unprognostic (5.85e-2)" "unprognostic (2.37e-1)" "unprognostic (1.44e-3)" 25.3 32.2 21.3 12.1 21.2 9.1 25.1 21.1 32.9 22.6 26.3 24.1 15.5 20.7 20.4 32.1 22.0 20.1 27.3 22.4 23.1 31.8 39.6 23.0 15.4 22.6 22.7 28.0 36.0 20.0 32.6 21.4 25.2 26.1 9.9 3.6 34.2 15.2 17.6 32.6 22.9 12.1 21.7 28.7 25.6 28.3 22.9 13.8 27.1 9.9 10.1 22.0 21.9 22.8 22.8 50.7 18.2 49.9 67.0 57.7 57.0 37.9 78.4 48.6 43.7 24.9 67.4 20.0 118.8 64.7 69.2 74.3 11.0 36.3 9.1 27.7 17.3 8.7 41.2 33.2 59.6 16.0 33.1 65.1 66.9 29.1 25.1 67.1 32.4 26.5 24.5 32.7 36.4 45.0 16.7 37.8 23.5 67.3 50.0 9.7 30.6 63.9 41.6 11.3 20.4 18.3 55.2 55.9 38.7 9.6 63.5 31.5 46.5 69.6 25.9 52.9 43.6 13.0 11.1 13.3 84.6 19.9 61.6 17.9 31.2 27.0 32.4 34.4 30.2 19.1 25.1 30.4 36.0 16.4 24.3 25.0 9.0 31.0 42.2 26.6 34.5 32.1 21.3 21.2 21.1 32.9 22.4 23.1 22.6 22.7 25.2 21.7 22.9 22.8 18.8 19.2 27.3 23.5 18.3 11.6 12.6 33.0 12.0 20.7 23.5 21.7 10.3 14.3 21.5 25.8 16.7 53.2 24.3 39.1 7.9 32.0 5.8 21.5 16.4 19.7 30.5 14.3 13.0 32.0 72.4 26.9 23.4 20.3 21.0 47.8 25.0 25.2 32.1 30.3 10.2 28.1 22.4 22.9 17.4 6.8 21.1 21.8 23.2 11.2 29.3 16.0 16.5 6.6 12.8 27.6 25.0 21.8 25.4 9.0 35.9 15.9 24.9 19.3 13.1 19.4 20.2 16.1 28.4 16.3 16.2 45.4 21.5 41.1 25.6 8.2 MAP4 ENSG00000047849 "Microtubule associated protein 4" P27816 3 47850690-48089272 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 743.9" "Cell type enhanced" "Detected in all" "Bipolar cells: 392.2;Cardiomyocytes: 921.5;Cone photoreceptor cells: 625.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038149, HPA038150" Enhanced Approved "Plasma membrane,Microtubules,Cytosol" NA NA 880000 "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 54: Cardiomyocytes - Muscle contraction" "Microtubules, Cytosol" "Plasma membrane" "HPA038149: AB_10672471, HPA038150: AB_10672505" "unprognostic (2.51e-1)" "unprognostic (4.48e-1)" "unprognostic (2.72e-1)" "unprognostic (1.95e-2)" "unprognostic (3.36e-1)" "unprognostic (4.57e-1)" "prognostic unfavorable (1.82e-4)" "unprognostic (6.82e-2)" "unprognostic (1.46e-2)" "unprognostic (5.02e-2)" "unprognostic (2.23e-2)" "unprognostic (1.30e-2)" "unprognostic (2.25e-2)" "unprognostic (8.89e-2)" "unprognostic (6.45e-2)" "unprognostic (1.88e-1)" "unprognostic (1.21e-3)" 127.4 55.7 475.5 50.4 483.4 16.1 98.0 433.2 406.8 118.0 215.5 193.2 35.1 111.7 69.7 90.7 94.7 52.9 380.9 351.2 408.7 88.3 66.0 105.0 35.0 567.9 490.6 90.0 71.4 31.4 56.1 64.8 509.2 92.7 47.6 149.0 71.4 88.1 743.9 120.6 80.6 94.5 526.1 64.0 93.9 80.0 552.3 42.1 61.1 491.0 37.8 135.5 115.2 533.2 121.9 95.7 117.1 89.3 168.6 298.5 49.5 222.6 241.2 184.1 204.9 81.3 74.4 102.3 50.7 337.9 172.8 79.2 151.4 201.6 204.7 148.7 63.8 69.3 102.8 106.0 228.6 48.6 53.9 251.4 246.4 224.0 271.6 167.1 245.1 70.6 91.2 115.3 146.9 69.1 69.5 58.9 70.9 59.9 195.0 36.6 110.1 128.1 118.2 100.1 46.4 72.3 171.0 68.3 118.6 163.0 50.1 44.8 334.5 172.7 132.3 182.9 144.4 80.4 66.9 47.8 222.2 58.6 167.3 10.5 6.6 3.7 15.6 10.6 7.5 12.3 10.2 12.7 7.1 11.5 4.9 7.6 2.6 13.4 27.3 10.8 13.0 9.7 475.5 483.4 433.2 406.8 351.2 408.7 567.9 490.6 509.2 526.1 552.3 533.2 147.9 70.5 48.2 124.4 45.1 74.8 55.4 53.1 42.7 392.2 34.7 36.2 921.5 48.6 53.4 80.9 625.5 33.8 54.6 43.7 27.4 97.8 116.2 78.2 143.2 110.4 28.8 21.6 63.7 65.3 81.0 105.5 39.8 93.4 27.8 81.6 50.0 57.3 38.0 47.1 71.2 31.7 34.6 28.3 50.5 38.8 77.0 40.0 78.2 95.5 72.0 82.8 47.4 77.9 167.2 92.0 28.0 103.0 47.2 89.0 37.1 39.2 43.6 97.5 72.3 149.0 119.0 65.6 64.3 58.7 69.6 22.4 60.5 137.4 39.5 44.7 MAP7D3 FLJ12649 ENSG00000129680 "MAP7 domain containing 3" Q8IWC1 X 136213220-136256482 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 264.2;Late spermatids: 288.5;Spermatogonia: 106.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA035598, HPA058101" Approved Uncertain Centrosome,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" Centrosome Cytosol "HPA035598: AB_10671108, HPA058101: AB_2683604" "unprognostic (2.89e-1)" "unprognostic (1.23e-1)" "unprognostic (9.56e-2)" "prognostic unfavorable (9.00e-5)" "unprognostic (8.83e-3)" "unprognostic (3.77e-3)" "unprognostic (4.16e-5)" "unprognostic (5.35e-2)" "unprognostic (6.57e-2)" "unprognostic (1.02e-1)" "unprognostic (1.12e-1)" "unprognostic (4.20e-2)" "unprognostic (9.91e-2)" "prognostic unfavorable (7.91e-4)" "unprognostic (2.04e-1)" "unprognostic (1.01e-2)" "prognostic unfavorable (5.38e-5)" 18.1 4.5 1.4 5.8 1.5 5.0 11.4 1.2 1.8 7.4 2.9 8.3 2.2 9.7 6.1 6.1 13.2 6.0 8.7 1.2 1.7 3.7 4.1 5.9 6.6 1.8 1.6 16.8 2.1 5.8 4.7 7.1 2.0 3.7 3.3 1.5 3.0 4.1 11.5 4.5 5.6 8.8 1.5 6.3 5.0 15.8 1.8 5.3 8.2 9.1 5.0 7.7 6.4 1.9 33.6 11.8 8.7 15.0 19.3 20.1 12.1 31.6 17.4 25.3 34.6 11.7 16.5 17.3 50.0 27.9 26.8 15.7 25.6 16.9 33.5 15.9 25.6 10.3 18.0 0.0 21.0 25.2 10.2 41.1 9.5 26.0 32.0 14.2 20.0 28.1 9.0 26.1 18.8 20.9 30.4 10.2 12.4 8.1 0.3 29.5 23.5 8.4 0.8 5.1 6.1 13.0 18.4 6.7 11.4 14.5 0.1 11.5 60.3 26.9 15.5 34.6 40.6 17.8 22.7 19.3 18.5 42.3 13.0 6.6 3.5 1.1 5.2 4.2 6.5 7.5 4.9 5.8 4.4 6.4 5.2 4.1 0.7 6.6 7.9 4.6 3.8 2.9 1.4 1.5 1.2 1.8 1.2 1.7 1.8 1.6 2.0 1.5 1.8 1.9 36.6 16.0 6.7 4.2 18.5 7.1 7.2 15.4 14.8 0.7 5.1 9.1 41.5 11.5 8.7 18.4 0.0 10.3 13.8 3.7 1.9 8.6 264.2 13.7 47.3 24.9 5.4 12.6 1.9 14.7 103.4 46.5 2.0 5.1 35.5 15.2 50.7 30.4 15.4 20.2 1.0 2.8 8.2 17.3 7.8 288.5 63.3 15.0 7.2 5.6 23.4 12.2 22.6 1.5 3.6 13.0 14.1 47.8 10.0 13.5 0.7 54.6 6.5 2.9 39.5 29.8 61.5 53.2 106.9 5.3 4.8 13.4 18.6 15.9 3.3 2.4 MAPK1IP1L C14orf32 ENSG00000168175 "Mitogen-activated protein kinase 1 interacting protein 1 like" Q8NDC0 14 55051647-55070194 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034506 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 24: Non-specific - Transcription regulation" "Nucleoplasm, Cytosol" "HPA034506: AB_10669784" "unprognostic (3.27e-2)" "unprognostic (1.30e-1)" "unprognostic (2.83e-1)" "unprognostic (2.68e-2)" "unprognostic (1.43e-1)" "unprognostic (1.28e-1)" "unprognostic (6.86e-3)" "unprognostic (8.17e-3)" "unprognostic (3.32e-1)" "unprognostic (2.91e-2)" "unprognostic (1.70e-1)" "unprognostic (4.65e-1)" "prognostic favorable (4.82e-5)" "unprognostic (7.96e-2)" "unprognostic (1.71e-1)" "unprognostic (2.45e-1)" "unprognostic (5.40e-2)" 31.2 26.3 15.6 27.5 16.5 83.2 26.5 16.7 22.3 26.0 15.4 24.4 18.9 30.2 29.4 27.6 28.9 26.4 33.3 16.0 19.6 42.0 27.3 25.7 29.5 18.0 17.8 34.6 21.9 23.4 22.3 30.2 17.5 24.6 24.8 19.1 30.2 24.6 25.7 27.0 21.2 35.6 17.0 24.2 23.1 21.6 18.0 23.9 25.8 19.9 36.5 34.2 21.8 18.1 49.0 42.3 73.1 46.8 57.8 56.6 56.5 53.7 56.8 65.2 75.2 34.1 42.2 56.3 44.4 72.0 39.2 52.5 79.3 81.3 90.7 51.4 50.6 54.3 39.4 51.7 63.0 67.3 57.4 73.6 60.0 54.5 85.9 47.5 87.9 35.4 51.2 48.7 95.6 59.0 56.9 51.7 53.1 46.2 70.4 48.1 80.4 34.0 89.9 54.1 47.5 55.0 51.9 36.7 51.6 65.1 65.5 38.4 66.8 66.6 87.0 41.7 48.6 29.9 46.3 73.3 53.3 34.7 49.0 44.1 26.7 32.1 24.2 37.4 32.0 31.8 28.3 26.3 29.0 27.4 26.0 26.1 19.7 26.0 36.4 37.2 37.9 25.1 15.6 16.5 16.7 22.3 16.0 19.6 18.0 17.8 17.5 17.0 18.0 18.1 73.5 70.5 66.9 25.5 106.3 71.9 164.0 77.3 53.5 22.9 44.1 36.2 71.2 40.0 66.3 47.8 37.5 121.2 78.0 60.3 70.5 65.0 28.5 73.7 57.1 69.5 57.9 57.7 34.3 69.4 112.3 60.7 70.3 86.2 83.1 41.5 43.2 51.5 75.1 38.7 32.2 54.8 50.8 64.4 88.4 14.1 51.3 72.9 49.8 28.1 65.0 60.0 49.4 27.2 38.1 94.4 44.2 54.2 109.5 104.8 44.1 103.4 39.6 24.9 32.9 59.1 66.5 81.1 60.6 53.6 71.6 151.3 86.4 40.5 46.9 145.3 MAPKAPK5 "MK5, PRAK" ENSG00000089022 "MAPK activated protein kinase 5" Q8IW41 12 111842228-111902222 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004546, HPA015515" Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoplasm, Cytosol" "CAB004546: AB_627910, HPA015515: AB_1853569" "unprognostic (6.45e-2)" "unprognostic (7.29e-2)" "unprognostic (1.27e-3)" "unprognostic (1.09e-2)" "unprognostic (5.52e-2)" "unprognostic (3.76e-2)" "prognostic unfavorable (2.98e-8)" "unprognostic (1.88e-1)" "unprognostic (3.09e-2)" "unprognostic (1.22e-1)" "unprognostic (1.75e-1)" "unprognostic (1.25e-2)" "unprognostic (3.20e-1)" "unprognostic (6.03e-2)" "unprognostic (3.39e-2)" "unprognostic (9.41e-2)" "unprognostic (3.25e-2)" 18.1 20.8 12.6 17.9 14.4 27.1 20.4 14.9 15.0 15.2 15.7 28.2 25.5 15.7 20.7 17.2 16.1 12.2 16.7 15.3 14.3 20.3 19.4 17.5 20.7 12.3 12.4 18.1 20.4 21.4 11.6 20.3 11.8 17.0 30.7 27.2 17.4 15.6 30.4 20.1 28.2 18.9 11.3 15.6 18.0 15.9 12.9 23.2 19.3 25.3 19.3 18.5 14.4 13.8 32.4 42.1 40.0 33.7 28.2 28.4 60.6 31.7 38.1 47.7 32.7 54.8 25.9 48.6 22.9 37.7 28.4 31.6 53.1 33.2 44.4 32.6 29.0 43.4 29.5 44.2 34.1 55.1 29.4 30.2 46.7 45.6 53.7 36.0 35.6 43.4 61.0 18.7 35.3 36.4 55.2 86.6 56.9 79.1 29.4 53.7 29.1 46.9 37.9 46.2 49.0 41.4 36.1 60.5 46.3 36.2 49.1 62.0 31.2 26.8 27.2 27.9 40.4 37.8 50.1 57.4 32.7 39.4 38.9 1.1 3.3 2.3 4.2 2.4 2.2 3.5 2.7 3.0 2.2 3.1 4.2 3.1 1.6 2.9 8.8 2.6 4.8 1.8 12.6 14.4 14.9 15.0 15.3 14.3 12.3 12.4 11.8 11.3 12.9 13.8 16.9 3.2 23.1 12.1 22.3 20.5 22.3 12.5 21.1 47.0 18.3 14.0 20.1 22.8 15.4 3.7 41.7 29.9 32.4 34.1 13.7 28.2 17.2 14.2 17.3 16.0 36.6 15.8 24.6 29.6 33.3 19.4 20.9 15.2 2.5 22.3 14.6 13.4 19.9 23.5 22.3 47.3 14.2 21.2 17.7 7.3 15.5 15.0 8.8 14.0 27.8 19.6 25.7 15.6 21.8 36.3 27.4 17.7 21.6 37.5 63.6 21.8 12.0 36.4 19.7 22.6 19.8 30.7 40.3 23.6 21.3 30.1 22.2 22.5 32.3 32.3 MARS1 "CMT2U, MARS, MetRS, SPG70" ENSG00000166986 "Methionyl-tRNA synthetase 1" P56192 12 57475445-57517569 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding" "Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 11.9;Cytotrophoblasts: 29.5;Extravillous trophoblasts: 22.0;Hofbauer cells: 19.3;Syncytiotrophoblasts: 38.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 738.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004125, CAB017097" Supported Approved Enhanced Cytosol NA NA 23000 "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 24: Non-specific - Transcription regulation" Cytosol "CAB017097: , HPA004125: AB_1079312" "prognostic unfavorable (1.73e-4)" "unprognostic (2.21e-1)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.57e-2)" "unprognostic (4.90e-3)" "prognostic unfavorable (4.55e-7)" "unprognostic (8.47e-2)" "unprognostic (1.73e-1)" "unprognostic (4.03e-2)" "unprognostic (2.85e-2)" "unprognostic (3.77e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (1.13e-2)" "unprognostic (1.96e-1)" "unprognostic (1.13e-1)" "unprognostic (2.06e-2)" 35.9 47.2 63.1 35.9 65.2 31.6 31.5 62.0 83.6 30.8 61.6 47.6 21.5 40.7 39.0 54.3 30.1 19.3 50.5 67.5 67.5 55.7 60.6 42.7 34.5 64.2 65.5 24.2 64.4 40.7 58.9 27.3 68.1 38.7 29.6 39.6 39.6 34.0 48.5 33.0 37.3 41.3 63.5 53.9 53.2 50.7 65.6 32.6 40.0 33.1 44.4 44.8 33.6 67.9 110.6 149.6 99.7 171.9 107.1 64.6 180.2 149.0 178.4 158.1 168.6 162.9 119.0 192.3 97.6 187.2 98.3 119.4 226.0 196.4 166.2 167.4 96.9 136.7 52.8 89.4 238.1 207.7 147.5 96.2 302.9 181.5 467.5 76.6 114.8 238.1 212.9 400.3 112.1 150.4 187.9 148.1 184.8 173.0 162.3 155.5 738.3 200.0 117.0 86.4 131.6 134.0 79.8 120.9 215.8 109.6 161.0 260.7 86.9 57.5 162.8 82.8 91.6 357.5 395.8 232.5 139.7 154.8 199.1 29.9 29.8 39.3 35.1 53.6 31.7 24.4 23.4 32.0 57.9 14.7 20.0 27.4 14.5 30.0 45.6 55.9 26.3 34.2 63.1 65.2 62.0 83.6 67.5 67.5 64.2 65.5 68.1 63.5 65.6 67.9 5.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 29.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 22.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 38.0 1.2 0.0 0.0 0.0 MBNL3 "CHCR, FLJ11316, MBLX39, MBXL" ENSG00000076770 "Muscleblind like splicing regulator 3" Q9NUK0 X 132369317-132489968 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.3;placenta: 170.8" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 328.3;Hepatocytes: 119.6;Syncytiotrophoblasts: 344.1" "Cancer enhanced" "Detected in all" "liver cancer: 13.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 123.8;Hep G2: 171.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA001584 Enhanced Approved "Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Vesicles "Golgi apparatus" "HPA001584: AB_1079326" "unprognostic (3.38e-2)" "unprognostic (1.40e-2)" "unprognostic (1.82e-1)" "prognostic unfavorable (1.57e-4)" "unprognostic (1.87e-1)" "unprognostic (2.67e-3)" "unprognostic (8.74e-2)" "unprognostic (3.46e-2)" "unprognostic (2.19e-2)" "unprognostic (5.77e-3)" "unprognostic (4.36e-3)" "unprognostic (1.65e-1)" "unprognostic (1.07e-1)" "unprognostic (1.67e-1)" "unprognostic (2.43e-1)" "unprognostic (8.28e-2)" "unprognostic (2.37e-1)" 6.8 11.6 1.3 8.7 1.9 14.8 4.7 1.7 1.0 3.7 2.4 11.7 9.9 4.9 24.3 10.9 9.4 5.7 9.7 1.1 4.4 8.0 59.3 5.9 13.8 3.6 3.1 4.8 10.0 4.2 1.6 170.8 3.2 4.0 11.5 0.1 6.6 11.1 0.6 12.6 9.8 4.0 2.0 11.3 13.0 42.8 1.6 14.3 8.2 3.4 15.1 8.5 2.8 3.7 7.2 0.0 8.6 1.4 1.6 3.6 15.7 0.5 3.2 1.1 0.0 123.8 22.7 32.6 0.7 1.3 1.1 7.7 19.8 8.2 0.8 3.3 7.6 29.1 25.9 171.5 1.5 32.9 10.2 1.5 7.1 0.0 3.6 0.1 1.1 20.4 2.6 9.2 1.6 19.2 56.3 12.5 1.3 27.5 1.6 53.2 10.7 18.6 5.7 18.6 3.1 10.5 14.8 8.6 4.3 15.1 3.1 8.4 3.9 6.3 1.2 8.2 6.7 18.2 13.0 47.0 1.2 21.8 20.2 11.9 7.9 5.5 16.6 9.9 14.4 20.6 9.8 11.6 8.8 25.5 10.0 11.2 1.2 18.7 21.7 17.0 2.2 9.1 1.3 1.9 1.7 1.0 1.1 4.4 3.6 3.1 3.2 2.0 1.6 3.7 4.1 3.2 6.8 16.0 16.9 8.8 2.2 2.1 5.2 0.7 3.5 3.6 14.7 41.5 5.0 11.0 0.0 328.3 9.5 12.8 3.9 1.5 5.8 12.6 1.3 3.6 6.7 55.8 0.9 5.4 56.6 7.5 15.3 6.6 8.8 6.8 6.4 119.6 29.3 0.0 0.9 9.8 0.0 27.2 6.5 9.4 23.0 9.6 7.2 30.0 10.6 0.2 9.2 0.0 20.6 1.3 3.6 50.8 12.2 1.4 6.4 9.7 4.5 1.9 0.0 3.1 2.7 2.1 1.7 13.6 8.5 344.1 10.3 5.7 10.3 3.3 MCCC2 MCCB ENSG00000131844 "Methylcrotonoyl-CoA carboxylase 2" Q9HCC0 5 71587288-71658706 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 120.5" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 107.0" "Cancer enhanced" "Detected in all" "prostate cancer: 81.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038300, HPA038301, HPA061546" Enhanced Enhanced Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 25: RPMI-8226 - Immune response" "Cluster 44: Endometrium - Transcription" Mitochondria "HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557" "unprognostic (2.39e-1)" "unprognostic (6.89e-3)" "prognostic favorable (3.62e-4)" "unprognostic (1.79e-2)" "unprognostic (1.89e-2)" "unprognostic (8.07e-2)" "prognostic favorable (1.70e-4)" "unprognostic (1.01e-1)" "unprognostic (3.37e-1)" "unprognostic (5.39e-2)" "unprognostic (2.90e-1)" "unprognostic (2.38e-1)" "prognostic favorable (6.43e-8)" "unprognostic (1.27e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (3.47e-2)" 21.3 47.6 13.4 13.5 13.7 6.0 60.0 12.4 15.5 21.3 24.9 30.5 27.2 14.4 38.9 25.4 17.2 15.2 54.9 12.0 13.1 73.3 120.5 13.4 17.8 14.8 13.4 14.2 24.6 32.8 14.1 14.2 14.8 48.2 35.9 12.2 28.2 20.6 34.4 19.8 20.7 11.7 16.3 15.6 25.8 8.6 16.0 14.2 44.6 35.4 21.5 27.0 15.0 18.4 38.5 52.4 21.4 82.5 22.4 23.0 36.9 16.4 29.4 35.7 25.7 91.1 46.9 90.4 62.8 25.9 28.0 30.8 37.8 58.8 44.3 47.6 45.6 48.2 24.7 100.5 39.2 24.4 42.8 29.5 30.1 32.6 25.8 15.8 31.7 24.9 63.2 31.6 24.9 103.0 0.3 42.9 29.0 33.2 27.2 46.3 64.5 130.9 92.5 66.9 32.9 36.7 80.1 111.8 38.8 10.1 92.7 59.6 22.7 14.4 22.1 26.1 49.9 22.4 46.2 54.6 23.7 66.3 36.6 2.0 8.4 1.9 6.5 13.5 8.5 9.7 8.4 7.4 19.4 9.9 8.3 9.1 1.3 14.7 8.1 8.1 12.1 8.3 13.4 13.7 12.4 15.5 12.0 13.1 14.8 13.4 14.8 16.3 16.0 18.4 9.1 16.0 23.6 27.4 26.8 13.3 17.5 20.2 22.2 12.6 54.9 28.3 61.5 20.0 22.3 16.5 6.2 48.5 17.6 26.3 21.5 20.6 4.3 94.0 24.0 15.1 29.5 13.9 22.2 18.2 23.0 13.1 30.1 107.0 12.7 22.7 9.7 93.1 18.0 3.3 21.6 22.8 8.2 12.1 11.2 9.8 13.7 14.0 12.4 11.2 17.9 15.4 20.6 30.2 28.0 15.3 17.0 20.3 27.2 29.6 23.6 59.1 17.7 10.8 6.6 15.2 9.0 4.2 12.0 35.9 13.8 63.6 17.9 30.9 33.9 20.9 MCM7 "CDC47, MCM2, PPP1R104" ENSG00000166508 "Minichromosome maintenance complex component 7" P33993 7 100092728-100101940 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication" "DNA-binding, Helicase, Hydrolase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 180.8;lymphoid tissue: 156.4" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 132.9;Erythroid cells: 173.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002163, HPA003898, CAB016312" Enhanced Enhanced Nucleoplasm NA Yes 150000 "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-4)" "unprognostic (1.36e-1)" "unprognostic (5.20e-2)" "unprognostic (1.94e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (2.18e-4)" "unprognostic (2.08e-2)" "unprognostic (5.79e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-1)" "unprognostic (9.34e-3)" "unprognostic (3.83e-2)" "unprognostic (5.41e-2)" "unprognostic (1.76e-1)" "unprognostic (1.32e-2)" "unprognostic (2.38e-1)" 22.9 14.2 56.4 50.2 61.7 180.8 32.0 51.4 70.4 17.4 45.8 45.3 38.7 29.7 13.1 31.2 25.6 18.2 17.0 48.8 50.5 13.7 26.3 23.0 82.4 58.5 59.8 37.0 24.1 15.1 8.9 35.0 55.1 20.4 50.8 10.6 21.3 22.2 25.7 44.9 41.3 32.3 55.1 29.4 27.4 49.4 55.6 156.4 20.4 28.5 88.5 21.6 11.9 60.8 310.1 359.5 399.9 306.7 28.7 35.5 214.4 195.7 165.5 374.9 407.7 281.9 335.2 469.2 184.6 112.0 321.6 252.5 439.3 241.6 303.9 238.6 498.1 274.7 251.9 248.9 18.9 553.6 226.2 30.1 43.4 306.9 179.6 61.8 154.0 295.1 542.2 444.6 200.8 786.2 940.1 442.9 361.9 295.2 236.4 572.5 517.7 651.6 92.3 221.5 253.4 397.0 264.9 294.3 104.9 217.9 126.2 314.4 81.0 198.1 346.7 379.8 411.1 200.3 311.8 875.0 135.9 463.1 354.3 3.7 4.0 4.3 14.1 7.5 10.9 9.1 10.3 13.2 9.3 15.0 11.2 10.5 1.4 15.9 13.3 11.3 17.2 11.6 56.4 61.7 51.4 70.4 48.8 50.5 58.5 59.8 55.1 55.1 55.6 60.8 23.2 9.6 17.9 6.2 34.5 46.7 28.5 25.7 37.0 9.4 30.8 36.3 9.6 11.5 13.3 3.7 14.6 132.9 32.5 42.3 9.8 28.2 54.7 11.8 16.3 23.8 17.4 173.6 4.0 26.2 102.7 22.8 40.8 19.8 24.1 67.3 10.4 10.3 40.4 6.7 4.0 48.8 18.3 10.4 22.2 32.0 21.1 17.6 19.6 3.7 14.1 11.1 18.6 12.1 11.7 16.7 22.8 15.4 59.8 20.8 19.0 11.5 18.0 12.5 13.1 30.7 46.0 90.0 79.8 41.3 35.4 72.0 29.4 14.9 79.0 22.9 MECR "CGI-63, ETR1, FASN2B, NRBF1" ENSG00000116353 "Mitochondrial trans-2-enoyl-CoA reductase" Q9BV79 1 29192657-29230942 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" Oxidoreductase "Disease variant, Dystonia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 42.1" "Cell type enhanced" "Detected in all" "Late spermatids: 82.5;Rod photoreceptor cells: 68.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022018, HPA022030, HPA028740" Enhanced Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 25: RPMI-8226 - Immune response" "Cluster 46: Photoreceptor cells - Phototransduction" Mitochondria "HPA022018: AB_1853714, HPA022030: AB_1853716, HPA028740: AB_10601133" "unprognostic (2.53e-1)" "unprognostic (1.09e-2)" "unprognostic (1.52e-1)" "unprognostic (1.84e-1)" "unprognostic (1.07e-1)" "unprognostic (2.46e-1)" "unprognostic (1.39e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-1)" "unprognostic (1.69e-1)" "unprognostic (3.06e-2)" "unprognostic (8.66e-2)" "prognostic favorable (5.81e-6)" "unprognostic (7.01e-3)" "unprognostic (3.29e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.29e-4)" 14.7 14.6 5.1 1.7 5.1 1.8 13.4 3.3 6.2 10.2 3.1 10.3 1.4 12.9 2.5 12.5 9.4 1.3 24.8 6.0 3.9 14.1 15.8 7.3 2.0 5.2 4.0 10.0 8.9 4.5 7.2 3.5 5.4 7.9 2.6 9.9 12.3 3.0 42.1 15.4 7.2 3.1 3.2 6.7 11.1 7.6 4.3 1.4 8.3 5.8 2.1 9.6 9.6 5.2 3.9 4.5 3.2 4.6 2.9 2.5 6.8 3.7 3.8 4.7 3.9 2.3 5.6 7.3 5.1 3.7 1.3 3.0 5.4 6.3 4.0 4.4 6.9 6.4 3.4 4.1 6.6 6.1 1.9 4.3 5.9 3.1 11.0 3.8 3.5 6.9 5.8 4.2 4.7 4.5 3.9 2.9 6.5 5.8 4.3 3.5 4.2 9.3 5.9 2.4 5.1 4.5 4.1 4.7 7.0 4.4 2.3 5.4 3.8 2.4 2.9 4.1 4.7 2.7 2.2 5.0 3.9 8.4 5.2 0.1 2.2 0.0 1.5 2.1 4.1 2.2 1.6 1.7 1.9 1.1 2.3 1.6 0.3 2.9 1.6 2.5 2.4 1.2 5.1 5.1 3.3 6.2 6.0 3.9 5.2 4.0 5.4 3.2 4.3 5.2 8.8 12.8 3.9 14.7 9.1 5.6 15.6 26.9 7.4 12.8 12.0 14.6 19.8 21.5 21.4 20.2 10.4 46.0 3.8 7.4 41.1 24.3 40.8 19.7 13.6 9.1 7.8 10.1 25.1 19.7 42.4 12.8 4.6 12.8 5.7 17.5 7.1 19.7 20.8 8.4 20.3 9.4 12.2 6.0 5.1 82.5 13.7 5.3 16.0 3.7 10.8 14.5 10.3 11.6 15.2 16.3 8.0 10.9 10.3 20.6 10.9 46.0 11.3 68.5 13.1 13.2 12.9 8.5 16.1 14.0 7.4 27.9 6.0 25.8 18.3 20.5 MED15 "Arc105, CAG7A, PCQAP, TIG-1, TNRC7" ENSG00000099917 "Mediator complex subunit 15" Q96RN5 22 20495913-20587632 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 240.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003179 Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA003179: AB_1079581" "unprognostic (7.98e-2)" "unprognostic (2.26e-1)" "unprognostic (1.70e-1)" "prognostic favorable (7.30e-5)" "unprognostic (2.53e-1)" "unprognostic (1.76e-3)" "prognostic unfavorable (3.71e-4)" "unprognostic (3.73e-2)" "unprognostic (1.12e-3)" "unprognostic (3.46e-1)" "prognostic unfavorable (9.09e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (1.32e-2)" "unprognostic (2.50e-1)" "unprognostic (3.60e-2)" "unprognostic (5.57e-2)" 33.0 32.6 16.4 28.5 20.5 42.1 28.7 24.8 33.5 31.0 12.9 34.1 31.7 40.5 6.2 33.4 26.2 23.1 26.4 17.9 18.4 24.1 14.9 35.8 31.6 14.9 15.7 26.5 22.4 15.2 20.6 25.0 18.5 26.2 11.9 8.8 26.7 14.9 55.1 36.1 30.9 17.3 9.1 31.8 23.9 20.1 13.5 23.2 23.3 15.8 16.1 33.9 30.7 26.2 73.6 38.5 24.2 29.3 25.0 24.2 44.3 72.9 52.9 56.4 51.9 58.8 32.5 29.6 32.9 51.8 25.4 74.1 22.1 54.2 22.7 42.5 39.5 56.4 42.2 43.2 41.4 51.7 49.6 29.7 41.7 44.7 45.0 31.8 44.3 22.2 240.2 26.8 36.4 49.0 21.7 29.4 26.2 32.2 26.0 37.7 54.7 12.1 34.3 52.7 22.7 39.0 55.0 54.9 77.4 15.7 31.0 28.7 80.4 90.3 67.6 48.7 59.4 35.3 34.3 22.6 65.3 31.5 82.5 6.3 11.8 10.5 24.3 12.4 11.5 5.7 16.9 27.8 10.1 6.3 9.7 16.4 13.0 21.9 23.1 9.0 28.9 15.0 16.4 20.5 24.8 33.5 17.9 18.4 14.9 15.7 18.5 9.1 13.5 26.2 24.4 51.3 30.9 26.4 19.4 29.8 26.3 25.1 22.8 20.2 18.7 17.5 4.6 12.8 26.5 25.8 18.8 48.9 33.4 46.9 15.6 32.3 34.3 36.3 24.9 25.6 18.0 10.3 31.4 28.6 42.0 21.4 39.8 49.1 20.8 21.3 23.6 9.7 31.4 15.2 32.7 26.0 14.2 24.1 35.1 19.8 14.3 31.1 24.9 34.7 30.7 13.8 47.4 21.6 28.2 67.8 43.4 14.7 24.8 40.2 36.5 11.9 33.1 16.3 46.0 23.2 23.3 22.6 15.4 26.2 27.6 61.8 43.7 24.7 25.4 36.5 MED6 NY-REN-28 ENSG00000133997 "Mediator complex subunit 6" O75586 14 70581257-70600690 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030764, HPA069039" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA030764: AB_2673601, HPA069039: AB_2686070" "unprognostic (1.65e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (2.22e-3)" "unprognostic (1.04e-1)" "unprognostic (1.72e-2)" "prognostic unfavorable (1.04e-4)" "unprognostic (1.74e-1)" "prognostic unfavorable (2.75e-4)" "unprognostic (2.23e-2)" "unprognostic (1.54e-1)" "unprognostic (1.48e-1)" "unprognostic (6.93e-2)" "unprognostic (2.86e-1)" "unprognostic (3.32e-1)" "unprognostic (1.01e-1)" "unprognostic (3.15e-2)" 13.0 14.9 13.3 14.0 13.3 21.6 17.2 22.5 17.3 14.8 10.6 13.2 11.8 14.8 17.7 17.2 15.0 12.2 14.6 12.6 13.8 11.5 16.8 13.0 24.3 10.3 11.6 19.0 11.2 12.2 12.1 15.3 10.8 11.2 13.0 22.0 12.3 12.4 23.2 18.6 12.2 14.4 10.1 15.0 12.4 13.7 12.9 24.3 14.8 22.6 26.5 16.4 13.9 13.3 81.0 43.5 56.1 24.2 29.6 32.0 44.9 39.6 42.7 60.8 60.3 43.8 48.9 60.9 22.7 34.6 36.0 37.9 67.5 41.0 64.4 44.0 35.7 44.8 31.6 59.5 36.0 39.5 34.4 36.1 47.2 43.1 39.7 26.7 48.1 45.8 42.3 37.4 45.2 60.3 56.7 53.2 41.9 56.7 53.7 46.5 51.9 32.0 37.8 42.4 37.9 40.3 41.8 44.3 47.0 32.6 69.2 49.1 37.7 49.7 71.2 24.8 37.3 39.2 63.7 85.8 43.1 34.1 34.7 19.1 16.2 24.6 17.6 18.9 20.9 17.9 23.1 20.3 18.5 20.2 21.3 21.7 15.8 22.6 22.9 13.9 23.4 14.1 13.3 13.3 22.5 17.3 12.6 13.8 10.3 11.6 10.8 10.1 12.9 13.3 36.7 19.2 25.7 16.0 48.7 19.4 34.2 50.3 28.5 73.5 23.0 21.1 7.4 12.8 34.5 18.4 79.2 39.1 49.4 13.9 5.9 30.3 7.6 22.7 24.9 27.6 22.1 22.5 27.1 23.1 44.3 30.1 24.5 30.5 46.3 29.5 25.4 15.0 26.2 26.9 24.2 14.0 20.3 19.2 15.4 6.3 27.1 21.4 17.8 16.9 30.4 38.5 47.4 18.6 18.6 27.2 19.5 29.3 41.6 38.3 22.5 14.1 37.2 97.7 26.3 28.0 26.4 25.3 37.7 23.5 20.0 49.0 44.7 25.2 14.8 39.2 MED9 "FLJ10193, MED25" ENSG00000141026 "Mediator complex subunit 9" Q9NWA0 17 17476994-17493221 "Predicted intracellular proteins" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056415 Uncertain Approved Nucleoplasm,Midbody Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 12: NES - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" Nucleoplasm Midbody "HPA056415: AB_2683120" "unprognostic (1.81e-2)" "unprognostic (4.58e-2)" "unprognostic (2.65e-1)" "unprognostic (3.48e-3)" "unprognostic (1.27e-1)" "unprognostic (2.18e-1)" "unprognostic (1.89e-1)" "unprognostic (3.21e-2)" "unprognostic (4.23e-1)" "unprognostic (7.65e-2)" "prognostic favorable (4.18e-5)" "unprognostic (3.96e-2)" "prognostic favorable (2.83e-9)" "unprognostic (2.26e-3)" "unprognostic (2.29e-1)" "unprognostic (3.09e-1)" "unprognostic (1.39e-1)" 9.3 14.9 21.6 4.9 23.0 10.6 10.3 20.6 28.0 12.4 19.2 11.3 8.2 12.1 11.9 10.2 8.6 4.6 32.7 22.5 21.0 20.4 23.6 7.3 6.8 21.8 22.1 9.4 10.0 18.3 12.8 5.7 20.6 11.8 7.4 9.9 12.9 8.5 27.3 14.2 9.4 5.8 20.9 10.4 12.4 10.9 22.3 11.6 13.8 41.5 6.7 8.8 9.4 21.8 12.0 15.0 12.7 13.7 10.0 9.0 11.0 9.6 11.9 14.5 13.0 22.0 5.9 14.7 10.8 9.9 8.8 15.3 16.3 13.2 13.5 9.6 26.3 9.0 10.0 15.9 10.8 7.2 7.5 14.6 12.3 12.2 12.5 10.8 10.0 21.3 10.7 6.7 9.7 10.1 32.7 14.9 11.7 24.8 15.4 24.8 28.7 9.8 13.0 8.4 8.2 13.0 12.6 9.8 21.7 47.6 11.6 9.3 6.8 10.6 12.3 18.6 15.3 12.4 9.9 8.2 13.3 12.5 11.5 2.6 7.0 11.8 9.3 9.5 12.3 9.9 9.7 9.7 7.7 9.1 10.2 11.4 2.3 10.7 12.4 12.5 10.2 7.8 21.6 23.0 20.6 28.0 22.5 21.0 21.8 22.1 20.6 20.9 22.3 21.8 6.0 3.2 4.4 10.1 5.8 4.6 8.9 5.5 5.2 25.9 8.2 6.7 19.6 10.0 5.0 9.2 14.6 8.6 8.1 9.1 11.7 6.6 8.7 6.0 6.3 6.0 15.7 4.2 14.4 4.5 5.8 5.6 11.7 8.8 0.0 14.5 7.5 5.5 6.1 16.8 12.9 9.6 8.2 4.4 2.8 8.9 5.6 4.0 1.8 1.9 4.7 24.1 10.3 14.1 6.5 3.3 5.7 9.4 7.2 8.4 9.5 6.1 4.0 25.0 0.0 6.0 6.9 10.9 29.9 5.6 4.8 9.6 6.6 13.4 8.1 9.0 MFAP1 AMP ENSG00000140259 "Microfibril associated protein 1" P55081 15 43804492-43824690 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Syncytiotrophoblasts: 147.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015583, HPA042370" Uncertain Supported Nucleoplasm,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm Centrosome "HPA015583: , HPA042370: AB_10796904" "unprognostic (1.05e-1)" "unprognostic (5.94e-2)" "unprognostic (2.56e-2)" "unprognostic (1.23e-2)" "unprognostic (2.06e-1)" "unprognostic (5.28e-2)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.08e-1)" "unprognostic (1.48e-1)" "unprognostic (1.66e-2)" "unprognostic (3.12e-1)" "unprognostic (7.02e-2)" "prognostic favorable (1.04e-9)" "unprognostic (1.66e-2)" "unprognostic (9.68e-2)" "unprognostic (3.82e-3)" "unprognostic (1.54e-2)" 15.9 24.0 17.5 17.6 18.0 12.9 21.4 21.3 23.2 16.6 19.7 17.1 14.5 18.8 23.4 22.2 18.4 14.9 22.1 17.7 19.3 23.7 18.1 15.2 26.6 18.3 19.3 24.8 15.3 33.2 14.5 23.2 18.7 22.8 18.1 25.0 17.0 17.7 26.3 20.5 15.0 19.1 17.7 17.1 16.8 19.3 18.5 24.4 24.7 23.2 32.4 20.6 17.5 19.1 40.1 41.0 69.4 46.0 57.9 36.3 42.7 63.1 43.8 50.3 58.2 64.1 25.6 42.8 58.7 39.4 50.9 70.8 62.5 51.7 58.9 72.9 37.6 103.7 71.6 48.5 45.4 62.3 53.2 34.1 55.3 48.0 43.3 48.0 49.8 48.3 95.8 35.7 60.9 30.0 51.1 47.0 49.2 74.2 35.4 73.9 69.6 27.6 52.0 59.0 43.8 43.0 55.6 47.0 27.0 55.2 70.7 39.5 47.4 50.6 35.8 56.3 51.7 43.5 112.2 91.8 42.5 58.4 37.9 42.5 25.5 56.9 35.3 34.8 34.7 35.0 35.1 33.6 32.6 28.3 35.7 35.0 22.6 50.5 29.1 26.8 44.1 26.3 17.5 18.0 21.3 23.2 17.7 19.3 18.3 19.3 18.7 17.7 18.5 19.1 30.4 35.3 30.2 5.2 32.8 30.3 59.6 50.1 35.9 41.8 22.4 28.8 31.0 25.8 43.2 51.5 6.2 94.6 33.2 27.4 56.7 44.2 6.2 43.1 39.9 35.6 11.3 32.0 9.0 29.4 55.0 29.8 21.4 39.4 46.3 37.6 20.7 18.8 35.4 32.0 8.6 24.4 38.7 20.7 20.5 6.3 28.0 25.5 26.6 5.6 30.6 51.5 33.0 2.0 8.2 26.8 27.1 35.7 20.6 39.3 22.1 42.9 60.0 35.2 19.7 35.9 41.7 49.7 84.8 28.1 27.7 147.4 33.6 39.4 21.3 50.6 MFNG ENSG00000100060 "MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase" O00587 22 37469063-37486393 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Developmental protein, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 69.1" "Cell type enhanced" "Detected in many" "Adipocytes: 51.4;dendritic cells: 54.6;Endothelial cells: 37.1;Hepatic stellate cells: 53.2;Kupffer cells: 45.8;monocytes: 40.6;NK-cells: 72.1;T-cells: 51.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 174.6;HEL: 143.4;HL-60: 220.9;HMC-1: 266.9;HUVEC TERT2: 232.9;TIME: 134.7;U-698: 166.8;U-937: 201.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA048936, HPA056479" Approved Approved Vesicles "Intracellular and membrane" NA NA 74000 "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Vesicles "HPA048936: AB_2680564, HPA056479: " "unprognostic (1.21e-1)" "unprognostic (4.17e-3)" "prognostic unfavorable (5.12e-4)" "prognostic favorable (1.65e-4)" "unprognostic (6.41e-3)" "unprognostic (1.00e-2)" "unprognostic (2.64e-1)" "unprognostic (2.36e-2)" "unprognostic (4.64e-2)" "unprognostic (2.91e-2)" "unprognostic (5.44e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.31e-5)" "unprognostic (2.67e-1)" "unprognostic (4.03e-2)" "unprognostic (3.86e-2)" "unprognostic (1.43e-1)" 22.2 7.1 8.9 37.0 8.9 40.3 14.8 8.4 10.8 8.9 6.4 10.5 8.6 9.7 2.4 7.5 11.0 14.5 14.6 7.9 9.2 9.5 7.1 26.3 69.1 18.1 10.8 3.1 3.9 2.6 3.1 30.3 20.5 6.6 7.8 0.7 5.4 5.7 7.5 5.0 24.0 11.5 10.2 58.9 8.6 2.9 11.0 50.5 9.6 8.8 42.5 13.9 6.2 10.3 6.0 2.2 0.2 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.2 7.1 3.0 174.6 0.7 0.0 0.8 10.8 45.1 8.7 0.2 81.6 1.0 143.4 0.6 1.5 0.6 220.9 266.9 0.0 2.6 1.7 3.2 0.9 232.9 69.0 0.7 73.8 0.0 1.5 27.8 3.0 0.4 6.1 1.0 67.0 1.8 128.7 0.4 0.1 94.1 0.9 0.5 0.3 0.3 0.8 1.3 14.1 134.7 0.0 5.8 22.8 0.6 0.4 0.4 166.8 1.1 201.1 2.7 210.3 198.9 386.5 196.1 196.1 214.5 103.0 222.7 206.1 204.1 113.5 243.4 209.9 127.9 217.1 218.7 51.7 284.3 314.0 8.9 8.9 8.4 10.8 7.9 9.2 18.1 10.8 20.5 10.2 11.0 10.3 51.4 0.0 3.8 0.0 35.4 3.7 0.4 0.2 0.0 6.3 1.0 1.3 1.6 5.7 3.1 0.0 0.0 0.3 54.6 1.1 0.0 2.9 0.2 0.4 0.2 37.1 1.2 30.1 0.1 0.9 0.3 1.1 2.0 1.0 31.6 0.1 53.2 1.5 31.9 0.0 0.1 2.1 0.0 45.8 20.2 0.3 0.0 33.5 3.6 6.5 40.6 0.1 72.1 0.0 0.0 3.7 4.0 0.0 35.0 0.5 2.3 0.3 0.1 0.6 0.0 1.6 1.0 0.1 0.7 0.3 2.4 0.7 51.0 0.1 0.8 0.4 MGA "FLJ12634, KIAA0518, MAD5, MXD5" ENSG00000174197 "MAX dimerization protein MGA" Q8IWI9 15 41621224-41773081 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.6" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 122.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042278, HPA058183" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA042278: AB_10794647, HPA058183: AB_2683632" "unprognostic (5.78e-2)" "unprognostic (7.97e-2)" "unprognostic (2.97e-1)" "unprognostic (7.20e-2)" "unprognostic (6.26e-3)" "unprognostic (5.82e-3)" "unprognostic (8.61e-3)" "unprognostic (1.70e-1)" "unprognostic (1.90e-2)" "unprognostic (3.96e-3)" "unprognostic (3.71e-1)" "unprognostic (3.80e-2)" "unprognostic (1.43e-2)" "unprognostic (1.57e-1)" "unprognostic (3.93e-1)" "unprognostic (2.50e-1)" "unprognostic (3.89e-1)" 3.9 5.2 7.0 5.4 12.1 8.7 7.2 33.6 8.5 7.3 0.0 4.5 3.7 7.4 6.0 4.5 5.8 4.2 4.5 4.9 11.6 5.2 4.6 4.3 7.6 6.4 6.9 12.0 5.0 6.0 3.9 6.9 8.8 5.7 5.1 7.0 5.1 5.5 5.1 6.2 3.9 5.7 3.8 6.8 4.6 8.7 8.6 11.6 7.5 7.8 7.6 5.4 3.9 17.3 2.4 13.5 16.6 10.9 12.8 10.1 13.3 6.7 6.8 7.8 7.7 14.5 7.8 16.2 11.8 7.8 14.2 9.3 25.9 5.9 10.7 7.7 8.5 34.3 22.1 12.8 11.3 31.9 16.4 7.7 7.2 10.9 10.7 3.2 10.3 15.5 40.7 7.2 7.1 6.7 19.4 12.3 10.3 7.0 6.9 21.7 16.9 8.5 4.1 9.8 15.7 15.3 24.0 8.2 4.3 12.1 6.6 20.1 11.0 9.5 13.3 9.8 8.0 9.8 15.7 15.3 6.0 11.9 4.8 3.6 1.4 1.6 2.5 1.0 2.5 2.8 2.1 2.9 1.4 3.0 2.1 2.4 0.6 5.8 3.3 2.4 1.1 1.0 7.0 12.1 33.6 8.5 4.9 11.6 6.4 6.9 8.8 3.8 8.6 17.3 18.5 22.4 19.8 56.5 28.1 7.9 10.9 7.2 13.6 25.5 11.1 8.9 29.5 5.7 16.2 12.9 33.3 18.1 23.6 9.7 7.9 11.8 16.7 16.8 35.4 18.6 7.8 28.6 62.4 5.3 12.0 20.5 18.8 24.9 14.5 32.9 15.0 9.3 11.8 13.5 60.1 10.0 8.2 11.9 8.8 7.0 20.8 17.1 8.8 44.0 13.2 16.0 25.7 64.8 122.6 8.1 13.5 20.7 16.4 16.2 7.6 5.2 14.9 23.6 39.5 35.6 19.2 45.4 40.4 11.7 11.2 26.0 27.5 23.5 11.3 10.7 MIEF1 "FLJ20232, L0R8F8, MiD51, SMCR7L" ENSG00000100335 "Mitochondrial elongation factor 1" Q9NQG6 22 39499432-39518132 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Early spermatids: 266.3;Late spermatids: 377.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA061059 Approved "Intermediate filaments,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Intermediate filaments, Mitochondria" "HPA061059: " "unprognostic (5.35e-2)" "unprognostic (2.66e-2)" "unprognostic (2.86e-3)" "unprognostic (1.11e-2)" "unprognostic (3.74e-2)" "unprognostic (1.49e-1)" "unprognostic (1.95e-3)" "unprognostic (1.85e-2)" "unprognostic (5.72e-2)" "unprognostic (1.76e-1)" "unprognostic (3.24e-1)" "unprognostic (6.65e-2)" "prognostic favorable (3.96e-5)" "unprognostic (1.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.50e-1)" "unprognostic (2.30e-1)" 9.6 8.1 10.9 7.9 10.4 12.8 8.4 10.9 10.4 6.3 8.5 9.5 12.0 7.6 6.8 9.3 7.1 5.5 8.8 10.2 9.9 13.1 16.3 7.4 11.2 10.4 11.5 7.7 9.5 10.9 5.1 8.6 11.1 6.9 9.3 8.3 9.8 8.1 8.4 7.9 10.4 6.8 10.8 9.2 8.2 17.1 11.4 9.5 8.4 9.3 11.7 7.3 6.3 10.3 16.0 15.9 16.5 26.6 15.5 17.0 19.5 15.0 17.4 16.7 15.0 25.9 8.1 44.4 12.2 15.7 10.9 20.0 37.6 20.4 20.1 18.8 36.3 18.1 22.4 26.2 30.1 63.7 23.1 22.3 24.3 14.7 30.7 16.1 17.9 14.5 32.5 23.4 16.7 11.0 20.5 17.8 15.4 32.5 17.2 27.7 23.4 44.6 19.0 18.8 15.3 12.7 16.6 27.6 42.8 17.3 12.3 22.7 17.8 15.7 22.1 14.0 18.6 42.2 47.5 43.9 18.1 28.0 24.7 0.4 5.6 4.7 5.2 6.2 6.4 4.8 5.0 5.1 6.0 4.7 5.4 5.1 0.4 6.8 6.2 3.3 4.7 6.3 10.9 10.4 10.9 10.4 10.2 9.9 10.4 11.5 11.1 10.8 11.4 10.3 10.9 12.8 18.7 7.5 13.6 19.5 16.0 11.4 10.8 19.0 13.6 12.1 19.3 20.0 8.6 16.5 25.0 19.6 17.0 22.0 25.4 13.1 266.3 5.2 14.3 13.1 9.7 14.7 7.4 13.8 19.8 10.4 8.2 8.9 9.5 14.2 16.8 49.8 15.8 6.7 8.3 11.5 24.4 20.7 20.5 377.2 15.5 12.2 16.0 9.4 19.0 18.7 7.2 2.0 8.9 17.6 7.6 13.9 29.1 23.4 21.9 27.8 8.9 15.2 0.0 14.1 10.2 20.4 28.0 16.2 23.0 13.0 10.8 14.7 20.7 19.1 MINPP1 MIPP ENSG00000107789 "Multiple inositol-polyphosphate phosphatase 1" Q9UNW1 10 87504875-87553461 "Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Hydrolase "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Erythroid cells: 288.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026859 Approved "Intracellular and membrane" NA NA 370000000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 2: Karpas-707 - Immune response" "Cluster 6: Erythroid cells - Oxygen transport" "HPA026859: AB_1853961" "unprognostic (9.15e-2)" "unprognostic (8.76e-3)" "unprognostic (2.08e-2)" "unprognostic (2.97e-1)" "unprognostic (1.35e-1)" "unprognostic (5.20e-3)" "unprognostic (3.47e-2)" "unprognostic (1.74e-1)" "unprognostic (4.55e-1)" "unprognostic (2.07e-2)" "unprognostic (6.54e-2)" "unprognostic (6.50e-3)" "prognostic unfavorable (6.98e-5)" "unprognostic (2.43e-1)" "unprognostic (2.09e-1)" "unprognostic (2.07e-1)" "unprognostic (7.01e-2)" 8.5 21.3 6.6 7.2 6.7 31.1 9.4 6.9 9.1 8.8 9.4 12.6 17.6 7.0 10.0 3.6 8.5 8.4 5.8 6.8 8.0 17.5 29.1 8.3 7.7 6.4 6.8 8.8 11.9 9.0 8.1 18.9 6.4 11.7 12.9 11.9 6.9 7.6 4.9 9.1 13.6 7.6 6.9 6.9 8.5 7.9 7.7 8.1 11.6 5.7 7.0 8.6 5.7 7.4 18.6 28.1 28.1 40.9 46.4 38.1 23.2 29.5 51.1 28.8 38.3 15.0 35.5 16.4 27.0 35.9 19.4 28.2 29.9 27.1 33.2 37.1 35.7 41.1 10.4 55.7 34.6 18.0 36.0 33.7 34.7 32.6 19.5 52.5 37.0 14.3 24.5 75.9 34.4 13.8 11.9 25.6 20.0 14.2 20.2 0.0 15.8 11.0 38.5 10.4 10.2 31.5 28.1 5.9 51.5 31.5 16.7 14.7 32.4 18.3 21.9 22.1 28.7 24.5 27.1 4.2 29.3 26.8 13.7 10.5 10.8 4.9 11.5 13.8 10.1 8.7 10.8 13.0 14.3 8.2 10.2 11.4 0.7 11.7 12.5 8.2 17.3 10.5 6.6 6.7 6.9 9.1 6.8 8.0 6.4 6.8 6.4 6.9 7.7 7.4 11.7 6.4 12.8 9.1 8.1 2.8 8.3 25.5 8.0 14.4 9.0 4.3 4.9 15.7 16.2 7.3 2.1 20.4 4.9 14.0 5.9 17.2 15.9 7.1 13.4 10.5 13.1 288.9 18.3 16.7 19.2 17.9 7.1 6.7 24.7 17.8 16.4 58.3 12.9 10.1 20.8 25.5 20.3 16.0 5.8 4.0 9.3 8.7 10.6 7.5 11.7 11.1 10.3 25.6 19.1 10.5 17.2 8.2 18.6 6.8 17.1 26.0 19.0 14.8 0.0 4.8 11.1 10.6 12.1 4.0 3.4 8.1 8.2 13.7 11.6 4.4 MIPEP MIP ENSG00000027001 "Mitochondrial intermediate peptidase" Q99797 13 23730189-23889400 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 108.0;Oligodendrocytes: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 64.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030676, HPA031669, HPA031670" Approved Enhanced Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198" "unprognostic (2.05e-1)" "unprognostic (3.17e-2)" "unprognostic (3.75e-3)" "unprognostic (3.72e-2)" "unprognostic (1.24e-1)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.21e-1)" "unprognostic (4.69e-2)" "unprognostic (1.12e-1)" "unprognostic (7.54e-2)" "unprognostic (4.76e-1)" "prognostic favorable (7.66e-12)" "unprognostic (1.62e-2)" "unprognostic (4.95e-2)" "unprognostic (2.79e-1)" "unprognostic (6.90e-3)" 6.3 9.6 3.7 6.2 4.3 5.3 11.1 3.2 5.0 7.5 13.4 12.9 8.8 7.2 12.4 11.5 17.3 7.7 18.4 14.4 4.0 25.4 12.0 7.1 5.1 4.0 5.0 5.4 8.2 14.6 5.4 4.7 4.6 10.9 13.1 6.1 9.7 8.7 13.9 21.4 7.6 7.8 4.0 4.3 8.6 9.8 3.7 6.0 11.1 16.9 7.8 7.7 6.4 4.9 14.6 16.1 7.8 18.4 17.4 23.4 16.6 10.3 16.0 15.1 12.7 21.7 28.1 17.0 10.2 8.4 13.3 35.8 18.1 21.6 18.8 9.9 11.5 7.4 7.0 18.8 14.3 17.5 3.9 11.6 26.4 15.7 13.9 12.7 19.2 12.7 14.5 2.7 24.0 10.8 12.6 9.8 10.8 64.8 16.1 13.8 21.0 14.8 33.7 9.6 18.2 6.1 11.0 17.8 21.8 9.8 18.3 9.7 10.7 9.2 7.6 15.3 11.2 2.6 4.0 9.1 15.9 8.8 11.7 0.0 3.0 1.3 7.4 3.7 9.3 8.7 7.1 6.8 6.5 7.2 6.7 6.7 0.0 10.3 12.0 5.5 5.2 4.0 3.7 4.3 3.2 5.0 14.4 4.0 4.0 5.0 4.6 4.0 3.7 4.9 2.5 16.0 8.6 18.9 5.9 39.9 7.7 13.8 6.2 3.6 6.2 5.8 108.0 11.5 12.6 9.2 6.2 9.8 2.4 8.2 29.4 23.4 8.2 26.0 8.5 5.4 6.0 4.6 43.8 10.6 9.3 8.0 7.1 8.5 2.5 4.2 3.6 5.9 9.7 15.2 47.5 7.1 14.2 3.5 5.0 7.4 6.8 4.3 5.4 12.2 3.4 5.5 5.2 18.1 62.8 8.6 7.0 8.6 4.9 7.5 6.6 25.6 46.3 11.4 0.0 7.3 5.7 9.7 19.0 10.1 42.3 5.1 4.0 8.9 13.6 5.6 MIS12 "hMIS12, KNTC2AP, MGC2488, MTW1" ENSG00000167842 "MIS12 kinetochore complex component" Q9H081 17 5486285-5490814 "Predicted intracellular proteins" "Cell cycle, Cell division, Chromosome partition, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 117.7;Late spermatids: 235.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044482 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "HPA044482: AB_10963834" "unprognostic (3.86e-2)" "unprognostic (4.85e-2)" "unprognostic (1.36e-1)" "unprognostic (4.22e-2)" "unprognostic (1.38e-1)" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (4.68e-2)" "unprognostic (2.34e-3)" "unprognostic (3.41e-2)" "prognostic favorable (8.00e-4)" "unprognostic (4.13e-3)" "unprognostic (3.00e-3)" "unprognostic (1.13e-1)" "unprognostic (1.53e-1)" "unprognostic (8.11e-3)" "unprognostic (3.65e-2)" 11.9 11.3 10.2 16.1 12.6 17.6 15.5 11.0 12.3 12.1 10.6 12.1 12.2 13.6 31.7 10.1 13.3 10.1 9.7 9.6 10.5 13.8 16.3 10.9 21.5 11.7 11.7 11.9 14.8 10.6 13.8 10.7 12.7 12.0 14.0 28.1 11.0 12.9 13.6 10.4 13.9 13.1 10.7 18.2 11.7 15.0 11.1 26.1 18.8 12.9 21.2 13.3 8.8 15.8 19.0 21.8 45.4 28.7 18.5 18.4 23.4 26.9 20.1 40.6 36.2 20.4 14.0 47.7 22.9 14.4 19.7 42.2 36.9 25.3 41.3 28.0 24.9 26.7 42.1 24.0 32.6 15.7 31.0 18.4 38.3 34.9 54.3 19.4 21.4 36.8 29.9 46.5 26.0 11.9 34.8 15.6 25.6 24.6 19.4 31.6 44.2 23.0 16.3 19.3 15.7 30.8 28.3 13.2 30.0 32.8 20.0 13.1 14.2 25.8 20.7 22.6 34.0 22.1 21.6 26.8 23.2 22.6 23.9 6.5 8.5 6.6 14.6 9.8 15.5 11.9 12.3 14.4 9.7 9.2 15.5 14.8 4.4 16.1 13.8 12.9 8.8 10.3 10.2 12.6 11.0 12.3 9.6 10.5 11.7 11.7 12.7 10.7 11.1 15.8 13.6 12.8 15.3 14.0 21.0 12.9 25.8 9.7 19.4 14.4 15.4 12.3 7.6 14.3 12.3 5.5 14.6 13.1 18.7 16.5 23.5 10.4 117.7 11.0 13.1 14.2 21.4 16.8 7.0 7.1 12.7 12.8 10.2 10.3 32.4 11.7 10.0 13.0 10.1 5.0 7.2 20.7 18.3 9.9 17.2 235.3 5.9 9.9 10.6 6.5 7.3 19.9 17.5 7.1 22.2 9.9 19.8 9.4 23.7 19.8 7.9 7.6 13.9 22.1 19.7 16.7 12.2 27.2 11.5 11.7 18.0 21.9 19.5 11.3 13.4 20.6 MLH1 "COCA2, FCC2, HNPCC, HNPCC2" ENSG00000076242 "MutL homolog 1" P40692 3 36993350-37050846 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes, Disease variant, Hereditary nonpolyposis colorectal cancer, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013294, HPA052707, HPA060714, CAB070868" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348" "unprognostic (1.26e-2)" "unprognostic (3.88e-3)" "unprognostic (2.36e-2)" "unprognostic (1.82e-1)" "unprognostic (3.33e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (8.24e-5)" "unprognostic (3.36e-2)" "unprognostic (2.18e-1)" "unprognostic (1.32e-1)" "unprognostic (8.54e-2)" "unprognostic (8.63e-3)" "unprognostic (2.10e-3)" "unprognostic (4.37e-2)" "unprognostic (1.38e-1)" "unprognostic (1.02e-2)" "unprognostic (8.86e-2)" 15.6 17.9 7.3 17.4 8.0 22.1 15.4 7.1 9.1 17.4 7.6 17.4 12.0 16.3 14.0 14.3 14.9 11.1 35.4 6.9 8.3 16.0 19.1 15.8 21.9 8.6 7.4 15.1 16.6 22.4 22.7 14.8 7.6 16.2 14.5 9.6 12.1 14.0 49.1 13.4 13.4 19.2 7.1 18.8 15.5 25.4 7.7 28.4 19.2 42.2 24.3 17.2 14.0 9.0 37.1 56.7 66.7 0.2 25.9 34.5 30.7 54.7 44.4 64.1 62.3 43.4 40.1 92.2 25.0 44.1 33.6 24.7 65.2 45.8 68.5 42.2 32.1 68.1 42.3 54.9 23.2 81.9 40.5 28.4 29.0 54.8 57.8 21.9 37.6 55.0 86.0 32.0 66.2 27.6 81.0 22.2 49.4 38.4 31.6 4.6 90.6 40.2 35.1 39.3 14.2 36.1 52.1 56.9 32.7 33.3 79.9 55.6 28.8 46.0 50.5 44.0 65.9 29.1 93.7 88.1 37.8 71.9 45.7 12.6 12.5 15.1 12.7 22.6 9.8 11.3 7.7 11.4 14.3 9.7 8.4 9.6 2.6 7.8 29.2 5.9 15.0 11.0 7.3 8.0 7.1 9.1 6.9 8.3 8.6 7.4 7.6 7.1 7.7 9.0 10.8 25.6 15.8 22.9 18.5 7.1 12.4 18.7 7.4 18.5 9.6 9.7 41.8 12.8 15.8 11.0 10.4 33.4 16.0 6.1 19.6 14.6 31.3 12.5 11.3 10.7 5.4 19.0 18.5 14.7 26.9 14.4 12.2 9.5 7.6 13.0 13.6 14.9 20.1 3.3 21.6 8.6 16.2 16.3 8.9 13.2 11.1 13.8 8.8 10.3 18.2 15.9 11.3 27.2 31.3 9.3 7.4 13.9 22.1 6.4 5.3 12.9 16.5 18.1 13.1 10.0 14.0 58.6 29.3 9.3 5.5 20.0 15.9 14.8 8.4 6.5 MLST8 "GbetaL, GBL, Lst8, Pop3" ENSG00000167965 "MTOR associated protein, LST8 homolog" Q9BVC4 16 2204248-2209453 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 105.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019935, HPA041841" Approved Approved "Nucleoplasm,Golgi apparatus,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "Golgi apparatus, Cell Junctions" "CAB019935: AB_561447, HPA041841: AB_2677701" "unprognostic (2.19e-1)" "unprognostic (7.68e-2)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (3.35e-3)" "unprognostic (1.74e-1)" "unprognostic (8.17e-3)" "unprognostic (1.52e-1)" "unprognostic (5.77e-2)" "unprognostic (5.70e-3)" "unprognostic (4.62e-2)" "unprognostic (1.65e-1)" "prognostic favorable (7.60e-4)" "unprognostic (8.74e-2)" "unprognostic (1.20e-1)" "unprognostic (2.29e-1)" "unprognostic (5.48e-2)" 16.7 29.4 31.5 9.8 31.8 13.3 17.1 31.4 51.1 16.0 25.5 17.3 12.5 15.5 5.6 24.8 14.6 9.1 25.0 32.4 29.9 26.0 31.3 13.3 10.5 32.0 31.0 19.4 35.8 13.3 19.8 11.1 32.4 20.5 4.6 5.7 19.7 8.0 39.4 22.2 15.6 4.5 29.4 16.5 22.3 33.6 32.5 9.7 22.4 21.8 5.2 16.7 15.5 34.1 20.5 61.9 23.1 60.5 29.6 20.8 38.2 17.9 20.4 26.7 22.9 83.4 29.5 51.3 40.6 20.1 12.7 25.8 23.1 51.4 3.1 39.4 113.4 36.0 61.0 51.7 44.7 57.3 49.7 29.7 34.8 31.7 41.8 22.6 28.6 74.1 54.9 35.9 14.8 89.4 55.5 74.9 47.3 18.1 57.4 55.6 23.4 93.8 20.7 13.4 73.5 40.1 26.6 62.1 46.3 8.7 38.6 54.2 22.4 33.5 38.9 27.3 23.7 43.0 26.4 57.8 17.6 47.5 29.9 0.0 25.0 4.2 14.1 29.9 11.8 14.4 13.1 15.2 24.6 12.5 15.0 15.1 2.8 14.6 30.1 13.3 13.1 20.7 31.5 31.8 31.4 51.1 32.4 29.9 32.0 31.0 32.4 29.4 32.5 34.1 11.5 6.4 16.0 10.4 24.6 14.7 16.2 29.6 21.6 31.5 24.7 29.8 3.3 15.7 16.2 16.5 20.9 63.2 13.0 44.6 35.2 34.4 48.7 9.6 13.1 16.8 28.8 26.9 8.9 42.6 50.4 19.2 42.8 11.2 8.2 26.8 20.3 16.7 46.9 30.3 8.4 37.9 22.4 19.1 14.6 105.4 14.9 18.4 17.8 1.0 28.0 29.4 19.6 5.5 5.9 28.6 37.9 15.1 34.1 17.9 43.2 36.3 11.1 30.6 19.7 11.6 16.5 34.7 28.2 29.4 15.5 52.7 15.4 26.8 49.3 17.4 MMAA cblA ENSG00000151611 "Metabolism of cobalamin associated A" Q8IVH4 4 145599042-145660033 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins" "Chaperone, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 24.5" "Cell type enhanced" "Detected in many" "Hepatocytes: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037361, HPA058187" Supported Supported Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 30: Epithelial cell lines - Translation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Cytosol "HPA037361: AB_10672107, HPA058187: " "unprognostic (1.20e-1)" "unprognostic (5.07e-2)" "prognostic favorable (3.38e-4)" "unprognostic (1.97e-3)" "unprognostic (1.44e-1)" "unprognostic (4.83e-3)" "unprognostic (1.31e-3)" "unprognostic (3.98e-1)" "unprognostic (7.03e-2)" "unprognostic (7.26e-2)" "unprognostic (3.19e-3)" "unprognostic (1.46e-1)" "prognostic favorable (2.23e-5)" "unprognostic (3.40e-2)" "unprognostic (1.45e-1)" "unprognostic (1.14e-1)" "prognostic favorable (3.21e-4)" 4.1 3.2 1.4 3.0 1.9 1.7 4.2 2.7 2.3 3.0 1.3 5.8 7.4 2.4 4.0 4.1 2.7 3.8 3.3 1.5 1.4 7.3 24.5 3.7 3.1 1.3 1.5 2.3 2.0 4.2 0.7 2.8 1.3 2.3 5.3 1.9 3.5 2.8 4.7 3.8 6.2 2.6 1.2 3.5 3.6 4.5 1.3 5.2 3.1 6.0 3.7 4.7 0.8 1.6 2.5 1.4 4.0 2.1 8.4 9.8 1.1 7.1 4.0 2.3 1.4 1.7 4.3 12.1 2.1 4.4 1.1 2.2 2.0 4.4 1.7 7.5 0.8 4.0 1.3 1.5 6.5 5.6 3.3 5.5 6.1 2.6 5.8 3.7 7.2 8.1 1.1 4.6 5.1 3.4 7.2 1.4 1.5 6.2 2.7 3.7 2.2 1.4 13.3 1.3 1.9 1.4 3.5 6.0 3.3 2.4 3.9 1.5 7.0 2.8 1.4 5.0 1.6 2.2 2.0 3.3 4.4 5.5 2.8 3.9 3.1 3.0 4.5 6.1 4.0 3.1 5.3 4.6 3.2 2.6 4.0 5.3 0.5 4.8 7.4 3.3 5.2 2.3 1.4 1.9 2.7 2.3 1.5 1.4 1.3 1.5 1.3 1.2 1.3 1.6 3.6 12.8 5.6 5.5 3.6 2.9 10.4 7.7 5.7 3.4 3.0 2.4 7.6 14.3 13.0 11.0 2.1 7.9 6.5 7.7 15.6 11.1 10.5 5.0 4.5 4.1 2.4 1.7 5.7 12.5 2.8 4.8 7.1 5.7 8.2 3.4 7.9 31.8 4.9 0.0 5.7 6.5 8.2 4.1 1.6 6.3 4.7 3.6 1.8 3.7 5.6 2.3 9.2 8.0 7.4 8.4 7.3 3.0 2.8 6.5 10.9 21.1 6.8 1.6 0.0 4.2 3.8 8.7 5.2 4.4 1.1 7.7 4.5 5.7 6.7 12.2 MMS22L "C6orf167, dJ39B17.2" ENSG00000146263 "MMS22 like, DNA repair protein" Q6ZRQ5 6 97142161-97283217 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 67.8;Oligodendrocytes: 52.3;Spermatocytes: 56.9;Spermatogonia: 45.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA067042 Supported Nucleoplasm NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "HPA067042: AB_2685768" "unprognostic (3.61e-2)" "unprognostic (2.80e-1)" "unprognostic (2.26e-2)" "unprognostic (1.97e-3)" "unprognostic (1.70e-1)" "unprognostic (1.52e-1)" "unprognostic (1.00e-5)" "unprognostic (9.63e-2)" "unprognostic (5.81e-3)" "unprognostic (8.21e-3)" "unprognostic (9.39e-2)" "unprognostic (6.58e-2)" "unprognostic (1.34e-6)" "unprognostic (3.48e-2)" "unprognostic (2.00e-1)" "unprognostic (1.66e-1)" "unprognostic (1.29e-1)" 1.1 1.1 0.7 2.0 1.8 7.0 2.3 1.3 1.2 1.6 0.7 1.6 1.2 1.5 0.5 1.7 1.4 1.0 0.7 0.7 1.0 0.8 0.9 1.1 3.4 2.1 1.4 1.4 1.3 1.4 0.5 2.0 1.8 1.3 2.3 2.4 1.0 0.8 0.6 2.9 1.6 1.5 1.2 1.4 1.1 6.8 1.5 5.2 1.1 0.5 3.4 1.3 1.1 2.4 7.5 8.2 13.5 14.8 2.2 4.0 10.6 15.0 6.9 13.8 20.1 11.4 8.6 16.4 9.0 5.7 16.0 13.4 17.1 8.3 27.4 14.1 12.7 16.7 11.3 7.2 1.3 25.8 11.3 2.2 4.3 19.5 9.0 2.8 6.0 15.2 23.1 25.6 13.1 8.9 9.5 10.4 5.2 12.1 6.1 15.8 12.8 5.8 5.9 9.7 7.7 6.6 9.8 4.9 4.0 7.6 7.6 15.7 4.5 14.0 13.3 11.8 20.8 3.2 10.3 18.3 8.0 16.0 15.7 0.5 0.4 0.9 0.6 0.7 1.0 0.5 0.9 1.0 1.1 0.7 0.8 1.1 0.4 0.6 1.6 1.2 0.9 0.4 0.7 1.8 1.3 1.2 0.7 1.0 2.1 1.4 1.8 1.2 1.5 2.4 5.9 3.2 8.6 16.6 9.7 9.2 5.8 4.0 4.0 11.6 6.1 6.2 4.2 5.7 6.9 3.7 41.7 12.5 14.6 3.3 1.9 2.9 67.8 4.4 6.1 6.5 1.2 26.3 11.3 4.1 11.2 6.1 7.7 2.8 7.6 24.0 10.8 3.1 6.4 3.3 7.7 8.4 8.2 7.5 6.0 17.2 9.9 6.8 7.2 36.5 6.4 6.1 6.2 22.6 52.3 3.0 2.0 5.7 13.1 2.9 5.4 0.8 6.1 31.9 6.6 7.9 5.1 56.9 45.8 7.1 8.2 3.6 9.6 5.2 10.3 3.0 MMUT "MCM, MUT" ENSG00000146085 "Methylmalonyl-CoA mutase" P22033 6 49430360-49463253 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" Isomerase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 199.0" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 62.5;Cytotrophoblasts: 26.5;Extravillous trophoblasts: 13.3;Hofbauer cells: 12.4;Syncytiotrophoblasts: 33.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035971, HPA035972" Enhanced Approved Mitochondria,Cytosol NA NA 150000 "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 24: Non-specific - Transcription regulation" Cytosol Mitochondria "HPA035971: AB_10696648, HPA035972: AB_2674895" "unprognostic (1.34e-2)" "unprognostic (1.12e-1)" "unprognostic (1.17e-2)" "unprognostic (3.72e-2)" "unprognostic (3.18e-3)" "unprognostic (1.20e-1)" "unprognostic (1.16e-2)" "unprognostic (1.16e-2)" "unprognostic (3.62e-2)" "unprognostic (1.89e-2)" "unprognostic (6.57e-2)" "unprognostic (9.89e-2)" "prognostic favorable (8.71e-13)" "unprognostic (5.38e-2)" "unprognostic (3.78e-1)" "unprognostic (6.01e-3)" "unprognostic (1.91e-1)" 19.8 23.3 12.1 11.5 13.2 8.6 18.4 14.2 16.2 14.0 19.3 22.6 27.1 15.2 15.6 17.9 13.9 14.2 31.0 12.1 13.5 50.6 199.0 12.5 11.8 13.0 12.7 24.2 24.6 31.1 11.7 13.2 13.2 20.8 21.5 17.2 18.7 15.8 23.6 15.0 20.1 14.9 14.1 9.4 20.1 14.6 13.3 12.2 19.2 36.1 11.2 13.0 11.9 16.3 23.9 8.3 24.6 28.8 47.8 45.1 13.6 20.9 27.3 21.6 31.7 9.7 12.1 21.9 16.3 22.4 32.6 13.3 27.6 14.8 30.2 18.9 20.0 11.7 17.5 25.4 34.8 15.1 10.8 27.4 21.6 22.0 25.4 19.3 21.1 23.4 21.6 25.6 25.7 15.0 17.9 14.9 10.5 25.0 6.0 15.8 30.8 30.7 24.9 22.6 22.7 15.8 23.0 16.3 35.7 25.6 14.2 23.9 15.4 20.0 14.6 27.4 28.7 10.0 12.2 18.8 28.1 17.6 17.9 16.0 6.5 11.4 6.4 8.8 8.2 7.6 7.7 8.1 7.8 6.9 9.6 7.2 3.8 12.5 14.7 5.5 10.9 5.8 12.1 13.2 14.2 16.2 12.1 13.5 13.0 12.7 13.2 14.1 13.3 16.3 6.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.5 0.0 0.0 0.0 0.0 26.5 2.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 13.3 5.3 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 33.4 0.6 0.0 0.0 0.0 MOCS3 "dJ914P20.3, UBA4" ENSG00000124217 "Molybdenum cofactor synthesis 3" O95396 20 50958818-50963929 "Enzymes, Predicted intracellular proteins" "Molybdenum cofactor biosynthesis, tRNA processing" "Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 90.9;Late spermatids: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027556 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 29: Early spermatids - Spermatogenesis" "HPA027556: AB_2672333" "unprognostic (1.29e-1)" "unprognostic (2.57e-1)" "unprognostic (3.16e-1)" "prognostic unfavorable (5.82e-4)" "unprognostic (2.11e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (1.39e-4)" "unprognostic (3.76e-1)" "unprognostic (3.19e-1)" "unprognostic (1.33e-2)" "unprognostic (8.67e-3)" "unprognostic (4.90e-2)" "prognostic favorable (7.55e-4)" "unprognostic (8.39e-2)" "unprognostic (8.48e-2)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" 1.5 1.9 1.8 1.9 1.6 1.0 1.8 1.8 1.9 1.6 1.7 1.8 2.1 1.8 2.7 2.3 2.6 1.4 1.6 1.6 1.8 1.8 2.5 1.5 2.4 1.5 1.5 2.7 2.2 2.1 1.2 1.8 1.5 1.7 1.6 1.4 2.3 1.8 2.4 2.1 2.2 1.4 1.2 2.3 2.0 5.0 1.8 2.0 2.2 1.4 2.2 1.9 1.3 1.6 3.5 5.9 3.6 5.0 5.0 4.1 6.6 4.1 4.4 10.1 4.3 12.8 5.1 5.3 5.3 3.7 6.6 10.0 3.8 10.1 6.4 1.9 4.0 4.2 4.7 7.4 5.1 4.2 4.3 4.6 8.4 4.2 4.1 3.3 3.5 4.6 6.2 3.1 3.8 5.8 7.0 5.1 5.3 5.4 10.2 2.7 5.6 4.7 4.0 5.4 5.2 6.0 6.4 20.3 6.8 4.0 8.5 8.0 4.2 7.6 4.3 4.2 4.5 7.7 7.4 2.2 6.8 2.5 3.3 2.8 4.1 3.8 3.2 3.8 4.2 4.7 3.4 3.6 4.8 3.3 5.6 4.4 2.1 4.5 5.9 2.6 5.9 3.9 1.8 1.6 1.8 1.9 1.6 1.8 1.5 1.5 1.5 1.2 1.8 1.6 2.2 0.0 1.5 0.3 3.7 1.8 5.0 5.2 5.7 5.6 3.8 3.8 2.0 4.3 4.6 0.0 4.2 10.3 1.3 4.0 1.9 7.8 90.9 7.4 5.3 2.7 2.4 5.2 1.7 8.0 6.3 3.4 2.0 5.5 0.0 6.6 6.1 7.5 4.9 0.0 1.8 3.8 4.1 3.8 1.1 26.2 5.0 3.2 3.6 0.0 5.2 6.9 5.2 0.5 1.0 5.9 2.5 3.0 2.0 3.2 3.7 7.3 7.7 5.9 13.1 2.2 3.3 20.0 7.6 5.4 3.8 11.6 3.1 5.8 4.6 4.8 MRRF RRF ENSG00000148187 "Mitochondrial ribosome recycling factor" Q96E11 9 122264603-122331337 "Predicted intracellular proteins" "Protein biosynthesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 210.0;Late spermatids: 191.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047177, HPA049987" Supported Approved "Microtubules,Cytokinetic bridge" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" "Microtubules, Cytokinetic bridge" "HPA047177: AB_2679970, HPA049987: AB_2680984" "unprognostic (8.38e-2)" "unprognostic (2.17e-1)" "unprognostic (6.40e-2)" "unprognostic (6.06e-3)" "unprognostic (3.64e-2)" "unprognostic (1.11e-1)" "unprognostic (4.48e-2)" "unprognostic (3.71e-2)" "unprognostic (1.89e-2)" "unprognostic (4.44e-2)" "unprognostic (2.98e-1)" "unprognostic (9.01e-2)" "prognostic favorable (2.14e-8)" "unprognostic (3.89e-2)" "unprognostic (4.05e-1)" "unprognostic (8.02e-2)" "unprognostic (8.88e-3)" 18.9 19.3 10.4 12.1 10.7 14.2 19.3 11.7 13.3 13.9 15.3 25.1 23.7 10.1 13.1 25.5 11.4 8.8 28.2 10.6 11.3 23.4 24.3 13.3 14.0 11.4 10.9 11.3 18.3 23.2 12.5 9.0 11.3 14.7 28.6 14.5 15.3 10.6 40.6 22.1 18.5 10.1 10.6 15.6 14.4 18.1 11.3 13.8 16.3 32.1 20.4 16.9 16.4 11.5 34.7 45.8 25.6 43.0 35.7 32.5 48.7 33.7 43.0 44.5 26.0 55.0 40.6 75.0 16.7 27.0 35.5 99.3 74.1 78.8 36.3 25.2 30.3 25.6 53.4 30.5 23.6 72.3 32.7 30.5 52.7 40.0 70.8 22.4 50.4 29.6 44.2 27.8 45.1 55.1 36.2 23.6 30.0 86.0 45.7 26.8 48.8 79.7 76.6 34.8 30.3 19.9 36.2 58.3 27.9 24.3 62.8 18.2 27.1 19.5 29.6 51.0 42.0 19.1 50.1 33.0 36.8 42.4 22.8 4.7 17.5 6.0 13.3 29.0 14.2 15.6 13.3 12.5 29.8 12.7 13.8 16.5 2.0 22.9 31.3 12.9 16.3 11.1 10.4 10.7 11.7 13.3 10.6 11.3 11.4 10.9 11.3 10.6 11.3 11.5 22.7 3.2 9.1 21.9 18.8 15.4 22.1 30.3 26.2 13.2 20.1 17.3 21.8 18.6 17.8 14.7 12.5 29.0 10.8 21.4 35.2 36.0 210.0 16.2 15.7 22.5 7.8 29.3 28.6 29.5 49.2 11.1 23.9 12.1 24.7 14.5 14.3 19.2 30.4 5.0 39.1 22.0 18.3 17.0 16.5 191.7 9.6 16.0 14.2 20.6 18.3 6.3 11.3 22.1 31.0 24.0 20.6 7.5 19.4 18.1 41.2 37.3 16.2 23.5 19.7 15.1 11.7 30.2 16.6 32.5 22.4 37.1 12.3 31.1 33.9 22.7 MSH3 "DUP, MRP1" ENSG00000113318 "MutS homolog 3" P20585 5 80654652-80876815 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 95.1;Inhibitory neurons: 98.9;Oligodendrocytes: 92.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036081 Approved "Nuclear bodies" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nuclear bodies" "HPA036081: AB_10673229" "unprognostic (1.91e-1)" "unprognostic (7.61e-2)" "prognostic favorable (5.90e-5)" "unprognostic (2.95e-2)" "unprognostic (1.89e-1)" "unprognostic (6.41e-2)" "unprognostic (1.81e-1)" "unprognostic (8.70e-2)" "unprognostic (3.17e-2)" "unprognostic (2.62e-2)" "unprognostic (2.63e-1)" "unprognostic (3.91e-1)" "prognostic favorable (1.77e-4)" "unprognostic (5.15e-3)" "unprognostic (1.46e-1)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" 9.4 4.6 1.8 4.3 2.4 5.0 5.5 1.6 2.0 6.6 1.5 6.0 6.0 5.2 5.3 5.0 7.0 5.7 4.9 1.7 2.0 12.5 11.4 4.2 4.9 1.7 2.0 5.3 5.2 8.8 3.3 4.3 1.7 5.2 6.2 3.7 4.5 5.2 5.1 5.1 5.6 5.1 2.2 4.1 5.0 3.9 2.5 7.1 10.8 4.7 6.1 6.3 3.9 2.0 12.4 15.0 11.7 13.1 6.6 12.3 16.6 12.2 11.8 13.6 16.7 10.0 15.6 22.2 14.0 15.3 12.8 10.4 15.6 20.5 17.3 14.2 13.9 8.4 13.4 9.9 6.8 9.9 8.5 10.9 9.5 15.8 16.6 13.8 12.9 7.9 12.1 12.9 16.1 11.9 19.0 4.7 9.0 4.8 7.7 13.2 24.2 16.4 15.2 13.0 11.6 13.9 10.4 11.5 13.0 14.4 15.2 9.4 12.4 7.8 9.5 6.2 23.0 8.7 15.6 21.6 12.2 16.8 10.2 0.7 2.9 1.9 3.3 3.4 3.8 3.4 3.5 3.6 3.3 2.2 2.6 2.6 1.7 3.1 4.6 2.8 4.8 2.4 1.8 2.4 1.6 2.0 1.7 2.0 1.7 2.0 1.7 2.2 2.5 2.0 16.7 35.3 9.3 66.9 18.1 10.5 12.3 12.4 12.5 25.8 19.4 12.8 17.6 8.6 14.3 14.7 14.6 18.9 18.7 18.2 15.6 12.4 14.6 28.4 20.2 12.0 14.5 17.0 95.1 10.3 12.9 15.9 31.6 18.9 8.2 19.9 10.0 20.1 11.5 21.9 98.9 13.2 8.2 13.0 7.0 17.2 13.7 16.3 3.6 72.1 19.9 22.5 19.6 71.9 92.3 10.6 9.6 25.9 22.0 6.5 16.8 43.6 65.4 28.3 19.7 20.2 14.7 24.7 25.5 22.3 10.1 13.1 25.4 14.7 17.4 10.7 MTMR6 ENSG00000139505 "Myotubularin related protein 6" Q9Y217 13 25246222-25287488 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 3: HMC-1 - Innate immune response" "Cluster 65: Plasmacytoid DCs - Unknown function" "unprognostic (8.68e-2)" "unprognostic (1.50e-2)" "unprognostic (1.21e-2)" "unprognostic (2.31e-3)" "unprognostic (1.91e-1)" "unprognostic (9.19e-2)" "unprognostic (3.21e-1)" "unprognostic (1.45e-1)" "unprognostic (3.41e-2)" "unprognostic (1.82e-2)" "unprognostic (1.69e-1)" "unprognostic (2.94e-1)" "unprognostic (1.71e-3)" "unprognostic (2.04e-1)" "unprognostic (1.18e-1)" "unprognostic (5.06e-2)" "unprognostic (1.30e-1)" 13.4 19.0 9.6 14.2 10.6 31.9 12.5 10.6 14.2 10.7 6.1 10.9 8.5 12.2 7.7 10.8 8.7 12.8 15.6 11.0 11.8 14.8 13.4 13.0 15.0 11.1 9.6 9.3 12.8 16.3 6.1 12.2 11.0 12.9 12.1 21.9 16.1 13.3 11.8 7.7 8.8 15.8 10.4 14.2 10.9 18.6 10.4 16.7 15.3 14.9 14.4 14.3 6.5 14.0 12.3 12.6 20.3 17.3 21.2 22.1 9.9 38.0 42.6 36.9 28.9 8.4 21.4 18.8 11.0 35.7 18.7 14.9 13.1 22.5 42.6 22.7 8.6 23.1 8.4 6.9 25.5 48.5 40.8 15.9 25.9 26.8 35.8 21.1 30.4 24.8 10.9 20.9 37.5 8.7 27.8 13.1 6.1 23.6 9.4 11.8 28.5 25.9 26.7 14.2 10.7 15.2 12.4 21.8 20.2 19.2 8.4 30.2 39.4 22.6 11.6 25.2 22.5 11.3 14.0 24.6 11.4 18.6 37.6 22.9 9.8 8.0 5.8 14.0 7.4 6.5 6.1 6.2 7.9 4.2 6.2 6.4 18.9 6.0 13.0 4.7 8.9 8.9 9.6 10.6 10.6 14.2 11.0 11.8 11.1 9.6 11.0 10.4 10.4 14.0 24.5 16.0 32.1 20.5 44.3 11.0 8.0 8.7 8.0 0.0 16.7 10.4 29.5 8.6 11.9 16.5 0.0 5.8 21.8 14.5 13.7 13.1 64.0 19.0 18.9 20.7 16.7 6.1 29.4 15.0 6.9 16.7 14.8 10.5 19.0 10.6 27.1 23.1 16.3 0.0 63.9 16.0 12.2 40.5 27.7 23.4 12.5 36.4 19.6 26.2 28.1 0.0 5.2 33.2 51.6 22.3 10.0 19.9 28.3 10.2 7.3 31.3 26.6 0.0 0.0 20.4 17.7 62.1 20.4 10.3 11.9 8.2 26.3 17.5 12.3 11.9 MTPAP "FLJ10486, PAPD1, SPAX4, TENT6" ENSG00000107951 "Mitochondrial poly(A) polymerase" Q9NVV4 10 30309801-30374448 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "mRNA processing, Transcription" "Nucleotidyltransferase, RNA-binding, Transferase" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 36.8" "Cell type enriched" "Detected in many" 7 "Early spermatids: 240.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038620, HPA058232" Approved Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Mitochondria "HPA038620: AB_10673015, HPA058232: AB_2683646" "unprognostic (2.76e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-1)" "unprognostic (3.43e-3)" "unprognostic (3.05e-2)" "unprognostic (1.01e-1)" "prognostic unfavorable (4.20e-6)" "unprognostic (1.16e-1)" "unprognostic (2.04e-1)" "unprognostic (4.78e-2)" "unprognostic (1.77e-1)" "unprognostic (3.56e-2)" "unprognostic (9.02e-2)" "unprognostic (6.28e-3)" "unprognostic (3.77e-1)" "unprognostic (1.14e-2)" "unprognostic (4.39e-2)" 8.9 7.4 4.9 10.3 4.8 36.8 9.7 12.6 6.7 6.1 3.1 9.6 10.6 9.0 6.2 8.3 6.6 5.2 8.8 4.8 4.3 9.6 10.6 6.3 10.7 3.4 3.5 8.2 10.0 8.4 2.7 9.6 3.9 7.2 11.0 7.1 8.0 4.9 13.2 8.4 9.0 9.1 3.2 9.3 7.1 5.1 3.6 9.2 10.2 12.0 10.3 8.1 5.2 6.2 26.0 25.3 15.8 23.0 15.2 14.2 20.6 17.6 6.2 17.7 18.4 27.0 35.4 36.9 12.3 11.7 16.3 29.7 31.1 20.7 21.6 18.7 24.0 37.3 23.7 27.5 16.0 24.6 28.2 14.3 19.0 19.9 11.7 9.8 19.6 34.0 41.2 28.1 13.5 21.8 29.8 21.8 10.8 19.5 13.3 29.6 27.9 34.4 16.2 17.1 25.9 20.8 16.0 16.4 24.7 14.8 15.8 15.6 18.7 18.4 23.8 26.0 19.8 6.2 16.3 50.8 15.9 44.5 6.6 27.4 25.2 27.3 21.7 35.0 23.0 20.8 20.4 21.1 33.0 17.1 21.6 22.0 4.2 25.1 27.9 17.3 23.1 13.1 4.9 4.8 12.6 6.7 4.8 4.3 3.4 3.5 3.9 3.2 3.6 6.2 12.2 9.6 7.4 9.1 11.2 25.2 13.9 7.4 4.6 0.0 9.8 9.8 16.7 15.7 9.2 3.7 0.0 13.1 13.9 8.1 19.6 9.6 240.7 9.9 14.8 12.9 4.2 16.6 12.7 9.1 12.0 12.7 7.7 12.5 5.1 18.8 12.5 14.6 14.7 0.0 14.5 15.6 6.1 15.8 13.6 34.3 12.2 10.8 8.8 8.4 14.8 0.0 5.2 4.5 14.4 8.9 5.2 16.6 5.3 14.1 8.7 14.2 8.6 0.0 13.1 14.7 10.8 25.3 19.5 11.4 24.9 11.5 8.8 12.6 18.4 16.6 MTREX "Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2" ENSG00000039123 "Mtr4 exosome RNA helicase" P42285 5 55307989-55425579 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "DNA damage, mRNA processing, mRNA splicing, rRNA processing" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 42.3;Endometrial stromal cells: 44.0;Exocrine glandular cells: 40.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037379 Supported Supported Nucleoplasm NA NA 13000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA037379: AB_10601713" "unprognostic (7.71e-2)" "unprognostic (1.21e-1)" "unprognostic (1.33e-3)" "unprognostic (1.32e-1)" "unprognostic (1.50e-1)" "unprognostic (2.08e-1)" "unprognostic (1.79e-2)" "unprognostic (5.08e-1)" "unprognostic (4.17e-2)" "unprognostic (1.46e-2)" "unprognostic (5.05e-2)" "unprognostic (7.67e-2)" "unprognostic (1.11e-2)" "unprognostic (2.09e-1)" "unprognostic (3.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.11e-1)" 20.4 22.7 10.2 21.9 11.5 18.5 22.0 17.4 12.7 22.5 14.4 17.7 24.6 22.1 14.1 19.1 17.8 19.8 24.3 9.7 11.2 20.8 19.6 16.7 25.9 11.1 10.8 20.1 21.2 26.6 17.2 18.9 11.5 21.6 19.9 17.8 18.9 14.7 29.9 20.8 24.1 13.8 11.4 19.2 20.9 23.4 10.3 21.9 25.8 22.5 21.8 21.0 19.8 14.9 40.9 49.2 38.4 39.9 32.8 35.0 49.5 33.4 28.3 39.7 50.1 57.1 51.2 79.3 37.4 33.1 52.9 28.5 76.8 50.3 59.9 14.2 53.2 51.6 45.4 45.9 31.3 33.4 44.8 27.5 31.3 42.9 51.6 33.6 35.1 29.7 60.9 45.0 37.9 35.8 32.3 36.5 38.4 16.8 46.6 39.5 44.1 33.9 41.3 56.9 42.0 28.8 40.4 24.5 35.4 42.4 52.5 44.8 33.2 10.0 27.5 28.4 62.0 31.5 33.6 59.0 27.0 69.5 40.8 3.6 5.0 5.4 7.2 4.7 6.9 6.1 5.7 6.8 6.4 6.4 6.1 6.2 1.3 4.5 7.9 6.7 5.6 4.1 10.2 11.5 17.4 12.7 9.7 11.2 11.1 10.8 11.5 11.4 10.3 14.9 27.6 32.1 42.3 0.0 10.1 0.0 0.0 0.0 0.0 0.0 22.3 13.8 0.0 0.0 21.7 20.2 0.0 25.0 24.6 0.0 11.7 32.0 0.0 28.2 44.0 10.0 0.0 0.0 0.0 40.7 21.5 16.2 0.0 26.2 25.2 30.8 0.0 0.0 15.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 13.9 0.0 0.0 0.0 0.0 35.7 0.0 0.0 8.3 0.0 0.0 22.3 26.2 0.0 0.0 0.0 12.2 0.0 0.0 0.0 0.0 34.9 11.6 31.7 0.0 0.0 MTX2 ENSG00000128654 "Metaxin 2" O75431 2 176269395-176338025 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 201.5;Spermatocytes: 247.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031550, HPA031551, HPA031552" Approved Approved Supported Nucleoli,Mitochondria "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria Nucleoli "HPA031550: AB_10599733, HPA031551: AB_10601442, HPA031552: AB_10794616" "unprognostic (2.61e-1)" "unprognostic (9.86e-2)" "unprognostic (6.54e-2)" "prognostic unfavorable (5.06e-4)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (1.05e-2)" "unprognostic (1.29e-1)" "unprognostic (2.87e-2)" "unprognostic (3.97e-2)" "unprognostic (1.80e-2)" "unprognostic (8.30e-2)" "unprognostic (1.22e-1)" "unprognostic (2.03e-1)" "unprognostic (9.92e-2)" "unprognostic (3.15e-2)" "unprognostic (1.33e-2)" 20.4 37.4 31.8 15.2 33.6 9.2 27.0 32.8 46.7 22.1 35.9 31.2 22.8 18.7 39.3 38.1 28.9 14.5 49.8 33.3 34.4 46.4 30.8 15.6 14.2 33.9 32.0 21.1 26.3 48.1 29.5 25.8 33.2 26.4 35.5 47.3 20.4 22.6 74.4 23.4 20.2 25.7 34.0 15.6 24.4 64.3 33.5 18.2 20.4 70.9 20.8 25.1 24.7 35.6 52.2 31.0 60.8 37.8 40.0 45.9 58.3 54.5 52.0 49.8 58.3 53.1 55.8 66.4 91.4 49.1 79.9 34.5 67.1 67.6 67.9 66.6 49.4 63.9 39.1 94.9 62.7 98.9 20.7 51.1 83.5 52.2 89.1 60.3 72.0 64.3 86.8 50.2 59.6 47.4 34.9 102.9 58.3 101.8 45.5 0.0 44.0 60.8 142.4 93.3 87.0 74.4 45.7 60.9 120.7 116.4 33.7 64.0 63.5 49.2 43.5 52.1 57.9 55.4 62.1 79.8 61.1 49.7 60.8 8.0 9.3 4.1 9.6 15.8 13.1 18.9 12.4 11.1 14.8 13.7 14.9 15.4 0.0 19.6 14.4 12.1 16.9 9.9 31.8 33.6 32.8 46.7 33.3 34.4 33.9 32.0 33.2 34.0 33.5 35.6 34.4 19.2 22.6 50.6 20.8 31.1 36.2 130.9 37.5 0.0 38.2 43.8 69.2 31.5 63.6 57.0 0.0 78.8 11.1 38.8 201.5 51.8 22.3 60.9 25.7 31.4 41.5 19.5 106.0 39.5 63.3 30.2 28.1 33.9 43.1 25.7 16.4 33.7 47.8 0.0 106.3 47.7 103.7 21.7 15.7 18.8 35.4 19.6 35.6 43.1 26.1 0.0 12.3 93.5 180.2 49.8 26.1 32.7 23.1 48.2 39.6 106.3 63.8 0.0 39.5 24.9 52.4 247.8 127.1 56.5 41.9 65.0 18.8 55.8 52.6 53.7 MUS81 "FLJ44872, SLX3" ENSG00000172732 "MUS81 structure-specific endonuclease subunit" Q96NY9 11 65857126-65867653 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" "Endonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 130.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059530 Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 2: Karpas-707 - Immune response" "Cluster 34: Spermatids - Unknown function" "Nucleoli fibrillar center" Nucleoplasm "HPA059530: AB_2684052" "unprognostic (2.34e-3)" "unprognostic (2.52e-1)" "unprognostic (8.68e-2)" "unprognostic (1.35e-1)" "unprognostic (6.31e-2)" "unprognostic (1.87e-1)" "prognostic unfavorable (6.05e-4)" "unprognostic (2.06e-1)" "unprognostic (7.18e-2)" "unprognostic (5.24e-2)" "unprognostic (9.64e-2)" "unprognostic (4.27e-2)" "unprognostic (1.05e-3)" "unprognostic (5.37e-2)" "unprognostic (2.98e-1)" "unprognostic (1.20e-1)" "unprognostic (8.86e-2)" 20.6 18.0 15.2 13.3 15.6 11.3 20.3 15.7 20.0 32.0 14.4 31.4 16.9 35.4 7.7 16.9 30.8 10.9 25.3 14.6 13.4 28.8 19.4 21.6 18.6 16.6 15.6 29.8 19.9 10.2 22.4 11.0 15.9 26.2 7.1 8.1 16.6 15.9 24.3 14.1 23.7 12.4 14.8 29.0 22.5 16.6 16.7 16.1 23.5 16.9 13.6 29.7 22.5 18.8 21.6 13.3 22.1 22.0 9.5 11.5 28.2 22.7 17.9 28.2 18.8 17.7 34.4 20.4 30.0 17.8 35.2 20.6 19.9 19.9 6.3 44.5 14.7 37.3 39.8 10.8 29.0 26.9 38.2 18.3 36.2 35.8 28.0 20.7 24.0 36.5 22.9 55.4 18.7 14.2 38.1 41.0 16.1 14.1 29.2 37.2 10.6 39.7 21.5 13.3 22.1 25.3 15.5 27.7 48.7 13.5 32.6 27.3 21.5 21.2 18.0 27.3 24.9 37.6 26.9 29.7 24.1 17.5 36.3 22.6 13.7 27.4 21.0 16.3 21.0 13.1 15.9 18.4 14.7 10.4 12.3 15.4 9.4 13.3 18.5 14.7 15.1 13.0 15.2 15.6 15.7 20.0 14.6 13.4 16.6 15.6 15.9 14.8 16.7 18.8 19.3 12.8 18.4 15.0 17.2 8.0 21.5 13.5 10.2 19.2 11.8 15.6 10.0 11.5 16.0 7.3 20.9 20.8 22.0 27.0 5.9 24.7 62.8 12.2 22.0 16.1 16.8 25.7 9.0 22.2 23.6 13.5 27.0 13.0 14.0 15.0 16.8 9.2 19.6 23.5 8.8 23.9 10.2 13.3 8.8 130.0 21.8 14.3 10.6 9.4 27.1 15.0 32.0 8.5 12.9 26.6 24.5 27.1 12.6 11.0 36.1 12.4 16.0 24.7 39.5 11.5 21.9 27.9 16.7 8.4 7.4 19.7 19.9 15.0 21.4 10.2 MYBBP1A "FLJ37886, P160, PAP2, Pol5" ENSG00000132382 "MYB binding protein 1a" Q9BQG0 17 4538897-4555386 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005466 Supported Supported Nucleoli,Vesicles No No 47000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli Vesicles "HPA005466: AB_2667327" "unprognostic (8.06e-2)" "unprognostic (2.33e-1)" "unprognostic (1.71e-1)" "unprognostic (9.01e-2)" "unprognostic (7.81e-2)" "unprognostic (1.29e-1)" "unprognostic (1.57e-3)" "unprognostic (2.22e-1)" "prognostic unfavorable (8.47e-4)" "unprognostic (1.84e-1)" "prognostic favorable (1.61e-4)" "unprognostic (3.88e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.78e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (8.12e-4)" "unprognostic (9.70e-2)" 12.3 11.0 3.8 13.4 3.8 11.4 15.9 1.3 7.6 13.3 0.8 11.9 9.6 14.6 4.6 17.0 15.2 6.2 11.0 5.0 4.2 9.8 10.8 11.4 13.8 5.2 4.9 14.1 24.4 6.7 12.7 5.2 3.5 17.1 5.1 3.8 18.9 10.1 27.9 22.0 12.9 7.3 2.1 14.0 12.4 8.1 3.4 7.4 11.2 8.0 8.7 14.9 13.8 3.8 60.1 90.0 11.9 56.2 15.4 17.1 40.8 39.8 17.5 39.5 30.8 67.1 24.4 80.4 47.2 23.9 19.8 74.2 50.1 61.3 19.0 40.3 133.8 38.8 58.3 62.2 25.2 45.5 34.7 25.7 34.6 58.8 29.1 11.0 26.6 45.0 64.2 37.1 18.2 51.4 54.2 19.5 56.0 19.1 48.0 69.8 19.7 54.0 9.8 45.5 25.5 48.5 40.8 29.7 28.2 8.6 27.5 19.1 34.3 35.1 31.5 32.7 118.6 32.1 26.5 34.4 32.5 53.9 45.3 0.0 1.9 0.3 2.8 1.6 3.4 2.9 2.3 3.1 2.9 1.7 2.5 2.8 0.1 2.4 3.4 2.1 1.0 2.7 3.8 3.8 1.3 7.6 5.0 4.2 5.2 4.9 3.5 2.1 3.4 3.8 13.4 9.6 14.5 4.6 13.1 12.9 6.8 7.1 12.0 8.2 12.9 14.4 4.1 8.6 13.3 3.7 12.5 2.9 5.8 9.2 0.0 7.7 0.5 6.7 15.3 17.0 11.4 7.2 11.3 12.7 5.4 10.2 10.7 8.5 5.1 12.2 8.6 7.8 6.5 10.1 6.1 8.0 4.1 4.5 6.8 0.6 5.6 6.3 3.6 7.5 3.8 3.8 6.2 3.5 6.5 8.2 4.5 12.0 13.7 13.9 4.6 3.2 12.2 6.2 6.6 10.8 12.9 2.6 11.1 12.8 11.9 1.1 9.7 13.8 12.4 6.2 NAA25 "C12orf30, FLJ13089" ENSG00000111300 "N-alpha-acetyltransferase 25, NatB auxiliary subunit" Q14CX7 12 112026689-112108796 "Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 146.0;Oligodendrocytes: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039322 Approved Supported "Golgi apparatus,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 9: Photoreceptor cells - Phototransduction" "Golgi apparatus, Cytosol" "HPA039322: AB_10697548" "unprognostic (1.26e-1)" "unprognostic (1.31e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.26e-4)" "unprognostic (1.91e-1)" "unprognostic (6.87e-2)" "prognostic unfavorable (5.53e-5)" "unprognostic (9.09e-3)" "unprognostic (3.24e-2)" "unprognostic (1.04e-1)" "unprognostic (2.06e-1)" "unprognostic (8.34e-2)" "prognostic unfavorable (1.32e-8)" "unprognostic (2.44e-2)" "unprognostic (2.01e-1)" "unprognostic (9.34e-2)" "unprognostic (9.18e-2)" 5.5 6.1 4.6 6.0 5.0 9.8 6.8 6.4 8.1 6.8 8.5 6.8 3.9 5.5 4.3 7.6 5.8 3.7 5.6 5.3 5.1 4.6 5.6 4.9 6.6 5.6 4.7 7.0 6.9 5.9 4.3 5.3 7.7 5.4 4.2 14.8 4.9 4.4 14.9 7.5 4.8 5.4 3.6 5.3 4.9 5.1 4.9 6.0 5.7 9.9 6.9 6.4 6.7 8.0 16.7 16.1 14.8 11.9 8.1 14.0 17.9 15.3 12.4 18.3 12.4 16.2 8.6 28.9 14.4 12.3 10.5 19.2 32.8 13.0 25.1 16.6 22.9 23.6 15.9 15.0 13.2 34.0 13.7 12.1 15.9 21.3 21.8 15.5 16.1 12.6 35.3 3.7 16.7 13.5 19.6 24.9 22.1 34.2 18.6 21.5 15.2 19.7 14.0 27.0 19.1 10.5 16.9 19.8 15.0 14.0 19.3 13.4 13.7 15.2 13.6 17.0 21.3 15.0 30.4 33.0 19.4 14.7 15.5 0.0 1.7 0.5 2.4 1.9 3.7 2.5 3.0 2.3 3.5 2.8 4.2 4.1 0.0 1.6 2.5 3.7 2.5 1.6 4.6 5.0 6.4 8.1 5.3 5.1 5.6 4.7 7.7 3.6 4.9 8.0 16.1 9.6 16.2 44.1 23.3 66.7 34.5 17.1 22.8 38.9 18.9 12.4 23.5 12.8 26.5 7.3 146.0 25.6 20.4 10.1 3.9 15.3 26.5 15.1 23.9 17.4 16.2 17.0 71.6 19.4 21.6 17.8 15.8 14.8 20.3 20.7 15.4 19.4 14.0 23.5 68.0 11.9 28.5 15.4 25.2 8.6 17.4 16.5 16.0 30.0 83.8 13.0 12.3 48.2 109.6 17.4 7.5 12.8 15.7 61.5 7.4 4.7 25.0 67.7 6.6 28.7 22.7 31.5 29.5 28.5 70.2 22.6 15.3 20.0 14.7 48.1 NAA30 "C14orf35, FLJ35355, MAK3, Mak3p, NAT12" ENSG00000139977 "N-alpha-acetyltransferase 30, NatC catalytic subunit" Q147X3 14 57390544-57415906 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 107.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057824 Uncertain Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "HPA057824: AB_2683539" "unprognostic (5.13e-2)" "unprognostic (7.59e-2)" "unprognostic (1.09e-1)" "unprognostic (1.52e-2)" "unprognostic (5.22e-2)" "unprognostic (6.31e-2)" "unprognostic (1.84e-2)" "unprognostic (5.44e-2)" "unprognostic (2.59e-1)" "unprognostic (1.12e-1)" "unprognostic (1.67e-1)" "unprognostic (5.21e-2)" "prognostic favorable (1.25e-8)" "unprognostic (1.77e-1)" "unprognostic (1.67e-1)" "unprognostic (5.75e-3)" "unprognostic (1.63e-1)" 9.6 7.7 9.7 7.2 11.3 15.0 9.6 10.6 11.8 7.8 6.5 8.4 9.9 9.1 7.1 11.3 7.4 7.1 14.2 11.6 11.6 12.4 16.7 6.4 9.0 8.6 9.3 14.9 9.0 12.5 5.7 13.4 9.2 10.1 7.9 12.0 8.0 10.1 31.8 8.3 8.7 10.1 9.3 8.3 7.0 18.5 12.4 9.0 10.6 27.3 9.1 8.2 6.0 9.4 19.4 18.2 10.2 16.7 16.8 21.9 17.1 22.1 21.3 16.5 15.0 16.5 13.9 14.1 19.0 18.4 12.5 20.1 18.5 14.3 27.4 24.7 9.4 11.4 10.1 14.5 17.5 23.1 12.8 15.0 20.7 15.0 24.9 18.4 25.8 17.3 11.3 13.6 22.1 22.1 19.5 13.4 11.0 17.8 20.0 15.3 29.4 11.0 16.9 17.4 21.8 11.5 18.7 18.3 23.0 18.2 23.6 11.9 22.7 25.7 27.0 14.2 14.3 10.1 13.2 16.9 17.1 11.5 18.7 0.8 0.4 0.2 1.2 0.9 1.2 1.0 1.1 1.8 0.3 1.1 1.2 1.2 0.2 2.4 2.8 0.6 1.7 0.4 9.7 11.3 10.6 11.8 11.6 11.6 8.6 9.3 9.2 9.3 12.4 9.4 11.8 9.6 6.3 10.1 16.7 41.0 11.8 8.6 25.0 13.5 16.5 10.9 34.9 17.2 8.0 3.7 18.8 18.3 20.1 11.6 9.8 12.5 107.1 9.0 13.1 17.0 21.0 9.0 20.3 11.6 15.6 13.1 12.8 10.8 7.0 14.9 11.0 25.5 9.9 10.1 20.3 13.7 6.1 13.2 12.1 37.6 13.7 8.2 23.2 10.3 9.9 13.3 8.2 16.6 18.9 14.5 13.8 13.5 18.1 18.9 13.6 17.9 9.5 15.3 19.7 13.3 15.4 69.2 20.5 25.5 41.2 22.2 17.0 13.3 12.6 16.7 NAB1 ENSG00000138386 "NGFI-A binding protein 1" Q13506 2 190646746-190692766 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal keratinocytes: 102.0;Suprabasal keratinocytes: 138.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002738 Uncertain Approved "Nucleoplasm,Golgi apparatus,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 20: HeLa - Mitochondria" "Cluster 28: Keratinocytes - Keratinization" "Nucleoplasm, Plasma membrane" "Golgi apparatus" "HPA002738: AB_1079447" "unprognostic (1.44e-1)" "unprognostic (2.65e-2)" "unprognostic (6.02e-3)" "unprognostic (4.04e-3)" "unprognostic (9.05e-2)" "unprognostic (9.45e-2)" "unprognostic (7.12e-3)" "unprognostic (6.41e-2)" "unprognostic (2.13e-2)" "unprognostic (1.79e-2)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.52e-1)" "unprognostic (7.23e-3)" "unprognostic (1.71e-1)" "unprognostic (1.90e-1)" "unprognostic (1.13e-1)" "unprognostic (3.85e-2)" 29.3 20.3 19.4 23.5 16.7 18.6 34.8 50.4 23.5 28.1 7.4 22.8 15.8 32.3 50.1 36.3 27.5 28.0 28.5 18.7 9.7 19.9 37.8 22.8 26.8 13.4 13.2 26.0 17.9 23.5 21.1 26.4 14.9 18.5 25.6 41.4 20.7 20.9 8.0 66.7 17.1 25.2 14.9 19.8 37.9 26.0 13.8 21.2 37.9 17.2 26.3 31.2 24.2 25.9 35.5 25.8 65.0 22.6 24.5 42.7 111.0 35.5 55.7 26.4 29.8 62.8 38.4 39.6 40.6 28.3 48.9 88.4 37.4 45.9 51.8 126.1 31.0 46.7 96.3 30.2 15.8 19.8 22.4 24.6 70.4 55.9 17.1 37.4 41.5 23.9 46.3 33.2 40.6 17.4 28.7 20.0 22.8 38.4 35.2 35.0 46.7 15.9 19.3 34.5 57.9 46.9 41.8 13.9 37.3 82.8 11.4 30.6 29.0 54.5 43.0 31.0 21.6 25.7 30.3 29.5 57.3 17.6 43.7 0.0 1.3 0.6 1.3 1.1 1.9 0.7 1.3 1.7 0.9 0.4 1.4 1.5 2.9 2.6 3.7 0.8 3.3 0.8 19.4 16.7 50.4 23.5 18.7 9.7 13.4 13.2 14.9 14.9 13.8 25.9 24.1 6.4 21.2 14.0 5.9 102.0 23.1 24.6 31.3 26.1 19.7 19.7 18.2 11.5 29.8 12.9 12.5 4.3 9.2 11.4 3.9 10.3 1.4 17.5 10.8 30.1 14.4 12.0 37.2 8.0 11.1 25.2 21.4 23.4 20.3 14.2 44.6 25.7 6.7 6.7 21.2 17.5 14.2 17.3 77.4 3.2 13.4 20.7 39.2 24.4 10.6 12.4 11.3 29.1 28.3 10.2 26.3 14.7 14.9 30.5 4.8 5.1 22.3 15.5 46.0 24.6 39.2 1.7 27.3 55.7 138.9 1.2 16.7 7.3 16.0 29.9 NAB2 MADER ENSG00000166886 "NGFI-A binding protein 2" Q15742 12 57089043-57095476 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Syncytiotrophoblasts: 56.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-MEL-30: 98.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004510, HPA027464" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 48: Smooth muscle cells - ECM organization" "Nucleoplasm, Cytosol" "CAB004510: AB_627982, HPA027464: AB_10601138" "prognostic favorable (7.41e-4)" "unprognostic (4.04e-2)" "unprognostic (2.20e-3)" "unprognostic (2.43e-2)" "unprognostic (4.74e-2)" "unprognostic (2.10e-1)" "unprognostic (1.88e-3)" "unprognostic (1.80e-1)" "unprognostic (5.85e-2)" "unprognostic (1.19e-1)" "unprognostic (2.13e-1)" "unprognostic (6.98e-2)" "prognostic unfavorable (9.38e-6)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (5.67e-3)" "unprognostic (6.19e-3)" 21.8 16.1 25.2 9.9 26.8 6.8 14.2 30.3 31.0 33.7 24.0 29.8 10.1 32.3 21.0 24.5 31.0 17.4 20.5 28.3 25.0 20.1 22.3 24.0 12.0 23.2 23.1 51.1 10.2 19.5 35.4 11.1 22.1 25.4 5.0 10.7 11.6 16.6 7.6 33.4 15.7 13.4 21.6 16.9 15.9 16.8 25.4 17.4 20.7 9.9 10.4 27.7 33.8 24.8 15.2 9.8 49.2 45.2 43.3 56.7 5.5 44.1 40.8 28.0 23.1 15.6 8.7 9.6 17.6 44.4 8.1 27.0 16.9 34.0 14.3 4.0 4.5 11.4 8.1 16.6 33.2 9.1 26.5 64.4 36.1 32.6 10.9 43.7 7.5 7.2 26.5 9.6 32.4 73.4 14.0 44.5 9.9 12.9 16.6 10.4 64.1 5.1 11.8 6.0 5.5 13.1 21.9 12.5 98.3 12.3 28.0 20.0 8.4 40.7 34.1 28.8 13.2 22.7 6.0 5.1 39.5 5.9 25.1 0.0 1.1 0.2 0.5 2.7 0.6 0.9 0.9 0.7 0.6 2.3 1.1 1.1 0.4 0.4 2.9 0.0 1.0 0.6 25.2 26.8 30.3 31.0 28.3 25.0 23.2 23.1 22.1 21.6 25.4 24.8 7.6 12.8 13.0 5.9 11.6 29.6 19.5 23.4 39.3 20.3 17.3 13.8 2.9 2.8 13.6 9.2 2.1 3.7 4.9 1.1 7.9 7.4 0.6 22.9 21.2 13.7 6.6 4.8 11.4 1.4 10.5 19.7 8.6 25.4 17.1 7.8 18.2 17.1 11.2 10.1 5.4 1.1 10.2 16.3 43.7 2.9 19.6 14.3 21.4 8.4 1.6 7.9 1.0 1.0 1.9 4.1 0.0 18.8 8.7 12.9 8.7 5.6 5.9 4.4 19.7 9.8 16.3 2.6 18.7 23.4 32.5 56.2 10.7 2.5 1.5 8.6 NANP "C20orf147, dJ694B14.3, HDHD4, MGC26833" ENSG00000170191 "N-acetylneuraminic acid phosphatase" Q8TBE9 20 25612935-25624014 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050342 Uncertain Approved "Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" "Nuclear membrane" "HPA050342: AB_2681098" "unprognostic (8.72e-2)" "unprognostic (1.88e-1)" "unprognostic (7.42e-3)" "unprognostic (6.01e-2)" "unprognostic (5.59e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (9.01e-6)" "unprognostic (3.20e-1)" "unprognostic (3.75e-2)" "unprognostic (7.70e-3)" "unprognostic (1.24e-1)" "unprognostic (3.46e-1)" "unprognostic (2.07e-2)" "unprognostic (1.11e-1)" "unprognostic (1.76e-1)" "unprognostic (1.71e-2)" "unprognostic (9.42e-2)" 3.3 3.8 1.4 2.6 1.4 3.4 3.0 2.8 1.4 2.3 1.7 2.1 2.9 2.3 2.4 2.8 2.1 2.5 2.5 1.3 1.8 4.4 4.8 2.4 2.0 1.3 1.5 2.7 3.2 2.8 1.5 2.6 1.4 2.3 2.5 2.9 2.1 1.9 1.7 2.0 2.0 2.8 1.1 1.9 2.3 2.8 1.7 4.9 3.0 3.7 2.4 2.9 1.9 1.4 14.2 8.5 6.7 9.4 10.7 11.0 9.5 7.1 13.9 9.3 11.8 7.4 9.7 4.9 7.9 13.6 11.0 8.9 10.6 10.7 17.9 1.7 5.9 13.3 3.8 20.1 9.1 10.0 3.7 9.9 5.1 10.7 13.6 5.1 8.2 17.8 11.1 8.5 11.7 8.0 19.4 4.8 4.8 12.6 12.6 9.3 14.1 6.4 5.7 7.7 12.6 5.2 8.0 12.7 8.7 6.6 5.3 8.5 6.8 14.5 10.9 13.6 10.2 4.3 4.1 12.4 4.3 22.7 9.1 0.3 2.3 0.9 1.3 2.4 2.0 0.6 0.9 1.0 3.3 0.6 0.8 1.4 0.3 2.2 1.4 0.7 0.8 1.1 1.4 1.4 2.8 1.4 1.3 1.8 1.3 1.5 1.4 1.1 1.7 1.4 3.6 3.2 1.5 4.2 1.9 5.9 5.8 4.6 2.8 4.5 3.0 2.3 2.8 5.7 3.6 7.3 0.0 4.1 5.2 1.7 13.7 5.2 0.3 2.0 4.7 4.4 3.0 16.0 3.3 4.2 2.1 4.9 4.6 2.0 5.7 3.4 3.6 5.3 4.6 6.7 3.6 2.3 6.1 4.1 4.8 0.8 3.1 2.8 5.4 1.9 2.4 5.5 9.2 2.5 2.3 4.8 2.0 2.6 3.5 5.1 1.8 8.2 2.1 7.3 0.0 4.6 3.4 5.5 11.3 2.6 5.1 1.9 1.9 7.4 2.2 3.1 NARS2 "DFNB94, FLJ23441, SLM5" ENSG00000137513 "Asparaginyl-tRNA synthetase 2, mitochondrial" Q96I59 11 78435968-78574874 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Deafness, Disease variant, Leigh syndrome, Non-syndromic deafness, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026793 Supported Approved Nucleoplasm,Mitochondria,Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Mitochondria" Cytosol "HPA026793: AB_1848833" "unprognostic (1.80e-1)" "unprognostic (1.95e-1)" "unprognostic (5.73e-3)" "unprognostic (1.79e-3)" "unprognostic (1.40e-2)" "unprognostic (2.05e-1)" "unprognostic (1.28e-1)" "unprognostic (5.62e-2)" "unprognostic (4.62e-3)" "prognostic favorable (1.39e-5)" "unprognostic (1.96e-1)" "unprognostic (1.56e-1)" "prognostic favorable (1.22e-6)" "unprognostic (8.57e-2)" "unprognostic (1.45e-1)" "unprognostic (2.93e-1)" "unprognostic (1.60e-1)" 7.3 11.9 10.7 6.8 12.3 6.2 11.1 12.4 13.3 9.6 19.8 11.3 10.3 9.1 11.2 8.1 9.9 7.0 11.7 10.4 11.7 19.0 23.5 7.6 9.6 11.7 13.9 11.4 10.6 11.4 7.6 8.0 13.1 10.8 10.9 13.4 10.7 7.3 23.5 7.2 9.7 7.4 11.3 7.4 9.9 7.5 11.4 11.7 11.5 19.6 9.7 8.7 8.1 12.3 16.7 22.8 23.5 15.4 16.1 13.5 19.5 13.5 13.1 20.6 16.9 39.4 17.4 40.9 34.1 8.7 19.8 21.5 39.9 26.3 28.3 27.0 21.3 28.9 17.3 33.7 13.3 31.3 10.1 9.4 16.8 18.1 32.0 18.3 17.9 33.7 44.5 11.0 23.1 19.4 32.7 50.3 25.6 67.3 27.3 33.6 38.2 55.5 27.2 23.0 27.8 17.5 20.1 25.4 35.5 25.1 24.1 12.3 10.9 27.7 32.8 32.0 23.1 18.1 33.1 91.1 5.4 27.7 19.2 9.5 9.3 4.4 11.1 10.4 13.8 17.6 12.8 12.5 16.6 15.0 18.5 16.7 2.0 20.3 12.8 12.7 10.5 10.3 10.7 12.3 12.4 13.3 10.4 11.7 11.7 13.9 13.1 11.3 11.4 12.3 5.8 19.2 26.4 27.7 14.5 13.5 14.2 12.0 12.5 5.2 9.4 6.5 8.8 5.7 10.3 5.5 2.1 20.0 4.4 4.0 29.4 9.5 13.1 10.1 7.4 6.6 12.0 9.2 34.7 7.3 23.6 9.0 10.2 9.0 8.2 14.0 2.5 19.8 12.4 0.0 45.1 8.3 22.4 6.3 11.6 5.4 7.8 6.3 17.8 45.0 2.9 6.3 4.1 42.7 47.7 7.5 9.9 4.9 14.6 17.5 7.0 28.9 10.2 9.0 6.6 7.5 8.8 8.6 19.5 12.0 13.8 15.3 7.8 9.0 14.6 10.7 NAT10 "FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43" ENSG00000135372 "N-acetyltransferase 10" Q9H0A0 11 34105617-34147670 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB035546, HPA057576, HPA071628" Approved Enhanced Nucleoli,Midbody Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoli Midbody "CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426" "unprognostic (3.04e-1)" "unprognostic (9.24e-2)" "unprognostic (2.46e-1)" "unprognostic (1.14e-1)" "unprognostic (1.92e-2)" "prognostic unfavorable (1.07e-4)" "prognostic unfavorable (9.61e-8)" "unprognostic (1.15e-1)" "unprognostic (2.57e-1)" "unprognostic (2.24e-1)" "unprognostic (1.12e-2)" "unprognostic (2.25e-1)" "prognostic unfavorable (8.83e-5)" "unprognostic (1.24e-1)" "unprognostic (7.18e-2)" "unprognostic (9.55e-2)" "unprognostic (8.69e-2)" 20.6 24.2 16.0 17.3 15.4 20.4 19.6 14.7 17.4 20.1 14.0 17.0 10.2 20.0 13.7 25.7 19.2 9.4 18.4 15.1 15.4 19.5 22.3 14.9 23.4 14.3 13.6 23.1 25.3 16.8 17.5 15.1 14.7 19.4 15.5 16.3 16.7 12.2 24.8 28.9 17.5 15.5 12.6 22.8 18.7 22.0 15.6 19.4 17.2 12.5 27.5 20.3 20.5 16.9 40.0 55.5 29.3 62.0 34.2 30.2 33.6 38.8 28.5 48.4 38.4 62.6 22.6 127.6 28.3 33.0 41.8 59.5 110.5 59.4 59.5 35.9 70.2 58.0 44.5 58.9 31.0 147.3 40.7 31.1 40.0 31.5 88.3 22.8 37.4 60.6 128.6 43.5 40.8 76.0 120.5 65.7 41.9 69.3 65.7 89.3 98.0 53.7 27.8 68.5 43.1 32.6 52.3 54.9 23.6 28.2 55.0 41.0 30.5 42.8 34.0 63.7 72.8 47.0 61.0 120.3 43.3 60.0 43.4 0.7 8.3 2.8 11.7 13.7 15.5 12.2 12.6 13.4 15.5 10.6 12.7 13.2 0.9 15.0 12.9 11.6 12.0 9.1 16.0 15.4 14.7 17.4 15.1 15.4 14.3 13.6 14.7 12.6 15.6 16.9 8.5 6.4 20.7 10.4 12.7 12.2 11.3 6.9 12.5 12.2 8.8 10.2 12.6 7.2 15.1 14.7 12.5 18.1 8.0 5.8 5.9 9.2 6.1 10.1 18.3 10.9 7.2 21.0 22.8 9.6 13.4 14.5 5.6 12.2 5.1 17.3 5.7 7.5 12.0 11.8 21.7 8.9 4.1 5.5 4.4 3.4 9.3 8.5 1.8 6.5 12.9 5.3 7.2 11.6 16.0 8.7 3.5 13.2 9.8 14.8 3.7 5.8 10.6 11.0 13.1 19.6 8.4 20.5 21.6 13.1 13.8 14.4 11.0 19.7 14.3 7.6 NBAS NAG ENSG00000151779 "NBAS subunit of NRZ tethering complex" A2RRP1 2 15166914-15561334 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Transport" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 217.8;Inhibitory neurons: 187.9;Oligodendrocyte precursor cells: 159.3;Oligodendrocytes: 159.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036817 Approved Approved "Nuclear membrane,Nucleoli,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Golgi apparatus" "Nuclear membrane, Nucleoli" "HPA036817: AB_10670925" "unprognostic (1.72e-1)" "unprognostic (1.69e-1)" "unprognostic (1.22e-1)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.10e-4)" "unprognostic (3.80e-2)" "unprognostic (4.16e-2)" "unprognostic (1.33e-1)" "unprognostic (1.55e-1)" "unprognostic (1.53e-2)" "unprognostic (1.17e-2)" "unprognostic (1.36e-1)" "unprognostic (2.56e-1)" "unprognostic (2.65e-1)" "prognostic unfavorable (5.84e-5)" 16.8 21.0 37.4 7.2 38.8 16.1 15.9 37.7 42.7 18.8 35.7 22.7 8.2 18.4 13.7 17.2 18.8 8.1 38.3 37.2 36.3 19.9 21.6 15.8 9.4 37.0 35.2 22.5 34.4 16.3 29.6 10.1 38.7 19.0 10.5 13.4 15.4 10.4 30.5 21.8 20.1 11.8 34.4 21.1 24.5 41.2 37.2 14.5 17.4 17.7 9.1 19.7 16.5 38.1 10.5 13.7 14.8 10.7 37.8 41.5 15.2 19.1 20.8 14.5 14.6 13.8 15.0 13.4 4.3 29.3 15.1 12.5 16.5 23.9 17.2 13.5 10.4 51.3 11.5 38.8 38.8 13.4 25.1 27.3 18.9 19.2 32.8 30.2 30.4 18.7 40.6 15.0 22.4 13.0 11.2 30.1 12.8 17.1 12.8 11.7 26.0 16.2 30.5 14.0 8.7 14.2 16.2 13.4 25.2 18.3 9.4 12.0 26.6 18.5 11.2 13.5 13.9 22.1 20.3 18.7 33.1 15.5 16.8 1.5 4.4 2.5 5.7 3.1 6.7 4.1 4.2 7.3 4.0 3.4 4.2 4.3 0.8 7.2 7.5 4.5 5.3 2.9 37.4 38.8 37.7 42.7 37.2 36.3 37.0 35.2 38.7 34.4 37.2 38.1 16.1 19.2 13.8 96.6 15.1 7.4 9.3 11.9 12.0 17.3 11.7 9.4 32.3 17.2 13.8 18.4 29.2 11.5 15.1 9.4 0.0 11.1 39.3 22.2 21.3 14.6 7.3 38.7 217.8 14.0 13.1 13.4 20.9 14.8 38.6 30.2 8.9 9.1 9.0 13.5 187.9 14.8 10.2 6.9 8.0 61.9 11.5 11.6 5.4 106.8 18.4 12.5 9.2 159.3 159.2 8.6 9.5 16.6 27.2 9.2 39.3 8.5 26.0 25.5 0.0 24.7 16.3 33.7 22.4 12.9 11.2 10.4 19.9 70.0 12.5 7.6 NCAPG2 "CAP-G2, FLJ20311, hCAP-G2, LUZP5, MTB" ENSG00000146918 "Non-SMC condensin II complex subunit G2" Q86XI2 7 158631169-158704804 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.4;lymphoid tissue: 27.9" "Cell type enhanced" "Detected in many" "Spermatocytes: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026631, HPA049637" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm "Nuclear speckles" "HPA026631: AB_1845983, HPA049637: " "unprognostic (2.73e-2)" "unprognostic (1.77e-1)" "unprognostic (6.81e-2)" "prognostic unfavorable (7.94e-4)" "unprognostic (1.66e-1)" "prognostic favorable (1.91e-4)" "prognostic unfavorable (3.00e-5)" "unprognostic (5.33e-3)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.79e-2)" "prognostic unfavorable (8.50e-4)" "unprognostic (5.19e-2)" "prognostic unfavorable (4.06e-5)" "unprognostic (2.58e-3)" "unprognostic (1.28e-1)" "unprognostic (8.21e-2)" "unprognostic (7.37e-2)" 3.7 2.5 2.0 8.8 2.2 24.4 5.4 2.5 2.1 4.0 1.3 6.9 4.4 4.3 2.1 6.9 3.0 2.9 2.9 2.2 2.1 2.6 4.1 3.1 12.4 2.0 1.7 3.1 2.2 4.6 3.5 5.9 2.1 2.8 7.6 2.8 3.5 2.8 3.4 6.8 5.8 4.8 1.6 4.6 5.6 14.8 1.8 27.9 3.2 4.1 13.8 4.0 3.9 2.4 103.9 53.7 64.1 41.8 9.5 15.4 25.3 74.3 47.4 89.0 99.0 48.5 52.0 64.0 45.0 30.3 95.1 51.7 53.7 33.8 117.2 68.4 40.4 57.2 64.8 38.8 4.2 72.2 62.3 6.8 3.7 73.1 21.0 16.2 50.4 72.9 71.9 91.6 82.8 111.4 119.2 48.8 63.7 58.8 43.3 69.7 67.8 60.6 22.6 45.9 69.6 54.5 91.6 35.0 20.2 40.4 31.4 46.5 25.9 60.6 45.9 166.2 120.6 61.3 48.2 77.2 64.6 89.6 118.5 5.9 0.9 1.1 5.2 1.2 7.5 1.6 5.2 3.6 2.3 1.0 1.6 1.8 0.7 5.2 5.1 1.1 7.2 2.2 2.0 2.2 2.5 2.1 2.2 2.1 2.0 1.7 2.1 1.6 1.8 2.4 3.6 6.4 1.5 3.9 4.1 4.0 2.1 2.8 1.8 3.9 3.7 3.3 4.8 2.8 4.6 1.8 0.0 6.7 5.1 3.4 0.0 2.3 15.1 4.0 4.6 4.3 0.0 19.6 10.7 3.3 10.4 4.5 4.1 5.9 1.3 12.6 2.9 2.6 7.3 8.4 7.2 2.9 2.0 3.8 5.2 7.2 2.8 4.4 1.8 3.7 2.7 2.1 2.1 10.1 10.7 2.3 0.4 4.1 11.0 1.1 0.3 1.3 6.0 2.8 6.6 4.3 5.7 48.2 18.5 6.1 2.0 2.6 4.9 5.0 5.7 3.0 NCBP1 "CBP80, NCBP, Sto1" ENSG00000136937 "Nuclear cap binding protein subunit 1" Q09161 9 97633668-97673748 "Predicted intracellular proteins, Transporters" "mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042411, HPA049031" Enhanced Supported Nucleoplasm,Cytosol NA NA 25000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 59: Non-specific - Transcription" Cytosol Nucleoplasm "HPA042411: AB_2677985, HPA049031: AB_2680606" "unprognostic (4.76e-3)" "unprognostic (2.16e-1)" "prognostic favorable (5.28e-4)" "unprognostic (4.63e-2)" "unprognostic (2.19e-1)" "unprognostic (1.13e-1)" "unprognostic (2.14e-3)" "unprognostic (1.53e-2)" "unprognostic (3.26e-2)" "unprognostic (9.46e-2)" "unprognostic (3.16e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.11e-2)" "unprognostic (3.84e-1)" "unprognostic (1.61e-1)" "unprognostic (1.17e-1)" "unprognostic (7.04e-2)" 10.9 11.0 11.9 16.0 13.7 29.5 11.7 28.3 13.6 10.5 13.7 15.4 12.7 11.7 10.0 12.3 8.8 11.4 12.2 11.8 11.8 11.0 16.6 9.7 19.8 11.6 11.1 12.7 13.2 10.1 10.5 14.6 11.7 12.2 17.9 30.6 10.8 10.2 18.7 15.8 12.6 11.4 11.2 13.3 13.0 16.9 10.9 21.3 15.7 14.9 18.7 14.0 10.6 17.4 57.7 40.6 44.2 41.0 30.8 30.9 41.6 41.2 25.9 40.1 37.4 54.7 30.2 49.0 17.9 41.1 38.5 62.1 72.3 51.6 57.3 33.8 22.2 45.8 58.5 34.4 30.0 60.8 43.2 23.5 25.0 47.3 35.8 28.5 42.4 35.4 68.6 27.0 68.5 43.5 44.3 33.5 46.4 85.4 39.8 41.9 100.4 20.4 33.0 42.9 55.2 35.4 44.2 38.5 23.5 37.9 23.7 38.7 35.2 31.1 28.0 61.9 44.5 21.7 34.3 25.7 27.3 48.6 40.9 14.0 10.0 9.4 7.2 13.4 8.0 5.3 7.7 7.2 12.7 6.5 6.6 8.0 2.9 12.7 13.9 4.5 7.9 7.4 11.9 13.7 28.3 13.6 11.8 11.8 11.6 11.1 11.7 11.2 10.9 17.4 9.8 6.4 11.1 34.9 13.9 13.6 6.8 9.3 13.1 21.9 7.9 5.6 23.4 10.0 13.7 9.2 20.9 13.7 9.7 16.0 3.9 8.9 20.3 12.2 16.7 10.4 9.1 21.4 26.1 6.9 15.0 11.7 17.3 13.2 8.2 12.8 7.1 16.5 11.3 21.9 25.5 12.1 14.2 12.0 9.6 9.8 6.5 12.0 5.4 12.2 15.8 8.9 11.3 20.1 24.4 9.7 7.8 7.5 15.9 7.9 9.0 5.3 15.1 23.4 6.6 10.4 11.2 29.4 14.1 14.3 7.4 14.4 15.0 9.5 10.9 8.4 NCBP2 "Cbc2, CBP20, NIP1" ENSG00000114503 "Nuclear cap binding protein subunit 2" P52298 3 196935402-196942594 "Predicted intracellular proteins, Transporters" "mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044850, HPA062483" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA044850: AB_10961012, HPA062483: AB_2684779" "unprognostic (1.82e-2)" "unprognostic (1.09e-1)" "unprognostic (4.04e-2)" "unprognostic (5.12e-3)" "unprognostic (3.17e-1)" "unprognostic (5.13e-3)" "prognostic unfavorable (2.37e-7)" "unprognostic (2.86e-2)" "unprognostic (9.63e-2)" "unprognostic (1.83e-1)" "prognostic unfavorable (4.75e-4)" "prognostic unfavorable (2.27e-4)" "unprognostic (3.28e-3)" "unprognostic (6.38e-2)" "unprognostic (1.97e-1)" "unprognostic (4.30e-2)" "unprognostic (5.04e-3)" 38.3 44.0 40.3 38.7 41.4 17.2 36.0 39.7 46.6 34.5 38.6 35.4 29.4 32.6 41.1 29.0 30.1 28.8 31.3 41.5 45.8 41.7 30.1 27.1 43.5 42.7 42.1 35.7 25.7 38.2 26.0 33.9 42.3 36.4 35.2 46.2 24.4 35.5 38.6 27.2 27.8 33.8 43.6 34.2 29.6 25.8 43.8 49.9 37.7 38.6 42.2 45.6 26.1 43.1 144.3 44.6 105.5 131.8 118.6 102.8 74.1 106.1 80.9 66.4 69.7 99.5 51.2 97.0 229.7 76.3 85.4 84.6 136.1 113.0 104.7 50.8 85.0 125.2 55.3 87.5 103.9 146.4 85.3 84.1 101.2 48.7 134.1 99.5 104.3 103.2 71.6 99.7 113.7 165.5 111.3 88.4 134.5 137.2 139.5 86.9 78.6 92.9 99.3 101.9 57.3 153.1 63.8 126.4 189.4 85.4 279.1 112.4 97.5 67.1 71.4 85.0 193.0 155.6 149.4 162.1 93.8 162.5 103.2 9.9 37.7 20.9 37.5 44.5 56.6 53.2 46.2 44.8 40.1 43.5 52.8 48.1 4.0 43.1 47.0 32.2 45.0 40.4 40.3 41.4 39.7 46.6 41.5 45.8 42.7 42.1 42.3 43.6 43.8 43.1 38.5 25.6 43.5 9.1 71.1 52.5 83.6 55.9 36.5 55.7 48.9 36.8 40.5 25.8 51.6 42.3 58.4 59.1 58.9 44.0 97.8 64.3 116.2 39.5 66.6 50.2 45.0 35.1 12.8 49.8 81.8 47.1 30.5 35.9 52.6 54.7 30.0 31.1 65.4 45.4 14.0 44.9 54.9 54.1 60.7 66.2 37.6 38.6 32.0 2.8 68.2 91.0 51.5 10.6 10.4 69.1 45.9 51.6 42.0 81.9 37.0 82.5 44.6 60.3 26.3 40.9 51.3 52.9 59.5 33.5 44.8 53.2 49.8 58.8 52.1 84.2 NCL "C23, Nsr1" ENSG00000115053 Nucleolin P19338 2 231453531-231483641 "Plasma proteins, Predicted intracellular proteins" "DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004210, HPA023981, HPA071110" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 1400000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli, Nucleoli rim" "Mitotic chromosome" "CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: " "unprognostic (1.91e-1)" "unprognostic (2.53e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.28e-4)" "unprognostic (1.63e-2)" "unprognostic (2.72e-3)" "prognostic unfavorable (1.41e-6)" "unprognostic (3.74e-2)" "unprognostic (4.31e-3)" "unprognostic (9.78e-2)" "unprognostic (6.70e-3)" "unprognostic (6.07e-2)" "unprognostic (1.66e-2)" "unprognostic (2.57e-2)" "unprognostic (9.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.42e-2)" 212.0 192.8 128.8 226.0 146.3 301.4 228.7 129.1 139.6 180.0 114.1 183.6 160.7 205.2 150.2 228.8 173.2 132.2 164.3 115.9 152.3 166.2 218.5 147.4 289.7 148.8 141.5 258.2 209.0 258.9 115.9 203.4 140.4 155.4 219.2 147.1 157.0 160.9 350.9 197.1 157.4 201.0 137.9 176.3 164.7 126.2 142.1 347.0 198.4 228.2 329.0 271.1 169.1 143.9 718.3 691.8 715.7 640.1 485.7 592.0 823.0 790.4 497.2 690.8 628.2 1227.4 521.4 1083.7 608.6 651.0 892.6 719.5 1614.4 1059.9 1284.7 554.6 644.0 1587.3 605.9 1749.5 544.0 1930.4 632.7 513.5 613.2 872.3 1019.6 394.9 834.2 770.5 1745.4 378.6 760.5 1176.4 1443.2 1086.7 1202.0 728.7 435.9 1290.8 1452.0 918.4 583.8 959.9 749.0 502.0 555.8 704.5 706.9 625.7 476.8 985.3 686.3 611.4 626.7 714.5 1063.7 624.3 554.5 1885.9 467.2 1173.1 685.2 27.3 95.6 62.5 136.5 100.3 152.8 113.5 118.4 121.9 130.6 111.9 130.3 114.2 16.8 177.8 121.7 102.0 102.3 151.0 128.8 146.3 129.1 139.6 115.9 152.3 148.8 141.5 140.4 137.9 142.1 143.9 286.2 291.7 411.7 8.1 468.9 459.9 633.8 241.0 644.9 145.0 315.2 303.8 320.9 147.3 401.6 195.0 47.9 386.9 596.2 215.0 230.9 294.4 20.6 348.7 669.8 291.1 200.0 419.2 9.3 254.4 444.6 370.9 292.0 421.8 451.7 262.7 130.6 242.0 239.5 80.8 10.4 319.6 156.6 133.7 231.1 32.2 217.2 281.8 165.4 10.3 268.9 199.6 346.1 14.1 14.9 268.0 153.9 159.9 543.5 651.1 120.1 277.6 250.3 141.0 151.2 548.9 442.0 433.3 532.4 707.9 441.4 379.0 454.0 442.6 380.6 449.1 NDUFAF2 "B17.2L, mimitin, MMTN, NDUFA12L" ENSG00000164182 "NADH:ubiquinone oxidoreductase complex assembly factor 2" Q8N183 5 60945177-61154531 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA048082, HPA054776" Supported Enhanced Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 47: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA048082: AB_2680254, HPA054776: AB_2682598" "unprognostic (7.28e-2)" "unprognostic (6.83e-2)" "unprognostic (1.37e-1)" "unprognostic (2.46e-3)" "unprognostic (2.41e-2)" "unprognostic (2.74e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.06e-1)" "unprognostic (4.76e-2)" "unprognostic (8.40e-3)" "unprognostic (1.28e-1)" "unprognostic (2.71e-1)" "prognostic unfavorable (2.49e-4)" "unprognostic (1.79e-2)" "unprognostic (6.10e-2)" "unprognostic (2.37e-1)" "unprognostic (4.66e-2)" 42.7 39.2 34.8 23.3 35.7 18.0 38.5 34.6 56.0 34.7 33.0 48.3 21.0 31.6 17.5 36.4 31.3 17.0 57.7 34.8 37.5 37.4 32.2 24.9 19.7 36.2 37.9 37.7 35.7 31.2 45.1 14.5 37.3 31.9 26.2 22.0 25.8 23.0 80.2 22.6 24.9 25.9 34.4 18.3 35.9 31.2 35.4 13.0 23.0 46.5 18.8 43.4 33.4 35.0 109.0 51.9 41.6 129.1 80.7 113.8 70.3 129.8 71.1 85.2 103.7 99.4 84.0 150.8 127.5 91.2 141.2 44.2 72.6 113.8 103.6 66.0 104.3 52.1 95.7 99.4 115.6 72.5 26.2 59.7 119.2 74.9 226.0 53.9 74.7 64.0 79.5 76.3 90.9 89.6 64.2 108.0 35.3 41.2 135.0 77.3 115.1 192.7 83.1 46.1 84.8 33.0 74.7 72.7 136.0 35.8 86.1 40.4 68.6 55.5 82.8 125.3 134.2 46.0 73.2 170.8 75.9 123.2 66.3 0.4 18.3 2.4 17.3 19.1 21.1 23.0 22.3 21.1 32.1 15.2 18.6 20.1 0.8 27.1 15.8 11.0 31.7 12.2 34.8 35.7 34.6 56.0 34.8 37.5 36.2 37.9 37.3 34.4 35.4 35.0 40.8 12.8 28.0 23.8 32.8 60.5 64.6 62.2 34.1 27.9 47.9 59.8 87.6 45.8 39.6 38.6 12.5 20.8 18.7 29.8 93.9 55.1 175.7 41.8 95.1 35.8 24.7 28.8 62.2 56.6 49.2 60.4 28.5 40.3 20.3 27.2 31.8 94.6 51.4 42.1 68.8 59.3 40.7 29.5 59.1 22.2 76.7 29.0 44.4 40.3 24.7 34.0 22.6 61.9 71.3 69.8 52.2 62.1 29.0 144.1 32.2 151.4 25.9 29.1 26.3 55.2 60.1 108.4 73.9 63.0 63.6 14.2 34.0 48.5 65.7 71.1 NDUFV1 CI-51K ENSG00000167792 "NADH:ubiquinone oxidoreductase core subunit V1" P49821 11 67605653-67612554 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Electron transport, Respiratory chain, Transport" "Oxidoreductase, Translocase" "Disease variant, Leigh syndrome, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 526.2" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 482.4;Proximal tubular cells: 499.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045211, HPA075051" Enhanced Supported Mitochondria,Cytosol No No 37000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Cytosol "HPA045211: AB_10962830, HPA075051: AB_2686732" "unprognostic (4.57e-2)" "unprognostic (2.17e-2)" "unprognostic (2.84e-1)" "unprognostic (7.07e-2)" "unprognostic (1.54e-1)" "unprognostic (4.54e-3)" "unprognostic (1.19e-1)" "unprognostic (3.31e-2)" "unprognostic (2.19e-1)" "unprognostic (4.95e-2)" "unprognostic (4.02e-2)" "unprognostic (3.03e-2)" "prognostic favorable (7.49e-10)" "unprognostic (1.12e-2)" "unprognostic (1.80e-1)" "unprognostic (2.12e-1)" "unprognostic (1.16e-1)" 95.0 126.5 87.6 52.5 93.7 72.5 90.9 105.6 107.1 93.9 104.8 142.3 124.5 85.2 33.8 114.0 84.6 47.1 400.2 91.6 97.0 188.4 187.0 77.1 66.7 103.3 91.5 101.9 117.2 169.8 84.5 46.7 110.4 77.4 73.7 81.6 90.2 73.2 526.2 117.7 96.6 51.1 86.9 98.8 132.0 76.0 104.9 51.6 107.6 440.5 62.8 88.1 88.6 99.9 132.9 133.6 68.8 141.3 85.6 83.4 130.6 84.1 76.4 122.2 82.6 256.8 155.3 241.9 167.3 69.2 99.7 176.8 146.1 126.4 38.4 125.2 114.9 100.0 189.1 127.9 119.0 136.9 106.9 126.7 119.0 100.4 88.0 76.9 109.3 173.9 180.9 192.6 75.8 190.2 163.1 268.0 68.5 295.3 168.8 184.5 135.8 399.1 99.3 95.3 109.9 104.6 104.3 347.4 275.3 46.0 177.4 138.0 90.7 118.9 88.8 172.3 87.5 187.7 116.8 122.6 138.0 144.6 117.7 39.0 72.8 38.1 65.1 83.4 71.6 59.8 55.0 63.2 110.7 60.1 50.2 63.7 13.1 104.0 51.2 73.0 78.1 77.0 87.6 93.7 105.6 107.1 91.6 97.0 103.3 91.5 110.4 86.9 104.9 99.9 54.6 60.9 75.0 33.3 76.2 80.3 95.9 187.6 77.4 68.7 82.1 94.4 482.4 61.5 120.7 86.5 50.1 203.5 72.8 235.7 397.2 114.9 74.0 43.1 47.5 56.7 98.5 85.0 32.9 112.1 158.8 82.4 137.1 55.2 61.4 99.6 56.4 136.2 136.5 63.9 36.5 155.9 152.5 68.8 81.4 222.7 65.6 68.4 113.8 13.1 81.0 89.3 60.8 19.1 34.6 70.1 122.8 59.0 146.6 55.0 199.4 499.2 80.3 78.5 46.0 90.8 136.9 100.7 83.3 127.0 80.6 189.1 79.3 145.9 274.8 111.7 NECAB3 "APBA2BP, dJ63M2.4, dJ63M2.5, EFCBP3, NIP1, SYTIP2, XB51" ENSG00000125967 "N-terminal EF-hand calcium binding protein 3" Q96P71 20 33657087-33674463 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 93.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044785, HPA070595, HPA071786" Supported Supported "Golgi apparatus" "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 45: Enterocytes - Digestion" "Golgi apparatus" "HPA044785: AB_2679086, HPA070595: AB_2732158, HPA071786: AB_2732186" "unprognostic (8.95e-2)" "unprognostic (1.45e-1)" "unprognostic (1.89e-2)" "prognostic unfavorable (9.57e-4)" "unprognostic (1.44e-1)" "unprognostic (4.05e-2)" "unprognostic (1.17e-1)" "unprognostic (1.80e-2)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "prognostic favorable (3.19e-5)" "unprognostic (3.13e-2)" "prognostic unfavorable (7.81e-4)" "unprognostic (6.13e-2)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (1.82e-1)" 10.2 55.9 20.1 2.2 21.2 1.5 10.4 18.9 33.9 11.8 20.4 14.4 13.6 9.1 6.9 8.9 10.9 4.5 45.7 21.7 21.2 13.3 13.3 11.1 2.3 23.3 19.1 41.2 19.1 17.5 10.3 3.9 24.4 27.2 4.4 6.5 13.6 7.8 60.3 6.9 10.6 3.7 16.6 6.5 30.5 10.6 23.2 1.9 19.2 31.7 1.7 14.6 10.0 22.3 8.2 7.1 5.1 10.5 4.0 7.8 24.6 11.2 4.2 7.1 6.2 33.2 5.3 9.1 26.2 6.6 16.7 9.7 5.3 3.3 2.6 3.2 7.7 8.7 30.7 39.3 10.5 2.1 8.0 9.7 4.8 6.6 2.1 7.6 4.8 4.8 12.6 4.8 9.3 12.5 3.3 8.6 2.2 8.7 17.5 9.7 13.3 15.9 6.6 6.1 32.4 9.0 26.1 28.7 12.0 5.6 36.6 10.4 4.0 8.6 12.4 11.3 12.7 17.7 7.8 17.1 16.9 4.0 3.8 0.0 1.3 1.8 0.3 1.3 0.9 0.2 0.6 0.3 1.2 0.9 0.4 0.1 0.0 1.2 3.5 0.0 1.6 0.6 20.1 21.2 18.9 33.9 21.7 21.2 23.3 19.1 24.4 16.6 23.2 22.3 5.4 16.0 45.5 14.7 4.1 3.1 6.5 2.7 8.6 19.4 20.5 11.6 29.9 10.0 5.9 5.5 8.4 20.6 3.8 22.5 33.2 3.7 93.1 5.7 7.2 2.4 19.9 4.0 13.0 7.5 26.1 12.5 26.5 5.4 3.8 14.0 2.2 9.1 8.9 8.4 14.5 16.2 4.1 6.0 6.2 54.0 26.4 5.5 12.4 1.0 3.6 18.2 2.1 6.0 4.5 4.4 15.1 23.7 11.7 14.2 45.9 12.2 3.8 20.8 6.6 9.2 12.1 20.5 20.6 9.3 3.1 20.7 5.4 23.9 20.0 10.0 NELFCD "HSPC130, NELF-C, NELF-D, TH1, TH1L" ENSG00000101158 "Negative elongation factor complex member C/D" Q8IXH7 20 58981208-58995133 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050641, HPA066262, HPA074936" Enhanced Supported "Nucleoplasm,Nuclear bodies,Vesicles,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" "Nucleoplasm, Nuclear bodies" "Vesicles, Cytosol" "HPA050641: AB_2681198, HPA066262: AB_2685644, HPA074936: " "unprognostic (1.70e-2)" "unprognostic (1.27e-1)" "unprognostic (2.60e-1)" "prognostic unfavorable (4.98e-5)" "unprognostic (6.20e-2)" "unprognostic (2.42e-1)" "prognostic unfavorable (1.90e-4)" "unprognostic (1.47e-1)" "unprognostic (3.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.07e-3)" "prognostic unfavorable (3.37e-4)" "unprognostic (4.62e-2)" "unprognostic (2.96e-1)" "unprognostic (9.88e-2)" "unprognostic (1.34e-1)" "unprognostic (2.59e-1)" 18.9 29.5 20.5 17.7 22.8 23.8 24.5 21.7 23.4 20.7 21.2 18.2 19.3 18.2 16.3 32.9 24.4 16.2 16.9 19.6 21.0 31.7 31.2 14.7 26.4 21.2 20.9 25.2 21.2 30.7 31.8 25.6 21.8 20.4 17.9 31.9 30.0 17.1 29.4 25.9 19.6 14.1 20.8 20.7 19.3 27.9 21.5 31.5 28.5 20.5 27.9 22.6 22.7 24.3 54.7 57.6 68.5 71.9 22.5 38.9 49.6 42.4 38.8 117.1 66.8 189.6 70.7 68.3 64.0 39.8 60.8 89.1 90.1 98.0 94.8 22.4 64.1 90.5 72.4 150.5 26.7 64.2 60.1 40.9 34.3 44.2 32.8 32.8 68.3 54.0 118.1 51.8 53.3 198.2 135.6 95.4 40.3 151.5 122.9 78.4 56.6 121.1 49.0 76.5 75.9 112.6 126.0 148.3 85.9 38.2 157.5 75.0 30.2 91.6 88.8 36.3 67.7 44.4 80.0 71.1 53.7 57.3 80.6 20.0 44.6 22.9 42.0 51.5 50.0 48.6 39.7 51.2 64.9 44.5 37.7 40.1 5.6 47.1 68.8 33.0 39.7 49.0 20.5 22.8 21.7 23.4 19.6 21.0 21.2 20.9 21.8 20.8 21.5 24.3 23.0 9.6 27.6 18.3 50.5 30.2 62.6 43.8 40.9 67.3 32.7 34.2 10.9 47.1 24.3 22.0 41.7 133.1 35.5 14.5 50.9 57.0 18.8 26.2 33.3 26.7 23.4 60.0 23.0 31.4 69.2 26.2 26.5 27.4 16.5 50.9 23.2 24.1 36.9 55.5 22.8 21.9 26.4 15.3 24.0 32.1 37.0 24.0 26.6 10.3 48.1 52.9 49.4 21.1 23.6 34.9 14.4 26.4 37.4 37.8 27.8 49.9 15.0 61.5 39.5 31.6 34.2 63.1 94.9 40.5 31.4 103.0 48.5 43.9 36.2 52.8 NF2 "ACN, BANF, merlin, SCH" ENSG00000186575 "Neurofibromin 2" P35240 22 29603556-29698598 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Disease variant, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 77.1;Late spermatids: 121.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003097, CAB005385" Supported Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" "Plasma membrane" "Nucleoplasm, Cytosol" "CAB005385: AB_2298548, HPA003097: AB_1079473" "unprognostic (3.27e-1)" "unprognostic (1.34e-2)" "unprognostic (1.34e-1)" "unprognostic (1.76e-2)" "unprognostic (3.14e-1)" "unprognostic (1.62e-1)" "unprognostic (5.76e-3)" "unprognostic (1.61e-1)" "unprognostic (3.67e-2)" "unprognostic (2.16e-2)" "unprognostic (2.01e-3)" "unprognostic (4.66e-1)" "prognostic favorable (2.89e-5)" "unprognostic (7.73e-3)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (9.62e-2)" 8.8 13.6 19.7 8.4 17.2 8.0 7.6 13.6 28.7 8.9 10.7 10.8 6.2 11.1 6.2 13.4 8.6 5.3 21.4 27.3 13.9 17.2 10.5 9.3 6.4 14.4 18.1 8.5 12.7 27.4 9.5 4.6 14.3 9.9 5.4 7.3 8.5 6.7 22.8 10.2 8.8 8.0 14.3 9.9 10.0 20.9 17.6 9.3 11.1 19.1 7.1 9.3 7.7 16.6 75.8 36.7 12.2 74.3 21.5 22.0 7.7 57.3 37.9 74.1 53.7 32.7 18.4 21.1 50.4 69.9 48.9 27.1 25.1 37.8 52.0 31.9 12.5 26.8 24.4 26.4 22.4 35.1 28.6 20.1 16.4 53.3 51.0 21.8 47.7 13.7 12.0 18.7 64.5 35.1 21.4 16.6 8.3 16.9 20.4 24.2 56.8 18.8 68.5 37.3 17.0 11.6 36.0 24.5 14.0 9.4 14.9 15.4 92.7 101.1 109.6 44.8 112.5 30.0 26.7 25.5 27.0 14.5 68.5 10.0 10.0 4.2 15.5 14.7 13.1 8.3 11.5 10.4 15.1 8.6 9.7 9.2 2.3 13.2 21.0 10.2 10.7 12.2 19.7 17.2 13.6 28.7 27.3 13.9 14.4 18.1 14.3 14.3 17.6 16.6 8.1 6.4 20.1 14.7 9.4 14.1 11.6 9.8 8.6 16.3 14.5 9.0 23.1 18.6 10.0 14.7 10.4 11.7 12.7 9.0 21.5 40.0 77.1 14.5 17.7 13.2 13.1 13.9 27.5 24.9 6.7 12.5 7.7 15.2 22.9 12.2 11.7 14.4 13.5 30.3 27.1 7.9 6.1 14.7 7.5 121.4 7.2 10.2 8.8 18.7 8.6 19.1 14.4 17.6 16.7 40.1 14.5 12.4 14.7 13.6 10.5 30.1 8.6 9.6 6.6 13.7 15.6 29.5 8.1 15.5 14.3 3.8 12.9 17.4 11.2 9.5 NFATC3 "NFAT4, NFATX" ENSG00000072736 "Nuclear factor of activated T cells 3" Q12968 16 68084751-68229259 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 102.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 105.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050665 Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 63: T-cells - Adaptive immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" "Nucleoplasm, Cytosol" "HPA050665: AB_2681210" "unprognostic (1.19e-1)" "unprognostic (1.56e-2)" "unprognostic (7.74e-2)" "unprognostic (7.25e-3)" "unprognostic (6.41e-2)" "unprognostic (1.28e-2)" "unprognostic (7.28e-3)" "unprognostic (2.97e-1)" "unprognostic (1.90e-1)" "unprognostic (1.03e-1)" "unprognostic (1.32e-1)" "unprognostic (8.93e-2)" "unprognostic (9.07e-3)" "unprognostic (1.60e-1)" "unprognostic (1.58e-1)" "unprognostic (4.04e-2)" "unprognostic (1.30e-1)" 10.5 6.5 11.3 12.0 13.2 23.0 11.3 15.0 12.3 11.4 13.0 9.2 11.8 10.0 9.1 10.7 10.6 8.4 7.2 10.2 11.2 11.0 19.8 17.6 23.4 13.1 12.4 11.7 11.6 23.1 5.1 11.2 12.5 10.3 10.2 10.4 10.6 9.8 28.6 22.6 11.7 11.4 11.6 17.6 9.1 27.2 12.2 102.0 14.0 22.2 22.8 9.4 6.9 14.6 12.8 15.5 24.6 26.3 20.9 13.6 21.4 8.3 10.7 23.6 19.9 21.4 11.0 43.0 12.4 14.1 7.7 18.7 29.0 14.4 22.1 8.6 18.9 44.0 15.2 48.3 13.6 37.1 105.0 10.2 17.4 23.5 12.6 12.1 20.0 35.4 54.5 12.7 17.3 25.5 60.5 51.0 15.0 19.4 7.7 34.3 23.0 44.7 9.9 14.4 17.7 18.5 62.6 15.0 8.1 14.3 20.7 28.4 11.9 12.0 12.5 14.2 12.5 16.2 30.7 77.7 9.3 34.9 16.6 17.7 3.5 7.7 20.4 5.3 19.3 7.3 11.6 20.5 4.1 8.2 11.6 18.3 4.7 20.4 11.2 4.4 8.5 15.0 11.3 13.2 15.0 12.3 10.2 11.2 13.1 12.4 12.5 11.6 12.2 14.6 26.4 35.3 49.5 50.3 41.8 78.4 41.7 39.4 33.0 28.8 64.0 36.4 1.5 78.6 32.5 58.8 33.3 53.1 64.9 20.8 23.5 27.2 155.3 33.8 17.0 27.2 26.0 34.0 46.2 21.9 16.0 19.7 7.1 37.4 49.4 24.3 37.1 117.0 23.7 37.0 53.8 37.3 34.6 51.0 28.9 99.9 21.8 29.5 23.2 91.8 40.6 9.1 129.8 45.8 73.5 33.1 33.1 26.7 28.6 75.3 57.6 53.5 31.3 27.3 19.7 27.9 18.0 68.6 61.7 25.9 143.2 85.0 59.4 19.7 39.1 58.1 NHLRC3 ENSG00000188811 "NHL repeat containing 3" Q5JS37 13 39038306-39050109 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013738 Uncertain "Secreted to blood" NA NA 310000 "Cluster 27: Non-specific - Gene expression" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "HPA013738: AB_1854455" "unprognostic (7.92e-2)" "unprognostic (3.51e-2)" "unprognostic (5.96e-2)" "unprognostic (3.90e-1)" "unprognostic (2.92e-2)" "unprognostic (1.22e-1)" "unprognostic (2.99e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-1)" "unprognostic (8.88e-2)" "unprognostic (2.28e-2)" "unprognostic (4.83e-2)" "unprognostic (3.21e-1)" "unprognostic (1.58e-2)" "unprognostic (2.99e-2)" "unprognostic (1.66e-1)" "unprognostic (7.81e-2)" 18.5 12.0 7.8 10.9 8.6 7.4 15.2 7.6 10.5 12.1 9.7 12.9 11.6 13.5 20.6 7.4 10.7 13.0 10.2 7.9 8.5 16.7 25.9 13.9 14.3 10.1 8.1 15.8 13.4 8.4 11.4 19.4 9.5 11.0 16.6 12.9 12.2 9.8 10.8 12.0 12.3 11.8 8.6 16.1 16.7 8.7 8.5 8.1 16.9 10.4 12.0 10.1 9.8 10.4 5.1 3.1 13.5 6.5 15.4 16.0 20.9 7.8 9.7 8.2 10.9 9.8 22.6 13.9 14.5 5.2 10.3 10.5 5.4 4.5 7.1 20.3 5.8 11.1 6.9 11.2 9.8 11.1 15.8 13.0 5.8 5.7 5.5 12.3 5.2 11.2 4.0 16.9 7.6 3.8 8.7 17.2 3.7 11.8 3.2 9.2 36.2 7.8 12.6 10.1 3.1 5.6 5.0 6.9 18.4 7.5 9.0 17.5 6.0 11.2 5.4 14.7 8.3 13.5 12.3 5.5 14.9 11.9 8.2 1.5 6.8 0.8 4.5 6.9 5.0 4.1 3.2 3.7 6.0 3.0 3.3 4.8 0.6 4.5 6.8 5.4 4.1 3.7 7.8 8.6 7.6 10.5 7.9 8.5 10.1 8.1 9.5 8.6 8.5 10.4 20.6 12.8 20.2 22.9 36.7 8.4 16.9 40.8 15.9 70.8 22.2 13.5 13.0 18.6 35.8 35.0 56.3 78.4 52.5 22.5 9.8 21.0 6.7 14.1 25.3 22.4 13.8 23.3 37.4 16.5 14.9 21.8 17.9 14.6 15.8 76.7 42.5 34.5 43.6 79.1 45.8 28.6 42.7 57.6 27.0 4.6 61.2 35.2 17.8 27.2 47.7 33.5 102.0 40.2 131.7 17.2 25.0 41.8 30.7 10.2 34.8 16.3 32.1 93.1 59.2 14.2 18.7 51.1 41.0 9.0 8.9 24.2 30.5 50.2 28.4 11.7 NME7 "CFAP67, FLJ37194, NM23-H7" ENSG00000143156 "NME/NM23 family member 7" Q9Y5B8 1 169132531-169367948 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Nucleotide metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 274.9;Inhibitory neurons: 307.2;Oligodendrocytes: 277.7;Respiratory ciliated cells: 142.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028334, HPA038014, HPA054289" Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA028334: , HPA038014: AB_10673037, HPA054289: AB_2682437" "unprognostic (1.28e-1)" "unprognostic (8.52e-2)" "unprognostic (6.21e-2)" "unprognostic (6.30e-2)" "unprognostic (1.11e-1)" "unprognostic (7.44e-3)" "prognostic unfavorable (3.24e-5)" "unprognostic (1.42e-1)" "unprognostic (1.96e-1)" "unprognostic (2.90e-1)" "unprognostic (1.05e-1)" "unprognostic (2.00e-1)" "unprognostic (6.63e-2)" "unprognostic (2.67e-2)" "unprognostic (1.12e-1)" "unprognostic (7.75e-2)" "unprognostic (2.74e-1)" 6.7 10.6 9.4 5.5 9.9 3.5 11.1 8.4 12.2 13.0 11.8 9.8 3.9 12.9 13.3 7.5 27.7 10.0 6.2 10.8 10.8 12.5 7.9 7.6 5.6 10.2 10.0 13.6 7.2 18.3 14.2 4.8 9.9 8.0 5.6 20.7 4.3 11.5 4.1 4.0 4.6 14.9 9.3 4.4 5.8 16.0 9.9 11.1 13.6 4.9 6.4 8.8 6.2 9.6 24.3 23.6 26.4 20.9 25.1 26.1 9.4 16.6 24.2 28.5 35.8 13.8 33.7 7.1 29.4 14.5 38.8 16.2 15.6 35.3 46.1 25.5 12.3 12.5 21.3 14.1 18.5 23.8 8.3 18.8 20.1 29.5 38.3 39.2 40.8 21.1 12.6 9.5 28.8 7.1 22.7 16.8 26.5 27.4 25.2 16.1 29.4 15.3 46.0 7.3 27.5 40.6 23.0 7.6 18.4 28.3 24.4 16.4 25.4 17.4 59.5 16.5 40.2 11.7 21.3 14.8 19.8 8.2 17.8 1.6 3.9 2.1 9.6 6.3 11.6 9.9 12.0 9.9 6.3 9.3 10.1 11.7 1.1 11.4 9.8 5.1 14.9 5.3 9.4 9.9 8.4 12.2 10.8 10.8 10.2 10.0 9.9 9.3 9.9 9.6 12.3 6.4 10.9 97.6 9.0 14.4 34.5 61.9 15.4 18.9 13.7 14.7 5.1 20.0 29.3 27.6 25.0 7.6 9.2 2.1 23.5 26.6 43.2 75.7 20.4 12.8 17.5 13.7 274.9 8.9 7.4 21.1 12.8 22.2 21.5 21.8 13.9 11.2 14.6 28.6 307.2 4.1 36.7 4.1 11.9 13.8 18.0 6.5 8.8 64.6 3.3 23.8 10.3 106.1 277.7 16.9 6.0 20.7 7.2 8.6 4.9 40.9 142.9 64.9 19.7 21.2 24.7 67.7 21.9 9.2 10.2 2.7 18.7 26.4 6.0 16.5 NNT ENSG00000112992 "Nicotinamide nucleotide transhydrogenase" Q13423 5 43602692-43707405 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Translocase "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 239.1;tongue: 384.0" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 344.3;Hepatocytes: 314.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004829, CAB004975" Enhanced Approved Mitochondria,Cytosol NA NA 110000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria Cytosol "CAB004975: AB_425908, HPA004829: AB_1079495" "unprognostic (1.51e-1)" "unprognostic (1.07e-1)" "unprognostic (3.33e-2)" "unprognostic (4.81e-2)" "unprognostic (5.02e-2)" "unprognostic (1.81e-1)" "unprognostic (4.04e-2)" "unprognostic (1.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.98e-2)" "unprognostic (1.65e-1)" "unprognostic (8.33e-2)" "prognostic favorable (1.22e-15)" "unprognostic (8.24e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (2.58e-1)" 26.0 16.5 12.8 11.8 16.0 15.0 13.7 11.2 21.7 16.4 34.9 25.9 17.2 11.0 16.7 16.8 10.7 15.0 137.7 16.1 11.5 57.0 116.4 13.2 16.5 10.3 12.0 10.1 17.8 55.6 9.6 12.7 9.5 18.3 27.8 12.9 26.6 18.2 239.1 10.4 16.1 20.6 9.3 11.5 31.2 6.2 15.8 26.8 31.1 384.0 17.2 17.3 9.3 15.1 15.4 12.6 30.5 59.6 44.0 50.3 9.9 17.5 39.8 24.8 20.8 19.0 30.4 18.5 21.5 43.9 22.3 16.6 120.5 5.4 27.4 31.1 33.6 24.0 70.7 23.8 27.5 50.2 43.1 37.9 17.5 16.3 18.6 42.6 56.3 22.7 21.4 81.3 60.0 15.1 55.8 35.8 6.4 0.1 15.2 54.7 73.8 70.8 58.0 15.5 44.2 37.7 62.9 1.4 46.7 6.9 47.7 58.3 23.2 29.5 28.3 12.0 8.3 36.1 45.1 26.5 7.1 68.8 22.1 12.5 18.2 16.0 16.7 23.0 17.1 12.0 17.1 15.5 32.0 12.0 15.5 14.7 2.9 23.2 24.7 9.1 22.2 19.3 12.8 16.0 11.2 21.7 16.1 11.5 10.3 12.0 9.5 9.3 15.8 15.1 12.0 54.5 37.8 60.7 19.6 11.5 9.5 19.0 13.1 17.9 9.6 6.3 344.3 38.6 27.0 27.6 35.5 8.7 20.4 34.4 27.4 14.4 16.7 18.5 16.6 19.2 19.9 34.9 124.8 10.7 2.3 27.2 23.9 25.1 25.2 26.8 21.0 314.3 25.0 6.7 110.6 22.6 20.3 40.6 11.9 4.6 14.9 19.8 14.2 45.9 25.9 12.5 35.0 77.9 63.4 9.5 16.7 19.2 20.0 11.7 23.6 21.7 18.1 12.8 0.0 14.0 20.1 4.0 1.4 17.6 8.1 2.1 20.9 18.8 28.9 9.9 NOC2L "DKFZP564C186, NET15, NET7, NIR, PPP1R112" ENSG00000188976 "NOC2 like nucleolar associated transcriptional repressor" Q9Y3T9 1 944203-959309 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044258, HPA062195" Approved Enhanced "Nucleoli,Nucleoli rim,Mitotic chromosome" Yes No 310000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim, Mitotic chromosome" "HPA044258: AB_10961284, HPA062195: AB_2684707" "unprognostic (3.18e-2)" "unprognostic (5.84e-2)" "unprognostic (1.59e-1)" "unprognostic (9.54e-3)" "unprognostic (6.75e-2)" "unprognostic (2.31e-3)" "unprognostic (1.94e-3)" "unprognostic (1.36e-2)" "unprognostic (1.51e-1)" "unprognostic (2.17e-1)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (6.25e-2)" "unprognostic (3.44e-2)" "unprognostic (1.52e-1)" 26.7 23.6 17.1 23.0 17.1 30.1 26.4 16.8 21.2 29.5 14.3 28.0 17.9 30.3 10.3 47.3 27.7 14.1 32.8 18.1 18.5 27.1 33.7 23.6 23.1 18.5 17.0 26.0 35.6 21.2 24.4 15.8 19.5 26.8 11.6 9.6 26.5 16.0 73.0 45.0 25.2 15.0 15.1 28.0 28.4 36.0 17.6 20.1 24.3 26.4 15.9 32.7 31.7 18.5 112.8 110.4 19.8 129.5 34.5 31.0 70.2 82.3 38.9 114.4 62.1 148.5 110.5 126.3 113.3 56.0 94.0 102.2 147.6 122.8 49.2 79.2 161.5 67.0 141.2 132.0 77.4 151.1 63.8 50.3 35.0 125.3 84.3 35.3 56.4 44.6 190.8 58.2 51.6 182.1 98.7 92.6 112.0 82.3 128.8 120.0 81.5 155.9 53.6 47.4 136.0 133.0 109.3 166.3 105.1 30.3 74.8 81.1 64.1 68.3 95.9 75.2 143.0 97.6 112.5 225.7 84.3 209.1 57.7 21.3 30.9 22.2 23.9 46.4 31.3 23.9 23.3 23.4 36.8 19.3 23.3 18.6 2.8 34.5 57.5 23.6 19.9 31.7 17.1 17.1 16.8 21.2 18.1 18.5 18.5 17.0 19.5 15.1 17.6 18.5 21.5 16.0 23.1 12.4 42.7 69.3 90.8 42.9 47.8 54.6 33.4 34.7 4.5 28.6 29.8 36.8 62.6 63.7 24.7 27.4 17.6 49.9 10.2 34.8 40.9 27.8 30.0 23.8 12.6 46.2 65.5 29.9 28.1 36.9 13.9 36.4 24.7 24.0 39.6 45.4 12.4 27.6 36.7 24.6 29.2 10.3 29.5 24.4 24.9 12.2 35.7 20.6 60.8 9.5 10.6 39.2 21.4 21.4 42.6 71.9 22.9 19.6 27.1 77.0 32.9 41.2 34.6 43.0 83.9 47.4 82.0 58.8 36.6 51.8 53.1 69.3 NOL10 "FLJ14075, PQBP5" ENSG00000115761 "Nucleolar protein 10" Q9BSC4 2 10570754-10689987 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 189.3;Late spermatids: 163.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035286, HPA043075" Approved Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoli "HPA035286: AB_2674552, HPA043075: AB_10794652" "unprognostic (6.53e-3)" "unprognostic (1.61e-1)" "unprognostic (6.84e-2)" "prognostic unfavorable (2.92e-5)" "unprognostic (1.31e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.43e-7)" "unprognostic (1.25e-1)" "unprognostic (3.29e-2)" "unprognostic (1.86e-2)" "unprognostic (1.61e-2)" "unprognostic (1.74e-2)" "prognostic unfavorable (7.51e-5)" "unprognostic (2.43e-2)" "unprognostic (2.92e-1)" "unprognostic (3.82e-1)" "unprognostic (3.87e-2)" 12.6 14.8 6.6 10.1 8.0 16.2 11.3 10.2 8.2 9.6 5.1 10.8 8.1 9.3 11.0 13.7 7.8 6.6 11.2 7.5 7.1 13.7 14.4 9.0 10.3 6.2 6.6 9.1 16.0 12.1 8.3 10.9 6.1 10.0 10.6 6.2 12.9 8.6 19.4 13.1 9.0 8.8 6.3 9.6 11.7 13.1 7.3 9.9 10.2 11.9 11.7 12.3 10.7 8.8 19.7 33.2 18.6 32.6 22.1 24.2 34.9 33.1 25.8 36.9 27.5 37.5 24.0 45.4 19.5 32.1 30.8 24.5 43.8 38.7 43.6 32.2 33.8 43.8 20.3 46.6 28.0 52.8 23.9 22.6 28.7 40.7 39.1 16.7 25.5 25.0 59.4 28.5 33.9 38.2 36.4 37.4 49.7 51.8 28.8 32.0 49.2 41.4 26.1 30.6 31.6 34.3 24.2 39.4 29.1 20.2 20.8 20.4 24.2 33.8 41.1 33.6 53.9 37.9 63.7 52.4 28.1 49.7 41.5 1.5 3.9 2.2 4.0 5.2 5.9 4.8 4.2 4.2 4.9 3.7 3.2 4.8 0.5 4.8 5.9 3.1 6.0 2.8 6.6 8.0 10.2 8.2 7.5 7.1 6.2 6.6 6.1 6.3 7.3 8.8 22.2 16.0 16.7 31.6 17.1 33.0 29.9 17.2 17.1 13.0 16.3 12.8 19.2 11.5 16.1 12.9 12.5 32.7 16.4 9.9 15.6 27.5 189.3 8.9 19.5 22.9 11.4 19.8 72.9 24.1 33.7 20.2 13.3 17.8 14.0 20.2 12.5 12.2 15.4 16.8 57.6 12.4 18.3 9.8 13.0 163.0 17.1 12.2 8.8 36.5 23.8 13.9 20.6 54.3 54.2 19.0 7.0 16.6 22.1 30.3 10.6 17.0 7.3 16.7 13.1 36.4 22.5 26.4 42.1 17.8 34.2 29.6 17.7 30.4 18.3 22.3 NOL4L "C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424" ENSG00000197183 "Nucleolar protein 4 like" Q96MY1 20 32443059-32585074 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 49.3;testis: 50.0" "Cell type enhanced" "Detected in many" "Early spermatids: 107.4;Late spermatids: 171.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 73.4;HEL: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041768, HPA043600" Enhanced Enhanced Nucleoplasm NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 39: CACO-2 - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA041768: AB_10964172, HPA043600: AB_10961001" "unprognostic (4.33e-2)" "unprognostic (1.71e-1)" "unprognostic (4.03e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.10e-1)" "unprognostic (7.88e-2)" "unprognostic (2.75e-3)" "unprognostic (1.65e-2)" "unprognostic (1.83e-1)" "unprognostic (1.41e-1)" "unprognostic (1.84e-1)" "unprognostic (1.72e-1)" "unprognostic (3.88e-2)" "unprognostic (9.32e-2)" "unprognostic (3.42e-1)" "unprognostic (6.08e-3)" "prognostic favorable (2.63e-4)" 10.4 9.1 12.8 8.7 17.5 20.8 10.2 20.8 19.9 8.7 3.1 17.2 18.7 6.6 12.0 2.5 8.6 8.6 5.6 13.2 14.7 14.5 7.0 13.4 8.0 14.5 13.5 4.0 11.1 4.3 22.3 11.1 14.8 8.7 13.6 49.3 9.7 8.2 1.6 3.5 19.8 6.5 10.3 12.9 13.2 50.0 13.1 15.1 9.7 1.7 5.8 9.7 5.2 19.5 9.1 27.4 16.9 11.6 3.6 5.4 2.3 5.7 4.6 7.1 4.9 73.4 20.8 0.6 16.6 7.5 11.0 2.5 5.4 15.9 3.2 2.1 4.3 58.2 14.5 53.2 9.3 0.9 3.3 13.6 2.2 5.2 3.4 16.1 43.1 12.5 17.7 7.6 3.4 5.1 19.3 17.8 9.9 27.7 25.3 8.2 2.1 3.0 12.0 1.6 22.3 18.1 17.9 0.4 9.8 17.4 3.7 17.8 45.5 6.6 22.6 6.1 5.9 5.6 2.1 4.0 7.2 31.4 20.3 2.9 2.0 1.2 5.8 4.5 5.1 1.6 3.8 3.4 2.1 1.1 7.6 6.4 6.5 8.3 12.1 0.2 6.9 4.9 12.8 17.5 20.8 19.9 13.2 14.7 14.5 13.5 14.8 10.3 13.1 19.5 23.1 6.4 3.3 7.2 4.1 0.0 10.8 0.0 2.2 49.9 20.8 18.3 8.8 11.5 1.3 12.9 66.7 0.3 29.5 57.9 9.8 8.0 107.4 9.4 2.9 25.3 17.5 4.6 29.7 7.8 2.1 5.8 20.4 8.7 12.0 11.1 21.8 4.7 9.8 8.4 22.0 36.6 0.0 3.3 0.0 171.5 5.6 8.6 0.0 33.7 6.1 17.2 24.7 14.1 51.2 14.0 36.6 4.9 9.0 15.2 59.4 24.0 2.2 57.3 19.7 1.7 5.0 75.3 3.8 0.8 0.0 0.4 16.5 16.9 29.5 28.7 NOL6 "bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22" ENSG00000165271 "Nucleolar protein 6" Q9H6R4 9 33461353-33473930 "Predicted intracellular proteins, Predicted membrane proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 30.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055891, HPA061002" Supported Enhanced Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Nucleoli Nucleoplasm "HPA055891: AB_2682959, HPA061002: AB_2684410" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (2.37e-1)" "unprognostic (5.23e-2)" "unprognostic (2.32e-1)" "unprognostic (2.67e-1)" "prognostic unfavorable (4.83e-5)" "unprognostic (7.37e-3)" "unprognostic (8.26e-2)" "unprognostic (3.03e-2)" "unprognostic (2.09e-1)" "unprognostic (4.24e-2)" "unprognostic (2.77e-1)" "unprognostic (2.92e-2)" "unprognostic (2.06e-1)" "prognostic unfavorable (9.49e-4)" "unprognostic (4.09e-1)" 19.0 22.0 15.6 13.5 15.5 19.9 17.8 14.3 17.6 19.8 14.5 15.3 8.7 19.5 9.3 29.7 17.1 8.0 20.5 16.5 14.4 21.4 27.0 18.1 14.3 15.2 14.6 19.3 28.4 13.6 24.3 12.1 15.1 23.5 11.8 6.8 17.3 10.1 31.0 27.9 16.2 13.7 13.9 23.5 18.0 28.8 15.8 13.8 17.3 12.0 16.0 22.9 20.6 15.6 37.5 52.3 20.0 45.6 30.5 20.6 33.6 41.2 30.8 46.7 39.3 57.8 13.5 65.3 18.3 46.4 20.7 25.7 58.8 59.1 49.5 41.5 23.9 33.8 62.9 33.1 29.8 78.2 47.0 23.7 48.0 62.9 60.9 19.7 31.6 23.5 54.8 24.5 38.1 33.1 43.3 77.1 71.4 42.0 47.6 36.9 19.9 33.5 36.7 44.1 23.3 31.8 34.0 43.9 14.9 21.3 17.7 44.1 34.7 28.2 38.5 36.6 72.7 22.9 34.4 54.5 25.3 40.6 33.4 0.0 3.0 0.2 3.6 5.9 4.1 2.8 2.7 3.6 5.0 2.2 3.3 3.2 0.1 2.8 6.3 2.7 3.0 2.7 15.6 15.5 14.3 17.6 16.5 14.4 15.2 14.6 15.1 13.9 15.8 15.6 4.8 3.2 12.9 5.2 5.7 20.0 6.6 3.7 4.0 6.5 6.7 6.5 6.6 4.3 8.6 3.7 6.2 4.2 5.4 3.8 3.9 6.3 30.4 7.1 7.7 6.5 10.2 5.7 11.6 4.0 6.1 4.8 9.2 13.6 3.8 7.3 4.2 8.8 5.0 3.3 7.3 5.6 2.0 1.6 4.0 22.0 5.9 3.4 5.4 4.7 3.8 4.2 4.1 6.0 5.9 5.7 2.1 6.0 4.8 10.6 2.4 3.0 6.0 3.8 0.0 6.9 4.5 2.7 5.6 9.5 25.9 3.0 4.9 7.0 7.2 9.5 NOLC1 "KIAA0035, NOPP130, NOPP140, P130, Srp40" ENSG00000166197 "Nucleolar and coiled-body phosphoprotein 1" Q14978 10 102152176-102163871 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032654, HPA037366, HPA050388" Supported Enhanced "Nucleoli fibrillar center" No Yes 44000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli fibrillar center" "CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109" "unprognostic (3.23e-1)" "unprognostic (5.58e-2)" "unprognostic (9.44e-2)" "unprognostic (9.13e-2)" "unprognostic (8.89e-2)" "unprognostic (7.03e-3)" "unprognostic (2.36e-3)" "unprognostic (7.34e-3)" "unprognostic (3.43e-1)" "unprognostic (3.74e-1)" "unprognostic (5.64e-3)" "unprognostic (3.73e-2)" "prognostic unfavorable (9.19e-5)" "unprognostic (3.15e-2)" "unprognostic (3.73e-1)" "prognostic unfavorable (8.25e-5)" "unprognostic (7.68e-2)" 36.5 23.9 10.7 41.9 12.3 37.2 32.3 14.6 20.5 27.1 4.5 31.8 21.8 30.3 18.7 33.3 34.4 29.0 24.0 12.6 18.2 21.4 37.5 24.9 43.1 10.9 14.4 34.4 38.4 42.9 14.6 38.3 11.9 31.5 39.1 38.0 26.3 26.6 45.3 21.9 22.8 33.8 10.8 27.6 27.4 19.3 12.2 54.2 37.6 46.4 55.7 64.2 19.6 18.3 202.1 175.1 98.2 209.0 84.7 66.0 166.6 108.5 87.8 150.1 130.5 302.1 132.4 401.5 118.1 69.5 73.9 225.1 285.0 236.1 173.3 127.0 194.8 267.9 143.6 200.3 112.0 389.8 122.8 86.3 169.8 158.3 328.7 94.5 96.5 194.3 286.6 172.6 102.6 170.3 373.7 95.0 196.5 150.7 137.1 277.3 261.6 233.3 100.2 123.5 148.3 141.9 103.5 124.1 144.5 95.6 207.5 99.3 79.3 67.7 93.5 81.3 256.9 165.5 254.4 442.4 110.5 422.7 60.7 2.4 12.5 11.6 20.4 14.4 24.9 16.6 16.1 19.2 16.2 12.1 18.5 22.6 1.3 17.3 17.2 12.4 13.0 17.9 10.7 12.3 14.6 20.5 12.6 18.2 10.9 14.4 11.9 10.8 12.2 18.3 47.8 60.9 74.7 6.2 47.6 120.4 112.6 37.7 101.9 20.8 52.6 48.0 35.3 20.0 68.2 16.5 14.6 49.2 29.1 28.3 25.4 42.2 29.0 38.5 56.3 47.3 27.6 56.8 8.8 23.1 62.7 63.9 43.3 73.1 44.2 28.6 16.8 23.4 27.1 10.1 7.9 38.3 18.3 11.2 46.0 9.7 23.0 26.8 26.6 4.7 22.9 15.1 32.0 2.5 6.8 48.8 21.0 21.1 62.3 89.5 10.2 19.9 56.6 20.0 6.6 85.8 58.9 32.1 53.5 103.3 117.5 48.6 44.5 40.1 49.1 100.5 NOP2 "NOL1, NOP120, NSUN1, p120" ENSG00000111641 "NOP2 nucleolar protein" P46087 12 6556863-6568691 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 47.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040119 Supported Enhanced Nucleoli No No "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA040119: AB_10965321" "unprognostic (2.88e-1)" "unprognostic (2.78e-2)" "unprognostic (1.04e-1)" "unprognostic (7.15e-2)" "unprognostic (8.74e-2)" "unprognostic (6.47e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (6.38e-2)" "unprognostic (2.19e-2)" "unprognostic (8.82e-2)" "unprognostic (2.41e-1)" "unprognostic (2.53e-1)" "prognostic unfavorable (2.35e-10)" "unprognostic (1.43e-2)" "unprognostic (1.09e-1)" "unprognostic (1.13e-1)" "unprognostic (2.96e-3)" 28.4 22.6 14.6 22.6 15.1 34.6 19.8 15.2 18.5 20.5 14.7 20.8 14.2 20.8 10.2 28.6 21.2 10.9 18.8 15.0 15.1 21.7 26.7 20.6 28.3 14.9 14.6 20.2 21.6 9.9 21.2 12.2 15.0 25.0 14.2 6.6 19.2 8.6 42.2 25.7 24.5 14.7 14.4 32.3 20.6 23.1 15.3 22.8 23.5 12.2 28.7 21.7 21.0 15.4 69.0 107.2 29.5 101.8 37.4 32.1 159.8 61.4 40.4 71.8 61.6 130.5 69.0 144.7 16.7 30.8 75.5 84.9 113.9 69.6 68.0 175.3 105.2 143.7 110.8 78.5 49.0 141.2 79.9 33.0 67.3 87.9 135.8 31.3 50.2 76.9 102.7 22.8 58.1 83.7 77.1 124.7 247.6 93.6 59.9 108.4 84.1 72.8 53.1 92.1 22.7 44.5 94.1 102.5 50.2 116.2 17.1 70.4 47.6 49.1 64.1 63.7 143.2 31.2 49.7 217.9 45.0 81.3 88.6 2.4 14.0 1.5 23.6 19.5 32.7 21.0 22.4 27.1 28.7 15.8 27.2 28.2 5.1 22.2 19.0 24.8 16.8 19.9 14.6 15.1 15.2 18.5 15.0 15.1 14.9 14.6 15.0 14.4 15.3 15.4 3.9 12.8 6.8 7.8 20.5 23.8 17.7 12.9 47.8 5.8 6.0 4.4 6.8 5.7 6.4 3.7 2.1 12.6 6.6 13.1 1.9 12.0 17.9 4.2 4.4 11.4 7.2 19.4 9.1 11.8 13.4 10.3 26.0 4.3 7.6 1.4 7.9 8.3 11.8 6.7 7.3 11.1 16.2 7.7 15.7 7.3 9.3 11.7 8.8 2.8 7.7 3.0 18.6 5.5 5.7 13.5 5.3 4.9 19.2 19.2 2.1 1.3 5.2 2.9 13.1 22.7 9.7 11.3 21.4 43.4 21.3 7.3 16.2 1.2 16.4 16.7 NPRL3 "C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11" ENSG00000103148 "NPR3 like, GATOR1 complex subunit" Q12980 16 84271-138677 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 134.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011741 Uncertain Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 6: Erythroid cells - Oxygen transport" Cytosol "HPA011741: AB_1845577" "unprognostic (1.34e-1)" "unprognostic (1.32e-1)" "unprognostic (3.13e-2)" "unprognostic (1.13e-1)" "unprognostic (1.24e-2)" "unprognostic (4.87e-2)" "unprognostic (6.18e-3)" "unprognostic (9.50e-2)" "unprognostic (7.28e-2)" "unprognostic (4.85e-2)" "unprognostic (9.07e-3)" "unprognostic (1.68e-1)" "unprognostic (3.15e-2)" "unprognostic (8.69e-2)" "unprognostic (1.65e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" 9.6 10.4 17.5 7.2 18.2 19.1 8.5 16.7 22.2 10.1 15.7 6.5 7.3 10.5 5.2 9.3 12.1 6.3 8.9 17.7 18.0 8.0 10.0 7.8 9.4 17.1 18.1 12.9 10.9 12.7 11.7 6.6 16.9 8.8 4.8 7.1 11.0 7.1 15.5 9.9 5.6 7.2 15.5 8.3 6.8 9.4 18.2 7.0 11.0 10.3 6.6 6.5 8.2 18.2 14.5 29.0 12.6 32.2 33.7 16.9 19.8 17.2 16.8 21.3 16.6 46.6 25.6 26.5 22.5 25.5 13.8 17.0 20.5 29.7 12.3 29.2 16.0 38.8 17.3 34.2 31.1 15.9 25.6 20.7 22.2 28.4 24.9 16.0 20.3 21.1 38.6 24.6 19.1 51.2 17.6 12.3 11.9 10.0 20.8 30.1 10.8 37.9 21.6 12.2 26.9 17.1 22.8 30.1 14.3 6.5 22.2 11.1 19.2 32.9 18.2 20.0 13.3 25.9 14.7 37.7 1.1 19.2 18.3 0.0 2.4 0.3 3.0 2.2 3.2 2.0 2.6 2.5 3.5 2.0 2.5 2.9 0.2 2.0 3.1 2.6 2.9 2.2 17.5 18.2 16.7 22.2 17.7 18.0 17.1 18.1 16.9 15.5 18.2 18.2 10.4 12.8 11.7 30.0 22.2 9.4 17.6 15.7 14.8 58.1 16.6 16.8 9.0 12.8 9.2 11.0 66.7 24.6 20.4 6.8 23.5 16.4 31.0 11.8 18.1 13.0 9.6 134.5 29.7 8.9 35.2 17.3 15.8 9.4 3.8 49.2 15.7 10.2 19.7 55.5 30.8 11.7 10.2 14.2 6.4 73.8 22.7 12.8 12.4 15.9 16.4 29.5 79.3 21.1 40.4 11.4 6.6 19.5 14.0 23.3 8.0 23.9 11.0 57.2 6.6 15.6 14.9 62.2 43.0 16.0 5.5 15.3 18.8 28.2 14.4 10.4 NSUN6 "ARL5B-AS1, FLJ23743, NOPD1" ENSG00000241058 "NOP2/Sun RNA methyltransferase 6" Q8TEA1 10 18545561-18659285 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 61.1" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045902 Approved Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" "Golgi apparatus" "HPA045902: AB_10962354" "unprognostic (7.34e-2)" "unprognostic (1.69e-2)" "unprognostic (3.10e-3)" "unprognostic (9.50e-2)" "unprognostic (4.92e-2)" "unprognostic (8.33e-3)" "unprognostic (1.63e-2)" "prognostic favorable (8.42e-4)" "unprognostic (1.60e-1)" "unprognostic (2.45e-1)" "unprognostic (9.96e-3)" "unprognostic (1.79e-1)" "prognostic unfavorable (5.55e-5)" "unprognostic (2.23e-1)" "unprognostic (7.53e-3)" "unprognostic (3.18e-2)" "unprognostic (2.00e-3)" 6.4 12.2 13.6 7.5 14.3 12.4 9.3 16.0 15.9 9.0 13.5 6.1 8.6 9.6 12.2 5.7 8.7 6.0 8.6 14.0 14.1 10.6 61.1 6.5 11.3 13.8 14.8 12.7 12.0 7.8 17.2 6.5 14.7 10.5 8.4 12.9 8.4 5.6 4.5 9.1 8.7 6.1 13.9 9.8 8.5 17.5 13.8 11.8 12.0 4.8 10.9 9.1 7.6 17.6 7.5 6.3 16.6 12.3 8.1 11.1 7.2 10.3 2.5 8.4 11.3 12.0 11.2 17.0 4.3 4.0 5.9 11.0 17.1 10.8 10.8 16.6 13.9 17.8 8.8 14.5 8.3 8.1 11.6 8.6 10.3 8.0 5.5 8.3 3.9 20.0 25.1 16.1 8.2 4.2 18.6 9.3 8.5 14.8 4.8 13.1 8.6 17.4 6.3 9.1 8.9 11.0 8.7 9.0 7.3 11.3 5.8 6.4 6.7 7.0 8.1 12.8 7.6 9.9 11.0 18.8 5.0 14.5 4.3 1.5 3.5 2.8 4.4 4.7 7.0 8.0 6.3 5.6 2.9 6.1 7.8 6.7 1.6 5.3 8.2 4.0 10.5 2.5 13.6 14.3 16.0 15.9 14.0 14.1 13.8 14.8 14.7 13.9 13.8 17.6 75.4 9.6 15.1 57.8 34.9 28.7 17.1 11.0 30.1 33.2 32.4 34.7 8.1 18.6 13.6 9.2 22.9 10.1 39.6 19.5 5.9 10.0 19.7 23.6 38.9 37.5 14.5 20.8 43.5 12.7 8.0 19.2 40.2 49.0 17.7 32.0 26.7 86.6 7.4 25.2 45.0 24.5 18.3 24.2 52.4 12.7 25.7 28.5 12.4 23.4 15.3 15.3 17.5 43.7 57.6 11.1 20.0 17.0 31.0 10.1 40.2 10.9 14.5 28.9 13.1 20.1 19.1 49.5 21.8 21.3 26.7 6.7 31.0 26.7 18.7 14.2 NUDT8 FLJ41567 ENSG00000167799 "Nudix hydrolase 8" Q8WV74 11 67627938-67629937 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 78.9" "Cell type enhanced" "Detected in many" "Hepatocytes: 222.8;Intestinal goblet cells: 102.5;Proximal enterocytes: 139.4;Proximal tubular cells: 237.1;Squamous epithelial cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPMI-8226: 218.9" "HPA041252, HPA041466" Enhanced Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 25: RPMI-8226 - Immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoli Cytosol "HPA041252: AB_10794551, HPA041466: AB_10793967" "unprognostic (8.31e-2)" "unprognostic (7.26e-3)" "unprognostic (7.31e-2)" "unprognostic (7.32e-2)" "unprognostic (2.87e-1)" "unprognostic (2.36e-3)" "unprognostic (2.69e-1)" "unprognostic (4.12e-2)" "unprognostic (8.28e-2)" "unprognostic (2.69e-2)" "unprognostic (3.11e-2)" "unprognostic (2.74e-1)" "prognostic favorable (3.70e-4)" "unprognostic (4.70e-2)" "unprognostic (2.29e-1)" "unprognostic (3.50e-1)" "unprognostic (2.19e-1)" 10.3 5.3 6.9 1.9 8.7 3.2 9.9 10.3 10.4 10.1 6.9 12.4 14.2 4.3 2.2 57.6 5.0 1.6 78.9 6.2 8.6 25.5 58.7 6.1 1.8 9.2 8.7 4.6 13.1 12.0 3.0 1.7 8.6 9.3 5.4 0.8 24.1 4.3 58.8 31.7 11.6 1.5 8.4 4.5 9.1 4.4 9.2 2.5 20.4 41.8 3.7 3.7 12.6 9.1 33.5 13.3 5.1 8.4 4.7 5.9 8.1 6.9 3.2 2.7 2.8 11.0 8.5 35.1 10.6 5.4 3.9 16.1 5.9 4.1 0.3 34.3 14.7 2.0 6.1 34.2 1.4 11.2 16.0 3.6 8.1 3.4 1.1 0.7 6.0 42.6 9.9 30.1 2.2 55.9 18.6 16.0 3.1 58.7 28.0 11.4 2.7 218.9 8.4 5.8 2.6 3.7 1.8 18.7 7.1 1.8 10.2 4.6 1.6 7.1 10.1 45.7 1.3 21.6 15.3 7.1 5.0 14.8 4.1 0.0 1.1 1.1 2.9 4.7 2.5 3.2 1.7 3.5 4.6 6.4 1.5 1.8 0.0 9.5 13.7 12.4 1.3 2.1 6.9 8.7 10.3 10.4 6.2 8.6 9.2 8.7 8.6 8.4 9.2 9.1 8.7 0.0 6.5 6.2 12.0 12.1 12.7 9.4 17.6 4.5 42.3 39.9 79.5 15.7 12.1 29.5 0.0 29.7 7.2 76.5 84.1 14.3 3.3 8.2 11.0 9.2 2.4 34.5 0.6 23.9 21.4 12.5 23.4 13.8 8.9 3.7 8.6 222.8 9.4 5.0 0.7 102.5 12.2 5.3 10.8 8.0 5.0 5.0 28.4 0.0 2.5 7.9 4.1 1.0 2.9 9.9 26.4 5.3 15.7 18.5 139.4 237.1 4.5 7.8 6.6 7.8 17.7 13.9 8.8 129.6 25.6 17.4 7.6 6.6 69.8 25.0 NUDT9 MGC3037 ENSG00000170502 "Nudix hydrolase 9" Q9BW91 4 87422573-87459455 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPTEC TERT1: 160.7" "Low region specificity" "Detected in all" "HPA036917, HPA044866, HPA078535" Approved Approved "Nuclear membrane,Nuclear bodies,Cell Junctions,Mitochondria" "Intracellular and membrane" NA NA 9900 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies, Mitochondria" "Nuclear membrane, Cell Junctions" "HPA036917: AB_10696790, HPA044866: AB_2679120, HPA078535: AB_2686885" "unprognostic (7.22e-2)" "unprognostic (2.59e-2)" "unprognostic (1.45e-2)" "prognostic favorable (7.43e-5)" "unprognostic (2.05e-2)" "unprognostic (1.36e-1)" "unprognostic (1.33e-1)" "unprognostic (3.47e-2)" "unprognostic (2.04e-1)" "unprognostic (1.02e-1)" "unprognostic (1.09e-2)" "unprognostic (4.23e-1)" "prognostic favorable (8.00e-11)" "unprognostic (1.21e-1)" "unprognostic (1.99e-1)" "unprognostic (1.19e-1)" "unprognostic (5.77e-3)" 23.6 36.1 20.8 16.2 21.4 6.7 19.7 25.5 38.5 27.6 39.1 27.0 42.6 24.8 32.2 19.6 24.9 16.2 28.8 21.9 24.7 40.4 46.6 23.0 13.7 21.0 20.5 26.7 67.6 55.3 29.1 19.9 21.9 30.4 27.1 20.1 28.1 23.8 42.1 16.6 40.3 23.8 19.6 14.7 22.3 22.5 22.1 13.4 28.8 45.0 14.8 22.4 24.3 26.0 30.8 25.6 34.0 19.8 67.6 39.6 26.0 59.8 35.6 21.3 21.1 17.1 53.1 47.6 58.9 47.6 41.0 21.1 32.1 38.1 33.2 34.5 24.0 13.4 34.5 31.8 42.4 25.6 21.2 41.5 52.4 25.6 22.6 45.5 41.6 13.7 40.3 30.0 38.7 33.4 39.1 23.2 29.1 68.5 12.0 45.0 31.8 27.0 160.7 24.2 41.3 28.7 37.6 63.0 30.8 44.5 36.8 38.2 43.7 34.7 34.3 25.8 27.8 21.5 18.7 37.9 51.3 21.9 48.2 1.6 17.9 5.9 19.1 21.2 18.2 22.2 18.5 19.5 21.4 18.8 22.5 26.0 1.8 15.6 24.0 20.6 19.0 16.0 20.8 21.4 25.5 38.5 21.9 24.7 21.0 20.5 21.9 19.6 22.1 26.0 32.6 67.3 44.8 20.2 14.9 9.9 40.4 45.0 9.6 15.3 11.3 13.1 40.9 30.0 55.0 23.9 27.1 33.2 13.1 21.0 41.1 44.7 28.6 26.0 26.2 25.8 16.8 6.7 21.7 36.5 32.5 29.4 8.6 27.0 20.8 23.3 18.2 47.5 33.2 6.7 24.0 18.0 40.7 12.7 11.0 11.5 25.4 14.7 10.6 20.6 16.4 26.8 8.2 18.6 24.8 29.4 37.0 26.7 15.8 32.9 55.7 56.2 41.0 18.6 26.3 36.9 23.7 44.5 23.6 15.7 9.5 37.6 12.1 29.8 24.9 27.3 NUP107 NUP84 ENSG00000111581 "Nucleoporin 107" P57740 12 68686951-68745809 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 89.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031679 Uncertain "Nucleoplasm,Nuclear membrane,Centrosome" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "Nuclear membrane, Centrosome" "HPA031679: AB_2673992" "unprognostic (2.89e-1)" "unprognostic (3.32e-1)" "unprognostic (4.10e-1)" "unprognostic (5.43e-2)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "prognostic unfavorable (3.12e-9)" "unprognostic (4.03e-2)" "unprognostic (1.23e-2)" "unprognostic (2.28e-1)" "unprognostic (1.17e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (1.28e-6)" "unprognostic (3.43e-2)" "unprognostic (2.05e-1)" "unprognostic (1.00e-1)" "unprognostic (1.96e-1)" 15.4 11.1 5.0 17.9 6.3 24.0 17.8 8.2 6.0 12.9 6.3 13.0 10.3 16.7 14.3 10.7 13.5 9.3 11.4 4.6 5.0 10.6 11.8 12.8 25.8 5.6 5.7 16.3 9.3 11.8 6.8 13.8 5.5 12.0 16.2 14.7 10.3 12.2 11.7 15.8 12.9 14.0 5.4 15.8 11.0 20.9 5.5 25.6 10.3 12.1 25.5 12.4 10.7 7.6 53.1 66.8 77.8 56.7 22.6 28.6 84.1 56.6 32.4 83.0 68.9 67.6 43.7 96.3 53.7 27.2 36.9 59.4 88.4 41.7 109.8 90.8 65.6 110.1 46.2 57.4 14.2 97.9 35.6 15.2 19.4 66.5 43.2 29.0 50.3 54.9 133.7 67.3 52.8 64.3 81.3 85.2 85.8 20.3 64.6 81.9 93.6 57.8 36.1 55.3 45.7 46.9 62.7 46.5 34.4 60.4 69.8 46.7 31.1 45.0 45.8 53.0 69.9 29.2 62.2 115.2 34.7 70.2 54.2 10.5 9.2 14.4 17.7 12.5 23.4 18.7 17.5 19.3 10.2 18.7 21.5 19.5 2.4 30.5 23.2 8.1 20.0 11.8 5.0 6.3 8.2 6.0 4.6 5.0 5.6 5.7 5.5 5.4 5.5 7.6 18.3 12.8 17.7 13.7 38.1 17.3 18.4 28.1 25.0 23.8 12.5 11.4 13.5 12.8 18.9 9.2 18.8 30.7 30.3 12.2 11.7 22.8 45.3 12.6 18.2 20.6 8.5 64.4 23.8 17.6 30.8 19.6 16.3 10.2 15.8 35.6 15.4 7.0 17.5 13.5 20.1 12.6 42.7 13.9 16.2 9.6 38.8 18.3 19.6 15.9 27.0 16.7 36.0 21.6 34.3 22.1 9.9 21.8 22.9 19.4 10.5 6.4 21.9 29.6 13.1 18.4 18.2 89.4 51.9 18.7 17.6 14.1 27.0 24.5 16.8 12.5 NUP133 FLJ10814 ENSG00000069248 "Nucleoporin 133" Q8WUM0 1 229440259-229508341 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 60.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059767 Approved Supported "Nuclear membrane" NA NA 6300 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 28: BEWO - Transcription regulation" "Cluster 59: Non-specific - Transcription" "Nuclear membrane" "HPA059767: AB_2684123" "unprognostic (2.05e-2)" "unprognostic (3.54e-1)" "unprognostic (5.75e-3)" "unprognostic (1.46e-1)" "unprognostic (1.09e-1)" "unprognostic (1.17e-1)" "unprognostic (3.02e-2)" "unprognostic (2.20e-2)" "unprognostic (5.72e-2)" "unprognostic (2.21e-1)" "unprognostic (4.93e-2)" "unprognostic (3.48e-1)" "unprognostic (8.31e-2)" "unprognostic (2.22e-1)" "unprognostic (7.01e-2)" "unprognostic (4.26e-2)" "unprognostic (3.30e-2)" 12.3 10.7 9.2 11.2 10.8 12.6 15.8 13.1 11.9 11.7 7.5 11.2 8.6 14.4 11.2 10.6 13.9 8.6 15.2 9.2 9.2 12.2 10.1 10.8 14.3 9.5 9.0 16.5 10.0 17.9 9.9 15.1 9.8 11.7 11.4 19.1 10.0 11.8 17.9 13.4 9.6 13.2 10.1 11.6 9.8 13.0 8.9 16.8 13.8 14.3 15.4 11.1 10.4 14.5 30.6 24.3 37.0 19.2 26.0 27.8 71.9 24.8 25.1 36.0 32.4 28.8 29.4 44.1 20.9 24.8 16.1 39.4 51.8 26.3 38.4 26.8 64.2 26.7 23.6 21.8 20.9 54.8 20.8 21.8 19.4 25.9 30.8 25.0 30.5 37.1 61.2 20.6 28.6 13.7 40.8 23.4 55.6 42.7 21.8 39.1 38.5 43.6 20.3 26.6 31.7 39.3 36.9 22.9 27.6 18.0 35.7 42.8 26.8 16.3 19.9 28.5 37.3 19.7 26.1 46.8 18.6 31.2 34.6 5.5 5.7 4.4 5.6 5.7 7.0 5.8 5.9 6.2 7.1 4.4 5.9 6.3 1.9 5.5 10.2 4.0 5.9 5.2 9.2 10.8 13.1 11.9 9.2 9.2 9.5 9.0 9.8 10.1 8.9 14.5 10.4 9.6 18.9 26.4 19.9 9.1 6.8 10.1 13.6 16.5 9.9 8.5 21.2 14.3 10.7 14.7 8.4 21.4 11.5 4.4 5.9 8.3 1.5 10.9 8.7 10.3 10.2 21.7 48.9 8.5 13.8 13.8 15.8 8.4 7.6 17.1 11.7 12.0 9.8 16.8 44.1 7.5 8.2 13.6 8.6 3.7 12.5 10.8 7.2 25.3 13.4 12.4 5.2 28.1 60.2 7.0 4.9 12.0 19.0 6.7 4.7 7.9 13.1 12.3 0.0 16.3 10.7 12.6 18.2 14.6 10.7 18.3 13.6 11.8 9.0 6.6 NUP155 "KIAA0791, N155" ENSG00000113569 "Nucleoporin 155" O75694 5 37288137-37371106 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Atrial fibrillation, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "testis: 70.8" "Cell type enhanced" "Detected in many" "Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037775 Enhanced Enhanced "Nuclear membrane" "Intracellular and membrane" NA NA 28000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" "HPA037775: AB_10671885" "unprognostic (1.10e-2)" "unprognostic (7.94e-2)" "unprognostic (1.28e-2)" "unprognostic (8.58e-3)" "unprognostic (7.14e-2)" "unprognostic (6.30e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (2.18e-1)" "unprognostic (9.91e-2)" "unprognostic (1.60e-2)" "unprognostic (2.51e-2)" "unprognostic (9.49e-2)" "unprognostic (1.49e-2)" "unprognostic (6.80e-2)" "unprognostic (2.27e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" 5.3 3.4 1.9 6.7 2.7 15.2 7.4 5.1 2.5 5.2 3.3 5.6 4.9 6.0 2.7 6.5 5.2 4.0 4.0 2.1 2.5 4.6 5.7 4.2 8.3 2.5 2.4 6.3 4.8 8.1 2.1 8.1 2.9 5.2 6.9 6.6 4.4 4.2 4.3 5.1 4.5 6.6 2.5 5.7 5.0 70.8 2.8 12.6 6.1 5.9 9.8 5.7 3.5 4.0 40.6 31.7 33.7 50.0 10.3 15.1 120.8 32.2 16.9 43.1 31.4 46.9 32.5 46.0 14.4 20.9 46.7 32.2 57.5 31.7 67.0 30.4 32.3 35.8 109.6 21.9 13.0 60.0 24.0 11.1 13.0 66.5 33.5 11.8 23.2 20.4 65.8 23.8 29.0 19.9 32.4 16.3 32.0 24.8 28.4 38.3 106.1 36.5 9.7 38.5 40.6 27.8 74.0 31.4 18.1 23.8 38.8 23.5 20.2 51.5 42.9 39.3 49.5 26.8 47.9 60.0 24.1 53.0 39.9 4.3 2.0 3.5 3.3 4.2 5.6 3.9 3.1 2.9 2.9 2.9 3.0 3.5 0.6 4.5 3.1 2.0 2.4 2.7 1.9 2.7 5.1 2.5 2.1 2.5 2.5 2.4 2.9 2.5 2.8 4.0 11.1 3.2 6.8 11.8 15.5 10.5 6.5 6.5 10.8 8.0 8.0 5.0 11.0 2.8 9.6 3.7 6.2 14.3 9.8 5.2 0.0 6.0 64.6 6.9 11.0 9.6 1.2 10.7 12.4 6.1 20.4 9.0 9.2 7.1 5.1 15.1 13.9 9.7 7.9 5.0 12.6 8.7 12.2 8.9 8.0 104.5 11.1 7.0 0.0 7.5 5.7 3.9 8.2 15.1 16.7 8.2 3.8 10.1 12.7 7.6 3.9 4.1 11.4 14.5 0.0 11.5 10.5 48.2 21.1 10.8 11.6 7.5 9.9 10.6 11.3 4.9 NUP35 MP44 ENSG00000163002 "Nucleoporin 35" Q8NFH5 2 183117513-183161680 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 151.6;Late spermatids: 424.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018401, HPA018410, HPA018441" Enhanced Supported "Nucleoplasm,Nuclear membrane,Plasma membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear membrane" "Plasma membrane" "HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720" "unprognostic (6.18e-3)" "unprognostic (3.15e-1)" "unprognostic (1.83e-1)" "unprognostic (3.58e-3)" "unprognostic (1.37e-1)" "unprognostic (9.91e-2)" "prognostic unfavorable (5.02e-4)" "unprognostic (3.95e-1)" "unprognostic (6.21e-3)" "prognostic favorable (3.45e-4)" "unprognostic (2.32e-2)" "unprognostic (1.61e-3)" "unprognostic (1.78e-3)" "unprognostic (6.78e-2)" "unprognostic (3.47e-2)" "unprognostic (1.24e-1)" "unprognostic (3.96e-2)" 7.7 8.9 5.9 6.9 7.3 4.6 13.1 8.9 7.8 8.5 5.0 7.6 6.3 8.1 7.7 8.7 8.9 6.9 6.2 6.1 5.9 10.2 14.4 5.9 9.1 5.5 5.9 10.4 10.2 8.9 6.3 7.8 5.5 7.8 9.1 9.0 8.4 7.0 7.4 9.0 6.5 8.9 6.6 5.7 7.2 24.2 5.5 10.4 8.2 8.7 11.0 9.2 8.0 6.4 19.7 19.7 32.5 20.5 11.8 11.5 23.2 23.0 18.8 35.3 33.5 37.6 24.7 34.6 22.0 12.4 40.9 17.4 45.4 26.7 57.8 29.6 27.8 32.6 16.4 43.9 8.2 23.6 21.8 8.2 13.8 29.9 28.9 7.9 20.8 20.5 28.7 25.3 27.8 23.7 28.7 29.1 57.9 31.6 61.9 34.3 25.2 25.0 34.0 24.7 29.4 20.3 21.6 26.6 26.0 24.4 17.0 16.2 10.6 28.6 19.7 23.3 26.5 16.4 38.3 37.9 19.3 16.8 39.2 0.0 4.1 1.4 4.9 5.5 8.6 7.2 6.3 6.0 3.2 6.5 7.5 6.7 0.2 5.6 6.6 3.1 6.7 4.1 5.9 7.3 8.9 7.8 6.1 5.9 5.5 5.9 5.5 6.6 5.5 6.4 9.6 9.6 6.8 6.5 10.3 26.0 20.7 17.5 12.5 10.8 9.3 8.9 4.7 14.3 13.8 16.5 18.8 23.6 8.5 3.3 11.7 15.5 151.6 5.3 8.1 10.2 3.6 12.6 11.5 12.7 20.2 10.8 5.1 6.4 8.2 8.1 12.8 12.6 8.4 6.7 12.0 7.5 16.2 4.4 9.9 424.7 9.6 3.6 21.4 2.8 5.0 11.4 7.2 17.1 12.8 11.1 5.1 8.2 7.5 12.8 4.2 14.5 6.9 19.1 13.1 18.7 11.6 39.8 21.1 11.3 27.4 9.4 11.5 9.0 9.6 11.2 NUP62 "DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI" ENSG00000213024 "Nucleoporin 62" P37198 19 49906825-49929763 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Langerhans cells: 119.2;Late spermatids: 315.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005435, CAB020724" Supported Supported "Nucleoplasm,Nuclear membrane" NA Yes 31000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" Nucleoplasm "CAB020724: , HPA005435: AB_1079510" "unprognostic (2.26e-1)" "unprognostic (4.06e-2)" "unprognostic (9.92e-2)" "unprognostic (9.68e-2)" "unprognostic (7.83e-2)" "unprognostic (1.12e-2)" "prognostic unfavorable (2.50e-7)" "unprognostic (2.76e-2)" "unprognostic (3.61e-3)" "unprognostic (3.97e-2)" "unprognostic (4.06e-2)" "unprognostic (2.03e-2)" "prognostic unfavorable (5.71e-12)" "unprognostic (3.89e-3)" "unprognostic (3.62e-1)" "unprognostic (3.96e-1)" "unprognostic (3.27e-3)" 19.9 29.4 14.2 37.3 13.2 27.1 18.9 18.4 15.9 22.5 14.0 22.5 23.7 27.6 11.0 25.0 24.8 18.4 20.4 13.9 15.7 18.5 31.7 19.4 38.3 15.5 14.2 29.8 21.0 18.0 22.8 22.4 15.8 19.9 21.1 11.1 21.8 17.5 33.7 23.4 24.3 27.7 13.6 29.8 19.4 50.4 14.7 41.9 16.3 24.5 37.7 24.6 20.1 16.9 126.7 115.5 88.8 74.0 26.0 30.0 79.7 92.8 65.8 99.3 98.8 79.8 71.9 141.2 51.7 60.8 65.9 73.6 108.3 62.1 96.1 211.6 112.0 109.8 59.4 72.6 30.9 108.8 106.8 28.6 44.8 62.0 54.8 44.1 71.5 82.7 138.6 135.5 69.2 59.7 196.7 83.6 82.0 117.4 102.8 170.3 99.9 120.3 46.9 93.7 96.2 68.8 88.2 103.8 46.3 63.8 78.8 51.5 53.0 150.2 85.3 49.1 155.4 96.3 295.9 132.5 62.2 90.1 113.9 12.3 33.4 6.7 17.7 34.7 24.1 15.1 17.6 19.6 33.1 14.9 11.9 15.4 5.2 22.0 20.1 29.0 17.2 22.1 14.2 13.2 18.4 15.9 13.9 15.7 15.5 14.2 15.8 13.6 14.7 16.9 16.8 25.6 22.4 0.0 28.4 34.2 16.5 16.0 21.1 11.4 23.7 26.0 15.4 21.5 18.3 9.2 6.2 37.0 24.4 24.9 9.8 23.7 113.5 19.2 23.9 27.7 21.6 39.1 0.0 16.3 48.4 19.5 20.4 25.6 23.4 30.4 30.4 13.3 49.5 63.9 0.0 27.0 16.2 36.1 119.2 315.1 24.8 41.5 21.4 0.0 77.1 19.1 22.6 0.0 0.0 22.9 22.8 23.0 23.3 24.1 20.6 16.1 19.2 16.3 19.7 18.0 16.0 71.0 39.3 20.0 32.0 21.8 24.4 17.2 33.4 16.6 NVL NVL2 ENSG00000143748 "Nuclear VCP like" O15381 1 224227334-224330189 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028207, HPA028219, HPA028224, HPA028654" Supported Enhanced Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoli "HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714" "unprognostic (1.50e-1)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (2.03e-1)" "unprognostic (3.76e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (5.77e-5)" "prognostic favorable (2.95e-4)" "unprognostic (4.43e-2)" "unprognostic (7.14e-2)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "prognostic unfavorable (4.10e-11)" "unprognostic (1.67e-1)" "unprognostic (2.01e-1)" "unprognostic (1.75e-1)" "unprognostic (1.37e-1)" 7.0 7.7 5.5 8.7 5.7 9.8 10.7 7.8 7.5 9.5 6.5 9.1 6.3 9.0 7.7 7.2 8.8 5.6 5.9 5.3 6.4 8.7 6.1 8.0 12.5 5.4 5.3 10.6 8.8 9.5 10.3 13.0 5.6 9.0 10.6 12.8 7.4 7.9 6.5 15.7 8.2 8.1 4.7 10.4 7.2 6.6 5.6 13.0 10.2 5.2 12.1 8.8 8.9 7.5 28.8 15.8 31.2 25.2 11.5 16.6 31.6 22.0 16.5 30.6 27.0 23.4 23.4 39.6 22.5 14.7 11.7 26.1 37.3 22.2 31.5 30.5 47.0 16.4 25.5 11.3 20.3 39.1 28.8 13.5 16.9 26.8 28.5 14.3 19.2 23.0 48.9 23.8 19.1 21.3 30.6 18.3 47.5 20.0 26.1 34.2 37.3 24.8 17.8 19.2 27.5 22.9 34.2 53.1 31.9 25.6 24.3 32.1 19.8 23.2 14.9 27.1 42.9 15.6 33.3 39.3 15.1 30.2 24.8 13.9 7.8 8.4 11.5 11.8 11.7 13.5 11.8 9.1 8.7 9.0 9.9 10.0 0.8 11.9 16.4 9.0 9.3 7.8 5.5 5.7 7.8 7.5 5.3 6.4 5.4 5.3 5.6 4.7 5.6 7.5 10.2 22.4 23.1 21.2 14.3 5.2 4.6 7.8 4.0 14.5 7.9 8.3 10.5 7.2 12.2 1.8 10.4 21.5 12.6 26.9 13.7 9.5 10.1 10.0 11.6 9.3 4.2 7.2 32.1 8.4 14.0 9.3 5.6 7.3 16.4 13.4 4.6 4.5 10.7 10.1 31.0 12.6 10.2 6.5 5.7 3.1 9.6 8.1 5.4 26.2 8.7 9.7 15.5 24.6 43.0 7.0 23.4 10.9 12.3 3.7 7.0 8.1 16.7 20.4 0.0 8.5 10.1 17.5 11.3 7.3 4.5 18.3 12.9 11.4 14.7 3.7 NXT2 P15-2 ENSG00000101888 "Nuclear transport factor 2 like export factor 2" Q9NPJ8 X 109535781-109544698 "Predicted intracellular proteins" "mRNA transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HL-60: 157.3;U-937: 166.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024199, HPA072010" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA024199: AB_1854738, HPA072010: AB_2686483" "unprognostic (1.72e-1)" "unprognostic (1.39e-2)" "unprognostic (7.99e-2)" "unprognostic (5.31e-2)" "unprognostic (6.58e-2)" "unprognostic (3.69e-2)" "unprognostic (5.39e-2)" "unprognostic (3.14e-1)" "unprognostic (8.77e-2)" "unprognostic (3.36e-3)" "unprognostic (2.83e-3)" "unprognostic (1.14e-1)" "unprognostic (2.16e-3)" "unprognostic (2.59e-2)" "unprognostic (5.70e-2)" "unprognostic (2.56e-1)" "unprognostic (4.90e-2)" 7.6 4.8 5.3 8.0 5.6 17.5 15.2 6.0 6.8 9.2 4.0 7.8 9.2 5.6 7.2 8.9 7.0 6.1 2.7 4.8 5.8 9.3 11.9 8.0 12.3 6.0 5.8 6.5 4.3 7.3 1.2 8.4 6.4 6.4 8.5 2.2 7.7 4.3 1.9 12.2 7.5 4.5 6.8 7.5 8.7 27.6 5.4 14.8 7.9 3.4 14.1 8.8 4.4 6.9 14.2 12.2 11.6 20.3 17.1 13.5 25.6 8.8 14.9 11.1 14.4 9.6 19.5 18.1 27.1 11.1 30.0 10.5 15.4 13.8 16.9 23.5 9.5 15.1 10.6 15.8 7.0 157.3 60.9 9.9 11.8 10.6 6.6 8.3 10.0 18.7 16.1 72.2 11.0 14.6 23.9 16.6 18.6 19.8 18.0 9.4 16.4 21.6 10.4 13.9 4.6 14.6 37.7 21.2 12.0 10.1 9.0 52.1 7.5 15.9 9.0 21.2 9.3 14.8 19.5 27.7 13.9 166.9 16.6 4.7 7.2 3.6 9.2 9.8 6.0 6.3 6.7 7.5 9.7 6.2 6.6 6.5 1.4 10.8 8.1 5.9 8.4 8.0 5.3 5.6 6.0 6.8 4.8 5.8 6.0 5.8 6.4 6.8 5.4 6.9 4.8 3.2 6.5 2.0 10.1 19.2 21.0 10.4 9.6 1.4 18.0 11.3 30.0 2.8 12.8 3.7 0.0 15.1 12.9 7.9 21.5 12.5 21.5 9.3 6.0 5.4 1.2 12.4 0.5 14.0 24.8 7.5 7.1 15.0 5.7 6.0 4.6 5.4 11.4 0.0 0.4 4.4 10.2 10.1 20.0 5.9 4.7 9.9 1.8 1.0 31.9 9.2 26.8 1.5 2.5 9.0 7.6 4.5 12.3 20.3 7.6 16.6 10.5 1.4 13.1 5.3 5.2 31.7 33.7 17.0 23.3 29.1 9.4 6.6 6.4 21.3 OAS2 ENSG00000111335 "2'-5'-oligoadenylate synthetase 2" P29728 12 112978395-113011723 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Nucleotidyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 67.2" "Cell type enhanced" "Detected in many" "Adipocytes: 22.8;Endothelial cells: 21.4;Macrophages: 27.6;monocytes: 26.1;NK-cells: 26.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 364.3;BJ hTERT+ SV40 Large T+ RasG12V: 297.5;Daudi: 88.7;SK-MEL-30: 135.0;U-266/70: 118.4;U-266/84: 115.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003320, CAB024984" Approved Approved Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Centrosome "CAB024984: , HPA003320: " "unprognostic (2.39e-1)" "unprognostic (9.51e-2)" "unprognostic (2.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.34e-1)" "unprognostic (7.94e-2)" "unprognostic (4.79e-2)" "unprognostic (2.05e-2)" "unprognostic (1.31e-1)" "unprognostic (7.64e-3)" "prognostic unfavorable (4.63e-4)" "unprognostic (4.20e-1)" "prognostic unfavorable (4.31e-6)" "unprognostic (1.12e-1)" "unprognostic (4.17e-2)" "unprognostic (1.11e-1)" "unprognostic (1.94e-2)" 11.9 4.3 5.1 25.7 5.5 15.1 7.2 5.6 7.9 9.8 4.6 8.6 9.3 6.2 2.9 13.4 6.2 17.8 8.7 5.1 5.0 5.8 19.6 26.3 38.0 10.6 6.4 2.1 1.6 2.8 2.3 23.4 8.0 7.2 9.0 1.0 67.2 3.6 2.5 2.7 9.1 12.9 12.0 43.5 18.5 3.8 6.0 36.7 5.2 6.9 33.1 22.8 5.6 6.5 3.0 0.5 0.2 0.2 1.7 12.3 0.2 0.5 41.9 364.3 297.5 0.6 5.9 88.7 8.4 6.9 71.3 3.4 0.8 0.9 12.1 22.8 0.2 0.2 0.8 0.5 2.5 0.1 0.2 0.8 6.0 19.7 0.0 0.3 5.2 4.2 0.1 42.2 0.2 1.2 2.4 4.2 0.1 0.4 12.4 20.5 0.1 13.5 0.1 31.2 0.1 0.1 3.3 0.6 135.0 0.2 2.6 5.4 8.1 0.6 0.1 1.1 0.3 118.4 115.4 13.6 2.6 4.5 2.7 3.9 35.5 2.7 25.6 55.6 33.5 24.3 30.0 29.6 26.9 15.5 28.9 21.7 3.6 32.1 60.2 11.5 35.4 30.9 5.1 5.5 5.6 7.9 5.1 5.0 10.6 6.4 8.0 12.0 6.0 6.5 22.8 3.2 6.0 0.3 16.6 2.0 1.6 4.0 2.8 0.1 2.1 1.3 1.6 0.0 5.1 1.8 0.0 0.2 15.1 1.2 0.0 1.0 0.7 3.5 3.4 21.4 0.0 4.0 0.2 1.2 2.4 4.8 6.1 1.7 1.3 2.5 12.1 2.6 16.1 0.0 0.5 3.8 0.0 19.7 4.7 1.2 0.6 27.6 5.4 10.3 26.1 0.4 26.8 2.0 0.1 3.8 1.2 3.4 15.5 2.6 0.4 0.3 12.2 0.2 0.0 1.0 2.7 0.1 0.1 7.6 1.1 0.1 15.5 6.0 0.4 10.4 OCIAD1 "Asrij, FLJ20455, OCIA, TPA018" ENSG00000109180 "OCIA domain containing 1" Q9NX40 4 48805212-48861817 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044803 Approved Approved Mitochondria NA NA 21000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "HPA044803: AB_10961287" "unprognostic (8.18e-2)" "unprognostic (1.60e-2)" "unprognostic (4.82e-2)" "unprognostic (7.39e-2)" "unprognostic (1.69e-1)" "unprognostic (4.17e-2)" "unprognostic (2.53e-1)" "unprognostic (1.60e-1)" "unprognostic (4.10e-1)" "unprognostic (2.83e-3)" "unprognostic (1.34e-1)" "unprognostic (5.42e-2)" "unprognostic (1.47e-3)" "unprognostic (9.23e-2)" "unprognostic (2.86e-1)" "unprognostic (1.56e-1)" "unprognostic (1.16e-2)" 129.5 184.0 161.1 99.4 170.6 107.7 153.9 154.6 212.9 150.3 173.5 161.1 155.8 138.0 192.2 118.1 167.2 124.6 219.3 177.3 177.0 238.1 326.5 124.1 127.3 161.1 153.1 159.1 156.1 248.7 109.9 118.4 157.6 145.9 159.9 143.7 161.9 148.1 255.0 107.1 134.6 133.3 163.1 105.1 141.3 91.0 165.8 133.6 239.4 255.9 133.9 136.3 72.3 172.6 165.2 118.2 231.7 162.8 230.8 283.0 178.6 253.1 393.8 261.1 311.3 110.6 473.2 190.4 241.5 238.0 311.4 141.7 229.4 250.4 296.2 149.4 152.7 293.4 105.7 88.1 336.5 309.1 300.9 292.0 353.5 208.3 258.4 315.4 270.0 173.9 339.8 104.1 300.0 107.7 261.4 287.6 195.2 211.7 110.4 169.6 216.9 203.1 502.9 154.5 139.8 261.0 120.4 101.1 306.5 179.8 212.8 271.5 196.9 176.1 200.7 120.7 333.1 256.3 380.4 283.1 223.2 251.0 220.2 47.8 60.2 76.5 62.6 68.0 90.8 74.1 73.1 79.2 75.4 64.9 90.2 80.5 48.3 95.4 86.5 85.2 68.5 73.5 161.1 170.6 154.6 212.9 177.3 177.0 161.1 153.1 157.6 163.1 165.8 172.6 176.7 160.3 124.5 85.8 107.1 79.7 111.3 243.3 102.4 126.6 96.7 119.6 152.3 102.9 169.4 121.4 66.7 170.5 103.1 140.0 137.0 140.0 34.3 147.3 120.5 120.2 130.1 89.8 125.1 128.3 168.8 124.4 84.1 110.5 141.8 102.6 118.9 167.3 152.7 89.2 137.2 131.3 124.1 94.0 77.2 35.5 132.3 106.1 87.2 76.8 107.2 206.1 121.5 106.1 158.1 130.7 122.5 139.2 115.3 104.2 164.1 178.9 151.2 111.6 124.9 121.3 112.7 188.3 88.3 94.1 75.9 164.7 109.8 197.2 142.7 100.4 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 37.8;Glandular and luminal cells: 38.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 21: OE19 - Mitochondria" "Cluster 7: Non-specific - Mitochondria" "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 14.4 7.5 7.2 9.2 15.0 14.0 10.4 10.1 13.3 8.4 10.8 13.4 9.4 17.2 7.8 8.8 10.6 10.0 7.6 8.2 16.7 21.8 9.5 6.7 8.9 8.6 10.3 29.1 32.4 12.4 14.2 9.2 16.6 12.7 15.2 21.7 12.2 9.0 10.3 13.6 8.8 8.7 8.5 13.1 8.3 8.2 6.4 19.9 9.5 7.1 11.5 8.2 11.9 12.6 13.9 15.1 12.1 17.5 16.3 28.8 19.9 12.2 12.7 12.8 28.2 29.7 8.7 23.5 9.9 11.6 32.3 11.4 10.9 12.5 7.1 10.9 8.2 17.7 15.9 16.4 13.8 9.6 12.5 21.3 15.4 24.1 13.2 13.8 9.0 32.1 17.3 15.3 13.5 9.7 14.3 21.6 46.0 5.0 11.2 10.5 25.0 26.1 12.9 11.0 17.2 15.1 33.0 24.5 26.9 29.1 12.4 13.2 18.1 11.5 12.2 18.9 20.2 13.3 13.3 9.8 7.4 16.7 1.4 9.0 2.5 3.0 8.9 4.5 3.6 3.8 4.2 7.6 2.3 4.7 3.6 3.9 10.0 11.4 4.8 5.7 3.9 7.5 9.2 10.4 10.1 7.6 8.2 8.9 8.6 9.2 8.7 8.2 11.9 28.1 28.9 37.8 0.0 4.2 0.0 0.0 0.0 0.0 0.0 18.8 16.5 0.0 0.0 29.7 25.8 0.0 22.0 12.6 0.0 9.8 22.8 0.0 26.8 27.0 9.8 0.0 0.0 0.0 25.4 25.7 12.3 0.0 38.6 12.6 26.4 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 6.7 0.0 0.0 0.0 0.0 24.7 0.0 0.0 4.0 0.0 0.0 10.7 15.3 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 28.0 6.9 29.0 0.0 0.0 OLA1 "GTPBP9, PTD004" ENSG00000138430 "Obg like ATPase 1" Q9NTK5 2 174072447-174248599 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035790, HPA041443" Approved Enhanced Cytosol NA NA 3300000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "HPA035790: AB_10601977, HPA041443: AB_2677483" "unprognostic (3.30e-1)" "unprognostic (1.06e-1)" "unprognostic (2.23e-2)" "unprognostic (2.85e-3)" "unprognostic (1.20e-1)" "unprognostic (3.08e-3)" "prognostic unfavorable (9.73e-8)" "unprognostic (6.51e-3)" "unprognostic (7.66e-2)" "unprognostic (1.09e-2)" "unprognostic (3.50e-3)" "unprognostic (1.63e-1)" "unprognostic (1.13e-3)" "unprognostic (4.32e-2)" "unprognostic (2.51e-2)" "unprognostic (2.62e-2)" "unprognostic (9.75e-2)" 42.2 44.3 39.7 38.2 42.7 53.7 57.3 42.5 48.9 34.3 30.0 48.0 50.1 34.7 38.8 58.1 38.0 35.1 57.4 44.5 43.8 56.4 43.0 23.5 47.9 38.0 36.6 31.1 56.3 44.1 27.4 42.0 40.1 41.1 52.7 42.5 36.3 33.6 105.6 52.0 45.7 37.0 38.0 24.6 35.2 48.8 40.7 58.3 59.7 93.1 53.3 48.3 31.0 39.1 181.4 84.1 134.9 225.5 70.1 152.2 243.0 142.1 142.8 194.2 147.1 200.9 104.4 246.5 138.9 114.5 143.9 139.9 165.3 164.6 227.3 113.7 142.5 231.3 76.4 209.9 135.3 264.3 90.2 134.8 200.6 206.3 217.4 177.4 174.5 88.0 256.8 82.3 170.3 116.6 241.4 272.9 159.1 193.9 273.0 180.4 217.8 170.7 245.1 192.0 218.3 124.7 96.8 141.6 206.2 142.2 101.2 220.6 127.5 127.1 161.4 128.5 210.8 76.2 207.3 190.5 124.6 180.0 115.4 18.1 24.9 7.4 16.2 24.2 23.4 17.9 18.6 20.8 37.1 16.4 21.5 21.2 2.1 26.1 20.0 22.5 25.3 22.7 39.7 42.7 42.5 48.9 44.5 43.8 38.0 36.6 40.1 38.0 40.7 39.1 43.2 35.3 33.0 57.5 49.0 62.7 73.5 92.4 76.8 47.3 86.0 83.8 68.3 47.1 57.0 31.3 35.5 153.7 47.7 44.6 103.7 145.1 267.8 37.1 55.2 47.8 70.7 92.5 132.6 105.3 112.8 53.0 60.1 43.1 41.2 73.3 29.3 25.8 97.3 33.7 129.8 79.6 65.1 59.6 54.4 99.5 40.4 55.9 32.0 65.6 83.1 60.3 52.5 101.6 101.8 112.8 51.8 51.1 56.3 84.2 78.4 141.7 36.1 35.9 26.3 69.7 92.3 104.8 35.9 113.7 64.1 105.9 55.9 94.6 107.6 79.3 OMA1 "FLJ33782, MPRP-1, YKR087C, ZMPOMA1" ENSG00000162600 "OMA1 zinc metallopeptidase" Q96E52 1 58415384-58546802 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 106.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055120 Approved Approved Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Mitochondria" "HPA055120: AB_2682702" "prognostic favorable (1.63e-4)" "unprognostic (2.67e-2)" "prognostic favorable (7.70e-4)" "unprognostic (1.60e-3)" "unprognostic (1.61e-1)" "unprognostic (9.57e-2)" "unprognostic (3.94e-3)" "prognostic favorable (8.52e-4)" "unprognostic (8.22e-3)" "unprognostic (6.91e-2)" "unprognostic (4.10e-2)" "unprognostic (1.40e-1)" "unprognostic (9.54e-3)" "unprognostic (2.52e-2)" "unprognostic (3.93e-2)" "unprognostic (1.74e-2)" "unprognostic (5.24e-3)" 11.4 18.7 15.1 14.0 22.8 12.8 19.7 23.1 14.9 16.7 14.9 20.8 14.9 13.5 17.8 13.3 19.4 15.1 19.8 13.0 19.5 28.4 31.1 11.9 23.4 18.8 17.9 13.5 17.9 18.1 10.4 11.5 21.1 20.8 20.0 20.5 19.5 16.7 28.2 12.8 14.2 12.4 15.6 20.2 17.3 8.2 18.3 20.2 20.1 29.9 21.5 14.8 10.5 27.3 31.2 13.0 8.3 7.9 41.7 39.0 24.6 12.7 13.9 10.9 13.7 4.0 18.7 69.8 26.3 13.1 37.8 31.2 31.1 31.3 13.3 55.1 17.9 22.0 10.4 16.1 20.3 54.3 14.7 37.3 33.6 10.4 22.4 24.1 9.3 34.3 42.7 20.1 29.2 19.5 18.0 19.4 12.4 47.4 28.5 22.1 27.7 29.1 23.6 20.5 8.7 4.3 26.0 41.9 37.6 38.4 19.5 20.1 5.4 5.6 10.8 27.8 13.5 16.3 23.4 46.2 16.8 42.2 14.1 20.1 14.4 32.1 19.4 24.1 25.6 35.6 23.7 23.1 15.4 35.0 33.9 31.5 17.2 30.9 35.1 8.2 23.6 15.9 15.1 22.8 23.1 14.9 13.0 19.5 18.8 17.9 21.1 15.6 18.3 27.3 8.4 19.2 11.5 37.9 25.7 6.0 18.2 35.6 13.6 7.8 15.0 12.3 27.2 8.6 33.0 25.8 12.5 22.9 14.4 8.4 25.4 11.2 5.8 31.6 10.8 6.3 6.0 15.6 18.3 5.5 10.0 12.0 5.6 18.4 6.3 10.9 6.4 18.7 15.8 1.7 31.7 17.7 36.7 10.1 9.7 12.7 9.9 12.9 7.2 29.0 11.3 10.9 15.5 52.8 106.5 3.8 10.9 8.6 16.8 12.3 8.5 32.4 63.1 20.5 6.6 12.0 8.6 14.3 13.6 17.3 6.8 18.3 20.7 17.1 14.6 17.1 PAK1IP1 "bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84" ENSG00000111845 "PAK1 interacting protein 1" Q9NWT1 6 10694972-10709782 "Predicted intracellular proteins" "Ribosome biogenesis" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030111, HPA030112" Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA030111: AB_2732454, HPA030112: AB_10603125" "unprognostic (9.41e-2)" "unprognostic (3.79e-1)" "unprognostic (1.67e-2)" "unprognostic (1.17e-1)" "unprognostic (1.51e-1)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.35e-6)" "unprognostic (7.23e-2)" "unprognostic (9.29e-3)" "unprognostic (1.06e-3)" "unprognostic (2.14e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (7.02e-8)" "unprognostic (8.14e-2)" "unprognostic (2.04e-1)" "unprognostic (1.11e-1)" "unprognostic (2.10e-1)" 13.5 10.3 5.6 7.6 5.7 10.6 12.4 5.7 8.1 9.3 5.5 8.4 4.2 10.3 7.2 16.3 8.4 5.2 9.6 5.7 6.2 9.3 11.3 7.3 7.8 5.7 6.0 8.0 9.6 5.7 6.7 7.0 5.9 37.8 7.3 4.9 9.2 5.7 15.2 8.8 7.1 8.1 5.8 8.2 7.8 5.7 5.9 7.0 7.5 9.7 9.6 11.5 9.9 6.9 35.3 13.7 17.2 29.9 21.3 19.4 24.9 22.4 18.7 33.7 32.9 30.2 15.4 35.6 54.9 19.4 41.4 18.4 35.8 29.2 48.1 20.9 23.3 19.4 12.4 35.2 31.1 54.5 24.3 17.9 25.2 32.6 55.3 11.1 22.9 19.2 60.2 10.0 28.3 21.2 27.4 49.5 37.4 32.7 24.1 27.9 22.4 55.0 24.4 21.0 25.7 22.4 16.8 42.7 51.1 28.9 18.9 19.6 19.6 26.9 19.5 29.2 56.4 23.3 68.7 38.9 11.0 36.3 51.7 2.0 8.1 2.9 9.4 12.4 9.6 10.0 8.3 9.4 11.7 7.2 11.1 13.5 0.4 9.9 10.3 13.7 5.9 6.8 5.6 5.7 5.7 8.1 5.7 6.2 5.7 6.0 5.9 5.8 5.9 6.9 22.6 19.2 12.3 8.8 18.5 66.4 54.2 47.3 30.1 13.2 18.6 28.3 18.6 17.2 35.0 11.0 4.2 24.9 24.8 10.3 19.6 43.3 12.4 26.0 35.0 24.1 5.4 31.1 9.9 26.9 32.0 32.0 14.8 34.3 35.5 16.6 15.0 21.7 36.6 13.5 10.9 12.7 42.7 16.1 12.6 8.4 21.5 18.2 12.4 6.5 22.1 12.0 12.3 9.5 12.5 31.3 7.7 20.7 18.2 56.5 5.1 27.0 17.7 11.8 6.6 40.9 31.4 27.3 44.2 29.3 49.9 17.5 16.3 23.1 24.0 28.6 PAN2 "hPAN2, KIAA0710, USP52" ENSG00000135473 "Poly(A) specific ribonuclease subunit PAN2" Q504Q3 12 56316223-56334053 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "unprognostic (2.43e-1)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (2.55e-1)" "unprognostic (1.67e-1)" "unprognostic (9.10e-3)" "unprognostic (1.03e-1)" "unprognostic (7.28e-2)" "unprognostic (7.35e-3)" "unprognostic (3.80e-1)" "unprognostic (1.74e-3)" "unprognostic (4.23e-3)" "prognostic unfavorable (2.77e-4)" "unprognostic (4.19e-1)" "unprognostic (3.87e-1)" "unprognostic (2.10e-1)" "unprognostic (2.68e-2)" 6.6 8.7 4.2 5.8 6.1 7.4 7.4 6.0 6.0 8.3 6.9 8.0 9.9 9.1 14.1 5.0 9.7 6.6 7.1 4.1 4.5 7.6 16.0 7.3 8.5 5.3 5.2 12.7 10.0 14.1 11.6 8.2 5.4 6.7 8.2 16.0 7.9 8.2 6.9 8.3 8.7 7.5 4.7 10.1 9.5 13.5 5.7 16.8 14.8 6.7 10.0 7.0 6.7 7.9 4.3 6.4 15.5 4.9 13.3 15.0 10.1 3.2 4.4 7.1 3.2 3.9 8.3 11.8 12.2 6.3 3.8 8.8 18.6 12.3 4.0 5.2 8.8 15.1 6.6 3.8 11.7 3.3 7.8 14.0 16.3 7.6 22.0 18.7 5.4 24.2 10.3 28.4 4.2 9.4 11.3 7.9 5.2 7.2 4.2 9.7 11.0 21.5 7.0 3.4 12.1 11.0 6.2 7.9 8.0 17.2 10.2 6.4 2.3 7.0 7.0 3.3 3.0 23.9 10.3 7.8 8.7 6.8 6.2 3.2 3.3 1.3 1.3 4.4 1.9 1.6 1.1 1.9 4.2 1.3 2.2 2.7 0.2 2.3 2.2 1.7 1.7 2.0 4.2 6.1 6.0 6.0 4.1 4.5 5.3 5.2 5.4 4.7 5.7 7.9 9.7 9.6 17.0 19.2 11.1 5.1 5.4 3.8 6.8 27.4 9.5 10.2 9.8 2.8 8.3 5.5 27.1 8.2 7.9 5.4 1.9 3.7 1.8 8.6 9.4 9.4 14.4 13.3 11.0 2.2 4.8 7.2 18.3 13.7 6.3 15.0 10.4 18.3 5.4 15.2 13.9 10.8 4.1 7.0 5.0 2.6 11.1 8.2 1.8 9.4 5.2 7.3 3.1 10.1 32.1 2.8 8.7 6.4 9.2 4.1 7.3 3.5 13.4 17.1 6.6 11.4 6.9 26.9 7.6 7.1 3.8 5.1 6.6 12.6 9.5 3.6 PARN DAN ENSG00000140694 "Poly(A)-specific ribonuclease" O95453 16 14435700-14632728 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Nonsense-mediated mRNA decay" "Exonuclease, Hydrolase, Nuclease, RNA-binding" "Disease variant, Dyskeratosis congenita" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006314, CAB011673, HPA012010" Supported Supported "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" "Nuclear speckles" "CAB011673: AB_778216, HPA006314: AB_1079567, HPA012010: AB_1854976" "unprognostic (2.54e-1)" "unprognostic (3.43e-2)" "unprognostic (1.55e-1)" "unprognostic (2.23e-1)" "unprognostic (2.28e-1)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.99e-3)" "unprognostic (5.07e-2)" "unprognostic (1.32e-1)" "unprognostic (1.94e-1)" "unprognostic (2.16e-3)" "unprognostic (1.75e-1)" "unprognostic (1.52e-1)" "unprognostic (3.25e-2)" "unprognostic (2.46e-1)" "unprognostic (3.10e-3)" "unprognostic (1.09e-2)" 16.6 20.2 10.8 13.9 12.1 9.2 15.9 11.7 11.4 17.2 12.0 19.3 11.8 19.1 24.7 15.6 16.0 13.4 14.8 10.6 14.0 12.7 16.4 14.2 21.2 11.7 11.9 16.4 16.5 21.1 16.3 15.6 11.9 16.1 16.8 7.0 15.3 17.1 16.8 17.9 16.1 18.0 11.3 15.7 16.2 18.1 12.6 21.6 20.6 9.7 23.4 19.3 16.0 13.5 28.0 39.9 17.6 22.9 32.9 33.2 20.3 24.4 32.4 29.8 28.3 21.9 28.7 56.2 63.1 32.3 25.3 30.4 46.7 32.3 41.0 42.9 29.4 28.8 24.2 53.2 35.5 46.0 36.2 32.5 38.5 32.0 43.1 25.5 22.5 32.6 28.5 29.9 32.5 44.9 36.7 33.1 26.0 28.2 16.7 56.2 36.1 57.1 23.1 17.1 18.7 16.9 53.4 29.6 36.3 28.6 31.6 28.0 21.2 31.5 15.8 16.4 26.9 32.5 31.0 63.5 34.6 30.8 35.8 8.9 8.0 15.8 8.6 13.2 7.7 16.0 10.4 12.4 13.6 9.4 14.2 14.4 6.2 15.0 15.6 8.3 19.1 7.1 10.8 12.1 11.7 11.4 10.6 14.0 11.7 11.9 11.9 11.3 12.6 13.5 18.0 32.1 39.1 37.9 26.2 7.1 7.8 9.7 21.6 13.0 13.4 14.0 22.3 7.2 11.8 11.0 8.4 29.2 24.7 13.6 11.7 14.2 14.1 15.2 20.5 15.2 14.9 20.4 48.0 12.9 23.2 19.5 21.9 21.7 2.5 19.2 11.7 15.6 14.8 8.4 48.2 14.3 6.1 14.2 5.8 6.3 21.1 18.2 10.6 54.4 35.8 10.3 52.5 38.2 72.4 15.2 10.6 17.7 23.0 7.1 12.2 10.8 19.2 10.8 19.7 13.1 15.0 70.5 70.5 20.0 8.2 22.4 21.5 20.1 13.4 4.8 PARS2 DKFZp727A071 ENSG00000162396 "Prolyl-tRNA synthetase 2, mitochondrial" Q7L3T8 1 54756898-54764523 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 9.8;Early spermatids: 11.0;Spermatocytes: 10.5;Spermatogonia: 11.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028308, HPA028314, HPA028518" Uncertain Approved "Nucleoli fibrillar center,Mitochondria" No No "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoli fibrillar center, Mitochondria" "HPA028308: AB_2672553, HPA028314: AB_10603981, HPA028518: AB_2672653" "unprognostic (1.95e-1)" "unprognostic (1.10e-1)" "prognostic favorable (1.26e-5)" "unprognostic (1.93e-2)" "unprognostic (1.19e-2)" "unprognostic (1.79e-3)" "prognostic unfavorable (2.34e-4)" "unprognostic (6.48e-2)" "unprognostic (2.72e-1)" "unprognostic (1.14e-1)" "unprognostic (9.42e-2)" "unprognostic (1.10e-1)" "prognostic favorable (1.24e-6)" "unprognostic (2.72e-2)" "unprognostic (9.77e-2)" "unprognostic (1.73e-2)" "unprognostic (9.64e-2)" 1.3 2.9 2.5 1.9 3.0 0.2 2.7 2.8 3.1 2.7 3.0 4.0 2.7 2.5 3.2 2.7 4.4 1.6 3.0 2.6 2.6 4.2 3.4 1.4 2.0 2.5 2.7 4.8 2.3 4.7 2.1 2.5 2.7 2.3 3.6 2.0 3.3 2.8 4.4 2.9 2.1 2.0 2.7 1.8 2.5 4.8 2.7 2.6 2.9 5.5 2.4 2.1 2.0 3.0 4.4 7.2 4.6 6.0 5.5 4.6 10.3 3.7 4.5 6.4 4.6 8.3 2.8 7.7 5.6 3.3 9.3 6.9 8.3 5.8 4.7 5.0 7.5 7.4 4.0 6.2 8.5 4.3 2.5 5.0 8.8 8.3 7.4 5.5 4.8 8.4 13.2 1.0 4.9 4.6 6.1 5.7 10.6 8.3 9.1 4.6 9.0 9.0 5.4 3.2 4.7 4.8 5.3 6.9 9.7 8.7 3.9 5.5 2.6 4.8 4.9 6.8 4.7 7.3 6.6 3.0 3.6 5.1 2.8 1.2 5.3 4.5 4.8 7.7 5.9 4.9 5.3 5.3 7.3 5.5 7.8 5.3 0.5 7.4 10.7 5.9 8.2 5.0 2.5 3.0 2.8 3.1 2.6 2.6 2.5 2.7 2.7 2.7 2.7 3.0 0.6 0.0 1.1 0.3 1.0 0.6 0.9 2.0 1.8 2.6 1.3 1.9 1.5 2.8 1.8 0.0 0.0 7.0 0.2 2.4 9.8 4.5 11.0 1.1 1.4 0.8 0.0 0.0 0.9 2.8 3.9 1.3 1.5 0.6 0.0 2.9 0.0 2.3 3.1 5.0 1.1 2.8 0.0 1.2 0.3 6.8 3.7 0.8 0.0 2.8 1.1 3.2 0.0 0.5 1.6 1.9 1.5 3.0 0.3 1.8 1.5 6.5 1.0 1.9 0.0 1.3 1.1 10.5 11.5 2.0 1.0 3.3 0.7 5.1 3.5 0.8 PCCA ENSG00000175198 "Propionyl-CoA carboxylase subunit alpha" P05165 13 100089015-100530437 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" Ligase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "epididymis: 218.2" "Cell type enhanced" "Detected in all" "Astrocytes: 152.8;Excitatory neurons: 152.8;Inhibitory neurons: 166.5;Microglial cells: 217.4;Oligodendrocyte precursor cells: 200.6;Oligodendrocytes: 182.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 167.0;SCLC-21H: 91.1;U-937: 131.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041716, HPA047792" Enhanced Supported Mitochondria NA NA 290000 "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 68: Oligodendrocytes - Mixed function" Mitochondria "HPA041716: AB_2677635, HPA047792: AB_2680156" "unprognostic (1.18e-1)" "unprognostic (2.13e-1)" "unprognostic (1.97e-2)" "unprognostic (4.71e-2)" "unprognostic (1.11e-2)" "unprognostic (1.71e-2)" "unprognostic (1.55e-1)" "unprognostic (5.90e-3)" "unprognostic (2.41e-1)" "unprognostic (1.55e-1)" "unprognostic (6.14e-2)" "unprognostic (1.42e-1)" "prognostic favorable (0.00e+0)" "unprognostic (7.08e-2)" "unprognostic (1.12e-1)" "unprognostic (1.18e-1)" "unprognostic (9.32e-2)" 35.4 56.3 29.0 12.4 29.8 6.2 25.8 55.5 34.6 22.3 44.4 37.5 13.2 14.9 218.2 19.4 17.4 11.6 35.4 28.6 26.3 111.7 104.3 12.0 8.0 28.9 27.4 19.9 27.6 25.7 12.3 21.3 31.1 25.9 27.6 25.2 26.9 16.9 17.6 18.6 18.0 13.7 30.3 17.2 40.9 9.2 33.9 11.4 20.4 27.2 6.4 21.3 17.5 38.7 10.6 18.5 29.8 9.9 27.9 24.2 16.6 10.2 15.4 9.5 9.0 23.0 13.9 0.8 15.2 10.1 12.0 11.8 9.1 14.1 15.6 17.5 10.1 24.6 12.7 49.7 15.4 1.2 11.3 22.4 15.2 8.8 14.6 23.0 19.6 13.0 9.8 13.4 17.1 11.6 2.6 54.8 18.6 37.2 8.1 21.4 12.9 17.3 167.0 20.5 91.1 10.9 7.0 38.4 17.9 31.9 27.9 43.1 14.3 9.6 8.0 6.7 7.3 13.1 12.9 0.4 18.4 131.6 6.9 1.6 9.1 1.7 4.5 11.2 5.9 3.6 2.8 4.2 13.5 2.3 3.9 4.9 1.1 8.7 12.3 1.1 6.5 5.2 29.0 29.8 55.5 34.6 28.6 26.3 28.9 27.4 31.1 30.3 33.9 38.7 11.3 3.2 8.7 152.8 6.6 1.9 29.1 12.7 8.6 15.5 13.5 8.8 10.5 52.9 14.8 20.2 29.2 25.7 4.3 20.7 99.7 19.7 17.6 76.5 22.4 12.0 3.6 3.4 152.8 8.4 6.9 12.9 12.2 72.9 14.0 20.7 12.1 48.8 11.8 28.6 166.5 12.4 12.2 14.2 2.2 12.0 8.7 8.2 5.4 217.4 6.0 11.5 10.3 200.6 182.5 5.8 17.5 13.5 9.4 11.2 13.2 86.9 13.2 31.7 13.1 12.3 10.1 7.2 6.2 10.6 3.8 30.2 6.4 17.6 27.6 19.2 PCED1A "bA12M19.1, C20orf81, FAM113A, FLJ22376" ENSG00000132635 "PC-esterase domain containing 1A" Q9H1Q7 20 2835314-2841190 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050816 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Cytosol" "HPA050816: AB_2681246" "unprognostic (3.20e-1)" "unprognostic (3.25e-2)" "unprognostic (2.42e-3)" "unprognostic (1.90e-2)" "unprognostic (3.42e-1)" "unprognostic (6.91e-3)" "prognostic unfavorable (7.31e-4)" "unprognostic (1.00e-1)" "unprognostic (8.02e-2)" "unprognostic (2.99e-1)" "prognostic favorable (5.96e-5)" "unprognostic (1.03e-1)" "unprognostic (1.29e-2)" "unprognostic (4.10e-1)" "unprognostic (2.48e-1)" "unprognostic (7.30e-2)" "unprognostic (2.97e-3)" 45.4 44.2 64.8 30.8 66.1 22.2 35.5 60.6 74.1 62.1 72.0 34.7 24.6 40.0 27.2 31.8 53.4 26.0 27.5 61.7 63.0 70.9 57.8 42.6 36.8 67.4 63.7 63.4 41.2 40.2 63.3 23.3 62.9 65.9 12.6 18.2 35.0 19.8 13.5 21.4 47.7 21.0 61.4 81.9 41.2 25.9 66.6 23.5 86.3 9.0 24.2 40.5 42.5 72.8 31.2 39.1 39.4 21.6 39.8 54.5 29.1 29.2 32.5 29.7 32.2 27.3 54.5 9.1 20.0 19.5 49.5 50.3 9.3 27.1 13.7 45.4 31.0 36.0 49.9 38.7 32.2 6.8 11.6 73.0 56.0 36.3 48.4 42.7 21.7 45.3 28.9 40.1 22.2 20.9 4.9 45.5 44.3 23.3 25.4 24.7 13.3 18.9 33.7 24.7 37.2 57.4 29.8 37.1 51.7 24.9 48.0 23.2 21.6 29.1 20.4 30.4 14.0 69.0 36.5 2.6 7.1 24.8 35.1 3.6 8.2 3.5 11.0 7.3 10.9 9.8 6.7 9.8 9.2 9.8 12.1 11.0 0.6 16.1 7.7 8.0 4.8 8.3 64.8 66.1 60.6 74.1 61.7 63.0 67.4 63.7 62.9 61.4 66.6 72.8 9.9 16.0 19.8 16.0 13.8 4.0 10.6 8.6 30.1 11.9 12.7 13.2 4.9 8.6 10.5 9.2 10.4 5.1 12.8 6.0 13.7 5.0 0.7 12.4 32.3 11.7 8.4 7.2 4.8 2.1 2.5 15.4 22.4 10.1 0.0 18.1 11.0 14.0 6.9 11.8 6.9 9.1 6.1 9.5 6.8 3.0 9.0 12.8 1.8 8.4 5.1 9.6 5.2 8.0 11.6 4.0 8.5 2.2 11.4 6.6 8.6 12.4 8.5 12.4 6.6 7.1 12.3 13.2 7.4 15.1 3.7 3.4 12.2 17.6 7.5 8.3 PCGF5 "MGC16202, RNF159" ENSG00000180628 "Polycomb group ring finger 5" Q86SE9 10 91163012-91284337 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 345.7;Oligodendrocytes: 252.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038349, HPA059071" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA038349: AB_10669523, HPA059071: " "unprognostic (1.34e-2)" "unprognostic (8.22e-2)" "unprognostic (1.25e-2)" "unprognostic (7.41e-2)" "unprognostic (1.15e-1)" "unprognostic (8.35e-2)" "unprognostic (6.53e-2)" "unprognostic (6.43e-2)" "unprognostic (3.89e-1)" "unprognostic (3.24e-2)" "unprognostic (3.75e-2)" "unprognostic (1.49e-1)" "prognostic favorable (4.98e-4)" "unprognostic (2.43e-1)" "unprognostic (2.00e-1)" "unprognostic (2.56e-2)" "prognostic favorable (6.90e-4)" 13.7 21.8 17.8 13.1 18.9 5.8 11.9 17.4 20.0 12.0 10.9 15.3 17.6 12.5 10.7 12.8 12.1 12.7 28.3 14.2 25.2 23.4 26.2 13.1 16.9 21.8 21.2 14.9 16.2 19.9 7.2 15.9 17.7 13.7 14.1 16.3 17.6 14.0 15.2 11.2 21.0 11.9 17.6 17.8 14.7 11.4 21.1 19.4 24.2 16.7 15.7 12.2 8.5 23.0 32.9 14.2 11.6 5.0 16.5 25.7 8.3 18.2 37.3 16.2 22.5 2.2 18.7 43.2 8.3 22.9 13.3 6.3 12.6 12.5 28.4 50.1 9.5 20.4 9.0 22.2 21.8 16.0 31.0 11.7 22.6 12.1 16.8 33.2 13.7 19.0 11.1 23.5 25.4 6.1 36.2 4.1 1.7 7.5 8.1 17.8 21.5 11.7 29.6 5.1 5.5 7.8 8.9 9.4 15.6 4.1 7.6 7.1 35.9 19.0 13.4 11.8 21.8 40.8 26.9 38.2 26.7 11.4 6.0 6.4 1.6 2.7 2.6 4.0 4.7 4.0 3.9 2.7 2.1 3.9 3.9 3.9 2.1 5.1 7.7 0.5 2.4 2.6 17.8 18.9 17.4 20.0 14.2 25.2 21.8 21.2 17.7 17.6 21.1 23.0 35.8 6.4 24.0 135.8 60.1 34.4 48.7 34.8 38.7 20.2 26.8 30.6 81.2 28.6 28.3 29.5 16.7 16.5 49.7 82.8 49.0 33.9 127.8 25.2 38.7 33.8 21.6 124.8 99.0 63.9 5.0 32.7 33.1 29.0 23.4 14.0 35.3 58.6 50.5 50.5 159.5 65.4 20.3 73.1 64.9 345.7 19.6 65.9 42.7 56.2 74.0 79.9 40.2 107.1 252.6 54.3 55.1 29.7 72.3 61.2 83.7 59.0 27.9 19.3 13.1 59.1 39.4 78.2 14.4 34.4 31.3 5.6 55.9 10.9 49.0 67.2 PDCD2 "RP8, ZMYND7" ENSG00000071994 "Programmed cell death 2" Q16342 6 170575295-170584692 "Predicted intracellular proteins" Apoptosis DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026713, HPA075534" Approved Approved "Nucleoplasm,Cytokinetic bridge" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 32: Non-specific - Translation" Nucleoplasm "Cytokinetic bridge" "HPA026713: AB_1855103, HPA075534: AB_2686754" "unprognostic (3.80e-3)" "unprognostic (1.90e-2)" "unprognostic (1.37e-2)" "unprognostic (4.61e-2)" "unprognostic (5.83e-2)" "unprognostic (8.91e-3)" "prognostic unfavorable (1.42e-6)" "unprognostic (9.91e-2)" "unprognostic (7.75e-2)" "unprognostic (1.25e-2)" "unprognostic (3.17e-2)" "unprognostic (3.85e-2)" "unprognostic (4.45e-3)" "unprognostic (9.16e-2)" "unprognostic (1.66e-1)" "unprognostic (2.00e-1)" "unprognostic (1.09e-1)" 26.3 25.6 18.9 30.0 19.1 35.4 43.0 20.2 23.7 27.1 18.4 31.1 32.4 25.9 39.9 32.6 33.7 23.4 22.8 19.3 20.2 33.2 32.7 23.4 43.2 19.2 20.0 29.8 45.4 29.6 16.9 28.4 19.3 25.9 38.4 17.7 31.7 30.3 36.4 25.8 25.9 28.7 19.0 27.5 30.6 19.9 19.5 42.3 34.6 27.0 50.6 32.8 21.6 19.3 50.5 36.2 53.8 126.7 75.8 82.6 59.3 58.6 66.7 67.9 75.3 65.2 43.1 90.6 46.6 64.8 90.8 70.5 116.5 97.1 98.9 74.7 127.2 128.6 46.2 119.3 91.9 161.6 83.3 75.6 93.4 86.2 138.7 71.2 95.8 123.9 260.3 57.7 84.1 109.5 113.0 116.6 77.5 161.6 54.9 79.4 41.5 117.8 103.7 29.3 98.4 102.4 66.7 107.8 71.6 58.1 54.8 162.8 73.0 33.3 71.4 80.1 105.1 76.5 96.4 97.9 62.1 154.9 87.0 4.1 12.4 11.5 14.1 12.0 16.5 14.2 15.9 14.9 17.3 13.8 15.5 14.8 5.3 18.8 15.2 15.9 20.3 12.0 18.9 19.1 20.2 23.7 19.3 20.2 19.2 20.0 19.3 19.0 19.5 19.3 47.2 12.8 15.3 9.4 54.1 49.5 76.4 14.6 40.5 36.9 58.0 59.7 27.4 52.9 14.0 29.5 12.5 63.9 82.2 29.2 78.2 55.3 17.0 36.1 38.5 38.8 47.2 64.1 13.2 74.1 71.6 32.2 32.1 33.5 15.9 59.8 44.6 28.2 49.2 16.8 12.7 44.0 22.4 41.9 33.2 15.0 49.0 40.9 35.6 8.4 62.8 34.7 84.5 8.0 12.4 58.6 36.4 40.6 58.0 103.9 47.8 83.6 16.0 35.3 19.7 43.8 55.5 33.0 85.8 58.7 46.0 46.7 60.7 60.8 68.0 84.1 PDCD6IP "AIP1, Alix, Hp95" ENSG00000170248 "Programmed cell death 6 interacting protein" Q8WUM4 3 33798571-33869707 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal enterocytes: 299.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA011905, CAB016212, HPA051604" Approved Approved Vesicles,Centrosome "Intracellular and membrane" NA NA 4100000 "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Vesicles Centrosome "CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: " "unprognostic (1.53e-1)" "unprognostic (2.63e-1)" "prognostic favorable (1.16e-4)" "unprognostic (2.17e-1)" "unprognostic (2.75e-1)" "unprognostic (5.12e-2)" "unprognostic (7.76e-3)" "unprognostic (1.23e-2)" "unprognostic (3.29e-1)" "unprognostic (2.86e-1)" "unprognostic (3.88e-3)" "unprognostic (4.49e-2)" "prognostic favorable (3.90e-9)" "unprognostic (9.61e-2)" "unprognostic (1.89e-1)" "unprognostic (4.78e-1)" "unprognostic (1.11e-1)" 33.1 27.6 16.3 24.5 17.9 21.2 32.9 18.4 23.3 35.0 23.0 46.4 36.2 35.1 26.4 46.0 30.9 25.9 30.5 17.6 19.7 35.0 33.2 35.2 26.1 25.2 18.1 34.3 25.0 40.6 22.8 31.2 26.4 30.0 41.5 30.5 29.7 23.7 33.9 39.8 38.8 31.8 18.6 27.5 37.2 23.8 18.8 24.4 34.2 22.1 30.1 26.9 35.9 21.4 47.2 46.4 30.2 25.1 78.5 80.6 34.3 67.2 56.2 50.9 52.2 33.3 43.8 75.9 33.8 77.7 32.2 45.5 47.8 61.4 57.8 27.4 39.5 56.7 37.4 28.2 50.8 56.5 57.6 62.2 69.5 57.6 67.8 60.5 77.1 32.4 50.3 26.2 74.4 27.0 36.3 31.8 29.9 43.5 57.8 32.8 36.5 43.8 64.6 39.2 14.7 26.8 61.6 67.8 30.7 48.9 62.0 51.4 101.1 59.5 28.2 50.1 46.9 26.6 37.6 55.6 56.7 62.6 28.8 6.8 13.5 11.0 8.0 18.1 8.7 12.0 8.9 8.1 12.4 10.8 7.7 7.5 6.8 12.1 18.0 5.0 9.4 10.0 16.3 17.9 18.4 23.3 17.6 19.7 25.2 18.1 26.4 18.6 18.8 21.4 78.5 86.6 84.8 85.8 76.1 41.7 62.6 62.7 51.8 28.6 42.5 34.0 53.4 62.9 80.6 64.4 52.1 53.0 58.5 299.9 37.2 67.2 85.3 121.6 84.0 68.8 36.1 40.6 83.5 78.3 52.8 54.3 96.8 77.8 53.7 53.0 54.3 57.3 60.6 25.2 69.2 97.1 63.1 93.0 44.7 50.4 74.0 85.0 28.4 75.9 71.0 23.1 42.2 96.0 161.7 122.5 127.1 80.5 46.9 56.5 130.2 61.0 130.9 49.9 46.0 42.3 50.4 93.0 48.4 61.5 43.2 96.6 55.2 47.7 86.7 70.3 PDE12 "2'-PDE, 3635, DKFZp667B1218" ENSG00000174840 "Phosphodiesterase 12" Q6L8Q7 3 57556274-57566848 "Enzymes, Predicted intracellular proteins" "mRNA processing" "Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043171 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "HPA043171: AB_10794654" "unprognostic (2.79e-1)" "unprognostic (3.18e-1)" "prognostic favorable (2.85e-5)" "unprognostic (2.39e-1)" "unprognostic (1.48e-1)" "unprognostic (9.21e-2)" "unprognostic (1.58e-2)" "unprognostic (8.43e-3)" "unprognostic (1.27e-1)" "unprognostic (6.45e-2)" "unprognostic (2.10e-1)" "unprognostic (9.88e-3)" "prognostic favorable (3.63e-8)" "unprognostic (6.97e-3)" "unprognostic (1.32e-1)" "unprognostic (7.85e-2)" "unprognostic (2.62e-1)" 7.6 8.6 4.1 8.3 4.6 13.9 6.0 5.1 4.4 5.2 4.7 7.2 9.1 5.7 3.9 9.0 4.2 7.1 5.7 4.3 5.2 8.0 10.6 5.5 8.9 3.9 3.9 4.7 9.8 9.2 4.4 7.3 3.5 6.3 6.7 7.3 5.9 6.4 8.4 4.9 7.2 6.9 4.2 7.1 7.2 4.2 3.9 7.0 7.2 7.9 8.1 8.6 4.9 6.2 19.5 18.8 11.5 21.3 14.6 10.3 20.8 16.1 15.3 17.8 15.8 24.9 12.9 31.6 5.9 14.6 23.7 12.5 24.8 16.8 14.5 14.7 12.7 23.5 15.4 19.3 16.6 31.1 23.5 14.2 11.3 21.5 19.0 9.3 15.6 16.1 19.4 22.3 16.3 15.0 28.0 10.2 17.8 15.1 32.0 10.5 9.4 23.0 14.4 22.3 10.2 16.0 17.3 20.2 17.4 9.1 15.0 17.6 19.3 14.7 13.7 28.1 26.4 21.9 34.2 27.4 17.3 24.1 22.2 20.6 9.3 8.7 10.9 12.7 12.3 6.7 10.2 11.3 10.2 11.4 12.4 12.4 2.3 14.9 13.8 5.3 13.5 10.2 4.1 4.6 5.1 4.4 4.3 5.2 3.9 3.9 3.5 4.2 3.9 6.2 15.9 25.6 21.9 32.0 20.0 36.8 18.5 13.2 14.8 21.0 17.9 10.0 10.8 22.8 14.8 31.3 12.5 19.0 23.9 17.9 5.9 10.0 1.3 15.5 19.3 14.6 12.5 20.4 50.8 9.8 11.3 14.6 12.8 21.7 19.7 12.8 13.6 27.8 15.0 26.9 49.0 10.8 10.2 18.5 16.8 1.3 10.5 16.1 12.4 26.2 15.8 18.3 17.5 47.7 56.6 9.0 9.8 12.4 20.4 18.6 14.8 16.5 8.9 31.1 6.6 32.7 15.1 18.6 10.3 21.7 39.6 20.5 19.2 19.7 19.5 19.1 PDHB PDHE1B ENSG00000168291 "Pyruvate dehydrogenase E1 subunit beta" P11177 3 58427630-58433857 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism, Tricarboxylic acid cycle" Oxidoreductase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 299.4" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 300.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033794, HPA036744, HPA036745" Enhanced Supported Nucleoplasm,Mitochondria No No 61000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "CAB033794: AB_2162946, HPA036744: AB_10670921, HPA036745: AB_2675285" "unprognostic (2.06e-2)" "unprognostic (1.79e-1)" "unprognostic (6.04e-3)" "unprognostic (1.22e-1)" "unprognostic (7.22e-2)" "unprognostic (1.42e-1)" "unprognostic (3.20e-2)" "unprognostic (6.13e-2)" "unprognostic (9.62e-2)" "unprognostic (5.94e-2)" "unprognostic (3.98e-1)" "unprognostic (2.35e-1)" "prognostic favorable (2.79e-8)" "unprognostic (2.67e-1)" "unprognostic (8.37e-2)" "unprognostic (1.06e-2)" "unprognostic (9.85e-2)" 59.9 76.5 48.7 42.2 50.2 25.7 42.9 53.9 62.7 43.3 63.6 56.8 42.5 38.5 44.6 57.4 37.7 35.9 175.0 49.7 52.3 100.8 110.7 36.4 53.1 51.7 49.4 26.5 36.4 88.8 44.1 57.0 51.5 48.5 60.4 30.7 45.9 52.1 272.6 36.8 37.6 63.8 51.6 42.8 53.9 42.3 53.1 53.1 40.8 299.4 56.0 49.7 35.9 54.3 66.5 90.9 92.3 69.8 91.7 111.1 110.4 81.6 101.3 117.9 120.6 165.1 62.6 140.3 44.9 103.8 109.0 37.6 113.2 74.9 90.0 81.7 83.0 125.4 163.7 126.0 92.5 103.0 67.9 97.9 67.7 95.5 55.8 137.5 103.1 114.2 65.9 61.5 129.5 63.1 98.2 107.8 127.2 69.2 101.3 46.3 71.8 136.1 188.1 89.1 63.7 70.2 75.6 107.2 85.4 131.3 159.0 108.7 76.3 62.9 83.7 66.8 94.2 85.2 129.9 99.2 96.2 120.8 60.7 57.8 98.9 98.7 83.2 115.1 87.9 102.2 81.7 80.5 141.1 103.4 90.9 82.4 19.6 129.4 109.7 94.7 113.2 124.1 48.7 50.2 53.9 62.7 49.7 52.3 51.7 49.4 51.5 51.6 53.1 54.3 57.8 60.9 34.5 5.9 45.3 27.9 40.7 142.0 26.7 31.8 29.4 31.6 300.6 48.6 96.0 35.0 25.0 174.1 35.3 41.0 230.9 95.9 76.3 37.0 37.3 58.0 58.0 22.5 10.9 72.2 101.6 54.1 29.6 34.2 39.3 48.5 46.1 76.1 84.6 57.2 13.3 50.4 162.8 37.9 26.6 16.9 60.3 37.2 56.9 9.4 76.5 61.7 70.0 9.0 13.6 55.9 43.0 51.1 38.8 19.1 45.8 146.8 70.7 45.9 65.7 30.8 72.3 98.2 88.3 42.8 29.8 157.2 44.7 224.4 53.0 37.7 PDHX "DLDBP, E3BP, OPDX, PDX1, proX" ENSG00000110435 "Pyruvate dehydrogenase complex component X" O00330 11 34915829-35020591 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 138.6;tongue: 125.2" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 115.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038484, HPA038485" Enhanced Approved "Nucleoplasm,Plasma membrane,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Plasma membrane" Mitochondria "HPA038484: AB_10669645, HPA038485: AB_10669540" "unprognostic (1.60e-1)" "unprognostic (1.91e-1)" "unprognostic (1.42e-2)" "unprognostic (1.06e-1)" "unprognostic (2.03e-1)" "unprognostic (8.34e-3)" "unprognostic (3.56e-3)" "unprognostic (1.94e-1)" "unprognostic (2.14e-1)" "unprognostic (5.41e-2)" "unprognostic (2.60e-2)" "unprognostic (2.08e-1)" "prognostic favorable (1.83e-5)" "unprognostic (2.24e-1)" "unprognostic (8.28e-2)" "unprognostic (9.53e-2)" "unprognostic (2.82e-1)" 23.5 21.6 16.5 12.2 19.9 7.4 16.6 21.6 21.9 13.3 9.4 22.8 20.1 14.2 13.3 17.2 10.0 12.3 77.8 21.1 14.5 21.5 31.0 12.7 11.9 16.6 17.2 11.7 21.5 21.0 15.4 24.4 16.5 18.9 20.6 27.1 20.4 16.0 138.6 14.6 15.0 17.8 13.4 11.1 23.1 27.8 19.7 13.2 14.3 125.2 14.8 15.0 11.7 21.1 20.4 54.3 29.9 11.9 20.7 25.5 28.5 38.9 30.1 40.3 38.9 69.3 18.8 27.2 24.7 31.4 49.1 39.4 58.9 31.9 41.1 25.8 47.2 26.9 54.6 82.3 45.0 50.7 30.7 25.6 37.9 23.2 31.5 23.8 31.1 23.9 57.9 25.4 33.1 35.7 32.2 29.9 25.2 54.2 30.5 27.0 53.5 23.8 62.1 54.7 32.0 23.3 33.8 48.1 52.2 29.3 54.8 29.9 21.0 30.4 35.5 32.3 42.7 24.4 53.3 35.7 23.9 24.2 32.5 14.0 19.4 17.5 15.4 21.4 14.3 18.8 14.4 12.7 27.5 16.0 17.2 12.6 3.9 22.1 34.6 7.4 22.1 14.7 16.5 19.9 21.6 21.9 21.1 14.5 16.6 17.2 16.5 13.4 19.7 21.1 9.0 35.3 24.6 34.3 14.5 26.0 21.4 26.7 15.4 25.8 15.1 11.4 115.3 20.0 26.0 5.5 29.2 62.9 9.0 14.4 64.6 21.4 52.6 15.1 12.2 13.0 9.0 13.5 85.4 14.3 34.9 20.6 16.3 16.6 5.7 16.5 11.7 23.6 26.4 20.2 80.3 17.2 42.7 18.6 13.6 54.0 10.8 14.7 21.4 24.4 23.2 21.0 9.2 40.2 53.4 16.7 15.9 13.5 14.1 22.4 15.0 30.7 19.8 26.7 0.0 14.5 18.8 57.2 36.1 17.9 25.4 83.0 13.4 27.5 20.0 19.7 PDK2 PDHK2 ENSG00000005882 "Pyruvate dehydrogenase kinase 2" Q15119 17 50094737-50112152 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Glucose metabolism" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 216.2;tongue: 285.0" "Cell type enhanced" "Detected in all" "Proximal enterocytes: 123.0;Proximal tubular cells: 131.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008287 Supported Approved Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 18: U-2197 - ECM organization" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Mitochondria" "HPA008287: AB_1079589" "unprognostic (2.74e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.16e-1)" "unprognostic (2.43e-3)" "unprognostic (1.22e-1)" "unprognostic (9.63e-3)" "unprognostic (9.80e-3)" "unprognostic (8.39e-3)" "unprognostic (3.19e-2)" "unprognostic (1.25e-1)" "unprognostic (1.17e-2)" "unprognostic (2.21e-1)" "prognostic favorable (9.59e-5)" "unprognostic (3.81e-1)" "unprognostic (2.54e-1)" "unprognostic (5.33e-1)" "unprognostic (1.55e-1)" 40.8 63.8 49.9 8.7 51.2 5.0 26.4 65.7 58.2 30.5 37.1 42.7 28.1 29.4 124.4 21.8 24.3 18.0 116.6 50.6 41.8 62.7 50.8 15.3 10.1 40.8 44.0 48.2 44.3 40.7 17.0 14.7 41.8 23.5 21.5 14.7 25.7 27.4 216.2 26.0 32.5 25.7 40.8 18.4 33.7 13.7 44.6 12.6 27.3 285.0 9.2 30.9 22.2 44.6 12.4 17.5 20.6 18.5 21.2 16.5 2.2 13.2 19.3 19.3 18.5 1.7 13.2 15.5 21.7 37.0 13.0 6.4 13.7 5.3 18.8 30.6 19.3 14.0 17.1 13.2 11.3 0.0 15.0 33.6 19.6 12.5 0.9 33.7 17.2 20.0 5.7 15.0 11.0 15.8 11.8 0.0 4.5 37.2 17.1 17.5 45.8 21.1 10.4 10.4 13.8 20.7 18.7 5.9 9.0 25.0 35.0 13.7 8.8 22.5 18.4 16.0 10.1 29.4 29.9 8.2 33.3 4.9 15.4 14.3 16.2 8.9 16.2 12.9 12.8 12.9 14.8 18.0 18.4 13.8 17.2 18.0 2.6 22.9 14.1 25.8 22.4 17.4 49.9 51.2 65.7 58.2 50.6 41.8 40.8 44.0 41.8 40.8 44.6 44.6 17.9 9.6 10.3 18.3 12.1 15.2 12.3 12.4 17.6 19.0 16.0 26.8 5.4 12.8 11.7 20.2 6.2 19.6 16.7 38.6 58.7 11.7 8.8 6.5 12.1 11.8 13.8 10.8 18.6 9.1 3.6 17.7 13.7 7.8 1.3 19.0 18.2 52.0 19.9 43.7 15.6 50.2 16.2 13.6 9.1 18.9 24.2 12.0 24.9 8.4 14.5 37.3 7.2 6.0 11.3 6.2 55.2 52.6 25.9 6.7 123.0 131.9 6.5 11.0 19.7 15.0 20.5 3.3 11.7 14.6 18.8 7.9 12.9 29.0 36.9 11.3 PDP1 "PDH, PDP, PPM2A, PPM2C" ENSG00000164951 "Pyruvate dehyrogenase phosphatase catalytic subunit 1" Q9P0J1 8 93857807-93926068 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 80.0;Early spermatids: 144.2" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 8 "amygdala: 14.2;basal ganglia: 20.1;cerebral cortex: 41.7;hippocampal formation: 23.4;white matter: 18.5" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 117.8;hTERT-RPE1: 117.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018483, HPA019081, HPA021152" Uncertain Approved Nucleoplasm,Mitochondria,Cytosol Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 29: Early spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria, Cytosol" "HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635" "prognostic unfavorable (8.61e-5)" "unprognostic (4.62e-1)" "unprognostic (8.79e-2)" "unprognostic (1.09e-1)" "unprognostic (9.46e-2)" "unprognostic (1.38e-1)" "unprognostic (1.59e-1)" "unprognostic (1.18e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.71e-2)" "unprognostic (3.25e-1)" "prognostic favorable (8.42e-9)" "unprognostic (1.85e-1)" "unprognostic (1.84e-1)" "unprognostic (5.04e-2)" "unprognostic (1.67e-1)" 10.6 62.6 14.2 10.5 20.1 14.4 16.1 0.0 41.7 14.2 1.2 8.9 7.2 15.5 17.0 14.2 12.2 19.4 49.2 23.4 0.0 12.8 4.2 12.6 12.9 0.0 2.3 19.3 19.9 29.9 5.4 13.8 0.0 10.3 12.4 14.1 11.7 9.4 72.9 4.3 7.6 11.2 0.0 13.2 11.7 26.7 3.0 11.6 18.8 16.9 12.4 14.0 6.8 18.5 25.7 12.0 25.9 10.9 21.0 37.9 8.6 19.3 21.7 22.1 25.8 12.7 90.3 13.9 63.8 30.8 117.8 54.4 11.0 16.1 32.8 1.5 5.6 6.6 15.7 4.5 23.9 3.3 9.0 24.5 31.5 37.7 59.8 117.1 50.9 12.4 2.4 22.8 27.6 6.0 20.3 10.3 12.1 26.8 15.4 4.8 15.5 2.6 15.3 17.0 2.4 11.4 12.7 1.4 61.8 20.9 4.0 3.9 90.9 27.5 17.2 63.8 23.3 12.6 5.8 12.1 34.2 11.7 25.1 6.4 27.9 14.5 9.2 25.3 8.9 15.6 15.1 12.0 22.5 17.9 8.9 7.8 3.1 5.4 41.1 3.7 34.9 18.0 14.2 20.1 0.0 41.7 23.4 0.0 0.0 2.3 0.0 0.0 3.0 18.5 10.7 12.8 7.8 15.0 18.0 13.0 12.7 36.3 68.9 38.3 11.6 7.0 80.0 14.3 35.6 16.5 8.4 4.3 13.7 27.5 5.9 33.3 144.2 33.3 14.9 15.0 10.2 1.3 73.6 14.0 3.9 20.8 16.3 70.2 6.3 3.7 12.5 3.3 6.3 10.1 23.4 5.5 10.2 19.2 19.1 28.1 11.5 19.9 10.6 19.7 22.4 18.8 10.3 13.0 8.5 24.5 9.6 13.5 8.1 15.6 4.9 11.4 30.5 11.5 6.6 35.4 13.1 10.1 11.4 26.5 10.9 4.4 19.3 7.1 10.7 23.9 PEDS1-UBE2V1 "CROC-1B, Kua-UEV, TMEM189-UBE2V1" ENSG00000124208 "PEDS1-UBE2V1 readthrough" 20 50081124-50153637 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 12.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "HPA052535, HPA053186" Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 70: Brain - Nervous system development" "Cluster 39: CACO-2 - Unknown function" Nucleoplasm "HPA052535: AB_2681863, HPA053186: AB_2682073" "unprognostic (3.69e-1)" "unprognostic (1.27e-1)" "unprognostic (2.41e-3)" "unprognostic (2.71e-2)" "unprognostic (1.52e-1)" "unprognostic (6.05e-3)" "unprognostic (2.40e-1)" "unprognostic (8.19e-2)" 2.1 1.6 3.0 1.7 8.4 0.0 1.5 11.3 5.7 2.3 1.3 1.1 0.2 1.7 0.0 4.1 0.9 0.4 1.6 3.6 6.7 0.7 1.2 1.8 0.7 9.2 7.0 0.8 2.1 2.9 1.0 3.5 10.9 0.7 0.1 0.1 1.7 0.5 2.9 2.9 0.9 0.9 8.0 0.9 1.5 2.7 6.1 1.1 1.0 1.3 0.2 1.6 2.5 12.3 3.8 6.9 2.2 6.5 9.7 6.4 6.8 6.8 4.5 9.1 5.1 15.7 8.3 2.0 8.5 3.7 8.0 16.3 3.6 7.5 1.5 1.0 1.3 2.8 12.2 9.3 4.4 5.2 5.0 6.6 13.6 6.7 2.4 0.6 9.2 0.8 4.9 6.1 4.2 5.3 3.9 0.7 1.8 1.4 1.6 3.5 1.9 3.4 2.5 10.9 3.5 1.4 3.0 13.5 2.3 0.0 3.1 4.5 13.7 10.6 3.8 3.0 4.2 1.5 2.1 0.8 4.6 1.3 7.1 7.7 8.7 11.0 7.6 12.5 6.6 3.6 6.8 7.4 8.4 6.0 6.1 6.6 1.2 7.8 15.2 5.0 7.8 10.8 3.0 8.4 11.3 5.7 3.6 6.7 9.2 7.0 10.9 8.0 6.1 12.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PER2 KIAA0347 ENSG00000132326 "Period circadian regulator 2" O15055 2 238244044-238290102 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Skeletal myocytes: 110.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053136, HPA060510" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 3: HMC-1 - Innate immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm Cytosol "HPA053136: , HPA060510: AB_2684298" "unprognostic (1.96e-2)" "unprognostic (4.41e-2)" "unprognostic (1.88e-2)" "unprognostic (9.28e-2)" "unprognostic (2.52e-1)" "prognostic favorable (2.29e-4)" "unprognostic (2.47e-2)" "unprognostic (2.17e-2)" "unprognostic (3.59e-3)" "unprognostic (3.59e-2)" "unprognostic (1.76e-2)" "unprognostic (2.13e-1)" "unprognostic (6.81e-2)" "unprognostic (1.37e-1)" "unprognostic (2.27e-1)" "unprognostic (2.58e-1)" "unprognostic (5.22e-2)" 12.2 3.3 4.7 5.0 5.2 8.4 14.2 7.2 5.8 11.9 2.4 7.6 5.1 10.2 5.7 13.6 7.9 12.3 5.7 5.7 5.1 3.9 12.4 7.1 4.7 5.2 5.7 7.8 14.4 4.2 9.0 2.9 4.4 9.3 6.2 5.1 14.1 8.9 11.4 17.0 8.0 4.9 5.4 4.8 13.4 11.8 4.7 4.1 8.8 7.6 6.2 8.7 8.2 4.7 1.6 11.7 2.4 4.2 0.1 1.2 8.2 1.1 4.1 1.5 1.4 1.8 5.8 10.3 1.2 2.7 1.5 8.6 2.4 3.5 2.2 2.9 1.7 9.1 6.2 8.2 2.0 13.8 9.2 1.6 8.3 1.8 6.1 1.5 0.8 4.2 4.5 6.3 1.3 7.7 6.9 15.2 3.5 7.6 2.3 16.5 5.5 3.3 1.5 3.3 9.7 1.2 2.9 6.3 1.8 0.7 5.9 8.5 2.1 3.6 4.2 2.8 4.1 7.1 1.8 12.3 6.7 5.9 4.5 2.1 1.2 0.3 1.0 2.2 1.6 1.5 1.6 1.2 1.4 1.5 1.5 1.6 1.0 1.2 2.1 1.8 1.2 0.3 4.7 5.2 7.2 5.8 5.7 5.1 5.2 5.7 4.4 5.4 4.7 4.7 24.9 16.0 30.1 18.6 9.9 73.9 61.7 21.3 38.1 20.6 67.8 33.8 5.7 31.5 46.9 27.6 2.1 9.2 27.0 22.5 7.9 7.5 9.6 69.7 30.1 15.6 24.6 6.9 20.9 10.4 6.3 39.8 52.5 86.1 9.5 3.3 11.4 35.8 3.9 11.8 13.9 35.1 18.3 10.1 25.3 4.7 11.1 12.4 24.9 5.6 5.3 13.5 2.1 9.0 7.2 7.6 35.3 18.4 10.9 15.0 10.9 5.5 44.2 7.8 6.6 110.1 32.2 31.3 17.0 38.4 85.4 13.0 13.6 3.7 36.9 33.9 PES1 "NOP7, PES" ENSG00000100029 "Pescadillo ribosomal biogenesis factor 1" O00541 22 30576625-30607083 "Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040210, HPA062439, HPA066670" Supported Enhanced "Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome" Yes Yes "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli, Nucleoli rim, Mitotic chromosome" Nucleoplasm "HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700" "unprognostic (1.82e-1)" "unprognostic (5.88e-2)" "unprognostic (5.59e-3)" "unprognostic (4.83e-2)" "unprognostic (1.48e-1)" "unprognostic (3.23e-3)" "prognostic unfavorable (1.84e-9)" "unprognostic (3.29e-2)" "unprognostic (3.40e-1)" "unprognostic (1.73e-1)" "unprognostic (4.79e-2)" "unprognostic (2.46e-2)" "unprognostic (5.65e-2)" "unprognostic (1.27e-3)" "unprognostic (1.65e-1)" "unprognostic (4.56e-2)" "unprognostic (1.42e-1)" 33.3 41.0 26.3 29.2 28.6 35.5 32.2 26.7 30.5 31.8 27.1 29.6 21.7 35.5 21.2 43.6 29.4 20.2 28.8 26.9 26.2 38.7 48.2 26.2 32.3 27.1 27.2 34.2 57.3 30.1 21.8 21.5 27.6 32.9 19.6 9.2 29.3 21.5 48.8 45.3 28.2 22.5 25.8 34.4 35.7 40.0 27.0 23.8 27.1 20.0 27.3 35.0 31.9 30.0 132.2 146.6 53.0 113.7 59.9 58.4 81.6 84.7 69.6 141.6 110.0 170.6 55.2 177.2 74.4 97.0 110.3 89.4 163.9 153.5 103.1 76.4 159.8 85.9 80.8 149.0 149.3 209.6 86.8 82.7 94.7 148.3 147.3 68.3 93.0 62.4 144.6 69.9 87.7 164.3 102.6 209.8 103.1 128.3 106.7 129.0 91.7 173.3 78.9 88.7 91.4 94.6 84.2 94.6 117.8 42.0 66.8 106.1 74.2 165.9 126.1 85.3 145.1 88.1 81.0 178.6 116.2 94.9 109.0 7.5 24.9 6.4 18.9 29.8 23.2 20.2 17.4 18.1 26.8 20.0 19.4 18.0 0.9 20.0 22.3 23.2 14.3 29.3 26.3 28.6 26.7 30.5 26.9 26.2 27.1 27.2 27.6 25.8 27.0 30.0 23.6 3.2 18.9 4.9 17.4 22.6 23.4 32.7 22.2 6.5 14.1 12.2 3.8 24.3 22.1 25.8 8.4 34.9 7.8 19.6 25.4 48.0 44.4 11.7 13.8 23.2 23.4 24.6 4.3 43.9 40.0 15.4 22.4 10.6 18.3 24.4 27.8 22.8 38.4 3.3 4.3 22.4 22.4 27.8 12.6 14.3 19.9 21.2 21.4 2.8 29.0 13.5 16.5 6.6 5.1 38.7 16.2 20.3 28.3 26.4 31.3 55.1 24.6 8.9 19.7 23.2 20.7 28.7 20.9 25.9 22.9 28.5 13.5 19.9 29.7 15.1 PET117 CSRP2BP ENSG00000232838 "PET117 cytochrome c oxidase chaperone" Q6UWS5 20 18137863-18143169 "Disease related genes, Predicted intracellular proteins" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" HPA047716 Approved "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "HPA047716: AB_2680128" "unprognostic (1.34e-2)" "unprognostic (2.83e-1)" "unprognostic (3.94e-1)" "unprognostic (2.02e-1)" "unprognostic (2.39e-1)" "unprognostic (2.11e-1)" "prognostic unfavorable (4.76e-6)" "unprognostic (7.74e-2)" "unprognostic (1.25e-1)" "unprognostic (3.13e-2)" "unprognostic (4.90e-1)" "unprognostic (2.78e-1)" "prognostic favorable (4.15e-4)" "unprognostic (3.73e-1)" "unprognostic (4.63e-1)" "unprognostic (2.52e-1)" "unprognostic (1.92e-1)" 8.7 16.8 12.5 5.5 13.0 8.0 8.5 12.8 17.8 8.4 13.5 12.2 15.6 9.9 10.4 8.0 8.5 5.1 12.9 12.6 12.9 14.1 12.5 8.0 6.0 12.7 12.4 10.0 11.4 9.7 11.8 7.4 13.0 9.3 9.4 9.7 10.4 6.5 22.9 10.8 10.9 5.8 12.8 8.6 16.5 7.2 12.8 4.5 8.9 9.6 5.3 9.5 7.6 13.8 33.0 28.7 10.4 10.6 14.9 11.3 29.8 16.8 16.5 19.6 18.2 26.5 26.7 19.5 27.0 16.1 34.9 17.6 19.0 31.5 20.5 4.4 20.9 21.9 19.2 63.8 24.6 29.2 23.2 17.8 17.1 19.3 20.1 15.7 15.7 23.3 18.6 17.1 14.3 26.8 17.1 33.5 15.4 35.2 31.8 15.3 33.4 35.0 21.2 19.4 18.9 18.6 23.1 43.0 46.9 27.1 26.2 21.3 15.0 17.7 13.7 19.0 29.4 24.4 41.8 31.5 8.8 9.5 16.3 3.4 24.9 11.4 18.3 23.3 20.7 26.2 22.7 23.0 22.0 23.2 31.6 24.2 1.5 21.0 29.7 41.0 20.4 15.8 12.5 13.0 12.8 17.8 12.6 12.9 12.7 12.4 13.0 12.8 12.8 13.8 10.3 19.2 10.6 0.3 11.4 3.8 16.7 17.2 8.0 16.9 13.5 14.6 13.7 35.8 16.3 16.5 4.2 29.8 12.4 15.4 33.2 21.8 1.0 12.3 8.8 9.1 15.7 16.8 2.6 26.7 34.5 10.1 24.5 11.9 8.8 6.9 8.9 25.8 14.9 23.5 2.5 18.4 16.2 13.9 4.0 3.2 16.1 7.7 7.2 1.9 15.1 19.7 16.5 3.5 1.4 34.0 12.3 6.8 9.4 26.8 44.0 53.1 9.4 13.7 6.6 9.6 10.8 16.3 31.3 13.4 6.3 13.0 11.9 9.7 23.6 14.5 PEX5 "PTS1R, PXR1" ENSG00000139197 "Peroxisomal biogenesis factor 5" P50542 12 7188685-7218574 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "Early spermatids: 277.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 156.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039259, HPA039260" Enhanced Supported "Golgi apparatus,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Golgi apparatus, Cytosol" "HPA039259: AB_10673419, HPA039260: AB_2676417" "unprognostic (7.44e-2)" "unprognostic (2.54e-2)" "unprognostic (1.41e-1)" "unprognostic (1.86e-1)" "unprognostic (1.27e-1)" "unprognostic (4.46e-1)" "unprognostic (1.48e-1)" "unprognostic (2.20e-2)" "unprognostic (5.14e-2)" "unprognostic (3.72e-2)" "unprognostic (1.63e-2)" "unprognostic (2.92e-1)" "unprognostic (5.70e-2)" "unprognostic (7.31e-3)" "unprognostic (1.96e-1)" "unprognostic (2.13e-2)" "unprognostic (1.13e-1)" 33.1 27.8 43.7 13.2 42.8 8.8 34.2 38.0 43.3 25.0 33.5 25.3 12.1 26.0 10.9 18.8 23.2 13.6 22.0 39.1 38.5 24.5 37.8 22.1 18.6 40.9 41.2 29.2 30.4 18.9 44.1 10.0 41.2 19.7 11.8 13.6 22.2 13.6 74.1 26.2 20.3 15.2 43.1 16.0 22.2 50.9 45.4 39.3 20.0 28.4 20.8 21.7 21.2 40.9 14.7 24.7 13.0 34.2 29.1 19.9 24.3 14.0 16.6 16.2 17.2 36.9 21.8 156.1 8.3 16.2 23.6 18.2 22.1 19.5 16.8 20.8 18.2 13.8 19.0 25.7 15.4 21.3 13.6 22.2 35.2 11.1 34.5 22.0 14.2 75.0 28.2 5.3 14.7 20.0 49.7 18.5 38.6 28.0 13.1 23.7 28.1 21.4 13.0 21.4 10.9 22.6 20.9 45.4 20.1 26.2 10.2 12.5 12.7 18.2 29.9 15.8 17.2 9.5 11.6 53.4 18.0 22.8 12.2 0.0 1.6 2.1 2.9 1.4 3.6 1.9 2.0 2.9 2.6 1.4 2.6 2.6 1.2 2.8 4.1 4.6 0.9 2.2 43.7 42.8 38.0 43.3 39.1 38.5 40.9 41.2 41.2 43.1 45.4 40.9 8.6 12.8 20.1 11.4 5.6 14.5 7.2 5.2 8.0 7.8 9.2 8.5 13.7 14.3 5.6 7.3 8.4 11.3 5.1 9.9 9.8 10.1 277.8 7.0 13.6 10.3 7.2 4.6 31.5 14.9 6.4 7.8 4.1 5.2 3.8 7.2 5.7 17.6 4.7 13.5 22.1 7.2 4.1 5.4 5.0 43.7 14.3 5.2 5.4 1.0 4.6 12.7 5.2 16.1 13.3 10.2 14.2 13.9 2.9 14.1 9.9 19.3 9.8 7.0 19.7 12.0 10.2 32.2 16.6 7.4 15.3 7.7 5.8 9.6 10.4 5.7 PFDN1 PFD1 ENSG00000113068 "Prefoldin subunit 1" O60925 5 140245035-140303113 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006499 Approved Approved "Nucleoli,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 7: Non-specific - Mitochondria" "Plasma membrane, Cytosol" Nucleoli "HPA006499: AB_1079596" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (1.37e-1)" "unprognostic (3.00e-2)" "unprognostic (6.11e-2)" "unprognostic (5.66e-3)" "prognostic unfavorable (8.81e-5)" "unprognostic (2.12e-2)" "unprognostic (2.19e-1)" "unprognostic (1.89e-1)" "unprognostic (1.50e-1)" "unprognostic (2.33e-1)" "unprognostic (4.10e-1)" "unprognostic (8.60e-3)" "unprognostic (2.53e-1)" "unprognostic (3.53e-2)" "unprognostic (3.00e-1)" 74.1 50.9 73.9 37.7 75.6 60.2 50.0 82.2 88.4 41.4 70.8 59.2 40.2 50.8 54.3 52.3 41.9 35.7 93.3 77.2 79.7 61.6 38.5 46.9 46.1 82.9 77.2 37.2 34.7 52.8 39.4 50.8 80.5 44.8 42.9 35.1 45.4 43.7 149.0 46.2 39.8 61.4 79.1 36.6 40.7 29.9 79.3 51.5 42.4 86.4 51.6 45.9 40.9 81.2 172.4 79.6 137.7 80.9 89.7 91.8 133.8 229.6 114.9 174.6 192.6 172.1 107.9 114.9 224.1 124.3 180.0 62.6 102.0 228.7 204.2 122.6 102.9 102.4 76.5 113.0 105.1 213.5 76.4 98.2 119.8 148.5 156.3 112.6 196.0 132.8 93.7 73.1 149.8 78.5 146.0 147.6 92.0 70.3 119.2 101.3 195.9 86.3 197.1 77.9 78.2 81.8 172.1 148.6 136.8 128.5 102.1 122.3 249.1 121.8 119.6 71.9 208.0 70.3 198.6 299.2 122.5 138.5 144.1 149.5 84.7 130.3 86.2 131.1 91.8 106.0 98.6 100.4 100.5 97.9 97.3 88.4 14.0 114.7 130.3 93.0 129.3 115.5 73.9 75.6 82.2 88.4 77.2 79.7 82.9 77.2 80.5 79.1 79.3 81.2 87.9 67.3 33.0 16.3 57.4 38.0 65.9 96.2 30.7 42.5 50.1 57.3 81.3 52.9 62.1 66.2 45.9 116.1 53.1 56.6 123.3 121.9 3.9 58.0 56.6 73.8 46.6 62.9 31.2 101.7 86.6 55.4 35.2 70.9 54.4 53.6 72.1 56.9 85.4 25.2 29.3 43.6 48.8 61.1 37.7 12.9 52.2 63.4 74.7 37.5 90.4 84.9 71.1 24.1 39.3 128.9 55.1 52.3 35.5 45.4 80.9 147.3 45.3 42.9 65.7 39.6 63.7 23.7 61.8 40.8 34.9 85.6 45.2 42.9 47.3 63.6 PHACTR4 "FLJ13171, PPP1R124" ENSG00000204138 "Phosphatase and actin regulator 4" Q8IZ21 1 28369582-28500364 "Predicted intracellular proteins" Neurogenesis "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Glandular and luminal cells: 212.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028985 Approved Approved "Plasma membrane,Intermediate filaments,Cytosol" NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 3: HMC-1 - Innate immune response" "Cluster 44: Endometrium - Transcription" "Plasma membrane, Cytosol" "Intermediate filaments" "HPA028985: AB_10602142" "unprognostic (1.55e-1)" "unprognostic (2.61e-2)" "unprognostic (4.50e-3)" "unprognostic (1.73e-1)" "unprognostic (5.27e-1)" "prognostic favorable (1.05e-4)" "unprognostic (9.65e-3)" "unprognostic (8.77e-2)" "unprognostic (2.03e-2)" "unprognostic (1.61e-1)" "unprognostic (1.05e-1)" "unprognostic (1.04e-1)" "unprognostic (2.94e-2)" "unprognostic (3.08e-1)" "unprognostic (4.81e-2)" "unprognostic (3.03e-2)" "unprognostic (2.26e-2)" 7.2 6.5 6.3 8.6 8.1 11.8 10.1 8.2 6.8 13.6 10.2 12.9 9.1 13.7 7.1 33.0 13.2 8.9 8.9 5.8 8.5 14.1 16.3 12.4 7.8 9.1 6.8 13.1 11.7 15.1 4.0 10.4 7.2 11.8 14.1 5.1 11.3 8.2 11.9 16.2 10.3 13.8 5.5 12.0 10.7 8.6 8.0 11.9 12.4 18.3 12.2 9.4 14.8 9.3 26.0 17.2 37.8 27.5 9.6 10.2 5.8 18.1 18.3 38.5 40.0 16.4 28.1 24.5 15.9 21.6 24.3 17.7 26.3 17.4 33.9 18.1 14.9 51.6 28.2 26.5 14.3 31.2 56.7 9.9 16.4 24.7 42.7 14.0 52.0 19.5 26.0 16.9 24.5 8.0 22.3 7.8 28.3 14.0 11.8 23.2 35.7 18.5 20.2 22.8 20.1 26.0 41.0 16.9 20.9 14.9 22.5 11.1 33.3 18.8 34.6 13.4 35.8 12.4 19.7 20.1 18.4 26.2 20.3 1.9 2.0 2.0 3.3 2.0 2.9 1.4 2.6 3.3 2.2 2.2 1.8 2.6 1.4 2.4 3.3 2.6 1.2 1.5 6.3 8.1 8.2 6.8 5.8 8.5 9.1 6.8 7.2 5.5 8.0 9.3 65.9 70.5 49.8 60.7 38.9 38.6 23.6 24.1 46.7 34.6 37.0 35.8 38.5 40.0 53.7 23.9 20.9 17.6 36.7 59.9 17.6 32.4 6.1 125.6 58.6 56.2 49.3 32.2 65.8 36.5 17.3 29.1 35.2 212.6 48.0 38.8 42.5 63.3 22.8 23.5 82.6 57.0 24.4 33.6 32.3 8.5 19.3 40.3 17.8 92.8 33.7 19.8 51.5 117.1 148.1 48.2 33.5 29.7 30.8 24.4 40.0 45.5 63.3 39.8 39.5 45.6 31.0 47.1 39.4 62.1 54.1 15.2 35.7 15.3 50.6 30.9 PHC1 "EDR1, HPH1, RAE28" ENSG00000111752 "Polyhomeotic homolog 1" P78364 12 8913896-8941467 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Developmental protein, DNA-binding" "Disease variant, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 48.3" "Cancer enriched" "Detected in many" 7 "testis cancer: 32.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 4 "BEWO: 141.8;NTERA-2: 492.6;SuSa: 178.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006973 Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 5: NTERA-2 - Transcription" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "HPA006973: AB_1855278" "unprognostic (4.00e-2)" "unprognostic (1.79e-1)" "unprognostic (2.57e-1)" "unprognostic (1.73e-1)" "unprognostic (4.21e-3)" "unprognostic (7.46e-2)" "unprognostic (1.33e-1)" "unprognostic (1.59e-1)" "unprognostic (2.52e-1)" "unprognostic (1.47e-1)" "unprognostic (4.79e-3)" "unprognostic (1.69e-1)" "unprognostic (1.34e-2)" "unprognostic (7.55e-2)" "unprognostic (2.47e-1)" "unprognostic (9.27e-2)" "unprognostic (3.63e-2)" 20.1 18.1 22.9 17.7 21.1 7.5 23.1 26.1 21.8 46.8 31.3 32.1 6.9 42.0 13.3 20.7 44.6 15.7 20.4 21.7 21.4 24.9 6.9 21.4 16.1 20.5 22.9 47.2 25.5 26.4 75.7 14.1 19.3 31.7 9.4 40.0 23.6 20.2 16.1 10.7 21.0 22.4 19.2 22.2 22.3 43.3 20.8 28.1 44.3 10.3 14.6 28.0 26.9 19.8 6.6 11.1 46.5 43.0 13.8 14.5 141.8 6.6 13.7 11.3 14.7 7.4 10.5 17.4 5.7 11.3 17.4 5.8 12.9 15.4 15.2 60.8 7.5 22.8 14.5 7.5 15.0 12.4 38.5 18.0 8.0 18.1 18.1 36.2 13.7 19.8 4.6 6.4 11.5 8.2 15.8 22.1 492.6 2.5 3.7 25.1 31.3 0.9 12.3 29.0 9.0 32.1 10.4 23.4 17.4 178.3 3.4 12.4 7.8 20.8 34.5 13.2 9.6 12.8 8.9 24.9 9.3 6.7 14.4 0.6 0.2 0.0 0.8 1.1 0.5 1.1 1.2 1.5 0.1 0.9 1.2 0.9 0.0 0.8 2.8 1.2 0.8 0.8 22.9 21.1 26.1 21.8 21.7 21.4 20.5 22.9 19.3 19.2 20.8 19.8 11.9 16.0 19.8 48.3 7.7 2.4 5.5 4.6 9.1 24.2 10.8 11.2 0.5 11.5 13.1 9.2 27.1 5.9 10.1 0.8 1.9 5.4 26.4 20.0 17.4 11.0 11.4 9.5 36.4 5.2 11.5 11.8 5.1 10.6 19.0 15.5 8.6 2.0 4.4 16.8 44.0 2.7 4.1 5.4 3.9 17.6 14.3 6.0 7.2 12.2 3.2 17.7 7.2 23.1 13.0 4.6 1.9 12.0 3.0 4.5 0.7 5.3 19.2 36.8 0.0 15.8 12.2 17.7 25.1 10.2 2.4 5.1 11.2 8.7 2.0 4.9 PIAS3 "FLJ14651, ZMIZ5" ENSG00000131788 "Protein inhibitor of activated STAT 3" Q9Y6X2 1 145848522-145859836 "Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006389, HPA067383" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 21: OE19 - Mitochondria" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA006389: AB_2667576, HPA067383: AB_2685828" "unprognostic (1.23e-1)" "unprognostic (2.21e-1)" "unprognostic (1.11e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-2)" "unprognostic (1.37e-1)" "prognostic unfavorable (6.12e-4)" "unprognostic (2.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.50e-1)" "unprognostic (2.77e-3)" "unprognostic (5.06e-1)" "prognostic unfavorable (1.21e-7)" "unprognostic (5.14e-2)" "unprognostic (4.98e-2)" "unprognostic (5.66e-2)" "unprognostic (2.11e-2)" 21.9 11.5 11.3 12.8 10.8 4.9 23.3 10.2 12.2 35.2 13.5 24.5 7.6 32.0 7.9 37.3 37.2 12.1 18.1 10.9 12.8 13.7 7.2 17.9 9.1 11.7 12.2 23.4 13.1 14.4 15.4 10.7 11.7 21.6 8.0 9.8 29.2 21.1 25.8 34.4 14.6 23.6 11.3 13.3 21.7 11.1 13.9 13.5 14.9 14.5 17.9 29.1 34.9 10.7 34.6 23.5 23.8 21.1 35.9 67.3 14.5 31.8 43.6 35.5 39.3 19.3 22.2 17.8 33.6 54.8 15.0 35.0 12.4 50.4 29.9 19.4 18.3 8.2 15.9 10.4 35.8 14.7 38.8 55.2 32.3 32.9 18.6 45.6 52.0 15.8 13.2 24.0 74.7 57.6 15.8 7.8 37.0 97.3 37.7 24.6 16.2 11.7 28.2 20.5 8.1 37.9 30.7 16.9 15.5 27.0 78.0 22.1 80.7 47.2 34.8 31.7 20.9 32.6 15.7 11.5 45.8 10.9 23.9 8.9 9.1 10.7 10.6 8.7 11.4 5.4 6.7 11.6 6.8 3.6 6.2 6.0 2.2 15.2 12.5 8.4 8.1 7.0 11.3 10.8 10.2 12.2 10.9 12.8 11.7 12.2 11.7 11.3 13.9 10.7 14.7 22.4 11.5 8.5 8.6 10.7 7.9 15.4 19.4 10.2 16.2 16.5 0.9 4.3 22.8 16.5 12.5 3.7 10.0 2.1 1.9 7.9 2.3 29.4 14.8 12.3 4.2 2.1 4.2 7.7 7.3 11.9 13.3 19.1 10.8 4.9 13.2 3.8 5.2 10.1 3.9 6.2 12.2 4.4 7.0 3.9 14.3 4.1 5.4 7.5 13.1 4.2 8.2 6.6 7.4 12.7 2.0 13.2 4.8 9.2 2.1 1.8 37.6 11.8 26.3 7.0 13.6 4.0 11.4 19.9 16.3 4.0 8.6 6.0 2.8 10.4 PIGO "DKFZp434M222, FLJ00135" ENSG00000165282 "Phosphatidylinositol glycan anchor biosynthesis class O" Q8TEQ8 9 35088688-35096601 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014905 Approved Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 55: Plasma cells - Humoral immune response" Nucleoli Nucleoplasm "HPA014905: AB_1855369" "unprognostic (1.41e-2)" "unprognostic (1.06e-1)" "unprognostic (4.03e-1)" "unprognostic (3.54e-1)" "unprognostic (1.09e-1)" "unprognostic (2.09e-1)" "unprognostic (6.98e-3)" "unprognostic (4.14e-2)" "unprognostic (5.08e-2)" "unprognostic (2.25e-1)" "unprognostic (3.63e-1)" "unprognostic (1.54e-1)" "prognostic favorable (3.05e-10)" "unprognostic (1.89e-2)" "unprognostic (1.30e-2)" "unprognostic (5.23e-3)" "unprognostic (3.81e-2)" 8.6 12.9 5.4 9.2 7.5 5.9 10.9 7.6 6.1 9.8 9.6 11.7 14.5 10.5 11.2 10.5 15.5 9.5 7.7 5.3 6.0 14.7 15.3 10.0 9.1 7.8 6.8 12.5 16.4 33.2 9.4 12.3 7.6 12.5 12.9 10.5 13.0 11.9 6.8 10.0 11.3 8.6 6.8 11.3 13.1 12.2 6.2 11.4 20.0 4.7 10.2 9.4 8.6 9.8 30.5 51.5 14.4 20.8 12.5 13.8 25.6 12.7 22.0 30.0 24.5 19.0 30.2 17.1 22.7 15.4 41.8 21.6 24.2 39.6 18.0 19.0 15.7 10.3 31.2 14.5 24.5 13.9 17.1 17.1 42.8 26.8 43.7 23.9 15.8 25.1 11.4 23.7 24.9 16.8 16.5 15.9 9.2 18.9 20.8 16.9 11.6 18.8 32.9 20.8 11.9 16.1 17.5 42.8 10.0 15.7 32.2 9.1 9.7 21.8 19.1 11.8 23.6 14.4 22.9 7.1 23.4 10.3 27.8 5.3 5.1 6.3 6.4 6.7 6.6 3.5 3.5 7.3 10.4 4.8 4.5 5.4 1.8 5.7 4.6 7.3 6.0 3.5 5.4 7.5 7.6 6.1 5.3 6.0 7.8 6.8 7.6 6.8 6.2 9.8 6.3 3.2 13.9 4.6 7.9 2.5 4.5 7.9 8.6 9.1 6.1 3.8 3.1 14.3 12.2 16.5 2.1 21.0 10.2 13.3 0.0 13.6 1.2 11.3 5.5 5.2 3.0 2.1 1.7 14.0 16.0 5.6 11.7 10.1 7.0 7.9 4.2 11.7 11.6 11.8 1.9 7.4 8.2 6.6 4.2 1.0 4.4 5.8 3.6 2.8 6.7 14.3 5.2 1.5 3.9 8.4 7.7 3.0 8.7 3.7 11.4 7.4 16.1 11.8 6.6 5.1 4.8 20.0 10.4 6.7 2.0 22.6 7.2 7.2 10.8 4.0 PIGW "FLJ37433, Gwt1" ENSG00000277161 "Phosphatidylinositol glycan anchor biosynthesis class W" Q7Z7B1 17 36534987-36539310 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Acyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023499 Approved "Plasma membrane" No Yes "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Plasma membrane" "HPA023499: " "unprognostic (4.96e-3)" "unprognostic (3.84e-2)" "unprognostic (5.40e-3)" "unprognostic (7.39e-2)" "unprognostic (2.32e-1)" "unprognostic (7.71e-2)" "unprognostic (8.14e-3)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (4.62e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-1)" "unprognostic (1.73e-2)" "unprognostic (1.41e-1)" "unprognostic (8.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.88e-1)" 4.5 3.8 1.0 3.9 1.1 2.7 3.9 1.4 1.5 3.2 1.8 4.3 2.6 4.2 2.0 7.4 3.4 1.9 3.7 1.0 1.5 6.5 6.5 3.7 3.8 1.5 1.2 2.5 4.7 2.6 4.0 2.0 1.5 3.3 3.6 1.8 5.0 1.3 8.2 5.8 4.3 2.6 1.1 4.4 4.5 2.8 1.4 2.1 4.1 3.4 3.5 3.6 4.3 1.3 10.8 15.2 9.0 9.2 4.9 4.2 15.0 11.6 6.2 12.2 9.3 11.7 12.2 19.9 3.8 7.9 14.9 15.7 16.5 8.0 16.1 11.3 23.3 14.7 7.3 11.0 3.8 32.2 17.2 5.2 9.6 12.5 5.4 2.5 7.9 6.3 26.9 9.5 8.9 10.1 16.4 11.2 16.5 7.5 13.0 15.3 24.0 18.8 7.6 11.6 20.7 16.7 21.0 8.6 9.3 8.4 27.8 4.7 10.4 21.7 29.1 20.8 26.1 8.8 32.8 22.0 5.2 18.0 19.6 0.8 1.7 0.3 2.0 2.7 2.8 1.5 2.6 2.1 3.5 2.9 3.2 3.1 0.4 2.6 3.5 2.1 1.6 2.2 1.0 1.1 1.4 1.5 1.0 1.5 1.5 1.2 1.5 1.1 1.4 1.3 3.6 3.2 3.1 1.6 4.6 3.4 9.5 4.6 12.5 2.2 4.3 2.9 1.6 10.0 4.2 0.0 0.0 6.1 5.4 2.9 7.9 6.8 0.2 2.4 3.6 4.7 1.2 12.6 2.0 6.4 6.7 3.8 5.1 2.7 0.0 2.3 1.1 6.0 4.5 3.3 2.6 4.0 0.0 3.3 2.2 0.6 2.8 3.5 0.0 0.0 3.1 4.2 1.0 1.5 2.5 7.1 3.6 2.2 4.9 10.2 1.0 4.9 2.8 3.1 0.0 3.7 3.6 3.4 7.4 9.4 6.8 4.1 3.1 3.5 5.6 5.3 PITRM1 "hMP1, KIAA1104, MP1, PreP" ENSG00000107959 "Pitrilysin metallopeptidase 1" Q5JRX3 10 3137728-3172841 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 186.1;Late spermatids: 98.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006753, HPA006754" Enhanced Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 18: U-2197 - ECM organization" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA006753: AB_1079624, HPA006754: AB_1079623" "unprognostic (1.83e-3)" "unprognostic (7.01e-3)" "unprognostic (2.19e-1)" "unprognostic (1.69e-1)" "unprognostic (3.20e-2)" "unprognostic (6.67e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (6.31e-2)" "unprognostic (3.41e-1)" "unprognostic (1.00e-2)" "unprognostic (3.32e-1)" "unprognostic (7.10e-2)" "unprognostic (3.99e-1)" "unprognostic (5.80e-2)" "unprognostic (4.76e-3)" "unprognostic (2.08e-2)" 40.8 64.9 22.7 19.1 24.9 26.0 36.9 23.8 34.2 40.9 22.9 40.9 19.6 40.5 23.8 38.4 38.0 18.3 60.2 25.2 24.5 50.5 44.9 40.4 21.0 25.3 26.0 54.4 41.1 33.3 42.3 17.0 26.0 42.6 22.1 49.6 41.3 22.1 94.9 39.2 32.7 25.8 21.0 30.4 37.0 43.6 26.1 42.4 41.7 59.6 21.7 43.6 38.4 28.5 81.8 67.2 21.7 31.7 62.1 67.6 22.3 125.9 51.0 92.5 49.1 55.5 45.5 38.5 39.5 70.7 33.2 55.8 37.8 82.4 74.3 72.3 55.0 61.1 42.9 39.2 36.2 21.8 62.3 50.4 57.0 103.5 55.8 55.4 81.2 56.3 60.1 44.5 115.7 67.1 59.6 14.0 15.0 97.9 71.0 27.5 34.1 54.0 67.9 54.8 29.4 16.4 95.9 57.5 46.6 35.8 67.2 23.9 114.5 63.7 17.2 160.5 47.8 36.1 48.6 41.7 108.8 38.2 31.5 3.1 6.9 1.5 10.3 8.8 10.5 10.4 9.5 10.9 13.3 5.3 9.7 11.1 0.3 13.7 11.9 5.3 12.6 8.5 22.7 24.9 23.8 34.2 25.2 24.5 25.3 26.0 26.0 21.0 26.1 28.5 12.2 28.9 29.0 13.4 9.3 6.8 17.6 11.1 6.2 13.1 10.7 12.2 44.9 8.6 23.5 3.7 20.9 13.4 7.9 12.4 7.9 18.2 186.1 14.5 14.6 14.0 18.0 10.7 18.4 29.2 20.0 14.7 16.8 23.1 14.5 18.0 7.1 16.3 14.8 6.7 17.9 12.7 20.3 10.1 6.3 98.7 17.1 10.0 19.6 6.5 9.9 7.1 4.1 11.1 14.7 34.8 10.0 14.7 13.7 23.9 10.6 8.5 19.1 19.7 6.6 16.9 15.3 28.1 21.6 17.0 5.7 13.5 10.1 30.4 12.9 17.7 PLRG1 "Cwc1, PRL1, Prp46, PRPF46, TANGO4" ENSG00000171566 "Pleiotropic regulator 1" O43660 4 154535005-154550400 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035931, HPA035932, HPA061486" Supported Enhanced "Nuclear membrane,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear speckles" "Nuclear membrane" "HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536" "unprognostic (6.51e-2)" "unprognostic (5.66e-3)" "unprognostic (6.10e-2)" "unprognostic (1.32e-1)" "unprognostic (1.83e-1)" "unprognostic (1.61e-2)" "unprognostic (2.17e-2)" "unprognostic (1.88e-1)" "unprognostic (1.85e-2)" "unprognostic (2.88e-1)" "unprognostic (1.24e-1)" "unprognostic (1.74e-2)" "prognostic favorable (8.20e-5)" "unprognostic (2.92e-1)" "unprognostic (9.84e-3)" "unprognostic (1.64e-2)" "unprognostic (1.97e-1)" 29.4 21.9 22.8 24.9 26.3 31.1 38.7 26.0 24.3 32.8 20.8 30.9 24.8 34.0 28.6 33.9 34.2 24.8 25.9 22.6 32.6 38.1 43.8 27.3 35.2 30.5 26.8 34.0 19.6 41.1 16.0 28.3 30.7 27.4 34.2 26.4 25.8 33.7 31.7 26.4 25.8 44.6 33.5 27.7 26.4 21.4 25.3 40.4 38.0 39.5 51.2 34.8 22.7 39.2 73.2 58.6 73.7 79.4 85.1 73.5 62.3 91.6 111.2 121.9 98.9 69.3 62.7 79.1 45.7 109.1 80.3 52.4 97.2 122.1 134.5 80.2 48.7 95.1 45.1 67.8 87.0 96.0 76.4 79.7 110.8 144.6 112.6 73.0 106.1 85.3 98.9 98.2 107.2 52.3 73.9 45.7 56.1 57.5 62.7 72.2 38.5 48.2 84.8 46.1 43.0 48.6 55.9 59.3 91.7 69.4 57.1 66.4 69.3 72.4 81.9 64.6 82.9 50.9 72.0 100.6 68.1 45.6 98.8 53.0 37.0 29.7 41.6 43.3 49.9 47.0 43.5 45.7 47.6 36.2 45.9 43.2 9.4 67.6 63.9 46.4 55.7 49.4 22.8 26.3 26.0 24.3 22.6 32.6 30.5 26.8 30.7 33.5 25.3 39.2 26.9 25.6 18.1 29.0 26.9 16.3 31.2 98.7 18.2 26.2 19.6 22.9 24.7 20.0 50.7 22.0 12.5 49.1 23.6 18.0 15.6 48.0 31.7 22.7 33.0 27.5 27.1 30.5 23.6 34.7 37.9 30.9 17.9 20.3 45.7 27.0 16.1 26.8 34.2 62.2 21.7 15.9 73.2 19.3 12.0 5.8 28.0 17.2 14.2 17.8 36.8 31.2 28.8 14.1 25.0 32.6 20.9 35.0 21.8 14.9 33.7 35.0 45.2 21.4 19.7 31.2 40.8 36.4 30.2 25.0 17.3 44.3 26.9 36.8 22.3 20.6 PMPCA "Alpha-MPP, CLA1, INPP5E, KIAA0123, SCAR2" ENSG00000165688 "Peptidase, mitochondrial processing subunit alpha" Q10713 9 136410641-136423761 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021648, HPA063735" Supported Enhanced Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Mitochondria "HPA021648: AB_1855491, HPA063735: AB_2685108" "unprognostic (9.80e-2)" "unprognostic (1.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.69e-2)" "unprognostic (4.01e-2)" "unprognostic (8.19e-2)" "unprognostic (6.09e-2)" "unprognostic (1.19e-2)" "unprognostic (1.97e-1)" "unprognostic (3.32e-2)" "prognostic favorable (8.00e-5)" "unprognostic (9.47e-3)" "prognostic favorable (2.14e-6)" "unprognostic (4.27e-3)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (3.54e-2)" 29.2 58.1 27.0 20.6 27.6 31.4 27.1 27.0 34.6 29.2 36.8 32.2 24.8 26.8 10.4 34.5 27.5 17.9 73.2 28.0 27.3 37.3 110.8 25.4 27.1 27.1 27.6 29.3 28.8 26.9 38.8 20.8 27.9 31.8 15.3 8.8 28.4 16.1 69.2 37.6 30.6 15.3 25.6 38.2 35.3 37.8 27.9 21.4 29.4 50.0 17.0 28.0 27.8 26.7 48.7 87.7 41.8 84.5 30.8 45.0 63.2 49.3 39.6 67.2 48.9 101.1 56.5 67.4 50.5 50.3 36.2 110.2 77.9 72.0 30.0 97.2 92.8 54.6 113.2 123.6 53.9 71.7 44.9 66.3 48.9 52.6 27.0 38.2 58.0 61.2 140.2 43.4 42.6 132.1 68.1 90.1 85.4 86.2 82.2 83.0 59.1 149.9 46.3 33.9 85.4 56.1 66.6 92.9 58.6 28.6 127.6 95.5 48.2 47.8 50.7 39.8 63.8 26.2 37.4 73.5 62.9 61.3 43.9 37.4 50.5 36.5 53.2 51.9 51.4 52.5 49.0 57.2 61.7 48.8 57.9 50.2 11.9 67.2 51.5 31.4 52.7 62.2 27.0 27.6 27.0 34.6 28.0 27.3 27.1 27.6 27.9 25.6 27.9 26.7 17.3 16.0 26.7 14.7 24.2 27.5 40.2 65.0 27.9 24.7 19.3 15.2 35.9 15.7 32.8 22.0 22.9 103.1 22.5 28.0 49.0 32.9 24.6 25.6 23.5 21.7 20.8 23.5 13.8 30.7 50.4 23.7 21.9 26.2 24.7 44.2 19.6 57.2 37.8 18.5 11.4 24.2 44.7 19.2 14.6 15.8 19.0 17.4 16.0 6.5 21.0 22.9 14.4 8.5 8.0 31.6 20.9 22.6 26.6 22.6 25.6 46.9 22.6 27.4 39.5 22.4 27.9 37.7 42.4 23.2 26.9 103.8 21.7 77.0 38.6 28.5 POGK "BASS2, KIAA15131, KRBOX2, LST003" ENSG00000143157 "Pogo transposable element derived with KRAB domain" Q9P215 1 166839447-166856359 "Predicted intracellular proteins" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007838, HPA031630, HPA075919" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 73: Brain - Neuropeptide signaling" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: " "unprognostic (3.48e-2)" "unprognostic (2.03e-2)" "unprognostic (4.31e-2)" "unprognostic (3.18e-3)" "unprognostic (4.20e-2)" "unprognostic (2.59e-1)" "prognostic unfavorable (5.93e-4)" "unprognostic (4.85e-1)" "unprognostic (6.09e-2)" "unprognostic (1.02e-2)" "unprognostic (2.19e-2)" "unprognostic (3.44e-2)" "unprognostic (1.33e-1)" "unprognostic (3.22e-1)" "unprognostic (9.74e-2)" "unprognostic (2.70e-1)" "unprognostic (2.11e-2)" 11.3 9.1 33.8 13.5 38.4 11.0 14.2 32.4 39.2 14.9 25.0 12.3 9.5 15.7 10.9 14.7 11.9 11.2 10.5 30.4 30.8 13.9 11.1 19.5 13.5 34.2 36.5 17.3 13.7 19.5 8.3 14.1 34.8 10.5 13.7 26.5 11.6 13.0 6.8 18.8 11.3 15.2 34.2 14.3 14.0 6.3 34.7 12.3 11.7 9.5 16.9 17.5 11.5 43.4 33.4 27.4 29.5 36.5 30.5 25.2 17.1 22.6 22.7 28.1 21.2 21.0 27.4 37.3 33.1 23.3 23.8 32.6 37.1 29.7 25.6 46.3 25.4 14.9 25.2 15.0 26.0 52.8 39.7 19.2 46.1 31.7 44.9 24.8 25.4 33.9 51.0 24.3 27.0 15.7 33.0 13.2 48.5 38.5 32.2 37.2 16.5 32.9 29.4 79.4 38.4 46.5 32.1 43.6 41.7 43.5 41.7 48.3 24.1 29.7 29.7 23.9 41.2 34.2 47.7 47.8 16.7 25.9 28.7 2.2 6.0 5.1 4.7 7.5 5.1 6.7 4.6 5.1 7.8 3.9 4.2 4.6 0.8 7.5 9.0 3.7 4.3 4.9 33.8 38.4 32.4 39.2 30.4 30.8 34.2 36.5 34.8 34.2 34.7 43.4 11.7 54.5 19.5 12.4 20.2 21.9 26.2 13.0 18.8 30.7 17.8 12.8 10.1 11.5 19.4 12.9 10.4 10.8 15.3 9.8 1.9 16.9 2.8 9.8 19.9 16.0 9.0 5.9 14.7 16.3 12.3 15.4 13.3 15.2 24.1 23.4 15.0 13.4 16.0 48.8 15.7 11.9 4.1 20.1 17.5 1.6 10.8 18.7 8.8 8.4 21.6 16.5 10.3 23.1 27.8 15.0 11.9 18.0 11.6 31.9 9.2 7.3 11.1 29.5 13.1 19.8 17.1 1.0 3.3 25.4 24.0 9.0 13.7 7.8 15.6 28.0 POLDIP3 "KIAA1649, PDIP3, PDIP46, SKAR" ENSG00000100227 "DNA polymerase delta interacting protein 3" Q9BY77 22 42583721-42614962 "Predicted intracellular proteins" "mRNA transport, Translation regulation, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 129.3;Late spermatids: 469.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018419, HPA048790" Approved Enhanced "Nuclear speckles,Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nuclear speckles" "Cytoplasmic bodies" "HPA018419: AB_1856928, HPA048790: AB_2680522" "unprognostic (2.00e-1)" "unprognostic (1.55e-1)" "unprognostic (1.32e-1)" "unprognostic (7.05e-3)" "prognostic favorable (7.79e-4)" "unprognostic (2.82e-1)" "unprognostic (1.17e-2)" "unprognostic (5.44e-2)" "unprognostic (8.16e-2)" "unprognostic (4.49e-3)" "unprognostic (2.48e-1)" "unprognostic (5.96e-2)" "prognostic favorable (3.36e-4)" "unprognostic (3.73e-2)" "unprognostic (3.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.19e-1)" 25.9 36.5 51.7 26.3 56.0 68.2 33.3 52.5 54.9 43.2 45.5 36.7 25.8 40.5 34.7 42.6 53.2 24.0 34.4 50.2 51.1 40.6 33.2 36.3 36.2 59.2 54.1 91.1 35.9 34.4 35.6 32.6 53.3 41.3 29.3 30.1 37.7 33.4 34.9 39.1 31.8 35.4 50.6 38.6 44.4 30.8 54.1 48.6 37.6 34.5 46.4 34.8 34.3 58.1 43.7 43.7 96.3 45.4 42.7 48.7 61.7 49.0 41.1 73.6 54.6 51.6 29.5 73.3 30.8 58.2 34.9 49.5 101.0 55.8 57.1 35.6 74.9 58.4 50.8 53.6 39.5 91.9 57.5 33.8 62.5 54.1 56.0 61.4 52.5 54.1 63.7 47.0 58.8 48.5 76.3 65.3 53.5 56.4 40.5 96.5 87.7 49.5 61.4 27.9 31.5 27.2 59.6 51.1 53.0 56.2 47.4 67.4 48.3 46.7 56.0 31.8 50.1 45.3 59.5 67.1 37.8 56.0 67.4 23.3 36.9 29.8 30.9 34.8 32.0 26.9 27.3 26.3 41.9 26.2 29.7 27.1 21.2 28.6 30.9 21.5 31.0 38.7 51.7 56.0 52.5 54.9 50.2 51.1 59.2 54.1 53.3 50.6 54.1 58.1 15.8 19.2 15.1 10.4 28.6 19.6 23.7 13.1 22.2 30.1 23.0 20.6 13.3 17.2 16.0 20.2 20.9 36.5 23.1 22.9 21.5 29.1 129.3 22.9 20.7 18.9 19.2 25.6 7.1 24.9 39.7 23.2 21.4 23.4 24.1 18.8 16.1 19.0 22.2 25.2 8.8 15.8 16.2 25.7 17.9 469.0 21.8 19.9 19.6 18.7 40.3 23.6 22.6 11.6 17.4 26.4 21.2 24.8 24.5 37.2 19.2 20.3 19.5 17.1 46.0 19.3 18.5 33.0 34.5 22.9 17.6 52.1 23.0 22.6 19.0 28.6 POLR2A "POLR2, POLRA, RPB1" ENSG00000181222 "RNA polymerase II subunit A" 17 7484366-7514616 "Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 2.4;lymphoid tissue: 1.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SCLC-21H: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012226, CAB016388, HPA021563, HPA053012" Enhanced Nucleoplasm,Cytosol NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm Cytosol "CAB012226: AB_304749, CAB016388: AB_677353, HPA021563: AB_1855526, HPA053012: AB_2682017" "unprognostic (2.03e-1)" "unprognostic (1.32e-1)" "unprognostic (1.58e-1)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (5.43e-2)" "unprognostic (8.77e-3)" "unprognostic (1.48e-1)" "unprognostic (5.19e-3)" "unprognostic (1.81e-1)" "unprognostic (1.52e-1)" "unprognostic (3.70e-2)" "unprognostic (1.01e-3)" "unprognostic (1.25e-1)" "unprognostic (2.30e-2)" "unprognostic (1.49e-1)" "unprognostic (4.70e-2)" 0.1 0.7 0.4 1.6 0.2 0.2 0.1 0.3 1.9 0.0 0.8 0.1 0.5 0.1 0.0 0.0 0.2 0.1 0.1 0.7 0.4 0.1 0.0 0.2 0.2 2.4 0.7 0.1 0.0 0.1 0.2 1.1 0.2 0.2 0.3 0.0 0.0 0.5 0.1 0.4 0.0 0.4 0.2 0.0 0.7 1.1 0.2 0.0 0.1 0.0 0.0 1.6 1.0 1.7 0.5 1.5 0.4 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.6 0.4 0.4 0.0 0.6 1.0 2.1 0.0 0.0 0.3 0.0 0.5 0.0 0.9 0.0 1.6 2.9 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.3 1.0 0.4 2.1 0.0 0.0 2.5 2.3 1.0 0.0 2.7 3.5 2.8 1.2 0.8 0.0 0.0 0.8 1.6 0.0 1.0 0.5 1.1 2.0 0.4 0.2 1.6 1.1 0.8 1.0 0.0 2.2 0.8 2.0 0.9 2.5 1.1 0.3 0.8 2.2 0.5 1.3 1.0 0.0 2.0 4.2 0.0 3.2 10.1 0.4 0.2 0.3 1.9 0.7 0.4 2.4 0.7 1.1 0.4 1.1 1.6 124.2 22.4 41.6 13.4 68.0 42.8 40.7 33.8 64.3 90.4 56.5 187.1 26.9 38.6 30.3 23.9 110.5 35.9 153.5 55.0 3.9 27.0 25.0 74.9 64.4 57.7 76.7 43.3 18.1 30.2 28.7 53.3 103.0 67.3 42.5 46.0 40.4 29.9 45.4 55.5 14.9 43.9 26.4 42.1 38.3 7.4 37.0 65.7 37.4 19.7 38.2 27.3 26.8 17.6 17.8 32.0 35.9 41.8 62.0 27.9 42.5 13.2 38.4 90.5 6.6 94.4 53.9 58.5 120.2 73.8 41.2 53.8 89.2 49.8 32.6 30.8 POLR2D RPB4 ENSG00000144231 "RNA polymerase II subunit D" O15514 2 127843553-127858155 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 74.3" "Cell type enhanced" "Detected in all" "Late spermatids: 170.2;Spermatocytes: 86.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034694, HPA046092" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Nuclear speckles" "HPA034694: AB_2674284, HPA046092: AB_10963049" "unprognostic (3.57e-2)" "unprognostic (3.76e-2)" "unprognostic (2.59e-1)" "unprognostic (2.54e-2)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "prognostic unfavorable (8.91e-4)" "unprognostic (2.51e-1)" "unprognostic (7.95e-3)" "unprognostic (2.64e-3)" "unprognostic (1.97e-1)" "unprognostic (2.51e-1)" "prognostic unfavorable (2.79e-4)" "unprognostic (3.66e-2)" "unprognostic (6.57e-2)" "unprognostic (1.17e-1)" "unprognostic (2.38e-1)" 12.3 10.4 7.2 14.4 9.8 32.4 11.9 9.6 8.3 9.4 7.3 12.0 9.7 10.3 8.0 12.3 10.6 8.4 10.0 7.5 8.7 8.8 19.2 10.2 19.7 8.0 8.9 15.0 14.7 10.4 8.3 15.9 8.3 9.5 14.7 8.1 8.4 9.2 29.3 11.3 9.3 15.0 8.4 12.8 9.4 74.3 8.1 28.3 9.1 27.1 26.9 15.3 8.4 11.0 63.4 40.6 73.9 51.9 26.8 29.2 59.0 59.1 27.9 69.6 61.9 92.0 50.9 97.7 49.6 40.0 39.8 32.7 107.0 51.2 107.3 57.7 58.3 96.6 37.9 85.4 31.4 104.9 51.6 20.8 37.8 93.3 53.2 19.3 46.1 70.4 137.1 84.8 40.4 50.1 105.0 47.5 103.6 65.9 46.4 99.3 77.8 88.0 23.1 42.6 45.7 60.9 39.9 48.9 50.7 54.7 54.6 71.4 47.0 60.1 84.4 34.4 69.0 99.4 173.4 173.0 52.4 51.2 60.5 9.9 22.8 17.3 26.3 31.7 25.0 22.8 21.0 23.2 29.9 20.2 27.6 23.7 7.3 25.8 35.0 19.5 20.6 21.3 7.2 9.8 9.6 8.3 7.5 8.7 8.0 8.9 8.3 8.4 8.1 11.0 10.9 3.2 11.7 2.6 22.0 10.8 22.0 7.6 15.9 15.1 9.8 6.2 10.4 11.5 10.1 12.9 8.4 33.0 23.4 7.6 11.7 20.3 70.8 13.2 16.1 12.5 8.4 31.1 4.7 17.5 31.0 15.2 9.7 10.4 18.4 23.1 11.4 17.0 21.7 33.7 5.2 11.9 8.2 11.1 14.1 170.2 17.7 13.3 8.8 2.8 23.4 13.2 16.5 2.5 7.5 18.4 8.4 18.4 46.6 26.2 10.2 11.1 6.8 13.7 13.1 18.5 15.5 86.1 48.9 19.3 10.1 26.7 17.1 31.5 14.0 18.9 POLR2M "GCOM1, Gdown, Gdown1, GRINL1A" ENSG00000255529 "RNA polymerase II subunit M" "P0CAP2, Q6EEV4" 15 57706695-57782762 "Predicted intracellular proteins" Transcription "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068141 Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm "HPA068141: AB_2685962" "unprognostic (3.07e-1)" "unprognostic (1.08e-1)" "unprognostic (2.63e-1)" "unprognostic (3.73e-1)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (9.80e-2)" "unprognostic (7.30e-2)" "unprognostic (4.30e-2)" "unprognostic (9.25e-2)" "unprognostic (2.81e-1)" "unprognostic (3.56e-2)" "unprognostic (6.61e-2)" "unprognostic (1.39e-1)" "unprognostic (3.25e-2)" "unprognostic (2.43e-1)" "unprognostic (1.07e-1)" 19.4 20.0 24.6 10.6 34.0 17.0 18.4 28.6 27.0 21.8 13.6 15.5 12.3 34.7 19.6 15.3 19.5 16.1 29.2 22.1 30.0 20.1 15.4 14.3 19.2 30.7 37.6 31.3 16.2 25.5 9.1 18.1 28.0 26.1 15.0 12.7 16.1 24.1 36.0 15.3 13.1 27.0 31.1 21.3 15.0 10.4 31.6 21.4 24.1 38.9 17.3 15.2 13.3 39.0 18.4 21.8 20.9 52.2 38.6 38.4 15.8 29.4 49.0 33.3 30.4 19.5 14.8 27.7 25.9 22.3 25.2 33.1 26.2 24.3 44.5 24.3 27.9 37.9 21.5 15.6 42.1 33.4 31.0 36.3 38.3 19.0 54.2 37.5 26.1 29.5 34.6 20.7 28.5 8.8 38.2 22.7 31.9 27.7 19.0 37.8 49.1 22.0 25.2 19.5 14.6 26.6 21.2 25.1 35.9 29.2 28.4 49.0 24.7 47.0 47.2 68.4 30.7 26.5 27.1 36.1 28.4 52.4 32.2 26.6 14.7 12.1 17.4 13.3 16.2 16.1 15.1 16.4 13.9 17.1 19.6 14.6 1.5 24.4 11.6 12.4 19.0 15.6 24.6 34.0 28.6 27.0 22.1 30.0 30.7 37.6 28.0 31.1 31.6 39.0 19.5 22.4 11.5 0.0 25.7 16.8 20.2 12.4 26.7 14.9 16.9 12.6 27.7 10.0 14.5 25.8 4.2 12.8 25.3 11.8 25.4 13.3 48.5 13.9 22.7 23.2 23.4 24.0 0.0 15.3 19.1 24.3 16.8 32.4 12.6 11.0 25.0 15.4 18.2 11.8 0.0 16.6 18.3 27.4 15.8 14.6 22.1 17.9 24.9 0.0 18.9 24.9 29.9 0.0 0.0 19.5 15.8 28.2 13.3 30.3 13.6 17.2 13.3 9.8 19.7 17.2 20.8 21.2 24.2 22.7 14.3 12.0 22.9 16.9 20.0 23.7 POLR3F "C34, RPC39, RPC6" ENSG00000132664 "RNA polymerase III subunit F" Q9H1D9 20 18467389-18484646 "Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins" "Antiviral defense, Immunity, Innate immunity, Transcription" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 42.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049441, HPA050173, HPA072298" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA049441: AB_2680768, HPA050173: AB_2681042, HPA072298: AB_2686510" "unprognostic (4.59e-2)" "unprognostic (1.83e-1)" "unprognostic (3.44e-1)" "unprognostic (1.69e-2)" "unprognostic (1.55e-1)" "unprognostic (7.39e-2)" "prognostic unfavorable (8.87e-9)" "unprognostic (1.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "prognostic favorable (6.48e-4)" "unprognostic (3.04e-1)" "unprognostic (4.01e-1)" "unprognostic (3.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.88e-3)" "unprognostic (4.98e-3)" 6.6 6.5 10.1 6.4 10.9 9.8 9.5 13.1 12.6 6.1 9.7 5.2 5.0 8.0 9.5 7.0 6.8 5.7 9.8 11.1 10.5 8.5 6.4 6.2 7.3 10.1 10.0 8.2 6.0 7.6 3.2 7.5 10.5 7.0 6.1 21.2 5.7 6.6 10.9 7.4 4.4 7.2 9.9 6.3 5.5 9.1 9.9 6.9 11.0 9.5 7.2 6.9 3.0 10.9 12.9 12.6 14.9 15.9 9.5 11.7 22.7 19.0 13.2 23.8 19.3 14.0 12.1 12.0 10.0 14.2 21.3 20.0 20.8 21.2 27.2 8.1 11.0 8.5 7.1 18.6 12.4 22.8 11.9 10.6 14.0 32.2 18.0 13.1 12.9 9.4 19.4 11.7 19.0 15.8 17.3 21.1 17.2 14.3 29.1 11.8 29.4 12.7 13.0 9.1 27.3 17.2 13.9 24.2 32.2 14.0 13.6 15.5 10.1 26.0 13.4 16.2 27.8 11.2 38.0 11.7 10.7 11.0 19.5 0.4 3.0 1.3 2.7 3.7 4.5 3.1 3.6 2.7 3.7 1.7 3.5 3.6 0.8 3.7 3.0 2.7 3.7 2.7 10.1 10.9 13.1 12.6 11.1 10.5 10.1 10.0 10.5 9.9 9.9 10.9 7.3 9.6 4.8 9.8 8.0 8.9 3.7 5.7 10.2 18.3 6.6 5.8 8.3 2.8 5.1 1.8 10.4 10.7 8.5 3.5 9.8 8.8 42.7 8.5 6.7 9.0 6.7 8.2 21.7 6.8 12.1 7.0 4.6 4.8 5.7 8.8 7.1 4.6 7.6 11.8 19.4 4.4 4.1 9.2 6.7 7.7 6.2 5.9 5.4 10.3 10.4 17.5 12.3 15.1 13.0 7.7 1.9 10.1 9.0 4.3 2.9 12.2 11.3 19.3 13.1 8.3 8.3 28.1 22.9 8.4 11.4 7.3 8.0 11.3 4.3 3.2 POM121 "DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A" ENSG00000196313 "POM121 transmembrane nucleoporin" Q96HA1 7 72879365-72951440 "Metabolic proteins, Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 98.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "CAB003710, HPA043809, HPA049817" Approved Enhanced "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear membrane" "CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896" "unprognostic (2.33e-1)" "unprognostic (3.05e-2)" "unprognostic (9.71e-2)" "unprognostic (5.86e-3)" "unprognostic (1.70e-1)" "unprognostic (2.06e-1)" "unprognostic (1.40e-1)" "unprognostic (6.38e-2)" "unprognostic (7.07e-3)" "unprognostic (3.08e-2)" "unprognostic (3.84e-2)" "unprognostic (1.71e-1)" "unprognostic (1.85e-1)" "unprognostic (3.66e-2)" "unprognostic (2.39e-1)" "unprognostic (7.43e-3)" "unprognostic (2.40e-1)" 25.4 20.4 10.3 18.8 10.1 44.7 21.0 7.2 14.3 18.3 3.4 19.5 21.6 19.6 9.4 20.1 18.7 13.6 16.0 11.9 9.7 16.6 23.5 17.4 21.3 6.8 8.5 23.8 25.5 16.1 21.4 17.0 6.4 19.2 12.1 17.5 19.3 11.2 25.7 21.6 22.8 13.0 2.3 22.9 21.8 18.7 8.8 17.8 20.0 16.0 17.1 18.8 18.1 9.1 49.6 35.4 43.5 98.0 23.0 18.8 36.0 34.6 29.2 33.8 29.3 63.0 30.6 67.7 11.0 30.1 37.5 37.0 43.5 33.6 37.6 59.2 86.5 50.6 36.6 42.4 23.5 106.1 61.8 24.8 23.3 44.9 41.0 21.9 25.5 38.5 141.2 49.3 33.7 37.8 63.7 67.0 45.5 27.4 42.3 57.4 33.8 57.1 17.2 42.8 61.7 54.3 30.3 57.3 31.1 28.8 48.1 55.0 36.2 60.2 36.8 48.0 70.5 58.8 58.8 96.0 35.2 66.6 61.0 0.0 0.8 1.4 1.7 0.5 1.0 1.0 1.1 1.3 0.9 1.1 0.9 1.4 0.9 1.6 1.4 1.5 0.6 1.1 10.3 10.1 7.2 14.3 11.9 9.7 6.8 8.5 6.4 2.3 8.8 9.1 31.8 38.5 28.9 33.0 28.6 25.2 10.1 17.5 29.0 34.6 19.5 19.7 4.4 20.0 19.9 18.4 98.0 17.1 30.6 19.7 5.9 12.3 13.2 14.6 24.7 18.3 18.0 30.7 55.6 17.1 13.2 19.2 32.1 21.3 16.5 31.1 17.2 24.9 16.2 40.4 58.9 21.7 16.2 18.9 21.7 6.3 14.9 23.3 19.6 23.4 13.8 18.2 32.0 30.2 38.6 21.8 14.1 17.7 37.6 22.2 19.1 8.4 17.6 26.6 13.1 27.0 17.6 19.2 13.1 29.6 31.0 19.4 27.9 24.7 23.2 21.9 PPAT "GPAT, PRAT" ENSG00000128059 "Phosphoribosyl pyrophosphate amidotransferase" Q06203 4 56393362-56435615 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Purine biosynthesis" "Allosteric enzyme, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Granulosa cells: 66.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036091, HPA036092" Approved Approved "Midbody ring" Yes No 11000 "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 40: Granulosa cells - Unknown function" "Midbody ring" "HPA036091: AB_2674936, HPA036092: AB_10603132" "unprognostic (5.11e-2)" "unprognostic (5.13e-2)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-5)" "unprognostic (1.38e-1)" "unprognostic (4.37e-3)" "prognostic unfavorable (1.14e-8)" "unprognostic (6.74e-3)" "unprognostic (2.95e-2)" "unprognostic (3.79e-2)" "unprognostic (2.88e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (8.34e-4)" "unprognostic (1.41e-1)" "unprognostic (3.01e-1)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.09e-1)" 2.8 6.1 3.8 5.4 4.0 5.6 7.1 3.7 4.7 4.3 3.6 3.9 4.0 4.6 3.4 4.5 4.4 3.0 2.3 4.1 4.0 6.0 6.1 2.2 8.4 3.4 4.0 7.4 5.9 3.9 2.5 6.7 4.3 3.9 4.8 4.4 5.6 3.1 2.9 4.3 3.2 3.6 3.7 4.3 3.5 8.6 4.1 8.3 5.9 2.9 8.0 6.7 2.6 4.2 23.1 19.0 38.0 18.7 12.2 15.7 31.0 25.2 11.1 20.4 21.6 38.1 27.5 80.6 33.4 11.9 19.0 16.8 74.0 25.4 40.7 21.1 32.8 32.6 22.6 42.2 18.4 65.0 19.5 13.6 19.4 29.0 32.4 12.6 21.8 32.5 83.5 43.3 23.2 20.9 80.6 49.1 50.6 52.0 22.4 67.2 24.9 56.9 34.2 16.2 64.0 31.2 20.1 36.3 23.0 35.4 24.5 13.8 15.3 21.2 36.6 21.4 45.0 32.2 34.5 82.9 23.6 40.7 20.1 4.7 1.8 0.9 3.8 2.7 5.9 7.4 5.1 5.2 2.5 6.1 7.7 7.1 0.5 10.2 3.9 3.2 4.3 3.5 3.8 4.0 3.7 4.7 4.1 4.0 3.4 4.0 4.3 3.7 4.1 4.2 4.8 0.0 5.5 16.6 10.7 31.0 16.0 5.6 28.5 8.4 10.1 9.7 3.8 4.3 8.0 3.7 2.1 29.7 10.3 1.5 9.8 3.7 2.6 5.5 14.1 7.8 4.2 14.9 22.9 2.7 25.2 9.4 4.1 6.9 7.0 66.2 5.3 7.1 7.9 38.7 15.8 4.3 4.1 1.6 6.0 2.6 7.8 5.2 8.8 5.6 3.1 6.4 2.1 5.5 9.1 3.3 2.7 5.7 15.3 15.0 0.8 12.7 6.2 4.7 0.0 9.3 10.8 16.4 27.5 18.3 31.8 7.7 10.7 21.9 9.0 8.7 PPIAL4G ENSG00000236334 "Peptidylprolyl isomerase A like 4G" P0DN37 1 148482548-148483302 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 1.5" "Cell type enhanced" "Detected in some" "Basal keratinocytes: 6.8;Langerhans cells: 7.4;NK-cells: 9.2;Suprabasal keratinocytes: 12.5" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 1.9;TIME: 1.9" HPA058345 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 6: Brain - Smell perception" "Cluster 20: HeLa - Mitochondria" "Cluster 63: NK-cells & T-cells - Immune response" "HPA058345: AB_2683685" "unprognostic (2.17e-3)" "unprognostic (3.63e-1)" "unprognostic (4.83e-1)" "unprognostic (2.26e-1)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (3.95e-1)" "unprognostic (2.67e-2)" "unprognostic (1.79e-1)" 0.1 0.5 0.7 0.5 0.4 1.0 0.1 1.5 0.7 0.0 0.1 0.2 0.7 0.1 0.4 0.0 0.0 0.0 0.1 0.4 0.3 0.3 0.1 0.3 0.7 0.2 0.3 0.3 0.1 0.1 0.0 0.0 0.3 0.3 0.1 1.1 0.4 0.0 0.9 0.7 0.7 0.0 0.1 0.4 0.4 0.4 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.8 0.9 0.1 1.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.7 0.0 1.9 0.9 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.4 1.1 0.0 0.3 0.0 0.9 0.4 0.5 0.1 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.8 1.4 0.2 0.6 0.9 0.0 1.9 0.2 1.1 1.2 0.3 1.1 0.8 0.9 0.0 0.5 0.4 0.2 0.2 0.5 1.2 0.4 0.7 1.2 0.8 0.7 0.4 0.8 0.6 0.7 0.0 2.2 1.7 0.3 1.1 0.6 0.7 0.4 1.5 0.7 0.4 0.3 0.2 0.3 0.3 0.1 0.5 0.6 0.1 0.0 0.6 0.0 1.0 6.8 0.4 0.8 0.0 1.8 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.1 1.4 0.1 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 1.3 0.1 0.4 0.5 0.2 1.7 0.0 0.0 0.0 1.2 7.4 0.3 0.0 0.2 1.8 0.0 0.4 0.2 9.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.1 1.1 0.0 0.5 2.6 0.0 0.1 0.0 12.5 0.1 3.2 0.1 0.0 0.2 PPIL2 "CYC4, Cyp-60, UBOX7" ENSG00000100023 "Peptidylprolyl isomerase like 2" Q13356 22 21666000-21700015 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 90.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "K-562: 190.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035344, HPA055637" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 34: Spermatids - Unknown function" Nucleoplasm "HPA035344: AB_10672863, HPA055637: AB_2682869" "unprognostic (1.97e-3)" "unprognostic (3.61e-2)" "unprognostic (2.70e-2)" "unprognostic (4.31e-2)" "unprognostic (2.27e-1)" "unprognostic (2.90e-3)" "unprognostic (5.16e-3)" "unprognostic (3.77e-2)" "unprognostic (9.46e-2)" "unprognostic (1.54e-1)" "unprognostic (2.33e-2)" "unprognostic (1.89e-2)" "unprognostic (2.45e-3)" "unprognostic (5.46e-2)" "unprognostic (5.39e-2)" "unprognostic (5.39e-2)" "unprognostic (1.54e-3)" 8.9 14.2 4.7 12.8 5.7 6.3 9.5 4.0 7.0 11.6 2.1 12.1 8.1 12.0 9.3 16.4 10.7 9.5 13.9 5.8 4.8 12.6 15.0 10.1 16.4 3.5 2.9 10.7 19.2 16.4 14.3 9.1 3.9 12.4 10.6 9.0 14.7 9.5 18.8 12.3 13.3 9.9 3.6 14.0 13.9 10.1 3.1 15.8 18.8 13.0 16.4 11.7 12.1 4.8 20.4 17.1 18.1 20.1 19.2 17.6 15.8 19.3 17.9 28.0 24.5 21.3 10.3 34.0 12.7 27.2 13.9 22.9 28.6 23.6 16.2 19.2 28.2 26.7 14.2 32.4 14.7 42.5 21.5 17.4 21.2 19.4 14.0 15.1 25.1 18.5 190.3 17.9 19.6 28.6 20.5 13.7 20.2 35.7 14.9 23.7 31.1 5.7 14.2 14.1 30.8 18.4 21.2 32.7 9.7 11.3 27.1 20.3 27.5 15.8 25.1 17.5 12.7 19.2 17.5 24.7 21.6 22.6 24.9 1.5 9.7 5.1 9.6 15.3 12.2 7.2 11.5 12.6 13.7 8.3 10.5 9.4 2.3 14.1 22.6 11.9 15.6 12.1 4.7 5.7 4.0 7.0 5.8 4.8 3.5 2.9 3.9 3.6 3.1 4.8 9.8 9.6 29.5 15.0 21.5 3.2 7.9 10.9 10.8 26.3 13.4 10.2 5.7 27.1 16.6 14.7 33.3 15.8 39.4 23.9 13.7 12.8 66.8 15.4 14.8 8.0 11.4 17.7 19.9 16.7 13.3 10.3 39.3 19.5 17.1 16.6 10.4 18.9 15.3 18.5 24.2 20.6 14.2 21.0 5.3 90.9 12.2 15.5 1.8 8.4 16.6 11.5 52.5 12.5 17.4 18.5 17.4 13.5 23.8 10.9 14.2 9.1 11.9 31.4 0.0 11.2 9.4 23.6 17.3 12.3 5.7 22.2 24.5 14.8 20.8 12.6 PPME1 "ABDH19, PME-1" ENSG00000214517 "Protein phosphatase methylesterase 1" Q9Y570 11 74171267-74254703 "Enzymes, Predicted intracellular proteins" "Hydrolase, Serine esterase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Erythroid cells: 96.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RH-30: 432.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004541, HPA043900, HPA064396" Enhanced Supported "Nucleoplasm,Nuclear bodies" NA NA 45000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm "Nuclear bodies" "CAB004541: AB_628161, HPA043900: AB_2678722, HPA064396: AB_2685254" "unprognostic (2.99e-2)" "unprognostic (1.27e-2)" "unprognostic (2.28e-1)" "unprognostic (1.98e-1)" "unprognostic (9.26e-2)" "unprognostic (5.77e-3)" "prognostic unfavorable (4.45e-6)" "unprognostic (2.31e-2)" "unprognostic (7.92e-2)" "unprognostic (9.76e-2)" "unprognostic (1.57e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (2.76e-4)" "unprognostic (1.84e-1)" "unprognostic (1.54e-1)" "unprognostic (4.14e-3)" "unprognostic (1.33e-3)" 14.7 25.1 16.8 10.0 18.1 16.9 14.9 8.5 21.3 17.3 7.8 15.2 11.0 16.8 29.1 20.8 24.1 14.0 21.4 18.8 19.4 18.6 10.1 13.0 9.3 12.7 14.5 18.3 15.4 62.5 14.5 14.9 17.5 23.8 15.7 23.8 20.1 24.9 29.7 28.7 11.5 21.4 9.8 8.1 13.4 31.9 13.4 18.8 23.1 24.1 14.7 22.3 13.9 14.0 50.5 62.3 42.4 45.9 45.4 36.0 41.3 71.8 48.4 134.8 103.6 139.1 32.3 26.3 47.7 55.1 73.6 79.9 63.4 50.3 123.1 36.4 23.8 38.7 66.6 64.1 96.7 28.9 33.2 34.6 41.8 69.7 32.7 54.8 39.1 37.5 93.0 22.5 236.6 34.1 38.0 36.1 34.4 71.2 50.3 39.9 432.4 39.9 56.7 33.9 57.2 49.2 85.1 38.7 108.4 46.2 72.7 29.1 23.5 52.1 67.6 51.5 55.2 41.4 54.6 46.9 39.2 26.7 43.4 1.4 8.7 11.3 10.4 10.5 13.2 7.2 13.4 12.6 11.2 8.3 13.3 10.9 4.9 13.7 9.5 11.8 10.9 9.2 16.8 18.1 8.5 21.3 18.8 19.4 12.7 14.5 17.5 9.8 13.4 14.0 16.1 28.9 12.8 28.7 10.8 20.3 24.4 30.5 23.3 31.3 18.5 17.7 18.0 7.2 28.5 35.0 37.5 14.1 11.2 15.4 17.6 16.9 51.4 44.9 32.8 15.0 25.7 96.4 65.3 13.4 38.9 19.1 23.9 24.2 8.2 21.2 10.8 9.7 13.6 33.7 59.3 13.5 34.6 6.7 14.8 13.4 13.7 11.1 3.6 20.6 10.8 15.2 16.5 35.7 40.5 16.6 12.0 25.2 8.2 19.2 10.3 11.6 40.9 18.8 6.6 19.0 33.0 61.9 45.6 21.5 24.9 15.5 12.4 18.8 13.4 17.3 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatocytes: 208.9;Proximal enterocytes: 440.8;Proximal tubular cells: 404.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "MCF7: 49.9" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 6.1 15.0 10.2 4.7 8.6 3.8 8.2 4.3 15.0 10.5 16.7 25.1 27.1 10.5 1.6 9.8 18.9 3.1 9.6 12.9 8.9 26.7 23.5 10.8 2.9 10.2 10.4 7.9 17.7 7.4 36.9 1.7 7.1 15.5 2.4 2.9 11.6 5.6 6.3 9.0 24.6 1.6 8.1 8.0 14.1 33.3 10.3 2.4 27.0 1.0 1.0 9.1 6.7 5.1 30.4 24.3 3.9 15.1 1.6 2.7 19.3 8.2 5.1 6.3 5.1 6.4 21.2 5.0 21.1 3.0 5.6 19.8 2.0 6.7 1.0 10.3 11.9 6.0 26.4 6.8 4.7 4.3 7.9 2.7 8.9 7.3 2.1 4.1 4.5 8.2 24.0 6.1 2.3 49.9 15.3 19.9 7.4 15.6 30.3 15.9 1.9 10.1 5.7 10.0 12.5 23.9 14.9 13.7 13.0 1.0 32.3 9.1 7.7 7.1 33.2 19.8 15.8 4.0 4.3 1.8 22.8 8.3 6.5 0.0 0.8 0.0 1.0 1.2 0.9 0.8 0.8 1.0 1.2 0.1 0.5 1.1 0.2 0.2 1.7 0.7 0.6 0.8 10.2 8.6 4.3 15.0 12.9 8.9 10.2 10.4 7.1 8.1 10.3 5.1 7.9 3.2 15.4 28.1 6.2 43.2 36.2 47.6 54.1 25.0 78.3 82.0 85.8 157.3 24.6 40.5 14.6 7.2 6.0 135.9 121.3 33.7 12.6 43.8 15.6 13.3 51.6 6.1 7.8 41.6 24.3 13.3 70.3 24.2 3.8 16.4 12.8 208.9 6.1 30.3 7.6 98.1 26.4 7.0 27.1 14.4 22.7 9.8 8.8 5.6 3.8 102.8 5.2 6.6 2.8 29.3 109.8 15.4 5.9 40.0 440.8 404.2 59.8 50.9 6.6 17.2 17.3 52.9 28.7 77.8 61.8 6.7 7.1 69.2 116.0 28.3 PPP2R1A "PP2A-Aalpha, PP2AA, PR65A" ENSG00000105568 "Protein phosphatase 2 scaffold subunit Aalpha" P30153 19 52190048-52229518 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Chromosome partition" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB018599 Approved Cytosol NA NA 2000000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol "CAB018599: AB_628178" "unprognostic (1.78e-1)" "unprognostic (2.31e-2)" "unprognostic (4.52e-2)" "unprognostic (2.87e-1)" "unprognostic (6.67e-2)" "unprognostic (7.82e-2)" "prognostic unfavorable (1.76e-4)" "prognostic unfavorable (2.50e-4)" "unprognostic (4.30e-2)" "unprognostic (3.06e-1)" "unprognostic (6.48e-3)" "unprognostic (8.28e-2)" "prognostic favorable (1.20e-4)" "unprognostic (1.97e-1)" "unprognostic (3.57e-2)" "unprognostic (1.70e-2)" "unprognostic (9.19e-2)" 98.5 300.7 305.0 60.5 311.1 58.1 98.7 292.0 394.2 126.9 261.4 115.7 91.5 126.8 101.0 164.4 126.8 63.2 322.8 342.6 299.4 156.9 106.0 87.5 72.7 308.9 301.1 163.7 100.7 129.9 123.9 69.1 312.8 123.3 82.2 89.8 99.8 92.2 239.7 119.3 98.5 96.0 280.1 87.6 106.0 67.2 331.7 76.9 107.9 170.7 90.0 123.5 121.9 299.2 153.6 248.4 210.9 182.0 166.9 173.4 105.3 130.3 173.2 174.1 151.1 129.3 122.1 132.5 91.0 213.9 95.7 108.8 228.0 197.9 100.6 101.3 562.8 99.6 126.9 148.2 152.6 105.6 93.1 234.3 163.8 163.5 149.2 162.9 167.9 92.1 114.3 96.8 196.3 178.6 159.6 215.4 204.6 162.2 218.4 148.6 118.3 152.5 285.0 251.7 153.3 161.3 149.0 160.1 100.3 136.3 141.9 197.3 153.1 133.2 120.5 65.7 154.2 96.9 151.5 160.0 143.1 109.7 170.5 172.6 172.0 169.4 143.9 212.2 131.0 143.1 126.3 134.3 192.8 157.1 101.6 119.6 103.7 228.6 199.0 119.7 177.5 255.6 305.0 311.1 292.0 394.2 342.6 299.4 308.9 301.1 312.8 280.1 331.7 299.2 55.3 44.8 35.4 21.5 76.0 70.4 99.0 178.0 56.9 114.0 64.5 71.1 100.2 74.4 99.5 119.5 25.0 203.7 47.3 157.0 117.4 213.5 4.4 77.5 79.7 72.4 107.0 39.7 27.4 155.7 259.9 85.7 77.5 100.7 68.5 96.7 65.0 52.8 146.2 144.7 39.5 128.8 144.5 68.1 39.3 10.4 72.4 58.0 53.4 17.8 103.7 118.0 62.8 25.6 29.9 168.2 189.0 85.4 60.3 88.3 147.5 135.3 80.6 61.5 78.9 49.2 90.3 16.5 68.8 74.4 63.2 182.0 64.2 99.7 185.2 104.2 PPP5C "PP5, PPP5" ENSG00000011485 "Protein phosphatase 5 catalytic subunit" P53041 19 46347087-46392981 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair" "Hydrolase, Protein phosphatase" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022641, HPA029065, HPA056933" Approved Supported Vesicles,Cytosol NA NA 120000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 24: NB-4 - Immune response" "Cluster 59: Non-specific - Transcription" "Vesicles, Cytosol" "CAB022641: , HPA029065: AB_10610284, HPA056933: AB_2683278" "unprognostic (8.25e-2)" "unprognostic (7.90e-2)" "unprognostic (1.44e-1)" "unprognostic (6.30e-2)" "unprognostic (5.92e-2)" "unprognostic (2.62e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.29e-1)" "unprognostic (1.04e-2)" "unprognostic (8.25e-2)" "unprognostic (5.56e-2)" "unprognostic (2.20e-2)" "unprognostic (3.24e-2)" "unprognostic (1.14e-1)" "unprognostic (1.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.37e-1)" 27.4 37.5 27.7 17.7 29.3 14.2 26.3 28.4 36.5 28.0 27.7 31.3 16.8 34.9 9.8 30.4 31.7 13.3 56.4 29.8 28.6 29.1 32.7 28.0 19.7 32.3 28.2 24.7 23.7 32.5 36.6 15.8 33.3 23.7 15.4 14.4 23.0 18.2 58.9 27.5 25.9 20.8 26.2 33.5 33.6 16.9 30.3 20.5 26.2 45.7 15.0 27.7 26.3 28.5 61.9 114.9 66.0 50.1 48.3 50.9 30.6 75.4 59.6 88.2 78.2 82.4 47.9 94.3 39.9 54.0 48.4 49.9 86.2 88.5 24.7 65.9 120.5 76.4 80.9 59.4 54.5 106.6 52.8 47.8 40.9 62.1 45.9 34.2 77.2 79.3 76.0 47.3 49.4 67.5 59.5 203.4 50.2 109.6 61.7 89.0 56.6 76.5 52.8 81.8 93.1 69.7 62.6 78.8 26.9 28.6 49.7 67.8 65.5 38.3 64.3 29.1 79.1 38.0 93.0 111.5 41.7 89.4 65.9 0.0 10.3 3.0 27.8 18.0 17.8 15.1 12.8 22.0 16.8 11.7 12.2 16.8 0.2 22.0 23.4 11.7 14.3 15.4 27.7 29.3 28.4 36.5 29.8 28.6 32.3 28.2 33.3 26.2 30.3 28.5 28.1 6.4 12.5 22.9 16.5 9.4 16.6 20.9 19.9 19.7 13.1 13.5 5.6 44.3 14.2 16.5 16.7 26.4 12.3 25.2 33.2 29.9 1.2 31.3 25.2 19.6 14.9 11.6 18.5 19.5 36.2 17.6 26.0 19.6 4.5 18.6 24.3 24.9 21.6 16.8 23.2 17.0 22.4 12.3 8.2 3.2 17.4 11.9 16.0 11.2 12.1 21.0 17.5 17.6 14.5 26.4 17.0 18.4 25.5 12.1 16.3 21.4 14.6 17.9 39.5 14.6 19.9 26.6 32.0 20.8 13.2 25.7 20.4 23.1 25.0 11.7 PRDM4 PFM1 ENSG00000110851 "PR/SET domain 4" Q9UKN5 12 107732871-107761272 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024322, HPA067437" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 30: Epithelial cell lines - Translation" "Cluster 57: B-cells - Immune response" Nucleoplasm "HPA024322: AB_1855691, HPA067437: AB_2685839" "unprognostic (4.64e-2)" "unprognostic (3.16e-3)" "unprognostic (1.73e-3)" "unprognostic (2.35e-1)" "unprognostic (1.94e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (1.86e-4)" "unprognostic (1.11e-3)" "prognostic unfavorable (7.66e-4)" "unprognostic (9.64e-2)" "unprognostic (9.06e-3)" "unprognostic (5.31e-2)" "prognostic favorable (3.15e-7)" "unprognostic (9.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.59e-1)" "unprognostic (2.62e-3)" 12.8 8.6 12.8 11.9 13.3 16.9 11.7 14.5 13.5 12.0 13.1 15.0 13.2 15.2 13.4 15.6 11.8 11.2 8.9 12.3 12.8 21.0 7.0 12.9 12.4 13.2 12.8 15.0 10.2 44.5 8.1 12.5 13.5 11.5 16.4 20.9 11.5 12.1 12.5 12.3 13.8 13.9 11.1 12.3 12.7 11.6 14.7 11.4 12.6 12.8 14.0 11.5 13.2 14.3 19.2 20.9 22.4 23.4 23.7 24.3 17.1 25.6 33.2 25.4 19.2 14.7 8.1 24.6 10.6 27.2 23.7 13.4 23.5 18.7 27.4 18.1 24.1 19.5 15.5 15.8 30.5 28.1 19.3 29.8 35.3 28.7 49.1 27.6 33.5 22.7 24.0 29.0 30.6 20.1 15.9 24.9 11.7 12.4 28.2 12.8 22.4 24.2 26.2 29.0 27.6 25.8 19.3 13.5 23.5 15.2 16.5 14.1 34.1 19.4 14.0 26.1 21.7 20.3 21.5 17.2 14.2 13.1 14.7 1.1 0.8 1.4 1.9 3.0 1.3 2.6 1.0 1.7 2.3 2.1 1.6 2.0 0.3 1.2 4.2 1.2 2.2 0.8 12.8 13.3 14.5 13.5 12.3 12.8 13.2 12.8 13.5 11.1 14.7 14.3 10.6 9.6 6.4 4.9 38.3 14.5 9.0 4.2 8.0 13.6 7.6 6.7 7.3 4.3 6.3 12.9 14.6 6.3 9.8 13.3 9.8 14.8 23.4 12.3 19.8 11.2 12.6 6.9 12.0 11.4 7.5 9.7 10.2 21.8 3.8 11.0 11.0 4.6 11.4 33.7 12.2 10.3 2.0 10.3 7.2 28.4 6.2 9.0 8.8 15.0 12.1 7.5 12.3 9.5 12.9 16.6 8.1 4.9 8.2 12.4 14.6 9.7 7.2 11.7 6.6 12.4 10.6 6.3 12.5 12.5 16.9 4.8 11.1 6.4 12.0 10.2 PREP ENSG00000085377 "Prolyl endopeptidase" P48147 6 105273218-105454062 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 84.8" "Cell type enhanced" "Detected in many" "Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025414, HPA031388, HPA031389, HPA031390" Supported Supported Cytosol NA NA 1700000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857" "unprognostic (3.05e-2)" "unprognostic (9.09e-3)" "unprognostic (2.85e-2)" "unprognostic (5.46e-2)" "unprognostic (3.36e-1)" "prognostic unfavorable (3.33e-4)" "unprognostic (2.63e-3)" "unprognostic (2.39e-1)" "unprognostic (6.78e-2)" "unprognostic (5.81e-2)" "unprognostic (2.66e-2)" "unprognostic (1.15e-1)" "unprognostic (4.47e-3)" "unprognostic (2.74e-2)" "unprognostic (8.98e-2)" "unprognostic (6.59e-2)" "unprognostic (2.33e-1)" 17.3 17.4 7.2 14.6 8.1 14.3 17.7 7.4 12.0 15.2 7.8 32.1 23.6 15.8 12.1 21.1 13.0 8.7 22.5 8.8 7.3 11.3 19.0 16.2 13.6 6.7 7.7 16.0 19.2 20.5 13.0 17.8 6.8 11.6 37.5 15.4 18.6 9.0 84.8 33.4 25.6 15.3 6.6 14.3 18.7 21.4 8.8 16.4 12.3 46.9 16.2 21.4 17.5 8.5 22.3 26.9 27.9 32.1 63.1 37.1 27.7 28.6 27.0 37.2 39.0 35.9 14.2 28.5 26.8 33.9 35.0 33.3 41.8 86.5 42.7 41.8 37.4 38.1 21.7 40.0 25.3 40.5 26.2 35.8 53.4 27.6 71.7 28.0 35.4 50.1 67.4 49.8 45.5 38.8 25.8 41.4 27.9 44.2 25.0 41.1 48.4 18.3 28.2 53.8 36.0 51.8 25.3 42.0 21.7 35.3 17.9 61.9 36.1 17.3 23.9 21.6 36.2 14.2 9.7 38.5 30.4 42.6 56.6 5.5 15.2 8.4 16.3 16.8 16.8 9.3 14.2 17.1 16.5 6.9 12.9 15.5 0.8 19.9 22.7 7.0 13.6 13.5 7.2 8.1 7.4 12.0 8.8 7.3 6.7 7.7 6.8 6.6 8.8 8.5 6.3 3.2 6.7 22.9 10.1 10.8 6.8 12.0 5.7 5.1 6.0 5.5 14.8 7.2 13.6 7.3 14.6 28.2 14.5 19.3 5.9 10.4 1.4 6.6 15.1 10.1 19.3 11.2 79.7 11.7 35.9 10.6 24.5 11.6 13.4 11.2 7.5 15.1 15.0 13.5 48.3 29.4 10.2 14.2 10.8 3.2 10.8 13.3 5.4 27.2 19.1 3.3 5.2 28.6 18.7 18.0 29.1 9.1 11.0 5.3 18.5 8.8 4.8 10.4 0.0 8.3 10.3 3.9 18.8 12.9 8.5 67.9 16.1 14.4 38.2 8.5 PRIM2 PRIM2A ENSG00000146143 "DNA primase subunit 2" P49643 6 57314805-57646850 "Plasma proteins, Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 30.6" "Cell type enhanced" "Detected in many" "Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046566 Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 18: U-2197 - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA046566: AB_2679701" "unprognostic (1.24e-1)" "unprognostic (1.55e-2)" "unprognostic (2.66e-2)" "prognostic unfavorable (6.98e-4)" "unprognostic (3.08e-1)" "unprognostic (6.24e-2)" "prognostic unfavorable (3.44e-5)" "unprognostic (2.31e-1)" "unprognostic (1.00e-2)" "prognostic favorable (3.00e-5)" "prognostic unfavorable (5.25e-4)" "unprognostic (3.89e-1)" "prognostic unfavorable (7.34e-6)" "unprognostic (2.04e-2)" "unprognostic (2.07e-1)" "unprognostic (1.67e-1)" "unprognostic (1.08e-1)" 4.3 3.3 3.9 6.6 4.6 15.0 6.9 6.0 4.3 5.6 6.9 6.9 6.0 7.2 6.9 4.3 6.2 4.3 3.3 3.9 5.6 3.9 5.0 4.8 10.6 4.2 4.7 7.2 4.0 3.9 1.9 7.5 4.4 30.6 8.4 4.0 4.2 5.6 2.3 5.8 5.2 8.0 2.8 5.5 4.8 6.5 4.5 15.3 4.4 2.4 11.8 5.8 4.1 7.1 44.8 17.7 34.1 37.6 16.8 29.5 27.3 53.1 48.8 57.0 74.7 26.6 21.1 39.4 27.7 66.6 39.6 27.9 30.2 29.2 71.6 35.1 24.2 47.6 22.7 43.0 7.3 43.5 27.4 12.1 12.0 61.0 20.3 14.2 26.9 44.1 46.2 38.9 48.3 28.2 49.8 37.6 22.0 37.1 17.2 34.7 46.9 31.2 21.0 20.7 24.5 19.2 31.5 15.9 21.3 38.9 33.3 47.4 17.9 54.7 55.5 106.2 44.2 14.4 29.3 47.2 26.6 50.5 30.4 0.7 1.9 1.8 4.1 3.7 4.3 3.5 3.5 5.4 3.0 4.0 2.8 5.7 1.4 5.2 4.2 5.1 4.7 2.1 3.9 4.6 6.0 4.3 3.9 5.6 4.2 4.7 4.4 2.8 4.5 7.1 5.9 0.0 2.7 30.0 11.2 4.0 6.7 4.1 11.4 5.6 6.2 4.2 1.1 2.8 4.6 3.7 12.5 17.0 15.1 4.3 3.9 5.1 10.3 4.9 7.1 5.0 1.2 26.5 38.0 5.2 22.0 6.9 4.1 6.0 12.0 13.7 4.2 3.5 9.3 6.7 32.6 6.5 10.2 6.6 6.4 3.7 6.5 7.0 0.0 70.3 7.3 4.8 17.5 56.8 54.5 4.9 5.3 6.8 12.7 7.1 4.4 1.8 4.1 5.6 19.7 4.9 6.8 10.1 11.2 8.7 3.0 5.7 13.6 8.0 8.6 5.3 PRMT3 HRMT1L3 ENSG00000185238 "Protein arginine methyltransferase 3" O60678 11 20387558-20509338 "Metabolic proteins, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 54.2;Excitatory neurons: 55.5;Inhibitory neurons: 66.9;Oligodendrocytes: 63.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007832, CAB022083" Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB022083: , HPA007832: AB_1855721" "unprognostic (2.08e-2)" "unprognostic (4.43e-2)" "unprognostic (1.08e-2)" "unprognostic (5.98e-2)" "unprognostic (2.57e-2)" "unprognostic (8.97e-2)" "prognostic unfavorable (2.81e-5)" "unprognostic (2.01e-1)" "unprognostic (9.92e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (3.17e-5)" "unprognostic (9.15e-2)" "unprognostic (7.22e-2)" "unprognostic (8.86e-2)" "unprognostic (2.09e-1)" "unprognostic (1.40e-2)" "unprognostic (4.11e-2)" 5.0 7.4 4.5 8.1 5.4 8.6 9.6 5.0 8.3 5.1 3.7 6.5 7.6 7.7 3.8 8.2 8.5 5.4 9.7 5.2 5.3 6.9 5.4 4.7 7.8 5.4 5.0 8.1 6.7 11.1 2.6 6.9 5.5 6.1 7.7 7.7 6.5 5.7 10.2 6.2 5.9 7.3 5.0 5.5 6.6 4.3 4.8 9.9 19.8 7.7 8.8 8.0 4.6 7.9 26.5 31.4 18.9 17.4 11.8 19.5 36.1 17.9 15.5 24.5 18.5 25.9 7.2 55.8 12.8 14.1 22.4 34.0 27.2 25.6 37.7 26.1 26.4 26.9 25.5 23.3 24.0 48.8 11.4 16.3 26.3 16.1 54.6 10.3 19.7 19.8 61.1 15.3 15.6 26.7 38.6 16.6 26.7 45.1 27.8 27.9 42.3 46.3 23.8 20.2 18.9 24.8 31.0 28.5 23.2 20.3 30.1 14.1 13.3 19.8 17.3 32.7 34.2 9.1 9.7 58.3 15.7 34.1 39.0 3.8 5.1 4.4 4.4 6.1 7.7 5.3 5.5 4.9 9.8 4.9 6.0 5.2 1.3 10.7 5.2 2.0 3.6 3.9 4.5 5.4 5.0 8.3 5.2 5.3 5.4 5.0 5.5 5.0 4.8 7.9 5.5 9.6 5.1 54.2 11.8 6.0 7.7 6.7 15.9 3.8 6.5 4.2 11.8 4.3 5.7 0.0 2.1 11.4 5.0 3.2 9.8 6.9 3.1 6.0 8.2 5.5 7.8 29.2 55.5 5.1 11.0 8.9 11.2 5.5 5.7 8.0 2.9 4.3 6.5 6.7 66.9 7.3 14.2 5.3 3.6 1.0 6.5 10.9 3.6 35.6 6.7 5.6 2.1 41.7 63.2 5.1 2.2 6.4 8.9 9.5 3.5 5.9 5.8 6.6 0.0 7.8 6.7 13.7 9.6 18.7 5.8 7.3 7.0 12.5 7.6 5.7 PRMT6 "FLJ10559, HRMT1L6" ENSG00000198890 "Protein arginine methyltransferase 6" Q96LA8 1 107056674-107067636 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "MCF7: 308.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059424 Approved Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoplasm, Nucleoli" "HPA059424: AB_2684012" "unprognostic (5.17e-3)" "unprognostic (1.48e-1)" "unprognostic (1.47e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (2.68e-1)" "unprognostic (2.55e-1)" "unprognostic (1.36e-3)" "unprognostic (2.13e-2)" "unprognostic (9.72e-2)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (2.63e-1)" "unprognostic (3.15e-2)" "unprognostic (1.03e-1)" "unprognostic (8.34e-2)" "unprognostic (1.01e-1)" "unprognostic (1.73e-3)" 4.9 10.0 5.7 7.2 5.6 4.2 8.0 5.6 5.7 6.1 13.8 7.9 6.1 7.0 8.0 6.8 8.8 6.0 3.9 5.2 6.9 12.0 7.1 4.6 9.6 6.1 6.5 8.6 10.9 9.6 8.4 7.3 5.3 8.5 7.2 6.4 6.5 7.8 1.8 5.6 7.2 5.9 5.5 8.3 7.4 6.6 8.2 10.3 7.0 3.1 8.7 7.9 5.0 6.0 13.6 0.2 25.7 11.3 16.6 18.4 7.0 17.8 13.2 16.9 17.2 17.2 9.2 33.1 24.1 16.5 9.2 18.9 23.9 26.2 13.3 0.0 25.4 20.0 35.6 25.0 16.5 41.6 11.9 17.4 14.2 15.2 15.5 11.4 14.8 18.5 27.1 5.0 15.4 308.1 24.5 14.6 11.1 10.6 24.6 30.8 56.0 12.6 41.3 27.1 47.8 58.3 24.2 34.5 12.1 15.5 24.0 30.7 17.2 12.5 25.5 26.3 26.8 5.4 4.0 5.7 18.4 19.3 10.2 2.1 10.4 1.9 7.9 11.9 9.5 7.4 8.3 7.6 14.1 10.3 11.5 11.9 0.6 17.4 12.0 17.2 9.2 9.3 5.7 5.6 5.6 5.7 5.2 6.9 6.1 6.5 5.3 5.5 8.2 6.0 3.0 0.0 4.4 1.3 6.2 4.5 6.9 9.7 8.6 14.2 8.9 5.0 2.6 5.7 5.8 14.7 0.0 18.3 8.5 3.3 27.4 10.3 1.2 5.2 6.2 4.7 17.5 15.8 1.5 7.4 14.6 6.7 4.6 4.9 1.3 9.4 7.5 2.4 10.0 15.2 2.2 7.4 8.2 7.0 1.6 3.0 8.7 3.8 1.8 3.7 3.9 6.9 3.1 2.0 2.2 4.7 8.5 9.1 2.0 5.1 4.1 18.4 7.4 5.1 13.1 5.9 6.3 9.1 8.1 8.9 6.1 7.1 5.0 13.7 10.3 5.4 PRPF31 "hPrp31, NY-BR-99, PRP31, RP11, SNRNP61" ENSG00000105618 "Pre-mRNA processing factor 31" Q8WWY3 19 54115410-54131719 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041939, HPA061873" Supported Supported Nucleoplasm NA NA 13000 "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "HPA041939: AB_10793938, HPA061873: AB_2684630" "unprognostic (1.32e-1)" "unprognostic (1.73e-2)" "unprognostic (1.26e-2)" "unprognostic (7.98e-2)" "unprognostic (1.28e-1)" "unprognostic (3.28e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (9.55e-2)" "unprognostic (2.16e-1)" "unprognostic (1.66e-1)" "unprognostic (5.26e-3)" "unprognostic (1.81e-2)" "unprognostic (2.06e-1)" "unprognostic (2.16e-1)" "unprognostic (5.94e-2)" "unprognostic (2.53e-1)" "unprognostic (7.04e-2)" 35.1 36.0 26.1 24.3 27.5 33.2 35.1 26.6 31.3 39.6 26.9 42.3 23.1 39.7 12.5 37.8 35.3 18.9 38.8 26.7 26.1 34.2 44.5 29.7 33.2 27.0 26.3 39.0 29.3 28.6 33.7 23.1 26.7 37.6 13.9 8.1 33.9 23.6 48.2 40.2 34.6 19.0 25.5 39.7 35.7 33.0 27.2 26.3 36.5 23.7 23.4 38.3 35.6 28.5 83.7 169.4 55.0 89.8 34.6 33.0 59.4 68.3 53.1 74.6 72.5 82.4 63.8 89.1 54.2 49.9 36.0 49.8 64.6 78.6 46.4 82.4 298.4 66.6 108.3 97.0 51.7 120.9 59.7 54.2 36.0 62.3 43.1 39.4 79.4 74.4 96.8 46.2 49.9 82.8 103.3 64.1 53.4 78.5 187.1 89.2 71.7 81.5 51.8 120.8 61.6 72.8 88.0 83.2 44.7 24.5 52.3 62.5 81.2 100.4 84.7 43.6 109.0 58.6 97.7 98.5 75.7 81.9 71.0 25.0 44.3 30.1 47.9 53.1 51.8 43.5 47.2 51.4 52.9 44.5 39.7 40.5 9.1 54.4 48.6 45.6 61.0 51.1 26.1 27.5 26.6 31.3 26.7 26.1 27.0 26.3 26.7 25.5 27.2 28.5 38.7 35.3 26.7 17.0 35.0 42.7 38.9 96.1 46.7 31.4 31.3 37.6 35.9 32.9 54.2 25.8 14.6 95.0 40.2 29.3 60.7 74.6 5.9 34.9 34.9 47.3 34.8 32.4 13.4 62.9 90.8 42.0 33.6 31.0 31.7 53.5 27.8 27.3 66.4 30.3 12.4 38.9 57.0 22.2 43.2 7.4 38.2 33.7 40.9 9.4 61.2 51.1 48.4 13.6 14.9 63.2 30.1 48.9 34.0 37.6 46.9 62.0 43.6 32.2 39.5 36.1 53.4 125.2 77.9 33.9 42.1 76.2 41.5 54.3 46.3 32.8 PSMD1 "P112, Rpn2, S1" ENSG00000173692 "Proteasome 26S subunit, non-ATPase 1" Q99460 2 231056845-231173116 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021092, HPA036736, HPA036737" Enhanced Approved "Nucleoplasm,Actin filaments" NA NA 230000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Actin filaments" "CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279" "unprognostic (9.32e-3)" "unprognostic (2.08e-2)" "unprognostic (1.07e-1)" "unprognostic (3.81e-2)" "unprognostic (2.71e-1)" "unprognostic (1.78e-2)" "prognostic unfavorable (8.63e-12)" "prognostic unfavorable (2.34e-4)" "unprognostic (2.57e-1)" "unprognostic (1.72e-2)" "unprognostic (3.09e-3)" "unprognostic (2.49e-1)" "unprognostic (8.91e-3)" "unprognostic (1.10e-2)" "unprognostic (6.26e-2)" "unprognostic (4.16e-2)" "unprognostic (1.70e-3)" 37.3 38.2 21.9 31.7 26.1 20.1 29.0 21.9 33.7 26.3 20.9 34.8 35.5 37.4 25.6 41.5 24.3 20.3 51.3 27.5 28.5 34.1 42.1 27.0 28.8 26.9 24.9 19.2 17.3 72.7 32.9 36.8 28.3 29.7 36.8 25.4 25.8 33.4 136.3 34.9 29.3 44.9 24.5 25.2 27.9 29.0 24.5 36.6 27.4 81.6 38.3 37.3 27.8 24.4 103.9 113.1 120.6 93.8 122.2 88.7 115.4 135.3 139.4 133.4 134.0 136.5 97.6 80.0 123.3 150.5 138.0 95.0 169.4 125.0 174.3 124.3 93.3 148.7 81.6 155.5 62.9 133.3 119.4 76.5 57.8 142.4 73.9 73.4 159.6 70.3 212.1 56.8 158.7 100.3 103.0 68.3 157.8 100.1 89.3 86.0 190.4 77.7 96.5 104.0 78.8 74.1 108.7 94.1 65.7 120.6 75.3 74.7 152.3 101.4 110.8 126.0 129.8 48.6 80.2 140.4 162.7 100.0 123.4 34.6 27.8 18.8 25.1 39.0 27.3 21.0 25.8 23.8 30.9 17.2 19.2 22.9 12.5 35.9 42.5 18.9 32.3 25.7 21.9 26.1 21.9 33.7 27.5 28.5 26.9 24.9 28.3 24.5 24.5 24.4 51.9 51.3 48.5 77.7 32.9 33.1 37.7 57.0 19.9 46.4 23.0 25.8 125.4 31.5 53.0 33.1 41.7 119.2 27.0 63.6 17.6 83.9 6.2 51.2 67.5 51.7 39.4 61.6 100.0 102.2 101.4 54.6 42.3 60.9 103.9 67.8 30.0 86.9 72.3 90.9 96.0 30.0 57.0 44.2 23.5 9.9 34.8 49.8 17.8 54.4 62.6 46.6 29.9 67.3 93.1 98.6 26.2 45.9 49.4 46.5 46.9 32.1 66.9 53.2 72.3 54.6 128.2 247.9 158.8 39.2 33.1 167.5 36.6 65.5 42.9 38.8 PTCD3 "DKFZp666K071, FLJ20758" ENSG00000132300 "Pentatricopeptide repeat domain 3" Q96EY7 2 86106223-86142157 "Predicted intracellular proteins, Ribosomal proteins" "Translation regulation" "Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041154, HPA041382" Supported Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 39: CACO-2 - Unknown function" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA041154: AB_10795488, HPA041382: AB_10795695" "unprognostic (1.16e-2)" "unprognostic (4.47e-2)" "unprognostic (1.37e-2)" "unprognostic (9.30e-3)" "unprognostic (2.40e-2)" "unprognostic (2.54e-1)" "unprognostic (4.92e-3)" "unprognostic (2.06e-2)" "unprognostic (4.78e-2)" "unprognostic (3.78e-1)" "unprognostic (7.42e-3)" "unprognostic (5.49e-3)" "unprognostic (1.26e-1)" "prognostic favorable (6.77e-4)" "unprognostic (3.69e-1)" "unprognostic (7.79e-2)" "prognostic favorable (6.86e-4)" 10.0 15.8 13.1 7.6 14.2 14.7 9.9 15.2 15.9 11.6 16.3 12.6 10.1 11.7 10.2 10.7 11.7 6.4 26.2 13.3 14.5 12.4 16.5 9.6 11.8 13.6 14.0 15.1 10.7 13.1 14.8 9.2 14.7 10.4 13.5 13.2 9.8 7.5 32.8 10.3 11.9 9.0 13.7 12.0 11.8 16.6 13.5 10.5 12.0 36.3 11.1 10.3 10.7 16.7 16.2 37.6 22.0 18.5 16.1 16.6 26.2 32.6 13.8 18.0 18.0 69.9 15.1 39.7 11.8 17.1 18.6 28.9 44.7 17.7 22.9 17.8 37.0 31.8 23.0 59.2 16.3 26.0 23.1 19.8 12.8 13.7 24.4 18.8 15.7 28.6 33.5 14.8 16.0 15.0 21.7 31.0 20.2 31.5 23.9 28.8 30.9 30.6 24.6 31.7 23.9 14.7 15.2 25.0 30.4 20.6 13.2 15.7 11.3 14.2 15.1 14.6 19.2 33.7 47.6 31.6 13.8 29.4 11.1 4.4 9.6 7.6 12.4 7.0 14.6 15.3 11.2 13.2 10.6 16.4 15.1 11.3 0.3 14.3 14.1 10.7 13.9 8.8 13.1 14.2 15.2 15.9 13.3 14.5 13.6 14.0 14.7 13.7 13.5 16.7 17.1 57.7 33.5 50.3 31.0 26.0 26.3 27.7 34.7 61.7 19.2 16.8 105.7 18.6 37.4 23.9 66.7 53.0 30.6 21.7 25.4 18.8 34.8 27.5 33.3 23.5 31.1 39.5 52.9 11.9 27.0 30.5 30.1 24.2 33.6 47.5 21.4 41.7 21.7 37.0 53.1 25.3 20.3 19.6 13.3 22.4 27.1 17.7 8.8 21.5 22.7 49.8 28.8 48.7 53.4 15.0 19.2 19.5 26.4 23.7 23.2 30.1 26.2 65.3 13.1 36.3 21.3 98.3 62.4 28.7 24.7 36.7 31.8 47.9 38.5 20.4 PTRH2 "BIT1, CFAP37, CGI-147, PTH2" ENSG00000141378 "Peptidyl-tRNA hydrolase 2" Q9Y3E5 17 59674636-59707626 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Apoptosis Hydrolase "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012897 Supported Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Mitochondria "HPA012897: AB_1855949" "unprognostic (2.26e-1)" "unprognostic (2.80e-2)" "unprognostic (1.02e-2)" "unprognostic (3.89e-2)" "unprognostic (1.31e-2)" "unprognostic (3.38e-2)" "prognostic unfavorable (1.50e-4)" "unprognostic (6.38e-2)" "unprognostic (2.02e-1)" "unprognostic (9.59e-3)" "unprognostic (2.72e-1)" "unprognostic (1.40e-1)" "prognostic unfavorable (1.01e-8)" "unprognostic (5.43e-3)" "unprognostic (6.82e-2)" "unprognostic (1.32e-1)" "unprognostic (1.49e-2)" 20.8 25.9 24.3 17.3 25.1 14.5 27.6 25.0 31.9 19.7 23.6 24.1 15.3 18.8 48.5 18.1 18.4 18.2 14.5 25.1 26.1 18.5 45.7 14.7 19.0 25.9 26.1 16.9 19.5 18.6 14.1 18.6 26.7 20.7 27.5 10.2 15.9 18.6 25.0 15.7 13.2 22.9 24.8 17.5 16.1 19.5 24.9 17.3 16.2 20.9 24.1 44.0 11.8 27.4 75.9 142.9 44.3 40.8 84.8 72.6 47.4 70.6 63.8 60.7 89.0 94.1 57.7 54.1 105.0 60.9 101.1 73.3 98.4 93.8 89.4 104.2 133.2 96.7 72.3 176.2 129.4 86.0 52.5 82.0 120.9 93.9 108.5 42.8 102.5 37.4 111.3 58.2 92.4 187.9 74.2 71.2 38.0 194.5 113.4 39.1 74.8 80.7 103.7 109.2 57.9 74.2 36.7 39.6 91.5 50.7 93.1 61.1 67.2 77.8 77.8 47.1 77.9 73.6 91.9 82.3 50.7 54.4 60.4 6.1 69.0 2.9 22.7 67.4 30.9 43.1 26.3 25.7 50.0 33.1 37.4 27.0 29.0 34.8 86.0 59.4 34.0 37.9 24.3 25.1 25.0 31.9 25.1 26.1 25.9 26.1 26.7 24.8 24.9 27.4 21.4 16.0 13.6 5.5 18.7 36.7 50.1 48.1 27.9 4.1 17.1 22.4 15.4 11.5 51.6 11.0 4.2 26.8 13.0 8.9 11.7 27.2 22.1 23.4 33.1 22.5 6.7 17.9 9.8 25.6 25.0 29.7 17.3 24.1 22.8 12.8 12.8 31.5 16.9 8.4 9.1 10.3 22.4 9.7 17.2 12.0 17.4 14.6 14.2 2.8 11.4 7.2 13.4 7.5 11.5 28.8 12.3 9.8 24.8 35.1 10.0 16.5 33.3 3.4 13.1 25.4 32.2 33.4 13.3 21.3 35.7 31.7 12.6 22.4 16.7 37.5 PUDP "DXF68S1E, FAM16AX, GS1, HDHD1, HDHD1A" ENSG00000130021 "Pseudouridine 5'-phosphatase" Q08623 X 6667865-7148158 "Enzymes, Predicted intracellular proteins" "Nucleotide metabolism" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA000292, HPA072672" Approved Approved Nucleoplasm,Cytosol NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 39: CACO-2 - Unknown function" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA000292: , HPA072672: AB_2732208" "unprognostic (1.84e-1)" "unprognostic (4.93e-2)" "unprognostic (5.15e-3)" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (5.63e-3)" "unprognostic (1.00e-3)" "unprognostic (3.22e-2)" "unprognostic (4.86e-2)" "unprognostic (4.85e-2)" "prognostic unfavorable (7.27e-4)" "unprognostic (2.24e-1)" "unprognostic (3.06e-2)" "unprognostic (2.23e-1)" "unprognostic (2.92e-2)" "prognostic favorable (4.80e-4)" "unprognostic (3.42e-2)" 8.3 9.1 8.3 12.4 8.8 3.5 8.8 9.2 8.6 9.3 10.6 17.4 18.0 6.4 4.8 8.4 19.9 8.2 20.4 8.0 10.3 15.1 9.8 11.9 16.8 9.0 8.7 10.4 6.7 8.4 3.7 20.1 9.7 6.9 12.3 7.4 11.1 7.7 33.0 5.1 12.3 10.9 8.8 8.9 19.3 4.4 10.1 13.3 10.3 20.2 14.1 9.2 7.2 9.6 48.0 42.1 68.4 28.3 34.7 34.0 11.8 14.8 15.7 18.6 18.7 64.2 28.7 21.9 31.5 16.5 61.5 14.4 31.7 37.9 28.1 20.1 60.4 23.4 15.7 35.7 16.3 20.7 24.4 16.5 14.6 50.7 23.0 12.1 56.2 27.2 45.3 17.8 29.3 23.3 22.5 30.6 29.1 19.9 21.1 16.2 26.0 60.8 26.7 18.0 15.4 16.1 12.7 24.4 25.5 59.6 27.2 18.9 17.4 10.4 6.6 43.7 13.0 55.6 0.2 33.8 15.9 11.5 21.5 2.6 17.8 2.2 7.4 18.9 7.6 8.1 7.8 7.1 13.6 5.9 5.8 6.5 1.9 6.8 19.3 4.3 12.2 10.1 8.3 8.8 9.2 8.6 8.0 10.3 9.0 8.7 9.7 8.8 10.1 9.6 6.6 12.8 4.6 0.0 7.8 0.0 4.1 0.0 5.7 3.9 5.2 3.9 0.0 15.7 3.7 18.4 4.2 48.0 2.4 20.8 9.8 21.1 0.4 10.7 5.3 7.0 0.0 3.4 0.0 16.9 27.6 4.6 10.2 6.1 1.3 10.7 6.8 11.1 22.1 5.0 0.0 10.7 0.0 19.8 0.0 1.6 6.2 8.3 0.0 0.0 13.2 11.9 1.0 0.0 0.0 19.7 20.8 4.9 14.6 8.0 23.5 24.6 5.1 3.9 6.6 6.1 4.0 11.1 15.9 6.0 0.0 28.2 4.8 9.4 14.6 6.1 PUM1 "KIAA0099, PUMH1" ENSG00000134644 "Pumilio RNA binding family member 1" Q14671 1 30931506-31065991 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Translation regulation" RNA-binding "Disease variant, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027424, HPA027449" Approved Enhanced Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" Cytosol Nucleoplasm "HPA027424: AB_10602918, HPA027449: AB_2672281" "unprognostic (1.26e-1)" "unprognostic (1.21e-1)" "unprognostic (1.44e-3)" "unprognostic (1.10e-1)" "unprognostic (1.31e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (3.73e-4)" "unprognostic (1.02e-1)" "unprognostic (2.11e-2)" "unprognostic (2.44e-2)" "unprognostic (3.19e-3)" "unprognostic (4.42e-2)" "prognostic favorable (7.62e-8)" "unprognostic (1.57e-1)" "unprognostic (5.41e-2)" "unprognostic (1.19e-1)" "unprognostic (2.74e-1)" 27.8 26.0 33.4 22.5 34.3 52.0 31.9 37.5 37.8 28.0 28.5 26.7 22.5 32.2 29.3 25.7 35.0 22.7 28.6 33.7 42.5 28.7 25.9 25.6 26.2 27.0 30.0 40.3 27.5 39.3 19.2 32.4 28.0 27.3 29.4 38.4 30.3 28.0 46.1 32.7 22.6 31.6 27.8 25.7 26.3 18.4 45.5 35.1 34.9 38.3 26.1 27.1 26.0 31.5 33.7 43.7 70.4 44.7 54.1 46.5 48.2 39.3 47.9 40.3 45.5 46.0 56.6 39.3 40.2 53.8 25.2 48.2 58.3 43.4 51.4 33.2 50.8 42.8 50.7 56.0 37.9 52.6 39.2 50.0 53.3 53.5 56.1 52.8 55.6 36.9 60.0 36.1 46.5 28.1 51.6 37.8 72.2 42.0 30.2 53.1 48.0 42.3 58.7 50.0 58.0 44.0 54.5 41.7 47.6 77.6 42.1 39.3 58.5 33.2 29.8 44.7 39.7 28.8 28.3 42.5 29.7 38.3 43.0 44.1 31.3 24.8 31.0 30.3 31.7 23.9 27.5 30.3 32.0 21.1 31.0 32.0 19.6 37.9 34.5 18.5 35.9 31.0 33.4 34.3 37.5 37.8 33.7 42.5 27.0 30.0 28.0 27.8 45.5 31.5 66.6 73.7 58.8 85.2 56.9 90.2 53.8 41.2 56.3 54.6 63.2 58.7 80.7 61.5 46.3 36.8 79.2 52.6 66.4 56.4 23.5 44.0 32.2 139.8 98.0 61.5 104.7 34.3 87.0 36.4 42.4 56.8 55.0 154.6 18.3 105.1 43.2 61.0 34.0 33.7 87.5 65.6 24.4 78.3 49.8 21.5 72.1 50.4 17.8 102.1 56.6 41.6 69.0 111.6 101.7 58.1 45.0 80.5 41.7 84.6 28.8 49.2 42.7 59.2 32.9 81.6 65.5 36.4 24.4 62.9 93.6 78.0 50.5 63.6 75.8 95.5 PUS7 FLJ20485 ENSG00000091127 "Pseudouridine synthase 7" Q96PZ0 7 105439661-105522271 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "tRNA processing" Isomerase "Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 43.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024116 Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA024116: AB_1848754" "unprognostic (3.07e-1)" "unprognostic (1.52e-3)" "unprognostic (9.03e-2)" "unprognostic (4.94e-2)" "unprognostic (8.91e-2)" "unprognostic (7.95e-2)" "prognostic unfavorable (4.89e-6)" "unprognostic (2.86e-2)" "prognostic unfavorable (7.58e-5)" "unprognostic (1.87e-1)" "unprognostic (5.64e-3)" "unprognostic (4.14e-2)" "prognostic unfavorable (1.03e-8)" "unprognostic (2.76e-1)" "unprognostic (1.09e-1)" "prognostic unfavorable (6.28e-4)" "unprognostic (4.90e-2)" 7.1 3.5 3.6 5.5 3.9 3.2 7.4 4.7 4.1 5.9 3.0 5.3 4.0 5.6 3.0 7.7 5.2 3.2 4.8 3.6 3.2 4.4 6.3 4.6 4.3 3.5 3.2 4.3 6.0 6.5 2.7 5.1 3.6 4.4 5.7 2.3 4.7 3.9 11.0 7.8 3.4 6.5 3.0 2.8 4.2 4.6 3.1 3.0 7.6 4.8 5.3 7.2 6.2 4.1 32.1 18.2 18.0 29.4 13.6 14.9 19.9 14.7 13.0 25.5 20.9 24.5 12.7 17.5 24.7 15.6 22.0 25.0 33.0 17.9 39.6 12.9 26.4 26.2 17.2 25.8 16.1 42.1 9.9 15.2 20.9 21.5 27.9 9.5 27.2 16.2 59.8 14.6 17.9 39.8 48.4 39.4 44.6 39.5 23.6 29.1 26.5 81.5 31.0 23.3 30.2 28.5 29.3 53.0 21.3 20.5 19.2 9.9 16.6 37.4 25.1 49.3 32.5 11.0 24.4 46.9 13.1 35.7 33.1 0.0 0.8 0.2 0.9 2.0 2.1 2.0 1.3 1.0 1.2 1.3 1.1 1.2 0.1 1.4 2.0 0.0 0.9 0.7 3.6 3.9 4.7 4.1 3.6 3.2 3.5 3.2 3.6 3.0 3.1 4.1 8.5 6.4 9.0 13.1 4.8 13.4 13.9 5.0 13.1 4.0 8.2 6.5 3.8 1.5 6.0 1.8 2.1 5.6 2.8 3.6 1.9 9.5 1.7 7.0 14.3 10.4 7.2 8.4 43.2 7.2 10.2 8.6 8.6 5.5 11.4 4.3 4.2 5.1 4.4 0.0 27.9 4.1 2.0 2.8 6.0 1.8 4.1 3.3 0.0 11.2 4.0 1.5 3.1 8.5 23.8 7.6 3.2 1.9 6.7 18.3 1.0 5.6 4.3 3.2 0.0 14.3 10.4 1.8 9.7 13.7 9.8 3.4 3.9 15.6 8.0 8.2 PWWP2B "bA432J24.1, FLJ46823, PWWP2" ENSG00000171813 "PWWP domain containing 2B" Q6NUJ5 10 132397168-132417859 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 70.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 56.2;MCF7: 44.5;SK-BR-3: 33.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA038056, HPA038502, HPA078118" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 28: BEWO - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: " "unprognostic (2.28e-1)" "unprognostic (5.47e-2)" "unprognostic (1.11e-2)" "unprognostic (1.30e-2)" "unprognostic (5.51e-1)" "unprognostic (1.05e-1)" "unprognostic (1.67e-2)" "unprognostic (8.82e-2)" "unprognostic (2.66e-1)" "unprognostic (2.40e-1)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "prognostic favorable (5.75e-4)" "unprognostic (4.77e-2)" "unprognostic (1.46e-1)" "unprognostic (3.15e-1)" "unprognostic (1.19e-2)" 10.4 31.0 9.5 3.2 15.1 2.4 10.1 3.6 10.8 9.8 9.1 19.1 4.8 10.4 1.0 22.1 9.3 2.0 14.0 10.6 7.1 11.6 5.9 11.0 2.9 8.5 7.2 8.3 38.1 6.5 14.5 4.2 7.9 11.3 2.3 1.9 15.4 3.9 22.3 16.1 10.6 1.2 4.7 27.2 16.3 17.4 7.8 1.0 13.5 5.1 1.6 12.1 12.2 5.2 21.9 12.9 1.6 8.2 1.2 1.0 56.2 2.6 2.6 1.5 1.4 5.8 12.4 0.0 8.8 1.6 3.2 22.9 2.3 3.1 0.2 16.5 6.4 2.5 12.4 5.7 5.8 7.2 9.3 0.8 8.0 0.9 2.3 1.3 1.2 2.9 4.3 1.8 1.0 44.5 0.2 27.0 2.5 8.5 9.5 5.2 0.1 5.0 0.7 16.3 10.4 12.9 1.7 33.1 6.9 1.6 10.2 17.5 4.3 0.8 4.4 4.0 1.8 0.4 0.2 4.5 5.0 6.4 1.6 0.0 1.6 2.6 1.3 3.5 1.0 0.9 0.7 0.8 1.5 3.3 0.5 0.5 0.3 5.4 5.3 0.9 0.0 0.8 9.5 15.1 3.6 10.8 10.6 7.1 8.5 7.2 7.9 4.7 7.8 5.2 5.8 22.4 11.0 2.3 18.0 17.6 14.0 5.8 9.1 7.3 13.5 11.0 5.4 14.3 10.2 9.2 8.4 31.8 12.1 33.5 13.7 15.0 33.0 29.5 4.7 7.1 25.3 2.1 4.3 22.0 47.4 4.1 16.3 19.9 2.5 13.6 13.2 1.6 13.1 15.2 3.8 29.1 10.2 12.6 17.2 70.8 3.7 13.3 14.2 5.6 7.3 3.1 6.2 2.0 0.2 10.6 25.5 2.2 2.2 16.3 5.5 1.5 29.4 14.9 0.0 3.9 5.0 1.2 1.6 8.8 20.3 52.9 7.8 17.4 19.4 31.8 PXMP4 PMP24 ENSG00000101417 "Peroxisomal membrane protein 4" Q9Y6I8 20 33702758-33720319 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 73.6;Late spermatids: 44.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 42.3;SK-BR-3: 75.8;T-47d: 64.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050077 Approved Approved "Nucleoli fibrillar center,Peroxisomes" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 11: Alveolar cells - Smell perception" Peroxisomes "Nucleoli fibrillar center" "HPA050077: AB_2681006" "unprognostic (3.41e-2)" "unprognostic (1.11e-1)" "unprognostic (2.59e-1)" "unprognostic (1.75e-1)" "unprognostic (5.08e-2)" "unprognostic (1.30e-2)" "unprognostic (1.17e-1)" "prognostic favorable (3.88e-4)" "unprognostic (3.53e-1)" "unprognostic (4.47e-2)" "unprognostic (4.32e-2)" "unprognostic (1.86e-1)" "prognostic favorable (4.03e-10)" "unprognostic (3.84e-2)" "unprognostic (2.20e-1)" "unprognostic (6.08e-2)" "unprognostic (2.20e-1)" 4.1 11.2 5.1 3.0 5.2 3.2 11.9 3.8 5.6 5.6 4.3 6.2 8.2 4.1 5.1 6.3 6.0 3.3 6.4 5.0 4.0 4.9 8.9 13.9 3.6 4.6 4.5 6.8 6.8 14.7 3.5 3.2 4.1 8.7 5.7 4.4 15.2 6.4 8.0 11.1 7.4 5.1 4.2 4.6 6.8 2.5 5.3 3.5 11.5 6.9 3.9 5.4 5.8 6.5 2.8 12.1 3.3 11.9 5.7 8.3 8.5 8.7 4.7 6.6 2.9 42.3 13.2 0.1 16.2 7.3 16.1 12.5 9.0 10.1 4.7 3.7 3.4 14.0 9.7 0.1 5.3 0.7 10.3 6.4 10.8 9.0 3.0 3.3 4.3 4.4 7.9 8.6 4.7 26.4 12.9 9.8 0.3 21.7 0.0 6.8 16.3 1.7 4.2 9.0 10.7 5.4 24.2 75.8 7.9 1.9 64.0 4.7 8.2 4.7 5.4 11.9 8.2 5.5 13.2 0.2 9.0 4.6 8.1 2.2 11.1 17.5 10.8 22.2 11.3 7.6 10.9 10.9 8.8 9.9 8.3 11.2 2.9 9.1 34.2 5.3 8.5 8.6 5.1 5.2 3.8 5.6 5.0 4.0 4.6 4.5 4.1 4.2 5.3 6.5 5.2 19.2 73.6 7.2 5.5 1.7 4.3 9.4 4.0 11.1 16.8 12.3 12.6 7.2 17.8 18.4 14.6 12.9 3.5 14.2 9.8 8.2 28.7 6.3 6.1 7.6 4.2 9.9 6.4 9.9 24.3 8.5 6.6 5.7 3.8 6.7 8.9 36.0 15.1 5.0 5.7 10.8 6.1 7.5 1.6 44.0 10.5 6.2 3.6 6.5 7.5 13.6 9.2 9.0 10.8 8.5 10.3 11.3 7.0 4.5 23.0 11.2 7.8 11.4 6.6 8.8 7.8 4.6 9.8 9.5 2.4 4.4 5.8 16.9 13.0 4.0 PYROXD1 "DKFZp762G094, FLJ22028" ENSG00000121350 "Pyridine nucleotide-disulphide oxidoreductase domain 1" Q8WU10 12 21437615-21471250 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Oxidoreductase "Disease variant, Limb-girdle muscular dystrophy, Myofibrillar myopathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 179.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038319, HPA038320" Uncertain Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 18: U-2197 - ECM organization" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear speckles" "HPA038319: AB_10669522, HPA038320: AB_2675956" "unprognostic (1.48e-1)" "unprognostic (1.68e-1)" "unprognostic (1.15e-2)" "unprognostic (9.89e-2)" "unprognostic (1.51e-1)" "unprognostic (2.64e-3)" "unprognostic (1.50e-1)" "unprognostic (9.31e-2)" "unprognostic (8.94e-3)" "unprognostic (1.17e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (1.06e-2)" "unprognostic (3.78e-2)" "unprognostic (2.30e-2)" "unprognostic (2.00e-1)" "prognostic favorable (1.70e-4)" 7.9 10.0 3.8 9.2 4.3 9.3 10.4 5.1 5.4 7.1 5.3 11.9 13.9 7.1 8.6 8.3 7.1 8.7 10.7 3.7 5.2 16.8 12.3 8.6 10.6 5.4 5.2 6.6 13.4 10.4 5.2 5.9 5.3 9.9 11.2 14.0 11.9 5.9 12.4 10.0 16.0 6.4 4.7 7.9 12.8 5.8 4.2 7.5 15.6 9.6 8.5 7.6 6.1 5.4 9.3 3.5 5.2 5.8 3.7 6.8 11.8 14.5 6.7 5.2 4.0 4.5 8.6 10.2 6.0 11.0 4.4 11.3 5.8 11.4 5.8 12.1 5.1 11.8 9.2 5.7 17.2 17.7 12.0 11.3 13.5 3.3 14.3 6.7 7.8 11.0 5.8 4.2 10.7 5.9 8.3 24.3 8.6 8.2 6.5 1.4 11.2 11.2 16.3 9.2 1.7 13.1 6.7 12.2 27.0 7.1 14.5 20.8 11.2 6.2 5.9 13.5 13.4 6.4 4.8 12.7 25.4 13.1 7.5 1.2 0.8 0.6 1.7 1.5 1.9 1.2 2.0 2.1 0.8 0.9 1.6 1.7 0.3 1.6 2.7 1.1 1.6 0.9 3.8 4.3 5.1 5.4 3.7 5.2 5.4 5.2 5.3 4.7 4.2 5.4 12.5 12.8 28.4 12.7 18.3 6.6 10.2 10.7 8.0 21.8 15.1 10.8 11.7 27.1 13.6 27.6 25.0 15.4 22.9 40.0 23.5 24.7 179.8 26.0 13.0 9.4 20.4 13.3 14.0 33.4 14.2 10.4 19.9 21.1 25.3 8.6 8.9 21.2 16.2 8.4 17.0 21.3 12.2 21.8 5.8 32.6 10.5 18.1 5.4 17.8 15.6 14.5 17.5 13.0 34.2 41.2 25.1 6.4 19.5 12.0 39.4 43.8 28.6 28.2 13.1 15.0 13.8 49.7 18.8 14.5 7.7 19.4 20.1 10.6 20.6 14.1 QARS1 QARS ENSG00000172053 "Glutaminyl-tRNA synthetase 1" P47897 3 49095932-49105130 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Epilepsy, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 9 "Cardiomyocytes: 55.5;Cytotrophoblasts: 193.9;Extravillous trophoblasts: 156.7;Hofbauer cells: 96.1;Syncytiotrophoblasts: 187.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036986, HPA036987" Enhanced Enhanced Cytosol No No 58000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA036986: AB_10672344, HPA036987: AB_2675418" "prognostic favorable (1.43e-4)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (1.10e-2)" "unprognostic (5.13e-3)" "unprognostic (6.62e-3)" "unprognostic (6.53e-3)" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-1)" "unprognostic (4.33e-1)" "unprognostic (9.14e-2)" "prognostic favorable (5.60e-6)" "unprognostic (2.73e-3)" "unprognostic (1.65e-1)" "unprognostic (2.74e-2)" "unprognostic (3.11e-1)" 61.1 58.8 20.0 57.2 21.3 96.6 89.5 23.5 18.5 58.3 34.2 104.8 101.6 45.5 58.5 102.5 71.0 48.3 72.0 18.4 21.1 57.1 51.1 52.3 75.8 23.8 21.0 69.0 73.9 78.1 33.0 76.7 23.0 60.4 121.0 21.4 103.2 61.1 156.1 105.0 84.6 60.2 22.7 60.1 75.0 30.0 23.0 92.3 53.2 146.2 118.8 72.8 58.1 24.6 95.9 97.8 128.0 197.4 146.4 180.8 159.2 90.5 188.2 160.5 152.9 123.0 113.5 257.1 61.4 136.7 95.3 119.9 166.3 137.8 111.4 78.2 148.0 206.4 156.0 216.1 91.2 187.2 130.9 184.8 123.1 127.4 108.1 175.3 184.7 144.6 95.3 112.4 118.0 89.2 130.7 154.9 116.1 159.0 122.9 76.0 123.7 200.6 108.5 163.9 48.7 161.6 85.4 211.0 147.8 122.7 184.4 205.5 137.6 82.8 127.3 131.7 117.9 111.9 176.5 142.9 88.4 156.3 60.3 30.7 84.3 25.8 44.5 104.1 57.4 62.2 54.1 47.0 127.0 49.9 46.6 49.0 8.0 71.8 94.5 57.4 82.1 81.2 20.0 21.3 23.5 18.5 18.4 21.1 23.8 21.0 23.0 22.7 23.0 24.6 15.1 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.5 0.0 0.0 0.0 0.0 193.9 11.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 156.7 14.7 0.0 0.0 0.0 0.0 0.0 0.0 96.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 187.0 2.0 0.0 0.0 0.0 R3HCC1 DKFZp564N123 ENSG00000104679 "R3H domain and coiled-coil containing 1" Q9Y3T6 8 23270120-23296279 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 113.2;Rod photoreceptor cells: 115.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023073, HPA023153" Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 54: Non-specific - Microtubule organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 46: Photoreceptor cells - Phototransduction" Cytosol Nucleoplasm "HPA023073: AB_1855987, HPA023153: AB_2237834" "unprognostic (5.80e-2)" "unprognostic (4.70e-3)" "prognostic favorable (4.08e-4)" "unprognostic (7.46e-3)" "unprognostic (1.97e-1)" "unprognostic (7.26e-2)" "unprognostic (8.49e-3)" "unprognostic (1.02e-2)" "unprognostic (7.73e-2)" "unprognostic (2.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (7.65e-2)" "prognostic favorable (6.80e-5)" "unprognostic (1.22e-2)" "unprognostic (1.17e-1)" "unprognostic (4.18e-1)" "unprognostic (3.43e-1)" 20.5 21.9 41.2 15.2 52.7 29.0 19.6 53.7 43.8 23.4 36.4 33.6 19.7 23.9 14.8 16.1 22.5 16.2 33.1 39.9 42.3 20.1 28.2 16.7 22.5 60.9 49.8 27.2 42.8 29.0 22.6 13.7 63.6 22.7 15.3 62.7 35.7 19.9 54.5 22.5 20.4 22.2 49.3 20.2 28.4 30.8 48.6 20.3 17.6 31.5 18.8 22.2 17.8 73.7 38.2 48.7 36.7 35.9 15.2 20.6 25.2 24.7 23.4 41.0 29.7 35.0 17.6 38.1 25.6 30.2 28.0 28.3 38.9 45.8 27.5 24.7 41.6 35.7 33.4 29.2 36.0 24.7 25.6 24.8 35.5 35.0 16.4 30.1 31.7 42.9 41.8 31.0 24.3 33.1 55.6 43.8 29.8 40.4 35.8 37.9 44.8 22.8 20.3 41.9 47.2 41.1 28.1 32.8 41.8 25.0 30.3 29.2 27.4 37.9 31.8 32.2 51.1 23.8 22.2 39.3 29.5 34.3 48.5 38.4 50.5 82.5 64.8 44.1 56.5 56.5 52.7 55.0 56.7 42.1 40.5 47.0 31.3 59.5 50.3 52.9 61.5 51.4 41.2 52.7 53.7 43.8 39.9 42.3 60.9 49.8 63.6 49.3 48.6 73.7 25.2 25.6 14.7 4.9 15.5 14.9 16.5 35.9 10.2 28.0 22.8 32.9 24.1 24.3 20.5 5.5 27.1 18.8 19.8 17.9 56.7 32.3 36.4 15.2 17.0 21.1 19.2 17.9 5.1 50.9 21.3 25.4 20.9 10.2 22.8 24.7 20.0 21.6 30.2 18.5 5.0 21.5 22.4 18.2 12.3 113.2 17.7 16.2 21.4 5.6 18.8 59.3 42.2 4.5 9.5 37.0 22.1 21.8 34.7 11.4 41.7 38.5 22.0 115.7 13.1 19.9 31.1 49.8 32.4 13.6 16.2 7.7 18.3 30.7 22.8 13.6 RABGGTB ENSG00000137955 "Rab geranylgeranyltransferase subunit beta" P53611 1 75786197-75795086 "Enzymes, Predicted intracellular proteins" "Prenyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026585, HPA027167, HPA030793" Approved Supported Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Vesicles "HPA026585: AB_1856026, HPA027167: AB_1856027, HPA030793: " "unprognostic (4.83e-2)" "unprognostic (3.04e-1)" "unprognostic (2.09e-2)" "unprognostic (2.45e-2)" "unprognostic (9.02e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (9.80e-5)" "unprognostic (9.62e-3)" "unprognostic (2.93e-1)" "unprognostic (1.93e-1)" "unprognostic (2.23e-1)" "unprognostic (6.95e-2)" "prognostic unfavorable (1.12e-5)" "unprognostic (6.05e-2)" "unprognostic (1.56e-1)" "unprognostic (6.77e-2)" "unprognostic (3.89e-1)" 37.5 56.5 41.0 20.3 44.9 18.3 41.4 44.7 52.8 31.4 40.4 33.9 33.3 24.6 23.6 35.2 28.1 21.4 49.6 40.0 44.8 75.9 67.2 29.0 26.9 44.8 43.6 38.1 67.7 37.5 25.1 31.5 44.8 27.5 29.3 41.2 32.0 23.0 79.7 21.7 24.9 23.0 47.1 29.1 33.9 15.3 43.6 30.6 30.5 84.0 31.3 37.3 30.4 47.9 74.8 40.2 68.6 31.4 85.2 108.8 43.8 99.5 68.2 91.6 70.4 97.3 17.6 68.2 101.3 55.7 146.0 46.0 178.3 77.7 133.8 67.1 48.3 58.0 66.5 158.0 106.6 74.8 32.9 67.5 165.1 84.3 95.4 125.6 75.8 59.7 96.9 65.7 109.9 30.8 61.5 81.4 64.5 53.3 78.0 49.2 114.5 29.9 69.9 41.7 43.5 39.1 24.1 123.6 231.0 58.8 26.1 69.8 77.5 59.6 67.0 142.1 199.5 41.9 127.1 46.4 67.5 60.3 27.0 8.4 7.2 4.7 7.7 11.3 9.3 9.5 7.7 7.2 12.3 5.9 9.4 9.3 1.1 6.3 8.1 11.3 7.7 4.0 41.0 44.9 44.7 52.8 40.0 44.8 44.8 43.6 44.8 47.1 43.6 47.9 35.3 35.3 44.3 12.7 83.3 127.7 59.4 132.6 66.0 22.6 58.5 45.6 71.1 72.9 86.0 27.6 20.9 45.9 65.7 38.6 103.7 44.9 1.6 36.1 42.5 45.8 89.8 41.6 17.1 51.8 60.3 48.6 57.6 40.4 70.5 26.5 41.7 68.6 61.2 32.0 17.8 62.2 75.3 61.3 91.4 4.4 32.3 54.8 58.7 9.4 52.0 36.5 32.0 14.6 21.9 44.1 46.0 33.4 78.8 84.8 58.4 206.5 45.8 22.3 6.6 40.1 59.8 20.1 14.0 73.6 142.9 53.5 60.2 37.5 69.6 88.7 RABL2B ENSG00000079974 "RAB, member of RAS oncogene family like 2B" Q9UNT1 22 50767501-50783662 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 99.4;Respiratory ciliated cells: 188.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA042642, HPA042700, HPA044007" Approved Approved Vesicles,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 49: Ciliated cells - Cilium organization" Centrosome Vesicles "HPA042642: , HPA042700: AB_2678120, HPA044007: AB_2678770" "unprognostic (2.09e-1)" "unprognostic (1.47e-2)" "unprognostic (1.86e-3)" "prognostic favorable (5.58e-4)" "unprognostic (7.85e-2)" "unprognostic (9.98e-2)" "prognostic unfavorable (4.58e-5)" "unprognostic (3.14e-1)" "unprognostic (6.97e-2)" "unprognostic (7.33e-2)" "unprognostic (1.19e-2)" "unprognostic (7.51e-2)" "unprognostic (3.71e-3)" "unprognostic (7.43e-3)" "unprognostic (1.37e-1)" "unprognostic (1.25e-1)" "unprognostic (8.37e-3)" 13.2 12.9 18.1 18.6 18.8 14.4 15.8 18.1 22.4 23.9 73.6 16.5 12.5 21.7 90.3 13.3 66.6 14.5 10.2 23.3 17.0 17.7 12.2 21.8 23.1 23.3 33.2 22.5 16.3 14.6 26.7 11.6 17.9 16.2 16.7 30.2 16.8 16.9 8.8 22.2 15.6 15.6 21.9 19.3 14.5 23.1 20.1 21.6 28.2 4.6 20.3 17.0 15.7 18.5 23.0 20.4 34.1 26.7 37.3 29.6 25.0 16.7 18.5 13.2 18.1 5.8 19.7 14.7 14.7 24.1 21.6 29.5 15.8 19.6 14.2 13.3 23.2 12.8 40.2 15.1 15.4 36.1 13.0 25.3 26.2 17.5 21.9 39.2 15.0 26.0 9.9 17.9 26.7 28.8 18.2 15.9 13.2 14.0 15.0 30.1 19.8 16.1 25.9 22.4 14.6 26.5 20.5 17.8 13.4 23.4 17.7 11.2 23.2 12.6 25.1 10.9 11.4 15.2 7.4 7.2 23.8 8.8 18.1 1.8 14.4 13.1 21.4 23.5 15.5 15.2 16.4 17.3 15.7 19.2 18.7 18.3 5.4 15.9 28.4 18.0 18.6 14.7 18.1 18.8 18.1 22.4 23.3 17.0 23.3 33.2 17.9 21.9 20.1 18.5 6.2 12.8 13.4 14.4 16.8 5.4 13.4 13.3 15.9 15.2 13.3 11.8 5.1 12.8 24.1 22.0 31.3 12.1 16.2 10.6 13.7 21.3 25.7 99.4 11.2 7.2 5.4 9.9 25.7 10.8 11.1 11.4 9.7 8.6 3.8 22.1 5.3 8.9 12.0 16.8 18.9 8.0 22.4 10.1 6.9 24.2 14.0 8.4 17.8 4.7 14.4 13.9 36.0 7.1 15.1 10.4 4.9 10.9 8.0 7.3 8.6 16.3 188.6 40.0 6.6 15.0 14.8 38.8 27.0 8.8 5.7 6.7 16.0 11.9 10.7 6.5 RABL3 MGC23920 ENSG00000144840 "RAB, member of RAS oncogene family like 3" Q5HYI8 3 120684938-120742993 "Disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035150, HPA035151, HPA069861" Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 9: Photoreceptor cells - Phototransduction" "Endoplasmic reticulum" "HPA035150: AB_2674493, HPA035151: AB_10601154, HPA069861: " "unprognostic (1.69e-2)" "unprognostic (5.10e-2)" "unprognostic (8.32e-2)" "unprognostic (3.96e-2)" "unprognostic (1.88e-1)" "unprognostic (7.22e-2)" "unprognostic (1.37e-1)" "unprognostic (1.27e-1)" "unprognostic (7.19e-2)" "unprognostic (2.94e-1)" "unprognostic (2.11e-3)" "unprognostic (2.78e-1)" "prognostic favorable (2.79e-5)" "unprognostic (2.33e-1)" "unprognostic (6.15e-2)" "unprognostic (8.44e-3)" "unprognostic (3.65e-1)" 10.8 16.1 2.3 5.6 2.5 5.3 8.8 2.6 4.1 7.0 2.6 8.1 5.5 7.0 2.7 7.9 5.9 5.7 7.3 2.1 3.1 9.8 9.7 5.6 5.9 3.0 2.8 9.2 6.4 11.8 6.3 6.9 2.9 6.9 8.6 5.8 6.9 6.5 13.8 6.3 6.0 6.2 2.7 5.6 7.1 4.2 2.4 6.4 12.3 11.9 7.3 7.3 7.9 3.7 20.6 17.8 12.6 3.9 11.7 17.0 11.4 18.8 13.8 10.0 8.3 12.6 6.5 17.3 8.5 15.4 17.6 7.1 14.0 9.2 18.3 14.8 5.9 16.0 12.9 15.7 8.1 31.2 9.1 8.4 11.2 8.9 10.7 11.6 15.1 9.4 14.2 9.7 12.8 20.8 18.2 3.0 6.4 19.9 8.6 7.7 17.4 6.6 9.6 10.0 5.8 4.5 9.2 5.5 5.4 4.8 10.5 9.8 22.1 6.5 7.5 4.8 17.1 5.4 7.9 13.6 16.7 25.4 8.4 3.7 3.6 2.6 4.6 5.6 3.6 3.2 4.5 5.1 6.5 2.6 3.8 4.4 3.7 5.6 3.1 3.4 5.3 3.4 2.3 2.5 2.6 4.1 2.1 3.1 3.0 2.8 2.9 2.7 2.4 3.7 17.6 9.6 11.7 14.7 11.6 6.4 17.2 17.3 11.4 39.8 13.7 10.0 14.3 12.8 16.7 9.2 116.7 13.3 7.7 13.1 7.9 15.2 25.5 22.3 11.9 12.8 5.4 10.7 11.7 16.2 18.0 13.8 9.7 14.2 8.2 10.4 8.2 18.1 14.7 8.4 10.2 12.7 16.2 10.6 7.2 9.8 5.9 12.0 10.6 2.8 11.4 19.2 9.2 7.5 17.1 14.6 15.8 6.0 11.3 12.2 9.6 26.4 15.7 20.0 0.0 16.5 10.4 26.9 8.5 10.5 11.1 22.0 10.0 16.6 12.1 15.4 RAD23A "HHR23A, MGC111083" ENSG00000179262 "RAD23 homolog A, nucleotide excision repair protein" P54725 19 12945855-12953642 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 984.0;tongue: 447.9" "Cell type enhanced" "Detected in all" "Erythroid cells: 901.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026418, HPA053901, HPA057003, HPA065599" Approved Supported Nucleoplasm,Cytosol NA NA 3400000 "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 6: Erythroid cells - Oxygen transport" Nucleoplasm Cytosol "HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516" "unprognostic (2.09e-1)" "unprognostic (1.58e-3)" "unprognostic (1.23e-3)" "unprognostic (7.90e-3)" "unprognostic (1.45e-1)" "unprognostic (1.48e-1)" "unprognostic (3.78e-3)" "unprognostic (3.57e-3)" "unprognostic (3.13e-1)" "unprognostic (3.12e-3)" "unprognostic (1.09e-1)" "unprognostic (4.08e-2)" "unprognostic (2.09e-3)" "unprognostic (2.32e-3)" "unprognostic (9.99e-2)" "unprognostic (8.56e-2)" "unprognostic (6.59e-3)" 79.2 63.4 77.8 49.4 79.8 85.8 71.0 78.1 95.7 59.2 71.0 91.6 48.4 65.0 31.2 70.0 64.1 38.2 132.4 80.5 79.8 54.1 70.4 66.4 55.9 80.5 76.7 56.2 76.7 66.1 47.7 55.5 80.1 57.5 35.8 24.5 68.0 52.5 984.0 72.6 52.8 54.8 77.0 54.5 66.4 48.7 79.4 53.0 54.9 447.9 44.0 78.5 57.1 82.0 138.0 52.6 55.7 57.4 91.5 104.1 94.7 66.1 130.2 152.6 137.2 59.8 95.3 117.3 150.0 99.4 104.4 102.7 78.0 137.7 55.9 170.0 109.8 47.2 57.3 58.3 181.7 102.1 130.7 107.9 199.6 110.1 208.9 89.7 105.4 188.0 124.1 102.1 138.2 139.8 126.6 124.2 76.5 124.6 135.6 65.4 59.4 189.6 118.9 53.8 104.3 81.8 75.4 129.1 145.8 40.2 100.4 173.7 82.5 214.9 57.4 263.3 203.9 148.2 133.8 86.0 177.9 193.3 183.2 31.3 76.3 64.9 81.1 102.4 87.3 77.5 66.8 69.1 68.3 73.5 63.3 73.4 9.2 79.1 105.3 86.0 82.0 69.1 77.8 79.8 78.1 95.7 80.5 79.8 80.5 76.7 80.1 77.0 79.4 82.0 120.2 86.6 56.2 11.8 127.6 120.4 176.8 165.2 122.3 51.7 110.3 121.3 59.5 108.7 108.4 55.2 20.9 212.0 99.6 95.7 166.3 179.5 193.1 74.3 76.9 120.4 87.3 901.4 22.0 191.0 240.1 101.4 101.9 74.1 111.5 77.7 86.4 96.2 175.3 52.2 22.9 138.5 136.3 88.3 170.3 44.1 118.4 119.6 142.3 12.2 182.5 73.9 94.7 15.6 25.8 184.1 119.0 114.0 159.0 351.3 139.9 163.3 91.1 56.1 111.7 138.3 129.3 263.6 179.6 153.3 146.5 244.8 113.0 117.8 154.8 211.1 RAD51D "HsTRAD, R51H3, RAD51L3, Trad" ENSG00000185379 "RAD51 paralog D" O75771 17 35092221-35121522 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 116.5;Late spermatids: 217.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (3.41e-2)" "unprognostic (3.32e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.37e-5)" "unprognostic (7.29e-2)" "unprognostic (9.59e-2)" "unprognostic (1.24e-3)" "unprognostic (1.14e-1)" "unprognostic (3.50e-2)" "unprognostic (1.73e-2)" "prognostic favorable (3.35e-6)" "unprognostic (2.34e-2)" "prognostic unfavorable (7.20e-9)" "unprognostic (7.34e-2)" "unprognostic (2.04e-1)" "unprognostic (1.73e-2)" "unprognostic (2.22e-2)" 5.7 3.9 7.3 4.2 7.8 5.0 5.4 7.1 8.9 6.5 6.6 5.5 4.5 6.3 2.8 3.9 4.8 3.8 4.4 7.7 7.3 4.9 4.3 4.6 6.0 7.4 7.6 6.6 4.9 3.7 4.1 4.8 6.8 5.0 3.7 1.8 3.5 4.6 2.8 3.3 4.6 6.0 6.8 6.5 3.9 5.7 8.0 7.9 5.8 4.7 5.9 6.0 5.2 8.2 10.0 17.4 4.4 9.0 4.1 6.7 6.1 19.1 9.8 14.2 13.4 10.4 10.9 22.4 12.5 10.8 9.3 13.5 9.8 5.8 8.3 12.4 10.8 11.2 11.6 6.6 8.5 22.3 19.7 8.6 5.8 13.5 8.9 6.8 10.5 17.8 14.7 30.7 12.1 10.8 28.0 11.2 6.3 8.8 8.2 20.9 11.1 14.3 5.4 10.2 6.7 6.7 10.3 5.2 12.1 11.1 10.7 14.7 8.6 7.0 8.5 10.5 16.0 6.0 10.7 13.2 10.2 15.5 12.4 3.5 3.6 4.0 7.9 3.5 6.0 7.2 5.0 7.1 4.0 6.7 4.7 6.0 0.7 9.2 5.1 6.5 5.1 3.9 7.3 7.8 7.1 8.9 7.7 7.3 7.4 7.6 6.8 6.8 8.0 8.2 9.1 0.0 4.8 0.0 8.5 2.3 4.7 1.6 1.8 10.4 5.6 5.6 3.3 4.3 1.5 3.7 10.4 10.8 10.9 3.2 1.9 6.4 116.5 3.3 6.6 8.7 1.2 11.1 0.0 6.8 11.0 7.0 4.6 4.0 6.3 17.7 11.4 4.7 11.0 8.4 0.0 5.0 2.0 5.7 3.1 217.6 9.6 5.8 1.8 0.0 11.0 8.0 28.8 0.0 0.0 7.0 5.7 6.8 8.7 3.7 5.3 8.5 0.8 4.2 0.0 10.7 7.8 7.9 12.6 5.4 1.4 2.9 11.1 14.0 6.3 3.0 RAD54L2 "ARIP4, KIAA0809, SRISNF2L" ENSG00000164080 "RAD54 like 2" Q9Y4B4 3 51541144-51668667 "Enzymes, Predicted intracellular proteins" "DNA-binding, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035004, HPA039992, HPA077351" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA035004: AB_10671930, HPA039992: AB_2676789, HPA077351: " "unprognostic (1.46e-2)" "unprognostic (3.67e-2)" "unprognostic (2.61e-1)" "unprognostic (5.01e-2)" "unprognostic (1.15e-1)" "unprognostic (4.38e-2)" "unprognostic (1.63e-1)" "unprognostic (1.45e-2)" "unprognostic (9.24e-2)" "unprognostic (2.76e-1)" "unprognostic (1.59e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.71e-5)" "unprognostic (3.72e-2)" "unprognostic (3.19e-1)" "unprognostic (3.30e-2)" "unprognostic (6.63e-2)" 4.6 4.8 5.6 3.7 6.1 6.1 4.6 6.5 5.6 4.8 2.9 5.8 2.5 5.6 4.2 4.0 4.6 2.7 4.4 5.0 5.2 4.0 7.8 4.9 4.2 5.5 5.7 5.3 5.3 3.8 4.5 4.8 5.5 4.4 3.4 7.5 4.5 3.9 7.1 5.5 5.0 4.1 5.3 5.2 5.2 5.0 6.3 6.2 4.6 5.3 5.2 4.8 4.3 6.2 6.6 5.1 12.8 12.7 7.0 5.0 6.7 5.5 7.8 7.4 6.9 9.1 3.8 17.4 1.5 9.7 7.8 5.0 20.5 6.8 9.1 9.2 4.6 14.9 11.5 6.0 6.4 16.8 8.5 5.8 5.4 11.3 10.9 4.6 8.3 14.8 10.3 9.1 5.9 5.1 15.0 7.6 10.2 3.2 5.5 6.9 9.9 2.3 3.8 8.4 5.2 10.0 8.7 8.2 5.7 7.7 5.4 9.9 10.9 7.7 8.9 8.0 10.8 9.8 10.7 16.8 8.3 9.2 10.0 3.1 2.2 2.2 3.3 2.6 3.5 1.8 2.9 2.8 2.3 2.9 1.9 2.3 0.9 3.0 3.5 2.3 2.9 2.2 5.6 6.1 6.5 5.6 5.0 5.2 5.5 5.7 5.5 5.3 6.3 6.2 10.8 9.6 14.4 31.3 11.3 9.2 8.6 6.7 3.4 33.8 8.7 8.0 11.0 15.7 7.8 9.2 31.3 19.3 12.2 7.7 1.9 9.3 7.5 9.5 12.0 15.1 16.3 3.8 54.9 10.4 8.7 9.6 9.2 19.8 18.3 14.2 10.4 21.9 8.9 47.1 54.3 8.1 4.1 9.1 8.4 3.1 15.2 9.4 14.2 26.2 13.2 9.1 30.9 42.7 42.3 13.9 9.7 17.0 11.3 12.4 4.6 4.4 9.5 29.9 13.1 17.1 11.6 43.9 36.4 5.5 8.9 29.7 12.5 10.1 7.9 12.5 RANGAP1 "Fug1, KIAA1835, SD" ENSG00000100401 "Ran GTPase activating protein 1" P46060 22 41244779-41286187 "Plasma proteins, Predicted intracellular proteins, Transporters" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Late spermatids: 1717.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004293, HPA050110, HPA062034" Supported Enhanced "Nuclear membrane,Vesicles,Cytosol" Yes Yes 75000 "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Nuclear membrane" "Vesicles, Cytosol" "CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667" "unprognostic (1.30e-2)" "unprognostic (3.16e-2)" "unprognostic (1.66e-1)" "unprognostic (7.97e-2)" "unprognostic (2.57e-1)" "unprognostic (2.54e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (8.28e-3)" "unprognostic (8.09e-2)" "unprognostic (9.87e-2)" "unprognostic (5.84e-2)" "unprognostic (7.56e-2)" "unprognostic (7.07e-3)" "prognostic favorable (5.39e-4)" "unprognostic (2.06e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-1)" 27.5 72.9 78.2 26.0 86.0 48.1 29.6 70.8 102.3 34.4 47.7 29.2 18.1 24.9 12.0 79.8 23.6 17.2 45.1 79.5 85.2 43.9 88.0 41.6 30.6 102.7 77.9 32.5 60.9 12.7 57.4 22.8 105.1 39.3 13.2 32.7 38.0 17.6 43.0 96.9 30.6 17.5 68.7 42.3 39.6 178.1 82.0 40.4 34.4 14.2 31.8 34.7 45.4 109.1 228.0 112.2 75.9 77.3 38.8 31.4 85.9 194.5 103.8 182.8 98.4 135.9 71.9 118.0 154.0 137.4 94.8 203.0 135.5 145.4 125.2 95.7 199.2 103.3 115.0 107.9 46.7 171.6 72.5 30.0 69.5 132.2 123.4 67.6 102.1 45.0 127.7 83.3 111.9 186.1 96.3 130.0 84.5 217.6 127.6 118.8 73.4 126.0 72.5 123.7 66.6 44.1 139.1 117.7 71.7 74.6 72.2 64.4 146.5 141.7 138.5 78.6 154.6 60.1 92.8 124.2 99.3 119.3 82.0 2.7 7.6 6.9 8.1 9.0 9.5 5.9 8.2 7.8 5.6 6.4 7.4 5.9 2.0 5.9 12.9 5.9 9.5 8.2 78.2 86.0 70.8 102.3 79.5 85.2 102.7 77.9 105.1 68.7 82.0 109.1 10.9 3.2 20.9 8.5 15.0 23.1 22.2 10.9 18.2 16.0 22.4 16.9 19.6 25.8 9.6 9.2 14.6 22.7 20.3 22.9 3.9 33.3 270.7 21.0 14.7 16.1 25.0 16.6 28.3 20.3 35.3 13.3 25.5 25.1 6.3 74.4 8.9 21.8 16.6 15.2 20.8 19.1 16.2 13.9 20.9 1717.0 14.9 16.8 12.4 5.6 8.9 10.1 14.4 6.0 32.2 39.8 5.7 12.0 25.8 37.4 7.1 13.1 11.4 26.4 0.0 6.8 18.2 25.6 17.7 38.8 31.0 23.7 24.3 42.5 24.8 23.3 RARS1 "DALRD1, RARS" ENSG00000113643 "Arginyl-tRNA synthetase 1" P54136 5 168486451-168519301 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Cardiomyocytes: 50.8;Cytotrophoblasts: 104.2;Extravillous trophoblasts: 96.8;Hofbauer cells: 57.2;Syncytiotrophoblasts: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003979, HPA004130" Approved Supported Nucleoplasm,Nucleoli,Cytosol NA NA 74000 "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 24: Non-specific - Transcription regulation" Cytosol "Nucleoplasm, Nucleoli" "HPA003979: AB_1856083, HPA004130: AB_1856084" "unprognostic (1.06e-2)" "unprognostic (1.92e-2)" "unprognostic (2.74e-3)" "unprognostic (2.82e-2)" "unprognostic (2.50e-1)" "prognostic unfavorable (7.59e-5)" "prognostic unfavorable (1.10e-8)" "unprognostic (3.26e-3)" "unprognostic (5.16e-1)" "unprognostic (4.22e-2)" "unprognostic (2.92e-2)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" "unprognostic (6.43e-2)" "unprognostic (2.35e-1)" "unprognostic (2.39e-1)" "unprognostic (1.33e-2)" 27.5 25.6 12.7 31.5 12.3 12.8 36.3 19.6 15.6 22.9 9.4 37.6 54.8 26.7 33.5 38.2 25.8 23.4 29.5 12.8 11.2 33.2 43.5 22.0 31.0 9.0 10.7 23.0 34.4 32.7 16.6 36.5 9.8 27.9 43.0 17.2 32.9 23.5 31.1 41.8 48.7 32.8 5.4 21.8 32.8 23.2 12.1 23.5 30.2 34.6 40.6 41.1 25.2 21.4 100.2 115.6 82.5 94.2 113.4 128.9 143.9 143.4 122.3 145.7 168.7 198.4 105.6 104.3 114.2 137.2 149.3 93.9 111.0 192.7 188.5 110.1 76.5 71.2 103.1 126.5 96.8 169.2 72.6 99.7 100.8 159.0 76.0 89.3 118.5 56.4 107.7 51.9 158.1 92.4 70.7 68.7 138.1 86.7 77.8 30.3 122.0 99.7 129.7 110.8 79.6 97.7 109.1 124.7 152.7 101.1 113.4 69.9 118.7 104.7 96.3 81.9 169.4 51.8 100.3 105.7 114.3 118.0 101.9 5.2 21.5 8.2 17.4 27.3 20.2 15.5 17.2 18.8 32.1 9.5 21.2 22.6 5.8 26.6 26.7 14.7 19.3 18.2 12.7 12.3 19.6 15.6 12.8 11.2 9.0 10.7 9.8 5.4 12.1 21.4 10.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 50.8 0.0 0.0 0.0 0.0 104.2 7.4 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 96.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 57.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 84.3 1.4 0.0 0.0 0.0 RBBP4 "lin-53, NURF55, RbAp48" ENSG00000162521 "RB binding protein 4, chromatin remodeling factor" Q09028 1 32651142-32686211 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, DNA replication, Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB006264, HPA060710, HPA060724" Supported Enhanced Nucleoplasm NA NA 150000 "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Nucleoplasm "CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350" "unprognostic (1.18e-3)" "unprognostic (1.79e-3)" "unprognostic (2.96e-3)" "unprognostic (1.82e-2)" "prognostic favorable (9.23e-4)" "unprognostic (1.62e-2)" "prognostic unfavorable (1.89e-6)" "unprognostic (1.24e-2)" "prognostic unfavorable (6.45e-4)" "unprognostic (1.57e-2)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (1.36e-3)" "unprognostic (3.05e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (1.88e-2)" 32.0 38.8 19.9 33.5 21.8 34.8 38.5 24.7 21.1 40.3 21.5 33.3 27.0 42.4 35.1 32.1 45.5 25.3 31.7 18.7 21.8 31.9 30.6 28.8 62.9 21.4 21.1 46.9 38.5 34.0 31.1 34.6 23.0 30.0 45.9 56.2 38.3 30.7 42.9 33.2 35.7 42.1 22.9 32.7 37.1 75.5 21.3 58.0 45.8 21.1 91.5 35.2 31.2 30.1 68.8 59.1 166.2 120.1 49.9 47.4 66.7 55.3 44.9 103.0 99.7 85.5 135.6 206.9 54.8 61.4 62.7 42.9 184.7 53.6 110.0 80.9 88.3 194.3 112.0 111.9 72.3 183.9 79.9 52.2 66.8 78.1 50.3 83.6 77.2 139.8 138.0 142.1 89.0 48.0 239.4 57.6 185.4 67.0 67.8 228.3 173.8 181.0 72.4 143.4 156.7 94.7 122.1 41.9 83.8 161.3 71.9 83.3 64.3 63.8 61.6 80.4 70.2 113.4 128.0 229.5 75.2 146.9 99.3 79.1 99.9 68.5 74.4 99.8 77.4 79.6 69.8 75.2 115.0 60.1 61.2 67.3 24.8 87.7 95.4 95.7 77.9 151.8 19.9 21.8 24.7 21.1 18.7 21.8 21.4 21.1 23.0 22.9 21.3 30.1 61.6 41.7 53.7 32.3 115.8 71.5 68.3 76.8 120.1 106.1 105.2 57.3 22.2 77.2 59.1 73.5 143.9 129.2 132.0 55.4 84.1 84.7 26.3 51.2 89.0 65.7 97.1 201.4 38.0 58.3 87.6 81.3 70.3 71.6 49.4 93.3 64.6 76.5 80.6 106.0 41.5 83.9 79.3 78.8 74.3 17.5 79.6 80.8 49.8 22.5 90.7 77.4 91.6 44.2 49.7 76.1 42.1 88.4 201.8 59.5 44.3 65.9 50.5 109.2 98.6 47.6 76.9 154.2 88.8 132.5 77.4 85.5 95.4 79.5 86.9 58.7 RBFA "C18orf22, FLJ21172, HsT169" ENSG00000101546 "Ribosome binding factor A" Q8N0V3 18 80034389-80050651 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040485, HPA041479" Approved Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 85: Liver - Metabolism" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA040485: AB_10795368, HPA041479: AB_10795697" "unprognostic (5.31e-3)" "unprognostic (3.21e-2)" "unprognostic (1.87e-1)" "unprognostic (4.55e-2)" "unprognostic (7.33e-2)" "unprognostic (5.00e-3)" "prognostic unfavorable (2.06e-6)" "unprognostic (2.98e-1)" "unprognostic (7.98e-2)" "unprognostic (7.22e-2)" "unprognostic (4.28e-2)" "unprognostic (3.76e-2)" "unprognostic (2.43e-1)" "unprognostic (3.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.82e-1)" "unprognostic (5.00e-3)" 18.6 19.9 6.2 9.8 6.1 13.6 17.8 8.1 6.6 13.6 4.7 13.6 12.0 12.4 5.5 17.6 11.0 5.9 18.3 6.3 6.3 14.8 31.3 10.6 8.5 5.8 5.4 10.1 16.7 9.1 8.9 8.3 5.8 11.6 7.9 5.9 12.7 6.8 22.3 20.0 10.9 10.0 5.4 12.4 11.9 12.1 5.8 10.3 11.0 13.3 10.7 13.4 14.2 6.4 28.4 32.6 20.5 20.0 17.5 20.2 27.7 24.0 11.9 25.8 21.9 19.1 22.1 58.6 8.9 16.5 22.6 26.1 21.8 26.1 20.5 22.1 23.9 35.3 24.6 53.0 14.6 55.7 16.7 18.8 24.9 18.6 26.3 11.3 22.4 35.3 19.1 35.7 15.5 30.0 55.6 38.4 22.4 17.7 30.6 38.0 19.6 72.5 26.8 35.2 35.7 21.3 21.0 23.4 17.3 17.0 17.7 29.5 19.7 37.6 37.2 5.5 27.0 14.1 24.5 48.7 22.1 46.2 22.4 0.0 4.8 0.0 6.4 6.5 10.1 8.9 6.5 6.4 7.6 6.5 7.4 6.8 0.2 7.3 10.3 5.7 5.5 5.3 6.2 6.1 8.1 6.6 6.3 6.3 5.8 5.4 5.8 5.4 5.8 6.4 25.4 32.1 10.9 14.0 24.1 18.5 24.4 29.8 25.6 13.5 29.2 32.5 12.2 18.6 24.4 27.6 18.8 50.1 14.8 9.9 31.3 28.4 17.7 23.7 39.0 20.3 20.9 29.9 18.3 24.2 49.9 24.7 19.4 20.9 13.3 34.5 15.7 40.8 24.4 32.0 17.5 21.7 14.2 8.2 20.5 17.0 19.0 15.2 33.8 12.2 9.6 8.0 19.6 19.6 14.1 21.3 7.6 18.4 26.2 23.8 13.7 46.4 19.4 21.8 19.7 17.3 26.3 37.7 49.2 38.2 23.4 24.9 16.7 47.5 25.5 20.9 RBM10 "DXS8237E, GPATC9, GPATCH9, KIAA0122, S1-1, ZRANB5" ENSG00000182872 "RNA binding motif protein 10" P98175 X 47145221-47186813 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034972, HPA057372" Approved Enhanced "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear speckles" "HPA034972: AB_10602919, HPA057372: AB_2683421" "unprognostic (9.07e-2)" "prognostic favorable (6.71e-4)" "unprognostic (7.83e-2)" "unprognostic (1.61e-2)" "unprognostic (1.86e-1)" "unprognostic (3.04e-2)" "unprognostic (4.47e-3)" "unprognostic (8.11e-2)" "unprognostic (9.86e-3)" "unprognostic (1.76e-1)" "prognostic favorable (2.86e-6)" "unprognostic (1.18e-1)" "unprognostic (6.23e-3)" "unprognostic (3.33e-2)" "unprognostic (1.09e-1)" "unprognostic (4.40e-2)" "unprognostic (1.20e-3)" 23.7 31.1 28.5 19.9 28.8 32.5 23.9 32.6 36.4 33.3 26.6 28.8 18.1 29.5 12.4 34.2 31.5 12.1 30.8 28.5 28.4 30.0 32.2 23.9 25.1 28.2 27.9 40.6 32.2 15.9 38.0 17.3 28.3 33.8 11.3 14.8 23.6 15.6 26.5 27.1 27.8 12.5 26.6 33.9 26.4 12.8 29.3 23.6 33.1 12.4 15.9 28.3 29.9 31.9 50.1 52.5 48.9 58.8 25.7 21.0 57.3 36.8 21.4 37.2 35.8 46.4 39.8 60.1 22.0 25.6 47.5 47.7 64.9 46.1 20.4 61.6 59.0 45.1 65.1 48.8 37.5 46.0 52.1 27.7 22.0 61.2 49.8 26.5 40.4 56.5 38.3 47.0 23.0 74.9 84.8 78.2 81.9 37.1 58.0 74.0 41.0 62.2 27.7 42.9 58.6 44.5 56.0 41.6 35.6 29.3 50.9 45.7 35.8 43.7 54.9 47.8 39.5 48.4 42.9 49.5 38.8 32.8 62.3 13.5 8.1 11.4 12.7 10.7 12.0 11.2 10.2 10.8 9.2 11.1 10.0 9.7 7.5 9.9 15.8 10.7 12.7 9.3 28.5 28.8 32.6 36.4 28.5 28.4 28.2 27.9 28.3 26.6 29.3 31.9 17.4 41.7 36.9 22.5 21.6 11.1 22.4 15.0 22.8 26.7 16.5 16.8 36.6 21.5 28.8 9.2 14.6 34.2 21.3 32.2 11.7 20.5 1.3 23.6 20.1 19.6 35.8 14.9 14.8 17.7 28.5 20.2 31.6 31.5 24.1 29.1 16.8 23.3 19.7 21.9 15.4 31.5 10.2 14.2 10.0 2.7 18.0 15.4 16.0 8.4 19.9 14.7 20.6 15.1 18.1 19.8 20.8 25.6 22.5 18.7 23.1 14.3 28.8 27.0 0.0 21.4 21.8 10.7 8.7 23.4 10.5 46.1 23.8 19.7 34.2 18.1 RBM15B "HUMAGCGB, OTT3" ENSG00000259956 "RNA binding motif protein 15B" Q8NDT2 3 51391285-51397908 "Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036645, HPA058136" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 22: Epithelial cell types - Mixed function" Nucleoplasm "HPA036645: AB_10671965, HPA058136: AB_2683618" "unprognostic (2.65e-3)" "unprognostic (1.31e-1)" "unprognostic (1.01e-2)" "unprognostic (1.39e-1)" "unprognostic (5.29e-1)" "unprognostic (5.28e-2)" "unprognostic (3.13e-3)" "unprognostic (1.70e-1)" "unprognostic (5.25e-2)" "unprognostic (3.11e-1)" "unprognostic (3.39e-1)" "unprognostic (3.01e-2)" "prognostic favorable (1.84e-5)" "unprognostic (1.35e-1)" "unprognostic (1.69e-1)" "unprognostic (1.89e-1)" "unprognostic (3.84e-1)" 13.0 10.3 10.2 10.6 9.5 11.1 12.3 8.8 10.5 12.0 7.4 14.4 10.4 16.9 10.6 17.0 12.0 9.3 10.4 9.9 9.5 9.7 9.9 11.5 11.2 9.9 10.1 14.6 17.8 13.8 10.7 8.0 8.9 10.9 11.9 8.2 12.3 11.0 6.1 16.5 13.0 12.2 9.3 11.4 14.6 11.4 9.7 19.7 10.8 7.0 12.2 13.0 10.5 9.6 19.2 16.7 38.2 40.1 33.7 26.2 23.3 17.4 32.2 27.2 22.3 20.8 13.6 27.5 14.1 31.5 30.0 17.3 22.0 31.3 13.1 22.2 17.3 23.9 26.2 17.9 19.7 31.4 13.0 28.6 38.2 25.0 29.5 29.6 28.5 44.3 18.1 18.2 23.6 20.4 54.8 19.8 30.5 17.6 25.9 19.4 16.8 23.5 24.5 45.5 24.7 35.5 22.4 29.5 20.6 25.2 23.4 36.7 26.0 27.7 24.1 23.6 33.3 26.6 25.9 30.3 22.6 24.8 30.2 0.0 1.9 0.7 1.8 2.7 1.9 1.0 2.2 1.9 2.1 2.4 2.2 1.3 0.4 1.7 2.7 2.3 1.1 1.6 10.2 9.5 8.8 10.5 9.9 9.5 9.9 10.1 8.9 9.3 9.7 9.6 16.7 3.2 5.4 4.2 15.2 25.4 38.9 12.6 16.5 18.2 24.9 20.2 17.3 20.0 12.5 14.7 10.4 15.2 19.8 19.9 11.7 19.4 22.4 17.6 17.2 19.1 12.6 19.0 4.4 23.2 20.7 16.7 21.4 19.6 5.1 31.0 17.9 20.5 18.4 15.2 5.1 21.0 12.2 33.1 20.9 10.6 15.8 15.1 7.2 2.8 16.3 14.2 22.6 3.5 5.0 28.2 13.4 15.1 16.4 32.8 15.2 16.5 11.2 15.5 26.3 26.0 21.1 14.9 7.9 28.0 28.1 19.7 16.3 21.0 24.4 36.7 RBM19 "DKFZp586F1023, KIAA0682, Mrd1" ENSG00000122965 "RNA binding motif protein 19" Q9Y4C8 12 113816738-113966325 "Plasma proteins, Predicted intracellular proteins" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038860, HPA058732" Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA038860: AB_10697400, HPA058732: AB_2683801" "unprognostic (2.10e-1)" "unprognostic (1.54e-1)" "unprognostic (3.61e-2)" "unprognostic (4.83e-3)" "unprognostic (1.50e-1)" "unprognostic (9.14e-2)" "prognostic unfavorable (5.87e-7)" "unprognostic (9.32e-3)" "unprognostic (2.61e-1)" "unprognostic (5.14e-2)" "unprognostic (4.43e-2)" "unprognostic (3.53e-3)" "unprognostic (8.37e-2)" "unprognostic (3.18e-2)" "unprognostic (2.22e-1)" "unprognostic (1.28e-1)" "unprognostic (2.06e-2)" 11.5 14.1 7.4 12.5 8.5 16.4 13.5 5.7 8.8 13.8 7.9 13.8 8.7 13.1 8.3 12.5 12.9 6.4 11.6 6.5 7.1 13.4 12.3 12.2 14.0 8.7 7.9 18.9 14.2 10.1 12.7 9.9 8.8 15.1 8.9 7.7 12.6 8.4 16.7 12.5 13.5 9.0 5.1 13.3 13.3 11.9 10.3 10.4 20.8 9.3 12.9 14.4 12.4 11.1 13.0 25.6 15.0 29.3 14.7 11.7 22.7 22.9 17.9 25.3 18.5 34.4 17.7 23.1 13.9 19.5 18.5 18.1 35.4 22.1 19.8 42.0 20.8 49.6 28.0 33.4 11.1 37.9 22.7 14.6 14.3 31.0 11.2 16.2 18.6 17.8 54.3 9.3 15.9 19.4 21.4 28.6 32.8 12.9 21.6 28.2 14.4 20.1 17.3 24.9 17.9 14.4 20.5 29.3 14.2 12.4 32.3 10.9 21.3 16.6 20.3 14.4 14.3 16.7 13.5 22.7 22.3 26.7 21.5 0.1 4.4 1.3 7.7 7.7 6.0 7.3 5.5 6.4 6.1 5.9 4.4 6.0 0.2 7.6 12.4 4.2 5.4 4.8 7.4 8.5 5.7 8.8 6.5 7.1 8.7 7.9 8.8 5.1 10.3 11.1 8.1 16.0 9.6 18.9 15.6 13.8 14.6 5.1 10.8 11.8 10.3 8.3 20.4 7.2 9.2 11.0 8.4 10.6 13.2 6.5 1.9 11.7 7.2 9.1 11.7 11.2 9.0 12.4 13.8 13.3 9.2 13.6 10.2 9.8 15.2 15.5 4.6 6.9 12.3 6.7 13.1 8.4 6.1 7.6 8.7 9.5 10.8 9.8 3.6 24.4 16.8 5.4 8.2 11.1 15.5 14.5 5.6 7.2 15.1 15.3 6.4 9.8 12.8 13.5 0.0 14.1 12.9 16.6 15.1 11.8 11.5 11.4 15.1 10.4 7.8 11.4 RECK "hRECK, ST15" ENSG00000122707 "Reversion inducing cysteine rich protein with kazal motifs" O95980 9 36036913-36124455 "Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Protease inhibitor, Serine protease inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025109, HPA071729" Supported Supported "Plasma membrane" NA NA 64000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Plasma membrane" "CAB025109: , HPA071729: AB_2686438" "unprognostic (3.42e-1)" "unprognostic (4.01e-3)" "unprognostic (5.50e-2)" "unprognostic (5.05e-4)" "unprognostic (8.87e-2)" "unprognostic (8.47e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.75e-2)" "unprognostic (1.51e-2)" "unprognostic (9.06e-2)" "unprognostic (8.48e-2)" "unprognostic (7.45e-2)" "prognostic unfavorable (7.31e-4)" "unprognostic (2.68e-2)" "unprognostic (1.50e-2)" "unprognostic (3.60e-2)" 14.7 7.4 3.0 4.6 3.3 1.2 13.7 3.4 4.3 15.2 2.7 6.8 3.7 14.4 6.1 11.7 8.0 13.7 8.5 4.6 3.3 5.7 5.8 12.7 5.8 3.4 3.1 14.3 3.2 3.7 3.1 11.3 3.5 8.3 6.3 4.7 4.7 7.3 3.7 7.6 5.1 14.7 3.1 7.3 5.7 3.2 3.4 6.6 6.2 16.0 4.4 12.1 7.5 4.0 1.4 2.4 8.0 4.4 199.5 158.5 0.1 65.1 93.0 4.7 11.0 0.0 0.0 2.5 6.0 57.8 3.7 0.4 1.8 1.2 6.4 4.1 3.7 2.6 2.8 0.2 16.2 0.3 11.1 71.3 1.6 7.1 2.7 18.4 14.6 4.8 0.0 2.1 12.2 0.3 6.6 1.0 2.7 0.0 2.0 6.9 6.2 0.0 3.2 0.2 0.7 4.5 1.5 0.8 2.7 8.3 0.0 8.9 44.4 9.0 3.3 5.9 3.6 2.9 3.4 2.7 5.5 8.7 5.8 1.0 2.6 0.7 3.9 2.8 4.4 1.2 5.2 4.2 2.9 2.7 6.3 4.6 0.3 3.0 4.8 1.6 2.6 2.3 3.0 3.3 3.4 4.3 4.6 3.3 3.4 3.1 3.5 3.1 3.4 4.0 12.8 3.2 5.4 40.1 11.7 7.1 4.0 5.0 4.6 12.5 4.2 5.6 3.6 1.5 2.5 3.7 14.6 0.9 9.3 0.2 0.0 6.6 38.3 0.9 11.6 19.6 6.1 5.7 63.1 1.5 7.7 53.4 3.6 0.6 9.5 9.2 25.4 1.1 15.6 8.4 71.1 1.3 4.1 15.7 15.9 35.5 18.6 8.3 3.6 41.2 8.8 14.3 2.1 80.4 119.8 1.3 0.4 17.7 5.9 4.3 0.3 1.6 4.1 7.8 0.0 14.2 15.3 41.2 27.4 1.3 7.5 0.8 10.2 7.8 0.8 1.2 REEP6 "C19orf32, DP1L1, FLJ25383, Yip2f" ENSG00000115255 "Receptor accessory protein 6" Q96HR9 19 1491166-1497927 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 217.5;liver: 398.0;testis: 283.9" "Cell type enhanced" "Detected in many" "Early spermatids: 559.1;Late spermatids: 3135.0;Proximal enterocytes: 898.7" "Cancer enhanced" "Detected in all" "liver cancer: 114.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 57.9;Hep G2: 56.2;K-562: 155.7;T-47d: 121.4" "HPA003895, HPA048015" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 1: K-562 - Erythropoiesis" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA048015: AB_2680233" "unprognostic (1.21e-1)" "unprognostic (1.56e-1)" "unprognostic (7.76e-2)" "unprognostic (1.63e-3)" "unprognostic (3.24e-1)" "unprognostic (2.43e-2)" "unprognostic (1.92e-1)" "unprognostic (6.85e-2)" "unprognostic (7.38e-2)" "unprognostic (4.56e-1)" "unprognostic (1.49e-1)" "unprognostic (1.93e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-1)" "unprognostic (8.08e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-2)" 8.4 86.5 11.1 1.3 12.4 1.2 17.5 10.1 18.0 5.6 7.7 3.0 217.5 3.5 14.6 14.3 4.6 7.0 3.9 12.7 8.8 22.1 398.0 1.6 1.3 9.7 10.1 7.7 28.5 2.0 9.8 1.6 9.9 20.1 1.7 94.0 17.9 6.8 2.0 9.3 199.6 0.9 8.4 1.7 4.2 283.9 12.1 0.7 6.0 0.7 1.0 9.2 7.0 10.9 7.3 9.2 2.6 34.3 5.6 2.0 39.5 1.8 0.7 1.9 1.9 57.9 22.5 3.9 12.2 1.1 2.3 7.3 9.8 0.6 1.0 1.9 4.1 21.3 1.3 56.2 4.2 1.6 6.6 4.7 4.1 0.4 1.4 3.2 1.1 4.9 155.7 5.0 0.3 29.6 1.8 4.7 12.8 21.1 19.5 4.9 1.1 10.0 10.9 2.7 0.7 17.2 9.8 14.2 6.3 1.9 121.4 5.7 3.4 2.8 5.4 8.7 1.2 16.4 5.3 0.8 11.2 9.4 8.2 0.0 1.1 0.0 5.5 1.2 2.8 0.1 1.4 1.2 1.9 0.6 2.0 2.2 0.0 4.9 4.3 3.3 1.6 1.6 11.1 12.4 10.1 18.0 12.7 8.8 9.7 10.1 9.9 8.4 12.1 10.9 1.5 3.2 3.2 2.6 2.7 6.8 7.9 6.8 10.8 30.4 47.4 20.3 1.8 91.5 10.5 5.5 33.3 69.4 2.5 7.8 7.9 34.5 559.1 4.5 7.1 4.2 6.0 10.1 1.5 69.2 12.8 4.7 2.6 3.0 10.2 132.9 5.0 267.4 9.6 23.5 1.2 51.9 4.1 6.3 4.3 3135.0 34.2 4.1 30.2 0.0 1.7 44.2 2.1 0.0 1.5 25.0 53.6 16.6 1.9 13.1 898.7 52.0 8.3 292.8 19.7 0.8 3.3 29.9 36.5 17.5 6.7 36.0 4.3 50.1 70.7 14.7 RETSAT FLJ20296 ENSG00000042445 "Retinol saturase" Q6NUM9 2 85341955-85354531 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 247.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 264.9;Proximal enterocytes: 249.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 197.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007961, HPA046513" Uncertain Uncertain Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 45: Enterocytes - Digestion" Nucleoli "HPA007961: AB_1079802, HPA046513: AB_2679680" "unprognostic (6.17e-2)" "unprognostic (1.02e-1)" "unprognostic (1.29e-1)" "unprognostic (5.84e-3)" "unprognostic (1.14e-1)" "unprognostic (1.31e-1)" "prognostic favorable (4.23e-4)" "unprognostic (1.89e-1)" "unprognostic (2.16e-1)" "unprognostic (3.59e-2)" "unprognostic (1.77e-2)" "unprognostic (1.59e-1)" "prognostic favorable (1.95e-10)" "unprognostic (2.73e-2)" "unprognostic (5.34e-1)" "unprognostic (8.24e-3)" "unprognostic (9.90e-2)" 247.0 52.3 16.5 17.6 20.9 3.8 63.9 19.8 15.8 18.9 27.3 89.6 167.0 16.0 38.4 36.9 15.7 32.0 20.3 14.9 20.0 54.9 115.9 24.6 11.7 21.0 20.0 17.0 37.5 36.9 7.2 11.6 20.0 32.5 73.5 9.5 27.8 23.6 68.3 48.8 142.4 22.0 19.2 11.7 60.9 14.6 19.9 12.2 47.4 55.1 19.9 19.0 23.7 23.7 52.7 30.1 16.8 40.0 197.8 37.0 22.1 37.8 46.5 22.5 31.5 20.9 36.2 18.5 30.3 29.6 17.9 42.6 22.9 65.6 21.6 22.8 15.9 9.0 23.5 50.6 47.6 17.9 19.3 48.6 87.2 28.7 38.1 51.4 37.6 15.4 9.7 43.1 42.0 11.0 12.5 9.0 5.6 52.6 36.2 8.1 33.7 23.9 39.1 30.1 8.3 13.8 31.4 59.9 101.8 11.2 28.2 2.9 30.0 25.3 13.8 23.5 19.9 23.0 22.9 7.2 30.9 20.5 17.6 0.0 3.8 1.8 4.8 4.0 6.2 2.6 3.5 6.0 4.0 1.5 2.5 2.5 3.7 5.1 8.7 2.7 4.2 3.4 16.5 20.9 19.8 15.8 14.9 20.0 21.0 20.0 20.0 19.2 19.9 23.7 7.3 28.9 29.6 5.9 4.5 11.3 10.8 18.6 12.5 3.7 13.0 7.9 21.7 21.5 15.5 12.9 18.8 10.9 4.3 264.9 0.0 23.7 27.6 9.7 6.8 9.7 10.8 2.5 5.7 36.1 6.5 9.0 56.1 16.6 10.8 5.5 7.5 54.7 9.9 11.8 4.5 45.0 8.2 10.4 8.6 60.0 14.6 7.4 30.2 7.5 8.3 8.3 10.3 6.6 12.1 32.7 79.2 12.4 10.3 11.8 249.9 17.8 11.9 4.9 0.0 7.7 8.8 2.9 3.1 24.9 14.9 8.5 7.7 9.9 56.6 9.8 RFC3 "MGC5276, RFC38" ENSG00000133119 "Replication factor C subunit 3" P40938 13 33818069-33966558 "Predicted intracellular proteins" "DNA replication" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 52.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 285.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030149 Approved Supported Nucleoplasm,Vesicles No Yes "Cluster 27: Non-specific - Gene expression" "Cluster 63: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Vesicles" "HPA030149: AB_10602921" "unprognostic (3.86e-2)" "unprognostic (5.27e-2)" "unprognostic (1.12e-1)" "unprognostic (1.16e-2)" "unprognostic (5.76e-2)" "unprognostic (3.07e-3)" "unprognostic (3.32e-2)" "unprognostic (4.93e-2)" "unprognostic (9.02e-3)" "unprognostic (4.49e-1)" "unprognostic (6.46e-2)" "unprognostic (4.05e-2)" "unprognostic (5.24e-3)" "unprognostic (4.05e-2)" "unprognostic (1.79e-1)" "unprognostic (5.08e-2)" "unprognostic (2.86e-1)" 5.3 13.8 2.6 12.9 2.4 19.5 12.8 8.7 2.6 5.7 1.7 9.0 8.5 10.6 4.3 6.7 8.3 4.6 6.1 2.7 2.5 5.1 7.4 5.4 24.3 2.7 2.2 7.8 4.8 5.1 2.6 10.8 2.8 6.3 11.6 5.9 5.5 4.1 3.5 7.5 7.9 7.6 3.7 6.6 6.5 12.8 2.6 24.1 6.5 4.4 23.4 5.7 4.6 2.5 49.0 51.1 86.4 69.5 6.5 10.0 47.5 66.6 29.2 85.5 73.7 63.0 72.2 179.8 26.8 25.3 53.2 72.5 111.6 45.9 112.0 71.5 68.9 105.0 54.4 68.0 7.5 127.2 48.3 9.8 5.8 74.5 49.9 14.1 28.9 63.7 75.1 44.2 51.4 56.1 108.8 58.1 104.2 101.2 42.1 40.3 103.4 41.1 25.4 42.7 45.1 79.2 49.4 65.3 33.4 45.7 52.2 66.8 15.5 45.1 49.7 57.1 70.9 24.9 36.7 285.3 32.4 73.7 86.6 1.5 4.4 7.2 3.2 6.1 3.7 5.8 3.9 3.3 6.1 5.5 5.0 4.5 0.9 2.5 5.3 2.5 6.3 3.1 2.6 2.4 8.7 2.6 2.7 2.5 2.7 2.2 2.8 3.7 2.6 2.5 9.3 9.6 6.2 5.9 11.2 12.2 6.9 6.9 7.4 16.5 8.9 10.5 7.5 1.5 8.6 3.7 8.4 29.6 5.1 3.0 3.9 7.3 8.4 7.0 7.9 9.4 6.1 43.8 30.2 8.9 39.3 7.5 3.1 7.7 1.3 17.8 8.9 7.2 11.9 8.4 20.3 4.3 4.1 6.7 4.0 7.9 6.2 6.5 8.8 34.7 6.4 5.4 1.0 33.7 18.0 5.4 1.5 4.5 21.0 2.7 1.1 5.4 3.8 12.2 6.6 7.9 29.8 52.6 43.2 9.2 7.0 16.4 6.6 9.2 10.1 3.3 RFTN1 "FLJ23866, KIAA0084, MIG2, Raftlin" ENSG00000131378 "Raftlin, lipid raft linker 1" Q14699 3 16313574-16514026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 117.4" "Cell type enhanced" "Detected in many" "Excitatory neurons: 87.6;monocytes: 143.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 151.7;Daudi: 122.9;HDLM-2: 177.5;SH-SY5Y: 132.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048725 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 3: Monocytes - Immune response regulation" "HPA048725: AB_2680502" "unprognostic (1.98e-1)" "unprognostic (5.82e-2)" "unprognostic (1.44e-1)" "unprognostic (1.61e-1)" "unprognostic (5.92e-2)" "unprognostic (1.19e-2)" "unprognostic (1.87e-1)" "unprognostic (7.55e-3)" "unprognostic (9.99e-3)" "unprognostic (7.24e-2)" "unprognostic (2.75e-2)" "unprognostic (1.98e-1)" "prognostic unfavorable (1.29e-7)" "unprognostic (6.19e-2)" "unprognostic (1.49e-2)" "unprognostic (2.88e-2)" "unprognostic (2.81e-1)" 57.2 11.2 15.1 44.7 18.3 13.3 33.2 13.6 22.7 28.2 15.8 15.2 9.3 36.6 4.9 14.5 26.0 15.4 44.7 18.3 20.2 18.4 24.8 46.9 117.0 21.7 14.9 30.4 4.7 9.0 7.4 51.0 16.1 16.4 14.1 11.4 11.3 10.3 25.5 17.1 22.8 31.3 13.9 45.5 11.8 7.0 15.2 73.2 53.4 26.6 117.4 26.2 14.5 17.5 0.1 2.9 5.3 0.0 151.7 75.7 7.7 38.8 65.9 19.3 15.6 21.5 1.0 122.9 18.6 71.2 4.3 0.6 0.1 51.4 25.5 177.5 9.0 19.8 4.9 0.3 78.6 14.7 10.8 111.3 3.4 60.7 19.0 67.5 40.5 19.8 0.5 0.4 47.0 6.6 31.3 5.0 3.5 0.0 1.4 29.6 60.8 15.0 8.0 0.1 0.1 132.6 1.3 1.3 7.2 7.4 0.2 12.2 59.9 47.3 23.0 47.8 16.8 0.4 0.5 82.5 22.0 38.6 19.2 56.0 19.6 13.2 35.3 46.4 18.1 16.3 27.2 37.6 33.6 32.0 18.4 27.8 1.2 80.1 81.7 25.8 60.4 38.3 15.1 18.3 13.6 22.7 18.3 20.2 21.7 14.9 16.1 13.9 15.2 17.5 37.9 22.4 40.0 8.1 51.2 6.5 0.3 2.3 0.0 3.2 0.7 1.5 14.3 5.7 6.9 0.0 0.0 6.2 61.1 0.1 0.0 7.2 38.0 2.6 51.8 34.4 1.2 10.3 87.6 0.9 1.1 32.4 3.1 2.0 24.7 2.1 36.0 7.2 10.5 0.0 16.5 0.0 0.0 17.6 63.6 12.2 18.6 27.0 10.6 19.7 143.8 37.2 64.9 3.0 2.4 0.9 0.1 8.6 43.2 0.6 0.0 0.4 3.3 3.2 0.0 28.2 35.2 2.8 2.4 0.8 5.1 2.5 39.5 12.6 0.3 0.4 RIF1 "FLJ10599, FLJ12870" ENSG00000080345 "Replication timing regulatory factor 1" Q5UIP0 2 151409883-151508013 "Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036887, HPA036888" Supported Uncertain "Nucleoplasm,Nuclear bodies,Plasma membrane" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies, Plasma membrane" "HPA036887: AB_2675361, HPA036888: AB_2675362" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.71e-1)" "unprognostic (4.71e-3)" "unprognostic (5.87e-2)" "unprognostic (1.79e-2)" "unprognostic (3.73e-2)" "unprognostic (1.86e-1)" "unprognostic (2.51e-2)" "unprognostic (2.84e-2)" "unprognostic (1.80e-3)" "unprognostic (4.07e-2)" "unprognostic (1.63e-2)" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (1.57e-2)" "unprognostic (8.41e-2)" 6.1 5.0 4.4 7.4 8.4 21.7 10.0 13.8 7.0 6.5 2.6 5.6 4.3 8.2 4.0 5.6 5.6 5.6 3.5 4.6 5.1 5.5 6.7 5.1 8.5 4.4 5.1 11.2 7.0 6.8 3.5 8.0 5.4 6.0 6.1 8.2 7.7 5.0 7.5 7.2 4.6 6.2 4.9 6.5 6.1 11.0 4.5 10.7 9.1 9.5 7.9 7.3 4.6 13.8 20.8 17.4 26.8 20.5 10.7 13.8 25.9 24.8 18.0 21.6 25.5 28.9 16.4 39.2 21.7 17.3 17.9 21.3 41.2 17.1 36.1 27.8 19.8 63.4 21.4 21.0 11.2 64.7 20.2 10.3 11.3 38.8 28.7 12.3 21.3 23.5 52.2 32.6 22.1 13.8 38.3 22.9 43.2 11.2 22.9 38.4 42.1 26.1 11.6 24.9 24.2 18.8 32.0 14.6 16.5 18.8 12.9 23.1 27.0 32.9 22.8 20.3 26.7 16.0 29.6 55.4 15.3 25.5 22.5 6.3 2.5 3.0 4.3 1.7 4.9 4.0 3.6 3.2 1.8 3.1 4.8 3.7 2.8 7.7 3.5 1.6 2.8 1.7 4.4 8.4 13.8 7.0 4.6 5.1 4.4 5.1 5.4 4.9 4.5 13.8 53.1 96.1 49.7 41.1 43.5 49.3 47.5 21.9 33.0 48.2 30.4 29.8 38.2 28.6 38.0 14.7 31.3 39.2 40.3 19.6 1.9 38.5 22.6 38.0 61.7 48.0 25.0 84.3 68.5 21.9 35.9 51.3 34.7 65.0 34.1 88.6 27.1 19.7 23.0 47.1 72.4 30.9 14.2 26.4 27.0 14.0 43.8 37.6 30.2 48.7 44.1 35.8 32.0 73.9 126.3 29.9 23.5 34.3 45.1 53.2 14.9 12.9 21.3 42.8 85.5 106.5 51.2 122.8 113.1 28.9 41.6 40.9 45.3 58.9 34.6 45.4 RMDN2 "FAM82A, FAM82A1, FLJ32954, RMD2" ENSG00000115841 "Regulator of microtubule dynamics 2" Q96LZ7 2 37923187-38067142 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 42.5" "Group enriched" "Detected in many" 4 "Early spermatids: 270.4;Late spermatids: 163.5;Theca cells: 77.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA034705, HPA034706" Enhanced Supported "Golgi apparatus,Mitotic spindle,Cytosol" Yes No "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 23: Spermatids - Flagellum & Golgi organization" "Mitotic spindle, Cytosol" "Golgi apparatus" "HPA034705: AB_2674292, HPA034706: AB_10696362" "unprognostic (1.34e-1)" "unprognostic (2.61e-1)" "unprognostic (4.03e-2)" "unprognostic (1.71e-3)" "unprognostic (2.49e-2)" "unprognostic (1.76e-1)" "unprognostic (3.06e-2)" "prognostic favorable (2.63e-4)" "unprognostic (7.85e-2)" "unprognostic (9.96e-2)" "unprognostic (7.50e-2)" "unprognostic (1.94e-1)" "unprognostic (2.88e-2)" "unprognostic (5.08e-3)" "unprognostic (1.20e-1)" "unprognostic (4.34e-3)" "unprognostic (3.34e-1)" 4.6 42.5 3.8 4.1 3.5 3.4 5.3 4.8 4.5 7.7 2.9 12.4 8.4 5.1 9.2 3.4 3.9 6.2 4.4 4.1 2.6 7.8 29.2 11.3 4.6 3.9 2.6 2.8 4.1 3.2 3.0 3.9 2.6 7.2 10.6 4.2 3.7 12.8 5.1 2.9 13.9 5.8 3.0 20.0 4.4 21.7 3.6 5.9 5.4 3.2 2.9 4.3 3.5 3.7 3.3 4.7 2.6 1.8 10.4 11.4 1.5 7.0 9.3 3.6 3.2 1.1 10.9 2.2 2.8 9.9 2.2 3.5 0.8 5.1 4.9 5.0 3.0 3.6 1.6 3.1 5.3 0.0 3.8 16.2 4.6 4.5 0.7 5.4 2.0 1.8 4.4 2.1 6.8 1.3 0.9 4.5 5.1 6.5 3.8 0.0 0.8 0.6 9.0 2.7 2.1 7.5 5.7 0.7 7.3 2.2 1.1 5.9 3.8 4.4 5.1 2.5 2.6 3.8 7.7 4.6 5.4 1.1 4.6 0.0 2.8 0.7 2.0 4.6 3.1 4.1 1.0 1.3 1.8 2.3 1.0 2.2 2.7 3.7 3.5 3.4 0.1 1.4 3.8 3.5 4.8 4.5 4.1 2.6 3.9 2.6 2.6 3.0 3.6 3.7 3.4 28.9 29.6 25.1 6.5 2.4 6.8 16.3 8.6 3.5 1.9 4.2 5.3 11.5 20.0 5.5 2.1 2.1 6.0 20.9 7.9 5.4 270.4 3.7 11.8 4.6 4.8 3.0 33.8 3.8 1.0 9.2 2.6 3.1 15.8 13.1 5.3 15.5 4.7 5.0 24.5 11.4 6.1 6.3 1.7 163.5 9.3 4.8 5.4 19.7 4.4 4.7 6.2 39.2 7.1 2.5 6.1 6.0 1.8 2.2 29.6 6.7 10.2 2.6 6.6 6.4 5.1 9.4 4.8 1.7 2.4 0.8 3.9 77.6 15.2 2.3 RMND1 "bA351K16.3, C6orf96, FLJ20627, RMD1" ENSG00000155906 "Required for meiotic nuclear division 1 homolog" Q9NWS8 6 151404762-151452158 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein biosynthesis" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031397, HPA031398, HPA031399" Approved Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 81: Kidney & Liver - Metabolism" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156" "unprognostic (1.12e-1)" "unprognostic (4.45e-2)" "unprognostic (9.70e-3)" "unprognostic (6.67e-2)" "unprognostic (2.65e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.50e-3)" "unprognostic (6.56e-2)" "unprognostic (1.02e-1)" "unprognostic (1.73e-1)" "unprognostic (2.03e-1)" "unprognostic (3.57e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (1.80e-1)" "unprognostic (9.74e-2)" "unprognostic (1.04e-1)" 12.6 13.9 7.7 6.4 8.1 4.4 13.6 7.8 8.9 9.9 8.2 10.3 13.4 8.9 11.7 7.5 11.9 8.0 12.1 7.8 8.6 36.9 30.5 7.5 9.2 8.2 8.1 14.6 9.5 8.9 6.3 9.6 8.4 6.8 11.3 7.1 7.1 7.7 10.9 7.7 12.1 7.5 8.0 7.3 8.0 9.1 8.6 8.1 18.6 10.0 10.1 9.2 8.1 8.2 16.0 7.2 15.1 32.3 20.6 46.7 21.3 24.6 23.4 18.6 25.4 21.5 11.7 14.9 17.4 16.1 23.1 13.5 29.3 14.9 32.1 17.7 23.8 24.1 11.0 44.5 43.4 53.9 7.2 33.4 19.5 26.9 39.7 22.8 25.0 22.6 26.3 11.5 29.0 54.1 18.6 18.1 11.1 16.8 14.3 21.0 19.7 18.2 26.7 7.2 26.1 25.5 17.9 22.2 29.5 18.6 36.6 34.8 13.8 14.6 19.0 30.6 20.0 12.1 17.5 17.6 36.7 42.3 17.5 1.9 5.6 7.1 6.4 8.2 10.4 11.6 7.6 9.1 7.0 8.9 10.1 9.3 2.8 13.3 13.3 3.2 11.8 4.5 7.7 8.1 7.8 8.9 7.8 8.6 8.2 8.1 8.4 8.0 8.6 8.2 11.6 0.0 11.2 12.1 6.9 3.8 6.4 10.2 9.1 8.9 15.4 13.7 11.9 5.7 11.9 12.9 12.5 27.0 7.4 7.6 17.6 15.6 9.4 10.9 18.4 7.8 3.0 8.0 22.4 10.7 21.7 8.8 4.1 12.4 9.5 25.0 10.8 16.7 13.7 5.0 20.6 9.7 6.1 12.5 5.7 6.4 6.8 9.8 3.6 8.4 12.3 7.7 10.3 15.6 21.7 9.9 11.2 6.4 5.8 3.6 33.8 45.1 9.3 6.9 0.0 6.7 14.9 13.0 16.8 8.3 2.7 16.8 8.4 27.3 15.3 5.3 RNF126 FLJ20552 ENSG00000070423 "Ring finger protein 126" Q9BV68 19 647526-663233 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043050 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm Cytosol "HPA043050: AB_10794768" "unprognostic (2.24e-1)" "unprognostic (1.64e-1)" "unprognostic (1.97e-1)" "unprognostic (2.48e-3)" "unprognostic (1.90e-1)" "unprognostic (2.32e-1)" "unprognostic (1.09e-3)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (1.70e-1)" "unprognostic (1.88e-2)" "unprognostic (2.68e-2)" "unprognostic (9.96e-3)" "unprognostic (7.04e-3)" "unprognostic (3.39e-2)" "unprognostic (2.05e-1)" "unprognostic (4.67e-2)" 21.2 23.4 11.8 16.0 13.0 21.8 21.7 10.8 19.4 19.1 3.8 26.6 21.6 20.8 2.7 42.3 19.1 4.6 25.9 13.4 9.7 20.7 40.2 19.3 14.1 13.2 10.3 16.8 23.0 6.8 20.2 8.8 13.1 20.2 4.9 4.3 21.0 7.0 61.6 45.3 27.2 4.9 10.2 30.6 24.3 49.4 11.9 10.1 14.7 12.8 5.8 21.6 24.0 16.6 79.7 26.5 21.0 30.6 4.8 6.7 38.5 40.6 15.0 22.5 21.2 52.1 26.9 64.2 25.9 16.5 8.9 51.7 12.6 30.0 6.2 43.8 98.8 32.7 24.5 47.0 18.2 64.9 46.0 11.3 22.9 18.5 14.3 9.0 20.6 51.8 68.5 63.4 12.0 62.9 67.7 35.0 62.4 22.5 50.6 48.9 18.1 102.0 17.0 43.6 52.0 42.1 30.1 39.8 42.4 7.2 25.3 51.5 28.6 40.6 30.6 62.1 71.1 112.3 59.5 77.6 52.1 39.2 43.0 3.7 14.7 12.3 25.1 18.4 21.1 23.9 23.1 24.7 19.0 25.5 17.7 16.6 3.7 27.7 22.6 21.5 28.3 14.8 11.8 13.0 10.8 19.4 13.4 9.7 13.2 10.3 13.1 10.2 11.9 16.6 34.2 12.8 7.4 9.1 66.9 137.9 61.2 44.3 45.5 31.4 35.7 39.6 27.6 27.1 23.2 9.2 16.7 72.8 74.8 60.9 54.8 60.6 146.4 20.2 17.8 31.0 21.7 37.8 11.9 75.6 139.2 29.3 40.2 22.7 14.7 23.1 22.9 22.9 43.2 32.0 9.9 39.3 26.4 26.7 58.9 36.8 21.5 32.9 42.7 3.7 47.5 32.7 112.3 7.1 15.7 136.2 70.0 19.5 76.5 98.2 68.1 40.8 14.8 24.6 59.2 22.0 40.5 153.6 65.3 74.4 144.8 88.1 60.7 43.2 58.1 87.0 RNF139 "HRCA1, RCA1, TRC8" ENSG00000170881 "Ring finger protein 139" Q8WU17 8 124474880-124488618 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway" "Receptor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 93.2" "Group enriched" "Detected in all" 10 "Early spermatids: 810.1;Late spermatids: 992.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001202 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 34: Spermatids - Unknown function" "HPA001202: AB_1079824" "unprognostic (3.28e-3)" "unprognostic (2.92e-2)" "unprognostic (5.16e-2)" "unprognostic (5.43e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-3)" "unprognostic (2.71e-2)" "unprognostic (2.00e-1)" "unprognostic (1.69e-1)" "unprognostic (1.51e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (9.85e-2)" "unprognostic (1.53e-2)" "unprognostic (1.62e-1)" "unprognostic (2.75e-1)" "unprognostic (7.75e-2)" "unprognostic (1.45e-1)" 23.5 20.8 10.0 15.9 11.1 93.2 18.9 14.8 12.7 16.6 11.2 15.6 9.2 20.2 13.6 16.5 16.7 16.8 15.3 11.0 11.0 15.3 26.1 16.6 17.3 11.0 10.8 23.6 14.4 11.8 10.2 19.4 11.0 14.9 14.8 12.4 16.5 13.3 20.3 17.2 14.2 20.3 11.8 13.9 13.9 68.7 11.7 19.3 16.3 22.6 14.8 16.7 12.4 15.0 26.6 17.1 21.6 20.3 43.2 34.1 16.6 23.5 44.4 18.6 24.7 10.9 21.6 27.5 27.8 31.7 14.3 19.7 18.3 28.4 28.9 37.6 24.5 41.1 11.9 22.9 33.3 19.6 23.2 30.5 41.0 20.5 55.9 27.1 26.2 26.8 29.1 41.3 22.2 70.2 32.9 13.6 14.3 52.6 25.6 13.2 14.9 27.0 35.3 34.4 9.4 22.3 31.0 76.5 33.4 16.5 35.7 20.7 20.6 13.9 29.7 22.2 26.3 32.9 40.9 28.6 19.9 31.7 13.9 2.7 6.2 10.1 8.7 4.1 11.0 7.9 7.8 10.5 8.4 7.1 8.1 8.4 8.5 7.2 11.4 4.0 11.4 6.7 10.0 11.1 14.8 12.7 11.0 11.0 11.0 10.8 11.0 11.8 11.7 15.0 21.1 3.2 8.4 11.8 66.2 66.2 62.1 27.2 58.6 14.5 31.6 19.7 16.2 34.3 18.5 22.0 6.2 42.3 58.5 22.5 11.7 19.9 810.1 31.3 22.6 24.9 21.7 27.1 12.9 18.0 55.9 40.1 23.4 37.1 20.3 23.2 22.9 31.8 25.0 16.8 12.8 18.5 10.2 33.7 74.4 992.2 29.5 43.4 35.6 12.2 26.5 21.3 26.8 8.5 18.5 22.5 11.4 27.1 35.4 41.1 17.0 16.9 20.1 22.7 19.7 39.7 49.2 62.3 24.3 46.7 70.5 75.5 83.5 22.6 18.2 55.5 RNF4 "RES4-26, SLX5, SNURF" ENSG00000063978 "Ring finger protein 4" P78317 4 2462220-2625320 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022047, HPA049356" Approved Supported "Nucleoplasm,Nuclear bodies,Microtubule ends" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Microtubule ends" "HPA022047: , HPA049356: AB_2680726" "unprognostic (8.38e-3)" "unprognostic (1.69e-1)" "unprognostic (1.29e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (9.31e-3)" "unprognostic (9.03e-3)" "prognostic unfavorable (6.38e-4)" "unprognostic (1.34e-1)" "unprognostic (6.79e-2)" "unprognostic (2.58e-1)" "unprognostic (5.64e-2)" "unprognostic (1.93e-2)" "unprognostic (6.40e-2)" "unprognostic (4.70e-2)" "unprognostic (8.67e-2)" "unprognostic (1.54e-1)" 30.2 30.9 24.0 36.0 24.9 46.4 29.2 26.0 25.1 29.4 26.5 27.9 29.0 29.5 28.3 30.7 28.5 28.3 27.0 24.5 25.5 32.6 25.9 27.8 49.9 26.0 25.9 31.0 31.2 33.6 26.8 28.4 25.2 28.2 27.4 24.0 28.0 28.1 27.7 29.7 30.4 33.1 23.9 40.3 30.1 31.9 26.3 50.1 30.7 23.2 50.0 35.0 26.8 25.5 60.9 57.0 57.9 42.0 50.6 52.2 65.6 73.3 83.4 77.3 70.0 65.1 56.8 77.6 42.0 76.0 101.5 39.7 63.5 58.6 72.7 37.6 38.5 92.4 54.6 62.6 76.6 66.7 77.8 61.0 69.7 72.3 59.4 53.6 73.1 64.8 50.0 103.2 80.4 43.5 105.0 92.5 89.8 52.3 70.9 76.6 55.3 40.8 52.6 74.5 54.3 51.0 50.5 40.4 52.1 62.9 63.1 50.6 60.0 65.8 32.0 64.2 115.4 131.3 189.5 82.6 64.6 72.7 69.5 44.7 70.0 104.6 97.7 95.4 97.2 85.0 82.2 97.0 84.1 59.1 78.8 80.3 77.2 99.2 103.8 56.5 98.8 128.6 24.0 24.9 26.0 25.1 24.5 25.5 26.0 25.9 25.2 23.9 26.3 25.5 31.1 22.4 17.5 17.0 36.0 27.5 18.4 17.7 31.3 11.9 24.0 16.0 20.7 12.8 21.3 22.0 16.7 21.3 45.9 16.5 21.5 22.2 14.0 17.0 22.8 21.7 12.1 15.4 15.9 23.3 35.0 19.5 23.0 23.9 14.5 22.7 16.4 20.4 19.7 13.5 17.8 16.8 8.2 34.0 28.5 22.4 17.1 27.8 7.2 18.7 35.1 11.5 43.3 13.0 16.3 29.8 14.3 20.7 47.8 27.1 23.1 21.2 17.6 17.7 26.3 18.2 22.0 31.2 48.6 27.0 32.1 21.8 39.7 16.4 18.9 32.9 RNF8 KIAA0646 ENSG00000112130 "Ring finger protein 8" O76064 6 37353979-37394734 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway" "Chromatin regulator, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 76.0" "Not detected" "Not detected" "HPA050731, HPA064925" Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm Cytosol "HPA050731: AB_2681222, HPA064925: AB_2685385" "unprognostic (1.80e-2)" "unprognostic (2.23e-1)" "unprognostic (1.39e-2)" "unprognostic (8.20e-2)" "unprognostic (5.17e-2)" "unprognostic (3.99e-2)" "prognostic unfavorable (3.33e-5)" "unprognostic (2.36e-2)" "prognostic unfavorable (1.91e-4)" "unprognostic (2.26e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (4.99e-5)" "unprognostic (7.95e-3)" "unprognostic (1.78e-1)" "unprognostic (3.41e-2)" "unprognostic (3.66e-3)" "unprognostic (1.09e-1)" 5.0 7.8 10.0 3.5 10.1 4.6 5.2 11.8 14.3 7.7 9.3 6.3 3.1 7.0 2.1 10.6 6.0 4.0 8.6 10.1 10.5 8.8 4.8 5.9 4.2 10.2 10.6 7.6 4.5 7.4 6.6 4.8 10.3 6.0 3.6 9.0 6.2 5.2 8.1 7.6 5.0 4.9 9.4 4.7 5.2 11.2 11.2 5.8 4.5 10.6 6.6 6.5 7.8 9.9 12.5 7.3 17.3 20.7 13.7 19.6 4.9 12.6 15.5 23.4 25.6 11.0 6.8 15.3 7.5 12.4 20.1 11.4 24.4 16.0 24.4 16.2 23.7 26.5 12.0 16.6 7.8 14.3 18.7 9.8 15.2 14.0 16.2 14.3 22.9 17.9 18.1 5.2 13.6 8.3 17.4 17.5 12.1 6.3 9.4 13.5 16.0 10.6 12.1 8.7 34.0 11.4 9.5 10.6 18.0 11.3 9.5 13.6 10.4 15.4 13.5 14.7 18.8 15.2 21.8 76.0 7.5 20.1 18.0 1.0 4.3 2.5 9.5 5.8 8.8 8.1 7.0 9.2 7.8 4.9 6.1 8.1 0.5 7.9 8.8 3.3 9.1 5.2 10.0 10.1 11.8 14.3 10.1 10.5 10.2 10.6 10.3 9.4 11.2 9.9 21.0 19.2 25.9 13.4 15.0 18.2 22.2 26.0 26.2 26.7 16.5 20.4 31.1 12.8 18.5 25.8 39.6 24.8 18.2 10.3 15.6 24.7 41.1 68.5 32.2 19.2 22.2 18.7 17.0 18.9 25.8 28.0 16.3 52.3 28.5 37.0 27.8 16.5 17.5 50.5 15.9 16.5 14.2 13.9 17.7 30.2 26.8 24.0 10.6 11.2 19.6 25.4 37.0 12.5 20.5 28.8 18.1 30.9 13.7 31.8 11.8 20.6 23.8 32.3 13.1 23.2 20.8 46.5 34.5 34.2 22.0 5.9 19.3 22.0 18.0 21.9 RPAP1 "DKFZP727M111, FLJ12732, KIAA1403, MGC858" ENSG00000103932 "RNA polymerase II associated protein 1" Q9BWH6 15 41517176-41544269 "Predicted intracellular proteins, Predicted membrane proteins" Transcription "DNA-binding, Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041739 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 16: U-266 - Nucleosome" "Cluster 52: Non-specific - Transcription" Nucleoplasm Cytosol "HPA041739: AB_2677647" "unprognostic (8.83e-3)" "unprognostic (2.78e-3)" "unprognostic (1.63e-1)" "unprognostic (4.45e-2)" "unprognostic (1.97e-1)" "unprognostic (8.61e-2)" "unprognostic (1.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.25e-2)" "unprognostic (4.72e-2)" "unprognostic (1.23e-2)" "unprognostic (7.02e-2)" "unprognostic (3.73e-2)" "unprognostic (3.26e-1)" "unprognostic (2.46e-1)" "prognostic unfavorable (9.32e-4)" "unprognostic (4.30e-3)" 7.0 5.7 4.9 6.1 5.4 3.5 5.1 4.4 5.2 5.4 3.7 7.2 5.7 6.4 3.2 8.1 6.7 3.9 6.7 5.1 4.2 4.0 4.9 4.7 7.2 5.0 5.1 8.0 5.9 7.2 3.9 5.9 4.8 6.1 4.6 2.8 7.0 5.6 19.0 7.0 5.2 6.6 4.7 6.5 6.1 6.5 5.0 6.9 5.2 11.6 6.8 6.9 5.3 5.9 13.3 15.3 20.8 21.9 17.1 12.3 17.7 12.8 11.0 16.4 15.8 42.3 11.7 10.3 20.6 14.2 26.1 30.5 37.9 18.7 13.8 18.3 18.5 19.6 21.2 18.8 10.7 16.3 11.9 12.6 23.3 19.2 13.3 11.0 18.4 23.1 46.4 11.5 15.2 8.3 17.6 10.0 36.9 20.3 14.3 31.4 18.0 11.2 7.2 30.5 19.0 25.4 16.4 16.9 8.8 18.0 28.1 20.0 16.9 25.3 16.4 25.5 20.6 19.2 57.5 11.6 18.1 17.4 24.4 0.0 1.9 0.0 4.6 2.4 4.0 2.9 2.6 2.8 2.9 3.3 3.7 3.4 0.0 3.1 4.4 1.9 3.1 2.5 4.9 5.4 4.4 5.2 5.1 4.2 5.0 5.1 4.8 4.7 5.0 5.9 4.1 3.2 5.4 10.4 7.7 2.8 4.4 4.6 8.6 10.2 5.1 5.2 9.0 2.8 4.7 5.5 12.5 6.5 6.1 3.9 1.9 5.5 1.5 3.7 6.5 5.8 2.4 11.2 7.7 5.3 5.8 6.1 8.6 5.2 2.5 11.9 5.0 9.6 4.8 16.8 6.7 5.6 6.1 5.2 2.8 1.7 3.7 3.5 1.8 6.5 6.0 5.0 5.2 7.5 9.3 5.3 2.7 9.4 4.4 6.7 4.1 3.0 5.2 7.4 0.0 6.5 4.6 10.6 9.5 6.1 4.1 2.7 7.0 10.8 7.5 3.1 RPE ENSG00000197713 Ribulose-5-phosphate-3-epimerase Q96AT9 2 210002565-210022260 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Carbohydrate metabolism" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036498, HPA036499" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 130000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 20: HeLa - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" Cytosol "Nucleoplasm, Plasma membrane" "HPA036498: AB_2675157, HPA036499: AB_10670109" "unprognostic (5.07e-2)" "unprognostic (8.15e-2)" "unprognostic (3.06e-1)" "unprognostic (2.34e-3)" "unprognostic (2.00e-1)" "unprognostic (2.53e-2)" "prognostic unfavorable (1.42e-6)" "unprognostic (1.59e-3)" "unprognostic (1.69e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.00e-6)" "unprognostic (2.33e-2)" "unprognostic (2.55e-2)" "unprognostic (1.10e-1)" "unprognostic (1.95e-1)" "unprognostic (2.89e-1)" "unprognostic (5.84e-2)" 21.9 27.6 15.9 20.1 20.0 19.4 25.4 18.3 21.7 19.7 11.9 24.0 21.8 22.6 22.3 29.1 21.0 19.8 14.5 16.2 14.7 30.0 27.4 17.9 25.1 11.0 13.3 25.4 15.1 21.0 17.2 29.4 12.8 22.5 31.8 17.8 20.6 31.1 11.0 19.7 19.8 29.3 14.6 19.2 24.2 15.3 16.5 22.9 29.5 27.4 29.4 27.4 17.4 23.1 62.4 81.0 47.5 47.9 71.3 68.0 85.4 80.2 60.9 67.9 93.1 118.7 92.1 39.9 50.6 58.8 104.1 59.9 69.7 81.9 103.3 49.7 47.8 78.2 112.3 112.3 98.8 80.7 56.1 51.7 75.4 83.2 107.5 60.2 94.8 39.1 79.7 57.2 55.5 106.7 43.5 63.5 68.2 121.4 59.8 52.4 58.4 56.7 78.6 94.7 56.6 31.4 70.2 63.7 52.3 85.6 54.4 85.2 80.0 96.7 66.9 47.5 73.8 31.9 49.5 88.6 69.6 76.0 62.5 20.2 40.2 19.1 23.1 51.0 19.8 20.2 17.7 21.7 69.5 21.6 23.4 21.0 3.7 77.2 34.8 25.4 26.7 28.8 15.9 20.0 18.3 21.7 16.2 14.7 11.0 13.3 12.8 14.6 16.5 23.1 14.9 6.4 7.5 14.4 13.1 16.6 15.2 21.6 13.1 13.2 13.2 10.3 6.2 10.0 20.1 18.4 20.9 35.4 18.1 14.0 31.3 24.5 10.7 13.5 17.4 14.3 10.2 17.2 61.9 17.5 42.8 17.4 14.3 11.2 6.3 18.1 18.2 17.5 37.0 10.1 44.7 14.6 14.2 19.4 45.8 11.8 11.1 17.2 14.2 15.0 19.7 8.9 26.8 27.2 39.2 19.4 11.6 14.7 12.2 19.9 14.2 48.6 15.9 12.7 6.6 11.1 16.1 14.7 17.4 20.1 20.3 25.6 10.5 24.8 21.3 14.8 RPP40 "bA428J1.3, RNASEP1" ENSG00000124787 "Ribonuclease P/MRP subunit p40" O75818 6 4994717-5004063 "Enzymes, Predicted intracellular proteins" "rRNA processing, tRNA processing" "Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Theca cells: 30.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035685, HPA035686" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "HPA035685: AB_2674734, HPA035686: AB_10670153" "unprognostic (2.93e-2)" "unprognostic (3.22e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (6.10e-6)" "unprognostic (8.00e-2)" "unprognostic (4.78e-2)" "prognostic unfavorable (5.41e-4)" "unprognostic (1.20e-1)" "unprognostic (1.72e-2)" "unprognostic (6.44e-2)" "unprognostic (8.17e-2)" "unprognostic (9.57e-2)" "prognostic unfavorable (7.54e-8)" "unprognostic (1.54e-1)" "unprognostic (5.10e-1)" "unprognostic (4.08e-2)" "unprognostic (2.19e-1)" 5.2 11.4 4.4 4.3 4.4 4.9 6.7 4.2 5.7 5.1 3.7 3.4 2.9 4.1 3.6 8.6 3.2 2.9 3.4 4.4 5.3 3.5 7.4 2.0 5.8 4.4 4.5 3.6 3.9 3.8 3.5 3.4 4.6 2.8 3.1 0.7 2.6 2.7 5.6 6.1 2.4 4.6 4.6 4.6 3.0 6.0 5.4 4.7 3.4 3.3 5.4 8.0 5.3 4.7 13.0 21.2 6.6 18.7 11.9 15.1 20.7 12.5 6.3 23.4 18.4 29.0 9.7 27.8 53.6 13.1 32.2 13.4 13.7 19.3 20.9 10.6 27.4 17.5 12.8 39.5 14.0 22.8 9.6 11.8 16.2 23.5 23.0 5.2 23.4 25.2 28.1 5.4 17.3 36.8 11.6 39.0 10.9 15.2 34.0 24.4 12.5 51.0 12.2 13.8 23.5 6.8 11.7 11.1 13.2 17.3 20.2 18.7 11.2 30.6 20.7 20.9 29.1 9.7 43.7 22.0 5.8 37.8 16.1 0.0 7.1 0.0 3.3 11.9 4.9 8.1 5.7 4.1 12.9 7.2 7.6 7.1 0.0 8.6 3.9 6.4 9.1 5.2 4.4 4.4 4.2 5.7 4.4 5.3 4.4 4.5 4.6 4.6 5.4 4.7 7.3 0.0 1.1 2.0 5.3 12.4 10.4 20.6 6.8 0.2 6.3 9.3 4.5 0.0 9.5 1.8 0.0 13.3 3.6 2.2 11.7 7.9 8.1 9.1 13.7 10.9 3.0 2.5 3.6 9.4 14.5 5.8 4.6 4.6 0.0 11.7 6.4 5.5 11.5 0.0 3.1 4.2 6.1 2.5 4.7 3.7 5.6 3.2 8.8 1.9 3.7 1.2 3.1 3.5 3.1 4.3 2.1 4.9 5.7 7.7 0.7 15.1 10.6 0.5 0.0 8.3 8.4 15.1 24.1 12.6 14.8 9.6 3.6 30.8 7.4 7.7 RPS6KB2 "KLS, P70-BETA, p70S6Kb, S6Kβ, S6KB, S6Kbeta, STK14B" ENSG00000175634 "Ribosomal protein S6 kinase B2" Q9UBS0 11 67428460-67435401 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010010, CAB019404" Approved Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "CAB019404: AB_331355, HPA010010: AB_1856469" "unprognostic (1.38e-1)" "unprognostic (2.36e-3)" "unprognostic (8.50e-2)" "unprognostic (2.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.41e-1)" "unprognostic (9.01e-3)" "unprognostic (5.10e-2)" "unprognostic (1.22e-1)" "unprognostic (9.49e-3)" "unprognostic (7.66e-2)" "unprognostic (2.79e-2)" "prognostic unfavorable (2.03e-7)" "unprognostic (1.28e-2)" "unprognostic (1.55e-1)" "unprognostic (2.12e-1)" "unprognostic (2.66e-1)" 16.2 28.0 9.7 13.8 10.8 28.2 17.0 9.9 12.4 23.5 13.2 22.8 26.5 17.7 6.0 71.9 20.0 10.6 22.1 9.1 9.3 21.3 50.2 19.5 18.4 10.9 10.3 16.2 35.4 17.5 20.6 13.6 10.6 31.6 12.8 4.2 31.5 9.9 37.9 81.6 25.4 10.1 10.2 33.7 35.2 9.6 9.9 24.0 20.1 26.0 20.1 19.3 31.4 11.3 58.2 42.7 22.8 39.0 10.4 20.0 30.0 27.4 33.9 49.7 34.2 67.2 37.5 21.1 46.3 26.9 31.0 41.8 25.9 41.4 19.9 36.9 70.0 34.5 54.2 55.5 35.2 43.7 40.4 25.5 42.8 26.3 26.9 12.5 37.5 54.8 55.8 54.8 25.4 88.5 68.1 68.4 24.9 83.7 54.6 50.0 31.8 100.5 23.0 32.6 34.4 37.1 28.0 76.8 59.8 13.2 90.4 35.7 15.8 25.8 27.6 63.1 31.1 48.8 43.9 34.4 42.4 27.3 33.1 18.8 37.2 28.5 23.8 42.6 24.5 23.4 22.9 23.9 44.1 21.9 16.1 17.9 24.7 29.6 49.9 30.4 34.5 37.3 9.7 10.8 9.9 12.4 9.1 9.3 10.9 10.3 10.6 10.2 9.9 11.3 22.0 9.6 20.5 6.8 48.1 49.8 28.0 48.9 19.9 25.3 32.6 27.8 1.3 28.6 31.2 7.3 10.4 71.8 45.0 66.9 43.0 44.5 14.9 16.0 16.9 17.9 46.2 65.0 7.7 64.8 89.1 21.9 48.9 19.3 27.9 23.2 18.2 57.4 61.3 33.7 7.1 67.7 34.6 45.8 29.1 29.4 20.2 36.9 19.6 3.7 56.6 28.5 73.2 5.0 12.1 46.6 70.4 17.3 82.1 43.7 115.0 42.2 16.0 27.6 19.7 16.7 26.9 15.8 16.0 52.5 63.6 103.6 41.7 27.5 58.3 39.4 RPUSD4 FLJ14494 ENSG00000165526 "RNA pseudouridine synthase D4" Q96CM3 11 126202096-126211692 "Metabolic proteins, Predicted intracellular proteins" "tRNA processing" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 135.5;tongue: 75.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039689 Approved Supported Nucleoplasm,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 36: HEL - Hemostasis" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria Nucleoplasm "HPA039689: AB_10673537" "unprognostic (2.02e-2)" "unprognostic (3.65e-1)" "prognostic favorable (6.14e-4)" "unprognostic (3.16e-3)" "unprognostic (2.90e-2)" "unprognostic (3.75e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (1.32e-1)" "unprognostic (7.64e-3)" "unprognostic (1.07e-1)" "unprognostic (3.03e-2)" "unprognostic (1.20e-2)" "unprognostic (1.56e-1)" "unprognostic (7.11e-2)" "unprognostic (5.44e-2)" "unprognostic (7.33e-2)" "unprognostic (5.47e-2)" 14.8 12.7 10.2 9.8 10.4 10.6 14.0 10.5 11.2 13.8 10.7 12.1 10.4 12.6 7.7 15.1 12.9 8.1 27.2 10.5 10.4 11.8 20.5 9.4 13.8 10.2 10.2 18.3 26.8 7.8 8.8 6.8 10.5 11.5 10.1 6.1 14.4 7.0 135.5 17.1 12.1 9.2 10.6 14.4 20.0 8.8 10.5 13.2 10.1 75.2 15.5 12.4 13.4 10.5 15.6 14.0 17.0 19.7 24.5 34.3 12.5 16.2 22.7 16.6 15.1 46.4 27.3 35.7 16.8 14.1 23.7 25.1 40.3 25.8 17.3 32.4 23.9 84.1 15.0 40.5 18.3 42.5 17.1 29.8 35.0 18.4 22.9 24.8 33.4 28.8 51.8 25.1 20.2 13.5 26.6 46.3 18.4 49.3 29.1 31.0 25.2 33.3 25.7 19.8 29.3 20.5 21.5 29.7 16.7 17.0 46.2 21.9 20.9 18.6 13.3 15.4 19.9 10.1 12.4 30.7 8.8 47.2 19.7 1.6 12.7 1.4 15.9 11.7 19.6 14.4 18.0 14.3 16.3 14.5 20.4 16.8 0.9 14.3 14.0 7.0 18.1 13.3 10.2 10.4 10.5 11.2 10.5 10.4 10.2 10.2 10.5 10.6 10.5 10.5 10.0 3.2 8.4 6.8 15.3 27.5 20.4 13.2 17.1 9.9 13.1 9.1 35.4 12.8 7.4 7.3 8.4 14.0 12.3 7.2 9.8 12.3 1.8 6.7 7.1 11.9 15.5 6.7 7.0 19.6 17.1 10.2 10.7 7.4 5.7 15.2 13.6 11.3 13.3 11.8 8.4 10.7 2.0 15.9 8.7 2.3 9.6 8.6 10.6 8.4 21.0 5.3 14.4 6.6 7.8 13.5 7.4 8.6 12.4 17.4 15.6 14.5 7.0 8.2 6.6 15.6 9.9 10.3 16.7 13.2 24.0 13.3 13.1 18.3 18.8 14.7 RRS1 KIAA0112 ENSG00000179041 "Ribosome biogenesis regulator 1 homolog" Q15050 8 66429014-66430733 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055549, HPA060937" Approved Supported Nucleoli NA No "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 32: Non-specific - Translation" Nucleoli "HPA055549: AB_2682846, HPA060937: AB_2684390" "unprognostic (7.68e-2)" "unprognostic (1.02e-1)" "unprognostic (3.72e-2)" "unprognostic (5.25e-2)" "unprognostic (2.64e-1)" "unprognostic (3.84e-3)" "unprognostic (4.93e-3)" "unprognostic (2.82e-3)" "unprognostic (3.55e-1)" "unprognostic (1.96e-2)" "unprognostic (2.13e-2)" "unprognostic (1.01e-2)" "unprognostic (3.46e-2)" "unprognostic (8.61e-2)" "unprognostic (2.30e-1)" "unprognostic (5.29e-2)" "unprognostic (8.35e-3)" 18.6 14.6 9.8 12.0 9.9 6.5 14.4 9.1 8.9 14.3 10.3 15.5 8.2 19.2 3.8 18.3 16.6 3.6 16.7 8.1 8.5 14.0 14.9 9.8 10.2 14.5 9.9 17.2 41.0 6.0 6.2 5.9 9.9 10.9 5.2 4.4 11.4 6.9 50.0 16.9 12.0 7.4 9.7 13.1 19.0 5.1 11.4 6.5 8.4 14.5 9.5 18.6 13.8 8.6 68.2 83.7 16.9 35.7 17.8 14.3 27.2 41.7 18.3 31.6 23.3 37.7 43.8 91.3 14.2 22.1 44.6 62.5 41.7 47.5 34.7 50.6 70.2 72.8 25.4 67.8 26.3 43.6 37.2 18.9 37.7 34.9 46.1 12.9 20.8 27.5 64.7 37.6 23.3 78.6 87.3 79.2 109.5 76.0 97.2 18.4 21.6 38.3 44.8 54.9 23.0 50.6 20.4 33.4 48.9 17.4 57.6 38.5 36.0 58.5 53.4 49.5 97.5 67.1 64.7 69.8 27.2 68.0 40.4 0.0 13.1 1.0 14.1 17.5 24.8 9.3 17.6 16.5 22.7 8.8 16.1 18.8 0.4 17.3 12.1 10.6 14.2 10.2 9.8 9.9 9.1 8.9 8.1 8.5 14.5 9.9 9.9 9.7 11.4 8.6 8.6 32.1 16.2 3.6 10.0 70.0 42.9 17.9 20.5 9.7 11.8 9.9 29.6 8.6 18.3 12.9 12.5 21.2 13.1 7.1 11.7 28.7 0.2 6.9 16.4 14.6 6.7 13.2 1.5 28.3 23.1 13.6 11.7 8.9 7.6 11.5 12.5 14.8 20.3 6.7 2.8 13.4 8.2 12.2 11.9 1.0 19.0 9.8 23.2 0.0 15.6 8.6 26.8 0.5 2.0 22.1 9.5 17.3 8.7 37.9 3.4 30.0 9.6 13.1 19.7 28.9 21.6 6.2 16.8 19.6 59.8 38.6 20.1 17.9 22.1 30.6 RSL1D1 "CSIG, DKFZP564M182, L12, PBK1, UTP30" ENSG00000171490 "Ribosomal L1 domain containing 1" O76021 16 11833850-11851580 "Predicted intracellular proteins, Ribosomal proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043483 Supported Enhanced "Nucleoli rim,Mitotic chromosome" Yes No 18000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" "Nucleoli rim, Mitotic chromosome" "HPA043483: AB_2678504" "unprognostic (4.46e-2)" "unprognostic (1.33e-1)" "unprognostic (2.23e-2)" "unprognostic (8.88e-2)" "unprognostic (7.77e-2)" "prognostic unfavorable (2.95e-4)" "prognostic unfavorable (1.38e-4)" "unprognostic (6.66e-2)" "unprognostic (1.73e-1)" "unprognostic (2.28e-1)" "unprognostic (2.24e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (3.24e-4)" "unprognostic (4.72e-2)" "unprognostic (1.36e-1)" "unprognostic (2.02e-2)" "unprognostic (2.68e-2)" 39.3 32.2 11.1 36.9 11.7 46.7 78.8 13.4 14.1 47.6 12.2 35.7 32.6 44.0 28.8 38.2 44.5 30.5 33.7 11.9 12.5 33.0 39.1 26.4 48.2 11.6 11.4 118.5 43.6 28.8 13.2 30.0 12.2 33.3 37.9 15.1 42.0 34.0 87.3 34.1 29.2 36.6 13.3 26.9 25.1 22.4 13.3 41.8 34.8 51.7 65.1 48.0 26.4 15.4 90.7 84.3 69.1 87.1 88.6 157.9 81.9 82.1 91.4 104.0 105.9 82.6 83.1 225.6 133.1 68.6 72.1 62.5 186.7 124.4 168.4 88.8 100.7 111.6 75.9 188.0 165.4 159.5 71.3 116.6 173.2 107.6 248.2 77.8 102.4 87.0 198.6 101.5 129.3 100.8 125.7 92.6 177.7 108.1 86.1 129.2 127.3 240.1 92.9 78.0 96.4 79.2 155.0 116.6 110.0 70.9 100.5 122.2 63.2 69.0 77.3 66.0 120.0 81.3 126.2 261.7 75.0 164.9 94.1 14.1 123.2 12.6 69.7 119.1 129.6 132.6 129.5 91.7 130.8 117.3 185.4 136.8 7.1 124.6 120.7 80.2 100.9 253.0 11.1 11.7 13.4 14.1 11.9 12.5 11.6 11.4 12.2 13.3 13.3 15.4 111.2 141.1 156.6 5.5 198.1 330.9 338.6 251.0 299.3 39.9 241.1 344.4 188.4 74.4 198.1 49.7 22.9 186.4 118.7 41.2 135.0 134.5 22.8 76.0 181.1 118.1 94.5 104.5 11.0 186.2 286.8 180.9 88.2 100.0 152.6 106.6 64.2 78.5 147.6 38.7 11.6 126.4 107.8 153.0 177.3 18.5 199.4 141.0 92.5 3.7 276.5 52.8 113.3 3.5 7.3 135.4 75.1 126.0 104.6 226.5 110.5 155.0 81.3 30.8 59.2 245.4 151.5 111.2 136.0 203.5 290.2 160.6 166.5 162.8 184.3 225.1 RSU1 "FLJ31034, RSP-1" ENSG00000148484 "Ras suppressor protein 1" Q15404 10 16590611-16817463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA025927 Uncertain Approved Vesicles NA NA 33000000 "Cluster 27: Non-specific - Gene expression" "Cluster 46: Fibroblasts - ECM organization" "Cluster 36: HEL - Hemostasis" "Cluster 51: Myeloid cells - Hemostasis" Vesicles "HPA025927: AB_10610420" "unprognostic (7.33e-2)" "unprognostic (1.42e-1)" "unprognostic (2.08e-1)" "unprognostic (4.89e-1)" "unprognostic (9.56e-3)" "unprognostic (2.91e-2)" "unprognostic (1.25e-3)" "unprognostic (1.99e-1)" "unprognostic (3.83e-2)" "unprognostic (3.72e-2)" "unprognostic (3.30e-2)" "unprognostic (7.79e-2)" "prognostic unfavorable (9.32e-5)" "unprognostic (1.11e-1)" "unprognostic (1.46e-1)" "unprognostic (2.48e-1)" "unprognostic (4.53e-2)" 35.6 14.2 8.8 22.0 8.9 27.9 25.4 8.8 10.1 21.2 10.1 27.8 12.0 30.3 19.9 27.7 19.2 19.7 25.1 8.7 10.1 19.4 16.7 27.7 22.3 10.5 9.4 21.8 21.2 14.1 3.9 23.2 9.8 17.9 23.8 9.9 14.5 27.0 15.8 15.9 13.7 41.8 8.6 20.4 15.6 5.5 10.4 18.1 18.7 13.8 22.3 24.0 18.0 9.6 27.3 18.6 15.0 88.5 78.4 80.3 18.3 66.3 28.2 45.1 48.6 17.3 25.0 27.0 10.5 91.2 24.1 23.9 18.3 34.7 48.3 40.6 14.6 85.2 11.1 16.7 34.5 13.1 47.8 40.0 36.0 43.3 13.7 40.9 47.8 27.8 14.0 18.2 61.6 17.6 30.5 23.5 15.7 39.6 10.5 19.6 20.3 18.4 44.0 10.0 5.9 11.6 33.1 21.6 33.6 26.8 7.6 34.4 58.8 38.4 13.3 48.5 34.6 15.9 20.6 23.3 51.0 37.1 16.9 33.0 20.9 22.8 24.7 26.0 28.0 16.6 28.1 26.7 34.7 17.9 20.5 25.8 14.6 31.3 25.5 25.9 36.0 48.5 8.8 8.9 8.8 10.1 8.7 10.1 10.5 9.4 9.8 8.6 10.4 9.6 111.1 35.3 24.5 26.4 29.9 36.7 30.3 74.0 12.0 1.7 22.5 36.2 41.2 27.1 48.3 42.3 2.1 131.9 41.6 57.0 68.4 72.1 80.5 20.7 47.2 69.6 7.2 74.7 52.8 119.2 83.0 52.8 28.5 24.8 34.2 20.5 64.2 32.7 121.7 3.3 34.7 19.0 52.9 61.1 80.7 163.3 39.4 106.2 60.5 52.5 92.3 5.8 66.9 45.8 51.7 81.2 16.8 68.4 36.7 17.4 14.9 58.3 48.8 17.9 65.7 32.4 136.1 3.9 22.6 34.1 42.8 96.2 46.8 35.9 27.2 24.9 SAP30L "FLJ11526, NS4ATP2" ENSG00000164576 "SAP30 like" Q9HAJ7 5 154445997-154461053 "Predicted intracellular proteins" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048665, HPA078308" Approved Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 10: Non-specific - Unknown function" "Nucleoplasm, Nucleoli fibrillar center" "HPA048665: AB_2680486, HPA078308: " "unprognostic (3.79e-3)" "unprognostic (1.44e-2)" "unprognostic (1.25e-1)" "unprognostic (7.70e-2)" "unprognostic (1.07e-1)" "prognostic favorable (9.09e-4)" "unprognostic (1.33e-1)" "unprognostic (1.61e-1)" "unprognostic (1.32e-1)" "unprognostic (4.33e-2)" "prognostic favorable (2.06e-5)" "unprognostic (3.36e-1)" "prognostic favorable (1.71e-4)" "unprognostic (1.62e-2)" "unprognostic (3.34e-2)" "unprognostic (1.45e-2)" "prognostic favorable (2.69e-4)" 10.0 8.4 12.2 5.3 13.7 1.6 11.3 13.0 13.2 14.0 10.2 14.9 10.5 13.4 9.0 7.1 12.9 6.7 9.8 11.1 12.9 13.1 8.0 9.3 6.8 13.2 13.4 19.7 6.4 13.8 5.0 7.7 12.7 10.6 8.7 6.1 7.3 12.4 14.1 11.4 11.0 11.6 13.7 8.9 8.9 7.7 13.1 9.9 9.3 15.3 8.3 10.9 10.0 13.8 9.0 7.3 13.3 8.8 28.4 22.5 6.5 9.2 19.9 10.4 11.2 4.9 5.0 9.7 7.2 14.0 12.1 7.1 10.1 7.5 11.6 4.9 9.9 7.9 6.8 3.6 8.5 10.5 5.7 8.2 13.4 4.6 11.3 16.0 8.5 9.1 3.3 6.0 8.8 4.5 9.9 6.7 3.3 8.2 5.0 9.4 13.3 4.8 6.0 4.4 8.0 10.5 7.3 15.6 17.6 12.4 5.6 12.8 12.1 7.2 5.3 9.6 6.6 5.6 8.6 5.0 10.6 8.1 4.2 0.0 0.3 0.3 0.5 0.4 0.6 0.2 0.6 0.6 0.3 0.5 0.6 0.4 0.2 1.4 1.2 0.4 0.6 0.3 12.2 13.7 13.0 13.2 11.1 12.9 13.2 13.4 12.7 13.7 13.1 13.8 25.7 19.2 6.9 7.8 7.1 17.3 8.7 4.2 8.0 4.5 17.0 14.1 19.8 17.2 6.3 3.7 6.2 7.7 15.5 26.5 3.9 4.8 22.4 15.6 18.4 17.6 7.2 11.0 6.6 8.2 12.3 18.1 4.6 9.8 1.3 16.4 15.7 16.3 8.5 10.1 6.5 11.4 0.0 9.7 12.4 18.0 20.5 11.3 10.6 9.4 10.7 21.4 14.4 6.0 12.1 10.6 13.9 18.0 7.8 16.9 32.7 10.5 9.5 5.8 0.0 14.9 16.0 16.1 17.2 5.5 18.2 6.3 8.9 10.5 12.1 13.3 SARS2 "FLJ20450, mtSerRS, SARS, SARSM, SerRSmt, SERS, SYS" ENSG00000104835 "Seryl-tRNA synthetase 2, mitochondrial" Q9NP81 19 38915266-38930763 "Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 40.1;Late spermatids: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA052730, HPA056957" Approved Uncertain Nucleoplasm,Vesicles,Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" Vesicles "HPA052730: AB_2681929, HPA056957: AB_2683286" "unprognostic (3.20e-3)" "unprognostic (1.17e-1)" "unprognostic (1.38e-1)" "unprognostic (3.53e-3)" "unprognostic (1.08e-1)" "unprognostic (1.88e-3)" "unprognostic (4.38e-3)" "unprognostic (1.22e-1)" "unprognostic (2.57e-2)" "unprognostic (8.62e-3)" "unprognostic (8.36e-2)" "unprognostic (1.67e-1)" "unprognostic (5.62e-3)" "unprognostic (2.50e-2)" "unprognostic (1.82e-1)" "unprognostic (9.24e-2)" "unprognostic (2.69e-2)" 7.3 17.3 4.2 7.2 4.7 9.3 8.2 4.4 6.8 9.7 3.6 10.1 9.3 9.3 2.8 14.3 8.5 5.9 12.4 4.7 4.4 14.6 18.7 6.6 9.8 5.0 4.4 9.8 15.9 7.8 11.9 7.6 5.3 12.2 5.3 2.3 11.3 6.2 16.4 12.3 10.2 5.1 4.2 12.0 11.9 10.7 4.4 7.5 14.4 11.5 6.6 9.4 9.6 5.4 17.6 47.3 15.5 10.7 5.8 13.3 23.7 10.7 12.6 23.1 17.7 36.0 18.4 17.2 16.3 12.5 9.7 13.9 14.7 29.2 5.3 12.7 24.4 33.7 17.7 32.0 15.4 29.1 31.9 20.7 13.5 14.5 7.6 9.5 14.2 26.3 29.9 14.2 10.6 28.4 21.4 20.7 18.5 21.6 8.5 31.2 16.4 18.6 20.5 36.2 29.1 18.1 14.2 32.7 8.9 4.6 21.8 19.1 11.4 13.7 17.7 11.7 15.1 11.0 7.1 13.2 10.9 18.5 13.8 0.0 8.0 1.0 14.2 14.4 11.5 12.0 10.7 14.7 25.2 10.7 7.5 8.6 0.5 14.0 13.7 9.9 13.4 8.9 4.2 4.7 4.4 6.8 4.7 4.4 5.0 4.4 5.3 4.2 4.4 5.4 2.7 6.4 7.9 6.2 8.4 4.2 3.8 8.3 3.4 8.0 7.0 5.3 8.1 7.2 6.8 5.5 8.4 40.1 5.6 8.9 15.6 15.5 15.7 3.6 3.6 3.8 11.4 13.2 6.8 12.7 23.0 4.8 9.7 3.9 5.7 7.4 6.1 10.1 12.9 5.0 6.7 9.2 10.2 6.7 4.2 56.9 4.7 4.8 3.6 1.9 7.7 3.1 5.2 1.5 3.1 8.4 5.6 4.9 10.1 2.6 7.4 10.3 5.1 13.4 0.0 2.7 4.2 1.9 8.2 12.8 4.1 29.1 7.4 10.6 17.8 3.2 SART3 "KIAA0156, p110, RP11-13G14, TIP110" ENSG00000075856 "Spliceosome associated factor 3, U4/U6 recycling protein" Q15020 12 108522214-108561400 "Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028840, HPA044322" Approved Supported Nucleoplasm No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Nucleoplasm "HPA028840: , HPA044322: AB_2678895" "unprognostic (1.72e-1)" "unprognostic (1.16e-1)" "unprognostic (7.59e-2)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (6.32e-6)" "unprognostic (2.74e-1)" "prognostic unfavorable (8.74e-4)" "unprognostic (1.38e-1)" "unprognostic (7.88e-2)" "unprognostic (1.05e-1)" "unprognostic (1.23e-1)" "unprognostic (1.23e-3)" "unprognostic (7.91e-2)" "unprognostic (1.61e-1)" "unprognostic (6.36e-2)" 14.6 15.1 14.0 18.5 14.0 25.5 14.8 17.6 15.1 18.8 12.2 15.9 12.6 19.3 13.7 19.2 17.4 11.9 13.9 13.7 14.6 13.9 16.1 14.5 26.3 12.5 12.9 23.8 13.2 18.3 18.9 15.4 13.0 16.5 15.2 20.3 14.1 14.5 17.8 19.0 17.2 13.9 13.5 19.8 15.1 16.8 14.5 25.7 18.8 15.1 23.2 15.5 16.0 16.8 34.5 61.5 45.4 53.8 24.2 18.9 43.6 29.3 35.8 50.1 37.2 51.5 23.4 51.3 20.1 26.4 32.2 32.0 68.2 33.9 44.1 61.8 43.0 74.1 40.9 47.9 39.2 74.0 44.4 26.4 31.4 31.9 46.8 38.1 30.8 42.1 85.7 33.7 30.9 34.6 69.9 57.5 90.2 27.6 59.9 67.3 44.7 59.3 26.1 57.5 56.8 40.3 45.0 17.0 30.7 38.7 49.0 51.1 26.0 39.0 21.0 30.1 30.7 42.6 68.3 75.6 34.1 42.2 46.2 6.9 6.2 6.4 8.3 5.1 9.9 7.7 6.3 8.3 9.0 7.1 9.4 6.0 1.6 8.6 7.6 6.1 10.5 7.9 14.0 14.0 17.6 15.1 13.7 14.6 12.5 12.9 13.0 13.5 14.5 16.8 14.7 19.2 24.5 16.0 25.9 14.7 16.3 15.4 16.5 42.0 11.5 11.4 19.9 10.0 23.4 18.4 35.5 21.4 21.1 12.0 7.9 14.7 53.6 15.1 21.6 20.0 12.5 23.1 22.1 12.7 14.0 17.1 15.3 15.9 17.7 21.9 11.7 12.5 13.2 35.3 22.2 9.3 24.4 14.1 13.8 30.8 10.2 17.0 16.0 16.9 18.6 23.4 14.4 19.1 24.9 13.5 7.7 17.7 29.6 16.1 9.5 8.2 27.4 39.1 32.9 22.0 18.0 27.2 31.1 19.6 18.0 23.7 24.2 19.1 14.0 17.0 SBNO1 "FLJ10701, FLJ10833, MOP3, Sno" ENSG00000139697 "Strawberry notch homolog 1" A3KN83 12 123289109-123364847 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.6" "Cell type enhanced" "Detected in all" "Spermatocytes: 265.4;Spermatogonia: 219.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042388 Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA042388: AB_10795704" "unprognostic (1.61e-2)" "unprognostic (9.61e-2)" "unprognostic (5.12e-2)" "unprognostic (2.54e-3)" "unprognostic (3.50e-1)" "unprognostic (3.59e-2)" "unprognostic (1.21e-2)" "unprognostic (1.48e-1)" "unprognostic (5.33e-2)" "unprognostic (2.22e-1)" "unprognostic (2.22e-1)" "unprognostic (1.22e-1)" "unprognostic (6.61e-3)" "unprognostic (2.06e-1)" "unprognostic (3.74e-1)" "unprognostic (2.44e-1)" "unprognostic (1.49e-2)" 5.5 5.7 5.9 6.8 7.4 16.8 6.5 11.5 9.2 5.4 5.7 6.1 5.3 6.7 6.4 7.2 5.5 4.2 5.3 8.2 5.7 6.4 6.2 4.8 8.9 5.7 5.4 7.2 5.0 6.9 5.1 5.6 5.8 6.8 6.6 10.2 5.1 6.3 11.6 8.3 5.9 6.1 5.6 7.1 5.3 37.6 5.9 9.6 10.0 7.8 8.7 5.7 5.5 7.9 14.0 24.3 11.7 21.6 16.6 11.9 22.8 11.7 11.6 10.0 8.2 19.1 8.3 31.0 13.6 14.4 11.0 16.8 22.3 13.9 16.8 19.8 9.2 27.1 15.6 18.0 10.2 33.8 22.9 10.0 13.1 14.5 15.3 13.8 10.9 16.4 35.2 8.6 18.7 14.7 20.2 25.0 18.0 13.5 13.2 20.7 15.4 15.9 10.8 31.3 18.3 9.5 19.5 16.4 13.6 13.1 24.4 17.8 14.7 15.1 16.7 16.7 11.9 9.9 19.5 34.2 10.3 21.9 17.2 5.0 4.5 4.5 7.2 5.0 7.5 6.0 6.6 5.8 4.0 5.0 6.9 6.9 5.9 4.6 8.0 4.4 5.2 4.5 5.9 7.4 11.5 9.2 8.2 5.7 5.7 5.4 5.8 5.6 5.9 7.9 29.8 28.9 25.7 42.1 59.3 63.3 48.1 40.4 37.0 92.6 38.0 30.4 39.6 25.8 38.3 36.8 79.2 65.8 54.3 22.1 23.5 36.5 62.5 53.1 56.0 34.7 40.2 47.9 58.3 27.2 49.6 36.5 23.9 44.0 29.2 47.3 32.2 26.7 26.2 63.9 47.6 25.1 52.9 35.3 46.4 35.2 25.4 41.2 33.8 31.9 56.5 49.7 54.6 27.2 46.2 38.1 21.2 60.5 33.0 55.5 29.8 27.5 36.4 59.9 26.3 51.5 58.1 265.4 219.3 40.7 61.4 106.0 53.3 42.1 38.9 44.3 SCAF8 "KIAA1116, RBM16" ENSG00000213079 "SR-related CTD associated factor 8" Q9UPN6 6 154733378-154834244 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035601, HPA035602" Enhanced Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA035601: AB_2674698, HPA035602: AB_10673220" "unprognostic (4.60e-3)" "unprognostic (3.67e-2)" "unprognostic (7.90e-3)" "unprognostic (2.50e-2)" "unprognostic (6.18e-2)" "unprognostic (1.13e-1)" "unprognostic (1.01e-2)" "unprognostic (3.41e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (6.61e-4)" "unprognostic (3.65e-1)" "unprognostic (2.08e-1)" "unprognostic (9.08e-2)" "unprognostic (2.66e-1)" "unprognostic (1.52e-1)" "unprognostic (2.42e-1)" "unprognostic (1.11e-1)" 19.2 11.8 7.9 15.6 10.3 37.2 18.9 17.8 9.9 18.2 2.7 14.9 12.7 22.1 16.4 13.2 17.4 13.6 14.8 6.9 8.5 16.6 15.4 16.2 22.6 7.3 8.5 27.0 14.9 21.3 10.2 18.9 6.2 16.9 17.6 23.2 15.6 15.6 18.7 18.3 14.3 20.3 6.8 19.1 15.2 23.5 8.7 26.8 21.3 19.1 20.8 15.3 14.7 10.4 16.2 15.3 44.6 27.1 29.3 29.8 27.2 25.7 35.8 33.1 33.4 24.2 16.0 49.7 20.4 29.6 29.4 21.1 39.5 33.8 44.2 21.7 19.7 44.6 16.0 29.8 33.8 41.7 28.8 32.3 35.0 29.0 45.0 25.7 28.6 21.6 52.6 29.4 30.8 29.1 44.6 28.2 31.0 24.4 11.3 42.3 24.4 27.1 28.1 29.0 27.4 32.3 26.7 34.7 19.9 32.1 22.8 47.8 26.3 18.8 23.0 24.6 26.2 27.2 21.7 54.0 23.4 25.6 30.0 0.6 1.5 1.8 2.8 2.0 2.8 2.4 3.0 2.9 1.7 2.6 3.0 2.7 1.9 3.1 3.8 1.6 4.0 1.4 7.9 10.3 17.8 9.9 6.9 8.5 7.3 8.5 6.2 6.8 8.7 10.4 23.1 25.6 18.1 89.8 22.6 12.6 12.2 11.9 17.6 19.5 14.6 12.4 33.9 7.2 11.7 12.9 25.0 11.1 23.2 15.8 1.9 11.3 3.6 18.8 25.4 16.6 13.1 18.7 105.4 11.8 8.8 17.5 23.0 25.0 34.2 29.3 18.5 11.6 13.3 13.5 114.2 14.1 6.1 20.8 9.7 5.4 16.4 16.6 10.6 119.9 13.5 16.1 8.2 121.2 145.8 13.6 11.8 12.4 13.7 13.7 11.7 6.5 15.8 21.4 26.3 24.5 16.3 21.4 21.2 14.8 10.7 10.7 19.2 19.5 16.1 15.4 SCFD2 "FLJ39514, STXBP1L1" ENSG00000184178 "Sec1 family domain containing 2" Q8WU76 4 52872982-53366066 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 7 "Astrocytes: 63.0;Excitatory neurons: 126.2;Inhibitory neurons: 131.6;Microglial cells: 82.4;Oligodendrocyte precursor cells: 182.0;Oligodendrocytes: 153.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036526, HPA036527" Enhanced Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 17: WM-115 - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA036526: AB_10673499, HPA036527: AB_2675175" "unprognostic (1.50e-2)" "unprognostic (7.99e-2)" "unprognostic (2.99e-2)" "unprognostic (3.31e-1)" "unprognostic (4.22e-2)" "unprognostic (6.16e-2)" "unprognostic (1.27e-2)" "unprognostic (7.08e-2)" "unprognostic (4.02e-2)" "unprognostic (4.29e-2)" "unprognostic (1.12e-1)" "unprognostic (2.78e-1)" "prognostic favorable (3.81e-6)" "unprognostic (9.39e-3)" "unprognostic (1.10e-1)" "unprognostic (4.86e-3)" "unprognostic (2.51e-2)" 7.3 9.0 5.7 7.3 6.2 7.6 7.3 5.5 6.6 6.2 4.8 6.3 5.6 6.9 3.3 8.5 4.6 4.5 6.4 5.6 6.8 7.1 5.6 5.2 7.4 6.5 6.0 6.6 6.1 5.6 5.8 6.0 6.8 4.4 6.2 4.0 5.5 5.1 7.6 7.2 4.3 7.5 5.6 5.8 5.8 2.8 6.9 6.5 5.2 6.2 7.9 6.0 6.6 8.3 13.5 12.2 6.8 16.0 22.2 22.3 8.3 30.0 22.6 10.3 8.7 8.7 16.6 25.7 22.8 57.7 11.1 8.1 22.2 26.2 19.6 7.7 13.0 14.1 12.1 10.6 10.3 18.3 24.8 15.5 15.6 19.9 7.8 9.9 18.2 6.5 24.4 14.3 17.7 15.2 25.0 10.8 4.3 37.6 15.0 15.4 6.6 26.8 11.4 8.7 19.5 11.3 6.8 25.0 13.7 7.9 9.8 8.2 16.3 22.1 14.2 25.7 22.3 16.5 9.8 29.7 15.1 20.7 65.0 0.1 7.2 1.8 9.2 12.2 9.5 8.0 7.4 10.6 19.6 6.4 10.9 10.1 1.4 17.9 13.5 12.7 7.1 11.1 5.7 6.2 5.5 6.6 5.6 6.8 6.5 6.0 6.8 5.6 6.9 8.3 5.4 0.0 3.1 63.0 10.3 3.7 5.4 5.8 8.0 4.1 3.9 3.4 2.9 11.5 3.5 3.7 6.2 8.4 5.4 3.5 1.9 3.8 2.9 2.6 8.4 4.2 1.2 5.5 126.2 5.1 6.7 7.3 5.6 3.6 12.7 5.9 4.2 6.0 5.3 5.0 131.6 3.5 2.0 2.5 3.1 1.5 6.5 10.0 5.4 82.4 2.7 2.7 3.1 182.0 153.7 2.5 2.8 5.7 14.3 2.8 2.4 8.5 4.3 3.3 0.0 5.3 3.8 5.4 3.5 10.5 5.4 4.2 6.8 16.4 4.9 3.5 SDAD1 FLJ10498 ENSG00000198301 "SDA1 domain containing 1" Q9NVU7 4 75940950-75990962 "Human disease related genes, Predicted intracellular proteins" "Protein transport, Ribosome biogenesis, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035949 Uncertain Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoli Nucleoplasm "HPA035949: AB_10673225" "unprognostic (8.82e-3)" "unprognostic (3.39e-3)" "unprognostic (7.62e-3)" "unprognostic (1.10e-1)" "unprognostic (2.17e-1)" "unprognostic (7.74e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (5.15e-2)" "unprognostic (1.44e-1)" "unprognostic (1.59e-1)" "unprognostic (2.08e-2)" "unprognostic (3.98e-2)" "prognostic favorable (2.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.41e-1)" "unprognostic (2.24e-2)" "unprognostic (4.62e-1)" 14.6 13.5 10.5 14.8 10.8 7.2 17.9 8.4 12.3 13.6 8.5 14.3 11.9 17.6 19.0 15.3 12.7 8.7 14.3 10.9 11.0 15.0 15.8 12.6 21.2 9.6 8.9 13.7 17.7 17.7 8.9 12.9 9.3 14.2 15.1 6.8 15.0 16.2 22.9 14.8 11.1 17.1 8.5 15.5 14.0 21.3 11.1 16.4 21.2 16.4 20.2 18.8 11.7 10.2 29.8 11.8 28.5 38.9 33.1 29.8 30.6 41.3 35.9 34.0 29.1 36.6 42.0 46.7 30.2 38.1 32.4 29.7 44.5 40.5 42.3 41.2 23.0 39.9 24.4 30.6 32.7 68.5 43.9 26.4 45.0 36.3 40.4 21.1 30.0 31.2 72.7 37.8 36.4 33.1 69.6 25.1 47.4 48.3 18.1 41.8 53.5 39.3 32.7 32.6 43.3 35.6 28.1 57.0 48.9 31.1 26.4 39.6 29.1 36.6 36.7 44.4 34.8 33.9 37.6 62.0 40.7 31.1 46.0 10.4 14.5 4.1 19.1 19.1 23.8 17.8 23.0 21.1 15.3 20.1 23.0 19.5 2.3 23.4 27.5 13.0 21.5 15.9 10.5 10.8 8.4 12.3 10.9 11.0 9.6 8.9 9.3 8.5 11.1 10.2 36.2 19.2 34.7 15.0 45.7 27.5 26.8 45.1 35.3 21.1 21.3 29.1 12.3 14.3 46.0 22.0 6.2 30.6 35.7 14.5 35.2 37.7 109.0 12.1 29.9 25.2 22.8 35.3 34.0 24.9 32.2 27.4 20.9 18.7 49.4 26.3 18.9 22.1 37.9 13.5 31.8 22.6 36.7 24.3 16.3 106.7 25.4 30.0 24.9 30.9 40.3 23.7 42.2 23.6 29.9 33.4 18.3 33.1 49.0 37.1 17.1 46.6 26.1 20.0 19.7 33.2 38.7 75.6 100.7 47.5 33.1 25.0 38.1 33.2 27.9 22.4 SEC16A "KIAA0310, p250, Sec16L" ENSG00000148396 "SEC16 homolog A, endoplasmic reticulum export factor" O15027 9 136440096-136483759 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005684 Supported Supported "Endoplasmic reticulum,Golgi apparatus" NA NA 48000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 27: Mucus-secreting cells - Mucin production" "Golgi apparatus" "Endoplasmic reticulum" "HPA005684: AB_1079189" "unprognostic (1.24e-3)" "unprognostic (2.07e-1)" "unprognostic (2.02e-1)" "prognostic favorable (1.30e-6)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (1.67e-1)" "unprognostic (3.84e-2)" "unprognostic (3.48e-1)" "unprognostic (5.30e-2)" "unprognostic (1.38e-3)" "unprognostic (4.75e-1)" "prognostic favorable (4.47e-4)" "unprognostic (5.57e-3)" "unprognostic (2.64e-1)" "unprognostic (2.47e-2)" "unprognostic (1.41e-1)" 16.8 18.2 6.4 16.6 6.7 35.3 17.1 8.0 9.4 16.6 19.3 17.3 14.9 17.9 9.0 17.9 16.4 12.4 14.5 7.0 5.2 14.3 37.9 19.4 16.9 4.4 4.9 16.2 29.2 14.0 24.3 10.8 3.5 18.7 10.5 9.2 25.8 13.1 23.5 19.7 19.1 10.7 2.4 20.7 27.2 17.6 5.2 17.4 15.3 11.9 12.3 15.9 14.5 5.0 26.5 57.7 28.5 47.2 29.6 30.3 33.6 32.1 27.9 23.4 17.8 41.9 22.1 26.4 22.1 39.2 28.8 71.3 31.8 46.2 12.7 56.2 20.7 26.9 55.1 33.7 28.6 46.2 45.8 32.8 32.5 32.7 38.1 18.9 32.2 34.5 34.1 35.6 25.0 114.3 31.2 24.9 25.1 79.0 40.4 44.3 35.2 45.0 23.8 35.0 40.0 26.6 41.6 62.2 19.8 13.8 63.6 35.9 47.0 37.6 28.1 30.8 25.2 16.9 27.7 33.4 29.2 20.6 38.3 1.7 2.8 1.2 2.5 3.1 2.7 2.3 2.6 3.0 1.6 1.4 1.6 2.8 2.0 1.5 3.4 2.6 1.9 2.4 6.4 6.7 8.0 9.4 7.0 5.2 4.4 4.9 3.5 2.4 5.2 5.0 20.0 25.6 41.7 16.6 16.4 24.9 15.3 18.4 10.8 20.2 38.7 30.6 11.5 12.8 23.6 12.9 25.0 8.1 17.5 30.1 7.9 14.2 5.1 26.9 19.5 18.2 40.7 12.0 27.4 16.4 11.8 16.0 46.9 38.2 23.5 25.4 17.9 62.2 16.5 33.7 19.2 65.5 20.3 23.4 19.5 6.0 13.1 22.3 14.2 17.8 19.5 13.0 11.3 9.5 14.7 22.8 14.7 16.6 25.1 26.3 22.3 10.1 34.7 17.1 13.1 20.5 16.6 24.4 16.1 17.2 26.9 15.1 17.8 15.8 22.8 22.1 SEC23IP p125 ENSG00000107651 "SEC23 interacting protein" Q9Y6Y8 10 119892730-119944657 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038403, HPA043305" Approved Enhanced Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" Vesicles "HPA038403: AB_10675796, HPA043305: AB_2678416" "unprognostic (4.05e-2)" "unprognostic (5.01e-2)" "unprognostic (8.70e-2)" "unprognostic (1.35e-1)" "unprognostic (3.12e-1)" "unprognostic (1.07e-1)" "unprognostic (9.52e-3)" "unprognostic (1.78e-1)" "unprognostic (3.36e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" "unprognostic (3.00e-2)" "unprognostic (1.11e-2)" "unprognostic (2.08e-1)" "unprognostic (2.23e-1)" "unprognostic (6.81e-3)" "unprognostic (3.43e-2)" 10.3 9.7 3.5 12.0 3.9 14.1 11.8 6.2 4.6 11.2 6.4 12.6 10.4 11.9 12.1 9.4 8.8 9.6 7.7 4.0 4.0 10.3 12.6 10.2 13.7 4.2 4.3 10.0 11.1 9.8 8.5 12.4 4.0 13.1 13.0 9.0 10.3 9.9 9.8 10.4 9.5 16.4 3.1 11.7 17.5 11.5 4.6 11.1 12.5 8.4 13.4 12.0 8.3 6.3 32.4 30.2 24.3 31.9 22.4 25.3 19.0 27.2 39.5 26.1 31.6 31.0 22.9 30.2 14.7 36.2 32.5 23.9 27.9 29.2 39.5 27.2 28.7 25.1 16.3 34.0 31.0 29.6 29.9 31.4 18.4 30.8 30.5 28.3 36.3 15.5 19.1 21.4 28.7 19.2 25.9 28.2 29.5 28.6 20.9 23.7 44.7 17.3 26.1 25.6 9.6 25.5 25.0 19.9 24.1 24.9 17.5 21.7 29.6 15.8 18.5 23.8 35.1 33.5 32.6 38.7 27.6 37.4 14.1 14.3 10.5 10.3 10.7 16.3 13.9 11.3 10.5 12.4 11.9 9.1 11.1 10.7 3.8 13.0 18.1 7.2 11.9 9.6 3.5 3.9 6.2 4.6 4.0 4.0 4.2 4.3 4.0 3.1 4.6 6.3 15.1 12.8 28.3 21.9 20.9 8.4 19.3 18.1 13.1 17.3 19.1 12.1 17.4 27.1 24.5 18.4 6.2 17.8 18.7 19.7 5.9 16.8 26.1 15.1 22.1 19.9 19.9 21.2 28.3 14.4 18.9 21.4 44.9 15.5 22.1 21.0 14.3 25.5 23.3 11.8 30.2 24.3 26.4 24.6 12.2 24.9 14.0 23.3 8.8 39.4 21.3 14.6 16.5 31.7 37.5 20.2 19.8 15.1 23.7 23.4 16.0 19.2 25.4 23.7 0.0 16.8 17.9 25.0 19.8 19.1 13.9 23.1 18.2 24.2 20.8 21.1 SEC24B ENSG00000138802 "SEC24 homolog B, COPII coat complex component" O95487 4 109433772-109540896 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Microglial cells: 88.1;Oligodendrocytes: 91.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038181 Approved Approved Nucleoplasm,Vesicles NA NA 14000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Vesicles" "HPA038181: AB_10672472" "unprognostic (1.19e-1)" "unprognostic (4.31e-3)" "unprognostic (8.58e-3)" "unprognostic (9.95e-2)" "unprognostic (1.22e-1)" "unprognostic (1.46e-1)" "unprognostic (6.67e-2)" "unprognostic (3.18e-2)" "unprognostic (1.06e-1)" "unprognostic (1.85e-3)" "unprognostic (2.51e-3)" "unprognostic (7.47e-2)" "prognostic favorable (2.33e-6)" "unprognostic (2.67e-1)" "unprognostic (2.40e-1)" "unprognostic (6.02e-2)" "unprognostic (1.73e-1)" 19.3 13.7 7.2 13.2 7.5 28.0 17.4 14.7 9.9 16.3 15.0 15.7 14.1 16.9 12.9 17.2 15.0 13.8 15.6 6.8 7.6 16.7 46.2 14.8 13.9 7.5 6.9 21.4 18.6 21.9 11.2 20.6 7.8 15.6 16.1 32.6 14.3 16.1 28.1 19.8 12.7 17.9 7.3 14.7 13.3 11.3 7.4 27.2 18.5 22.9 16.7 17.5 16.0 9.6 21.1 18.9 29.3 22.1 34.9 34.7 16.8 27.0 32.8 22.5 19.8 17.4 23.8 19.4 13.8 41.1 19.3 17.4 33.2 26.9 33.0 24.0 16.6 20.3 16.6 19.2 23.4 27.0 22.9 34.4 33.7 25.8 30.8 31.8 33.7 19.7 31.5 17.3 33.6 17.1 39.2 12.5 11.2 26.1 15.0 25.1 25.9 11.3 27.1 25.8 20.6 16.5 20.8 43.8 16.0 30.0 12.9 10.3 31.3 26.2 17.6 23.1 19.5 16.6 22.3 18.1 23.3 10.7 21.5 6.1 9.5 11.5 8.6 10.4 9.5 10.3 9.5 9.0 11.8 8.9 10.8 9.3 9.2 11.5 10.5 4.6 9.1 9.0 7.2 7.5 14.7 9.9 6.8 7.6 7.5 6.9 7.8 7.3 7.4 9.6 25.1 25.6 15.4 63.0 23.0 35.4 20.1 11.8 28.5 27.0 12.9 10.8 30.5 14.3 17.4 5.5 6.2 13.3 13.2 22.7 5.9 10.4 4.4 18.7 14.6 22.5 15.6 11.6 71.1 13.1 9.2 16.4 19.9 21.9 11.4 15.9 16.8 29.9 12.3 16.8 84.1 15.6 4.1 17.6 16.8 7.9 20.5 18.7 17.8 88.1 14.5 20.3 13.4 76.9 91.6 12.6 18.7 21.8 21.3 22.5 16.5 9.6 19.6 22.0 13.1 16.3 16.8 14.7 13.6 22.2 36.7 16.1 17.0 9.9 14.4 30.3 SEC31A "ABP125, ABP130, KIAA0905, SEC31L1" ENSG00000138674 "SEC31 homolog A, COPII coat complex component" O94979 4 82818509-82901166 "Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "ER-Golgi transport, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA005457 Approved Supported Vesicles,Cytosol NA NA 40000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 40: Granulosa cells - Unknown function" "Vesicles, Cytosol" "HPA005457: AB_1079896" "unprognostic (3.50e-2)" "unprognostic (2.28e-3)" "unprognostic (2.55e-2)" "unprognostic (1.58e-2)" "unprognostic (2.93e-1)" "unprognostic (6.52e-2)" "prognostic unfavorable (3.32e-4)" "unprognostic (6.14e-3)" "unprognostic (1.54e-1)" "unprognostic (1.17e-1)" "unprognostic (4.21e-3)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (5.53e-3)" "unprognostic (2.92e-1)" "unprognostic (2.85e-1)" "prognostic unfavorable (2.69e-4)" 98.7 103.3 52.2 78.4 54.3 119.4 111.4 62.4 70.1 145.5 94.9 107.1 124.2 119.7 162.1 92.6 90.9 122.1 110.7 54.0 61.4 133.6 174.8 96.2 88.2 58.4 58.7 152.8 192.6 116.4 108.4 143.2 58.7 113.4 127.2 87.9 134.0 111.3 96.8 107.8 111.0 131.5 50.9 76.5 110.1 77.8 54.4 93.8 168.0 85.6 102.1 113.1 94.1 63.9 146.2 65.2 183.6 130.4 318.9 394.5 133.3 264.8 295.4 146.0 179.2 113.2 182.3 188.3 113.7 532.2 84.6 68.1 183.3 176.2 200.4 193.4 72.7 115.3 110.5 302.1 316.4 124.4 140.7 380.5 217.7 223.5 254.3 251.2 240.5 83.8 178.4 181.1 264.2 128.6 164.9 99.6 126.1 154.0 58.3 121.2 100.1 140.3 237.2 83.0 118.6 131.2 105.7 180.7 174.9 184.8 142.1 137.8 248.2 190.7 98.9 169.0 168.8 135.1 62.4 256.7 190.6 147.8 224.2 84.3 66.9 51.2 65.1 74.0 80.5 60.0 57.6 64.3 73.3 50.0 56.9 54.6 19.2 89.9 83.1 61.1 52.7 71.8 52.2 54.3 62.4 70.1 54.0 61.4 58.4 58.7 58.7 50.9 54.4 63.9 62.6 105.8 85.3 50.9 58.1 60.5 60.5 64.1 56.9 52.3 54.5 43.7 85.5 51.5 109.8 47.8 54.2 57.3 61.0 62.8 27.4 65.8 30.6 90.1 164.6 65.0 38.3 41.2 61.0 71.2 85.3 125.2 100.9 119.7 75.2 241.0 65.0 94.0 45.9 42.1 60.0 99.4 50.8 51.2 55.3 19.3 139.1 63.8 51.6 67.5 60.4 36.5 38.1 74.9 72.6 67.5 46.3 126.0 152.2 76.3 121.0 65.9 100.5 66.9 52.6 86.5 98.9 30.3 34.6 62.2 74.2 81.5 55.4 78.9 54.9 101.1 SEC63 "DNAJC23, ERdj2, PRO2507, SEC63L" ENSG00000025796 "SEC63 homolog, protein translocation regulator" Q9UGP8 6 107867756-107958208 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Protein transport, Transport" Chaperone "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Theca cells: 354.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA053295, HPA060535" Supported Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "Endoplasmic reticulum" "HPA053295: AB_2682105, HPA060535: AB_2684312" "prognostic unfavorable (3.32e-4)" "prognostic unfavorable (4.01e-4)" "unprognostic (4.08e-1)" "unprognostic (1.56e-1)" "unprognostic (4.36e-3)" "unprognostic (1.51e-2)" "unprognostic (8.33e-3)" "unprognostic (1.24e-1)" "unprognostic (1.80e-1)" "unprognostic (1.04e-1)" "unprognostic (3.27e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (6.16e-4)" "unprognostic (2.35e-1)" "unprognostic (1.93e-1)" "unprognostic (1.56e-1)" "unprognostic (4.41e-2)" 27.5 33.0 11.6 22.0 14.3 32.9 23.3 14.4 12.9 30.2 25.7 19.2 16.8 25.2 29.6 19.5 21.8 22.0 19.0 12.4 15.3 20.0 46.6 21.7 16.7 13.3 12.0 40.4 61.2 31.7 14.4 20.9 14.2 27.7 18.6 21.2 77.8 23.3 14.3 15.5 18.0 22.2 12.3 16.1 23.1 33.0 12.1 22.6 52.1 14.1 17.3 21.8 14.0 17.7 28.5 17.1 46.0 57.6 47.1 55.2 41.4 59.2 65.0 27.8 39.2 30.8 34.6 52.8 49.4 53.7 34.4 40.9 32.3 38.3 42.5 63.8 35.7 57.2 25.2 31.6 73.2 65.9 32.5 43.5 61.4 44.5 97.6 50.0 39.3 31.7 48.5 82.8 57.7 22.7 20.6 29.5 36.4 30.0 18.1 65.2 54.4 43.7 33.5 37.1 40.3 45.7 32.9 48.8 59.1 31.2 34.9 95.8 42.5 41.6 25.8 42.2 46.6 31.4 25.0 52.9 45.9 56.4 48.7 5.6 5.2 5.0 4.8 4.7 7.5 4.4 3.9 3.9 5.4 4.0 4.3 3.4 1.7 7.1 9.8 6.9 2.2 3.5 11.6 14.3 14.4 12.9 12.4 15.3 13.3 12.0 14.2 12.3 12.1 17.7 55.6 118.6 143.3 38.2 64.4 85.0 70.5 90.9 42.7 57.7 67.8 54.2 78.8 81.5 125.5 53.3 39.6 80.8 71.6 39.2 11.7 86.0 40.3 48.7 102.8 61.6 53.5 31.5 52.5 125.4 96.4 107.1 46.9 54.8 68.9 84.8 59.6 126.7 62.7 47.1 50.8 80.0 83.4 56.7 78.9 23.9 106.2 54.8 80.0 42.2 54.3 61.0 59.8 60.3 64.8 81.9 53.5 118.8 144.6 91.1 37.2 38.4 116.7 49.9 46.0 108.2 77.2 143.1 75.0 44.7 80.0 91.0 52.3 354.8 60.8 73.8 SECISBP2L KIAA0256 ENSG00000138593 "SECIS binding protein 2 like" Q93073 15 48988476-49046447 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 119.4" "Cell type enhanced" "Detected in all" "Alveolar cells type 2: 248.6;Oligodendrocytes: 429.8;Syncytiotrophoblasts: 711.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039875 Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 44: HDLM-2 - Immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Nucleoplasm "HPA039875: AB_10673365" "unprognostic (7.86e-3)" "unprognostic (2.53e-2)" "unprognostic (1.33e-1)" "unprognostic (3.19e-3)" "unprognostic (9.29e-2)" "unprognostic (5.35e-2)" "unprognostic (1.58e-1)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (9.58e-3)" "unprognostic (2.16e-1)" "unprognostic (3.08e-2)" "prognostic favorable (5.65e-8)" "unprognostic (1.87e-2)" "unprognostic (1.27e-1)" "unprognostic (2.01e-2)" "unprognostic (2.28e-1)" 18.8 16.1 36.4 11.9 72.7 22.6 18.6 61.1 57.1 18.6 5.8 13.5 9.6 18.4 21.9 17.0 18.4 14.6 15.4 39.5 43.2 25.0 18.7 37.2 13.7 69.2 58.2 19.5 15.0 76.3 9.2 29.9 61.8 20.8 11.6 32.4 45.0 17.5 12.1 11.0 11.4 14.9 58.8 15.1 19.1 13.9 54.7 14.9 23.9 18.3 13.4 12.9 11.8 119.4 9.5 10.4 20.7 18.0 28.6 21.9 12.9 31.3 25.8 25.1 31.6 11.2 8.2 6.6 15.1 24.0 26.5 8.0 26.2 8.2 30.0 40.7 7.0 18.4 14.1 8.4 15.5 10.0 20.0 17.5 9.7 22.1 12.3 27.0 25.3 16.2 11.4 16.0 29.9 4.2 11.8 9.6 7.5 5.9 9.0 11.1 23.2 25.4 32.8 19.5 3.7 14.7 21.5 36.5 29.5 34.7 11.2 11.4 31.7 23.3 11.3 23.6 15.1 13.5 25.0 11.5 17.9 14.8 30.8 10.8 5.3 16.3 8.9 5.1 8.2 12.8 7.9 6.2 3.8 14.4 10.7 8.6 9.9 8.7 6.9 8.8 6.3 4.5 36.4 72.7 61.1 57.1 39.5 43.2 69.2 58.2 61.8 58.8 54.7 119.4 41.6 115.4 248.6 60.7 47.8 14.8 15.1 24.3 18.2 34.7 26.0 21.7 43.1 18.6 55.2 33.1 27.1 105.2 33.3 27.3 15.6 28.1 15.0 94.8 49.2 39.4 9.6 15.8 105.9 18.6 37.8 37.8 34.1 153.2 33.5 32.3 29.6 25.2 26.5 57.2 74.0 14.9 28.5 20.8 18.3 11.1 33.5 29.8 46.2 53.4 30.9 39.7 37.0 82.4 429.8 37.8 15.7 36.5 48.8 31.3 20.9 37.9 86.4 27.2 6.6 47.0 35.2 22.2 31.1 18.8 13.5 711.3 35.6 21.1 11.7 41.5 SEMA4C "Semacl1, Semaf, SEMAI" ENSG00000168758 "Semaphorin 4C" Q9C0C4 2 96859718-96870757 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 137.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in many" 5 "BEWO: 298.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011090 Approved NA NA 700000 "Cluster 27: Non-specific - Gene expression" "Cluster 57: Non-specific - Angiogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA011090: AB_2185705" "unprognostic (1.25e-1)" "unprognostic (4.95e-2)" "prognostic unfavorable (3.53e-5)" "unprognostic (7.10e-2)" "unprognostic (4.46e-2)" "unprognostic (1.57e-2)" "unprognostic (4.20e-3)" "unprognostic (3.08e-1)" "unprognostic (2.16e-1)" "unprognostic (3.56e-2)" "unprognostic (1.82e-1)" "unprognostic (3.57e-1)" "prognostic unfavorable (9.50e-7)" "unprognostic (4.78e-3)" "unprognostic (3.09e-1)" "unprognostic (7.31e-2)" "unprognostic (4.08e-1)" 21.3 8.9 11.5 11.3 24.2 3.0 17.7 16.8 19.9 29.0 0.5 42.1 7.4 37.2 6.0 14.0 33.3 15.3 20.2 11.8 15.6 14.9 13.3 14.4 9.8 24.9 21.1 23.1 9.4 7.1 10.2 41.8 21.0 20.8 5.7 7.0 16.5 20.6 7.5 15.9 14.6 19.3 18.7 28.5 15.1 2.7 19.0 6.5 12.3 13.4 5.3 32.3 22.3 39.1 8.0 11.7 35.6 39.7 8.4 10.5 298.5 13.9 17.4 13.4 13.5 11.8 13.3 0.0 22.3 8.5 13.3 8.1 10.2 6.9 6.5 15.2 11.8 5.4 10.5 22.2 19.2 2.2 13.7 16.1 5.4 12.3 10.4 14.9 9.9 2.6 36.5 11.6 12.7 41.0 0.1 17.4 49.1 0.4 10.6 12.5 20.0 13.8 4.8 17.1 22.4 32.4 11.2 24.6 60.8 27.6 8.7 21.4 3.1 21.9 27.3 30.9 14.6 0.2 1.0 0.1 10.6 17.2 37.1 0.5 0.0 0.0 0.6 0.2 0.8 0.0 0.2 0.4 0.0 0.0 0.4 0.1 0.0 1.4 1.5 0.8 0.3 0.4 11.5 24.2 16.8 19.9 11.8 15.6 24.9 21.1 21.0 18.7 19.0 39.1 28.1 0.0 10.3 15.3 1.1 11.5 7.9 7.6 18.2 32.2 9.9 8.3 6.9 12.8 8.6 5.5 10.4 46.8 9.7 1.8 1.9 9.7 0.5 7.4 15.8 26.6 5.4 2.1 7.2 5.0 137.3 17.3 3.1 11.6 1.3 10.2 23.9 9.8 7.9 15.2 4.1 5.7 6.1 4.4 6.1 1.5 13.4 9.2 21.4 18.7 3.2 23.6 12.3 4.5 35.5 10.5 1.2 9.1 3.6 9.4 0.1 0.8 7.4 38.8 19.7 11.4 24.1 0.6 4.2 13.0 10.2 45.0 9.5 4.9 3.9 4.8 SENP8 "DEN1, HsT17512, NEDP1, PRSC2" ENSG00000166192 "SUMO peptidase family member, NEDD8 specific" Q96LD8 15 72114258-72143692 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 15.6" "Group enriched" "Detected in many" 11 "Early spermatids: 86.5;Late spermatids: 222.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036273 Approved Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Nucleoplasm, Vesicles" "HPA036273: AB_10669985" "unprognostic (1.83e-2)" "unprognostic (1.78e-1)" "unprognostic (9.85e-4)" "unprognostic (5.43e-2)" "unprognostic (1.49e-1)" "unprognostic (6.09e-3)" "unprognostic (3.06e-2)" "unprognostic (4.35e-2)" "unprognostic (1.06e-1)" "unprognostic (2.04e-1)" "unprognostic (3.11e-2)" "unprognostic (1.19e-1)" "unprognostic (8.46e-12)" "unprognostic (1.24e-1)" "unprognostic (1.12e-1)" "unprognostic (1.85e-2)" "unprognostic (1.54e-2)" 1.1 1.7 2.7 1.1 2.4 2.8 2.0 1.1 3.1 1.7 0.0 1.9 1.8 1.7 3.3 2.3 2.5 1.9 4.0 2.2 2.1 4.4 2.5 1.5 1.5 1.4 1.7 2.4 1.5 2.4 2.1 1.7 1.9 2.1 1.9 4.6 1.6 1.7 6.3 1.6 1.5 1.6 0.4 1.5 2.0 15.6 1.7 1.5 5.0 5.7 1.2 1.7 1.0 2.6 1.5 2.7 4.7 3.8 5.6 6.9 2.7 4.1 2.5 2.2 2.0 2.1 3.4 1.5 5.7 2.4 4.0 3.4 7.4 5.9 3.3 1.6 4.0 2.5 3.7 1.9 3.9 2.8 1.3 3.3 5.8 1.4 6.2 2.9 2.1 4.4 3.7 2.7 5.4 3.8 2.9 3.7 4.0 3.4 2.5 1.9 4.2 3.3 6.0 2.6 5.8 2.0 4.4 3.3 4.2 5.6 5.1 2.1 2.2 4.5 1.7 7.8 2.0 2.2 2.9 1.8 2.1 4.0 3.3 1.1 0.9 0.7 0.8 2.2 1.1 1.9 1.3 1.2 2.9 0.6 1.5 1.8 0.3 3.5 3.2 0.8 1.1 1.0 2.7 2.4 1.1 3.1 2.2 2.1 1.4 1.7 1.9 0.4 1.7 2.6 1.2 6.4 5.3 3.9 0.4 0.3 1.4 2.5 1.2 4.5 2.4 2.4 5.4 1.5 4.5 1.8 4.2 6.7 0.3 1.5 13.7 3.3 86.5 2.5 2.7 1.8 1.2 3.2 4.6 1.7 3.4 2.6 4.1 2.6 0.0 3.4 1.8 1.5 2.1 1.7 6.1 1.5 2.0 2.6 0.6 222.9 1.8 1.7 0.0 2.8 3.8 10.6 0.0 6.0 4.0 1.4 3.2 1.2 0.2 1.7 2.3 8.1 6.0 4.0 0.0 2.3 1.3 10.7 12.6 1.4 0.4 7.8 1.0 3.0 2.2 1.0 SEPHS1 "SPS, SPS1" ENSG00000086475 "Selenophosphate synthetase 1" P49903 10 13317428-13348298 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037645, HPA062118" Enhanced Uncertain Nucleoplasm NA NA 21000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 5: NTERA-2 - Transcription" "Cluster 65: Plasmacytoid DCs - Unknown function" Nucleoplasm "HPA037645: AB_10671631, HPA062118: AB_2732676" "unprognostic (8.18e-3)" "unprognostic (1.79e-1)" "unprognostic (1.06e-3)" "unprognostic (2.07e-1)" "unprognostic (3.50e-2)" "unprognostic (2.99e-2)" "prognostic unfavorable (2.16e-7)" "unprognostic (2.66e-2)" "unprognostic (1.43e-1)" "unprognostic (2.61e-2)" "prognostic favorable (3.12e-4)" "unprognostic (1.09e-1)" "unprognostic (1.38e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" "unprognostic (1.66e-1)" "unprognostic (5.11e-2)" 27.8 28.6 23.2 23.6 23.9 25.3 33.5 25.3 22.3 25.6 28.1 31.2 23.2 32.3 35.9 24.6 35.3 23.8 30.8 21.7 24.1 56.5 48.6 24.3 29.3 26.7 28.4 35.7 33.6 48.1 23.5 27.8 23.1 26.4 32.7 25.0 26.9 24.7 33.3 20.9 24.6 33.2 25.9 21.8 25.6 22.1 24.6 64.3 55.4 36.6 34.3 24.8 17.4 24.4 127.7 90.8 182.4 176.3 59.4 45.1 85.8 55.4 42.6 115.6 97.9 103.5 116.4 123.1 67.2 65.0 55.9 79.6 195.2 91.4 120.5 186.7 80.9 67.4 66.8 132.9 61.4 92.0 41.4 39.6 64.6 67.7 39.5 53.9 95.0 255.9 90.7 97.5 83.2 168.1 228.8 39.3 301.8 119.8 40.9 176.3 88.8 73.7 62.2 51.0 64.5 119.5 169.6 74.1 75.7 157.7 93.8 96.1 64.1 51.1 96.3 67.6 117.6 71.3 143.4 228.1 41.2 67.6 41.9 10.2 11.6 8.8 7.7 17.1 9.5 9.5 7.8 8.9 13.6 6.4 10.0 9.4 1.7 15.4 24.8 15.4 13.3 8.3 23.2 23.9 25.3 22.3 21.7 24.1 26.7 28.4 23.1 25.9 24.6 24.4 24.1 12.8 13.1 8.1 12.3 17.2 16.5 19.3 9.6 17.1 23.8 19.4 14.1 20.0 18.0 22.0 0.0 31.6 27.1 17.6 33.2 26.4 13.5 16.9 15.4 26.1 16.7 19.3 8.2 30.1 45.2 18.0 11.7 16.1 15.8 27.7 19.6 32.7 21.1 21.9 8.3 13.7 20.3 10.1 11.7 14.1 14.9 13.1 16.0 4.7 8.0 35.2 9.2 4.0 12.9 34.1 15.3 18.4 18.7 17.5 16.4 44.6 13.4 15.6 6.6 14.2 26.1 17.6 21.2 15.0 16.9 25.6 13.2 25.9 18.0 15.1 SEPTIN2 "DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3, SEPT2" ENSG00000168385 "Septin 2" Q15019 2 241315100-241354027 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Adipocytes: 89.9;Cardiomyocytes: 133.5;Cytotrophoblasts: 135.9;Extravillous trophoblasts: 190.1;Hofbauer cells: 136.8;Syncytiotrophoblasts: 139.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017190, HPA018481" Supported Enhanced "Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge" Yes No 3300000 "Cluster 27: Non-specific - Gene expression" "Cluster 57: Non-specific - Angiogenesis" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 24: Non-specific - Transcription regulation" "Actin filaments" "Nucleoplasm, Plasma membrane, Cytokinetic bridge" "CAB017190: , HPA018481: AB_1856684" "unprognostic (6.31e-2)" "unprognostic (5.27e-2)" "unprognostic (2.95e-2)" "unprognostic (4.03e-2)" "prognostic favorable (8.21e-4)" "unprognostic (3.32e-1)" "prognostic unfavorable (3.66e-4)" "unprognostic (1.96e-3)" "unprognostic (1.83e-2)" "unprognostic (5.69e-2)" "unprognostic (1.11e-3)" "unprognostic (3.16e-1)" "unprognostic (9.58e-3)" "unprognostic (8.11e-2)" "unprognostic (9.53e-2)" "unprognostic (1.40e-1)" "unprognostic (2.17e-2)" 246.0 155.0 192.8 159.7 216.1 125.3 177.2 208.8 220.6 233.8 183.2 179.7 140.8 209.0 176.7 161.1 168.7 193.8 211.8 180.5 209.6 212.6 117.1 184.5 157.2 227.2 203.3 221.7 214.2 220.1 112.7 217.3 232.2 186.1 188.6 114.0 163.3 218.2 160.6 119.0 154.8 253.1 224.1 164.9 152.6 145.0 198.3 141.8 224.6 163.5 180.5 221.0 116.7 245.3 245.1 207.7 561.7 370.8 511.5 555.0 289.1 517.3 508.9 329.1 417.2 118.7 258.4 96.1 119.4 599.0 176.7 209.6 377.7 347.9 535.5 241.9 262.2 388.9 200.5 444.5 311.6 374.4 228.0 495.1 224.8 275.0 259.1 369.8 576.2 240.9 357.4 138.0 491.9 171.5 226.7 227.3 412.5 215.2 152.8 216.2 707.4 204.7 483.5 359.9 401.4 270.0 363.0 245.7 353.0 397.9 146.9 333.4 555.5 399.2 166.2 392.9 320.6 267.7 251.9 340.9 344.7 225.1 571.6 172.0 165.0 98.3 101.0 184.1 125.1 87.4 97.9 104.2 183.8 77.2 84.4 89.6 58.9 191.4 144.8 138.7 108.0 241.2 192.8 216.1 208.8 220.6 180.5 209.6 227.2 203.3 232.2 224.1 198.3 245.3 89.9 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 133.5 0.0 0.0 0.0 0.0 135.9 39.9 0.0 0.0 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 190.1 50.4 0.0 0.0 0.0 0.0 0.0 0.0 136.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 44.7 0.0 0.0 0.0 0.0 139.0 6.5 0.0 0.0 0.0 SERBP1 "CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1" ENSG00000142864 "SERPINE1 mRNA binding protein 1" Q8NC51 1 67407810-67430415 "Plasma proteins, Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020559, CAB026297" Supported Enhanced Cytosol NA NA 810000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "CAB026297: AB_425924, HPA020559: AB_1856701" "unprognostic (1.58e-1)" "unprognostic (6.35e-2)" "unprognostic (1.45e-2)" "unprognostic (6.80e-3)" "unprognostic (2.71e-3)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.36e-4)" "unprognostic (1.98e-2)" "unprognostic (1.32e-3)" "unprognostic (5.97e-2)" "unprognostic (8.25e-3)" "unprognostic (3.04e-1)" "unprognostic (1.33e-2)" "unprognostic (1.40e-2)" "unprognostic (4.76e-1)" "unprognostic (6.64e-2)" "unprognostic (1.34e-3)" 116.2 79.6 45.9 110.1 48.9 130.5 106.9 45.7 48.5 98.3 44.4 91.2 99.6 89.9 65.7 188.2 81.5 66.5 93.4 42.5 46.5 85.9 131.4 76.6 123.8 51.6 47.5 86.8 121.1 131.5 48.0 92.9 52.4 77.3 84.5 47.6 119.0 66.2 336.9 149.6 92.7 82.1 50.3 81.4 94.1 82.9 49.3 125.7 91.1 159.0 118.1 101.4 118.4 52.8 444.4 272.4 274.9 280.4 236.9 214.0 420.9 452.9 163.8 294.7 241.6 524.8 195.4 828.9 341.1 236.0 294.6 337.4 435.2 411.2 309.5 375.7 535.8 764.1 488.7 460.7 207.0 614.9 290.8 221.3 272.1 384.6 356.0 205.9 319.7 276.0 867.4 293.0 236.2 314.9 494.9 412.9 978.1 298.1 355.2 566.3 600.4 429.8 231.0 349.8 468.8 330.8 351.0 385.6 442.4 231.1 212.0 386.4 345.9 283.4 351.5 421.2 618.3 273.6 369.2 747.9 233.0 603.3 326.9 37.8 84.1 53.7 100.4 92.5 125.4 101.3 99.0 100.9 107.5 102.1 114.6 105.6 27.1 147.4 90.1 98.2 131.5 119.2 45.9 48.9 45.7 48.5 42.5 46.5 51.6 47.5 52.4 50.3 49.3 52.8 251.3 250.0 225.5 17.6 262.6 686.4 437.3 363.8 536.7 146.7 262.1 251.8 144.8 214.4 311.4 117.7 91.8 271.5 343.7 200.0 242.6 324.4 555.9 368.1 411.9 314.9 230.1 398.8 24.1 361.5 531.0 231.0 169.7 400.5 219.2 215.6 179.2 331.5 297.9 143.0 24.6 338.7 183.1 247.7 281.2 240.9 221.2 214.2 192.1 27.2 298.4 153.6 325.4 26.7 33.2 349.3 192.0 278.7 277.4 540.5 168.4 323.0 206.3 139.7 138.1 301.6 516.0 569.8 281.6 597.9 719.7 229.3 271.4 318.8 405.0 470.2 SHFL "C19orf66, FLJ11286, IRAV, RyDEN, SFL" ENSG00000130813 "Shiftless antiviral inhibitor of ribosomal frameshifting" Q9NUL5 19 10086122-10093252 "Predicted intracellular proteins" "Antiviral defense" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 75.7" "Cell type enhanced" "Detected in some" "Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042001 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Cytosol "HPA042001: AB_10794167" "prognostic favorable (4.04e-4)" "unprognostic (1.21e-2)" "unprognostic (2.39e-3)" "unprognostic (2.03e-1)" "unprognostic (2.19e-2)" "unprognostic (2.00e-2)" "unprognostic (1.46e-1)" "unprognostic (3.93e-1)" "unprognostic (6.57e-2)" "unprognostic (4.22e-3)" "unprognostic (2.34e-1)" "unprognostic (1.88e-1)" "prognostic unfavorable (8.96e-11)" "unprognostic (5.92e-2)" "unprognostic (1.81e-1)" "unprognostic (4.41e-3)" "prognostic favorable (1.35e-4)" 12.8 18.5 27.1 14.2 27.4 15.7 12.2 26.3 30.1 17.0 24.4 12.8 14.8 15.8 16.5 8.6 17.6 18.1 8.2 27.2 28.5 14.0 75.7 16.8 22.8 27.3 27.0 18.9 9.9 16.7 14.1 12.7 27.2 11.9 9.9 15.0 16.3 19.1 4.4 9.5 18.4 15.4 28.8 19.9 11.0 4.3 29.5 20.4 12.2 6.9 16.6 14.7 12.3 28.1 9.4 3.8 5.0 3.9 20.3 23.6 1.4 7.6 46.3 71.8 81.2 0.4 7.4 4.8 2.1 24.0 25.7 3.9 3.9 20.7 12.0 30.4 0.4 15.5 3.0 10.6 32.6 4.7 9.7 34.3 11.7 11.5 4.1 27.1 22.9 20.6 1.8 20.2 15.0 6.5 20.1 13.3 1.1 7.0 5.5 16.2 0.0 8.0 14.8 13.0 0.7 3.5 12.9 1.3 42.2 0.9 1.2 12.9 14.8 6.0 3.0 9.6 1.6 24.1 7.2 1.2 16.8 6.0 12.1 16.4 12.8 18.2 23.3 11.7 31.1 13.0 19.5 25.4 10.2 10.1 16.3 17.7 16.4 32.7 20.3 2.0 21.7 15.5 27.1 27.4 26.3 30.1 27.2 28.5 27.3 27.0 27.2 28.8 29.5 28.1 23.3 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 5.4 21.7 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 6.7 6.8 0.0 0.0 0.0 0.0 0.0 0.0 32.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 2.6 3.3 0.0 0.0 0.0 SIN3A "DKFZP434K2235, KIAA0700" ENSG00000169375 "SIN3 transcription regulator family member A" Q96ST3 15 75369379-75455842 "Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, Transcription, Transcription regulation" Repressor "Cancer-related genes, Disease variant, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004506, HPA047213, HPA062123" Enhanced Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 44: Endometrium - Transcription" Nucleoplasm "CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689" "unprognostic (1.94e-1)" "unprognostic (1.38e-1)" "unprognostic (1.48e-1)" "unprognostic (1.27e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-1)" "unprognostic (4.74e-2)" "unprognostic (1.91e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" "unprognostic (8.52e-2)" "unprognostic (1.37e-1)" "unprognostic (1.17e-3)" "unprognostic (7.33e-2)" "unprognostic (2.19e-1)" "unprognostic (1.33e-1)" "unprognostic (3.52e-1)" 19.2 12.4 10.0 19.8 10.9 42.5 18.0 21.0 11.7 21.0 12.5 19.6 13.8 25.6 16.6 19.1 24.3 17.4 14.8 9.6 13.3 15.1 16.0 18.0 25.9 11.7 12.0 30.0 15.3 22.5 12.1 20.1 10.3 19.7 16.1 24.1 16.6 20.7 16.6 21.5 16.3 19.6 8.3 22.1 16.5 29.6 14.0 43.2 27.2 18.7 26.3 20.2 16.7 10.8 31.2 63.6 55.5 36.7 27.0 28.4 32.1 22.9 35.3 33.0 35.2 35.2 41.2 67.8 23.3 34.0 45.0 54.5 81.2 34.4 35.9 55.0 42.1 64.0 46.2 27.9 20.5 61.4 52.5 34.7 26.1 38.5 39.8 34.0 30.0 47.5 51.5 73.2 27.0 36.2 60.7 39.1 54.2 41.3 26.3 60.5 73.3 41.8 23.6 56.4 43.7 43.7 56.6 25.0 31.0 53.0 38.1 47.9 26.4 40.6 54.5 27.2 34.3 49.8 85.0 70.8 24.2 61.2 23.2 2.9 4.2 5.9 6.3 3.8 9.6 7.0 8.1 8.1 5.2 7.7 8.2 7.2 7.3 8.1 7.4 3.5 7.7 5.7 10.0 10.9 21.0 11.7 9.6 13.3 11.7 12.0 10.3 8.3 14.0 10.8 26.0 35.3 32.4 13.7 35.8 39.4 23.6 21.2 60.9 19.7 36.5 25.4 13.4 17.2 30.5 27.6 31.3 23.5 29.0 17.8 5.9 15.1 10.1 35.7 30.8 32.1 17.3 24.4 19.2 12.8 11.1 24.4 15.3 42.1 29.9 30.1 26.0 17.4 13.2 20.2 18.3 19.0 10.2 21.3 31.7 5.8 23.0 19.5 10.6 27.2 18.8 16.8 24.7 16.6 24.1 14.1 14.0 20.3 33.1 29.8 13.7 9.2 33.4 33.8 13.1 34.7 24.7 42.1 42.7 37.5 53.1 21.9 34.6 21.2 19.2 19.4 SIRT3 SIR2L3 ENSG00000142082 "Sirtuin 3" Q9NTG7 11 215030-236931 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026809, CAB037142" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 59: Non-specific - Transcription" "CAB037142: AB_1079982, HPA026809: AB_10601160" "unprognostic (1.76e-2)" "unprognostic (2.69e-1)" "unprognostic (2.04e-1)" "prognostic favorable (8.51e-5)" "unprognostic (1.52e-3)" "unprognostic (2.65e-1)" "unprognostic (3.45e-2)" "unprognostic (5.52e-2)" "unprognostic (8.64e-2)" "unprognostic (1.31e-1)" "prognostic favorable (4.45e-4)" "unprognostic (2.06e-1)" "prognostic favorable (4.85e-9)" "unprognostic (1.04e-1)" "unprognostic (5.53e-2)" "unprognostic (3.45e-1)" "unprognostic (3.75e-2)" 11.1 13.8 24.5 10.4 28.8 11.8 18.6 19.7 28.8 14.3 26.1 13.9 13.3 12.6 40.1 9.9 14.4 7.6 24.4 25.1 20.8 17.2 25.8 10.3 13.8 19.0 20.4 18.3 18.0 11.2 28.0 5.8 18.4 16.7 14.2 26.8 12.6 12.4 27.3 20.2 14.6 9.7 19.0 14.7 13.5 25.2 21.6 6.8 15.7 19.9 14.9 11.5 11.1 24.0 9.7 11.1 16.7 17.7 19.1 24.1 8.0 13.6 11.0 10.1 7.9 11.5 22.8 5.9 6.2 8.5 9.8 18.6 8.2 7.4 9.8 11.2 12.7 7.4 15.7 12.6 8.4 9.7 17.3 17.8 14.1 10.2 10.9 17.3 6.7 11.1 15.3 11.0 4.6 10.8 4.0 15.0 7.5 8.5 13.2 10.8 13.2 9.8 10.2 6.6 9.3 7.5 11.5 16.7 6.4 10.8 11.9 2.2 9.3 11.4 5.4 3.2 4.1 19.4 17.3 8.4 12.4 7.7 5.9 0.1 3.1 3.1 3.6 2.5 3.8 5.3 3.3 4.1 2.8 4.3 6.0 4.9 3.1 8.1 6.6 4.8 4.0 2.7 24.5 28.8 19.7 28.8 25.1 20.8 19.0 20.4 18.4 19.0 21.6 24.0 6.0 3.2 6.5 17.0 10.4 5.0 7.0 13.1 12.5 7.4 16.0 15.5 23.4 14.3 7.4 5.5 8.4 12.6 7.2 7.2 33.2 7.5 22.0 7.4 5.8 6.7 6.0 14.3 19.2 5.8 10.3 8.6 11.7 4.6 10.2 8.4 7.5 18.3 8.8 10.1 18.3 8.1 10.2 5.5 3.3 21.0 9.0 6.4 10.6 8.4 3.5 13.5 5.2 9.0 11.6 5.1 9.3 9.1 14.6 5.5 14.3 18.9 9.0 9.5 0.0 7.3 6.5 25.5 9.6 9.9 4.1 6.8 8.4 14.2 11.2 4.0 SIRT5 ENSG00000124523 "Sirtuin 5" Q9NXA8 6 13574227-13615158 "Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 52.5;Distal tubular cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021798, HPA022002, HPA022992" Approved Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 38: EFO-21 - Unknown function" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915" "unprognostic (8.53e-2)" "unprognostic (7.79e-2)" "unprognostic (4.71e-2)" "unprognostic (5.26e-3)" "unprognostic (6.19e-2)" "unprognostic (1.63e-1)" "unprognostic (8.72e-2)" "unprognostic (1.38e-1)" "unprognostic (8.54e-3)" "unprognostic (2.77e-3)" "unprognostic (1.02e-1)" "unprognostic (1.65e-1)" "prognostic favorable (8.76e-10)" "unprognostic (2.39e-1)" "unprognostic (6.88e-2)" "unprognostic (6.86e-2)" "unprognostic (2.36e-3)" 7.2 6.0 9.4 5.2 10.6 5.8 6.6 10.4 12.2 5.4 13.5 8.1 7.7 6.1 5.6 5.6 9.2 5.2 28.6 10.5 10.6 11.5 33.5 5.4 8.3 9.2 9.6 10.1 6.7 16.2 7.3 5.6 9.9 6.4 8.7 6.1 10.6 6.8 33.4 7.9 9.8 5.9 8.4 9.6 8.2 6.8 10.9 8.2 9.0 38.0 7.2 6.0 5.4 11.1 10.5 8.9 8.1 10.4 5.7 8.9 7.6 5.1 5.3 6.1 8.0 12.9 11.1 14.1 35.7 4.3 10.9 16.9 7.4 11.1 7.6 5.9 10.3 8.5 5.6 20.5 11.0 6.7 6.7 7.8 19.9 4.5 19.9 12.7 10.3 20.3 13.8 4.6 6.5 12.3 8.2 13.2 7.7 16.9 13.7 15.4 4.4 24.4 10.3 11.0 13.7 4.5 4.3 7.9 25.9 25.0 11.6 4.9 8.6 6.6 3.4 4.2 5.8 11.6 15.4 10.7 4.5 7.3 8.4 0.7 6.0 16.7 9.9 9.2 10.7 14.0 13.0 9.5 6.3 12.7 11.8 10.8 2.6 11.8 17.3 5.9 10.7 7.9 9.4 10.6 10.4 12.2 10.5 10.6 9.2 9.6 9.9 8.4 10.9 11.1 16.6 28.9 3.2 30.0 8.2 4.1 11.4 14.9 10.8 7.3 9.7 9.9 52.5 15.7 16.8 11.0 0.0 20.5 6.6 9.4 52.8 13.0 2.9 13.1 5.4 12.3 6.1 15.8 36.6 6.7 10.5 6.7 6.6 8.1 0.0 23.5 9.7 25.7 9.4 1.7 39.2 13.2 8.2 13.9 3.8 2.0 8.1 8.4 5.4 14.0 6.3 11.6 10.3 15.1 25.8 7.2 13.4 5.7 4.7 6.2 18.1 34.1 22.5 7.2 0.0 9.8 6.6 8.5 12.0 9.8 4.5 10.7 7.9 13.2 15.0 9.0 SKIV2L "170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1" ENSG00000204351 "Ski2 like RNA helicase" Q15477 6 31959117-31969751 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-266/70: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047122, HPA051959, HPA054419" Uncertain Approved "Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 29: U-266 - Adaptive immune response" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nuclear bodies" "Mitotic spindle, Cytosol" "HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482" "unprognostic (1.43e-1)" "unprognostic (5.75e-2)" "unprognostic (3.41e-2)" "unprognostic (1.66e-2)" "unprognostic (6.43e-2)" "unprognostic (7.03e-2)" "prognostic unfavorable (6.58e-4)" "unprognostic (3.36e-2)" "unprognostic (2.14e-2)" "unprognostic (7.75e-2)" "unprognostic (7.99e-3)" "unprognostic (1.53e-3)" "prognostic unfavorable (3.02e-7)" "unprognostic (6.77e-2)" "unprognostic (2.23e-1)" "unprognostic (1.20e-1)" "unprognostic (9.06e-2)" 21.9 33.1 0.0 5.2 0.3 4.1 21.6 0.0 0.4 26.5 0.0 25.1 10.5 22.6 9.4 23.0 25.0 0.0 22.0 0.0 0.1 24.0 54.7 22.2 3.4 0.0 0.5 24.6 25.7 2.4 39.7 2.6 0.0 31.9 2.4 2.1 22.4 3.2 20.4 20.2 31.2 5.7 0.0 40.6 27.6 16.6 0.1 4.3 27.7 5.3 2.7 23.6 20.9 0.0 0.2 12.7 13.3 0.0 16.5 11.8 27.1 10.9 11.7 13.6 13.2 0.4 0.0 0.0 26.0 25.5 13.2 11.9 0.0 30.8 9.9 14.8 15.7 0.0 0.0 0.2 0.0 0.1 0.2 28.3 17.9 0.1 0.0 12.7 0.0 19.3 0.0 13.6 0.0 0.0 0.0 0.3 20.6 0.0 0.0 0.3 0.0 0.0 11.2 0.0 0.0 0.0 23.6 0.0 17.6 11.5 0.0 15.7 12.8 16.0 7.2 18.7 0.2 42.2 35.7 12.0 20.4 0.1 0.0 0.3 0.5 0.2 1.5 1.4 1.1 0.2 0.7 0.3 1.1 0.9 0.8 0.8 0.1 0.0 2.2 0.5 0.2 0.4 0.0 0.3 0.0 0.4 0.0 0.1 0.0 0.5 0.0 0.0 0.1 0.0 6.4 16.0 11.3 10.1 13.3 2.8 5.0 7.9 11.4 5.0 9.3 5.1 8.5 10.0 8.8 7.3 8.4 12.6 12.7 19.7 1.9 9.5 3.1 7.7 7.9 7.9 12.6 6.5 7.2 8.6 7.9 7.4 28.1 6.3 8.2 10.8 8.6 19.4 9.2 0.0 5.0 13.2 8.2 6.3 4.1 1.5 9.3 7.8 7.2 2.8 10.2 4.9 18.6 3.0 4.8 9.4 16.0 6.0 20.2 5.9 25.5 6.9 16.5 8.3 0.0 4.1 10.2 4.7 7.5 6.6 3.7 12.4 14.4 12.3 11.0 5.2 SLAMF8 "BLAME, CD353, SBBI42" ENSG00000158714 "SLAM family member 8" Q9P0V8 1 159826811-159837492 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 32.9" "Group enriched" "Detected in some" 9 "Hofbauer cells: 36.9;Kupffer cells: 19.8;Langerhans cells: 61.8;Macrophages: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "myeloid DC: 14.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.7;HL-60: 1.4;U-138 MG: 1.9;U-87 MG: 1.0;U-937: 1.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA067601 Enhanced NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "HPA067601: AB_2685870" "unprognostic (1.04e-1)" "unprognostic (8.80e-3)" "unprognostic (5.12e-2)" "unprognostic (2.14e-3)" "unprognostic (3.07e-2)" "unprognostic (3.22e-2)" "unprognostic (7.87e-2)" "unprognostic (4.29e-1)" "unprognostic (2.20e-2)" "unprognostic (4.56e-2)" "unprognostic (6.47e-2)" "unprognostic (1.77e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.50e-1)" "unprognostic (4.42e-2)" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" 6.9 3.7 1.7 29.8 1.8 0.9 3.0 1.8 3.6 3.8 2.9 7.6 6.6 1.5 0.7 4.2 2.8 8.0 2.6 1.4 2.3 3.9 3.3 16.1 32.9 4.9 3.9 2.8 2.1 0.6 3.5 5.5 5.3 2.5 9.5 0.3 3.4 1.4 0.9 2.8 9.3 7.6 2.5 11.7 4.9 0.8 9.2 10.5 3.0 0.6 17.7 10.3 2.1 4.9 0.0 0.0 0.0 0.0 0.2 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 1.9 0.0 0.0 0.3 0.0 0.0 0.0 1.0 1.2 0.0 0.0 5.8 0.0 3.5 8.0 0.2 0.0 1.2 4.6 14.3 0.0 0.2 2.7 0.5 8.8 0.5 0.1 0.0 3.1 1.7 1.8 1.8 3.6 1.4 2.3 4.9 3.9 5.3 2.5 9.2 4.9 0.3 0.0 2.3 0.0 1.0 1.8 0.0 0.0 0.0 0.4 0.1 0.4 0.3 0.0 0.6 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.0 0.3 0.1 0.8 0.0 0.4 0.1 0.2 0.3 0.3 0.0 0.1 0.0 0.1 0.0 0.2 36.9 0.0 0.1 0.0 0.0 19.8 61.8 0.0 0.3 41.1 0.0 1.0 1.3 0.1 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.2 2.9 0.1 0.0 0.0 1.0 0.5 1.3 0.0 0.0 0.0 SLC11A2 "DCT1, DMT1, NRAMP2" ENSG00000110911 "Solute carrier family 11 member 2" P49281 12 50979401-51028566 "Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Iron transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Respiratory ciliated cells: 109.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032139, HPA032140" Uncertain Supported Mitochondria No No "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 28: BEWO - Transcription regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" Mitochondria "HPA032139: AB_10964213, HPA032140: AB_10962932" "unprognostic (4.40e-3)" "unprognostic (1.41e-2)" "unprognostic (1.50e-1)" "unprognostic (2.07e-3)" "unprognostic (2.35e-1)" "unprognostic (1.92e-1)" "unprognostic (2.09e-1)" "prognostic favorable (3.07e-6)" "unprognostic (1.06e-2)" "unprognostic (1.99e-2)" "unprognostic (1.15e-1)" "unprognostic (7.28e-2)" "unprognostic (2.29e-1)" "unprognostic (3.20e-2)" "unprognostic (2.61e-1)" "unprognostic (2.32e-2)" "unprognostic (2.24e-1)" 12.1 17.0 12.8 14.0 21.6 15.9 30.3 19.6 18.1 29.3 12.7 16.4 53.8 15.7 17.6 23.9 21.4 17.7 14.7 13.2 16.5 22.5 25.6 23.2 10.3 22.8 18.3 12.8 22.6 42.5 10.9 23.7 22.9 24.4 16.2 23.1 31.2 19.3 18.4 20.3 13.8 15.3 19.1 8.7 17.8 13.3 18.5 19.2 41.6 20.3 17.2 20.4 13.9 31.1 19.0 22.4 31.4 28.7 33.5 28.6 106.3 19.7 73.9 19.0 21.8 30.6 35.3 11.8 38.8 22.8 35.7 25.3 26.6 19.2 21.9 17.1 17.4 27.4 29.2 35.5 35.7 19.0 54.5 31.6 24.3 32.7 35.1 45.6 22.8 23.6 24.4 5.6 22.4 21.7 21.8 12.9 46.6 19.8 15.5 14.7 28.6 21.1 23.4 27.7 21.6 19.0 16.3 47.1 20.9 36.2 50.8 12.6 26.8 19.2 15.8 21.5 10.9 14.1 20.4 4.7 54.1 10.2 8.3 0.6 4.7 1.9 4.2 6.8 3.7 2.6 3.3 4.3 7.0 3.3 4.6 4.3 2.3 6.0 4.8 2.9 2.9 3.4 12.8 21.6 19.6 18.1 13.2 16.5 22.8 18.3 22.9 19.1 18.5 31.1 9.8 38.5 46.1 32.7 6.9 15.4 24.8 84.0 22.2 26.6 37.6 18.5 15.5 25.8 69.4 57.0 18.8 27.0 11.9 14.0 3.9 30.6 1.5 31.7 11.6 13.1 16.4 64.8 33.6 28.3 22.5 17.3 15.3 43.6 71.4 20.1 11.4 41.3 35.2 28.6 38.1 14.3 42.7 16.9 25.4 1.7 9.6 30.1 26.6 26.2 15.7 26.5 6.2 51.8 94.5 20.6 15.0 8.6 8.2 47.8 13.2 9.0 109.6 17.8 6.6 14.2 13.2 9.0 12.2 14.3 13.4 19.4 10.7 10.4 15.0 23.1 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596029-59789855 "Metabolic proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.4" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 22.2" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 18: U-2197 - ECM organization" "Cluster 59: Non-specific - Transcription" "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 6.8 1.2 3.9 1.2 4.7 4.1 5.7 3.9 2.8 3.7 2.0 1.6 3.0 1.5 6.3 2.2 5.4 34.4 1.3 0.3 11.6 3.9 4.5 4.9 2.9 0.4 2.7 9.8 1.0 1.5 1.6 2.9 1.6 2.5 1.8 2.9 1.6 1.8 7.9 2.5 3.5 0.5 6.3 10.0 2.2 1.3 4.5 1.6 3.6 4.2 4.0 3.0 4.2 0.2 3.6 0.8 0.5 10.9 18.1 0.2 8.8 8.1 4.0 3.4 0.3 6.3 5.8 2.5 16.8 3.8 0.8 1.0 1.7 6.0 2.4 0.5 10.7 12.6 0.5 5.9 14.3 0.1 8.5 3.9 1.4 10.3 7.5 1.6 7.2 0.2 13.0 6.5 3.4 5.5 3.2 0.8 1.2 3.3 0.5 0.1 2.7 9.5 16.0 3.0 1.0 0.1 0.4 6.2 0.7 0.5 2.4 0.0 8.6 3.3 15.6 0.5 11.3 0.2 10.0 10.2 0.1 1.6 0.2 1.5 0.0 4.2 3.2 5.6 1.8 3.3 3.6 1.5 4.1 3.5 5.8 0.1 3.0 8.4 2.1 3.8 2.3 1.2 1.2 5.7 3.9 1.3 0.3 2.9 0.4 2.9 0.5 1.3 4.2 15.3 28.9 21.4 13.7 28.4 10.1 7.8 9.9 16.5 24.5 1.5 3.9 135.4 90.1 16.5 46.0 10.4 0.3 29.7 0.8 23.5 53.3 117.3 2.1 25.0 22.0 0.0 2.5 150.5 67.1 0.3 36.2 7.1 9.1 10.1 4.7 9.3 14.5 3.6 8.4 128.2 27.2 6.1 32.7 6.1 135.5 6.8 24.8 3.6 14.0 14.9 1.3 37.0 63.8 82.8 28.0 1.2 10.1 26.3 8.1 1.0 0.7 14.4 6.0 6.6 14.0 18.9 4.2 4.5 61.5 12.6 0.7 35.8 80.1 1.5 3.4 SLC25A36 "FLJ10618, PNC2" ENSG00000114120 "Solute carrier family 25 member 36" Q96CQ1 3 140941830-140980995 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027036 Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 52: Non-specific - Transcription" "Mitochondria, Cytosol" Nucleoplasm "HPA027036: AB_1857048" "unprognostic (4.12e-2)" "unprognostic (9.98e-2)" "unprognostic (2.86e-1)" "unprognostic (1.37e-1)" "unprognostic (6.52e-2)" "unprognostic (3.46e-1)" "unprognostic (9.00e-2)" "unprognostic (1.71e-2)" "unprognostic (1.99e-2)" "unprognostic (2.47e-2)" "unprognostic (3.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.33e-1)" "unprognostic (1.20e-1)" "unprognostic (2.34e-1)" "unprognostic (6.03e-2)" "prognostic favorable (1.55e-4)" 27.1 22.2 16.6 14.3 16.2 61.6 33.5 16.2 22.7 31.9 13.9 25.7 30.9 34.4 47.7 15.0 32.6 18.4 39.8 16.1 20.1 38.7 4.2 27.5 21.3 17.0 16.4 39.0 45.2 28.9 26.9 26.4 17.5 27.1 19.5 42.6 23.4 20.8 38.4 22.5 22.9 19.2 16.9 20.1 34.0 23.8 18.2 20.6 31.8 20.8 17.6 23.0 23.9 21.5 52.3 11.5 36.0 30.8 33.0 40.7 46.2 19.4 23.6 18.2 27.3 28.6 24.0 42.1 46.9 17.3 31.2 34.9 40.1 15.2 40.6 33.8 36.5 33.9 29.8 20.9 45.9 48.8 21.3 44.1 61.1 15.4 45.8 44.4 22.0 32.0 17.6 27.4 29.2 22.8 30.6 34.1 37.8 12.8 18.4 34.2 32.0 59.6 23.5 17.7 22.4 38.2 26.7 45.1 80.9 30.3 32.6 29.2 24.1 29.5 17.1 52.2 19.0 56.4 36.8 51.2 36.0 21.1 15.0 10.7 9.2 15.1 9.6 11.5 11.8 16.3 9.6 10.2 14.0 15.1 13.5 12.6 1.7 18.3 13.5 9.7 9.9 9.8 16.6 16.2 16.2 22.7 16.1 20.1 17.0 16.4 17.5 16.9 18.2 21.5 60.3 99.3 143.0 85.5 47.6 68.2 68.0 38.1 116.7 106.0 72.2 77.5 90.3 38.6 52.0 71.7 133.5 58.8 58.2 22.7 64.6 26.4 10.6 113.4 78.0 45.8 59.3 27.3 127.7 38.3 38.0 73.9 58.1 106.3 65.9 92.8 35.7 0.5 26.5 92.5 115.6 32.5 30.5 38.2 45.8 16.0 59.7 38.4 56.9 46.9 36.9 68.2 25.7 108.6 109.1 29.3 22.8 59.5 48.2 88.9 44.9 57.5 98.8 121.8 59.2 80.0 59.2 59.4 68.8 61.3 54.4 49.4 49.1 83.2 46.8 78.9 SLC25A39 "CGI-69, FLJ22407" ENSG00000013306 "Solute carrier family 25 member 39" Q9BZJ4 17 44319625-44324870 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Heme biosynthesis, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Distal tubular cells: 491.0;Erythroid cells: 1310.3;Late spermatids: 756.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026785 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 6: Erythroid cells - Oxygen transport" "HPA026785: AB_10601715" "unprognostic (8.10e-2)" "unprognostic (2.46e-1)" "unprognostic (1.41e-2)" "unprognostic (1.29e-1)" "unprognostic (6.04e-2)" "unprognostic (2.35e-3)" "prognostic unfavorable (5.90e-5)" "unprognostic (1.52e-1)" "unprognostic (1.08e-1)" "unprognostic (1.95e-1)" "unprognostic (1.29e-1)" "unprognostic (1.05e-1)" "prognostic favorable (3.58e-5)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.22e-1)" "unprognostic (3.21e-2)" 52.4 123.2 71.4 49.3 72.6 305.6 49.6 72.1 84.4 53.3 84.4 77.5 73.9 47.3 39.8 143.4 44.6 41.7 68.4 67.8 72.4 178.0 142.8 56.1 48.7 75.3 72.7 44.9 120.8 98.9 73.4 46.3 74.9 75.3 47.3 9.4 77.7 43.9 44.7 87.1 62.7 30.4 72.4 89.2 81.8 89.4 76.2 35.6 87.1 47.9 40.2 55.9 62.2 71.4 247.0 152.9 47.0 198.0 89.3 68.8 163.0 79.9 71.8 101.8 78.3 151.9 116.0 131.0 137.7 114.0 180.6 124.0 147.2 242.6 35.9 154.9 236.2 68.9 131.2 281.2 97.1 120.9 145.0 104.8 211.9 95.5 122.2 92.2 105.2 195.3 205.7 204.0 87.4 463.5 153.3 118.0 92.5 187.3 417.4 182.6 129.1 375.6 177.9 128.8 316.1 118.2 92.5 146.5 166.8 85.9 281.3 102.4 76.2 132.9 185.9 229.6 160.3 126.9 165.1 122.6 119.7 93.8 82.4 36.5 56.2 29.2 73.7 83.5 83.0 96.1 79.1 79.0 89.5 78.0 80.3 74.1 8.2 139.6 87.7 103.5 80.3 93.2 71.4 72.6 72.1 84.4 67.8 72.4 75.3 72.7 74.9 72.4 76.2 71.4 36.1 9.6 25.4 17.6 52.2 53.3 71.2 117.2 42.1 18.8 93.2 77.0 27.0 52.9 79.9 69.9 10.4 93.1 42.3 123.7 491.0 188.1 223.6 28.6 24.7 44.5 65.3 1310.3 20.7 310.6 166.3 35.2 71.9 54.1 32.9 44.4 30.0 75.7 134.7 13.5 19.5 120.9 132.2 62.5 44.7 756.5 39.7 61.6 92.5 10.3 99.9 45.3 62.8 8.0 16.0 176.7 88.9 38.7 80.0 162.4 130.9 322.8 41.3 15.3 19.7 27.9 52.3 134.4 105.5 110.7 64.6 117.5 51.8 75.4 157.7 108.2 SLC30A9 "C4orf1, GAC63, HUEL, ZNT9" ENSG00000014824 "Solute carrier family 30 member 9" Q6PML9 4 41990502-42090461 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transcription, Transcription regulation, Transport, Zinc transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004014 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 39: Non-specific - Basic cellular processes" "HPA004014: AB_1080005" "unprognostic (4.26e-2)" "unprognostic (2.20e-1)" "unprognostic (1.31e-3)" "unprognostic (1.44e-2)" "unprognostic (1.14e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (1.82e-1)" "unprognostic (2.63e-2)" "unprognostic (1.43e-1)" "unprognostic (1.55e-1)" "unprognostic (6.99e-2)" "prognostic favorable (2.86e-14)" "unprognostic (4.67e-2)" "unprognostic (1.34e-1)" "unprognostic (2.22e-2)" "unprognostic (1.39e-2)" 8.8 15.4 11.4 6.9 12.4 5.8 13.8 12.0 16.1 11.8 12.2 13.4 12.6 10.3 16.0 9.3 9.9 8.6 21.1 12.8 11.9 30.5 14.2 8.9 7.4 11.1 11.3 11.1 12.9 22.7 14.6 9.4 11.6 13.6 13.9 19.8 12.2 10.0 14.7 9.6 11.6 8.5 10.9 7.9 12.9 6.8 11.5 9.1 17.3 20.5 7.8 9.5 8.0 11.7 12.7 6.2 20.3 23.2 15.3 21.3 11.4 17.3 20.8 14.8 17.5 6.4 16.2 13.0 12.2 20.0 19.1 6.3 17.3 14.3 21.1 4.4 10.2 14.9 10.7 10.9 27.1 20.8 10.3 17.0 14.4 12.7 16.5 23.8 16.3 12.9 20.4 6.0 26.2 6.1 12.0 19.6 15.6 19.7 8.5 5.9 18.4 10.8 30.2 10.6 22.5 25.3 12.3 13.5 15.9 14.3 17.2 15.5 17.7 17.4 10.1 17.6 20.3 11.9 9.5 12.3 23.8 17.4 15.5 3.1 1.8 1.0 1.2 2.3 1.3 1.3 1.3 1.5 2.5 1.1 1.7 1.4 0.8 2.1 1.9 1.8 1.6 1.4 11.4 12.4 12.0 16.1 12.8 11.9 11.1 11.3 11.6 10.9 11.5 11.7 19.7 48.1 44.5 48.3 26.5 15.2 22.8 24.7 24.5 34.9 30.3 16.9 90.7 32.9 33.8 38.6 25.0 44.4 11.4 33.8 103.7 35.9 7.1 27.3 29.2 22.1 33.5 32.2 70.0 36.4 34.0 27.7 37.8 26.8 34.2 33.3 21.4 25.4 24.2 50.5 74.7 36.7 30.5 22.2 21.1 8.7 20.8 23.8 24.9 43.1 28.0 29.7 9.2 63.3 84.7 34.3 17.4 22.6 35.8 27.1 25.5 111.7 43.6 39.3 6.6 29.3 28.1 16.1 18.0 40.8 22.7 49.4 21.2 44.8 38.3 24.2 SLC35A4 ENSG00000176087 "Solute carrier family 35 member A4" "L0R6Q1, Q96G79" 5 140564446-140569100 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062210 Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA062210: AB_2684712" "unprognostic (3.01e-3)" "unprognostic (1.35e-2)" "unprognostic (5.88e-2)" "unprognostic (1.09e-1)" "unprognostic (2.46e-2)" "unprognostic (1.65e-2)" "unprognostic (1.91e-3)" "unprognostic (9.63e-2)" "unprognostic (3.61e-2)" "unprognostic (9.32e-2)" "unprognostic (1.78e-2)" "unprognostic (2.87e-1)" "prognostic favorable (4.56e-5)" "unprognostic (2.96e-2)" "unprognostic (3.04e-2)" "unprognostic (2.06e-2)" "unprognostic (1.55e-1)" 45.6 62.1 34.0 39.8 37.3 23.2 42.2 38.9 35.6 36.7 29.9 51.6 45.6 38.0 31.3 69.1 39.4 33.9 72.2 31.5 36.7 58.6 53.8 46.3 42.0 39.6 38.7 32.7 44.3 59.4 24.1 33.1 38.2 41.1 47.5 19.5 66.0 33.6 138.5 64.3 44.0 36.1 36.9 47.5 46.4 45.1 38.0 44.3 44.6 94.1 44.4 42.2 41.6 34.9 43.9 134.2 57.5 124.6 77.5 43.0 92.4 60.8 45.5 84.3 91.3 186.2 57.0 115.7 80.0 65.7 105.2 55.2 0.0 107.7 59.3 155.0 96.7 91.3 109.1 1.3 74.7 91.7 83.7 65.5 92.6 83.3 71.0 38.2 74.2 73.0 83.6 136.4 80.5 98.3 110.5 62.7 43.5 74.2 92.1 82.5 93.5 129.2 69.1 79.5 66.6 91.1 79.8 157.1 84.0 50.4 131.4 52.7 69.3 78.2 52.9 70.0 78.7 57.8 127.8 53.9 54.0 127.6 91.9 16.6 65.0 37.0 56.5 83.1 54.4 29.9 45.5 52.1 75.5 32.7 53.5 49.3 24.5 63.4 79.4 28.3 33.7 83.4 34.0 37.3 38.9 35.6 31.5 36.7 39.6 38.7 38.2 36.9 38.0 34.9 13.0 12.8 22.4 4.9 17.0 10.5 23.2 20.3 15.4 13.7 21.1 15.4 30.0 32.9 21.8 16.5 4.2 32.1 13.2 56.4 45.0 33.3 71.3 9.4 11.8 18.1 25.2 19.0 3.3 35.1 50.2 16.2 24.5 15.5 21.0 14.3 25.4 25.0 32.9 13.5 3.5 27.9 20.3 24.2 13.3 127.2 12.5 18.9 17.8 5.6 27.6 28.6 44.3 3.5 5.7 39.5 26.4 12.4 15.7 22.1 33.5 39.9 10.5 10.3 32.9 11.8 15.0 9.7 17.5 20.4 11.6 30.5 17.6 18.1 38.5 28.8 SLC35B3 "C6orf196, CGI-19, dJ453H5.1, PAPST2" ENSG00000124786 "Solute carrier family 35 member B3" Q9H1N7 6 8411435-8435561 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054661, HPA057801" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 27: Mucus-secreting cells - Mucin production" "HPA054661: AB_2682561, HPA057801: AB_2683532" "unprognostic (2.84e-1)" "unprognostic (1.52e-1)" "unprognostic (1.10e-2)" "unprognostic (1.34e-1)" "unprognostic (1.17e-1)" "unprognostic (1.30e-1)" "unprognostic (1.19e-1)" "unprognostic (4.93e-2)" "unprognostic (5.23e-3)" "unprognostic (5.00e-2)" "unprognostic (9.45e-2)" "unprognostic (9.27e-2)" "unprognostic (3.43e-1)" "unprognostic (2.32e-1)" "unprognostic (2.20e-1)" "unprognostic (3.08e-3)" "unprognostic (3.88e-3)" 11.3 9.7 6.0 10.2 7.6 4.6 12.9 6.3 10.6 12.2 7.2 24.2 14.8 9.4 43.0 10.3 9.6 15.1 10.3 6.3 6.2 16.4 23.4 10.6 12.2 7.2 6.6 8.1 18.4 14.6 12.0 14.7 7.1 12.1 24.9 5.2 15.0 17.4 5.7 10.7 16.9 9.4 6.4 13.4 17.9 8.8 6.6 9.9 18.2 4.5 11.8 12.3 10.9 9.4 14.8 7.7 10.4 14.1 23.4 35.7 8.5 37.9 31.4 13.5 17.3 24.7 13.9 12.5 20.9 27.7 19.5 10.6 11.5 10.3 22.6 18.0 8.4 6.1 6.1 15.0 24.5 9.1 13.2 24.4 14.3 14.3 15.5 17.5 18.5 7.4 13.2 5.1 30.5 10.2 6.9 13.7 8.2 20.6 9.2 6.2 9.7 12.6 36.7 13.2 9.9 8.4 9.8 8.6 17.9 29.6 6.5 18.4 15.9 22.3 6.4 15.9 17.2 12.8 23.9 6.3 12.8 10.0 29.6 5.4 4.5 4.8 6.2 3.5 6.9 4.2 6.2 6.6 4.0 5.8 7.0 5.5 5.2 10.8 5.8 2.7 7.0 4.3 6.0 7.6 6.3 10.6 6.3 6.2 7.2 6.6 7.1 6.4 6.6 9.4 13.3 6.4 10.6 21.9 14.9 13.5 13.0 29.4 10.8 5.7 20.9 10.3 9.1 20.0 27.5 29.5 4.2 21.1 18.5 42.8 7.9 20.5 9.9 28.6 19.4 15.1 14.9 5.5 19.5 24.3 29.1 21.8 28.1 15.5 6.3 11.5 18.5 23.6 19.9 10.1 17.7 47.3 36.7 15.1 10.4 7.6 15.5 11.3 21.4 24.4 16.7 7.1 13.4 30.7 65.7 15.4 33.4 12.0 22.2 22.6 31.1 27.5 46.8 3.7 13.1 9.9 15.7 32.1 14.2 13.7 17.6 16.4 13.1 10.7 33.5 22.9 SLC35B4 "FLJ14697, YEA4" ENSG00000205060 "Solute carrier family 35 member B4" Q969S0 7 134289332-134316930 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 95.2;Syncytiotrophoblasts: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049779 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 57: Non-specific - Angiogenesis" "Cluster 5: NTERA-2 - Transcription" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA049779: AB_2680878" "unprognostic (1.84e-1)" "unprognostic (1.94e-2)" "unprognostic (7.19e-2)" "unprognostic (2.49e-2)" "unprognostic (1.77e-3)" "unprognostic (3.47e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (1.57e-1)" "unprognostic (3.32e-2)" "unprognostic (6.88e-3)" "unprognostic (1.86e-1)" "unprognostic (2.24e-3)" "unprognostic (3.18e-2)" "unprognostic (2.86e-1)" "unprognostic (9.81e-2)" "unprognostic (1.00e-1)" 5.1 6.4 8.8 5.2 8.7 1.9 3.3 9.8 8.5 4.0 7.6 4.0 2.9 6.0 6.3 3.3 4.4 3.9 2.5 8.5 8.9 10.4 8.5 3.3 4.5 8.0 8.5 6.4 2.6 4.6 4.2 11.8 7.7 5.2 3.5 12.3 2.3 6.1 2.5 3.1 4.1 7.1 7.7 4.2 3.5 4.7 10.1 4.8 3.4 2.9 4.8 4.0 2.8 8.7 6.8 22.5 19.3 29.0 18.4 15.3 9.9 16.9 14.1 14.7 12.4 8.7 6.3 22.9 5.6 18.3 19.2 7.2 29.0 15.0 24.3 14.5 21.4 15.5 12.9 11.6 13.6 22.1 13.4 13.6 6.3 17.7 14.9 11.0 14.4 15.6 15.2 8.2 22.2 6.1 19.7 16.1 40.0 7.0 20.0 14.1 17.0 11.2 8.3 8.3 6.7 39.5 15.1 5.0 19.0 16.0 2.7 12.4 16.1 19.0 6.2 11.5 16.9 26.9 39.9 25.9 34.0 20.5 22.4 0.7 1.5 0.3 1.6 2.1 2.5 1.3 1.5 2.1 3.1 1.4 1.4 2.1 0.1 1.9 1.7 2.1 1.7 1.4 8.8 8.7 9.8 8.5 8.5 8.9 8.0 8.5 7.7 7.7 10.1 8.7 7.2 9.6 5.4 22.9 10.2 2.2 5.7 10.7 6.2 52.6 4.9 3.4 6.9 11.5 8.5 1.8 45.9 95.2 3.7 2.2 11.7 8.1 2.4 5.3 15.2 11.8 4.2 8.8 33.4 5.3 27.8 13.3 14.8 6.5 1.3 27.8 7.5 15.1 20.9 42.1 36.6 5.7 22.4 9.3 3.9 3.4 11.1 11.9 5.4 14.0 8.4 16.2 14.4 24.1 24.3 9.0 4.9 12.4 9.2 4.9 7.0 13.9 6.2 21.6 6.6 10.0 10.0 10.8 24.0 9.3 3.3 83.2 10.7 31.3 4.1 3.7 SLC35D2 "SQV7L, UGTrel8" ENSG00000130958 "Solute carrier family 35 member D2" Q76EJ3 9 96313444-96383711 "Metabolic proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 117.2;Proximal enterocytes: 67.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 103.8;Hep G2: 132.3" HPA064047 Approved Supported "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "HPA064047: AB_2685182" "unprognostic (3.67e-1)" "unprognostic (5.73e-2)" "unprognostic (2.59e-1)" "unprognostic (1.16e-2)" "unprognostic (3.17e-1)" "unprognostic (8.86e-3)" "unprognostic (4.25e-3)" "unprognostic (2.24e-2)" "unprognostic (4.12e-1)" "unprognostic (5.67e-2)" "unprognostic (1.97e-1)" "unprognostic (1.63e-1)" "unprognostic (1.74e-2)" "unprognostic (1.33e-2)" "unprognostic (2.04e-1)" "unprognostic (1.99e-2)" "unprognostic (1.44e-1)" 14.7 8.8 13.5 14.4 20.6 11.4 16.4 17.8 20.6 16.5 12.3 49.1 65.1 14.9 12.1 13.7 14.6 20.6 12.2 14.3 16.0 32.1 56.4 19.2 12.4 25.5 19.7 17.3 31.4 16.4 7.2 25.5 22.1 14.2 46.4 4.3 13.0 11.0 3.9 9.4 65.8 13.9 16.6 10.0 43.1 7.2 20.1 7.5 29.5 6.9 11.7 17.2 13.1 27.8 33.2 27.6 15.8 30.2 20.3 37.3 27.9 14.7 30.2 21.6 17.5 60.4 103.8 0.6 24.5 13.5 49.9 47.6 22.2 21.8 18.7 16.4 16.8 11.3 9.8 132.3 32.5 0.1 0.0 32.2 27.6 16.3 48.7 51.0 46.7 0.0 22.3 0.4 23.7 27.2 0.3 0.1 13.2 67.5 28.5 0.1 0.0 0.0 54.4 21.3 5.5 35.9 11.9 24.8 68.5 53.3 16.4 24.7 41.3 14.5 16.2 21.2 13.8 0.0 0.9 0.1 30.2 0.1 20.4 1.2 0.9 0.6 1.3 1.1 1.6 0.7 2.1 2.9 1.2 0.9 0.7 1.4 0.1 1.8 2.1 0.2 3.9 0.5 13.5 20.6 17.8 20.6 14.3 16.0 25.5 19.7 22.1 16.6 20.1 27.8 14.5 9.6 11.0 12.1 4.3 5.2 8.9 2.1 1.8 1.1 15.1 13.1 7.2 27.1 4.6 12.9 2.1 28.1 12.9 61.7 11.7 8.1 0.2 21.0 14.0 12.6 9.6 1.3 0.8 24.5 45.1 9.5 20.4 31.6 4.5 20.0 13.2 43.2 20.5 1.7 1.1 42.0 4.1 23.0 9.7 0.6 10.8 17.7 17.8 20.6 8.9 10.2 7.2 11.1 117.2 25.4 43.5 6.0 6.3 15.5 67.0 23.6 6.7 3.6 13.1 6.8 11.2 1.4 4.4 8.6 5.4 26.5 14.6 7.0 34.9 17.9 SLC38A7 FLJ10815 ENSG00000103042 "Solute carrier family 38 member 7" Q9NVC3 16 58665109-58684770 "Predicted membrane proteins, Transporters" "Amino-acid transport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 32.8" "Group enriched" "Detected in all" 13 "Early spermatids: 271.8;Late spermatids: 753.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041777, HPA049428" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 78: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 25: Spermatids - Spermatogenesis" "Plasma membrane, Cytosol" Nucleoplasm "HPA041777: AB_10796782, HPA049428: " "unprognostic (2.16e-3)" "unprognostic (2.30e-2)" "unprognostic (6.23e-3)" "prognostic favorable (6.87e-4)" "unprognostic (3.49e-1)" "unprognostic (8.08e-3)" "unprognostic (9.76e-3)" "unprognostic (6.34e-3)" "unprognostic (1.98e-2)" "unprognostic (2.02e-1)" "unprognostic (2.77e-1)" "unprognostic (4.90e-2)" "prognostic favorable (2.87e-4)" "unprognostic (1.85e-1)" "unprognostic (4.38e-2)" "unprognostic (7.50e-2)" "unprognostic (4.93e-3)" 6.0 11.4 7.5 6.0 7.8 2.6 5.3 6.0 8.9 5.1 6.1 5.1 4.3 5.5 6.2 6.5 4.0 5.6 15.9 7.9 7.4 7.3 13.6 5.4 4.3 7.7 7.6 4.6 4.8 14.1 7.2 7.5 8.1 5.5 5.9 4.7 6.2 4.6 9.4 5.3 5.5 7.4 5.8 10.3 5.4 32.8 9.8 3.6 7.8 8.3 4.6 5.4 4.9 7.0 6.9 10.9 10.8 16.5 22.0 12.9 19.3 16.2 18.7 22.7 15.6 9.9 11.0 4.5 8.9 22.9 17.9 15.9 10.2 11.7 13.3 2.8 9.4 5.1 9.3 16.5 32.9 10.6 14.0 25.9 23.6 16.1 10.3 12.3 23.5 10.4 14.9 6.3 16.7 8.0 4.3 6.3 11.7 7.5 16.0 15.2 11.6 12.1 10.0 15.4 7.9 11.3 25.7 17.0 7.0 14.4 7.6 4.2 18.7 12.3 9.3 21.8 5.0 9.7 6.7 5.2 16.8 6.3 9.3 0.1 6.8 2.0 4.0 6.6 2.2 1.3 2.4 2.9 4.5 2.5 1.9 2.1 0.5 1.8 6.4 1.7 1.8 5.5 7.5 7.8 6.0 8.9 7.9 7.4 7.7 7.6 8.1 5.8 9.8 7.0 3.3 3.2 4.4 7.8 2.0 3.8 4.0 4.4 1.2 9.8 4.7 3.2 12.8 4.3 4.8 11.0 12.5 8.4 5.0 3.7 3.9 14.0 271.8 3.5 6.8 6.2 13.1 2.1 13.3 8.5 9.5 5.1 9.7 6.0 1.3 10.7 8.2 9.3 38.6 16.8 15.5 3.1 12.2 10.1 8.2 753.3 9.6 11.6 8.8 9.4 4.0 7.1 8.2 5.0 7.6 12.8 2.7 8.6 1.8 3.7 4.8 5.9 3.8 7.1 6.6 4.8 5.1 6.9 7.6 4.6 4.3 15.3 2.7 8.6 4.9 3.2 SLC38A9 FLJ90709 ENSG00000177058 "Solute carrier family 38 member 9" Q8NBW4 5 55625845-55773194 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 57.8" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 182.5;Early spermatids: 262.6;Syncytiotrophoblasts: 619.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 110.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043785, HPA061702" Uncertain Supported Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Vesicles "HPA043785: AB_10961859, HPA061702: " "unprognostic (4.80e-2)" "unprognostic (1.18e-1)" "unprognostic (3.26e-2)" "prognostic unfavorable (7.24e-5)" "unprognostic (2.49e-1)" "unprognostic (8.19e-2)" "unprognostic (8.35e-2)" "unprognostic (7.95e-2)" "unprognostic (5.47e-2)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" "unprognostic (4.87e-1)" "unprognostic (4.18e-3)" "unprognostic (1.76e-1)" "unprognostic (2.25e-1)" "unprognostic (2.84e-2)" "unprognostic (1.12e-1)" 6.1 4.8 5.4 8.8 7.3 7.1 8.2 8.1 6.3 6.5 4.1 9.4 8.1 6.6 6.6 8.4 5.0 8.3 3.8 4.3 6.6 7.4 16.6 8.0 11.2 6.3 5.9 5.4 12.1 10.7 3.3 57.8 6.6 6.1 9.8 10.0 6.4 6.0 4.4 7.6 6.6 8.5 5.5 8.4 8.1 19.2 6.3 8.8 7.7 3.8 14.5 8.4 4.8 8.9 17.9 17.3 17.1 20.0 22.0 20.4 110.0 16.5 21.3 18.3 30.4 29.5 27.2 31.6 28.6 12.7 32.1 22.5 20.2 18.2 22.8 15.4 18.4 10.8 16.4 18.7 31.1 18.9 10.8 26.3 21.0 20.2 25.7 13.7 20.0 21.3 20.9 18.6 16.5 15.0 23.6 16.4 29.4 7.2 15.6 17.6 28.6 32.2 24.7 14.0 8.1 14.5 17.3 9.3 25.4 24.0 20.1 34.4 29.6 3.6 11.7 26.8 16.6 20.5 47.6 20.8 10.9 17.4 11.4 3.3 9.3 5.5 5.2 8.7 7.5 7.4 4.5 6.1 8.4 4.2 6.2 5.3 2.0 7.7 6.9 8.0 5.9 4.9 5.4 7.3 8.1 6.3 4.3 6.6 6.3 5.9 6.6 5.5 6.3 8.9 7.3 6.4 3.1 21.9 14.2 3.2 4.2 8.5 2.8 6.6 5.7 3.9 2.8 11.5 9.8 9.2 8.4 182.5 10.4 8.9 1.9 8.9 262.6 4.4 9.2 8.1 4.2 8.4 56.2 11.4 71.5 7.2 8.6 7.3 2.5 8.0 10.4 22.1 26.3 1.7 57.3 4.3 8.2 10.0 8.0 82.4 7.5 11.7 5.4 38.4 11.0 5.6 4.1 55.8 103.2 10.9 9.7 4.9 8.4 4.6 4.4 7.2 6.3 7.4 6.6 3.3 7.0 15.8 6.5 8.1 3.4 619.9 8.7 4.0 5.2 4.7 SLC5A6 SMVT ENSG00000138074 "Solute carrier family 5 member 6" Q9Y289 2 27199587-27212958 "Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 104.0" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 119.1;Extravillous trophoblasts: 111.7;Hepatocytes: 67.7;Syncytiotrophoblasts: 227.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 310.9;SK-BR-3: 337.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036958 Approved Approved "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane" "HPA036958: AB_10672343" "unprognostic (5.85e-2)" "unprognostic (8.32e-3)" "unprognostic (1.38e-1)" "unprognostic (2.61e-3)" "unprognostic (9.38e-2)" "unprognostic (7.14e-2)" "unprognostic (3.20e-3)" "unprognostic (7.92e-2)" "unprognostic (6.96e-2)" "unprognostic (9.80e-2)" "unprognostic (2.05e-2)" "unprognostic (7.46e-2)" "prognostic unfavorable (3.60e-7)" "unprognostic (2.40e-3)" "unprognostic (1.20e-2)" "unprognostic (4.56e-3)" "unprognostic (4.18e-2)" 42.4 8.6 27.5 14.2 25.2 18.1 31.5 24.0 30.6 9.4 46.2 13.0 20.9 14.3 67.4 10.9 11.5 7.5 7.7 23.4 23.9 8.5 104.0 7.9 13.8 24.0 24.4 10.2 11.6 9.8 8.0 39.1 25.9 9.3 12.7 6.4 12.5 11.1 17.0 10.0 15.3 9.7 23.9 9.1 10.1 23.4 30.6 11.6 8.0 8.8 26.5 11.3 8.8 21.9 78.9 79.6 49.9 66.1 45.4 16.5 310.9 28.1 19.1 41.8 28.7 118.8 27.0 54.2 41.3 15.4 44.7 42.8 108.3 32.4 29.1 42.2 63.5 96.6 34.9 184.4 53.8 125.1 47.8 57.1 27.1 51.4 39.7 11.1 38.2 43.3 143.6 21.1 27.0 161.0 42.7 60.4 144.8 90.1 29.0 70.7 58.7 78.2 24.0 74.5 42.0 61.7 30.3 337.1 40.1 48.6 74.9 26.0 17.5 45.3 62.5 27.9 76.1 35.7 88.6 84.7 24.5 86.1 65.2 0.1 5.9 1.8 7.4 6.6 8.9 5.8 7.0 7.0 8.7 5.3 7.1 8.6 0.3 6.3 8.9 8.9 7.6 5.8 27.5 25.2 24.0 30.6 23.4 23.9 24.0 24.4 25.9 23.9 30.6 21.9 2.5 0.0 4.4 7.8 13.4 8.0 8.6 3.8 7.4 5.3 41.9 31.9 6.8 8.6 3.1 7.3 4.2 119.1 12.5 6.7 1.9 9.8 15.1 3.9 7.4 6.2 5.4 12.6 7.2 8.2 111.7 6.0 5.6 6.9 0.0 18.1 7.1 67.7 21.8 11.8 9.0 9.2 4.1 9.1 6.0 32.0 7.2 6.6 0.0 29.0 47.9 2.5 6.2 6.6 5.0 7.0 4.3 13.9 10.0 14.1 11.7 3.9 2.9 3.1 13.1 5.5 5.2 35.1 21.5 7.6 6.3 227.9 8.6 9.4 15.2 7.8 SLC7A1 "ATRC1, CAT-1, ERR, HCAT1, REC1L" ENSG00000139514 "Solute carrier family 7 member 1" P30825 13 29509414-29595688 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 55.1" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 235.6;Microglial cells: 162.1;Squamous epithelial cells: 175.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039721, HPA077838" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA039721: AB_10672893, HPA077838: " "unprognostic (1.85e-1)" "unprognostic (1.04e-3)" "unprognostic (1.26e-1)" "unprognostic (1.96e-1)" "unprognostic (3.95e-3)" "unprognostic (2.43e-2)" "unprognostic (1.36e-3)" "unprognostic (2.02e-3)" "unprognostic (4.98e-2)" "unprognostic (1.23e-2)" "unprognostic (7.45e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (1.32e-5)" "unprognostic (3.20e-2)" "unprognostic (3.02e-1)" "unprognostic (1.19e-1)" "unprognostic (7.37e-3)" 6.2 6.0 34.8 10.7 21.9 11.3 7.7 28.6 31.1 8.5 24.4 10.1 10.2 8.4 10.2 55.1 7.4 4.5 7.5 31.0 25.9 6.6 2.0 4.9 8.6 40.5 27.6 2.8 30.5 4.5 7.5 3.0 41.4 7.7 7.4 9.0 16.1 9.2 2.1 17.7 14.8 9.1 33.9 5.9 11.3 6.9 39.5 7.8 9.6 1.7 10.4 11.0 11.1 27.6 42.2 33.2 28.7 58.0 14.5 28.6 32.6 87.8 58.3 74.2 55.0 68.0 72.1 82.9 23.3 134.5 82.8 188.0 50.4 62.2 97.1 78.3 30.1 62.1 36.3 37.0 75.0 91.6 39.4 36.6 129.4 82.6 96.9 17.4 37.1 92.8 40.5 37.6 31.5 56.5 67.2 24.6 27.5 74.2 22.1 45.7 59.1 48.3 47.2 27.5 97.3 46.3 50.0 48.3 79.4 17.9 21.3 76.6 35.1 58.2 40.6 51.6 63.6 42.1 33.1 93.8 46.4 36.3 60.1 0.0 0.4 0.1 1.0 0.4 0.8 0.6 0.7 0.8 0.6 0.4 0.5 0.9 0.0 0.2 1.0 1.2 0.6 0.7 34.8 21.9 28.6 31.1 31.0 25.9 40.5 27.6 41.4 33.9 39.5 27.6 12.1 0.0 5.0 7.2 14.4 49.8 53.9 33.0 235.6 15.6 21.4 12.8 10.2 12.8 16.2 71.7 16.7 1.1 10.3 14.7 1.9 19.9 0.2 32.5 10.0 29.2 31.1 54.7 28.9 56.9 40.0 10.3 26.5 69.2 7.0 8.0 5.7 0.4 6.1 25.2 27.0 34.5 26.4 5.7 18.2 0.8 6.2 8.6 8.8 162.1 5.7 3.1 3.1 23.6 13.1 56.5 21.1 3.8 36.8 55.2 20.7 0.3 10.1 18.6 6.6 28.1 9.0 4.5 2.1 175.1 34.9 4.0 11.3 10.8 33.5 41.6 SMARCA4 "BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2" ENSG00000127616 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4" P51532 19 10960932-11079426 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding" "Cancer-related genes, Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 372.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004208, HPA048340" Supported Supported "Nucleoplasm,Nucleoli fibrillar center,Nucleoli rim" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Nucleoli fibrillar center, Nucleoli rim" "CAB004208: AB_626762, HPA048340: " "unprognostic (2.68e-1)" "unprognostic (4.85e-2)" "unprognostic (1.71e-1)" "unprognostic (3.43e-3)" "unprognostic (1.40e-1)" "unprognostic (6.33e-3)" "prognostic unfavorable (1.11e-4)" "unprognostic (7.19e-2)" "unprognostic (7.29e-2)" "unprognostic (1.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.15e-2)" "unprognostic (6.80e-3)" "unprognostic (6.83e-3)" "unprognostic (5.44e-2)" "unprognostic (1.01e-1)" "unprognostic (1.29e-1)" 13.8 16.2 14.4 22.6 14.3 31.8 13.0 15.3 23.7 16.1 13.2 18.1 19.9 14.5 9.5 32.9 20.8 13.3 16.2 15.4 9.6 15.7 8.6 17.9 27.0 10.4 10.4 14.9 18.3 22.9 11.1 20.2 11.0 17.7 12.9 19.7 25.9 15.6 23.7 28.1 17.2 14.5 3.9 19.5 20.4 30.2 11.8 43.1 20.6 13.9 23.7 17.4 14.7 19.3 92.5 5.0 157.2 149.8 30.3 25.4 68.9 62.7 37.2 74.6 54.9 126.9 4.0 215.4 94.2 54.9 3.0 65.9 123.6 77.5 40.8 89.5 93.3 171.3 76.5 149.6 45.7 125.5 82.0 43.1 36.7 63.1 64.5 33.3 67.5 92.0 156.7 78.3 59.2 188.0 210.0 107.5 159.9 45.1 134.7 220.6 99.5 111.7 47.9 114.8 177.8 161.7 66.6 84.4 73.5 50.1 71.9 93.3 90.9 110.3 57.3 102.5 104.9 160.6 192.2 209.1 62.6 118.5 96.0 5.7 5.8 6.4 9.3 6.9 8.2 5.3 6.8 7.9 6.1 6.8 7.6 7.5 3.4 8.5 10.8 7.9 6.4 4.7 14.4 14.3 15.3 23.7 15.4 9.6 10.4 10.4 11.0 3.9 11.8 19.3 25.4 67.3 72.6 27.4 28.5 37.0 43.7 43.8 24.5 91.3 42.2 28.4 372.9 40.0 62.7 44.1 70.9 65.9 21.2 60.1 41.1 79.8 53.0 58.8 49.2 58.3 63.2 41.8 32.2 61.4 57.3 43.8 50.0 63.5 30.4 75.3 28.5 21.9 42.3 101.0 39.6 47.7 57.0 23.8 21.5 37.6 26.1 30.4 16.0 14.0 43.8 36.1 23.7 32.6 28.1 76.4 41.8 13.5 37.6 66.0 29.8 27.6 62.5 69.1 13.1 45.1 66.4 99.4 86.0 52.2 51.7 61.0 30.4 68.1 60.5 50.1 SMARCA5 "hISWI, hSNF2H, ISWI" ENSG00000153147 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5" O60264 4 143513702-143557486 "Predicted intracellular proteins, Transcription factors" "Chromatin regulator, Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 307.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005227, HPA008751" Supported Supported "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Nucleoli fibrillar center" "CAB005227: AB_2191863, HPA008751: AB_1857268" "unprognostic (9.21e-3)" "unprognostic (7.99e-2)" "unprognostic (4.99e-3)" "unprognostic (8.03e-2)" "unprognostic (8.96e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.61e-4)" "unprognostic (3.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.99e-1)" "unprognostic (4.19e-2)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (2.19e-1)" "unprognostic (1.61e-1)" "unprognostic (4.20e-2)" "unprognostic (1.82e-1)" 16.9 26.0 15.1 21.1 20.1 32.7 17.6 17.6 17.3 18.1 13.5 17.2 14.9 20.4 20.5 14.1 14.6 19.3 17.1 13.0 16.6 16.7 16.8 27.9 27.0 17.9 16.8 21.2 16.4 22.6 13.5 22.8 19.1 18.1 17.9 26.4 12.4 17.0 15.3 11.1 16.4 18.4 18.3 22.8 16.2 32.6 16.0 29.9 23.1 15.3 25.7 22.7 11.0 26.0 33.4 25.8 92.5 58.5 53.4 38.4 55.5 41.5 49.4 59.5 50.0 44.3 45.8 90.0 27.9 35.7 23.7 26.0 85.9 38.9 57.1 60.2 30.2 67.7 36.9 36.7 39.3 84.2 38.3 34.0 27.8 42.1 36.0 34.5 46.9 45.1 62.0 55.4 39.2 30.1 98.7 29.4 75.7 55.6 36.6 108.2 59.1 29.4 46.6 40.4 73.6 62.2 54.0 37.9 49.5 69.2 27.4 39.1 50.0 38.9 29.7 41.0 41.2 60.0 77.4 106.8 30.6 69.5 40.3 5.8 10.7 16.0 12.7 12.8 15.3 11.4 13.1 14.2 13.3 11.2 13.4 13.6 9.4 15.8 21.5 10.0 16.7 11.5 15.1 20.1 17.6 17.3 13.0 16.6 17.9 16.8 19.1 18.3 16.0 26.0 77.3 307.7 291.0 30.7 95.7 46.4 78.9 50.6 55.2 93.9 56.4 49.0 104.1 31.5 96.9 44.1 64.6 70.6 125.6 39.8 39.2 77.9 63.2 104.5 127.1 74.3 79.9 85.4 42.5 61.4 66.4 73.8 46.4 94.2 103.1 97.3 39.3 25.4 44.8 85.8 41.7 41.3 69.2 51.9 49.4 27.9 60.3 79.2 30.2 27.2 98.6 84.7 55.6 37.7 85.2 66.0 35.3 62.1 93.9 57.7 36.6 36.8 109.6 116.4 52.6 113.9 88.3 144.4 130.8 47.4 40.9 102.1 107.9 118.7 46.2 71.2 SMARCAL1 "HARP, HHARP" ENSG00000138375 "SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1" Q9NZC9 2 216412414-216483053 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Helicase, Hydrolase" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020337 Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA020337: AB_2670410" "unprognostic (4.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.65e-1)" "unprognostic (2.20e-2)" "unprognostic (3.39e-2)" "unprognostic (2.68e-2)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.35e-3)" "unprognostic (3.31e-2)" "unprognostic (2.33e-1)" "unprognostic (1.36e-1)" "unprognostic (7.46e-2)" "unprognostic (2.00e-2)" "unprognostic (2.67e-1)" "unprognostic (1.41e-1)" "unprognostic (1.97e-1)" "unprognostic (3.16e-1)" 9.2 9.8 7.5 8.9 10.3 9.1 8.8 8.0 9.7 10.6 7.6 8.0 6.8 10.7 7.5 9.8 11.0 9.5 8.9 8.0 9.0 7.2 6.7 7.9 13.1 10.6 9.1 16.3 8.2 10.8 9.3 9.1 10.6 8.1 7.4 5.6 8.0 8.9 10.5 10.6 7.9 10.1 8.4 9.7 8.0 10.3 10.2 15.1 10.2 10.6 11.9 8.8 9.0 14.2 16.7 16.3 22.2 12.7 21.5 25.1 21.3 22.0 22.7 23.0 26.1 26.7 20.3 15.0 21.8 27.6 28.8 12.3 19.1 24.4 30.5 45.7 18.9 42.8 12.0 19.9 22.0 11.5 23.9 16.7 25.7 24.9 24.4 24.0 27.6 23.5 42.6 15.8 26.3 12.3 22.2 26.8 16.1 14.7 8.9 24.6 14.6 9.3 18.2 11.4 18.4 11.9 12.0 9.1 18.7 38.2 12.4 18.1 21.3 28.3 13.0 13.7 13.9 18.0 18.6 13.3 28.8 15.6 20.2 25.9 9.5 14.1 12.2 10.5 11.6 9.6 11.5 14.3 14.9 9.2 9.6 11.8 1.7 21.0 18.1 18.0 14.7 8.5 7.5 10.3 8.0 9.7 8.0 9.0 10.6 9.1 10.6 8.4 10.2 14.2 6.3 6.4 6.1 20.2 8.2 0.9 3.3 4.6 8.6 5.1 4.3 3.4 5.0 7.2 3.7 0.0 0.0 10.4 6.7 3.4 5.9 7.4 14.5 10.4 7.2 7.0 3.6 11.4 20.6 3.8 12.2 8.0 5.6 5.8 17.7 11.0 4.2 3.2 9.7 8.4 30.8 3.7 2.0 8.9 3.1 13.7 6.2 6.2 1.8 12.2 10.1 4.7 10.3 24.6 35.9 4.0 13.3 8.6 7.0 1.3 4.7 5.8 4.4 4.8 13.1 6.0 6.8 7.7 4.4 5.3 1.3 7.3 6.5 7.5 5.3 2.0 SMC1A "DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb" ENSG00000072501 "Structural maintenance of chromosomes 1A" Q14683 X 53374149-53422728 "Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis" "Cancer-related genes, Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005499, CAB025404" Supported Enhanced Nucleoplasm NA NA 33000 "Cluster 27: Non-specific - Gene expression" "Cluster 63: T-cells - Adaptive immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB025404: , HPA005499: AB_1080028" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (4.00e-2)" "unprognostic (5.76e-2)" "unprognostic (1.04e-1)" "unprognostic (9.89e-2)" "unprognostic (1.29e-3)" "unprognostic (1.89e-1)" "unprognostic (9.80e-3)" "unprognostic (9.49e-2)" "unprognostic (4.48e-2)" "unprognostic (6.55e-2)" "unprognostic (2.58e-1)" "unprognostic (4.18e-3)" "unprognostic (6.28e-2)" "unprognostic (2.89e-1)" "unprognostic (9.39e-2)" 16.6 11.8 8.7 28.4 11.7 30.3 17.2 15.0 9.5 13.8 9.6 20.0 18.6 21.0 8.0 17.1 16.7 11.5 15.6 7.8 9.5 16.3 18.8 16.0 34.4 10.2 10.7 19.1 14.4 25.8 6.3 18.2 10.7 14.0 18.4 21.0 15.1 13.0 17.9 18.1 15.9 22.9 8.7 20.1 15.7 7.8 11.3 58.1 16.8 18.8 29.9 15.5 12.4 13.9 110.0 115.1 92.4 76.1 32.4 35.4 51.5 68.0 37.0 76.4 59.4 71.6 60.5 115.8 54.1 40.7 105.2 78.9 162.9 92.6 85.1 91.7 176.0 94.3 133.9 51.1 15.4 134.9 120.9 20.6 23.3 86.0 52.8 19.4 67.5 68.7 144.7 64.7 58.6 69.2 122.0 40.8 139.9 47.8 55.6 117.2 165.5 100.1 34.4 69.4 92.8 83.5 176.9 84.4 33.5 122.8 87.9 54.0 45.7 63.3 68.0 65.1 62.2 45.8 77.9 91.9 39.1 152.1 64.1 2.7 6.8 4.5 7.3 8.5 7.6 5.4 5.8 6.7 8.4 5.8 5.2 6.3 2.7 4.6 12.4 4.6 5.7 6.7 8.7 11.7 15.0 9.5 7.8 9.5 10.2 10.7 10.7 8.7 11.3 13.9 40.7 44.8 39.9 16.0 45.6 24.1 37.0 27.7 28.5 46.6 30.7 27.4 63.5 27.1 47.4 20.2 27.1 43.2 57.7 49.6 7.9 31.6 10.5 46.5 62.6 41.7 19.9 70.7 12.0 27.1 61.4 37.2 29.0 44.0 35.4 42.7 18.9 54.1 47.6 60.6 14.2 43.5 22.4 41.1 27.6 7.6 37.9 51.5 23.2 24.4 55.2 38.1 59.8 16.6 30.2 33.1 23.6 36.1 61.2 40.7 29.0 24.6 47.1 48.4 39.5 49.5 71.0 54.5 51.2 39.8 24.4 48.4 47.9 34.0 51.4 32.0 SMG9 "C19orf61, FLJ12886" ENSG00000105771 "SMG9 nonsense mediated mRNA decay factor" Q9H0W8 19 43727983-43754962 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Nonsense-mediated mRNA decay" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 103.2;Late spermatids: 329.5;Syncytiotrophoblasts: 95.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041763, HPA042096" Uncertain Approved "Plasma membrane,Mitochondria,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 78: Testis - Spermatogenesis" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 25: Spermatids - Spermatogenesis" "Mitochondria, Cytosol" "Plasma membrane" "HPA041763: AB_2677659, HPA042096: AB_2677845" "unprognostic (2.22e-1)" "unprognostic (1.32e-1)" "unprognostic (7.41e-2)" "unprognostic (6.46e-2)" "unprognostic (2.71e-1)" "unprognostic (1.55e-2)" "prognostic unfavorable (2.15e-5)" "unprognostic (2.71e-1)" "unprognostic (4.11e-2)" "unprognostic (9.24e-3)" "unprognostic (3.88e-2)" "unprognostic (8.76e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (8.00e-2)" "unprognostic (1.27e-1)" "unprognostic (2.36e-1)" "prognostic favorable (8.09e-4)" 9.0 11.7 10.3 10.9 10.8 8.4 8.7 10.9 13.5 10.6 5.9 9.0 8.0 9.0 7.7 9.2 7.7 6.8 7.7 10.2 10.6 7.7 6.6 10.0 13.0 13.1 11.6 7.8 5.8 8.8 9.4 10.1 13.6 11.5 6.2 5.9 12.0 6.9 7.5 10.7 10.0 8.1 9.5 13.5 8.7 33.8 11.6 11.8 8.3 7.1 12.0 10.0 9.9 14.9 25.3 27.2 19.5 12.5 13.4 18.9 13.1 35.1 20.8 38.4 28.7 19.4 32.5 27.4 16.9 24.1 13.2 10.7 22.9 19.7 24.9 21.1 13.2 49.2 20.5 12.9 15.6 37.4 25.9 10.1 16.6 27.9 29.6 32.1 15.8 25.0 37.7 23.6 18.0 17.9 39.9 10.6 9.4 48.0 18.2 21.2 16.1 12.3 20.4 20.4 32.4 15.9 36.7 27.4 21.3 15.4 16.6 20.5 19.2 59.7 35.4 22.3 27.1 11.5 26.8 33.4 17.9 28.4 49.7 1.0 5.3 3.3 5.1 7.7 4.5 7.4 5.1 4.3 6.9 5.3 6.7 4.5 1.3 4.2 11.7 6.1 4.1 11.3 10.3 10.8 10.9 13.5 10.2 10.6 13.1 11.6 13.6 9.5 11.6 14.9 7.7 32.1 8.3 20.9 13.7 9.3 15.0 16.8 11.4 13.2 10.0 11.0 4.4 4.3 9.0 9.2 4.2 49.5 11.3 9.5 1.9 12.2 103.2 5.5 7.0 12.0 4.2 7.8 19.5 8.7 15.8 11.4 15.8 8.9 9.5 12.1 11.0 3.3 21.4 13.5 23.0 11.3 8.2 10.3 9.2 329.5 13.1 12.1 10.6 11.2 16.2 6.0 4.1 16.1 29.6 13.6 9.2 12.0 11.2 15.9 8.5 6.8 8.4 9.2 6.6 11.2 8.5 42.6 16.2 8.4 7.1 95.4 9.3 11.8 12.2 11.1 SMIM15 "C5orf43, DKFZP686E2158" ENSG00000188725 "Small integral membrane protein 15" Q7Z3B0 5 61157704-61162468 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 38: EFO-21 - Unknown function" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (1.18e-1)" "unprognostic (2.56e-1)" "unprognostic (2.33e-2)" "unprognostic (3.82e-1)" "unprognostic (3.32e-2)" "unprognostic (6.03e-2)" "unprognostic (9.83e-3)" "unprognostic (4.43e-2)" "unprognostic (2.44e-2)" "unprognostic (4.09e-1)" "unprognostic (5.08e-2)" "unprognostic (1.72e-1)" "unprognostic (5.34e-3)" "unprognostic (1.77e-1)" "unprognostic (1.15e-1)" "unprognostic (1.89e-1)" "prognostic favorable (9.23e-4)" 19.0 23.6 13.5 24.6 14.7 22.5 29.1 14.4 17.2 26.9 12.0 49.1 42.6 22.3 23.4 32.5 30.9 25.1 15.8 12.8 15.2 31.8 43.3 24.3 26.8 14.1 13.7 33.1 27.5 36.4 16.1 30.3 14.6 30.7 41.4 21.4 27.1 27.7 11.2 18.5 40.8 23.7 15.6 19.5 46.6 15.3 13.6 27.7 35.6 15.6 28.9 40.3 21.5 17.7 95.3 79.6 51.4 84.1 48.8 58.0 52.9 78.5 86.0 77.1 103.2 69.4 141.4 46.2 133.4 82.6 101.3 54.5 0.0 94.3 90.3 97.4 42.1 72.9 60.7 67.9 95.4 54.2 65.9 69.0 85.9 95.7 108.6 58.9 62.9 57.1 87.0 61.7 87.4 99.5 27.9 0.7 63.4 38.7 92.7 9.8 63.8 106.2 83.3 112.6 71.0 67.9 90.4 48.2 99.4 35.9 90.9 58.3 72.4 46.1 73.9 58.9 100.9 62.6 117.3 85.9 63.2 29.6 96.7 33.2 56.4 20.2 34.7 70.5 38.7 41.6 38.3 39.9 51.4 33.9 46.0 32.1 11.3 58.8 57.8 41.2 55.9 39.4 13.5 14.7 14.4 17.2 12.8 15.2 14.1 13.7 14.6 15.6 13.6 17.7 26.8 57.7 37.1 4.9 39.4 86.8 122.1 58.1 60.3 25.7 45.2 33.4 21.2 35.8 53.2 42.3 8.4 71.9 34.6 79.9 135.0 70.8 23.3 35.6 40.3 25.7 55.2 29.2 3.9 61.3 62.9 50.0 57.1 40.9 23.5 35.4 25.7 40.4 73.4 40.4 4.3 74.0 42.7 40.8 30.5 24.5 46.3 40.5 40.9 2.8 33.8 59.3 44.3 4.5 8.7 75.2 116.1 42.2 41.9 108.6 73.2 93.0 37.0 20.8 26.3 28.2 37.6 18.7 12.3 78.6 82.7 47.5 34.9 45.7 82.8 152.6 SNAP47 "C1orf142, SNAP-47, SVAP1" ENSG00000143740 "Synaptosome associated protein 47" Q5SQN1 1 227728200-227781826 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028167 Supported Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 39: Non-specific - Basic cellular processes" Cytosol "HPA028167: AB_10603032" "unprognostic (3.31e-2)" "unprognostic (1.31e-1)" "unprognostic (1.93e-2)" "unprognostic (7.31e-2)" "unprognostic (4.88e-2)" "unprognostic (2.23e-2)" "unprognostic (1.20e-1)" "unprognostic (7.28e-2)" "unprognostic (1.48e-1)" "unprognostic (2.07e-1)" "unprognostic (1.34e-2)" "unprognostic (7.26e-2)" "unprognostic (1.48e-1)" "unprognostic (6.14e-2)" "unprognostic (4.81e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-1)" 14.2 43.8 19.8 10.0 22.0 10.1 16.9 18.3 23.8 23.9 12.5 20.5 10.1 28.9 15.3 14.0 25.9 12.4 38.6 22.4 17.0 19.4 27.0 11.7 18.1 14.4 15.4 47.2 16.5 23.5 27.4 20.1 15.2 17.3 8.9 12.9 18.2 12.1 36.3 16.6 15.3 18.5 15.3 14.6 17.0 38.6 16.7 17.1 17.1 23.4 14.1 19.9 14.7 17.7 33.5 44.2 27.2 27.7 30.3 25.1 35.0 21.2 33.7 35.5 26.5 29.4 29.8 23.8 37.9 33.2 27.3 36.2 33.6 37.9 27.6 48.1 63.4 19.8 28.0 18.9 21.6 30.8 17.8 28.0 32.2 43.3 24.7 28.3 29.4 28.7 37.6 23.7 32.1 22.0 31.5 29.0 44.3 42.5 65.1 32.8 32.3 37.7 20.4 28.1 50.5 32.1 33.6 44.0 33.5 26.4 55.1 27.8 21.3 30.9 38.4 30.7 52.5 30.2 23.2 28.9 28.0 23.0 40.8 19.1 21.0 34.0 29.4 21.2 28.3 22.6 33.1 34.2 23.3 21.3 27.1 25.4 7.4 30.5 27.7 24.0 46.4 25.4 19.8 22.0 18.3 23.8 22.4 17.0 14.4 15.4 15.2 15.3 16.7 17.7 10.1 6.4 13.1 9.4 16.1 13.4 15.9 16.2 16.5 30.8 16.5 14.7 13.0 22.8 13.2 14.7 27.1 24.3 18.7 8.7 35.2 19.9 49.4 7.2 14.3 11.7 16.2 13.5 12.0 18.2 28.4 15.1 10.7 6.9 5.7 21.0 11.0 13.8 16.3 42.1 9.6 8.6 22.4 8.8 6.2 95.9 25.7 7.6 12.4 8.4 22.3 30.5 45.3 6.6 6.1 17.0 3.3 20.7 22.7 16.5 12.4 15.8 8.9 33.5 13.1 12.0 14.0 41.9 26.4 8.5 15.3 27.5 19.4 23.3 10.5 10.1 SNUPN "RNUT1, SNURPORTIN-1, Snurportin1" ENSG00000169371 "Snurportin 1" O95149 15 75598083-75626469 "Predicted intracellular proteins" Transport RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 137.1;Spermatocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005004 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "CAB005004: AB_425829" "unprognostic (2.37e-2)" "unprognostic (1.54e-1)" "unprognostic (2.36e-2)" "unprognostic (8.73e-2)" "unprognostic (2.25e-1)" "unprognostic (1.18e-1)" "unprognostic (4.76e-2)" "unprognostic (6.74e-2)" "unprognostic (1.35e-1)" "unprognostic (2.14e-1)" "unprognostic (1.99e-3)" "unprognostic (9.07e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-1)" "unprognostic (2.14e-2)" 18.2 16.0 21.0 15.5 21.6 13.8 23.5 20.5 26.3 20.4 21.9 18.1 14.9 18.9 20.3 14.3 23.7 13.5 16.4 22.1 20.9 20.1 22.1 14.9 20.1 19.5 20.1 26.3 12.7 21.0 12.1 15.2 20.1 16.5 17.4 13.2 19.8 17.6 34.7 16.7 15.4 24.5 18.7 17.2 15.8 34.3 20.5 22.1 20.9 30.5 21.1 18.0 15.5 21.2 26.1 34.1 30.4 21.6 42.1 46.8 23.2 26.1 38.5 44.2 47.8 25.4 62.6 47.4 35.7 34.0 36.6 29.9 60.3 38.3 34.5 27.3 56.1 56.4 29.3 16.4 40.6 39.4 37.3 44.6 37.3 32.8 41.0 40.1 42.4 36.8 36.8 30.9 45.4 9.0 38.5 38.7 40.6 42.7 19.5 48.7 23.7 46.7 39.7 13.6 28.5 19.9 11.4 38.7 68.9 37.5 33.0 73.8 27.9 35.3 32.8 19.4 23.3 21.9 43.7 69.8 38.7 59.6 47.0 10.3 39.5 12.2 47.4 37.7 57.3 34.7 48.9 45.8 47.7 41.1 63.2 53.0 6.7 36.9 40.1 47.0 42.1 41.0 21.0 21.6 20.5 26.3 22.1 20.9 19.5 20.1 20.1 18.7 20.5 21.2 19.1 12.8 14.5 7.8 13.1 13.3 10.4 30.5 18.2 19.0 18.7 21.5 11.7 14.3 16.8 9.2 12.5 28.7 19.2 10.3 54.8 23.1 137.1 14.9 23.6 14.4 16.2 14.1 9.0 19.3 38.5 25.2 10.7 12.8 12.7 20.4 17.2 18.5 24.7 13.5 8.2 12.4 14.2 17.7 17.3 60.3 31.4 19.1 19.6 7.5 24.2 18.3 25.7 3.0 7.6 14.7 10.5 29.3 9.9 11.5 17.6 34.1 15.1 20.4 19.7 16.6 14.5 93.2 14.6 15.0 10.9 11.9 16.2 27.3 18.1 5.7 SNX15 ENSG00000110025 "Sorting nexin 15" Q9NRS6 11 65027439-65040572 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Distal enterocytes: 5.6;Enteroendocrine cells: 7.8;granulocytes: 8.2;monocytes: 7.9;Paneth cells: 8.0;Proximal enterocytes: 6.5;Undifferentiated cells: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038955 Approved Approved "Nucleoli,Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 44: HDLM-2 - Immune response" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nucleoli, Cytosol" "Vesicles, Plasma membrane" "HPA038955: AB_10672834" "unprognostic (2.00e-2)" "unprognostic (4.90e-2)" "unprognostic (3.93e-1)" "unprognostic (9.61e-4)" "unprognostic (2.79e-1)" "unprognostic (4.06e-3)" "unprognostic (4.45e-3)" "unprognostic (4.74e-2)" "unprognostic (1.09e-1)" "unprognostic (9.55e-2)" "unprognostic (8.93e-3)" "unprognostic (1.79e-2)" "unprognostic (8.84e-2)" "unprognostic (7.86e-2)" "unprognostic (2.93e-2)" "unprognostic (1.88e-1)" "unprognostic (2.68e-4)" 17.1 13.3 17.3 10.2 18.5 10.5 15.3 19.4 19.2 16.6 9.0 22.5 15.3 15.8 6.4 14.9 12.9 7.4 15.0 18.4 17.1 17.0 10.1 11.9 9.3 19.3 18.2 14.8 12.7 10.7 9.4 7.3 16.1 12.9 8.8 5.8 12.3 10.9 25.7 17.5 16.8 8.9 16.1 10.8 16.4 5.3 17.8 9.4 10.6 15.5 7.4 18.0 14.9 18.5 31.1 22.3 14.7 14.2 17.3 12.4 7.9 10.0 13.6 23.3 21.3 17.6 23.7 30.7 16.7 17.4 29.3 16.8 16.8 15.2 9.8 47.0 14.0 15.8 18.2 30.2 18.3 10.7 24.5 10.6 22.2 24.7 14.5 13.0 14.1 22.6 27.0 19.6 12.5 18.8 29.2 36.8 15.5 12.0 21.9 23.7 8.4 34.0 17.6 6.7 25.6 19.2 25.3 23.0 23.2 9.7 23.4 18.6 27.5 23.5 22.9 24.1 14.7 20.9 38.3 30.3 23.2 14.5 8.4 9.2 13.6 13.6 7.6 16.2 6.2 8.9 7.8 6.8 9.4 8.7 5.6 5.1 2.1 4.3 23.6 6.4 8.3 7.3 17.3 18.5 19.4 19.2 18.4 17.1 19.3 18.2 16.1 16.1 17.8 18.5 0.3 0.0 3.3 0.0 0.8 1.0 0.1 0.4 4.0 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.4 0.1 5.6 0.0 4.8 0.0 0.1 0.2 0.9 7.8 1.3 0.0 3.1 0.6 0.4 1.1 0.1 8.2 0.4 0.7 0.1 1.0 0.0 0.0 3.3 0.0 0.0 0.3 0.0 0.0 0.5 0.0 0.0 7.9 0.2 0.0 0.0 0.0 3.9 8.0 0.4 1.1 0.0 6.5 0.6 0.7 0.4 0.0 0.7 1.0 0.0 0.0 1.5 0.4 0.4 1.1 0.2 5.6 0.1 SOCS5 "CIS6, Cish5, CISH6, KIAA0671, SOCS-5" ENSG00000171150 "Suppressor of cytokine signaling 5" O75159 2 46698952-46780245 "Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 51.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "BJ hTERT+: 121.0;fHDF/TERT166: 121.9;U-138 MG: 80.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020884, CAB025510" Approved Approved "Nucleoplasm,Plasma membrane,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 65: Plasmacytoid DCs - Unknown function" Cytosol "Nucleoplasm, Plasma membrane" "CAB025510: , HPA020884: AB_1857356" "unprognostic (1.69e-1)" "unprognostic (1.98e-2)" "unprognostic (5.71e-2)" "unprognostic (1.64e-2)" "unprognostic (2.20e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (7.28e-4)" "unprognostic (4.52e-2)" "unprognostic (9.13e-2)" "prognostic unfavorable (7.53e-4)" "unprognostic (2.10e-3)" "unprognostic (3.01e-1)" "unprognostic (1.47e-3)" "unprognostic (8.29e-2)" "unprognostic (1.71e-1)" "unprognostic (1.17e-1)" "unprognostic (1.29e-1)" 12.0 10.2 7.6 6.3 7.7 7.7 13.0 15.9 9.6 13.0 7.5 9.7 5.2 14.1 9.1 8.5 9.3 11.3 11.3 8.1 7.6 9.2 6.7 8.7 6.7 8.3 8.3 23.2 6.2 14.2 5.6 7.3 8.5 9.9 6.6 12.7 8.7 12.4 9.0 7.5 6.7 13.9 8.5 9.0 6.6 10.3 8.2 7.6 9.9 16.0 6.7 9.3 8.5 8.6 14.5 10.8 9.3 13.8 29.9 42.3 11.4 66.5 121.0 31.5 18.6 10.3 6.9 7.5 12.7 121.9 9.7 7.1 9.9 10.8 41.2 7.3 9.4 11.8 10.0 13.2 18.4 6.9 12.7 33.9 15.8 26.7 10.7 35.8 11.0 3.0 10.2 8.1 21.5 5.3 5.9 12.0 10.4 15.1 8.7 7.8 15.9 9.5 13.2 11.1 7.3 19.8 16.4 10.7 13.0 8.9 4.4 10.3 12.8 80.0 17.7 26.9 13.2 9.7 6.4 6.5 36.9 13.7 25.5 0.5 0.4 2.5 0.9 0.4 1.1 1.8 0.5 0.6 0.5 3.0 1.1 1.5 0.4 1.0 1.7 0.5 1.0 0.7 7.6 7.7 15.9 9.6 8.1 7.6 8.3 8.3 8.5 8.5 8.2 8.6 17.2 3.2 6.1 18.9 11.3 16.6 7.2 8.3 16.5 12.8 15.1 12.2 14.2 18.6 8.0 3.7 22.9 3.7 6.2 11.0 5.9 7.3 12.3 9.9 29.2 24.3 10.8 6.1 43.4 6.8 2.5 18.8 10.2 12.0 17.1 17.4 17.2 7.9 4.5 18.5 51.5 7.1 2.0 8.4 15.2 8.1 17.4 7.7 7.2 18.7 8.4 9.7 6.2 38.2 25.4 6.8 8.8 17.0 7.0 11.0 5.1 7.3 5.3 5.5 13.1 13.8 20.1 13.3 18.8 9.9 14.5 2.7 7.0 7.3 5.6 7.8 SPATA20 "FLJ21347, SSP411, Tisp78" ENSG00000006282 "Spermatogenesis associated 20" Q8TB22 17 50543058-50555852 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 117.5" "Group enriched" "Detected in all" 15 "Early spermatids: 594.1;Late spermatids: 1543.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 60.1;MCF7: 59.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA022023, HPA027144, HPA031442" Enhanced Approved Nucleoplasm "Secreted in male reproductive system" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 43: Testis - Unknown function" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA022023: AB_1857417, HPA027144: AB_1857418, HPA031442: AB_10610557" "unprognostic (9.27e-3)" "unprognostic (1.90e-1)" "unprognostic (9.60e-2)" "unprognostic (9.74e-3)" "unprognostic (2.63e-3)" "unprognostic (7.23e-2)" "unprognostic (1.56e-1)" "unprognostic (3.07e-1)" "unprognostic (7.09e-2)" "unprognostic (8.71e-2)" "unprognostic (6.12e-3)" "unprognostic (4.93e-2)" "unprognostic (6.74e-2)" "unprognostic (1.75e-1)" "unprognostic (2.29e-1)" "unprognostic (2.66e-1)" "prognostic favorable (9.69e-5)" 10.3 36.8 25.7 7.2 24.6 4.4 10.5 25.5 33.2 16.9 30.0 14.8 10.0 18.0 9.7 10.1 13.7 12.9 33.3 24.2 27.6 18.6 17.6 8.9 6.4 26.9 28.0 21.1 22.0 17.0 11.7 6.4 27.5 17.1 6.4 3.2 17.7 11.2 18.5 8.6 10.8 8.3 26.0 14.1 22.0 117.5 33.1 2.3 22.5 18.4 3.8 14.6 10.3 24.8 8.8 39.4 4.8 25.7 7.9 22.7 6.0 14.9 24.2 9.2 7.3 29.1 12.9 9.2 38.4 13.9 8.9 7.0 1.4 6.3 4.2 14.4 5.3 7.4 9.5 60.1 27.8 2.4 17.1 33.3 8.8 4.7 13.0 17.9 11.6 2.4 0.7 16.8 5.5 59.3 0.0 2.1 3.1 19.0 18.0 4.4 6.9 2.9 35.4 39.5 4.5 11.3 13.0 12.1 17.0 5.6 21.0 1.1 19.7 9.8 22.2 5.6 3.7 31.8 14.0 0.2 14.9 1.4 6.9 0.0 5.0 1.0 1.6 4.5 1.9 2.8 1.2 1.1 8.3 1.7 1.5 1.7 0.2 7.3 3.4 1.6 0.8 3.7 25.7 24.6 25.5 33.2 24.2 27.6 26.9 28.0 27.5 26.0 33.1 24.8 12.6 6.4 5.0 17.3 14.0 10.7 15.1 13.4 25.6 5.3 13.3 17.4 32.5 20.0 13.1 23.9 4.2 17.3 9.8 32.6 27.4 35.6 594.1 13.0 13.2 11.7 37.9 6.1 10.3 39.0 10.3 23.5 66.8 23.2 17.7 38.5 10.8 26.7 34.6 11.8 9.5 28.4 16.2 23.6 14.8 1543.1 38.2 20.0 21.4 6.5 19.3 26.9 12.3 8.5 2.3 23.7 31.1 38.0 17.9 12.2 18.4 38.8 5.9 2.4 6.6 18.1 19.1 10.0 13.8 11.9 8.8 9.9 11.2 39.9 23.8 17.1 SPRYD7 "C13orf1, CLLD6" ENSG00000123178 "SPRY domain containing 7" Q5W111 13 49912702-49936490 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 131.4;Spermatocytes: 167.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043934 Approved Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 54: Non-specific - Microtubule organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA043934: AB_10960545" "unprognostic (1.83e-2)" "prognostic unfavorable (8.48e-6)" "unprognostic (2.57e-1)" "unprognostic (4.95e-2)" "unprognostic (4.45e-1)" "unprognostic (1.87e-3)" "unprognostic (3.54e-2)" "unprognostic (1.12e-1)" "unprognostic (4.05e-1)" "unprognostic (3.12e-3)" "unprognostic (3.34e-3)" "unprognostic (1.17e-1)" "unprognostic (1.01e-1)" "unprognostic (6.53e-2)" "unprognostic (1.51e-1)" "unprognostic (1.65e-2)" "unprognostic (1.06e-2)" 5.3 8.6 9.4 3.8 9.9 3.2 5.6 7.9 14.6 4.9 4.8 7.6 6.3 4.3 5.3 7.7 4.7 3.1 11.6 10.3 10.4 8.4 10.7 10.2 3.2 8.6 9.0 5.4 5.5 9.5 6.0 6.2 9.8 6.4 6.6 12.3 4.7 4.9 23.9 6.0 7.2 5.2 7.9 4.0 7.0 8.9 10.0 2.6 6.7 15.4 3.6 5.7 5.4 9.1 10.1 8.5 5.4 6.0 6.5 9.2 12.3 19.5 9.1 13.5 7.7 15.5 8.1 9.8 6.1 14.4 11.1 8.5 12.1 18.1 18.7 16.3 10.9 10.5 6.5 10.9 22.1 25.4 7.2 8.0 20.0 11.8 23.0 8.4 8.4 5.5 12.0 8.6 31.6 6.2 0.9 11.9 2.1 15.3 9.6 4.7 9.1 6.0 14.1 7.6 4.5 5.6 5.7 12.8 9.8 6.8 11.9 15.7 10.8 12.2 6.8 11.3 19.8 5.3 8.8 7.5 9.5 10.2 14.0 0.7 2.0 1.7 2.0 2.3 4.1 5.3 1.9 2.6 2.5 4.3 1.5 2.3 0.4 6.8 4.6 1.7 3.1 1.8 9.4 9.9 7.9 14.6 10.3 10.4 8.6 9.0 9.8 7.9 10.0 9.1 23.7 131.4 32.8 22.2 17.0 20.3 23.3 64.1 21.1 29.4 17.2 20.1 60.1 21.5 32.1 12.9 8.4 38.8 11.2 42.4 52.8 32.1 118.5 25.9 20.0 21.5 23.4 6.5 35.5 25.8 45.0 21.4 15.3 13.3 17.7 12.5 19.2 52.1 27.9 23.5 33.3 21.4 26.4 7.6 13.9 24.3 21.1 14.1 23.2 24.4 14.6 21.6 12.3 24.6 60.1 37.2 23.6 20.3 12.4 23.9 34.5 82.1 26.6 30.7 6.6 20.1 29.8 167.1 56.9 33.8 31.0 39.8 11.9 27.7 22.2 10.4 SRFBP1 "BUD22, FLJ25286, p49, Rlb1, STRAP" ENSG00000151304 "Serum response factor binding protein 1" Q8NEF9 5 121961975-122075570 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042737 Approved Approved "Nucleoli rim" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "Nucleoli rim" "HPA042737: AB_10796583" "unprognostic (8.94e-2)" "unprognostic (1.80e-1)" "unprognostic (4.68e-2)" "unprognostic (1.61e-2)" "unprognostic (4.14e-1)" "unprognostic (1.18e-1)" "unprognostic (5.07e-3)" "unprognostic (2.03e-1)" "unprognostic (8.96e-3)" "unprognostic (6.31e-3)" "prognostic unfavorable (5.31e-4)" "unprognostic (1.11e-1)" "unprognostic (1.41e-2)" "unprognostic (1.78e-1)" "unprognostic (4.71e-1)" "unprognostic (1.43e-1)" "unprognostic (8.45e-2)" 6.8 4.3 2.3 6.3 3.0 6.2 9.1 3.6 2.6 6.3 2.3 5.3 4.9 6.2 4.3 6.9 5.2 5.1 4.6 1.9 2.3 7.2 6.9 4.7 7.4 2.9 3.2 4.8 4.3 7.4 1.7 6.3 3.1 5.4 5.7 4.2 5.0 4.7 6.3 3.8 4.1 5.8 2.8 6.1 4.6 4.5 3.2 5.4 8.3 6.9 6.5 7.7 3.5 4.1 14.7 10.6 9.5 15.2 10.7 9.9 15.9 13.8 10.0 14.8 17.3 8.7 14.2 18.4 15.6 8.6 25.5 10.5 15.7 18.8 27.5 26.4 8.9 17.7 7.0 9.0 11.5 20.6 14.0 12.0 14.2 18.7 18.3 7.1 16.3 9.3 16.5 14.5 15.7 6.8 14.4 6.6 14.1 11.6 6.9 14.6 22.6 19.4 16.5 14.9 9.9 9.2 12.7 12.5 24.2 11.8 12.7 12.2 11.9 22.8 13.8 16.4 20.3 7.7 15.5 20.8 13.0 16.4 20.4 0.6 7.0 2.8 6.0 12.7 7.8 10.3 6.7 6.8 9.6 8.8 7.8 10.7 0.9 7.8 10.4 9.0 6.8 4.3 2.3 3.0 3.6 2.6 1.9 2.3 2.9 3.2 3.1 2.8 3.2 4.1 45.5 16.0 15.2 15.7 32.4 19.2 36.7 27.8 12.0 38.7 19.7 26.3 14.3 18.6 26.2 14.7 25.0 20.6 21.2 8.0 41.1 33.0 35.2 29.5 37.5 25.2 16.2 22.9 26.2 20.2 19.7 24.2 16.3 27.8 44.4 24.9 8.6 9.4 20.0 47.1 24.3 11.2 12.2 8.1 11.7 7.5 24.2 22.9 19.6 23.4 16.6 29.8 21.6 35.7 34.0 20.2 9.7 26.7 10.7 35.1 4.4 34.8 17.8 28.6 13.1 41.3 28.3 29.6 27.4 18.3 19.0 12.9 19.0 30.5 19.6 27.8 SRP54 ENSG00000100883 "Signal recognition particle 54" P61011 14 34981957-35029686 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Hydrolase, Ribonucleoprotein, RNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 327.3;Late spermatids: 901.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048977, HPA062044" Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 25: Spermatids - Spermatogenesis" Cytosol "HPA048977: AB_2680583, HPA062044: AB_2684668" "unprognostic (1.22e-3)" "unprognostic (6.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.72e-2)" "unprognostic (3.88e-1)" "unprognostic (2.67e-3)" "unprognostic (2.06e-3)" "unprognostic (6.44e-2)" "unprognostic (2.53e-1)" "unprognostic (1.88e-2)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.10e-3)" "unprognostic (1.81e-1)" "unprognostic (1.98e-1)" "unprognostic (2.86e-1)" "unprognostic (2.50e-3)" 22.8 33.1 17.1 30.2 18.1 17.4 28.7 19.3 22.5 32.5 20.9 28.1 25.8 23.3 35.8 28.5 22.0 23.2 32.1 17.6 21.3 35.3 61.9 25.0 34.6 19.8 19.2 22.7 55.0 39.7 36.2 29.5 20.5 31.2 29.5 24.2 60.3 28.7 39.8 26.1 26.8 23.5 20.0 28.4 30.4 44.0 18.1 35.5 30.9 33.7 42.6 34.8 23.1 21.4 59.3 66.9 56.7 54.9 62.8 61.3 67.8 83.2 78.3 87.3 107.0 71.3 62.8 75.8 77.5 81.4 75.8 56.1 79.0 66.7 125.6 87.5 37.8 70.9 54.6 184.6 92.7 70.5 65.4 51.5 64.8 63.5 102.3 66.1 88.8 64.9 61.7 82.7 93.1 98.8 81.9 42.4 45.0 96.1 61.3 58.5 72.2 67.4 104.9 89.3 48.9 59.4 59.3 76.7 74.6 71.4 99.4 49.7 66.6 48.7 51.0 62.8 57.1 73.2 108.3 101.1 36.8 45.9 63.5 23.8 27.4 39.2 31.0 35.0 39.6 25.6 31.4 34.0 32.8 25.8 28.7 28.3 27.1 42.1 47.0 21.9 48.2 30.5 17.1 18.1 19.3 22.5 17.6 21.3 19.8 19.2 20.5 20.0 18.1 21.4 40.8 12.8 49.3 25.5 63.2 40.0 56.0 74.6 37.5 37.5 40.7 29.0 41.0 34.3 81.2 40.5 58.4 67.3 59.6 39.4 64.6 73.2 327.3 53.1 43.9 40.7 44.9 36.2 25.4 79.8 75.6 45.8 38.7 64.3 47.5 37.3 36.4 110.0 49.7 26.9 26.8 48.7 87.5 39.0 43.6 901.8 38.5 47.4 28.4 24.4 56.1 44.3 41.2 27.6 54.6 55.1 34.0 37.6 133.1 60.7 39.0 79.2 93.0 50.1 26.3 38.3 46.1 95.4 76.0 36.0 50.3 94.0 64.7 43.0 31.6 64.5 SRR "ILV1, ISO1" ENSG00000167720 "Serine racemase" Q9GZT4 17 2303383-2325260 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Allosteric enzyme, Isomerase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007529, CAB015343" Approved Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Vesicles "CAB015343: AB_2195009, HPA007529: AB_2667853" "unprognostic (2.96e-1)" "unprognostic (7.86e-2)" "unprognostic (6.01e-2)" "prognostic favorable (6.20e-5)" "unprognostic (3.05e-1)" "unprognostic (1.57e-2)" "unprognostic (4.32e-2)" "unprognostic (9.97e-2)" "unprognostic (9.09e-2)" "unprognostic (4.85e-2)" "prognostic favorable (8.16e-4)" "unprognostic (5.17e-2)" "prognostic favorable (2.45e-6)" "unprognostic (6.14e-2)" "unprognostic (1.99e-1)" "unprognostic (1.89e-1)" "unprognostic (5.84e-2)" 10.5 7.8 11.0 6.6 11.5 13.9 8.9 12.5 13.1 6.8 13.0 9.4 6.9 7.5 10.3 10.9 8.7 8.3 10.9 9.4 13.4 9.0 8.2 6.1 6.6 11.2 12.4 8.4 11.9 12.3 4.9 5.4 12.7 8.4 7.5 16.6 10.7 7.7 15.6 11.8 5.9 7.0 11.1 6.9 8.0 7.1 12.5 9.0 11.8 6.7 5.4 8.4 5.3 11.8 14.8 27.0 42.7 17.9 24.9 24.4 22.8 29.8 20.2 19.4 20.5 25.3 18.1 27.5 4.1 29.1 14.3 30.2 12.2 11.4 24.6 32.6 26.0 14.6 20.3 9.6 22.5 4.3 8.0 22.9 11.5 41.4 21.0 21.2 28.6 28.2 15.2 19.8 43.9 8.4 28.7 5.8 10.0 13.8 19.9 45.5 48.8 13.3 22.9 6.9 9.2 23.4 26.8 3.3 14.3 14.6 20.7 10.3 21.3 21.4 14.7 24.7 19.0 16.7 26.0 5.1 36.9 13.7 29.8 4.3 8.1 5.6 8.8 8.4 9.1 10.1 11.2 9.1 15.6 10.2 9.2 12.1 1.0 15.7 14.0 11.0 8.8 8.5 11.0 11.5 12.5 13.1 9.4 13.4 11.2 12.4 12.7 11.1 12.5 11.8 5.0 3.2 3.7 3.6 2.1 2.9 3.5 17.4 1.8 8.5 5.5 4.6 4.2 1.5 8.4 1.8 0.0 5.9 3.4 3.0 13.7 9.6 1.9 6.6 5.5 5.4 1.8 5.2 3.5 6.6 3.2 5.7 3.6 4.6 0.0 13.2 8.2 3.2 9.3 16.8 4.9 2.5 12.2 4.6 4.9 1.5 4.1 3.7 5.4 4.7 9.3 11.0 5.2 5.0 7.8 6.7 0.8 5.3 6.1 2.9 2.9 6.3 10.2 5.6 0.0 4.6 6.5 23.3 13.1 4.7 2.4 3.4 2.3 9.7 3.5 4.0 SRSF1 "ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a" ENSG00000136450 "Serine and arginine rich splicing factor 1" Q07955 17 58000919-58007346 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013073, HPA061301" Supported Supported Nucleoplasm NA NA 980000 "Cluster 27: Non-specific - Gene expression" "Cluster 14: B-cells - Humoral immune response" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "CAB013073: AB_2533079, HPA061301: AB_2684474" "unprognostic (9.86e-2)" "prognostic favorable (7.00e-4)" "prognostic favorable (4.56e-5)" "unprognostic (8.11e-2)" "unprognostic (2.00e-1)" "unprognostic (3.88e-3)" "prognostic unfavorable (1.64e-6)" "unprognostic (8.28e-2)" "unprognostic (2.60e-3)" "unprognostic (3.07e-2)" "unprognostic (1.98e-1)" "unprognostic (5.48e-2)" "prognostic unfavorable (2.95e-5)" "unprognostic (1.02e-2)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (1.59e-2)" 71.1 81.1 44.0 84.0 47.5 54.7 62.8 52.1 50.0 78.6 53.8 76.1 69.7 79.1 70.0 84.0 73.5 42.5 61.8 43.0 45.9 71.0 71.4 60.8 107.1 44.1 45.7 78.4 58.6 73.0 69.2 64.8 45.0 70.2 77.1 60.5 67.5 57.4 71.2 57.2 73.4 59.6 47.4 72.6 69.0 38.9 46.3 104.5 72.7 51.5 119.7 69.3 73.6 50.7 211.4 157.1 264.9 153.3 72.3 67.3 164.6 187.0 102.9 177.9 167.8 195.9 180.6 352.0 121.1 129.8 134.3 178.9 298.4 192.6 325.5 196.8 176.1 263.0 202.2 220.9 83.2 292.4 169.9 56.3 90.5 164.6 168.3 84.3 145.1 131.9 291.0 166.9 181.2 162.6 370.2 258.4 246.5 191.7 160.9 349.4 216.1 217.1 176.6 177.5 192.4 206.8 142.5 128.6 139.5 142.0 180.8 220.5 139.3 158.6 197.0 122.7 258.8 149.7 217.3 333.3 150.1 272.2 193.8 23.9 48.3 32.5 38.9 64.4 38.6 35.7 30.7 37.1 71.1 24.9 32.8 33.3 22.0 48.1 45.1 40.5 36.9 45.2 44.0 47.5 52.1 50.0 43.0 45.9 44.1 45.7 45.0 47.4 46.3 50.7 74.1 35.3 48.3 66.0 89.1 133.7 130.0 53.1 96.2 62.9 73.1 58.0 31.3 41.5 48.6 44.1 31.3 70.3 68.1 57.5 70.5 68.2 57.8 44.9 59.2 66.2 65.8 93.2 33.0 60.1 116.6 74.7 53.5 59.3 59.6 92.2 44.6 46.3 59.1 52.2 51.8 76.2 52.9 54.0 73.5 34.0 84.2 52.3 55.2 36.5 60.7 43.5 80.3 56.3 59.2 61.4 84.9 60.2 73.3 102.8 76.3 56.4 43.4 83.1 105.2 87.7 89.5 74.6 58.0 86.6 137.5 60.9 69.4 57.3 93.3 120.6 STIP1 "HOP, STI1" ENSG00000168439 "Stress induced phosphoprotein 1" P31948 11 64185272-64204543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 340.6" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017448, HPA039291, HPA044062" Enhanced Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA 3600000 "Cluster 27: Non-specific - Gene expression" "Cluster 47: Non-specific - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 22: Epithelial cell types - Mixed function" "Nucleoplasm, Plasma membrane" Cytosol "CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795" "unprognostic (2.49e-3)" "unprognostic (6.04e-2)" "unprognostic (1.57e-1)" "unprognostic (4.65e-2)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.23e-4)" "prognostic unfavorable (6.18e-8)" "unprognostic (2.16e-3)" "unprognostic (4.56e-2)" "unprognostic (1.12e-2)" "unprognostic (3.56e-2)" "unprognostic (3.04e-3)" "unprognostic (1.70e-1)" "unprognostic (6.72e-2)" "unprognostic (8.23e-2)" "unprognostic (7.16e-2)" "unprognostic (2.99e-2)" 68.0 128.0 114.5 70.2 119.9 61.3 49.7 124.6 340.6 69.5 122.1 72.9 40.4 74.1 49.0 79.5 72.4 43.5 98.5 120.2 133.4 86.7 68.9 70.8 72.9 124.0 131.3 87.6 53.3 61.4 71.7 77.5 139.2 60.7 56.0 62.9 56.1 56.1 140.3 60.5 53.9 66.7 123.6 69.0 66.1 126.3 134.2 66.2 57.6 92.2 88.2 81.2 63.8 159.4 321.0 486.3 298.1 251.7 161.8 108.1 271.5 277.2 150.1 393.9 228.1 361.3 265.2 371.1 322.9 220.3 475.4 329.7 745.4 280.3 427.6 302.1 311.7 521.5 302.6 336.7 142.8 278.7 325.1 109.4 174.5 327.1 242.7 162.4 284.2 276.1 537.2 209.5 232.1 468.8 432.0 388.6 366.4 306.0 407.2 418.3 279.1 385.6 282.8 271.8 242.7 217.3 314.4 338.9 266.7 310.3 357.1 194.0 253.8 252.0 310.9 333.1 389.0 189.8 434.0 388.0 328.8 282.6 374.1 61.0 66.8 57.4 87.6 95.1 88.2 85.9 65.5 79.5 69.9 68.5 72.7 81.6 20.0 108.2 114.6 58.1 66.1 119.1 114.5 119.9 124.6 340.6 120.2 133.4 124.0 131.3 139.2 123.6 134.2 159.4 31.3 44.8 32.9 7.8 40.0 80.4 184.1 61.5 40.9 37.5 32.5 29.8 46.1 31.5 59.1 20.2 41.7 124.8 39.8 38.3 49.0 76.3 31.0 65.8 48.6 45.9 67.3 69.0 9.5 55.2 146.1 49.6 24.5 51.1 79.3 47.8 14.3 27.4 91.5 63.9 14.9 39.9 97.6 21.9 90.3 77.5 27.4 46.7 62.2 12.2 51.8 36.9 53.5 11.1 17.2 69.5 32.7 39.9 56.4 75.7 22.3 39.6 85.8 36.7 26.3 36.1 65.4 96.3 118.6 47.6 72.0 211.0 67.0 62.8 48.6 95.3 STK25 "SOK1, YSK1" ENSG00000115694 "Serine/threonine kinase 25" O00506 2 241492670-241509730 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 489.9;tongue: 213.8" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047147 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 33: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA047147: AB_10966137" "unprognostic (1.75e-1)" "unprognostic (8.29e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (3.42e-2)" "unprognostic (2.71e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (3.91e-8)" "unprognostic (6.16e-2)" "unprognostic (7.15e-3)" "unprognostic (1.11e-1)" "unprognostic (2.58e-3)" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (2.00e-1)" "unprognostic (1.37e-1)" "unprognostic (3.19e-1)" "unprognostic (4.58e-1)" 53.2 50.6 48.2 37.1 48.9 47.0 52.8 35.8 56.7 59.8 27.8 59.8 36.2 62.9 24.0 62.6 60.5 32.9 69.1 50.4 47.1 56.5 50.0 49.6 36.7 37.5 40.9 59.4 70.3 45.9 65.3 38.7 43.3 55.4 30.5 28.9 48.7 40.2 489.9 53.1 50.5 42.1 30.7 61.6 58.7 48.7 46.4 38.5 71.9 213.8 31.8 60.8 56.7 41.2 75.2 46.9 91.1 114.0 109.9 75.9 140.1 122.3 81.8 90.9 103.4 52.3 64.4 28.5 33.7 163.9 82.3 62.9 130.2 132.9 109.9 107.0 136.4 79.7 98.3 136.6 99.3 48.7 59.0 110.1 93.9 88.3 70.3 111.1 208.7 102.6 125.2 24.6 168.8 78.6 73.0 75.9 127.9 69.5 66.3 121.1 116.2 42.6 79.5 62.4 152.8 70.2 59.4 44.2 77.0 102.7 35.7 85.2 245.7 68.2 83.0 79.1 88.3 50.3 12.1 48.8 66.0 39.6 79.1 17.0 16.3 12.9 17.3 15.5 16.3 15.9 15.9 18.5 15.0 16.9 12.3 11.8 5.8 24.6 19.7 11.8 23.3 12.6 48.2 48.9 35.8 56.7 50.4 47.1 37.5 40.9 43.3 30.7 46.4 41.2 43.6 22.4 41.4 23.2 19.7 25.5 29.0 29.7 19.9 48.7 33.2 39.4 36.3 42.9 24.0 25.8 27.1 82.7 19.8 35.2 27.4 46.0 13.8 18.5 28.4 52.7 35.4 48.6 29.8 34.2 80.7 35.1 36.7 25.4 25.4 40.8 45.7 21.5 45.1 32.0 26.1 40.0 20.3 27.3 25.7 14.4 32.6 20.8 19.6 21.5 47.0 58.9 18.6 16.1 27.5 36.9 74.5 39.9 15.8 37.1 43.4 46.1 16.2 41.1 46.0 41.7 35.3 90.2 54.7 31.7 30.4 52.4 25.4 53.2 44.9 29.9 STOML1 "FLJ36370, hUNC-24, SLP-1, STORP" ENSG00000067221 "Stomatin like 1" Q9UBI4 15 73978926-73994622 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042353 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 65: Brain - Ion transport" "Cluster 18: U-2197 - ECM organization" "Cluster 1: Pancreatic cells - Digestion" Cytosol "HPA042353: AB_10797387" "unprognostic (5.75e-2)" "unprognostic (1.70e-1)" "unprognostic (7.76e-2)" "unprognostic (4.54e-3)" "unprognostic (1.39e-2)" "unprognostic (1.81e-2)" "unprognostic (1.54e-1)" "unprognostic (2.45e-1)" "unprognostic (1.78e-1)" "unprognostic (2.64e-1)" "unprognostic (1.13e-1)" "unprognostic (2.30e-3)" "unprognostic (2.26e-3)" "unprognostic (2.14e-1)" "unprognostic (1.37e-1)" "unprognostic (1.55e-1)" "unprognostic (2.67e-2)" 11.4 17.3 33.0 6.5 33.7 4.5 10.4 22.0 38.5 9.8 17.1 11.0 5.9 9.1 5.6 9.4 7.3 6.3 23.6 36.8 32.4 8.6 13.2 10.2 5.6 34.6 30.5 8.5 10.1 7.8 16.6 7.5 36.8 9.9 3.6 3.1 8.3 8.8 18.6 9.4 7.9 7.7 26.5 7.9 9.5 13.1 32.6 8.1 13.6 8.9 3.8 11.8 9.2 28.4 5.8 10.8 6.4 8.8 12.7 8.0 5.4 18.3 7.1 9.8 8.3 3.2 31.4 5.8 28.3 14.9 7.3 18.9 6.1 12.9 3.1 19.4 6.6 6.1 10.0 3.6 12.5 4.0 4.6 14.3 9.9 15.4 14.5 8.1 9.3 13.1 14.6 10.9 14.3 8.8 7.6 2.9 3.1 8.9 8.6 4.5 6.5 8.9 20.7 6.3 12.1 7.9 8.4 10.9 11.9 4.0 9.1 4.4 14.3 22.4 7.2 25.8 24.9 10.6 5.8 3.0 20.6 12.1 11.6 1.0 4.1 2.5 5.3 7.7 4.4 4.5 4.3 7.0 6.5 5.6 8.7 9.2 2.1 8.0 18.2 11.5 8.1 5.5 33.0 33.7 22.0 38.5 36.8 32.4 34.6 30.5 36.8 26.5 32.6 28.4 15.2 0.0 4.1 7.2 5.3 3.2 3.7 7.2 1.8 13.1 7.0 4.8 10.8 2.8 5.8 7.3 6.2 13.0 3.5 8.9 1.9 25.1 1.0 2.8 6.2 7.7 10.2 4.2 6.9 19.0 8.6 11.4 12.8 5.4 4.5 8.5 5.0 5.1 10.8 16.8 8.1 7.3 4.1 3.3 2.2 2.6 9.0 3.3 3.6 2.8 2.5 11.9 2.1 7.5 4.1 20.8 4.9 11.7 3.4 6.8 12.6 4.8 2.7 14.0 6.6 7.5 9.7 20.8 7.8 4.7 2.0 5.6 4.1 13.7 5.6 3.3 STRIP1 "FAM40A, FAR11A, FLJ14743, KIAA1761" ENSG00000143093 "Striatin interacting protein 1" Q5VSL9 1 110031577-110074641 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 58.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA060302, HPA060498" Approved Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA060302: AB_2684247, HPA060498: AB_2684293" "unprognostic (2.75e-2)" "unprognostic (3.91e-1)" "unprognostic (2.81e-2)" "unprognostic (1.63e-1)" "unprognostic (5.09e-1)" "unprognostic (2.90e-2)" "unprognostic (1.01e-2)" "unprognostic (9.08e-2)" "unprognostic (2.83e-1)" "unprognostic (6.29e-2)" "unprognostic (1.41e-3)" "unprognostic (2.86e-1)" "unprognostic (1.42e-1)" "unprognostic (1.88e-2)" "unprognostic (1.82e-1)" "unprognostic (6.23e-2)" "unprognostic (2.23e-2)" 14.9 14.9 13.0 11.7 13.9 22.6 13.9 9.9 14.3 19.2 8.8 16.1 13.1 19.1 15.6 15.2 15.6 10.8 12.7 14.5 13.4 12.3 9.8 12.7 15.6 11.9 12.9 21.5 12.6 21.3 15.7 16.6 14.0 12.9 13.4 11.9 14.1 13.8 14.1 17.5 19.7 18.0 10.1 22.6 13.5 19.4 17.2 16.2 13.6 13.7 15.4 15.4 14.9 12.0 19.7 12.8 34.3 23.4 29.3 19.3 24.7 30.3 26.3 30.9 26.8 13.5 11.2 16.0 16.2 27.0 19.6 18.3 18.4 21.5 21.7 34.2 22.3 26.7 23.1 17.7 16.2 24.3 25.6 20.7 25.3 26.2 28.6 22.7 25.0 21.6 24.1 19.9 30.3 23.3 28.0 25.5 27.9 14.8 17.2 27.0 44.1 14.3 21.4 28.5 44.1 25.4 25.9 32.4 19.5 19.7 16.2 21.9 25.9 23.2 22.1 27.2 20.5 20.3 12.0 16.3 26.5 25.9 34.2 13.9 10.5 14.8 14.9 11.4 13.0 10.7 12.5 15.7 12.2 10.2 14.4 13.0 9.6 16.1 15.5 5.6 12.6 12.8 13.0 13.9 9.9 14.3 14.5 13.4 11.9 12.9 14.0 10.1 17.2 12.0 9.0 3.2 7.8 17.3 16.4 13.8 10.0 7.2 9.6 12.6 8.3 5.7 8.5 4.3 8.2 9.2 18.8 16.1 11.9 15.5 1.9 10.7 47.3 9.1 9.6 13.2 15.0 13.0 15.6 7.2 10.4 10.6 11.7 15.1 7.0 16.2 14.6 9.8 12.9 6.7 17.7 13.0 8.2 11.1 11.6 58.0 9.9 8.9 3.6 7.5 14.3 7.1 17.5 15.1 12.6 12.5 10.2 10.1 11.9 11.5 23.1 3.9 3.0 18.9 6.6 11.4 12.5 11.3 10.2 10.9 12.8 25.9 15.2 13.0 11.5 14.1 SUCLA2 LINC00444 ENSG00000136143 "Succinate-CoA ligase ADP-forming subunit beta" Q9P2R7 13 47745736-48037968 "Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 232.2;tongue: 271.9" "Cell type enhanced" "Detected in all" "Early spermatids: 256.2;Late spermatids: 314.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039435, HPA039536, HPA061528" Enhanced Supported Enhanced Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria "HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553" "unprognostic (5.66e-3)" "unprognostic (1.72e-2)" "unprognostic (1.14e-1)" "unprognostic (8.76e-2)" "unprognostic (1.60e-1)" "unprognostic (3.45e-2)" "unprognostic (2.48e-1)" "unprognostic (1.71e-1)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (1.10e-1)" "unprognostic (1.38e-1)" "prognostic favorable (7.59e-14)" "unprognostic (3.53e-1)" "unprognostic (2.19e-1)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.22e-4)" 53.9 40.6 28.4 20.2 30.8 13.6 38.7 36.6 39.2 32.4 33.6 37.1 58.2 27.2 24.8 33.1 24.7 20.3 100.2 30.7 38.2 77.5 29.0 18.2 22.0 30.6 30.0 30.9 25.4 71.2 20.4 28.1 32.3 35.8 36.3 44.2 33.9 31.3 232.2 20.5 44.7 33.1 30.6 19.9 29.7 17.9 33.8 30.7 36.4 271.9 23.9 26.0 25.3 35.1 44.9 49.5 60.6 37.1 68.4 51.3 38.9 64.8 72.4 66.9 44.5 91.3 47.9 61.3 49.3 63.9 39.9 60.0 81.9 61.9 81.6 59.8 75.9 69.2 45.8 58.0 47.6 69.9 38.9 48.4 71.2 45.3 52.6 54.4 49.0 70.7 47.7 21.1 65.8 31.4 73.1 80.8 64.4 150.2 64.7 60.9 55.4 49.3 94.4 41.9 34.7 41.2 54.5 49.3 39.1 66.5 43.8 60.8 39.0 36.2 24.1 53.0 45.7 23.0 37.4 72.7 22.8 50.9 54.8 12.6 50.2 27.8 34.4 53.7 41.9 34.6 38.0 42.2 62.5 33.1 47.7 47.5 8.8 51.8 46.1 49.8 46.6 36.5 28.4 30.8 36.6 39.2 30.7 38.2 30.6 30.0 32.3 30.6 33.8 35.1 20.8 25.6 16.8 17.6 20.1 32.4 37.7 57.5 21.1 44.8 28.9 26.5 148.8 17.2 40.2 31.3 12.5 48.7 18.1 29.1 164.4 32.3 256.2 50.9 32.0 22.0 19.2 21.0 37.0 17.8 42.7 37.7 19.9 52.6 33.7 25.2 16.1 14.7 29.9 45.4 39.0 19.5 71.2 16.7 20.4 314.2 37.0 21.7 42.7 21.5 24.9 43.3 13.4 26.2 38.2 20.2 30.6 46.3 22.1 35.9 62.3 127.4 29.9 42.4 39.5 33.3 50.0 36.3 29.0 22.8 31.7 52.1 19.7 47.3 30.4 39.0 SUGP1 "DKFZp434E2216, F23858, RBP, SF4" ENSG00000105705 "SURP and G-patch domain containing 1" Q8IWZ8 19 19276018-19320509 "Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 115.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004890 Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm "HPA004890: AB_1079935" "unprognostic (1.08e-1)" "unprognostic (4.51e-3)" "unprognostic (5.21e-2)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (7.34e-3)" "unprognostic (1.67e-2)" "unprognostic (4.90e-3)" "unprognostic (2.14e-2)" "unprognostic (1.26e-1)" "unprognostic (1.37e-3)" "unprognostic (4.25e-2)" "unprognostic (3.52e-2)" "unprognostic (2.06e-3)" "unprognostic (5.51e-2)" "unprognostic (1.50e-2)" "unprognostic (3.42e-3)" 5.3 5.5 2.7 4.1 3.1 2.5 5.1 2.4 3.4 4.7 2.5 6.4 4.0 6.3 2.5 6.8 5.0 1.7 8.4 3.3 3.0 4.8 4.1 4.0 3.0 3.0 3.3 4.5 4.3 4.0 4.1 2.7 3.1 4.1 2.4 2.0 5.7 3.0 15.0 5.9 5.7 2.9 2.5 5.5 6.0 14.9 3.0 5.6 4.4 5.6 3.5 5.3 4.7 4.1 13.2 2.7 6.3 8.1 5.8 5.7 15.6 8.1 11.2 11.1 8.9 3.9 9.4 11.1 12.8 10.9 6.7 9.4 6.4 10.3 6.4 7.9 5.2 9.3 3.5 4.0 6.0 8.3 11.9 10.4 5.4 10.0 3.7 6.3 7.4 7.8 14.1 6.9 9.9 8.2 16.1 12.1 14.9 10.2 8.0 15.0 7.1 11.9 8.5 6.0 10.5 12.5 6.3 8.6 15.4 6.9 8.4 13.1 14.7 9.0 9.6 12.8 11.0 11.4 11.8 13.3 11.8 9.1 11.0 6.4 8.9 9.0 9.2 10.8 7.2 7.6 7.9 9.5 9.0 7.4 7.8 8.1 10.2 10.9 13.9 6.9 8.3 9.5 2.7 3.1 2.4 3.4 3.3 3.0 3.0 3.3 3.1 2.5 3.0 4.1 6.4 16.0 14.1 14.4 11.4 4.7 6.5 20.1 12.5 11.5 6.2 6.9 21.5 14.3 16.9 14.7 4.2 18.6 10.7 11.8 17.6 15.1 44.1 9.2 7.6 9.5 9.6 19.0 12.1 14.1 14.3 8.9 13.7 7.2 9.5 11.8 10.4 8.2 14.2 1.7 13.4 10.3 8.2 9.4 7.2 115.2 11.1 10.3 10.6 3.7 17.6 15.2 14.4 10.1 8.6 13.4 13.7 12.4 8.4 3.3 16.5 16.4 10.4 10.2 6.6 8.9 13.7 32.5 17.8 7.1 5.7 16.8 12.0 24.1 11.1 4.4 SUPT16H "CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68" ENSG00000092201 "SPT16 homolog, facilitates chromatin remodeling subunit" Q9Y5B9 14 21351476-21384019 "Enzymes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022551, HPA049787" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center" NA NA 27000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Nucleoli fibrillar center" "CAB022551: , HPA049787: AB_2680881" "unprognostic (1.65e-1)" "unprognostic (2.22e-1)" "unprognostic (3.52e-2)" "unprognostic (7.12e-2)" "unprognostic (7.32e-2)" "unprognostic (1.22e-2)" "unprognostic (1.38e-3)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (4.91e-2)" "unprognostic (1.09e-1)" "unprognostic (1.26e-1)" "unprognostic (6.48e-3)" "unprognostic (1.02e-1)" "unprognostic (7.58e-3)" "unprognostic (9.05e-2)" "unprognostic (5.87e-3)" 29.3 24.8 9.7 36.6 11.1 42.3 35.9 18.8 13.9 34.2 8.2 30.6 23.1 41.1 19.5 29.0 32.0 24.1 24.1 9.7 15.6 28.6 22.4 26.3 51.2 11.3 12.0 43.6 22.6 46.2 13.5 32.1 12.0 29.9 35.1 44.4 20.9 32.6 21.8 28.9 25.9 36.6 10.7 32.9 26.3 43.3 12.1 56.8 33.3 24.6 51.8 35.6 20.1 12.3 147.8 136.9 185.5 136.6 85.5 81.7 131.4 130.3 103.2 155.5 145.4 133.9 129.5 311.3 48.5 96.5 99.7 153.9 237.2 118.9 234.0 99.8 100.9 188.7 121.9 195.1 87.0 270.1 134.7 73.4 72.6 131.0 146.3 75.4 107.7 174.2 158.1 129.4 131.3 99.9 253.6 85.8 207.1 136.2 134.1 270.3 210.6 168.0 63.9 160.8 183.8 157.2 209.8 125.3 81.1 118.7 69.2 127.9 91.1 135.0 113.4 85.0 143.3 128.8 230.2 306.7 49.9 158.0 104.9 35.6 18.3 28.2 29.6 23.9 34.7 31.2 27.9 33.2 23.7 27.4 31.3 32.2 15.0 34.0 31.1 22.2 28.4 25.2 9.7 11.1 18.8 13.9 9.7 15.6 11.3 12.0 12.0 10.7 12.1 12.3 41.5 64.1 55.9 24.2 51.6 35.6 44.3 51.5 45.5 48.9 46.3 49.7 64.2 22.8 50.3 53.3 47.9 65.1 73.6 28.4 25.4 71.0 142.5 52.0 124.3 46.9 23.4 74.6 27.4 61.1 63.9 61.1 29.6 61.7 84.2 73.4 29.3 32.0 41.9 55.5 30.1 31.2 40.7 34.9 25.2 96.1 59.7 40.7 17.8 20.6 90.9 53.3 64.9 16.1 25.2 68.9 15.2 59.8 39.5 46.1 16.5 30.4 40.2 41.1 19.7 78.5 69.5 128.9 152.8 45.1 41.5 45.6 56.3 61.6 43.0 35.7 SUV39H1 "KMT1A, SUV39H" ENSG00000101945 "Suppressor of variegation 3-9 homolog 1" O43463 X 48695554-48709016 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Differentiation, Host-virus interaction, rRNA processing, Transcription, Transcription regulation" "Chromatin regulator, Methyltransferase, Repressor, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "unprognostic (4.92e-2)" "prognostic favorable (8.93e-5)" "unprognostic (9.51e-2)" "unprognostic (4.18e-2)" "unprognostic (1.75e-1)" "unprognostic (1.66e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (1.03e-1)" "unprognostic (3.59e-2)" "unprognostic (1.13e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (1.91e-7)" "unprognostic (2.29e-3)" "unprognostic (6.47e-3)" "unprognostic (2.01e-1)" "unprognostic (5.67e-2)" 4.0 2.2 4.7 4.2 4.4 13.7 3.5 4.9 5.1 2.9 2.0 3.4 3.1 3.2 12.5 5.0 3.3 1.7 3.6 4.3 5.1 2.6 6.6 2.7 7.5 5.2 5.6 3.8 2.9 2.3 3.0 3.3 4.8 3.0 3.2 3.3 2.6 3.0 4.9 4.4 4.2 2.6 3.9 6.0 3.6 4.9 5.0 9.7 2.6 3.8 7.0 3.4 2.4 4.3 28.7 34.3 13.3 14.0 3.4 4.0 27.0 13.5 10.2 25.8 21.0 21.0 18.7 31.4 8.0 9.9 26.1 19.8 33.0 19.3 15.4 24.2 33.8 12.3 31.8 17.4 2.0 30.7 6.6 3.6 3.7 22.8 11.6 4.2 18.6 20.2 31.9 21.6 14.2 33.1 26.8 32.0 15.7 14.0 32.8 19.3 24.5 33.1 8.6 15.7 17.4 11.4 18.3 17.4 9.8 14.8 26.0 25.5 10.0 15.8 27.0 22.1 23.3 14.6 23.9 26.4 11.8 43.6 17.7 4.9 2.8 6.8 8.5 4.0 6.2 4.6 5.5 9.1 2.2 5.4 6.8 6.6 2.0 10.6 6.5 2.6 11.0 6.5 4.7 4.4 4.9 5.1 4.3 5.1 5.2 5.6 4.8 3.9 5.0 4.3 1.2 6.4 0.0 0.3 3.5 1.8 0.9 2.0 2.8 5.3 2.2 2.5 2.5 2.8 1.3 1.8 0.0 6.5 6.6 2.1 3.9 2.9 0.2 1.3 0.9 1.7 3.0 6.9 0.7 2.9 28.3 1.9 3.1 1.0 1.3 2.9 1.8 6.7 5.2 0.0 1.0 2.6 0.0 2.9 1.6 0.2 1.2 2.4 5.4 1.0 3.0 0.9 6.2 1.0 0.8 2.3 1.7 1.5 7.1 0.6 1.6 2.4 2.6 3.8 0.0 1.8 2.5 3.7 0.8 2.5 1.1 6.2 3.6 1.7 3.2 0.6 SWSAP1 "C19orf39, FLJ35119, SWS1AP1, ZSWIM7AP1" ENSG00000173928 "SWIM-type zinc finger 7 associated protein 1" Q6NVH7 19 11374666-11376951 "Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Distal tubular cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052712 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 64: Macrophages - Immune response" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm Cytosol "HPA052712: AB_2681925" "unprognostic (6.45e-2)" "unprognostic (3.99e-2)" "unprognostic (1.48e-1)" "unprognostic (2.75e-1)" "unprognostic (1.92e-1)" "unprognostic (1.79e-2)" "unprognostic (5.03e-1)" "unprognostic (1.34e-2)" "unprognostic (4.65e-2)" "unprognostic (8.62e-3)" "unprognostic (1.40e-3)" "unprognostic (2.53e-1)" "unprognostic (1.34e-2)" "prognostic favorable (4.07e-4)" "unprognostic (1.61e-1)" "unprognostic (1.78e-1)" "unprognostic (4.18e-3)" 2.4 3.6 1.6 3.9 1.5 5.1 4.0 3.9 2.0 3.7 2.5 4.4 4.5 2.9 3.6 3.6 4.8 3.9 3.1 1.6 1.2 3.7 5.3 3.6 7.1 1.6 1.4 5.3 4.5 2.6 2.0 4.1 1.8 4.0 3.2 0.7 5.1 4.4 3.6 5.0 3.7 2.2 1.3 6.5 4.6 3.6 1.5 4.2 5.0 3.0 4.2 3.4 1.6 2.4 8.1 6.8 3.6 2.2 3.6 3.0 5.3 2.0 2.2 4.6 4.2 7.1 5.5 14.9 10.0 1.9 3.2 5.7 3.4 8.6 0.5 4.8 8.5 6.9 3.0 10.3 3.3 11.3 12.0 4.7 7.4 2.6 1.7 2.7 5.5 6.9 8.4 6.4 2.5 17.6 6.6 15.0 9.0 6.0 9.0 5.5 1.7 16.2 8.6 5.5 7.4 5.5 2.6 8.7 5.5 1.9 11.9 12.9 5.7 3.8 2.7 5.4 4.0 9.5 14.8 10.6 2.1 13.2 3.0 3.2 31.4 7.9 12.5 30.5 12.1 20.9 13.1 13.6 24.3 19.4 16.1 13.9 20.2 16.7 29.5 15.3 13.8 12.3 1.6 1.5 3.9 2.0 1.6 1.2 1.6 1.4 1.8 1.3 1.5 2.4 4.9 3.2 2.0 2.3 10.3 2.7 8.5 16.7 4.0 7.2 9.8 9.3 3.2 2.8 10.6 16.5 8.4 17.8 11.3 10.5 41.1 7.1 10.8 4.5 3.7 6.7 2.4 7.0 1.1 10.7 10.5 4.0 3.1 4.1 1.3 3.7 6.8 13.5 12.1 10.1 1.0 14.2 22.4 9.8 5.4 1.9 11.8 6.5 7.2 0.0 9.6 8.8 19.6 0.0 2.7 6.1 12.2 7.9 3.4 5.6 11.2 17.2 14.6 10.2 6.6 3.2 6.3 10.7 15.0 4.1 3.1 31.7 8.8 13.7 8.9 5.5 SYNC "SYNC1, SYNCOILIN" ENSG00000162520 "Syncoilin, intermediate filament protein" Q9H7C4 1 32679906-32703596 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "skeletal muscle: 106.8;smooth muscle: 54.1;tongue: 73.4" "Cell type enhanced" "Detected in many" "Horizontal cells: 74.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 121.0;U-138 MG: 113.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA028311, HPA063549" Enhanced Approved "Golgi apparatus,Vesicles,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" "Golgi apparatus, Vesicles" "HPA028311: AB_2672554, HPA063549: " "unprognostic (3.99e-1)" "unprognostic (6.04e-3)" "unprognostic (2.02e-2)" "unprognostic (7.60e-3)" "unprognostic (1.99e-2)" "unprognostic (5.07e-2)" "unprognostic (5.05e-2)" "unprognostic (5.44e-3)" "unprognostic (1.71e-1)" "unprognostic (1.79e-2)" "unprognostic (5.04e-2)" "unprognostic (3.71e-1)" "unprognostic (1.32e-4)" "unprognostic (1.56e-2)" "unprognostic (1.33e-1)" "unprognostic (1.45e-1)" "unprognostic (8.15e-4)" 10.5 8.5 6.4 15.6 6.1 0.7 5.4 6.7 6.6 9.7 6.1 11.6 6.5 10.9 4.9 17.9 7.4 9.5 17.3 5.8 7.9 2.4 2.2 10.5 6.4 8.3 8.7 3.7 2.6 4.7 0.7 2.5 7.9 13.1 8.7 0.4 9.6 14.6 106.8 2.5 7.3 54.1 9.0 6.2 9.0 9.7 7.4 1.1 4.5 73.4 1.7 12.3 2.9 8.2 8.7 7.0 11.2 19.3 19.4 30.5 6.6 41.9 81.5 28.7 19.6 1.2 24.8 23.9 13.0 121.0 43.4 5.8 1.0 0.7 16.2 12.4 0.8 26.1 22.6 18.0 16.4 33.0 12.0 46.6 2.9 31.6 1.1 86.1 9.0 17.2 19.6 26.2 24.3 4.2 32.0 8.9 5.9 11.2 9.6 34.5 36.5 12.7 32.6 14.2 18.1 1.7 57.1 17.6 21.7 22.2 16.0 10.4 14.4 113.0 19.4 69.4 18.8 11.4 21.1 30.2 39.0 10.4 98.3 5.9 7.7 6.1 6.1 9.6 8.1 6.9 6.9 6.4 9.7 5.2 6.2 7.0 0.9 9.1 9.5 12.3 7.9 12.0 6.4 6.1 6.7 6.6 5.8 7.9 8.3 8.7 7.9 9.0 7.4 8.2 10.6 9.6 9.8 15.7 15.1 22.0 14.2 14.5 8.0 50.2 20.6 7.0 1.0 20.0 14.1 9.2 39.6 9.4 20.7 8.3 5.9 11.7 11.2 12.9 25.0 13.1 7.3 16.0 12.2 5.4 9.3 17.1 0.5 16.3 22.2 12.4 22.9 19.1 5.4 74.0 13.2 8.4 8.2 17.7 23.2 14.8 41.7 7.3 33.8 7.5 11.4 20.0 34.0 15.1 11.6 7.9 7.9 64.3 5.7 16.0 10.7 10.1 6.0 53.9 19.7 16.6 12.8 32.8 36.0 7.2 22.3 5.1 15.3 9.4 12.6 9.4 SYNCRIP "dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1" ENSG00000135316 "Synaptotagmin binding cytoplasmic RNA interacting protein" O60506 6 85607779-85644063 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010895, HPA041275, HPA069241" Supported Approved Nucleoplasm,Vesicles,Cytosol NA NA 1300000 "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 32: U-937 - Innate immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "Vesicles, Cytosol" "CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: " "unprognostic (1.01e-1)" "unprognostic (3.49e-2)" "unprognostic (1.02e-2)" "unprognostic (1.20e-1)" "unprognostic (1.49e-2)" "unprognostic (6.22e-2)" "prognostic unfavorable (6.28e-5)" "unprognostic (6.84e-2)" "unprognostic (6.48e-2)" "prognostic favorable (5.59e-4)" "unprognostic (1.58e-2)" "unprognostic (1.43e-1)" "unprognostic (4.86e-2)" "unprognostic (1.37e-1)" "unprognostic (2.34e-1)" "unprognostic (1.00e-1)" "unprognostic (4.11e-1)" 60.5 43.2 25.1 80.2 28.0 67.3 55.6 28.1 24.8 51.4 26.0 54.1 48.0 46.1 41.7 75.8 34.0 47.8 45.6 22.8 29.9 53.1 66.7 49.4 88.1 28.9 27.4 36.2 51.9 56.9 19.5 68.5 31.0 44.9 62.7 36.0 41.4 46.5 55.9 43.5 44.0 62.1 27.7 51.3 50.0 38.7 27.6 91.0 87.3 56.0 101.9 81.5 40.8 29.0 209.5 147.5 239.9 157.1 150.8 165.3 162.8 258.6 218.1 244.4 239.9 250.4 132.6 480.0 200.0 262.8 203.1 197.4 331.1 269.0 405.4 175.9 163.9 405.4 152.8 165.2 130.3 497.6 177.7 141.8 179.6 276.4 272.1 138.4 254.9 133.2 451.5 210.0 295.1 243.5 255.2 218.9 231.5 209.4 153.2 364.7 345.5 209.9 236.2 307.1 239.5 184.6 188.5 180.8 128.6 137.2 150.8 360.9 247.4 165.8 142.7 189.8 374.2 138.0 260.5 275.4 165.4 328.7 251.4 1.8 24.7 8.8 30.6 36.2 30.0 21.9 27.1 27.5 37.7 21.2 23.4 27.7 3.0 36.1 41.1 29.0 31.6 24.6 25.1 28.0 28.1 24.8 22.8 29.9 28.9 27.4 31.0 27.7 27.6 29.0 106.9 115.4 119.5 26.4 73.0 148.2 160.9 124.4 83.6 44.5 89.0 82.8 88.9 52.9 126.7 46.0 16.7 101.3 97.2 50.4 54.8 120.7 117.6 105.1 156.2 100.7 56.7 65.6 24.0 99.6 133.3 101.8 79.5 152.1 61.4 81.6 57.5 81.4 96.9 62.2 24.3 78.0 79.3 71.1 67.1 28.7 73.7 92.9 53.4 31.9 90.7 45.1 57.7 32.2 40.9 130.0 45.7 64.3 97.4 133.0 47.7 80.7 84.6 42.2 19.7 158.6 131.8 93.7 65.8 142.4 141.6 118.1 81.6 85.8 106.7 159.8 TAB1 MAP3K7IP1 ENSG00000100324 "TGF-beta activated kinase 1 (MAP3K7) binding protein 1" Q15750 22 39399778-39437060 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Bipolar cells: 55.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032328, HPA039988, HPA057104" Approved Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 56: Bipolar cells - Visual perception" "Nuclear speckles" "CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338" "unprognostic (1.76e-1)" "unprognostic (1.79e-2)" "unprognostic (7.88e-2)" "unprognostic (6.73e-3)" "unprognostic (9.23e-3)" "unprognostic (4.30e-2)" "unprognostic (6.44e-2)" "unprognostic (1.79e-2)" "unprognostic (4.93e-2)" "unprognostic (7.05e-2)" "unprognostic (1.63e-1)" "unprognostic (7.35e-2)" "unprognostic (7.80e-3)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (1.33e-1)" "unprognostic (1.18e-1)" 13.1 14.8 18.2 9.0 20.6 9.7 12.9 17.0 19.8 18.2 10.6 18.9 10.7 16.5 6.2 13.8 15.9 7.4 17.0 17.3 16.1 12.4 16.6 11.0 11.1 18.7 19.3 20.5 15.6 10.0 10.5 8.6 17.7 16.7 5.4 12.2 13.7 10.9 19.9 17.4 13.5 8.7 15.8 15.9 14.7 10.2 18.5 11.9 13.3 10.7 7.8 17.9 14.9 20.6 15.0 15.3 15.2 17.5 15.8 13.2 13.5 12.3 15.1 18.4 17.3 14.2 10.6 22.5 9.4 12.0 10.3 18.0 15.5 18.0 7.2 17.6 24.8 9.9 19.0 14.2 13.7 18.8 18.3 13.5 15.7 13.9 15.1 14.0 13.6 13.5 18.4 15.0 9.3 9.7 14.6 15.6 10.6 23.6 15.4 26.0 21.6 22.6 14.4 15.7 13.5 9.9 17.4 21.5 15.4 9.4 17.6 20.4 11.8 12.8 20.2 9.9 10.1 23.6 16.2 16.4 15.1 13.1 12.8 0.8 5.6 4.1 4.3 4.3 3.4 3.3 2.6 3.5 5.0 3.2 4.1 3.9 0.7 3.3 4.5 2.3 2.8 4.3 18.2 20.6 17.0 19.8 17.3 16.1 18.7 19.3 17.7 15.8 18.5 20.6 6.0 3.2 6.7 17.9 7.0 2.0 2.8 4.0 6.8 55.2 5.9 6.9 7.4 8.6 4.1 3.7 18.8 12.4 4.7 4.9 0.0 6.2 1.6 4.5 7.0 5.4 11.4 6.9 9.1 3.8 7.9 6.2 7.1 4.4 5.1 12.5 2.2 4.7 7.1 28.6 12.6 4.8 0.0 6.0 1.0 3.2 7.8 6.4 5.4 9.4 8.6 12.1 8.2 7.5 18.6 5.4 4.1 9.1 8.4 2.8 7.6 5.4 4.7 18.8 6.6 6.4 7.4 8.2 9.1 5.5 3.3 5.6 8.1 10.3 4.9 1.8 TADA2A "ADA2, ADA2A, hADA2, TADA2L" ENSG00000276234 "Transcriptional adaptor 2A" 17 37406886-37479725 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 125.0;Late spermatids: 87.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076497 Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear speckles" "HPA076497: AB_2686801" "unprognostic (3.49e-1)" "unprognostic (5.12e-2)" "unprognostic (7.32e-2)" "unprognostic (7.86e-2)" "unprognostic (4.80e-1)" "unprognostic (1.23e-3)" "unprognostic (3.58e-2)" "unprognostic (1.04e-1)" "unprognostic (6.13e-3)" "unprognostic (8.18e-2)" "unprognostic (1.10e-3)" "unprognostic (7.81e-2)" "prognostic unfavorable (2.25e-5)" "unprognostic (4.38e-2)" "unprognostic (1.06e-1)" "unprognostic (2.56e-2)" "unprognostic (4.41e-2)" 3.8 3.5 2.8 3.1 3.6 2.6 3.8 5.5 5.3 4.9 1.4 5.0 1.8 5.0 2.6 3.8 4.9 1.5 4.2 2.8 2.9 3.9 4.7 3.3 2.0 2.7 3.1 3.9 5.0 1.2 4.6 1.5 2.9 4.4 2.8 5.0 3.9 1.7 6.2 4.8 5.3 1.5 2.8 5.4 4.3 10.1 3.3 1.7 5.5 1.5 3.2 4.9 4.3 4.1 0.8 6.4 6.2 4.9 3.0 4.3 6.9 4.0 4.0 6.9 5.0 7.8 0.0 12.7 5.9 2.9 9.0 10.0 8.9 4.9 7.6 8.9 7.6 6.6 8.2 4.3 5.3 10.4 4.0 3.2 3.3 7.9 3.9 3.7 6.9 16.3 11.0 3.7 9.0 3.4 19.7 8.5 4.9 3.1 4.5 13.5 19.3 10.4 4.4 6.5 7.2 6.9 5.3 2.8 4.9 6.4 8.9 3.4 5.7 7.9 6.9 5.7 6.2 6.4 6.1 16.6 7.6 4.4 6.8 2.4 3.8 4.5 5.4 4.2 3.9 3.9 3.4 4.5 4.7 7.1 5.3 5.1 0.5 3.1 5.9 8.6 3.2 2.8 2.8 3.6 5.5 5.3 2.8 2.9 2.7 3.1 2.9 2.8 3.3 4.1 6.8 6.4 9.3 8.5 6.1 2.5 6.7 9.7 6.8 15.1 3.9 4.4 7.4 8.6 11.3 9.2 16.7 15.2 11.0 4.3 1.9 7.1 125.0 7.5 9.7 8.2 4.2 9.9 22.9 5.9 9.7 5.5 5.1 6.8 10.1 9.1 5.7 3.9 8.0 23.5 19.7 7.3 4.1 5.5 4.7 87.9 8.1 6.5 1.8 20.6 10.5 11.4 5.2 17.6 21.6 6.6 4.0 7.9 7.1 5.3 6.6 5.1 11.4 21.8 13.1 8.7 10.1 27.3 33.5 4.8 3.3 5.1 6.8 7.4 7.4 4.0 TAF1 "BA2R, CCG1, CCGS, DYT3, DYT3/TAF1, KAT4, NSCL2, TAF2A, TAFII250" ENSG00000147133 "TATA-box binding protein associated factor 1" P21675 X 71366264-71532374 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Acyltransferase, DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, Disease variant, Dystonia, Mental retardation, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 81.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA001075, CAB016283" Supported Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 9: Photoreceptor cells - Phototransduction" Nucleoplasm "CAB016283: AB_671202, HPA001075: AB_1080179" "unprognostic (2.95e-2)" "unprognostic (1.77e-1)" "unprognostic (6.45e-3)" "unprognostic (1.91e-2)" "unprognostic (1.88e-2)" "unprognostic (1.23e-1)" "unprognostic (1.44e-1)" "prognostic favorable (6.54e-4)" "unprognostic (2.68e-2)" "unprognostic (3.43e-2)" "unprognostic (2.03e-1)" "unprognostic (5.59e-2)" "prognostic unfavorable (6.03e-4)" "unprognostic (1.14e-2)" "unprognostic (1.41e-1)" "unprognostic (1.82e-2)" "unprognostic (2.56e-2)" 10.9 8.6 10.3 11.4 12.7 12.8 12.3 13.7 11.1 11.1 10.2 10.0 6.6 13.8 12.9 7.5 11.1 7.8 7.0 9.3 14.1 7.5 7.8 9.1 14.1 11.5 11.3 14.4 9.8 12.2 8.4 10.0 10.9 10.0 10.0 27.3 7.7 10.1 10.5 13.3 9.3 10.9 8.2 15.4 10.6 7.2 12.5 14.8 12.7 10.3 12.4 9.2 8.6 16.8 18.6 15.9 18.2 12.4 14.6 23.2 11.0 13.3 12.1 13.7 11.1 12.3 11.3 17.6 11.5 14.9 12.3 17.5 24.1 11.0 17.0 11.2 21.9 20.1 22.1 13.1 11.1 39.7 19.4 14.1 11.3 14.2 27.2 12.8 14.7 13.2 28.2 41.1 14.4 14.5 22.4 25.4 20.9 23.5 20.8 19.8 35.8 21.6 11.1 25.0 9.0 14.5 37.7 13.6 18.7 14.3 9.6 22.9 18.6 16.5 14.2 13.4 9.7 17.5 17.4 21.4 9.0 33.2 12.5 1.6 1.4 0.7 1.4 0.9 1.3 1.0 1.4 1.4 1.5 1.5 1.6 1.8 1.8 1.5 1.6 1.4 1.0 0.7 10.3 12.7 13.7 11.1 9.3 14.1 11.5 11.3 10.9 8.2 12.5 16.8 26.7 32.1 26.7 44.7 21.2 11.9 8.9 10.4 18.2 37.5 12.5 13.3 17.2 10.0 23.9 3.7 81.3 8.6 21.5 7.8 1.9 6.3 2.5 17.0 23.4 24.6 11.4 28.6 54.3 7.0 5.9 17.6 12.2 18.9 23.4 23.9 18.9 12.6 8.8 16.8 52.2 14.6 6.1 16.2 20.0 2.6 22.1 20.4 5.4 47.8 23.9 17.0 29.9 49.3 79.1 7.6 13.3 22.2 18.7 11.2 13.4 5.2 14.8 67.9 0.0 27.4 18.0 9.3 10.7 17.8 17.3 5.7 23.8 25.9 13.6 9.6 TAF1B "RAF1B, RAFI63, SL1, TAFI63" ENSG00000115750 "TATA-box binding protein associated factor, RNA polymerase I subunit B" Q53T94 2 9843443-9934416 "Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071254 Supported Nucleoplasm,Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 28: BEWO - Transcription regulation" "Cluster 59: Non-specific - Transcription" Nucleoli Nucleoplasm "HPA071254: " "unprognostic (1.12e-1)" "unprognostic (1.74e-1)" "prognostic favorable (8.58e-5)" "unprognostic (1.44e-3)" "unprognostic (5.43e-2)" "unprognostic (1.24e-1)" "prognostic unfavorable (6.94e-7)" "unprognostic (9.17e-2)" "unprognostic (3.29e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (2.98e-1)" "prognostic favorable (8.55e-4)" "unprognostic (2.59e-1)" "unprognostic (2.49e-1)" "unprognostic (2.79e-2)" "unprognostic (1.49e-2)" 7.2 7.6 4.1 8.4 4.1 7.1 8.7 5.3 4.2 6.9 6.4 5.9 5.1 9.7 6.6 9.6 9.6 7.2 4.8 3.8 5.1 13.3 6.3 8.7 11.4 3.9 5.4 5.7 4.4 14.7 3.7 13.0 3.7 9.0 5.7 9.0 8.1 9.0 2.8 8.6 4.2 8.1 3.8 7.1 6.1 11.0 5.4 11.4 10.5 3.4 12.7 7.9 6.0 4.7 25.1 20.4 29.2 9.6 14.1 21.2 52.7 29.9 23.3 25.3 23.3 19.1 18.1 27.1 13.6 21.3 26.7 15.0 26.9 31.7 27.3 31.3 35.9 31.5 8.9 28.3 19.5 22.1 32.4 17.0 16.5 21.4 28.5 20.8 37.4 14.8 19.8 27.2 25.0 15.3 16.6 20.1 37.7 15.6 17.5 10.2 27.2 8.0 24.9 24.3 12.3 33.6 23.5 28.9 21.9 18.9 10.4 17.4 20.4 31.9 39.8 31.1 35.7 14.9 19.9 39.7 18.4 24.8 26.7 3.6 9.1 6.2 12.1 15.5 12.1 11.1 10.2 14.3 13.4 11.7 6.3 10.0 0.5 10.2 12.4 10.6 11.1 5.2 4.1 4.1 5.3 4.2 3.8 5.1 3.9 5.4 3.7 3.8 5.4 4.7 12.5 19.2 22.0 22.2 13.1 16.2 29.9 17.9 19.9 24.5 8.0 6.1 4.0 2.8 26.0 12.9 27.1 25.0 12.6 2.4 13.7 19.5 11.6 26.8 21.0 15.4 1.8 10.5 38.8 18.9 37.4 18.4 13.7 17.3 8.8 12.7 6.8 4.7 12.7 15.2 27.1 3.3 8.2 12.0 11.5 3.8 19.0 14.6 0.0 15.0 15.5 25.5 15.5 32.6 23.5 15.7 3.8 13.2 16.6 9.5 1.7 26.5 29.7 21.0 19.7 15.9 16.2 47.6 33.9 19.7 13.2 23.7 15.1 24.8 4.4 18.7 TAF3 "TAF140, TAFII140" ENSG00000165632 "TATA-box binding protein associated factor 3" Q5VWG9 10 7818505-8016631 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA066184 Supported "Nucleoplasm,Nuclear membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "Nuclear membrane" "HPA066184: AB_2685631" "unprognostic (3.82e-2)" "unprognostic (2.87e-3)" "unprognostic (6.60e-2)" "unprognostic (4.23e-1)" "unprognostic (6.88e-2)" "unprognostic (2.38e-1)" "prognostic unfavorable (2.14e-7)" "unprognostic (2.97e-1)" "unprognostic (1.45e-1)" "unprognostic (2.71e-2)" "unprognostic (9.71e-2)" "unprognostic (6.30e-3)" "prognostic unfavorable (5.01e-4)" "unprognostic (8.59e-2)" "unprognostic (3.44e-1)" "unprognostic (9.44e-2)" "unprognostic (1.74e-1)" 5.4 4.9 7.1 4.8 7.9 6.9 4.5 9.9 9.0 4.7 4.8 5.1 2.8 5.2 2.2 3.0 4.3 3.3 5.9 6.1 7.6 4.0 3.7 3.9 6.1 7.9 9.0 7.0 4.3 5.2 3.1 4.5 7.9 3.5 3.5 5.3 3.6 4.4 10.7 5.2 3.8 4.2 7.2 5.5 3.7 7.5 8.2 7.0 4.3 7.6 4.6 5.0 4.2 7.2 7.9 7.2 8.0 4.3 9.0 6.2 11.1 9.2 3.5 6.8 7.7 15.6 5.8 13.4 6.9 5.4 2.8 8.4 8.9 7.9 8.5 10.9 9.8 11.5 5.0 10.0 7.7 7.8 10.1 4.2 7.8 9.5 4.6 4.3 6.5 14.5 13.0 13.5 7.8 14.9 17.7 5.5 6.1 11.5 4.2 14.2 7.6 9.0 3.9 4.9 4.3 6.1 10.0 7.2 9.4 7.8 13.1 8.1 8.1 6.1 10.7 16.3 9.1 8.0 10.3 14.4 5.9 8.8 5.6 5.8 3.9 5.7 6.0 3.4 7.1 5.2 5.4 5.9 3.2 5.6 6.7 5.8 1.5 6.2 6.6 3.1 4.9 3.9 7.1 7.9 9.9 9.0 6.1 7.6 7.9 9.0 7.9 7.2 8.2 7.2 26.2 28.9 29.5 41.1 45.2 32.0 20.7 13.3 23.3 28.6 15.3 16.5 40.1 14.3 10.5 27.6 35.5 26.6 32.0 18.0 0.0 17.0 39.6 16.7 22.9 29.9 18.7 25.2 45.1 14.7 36.8 23.2 19.9 16.7 22.1 18.0 19.6 14.5 19.8 26.9 54.4 14.6 8.2 21.3 24.2 22.0 27.4 25.3 24.9 71.2 25.7 27.0 53.5 43.2 63.9 15.0 5.9 28.6 37.7 14.1 20.5 4.5 16.3 47.8 26.3 39.3 31.0 58.9 46.2 16.4 43.0 20.0 48.6 16.4 16.5 17.6 TAF6 "MGC:8964, TAF2E, TAFII70, TAFII80, TAFII85" ENSG00000106290 "TATA-box binding protein associated factor 6" P49848 7 100107070-100119841 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006566 Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "HPA006566: AB_1080194" "unprognostic (5.60e-2)" "unprognostic (3.11e-2)" "unprognostic (1.73e-2)" "unprognostic (2.10e-1)" "unprognostic (7.79e-2)" "unprognostic (4.20e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (2.02e-1)" "unprognostic (1.89e-1)" "unprognostic (1.29e-1)" "unprognostic (3.70e-3)" "unprognostic (1.68e-1)" "unprognostic (4.55e-2)" "unprognostic (1.95e-1)" "unprognostic (3.38e-1)" "unprognostic (4.78e-1)" "unprognostic (1.37e-1)" 24.2 37.0 28.9 23.4 29.2 23.4 24.4 24.1 42.7 39.5 23.8 38.9 17.2 42.9 21.9 27.3 34.9 20.5 32.2 31.3 25.2 30.9 20.6 24.8 22.6 25.2 23.2 41.2 23.0 30.5 41.1 24.9 24.4 30.7 19.5 19.2 25.5 31.1 45.0 26.5 28.0 33.9 19.0 28.3 28.0 38.5 25.4 29.3 32.9 35.8 25.7 37.3 29.9 25.6 55.1 101.8 64.4 105.7 84.1 44.5 89.3 60.0 66.4 77.2 70.6 76.1 65.6 50.4 65.5 92.7 130.4 45.7 90.6 73.2 81.3 82.0 57.0 49.4 99.3 50.8 86.6 46.2 43.5 46.4 44.5 111.0 121.7 61.0 63.0 87.7 84.6 89.0 69.2 194.4 101.1 76.9 94.7 50.1 82.4 73.2 78.7 75.0 54.5 44.8 57.9 84.4 73.7 115.3 49.3 93.2 42.1 47.2 60.4 113.2 114.6 146.2 77.6 55.0 104.0 85.1 74.9 65.7 99.2 17.2 13.5 17.5 18.0 14.4 21.5 11.9 17.3 18.3 17.6 17.9 17.0 16.3 7.1 18.8 35.3 10.3 18.3 17.5 28.9 29.2 24.1 42.7 31.3 25.2 25.2 23.2 24.4 19.0 25.4 25.6 13.0 9.6 11.8 10.1 15.4 11.3 21.0 25.1 12.5 12.7 13.2 15.9 0.9 18.6 15.7 25.8 0.0 72.1 13.0 12.9 17.6 25.7 28.3 20.7 18.5 14.8 15.6 12.8 12.6 16.6 34.5 16.3 18.3 14.6 0.0 25.6 13.6 6.1 20.9 13.5 10.7 11.9 26.4 8.8 6.9 50.7 21.8 12.3 12.4 3.7 18.7 18.7 18.6 6.0 7.3 14.9 18.7 31.2 12.8 13.0 14.2 25.8 21.8 14.0 26.3 14.6 23.8 25.5 52.3 15.4 11.8 34.5 18.3 16.2 17.4 14.4 TAMM41 "C3orf31, DKFZp434E0519, MGC16471" ENSG00000144559 "TAM41 mitochondrial translocator assembly and maintenance homolog" Q96BW9 3 11790442-11846919 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Nucleotidyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036834, HPA044861" Uncertain Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Cytosol "HPA036834: AB_10672270, HPA044861: AB_2679116" "unprognostic (2.40e-2)" "unprognostic (4.41e-2)" "prognostic favorable (1.23e-4)" "unprognostic (4.45e-2)" "unprognostic (1.44e-2)" "unprognostic (5.60e-2)" "unprognostic (2.03e-5)" "unprognostic (1.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.95e-1)" "unprognostic (1.60e-1)" "unprognostic (7.33e-3)" "unprognostic (3.78e-2)" "unprognostic (2.04e-1)" "unprognostic (1.63e-1)" "unprognostic (7.34e-2)" "unprognostic (3.59e-3)" 8.3 7.4 5.8 5.6 6.2 4.3 8.0 6.4 8.5 8.0 2.6 6.5 4.9 7.2 9.7 9.0 6.9 4.1 8.0 5.3 6.9 6.7 5.5 5.0 7.1 3.9 4.1 11.0 5.6 5.8 5.6 4.1 4.0 5.2 4.9 6.3 6.8 4.5 9.2 10.1 6.2 6.2 2.8 6.5 6.0 5.7 5.4 6.5 6.0 5.2 7.8 8.4 8.2 6.2 6.2 11.3 13.5 9.4 14.3 18.0 24.9 9.3 6.6 13.9 13.8 13.6 9.9 23.4 13.3 9.8 6.2 7.4 22.9 13.9 17.9 8.8 21.6 14.0 10.6 15.9 16.7 25.8 7.1 10.3 20.3 13.1 14.6 9.1 21.8 18.3 20.8 7.0 18.0 17.8 14.6 19.2 10.9 9.6 23.8 14.4 7.7 20.7 21.6 14.8 6.2 5.4 8.1 10.3 16.6 15.1 13.5 11.6 5.7 7.2 8.3 21.8 13.5 5.4 14.2 12.1 8.8 21.8 6.7 1.9 4.5 7.1 5.7 3.2 7.6 7.5 9.1 5.8 7.8 7.1 8.4 8.8 0.2 6.9 6.7 5.8 7.7 4.8 5.8 6.2 6.4 8.5 5.3 6.9 3.9 4.1 4.0 2.8 5.4 6.2 9.4 6.4 7.0 24.5 11.4 4.2 8.1 15.7 5.7 11.5 5.5 8.3 8.9 0.0 8.7 3.7 12.5 12.2 8.6 3.3 9.8 10.1 2.2 5.4 9.2 7.6 3.0 9.4 34.5 9.3 11.0 7.2 6.6 4.4 2.5 10.5 5.7 5.8 9.2 10.1 34.7 8.1 12.2 6.4 6.4 1.5 7.8 6.8 3.6 14.0 5.9 11.0 10.3 34.7 32.0 7.9 3.4 6.4 7.1 6.7 4.2 10.3 11.8 14.7 0.0 8.6 8.7 7.4 12.4 6.6 4.1 7.0 9.5 10.8 7.3 5.9 TARDBP "ALS10, TDP-43" ENSG00000120948 "TAR DNA binding protein" Q13148 1 11012344-11030528 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation" "DNA-binding, Repressor, RNA-binding" "Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003703, HPA017284" Supported Enhanced Nucleoplasm NA NA 29000 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "CAB003703: AB_425904, HPA017284: AB_1857775" "unprognostic (3.72e-3)" "prognostic favorable (1.15e-5)" "unprognostic (1.06e-1)" "unprognostic (1.22e-1)" "unprognostic (8.52e-2)" "unprognostic (4.10e-2)" "prognostic unfavorable (1.20e-7)" "unprognostic (1.06e-1)" "unprognostic (3.41e-3)" "unprognostic (4.75e-3)" "unprognostic (2.24e-1)" "unprognostic (2.54e-2)" "unprognostic (2.27e-3)" "unprognostic (2.27e-1)" "unprognostic (1.87e-1)" "unprognostic (2.86e-1)" "unprognostic (2.71e-2)" 83.4 80.1 71.9 87.1 80.6 69.7 83.3 84.7 79.0 93.9 78.1 94.5 77.4 90.9 78.8 111.1 84.1 58.7 93.0 69.4 78.5 93.8 105.5 91.6 106.5 75.5 77.2 103.5 77.2 86.7 89.1 82.7 76.4 90.1 94.5 119.9 86.6 78.8 138.9 96.1 94.5 81.2 74.8 97.4 82.4 68.2 74.7 115.1 96.6 102.9 122.9 87.6 95.8 86.0 244.7 164.4 270.4 143.5 143.9 118.2 160.3 164.7 142.3 263.6 195.5 187.9 175.6 316.3 118.1 180.6 154.3 169.2 333.1 187.6 336.0 175.1 153.8 241.2 275.2 257.9 119.4 290.5 158.9 99.5 211.4 184.5 147.9 143.8 188.6 126.7 319.0 176.4 221.7 195.0 215.6 228.6 221.0 232.2 141.7 256.9 214.4 206.2 186.0 179.1 187.9 150.8 221.3 173.7 128.8 197.1 173.8 200.9 174.8 173.8 207.8 146.3 236.9 133.3 176.2 336.3 116.2 288.2 192.0 38.0 38.0 33.7 46.7 48.6 57.4 55.2 46.9 45.4 61.7 39.6 46.3 50.5 15.4 67.2 50.0 43.1 54.3 36.4 71.9 80.6 84.7 79.0 69.4 78.5 75.5 77.2 76.4 74.8 74.7 86.0 35.5 32.1 74.4 29.4 57.6 114.6 89.9 40.8 52.3 37.6 52.0 38.6 68.0 31.5 57.0 29.5 29.2 63.2 46.3 54.2 33.2 50.8 9.7 50.7 50.0 54.9 66.3 63.5 29.5 54.2 84.5 45.2 34.7 61.7 42.3 45.8 40.0 51.7 50.1 37.0 29.8 50.1 38.7 45.9 46.3 12.3 47.2 37.8 35.6 23.4 54.3 36.2 35.0 37.2 57.2 52.9 36.1 51.6 48.8 71.7 43.2 43.9 54.4 38.8 32.9 42.8 56.9 64.9 32.8 52.4 114.5 73.5 41.3 23.6 52.6 71.3 TBL3 "SAZD, UTP13" ENSG00000183751 "Transducin beta like 3" Q12788 16 1972053-1982929 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 113.8;Late spermatids: 72.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042562, HPA055695" Enhanced Supported Enhanced Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoli "HPA042562: AB_10964911, HPA055695: AB_2682888" "unprognostic (1.96e-1)" "unprognostic (5.49e-3)" "unprognostic (8.49e-2)" "unprognostic (1.56e-1)" "unprognostic (4.67e-1)" "unprognostic (2.65e-1)" "unprognostic (2.97e-2)" "unprognostic (1.17e-1)" "unprognostic (3.78e-2)" "unprognostic (8.03e-2)" "unprognostic (2.14e-2)" "unprognostic (8.32e-2)" "prognostic favorable (7.33e-4)" "unprognostic (3.65e-2)" "unprognostic (1.87e-1)" "unprognostic (2.32e-1)" "unprognostic (3.77e-1)" 3.6 3.5 1.8 3.2 2.2 2.1 3.9 4.5 2.7 3.4 1.0 3.4 2.4 3.8 0.6 4.9 3.0 1.4 4.7 2.3 2.3 3.3 3.1 2.8 2.3 3.3 2.0 3.7 5.9 2.8 2.4 1.2 3.4 2.8 1.0 1.5 4.8 1.1 10.6 5.4 3.5 1.4 1.7 3.0 3.7 6.8 1.8 2.0 3.1 3.1 1.5 3.3 3.5 2.7 7.1 13.4 3.6 7.2 3.5 2.8 11.8 6.4 4.2 5.4 4.4 17.3 13.3 9.4 14.6 4.9 4.9 18.8 5.9 7.5 2.8 6.9 8.5 5.9 7.1 6.6 4.0 10.3 5.4 2.8 5.5 6.7 3.9 4.3 6.8 5.6 12.1 6.7 3.2 11.3 13.2 5.8 8.6 6.2 5.4 23.1 6.7 15.7 2.6 2.7 8.4 6.5 5.8 14.6 6.0 3.5 11.1 6.9 10.8 7.4 8.8 6.6 12.6 12.1 5.6 15.0 4.5 6.5 8.7 4.5 9.4 5.5 10.6 11.0 9.3 6.4 7.6 10.4 10.4 6.9 9.7 7.4 2.2 14.5 11.8 5.3 9.2 8.5 1.8 2.2 4.5 2.7 2.3 2.3 3.3 2.0 3.4 1.7 1.8 2.7 9.1 3.2 12.2 2.3 11.9 13.0 15.8 21.9 12.0 13.0 12.6 10.4 16.4 7.2 16.4 18.4 8.4 26.4 10.7 23.4 7.9 25.4 113.8 7.4 8.5 11.2 13.8 18.5 2.0 22.5 26.0 10.5 20.4 9.7 14.7 14.5 7.1 12.7 19.6 10.1 2.1 16.1 18.3 8.9 6.6 72.1 14.9 8.5 7.2 0.0 24.1 13.6 9.2 2.0 2.0 24.0 22.0 10.9 13.5 15.6 31.9 16.9 8.8 9.8 26.3 11.1 24.7 21.8 20.8 13.7 18.3 22.4 11.1 11.6 24.2 14.4 TCAF1 "FAM115A, KIAA0738" ENSG00000198420 "TRPM8 channel associated factor 1" Q9Y4C2 7 143851375-143902198 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 251.7;Syncytiotrophoblasts: 521.5;Theca cells: 377.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011732 Approved Approved "Nuclear bodies,Vesicles,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 52: Non-specific - Transcription" "Cell Junctions" "Nuclear bodies, Vesicles" "HPA011732: AB_2668526" "unprognostic (1.57e-1)" "unprognostic (7.28e-2)" "unprognostic (2.61e-1)" "unprognostic (3.11e-1)" "unprognostic (2.73e-1)" "unprognostic (7.00e-2)" "unprognostic (5.70e-3)" "unprognostic (3.07e-2)" "unprognostic (4.93e-2)" "prognostic favorable (5.93e-4)" "unprognostic (1.43e-1)" "unprognostic (2.69e-1)" "unprognostic (3.95e-3)" "unprognostic (6.45e-2)" "unprognostic (1.34e-1)" "unprognostic (1.55e-2)" "unprognostic (1.89e-1)" 29.0 46.5 22.7 12.9 51.4 4.7 21.7 15.1 30.3 27.5 2.7 18.8 12.2 32.2 15.2 15.1 22.2 19.3 23.7 29.4 42.7 14.8 29.3 19.0 8.4 15.4 13.4 39.9 19.4 35.1 27.2 81.1 19.8 36.2 20.3 28.0 15.8 19.8 17.5 16.9 15.8 30.6 11.5 11.7 21.7 9.4 31.0 17.1 26.8 55.7 9.0 14.8 13.4 20.1 47.2 29.0 90.1 93.7 57.9 55.7 55.1 54.3 64.9 42.4 56.3 60.5 33.0 0.2 25.2 63.3 54.5 29.7 34.8 35.7 46.5 25.7 26.0 25.7 15.7 54.0 39.7 0.3 16.2 58.2 31.5 50.0 18.4 66.8 53.4 32.2 43.2 4.5 83.2 70.7 42.3 15.9 27.6 52.0 17.4 26.0 60.7 6.2 33.7 37.5 25.6 153.1 55.5 34.2 25.7 63.7 51.5 4.0 48.8 44.6 28.5 42.2 32.7 14.0 19.2 0.4 81.9 7.6 62.3 0.4 1.5 0.9 4.7 1.8 3.3 1.6 2.8 3.1 2.9 1.6 2.4 3.0 0.4 4.4 3.1 1.4 2.3 2.5 22.7 51.4 15.1 30.3 29.4 42.7 15.4 13.4 19.8 11.5 31.0 20.1 36.3 44.8 37.1 30.3 7.3 0.0 15.0 0.0 16.5 47.7 29.4 38.6 43.0 31.5 14.9 3.7 25.0 251.7 15.2 18.7 0.0 30.9 2.4 27.6 62.7 35.1 19.4 22.1 71.2 35.6 43.7 54.6 20.9 40.5 7.6 167.5 34.6 83.6 32.9 30.3 63.1 29.3 0.0 10.5 0.0 3.5 53.1 12.2 0.0 29.0 10.8 27.5 20.6 57.3 43.7 49.9 15.4 56.4 8.4 27.3 20.1 8.9 8.0 26.7 13.1 72.1 53.3 13.3 11.7 14.1 0.0 521.5 10.4 377.5 23.5 24.3 TCERG1 "CA150, TAF2S, Urn1" ENSG00000113649 "Transcription elongation regulator 1" O14776 5 146447311-146511961 "Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064854, HPA069752, HPA069808" Supported Enhanced Nucleoplasm NA NA 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204" "unprognostic (2.73e-1)" "unprognostic (5.11e-2)" "unprognostic (1.27e-3)" "unprognostic (8.58e-2)" "unprognostic (1.32e-1)" "unprognostic (9.32e-2)" "prognostic unfavorable (5.34e-5)" "unprognostic (1.07e-1)" "unprognostic (3.38e-2)" "unprognostic (2.13e-2)" "unprognostic (2.41e-1)" "unprognostic (1.35e-3)" "prognostic unfavorable (4.70e-11)" "unprognostic (1.52e-2)" "unprognostic (7.76e-2)" "unprognostic (3.98e-2)" "unprognostic (1.24e-3)" 11.6 8.6 6.6 15.5 6.1 28.1 12.0 7.9 10.0 11.6 4.1 12.2 10.5 13.3 6.4 13.1 12.5 7.3 10.0 6.4 5.2 9.2 6.7 10.5 17.7 5.5 5.1 13.7 9.0 8.9 11.3 12.4 5.5 10.4 10.8 16.9 10.9 8.4 23.7 13.2 11.2 10.4 4.2 12.0 11.7 10.3 5.3 19.0 10.0 13.6 17.1 12.4 12.3 8.8 51.7 37.6 56.6 39.1 15.2 23.9 72.0 38.0 30.6 42.1 48.8 61.0 53.8 89.0 27.8 31.7 30.0 44.6 70.1 48.1 63.8 52.6 56.3 58.1 43.4 37.4 16.3 87.8 43.5 16.8 28.0 40.8 43.7 23.0 37.3 73.5 69.4 31.9 32.2 36.8 76.8 49.3 56.3 29.2 42.3 74.3 66.9 58.7 26.3 40.2 36.8 45.6 42.7 44.6 28.3 34.1 47.5 43.9 42.2 36.3 42.1 31.0 60.2 32.4 38.3 116.8 33.7 73.0 41.3 0.9 5.7 2.5 5.7 8.8 6.9 5.5 6.6 7.2 9.7 5.5 6.8 6.8 0.5 9.5 11.9 4.9 6.5 5.3 6.6 6.1 7.9 10.0 6.4 5.2 5.5 5.1 5.5 4.2 5.3 8.8 35.8 54.5 49.8 50.6 49.5 44.9 49.5 35.6 54.7 54.1 32.4 33.1 35.6 14.3 39.9 23.9 62.6 48.6 42.9 20.8 1.9 31.9 3.2 23.8 62.1 37.6 28.2 77.0 100.9 33.4 60.7 43.3 56.6 44.1 37.9 57.4 21.4 17.6 30.8 35.3 91.0 36.9 24.4 28.9 30.4 7.4 28.6 36.5 24.9 42.2 33.1 20.8 35.0 73.4 76.3 44.9 25.3 24.5 61.9 60.7 13.8 7.6 33.8 38.4 19.7 53.2 51.1 73.3 60.8 66.6 45.7 43.9 42.8 43.7 47.5 62.2 TCF12 "bHLHb20, HEB, HsT17266, HTF4, p64" ENSG00000140262 "Transcription factor 12" Q99081 15 56918623-57299281 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Craniosynostosis, Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Inhibitory neurons: 319.8;Microglial cells: 440.3;Oligodendrocyte precursor cells: 618.3;Oligodendrocytes: 1512.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004432, HPA065827" Approved Supported "Nucleoplasm,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 12: NES - Nervous system development" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Nuclear speckles" "CAB004432: AB_671267, HPA065827: AB_2685564" "unprognostic (1.19e-1)" "unprognostic (1.11e-1)" "unprognostic (8.26e-2)" "unprognostic (1.65e-1)" "unprognostic (2.07e-3)" "unprognostic (1.11e-1)" "unprognostic (6.63e-2)" "unprognostic (1.85e-1)" "prognostic unfavorable (8.89e-4)" "unprognostic (7.83e-2)" "unprognostic (7.26e-3)" "unprognostic (5.57e-3)" "prognostic unfavorable (5.24e-5)" "unprognostic (2.03e-1)" "unprognostic (2.93e-1)" "unprognostic (3.15e-2)" "unprognostic (1.41e-1)" 26.1 21.5 29.2 23.4 45.5 21.2 29.5 37.1 34.0 75.6 17.2 26.7 28.4 47.9 24.3 26.6 46.3 37.1 21.8 30.5 32.6 28.4 25.0 28.9 26.0 43.1 39.3 43.3 19.7 44.0 11.5 33.4 38.3 32.0 30.3 29.4 23.3 28.3 20.5 21.3 28.4 44.1 34.5 25.0 25.5 27.4 35.5 133.0 29.0 26.6 28.1 31.2 22.4 55.7 25.4 50.8 204.5 70.6 90.0 79.0 36.1 52.2 89.6 45.1 58.9 34.0 20.3 35.5 42.3 78.3 33.4 30.4 84.3 37.3 56.7 47.5 29.8 71.7 52.7 40.4 62.4 46.1 36.1 69.4 66.2 42.9 112.2 60.1 81.0 163.0 81.7 46.8 61.8 9.5 109.4 25.0 57.5 26.4 20.9 143.2 234.9 33.9 61.5 53.1 43.6 121.2 58.7 21.0 52.0 65.3 33.6 93.9 63.2 75.5 57.5 32.2 78.2 24.6 49.7 59.4 40.8 86.3 90.9 27.4 13.8 11.3 17.4 17.9 14.3 13.4 14.0 16.5 20.0 14.7 16.2 14.8 1.5 16.8 26.3 8.4 23.0 14.1 29.2 45.5 37.1 34.0 30.5 32.6 43.1 39.3 38.3 34.5 35.5 55.7 35.5 54.5 19.6 212.9 37.7 26.6 20.6 14.2 44.9 13.8 24.0 20.4 19.3 14.3 21.2 16.5 35.5 10.4 20.6 17.0 13.7 16.0 23.7 25.9 148.0 38.2 9.0 34.9 117.7 11.8 15.5 42.3 52.0 33.3 23.4 26.9 25.7 18.2 27.5 13.5 319.8 16.8 10.2 38.1 30.0 19.9 25.7 33.0 14.2 440.3 17.4 29.0 18.6 618.3 1512.7 15.9 18.4 34.6 29.1 23.4 20.0 15.3 15.9 23.3 46.0 39.9 36.5 22.2 15.0 33.6 33.8 13.0 28.4 16.5 20.1 18.2 TCTN3 "C10orf61, DKFZP564D116, JBTS18, TECT3" ENSG00000119977 "Tectonic family member 3" Q6NUS6 10 95659823-95694143 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Joubert syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026987 Approved Approved Microtubules "Intracellular and membrane" NA NA 4400000 "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 41: Macrophages - Immune response" Microtubules "HPA026987: AB_10600911" "unprognostic (1.58e-1)" "unprognostic (1.54e-1)" "unprognostic (9.78e-2)" "prognostic favorable (5.77e-4)" "unprognostic (1.52e-1)" "unprognostic (2.50e-2)" "unprognostic (8.88e-3)" "unprognostic (1.08e-1)" "unprognostic (3.03e-2)" "unprognostic (9.25e-3)" "unprognostic (3.78e-3)" "unprognostic (7.29e-2)" "unprognostic (4.60e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (9.30e-3)" "unprognostic (1.59e-1)" 21.3 25.3 8.6 15.7 9.0 5.1 25.2 9.1 11.3 26.3 24.0 22.1 17.6 24.8 65.0 17.0 35.4 22.7 18.4 8.8 9.8 32.5 26.8 19.4 14.3 9.7 9.5 30.6 27.1 69.9 22.8 26.9 9.5 25.6 25.6 22.2 25.4 27.7 9.5 20.5 15.4 26.8 9.2 17.3 19.1 19.4 9.6 14.0 70.6 11.5 18.0 23.9 18.6 9.2 34.0 54.1 44.1 89.3 93.6 74.6 25.7 45.3 94.8 46.9 55.3 35.4 57.3 31.3 40.1 60.4 49.8 46.7 43.9 54.5 56.5 33.6 36.4 10.9 21.6 49.2 46.9 37.4 22.8 65.2 49.2 46.6 72.4 88.0 80.7 27.7 21.0 40.3 63.4 32.5 23.4 27.9 12.1 49.7 38.1 25.3 33.9 38.3 67.8 23.3 11.5 24.5 37.7 18.5 52.6 40.8 71.0 35.1 37.9 35.6 24.9 23.9 49.5 18.9 37.9 20.7 57.5 47.1 19.0 6.8 14.2 4.9 25.8 21.9 32.0 28.3 23.1 25.2 45.2 19.4 24.2 20.0 1.6 26.8 24.3 23.6 22.2 21.3 8.6 9.0 9.1 11.3 8.8 9.8 9.7 9.5 9.5 9.2 9.6 9.2 14.8 19.2 16.2 16.6 29.3 14.4 23.7 33.8 31.3 24.0 18.2 15.0 8.5 27.1 20.3 31.3 37.5 50.3 18.8 20.2 7.9 27.2 18.6 25.5 25.7 20.4 13.8 11.6 17.3 20.3 44.2 27.3 11.7 18.3 8.2 29.8 21.4 16.8 28.5 25.2 17.7 12.5 26.4 14.1 59.1 14.1 20.8 18.7 16.0 16.9 14.8 36.7 15.5 20.6 13.7 14.1 12.7 25.2 35.9 19.8 16.2 16.1 27.5 44.4 13.1 23.9 19.8 39.8 34.1 15.3 11.5 31.5 23.0 34.2 23.7 14.6 TEFM "C17orf42, FLJ22729" ENSG00000172171 "Transcription elongation factor, mitochondrial" Q96QE5 17 30897336-30906238 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023788, HPA053044" Approved Enhanced Mitochondria No No "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA023788: AB_1848818, HPA053044: AB_2682023" "unprognostic (1.22e-1)" "unprognostic (1.18e-2)" "unprognostic (1.11e-3)" "unprognostic (3.31e-2)" "unprognostic (7.89e-2)" "unprognostic (3.75e-1)" "prognostic unfavorable (9.20e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (8.64e-4)" "unprognostic (2.11e-1)" "unprognostic (6.18e-3)" "unprognostic (9.39e-2)" "unprognostic (4.79e-2)" "unprognostic (7.90e-2)" "unprognostic (1.92e-1)" "unprognostic (2.23e-1)" "unprognostic (8.37e-3)" 4.9 6.0 4.4 5.9 4.6 2.2 6.7 5.7 6.0 4.0 5.5 5.7 5.6 4.9 4.1 5.2 4.8 4.1 8.9 4.6 4.4 9.6 8.8 4.0 7.3 4.5 4.4 4.8 3.3 6.6 3.2 6.8 4.6 5.0 6.6 6.9 5.4 4.8 6.8 5.3 4.6 5.1 4.3 5.7 5.1 4.2 4.6 5.4 5.4 11.7 6.7 5.4 2.9 5.1 12.8 19.2 10.7 14.9 12.7 12.4 10.1 13.1 9.5 23.7 21.4 15.6 7.2 17.4 12.7 8.1 15.5 21.6 18.6 9.1 22.4 5.5 23.9 8.8 15.1 15.5 8.5 18.7 11.2 7.9 11.7 13.4 6.9 7.2 11.9 12.4 19.1 14.3 13.9 11.7 16.0 24.3 8.9 19.6 12.1 10.5 22.9 17.6 19.2 14.4 16.3 7.5 9.8 11.7 15.4 10.9 23.7 14.1 7.8 10.9 14.7 11.2 13.8 7.9 14.0 16.2 7.3 13.8 13.2 2.6 7.7 6.5 6.4 12.2 8.8 9.8 8.2 6.5 8.1 6.3 9.9 9.2 2.3 8.6 9.9 7.0 10.0 7.1 4.4 4.6 5.7 6.0 4.6 4.4 4.5 4.4 4.6 4.3 4.6 5.1 10.1 16.0 10.6 13.7 11.3 4.1 8.0 22.6 9.1 17.8 6.8 6.9 5.8 11.5 13.6 9.2 8.4 26.0 11.5 5.4 25.4 13.4 10.4 12.6 15.3 9.6 5.4 6.9 27.1 8.5 17.3 10.2 5.1 7.8 5.1 17.2 10.4 10.1 20.4 16.8 27.3 7.4 22.4 7.8 3.0 6.3 8.1 9.6 7.2 21.5 14.0 15.0 16.5 27.2 32.2 12.5 5.6 7.5 7.1 5.2 9.4 17.7 17.8 19.4 19.7 11.0 11.6 27.7 17.8 8.7 4.3 17.8 10.0 18.9 7.9 4.7 TELO2 "hCLK2, KIAA0683, TEL2" ENSG00000100726 "Telomere maintenance 2" Q9Y4R8 16 1493344-1510457 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041348, HPA041473" Approved Supported "Nuclear bodies,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Nuclear bodies, Cytosol" "HPA041348: AB_10794514, HPA041473: AB_10795593" "unprognostic (1.27e-1)" "unprognostic (2.14e-2)" "unprognostic (2.45e-1)" "unprognostic (1.35e-1)" "unprognostic (1.13e-1)" "unprognostic (2.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.39e-1)" "unprognostic (2.64e-1)" "unprognostic (1.91e-1)" "unprognostic (3.08e-2)" "unprognostic (2.94e-2)" "unprognostic (5.99e-3)" "unprognostic (1.47e-3)" "unprognostic (2.21e-1)" "unprognostic (6.75e-2)" "unprognostic (3.15e-3)" 12.3 13.2 7.3 7.6 7.2 11.3 13.4 8.8 11.0 15.2 5.7 12.6 8.9 14.1 1.1 14.4 15.1 3.7 13.2 6.9 6.4 13.6 14.8 11.6 8.1 10.2 7.6 14.4 12.2 4.3 12.5 4.8 7.6 15.8 1.4 1.8 11.4 4.8 17.0 14.4 14.4 2.4 6.4 18.6 11.9 10.0 7.6 5.8 13.2 4.9 3.1 13.6 13.9 8.3 19.7 28.8 8.8 16.8 3.4 3.6 33.9 30.5 5.7 14.4 10.4 37.0 18.3 28.8 25.8 4.9 7.1 20.5 6.3 11.6 2.7 16.9 55.1 16.5 36.7 21.8 5.7 21.0 23.9 7.0 4.3 13.4 2.8 4.9 8.6 24.6 43.2 10.1 5.8 66.3 24.9 56.1 28.2 6.9 23.9 73.5 12.3 29.4 5.4 18.3 36.8 20.6 26.5 24.8 9.8 3.3 23.2 25.3 13.8 31.2 21.7 30.5 25.8 18.2 12.6 53.3 9.9 29.3 26.7 0.0 5.7 2.9 4.1 7.2 3.9 4.1 2.9 3.4 6.9 6.0 3.1 2.5 0.5 3.4 10.7 4.3 2.7 4.7 7.3 7.2 8.8 11.0 6.9 6.4 10.2 7.6 7.6 6.4 7.6 8.3 15.8 0.0 2.7 18.9 15.2 6.9 7.8 10.4 10.2 13.7 12.7 9.8 1.6 11.5 6.3 9.2 12.5 25.5 9.1 19.4 5.9 8.2 2.0 8.4 11.0 9.6 2.4 10.8 5.3 7.2 20.2 11.4 15.8 9.2 2.5 21.2 8.9 12.3 19.6 18.5 6.4 17.2 8.2 11.8 7.0 1.9 7.5 8.6 8.8 10.3 13.3 17.3 8.2 8.5 7.0 6.9 5.5 14.7 8.7 8.8 13.7 6.3 5.1 20.1 13.1 9.9 11.4 9.8 8.2 10.3 6.5 22.0 9.6 19.0 23.5 5.1 TENT2 "FLJ38499, GLD2, PAPD4, TUT2" ENSG00000164329 "Terminal nucleotidyltransferase 2" Q6PIY7 5 79612120-79686648 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "mRNA processing" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "dendritic cells: 37.6;Glandular and luminal cells: 33.2;Granulosa cells: 31.9;Hofbauer cells: 33.9;Syncytiotrophoblasts: 33.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054468 Approved Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA054468: AB_2682497" "unprognostic (1.52e-1)" "unprognostic (2.17e-1)" "unprognostic (6.25e-3)" "unprognostic (1.91e-1)" "unprognostic (8.03e-2)" "unprognostic (2.80e-3)" "unprognostic (2.10e-2)" "unprognostic (1.10e-1)" "unprognostic (6.80e-2)" "unprognostic (1.57e-3)" "unprognostic (9.37e-2)" "unprognostic (2.21e-1)" "unprognostic (7.71e-2)" "unprognostic (2.38e-1)" "unprognostic (8.43e-3)" "unprognostic (5.84e-3)" "unprognostic (2.67e-3)" 19.1 15.1 10.4 20.4 12.8 44.4 25.0 11.5 15.6 17.9 15.0 18.5 17.8 19.6 23.6 16.5 16.0 17.3 14.5 9.6 10.8 17.6 23.8 17.9 30.2 12.0 11.1 22.7 15.2 15.5 11.5 21.0 12.5 15.7 20.8 14.3 15.1 15.3 16.2 23.8 19.1 18.3 10.9 27.8 17.7 17.5 11.2 27.2 22.4 14.3 28.1 19.1 15.9 15.2 22.5 15.3 16.8 26.7 28.8 33.2 26.8 26.6 40.6 30.5 48.3 13.8 26.1 41.8 13.6 29.6 35.9 21.1 21.8 29.6 34.6 31.3 19.9 23.9 19.4 21.6 37.3 35.7 31.6 29.5 31.4 21.6 40.1 29.7 26.2 30.0 27.7 30.0 34.0 12.3 40.8 45.6 15.6 17.0 10.8 36.2 16.8 47.2 29.4 31.8 11.0 20.1 21.1 22.8 42.8 26.4 19.6 55.6 24.2 16.4 11.1 16.0 29.9 31.3 27.8 40.7 28.9 36.8 23.4 30.7 21.5 21.6 19.0 24.8 31.3 21.6 20.5 21.0 21.9 17.2 19.5 20.6 19.2 21.8 26.0 12.0 23.4 19.0 10.4 12.8 11.5 15.6 9.6 10.8 12.0 11.1 12.5 10.9 11.2 15.2 25.9 0.0 0.0 0.0 14.0 0.0 0.0 0.0 0.0 0.0 24.2 16.5 0.0 0.0 0.0 27.6 0.0 26.3 37.6 0.0 17.6 10.2 0.0 21.3 29.0 7.2 0.0 0.0 0.0 10.2 22.6 8.7 0.0 33.2 0.0 31.9 0.0 0.0 33.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.9 0.0 0.0 9.8 0.0 0.0 0.0 0.0 14.9 0.0 0.0 11.5 0.0 0.0 26.5 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 33.7 11.0 23.7 0.0 0.0 TFAM "TCF6, TCF6L2" ENSG00000108064 "Transcription factor A, mitochondrial" Q00059 10 58385345-58399220 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 7 "Early spermatids: 631.4;Late spermatids: 933.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040648, HPA063684" Supported Enhanced Mitochondria "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 34: Spermatids - Unknown function" Mitochondria "HPA040648: AB_10795635, HPA063684: AB_2685089" "unprognostic (5.30e-2)" "unprognostic (1.14e-1)" "unprognostic (6.34e-3)" "prognostic unfavorable (8.73e-4)" "unprognostic (1.10e-2)" "unprognostic (3.40e-2)" "unprognostic (1.54e-2)" "unprognostic (3.23e-2)" "unprognostic (1.24e-2)" "prognostic favorable (2.74e-4)" "unprognostic (1.99e-2)" "unprognostic (5.39e-2)" "prognostic favorable (2.22e-5)" "unprognostic (1.31e-1)" "unprognostic (2.24e-1)" "unprognostic (1.79e-1)" "unprognostic (6.76e-2)" 16.5 20.1 5.7 21.6 6.1 38.1 17.3 10.8 8.4 11.4 6.8 20.0 21.0 13.7 9.5 14.7 12.6 10.7 18.5 5.5 7.3 21.5 22.6 10.9 27.7 5.8 6.1 17.8 13.9 16.2 6.3 20.4 6.5 14.5 17.3 9.8 17.3 11.4 17.7 9.0 17.8 11.6 7.0 17.3 16.1 33.0 6.4 24.9 19.6 16.1 23.0 16.7 7.5 8.8 85.7 47.7 52.8 54.7 15.3 19.4 59.8 37.9 37.3 46.8 51.1 170.0 88.6 170.1 53.9 17.6 34.8 65.2 97.6 53.5 73.4 73.4 85.7 64.1 33.4 64.5 23.3 164.7 49.4 19.2 24.4 57.0 51.6 22.2 41.1 49.9 153.4 74.8 33.2 46.4 130.2 65.1 100.0 39.2 49.9 102.9 113.0 76.0 28.3 57.0 69.8 48.1 75.1 103.7 97.0 42.9 112.8 47.9 32.0 34.4 109.5 39.5 102.5 75.6 125.8 214.2 44.1 125.1 26.4 1.0 9.5 4.0 8.3 9.5 10.8 12.8 10.0 8.8 12.1 12.5 12.4 10.1 7.1 15.0 8.3 14.7 9.0 6.9 5.7 6.1 10.8 8.4 5.5 7.3 5.8 6.1 6.5 7.0 6.4 8.8 46.4 54.5 27.9 6.2 52.5 50.1 44.0 52.4 59.2 25.1 48.6 62.9 35.0 38.6 51.0 20.2 16.7 98.1 56.8 17.1 88.0 41.0 631.4 36.8 44.5 39.5 15.5 46.7 10.1 44.7 77.4 38.8 25.0 41.2 29.7 34.1 26.0 64.1 44.0 38.7 11.5 37.5 18.3 21.9 19.3 933.1 41.3 32.3 23.2 2.8 36.3 38.2 48.4 10.6 11.7 35.2 23.0 30.9 35.8 47.3 14.1 72.0 31.4 21.4 26.3 74.8 40.5 55.3 63.9 48.6 54.7 52.5 38.3 69.1 48.1 31.8 TFB2M "FLJ22661, FLJ23182, Hkp1" ENSG00000162851 "Transcription factor B2, mitochondrial" Q9H5Q4 1 246540561-246566261 "Metabolic proteins, Predicted intracellular proteins" "rRNA processing, Transcription, Transcription regulation" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028482, HPA028554, HPA030265" Approved Enhanced Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209" "unprognostic (4.38e-2)" "unprognostic (2.45e-2)" "unprognostic (3.79e-3)" "unprognostic (5.63e-2)" "unprognostic (1.10e-1)" "unprognostic (8.13e-2)" "unprognostic (8.76e-2)" "unprognostic (1.41e-1)" "unprognostic (2.51e-2)" "unprognostic (1.68e-2)" "unprognostic (2.46e-1)" "unprognostic (6.81e-2)" "unprognostic (5.26e-2)" "unprognostic (2.27e-1)" "unprognostic (9.44e-2)" "unprognostic (6.41e-2)" "unprognostic (3.53e-2)" 11.6 23.5 3.6 9.4 3.7 24.2 12.1 6.2 5.0 8.5 6.3 12.6 11.4 7.2 9.5 10.9 8.6 7.1 14.0 3.4 3.9 21.2 37.8 6.3 13.3 3.4 3.5 6.9 15.6 10.8 6.3 9.1 3.5 8.8 12.9 5.0 11.3 7.5 22.7 9.3 9.1 8.0 3.8 7.0 10.1 8.7 3.9 9.3 13.6 24.3 13.2 13.3 6.1 4.1 33.9 31.9 12.1 21.5 14.8 21.1 42.2 24.2 24.8 26.9 24.6 39.0 31.6 59.8 36.9 24.7 17.4 28.5 29.3 25.7 36.8 23.4 11.3 30.3 18.1 34.5 24.2 54.1 26.3 21.0 30.2 23.1 25.8 14.8 21.2 20.9 89.2 19.8 23.4 15.7 27.5 24.1 53.8 58.6 32.1 27.2 23.9 72.9 24.5 36.7 26.7 53.8 23.4 41.9 82.2 13.3 30.6 51.3 15.6 18.7 22.7 26.6 63.8 57.1 102.9 47.6 23.0 52.6 23.9 0.3 5.4 1.5 9.1 5.7 11.5 11.9 8.0 9.7 12.9 12.0 10.3 8.9 1.2 14.8 9.8 11.1 12.3 5.3 3.6 3.7 6.2 5.0 3.4 3.9 3.4 3.5 3.5 3.8 3.9 4.1 11.9 6.4 9.4 4.2 17.2 53.3 13.7 27.9 31.9 3.2 12.4 11.9 16.5 14.3 18.4 16.5 10.4 24.4 13.1 7.6 29.4 13.8 1.5 17.6 12.9 13.2 11.4 8.6 8.1 15.5 28.1 10.2 18.8 22.4 14.0 7.5 5.7 33.9 11.9 0.0 7.2 14.3 6.1 9.3 7.7 3.4 6.5 7.3 5.4 1.9 6.9 6.6 7.2 6.0 5.5 11.0 10.3 4.5 12.7 17.2 7.8 39.2 15.4 3.4 13.1 14.4 12.2 13.2 21.6 21.3 44.9 21.1 10.9 17.7 19.8 10.4 TFRC "CD71, p90, TFR1" ENSG00000072274 "Transferrin receptor" P02786 3 196027183-196082096 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Endocytosis, Host-virus interaction" "Host cell receptor for virus entry, Receptor, Transducer" "Cancer-related genes, Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 254.5" "Cell type enhanced" "Detected in many" "Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HDLM-2: 860.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000153, HPA028598" Enhanced Supported Endosomes,Lysosomes "Secreted to blood" NA NA 1310000000 38000000 "Cluster 27: Non-specific - Gene expression" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "Endosomes, Lysosomes" "CAB000153: AB_2533029, HPA028598: AB_10601599" "unprognostic (2.95e-2)" "prognostic unfavorable (3.67e-4)" "unprognostic (2.55e-1)" "unprognostic (1.48e-2)" "unprognostic (6.75e-2)" "unprognostic (7.88e-3)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.92e-2)" "unprognostic (3.30e-3)" "unprognostic (4.35e-2)" "unprognostic (1.34e-2)" "unprognostic (1.14e-2)" "unprognostic (3.63e-3)" "unprognostic (3.65e-2)" "unprognostic (1.19e-2)" "prognostic unfavorable (2.96e-4)" "unprognostic (2.62e-2)" 44.6 28.7 21.6 63.4 18.3 254.5 20.2 18.5 32.3 31.3 15.7 77.2 35.9 23.8 11.1 36.0 25.9 24.9 31.0 21.9 19.0 26.4 27.8 78.0 23.0 24.2 19.9 93.9 15.9 44.8 13.1 103.2 26.3 13.2 55.6 47.3 15.7 13.4 76.2 21.8 32.1 31.5 20.8 15.5 21.4 21.6 25.3 22.0 20.1 68.7 28.1 68.5 17.4 20.7 175.3 155.0 69.8 142.1 151.7 87.3 438.7 242.5 183.7 168.1 276.3 384.6 156.6 178.5 446.3 91.0 363.5 261.8 243.3 81.1 204.2 860.4 82.4 677.4 120.2 179.2 119.4 561.8 130.4 99.1 78.6 144.5 129.0 47.8 56.9 95.6 287.3 164.1 132.8 161.7 185.8 116.8 214.9 228.6 314.0 97.3 103.9 214.1 148.3 435.3 159.3 65.9 234.4 613.9 55.2 115.9 595.0 115.8 72.5 198.4 159.7 175.3 369.7 46.3 387.8 276.7 232.3 149.2 122.3 0.0 1.6 2.2 2.2 7.3 1.4 5.1 2.4 1.5 3.5 3.1 2.1 1.7 0.2 1.9 13.2 7.1 6.4 2.1 21.6 18.3 18.5 32.3 21.9 19.0 24.2 19.9 26.3 20.8 25.3 20.7 25.4 44.8 32.1 43.1 46.6 60.3 37.2 33.6 21.1 53.1 37.1 34.9 103.0 41.5 38.8 20.2 148.0 122.5 53.2 156.6 0.0 49.4 3.5 35.3 20.3 23.6 56.1 556.4 24.7 41.8 25.3 32.4 77.5 56.1 23.4 40.2 8.6 93.2 73.4 13.5 28.3 67.8 22.4 37.1 77.6 5.3 11.5 161.7 17.8 44.0 49.4 22.0 9.2 11.6 8.2 52.0 50.8 8.6 42.1 25.6 48.3 13.1 32.1 44.4 26.3 36.3 29.3 23.8 18.2 51.3 35.8 502.7 42.6 16.6 103.5 23.7 THAP8 FLJ32891 ENSG00000161277 "THAP domain containing 8" Q8NA92 19 36034984-36054739 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Spermatocytes: 18.8;Spermatogonia: 21.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA064056, HPA070139" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 78: Testis - Spermatogenesis" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Nucleoplasm "HPA064056: AB_2685184, HPA070139: AB_2686230" "unprognostic (1.33e-3)" "unprognostic (2.24e-1)" "unprognostic (8.03e-2)" "unprognostic (1.08e-2)" "unprognostic (3.10e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.32e-4)" "unprognostic (9.01e-3)" "unprognostic (3.94e-1)" "unprognostic (1.27e-1)" "prognostic favorable (3.19e-4)" "unprognostic (2.50e-1)" "unprognostic (2.10e-2)" "unprognostic (9.11e-2)" "unprognostic (1.26e-1)" "unprognostic (2.48e-2)" "unprognostic (2.48e-1)" 3.3 3.2 9.1 2.5 9.8 0.9 2.7 9.4 9.6 5.0 6.3 9.5 3.7 4.7 3.4 3.7 3.8 3.5 3.5 8.3 9.7 4.1 4.6 2.8 3.1 10.1 9.8 3.5 2.8 3.7 3.4 2.8 10.2 3.6 2.4 4.6 3.0 4.3 10.2 5.2 3.5 4.4 8.9 3.4 3.6 9.7 9.7 4.0 3.1 3.3 2.2 6.6 4.0 11.2 3.3 8.2 4.4 3.7 11.6 8.0 2.8 2.7 4.8 5.5 7.8 3.6 2.3 4.5 9.7 4.5 5.7 1.5 2.5 3.3 2.1 3.2 1.6 2.8 3.0 4.3 12.7 1.6 2.7 6.2 5.0 3.8 2.6 6.2 2.6 8.2 2.4 5.3 5.8 5.5 4.1 3.4 3.9 5.6 3.1 3.9 1.4 4.2 4.5 2.9 8.1 6.1 4.6 3.9 3.3 5.7 4.1 2.2 2.3 7.3 4.5 4.5 2.2 5.2 4.5 3.3 8.0 2.6 4.7 7.1 6.5 7.9 5.2 7.6 5.9 4.1 5.5 5.4 4.7 3.0 4.1 6.1 2.7 6.2 6.6 4.5 5.8 4.1 9.1 9.8 9.4 9.6 8.3 9.7 10.1 9.8 10.2 8.9 9.7 11.2 1.4 3.2 3.7 3.6 3.4 1.1 1.2 3.2 2.8 2.2 3.0 2.4 3.7 5.7 2.9 7.3 2.1 10.2 3.5 2.1 1.9 5.7 3.0 1.5 3.9 2.5 6.6 1.3 2.7 0.5 5.5 3.8 4.1 2.7 5.7 8.8 3.9 3.5 15.8 3.3 3.3 1.3 12.2 4.4 0.8 6.1 1.8 3.2 1.8 1.9 4.4 5.2 8.2 4.5 5.5 2.6 2.7 4.1 2.5 1.2 5.3 11.7 1.2 3.0 0.0 1.7 2.9 18.8 21.5 2.3 2.3 10.5 2.5 5.8 2.2 1.0 THOC2 "CXorf3, dJ506G2.1, MRX12, MRX35, THO2" ENSG00000125676 "THO complex 2" Q8NI27 X 123600561-123733056 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, mRNA transport, Transport" RNA-binding "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047921 Supported Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 1: K-562 - Erythropoiesis" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA047921: AB_10960388" "unprognostic (2.12e-2)" "unprognostic (5.64e-2)" "unprognostic (3.49e-1)" "unprognostic (3.74e-2)" "unprognostic (2.22e-2)" "unprognostic (3.08e-1)" "prognostic unfavorable (5.77e-5)" "unprognostic (1.43e-2)" "unprognostic (1.04e-2)" "unprognostic (2.24e-2)" "unprognostic (3.24e-1)" "unprognostic (6.29e-2)" "unprognostic (4.27e-3)" "unprognostic (6.43e-3)" "unprognostic (1.05e-1)" "unprognostic (1.06e-2)" "unprognostic (1.35e-1)" 22.8 26.1 26.2 22.7 28.2 25.1 26.3 29.0 43.8 28.6 33.3 28.5 23.0 27.1 38.1 26.3 26.6 19.6 21.0 25.9 28.1 22.5 26.0 27.3 32.7 27.9 26.8 32.1 27.8 23.9 21.8 23.4 28.8 26.8 22.8 34.9 22.4 19.2 23.5 29.6 28.1 22.6 26.3 30.8 24.1 15.1 28.0 38.2 26.0 17.7 27.4 24.6 25.8 30.5 59.6 48.6 61.1 66.1 44.0 42.0 32.8 39.6 38.9 42.8 56.9 34.3 59.4 60.5 44.3 43.6 41.2 44.1 74.6 29.6 72.3 58.1 67.5 84.8 69.1 46.8 40.8 99.5 58.0 83.5 36.1 49.1 56.2 37.3 40.2 90.6 129.3 53.5 43.9 62.6 86.0 96.3 34.0 79.7 47.5 86.3 38.2 50.0 67.6 66.4 46.9 41.5 111.0 30.2 39.3 48.6 30.3 60.0 41.8 38.4 19.8 55.2 67.8 37.1 58.0 51.7 34.3 86.8 43.2 9.8 8.3 9.2 11.1 10.9 12.9 10.7 12.1 12.1 7.9 11.5 13.1 12.6 4.7 11.0 12.2 13.3 10.2 7.9 26.2 28.2 29.0 43.8 25.9 28.1 27.9 26.8 28.8 26.3 28.0 30.5 65.8 137.8 151.4 68.2 81.2 83.4 67.7 69.3 80.8 67.5 45.3 45.3 53.6 20.0 89.0 64.4 158.4 42.3 69.5 65.9 11.7 55.0 5.7 54.9 102.4 68.4 67.5 88.5 64.8 50.9 36.4 68.2 46.9 70.8 80.4 90.4 59.6 37.9 38.9 53.8 72.7 55.9 46.8 44.6 58.1 9.0 93.2 61.9 30.2 75.9 82.4 41.2 69.0 96.5 119.9 47.3 36.3 91.4 66.4 76.2 55.1 28.9 77.5 108.9 124.9 81.0 98.1 69.0 35.8 55.7 77.0 43.6 76.2 84.2 57.9 73.8 TIAM1 ENSG00000156299 "TIAM Rac1 associated GEF 1" Q13009 21 31118416-31559977 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 207.9" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 327.3;Microglial cells: 133.0;Oligodendrocyte precursor cells: 120.6;Oligodendrocytes: 124.6;Suprabasal keratinocytes: 143.3" "Cancer enhanced" "Detected in many" "testis cancer: 15.1" "Region enriched" "Detected in all" 4 "cerebellum: 207.9" "Group enriched" "Detected in many" 5 "classical monocyte: 17.4;intermediate monocyte: 15.3;memory CD4 T-cell: 12.5;myeloid DC: 9.6;naive CD4 T-cell: 16.2;NK-cell: 11.3;non-classical monocyte: 22.0;T-reg: 27.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 34.5;HEL: 34.7;HMC-1: 29.1;RT4: 35.5;SCLC-21H: 32.6" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 245.9" "CAB010416, HPA034853" Enhanced Supported "Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol" Yes NA "Cluster 27: Non-specific - Gene expression" "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 36: HEL - Hemostasis" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Cell Junctions" "Nuclear membrane, Cytokinetic bridge, Cytosol" "CAB010416: AB_2240410, HPA034853: " "unprognostic (9.59e-2)" "unprognostic (7.44e-3)" "unprognostic (5.64e-3)" "unprognostic (1.07e-1)" "unprognostic (1.58e-1)" "unprognostic (2.81e-3)" "unprognostic (2.84e-2)" "unprognostic (3.73e-1)" "unprognostic (8.08e-2)" "unprognostic (2.70e-3)" "unprognostic (7.97e-3)" "unprognostic (9.52e-2)" "unprognostic (1.20e-3)" "unprognostic (2.38e-3)" "unprognostic (1.61e-1)" "unprognostic (1.04e-2)" "unprognostic (2.21e-1)" 7.2 12.7 40.3 6.6 35.2 2.8 5.4 207.9 49.2 17.8 12.5 5.1 1.7 9.9 3.2 39.7 11.0 4.6 5.5 51.8 26.5 5.5 7.9 5.8 11.1 26.7 33.4 3.3 2.2 0.3 12.9 4.3 36.1 9.0 3.1 8.6 5.6 3.3 0.9 27.2 5.0 11.1 27.5 5.2 2.4 10.5 37.3 18.7 1.9 0.8 11.1 12.1 18.5 28.6 2.9 1.0 21.7 1.3 0.4 4.9 34.5 0.0 0.0 2.7 0.9 0.2 3.9 7.6 1.5 0.5 4.0 5.1 2.5 4.4 4.3 0.6 12.0 34.7 0.7 0.2 0.5 0.0 29.1 2.2 1.5 14.7 5.9 2.6 0.0 11.3 0.0 10.9 11.1 14.7 5.4 0.2 7.1 5.3 9.4 7.0 6.8 0.0 3.3 35.5 32.6 8.1 1.5 11.4 1.3 7.5 4.7 0.1 0.2 3.1 12.5 0.0 1.5 12.3 9.9 6.6 7.2 2.6 24.2 1.5 17.4 0.0 0.5 15.3 3.1 0.1 12.5 2.4 9.6 0.0 16.2 1.0 1.0 11.3 22.0 0.5 27.8 5.9 40.3 35.2 207.9 49.2 51.8 26.5 26.7 33.4 36.1 27.5 37.3 28.6 3.7 3.2 2.3 21.2 1.7 83.7 65.6 3.0 22.8 8.9 4.9 1.9 1.1 1.5 11.8 0.0 2.1 10.1 8.0 1.3 0.0 1.8 11.7 25.2 2.2 31.4 5.4 2.7 43.9 0.7 29.7 11.4 2.0 28.4 24.1 2.0 35.0 5.5 8.1 74.0 327.3 0.4 10.2 22.9 73.4 11.3 34.5 26.3 10.6 133.0 37.3 35.2 4.1 120.6 124.6 1.8 11.6 58.3 3.2 30.8 0.0 0.5 1.2 4.6 6.6 0.9 2.1 1.3 9.8 60.2 143.3 10.7 16.3 82.6 1.2 106.7 TIMM21 "C18orf55, HSPC154, TIM21" ENSG00000075336 "Translocase of inner mitochondrial membrane 21" Q9BVV7 18 74148523-74160531 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cardiomyocytes: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010587, HPA051543" Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 32: U-937 - Innate immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" "HPA010587: AB_1851244, HPA051543: AB_2681528" "unprognostic (4.88e-1)" "unprognostic (2.20e-2)" "unprognostic (1.16e-1)" "unprognostic (8.61e-2)" "unprognostic (3.81e-2)" "unprognostic (3.19e-1)" "prognostic unfavorable (9.22e-5)" "unprognostic (1.42e-1)" "unprognostic (1.59e-2)" "unprognostic (1.93e-2)" "unprognostic (4.79e-3)" "unprognostic (1.55e-3)" "prognostic favorable (1.38e-9)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.31e-1)" "unprognostic (6.66e-2)" 13.8 14.6 22.7 10.1 23.8 8.1 10.6 25.7 29.6 9.7 23.0 16.2 12.2 10.4 11.9 13.3 9.5 5.6 48.7 22.8 23.2 21.0 22.3 7.4 9.9 22.9 22.5 11.9 9.6 18.0 11.4 10.0 23.0 12.2 13.5 14.8 10.2 9.9 50.8 11.1 11.5 9.5 22.6 13.8 12.4 7.0 23.1 7.7 12.4 47.9 10.1 12.6 10.2 24.3 25.6 26.6 24.4 30.2 19.7 17.4 35.9 38.5 12.8 22.8 19.2 19.5 18.3 34.2 12.1 15.0 19.1 41.6 34.0 32.8 38.1 21.7 19.6 14.7 46.2 53.9 10.0 55.6 23.7 16.2 19.4 29.0 19.9 18.6 17.5 19.0 30.2 23.2 27.9 25.6 29.6 45.6 23.5 15.3 48.6 27.5 28.2 42.6 30.2 35.5 25.9 14.2 14.5 35.9 23.8 19.1 24.9 28.6 12.6 53.3 37.9 17.5 40.3 7.3 60.3 37.2 26.0 59.7 38.0 8.7 9.8 6.3 12.7 15.6 15.2 16.0 12.2 10.7 13.2 12.3 15.3 17.6 1.2 17.1 18.2 15.7 10.0 8.8 22.7 23.8 25.7 29.6 22.8 23.2 22.9 22.5 23.0 22.6 23.1 24.3 8.0 12.8 17.8 8.1 12.1 8.0 9.3 30.2 21.6 17.1 9.0 12.6 165.5 14.3 16.7 5.5 6.2 29.4 10.2 9.4 54.8 13.2 3.1 7.3 13.5 13.1 14.4 16.2 8.6 9.4 28.3 19.0 14.8 6.7 9.5 12.6 11.7 20.2 18.8 16.8 11.1 11.5 8.2 11.7 3.5 1.5 11.5 8.5 1.8 6.5 13.4 20.0 9.2 8.5 9.2 9.1 6.2 12.4 25.7 10.5 12.5 34.5 15.0 20.1 6.6 15.0 16.5 12.8 12.7 20.2 8.0 16.4 7.5 12.9 18.2 7.7 TIMM23B bA592B15.7 ENSG00000204152 "Translocase of inner mitochondrial membrane 23 homolog B" Q5SRD1 10 49942049-49974850 "Predicted membrane proteins" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" "unprognostic (8.84e-2)" "unprognostic (2.67e-2)" "unprognostic (5.92e-2)" "unprognostic (4.19e-3)" "unprognostic (9.37e-2)" "unprognostic (7.64e-2)" "unprognostic (2.04e-1)" "unprognostic (1.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.43e-3)" "unprognostic (4.03e-2)" "unprognostic (3.30e-3)" "unprognostic (5.39e-2)" "unprognostic (9.66e-2)" "unprognostic (1.62e-1)" "unprognostic (4.90e-3)" "unprognostic (1.18e-1)" 5.0 4.4 3.4 4.2 3.9 15.1 5.9 4.1 4.4 3.1 1.8 3.9 6.0 4.6 4.5 4.2 3.1 2.7 9.0 3.0 4.6 3.2 5.5 3.9 3.8 5.2 4.3 3.9 5.1 3.2 4.0 3.6 5.2 4.3 3.8 5.9 3.8 3.6 18.3 6.4 3.9 4.4 4.3 3.5 4.1 3.8 4.6 3.5 3.9 14.7 3.5 5.2 2.9 5.0 4.0 2.2 2.1 4.6 5.1 7.7 2.2 4.8 10.9 4.0 2.2 3.2 5.6 5.8 2.9 14.6 4.0 3.3 1.8 4.8 8.2 6.8 0.3 0.7 0.0 5.8 8.3 11.6 1.0 11.7 2.6 5.4 13.5 3.6 5.7 5.0 5.3 4.4 7.8 0.6 4.9 4.0 5.3 1.2 3.4 3.7 4.4 4.5 3.7 4.4 4.6 10.6 2.5 7.2 5.6 5.0 5.1 4.1 4.9 3.8 3.5 7.5 8.6 5.4 2.6 13.4 9.1 2.6 3.0 1.5 0.9 1.2 1.2 1.1 2.0 1.5 1.1 1.2 1.4 1.0 1.9 1.3 0.3 2.6 2.4 1.2 0.6 1.3 3.4 3.9 4.1 4.4 3.0 4.6 5.2 4.3 5.2 4.3 4.6 5.0 8.2 19.2 10.9 27.4 11.4 0.0 10.1 0.0 10.2 15.2 5.0 4.3 7.1 7.2 5.6 5.5 29.2 5.0 7.7 2.5 1.9 6.1 1.1 9.2 10.8 6.1 0.0 10.3 30.5 8.2 5.4 7.5 10.7 8.3 7.0 8.7 5.3 10.5 5.6 20.2 39.8 2.8 0.0 3.2 0.0 2.3 5.6 5.8 0.0 19.7 9.2 8.0 7.2 24.6 33.3 9.8 1.1 8.6 13.4 9.1 2.9 3.5 2.9 17.5 6.6 9.4 6.7 15.5 9.1 8.0 0.0 5.9 9.3 9.1 3.7 9.7 TIMM50 "TIM50, TIM50L" ENSG00000105197 "Translocase of inner mitochondrial membrane 50" Q3ZCQ8 19 39480412-39493785 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protein transport, Translocation, Transport" RNA-binding "Disease variant, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 185.5;Late spermatids: 662.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048843, HPA056448" Enhanced Supported Nucleoplasm,Mitochondria NA NA 12000 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 31: Spermatids - Spermatogenesis" "Nucleoplasm, Mitochondria" "HPA048843: , HPA056448: AB_2683137" "unprognostic (1.49e-1)" "unprognostic (6.97e-2)" "unprognostic (4.90e-2)" "unprognostic (2.80e-3)" "unprognostic (4.62e-2)" "unprognostic (1.45e-1)" "unprognostic (3.11e-2)" "unprognostic (7.91e-2)" "unprognostic (2.76e-1)" "unprognostic (3.11e-2)" "unprognostic (9.43e-2)" "unprognostic (2.01e-2)" "unprognostic (4.14e-3)" "unprognostic (3.04e-2)" "unprognostic (9.87e-2)" "unprognostic (3.82e-2)" "unprognostic (4.04e-2)" 37.3 37.2 31.2 30.4 33.7 45.4 29.7 34.3 44.2 27.7 31.5 32.2 30.4 33.2 11.2 35.8 27.9 18.5 75.7 35.0 35.0 32.9 43.9 25.7 27.7 35.0 32.8 27.4 35.3 36.2 22.7 25.2 33.0 27.4 15.4 8.9 32.0 17.5 127.0 26.6 29.6 23.0 30.6 26.2 31.8 80.5 32.9 21.6 31.7 76.6 18.2 30.9 26.1 33.1 147.2 365.3 59.6 155.1 43.8 33.4 116.8 115.8 54.2 119.6 97.4 262.6 96.6 156.5 126.0 67.9 71.9 81.6 100.9 114.8 56.4 148.7 170.8 140.3 94.5 197.3 81.5 282.8 106.6 51.9 73.2 97.2 78.7 33.9 76.4 184.5 237.8 91.3 77.2 202.9 178.4 110.5 113.7 159.2 123.3 190.8 112.5 119.3 88.1 195.5 166.3 99.4 133.6 190.0 251.8 35.7 89.1 168.0 86.4 154.7 165.6 140.1 262.7 96.1 181.1 232.8 117.9 146.7 179.2 42.5 53.7 13.4 36.3 58.5 34.9 41.8 34.1 40.0 60.5 46.4 41.4 35.7 5.9 45.2 58.1 47.0 47.8 62.1 31.2 33.7 34.3 44.2 35.0 35.0 35.0 32.8 33.0 30.6 32.9 33.1 20.0 22.4 26.0 4.6 19.3 26.0 43.6 57.4 18.8 10.4 23.8 28.7 47.6 24.3 37.6 25.8 12.5 83.8 14.7 27.4 66.5 56.3 185.5 19.8 24.2 28.6 23.4 29.6 8.7 51.8 84.4 30.9 25.0 21.5 39.3 29.5 19.2 31.3 67.1 28.6 9.3 27.5 48.8 18.8 27.7 662.8 23.3 22.3 30.2 3.7 22.1 17.4 21.6 6.6 4.9 50.9 22.2 21.1 34.6 68.0 35.7 66.0 22.1 11.4 6.6 27.2 55.7 111.5 46.5 32.3 26.7 94.5 19.9 34.1 48.1 47.6 TMCO4 DKFZp686C23231 ENSG00000162542 "Transmembrane and coiled-coil domains 4" Q5TGY1 1 19682240-19799945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 42.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA014601, HPA014620" Uncertain Approved "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" "Endoplasmic reticulum" "HPA014601: AB_2204302, HPA014620: AB_2669051" "unprognostic (3.31e-3)" "unprognostic (8.94e-2)" "unprognostic (9.71e-2)" "prognostic favorable (3.71e-4)" "unprognostic (6.99e-3)" "unprognostic (5.46e-2)" "prognostic unfavorable (1.12e-4)" "unprognostic (9.21e-2)" "unprognostic (2.60e-2)" "unprognostic (2.30e-1)" "unprognostic (1.84e-1)" "unprognostic (2.71e-2)" "prognostic favorable (4.12e-11)" "unprognostic (1.67e-1)" "unprognostic (2.22e-1)" "unprognostic (9.81e-2)" "prognostic favorable (3.64e-4)" 7.9 8.9 1.4 5.3 2.4 4.7 9.5 1.3 1.4 8.7 6.5 7.9 17.3 9.8 21.0 8.4 10.3 6.4 4.8 1.6 1.7 9.2 5.4 6.1 6.9 1.9 2.2 7.2 10.8 34.6 3.6 3.1 1.7 13.2 6.1 0.3 17.0 10.6 2.3 5.7 9.6 5.6 1.7 9.5 11.7 1.7 2.0 3.7 11.5 2.4 5.0 9.4 7.9 1.5 9.3 5.6 0.0 0.3 7.5 5.2 6.2 6.8 20.9 13.1 7.3 4.6 42.5 16.2 9.9 19.7 5.8 6.9 1.7 6.8 2.7 13.8 1.7 6.1 6.6 2.3 6.1 0.0 8.1 5.4 7.6 4.4 2.5 4.8 6.3 0.3 1.2 10.7 5.8 7.9 0.0 3.6 0.6 12.6 7.9 3.1 17.5 10.0 11.2 7.2 0.0 0.7 9.0 12.3 13.9 0.9 10.6 10.4 4.0 10.0 4.6 7.2 4.7 1.2 0.6 4.6 11.4 13.8 6.5 0.1 3.8 2.1 4.7 6.7 4.7 4.2 5.0 5.0 7.4 4.9 3.7 3.2 0.3 4.2 4.1 0.2 3.9 3.6 1.4 2.4 1.3 1.4 1.6 1.7 1.9 2.2 1.7 1.7 2.0 1.5 5.8 12.8 11.0 8.8 9.9 2.8 9.6 6.3 4.6 0.2 17.0 15.4 8.0 2.8 12.0 11.0 0.0 9.3 6.0 12.3 9.8 13.2 0.3 10.6 8.1 5.2 6.0 6.5 2.4 16.9 18.6 7.7 15.8 16.5 3.8 7.7 5.3 5.1 9.1 0.0 5.0 15.9 12.2 7.1 3.3 0.5 6.2 6.7 10.6 11.2 9.5 3.0 5.2 3.0 0.4 11.0 7.5 5.7 6.9 11.4 4.5 7.9 18.8 0.5 0.0 6.1 7.7 0.3 2.1 7.9 2.6 7.3 8.2 5.7 14.2 7.9 TMEM104 "FLJ00021, FLJ20255" ENSG00000109066 "Transmembrane protein 104" Q8NE00 17 74776499-74839753 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044330 Approved Approved "Nucleoplasm,Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm "Golgi apparatus" "HPA044330: AB_10960543" "unprognostic (1.05e-1)" "unprognostic (1.42e-1)" "unprognostic (2.70e-1)" "unprognostic (1.71e-2)" "unprognostic (5.95e-2)" "unprognostic (4.99e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (7.46e-2)" "unprognostic (2.86e-2)" "unprognostic (4.75e-1)" "prognostic favorable (1.97e-5)" "unprognostic (8.14e-2)" "unprognostic (6.17e-2)" "unprognostic (8.46e-2)" "unprognostic (7.95e-2)" "unprognostic (2.82e-3)" "unprognostic (1.00e-2)" 6.5 10.7 7.0 5.6 9.1 8.4 5.3 9.2 7.9 3.9 5.6 5.0 3.5 4.7 3.8 6.6 4.2 3.4 7.2 6.5 6.8 7.7 14.9 7.8 4.5 10.4 9.3 3.8 8.1 8.1 9.9 5.0 9.8 5.5 2.9 2.0 7.5 3.8 5.4 5.2 5.3 4.2 8.2 7.0 6.1 8.4 9.3 4.2 7.8 3.8 4.4 5.1 4.2 10.8 10.8 26.0 13.4 15.4 18.9 11.7 8.1 18.2 18.1 22.8 25.1 21.1 11.2 5.6 5.8 20.9 23.4 12.0 13.8 10.2 12.0 4.2 19.5 14.1 10.5 15.0 13.8 23.5 12.6 9.3 10.9 23.1 5.0 6.8 16.5 13.6 8.4 8.5 15.6 10.3 14.1 9.3 7.5 14.2 20.6 8.7 21.3 9.4 9.9 9.3 11.4 15.1 10.1 12.9 13.6 10.0 16.5 35.8 13.2 48.0 12.1 18.4 24.0 5.9 5.5 6.5 18.5 24.0 18.6 1.4 5.0 3.7 4.7 4.1 2.4 3.3 4.5 4.4 5.3 0.8 3.7 2.6 2.1 2.8 4.6 5.5 5.0 3.6 7.0 9.1 9.2 7.9 6.5 6.8 10.4 9.3 9.8 8.2 9.3 10.8 2.3 6.4 5.8 7.8 2.2 2.5 1.1 3.4 0.6 2.7 5.6 3.3 49.5 8.6 4.6 5.5 2.1 4.1 5.2 6.0 0.0 5.0 3.0 3.3 2.7 4.8 8.3 1.7 5.6 5.6 4.3 4.6 5.6 6.4 1.3 3.2 2.9 14.2 13.3 0.0 4.4 4.7 4.1 7.3 3.8 3.5 2.8 9.5 0.0 4.7 4.7 4.1 3.1 4.0 11.1 6.2 3.4 2.2 8.2 2.5 3.4 1.9 2.0 3.1 0.0 3.3 4.2 4.4 3.8 2.8 2.3 3.8 4.3 2.5 3.6 1.6 TMEM106B "FLJ11273, MGC33727" ENSG00000106460 "Transmembrane protein 106B" Q9NUM4 7 12211270-12243367 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Amyotrophic lateral sclerosis, Disease variant, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058342 Approved Supported Endosomes,Lysosomes NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 33: Fibroblasts - ECM organization" "Endosomes, Lysosomes" "HPA058342: AB_2683684" "unprognostic (5.29e-2)" "unprognostic (2.34e-2)" "unprognostic (4.20e-2)" "unprognostic (6.20e-2)" "unprognostic (2.73e-1)" "unprognostic (1.87e-2)" "unprognostic (3.50e-2)" "unprognostic (5.89e-2)" "unprognostic (4.44e-2)" "unprognostic (1.30e-1)" "unprognostic (3.01e-3)" "unprognostic (2.09e-2)" "unprognostic (1.75e-3)" "unprognostic (5.52e-2)" "unprognostic (3.06e-2)" "unprognostic (2.16e-2)" "unprognostic (1.70e-1)" 9.9 26.1 6.0 7.1 8.5 7.2 10.9 10.7 9.1 13.1 7.6 12.6 8.6 14.7 12.2 10.3 11.2 9.1 11.4 6.3 7.0 17.8 18.8 7.7 7.9 7.4 7.4 12.0 10.1 12.7 9.9 14.0 8.1 14.6 11.5 14.6 13.1 13.9 14.7 9.0 10.2 12.7 10.5 8.4 8.9 7.0 7.4 6.7 16.0 12.2 6.8 10.7 10.2 14.5 13.9 26.3 14.8 24.2 26.3 21.3 11.5 19.7 33.3 12.6 12.7 8.6 42.1 3.7 21.2 23.5 30.0 14.6 11.9 12.5 10.5 7.2 11.5 5.5 14.5 8.3 20.8 20.5 8.6 22.1 14.1 9.9 19.2 57.5 16.0 10.2 16.1 11.1 14.9 4.4 3.9 8.6 17.4 17.5 13.9 11.1 10.9 10.1 23.5 12.4 15.4 21.4 18.8 15.4 16.7 20.0 13.9 10.0 18.9 14.0 20.3 14.1 16.2 15.0 28.6 5.9 19.6 6.7 35.2 11.6 4.3 5.3 9.1 5.2 12.8 6.1 10.6 10.6 2.9 7.8 17.3 13.2 2.8 14.4 7.9 0.9 10.3 6.8 6.0 8.5 10.7 9.1 6.3 7.0 7.4 7.4 8.1 10.5 7.4 14.5 45.0 73.7 40.3 41.1 34.3 36.8 42.6 38.5 62.6 55.0 46.0 30.4 46.0 38.6 49.3 66.2 45.9 54.0 18.9 53.6 17.6 115.4 5.0 29.2 56.3 34.6 57.6 24.4 60.1 58.7 36.0 65.8 36.7 37.8 14.5 53.8 41.7 85.1 33.3 65.6 78.6 37.9 57.0 29.2 23.9 4.3 49.0 23.9 37.4 28.1 19.1 95.2 39.1 66.9 82.3 75.3 53.4 60.9 39.9 85.0 57.1 67.7 47.4 51.8 32.9 49.5 41.6 40.1 31.6 56.4 43.3 135.6 41.1 70.7 47.2 81.9 TMEM150A "FLJ90024, TM6P1, TMEM150, TTN1" ENSG00000168890 "Transmembrane protein 150A" Q86TG1 2 85598547-85603196 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 133.5;Early spermatids: 137.5;Proximal tubular cells: 85.0;Syncytiotrophoblasts: 146.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 52.9;HHSteC: 49.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019015 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA019015: AB_2204758" "unprognostic (2.80e-1)" "unprognostic (1.62e-2)" "unprognostic (2.29e-2)" "unprognostic (1.42e-3)" "unprognostic (4.09e-3)" "unprognostic (5.65e-2)" "unprognostic (2.38e-2)" "unprognostic (1.42e-2)" "unprognostic (5.80e-2)" "unprognostic (2.64e-2)" "unprognostic (2.54e-3)" "unprognostic (7.16e-2)" "unprognostic (8.27e-3)" "unprognostic (2.09e-2)" "unprognostic (2.89e-1)" "unprognostic (1.37e-2)" "unprognostic (6.87e-3)" 18.7 16.3 10.0 5.2 10.8 1.2 17.0 9.8 11.1 16.3 11.1 21.0 6.5 17.7 6.3 11.0 17.1 10.4 15.5 9.7 10.3 32.8 38.5 19.3 6.0 11.9 10.7 17.1 37.9 8.0 11.7 22.4 10.9 17.4 4.1 1.4 14.9 10.2 53.7 9.3 12.9 11.5 10.6 9.7 20.6 24.4 11.3 2.5 14.9 27.2 4.2 22.2 13.1 10.1 2.7 5.1 6.3 9.3 52.9 23.7 15.3 5.2 9.1 4.3 2.0 23.6 7.1 0.8 19.8 15.3 8.0 2.2 6.8 13.7 2.0 1.2 6.7 1.5 3.0 39.9 49.6 0.4 4.7 28.5 18.4 7.0 9.9 20.6 15.2 1.0 14.0 1.5 17.5 11.9 0.4 6.9 11.5 10.8 5.1 4.1 0.6 15.8 13.4 10.6 1.0 3.9 5.4 35.4 13.5 5.9 8.7 6.2 12.6 5.2 4.4 4.5 1.8 10.6 2.8 5.2 8.5 6.0 2.3 0.0 15.2 7.2 5.5 17.9 6.5 5.3 6.2 5.6 12.8 8.1 6.9 4.2 0.7 8.4 15.1 7.6 1.5 6.0 10.0 10.8 9.8 11.1 9.7 10.3 11.9 10.7 10.9 10.6 11.3 10.1 24.1 9.6 14.9 10.7 9.0 4.5 15.3 16.0 10.2 6.8 15.3 12.7 5.2 12.8 16.2 14.7 0.0 133.5 10.4 3.5 29.4 16.9 137.5 5.0 9.0 14.9 3.0 1.7 3.9 14.4 18.2 14.3 5.6 6.0 10.2 5.2 15.7 19.7 37.9 3.3 5.0 5.2 16.2 10.3 13.1 64.8 19.9 14.6 10.6 9.4 15.2 6.5 7.2 5.5 5.9 12.8 7.0 24.5 5.9 20.3 16.4 85.0 8.3 3.4 13.1 14.6 11.7 2.4 5.6 7.9 3.7 146.0 7.0 9.2 7.0 13.1 TMEM80 FLJ38216 ENSG00000177042 "Transmembrane protein 80" Q96HE8 11 695428-705028 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 82.2;Spermatogonia: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059592, HPA067046" Uncertain Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Golgi apparatus" "HPA059592: AB_2684076, HPA067046: AB_2685769" "unprognostic (1.48e-1)" "unprognostic (6.55e-3)" "unprognostic (1.70e-2)" "unprognostic (2.64e-2)" "unprognostic (2.71e-3)" "unprognostic (1.68e-3)" "unprognostic (4.36e-2)" "unprognostic (5.39e-3)" "unprognostic (3.85e-2)" "unprognostic (2.04e-1)" "unprognostic (1.41e-3)" "unprognostic (1.03e-1)" "prognostic favorable (2.47e-4)" "unprognostic (1.51e-1)" "unprognostic (2.78e-1)" "unprognostic (3.27e-1)" "unprognostic (4.23e-3)" 21.0 23.0 18.4 14.7 18.2 6.5 23.8 19.5 22.0 30.5 17.3 30.2 23.7 27.8 24.8 42.5 30.1 8.4 15.3 19.3 16.5 36.0 20.2 17.5 21.2 21.2 18.1 29.7 29.7 17.8 34.3 8.7 19.0 29.9 17.5 9.1 31.5 19.4 19.7 31.0 31.1 12.7 18.9 34.3 30.8 24.8 19.0 19.7 47.6 11.8 21.3 27.8 30.6 19.9 37.8 17.5 11.0 14.3 23.6 11.1 19.0 8.5 4.7 8.9 9.6 23.9 42.0 16.0 7.3 13.2 15.8 26.8 16.2 9.7 6.3 11.0 41.7 9.7 19.0 14.5 13.9 12.8 16.8 25.7 19.9 4.0 6.2 17.5 10.5 18.9 12.1 17.7 11.4 12.2 16.8 8.7 10.4 29.9 8.4 12.2 7.6 31.5 12.7 5.7 31.1 9.8 12.8 23.5 12.3 7.3 18.2 11.9 15.0 14.9 7.8 3.4 6.4 8.4 3.2 14.8 15.6 15.9 6.5 8.3 26.5 35.4 21.0 25.9 18.4 26.7 15.7 16.0 21.8 30.1 22.3 20.0 12.8 21.4 32.0 22.0 21.4 20.7 18.4 18.2 19.5 22.0 19.3 16.5 21.2 18.1 19.0 18.9 19.0 19.9 15.1 6.4 20.7 13.7 24.0 15.3 15.9 25.6 17.6 22.7 31.7 36.8 19.3 15.7 20.2 20.2 8.4 33.9 19.4 15.4 11.7 13.0 9.2 17.1 15.8 14.4 12.1 8.6 13.9 17.1 9.8 20.8 9.7 19.9 7.0 15.9 12.8 6.2 17.6 55.5 13.1 22.7 28.5 13.2 13.6 9.5 42.6 12.7 12.4 11.2 19.7 23.2 26.8 16.6 16.7 10.6 10.3 28.6 11.5 12.3 22.1 8.1 19.4 9.1 32.9 23.4 21.2 82.2 87.2 13.7 17.2 15.2 16.7 21.6 19.5 12.3 TMX1 "PDIA11, TMX, TXNDC, TXNDC1" ENSG00000139921 "Thioredoxin related transmembrane protein 1" Q9H3N1 14 51240162-51257655 "Predicted membrane proteins, Transporters" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003085 Approved Supported "Nucleoli,Endoplasmic reticulum" NA NA 26000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" "Endoplasmic reticulum" Nucleoli "HPA003085: AB_1080424" "unprognostic (1.83e-1)" "unprognostic (7.42e-2)" "unprognostic (6.97e-3)" "unprognostic (1.49e-2)" "unprognostic (2.63e-1)" "unprognostic (1.12e-2)" "prognostic unfavorable (1.29e-6)" "unprognostic (3.70e-2)" "unprognostic (1.51e-1)" "unprognostic (6.84e-2)" "unprognostic (2.44e-3)" "unprognostic (5.07e-2)" "unprognostic (9.30e-2)" "unprognostic (1.85e-2)" "unprognostic (1.66e-1)" "unprognostic (1.18e-1)" "unprognostic (3.21e-3)" 11.0 8.8 5.8 10.8 6.3 10.7 11.3 6.7 8.7 7.8 7.4 12.3 10.6 8.1 10.8 9.1 6.6 8.5 4.8 5.4 6.6 10.2 12.6 9.3 12.4 6.5 6.8 6.6 9.1 9.4 5.5 13.2 7.0 7.9 12.2 6.8 8.3 9.2 5.2 9.8 9.3 9.9 6.9 10.7 10.4 5.0 7.0 11.6 11.4 4.4 10.5 13.0 6.6 7.0 27.0 23.8 33.8 18.4 26.0 20.3 35.5 33.5 26.8 33.2 42.2 24.9 49.0 38.8 30.0 22.6 15.6 26.1 60.3 21.5 60.4 38.6 19.6 28.4 19.4 24.7 22.4 66.2 27.4 24.4 19.5 22.2 16.3 24.0 29.7 31.2 23.6 25.9 32.1 32.6 29.7 35.5 38.3 42.2 28.5 30.9 60.9 23.4 32.2 34.8 21.1 15.5 26.6 17.8 24.6 22.2 25.8 28.6 19.0 34.9 32.2 24.8 30.9 22.4 23.9 31.4 15.4 36.6 33.5 10.5 12.2 6.2 8.6 14.7 10.6 7.7 8.8 9.0 13.6 6.3 8.5 10.1 4.3 11.5 11.0 15.7 11.0 12.4 5.8 6.3 6.7 8.7 5.4 6.6 6.5 6.8 7.0 6.9 7.0 7.0 43.0 38.5 29.1 24.5 55.9 108.6 63.1 80.5 71.2 13.7 40.7 20.8 9.2 44.3 55.7 35.0 12.5 73.9 82.6 38.2 9.8 62.1 2.5 22.0 42.2 47.5 17.4 81.2 8.9 67.6 149.3 48.4 32.1 28.0 43.6 24.4 43.2 44.0 73.2 10.1 11.2 29.2 63.1 61.1 84.3 4.3 24.8 65.7 55.2 18.7 70.0 27.0 46.4 22.1 25.2 50.3 44.0 28.6 79.2 58.4 29.3 32.4 42.2 32.6 59.2 37.3 49.4 59.5 68.7 79.0 97.3 57.7 62.5 58.7 46.5 59.5 TMX2 "PDIA12, TXNDC14" ENSG00000213593 "Thioredoxin related transmembrane protein 2" Q9Y320 11 57712593-57740973 "Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease variant, Lissencephaly, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040282, HPA063763" Approved Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Cytosol" "HPA040282: AB_10697715, HPA063763: AB_2685116" "unprognostic (3.66e-3)" "unprognostic (6.96e-2)" "unprognostic (6.69e-3)" "unprognostic (2.73e-2)" "unprognostic (2.12e-1)" "prognostic unfavorable (3.64e-4)" "prognostic unfavorable (4.11e-4)" "unprognostic (4.48e-2)" "unprognostic (2.98e-1)" "unprognostic (7.26e-3)" "unprognostic (1.90e-2)" "unprognostic (2.22e-1)" "prognostic favorable (1.55e-5)" "unprognostic (5.88e-3)" "unprognostic (4.19e-2)" "unprognostic (3.40e-1)" "prognostic unfavorable (3.37e-4)" 52.9 75.1 77.7 37.3 83.0 27.0 50.5 87.4 101.9 43.6 103.3 70.0 56.4 39.4 58.2 62.8 42.7 33.2 71.5 75.0 84.1 78.7 83.4 45.0 31.5 81.7 81.5 40.9 57.7 84.9 43.1 44.0 83.5 50.1 80.8 64.7 49.6 53.8 44.7 45.1 58.3 43.1 84.3 44.9 60.9 30.6 85.5 34.9 57.1 41.3 47.6 48.2 43.8 90.6 122.7 141.4 78.5 143.4 144.8 77.2 86.6 144.2 111.8 140.0 117.9 135.3 205.6 115.1 156.6 116.3 207.1 220.0 203.5 115.4 146.3 83.3 88.9 110.2 105.7 136.8 119.3 156.6 145.5 94.8 166.5 154.8 243.2 76.3 80.6 95.3 194.4 130.9 157.7 62.7 93.0 177.1 153.8 227.7 191.5 124.7 97.9 242.5 174.4 136.4 90.3 129.3 110.2 255.7 168.3 76.7 228.5 102.2 66.7 130.5 84.8 176.1 152.1 127.9 269.5 115.3 146.6 109.3 198.3 37.8 41.5 40.0 34.6 72.4 44.0 36.8 34.4 40.9 40.6 34.9 43.1 43.8 11.2 37.8 86.0 49.7 32.0 45.0 77.7 83.0 87.4 101.9 75.0 84.1 81.7 81.5 83.5 84.3 85.5 90.6 37.9 38.5 34.0 0.0 32.0 32.1 44.9 108.2 19.9 43.4 35.8 28.1 42.6 30.0 60.8 49.7 31.3 108.0 29.9 39.5 43.0 72.4 2.0 19.6 27.4 36.8 28.8 37.6 0.0 43.5 85.6 38.6 23.0 20.7 43.1 29.9 31.8 48.7 62.0 30.3 0.0 49.6 81.4 30.8 21.4 3.6 48.7 31.9 48.0 0.0 37.8 91.1 19.6 0.0 0.0 54.5 32.0 43.6 32.5 49.0 51.4 41.1 37.4 66.7 39.5 36.3 34.5 60.7 62.2 33.6 32.7 99.6 26.6 46.6 75.2 43.6 TMX3 "FLJ20793, KIAA1830, PDIA13, TXNDC10" ENSG00000166479 "Thioredoxin related transmembrane protein 3" Q96JJ7 18 68673688-68715108 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014157 Uncertain "Intracellular and membrane" NA NA 36000 "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "HPA014157: AB_1858469" "unprognostic (2.11e-1)" "unprognostic (5.15e-2)" "unprognostic (2.14e-2)" "unprognostic (9.47e-2)" "unprognostic (6.82e-2)" "unprognostic (7.20e-2)" "unprognostic (4.96e-3)" "unprognostic (1.54e-1)" "unprognostic (3.21e-3)" "unprognostic (5.20e-2)" "unprognostic (9.83e-3)" "unprognostic (2.73e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (2.69e-2)" "unprognostic (1.53e-2)" "unprognostic (1.38e-2)" "unprognostic (1.21e-1)" 22.7 16.2 11.7 24.1 13.0 14.1 19.2 14.2 15.4 15.0 9.9 12.7 18.2 16.6 20.4 14.1 13.8 16.5 20.8 13.5 13.2 14.6 16.2 19.5 27.9 11.1 11.2 13.0 11.9 15.9 9.6 19.8 12.1 17.7 16.3 26.0 10.6 13.0 11.0 16.7 18.8 21.0 11.4 22.6 14.0 11.4 12.1 23.3 17.7 21.0 22.7 20.1 11.2 11.5 11.1 17.4 32.9 25.9 66.6 70.7 24.5 85.7 91.0 61.0 67.7 8.4 31.9 31.4 16.6 125.4 25.9 40.8 21.9 42.9 92.8 30.3 19.6 28.8 27.4 14.7 70.6 62.0 45.7 56.5 27.1 66.2 59.2 61.8 78.4 27.0 18.9 42.5 73.1 6.9 33.3 19.6 13.9 9.1 28.2 30.7 65.5 38.5 51.7 24.2 31.5 24.5 42.0 26.7 31.8 32.4 17.6 52.1 76.4 108.4 30.0 24.7 63.6 28.4 30.4 29.4 65.5 50.1 81.3 2.2 2.9 2.4 3.8 4.7 5.5 3.1 3.9 3.6 4.7 2.1 4.3 4.4 0.7 4.9 3.3 6.4 4.4 2.7 11.7 13.0 14.2 15.4 13.5 13.2 11.1 11.2 12.1 11.4 12.1 11.5 31.4 28.9 27.8 36.2 25.0 20.3 17.2 17.6 12.0 29.1 21.0 15.6 25.1 10.0 18.8 16.5 18.8 15.0 44.3 10.6 1.9 15.2 8.9 18.7 38.5 27.3 18.0 17.0 77.9 10.2 20.8 34.5 13.3 25.6 20.3 24.2 34.2 26.6 18.6 26.9 45.6 13.8 14.2 23.3 26.8 3.3 24.2 23.9 24.9 32.8 18.2 20.5 20.6 49.8 53.1 15.4 15.4 16.6 29.8 19.4 17.5 8.0 28.8 32.5 39.5 23.6 32.0 23.8 28.3 21.7 24.3 12.4 23.3 22.9 9.4 16.6 TNFAIP1 "B12, B61, BTBD34, EDP1, MGC2317" ENSG00000109079 "TNF alpha induced protein 1" Q13829 17 28335602-28347009 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 112.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "CACO-2: 166.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013333, HPA014641" Uncertain Approved Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 86: Liver & Placenta - Transport via ER" "Cluster 39: CACO-2 - Unknown function" "Cluster 1: Pancreatic cells - Digestion" Nucleoli "HPA013333: AB_1858160, HPA014641: AB_1858159" "unprognostic (4.42e-1)" "unprognostic (1.54e-2)" "unprognostic (4.32e-2)" "prognostic unfavorable (7.48e-5)" "unprognostic (2.29e-1)" "unprognostic (4.97e-3)" "unprognostic (3.21e-1)" "unprognostic (1.94e-1)" "unprognostic (2.64e-2)" "unprognostic (1.31e-2)" "unprognostic (8.27e-3)" "unprognostic (1.43e-2)" "unprognostic (4.21e-3)" "unprognostic (2.49e-2)" "unprognostic (2.04e-1)" "unprognostic (4.09e-1)" "unprognostic (7.02e-2)" 36.1 30.4 32.4 19.3 31.1 8.1 30.3 28.5 32.0 22.0 38.6 19.9 17.7 21.7 14.9 39.6 19.2 28.9 46.7 30.9 29.1 35.9 54.8 40.9 17.0 30.3 30.1 17.4 37.6 23.0 17.5 44.7 29.4 20.5 16.9 26.3 23.9 20.5 23.3 29.0 17.7 30.9 28.9 50.2 25.4 17.2 35.7 22.0 24.0 23.8 19.5 35.1 23.4 28.9 43.3 61.3 40.2 28.4 34.3 30.1 39.0 50.4 62.4 60.6 47.6 166.1 25.8 8.7 34.4 67.0 29.4 49.1 22.3 86.9 46.5 24.0 28.0 7.7 66.0 24.2 45.9 13.5 12.5 38.9 99.7 47.7 37.0 56.9 71.7 17.4 20.0 12.8 28.8 25.8 25.6 7.4 9.3 36.4 22.3 11.3 50.8 15.5 89.5 45.9 29.3 31.7 62.3 102.5 25.8 55.8 42.9 11.4 76.4 44.2 43.7 34.4 39.3 20.8 18.7 9.3 34.3 9.0 28.5 1.7 7.2 9.5 6.5 7.0 7.7 5.3 4.7 5.9 9.3 3.9 4.5 5.5 2.5 9.1 8.7 4.5 4.3 5.0 32.4 31.1 28.5 32.0 30.9 29.1 30.3 30.1 29.4 28.9 35.7 28.9 66.6 38.5 12.9 5.5 4.6 24.6 47.5 32.0 12.5 25.6 18.2 11.9 21.8 20.0 17.5 22.0 16.7 31.5 6.2 14.3 23.5 60.5 40.1 23.0 13.9 62.4 17.4 7.4 11.7 82.5 34.9 13.5 12.8 30.2 7.0 14.0 60.3 29.5 11.0 11.8 7.5 11.0 10.2 12.5 12.1 6.9 7.8 7.0 0.0 9.4 30.1 10.0 4.1 7.1 7.2 112.9 15.1 7.9 7.1 46.9 13.6 16.9 20.2 9.8 13.1 10.9 22.3 5.4 5.6 15.9 28.4 69.2 5.0 18.1 9.7 43.0 TNPO1 "IPO2, KPNB2, MIP, MIP1, TRN" ENSG00000083312 "Transportin 1" Q92973 5 72816312-72916733 "Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016325 Approved Supported "Nucleoplasm,Cytosol,Cytoplasmic bodies" NA NA 130000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Cytosol, Cytoplasmic bodies" "CAB016325: AB_675691" "unprognostic (1.16e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-3)" "unprognostic (1.43e-1)" "unprognostic (3.15e-1)" "unprognostic (6.43e-3)" "prognostic unfavorable (6.55e-5)" "unprognostic (8.93e-3)" "unprognostic (9.03e-2)" "unprognostic (3.40e-3)" "unprognostic (2.09e-1)" "unprognostic (3.07e-1)" "unprognostic (1.48e-1)" "unprognostic (1.23e-1)" "unprognostic (1.76e-1)" "unprognostic (1.27e-2)" "unprognostic (2.49e-2)" 23.5 23.0 10.6 28.8 14.6 31.7 25.0 14.0 10.0 20.2 23.0 24.5 20.5 24.0 33.8 23.1 20.6 27.7 20.8 10.5 17.1 30.5 28.4 17.3 29.9 18.2 13.4 22.4 31.5 39.8 15.6 36.8 16.5 23.4 29.9 65.0 20.9 28.1 25.0 11.6 20.9 28.2 15.1 20.6 30.7 37.3 13.1 35.6 36.8 27.0 32.3 33.3 14.0 21.5 94.8 123.7 154.5 104.8 133.3 144.5 110.4 112.3 145.6 112.2 113.6 111.4 87.1 117.5 78.5 173.0 140.4 71.6 126.3 108.8 160.8 66.6 71.9 76.2 144.8 55.9 103.9 78.4 55.1 110.8 80.2 151.0 184.8 78.2 248.6 52.9 113.4 54.8 298.1 50.3 87.2 37.3 99.3 39.8 90.9 83.1 150.5 74.1 73.4 109.5 87.5 73.6 160.6 60.3 135.8 99.8 71.2 61.9 225.1 79.5 113.8 116.8 136.7 53.2 95.8 155.8 69.9 91.3 154.4 8.2 8.2 6.9 11.9 11.0 16.5 10.3 10.9 9.3 10.3 10.8 11.6 11.9 8.4 14.1 14.0 5.0 8.3 10.5 10.6 14.6 14.0 10.0 10.5 17.1 18.2 13.4 16.5 15.1 13.1 21.5 42.3 12.8 25.0 45.7 49.0 59.1 40.9 29.7 60.3 105.0 38.7 24.0 53.8 30.0 28.7 27.6 98.0 81.9 44.9 39.8 17.6 39.0 105.4 38.6 46.1 64.8 53.2 27.1 142.2 41.5 50.0 52.8 53.0 46.7 22.1 62.8 50.7 38.1 42.7 89.2 77.8 46.3 28.5 40.0 42.2 60.9 46.6 42.1 24.9 50.6 47.4 143.1 26.8 79.9 84.7 58.9 24.9 60.2 42.9 57.0 33.9 36.1 27.6 187.9 26.3 72.5 48.8 58.5 76.3 42.0 53.3 131.3 36.9 40.2 37.2 60.2 TOB2 "APRO5, bK223H9, TOB4, TOBL, TROB2" ENSG00000183864 "Transducer of ERBB2, 2" Q14106 22 41433494-41446801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016603, HPA054112" Approved Approved Cytosol NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 54: Non-specific - Microtubule organization" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" Cytosol "HPA016603: AB_2669400, HPA054112: AB_2682385" "unprognostic (1.21e-3)" "unprognostic (3.10e-2)" "unprognostic (3.41e-1)" "prognostic favorable (3.08e-5)" "unprognostic (3.89e-2)" "unprognostic (1.38e-1)" "unprognostic (1.36e-1)" "unprognostic (5.36e-2)" "unprognostic (4.94e-2)" "unprognostic (5.74e-2)" "unprognostic (3.18e-2)" "unprognostic (1.17e-1)" "prognostic favorable (1.18e-6)" "unprognostic (1.50e-2)" "unprognostic (7.14e-2)" "unprognostic (1.85e-1)" "unprognostic (7.13e-2)" 46.1 31.3 39.3 15.6 56.3 9.7 25.5 78.1 40.1 26.5 18.5 30.1 22.4 25.0 11.8 26.6 38.4 28.8 41.2 39.3 43.8 24.6 27.1 20.7 18.5 61.7 42.9 38.0 29.0 35.6 22.8 22.0 44.0 26.6 15.5 55.0 17.2 19.4 86.5 27.1 23.9 20.1 39.5 20.6 30.5 13.6 52.0 19.6 36.1 68.1 19.7 23.3 21.0 71.9 36.8 16.6 28.5 19.4 65.4 45.5 27.5 23.9 36.7 29.8 26.2 21.9 17.0 22.4 23.5 34.8 11.6 31.4 26.7 13.4 27.1 23.0 34.2 12.3 23.9 33.4 44.8 33.5 15.9 42.1 22.5 35.6 15.4 30.1 30.2 7.6 18.9 24.5 24.6 40.8 13.9 19.2 24.4 48.1 17.6 29.7 19.2 19.4 21.3 25.3 13.1 8.8 60.0 32.2 44.6 17.7 17.9 16.5 37.9 29.3 27.1 23.0 22.7 22.9 10.7 12.2 17.8 14.2 19.7 3.9 5.9 4.1 7.5 8.0 7.1 10.0 6.2 6.3 5.3 7.5 3.2 4.7 3.8 3.8 8.4 8.0 5.5 6.1 39.3 56.3 78.1 40.1 39.3 43.8 61.7 42.9 44.0 39.5 52.0 71.9 48.5 48.1 59.6 48.6 61.4 126.8 66.6 24.3 105.3 56.0 83.1 56.9 59.8 58.6 31.7 47.8 64.6 34.7 56.9 76.9 23.5 29.7 41.1 88.6 59.3 45.3 54.3 16.8 12.2 19.1 37.3 54.1 42.3 116.9 34.1 13.7 52.5 29.7 19.6 25.2 15.1 67.7 10.2 22.0 117.9 61.6 66.8 51.4 53.4 14.0 34.6 58.3 18.6 10.1 43.6 32.3 60.0 82.0 26.2 73.6 103.6 29.2 45.9 105.2 52.6 97.4 60.9 23.8 28.9 88.7 136.7 63.3 57.4 19.6 61.9 92.2 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.4;pancreas: 91.4" "Cell type enhanced" "Detected in all" "Distal enterocytes: 177.7;Proximal enterocytes: 95.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "MCF7: 61.9" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 23.6" "HPA020899, HPA076667" Approved Approved "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 6: T47d - Mammary gland" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favorable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favorable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.7 5.1 24.3 4.4 37.8 2.7 4.8 29.9 33.1 5.2 15.1 25.4 22.0 4.7 0.9 20.5 5.1 3.2 10.7 23.5 23.7 19.1 24.3 8.1 2.4 33.1 32.4 6.4 91.4 2.5 6.0 3.3 28.2 8.0 6.9 1.7 11.8 3.4 6.2 15.6 26.0 1.5 20.8 5.0 29.3 9.3 31.9 2.0 5.5 3.1 1.5 7.8 6.9 56.4 10.2 11.4 3.8 17.0 5.2 5.5 30.1 7.0 4.3 7.0 3.9 38.5 12.1 18.6 10.1 3.6 9.2 30.4 7.9 3.9 0.9 11.9 11.1 8.7 17.5 25.5 7.9 13.5 10.8 4.7 7.5 6.2 4.3 4.6 4.5 8.2 16.1 6.4 2.1 61.9 8.9 29.0 13.5 55.5 14.8 26.3 9.1 28.4 15.9 21.0 24.4 8.9 10.8 49.6 13.0 2.9 57.8 21.0 5.0 12.7 6.0 20.1 15.1 5.3 11.0 9.7 9.1 12.1 7.2 0.0 0.8 0.0 0.3 0.8 0.1 0.3 0.3 0.5 0.6 0.3 0.1 0.3 0.0 0.8 0.4 0.6 0.6 0.2 24.3 37.8 29.9 33.1 23.5 23.7 33.1 32.4 28.2 20.8 31.9 56.4 4.6 19.2 5.5 6.2 3.5 1.8 1.3 2.6 2.2 19.3 13.2 9.5 7.6 15.7 2.6 16.5 6.2 5.4 8.4 177.7 7.9 8.0 3.1 7.6 4.1 2.9 9.0 7.4 3.3 45.4 1.3 3.0 15.3 9.6 1.3 8.7 3.9 19.5 3.6 11.8 3.8 46.0 6.1 2.8 1.6 5.3 3.4 5.2 5.4 1.0 2.8 12.4 1.0 2.5 30.4 15.3 39.7 4.5 1.9 3.3 95.9 20.0 2.3 7.3 6.6 3.2 4.5 2.7 4.4 5.8 2.8 1.9 4.5 10.3 36.7 1.7 TRAM2 KIAA0057 ENSG00000065308 "Translocation associated membrane protein 2" Q15035 6 52497408-52577060 "Predicted membrane proteins, Transporters" "Protein transport, Translocation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 122.0;Plasma cells: 69.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "ASC diff: 250.1;ASC TERT1: 265.8;fHDF/TERT166: 253.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA035092, HPA057925" Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 28: Placenta - Pregnancy" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "HPA035092: AB_10610562, HPA057925: AB_2683557" "unprognostic (2.32e-2)" "unprognostic (2.19e-1)" "unprognostic (1.72e-1)" "prognostic unfavorable (1.88e-4)" "unprognostic (1.12e-1)" "unprognostic (4.07e-2)" "unprognostic (8.90e-3)" "unprognostic (1.14e-1)" "unprognostic (1.65e-1)" "unprognostic (3.03e-1)" "unprognostic (3.01e-1)" "unprognostic (5.05e-1)" "prognostic unfavorable (1.41e-9)" "unprognostic (1.37e-2)" "unprognostic (1.60e-1)" "unprognostic (6.64e-2)" "unprognostic (1.19e-2)" 19.5 4.9 3.4 14.8 4.7 5.3 13.8 3.0 4.3 14.9 7.8 12.5 14.0 13.1 11.5 5.6 13.5 17.3 10.4 3.0 3.3 7.4 16.2 14.1 7.5 4.3 3.5 12.4 7.0 2.8 3.9 35.8 3.6 6.0 14.7 3.9 6.4 5.8 3.6 11.5 12.6 17.5 3.3 19.2 9.5 13.3 4.4 4.5 12.4 5.9 13.3 13.3 9.6 3.3 45.4 19.8 22.7 22.6 250.1 265.8 39.8 130.0 130.8 106.7 98.2 43.2 9.2 11.0 21.4 253.4 76.0 10.0 14.9 81.3 133.6 24.8 8.0 24.1 20.5 54.9 71.3 6.2 13.1 97.4 8.0 93.5 41.2 155.1 124.1 9.1 15.1 78.4 154.5 16.2 8.9 17.7 10.4 17.9 8.8 10.9 59.8 91.0 25.3 7.5 5.5 8.7 29.9 13.2 31.6 47.7 20.6 12.9 198.8 177.6 38.4 65.0 72.1 53.4 97.7 31.1 64.7 16.1 110.8 0.1 1.0 1.0 0.9 1.1 0.5 1.2 0.7 0.5 1.1 0.8 0.3 0.6 0.2 0.7 2.1 0.5 0.2 0.7 3.4 4.7 3.0 4.3 3.0 3.3 4.3 3.5 3.6 3.3 4.4 3.3 12.8 6.4 3.2 6.8 15.9 8.2 2.8 8.5 3.4 3.1 4.0 5.1 9.9 4.3 4.1 7.3 25.0 36.2 6.6 7.8 3.9 3.6 38.3 4.0 28.9 17.9 9.0 8.6 12.0 3.2 30.8 26.2 6.1 5.0 2.5 34.0 19.6 36.1 15.7 5.0 9.2 19.6 6.1 12.0 6.9 122.0 20.8 5.7 26.6 13.1 4.3 1.8 8.2 3.5 3.1 6.2 1.7 23.3 69.5 2.8 7.0 3.1 4.9 12.7 13.1 16.2 15.7 23.4 8.6 1.2 4.1 20.7 6.0 14.3 5.7 1.5 TRAP1 "HSP75, HSP90L" ENSG00000126602 "TNF receptor associated protein 1" Q12931 16 3651639-3717553 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041082, HPA044227" Enhanced Enhanced Mitochondria NA NA 1700000 "Cluster 27: Non-specific - Gene expression" "Cluster 55: Non-specific - Mitochondria & Proteasome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Mitochondria "HPA041082: AB_2677291, HPA044227: AB_2678864" "unprognostic (1.18e-1)" "unprognostic (1.51e-1)" "prognostic favorable (1.80e-4)" "unprognostic (7.10e-2)" "unprognostic (6.80e-2)" "unprognostic (2.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.61e-2)" "unprognostic (8.58e-2)" "unprognostic (5.71e-3)" "unprognostic (1.54e-1)" "unprognostic (7.69e-3)" "unprognostic (1.01e-2)" "unprognostic (2.24e-2)" "unprognostic (6.68e-2)" "unprognostic (9.90e-2)" "unprognostic (3.82e-2)" 46.4 50.6 32.5 32.7 35.6 35.6 45.7 28.9 37.6 54.0 22.7 50.0 39.7 42.5 18.5 72.2 59.0 33.3 88.1 34.5 34.2 59.9 121.5 33.3 47.6 33.1 32.2 58.8 76.2 39.9 35.3 33.3 33.5 41.6 36.9 22.3 46.1 26.5 193.9 67.7 36.7 30.3 26.8 39.9 49.5 40.1 36.7 27.5 33.3 138.9 36.4 48.9 50.4 32.5 113.4 277.6 56.7 150.2 61.1 62.1 167.6 67.6 60.7 152.2 95.3 347.9 156.5 361.1 123.7 65.1 41.1 207.3 223.0 167.7 67.1 139.3 241.8 105.9 225.1 246.0 105.3 192.0 69.4 74.2 114.6 121.1 188.2 55.0 106.1 122.5 338.4 120.8 50.5 367.8 138.6 141.5 106.0 133.8 140.1 314.1 118.9 500.6 112.8 83.0 268.4 102.2 70.0 254.5 135.8 46.5 184.5 137.2 60.2 63.7 112.9 112.5 99.5 135.5 161.1 289.2 39.7 152.1 88.8 0.1 24.0 0.8 24.7 38.9 47.3 42.1 36.0 31.5 54.9 30.7 42.1 35.9 2.6 31.9 29.8 8.4 33.4 33.0 32.5 35.6 28.9 37.6 34.5 34.2 33.1 32.2 33.5 26.8 36.7 32.5 20.4 22.4 17.5 16.3 21.3 25.4 44.3 63.2 38.1 29.3 32.4 36.8 2.1 45.8 39.8 31.3 10.4 112.6 5.9 28.7 88.0 67.7 24.1 30.6 21.1 21.3 35.5 42.1 31.6 53.8 56.2 23.7 36.2 28.1 16.5 41.5 12.8 48.8 46.1 47.1 31.1 37.5 59.0 14.5 14.8 13.0 16.4 14.7 12.4 12.2 26.3 20.2 12.3 11.6 16.2 31.9 14.5 21.4 37.9 45.9 14.1 140.9 30.1 22.2 19.7 29.9 29.4 37.2 70.9 70.7 28.1 67.2 15.1 58.9 74.9 42.8 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662775-35818007 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 9: Photoreceptor cells - Phototransduction" Vesicles "Plasma membrane" "HPA049053: AB_2680613, HPA057633: AB_2683484" "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 12.6 10.7 16.9 12.3 16.4 6.0 11.1 18.5 21.9 10.9 8.3 13.5 10.6 10.9 10.2 9.1 11.1 11.6 11.6 16.6 17.0 18.0 14.4 11.9 12.8 16.0 16.7 10.3 15.5 11.1 7.9 13.3 16.1 10.4 11.1 27.0 9.4 11.4 11.5 8.3 12.0 12.2 17.8 14.1 11.3 6.7 17.3 12.1 14.9 9.8 13.2 11.1 8.6 19.0 20.1 16.9 26.4 12.3 19.6 29.6 0.1 18.5 21.9 22.7 20.6 19.7 13.3 26.7 17.1 24.3 25.7 15.4 9.1 21.1 25.4 17.6 17.4 28.7 23.0 11.4 26.0 22.7 23.7 22.4 23.2 13.3 36.0 25.1 24.3 9.2 45.4 9.3 24.1 12.1 24.1 11.1 14.9 4.2 14.5 16.6 68.4 14.5 21.0 26.9 18.1 15.5 27.7 19.6 21.0 14.3 29.5 19.0 27.4 28.9 23.8 16.6 21.2 15.7 15.0 0.1 23.9 23.7 22.2 0.2 0.9 0.3 0.9 1.2 0.8 1.1 0.9 0.9 0.8 1.5 1.1 1.2 0.0 1.2 1.5 1.8 0.3 0.5 16.9 16.4 18.5 21.9 16.6 17.0 16.0 16.7 16.1 17.8 17.3 19.0 67.5 60.9 72.6 78.4 68.5 26.8 57.9 19.8 74.0 221.5 45.3 38.2 58.9 55.8 45.6 25.8 204.3 55.4 72.1 70.3 33.2 62.8 18.8 78.0 74.0 62.4 51.4 39.3 151.7 71.1 25.9 49.4 74.9 54.4 58.9 107.1 49.2 53.3 42.7 84.1 134.5 57.6 16.2 65.7 37.8 13.4 36.1 70.3 19.6 84.3 76.9 72.2 72.1 121.7 171.0 53.3 50.4 37.2 59.6 90.3 50.9 75.6 48.4 173.4 98.6 71.9 52.1 88.2 81.5 46.1 26.7 52.1 47.0 58.5 54.5 59.9 TRIM66 "C11orf29, KIAA0298, TIF1D" ENSG00000166436 "Tripartite motif containing 66" O15016 11 8612037-8682694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 47.7;Early spermatids: 46.0;Late spermatids: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027420 Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 20: HeLa - Mitochondria" "Cluster 64: Astrocytes - Nervous system maintenance" Nucleoplasm "HPA027420: AB_1858316" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (2.43e-1)" "unprognostic (7.54e-2)" "unprognostic (3.99e-2)" "unprognostic (1.37e-3)" "unprognostic (8.01e-2)" "unprognostic (1.18e-1)" "unprognostic (8.49e-2)" "unprognostic (6.79e-2)" "prognostic favorable (8.89e-4)" "unprognostic (1.42e-1)" "prognostic unfavorable (3.96e-4)" "unprognostic (1.67e-1)" "unprognostic (4.26e-1)" "unprognostic (4.67e-2)" "unprognostic (4.31e-1)" 4.4 5.9 4.5 4.0 5.6 2.8 4.6 2.8 4.6 3.9 5.2 4.4 3.5 3.8 8.2 5.2 4.2 3.0 2.4 3.0 5.1 4.9 10.9 3.6 5.3 4.1 5.4 3.6 8.9 3.1 9.5 1.5 4.0 4.2 4.6 3.6 4.3 3.3 3.6 11.9 5.5 3.5 3.3 5.7 5.4 17.3 5.4 4.5 6.2 3.1 5.2 4.2 4.2 3.6 5.3 4.9 2.9 10.2 6.0 4.5 3.6 3.2 3.7 2.2 2.9 6.5 9.9 5.2 2.2 2.9 2.1 7.2 3.1 2.8 2.7 6.1 2.4 5.0 9.2 3.6 2.5 4.5 3.9 7.1 2.8 1.9 6.6 2.4 2.9 13.1 2.7 5.5 2.9 5.8 2.1 3.4 1.8 2.7 4.6 3.0 2.2 2.1 3.1 6.7 2.1 2.0 4.6 3.2 2.2 2.8 4.2 1.0 2.3 4.2 3.8 2.5 2.8 2.3 3.7 6.4 2.8 4.6 2.4 0.0 0.5 0.6 0.7 0.1 0.4 0.6 0.7 0.9 0.7 0.8 0.7 1.1 0.3 0.8 1.3 1.3 0.6 0.3 4.5 5.6 2.8 4.6 3.0 5.1 4.1 5.4 4.0 3.3 5.4 3.6 3.0 3.2 5.6 47.7 4.0 1.8 2.3 3.6 2.2 8.0 5.1 5.6 1.9 4.3 5.1 5.5 12.5 3.6 3.1 4.5 0.0 3.4 46.0 5.0 4.0 3.2 6.0 5.7 14.2 3.2 1.8 2.6 5.1 3.7 1.3 6.7 5.0 9.8 2.6 11.8 17.1 4.2 0.0 5.2 2.2 27.3 1.8 3.8 0.0 13.1 5.9 4.3 3.1 9.5 22.6 3.9 3.9 2.2 3.1 1.6 8.3 2.4 5.4 9.0 13.1 6.5 2.5 14.6 7.2 3.8 1.1 1.4 3.3 8.0 4.4 1.0 TRMU "FLJ10140, MTO2, MTU1, TRMT" ENSG00000100416 "TRNA mitochondrial 2-thiouridylase" O75648 22 46330875-46357340 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "RNA-binding, Transferase, tRNA-binding" "Deafness, Disease variant, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000824, HPA035273, HPA043300" Uncertain Supported Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Mitochondria "HPA000824: AB_2732393, HPA035273: AB_10602901, HPA043300: AB_2678415" "unprognostic (2.96e-1)" "unprognostic (1.09e-2)" "unprognostic (8.07e-2)" "unprognostic (4.27e-2)" "unprognostic (2.64e-1)" "unprognostic (3.52e-3)" "prognostic unfavorable (3.04e-5)" "unprognostic (4.72e-2)" "unprognostic (7.14e-2)" "unprognostic (7.89e-2)" "prognostic favorable (6.86e-4)" "unprognostic (4.74e-3)" "prognostic unfavorable (5.63e-6)" "unprognostic (7.26e-2)" "unprognostic (1.73e-1)" "unprognostic (3.56e-1)" "unprognostic (7.44e-3)" 4.2 7.5 7.7 2.3 7.8 2.9 4.0 8.3 9.6 4.3 8.3 4.5 4.7 3.6 7.5 5.6 3.4 2.6 11.2 7.6 8.5 9.1 8.8 3.5 5.0 8.5 8.6 4.0 10.2 8.0 5.3 4.1 8.5 4.4 4.1 2.8 5.5 4.7 6.9 4.8 4.0 3.9 7.9 4.2 4.3 2.3 8.5 3.0 4.6 8.4 4.3 4.2 4.1 7.8 17.8 16.0 6.6 15.1 12.2 8.6 16.6 18.1 12.6 24.9 19.2 22.7 4.5 11.5 12.5 16.2 10.9 15.3 28.5 16.0 21.1 7.5 38.4 13.6 25.0 27.1 10.4 26.5 9.0 8.2 17.6 25.8 8.1 10.3 16.2 5.8 19.3 2.7 15.3 19.1 10.4 21.5 25.5 10.6 27.5 12.2 14.4 21.2 12.5 12.1 15.9 19.0 16.0 18.5 31.7 8.2 10.7 10.9 11.9 11.1 19.8 15.8 20.7 6.5 7.8 12.6 15.7 19.1 22.8 0.0 6.2 3.8 9.4 9.0 8.3 5.4 8.2 8.9 7.1 5.5 7.3 6.9 1.3 8.0 9.8 5.8 11.0 5.9 7.7 7.8 8.3 9.6 7.6 8.5 8.5 8.6 8.5 7.9 8.5 7.8 12.7 9.6 6.1 22.9 13.2 6.2 10.8 16.8 7.4 26.4 10.6 11.8 14.7 10.0 10.7 11.0 16.7 24.9 16.1 14.1 27.4 20.1 1.6 6.3 10.2 14.5 12.5 14.3 19.4 19.6 21.0 11.9 21.9 6.6 9.5 26.8 13.9 16.8 15.9 13.5 18.0 12.3 10.2 9.9 4.0 3.3 15.2 8.8 8.8 5.6 14.9 11.9 20.6 10.1 14.6 19.5 9.9 17.0 13.8 14.2 15.3 27.9 10.2 26.4 6.6 7.6 14.4 18.5 12.9 9.6 9.7 15.3 13.1 21.0 19.3 9.9 TRPA1 ANKTM1 ENSG00000104321 "Transient receptor potential cation channel subfamily A member 1" O75762 8 72019917-72075584 "Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease variant, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 9.2;stomach 1: 10.3;urinary bladder: 27.7" "Cell type enhanced" "Detected in some" "Early spermatids: 10.9;Excitatory neurons: 5.0;Fibroblasts: 8.1;Intestinal goblet cells: 17.2;Skeletal myocytes: 4.5" "Cancer enhanced" "Detected in many" "breast cancer: 2.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HHSteC: 25.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 37: Intestine - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 27: Mucus-secreting cells - Mucin production" "unprognostic (2.14e-2)" "unprognostic (2.50e-2)" "prognostic favorable (6.57e-4)" "unprognostic (1.28e-2)" "unprognostic (2.34e-1)" "unprognostic (1.95e-1)" "unprognostic (1.37e-2)" "unprognostic (8.11e-3)" "unprognostic (4.22e-2)" "unprognostic (2.47e-1)" "unprognostic (2.78e-3)" "unprognostic (1.49e-1)" "unprognostic (2.16e-4)" "unprognostic (2.37e-1)" "unprognostic (9.67e-2)" "unprognostic (1.57e-1)" "unprognostic (2.90e-1)" 0.3 0.4 0.1 3.8 0.0 0.0 0.0 0.0 0.7 0.1 0.0 7.9 6.3 0.3 0.0 1.0 0.2 7.0 0.8 0.8 0.0 0.1 0.0 0.2 0.8 0.3 0.0 0.8 0.1 0.0 0.0 0.7 0.0 0.1 9.2 0.0 0.2 0.0 0.1 0.1 7.4 0.3 0.0 0.5 10.3 0.5 0.0 0.2 0.1 0.0 0.2 27.7 0.3 0.2 0.0 2.8 0.8 0.0 0.0 0.1 0.0 0.3 2.5 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.0 0.4 1.5 0.1 0.0 0.5 0.0 25.9 0.0 0.2 1.7 0.0 1.2 0.2 5.5 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.1 0.5 0.0 2.6 0.2 0.0 0.4 0.0 0.1 4.0 1.2 0.0 0.3 0.3 0.0 1.9 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.2 0.0 0.1 0.0 0.0 0.7 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 5.0 0.0 0.0 8.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 17.2 0.0 0.0 0.0 0.8 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 4.5 0.8 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.5 0.0 TRPM7 "CHAK1, LTRPC7, TRP-PLIK" ENSG00000092439 "Transient receptor potential cation channel subfamily M member 7" Q96QT4 15 50552473-50686797 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Necrosis, Transport" "Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase" "Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 108.9" "Cell type enhanced" "Detected in all" "Excitatory neurons: 122.2;Oligodendrocytes: 109.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-2197: 122.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035522, HPA052173" Enhanced Approved "Vesicles,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 18: U-2197 - ECM organization" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "Plasma membrane" "Vesicles, Cytosol" "HPA035522: , HPA052173: AB_2681749" "unprognostic (3.14e-2)" "unprognostic (1.86e-1)" "unprognostic (1.58e-1)" "unprognostic (1.42e-2)" "unprognostic (1.89e-1)" "unprognostic (1.60e-2)" "unprognostic (1.85e-2)" "unprognostic (2.59e-2)" "unprognostic (5.46e-3)" "unprognostic (2.64e-1)" "unprognostic (2.91e-1)" "unprognostic (1.59e-2)" "unprognostic (3.20e-2)" "unprognostic (2.08e-1)" "unprognostic (7.59e-2)" "unprognostic (9.45e-2)" "unprognostic (1.97e-1)" 11.5 9.6 4.3 13.3 6.5 21.4 13.6 15.4 6.7 10.3 29.3 13.8 14.4 12.7 14.6 8.6 9.4 11.1 15.5 4.8 3.5 22.9 25.3 11.6 16.6 4.9 3.9 16.4 12.2 108.9 5.3 13.3 5.9 10.9 14.4 10.5 10.9 10.6 7.8 16.6 13.1 11.4 3.2 12.2 13.6 9.9 6.4 15.5 17.3 9.1 14.4 11.4 8.1 10.4 21.4 21.0 17.2 19.1 48.5 36.2 20.9 26.4 36.7 16.5 21.6 29.1 11.6 46.4 12.7 30.8 42.5 35.1 23.3 19.5 23.4 26.0 13.7 37.1 31.5 15.4 44.0 38.8 27.6 33.9 22.4 18.8 35.0 24.0 13.5 28.8 42.6 34.5 30.4 33.7 25.1 18.8 13.0 29.4 12.8 27.2 23.7 22.7 23.0 49.9 14.2 18.1 18.2 28.7 35.8 30.1 18.0 41.6 20.7 26.1 12.4 122.4 30.8 23.3 54.9 44.0 28.4 77.5 24.8 1.8 1.3 1.6 2.5 1.3 2.9 2.2 1.8 1.7 1.5 2.3 1.6 1.9 1.7 2.4 1.4 1.9 2.0 0.8 4.3 6.5 15.4 6.7 4.8 3.5 4.9 3.9 5.9 3.2 6.4 10.4 23.9 19.2 31.3 73.1 36.4 31.6 17.2 11.0 44.9 21.9 18.8 11.9 25.9 21.5 8.2 12.9 12.5 23.0 38.4 17.0 3.9 11.7 33.3 21.6 27.1 19.7 18.5 29.6 122.2 12.7 9.4 26.1 37.8 23.1 17.7 26.0 14.6 43.9 14.6 21.9 92.7 19.5 6.1 22.4 19.8 26.0 26.4 26.5 19.6 66.5 24.2 8.5 29.9 80.9 109.1 15.5 13.9 20.3 33.2 24.9 23.4 11.0 19.3 22.6 13.1 30.0 22.0 23.1 23.6 25.7 24.2 16.3 34.5 22.2 20.4 11.1 TRPV2 "VRL, VRL-1, VRL1" ENSG00000187688 "Transient receptor potential cation channel subfamily V member 2" Q9Y5S1 17 16415571-16437003 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "granulocytes: 50.0;Hofbauer cells: 50.6;monocytes: 39.4;NK-cells: 49.4" "Cancer enriched" "Detected in all" 8 "melanoma: 59.8" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 78.8;fHDF/TERT166: 108.4;HMC-1: 89.0;SK-MEL-30: 94.7;TIME: 84.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA044993 Uncertain Supported "Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 2: Immune cells - Immune response" "Cluster 3: HMC-1 - Innate immune response" "Cluster 4: Macrophages - Innate immune response" "Plasma membrane" "HPA044993: AB_10960889" "unprognostic (1.57e-1)" "unprognostic (4.34e-3)" "unprognostic (2.05e-2)" "unprognostic (1.58e-2)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" "unprognostic (8.40e-3)" "unprognostic (2.43e-1)" "unprognostic (3.11e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (1.19e-6)" "unprognostic (7.94e-2)" "prognostic unfavorable (5.53e-4)" "unprognostic (8.07e-2)" "unprognostic (1.23e-1)" 17.1 20.5 6.2 18.3 8.0 22.8 10.4 5.7 7.6 7.9 3.9 7.0 6.6 7.6 1.8 5.3 7.3 8.5 11.2 6.1 9.8 4.7 4.0 30.2 24.6 10.6 15.4 7.8 6.3 8.9 1.6 20.1 17.2 6.0 6.2 1.0 4.5 2.6 3.9 6.5 10.7 11.8 7.1 23.7 5.9 2.0 7.3 15.7 6.2 5.5 16.2 10.7 7.2 8.0 0.3 1.6 0.0 0.0 25.6 78.8 4.9 8.3 9.4 9.1 8.9 0.3 0.3 9.6 2.2 108.4 7.8 0.2 0.2 0.0 5.1 43.0 0.7 10.7 0.0 26.1 30.0 14.8 89.0 35.2 0.0 54.0 0.7 4.1 3.8 12.9 37.2 26.0 43.4 0.5 19.1 20.5 0.1 0.1 0.2 11.3 0.3 4.3 40.6 1.1 1.2 0.1 0.0 0.0 94.7 41.0 0.0 12.7 84.9 0.2 0.3 0.3 1.1 0.1 0.3 5.1 8.2 21.6 12.6 60.8 26.6 35.8 63.4 52.8 55.5 19.2 46.0 59.3 58.7 20.3 25.7 44.8 6.8 63.2 49.4 51.3 49.9 43.1 6.2 8.0 5.7 7.6 6.1 9.8 10.6 15.4 17.2 7.1 7.3 8.0 15.8 0.0 5.3 1.0 11.1 2.8 0.1 0.0 0.0 0.6 0.5 0.4 1.1 1.5 0.6 0.0 0.0 2.2 29.3 0.0 0.0 0.2 0.3 0.4 0.1 12.3 0.0 6.7 3.3 3.6 2.3 11.0 1.1 0.1 50.0 16.7 8.9 0.4 50.6 0.0 2.6 0.0 0.0 19.5 18.2 0.0 1.8 28.7 28.4 4.7 39.4 0.3 49.4 0.5 0.5 4.7 0.1 4.5 15.1 0.0 0.0 0.1 0.8 0.6 26.3 7.9 23.6 1.3 5.9 0.4 1.7 16.1 26.8 2.8 0.0 0.1 TRUB1 PUS4 ENSG00000165832 "TruB pseudouridine synthase family member 1" Q8WWH5 10 114938195-114977676 "Predicted intracellular proteins" Isomerase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 62.2;Theca cells: 74.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037914, HPA057552" Approved Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 23: Spermatids - Flagellum & Golgi organization" Vesicles "HPA037914: AB_10672399, HPA057552: AB_2683465" "unprognostic (1.98e-1)" "unprognostic (1.91e-2)" "unprognostic (1.27e-2)" "unprognostic (2.93e-2)" "unprognostic (3.20e-3)" "unprognostic (9.79e-2)" "unprognostic (9.26e-2)" "unprognostic (4.89e-2)" "unprognostic (6.87e-2)" "unprognostic (2.51e-2)" "unprognostic (2.26e-2)" "unprognostic (1.56e-1)" "unprognostic (1.50e-3)" "unprognostic (7.54e-2)" "unprognostic (2.12e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-1)" 7.4 29.3 6.3 7.5 7.4 4.2 11.3 5.1 9.0 9.8 7.3 9.5 8.9 12.8 9.3 8.3 9.7 7.7 21.5 7.6 7.1 16.0 12.9 6.6 10.0 5.8 6.0 16.8 6.8 15.8 4.9 7.5 6.1 11.7 10.4 6.7 9.3 9.9 7.5 6.5 8.2 11.1 5.6 9.3 8.7 17.9 7.0 11.5 12.3 9.7 10.1 7.8 4.8 6.4 25.5 19.6 18.8 47.0 13.3 17.7 25.3 21.4 24.1 28.4 32.0 16.1 25.5 31.4 24.2 16.9 12.4 21.3 25.6 26.5 41.8 23.9 27.5 14.4 9.2 28.8 22.8 27.2 20.7 18.2 35.8 20.2 39.6 30.1 16.2 24.9 15.1 12.5 34.1 12.3 25.7 21.6 17.8 17.0 19.1 25.4 47.5 19.2 37.4 12.7 17.5 19.3 18.0 26.4 47.7 20.0 21.1 16.6 14.5 13.0 13.0 20.8 26.5 23.6 20.4 26.3 18.3 34.2 11.9 4.0 2.6 0.9 4.4 4.0 6.5 7.3 4.7 4.7 4.8 5.9 6.2 5.8 0.2 8.1 7.3 4.3 6.2 4.6 6.3 7.4 5.1 9.0 7.6 7.1 5.8 6.0 6.1 5.6 7.0 6.4 6.9 12.8 8.4 8.8 11.2 5.6 4.7 15.3 6.2 13.9 11.9 8.1 13.6 4.3 12.0 9.2 2.1 9.1 10.5 7.1 21.5 7.6 62.2 11.1 12.8 6.6 7.7 9.0 23.0 4.9 6.6 11.2 6.6 12.0 10.2 26.7 12.1 20.2 7.6 25.2 22.0 8.2 6.1 7.3 4.2 9.6 8.4 5.0 3.6 8.4 5.4 10.4 9.2 31.2 16.7 7.0 3.6 10.1 12.7 4.2 6.2 27.9 9.8 5.6 6.6 8.4 9.3 14.5 23.3 15.9 7.0 6.2 8.0 74.1 12.9 5.8 TSFM "EF-TS, EF-Tsmt" ENSG00000123297 "Ts translation elongation factor, mitochondrial" P43897 12 57782761-57808071 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cardiomyopathy, Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 146.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 6 "RH-30: 962.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006204 Supported Nucleoplasm,Mitochondria NA NA 9200 "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 39: Non-specific - Basic cellular processes" Mitochondria Nucleoplasm "HPA006204: AB_1080405" "unprognostic (1.17e-1)" "unprognostic (6.84e-3)" "unprognostic (1.93e-2)" "unprognostic (6.87e-2)" "unprognostic (1.87e-1)" "unprognostic (2.56e-3)" "unprognostic (2.49e-2)" "unprognostic (1.53e-1)" "unprognostic (8.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.49e-1)" "unprognostic (1.49e-3)" "prognostic favorable (8.82e-4)" "unprognostic (3.05e-1)" "unprognostic (6.97e-2)" "unprognostic (1.39e-1)" "unprognostic (1.23e-1)" 23.1 57.6 17.7 23.5 18.5 26.1 26.3 18.8 20.9 16.7 21.1 28.9 27.4 15.0 17.4 22.3 18.0 13.9 43.6 18.8 19.0 39.2 45.2 15.1 24.2 18.4 18.3 13.5 17.1 35.0 16.5 16.5 19.7 16.6 26.8 16.7 20.0 16.4 58.6 21.6 21.0 17.5 19.0 17.4 19.7 25.2 18.9 22.5 16.2 64.3 20.7 24.4 15.7 18.7 56.3 63.1 35.5 52.5 33.7 33.9 53.2 46.4 39.8 71.6 50.2 74.1 71.6 142.6 85.8 38.9 39.1 64.9 60.1 66.2 51.3 57.7 78.0 82.6 51.9 64.7 50.5 112.7 47.2 39.6 65.3 55.6 25.4 52.2 44.7 75.7 110.3 70.0 56.3 64.8 64.8 113.0 57.5 81.7 83.7 78.3 962.0 125.5 70.5 64.1 80.0 49.1 47.7 84.8 83.6 31.5 148.9 71.7 33.1 39.6 54.6 58.9 49.1 52.0 120.2 108.7 53.6 63.7 48.1 8.5 24.6 15.3 28.0 23.7 36.0 28.5 30.9 28.3 30.3 26.9 31.1 31.7 6.5 33.6 30.5 23.4 30.9 26.9 17.7 18.5 18.8 20.9 18.8 19.0 18.4 18.3 19.7 19.0 18.9 18.7 16.5 19.2 10.8 6.2 18.5 25.9 14.5 57.4 10.8 19.4 24.6 21.1 31.8 27.1 28.7 46.0 14.6 68.5 23.5 13.2 95.9 66.0 73.3 19.5 19.7 18.7 13.8 20.0 8.4 87.6 52.3 18.8 13.3 16.3 22.2 31.0 16.4 38.3 35.4 15.2 8.5 20.9 36.7 11.4 13.9 42.5 22.7 18.1 26.6 10.3 66.6 23.1 12.3 9.5 8.4 47.2 15.7 24.0 17.5 21.3 19.9 146.2 26.0 20.1 59.2 19.7 31.6 46.1 65.8 21.1 36.2 47.6 18.6 71.1 35.3 13.9 TSPAN32 "PHEMX, TSSC6" ENSG00000064201 "Tetraspanin 32" Q96QS1 11 2301997-2318204 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 19.9;heart muscle: 11.4;lymphoid tissue: 5.5" "Cell type enhanced" "Detected in some" "dendritic cells: 44.6;Erythroid cells: 20.6;granulocytes: 30.4;Langerhans cells: 19.6;NK-cells: 87.6;T-cells: 21.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 7 "HEL: 15.0;HL-60: 6.6;NB-4: 5.3;THP-1: 5.6;U-937: 8.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA024135 Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 32: U-937 - Innate immune response" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm "HPA024135: AB_1858409" "unprognostic (7.50e-3)" "unprognostic (4.88e-4)" "unprognostic (1.58e-2)" "unprognostic (1.74e-1)" "unprognostic (4.45e-3)" "unprognostic (2.10e-4)" "unprognostic (7.72e-3)" "unprognostic (8.25e-3)" "unprognostic (9.74e-2)" "unprognostic (2.62e-1)" "unprognostic (2.70e-2)" "unprognostic (1.02e-1)" "unprognostic (2.28e-7)" "unprognostic (1.07e-1)" "unprognostic (4.20e-1)" "unprognostic (4.35e-1)" "unprognostic (8.13e-2)" 0.5 0.5 0.2 1.6 0.2 19.9 0.3 0.5 0.2 1.1 0.0 0.5 0.3 0.7 0.2 0.4 0.5 1.4 11.4 0.2 0.3 0.2 0.4 2.0 5.5 0.5 0.3 0.5 0.0 0.0 0.0 0.3 0.3 0.2 0.3 0.2 0.9 0.5 0.3 0.6 0.5 0.0 0.1 3.5 0.9 0.2 0.2 0.9 0.2 0.2 2.4 0.7 0.2 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 15.0 0.0 0.1 0.6 6.6 1.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.2 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 8.9 0.0 40.5 31.8 4.2 25.8 40.9 16.5 2.4 9.1 22.7 32.2 1.1 7.2 27.1 17.3 58.6 46.0 1.6 13.2 21.7 0.2 0.2 0.5 0.2 0.2 0.3 0.5 0.3 0.3 0.1 0.2 0.5 0.5 0.0 6.7 0.0 4.5 0.9 0.0 0.0 0.0 0.0 0.2 0.1 15.9 0.0 0.6 0.0 0.0 0.1 44.6 0.0 0.0 0.0 0.8 0.1 0.3 0.8 0.0 20.6 0.0 0.0 0.3 1.3 0.5 0.0 30.4 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 6.5 19.6 4.1 0.9 13.6 1.8 1.0 14.4 0.2 87.6 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.2 1.5 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.6 0.0 21.9 0.0 0.0 0.1 TSR1 FLJ10534 ENSG00000167721 "TSR1 ribosome maturation factor" Q2NL82 17 2322396-2336657 "Predicted intracellular proteins" "Ribosome biogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024434, HPA053087" Approved Approved Nucleoplasm NA NA 13000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA024434: AB_1858413, HPA053087: AB_2682040" "unprognostic (1.45e-2)" "unprognostic (1.43e-2)" "unprognostic (1.36e-1)" "unprognostic (1.53e-1)" "unprognostic (4.76e-2)" "unprognostic (2.74e-1)" "unprognostic (1.95e-3)" "unprognostic (9.80e-3)" "unprognostic (6.16e-2)" "unprognostic (2.38e-1)" "unprognostic (6.74e-2)" "unprognostic (1.60e-2)" "unprognostic (8.61e-2)" "unprognostic (1.40e-1)" "unprognostic (5.60e-2)" "unprognostic (1.70e-2)" "unprognostic (9.46e-3)" 18.2 10.9 11.7 17.2 12.1 15.5 17.3 11.2 12.2 10.5 11.5 13.0 9.4 14.8 12.2 20.1 12.3 10.8 17.2 11.5 11.4 12.3 14.8 10.1 15.9 11.7 11.8 15.2 19.9 16.1 8.3 14.6 11.9 13.4 14.6 14.0 12.8 13.9 49.4 19.6 9.4 18.4 12.6 11.0 11.8 18.1 12.4 15.3 11.8 30.7 19.2 22.2 11.8 12.1 80.2 85.1 39.6 77.6 31.6 36.9 80.4 65.5 36.3 39.8 30.6 138.2 33.4 85.5 54.6 52.2 36.4 70.3 86.5 76.8 50.7 39.1 97.3 63.9 66.4 65.5 44.0 59.4 42.3 37.4 48.1 76.6 87.2 43.5 39.5 45.5 84.1 46.5 49.1 49.8 56.6 29.3 94.0 60.0 50.6 59.6 55.1 57.6 49.1 52.5 27.7 61.7 57.6 43.4 45.7 37.6 40.4 26.0 43.9 54.6 43.3 65.7 122.8 33.3 45.7 49.7 53.5 67.3 67.3 1.9 7.1 1.5 8.3 10.5 11.0 7.1 6.8 7.7 11.5 8.7 7.4 9.0 1.3 6.5 11.5 4.8 9.1 6.3 11.7 12.1 11.2 12.2 11.5 11.4 11.7 11.8 11.9 12.6 12.4 12.1 13.5 32.1 29.3 7.2 21.5 34.4 42.8 18.1 31.3 16.2 18.3 13.7 17.6 12.8 30.7 14.7 18.8 29.9 17.3 7.8 3.9 27.7 68.2 18.0 32.6 20.8 10.3 30.5 7.7 16.5 39.7 24.0 18.3 24.8 43.1 24.4 12.5 13.2 16.0 18.5 6.7 12.0 10.2 12.4 10.2 73.6 13.1 14.4 16.0 3.7 18.2 12.6 10.3 3.0 6.4 23.3 5.8 12.0 23.2 35.8 4.8 11.4 21.9 19.7 19.7 36.4 27.7 29.7 47.7 42.2 41.2 24.2 16.1 25.4 15.7 33.1 TTC13 FLJ22584 ENSG00000143643 "Tetratricopeptide repeat domain 13" Q8NBP0 1 230906243-230978875 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Astrocytes: 42.7;Excitatory neurons: 70.9;Inhibitory neurons: 76.7;Microglial cells: 56.2;Oligodendrocyte precursor cells: 41.7;Oligodendrocytes: 70.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018022, HPA051558" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 16: Immune cells - Immune response" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm "HPA018022: AB_2211524, HPA051558: AB_2681534" "unprognostic (2.68e-1)" "unprognostic (1.64e-1)" "unprognostic (3.42e-1)" "unprognostic (9.59e-3)" "unprognostic (8.10e-2)" "prognostic favorable (7.66e-4)" "unprognostic (2.60e-2)" "unprognostic (5.40e-3)" "unprognostic (1.97e-1)" "unprognostic (1.80e-2)" "prognostic favorable (4.59e-5)" "unprognostic (2.29e-1)" "prognostic unfavorable (1.60e-11)" "unprognostic (4.48e-2)" "unprognostic (3.01e-1)" "unprognostic (5.96e-2)" "unprognostic (7.54e-3)" 7.8 5.1 7.4 11.7 9.4 11.6 7.0 7.9 7.9 7.1 4.8 11.2 8.0 5.9 6.5 6.0 6.5 6.1 6.5 7.3 9.2 6.4 7.9 9.9 19.6 7.3 6.7 5.6 10.5 6.8 9.2 7.5 7.5 6.3 15.9 11.8 6.7 5.1 11.4 9.8 12.2 6.1 7.7 20.3 12.2 2.9 8.4 10.2 6.8 6.2 14.8 6.5 6.7 9.5 12.4 12.4 12.0 23.5 11.0 7.1 24.5 17.7 13.9 9.8 11.0 18.4 13.2 22.7 15.9 10.8 9.7 19.4 8.0 6.6 6.5 25.6 23.3 6.8 13.7 12.5 11.6 14.1 6.0 6.3 11.4 9.2 8.5 9.8 17.5 9.7 7.3 12.9 9.1 6.5 7.5 13.5 13.5 41.1 15.2 12.0 17.2 31.9 10.2 8.5 16.5 14.2 13.5 13.8 24.2 5.2 14.8 18.1 9.0 11.5 1.6 15.7 31.9 15.8 27.9 6.8 11.3 8.8 19.2 5.7 5.5 4.9 6.6 4.1 4.5 2.8 4.5 5.3 7.7 2.2 3.5 4.4 1.9 7.9 5.3 4.9 3.9 4.2 7.4 9.4 7.9 7.9 7.3 9.2 7.3 6.7 7.5 7.7 8.4 9.5 7.2 6.4 7.4 42.7 18.9 3.3 1.0 1.8 1.2 6.1 3.4 2.4 3.0 1.5 4.0 1.8 6.2 4.3 21.8 6.6 1.9 5.6 1.7 1.7 2.4 5.4 6.1 11.6 70.9 8.6 5.1 5.2 14.3 3.0 9.5 4.6 1.8 5.0 5.0 11.8 76.7 11.3 8.2 7.8 6.6 2.3 2.8 8.9 1.8 56.2 7.2 4.5 17.5 41.7 70.6 4.1 8.7 6.8 13.6 1.9 2.6 1.2 1.3 10.8 6.6 5.5 4.9 3.1 3.5 3.8 2.7 1.6 16.9 2.1 9.4 1.6 TTC27 FLJ20272 ENSG00000018699 "Tetratricopeptide repeat domain 27" Q6P3X3 2 32628032-32821051 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Oligodendrocytes: 66.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031246 Approved Approved Nucleoli,Mitochondria No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 1: K-562 - Erythropoiesis" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria Nucleoli "HPA031246: AB_10603139" "unprognostic (3.10e-2)" "unprognostic (8.84e-2)" "unprognostic (3.21e-3)" "unprognostic (6.28e-3)" "unprognostic (8.90e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.42e-5)" "unprognostic (7.68e-2)" "unprognostic (2.30e-1)" "unprognostic (2.13e-1)" "unprognostic (2.07e-3)" "unprognostic (1.58e-1)" "prognostic unfavorable (7.32e-4)" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (2.26e-1)" "unprognostic (2.15e-1)" 7.9 8.2 3.4 8.1 4.4 7.5 12.2 3.9 4.1 7.7 3.6 7.3 5.7 9.1 8.9 9.2 9.6 5.4 8.6 3.2 6.2 7.3 7.9 6.3 9.4 3.8 3.3 11.7 8.3 10.8 4.4 8.3 4.1 6.9 8.6 5.2 8.9 5.6 9.9 8.4 5.9 9.3 3.4 8.6 6.7 12.5 4.6 7.5 9.9 8.4 11.3 9.5 7.1 8.2 43.0 20.6 13.9 10.5 11.5 23.1 6.7 17.5 14.2 26.3 22.9 31.6 25.3 37.3 15.2 26.3 27.3 21.2 22.4 27.4 38.1 17.9 27.4 42.0 10.3 43.7 21.9 40.7 21.3 15.3 24.5 32.0 34.5 12.9 24.4 9.2 59.5 10.7 23.6 17.0 32.4 14.0 25.3 18.9 21.3 21.2 29.9 32.1 20.2 24.8 11.4 16.6 14.3 13.1 16.7 16.1 16.2 9.6 20.6 16.4 18.2 19.8 30.3 15.0 4.1 41.8 17.8 31.2 17.9 0.0 4.7 0.0 9.1 10.0 10.1 9.9 10.1 9.1 10.5 9.7 12.6 9.8 0.2 9.3 7.1 4.9 9.6 5.9 3.4 4.4 3.9 4.1 3.2 6.2 3.8 3.3 4.1 3.4 4.6 8.2 6.8 9.6 10.4 19.9 10.1 5.6 9.2 7.2 8.0 5.1 6.3 4.3 8.2 4.3 8.8 0.0 4.2 13.4 4.8 2.2 7.9 10.1 18.2 5.6 6.7 8.0 7.3 6.3 27.6 9.5 12.7 8.8 7.7 5.2 12.0 12.0 3.9 4.9 7.6 3.3 33.7 4.5 2.0 8.1 4.6 2.7 8.4 4.0 5.4 27.2 6.5 5.5 1.0 32.2 66.7 5.1 4.7 7.2 6.5 7.0 2.2 4.8 12.4 6.0 6.6 9.7 6.4 28.3 11.3 7.4 5.7 6.4 8.2 9.9 7.9 6.8 TTC31 FLJ12788 ENSG00000115282 "Tetratricopeptide repeat domain 31" Q49AM3 2 74483073-74494559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 39.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041783 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" Cytosol Nucleoplasm "HPA041783: AB_10794306" "unprognostic (2.38e-2)" "unprognostic (7.44e-2)" "unprognostic (3.87e-2)" "prognostic unfavorable (6.70e-4)" "unprognostic (2.64e-1)" "unprognostic (7.78e-2)" "unprognostic (1.05e-1)" "unprognostic (2.89e-2)" "unprognostic (6.56e-2)" "unprognostic (7.22e-2)" "unprognostic (7.61e-2)" "unprognostic (1.13e-2)" "unprognostic (1.46e-3)" "unprognostic (9.61e-2)" "unprognostic (3.24e-1)" "unprognostic (4.83e-2)" "prognostic favorable (2.49e-4)" 6.4 4.8 3.5 8.4 3.9 9.0 4.8 3.4 4.3 5.4 3.8 7.9 11.1 5.9 4.5 6.1 5.9 5.9 5.7 3.3 3.6 6.0 18.7 6.8 9.8 4.3 3.8 6.3 7.9 9.2 3.2 9.2 3.9 5.2 8.2 4.8 4.7 4.5 3.7 8.8 9.9 7.4 3.8 8.2 7.5 3.2 3.8 9.7 4.8 3.9 10.6 5.7 4.6 4.5 16.0 13.1 11.7 6.3 7.3 17.0 12.9 11.2 11.4 16.2 11.9 11.3 13.0 20.6 6.4 9.5 14.2 11.8 9.5 10.5 11.0 23.0 8.3 22.4 12.9 24.9 11.0 10.1 21.5 11.5 13.7 14.0 9.8 14.3 11.0 12.0 15.0 11.5 12.0 13.7 17.4 9.2 7.6 12.2 7.9 13.7 24.0 11.5 11.5 11.8 5.6 16.5 7.9 12.4 10.2 7.4 9.7 6.2 17.6 12.5 18.7 9.5 12.6 13.6 10.8 14.1 13.5 12.5 11.4 4.9 8.3 6.1 6.5 8.1 7.2 7.0 4.9 6.2 8.1 4.7 4.6 5.4 0.8 6.6 8.7 4.4 7.3 7.4 3.5 3.9 3.4 4.3 3.3 3.6 4.3 3.8 3.9 3.8 3.8 4.5 5.4 16.0 9.2 7.2 10.8 2.8 4.1 5.2 4.6 11.1 5.2 5.0 3.5 14.3 7.8 9.2 39.6 8.3 9.8 7.8 1.9 5.8 4.6 3.8 8.0 6.7 6.1 13.3 3.0 5.5 5.3 6.0 7.1 5.9 19.0 8.8 4.6 20.8 8.3 5.0 3.4 5.9 6.1 7.9 3.5 5.0 6.2 7.5 3.6 10.3 13.2 9.2 19.6 2.5 4.4 5.9 9.4 5.7 9.6 3.1 13.9 6.0 4.3 23.6 6.6 7.3 5.3 8.3 10.0 4.2 3.3 8.1 9.8 8.2 6.5 3.8 TTC4 "CNS1, FLJ41930, MGC5097" ENSG00000243725 "Tetratricopeptide repeat domain 4" O95801 1 54715861-54742657 "Plasma proteins, Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041608, HPA042459" Approved Enhanced "Intermediate filaments,Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 80: Striated muscle - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Intermediate filaments" "Cytoplasmic bodies" "HPA041608: AB_10794485, HPA042459: AB_10797496" "unprognostic (4.89e-2)" "unprognostic (1.81e-1)" "unprognostic (2.05e-2)" "unprognostic (8.62e-4)" "unprognostic (8.91e-2)" "unprognostic (1.34e-1)" "unprognostic (1.21e-5)" "unprognostic (1.39e-4)" "unprognostic (1.51e-2)" "unprognostic (1.47e-1)" "unprognostic (3.18e-1)" "unprognostic (2.42e-3)" "unprognostic (7.12e-2)" "unprognostic (2.85e-1)" "unprognostic (7.79e-2)" "unprognostic (5.86e-2)" "unprognostic (1.76e-3)" 8.9 8.8 21.2 5.3 21.8 2.0 10.4 22.0 24.7 10.4 20.4 9.7 5.6 8.5 8.1 10.6 9.1 3.9 16.5 21.7 22.2 11.0 10.2 5.6 7.2 22.2 22.2 12.5 11.7 11.7 12.8 7.7 22.3 8.8 6.3 9.0 9.1 8.3 33.7 10.3 8.0 7.6 22.5 6.6 10.8 8.6 22.0 12.8 8.0 22.2 8.9 11.0 10.1 23.9 24.3 18.2 20.1 10.9 29.2 16.6 17.9 32.6 16.0 39.8 26.6 20.5 6.9 40.1 17.4 22.4 42.2 13.1 43.7 31.1 41.6 38.2 31.7 38.4 7.7 11.9 27.4 32.4 10.6 16.1 30.4 58.2 34.9 17.8 17.3 31.3 45.5 6.3 22.7 11.3 30.0 18.3 41.0 29.1 30.9 27.1 43.0 22.5 19.9 6.5 13.5 9.7 28.4 13.8 27.2 33.0 13.2 16.5 17.4 19.5 21.2 20.5 44.9 16.1 29.9 34.0 25.9 36.5 20.8 7.3 12.3 10.3 13.9 14.0 14.8 12.6 11.1 13.3 13.5 12.6 15.9 14.3 0.2 18.9 15.1 11.2 11.8 13.0 21.2 21.8 22.0 24.7 21.7 22.2 22.2 22.2 22.3 22.5 22.0 23.9 3.7 9.6 2.6 0.0 6.2 1.1 3.4 2.1 7.4 4.5 3.1 3.3 3.2 1.5 5.2 0.0 0.0 3.9 2.4 1.5 0.0 3.5 0.5 4.7 8.8 3.4 1.2 3.0 0.0 4.2 2.4 5.4 3.6 4.5 7.0 3.0 3.9 2.4 1.4 5.0 0.0 1.3 0.0 0.6 1.5 0.7 4.1 2.7 1.8 0.0 5.9 2.3 6.2 0.0 0.0 3.9 1.7 2.6 6.1 3.0 2.0 6.4 2.6 3.8 0.0 3.8 3.5 9.2 8.2 5.7 1.6 1.4 4.6 1.9 2.5 1.8 TTC5 Strap ENSG00000136319 "Tetratricopeptide repeat domain 5" Q8N0Z6 14 20256558-20305960 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045008, HPA054198" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA045008: AB_10960209, HPA054198: AB_2682414" "unprognostic (2.19e-3)" "unprognostic (1.00e-1)" "unprognostic (1.94e-1)" "unprognostic (1.47e-1)" "unprognostic (1.39e-2)" "unprognostic (6.48e-2)" "unprognostic (8.15e-2)" "unprognostic (6.82e-2)" "unprognostic (4.68e-2)" "unprognostic (1.03e-1)" "unprognostic (8.32e-2)" "unprognostic (3.29e-1)" "prognostic favorable (8.54e-4)" "unprognostic (3.01e-1)" "unprognostic (1.77e-1)" "unprognostic (1.10e-1)" "unprognostic (5.07e-2)" 2.1 2.8 2.8 1.8 2.8 2.9 3.8 2.2 3.1 3.1 4.8 2.2 2.1 3.1 3.2 2.2 5.7 2.2 1.8 2.6 3.1 3.5 1.4 2.5 3.2 2.1 2.7 3.0 1.9 6.1 2.1 2.4 2.1 3.8 2.3 2.6 2.3 3.0 0.7 3.4 1.6 2.9 2.1 2.4 2.4 2.5 4.3 2.6 4.9 2.3 3.1 2.3 1.7 2.2 3.4 5.4 6.5 0.7 4.7 6.8 3.5 4.3 5.0 6.4 6.6 2.4 7.6 7.2 2.7 4.5 3.3 2.8 6.4 3.0 9.8 6.3 2.4 5.9 2.2 4.3 4.8 11.0 3.5 4.2 6.7 5.6 7.2 5.8 6.3 5.1 4.3 3.5 6.3 4.6 6.5 4.6 5.5 5.6 5.2 3.4 4.8 5.2 5.6 3.5 2.2 4.3 4.9 5.1 3.0 2.6 4.0 5.3 6.6 2.5 4.1 3.4 2.3 5.0 4.7 8.9 2.0 4.6 6.0 1.3 2.0 2.9 2.7 2.0 2.3 2.7 2.0 2.2 2.2 3.0 2.1 2.5 0.8 3.0 2.9 1.6 2.7 2.0 2.8 2.8 2.2 3.1 2.6 3.1 2.1 2.7 2.1 2.1 4.3 2.2 13.9 12.8 7.2 6.5 15.2 6.4 9.4 21.5 13.6 15.5 9.4 12.8 4.3 12.8 9.8 18.4 16.7 20.4 12.2 2.3 11.7 10.6 1.6 27.7 13.4 12.3 9.0 6.7 18.2 6.5 12.4 12.5 8.6 7.9 12.0 16.0 10.8 6.4 15.4 5.0 12.4 6.9 18.3 11.2 6.8 3.4 10.2 10.5 7.2 6.5 11.5 12.4 19.6 11.6 8.7 6.4 5.0 9.8 7.8 4.6 8.6 13.1 32.8 19.4 6.6 14.1 11.6 26.6 36.1 8.8 8.7 4.7 12.7 14.6 8.3 5.3 TTC9 "KIAA0227, TTC9A" ENSG00000133985 "Tetratricopeptide repeat domain 9" Q92623 14 70641916-70675366 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 60.1" "Cell type enhanced" "Detected in many" "Pancreatic endocrine cells: 36.0;Respiratory ciliated cells: 38.1;Urothelial cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 18.2;Daudi: 15.9;RH-30: 21.3;SK-BR-3: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA079473 Approved "Nuclear bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nuclear bodies" "HPA079473: " "unprognostic (2.37e-2)" "unprognostic (6.01e-2)" "unprognostic (9.29e-2)" "prognostic favorable (1.82e-5)" "unprognostic (3.81e-2)" "unprognostic (2.38e-2)" "unprognostic (2.53e-2)" "unprognostic (7.12e-2)" "unprognostic (2.34e-1)" "unprognostic (1.81e-2)" "unprognostic (1.18e-2)" "unprognostic (2.39e-1)" "prognostic favorable (2.10e-8)" "unprognostic (1.22e-2)" "unprognostic (1.01e-1)" "unprognostic (3.16e-2)" "unprognostic (9.38e-2)" 1.4 1.2 6.4 4.0 6.8 0.9 3.7 3.3 9.8 5.4 1.5 0.8 0.8 1.2 1.4 60.1 10.2 3.4 2.1 6.4 5.9 2.9 1.1 4.4 9.3 5.7 3.9 0.1 1.5 2.9 3.7 4.0 5.5 2.5 0.8 6.0 12.6 1.6 9.5 5.9 2.5 0.8 3.7 5.7 4.1 0.5 4.3 5.1 4.0 5.2 15.4 4.4 13.7 6.5 18.2 2.1 6.7 0.3 0.0 0.0 7.1 0.3 0.1 0.5 2.2 0.4 8.9 15.9 2.4 0.1 1.5 6.6 5.0 0.6 0.3 0.5 1.9 2.2 0.7 5.2 0.0 0.0 4.4 0.6 1.2 0.0 0.1 0.3 0.0 3.5 0.0 1.4 7.3 9.0 0.4 0.2 3.7 13.0 2.3 3.7 21.3 0.1 11.0 4.1 4.1 2.0 2.0 36.4 0.0 4.0 12.7 0.6 0.0 0.0 3.2 0.0 0.3 0.0 0.2 4.9 0.0 0.4 0.1 0.0 0.0 0.6 0.4 0.3 0.9 0.6 0.7 0.5 0.0 1.2 1.1 0.7 0.8 0.0 1.5 0.0 0.4 0.2 6.4 6.8 3.3 9.8 6.4 5.9 5.7 3.9 5.5 3.7 4.3 6.5 3.8 3.2 7.2 1.3 11.3 1.0 4.7 16.3 1.2 3.8 13.7 10.5 1.8 14.3 24.8 9.2 6.2 24.1 1.5 0.2 1.9 21.0 0.4 8.3 2.3 5.9 1.2 0.0 10.5 5.8 2.5 1.2 4.1 19.1 1.3 15.2 0.4 2.2 2.8 0.0 13.6 0.5 16.2 4.1 0.8 0.7 0.0 2.1 7.2 3.7 3.0 15.8 4.1 9.0 0.7 36.0 0.5 0.0 4.4 13.0 0.0 0.3 38.1 5.4 0.0 0.7 2.1 0.1 2.6 9.0 1.7 7.4 7.6 0.2 0.5 56.9 TUBGCP2 "GCP2, SPBC97, Spc97p" ENSG00000130640 "Tubulin gamma complex associated protein 2" Q9BSJ2 10 133278635-133312337 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease variant, Epilepsy, Lissencephaly, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037885 Approved Supported Nucleoplasm,Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Centrosome" "HPA037885: AB_10672397" "unprognostic (3.57e-2)" "unprognostic (5.53e-2)" "unprognostic (6.17e-2)" "unprognostic (1.64e-2)" "unprognostic (1.50e-1)" "unprognostic (1.96e-1)" "unprognostic (7.72e-2)" "unprognostic (3.35e-1)" "unprognostic (3.09e-2)" "unprognostic (1.64e-1)" "unprognostic (5.71e-2)" "unprognostic (1.95e-2)" "unprognostic (3.52e-1)" "unprognostic (4.24e-2)" "unprognostic (5.21e-2)" "unprognostic (1.41e-1)" "unprognostic (4.89e-2)" 20.0 22.2 14.4 20.9 15.4 35.0 13.4 13.5 19.3 15.7 18.2 18.2 22.1 16.0 10.5 17.3 30.3 14.9 20.4 14.8 14.1 19.3 16.4 17.3 20.9 17.1 15.2 26.8 28.3 26.0 3.5 15.8 17.5 17.8 13.3 11.8 28.2 17.1 33.2 22.5 22.1 14.9 13.0 21.9 20.4 21.7 15.0 20.7 19.0 24.4 14.4 15.9 5.8 14.5 64.2 84.2 30.7 35.6 28.3 29.8 42.9 47.5 66.5 50.0 49.5 97.0 45.9 42.1 27.7 48.6 21.6 47.2 35.8 32.3 22.8 50.5 75.7 24.6 46.7 52.3 35.5 63.4 57.0 31.3 29.9 46.5 58.0 55.3 33.3 29.9 36.4 45.6 41.2 79.9 41.4 56.3 30.4 37.2 64.6 32.7 32.9 19.5 32.7 40.8 20.6 43.0 33.0 40.1 36.1 17.9 23.6 38.3 45.6 30.9 27.6 38.0 47.9 43.7 25.9 53.8 102.3 27.3 19.8 6.4 22.5 15.9 15.3 23.2 14.8 11.4 13.3 14.6 27.6 12.3 14.0 15.4 13.8 27.7 25.8 11.7 18.3 19.0 14.4 15.4 13.5 19.3 14.8 14.1 17.1 15.2 17.5 13.0 15.0 14.5 29.1 48.1 38.5 18.9 36.7 13.9 27.4 30.2 23.3 45.7 25.9 25.3 33.9 22.8 38.8 40.5 31.3 41.4 40.1 34.8 23.5 34.5 25.9 78.0 41.6 26.4 29.3 28.0 17.5 37.1 32.9 35.9 38.7 37.1 39.9 49.5 28.9 27.5 44.4 38.7 15.9 36.2 8.2 42.7 25.5 28.6 33.8 51.6 14.2 15.9 75.0 39.3 62.8 9.5 20.1 37.3 33.5 35.3 37.2 28.6 37.3 53.4 112.2 74.8 32.9 39.9 32.1 74.3 65.3 29.0 13.8 42.5 35.7 50.4 36.0 30.3 TXLNA DKFZp451J0118 ENSG00000084652 "Taxilin alpha" P40222 1 32179675-32198285 "Cancer-related genes, Predicted intracellular proteins" Exocytosis "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045383, HPA072477" Supported Approved Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 18: Non-specific - Mitochondria" "Cluster 18: U-2197 - ECM organization" "Cluster 36: Stromal cells - Cell proliferation" Cytosol "Nucleoplasm, Centrosome" "HPA045383: AB_10967649, HPA072477: AB_2686525" "prognostic favorable (6.24e-4)" "unprognostic (1.19e-2)" "unprognostic (3.01e-1)" "unprognostic (1.99e-1)" "unprognostic (5.04e-2)" "prognostic favorable (5.53e-4)" "prognostic unfavorable (1.57e-6)" "unprognostic (3.67e-3)" "unprognostic (2.75e-1)" "unprognostic (5.25e-3)" "prognostic favorable (8.69e-5)" "unprognostic (5.06e-2)" "prognostic unfavorable (7.21e-7)" "unprognostic (3.94e-3)" "unprognostic (3.28e-1)" "unprognostic (7.24e-2)" "unprognostic (1.03e-1)" 26.1 35.8 20.6 20.7 22.0 16.5 20.3 20.6 21.3 30.7 27.5 32.2 16.9 35.4 22.7 30.7 30.5 18.7 22.2 20.4 22.8 30.0 45.6 23.1 22.0 25.3 23.6 29.0 29.2 32.5 31.7 16.7 22.1 30.1 17.9 12.6 23.2 21.7 21.8 31.3 24.4 27.8 21.5 28.5 26.5 29.4 23.9 19.3 27.0 14.5 27.0 28.6 24.3 22.7 45.1 37.7 38.5 43.5 48.8 63.8 31.1 62.7 49.6 59.3 56.6 42.4 47.4 51.1 24.9 61.2 19.5 49.5 53.0 41.2 53.7 58.8 41.0 80.8 57.6 55.8 51.7 59.4 61.4 64.3 54.2 62.8 29.6 43.6 47.6 60.8 33.5 51.3 49.2 25.0 43.8 38.1 56.1 32.0 34.3 50.8 58.3 45.1 40.6 56.4 40.1 41.3 65.1 40.8 68.5 46.9 37.8 35.6 49.9 62.3 53.5 83.3 81.1 75.8 63.0 45.7 64.5 79.5 58.9 11.0 8.8 4.6 12.9 9.8 11.0 6.8 8.8 9.7 6.9 7.4 7.6 8.3 1.4 14.2 13.3 14.3 7.0 10.6 20.6 22.0 20.6 21.3 20.4 22.8 25.3 23.6 22.1 21.5 23.9 22.7 26.2 22.4 21.4 13.4 13.4 8.8 11.3 14.1 17.1 16.0 26.4 24.6 9.5 11.5 16.8 14.7 39.6 10.8 18.9 15.0 1.9 17.4 14.4 26.9 44.7 23.6 26.3 12.4 9.7 16.4 14.3 27.7 23.9 27.4 13.3 20.2 16.1 32.2 18.2 26.9 9.6 18.1 12.2 11.0 10.0 16.8 23.9 15.9 5.4 7.5 20.9 13.3 10.3 9.5 12.9 22.4 7.2 20.7 19.8 12.4 8.3 12.7 24.1 26.1 13.1 33.6 25.8 34.3 23.8 21.2 12.1 6.8 15.5 23.2 14.7 7.7 TYW1 "FLJ10900, MGC23001, MGC60291, RSAFD1, TYW1A, YPL207W" ENSG00000198874 "TRNA-yW synthesizing protein 1 homolog" Q9NV66 7 66995173-67239519 "Enzymes, Predicted membrane proteins" "tRNA processing" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 57.8;Oligodendrocytes: 58.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA013568, HPA014118, HPA015535, HPA043136, HPA047029, HPA047052, HPA052097" Approved Approved "Nucleoplasm,Nucleoli,Nucleoli rim" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 59: Non-specific - Transcription" "Nucleoplasm, Nucleoli, Nucleoli rim" "HPA013568: AB_2668852, HPA014118: AB_2668941, HPA015535: AB_1856487, HPA043136: AB_2678333, HPA047029: AB_2679909, HPA047052: AB_2679918, HPA052097: AB_2681723" "unprognostic (1.53e-1)" "unprognostic (5.49e-3)" "unprognostic (1.62e-1)" "unprognostic (3.05e-2)" "unprognostic (1.84e-2)" "unprognostic (2.20e-1)" "unprognostic (1.83e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "prognostic unfavorable (1.73e-4)" "unprognostic (4.86e-2)" "unprognostic (1.30e-1)" "unprognostic (1.85e-2)" "unprognostic (4.70e-2)" "unprognostic (1.60e-1)" "unprognostic (1.36e-2)" "unprognostic (1.79e-2)" 7.7 10.8 5.5 8.1 5.9 9.1 10.0 6.6 7.6 13.0 8.8 9.0 9.5 9.2 9.7 6.6 10.1 7.1 7.9 5.6 6.4 8.8 12.0 7.2 9.8 6.4 5.8 12.2 7.3 13.1 6.9 8.4 6.1 9.8 10.7 9.0 7.1 9.5 15.6 7.9 7.8 9.2 5.6 7.7 7.7 8.1 5.7 10.4 12.8 8.4 9.4 8.5 8.7 7.3 16.3 20.5 12.1 24.9 17.4 12.0 13.8 16.8 12.9 12.9 12.0 23.3 20.2 28.1 25.2 15.4 18.6 18.4 24.9 20.3 18.4 22.1 24.1 11.9 17.1 15.6 17.7 27.7 15.1 12.4 20.3 17.5 27.0 10.6 13.0 20.9 32.3 16.0 15.6 15.7 18.1 23.4 21.1 27.2 18.8 19.7 16.6 34.8 17.4 16.4 18.2 18.3 20.4 38.4 17.6 22.7 26.6 19.6 14.0 15.0 10.8 11.8 23.3 16.1 25.7 33.2 12.1 25.9 20.8 2.4 7.4 3.9 8.5 7.7 11.2 8.3 8.8 9.5 8.8 9.8 10.8 11.7 1.8 11.1 10.0 6.7 6.8 6.2 5.5 5.9 6.6 7.6 5.6 6.4 6.4 5.8 6.1 5.6 5.7 7.3 10.0 6.4 15.3 39.2 18.2 10.5 5.3 10.0 17.1 12.0 11.4 11.7 9.5 10.0 7.6 11.0 4.2 18.6 11.7 7.8 0.0 7.8 7.3 10.9 18.0 8.8 4.8 12.6 57.8 6.9 13.1 11.0 12.8 10.9 34.2 9.1 6.1 14.2 7.7 3.3 53.4 12.3 12.2 7.1 11.2 4.5 8.4 10.3 8.8 43.1 10.0 6.8 10.3 50.3 58.7 7.1 4.0 8.2 18.0 6.2 4.9 2.4 9.6 11.5 19.7 11.2 10.4 23.9 23.4 15.6 16.9 15.2 17.1 10.2 11.4 3.3 UBAP2 "bA176F3.5, FLJ22435, KIAA1491" ENSG00000137073 "Ubiquitin associated protein 2" Q5T6F2 9 33921693-34048949 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021684 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Cytosol "HPA021684: AB_2211887" "unprognostic (2.71e-1)" "unprognostic (1.99e-1)" "unprognostic (1.17e-1)" "unprognostic (1.61e-2)" "unprognostic (1.69e-1)" "unprognostic (5.18e-2)" "prognostic unfavorable (3.45e-6)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "prognostic favorable (8.59e-4)" "unprognostic (1.75e-1)" "unprognostic (9.76e-3)" "prognostic favorable (1.95e-4)" "unprognostic (8.06e-2)" "unprognostic (2.39e-1)" "unprognostic (2.95e-1)" "unprognostic (8.77e-2)" 12.2 25.7 12.5 8.2 12.9 17.2 12.8 17.3 13.4 15.5 5.3 13.8 8.7 13.0 8.8 19.1 11.4 6.6 15.3 9.5 13.7 14.9 11.1 13.2 10.4 9.4 9.5 15.2 15.4 9.3 11.0 11.8 9.7 14.3 12.1 9.9 13.1 6.7 37.8 22.2 10.8 10.3 6.8 10.9 14.0 32.5 13.6 13.9 15.8 20.5 12.1 12.5 15.2 12.9 40.5 36.5 25.9 32.9 25.2 22.0 31.2 31.8 19.6 32.1 31.0 49.9 21.0 46.8 9.8 26.7 24.7 23.1 43.9 34.9 35.5 34.8 21.5 26.2 47.2 55.0 20.5 59.6 40.3 20.4 28.8 40.8 28.2 16.7 26.3 28.3 36.5 37.6 29.4 26.9 44.6 100.4 27.7 22.6 28.5 34.1 16.0 29.9 31.2 30.1 26.5 18.4 37.6 30.3 9.4 25.8 26.9 26.3 30.9 19.0 25.5 22.8 35.7 14.5 32.3 49.3 20.9 22.5 48.3 1.6 2.7 3.0 2.2 3.1 4.7 2.7 2.7 3.2 3.1 1.4 2.4 3.3 1.6 4.5 7.2 4.1 3.3 2.3 12.5 12.9 17.3 13.4 9.5 13.7 9.4 9.5 9.7 6.8 13.6 12.9 23.8 54.5 23.1 56.8 15.0 28.2 23.8 21.0 27.3 28.7 25.3 26.2 59.9 8.6 32.4 12.9 60.5 44.4 24.7 28.1 3.9 20.0 102.8 52.5 30.3 28.6 25.1 20.8 46.8 19.8 36.3 23.7 32.6 68.8 14.5 36.2 11.7 14.0 16.6 16.8 48.3 30.4 14.2 17.0 21.4 85.0 30.4 17.1 26.6 33.7 19.0 12.5 16.5 50.8 46.3 27.0 26.8 24.5 28.4 24.9 12.3 15.9 24.1 27.0 26.3 27.4 22.6 81.0 70.4 25.9 31.1 72.9 22.3 68.4 29.6 23.7 UBAP2L "KIAA0144, NICE-4" ENSG00000143569 "Ubiquitin associated protein 2 like" Q14157 1 154220179-154271510 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 147.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035068 Approved Approved "Nuclear speckles,Cytosol" NA NA 67000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nuclear speckles, Cytosol" "HPA035068: AB_10696366" "unprognostic (3.14e-2)" "unprognostic (1.50e-1)" "unprognostic (8.82e-2)" "unprognostic (2.93e-3)" "unprognostic (3.98e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (4.65e-5)" "unprognostic (1.97e-2)" "unprognostic (5.10e-3)" "unprognostic (9.01e-2)" "unprognostic (1.67e-1)" "unprognostic (6.96e-2)" "prognostic unfavorable (2.89e-5)" "unprognostic (7.40e-3)" "unprognostic (9.14e-2)" "unprognostic (2.69e-1)" "unprognostic (3.72e-1)" 54.1 49.3 30.7 60.9 31.3 62.8 50.0 29.2 40.4 52.2 32.5 53.2 34.2 59.8 48.6 55.0 54.6 44.8 62.7 32.0 31.2 39.8 36.6 54.5 60.7 26.3 27.6 60.5 37.9 60.4 49.4 70.6 26.3 45.7 40.8 46.0 48.0 47.1 83.1 60.2 40.6 55.2 20.4 53.6 45.9 64.5 27.2 59.5 53.6 49.1 65.9 54.0 50.9 35.0 189.3 184.8 167.4 136.5 121.0 138.0 148.1 212.1 154.9 187.6 131.6 197.9 143.6 235.3 213.2 178.9 94.6 160.8 224.3 158.4 167.7 208.1 199.7 255.7 184.6 162.7 113.7 269.6 144.0 130.5 68.3 173.8 114.8 117.9 153.1 92.0 235.0 111.5 152.6 212.6 207.8 101.1 320.4 140.1 170.9 148.9 135.5 207.8 120.7 220.5 173.1 209.3 245.1 227.2 91.4 186.8 226.6 180.6 245.9 117.0 123.8 145.1 205.7 239.1 278.4 313.2 125.7 144.8 179.0 15.1 28.2 20.4 23.1 35.9 25.4 20.9 21.8 21.2 34.9 26.4 24.6 27.7 24.5 36.4 41.3 16.3 21.5 29.6 30.7 31.3 29.2 40.4 32.0 31.2 26.3 27.6 26.3 20.4 27.2 35.0 29.2 25.6 38.5 22.9 31.7 18.4 18.7 21.5 22.2 18.4 21.5 21.5 39.0 17.2 32.3 18.4 8.4 51.3 32.7 16.7 17.6 28.4 80.6 34.3 43.8 26.8 23.4 34.9 26.7 27.1 39.5 29.0 21.9 35.7 24.7 32.3 23.2 19.1 36.1 15.2 25.3 21.7 26.4 22.6 30.2 147.1 21.5 32.4 19.6 26.2 24.5 13.7 24.7 29.1 29.1 30.9 10.4 22.6 20.6 25.1 12.5 15.9 29.7 20.4 13.1 31.1 51.6 42.2 48.8 31.7 20.5 77.8 23.5 35.6 22.0 21.9 UBE2G2 UBC7 ENSG00000184787 "Ubiquitin conjugating enzyme E2 G2" P60604 21 44768580-44801826 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 211.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003332 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 16: U-266 - Nucleosome" "Cluster 31: Spermatids - Spermatogenesis" "HPA003332: AB_1858525" "unprognostic (7.58e-2)" "unprognostic (5.41e-2)" "unprognostic (1.58e-2)" "unprognostic (4.45e-2)" "unprognostic (6.30e-2)" "unprognostic (4.67e-2)" "unprognostic (5.99e-2)" "unprognostic (3.79e-3)" "unprognostic (6.93e-3)" "unprognostic (7.02e-2)" "unprognostic (1.40e-2)" "unprognostic (6.98e-3)" "prognostic unfavorable (7.02e-5)" "unprognostic (1.79e-1)" "unprognostic (1.69e-1)" "unprognostic (2.75e-2)" "unprognostic (3.55e-2)" 26.7 20.9 21.1 13.4 22.8 25.9 17.5 21.9 24.7 13.5 20.0 22.2 13.3 20.2 8.4 16.1 16.3 12.1 34.7 21.3 21.8 24.4 27.6 16.9 16.2 22.4 22.3 13.7 26.7 20.5 8.2 14.2 22.6 14.8 14.1 20.7 12.6 21.3 61.3 15.3 16.6 20.4 22.1 19.7 21.6 12.2 22.0 22.9 16.9 51.8 14.9 21.2 12.5 24.2 51.9 11.5 34.9 44.3 46.2 20.6 31.3 37.0 27.5 29.5 31.7 40.5 6.7 66.4 33.4 35.8 38.6 20.5 49.4 43.5 27.2 61.9 51.1 107.3 7.0 33.6 35.5 79.2 19.4 33.3 50.0 39.5 39.5 14.7 47.0 71.3 99.8 47.9 43.0 24.6 89.2 13.3 86.7 35.4 44.2 73.2 31.1 61.2 41.4 28.3 39.3 72.5 49.6 18.2 52.3 30.5 17.6 68.5 37.3 31.1 21.2 28.5 58.5 73.8 144.7 64.1 29.3 96.1 36.3 3.2 16.1 8.5 20.8 16.8 22.8 16.0 19.0 21.5 17.3 16.2 20.1 21.3 4.9 20.8 20.1 24.6 21.1 17.4 21.1 22.8 21.9 24.7 21.3 21.8 22.4 22.3 22.6 22.1 22.0 24.2 54.6 57.7 115.4 70.8 48.3 47.7 38.4 32.0 39.3 58.8 37.3 34.0 70.6 28.6 48.4 53.3 66.7 40.7 53.3 29.8 25.4 32.9 63.4 36.8 68.5 54.1 30.0 37.4 56.3 40.7 26.3 41.3 26.0 49.7 43.6 66.6 37.1 69.7 35.3 32.0 57.5 31.2 26.4 42.2 37.4 211.1 41.3 42.9 28.4 32.8 43.2 39.5 49.4 73.9 56.7 43.2 21.5 50.4 53.6 55.6 27.4 36.7 43.0 102.2 26.3 59.3 42.8 42.9 49.4 44.9 56.0 35.8 49.4 75.6 46.0 40.9 UBE2T "FANCT, HSPC150" ENSG00000077152 "Ubiquitin conjugating enzyme E2 T" Q9NPD8 1 202331657-202341980 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease variant, Fanconi anemia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 47.1" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 74.5;Erythroid cells: 134.3;Extravillous trophoblasts: 103.4;Spermatocytes: 114.1;Spermatogonia: 113.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA002831 Approved Nucleoplasm,Nucleoli NA Yes "Cluster 27: Non-specific - Gene expression" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoli Nucleoplasm "HPA002831: AB_1080445" "unprognostic (2.38e-3)" "unprognostic (6.37e-2)" "unprognostic (5.27e-2)" "unprognostic (5.19e-2)" "unprognostic (2.81e-1)" "unprognostic (6.13e-3)" "prognostic unfavorable (4.79e-6)" "unprognostic (1.71e-2)" "unprognostic (2.32e-2)" "prognostic favorable (6.90e-6)" "unprognostic (6.28e-3)" "unprognostic (2.85e-2)" "prognostic unfavorable (2.22e-16)" "unprognostic (5.37e-3)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (4.86e-2)" 2.3 3.7 6.6 10.4 6.5 28.7 4.5 5.8 13.7 4.1 5.0 13.1 8.7 4.5 4.4 10.6 3.3 2.5 11.3 6.8 7.4 3.5 3.2 3.0 19.0 6.5 6.6 1.0 0.7 4.4 3.0 10.1 6.9 2.1 15.5 2.5 2.7 3.1 17.2 5.3 8.2 9.4 6.0 6.2 4.7 19.3 6.7 47.1 2.9 13.0 18.6 6.3 5.0 6.1 123.3 111.6 167.1 79.8 15.4 27.9 94.2 130.2 72.8 146.0 102.6 79.9 147.1 140.4 50.0 47.0 108.4 98.6 154.1 76.7 131.2 128.1 87.2 85.6 54.0 93.8 6.9 105.2 102.0 9.8 18.1 114.0 47.2 34.3 85.8 157.4 111.0 114.0 116.4 113.3 190.8 135.1 65.4 126.9 57.4 145.0 176.2 122.9 57.1 58.1 131.3 132.8 90.2 112.1 44.8 49.8 117.1 64.6 41.8 65.7 104.6 116.1 159.6 57.8 120.1 182.9 64.5 107.0 139.1 0.0 0.7 1.7 3.3 2.3 2.5 8.5 4.5 3.3 1.7 6.6 6.4 7.1 0.0 1.2 8.9 3.4 10.8 2.4 6.6 6.5 5.8 13.7 6.8 7.4 6.5 6.6 6.9 6.0 6.7 6.1 1.9 0.0 2.2 1.3 13.3 14.3 10.4 29.9 2.8 6.4 6.3 8.6 12.8 0.0 12.1 5.5 0.0 74.5 5.4 10.1 5.9 10.9 24.4 15.7 7.6 5.3 1.2 134.3 8.3 7.5 103.4 11.8 10.7 6.7 8.8 32.2 3.9 2.4 27.7 10.1 6.1 14.4 32.6 1.9 5.4 8.2 3.1 5.8 3.6 1.9 2.6 1.6 0.0 1.0 1.4 10.3 2.9 4.1 32.1 5.2 3.3 12.2 16.2 1.2 6.6 0.8 11.3 114.1 113.1 15.5 10.9 22.4 9.3 12.1 30.5 11.3 UBTF "NOR-90, UBF, UBF1, UBF2" ENSG00000108312 "Upstream binding transcription factor" P17480 17 44205033-44221626 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004611, HPA006385" Supported Supported Enhanced "Nucleoli fibrillar center" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" "Nucleoli fibrillar center" "CAB004611: AB_671403, HPA006385: AB_1080447" "unprognostic (1.37e-3)" "unprognostic (1.12e-3)" "unprognostic (2.54e-1)" "unprognostic (1.12e-2)" "unprognostic (3.15e-1)" "unprognostic (8.54e-3)" "unprognostic (1.35e-3)" "unprognostic (4.10e-2)" "unprognostic (5.39e-2)" "unprognostic (1.15e-1)" "unprognostic (1.12e-2)" "unprognostic (2.10e-1)" "unprognostic (1.96e-3)" "unprognostic (5.44e-2)" "unprognostic (9.01e-2)" "unprognostic (1.91e-2)" "unprognostic (2.00e-1)" 34.8 36.5 36.2 44.8 33.7 54.9 35.4 38.2 37.1 50.6 30.1 49.4 33.6 50.8 27.5 41.8 41.9 32.5 38.8 35.5 32.7 38.1 36.1 32.3 67.6 34.0 34.5 41.6 41.4 38.2 33.8 29.2 32.2 41.6 28.2 23.1 37.7 40.8 63.7 47.4 42.5 36.3 31.6 49.8 34.7 20.8 34.9 73.6 46.4 36.6 51.7 45.1 41.8 35.0 69.1 104.3 77.3 93.2 49.6 56.5 72.3 70.6 46.7 70.1 52.0 50.7 54.8 250.0 69.3 65.3 51.9 63.6 99.1 59.2 57.9 145.3 109.5 100.5 73.8 83.7 32.5 192.1 85.7 56.9 52.2 44.6 65.6 67.2 58.9 108.8 117.4 75.9 58.9 113.7 188.3 75.0 73.7 46.6 81.6 184.0 104.3 112.0 40.4 54.5 119.5 90.3 70.4 62.2 54.2 47.9 89.9 120.8 75.5 109.9 133.1 65.1 95.0 66.6 61.7 151.1 64.8 86.0 100.1 9.6 5.7 6.1 15.5 6.3 16.7 11.7 10.8 16.2 6.7 14.1 12.2 13.1 9.7 15.7 11.6 12.7 10.0 11.3 36.2 33.7 38.2 37.1 35.5 32.7 34.0 34.5 32.2 31.6 34.9 35.0 41.4 41.7 42.1 14.7 57.5 20.5 19.6 17.9 57.5 88.8 31.0 29.6 44.5 35.8 32.2 38.6 79.2 30.9 60.3 41.7 35.2 27.2 2.3 39.3 57.7 42.7 47.3 61.2 8.5 40.8 40.7 38.9 23.9 48.1 31.7 43.1 32.5 26.5 25.9 26.9 8.2 32.5 12.2 18.4 13.3 3.6 36.7 27.4 23.2 8.4 38.1 33.9 54.6 3.5 10.6 28.1 30.7 50.8 42.2 17.4 26.7 25.4 26.5 57.6 52.6 48.5 45.9 5.3 44.0 52.1 24.3 32.7 53.1 40.2 32.8 11.8 UHRF1BP1 "C6orf107, dJ349A12.1, FLJ20302, ICBP90" ENSG00000065060 "UHRF1 binding protein 1" Q6BDS2 6 34792015-34883138 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Inhibitory neurons: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032099, HPA032100" Uncertain Approved "Nucleoplasm,Nuclear membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "Nucleoplasm, Nuclear membrane" Cytosol "HPA032099: AB_10696057, HPA032100: AB_10671087" "unprognostic (2.30e-2)" "unprognostic (9.52e-2)" "unprognostic (4.58e-3)" "unprognostic (1.28e-2)" "unprognostic (3.42e-2)" "unprognostic (7.01e-2)" "prognostic unfavorable (3.86e-4)" "unprognostic (3.58e-2)" "unprognostic (4.39e-3)" "unprognostic (9.82e-2)" "unprognostic (4.68e-1)" "unprognostic (1.30e-1)" "unprognostic (1.47e-1)" "unprognostic (1.04e-1)" "unprognostic (1.98e-1)" "unprognostic (1.90e-1)" "unprognostic (4.24e-2)" 4.3 4.4 2.8 4.3 2.8 14.2 3.6 7.1 3.2 2.7 4.6 3.1 3.2 3.3 2.4 3.2 2.8 2.5 6.8 2.4 3.4 3.7 3.9 4.2 4.9 3.5 3.7 3.3 8.0 8.5 3.0 5.3 3.9 3.6 3.9 7.5 5.9 2.9 14.3 3.1 3.6 3.9 3.5 4.4 4.0 12.0 3.5 5.8 6.0 7.5 4.2 3.5 2.4 3.8 12.9 9.1 7.9 25.9 4.1 3.0 14.3 7.4 5.0 7.1 10.0 18.2 3.4 19.4 7.9 7.7 12.3 9.6 29.2 4.2 9.6 10.0 9.4 17.2 8.7 15.2 16.7 15.7 10.3 6.8 12.0 5.7 12.0 6.6 9.1 16.6 29.3 7.5 3.1 12.3 12.2 10.2 3.6 9.3 6.3 7.3 12.7 11.8 9.6 11.8 9.5 9.7 18.7 9.7 24.7 8.1 18.5 20.3 5.6 3.5 12.7 5.5 8.2 11.1 18.6 12.0 1.9 21.5 8.8 0.1 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.2 0.1 0.4 1.3 0.1 0.1 0.2 2.8 2.8 7.1 3.2 2.4 3.4 3.5 3.7 3.9 3.5 3.5 3.8 5.1 16.0 6.3 16.0 5.0 1.0 3.0 3.9 5.7 10.1 5.2 2.9 16.8 4.3 9.1 0.0 20.9 6.9 3.7 3.0 1.9 5.4 10.0 5.8 4.9 6.3 9.5 6.7 20.8 5.8 3.8 4.9 10.2 11.5 1.3 14.3 15.0 6.0 15.6 5.0 39.3 4.9 10.2 19.0 6.0 18.2 5.6 11.9 0.0 22.5 9.4 4.6 4.1 25.6 14.1 7.2 3.3 2.6 11.4 9.9 4.1 3.9 5.1 10.8 13.1 7.5 5.4 16.4 10.8 8.3 2.8 4.9 3.9 4.0 3.8 8.5 UNC45A "GC-UNC45, SMAP-1" ENSG00000140553 "Unc-45 myosin chaperone A" Q9H3U1 15 90930180-90954093 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Myogenesis" "Chaperone, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039228 Approved Supported "Nuclear speckles,Cytosol" NA NA 17000 "Cluster 27: Non-specific - Gene expression" "Cluster 12: Smooth muscle tissue - Mixed function" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 55: Plasma cells - Humoral immune response" "Nuclear speckles" Cytosol "HPA039228: AB_2676402" "unprognostic (1.46e-1)" "unprognostic (3.83e-2)" "unprognostic (4.51e-2)" "unprognostic (1.97e-1)" "unprognostic (2.68e-2)" "unprognostic (1.70e-3)" "prognostic unfavorable (7.72e-4)" "unprognostic (2.27e-2)" "unprognostic (1.58e-1)" "unprognostic (1.16e-1)" "unprognostic (1.98e-1)" "unprognostic (9.85e-2)" "prognostic favorable (7.46e-7)" "unprognostic (9.30e-2)" "unprognostic (1.74e-1)" "unprognostic (1.95e-1)" "unprognostic (2.28e-2)" 25.0 25.3 7.7 16.7 8.2 17.3 23.2 8.6 9.1 32.0 10.0 41.2 16.4 38.1 11.0 31.4 28.4 17.3 15.9 7.8 7.7 18.9 13.0 20.2 18.9 8.9 11.6 26.1 22.3 33.2 17.5 19.6 9.5 25.2 13.4 5.6 25.8 34.1 9.6 37.7 23.5 28.0 8.3 19.7 28.5 13.1 9.6 18.0 19.5 10.6 17.3 39.3 29.4 8.0 38.2 76.3 30.9 27.2 83.0 38.0 27.3 42.4 36.2 56.5 45.1 61.3 49.4 44.7 55.5 53.8 32.5 82.1 52.9 54.4 26.6 49.8 75.9 86.2 77.0 44.4 46.8 21.5 56.2 47.3 65.8 55.7 40.5 54.2 77.5 35.1 38.6 35.8 43.3 62.2 28.1 18.6 41.8 69.5 38.0 54.8 46.9 48.1 38.4 89.2 43.1 39.4 57.1 55.9 54.3 36.8 50.8 44.3 77.0 48.0 34.1 40.4 45.0 33.6 50.5 21.1 46.6 49.7 49.8 11.5 8.3 5.0 11.8 7.3 11.3 7.9 9.6 9.1 10.4 6.3 7.8 7.4 1.6 9.8 11.6 9.1 9.3 9.8 7.7 8.2 8.6 9.1 7.8 7.7 8.9 11.6 9.5 8.3 9.6 8.0 21.7 22.4 22.4 9.4 23.2 16.3 24.8 26.1 30.1 27.2 17.2 19.6 12.7 35.8 23.8 18.4 18.8 53.6 17.5 26.9 13.7 33.6 26.7 12.8 20.3 25.3 37.0 25.2 19.1 18.2 22.7 23.7 26.5 22.1 29.2 30.9 18.9 13.4 28.2 18.5 18.4 15.9 26.4 12.2 14.0 29.0 29.5 20.7 19.6 9.4 28.8 21.5 27.8 7.1 11.0 23.3 26.0 51.6 20.6 16.8 22.0 19.6 11.7 35.1 32.9 15.2 33.9 24.8 6.4 33.9 18.8 46.2 21.4 26.0 22.7 20.3 UPRT "DKFZp781E1243, FUR1, MGC23937, RP11-311P8.3" ENSG00000094841 "Uracil phosphoribosyltransferase homolog" Q96BW1 X 75156388-75304885 "Metabolic proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000805 Uncertain Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 3: T-cells - Adaptive immune response" "Cluster 16: U-266 - Nucleosome" "Cluster 24: Non-specific - Transcription regulation" Nucleoplasm Vesicles "HPA000805: AB_1080482" "unprognostic (3.12e-3)" "unprognostic (5.85e-2)" "unprognostic (1.40e-1)" "unprognostic (2.67e-2)" "unprognostic (2.43e-1)" "unprognostic (1.18e-2)" "unprognostic (4.62e-2)" "unprognostic (1.04e-3)" "unprognostic (9.64e-2)" "unprognostic (1.37e-2)" "unprognostic (1.05e-2)" "unprognostic (2.62e-1)" "prognostic favorable (4.14e-4)" "unprognostic (6.09e-2)" "unprognostic (2.54e-2)" "unprognostic (2.74e-1)" "unprognostic (4.53e-3)" 6.2 10.9 7.2 6.3 7.4 13.4 7.9 7.4 8.7 8.1 8.1 7.6 10.9 5.9 8.9 7.9 7.2 6.1 9.3 7.1 8.2 11.4 8.6 7.6 8.9 7.2 8.3 6.1 6.5 14.0 7.0 5.8 7.9 9.2 7.9 6.4 8.7 6.0 8.9 5.6 8.1 6.5 7.4 7.3 10.3 1.9 8.1 8.9 10.2 10.8 8.2 6.9 4.7 8.1 11.6 7.6 8.9 8.1 9.4 9.9 8.4 8.0 9.2 8.4 9.6 7.2 7.7 16.3 6.6 8.5 15.1 4.8 20.7 6.8 13.9 14.3 8.0 10.2 7.8 9.1 9.0 20.2 20.1 7.5 5.0 11.2 6.1 13.4 15.1 13.1 12.1 15.7 22.6 4.8 22.7 12.4 17.8 8.6 13.0 10.7 22.8 8.1 21.9 6.4 0.6 9.2 11.0 11.4 11.4 15.7 5.3 12.6 12.6 10.6 6.3 19.4 6.8 10.7 36.5 15.8 11.2 21.9 6.9 6.9 7.3 9.2 7.7 10.6 9.0 8.2 7.6 8.0 10.9 7.0 9.4 8.3 1.4 14.4 17.9 5.2 13.5 7.1 7.2 7.4 7.4 8.7 7.1 8.2 7.2 8.3 7.9 7.4 8.1 8.1 8.5 6.4 5.0 8.1 8.0 6.2 8.7 10.0 3.4 8.5 5.3 3.8 6.6 5.7 11.2 9.2 0.0 8.4 8.1 5.3 27.4 8.8 2.0 4.8 4.1 8.6 6.0 4.6 8.8 6.0 15.1 5.2 5.1 4.1 24.1 5.2 11.7 6.0 11.6 10.1 8.8 5.3 22.4 16.1 8.8 1.8 4.4 10.8 14.2 3.7 7.8 9.4 13.4 13.0 8.4 5.6 3.2 3.4 9.8 5.5 8.4 15.4 6.1 7.2 6.6 4.8 7.1 0.7 2.4 4.2 6.0 12.2 12.1 6.5 7.2 7.4 USO1 "p115, TAP, VDP" ENSG00000138768 "USO1 vesicle transport factor" O60763 4 75724577-75814286 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 219.2" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010108, HPA038282, HPA038283" Supported Supported "Nucleoli fibrillar center,Golgi apparatus" NA NA 170000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 30: Epithelial cell lines - Translation" "Cluster 40: Granulosa cells - Unknown function" "Golgi apparatus" "Nucleoli fibrillar center" "CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929" "unprognostic (9.45e-3)" "unprognostic (3.12e-2)" "unprognostic (3.14e-3)" "unprognostic (1.99e-2)" "unprognostic (1.78e-1)" "unprognostic (2.30e-1)" "unprognostic (2.56e-3)" "unprognostic (6.29e-2)" "unprognostic (2.11e-1)" "unprognostic (2.03e-1)" "unprognostic (3.24e-2)" "unprognostic (9.18e-2)" "unprognostic (7.95e-3)" "unprognostic (4.01e-1)" "unprognostic (4.97e-2)" "unprognostic (1.55e-1)" "unprognostic (1.78e-2)" 35.0 38.7 13.1 32.3 14.7 13.0 39.0 15.6 19.0 44.3 26.1 33.9 35.6 32.3 64.2 50.1 30.1 32.0 57.4 14.9 16.1 38.7 76.8 30.4 32.5 16.7 14.4 56.9 57.5 37.7 31.5 43.7 16.4 39.9 36.9 39.2 54.7 37.5 219.2 36.2 33.7 35.7 14.9 26.3 40.8 43.1 15.6 30.7 53.4 138.7 39.7 40.2 27.6 19.2 46.8 36.0 49.5 66.7 118.6 155.8 45.5 106.2 129.4 57.2 69.2 36.2 70.4 60.6 64.0 98.0 49.2 52.8 74.9 66.5 85.6 67.2 29.3 41.8 31.4 76.3 93.0 55.8 46.2 89.2 80.6 59.8 116.4 110.6 87.1 41.7 73.7 67.9 85.8 30.9 55.4 29.5 67.9 98.2 21.3 36.3 47.2 49.2 85.5 53.1 39.4 38.3 39.1 82.4 67.3 73.6 60.6 45.1 67.4 52.2 32.2 95.8 40.7 63.6 36.6 29.5 77.6 33.1 63.2 21.9 13.1 11.9 16.4 18.7 22.2 9.8 13.6 15.7 16.8 11.2 13.9 13.8 8.1 22.2 26.9 13.4 15.1 13.7 13.1 14.7 15.6 19.0 14.9 16.1 16.7 14.4 16.4 14.9 15.6 19.2 34.5 60.9 84.5 59.1 43.2 38.0 52.8 59.6 51.2 33.3 35.0 28.4 126.9 28.6 71.7 25.8 43.8 47.9 32.6 32.0 35.2 38.4 11.1 35.7 57.5 36.4 40.1 20.8 70.9 48.6 49.0 62.7 61.2 55.0 48.8 126.2 32.9 62.0 42.8 26.9 68.7 63.7 40.7 38.0 35.1 10.9 78.6 41.3 28.4 60.9 54.8 32.8 45.3 77.4 113.7 48.5 33.4 68.4 106.9 78.2 44.3 50.4 66.4 51.2 39.5 54.0 50.5 73.8 68.2 58.7 40.3 90.6 37.8 36.3 41.9 63.8 USP34 "KIAA0570, KIAA0729" ENSG00000115464 "Ubiquitin specific peptidase 34" Q70CQ2 2 61187463-61471087 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 310.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025815, HPA070764" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA025815: AB_1858681, HPA070764: AB_2686308" "unprognostic (4.04e-2)" "unprognostic (8.21e-3)" "unprognostic (5.08e-2)" "unprognostic (3.14e-2)" "unprognostic (4.13e-2)" "unprognostic (1.43e-2)" "unprognostic (1.04e-1)" "unprognostic (2.66e-1)" "unprognostic (1.47e-1)" "unprognostic (2.90e-2)" "unprognostic (8.91e-2)" "unprognostic (4.62e-2)" "unprognostic (9.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.53e-1)" "unprognostic (6.34e-2)" "unprognostic (7.01e-2)" 32.2 36.0 49.9 21.7 53.9 37.7 35.6 57.7 58.3 36.1 59.9 47.0 14.8 38.4 54.4 35.8 33.3 21.1 33.7 49.7 53.5 43.3 34.8 36.4 44.1 52.1 51.8 43.4 32.4 35.1 45.0 17.4 52.3 38.6 26.8 77.5 27.2 32.4 53.9 41.4 40.8 27.9 50.3 45.8 36.3 45.1 54.5 47.8 32.2 36.8 45.1 36.9 32.8 56.8 43.6 29.9 38.9 40.3 71.8 48.1 32.4 26.3 37.1 23.0 21.7 43.0 16.3 102.2 27.0 56.9 24.3 23.4 30.9 34.4 42.6 36.7 24.4 61.6 29.5 69.6 60.2 46.1 37.8 52.9 43.6 41.9 62.1 55.7 49.0 28.8 42.7 32.2 51.5 40.6 30.6 66.6 26.3 43.9 23.9 32.4 46.5 27.7 67.9 52.2 31.9 34.0 40.5 30.1 48.3 49.4 16.0 33.2 43.6 36.1 48.2 21.5 34.7 37.0 19.7 103.6 33.8 42.5 31.7 2.1 1.2 1.6 3.8 1.1 3.5 2.6 2.6 2.9 1.0 3.1 2.9 3.9 1.8 3.1 2.8 3.2 2.5 1.4 49.9 53.9 57.7 58.3 49.7 53.5 52.1 51.8 52.3 50.3 54.5 56.8 64.5 64.1 68.3 193.6 82.8 61.1 54.2 40.3 46.7 139.7 54.0 46.6 46.0 48.6 54.6 33.1 250.2 33.5 87.3 46.0 9.8 41.4 133.5 59.9 66.9 59.3 48.6 53.2 256.6 33.6 23.8 53.0 73.9 70.6 32.3 78.0 31.8 38.9 21.6 107.7 240.4 37.8 59.0 45.4 48.6 138.0 56.8 56.0 40.9 212.7 55.2 60.0 87.6 232.2 310.0 49.9 41.1 67.0 69.9 79.9 38.3 23.4 44.1 178.1 26.3 78.2 63.9 95.8 115.9 53.1 61.4 53.4 70.5 74.7 35.6 69.9 USP5 IsoT ENSG00000111667 "Ubiquitin specific peptidase 5" P45974 12 6852148-6866632 "Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006756 Uncertain Approved Nucleoplasm,Cytosol NA NA 1200000 "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 5: NTERA-2 - Transcription" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA006756: AB_1080534" "unprognostic (2.19e-1)" "unprognostic (5.83e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-1)" "unprognostic (7.60e-2)" "unprognostic (2.21e-2)" "unprognostic (4.02e-2)" "unprognostic (3.93e-2)" "unprognostic (2.57e-1)" "unprognostic (4.71e-2)" "unprognostic (8.90e-3)" "unprognostic (4.69e-2)" "unprognostic (1.17e-2)" "unprognostic (2.65e-2)" "unprognostic (3.56e-1)" "unprognostic (3.23e-1)" "unprognostic (2.02e-3)" 27.1 37.9 23.7 26.7 26.1 22.8 19.5 15.5 38.0 24.1 2.4 31.3 25.3 31.5 17.4 38.2 25.9 18.5 33.0 25.3 33.6 20.1 23.1 20.5 29.2 31.0 31.3 19.4 17.8 41.4 27.8 25.4 38.8 26.5 22.2 15.7 20.0 29.6 66.7 48.1 26.1 35.5 15.0 21.2 22.9 40.9 28.9 36.5 26.7 42.5 29.4 29.8 24.2 29.0 88.1 135.7 88.4 100.4 59.0 53.9 113.4 93.0 70.9 109.2 78.8 129.4 84.9 105.7 47.6 98.5 86.5 75.2 98.6 92.7 69.5 198.6 84.0 97.1 105.5 71.0 45.8 88.5 97.2 55.6 52.9 94.8 64.9 72.9 94.8 41.7 85.4 40.9 91.1 97.4 132.9 44.4 172.8 89.3 56.5 103.4 115.5 73.5 62.9 84.5 48.5 97.4 63.5 96.3 41.1 110.6 38.3 72.4 92.4 91.5 109.1 70.4 117.6 49.0 124.5 163.8 102.1 55.3 91.3 5.4 19.3 8.3 24.3 25.1 23.1 15.0 21.7 20.8 28.4 13.9 20.1 20.9 1.3 17.6 24.4 20.5 19.9 27.7 23.7 26.1 15.5 38.0 25.3 33.6 31.0 31.3 38.8 15.0 28.9 29.0 11.3 9.6 13.1 7.5 14.0 11.6 11.4 18.0 8.6 18.7 13.1 10.8 9.5 17.2 11.5 22.0 60.5 45.9 14.8 21.5 11.7 28.1 14.7 10.6 14.7 15.3 16.7 19.4 11.5 20.5 30.7 16.6 10.2 13.7 14.7 29.6 11.4 22.2 28.4 40.4 11.9 19.3 14.2 13.0 7.4 19.2 23.0 10.9 16.0 9.4 32.4 16.0 13.4 6.0 11.9 20.2 17.4 33.8 14.1 10.3 22.5 18.5 7.9 16.2 32.9 13.3 17.2 51.7 25.6 17.6 15.5 52.8 15.4 27.6 27.5 7.9 USP54 "bA137L10.3, bA137L10.4, C10orf29, FLJ37318" ENSG00000166348 "Ubiquitin specific peptidase 54" Q70EL1 10 73497538-73625994 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 134.8" "Cell type enriched" "Detected in many" 4 "Oligodendrocytes: 476.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "OE19: 33.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047663, HPA063665" Approved Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 70: Brain - Nervous system development" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Mitochondria "HPA047663: AB_2680116, HPA063665: " "unprognostic (2.46e-2)" "unprognostic (1.67e-1)" "unprognostic (3.17e-2)" "unprognostic (1.89e-2)" "unprognostic (2.48e-2)" "unprognostic (4.89e-3)" "unprognostic (6.63e-4)" "prognostic favorable (7.00e-4)" "unprognostic (6.24e-2)" "unprognostic (4.35e-2)" "unprognostic (8.91e-3)" "unprognostic (3.49e-1)" "unprognostic (1.95e-3)" "unprognostic (8.18e-2)" "unprognostic (6.88e-2)" "unprognostic (1.65e-2)" "unprognostic (1.31e-1)" 4.6 3.1 61.5 5.5 103.5 2.1 16.3 85.5 72.4 14.5 32.2 15.0 4.9 9.3 13.2 13.9 12.0 5.6 7.0 60.5 71.9 5.2 1.5 17.9 2.8 99.8 97.5 6.8 10.8 8.9 2.9 2.8 94.0 12.1 19.7 14.8 16.8 7.6 49.7 15.2 6.7 7.1 70.4 2.9 20.7 9.1 85.0 8.4 40.7 17.0 7.1 6.6 4.9 134.8 10.0 8.4 15.9 13.7 4.4 4.8 4.7 4.7 11.2 7.9 8.6 8.1 16.7 6.6 6.5 3.7 6.1 14.2 10.7 4.3 10.2 2.8 8.6 5.0 6.3 8.0 4.1 5.6 2.3 3.9 3.8 9.0 10.9 20.6 3.4 5.7 7.5 3.0 6.3 5.6 4.5 6.8 8.0 33.4 30.2 7.0 11.9 3.0 8.7 7.6 4.8 5.4 10.1 11.7 15.8 10.2 15.8 5.8 4.9 3.5 11.2 6.6 6.8 2.4 4.3 4.1 8.3 5.3 3.1 0.2 0.4 0.5 0.6 0.4 0.7 0.4 0.5 0.4 0.4 0.3 0.7 0.4 0.0 0.3 0.5 0.4 0.6 0.4 61.5 103.5 85.5 72.4 60.5 71.9 99.8 97.5 94.0 70.4 85.0 134.8 5.9 48.1 34.3 33.0 1.7 2.7 8.5 11.0 4.0 7.7 15.3 8.4 7.2 5.7 18.9 12.9 16.7 1.0 1.2 19.6 0.0 4.7 2.4 25.8 12.9 6.3 10.3 2.1 23.1 8.0 1.0 7.6 40.2 44.3 3.8 3.5 2.5 3.0 1.4 5.0 33.4 23.4 2.0 1.3 1.4 2.2 3.4 1.8 8.8 76.8 0.8 12.5 0.0 116.1 476.0 12.2 9.7 10.9 2.3 52.6 10.5 1.9 21.7 12.2 6.6 19.6 3.8 9.2 6.0 7.7 4.0 1.4 3.0 2.9 11.2 15.2 UTP11 "CGI-94, UTP11L" ENSG00000183520 "UTP11 small subunit processome component" Q9Y3A2 1 38009258-38024820 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 111.4;tongue: 85.5" "Cell type enhanced" "Detected in many" "Ductal cells: 60.2;Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 72.6;Syncytiotrophoblasts: 77.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045830 Approved Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA045830: AB_10969917" "unprognostic (1.95e-1)" "unprognostic (2.23e-1)" "unprognostic (1.52e-1)" "unprognostic (3.18e-2)" "unprognostic (7.29e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (7.44e-8)" "unprognostic (3.51e-1)" "unprognostic (2.99e-2)" "unprognostic (1.66e-3)" "unprognostic (1.40e-1)" "unprognostic (9.65e-2)" "prognostic unfavorable (1.42e-8)" "unprognostic (1.39e-2)" "unprognostic (2.44e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-1)" 15.4 18.7 11.0 15.4 11.9 16.7 13.6 11.9 15.9 11.4 10.6 18.4 11.3 15.9 13.4 18.4 12.3 12.9 19.9 11.7 11.6 12.3 17.0 11.4 14.9 12.9 12.3 11.0 15.6 12.0 7.3 14.8 12.4 13.7 13.3 7.0 14.1 12.8 111.4 14.6 9.9 19.7 12.0 10.7 14.0 15.1 11.9 13.5 11.0 85.5 17.5 19.7 11.0 14.7 37.6 22.9 38.5 36.8 27.8 37.8 34.6 41.5 39.4 55.4 50.4 32.8 44.9 62.6 37.9 34.2 27.2 31.6 44.2 37.2 68.8 47.3 39.9 72.6 27.9 28.8 37.9 72.7 45.3 35.3 23.7 61.4 53.3 34.1 44.6 47.6 84.1 32.5 63.5 26.6 56.9 75.4 92.1 41.9 29.1 49.7 80.8 57.3 36.5 36.2 49.8 41.5 36.1 30.7 67.8 40.1 28.1 44.5 33.2 36.8 45.0 40.8 80.0 31.0 65.8 52.6 49.3 79.3 46.5 18.1 27.6 15.2 23.1 30.6 24.3 15.0 18.3 19.3 27.6 17.5 16.3 20.3 8.3 32.2 36.5 26.3 23.4 20.5 11.0 11.9 11.9 15.9 11.7 11.6 12.9 12.3 12.4 12.0 11.9 14.7 37.9 35.3 43.6 0.0 5.7 0.0 0.0 0.0 0.0 0.0 29.8 27.6 0.0 0.0 21.1 25.8 0.0 54.2 23.6 0.0 39.2 60.2 0.0 23.6 43.5 31.4 0.0 0.0 0.0 67.4 51.7 23.4 0.0 24.8 25.2 19.0 0.0 0.0 52.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.4 0.0 0.0 19.1 0.0 0.0 0.0 0.0 72.6 0.0 0.0 3.5 0.0 0.0 49.4 25.5 0.0 0.0 0.0 25.1 0.0 0.0 0.0 0.0 77.8 10.5 39.1 0.0 0.0 UTP4 "CIRH1A, CIRHIN, FLJ14728, KIAA1988, NAIC, TEX292" ENSG00000141076 "UTP4 small subunit processome component" Q969X6 16 69131291-69231130 "Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 100.0;Spermatogonia: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 398.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041139, HPA043542" Approved Supported "Nucleoli fibrillar center" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoli fibrillar center" "HPA041139: AB_10961278, HPA043542: AB_2678542" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (1.48e-1)" "unprognostic (1.89e-2)" "unprognostic (6.16e-3)" "prognostic unfavorable (9.05e-5)" "prognostic unfavorable (8.18e-7)" "unprognostic (1.31e-1)" "unprognostic (4.76e-2)" "prognostic favorable (2.88e-5)" "unprognostic (2.12e-2)" "unprognostic (4.45e-2)" "unprognostic (2.32e-3)" "unprognostic (9.57e-3)" "unprognostic (2.12e-1)" "unprognostic (1.33e-1)" "unprognostic (3.20e-2)" 25.4 17.4 7.7 17.5 8.6 27.1 21.0 7.3 10.1 16.3 7.3 21.1 10.8 20.6 9.9 23.0 19.5 12.7 19.2 10.3 7.5 31.7 19.1 16.3 19.1 6.1 6.9 18.3 24.1 16.6 14.2 15.5 6.6 16.1 17.6 11.4 15.7 14.4 61.7 20.2 13.9 22.7 5.9 14.0 19.1 31.4 8.0 17.6 23.2 26.3 23.3 28.8 16.8 7.3 79.6 95.6 56.9 79.8 48.5 42.9 94.5 83.7 57.2 152.1 112.8 188.1 68.8 166.4 68.0 57.7 63.1 106.0 130.8 102.7 167.4 33.2 74.6 82.2 58.6 99.7 58.6 96.5 52.7 41.0 55.2 143.0 129.5 40.7 68.6 88.8 169.4 22.9 90.0 96.2 105.4 50.5 139.1 80.3 66.7 174.3 85.3 163.4 63.6 77.7 96.4 67.1 178.3 45.3 48.3 63.3 80.2 53.4 48.2 83.3 83.6 73.4 119.2 59.5 116.1 398.1 56.5 76.5 87.4 4.5 18.6 3.5 26.7 26.1 38.5 30.6 30.0 26.9 25.6 20.1 34.7 31.6 1.7 35.0 19.4 21.6 31.5 30.2 7.7 8.6 7.3 10.1 10.3 7.5 6.1 6.9 6.6 5.9 8.0 7.3 12.1 6.4 11.4 0.0 14.6 0.0 30.0 0.0 28.5 5.7 12.4 11.6 0.0 5.7 9.9 5.5 8.4 18.9 7.4 1.7 9.8 27.4 17.9 7.0 13.2 12.1 0.0 12.4 0.0 25.4 22.1 14.8 10.2 9.0 2.5 12.0 9.3 7.9 16.7 6.7 0.0 6.4 0.0 8.9 0.0 7.6 15.8 9.8 0.0 0.0 8.2 7.6 11.3 0.0 0.0 24.4 5.4 14.7 13.4 26.7 4.5 100.0 5.8 5.7 6.6 26.7 12.8 30.1 49.5 25.1 0.0 12.9 11.0 16.5 10.0 22.6 VDAC1 "MGC111064, PORIN" ENSG00000213585 "Voltage dependent anion channel 1" P21796 5 133971871-134004975 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Ion transport, Transport" Porin "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 1045.7;tongue: 812.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005885, HPA030780, CAB072343" Supported NA NA 1300000 "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 39: Non-specific - Basic cellular processes" "CAB005885: AB_2214787, CAB072343: , HPA030780: AB_2673608" "prognostic unfavorable (5.30e-4)" "unprognostic (7.63e-3)" "unprognostic (3.07e-3)" "unprognostic (2.01e-1)" "unprognostic (5.11e-3)" "prognostic unfavorable (4.90e-4)" "prognostic unfavorable (8.49e-4)" "prognostic unfavorable (2.87e-5)" "unprognostic (1.81e-1)" "unprognostic (1.86e-1)" "unprognostic (1.20e-2)" "unprognostic (2.64e-1)" "unprognostic (3.19e-2)" "unprognostic (8.98e-2)" "unprognostic (1.78e-1)" "unprognostic (1.29e-1)" "unprognostic (1.22e-1)" 96.3 129.8 104.8 96.2 113.5 53.9 106.2 112.8 137.4 62.8 149.0 154.1 265.7 54.4 196.9 172.3 61.5 90.3 403.5 116.7 122.3 200.9 206.2 79.3 89.6 113.4 105.1 60.8 99.7 181.8 63.4 104.5 118.3 82.4 166.4 316.0 132.9 72.5 1045.7 113.9 179.1 90.7 101.1 60.2 163.6 37.5 117.3 90.9 68.5 812.0 129.3 108.3 91.0 106.4 364.5 315.8 282.8 295.3 277.5 385.0 398.0 398.1 292.2 386.5 395.2 650.0 282.9 497.4 291.5 418.0 515.1 278.2 403.4 701.2 480.7 296.1 331.7 287.3 308.9 526.0 282.2 266.5 272.9 353.3 368.5 301.1 333.0 385.3 381.2 248.0 260.1 197.8 511.8 404.5 326.3 264.1 198.5 555.2 264.3 296.5 282.6 474.3 608.6 450.0 315.0 177.7 253.7 305.2 416.0 385.9 147.0 257.6 311.6 361.4 241.6 335.9 530.2 262.9 278.3 309.4 537.1 351.9 420.7 24.9 83.2 30.3 54.5 118.4 60.0 58.3 55.6 57.3 140.7 40.5 38.8 43.8 6.9 87.7 105.1 41.1 74.5 72.9 104.8 113.5 112.8 137.4 116.7 122.3 113.4 105.1 118.3 101.1 117.3 106.4 89.9 105.8 63.1 21.2 101.9 204.8 246.6 250.8 128.7 463.6 163.7 98.3 276.0 198.8 133.2 126.9 81.3 372.4 94.9 333.1 729.8 303.4 68.7 140.8 161.1 120.7 104.1 96.7 41.5 302.6 471.4 136.9 225.8 184.6 121.8 163.9 57.1 203.9 332.7 519.9 40.6 202.7 189.2 130.6 243.5 50.3 95.7 165.7 249.1 31.9 315.8 277.0 60.8 24.1 23.8 300.7 227.7 112.1 162.0 353.6 415.8 585.3 121.2 257.2 85.5 132.8 171.4 10.9 32.7 275.5 232.9 325.6 111.0 229.1 326.7 265.1 VMA21 "MEAX, XMEA" ENSG00000160131 "Vacuolar ATPase assembly factor VMA21" Q3ZAQ7 X 151396515-151409364 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010972 Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 4: Macrophages - Innate immune response" "HPA010972: AB_1853034" "unprognostic (1.17e-1)" "prognostic favorable (2.30e-5)" "unprognostic (6.75e-2)" "unprognostic (9.78e-3)" "unprognostic (6.48e-2)" "unprognostic (4.68e-2)" "unprognostic (1.88e-3)" "unprognostic (4.36e-2)" "unprognostic (5.16e-2)" "unprognostic (1.74e-2)" "unprognostic (2.55e-1)" "unprognostic (8.30e-2)" "unprognostic (7.88e-2)" "unprognostic (4.17e-2)" "unprognostic (3.21e-2)" "unprognostic (3.90e-2)" "unprognostic (2.76e-1)" 10.4 12.2 16.5 7.6 17.0 22.8 10.6 16.2 17.1 9.6 18.3 6.8 6.3 9.0 14.1 9.3 13.6 6.6 7.5 18.5 23.5 12.8 9.8 8.0 11.4 19.8 20.8 10.5 8.7 11.6 10.9 12.0 20.3 8.6 6.6 15.6 8.1 8.2 7.9 12.5 6.6 7.8 20.1 9.9 7.0 8.3 18.3 10.3 13.3 7.1 12.4 8.5 7.6 19.6 21.5 23.5 26.7 28.3 25.9 24.7 26.2 23.7 25.4 21.4 21.1 17.8 27.5 63.1 75.3 24.2 24.0 19.1 37.5 22.6 33.2 22.2 18.6 27.5 25.9 32.3 34.6 52.4 30.4 25.8 27.4 24.3 34.1 22.8 24.9 27.2 14.9 32.2 40.6 20.4 35.8 51.9 33.3 25.7 24.5 35.9 31.8 40.6 25.5 17.3 9.6 20.3 18.4 24.3 29.0 24.4 14.9 34.1 25.4 34.6 15.6 44.3 38.5 27.1 50.8 91.7 35.2 63.9 35.4 11.9 12.4 7.7 6.5 14.4 8.5 7.7 8.5 8.3 13.6 6.0 11.3 10.5 2.8 12.8 13.1 12.2 9.4 10.6 16.5 17.0 16.2 17.1 18.5 23.5 19.8 20.8 20.3 20.1 18.3 19.6 38.5 22.4 24.4 9.1 46.5 44.9 28.0 35.3 42.7 40.2 35.8 31.1 46.8 30.0 21.0 31.3 18.8 33.2 62.9 21.0 19.6 28.2 50.6 44.1 22.4 34.6 22.1 52.5 16.4 33.0 66.7 28.0 15.8 24.1 24.1 25.7 32.2 38.9 143.7 20.2 19.1 22.5 20.3 150.3 86.6 51.5 18.3 89.8 39.2 5.6 142.9 49.9 53.5 13.0 14.3 47.7 17.6 22.6 50.9 43.8 26.8 33.5 28.6 26.2 52.6 31.7 34.5 27.4 58.8 46.0 51.6 31.9 41.6 37.0 21.8 30.5 VMAC ENSG00000187650 "Vimentin type intermediate filament associated coiled-coil protein" Q2NL98 19 5904872-5910853 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Early spermatids: 28.1;Late spermatids: 31.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 29: U-266 - Adaptive immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (6.81e-2)" "unprognostic (4.08e-2)" "unprognostic (2.05e-1)" "prognostic favorable (5.67e-6)" "unprognostic (3.59e-1)" "prognostic favorable (8.20e-4)" "unprognostic (1.40e-1)" "unprognostic (1.73e-3)" "unprognostic (2.36e-1)" "unprognostic (1.36e-2)" "unprognostic (9.52e-2)" "unprognostic (5.48e-2)" "unprognostic (1.09e-2)" "unprognostic (1.69e-1)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favorable (7.24e-4)" 4.6 5.1 3.1 5.0 5.3 6.0 5.0 4.0 4.4 5.2 4.1 5.2 3.1 5.3 2.4 5.1 5.1 2.6 3.5 2.7 2.6 3.8 4.5 3.7 5.3 6.1 4.4 5.1 7.8 2.0 6.9 2.6 5.3 7.3 3.1 2.2 7.0 3.5 2.9 5.3 6.7 2.8 3.2 6.3 7.6 2.6 4.7 3.3 7.2 0.9 4.2 5.9 4.4 9.3 1.4 0.7 1.4 2.4 2.4 1.6 1.4 0.9 1.4 0.4 0.6 1.0 1.5 1.4 3.6 1.4 0.8 2.2 0.3 1.8 0.2 2.9 2.1 1.3 1.6 0.8 1.8 1.7 3.0 3.9 2.1 0.5 1.8 3.5 1.4 4.4 1.0 4.7 0.6 1.6 2.5 1.7 0.7 5.1 2.8 1.9 0.4 3.8 0.9 2.4 0.9 3.9 1.3 4.4 2.0 3.4 3.4 2.5 3.0 1.0 0.4 3.6 1.2 15.9 3.7 1.1 1.7 1.4 1.6 6.6 4.2 3.2 4.6 4.6 3.4 4.0 4.0 5.0 2.6 4.2 5.5 5.2 3.6 3.9 6.3 5.9 6.0 3.9 3.1 5.3 4.0 4.4 2.7 2.6 6.1 4.4 5.3 3.2 4.7 9.3 3.6 0.0 1.1 2.3 5.2 1.8 5.1 3.9 1.8 1.5 5.0 8.0 1.0 2.8 2.8 11.0 0.0 16.3 11.2 3.7 13.7 6.1 28.1 19.9 3.8 3.0 4.9 5.2 0.9 8.7 5.9 4.3 6.6 5.6 2.5 5.9 5.0 3.4 8.6 0.0 1.1 6.7 6.1 9.1 3.7 31.8 1.2 5.0 3.6 1.9 5.5 4.5 12.3 0.5 2.9 5.1 2.9 2.6 2.6 3.7 4.9 5.4 2.0 3.6 0.0 2.1 3.2 1.3 1.4 3.8 3.0 8.8 6.1 6.0 4.2 4.3 VPS11 "PEP5, RNF108" ENSG00000160695 "VPS11 core subunit of CORVET and HOPS complexes" Q9H270 11 119067818-119081972 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant, Leukodystrophy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039020 Approved Approved Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 4: Macrophages - Innate immune response" Cytosol "HPA039020: AB_10674847" "unprognostic (6.97e-2)" "unprognostic (3.76e-1)" "unprognostic (1.77e-1)" "unprognostic (1.15e-2)" "unprognostic (1.43e-2)" "unprognostic (1.28e-1)" "unprognostic (2.59e-3)" "unprognostic (1.11e-1)" "unprognostic (3.21e-1)" "unprognostic (9.17e-2)" "unprognostic (6.01e-2)" "unprognostic (1.56e-1)" "prognostic favorable (1.44e-4)" "unprognostic (4.07e-2)" "unprognostic (4.05e-2)" "unprognostic (2.71e-2)" "unprognostic (2.25e-1)" 21.6 25.1 16.7 14.7 16.8 17.6 19.4 16.7 18.6 20.8 15.3 19.6 13.4 23.5 19.0 14.6 20.1 12.8 16.6 17.6 17.8 16.9 11.5 16.8 18.1 17.0 17.6 22.5 18.0 22.4 22.8 17.3 17.3 18.4 13.4 17.6 18.2 16.5 21.7 21.4 17.9 19.5 16.0 21.7 18.5 13.3 17.5 20.1 21.1 21.1 17.2 21.0 17.4 18.4 11.6 11.8 12.8 9.8 27.5 24.2 14.0 15.4 18.4 15.3 16.5 19.9 24.2 16.6 21.5 30.2 27.1 21.0 16.1 20.7 15.1 17.1 8.0 36.6 12.0 19.5 30.8 22.9 21.5 29.6 21.3 23.2 15.9 27.2 24.4 13.9 29.5 28.8 20.2 30.5 19.3 21.6 6.4 21.2 22.5 21.7 21.1 12.6 18.2 24.1 10.2 17.5 19.2 25.3 16.8 13.7 38.3 20.1 24.5 19.1 7.1 6.9 11.5 11.3 11.0 15.6 14.0 27.2 17.0 24.8 16.8 12.8 16.4 13.9 16.8 11.3 13.7 15.2 20.7 11.9 12.9 16.6 3.8 16.5 19.0 8.7 16.5 13.9 16.7 16.8 16.7 18.6 17.6 17.8 17.0 17.6 17.3 16.0 17.5 18.4 9.9 6.4 10.5 8.1 10.2 2.9 4.4 7.0 8.6 10.2 8.1 9.8 7.6 8.6 12.1 9.2 12.5 11.2 16.2 9.7 9.8 8.2 7.8 9.9 10.0 10.7 9.6 6.3 9.6 10.1 7.0 9.7 11.2 9.9 15.2 10.2 13.2 6.0 17.0 5.0 9.9 10.1 6.1 14.8 8.9 3.0 17.1 12.6 7.2 7.5 11.6 9.2 5.2 6.6 14.4 7.2 6.8 15.4 11.5 3.6 9.2 11.0 10.5 15.5 13.1 6.2 10.2 11.3 7.3 6.5 4.8 14.1 12.2 9.4 9.5 3.8 VPS16 ENSG00000215305 "VPS16 core subunit of CORVET and HOPS complexes" Q9H269 20 2840703-2866732 "Disease related genes, Predicted intracellular proteins" "Autophagy, Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043229, HPA048661" Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 50: Non-specific - Ribosome" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 63: NK-cells & T-cells - Immune response" "HPA043229: AB_2678373, HPA048661: AB_2680484" "unprognostic (5.04e-2)" "unprognostic (2.26e-2)" "unprognostic (7.13e-3)" "unprognostic (2.22e-1)" "unprognostic (3.72e-2)" "unprognostic (2.56e-3)" "prognostic unfavorable (1.43e-4)" "unprognostic (9.30e-2)" "unprognostic (5.48e-3)" "unprognostic (8.65e-2)" "prognostic favorable (5.89e-5)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.02e-5)" "unprognostic (1.33e-1)" "unprognostic (1.54e-1)" "unprognostic (1.51e-1)" "unprognostic (2.22e-3)" 18.2 16.0 9.9 18.2 10.1 23.1 17.6 9.7 11.2 21.3 10.6 17.6 16.9 22.1 10.7 16.4 18.3 13.8 12.8 10.4 10.3 14.8 15.9 17.9 17.9 12.0 9.7 19.1 21.9 19.5 16.0 14.0 11.0 17.9 10.9 8.9 19.1 12.7 18.5 21.5 20.8 20.4 9.1 23.5 18.1 11.3 10.6 21.1 22.5 14.7 17.3 17.0 17.8 10.1 27.1 36.7 28.8 27.8 27.5 30.1 16.0 24.0 31.3 27.5 24.8 22.1 25.5 18.3 16.6 27.6 43.9 34.6 25.0 45.5 14.8 30.0 20.7 21.4 15.4 24.4 27.8 21.6 21.3 38.7 21.0 32.6 21.1 18.1 27.5 35.2 30.6 30.2 23.9 28.2 20.4 40.1 27.3 42.7 30.4 26.4 20.8 28.2 26.0 24.8 23.9 39.6 25.7 57.1 26.7 18.7 29.3 26.2 24.0 27.0 24.7 17.6 16.3 40.9 44.4 17.0 12.7 38.6 26.1 24.0 25.8 28.4 35.2 24.6 19.5 12.3 15.4 22.6 32.1 9.1 15.8 20.4 14.5 34.3 29.5 10.6 25.7 25.5 9.9 10.1 9.7 11.2 10.4 10.3 12.0 9.7 11.0 9.1 10.6 10.1 12.7 12.8 15.9 1.3 10.4 6.0 14.5 13.7 8.6 14.4 9.7 7.6 7.5 18.6 11.0 12.9 8.4 14.2 18.7 24.8 9.8 16.1 2.6 8.2 11.9 11.5 5.4 8.6 4.2 13.2 17.8 12.9 16.3 6.9 7.0 11.8 10.0 15.5 23.3 23.5 4.1 13.0 12.2 18.4 8.8 3.3 13.1 15.2 14.2 1.9 22.3 20.8 33.0 3.0 3.5 13.0 11.6 9.4 12.8 5.6 33.2 19.4 11.2 15.0 13.1 8.4 17.9 20.9 16.1 8.0 3.8 14.1 17.4 17.6 13.9 9.2 VPS33B FLJ14848 ENSG00000184056 "VPS33B late endosome and lysosome associated" Q9H267 15 90998673-91022603 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA040415 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 27: Brain & Skin - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" "HPA040415: AB_10795419" "unprognostic (7.49e-2)" "unprognostic (1.40e-1)" "unprognostic (1.15e-1)" "unprognostic (2.55e-2)" "unprognostic (3.06e-1)" "unprognostic (1.79e-2)" "unprognostic (2.97e-2)" "unprognostic (2.42e-2)" "unprognostic (1.30e-1)" "unprognostic (2.84e-3)" "unprognostic (2.78e-2)" "unprognostic (7.94e-2)" "unprognostic (3.70e-1)" "unprognostic (6.75e-2)" "unprognostic (6.04e-2)" "unprognostic (8.24e-2)" "unprognostic (1.00e-2)" 5.7 5.4 5.9 5.1 7.2 2.8 6.1 6.3 7.6 6.6 6.7 6.7 5.8 6.3 7.0 6.8 8.1 4.7 3.8 6.6 7.1 5.9 4.3 5.6 6.9 6.3 6.3 6.8 6.9 8.1 5.3 6.8 6.4 6.6 6.4 5.8 6.7 6.7 4.1 11.0 6.9 6.2 6.3 6.9 7.9 6.1 7.2 5.4 5.5 4.3 6.5 6.1 6.4 7.7 5.6 16.4 3.4 6.0 8.9 15.1 17.7 6.8 12.7 10.7 10.9 7.0 11.0 7.1 9.4 11.9 9.6 10.0 4.7 10.3 5.6 3.8 4.9 7.7 6.6 10.3 10.9 9.6 10.3 17.0 10.7 8.0 9.5 9.3 15.2 8.6 12.6 1.7 7.9 11.9 6.5 6.8 8.3 14.8 5.8 4.9 8.9 8.7 12.2 12.3 5.2 9.6 10.0 7.9 17.5 8.1 8.1 12.6 10.4 7.0 7.8 5.0 5.2 3.6 12.9 2.7 14.7 9.3 6.4 12.5 7.1 12.1 7.7 11.8 8.9 5.6 6.8 6.9 9.5 7.8 7.8 11.0 3.2 7.9 13.4 4.7 5.9 6.4 5.9 7.2 6.3 7.6 6.6 7.1 6.3 6.3 6.4 6.3 7.2 7.7 2.2 0.0 7.3 5.5 5.3 2.2 3.0 3.5 1.8 9.2 2.6 1.8 4.8 2.8 4.4 3.7 2.1 16.8 5.0 6.9 5.9 9.0 3.1 3.0 2.7 4.7 2.4 5.7 11.4 9.4 10.8 2.9 7.7 2.9 8.2 6.7 5.7 4.9 8.0 8.4 11.3 5.1 4.1 6.0 4.1 4.0 3.7 4.5 8.8 3.7 7.7 6.3 3.1 7.5 9.7 9.3 5.0 5.3 4.9 4.1 7.9 4.3 7.9 7.0 6.6 2.7 3.5 11.0 8.2 2.3 2.6 12.3 5.0 3.6 4.3 3.0 VPS35L "C16orf62, MGC16824" ENSG00000103544 "VPS35 endosomal protein sorting factor like" Q7Z3J2 16 19555240-19706793 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 32.4;Cytotrophoblasts: 29.4;Distal tubular cells: 29.4;Hofbauer cells: 44.9;Syncytiotrophoblasts: 40.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042969, HPA053547" Uncertain Approved Mitochondria NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 48: Parathyroid gland - membrane proteins" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 7: Non-specific - Mitochondria" Mitochondria "HPA042969: AB_10794920, HPA053547: AB_2682183" "unprognostic (7.15e-2)" "unprognostic (6.54e-2)" "unprognostic (1.17e-1)" "unprognostic (7.20e-2)" "unprognostic (1.51e-1)" "unprognostic (2.67e-1)" "unprognostic (1.15e-1)" "unprognostic (2.74e-1)" "unprognostic (2.52e-1)" "unprognostic (1.22e-3)" "unprognostic (3.57e-2)" "unprognostic (2.06e-1)" "prognostic favorable (1.31e-8)" "unprognostic (1.82e-3)" "unprognostic (8.92e-2)" "unprognostic (5.08e-2)" "unprognostic (1.13e-2)" 19.3 22.7 23.3 15.9 33.5 13.2 17.1 21.8 24.9 21.2 11.7 19.2 13.7 20.1 22.4 16.8 19.2 17.5 17.8 20.7 23.5 22.2 14.4 16.2 14.6 23.3 24.4 23.3 16.5 35.6 20.4 20.2 24.6 15.9 19.4 16.1 12.4 18.9 22.2 13.8 15.3 25.1 20.5 17.2 13.3 31.5 28.0 16.1 22.7 25.2 16.6 18.3 15.6 40.3 22.3 37.5 35.7 28.4 44.2 60.1 5.8 32.5 52.3 33.9 38.9 6.4 37.0 27.1 67.4 51.7 0.2 6.2 27.5 16.7 36.5 1.6 15.7 16.4 32.6 0.6 57.4 25.9 31.6 43.9 24.4 31.7 21.5 48.2 54.4 13.2 22.3 6.2 55.7 15.7 23.0 7.2 24.8 3.9 5.1 19.6 11.7 7.1 38.6 5.2 21.8 22.1 43.7 1.5 18.6 27.2 12.9 22.2 61.0 17.4 16.2 25.7 3.7 23.8 45.2 10.6 33.6 21.1 27.5 26.5 35.3 16.5 18.9 42.0 23.5 14.7 18.0 18.8 42.6 23.5 21.0 18.6 4.2 37.6 37.7 11.5 21.6 28.5 23.3 33.5 21.8 24.9 20.7 23.5 23.3 24.4 24.6 20.5 28.0 40.3 32.4 6.4 16.4 0.0 3.0 0.0 0.0 0.0 0.0 0.0 9.5 9.1 0.0 0.0 8.1 16.5 0.0 29.4 5.0 0.0 29.4 20.4 0.0 8.2 15.8 15.5 0.0 0.0 0.0 17.0 19.5 8.1 0.0 11.1 3.8 18.1 0.0 0.0 44.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 1.2 0.0 0.0 21.9 2.9 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 40.2 3.4 21.0 0.0 0.0 VPS36 "C13orf9, CGI-145, Eap45" ENSG00000136100 "Vacuolar protein sorting 36 homolog" Q86VN1 13 52412602-52450634 "Predicted intracellular proteins" "Protein transport, Transcription, Transcription regulation, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Rod photoreceptor cells: 265.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039734, HPA043947" Approved Supported "Vesicles,Lysosomes,Plasma membrane,Cell Junctions" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 31: Skin - Epidermis development" "Cluster 43: THP-1 - Innate immune response" "Cluster 46: Photoreceptor cells - Phototransduction" "Vesicles, Lysosomes" "Plasma membrane, Cell Junctions" "HPA039734: AB_2676652, HPA043947: AB_2678744" "unprognostic (2.43e-1)" "unprognostic (1.44e-1)" "unprognostic (2.80e-1)" "unprognostic (2.94e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-1)" "unprognostic (6.57e-2)" "unprognostic (7.84e-2)" "unprognostic (3.96e-3)" "unprognostic (1.19e-2)" "unprognostic (9.37e-2)" "unprognostic (5.57e-2)" "prognostic favorable (9.91e-6)" "unprognostic (6.47e-3)" "unprognostic (1.83e-1)" "unprognostic (1.94e-1)" "unprognostic (9.83e-2)" 17.1 15.1 10.1 16.8 11.5 8.6 26.1 14.0 16.3 20.0 9.6 24.5 27.6 18.7 12.2 23.7 16.8 16.6 24.0 11.8 10.1 25.4 23.6 19.9 19.5 12.4 11.0 17.9 17.9 23.3 11.0 25.0 12.8 21.8 27.5 43.1 25.2 18.3 23.4 51.1 27.7 20.7 9.9 24.1 18.1 4.0 12.1 22.3 22.5 26.2 20.7 18.9 21.3 12.1 7.3 11.8 20.4 13.5 21.1 29.3 17.8 16.7 12.5 16.1 9.6 14.3 22.9 25.5 8.6 23.8 10.6 20.1 16.6 19.7 18.0 19.3 16.0 30.2 18.7 12.8 25.3 40.2 31.4 20.5 37.9 11.2 18.0 18.0 16.6 33.6 22.7 21.8 31.8 9.6 30.4 40.6 19.5 29.0 6.3 31.0 11.9 15.9 28.7 18.9 10.4 22.0 11.9 27.3 25.9 24.0 15.9 67.1 26.3 10.3 12.6 10.3 19.1 16.3 22.0 26.8 10.6 28.4 24.7 15.6 14.6 12.3 12.3 16.3 19.8 15.3 13.5 15.4 15.6 13.0 12.2 13.1 3.6 21.6 22.7 16.3 16.0 13.7 10.1 11.5 14.0 16.3 11.8 10.1 12.4 11.0 12.8 9.9 12.1 12.1 54.2 83.3 51.5 41.1 49.9 42.8 48.9 57.6 62.0 132.2 51.6 72.8 80.8 38.6 47.7 33.1 120.9 60.2 83.4 62.6 68.4 35.4 1.2 28.0 45.9 55.7 49.8 31.1 57.0 29.3 43.0 46.6 36.7 37.0 44.3 44.9 38.2 54.0 43.8 52.2 54.6 64.1 40.7 44.0 29.1 3.7 49.7 47.1 28.4 36.5 60.8 39.8 59.8 44.7 40.7 29.8 63.0 52.3 55.0 65.4 77.4 78.5 33.2 265.8 46.0 52.7 76.1 15.3 25.9 83.5 58.2 38.2 48.2 40.6 58.6 45.4 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50 subunit of EARP/GARPII complex" Q96JG6 7 93232340-93361123 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favorable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 7.4 9.0 4.2 3.4 4.6 2.6 8.2 5.7 5.3 7.3 4.6 8.9 1.9 8.2 4.2 9.2 6.8 2.7 7.7 4.4 4.0 7.1 6.1 6.1 4.9 4.1 4.0 7.6 7.8 6.0 7.7 4.8 4.2 6.4 5.2 5.1 8.8 3.2 12.0 8.8 8.2 3.5 4.2 9.5 7.8 6.5 3.8 4.3 7.3 4.9 4.8 7.9 7.8 5.0 6.5 2.2 2.6 5.0 8.2 7.9 6.3 5.5 5.0 9.1 6.1 5.5 9.0 5.5 5.1 4.2 13.6 3.6 10.4 7.0 11.3 5.8 4.6 14.6 3.1 2.4 4.9 3.4 4.5 3.8 8.7 9.9 9.5 5.9 11.5 3.9 10.2 8.2 11.3 4.7 5.3 4.6 6.2 8.7 5.9 3.5 6.3 8.1 5.1 2.9 3.7 7.8 4.8 13.5 4.4 7.5 6.3 2.8 5.8 12.4 4.4 16.3 4.5 3.3 8.0 9.1 6.9 6.1 6.8 3.1 3.2 2.1 2.6 3.5 4.6 2.4 2.7 2.7 4.5 2.4 2.0 2.5 1.1 1.4 2.5 2.8 2.9 2.0 4.2 4.6 5.7 5.3 4.4 4.0 4.1 4.0 4.2 4.2 3.8 5.0 10.9 12.8 11.3 0.0 13.5 0.0 3.4 0.0 6.8 14.1 11.7 6.3 0.0 2.8 5.0 5.5 16.7 7.5 11.0 5.5 3.9 6.2 27.9 7.6 10.8 7.9 2.4 10.8 0.0 5.5 11.7 6.4 11.2 8.2 7.6 12.6 9.7 6.1 10.7 10.1 0.0 7.1 0.0 13.7 0.0 14.2 9.0 10.0 0.0 0.0 9.4 10.3 6.2 0.0 0.0 6.9 9.4 7.2 10.2 2.7 6.1 8.3 5.8 14.3 6.6 11.2 6.3 18.1 12.8 7.9 0.0 9.4 8.5 13.9 5.1 2.8 WASH6P "CXYorf1, FAM39A" ENSG00000182484 "WASP family homolog 6, pseudogene" X 156020826-156025710 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "granulocytes: 225.3" "Cancer enhanced" "Detected in all" "urothelial cancer: 10.6" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" HPA002689 Uncertain Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 60: Granulocytes - Receptor signaling" Vesicles "HPA002689: AB_1078803" "unprognostic (2.01e-1)" "unprognostic (3.42e-2)" "unprognostic (1.06e-1)" "prognostic unfavorable (7.56e-4)" "unprognostic (4.69e-2)" "unprognostic (4.20e-2)" "unprognostic (1.53e-2)" "unprognostic (2.23e-2)" "unprognostic (1.19e-1)" "unprognostic (8.93e-2)" "unprognostic (1.33e-3)" "unprognostic (3.94e-2)" "unprognostic (8.18e-2)" "unprognostic (2.11e-1)" "unprognostic (2.15e-1)" "unprognostic (1.45e-1)" "unprognostic (5.86e-3)" 1.0 1.3 1.0 1.7 1.0 3.5 1.0 1.2 1.6 0.5 1.3 1.0 2.6 1.6 2.7 0.4 1.1 0.8 1.2 1.2 1.0 2.3 0.7 1.2 1.8 1.8 1.2 1.7 4.1 0.7 1.2 1.5 1.1 0.7 3.6 0.9 1.2 6.5 3.1 2.2 0.6 0.8 2.9 1.7 2.3 1.6 1.1 1.2 0.6 0.9 0.7 2.5 9.6 1.5 1.6 5.0 0.7 0.0 5.9 2.5 0.4 0.8 1.5 0.4 5.2 3.1 1.7 1.4 4.0 7.3 1.2 2.0 0.7 0.7 1.7 4.7 0.6 1.3 0.0 1.8 3.7 0.2 0.9 1.4 2.0 0.5 1.2 0.9 6.2 4.6 0.0 1.2 7.9 4.1 2.3 4.2 0.9 7.0 3.0 2.0 0.3 0.4 4.2 6.3 3.1 4.7 5.7 1.3 6.6 5.8 3.1 3.5 3.4 3.3 3.9 8.0 9.8 1.8 0.8 3.1 3.9 0.4 0.2 0.0 0.3 0.2 0.3 0.4 0.0 0.3 0.2 0.3 0.1 0.2 0.1 0.8 1.1 0.2 0.4 0.3 1.0 1.0 1.2 1.6 1.2 1.0 1.8 1.2 1.5 0.8 1.6 2.5 0.0 35.3 23.1 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.2 5.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 225.3 0.0 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 5.3 0.0 WASHC5 "KIAA0196, SPG8" ENSG00000164961 "WASH complex subunit 5" Q12768 8 125024260-125091819 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 19.8;Exocrine glandular cells: 17.2;Hofbauer cells: 21.8;Proximal tubular cells: 17.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034216, CAB034219, HPA064649, HPA070916" Supported Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322" "unprognostic (1.98e-3)" "unprognostic (3.75e-2)" "unprognostic (8.40e-2)" "unprognostic (3.89e-3)" "unprognostic (2.98e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (6.74e-5)" "unprognostic (2.54e-2)" "unprognostic (3.54e-1)" "unprognostic (5.69e-2)" "unprognostic (9.10e-3)" "unprognostic (1.53e-1)" "unprognostic (9.39e-3)" "unprognostic (5.95e-2)" "unprognostic (2.17e-1)" "unprognostic (1.62e-1)" "unprognostic (2.33e-2)" 18.1 18.6 10.5 18.5 16.9 21.3 19.6 14.9 13.2 17.2 16.5 18.5 18.1 16.2 15.7 16.6 13.3 17.8 16.1 11.1 12.5 22.9 18.5 17.1 19.6 14.7 13.7 15.6 13.0 24.8 9.5 21.2 14.6 17.4 20.1 11.4 14.3 16.1 15.9 13.6 14.7 20.2 14.0 19.3 16.1 9.5 13.8 21.8 23.3 18.5 21.0 21.1 10.3 24.7 40.0 45.4 24.9 30.6 55.3 58.8 16.3 42.0 63.6 43.0 45.8 17.0 42.1 36.1 29.1 54.1 25.3 30.6 40.2 37.7 56.8 47.5 23.1 48.1 26.5 22.8 53.8 14.8 46.6 58.7 25.1 35.5 31.2 33.2 49.9 30.9 28.3 35.6 53.0 87.6 44.3 11.8 23.7 66.7 46.7 29.8 22.4 36.7 33.2 48.5 13.1 26.3 48.8 109.2 39.5 25.8 47.3 25.5 44.7 23.6 51.9 39.4 37.7 31.7 31.2 31.7 62.4 27.5 33.4 10.4 17.0 12.5 13.5 20.9 14.3 9.5 12.8 13.9 19.7 10.6 10.1 14.3 5.8 17.2 29.3 7.2 16.9 13.0 10.5 16.9 14.9 13.2 11.1 12.5 14.7 13.7 14.6 14.0 13.8 24.7 10.9 3.2 19.8 0.0 1.8 0.0 0.0 0.0 0.0 0.0 14.4 9.3 0.0 0.0 5.0 11.0 0.0 13.4 6.9 0.0 5.9 12.2 0.0 9.9 13.5 4.9 0.0 0.0 0.0 17.2 11.0 5.4 0.0 14.8 8.8 11.1 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 5.7 0.0 0.0 0.0 0.0 16.2 0.0 0.0 1.9 0.0 0.0 17.2 4.4 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 12.3 3.8 9.6 0.0 0.0 WASL "N-WASP, NWASP, WASPB" ENSG00000106299 "WASP like actin nucleation promoting factor" O00401 7 123681943-123749003 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Urothelial cells: 282.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RT4: 138.3;U-2197: 128.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005399, HPA005750" Supported Approved Nucleoli,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 15: RT4 - Unknown function" "Cluster 53: Intestinal epithelial cells - Unknown function" Cytosol Nucleoli "CAB005399: AB_2288632, HPA005750: AB_1854729" "unprognostic (1.91e-1)" "unprognostic (3.60e-2)" "unprognostic (8.19e-2)" "unprognostic (1.83e-1)" "unprognostic (3.20e-1)" "unprognostic (4.61e-2)" "unprognostic (4.08e-2)" "unprognostic (1.95e-1)" "unprognostic (1.30e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.30e-5)" "unprognostic (7.32e-2)" "prognostic favorable (4.51e-8)" "unprognostic (9.49e-2)" "unprognostic (2.30e-1)" "unprognostic (3.81e-1)" "unprognostic (5.14e-1)" 20.4 24.7 19.2 12.8 22.2 5.6 21.7 13.5 42.4 29.1 13.6 42.4 37.2 27.1 18.3 29.5 18.7 28.4 18.2 43.0 20.4 44.1 46.8 19.9 7.8 18.0 19.1 35.1 29.5 40.0 13.0 34.6 17.4 25.3 37.9 24.9 22.3 24.0 24.7 18.0 41.5 23.6 13.5 17.0 30.1 22.5 20.9 10.3 35.2 28.7 11.0 38.7 22.5 18.4 34.4 24.8 26.7 23.0 41.2 42.4 34.7 23.3 38.7 16.9 21.7 20.5 42.2 3.5 18.1 35.3 36.0 25.1 50.1 25.7 25.9 6.0 19.9 3.0 19.6 22.2 44.7 4.6 2.9 34.2 47.0 25.0 42.2 37.9 29.5 3.6 15.5 6.6 40.6 20.7 6.0 6.1 50.1 36.5 22.4 3.6 21.6 7.7 35.6 138.3 32.9 48.1 32.1 95.0 63.0 41.4 18.6 4.5 33.8 44.9 12.6 128.1 23.2 7.2 2.7 7.5 38.8 3.8 36.7 2.4 1.7 0.8 1.7 1.7 1.4 2.0 1.1 1.0 1.5 1.3 1.4 1.5 0.7 2.5 3.0 1.9 0.6 0.6 19.2 22.2 13.5 42.4 43.0 20.4 18.0 19.1 17.4 13.5 20.9 18.4 71.2 86.6 61.1 36.9 11.5 60.4 48.9 44.4 46.1 32.9 67.6 57.1 69.8 52.9 53.7 53.3 20.9 41.6 12.6 200.2 52.8 52.6 26.2 58.0 53.1 43.9 67.9 5.9 55.9 54.1 52.4 62.6 50.0 68.8 3.8 35.0 56.4 61.9 12.7 26.9 51.2 105.1 40.7 13.8 25.1 9.3 48.1 15.6 30.2 34.7 14.0 60.9 6.2 42.7 48.7 70.6 113.4 64.7 14.0 104.4 108.0 96.0 49.5 32.4 19.7 54.1 75.3 17.2 21.3 54.9 68.3 81.3 13.1 76.0 74.8 282.3 WBP11 "BUG13, CFAP90, FAP90, NPWBP, PPP1R165, SIPP1" ENSG00000084463 "WW domain binding protein 11" Q9Y2W2 12 14784582-14803486 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039710, HPA040037, HPA046403, HPA049126" Approved Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 5: NTERA-2 - Transcription" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644" "unprognostic (4.40e-2)" "unprognostic (1.58e-1)" "unprognostic (4.16e-2)" "unprognostic (1.39e-2)" "unprognostic (1.55e-1)" "unprognostic (4.15e-2)" "prognostic unfavorable (9.40e-4)" "unprognostic (5.67e-3)" "unprognostic (3.30e-2)" "unprognostic (2.68e-1)" "unprognostic (9.69e-2)" "unprognostic (1.68e-1)" "unprognostic (2.96e-3)" "unprognostic (6.11e-2)" "unprognostic (3.07e-1)" "unprognostic (1.94e-1)" "unprognostic (4.09e-2)" 22.3 23.4 14.2 22.4 15.3 65.7 20.8 14.3 17.1 17.8 14.3 19.4 16.1 22.4 17.4 19.8 24.1 18.2 31.2 14.6 19.0 20.0 23.1 20.4 27.4 14.5 17.6 24.8 21.0 25.0 13.3 25.1 14.4 21.8 22.2 21.3 21.3 18.0 38.8 23.3 18.8 22.2 13.5 22.9 18.8 39.0 16.8 26.0 24.3 32.9 29.6 21.5 16.8 14.9 52.1 45.3 53.0 102.4 34.7 32.9 95.6 41.8 35.0 62.3 62.3 83.9 63.2 64.1 26.7 38.0 53.0 42.4 82.3 55.3 76.5 114.6 54.5 94.3 48.1 52.0 34.8 89.6 50.1 32.2 43.7 69.8 52.0 33.6 50.2 59.5 61.3 33.7 50.1 50.1 84.0 48.7 171.9 35.4 29.0 70.7 84.3 40.6 45.3 70.8 28.3 57.6 55.8 46.3 44.9 123.8 24.6 58.2 37.8 43.7 66.1 38.9 72.8 29.2 43.8 116.6 45.7 43.6 59.3 12.3 14.0 12.7 18.8 19.4 20.8 18.3 18.1 19.1 13.2 16.9 20.9 19.6 8.7 19.2 20.6 9.6 21.3 13.7 14.2 15.3 14.3 17.1 14.6 19.0 14.5 17.6 14.4 13.5 16.8 14.9 56.8 57.7 61.0 10.1 79.3 54.9 86.9 49.7 41.5 43.7 53.5 40.6 108.6 54.3 60.7 36.8 47.9 57.8 87.2 36.6 43.0 62.5 98.5 70.1 66.8 52.5 39.5 72.6 17.5 59.5 93.3 62.2 32.6 56.7 106.3 41.0 45.0 48.6 46.6 43.7 16.2 37.8 32.6 44.3 42.1 58.4 45.4 56.7 35.6 9.4 104.6 49.6 74.2 13.0 23.0 52.8 22.3 32.7 64.0 64.1 34.0 53.8 78.7 54.1 59.2 79.3 81.3 207.5 140.4 43.5 55.7 75.9 84.8 42.9 42.6 68.1 WDFY1 "FENS-1, KIAA1435, WDF1, ZFYVE17" ENSG00000085449 "WD repeat and FYVE domain containing 1" Q8IWB7 2 223855716-223945357 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050603, HPA079597" Approved Supported "Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 40: Neutrophils - Inflammatory response" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 44: Endometrium - Transcription" "Golgi apparatus, Vesicles" "HPA050603: AB_2681188, HPA079597: " "unprognostic (2.49e-1)" "unprognostic (1.24e-1)" "unprognostic (2.94e-1)" "unprognostic (7.62e-2)" "unprognostic (8.24e-2)" "unprognostic (5.31e-2)" "unprognostic (2.63e-2)" "unprognostic (7.10e-2)" "unprognostic (1.26e-1)" "unprognostic (2.29e-2)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (3.81e-3)" "unprognostic (3.94e-1)" "unprognostic (2.98e-1)" "unprognostic (3.04e-1)" "unprognostic (7.55e-2)" 18.6 13.2 9.3 18.0 9.5 48.5 14.4 9.3 12.0 20.5 11.2 20.4 15.6 22.6 19.8 14.4 20.5 17.5 11.7 9.2 10.7 14.8 18.0 18.4 23.3 11.0 10.2 20.2 14.1 19.8 8.7 27.4 11.4 16.2 20.1 15.9 13.5 12.8 11.4 13.5 15.9 19.6 9.7 21.2 19.8 10.9 10.5 15.9 22.1 12.6 18.9 17.9 13.7 11.1 27.9 19.3 34.9 27.2 46.4 44.0 43.7 34.7 48.3 37.5 30.4 81.4 25.0 7.7 30.8 60.6 47.3 19.2 18.7 52.3 40.4 15.6 15.8 19.2 31.9 59.2 36.4 15.2 15.8 39.0 37.9 46.3 71.0 62.4 63.9 16.2 34.3 23.4 44.4 26.8 6.5 11.1 34.5 20.7 16.6 25.3 44.8 8.6 28.4 47.7 29.6 15.7 20.7 19.2 90.9 41.6 12.5 38.1 70.9 74.9 25.7 13.5 18.0 28.8 4.6 21.4 36.3 32.9 26.2 4.4 21.5 8.1 13.7 29.0 16.6 14.1 9.7 13.5 14.8 11.7 10.0 9.5 10.3 24.0 25.7 3.0 9.7 17.6 9.3 9.5 9.3 12.0 9.2 10.7 11.0 10.2 11.4 9.7 10.5 11.1 40.0 16.0 9.3 22.5 22.0 12.5 14.5 19.9 17.1 14.0 11.8 7.6 7.7 12.8 24.4 16.5 8.4 22.6 25.5 36.4 9.8 12.9 0.8 23.2 30.7 34.1 10.3 11.2 28.7 17.2 11.2 21.4 29.6 36.5 17.7 12.5 16.8 25.7 17.9 28.6 28.1 15.2 8.2 26.3 17.2 2.4 14.6 24.4 35.6 27.2 25.6 13.9 24.7 33.7 39.8 18.0 24.4 23.7 21.8 16.6 16.0 14.4 29.9 10.9 6.6 13.1 26.7 3.8 8.8 24.4 15.5 19.0 21.1 15.0 21.8 28.7 WDR24 "C16orf21, DKFZp434F054, JFP7" ENSG00000127580 "WD repeat domain 24" Q96S15 16 684622-690444 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Late spermatids: 48.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039506 Approved Supported Vesicles,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 31: Spermatids - Spermatogenesis" Vesicles Cytosol "HPA039506: AB_10795148" "unprognostic (9.07e-2)" "unprognostic (2.67e-3)" "unprognostic (6.67e-2)" "unprognostic (1.48e-1)" "unprognostic (1.67e-1)" "unprognostic (8.15e-2)" "unprognostic (7.05e-2)" "unprognostic (4.35e-2)" "unprognostic (1.75e-1)" "unprognostic (5.09e-3)" "unprognostic (2.29e-3)" "unprognostic (2.05e-1)" "prognostic favorable (3.75e-6)" "unprognostic (5.38e-2)" "unprognostic (3.16e-1)" "unprognostic (1.52e-1)" "unprognostic (2.82e-2)" 6.1 9.1 3.9 4.0 3.6 3.9 6.2 5.0 6.9 7.5 4.1 7.1 4.8 7.9 1.0 7.1 7.5 2.8 7.9 3.8 3.0 7.5 11.2 6.0 4.8 4.2 4.0 9.2 7.2 5.8 9.4 3.2 3.5 8.5 1.1 1.8 6.9 3.0 11.7 8.5 7.1 2.0 3.2 9.2 7.8 14.2 3.9 4.3 8.7 4.1 2.4 7.5 6.6 3.7 6.1 14.0 6.2 8.6 5.9 4.2 10.9 7.5 6.7 9.2 8.0 15.3 8.8 9.4 12.8 3.4 2.3 9.4 6.1 7.4 2.0 15.9 19.0 6.4 19.8 5.8 9.4 7.9 9.6 7.4 4.9 6.6 5.5 4.8 5.0 9.0 12.7 10.3 3.4 22.2 14.0 5.8 9.7 3.1 10.6 20.4 5.1 17.6 3.0 4.2 15.1 6.9 8.5 14.3 8.7 2.8 13.2 7.8 7.3 6.6 6.8 7.4 7.3 21.9 21.5 15.3 4.3 7.8 9.4 4.3 5.1 2.8 6.6 3.0 5.4 4.3 4.2 4.9 5.1 3.7 4.9 4.8 1.2 3.0 7.8 4.1 6.1 5.0 3.9 3.6 5.0 6.9 3.8 3.0 4.2 4.0 3.5 3.2 3.9 3.7 2.9 6.4 6.2 2.3 4.2 1.1 2.6 4.7 4.0 5.1 5.2 4.4 5.0 1.5 5.0 7.3 2.1 7.4 2.9 6.0 7.9 4.9 17.1 12.2 2.9 3.1 10.1 5.2 2.0 5.6 4.4 3.1 6.6 2.9 4.5 6.9 2.5 9.6 5.1 21.9 2.0 7.3 4.1 6.3 1.6 48.0 5.6 3.9 0.0 1.9 4.4 7.3 1.0 2.0 2.4 4.5 2.1 3.0 6.8 3.8 8.0 6.4 19.4 2.6 19.7 2.6 4.2 18.8 8.7 2.1 1.6 7.4 3.4 7.6 5.5 2.0 WDR3 "DIP2, FLJ12796, UTP12" ENSG00000065183 "WD repeat domain 3" Q9UNX4 1 117929720-117966543 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027509, HPA054354, HPA072915" Enhanced Nucleoplasm,Nucleoli No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoli Nucleoplasm "HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: " "unprognostic (6.77e-2)" "unprognostic (4.53e-3)" "unprognostic (1.50e-1)" "unprognostic (2.46e-3)" "unprognostic (1.91e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (7.33e-5)" "unprognostic (1.29e-1)" "unprognostic (9.52e-2)" "unprognostic (6.04e-2)" "prognostic unfavorable (8.82e-4)" "unprognostic (8.90e-3)" "unprognostic (7.47e-2)" "unprognostic (5.29e-2)" "unprognostic (1.26e-1)" "unprognostic (1.93e-1)" "unprognostic (8.65e-2)" 9.1 6.3 2.2 8.4 2.8 2.9 9.3 2.8 2.6 7.3 7.4 5.9 5.4 6.7 4.2 6.6 7.4 3.1 4.4 2.6 3.1 5.9 11.2 4.5 7.1 2.2 2.7 7.6 5.1 9.2 3.0 6.2 2.2 5.8 7.7 4.3 4.4 4.9 10.3 5.0 4.9 8.0 2.3 6.2 6.6 11.7 2.7 8.5 6.0 7.4 11.8 9.4 4.3 2.7 35.6 22.2 21.7 33.5 23.0 18.8 24.9 24.1 15.9 27.8 24.3 23.8 11.6 42.4 32.4 18.2 17.7 23.1 55.0 28.4 44.4 34.3 28.1 39.7 22.7 19.0 19.1 74.8 20.0 18.5 19.8 35.4 53.3 16.3 27.2 29.1 49.7 20.2 24.2 20.4 35.9 15.5 78.7 30.7 34.7 33.9 75.5 32.5 13.8 23.4 33.4 30.1 27.8 33.6 39.6 29.6 13.5 29.9 24.0 20.9 33.1 38.4 54.9 29.3 36.8 64.5 30.5 47.2 55.0 0.1 6.8 0.6 9.3 7.1 12.0 9.3 8.4 11.0 13.5 8.6 12.9 11.9 0.6 9.6 8.1 7.4 12.4 7.4 2.2 2.8 2.8 2.6 2.6 3.1 2.2 2.7 2.2 2.3 2.7 2.7 11.4 9.6 14.3 5.9 13.1 20.9 21.9 13.1 15.4 11.3 11.2 9.7 14.9 8.6 23.4 7.3 6.2 10.7 8.6 4.6 9.8 12.8 33.2 11.7 20.4 13.2 3.6 10.7 12.4 13.8 9.9 14.9 8.2 7.5 16.4 11.9 8.9 27.4 7.9 15.2 12.5 6.4 14.2 7.3 5.7 43.6 12.5 7.1 10.6 5.6 8.2 7.4 10.3 13.0 7.5 12.3 4.1 11.7 10.9 31.4 3.0 7.4 17.6 7.3 13.1 23.0 13.8 52.3 50.8 21.7 22.4 5.1 10.6 31.1 9.8 15.4 WDR36 "GLC1G, TA-WDRP, UTP21" ENSG00000134987 "WD repeat domain 36" Q8NI36 5 111091716-111130502 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Ribosome biogenesis, rRNA processing, Sensory transduction, Vision" "Disease variant, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Basal squamous epithelial cells: 113.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037796, HPA037797" Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 3: T-cells - Adaptive immune response" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 59: Non-specific - Transcription" Nucleoli "HPA037796: AB_2675673, HPA037797: AB_10672725" "unprognostic (2.14e-1)" "unprognostic (4.56e-2)" "unprognostic (1.45e-2)" "unprognostic (2.81e-1)" "unprognostic (2.60e-1)" "unprognostic (1.09e-2)" "unprognostic (1.29e-2)" "unprognostic (1.64e-1)" "unprognostic (9.79e-2)" "unprognostic (7.10e-3)" "unprognostic (3.09e-1)" "unprognostic (1.92e-1)" "unprognostic (5.31e-2)" "unprognostic (1.12e-1)" "unprognostic (1.93e-1)" "prognostic unfavorable (1.18e-4)" "unprognostic (4.91e-2)" 9.1 6.3 3.5 9.4 3.5 9.9 10.1 4.7 4.5 7.4 4.1 7.0 6.5 9.0 6.6 7.9 6.8 7.2 6.0 3.9 4.1 7.5 14.1 6.3 11.3 3.6 4.0 10.1 6.4 7.3 4.5 7.5 3.8 8.3 8.1 4.7 6.0 7.0 9.1 10.1 6.8 7.5 3.8 8.8 7.3 6.3 3.9 9.1 9.7 7.2 12.0 9.8 6.1 4.2 17.0 14.9 13.7 36.6 24.7 32.2 19.2 14.6 13.9 19.5 27.9 19.1 19.7 53.8 17.0 12.2 22.7 19.2 26.8 33.8 34.8 15.9 15.7 26.6 17.2 19.5 26.3 25.6 38.8 19.2 21.4 34.6 37.5 36.5 20.3 18.4 32.3 18.1 25.8 14.3 31.7 24.9 18.3 16.8 15.6 25.6 29.9 42.4 18.1 19.3 24.3 19.5 18.6 15.2 22.4 15.0 15.2 21.3 19.1 28.1 15.6 20.0 30.5 18.1 14.0 48.6 22.4 37.9 22.2 0.3 2.5 1.0 3.3 3.3 3.8 2.7 3.0 3.7 4.0 2.4 4.3 3.6 0.1 3.3 5.0 2.1 3.8 2.6 3.5 3.5 4.7 4.5 3.9 4.1 3.6 4.0 3.8 3.8 3.9 4.2 17.2 19.2 13.8 15.3 26.0 61.1 15.4 18.3 113.3 9.9 14.5 12.1 15.6 18.6 19.6 16.5 6.2 9.4 15.4 5.3 7.9 9.5 5.1 10.6 26.0 20.4 6.0 20.6 30.5 13.8 9.9 20.7 13.7 16.2 14.0 16.9 12.5 35.1 14.7 11.8 24.8 12.9 16.2 24.1 16.0 4.2 8.7 18.2 21.4 20.6 18.3 5.7 16.5 27.6 22.3 9.9 6.4 11.3 27.5 20.8 5.3 11.3 12.3 8.6 19.7 20.2 17.3 18.5 17.8 42.3 57.8 5.3 18.0 18.1 13.4 11.2 WDR46 "BING4, C6orf11, UTP7" ENSG00000227057 "WD repeat domain 46" O15213 6 33279108-33289247 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA043004, HPA055425" Uncertain Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 16: U-266 - Nucleosome" "Cluster 39: Non-specific - Basic cellular processes" Nucleoli "HPA043004: AB_10967417, HPA055425: " "unprognostic (1.84e-1)" "unprognostic (7.54e-2)" "unprognostic (2.82e-1)" "unprognostic (1.68e-2)" "unprognostic (1.17e-1)" "unprognostic (1.46e-1)" "unprognostic (1.51e-3)" "unprognostic (2.63e-3)" "unprognostic (2.62e-1)" "unprognostic (6.07e-2)" "unprognostic (1.74e-1)" "unprognostic (4.22e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (9.03e-2)" "unprognostic (1.35e-1)" "unprognostic (3.97e-1)" "unprognostic (2.32e-1)" 19.4 19.0 2.2 14.1 2.4 12.6 18.9 1.8 3.8 21.2 2.5 16.4 13.5 23.6 13.6 19.1 17.4 3.2 12.8 2.7 2.7 15.6 17.1 14.7 10.6 2.2 2.4 17.3 19.2 3.0 19.7 5.5 2.6 16.8 11.2 3.0 18.7 2.7 26.1 23.9 15.6 9.6 2.2 20.4 16.7 14.8 2.5 6.3 16.4 12.6 18.8 19.6 17.8 3.5 0.9 21.1 15.3 61.2 11.4 1.6 56.2 42.3 4.9 0.2 7.0 27.8 15.5 49.4 35.5 22.5 60.2 23.4 3.9 31.0 19.3 31.6 32.2 65.6 20.3 54.0 10.4 56.6 74.2 12.5 5.2 18.4 9.5 15.6 0.0 26.6 37.5 13.8 6.8 23.3 32.1 46.8 45.1 8.5 18.3 47.1 28.1 40.3 9.3 20.7 30.9 40.3 20.4 44.4 46.9 18.3 17.2 37.8 30.9 37.9 42.8 31.6 64.3 56.5 104.3 83.5 16.4 55.9 35.3 12.1 17.3 6.2 24.9 28.7 21.4 16.1 18.2 22.4 27.9 18.9 17.0 21.7 1.2 28.1 33.9 13.7 18.6 20.1 2.2 2.4 1.8 3.8 2.7 2.7 2.2 2.4 2.6 2.2 2.5 3.5 21.0 0.0 11.7 2.9 30.4 43.7 30.8 40.7 28.5 14.4 23.8 20.2 7.2 17.2 25.7 23.9 6.2 44.0 33.9 20.4 11.7 43.5 65.0 19.0 30.9 22.9 13.8 13.7 11.1 43.0 48.7 27.7 20.4 24.3 21.6 35.1 14.6 26.4 28.9 13.5 6.5 21.5 22.4 19.0 24.1 23.3 25.7 22.0 17.8 5.6 29.0 17.9 36.0 2.5 2.8 33.1 15.6 23.0 25.0 38.0 18.2 37.8 14.7 10.1 13.1 35.7 28.3 42.3 37.2 23.6 42.6 38.2 26.1 46.8 31.9 30.0 WDR48 "KIAA1449, P80, SPG60" ENSG00000114742 "WD repeat domain 48" Q8TAF3 3 39052013-39096671 "Predicted intracellular proteins" "DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038421, HPA058015" Approved Supported Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 44: HDLM-2 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA038421: AB_10670780, HPA058015: AB_2683580" "unprognostic (1.95e-1)" "unprognostic (2.14e-1)" "unprognostic (2.99e-2)" "unprognostic (3.78e-1)" "unprognostic (7.68e-2)" "unprognostic (2.34e-3)" "unprognostic (6.14e-3)" "unprognostic (9.87e-3)" "unprognostic (8.02e-2)" "unprognostic (2.22e-2)" "unprognostic (2.28e-1)" "unprognostic (2.14e-2)" "prognostic favorable (1.63e-7)" "unprognostic (2.41e-1)" "unprognostic (2.94e-2)" "unprognostic (1.43e-1)" "unprognostic (1.69e-2)" 14.1 15.5 20.7 13.3 22.2 35.1 17.7 20.3 25.7 17.7 17.1 14.3 15.1 20.0 14.1 14.0 15.7 13.2 16.2 21.9 22.9 21.4 16.1 13.9 17.6 21.2 21.8 21.1 16.1 22.0 4.4 20.8 21.3 16.0 15.1 17.9 15.4 20.9 11.5 14.1 15.1 16.9 21.6 16.1 14.2 47.9 22.8 26.8 24.8 17.1 19.4 16.8 6.3 24.2 11.6 16.4 32.9 23.6 23.8 27.2 14.4 14.4 20.6 17.6 22.5 11.5 12.7 27.8 10.0 20.2 15.7 13.8 30.3 18.7 20.5 70.3 38.8 26.1 22.8 19.0 10.8 18.8 13.7 18.1 21.2 19.0 21.9 31.9 21.8 20.1 30.7 27.8 16.3 9.9 24.6 20.1 36.3 16.8 19.8 9.6 17.3 24.1 21.9 24.2 24.1 29.0 14.7 29.8 25.4 29.0 15.6 26.7 18.8 15.9 12.0 14.7 16.2 30.2 48.6 22.7 18.5 16.9 15.5 13.3 6.0 7.5 9.2 7.9 9.1 9.4 10.6 10.7 8.7 10.9 10.7 9.3 8.0 15.1 13.0 7.2 12.6 8.9 20.7 22.2 20.3 25.7 21.9 22.9 21.2 21.8 21.3 21.6 22.8 24.2 27.0 16.0 22.0 45.4 26.6 17.6 13.3 9.2 20.5 21.6 18.1 16.6 23.2 7.2 15.5 11.0 16.7 15.9 26.0 14.4 17.6 13.9 77.2 20.2 28.5 20.6 22.1 17.9 35.3 12.4 12.2 18.0 9.7 29.7 24.1 25.5 16.1 13.0 8.6 21.9 37.0 13.7 4.1 11.4 15.9 71.9 18.6 16.2 14.2 26.2 19.8 23.6 13.4 38.7 41.1 12.0 12.9 16.6 20.9 21.9 17.3 13.4 17.8 17.9 26.3 21.9 19.2 104.5 59.9 16.7 21.2 21.5 25.7 23.0 12.3 19.5 WDR7 "KIAA0541, TRAG" ENSG00000091157 "WD repeat domain 7" Q9Y4E6 18 56651343-57029811 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Astrocytes: 99.6;Excitatory neurons: 268.8;Inhibitory neurons: 223.0;Microglial cells: 111.5;Oligodendrocyte precursor cells: 146.3;Oligodendrocytes: 244.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042074, HPA051057" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 58: Brain - Synaptic function" "Cluster 2: Karpas-707 - Immune response" "Cluster 42: Oligodendrocytes - Myelin sheath organization" Nucleoplasm Cytosol "HPA042074: AB_2677833, HPA051057: AB_2732563" "unprognostic (1.03e-1)" "unprognostic (1.32e-2)" "unprognostic (1.65e-2)" "unprognostic (1.40e-1)" "unprognostic (3.71e-2)" "unprognostic (3.66e-2)" "unprognostic (1.97e-1)" "unprognostic (3.58e-1)" "unprognostic (7.70e-2)" "unprognostic (9.21e-2)" "unprognostic (2.00e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.13e-5)" "unprognostic (4.80e-2)" "unprognostic (4.52e-3)" "unprognostic (7.76e-2)" "unprognostic (2.23e-2)" 5.9 7.6 13.2 5.9 14.2 7.2 4.9 7.0 19.8 4.8 3.1 5.4 4.1 4.8 5.3 4.4 4.2 5.3 5.9 16.2 11.1 5.3 7.4 5.0 7.4 14.6 8.8 4.2 4.2 9.2 8.4 4.7 14.7 7.5 4.9 18.8 4.2 5.7 8.2 4.3 4.3 5.6 7.8 6.2 4.9 4.6 9.6 10.3 9.1 9.6 5.8 5.0 4.5 16.0 4.7 7.7 8.7 4.9 13.5 7.8 2.2 9.2 7.8 7.4 8.8 3.1 2.9 13.0 3.6 8.3 6.3 4.9 8.8 7.2 9.2 15.1 5.4 12.3 5.8 2.8 8.1 18.7 15.0 6.7 5.9 9.9 6.6 6.1 9.3 6.1 6.0 17.5 9.3 4.6 13.0 5.5 3.7 2.4 5.1 5.8 6.7 6.3 5.7 8.4 11.3 5.6 6.5 3.1 4.3 7.4 4.9 5.2 8.3 10.5 5.3 3.2 5.0 17.4 14.2 13.9 8.6 9.3 7.2 4.0 3.0 5.5 3.6 4.4 4.5 2.4 4.0 3.7 3.6 2.2 4.2 3.8 2.6 4.6 5.5 1.7 5.2 2.0 13.2 14.2 7.0 19.8 16.2 11.1 14.6 8.8 14.7 7.8 9.6 16.0 8.7 3.2 4.8 99.6 7.5 2.9 1.9 2.3 2.8 24.5 3.4 2.4 12.5 5.7 6.8 0.0 31.3 2.0 7.7 5.8 3.9 3.2 21.0 4.4 6.0 6.6 8.4 8.2 268.8 3.6 1.2 6.3 7.7 3.9 10.8 9.0 9.3 8.9 5.8 26.9 223.0 2.7 0.0 16.2 2.8 7.0 5.6 11.3 0.0 111.5 8.8 7.1 10.3 146.3 244.7 2.6 2.6 8.2 10.1 2.6 4.5 3.2 5.7 26.3 6.6 10.7 5.8 2.0 1.7 5.8 2.4 0.7 9.9 9.3 4.1 1.6 WDR77 "MEP50, p44" ENSG00000116455 "WD repeat domain 77" Q9BQA1 1 111439890-111449256 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 104.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026437, HPA026448, HPA027271" Enhanced Supported "Nucleoplasm,Golgi apparatus,Cytosol" NA NA 18000 "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 44: Endometrium - Transcription" "Nucleoplasm, Cytosol" "Golgi apparatus" "HPA026437: AB_10600199, HPA026448: AB_10600993, HPA027271: AB_10602004" "unprognostic (1.84e-1)" "unprognostic (7.01e-2)" "unprognostic (6.26e-3)" "unprognostic (1.19e-3)" "unprognostic (1.12e-2)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.06e-6)" "unprognostic (5.14e-1)" "unprognostic (3.88e-3)" "prognostic favorable (7.88e-4)" "unprognostic (6.16e-2)" "unprognostic (1.72e-3)" "unprognostic (1.63e-2)" "unprognostic (8.13e-2)" "unprognostic (1.92e-1)" "unprognostic (6.17e-2)" "unprognostic (1.23e-2)" 16.5 23.5 13.5 18.2 13.6 10.3 14.1 13.0 13.5 14.2 13.3 17.0 14.9 20.1 17.7 27.3 104.9 12.4 29.6 15.1 14.6 19.5 22.7 13.8 28.4 14.1 15.2 12.6 17.5 18.2 14.2 18.5 14.2 17.4 24.1 11.4 19.4 14.7 42.2 13.6 16.3 19.2 13.4 22.5 21.2 14.1 15.1 20.5 13.6 32.9 36.2 24.6 16.7 14.1 70.0 58.6 56.0 46.2 32.5 19.6 76.6 51.8 27.6 76.4 50.1 86.0 25.5 118.8 48.6 44.0 49.1 49.4 101.2 96.9 91.1 46.9 80.0 70.9 67.4 125.2 36.9 71.7 114.6 23.8 68.6 75.4 47.6 20.5 51.7 51.9 96.3 30.1 74.5 86.0 94.0 38.8 109.7 64.5 99.4 92.2 88.2 44.9 68.9 118.7 45.6 33.4 45.5 54.7 42.3 70.6 45.1 50.5 38.7 42.3 86.4 82.6 111.1 25.4 34.1 106.3 54.6 81.1 126.5 17.6 24.6 6.6 27.5 38.2 31.2 53.6 30.0 31.5 54.5 42.3 31.2 29.4 3.6 58.5 35.6 34.1 27.8 27.1 13.5 13.6 13.0 13.5 15.1 14.6 14.1 15.2 14.2 13.4 15.1 14.1 11.1 12.8 11.4 8.1 29.6 20.8 27.9 34.8 10.8 11.5 13.2 11.7 22.2 10.0 17.7 18.4 25.0 56.1 19.4 7.0 25.4 30.6 4.8 42.1 18.2 15.3 15.7 18.1 6.0 13.6 57.0 12.9 26.5 40.9 15.8 21.2 8.2 15.6 47.4 8.4 7.2 14.4 20.3 20.3 8.0 4.1 7.5 18.9 5.4 7.5 16.0 9.7 13.4 7.1 5.8 22.1 7.8 9.1 20.1 28.2 8.8 29.3 34.2 9.2 13.1 10.6 18.3 22.3 24.8 26.1 18.5 45.6 15.3 36.0 22.5 23.5 WDR89 "C14orf150, MGC9907" ENSG00000140006 "WD repeat domain 89" Q96FK6 14 63597039-63641871 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000813 Uncertain Approved "Intermediate filaments,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 58: T-cells - T-cell receptor" "Intermediate filaments, Cytosol" "HPA000813: AB_1078324" "prognostic favorable (3.37e-4)" "unprognostic (6.46e-2)" "unprognostic (5.40e-2)" "unprognostic (1.00e-1)" "unprognostic (6.05e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (3.26e-4)" "unprognostic (1.05e-1)" "unprognostic (3.08e-2)" "unprognostic (8.66e-3)" "unprognostic (3.63e-1)" "unprognostic (3.28e-1)" "unprognostic (1.86e-1)" "unprognostic (1.09e-2)" "unprognostic (3.08e-1)" "unprognostic (8.63e-2)" "unprognostic (3.29e-1)" 4.9 5.8 4.4 7.6 4.9 3.0 8.1 7.0 5.9 6.8 3.3 6.1 5.1 6.9 6.8 5.3 6.4 4.8 4.4 4.5 4.6 8.8 8.8 5.4 11.2 4.5 4.4 8.2 5.9 7.4 3.0 6.6 4.2 5.8 6.8 11.4 4.1 4.5 5.8 6.1 4.0 5.3 3.9 8.6 5.4 5.3 5.1 10.1 9.2 7.3 10.3 6.6 4.4 5.7 35.4 16.2 18.2 10.2 10.7 11.2 27.2 14.0 7.6 14.4 16.2 11.6 17.0 33.7 11.4 4.2 9.7 16.7 22.8 13.2 24.3 21.8 13.1 22.7 10.5 14.4 13.8 29.9 15.5 10.1 17.1 16.0 22.7 8.1 12.8 24.0 19.7 17.8 10.5 19.5 24.0 17.3 17.5 23.9 29.2 18.2 18.3 19.2 15.5 14.6 16.5 12.4 15.0 16.8 11.1 18.1 19.2 16.0 9.2 16.8 16.4 11.0 16.6 10.4 8.8 20.9 7.2 20.9 11.9 0.1 2.8 0.5 8.4 2.7 10.5 8.0 8.8 7.8 4.8 7.3 14.3 12.4 0.6 9.4 4.6 3.1 10.1 5.3 4.4 4.9 7.0 5.9 4.5 4.6 4.5 4.4 4.2 3.9 5.1 5.7 5.6 9.6 6.7 4.9 14.5 9.7 13.9 4.6 8.0 6.7 6.3 5.3 4.8 8.6 7.0 5.5 4.2 9.9 7.0 3.8 13.7 6.8 2.8 3.4 7.7 7.0 3.6 11.6 11.3 5.5 13.6 6.5 2.6 4.1 1.3 7.5 5.3 8.0 6.3 1.7 13.2 5.1 4.1 6.3 4.2 4.6 4.4 5.1 3.6 6.5 5.6 7.0 8.2 8.5 14.5 3.6 2.4 6.4 6.1 11.2 2.7 7.9 3.1 9.3 13.1 6.9 4.9 6.1 11.6 6.3 10.9 7.0 11.2 8.7 5.5 7.3 XAB2 "HCNP, HCRN, NTC90, SYF1" ENSG00000076924 "XPA binding protein 2" Q9HCS7 19 7619525-7629545 "Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Proximal tubular cells: 159.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048751 Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 29: U-266 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Vesicles "HPA048751: AB_2680512" "unprognostic (1.13e-1)" "prognostic favorable (4.04e-4)" "unprognostic (1.99e-3)" "prognostic favorable (4.96e-4)" "unprognostic (1.35e-1)" "unprognostic (4.98e-3)" "unprognostic (4.95e-2)" "unprognostic (4.56e-3)" "unprognostic (1.40e-1)" "unprognostic (2.10e-1)" "prognostic favorable (7.47e-4)" "unprognostic (2.69e-1)" "unprognostic (7.43e-3)" "unprognostic (3.88e-2)" "unprognostic (1.61e-1)" "unprognostic (1.51e-1)" "unprognostic (1.80e-3)" 29.4 23.6 17.7 15.1 19.9 44.5 30.6 19.6 24.8 37.0 16.9 28.3 17.5 33.8 6.9 25.4 32.0 11.8 24.3 17.8 17.9 27.7 27.8 27.2 20.7 19.9 18.0 45.8 35.9 13.4 27.1 15.4 20.2 32.7 5.4 9.0 31.1 17.5 35.6 39.0 27.6 9.3 18.6 34.5 30.9 37.7 18.3 21.1 34.7 13.3 10.6 29.1 29.6 25.5 39.8 35.7 21.2 27.9 21.9 16.3 41.2 22.8 26.5 39.6 40.0 46.4 25.4 26.7 44.1 21.3 28.9 34.2 30.2 33.2 10.0 47.1 39.0 35.5 30.2 41.3 28.3 47.5 30.8 28.8 27.0 28.0 20.2 21.3 24.2 56.4 32.4 69.0 12.4 44.0 44.9 73.8 48.3 24.8 69.6 49.3 26.8 47.0 15.8 30.7 30.2 34.4 25.9 25.1 23.2 13.8 32.0 41.6 24.1 18.1 29.5 41.3 39.0 117.7 75.0 39.0 31.0 40.1 27.4 8.8 10.0 9.3 11.8 10.2 11.3 10.1 11.0 9.1 8.0 12.2 13.1 10.0 6.4 8.3 13.9 6.9 14.2 12.1 17.7 19.9 19.6 24.8 17.8 17.9 19.9 18.0 20.2 18.6 18.3 25.5 18.3 0.0 1.8 3.9 22.9 19.6 16.2 28.1 14.2 14.1 89.4 54.4 1.4 25.8 20.1 47.8 12.5 46.0 24.8 28.3 35.2 19.8 39.9 24.7 13.3 16.4 18.6 14.1 2.3 34.4 26.4 16.7 33.6 32.3 19.7 27.7 17.5 46.4 19.8 3.3 2.5 21.2 24.4 19.2 11.0 19.1 28.3 18.3 26.6 3.7 26.5 13.9 23.7 1.0 3.7 15.1 12.4 21.8 19.4 12.2 28.9 159.5 13.4 14.2 39.5 15.9 21.6 36.1 57.3 14.6 17.8 65.9 20.6 17.8 23.9 14.3 XPNPEP1 "XPNPEP, XPNPEPL, XPNPEPL1" ENSG00000108039 "X-prolyl aminopeptidase 1" Q9NQW7 10 109864766-109923553 "Enzymes, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025196, HPA030419, HPA030420, HPA030422" Supported Enhanced Cytosol NA NA 810000 "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 51: Myeloid cells - Hemostasis" Cytosol "CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783" "unprognostic (3.17e-2)" "unprognostic (2.36e-2)" "unprognostic (1.11e-1)" "unprognostic (2.31e-2)" "unprognostic (2.46e-1)" "unprognostic (2.01e-3)" "prognostic unfavorable (2.12e-5)" "unprognostic (8.03e-2)" "unprognostic (2.10e-2)" "unprognostic (1.88e-1)" "unprognostic (4.89e-2)" "unprognostic (7.61e-2)" "unprognostic (2.43e-2)" "unprognostic (1.34e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-1)" "unprognostic (5.18e-2)" 19.7 19.4 13.2 22.9 13.6 23.3 20.1 13.1 14.8 19.7 17.2 32.2 51.7 19.4 22.7 25.1 22.3 27.5 27.9 15.3 13.4 21.4 18.9 19.2 25.4 13.2 12.7 19.8 62.0 24.5 19.2 26.6 13.1 21.7 40.4 18.7 30.4 15.7 28.4 29.5 61.8 28.2 13.2 19.3 24.4 18.1 13.3 19.5 23.6 22.1 28.4 24.6 19.3 13.7 78.1 33.6 52.3 72.1 83.6 77.4 40.2 42.4 85.5 61.8 66.5 65.4 65.2 110.3 35.9 65.0 31.3 40.5 41.7 52.2 60.4 33.0 40.3 74.0 20.5 27.6 58.2 58.3 59.0 76.9 31.8 67.8 60.1 94.6 103.1 70.0 24.3 34.3 80.1 26.3 41.7 36.0 20.6 58.7 35.7 46.1 105.3 19.8 78.5 24.3 15.9 60.5 36.9 23.1 70.6 56.9 28.3 53.6 53.9 25.3 32.9 40.4 38.1 58.4 30.4 92.8 59.4 80.0 20.3 25.7 26.8 11.3 19.5 42.2 13.4 10.6 12.6 17.5 46.4 8.9 8.7 11.7 2.2 30.5 36.8 36.4 15.5 29.6 13.2 13.6 13.1 14.8 15.3 13.4 13.2 12.7 13.1 13.2 13.3 13.7 13.4 6.4 14.4 24.5 14.6 8.9 13.2 32.9 11.4 20.5 12.1 9.7 17.0 18.6 26.3 3.7 6.2 38.2 33.1 34.5 17.6 37.4 6.4 12.3 16.5 18.2 16.8 14.7 18.9 72.9 29.6 22.7 24.5 13.6 11.4 17.0 15.7 12.1 30.9 26.9 25.3 37.1 18.3 20.5 9.6 5.1 18.3 37.5 8.8 15.9 33.5 27.1 24.7 21.6 27.0 54.4 35.1 29.7 18.1 22.5 63.5 31.1 22.8 19.5 13.1 9.8 14.2 17.5 35.9 18.6 8.7 25.2 19.4 30.0 36.5 27.1 XPO1 "CRM-1, CRM1, emb" ENSG00000082898 "Exportin 1" O14980 2 61476032-61538741 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters" "Host-virus interaction, mRNA transport, Protein transport, Transport" RNA-binding "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010184, HPA042933" Supported Enhanced "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA 410000 "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 36: Stromal cells - Cell proliferation" "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "CAB010184: AB_2215817, HPA042933: AB_2678229" "unprognostic (7.34e-2)" "unprognostic (7.04e-2)" "unprognostic (6.37e-2)" "unprognostic (1.67e-2)" "unprognostic (5.61e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (1.84e-1)" "unprognostic (1.99e-3)" "unprognostic (4.43e-1)" "unprognostic (3.53e-3)" "unprognostic (4.90e-2)" "prognostic unfavorable (3.74e-4)" "unprognostic (5.69e-2)" "unprognostic (2.08e-1)" "unprognostic (2.43e-1)" "unprognostic (5.55e-2)" 33.2 29.8 30.1 48.7 31.4 25.8 39.2 35.7 44.3 37.9 31.6 34.9 24.7 52.5 37.0 35.1 45.9 32.0 36.0 27.9 33.7 30.8 41.7 31.9 65.3 28.9 30.5 58.9 26.2 38.5 22.0 52.1 30.4 34.2 42.0 52.0 19.9 34.9 37.5 34.2 33.2 48.6 30.9 43.4 31.9 54.5 32.8 73.6 38.8 47.2 60.9 38.6 22.4 38.9 169.1 152.9 194.1 135.8 91.4 107.9 145.5 166.6 109.2 192.9 151.8 217.3 114.7 256.0 117.4 127.1 186.3 125.0 307.9 126.5 268.6 151.6 110.7 242.8 136.2 148.4 55.4 234.6 145.4 62.9 103.8 149.4 145.9 126.0 149.5 108.7 285.5 127.7 164.9 97.8 212.6 100.4 213.1 189.9 111.5 175.6 208.0 148.1 103.0 124.9 152.8 77.5 174.2 142.8 87.1 185.6 108.6 110.8 98.9 153.7 178.7 137.2 175.0 102.8 203.2 347.0 96.8 214.0 151.0 3.3 1.4 2.2 1.8 2.2 1.9 1.1 1.0 1.8 2.1 0.7 1.0 1.0 0.6 2.7 1.2 1.6 1.2 1.2 30.1 31.4 35.7 44.3 27.9 33.7 28.9 30.5 30.4 30.9 32.8 38.9 42.0 41.7 43.2 114.3 55.3 52.1 32.1 45.5 78.6 67.5 40.2 38.6 64.5 38.6 38.7 31.3 95.9 54.1 56.6 27.3 13.7 29.7 4.2 58.6 79.7 47.7 45.1 73.2 87.9 26.1 49.3 49.9 42.3 68.6 41.8 100.4 41.4 55.8 57.2 72.3 101.3 34.2 40.7 55.3 58.4 11.9 33.5 63.9 37.4 68.4 64.2 33.4 61.8 83.4 102.5 32.3 20.9 30.9 57.2 55.6 21.0 22.2 56.9 101.7 19.7 50.5 55.7 65.9 91.6 83.3 56.8 30.1 54.5 54.4 46.2 47.7 XPO4 "FLJ13046, KIAA1721" ENSG00000132953 "Exportin 4" Q9C0E2 13 20777329-20903048 "Plasma proteins, Predicted intracellular proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 44.1" "Cell type enhanced" "Detected in many" "Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053768 Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 13: Striated muscle - Muscle contraction" "Cluster 32: U-937 - Innate immune response" "Cluster 58: T-cells - T-cell receptor" "Nucleoplasm, Cytosol" "HPA053768: AB_2682254" "unprognostic (2.24e-1)" "unprognostic (1.20e-2)" "unprognostic (3.79e-2)" "prognostic unfavorable (8.25e-4)" "unprognostic (2.04e-1)" "unprognostic (1.66e-1)" "prognostic unfavorable (4.63e-4)" "unprognostic (1.67e-1)" "unprognostic (7.24e-3)" "unprognostic (9.50e-3)" "unprognostic (2.99e-1)" "unprognostic (1.67e-2)" "unprognostic (1.00e-2)" "unprognostic (9.82e-2)" "unprognostic (1.16e-1)" "unprognostic (3.23e-2)" "unprognostic (2.42e-1)" 4.3 3.6 3.1 5.7 4.3 10.2 6.1 5.6 3.8 4.4 4.5 4.7 3.7 6.1 4.1 4.8 4.1 3.5 10.7 3.0 3.5 5.1 4.1 6.0 7.3 3.7 3.6 6.1 4.2 6.5 3.0 5.2 3.8 5.4 5.7 13.5 3.7 3.9 44.1 5.6 3.8 5.6 3.8 5.8 4.6 5.8 3.7 7.1 6.5 16.7 7.0 4.6 3.7 5.6 10.1 7.5 12.0 11.5 5.7 9.9 12.4 11.2 8.2 13.0 10.7 15.3 12.4 22.0 5.9 10.8 9.8 16.2 28.0 15.2 24.0 15.1 8.0 35.0 9.5 10.3 8.6 31.0 11.0 9.8 9.4 13.1 24.7 7.6 15.9 12.5 16.8 7.1 12.4 8.3 14.9 13.6 13.6 21.2 6.9 16.3 19.8 9.2 9.0 12.1 13.6 9.4 9.7 13.9 11.5 12.0 8.2 16.8 13.2 9.1 7.1 11.3 16.1 4.7 7.4 17.9 4.5 19.5 13.9 1.5 0.7 0.8 1.1 0.8 1.3 1.0 1.0 1.0 1.0 0.8 1.2 1.2 0.0 1.1 2.5 0.7 1.0 0.4 3.1 4.3 5.6 3.8 3.0 3.5 3.7 3.6 3.8 3.8 3.7 5.6 10.0 12.8 12.5 36.6 24.0 8.3 10.7 12.1 11.4 17.0 8.5 6.1 22.2 10.0 5.6 9.2 64.6 8.3 11.4 4.7 0.0 5.4 10.4 6.1 11.9 9.5 1.2 10.9 72.8 4.1 7.4 9.8 18.3 7.7 15.2 11.9 12.1 10.5 10.8 10.1 70.8 7.5 6.1 10.0 8.0 8.2 17.4 9.5 12.4 44.0 11.6 5.4 10.3 58.8 82.5 5.4 3.6 8.2 21.3 11.8 3.4 5.4 6.3 21.4 32.9 11.6 10.0 14.2 18.8 14.7 11.2 12.9 18.6 7.1 9.6 10.4 XPO5 KIAA1291 ENSG00000124571 "Exportin 5" Q9HAV4 6 43522334-43576038 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012357, HPA018402, HPA023959, HPA029909" Enhanced Enhanced Nucleoplasm NA NA 13000 "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 39: Non-specific - Basic cellular processes" Nucleoplasm "CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245" "unprognostic (6.98e-2)" "unprognostic (4.34e-2)" "unprognostic (5.13e-2)" "prognostic unfavorable (4.94e-7)" "unprognostic (6.16e-2)" "unprognostic (2.43e-2)" "prognostic unfavorable (3.98e-8)" "unprognostic (4.78e-1)" "unprognostic (4.72e-3)" "unprognostic (1.72e-1)" "unprognostic (4.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.07e-2)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (9.48e-2)" "unprognostic (5.66e-3)" 7.3 8.0 4.6 9.1 5.3 8.3 8.5 5.1 5.8 7.6 4.1 7.2 6.3 8.0 9.1 12.0 6.9 5.8 7.0 4.7 4.7 7.4 6.7 6.5 8.7 4.8 4.6 6.3 14.0 11.1 6.5 7.6 4.5 7.9 8.8 11.7 8.1 7.1 11.2 12.3 6.4 9.7 4.2 6.9 8.3 23.7 5.2 12.0 13.1 6.0 11.2 11.2 7.9 4.7 48.8 28.5 46.7 94.4 23.7 19.9 43.3 24.8 17.3 47.9 34.4 79.1 16.5 65.6 31.4 23.7 45.1 40.8 78.4 36.2 53.5 48.0 61.9 63.6 34.5 57.8 34.0 71.0 32.6 14.5 36.8 50.4 78.0 17.2 34.6 46.0 138.5 50.2 32.6 59.5 53.9 35.1 50.1 132.3 28.7 57.9 49.5 49.2 27.6 37.6 95.7 39.7 34.5 31.5 44.7 40.6 36.3 56.1 29.2 35.2 41.9 34.0 52.8 31.8 37.1 126.3 12.6 60.7 38.4 0.0 4.3 3.1 4.8 5.4 4.4 2.8 4.3 5.3 4.9 2.4 3.4 4.6 0.4 7.1 10.8 1.4 4.7 4.0 4.6 5.3 5.1 5.8 4.7 4.7 4.8 4.6 4.5 4.2 5.2 4.7 4.7 6.4 3.3 21.2 6.0 8.9 6.8 4.6 5.2 11.3 7.0 7.4 6.5 2.8 3.5 11.0 8.4 5.5 8.4 3.6 1.9 6.7 12.3 7.1 10.9 6.6 14.4 9.4 31.7 7.7 6.5 7.5 10.2 7.5 11.4 13.4 2.5 4.6 6.2 21.9 35.2 5.9 2.0 5.3 2.5 13.5 4.1 4.9 1.8 25.3 5.1 4.5 13.4 26.7 32.0 6.6 2.2 8.2 10.8 13.0 4.1 4.7 5.5 14.3 0.0 10.0 7.3 26.9 23.5 10.2 7.1 4.4 5.4 11.5 7.2 5.8 YARS2 "CGI-04, FLJ13995, mt-TyrRS" ENSG00000139131 "Tyrosyl-tRNA synthetase 2" Q9Y2Z4 12 32727490-32755897 "Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038721, HPA057610, HPA074097" Uncertain Supported "Nuclear bodies,Mitochondria" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 5: NTERA-2 - Transcription" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Mitochondria "Nuclear bodies" "HPA038721: AB_10674837, HPA057610: AB_2683483, HPA074097: AB_2686660" "unprognostic (1.55e-1)" "unprognostic (1.41e-2)" "unprognostic (2.30e-3)" "unprognostic (1.02e-2)" "unprognostic (2.12e-1)" "unprognostic (5.99e-3)" "prognostic unfavorable (3.19e-5)" "unprognostic (1.41e-2)" "unprognostic (4.98e-2)" "unprognostic (1.40e-2)" "unprognostic (1.15e-2)" "unprognostic (8.39e-2)" "unprognostic (7.45e-2)" "unprognostic (1.99e-1)" "unprognostic (4.71e-1)" "unprognostic (4.07e-1)" "unprognostic (2.09e-1)" 6.1 6.0 4.1 6.5 3.8 7.8 6.6 4.3 4.5 5.9 3.9 5.8 4.8 5.8 5.0 7.1 5.2 4.4 6.2 3.9 3.3 4.8 6.0 4.3 8.1 3.7 3.0 6.1 5.8 6.5 3.7 7.8 4.3 4.6 6.4 4.6 8.1 4.5 7.3 5.4 5.2 5.3 3.1 6.1 5.8 4.6 3.2 7.9 4.6 8.5 8.3 7.4 5.1 4.3 19.8 23.3 13.3 15.8 14.3 16.6 42.0 14.8 15.0 17.9 17.4 58.8 24.6 35.4 23.6 15.0 25.8 24.9 26.7 38.9 20.0 15.5 41.8 23.6 16.4 33.0 20.6 25.3 13.2 15.6 24.4 16.9 30.5 23.0 28.5 18.4 33.7 15.9 19.1 16.1 18.9 30.4 73.5 13.0 28.2 21.0 28.4 21.1 22.9 27.8 20.5 10.0 22.7 19.5 14.7 51.5 36.5 22.7 19.5 16.9 17.7 27.8 25.3 9.4 10.7 37.0 15.7 18.6 14.3 10.2 6.1 3.7 8.4 8.0 8.8 7.3 8.8 8.7 8.5 9.6 9.0 10.5 1.0 11.9 9.6 8.2 8.4 5.1 4.1 3.8 4.3 4.5 3.9 3.3 3.7 3.0 4.3 3.1 3.2 4.3 14.5 6.4 4.4 25.5 16.1 10.1 20.1 27.0 14.2 16.8 11.4 8.4 7.7 1.5 15.1 11.0 20.9 34.7 15.9 5.4 7.9 19.9 6.5 19.7 17.7 10.2 7.2 21.2 22.2 16.5 36.9 12.5 6.6 24.6 7.0 18.9 6.8 5.6 20.1 15.2 31.2 7.3 16.2 9.3 6.0 4.6 10.5 10.4 5.4 18.7 16.0 12.3 16.5 26.7 44.1 14.2 7.6 8.6 9.3 13.9 7.9 11.5 9.0 19.9 13.1 10.5 19.1 6.3 12.8 12.9 8.4 17.9 13.9 24.3 12.8 12.6 YTHDF2 "CAHL, HGRG8, NY-REN-2" ENSG00000198492 "YTH N6-methyladenosine RNA binding protein 2" Q9Y5A9 1 28736621-28769775 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation, Host-virus interaction, Immunity, Innate immunity, Mitosis, Oogenesis, Spermatogenesis" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030063, HPA054080, HPA059621" Approved Enhanced "Cytosol,Cytoplasmic bodies" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Cytosol "Cytoplasmic bodies" "HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084" "unprognostic (8.75e-2)" "unprognostic (1.90e-2)" "unprognostic (4.66e-3)" "unprognostic (1.63e-1)" "unprognostic (3.03e-1)" "unprognostic (1.49e-1)" "prognostic unfavorable (6.14e-9)" "unprognostic (1.75e-2)" "unprognostic (4.82e-2)" "unprognostic (4.18e-2)" "unprognostic (1.69e-1)" "unprognostic (4.11e-2)" "unprognostic (2.07e-1)" "unprognostic (1.21e-1)" "unprognostic (6.38e-2)" "unprognostic (9.29e-2)" "unprognostic (6.97e-3)" 33.5 33.0 20.0 26.7 21.0 63.9 38.3 22.1 24.8 27.5 29.5 32.0 29.4 27.8 43.6 37.5 27.7 27.0 27.0 21.3 22.5 31.8 42.2 35.6 35.6 20.2 19.6 29.3 27.4 37.1 18.0 34.4 20.6 22.9 33.8 20.2 39.8 23.9 43.9 41.9 26.2 32.9 21.4 32.1 27.6 29.3 21.2 44.1 28.0 33.7 43.8 32.8 26.1 23.1 68.8 46.3 99.6 96.8 75.5 58.1 117.8 66.1 80.7 80.0 80.4 42.8 78.1 117.8 64.4 84.4 47.8 62.2 117.3 105.7 94.0 76.0 91.9 98.7 60.7 78.4 90.0 105.1 74.4 78.5 106.4 86.1 121.1 70.0 99.0 70.0 101.9 55.6 89.7 53.3 112.1 80.8 161.8 61.1 61.1 95.4 74.2 96.8 111.3 95.8 85.7 91.2 68.6 102.1 181.7 82.6 67.8 95.8 69.4 55.4 57.8 52.5 93.5 68.2 47.7 133.3 63.3 81.2 89.9 108.3 78.4 78.7 66.1 91.1 88.3 80.3 72.7 80.3 96.7 59.0 77.9 73.2 26.5 92.4 94.4 62.6 92.3 109.5 20.0 21.0 22.1 24.8 21.3 22.5 20.2 19.6 20.6 21.4 21.2 23.1 70.8 51.3 61.2 13.7 70.8 152.7 104.9 111.0 109.8 45.4 110.2 101.3 52.8 77.2 85.3 44.1 31.3 149.6 79.5 46.4 66.5 102.0 16.3 65.8 78.2 78.5 75.7 52.8 22.5 69.6 108.3 64.5 49.5 76.6 72.3 63.6 77.4 102.3 77.3 58.9 20.4 76.0 105.8 65.4 75.4 19.3 71.1 56.7 37.4 21.5 74.1 66.4 73.2 14.1 23.5 80.7 43.8 75.2 71.0 78.6 42.4 96.0 53.8 45.9 92.1 61.5 83.0 142.2 115.5 95.3 161.7 260.2 69.2 69.5 65.9 118.7 ZBTB33 "kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348" ENSG00000177485 "Zinc finger and BTB domain containing 33" Q86T24 X 120250752-120258398 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation, Wnt signaling pathway" "Activator, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000755, CAB001980, HPA005732" Approved Enhanced "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 7: SCLC-21H - Neuronal signaling" "Cluster 65: Plasmacytoid DCs - Unknown function" "Nucleoplasm, Plasma membrane, Cytosol" "CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166" "unprognostic (9.14e-3)" "unprognostic (1.45e-2)" "unprognostic (1.17e-1)" "unprognostic (1.01e-2)" "unprognostic (2.47e-2)" "unprognostic (6.13e-2)" "unprognostic (1.72e-2)" "unprognostic (1.94e-1)" "unprognostic (1.04e-1)" "unprognostic (1.52e-1)" "unprognostic (1.25e-1)" "unprognostic (4.51e-2)" "unprognostic (5.08e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (6.44e-2)" "unprognostic (2.59e-2)" 6.4 7.0 6.4 8.5 7.0 19.5 15.4 7.1 9.0 6.8 4.7 6.8 7.7 6.2 9.4 9.9 8.2 7.3 4.9 6.4 9.2 6.4 19.0 8.7 13.2 7.3 8.7 9.7 8.4 13.7 4.8 8.8 8.5 7.4 6.5 5.7 10.4 6.0 5.4 18.8 6.4 4.8 8.4 11.5 8.6 5.7 9.3 16.2 10.2 7.7 12.8 8.0 4.8 9.7 13.6 12.9 19.6 18.1 15.9 17.8 23.4 10.3 13.5 11.7 14.5 9.0 11.7 19.5 18.8 10.4 15.7 20.7 31.9 15.7 15.3 22.0 21.6 20.3 20.3 12.7 11.6 21.2 22.7 12.7 19.9 11.2 17.6 17.1 20.9 18.7 13.5 23.2 14.6 15.6 19.2 14.1 24.3 20.9 15.3 21.9 14.9 32.0 12.5 22.2 35.6 15.2 20.9 21.3 25.3 14.9 11.5 29.6 19.6 9.5 6.9 14.3 18.5 12.7 13.1 24.7 12.6 29.4 11.9 11.5 4.2 5.6 2.9 6.4 5.0 2.4 3.8 3.9 6.2 2.2 4.6 3.4 0.9 4.0 4.2 6.7 3.5 3.6 6.4 7.0 7.1 9.0 6.4 9.2 7.3 8.7 8.5 8.4 9.3 9.7 15.7 16.0 7.0 3.9 7.9 12.7 7.8 5.1 12.5 4.5 11.5 13.1 5.2 8.6 11.9 1.8 0.0 7.7 21.7 5.3 1.9 5.5 0.1 12.9 8.7 8.5 8.4 10.3 3.4 6.7 8.7 7.9 7.1 10.3 0.0 16.0 7.9 16.6 7.6 3.3 4.6 7.0 6.1 12.8 10.3 0.4 4.4 8.2 3.6 3.7 14.6 7.0 14.4 5.0 4.6 6.9 5.7 2.6 5.4 9.5 6.8 4.0 15.3 1.6 6.6 6.9 4.1 5.0 10.0 12.7 13.1 9.3 8.7 11.2 6.0 11.9 ZBTB4 "KAISO-L1, KIAA1538, ZNF903" ENSG00000174282 "Zinc finger and BTB domain containing 4" Q9P1Z0 17 7459366-7484263 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008980, HPA064763" Supported Supported "Nucleoplasm,Nuclear bodies,Cytosol" No No "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 56: Bipolar cells - Visual perception" "Nuclear bodies" "Nucleoplasm, Cytosol" "CAB008980: , HPA064763: AB_2685347" "unprognostic (2.23e-1)" "unprognostic (3.95e-1)" "unprognostic (7.17e-2)" "unprognostic (2.92e-2)" "unprognostic (5.32e-2)" "unprognostic (7.62e-3)" "unprognostic (2.43e-1)" "unprognostic (1.67e-2)" "unprognostic (1.28e-1)" "unprognostic (1.63e-3)" "prognostic favorable (2.53e-4)" "unprognostic (1.73e-1)" "prognostic favorable (1.65e-9)" "unprognostic (1.10e-1)" "unprognostic (4.86e-2)" "unprognostic (1.88e-1)" "unprognostic (6.04e-3)" 34.8 36.1 22.1 7.4 20.6 3.0 31.4 19.9 23.1 41.9 11.7 47.2 6.3 40.3 16.2 26.4 40.5 9.6 38.8 21.2 21.0 24.1 7.8 30.0 8.3 27.1 21.7 48.4 23.1 36.1 28.6 10.8 27.0 33.1 6.6 23.1 28.0 21.4 32.4 27.2 23.0 16.4 19.7 22.1 27.3 15.9 23.3 9.5 43.9 14.8 9.0 42.3 33.9 21.5 10.7 14.4 3.6 6.9 37.1 19.1 6.5 14.7 21.0 13.0 12.9 4.8 5.1 1.1 11.4 28.0 9.5 16.7 3.6 20.6 9.5 17.0 6.2 5.3 12.3 3.4 10.4 1.0 12.2 13.4 21.1 12.5 15.9 30.6 11.5 4.0 1.8 3.4 14.5 7.1 3.7 2.2 1.5 4.3 6.8 6.8 6.2 1.6 15.9 8.9 2.1 5.3 6.5 4.6 6.9 6.3 8.6 2.4 16.1 14.6 5.7 13.9 12.3 6.1 4.5 0.7 15.7 3.3 7.7 0.4 0.3 0.5 1.0 0.5 1.0 0.5 0.8 0.8 0.2 0.5 1.0 1.0 0.2 0.6 1.7 0.4 0.4 0.6 22.1 20.6 19.9 23.1 21.2 21.0 27.1 21.7 27.0 19.7 23.3 21.5 27.4 51.3 53.1 33.6 14.6 30.7 16.3 18.4 18.8 86.6 23.6 20.6 92.6 20.0 24.8 20.2 68.8 10.3 24.5 4.6 3.9 14.4 40.8 21.1 25.2 26.1 17.4 9.5 36.9 14.4 2.2 24.8 7.1 26.0 13.9 25.7 23.9 8.1 13.5 74.0 37.3 10.1 14.2 30.0 34.6 57.0 51.9 18.6 17.8 15.9 12.0 27.0 24.7 21.6 26.7 19.0 5.3 70.0 9.5 16.2 8.2 11.2 32.2 39.9 32.9 37.8 27.4 7.3 4.3 17.3 23.4 5.2 21.1 16.3 9.0 14.7 ZC3H14 "FLJ11806, NY-REN-37, UKp68" ENSG00000100722 "Zinc finger CCCH-type containing 14" Q6PJT7 14 88562970-88627596 "Disease related genes, Human disease related genes, Predicted intracellular proteins" RNA-binding "Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "testis: 173.6" "Cell type enhanced" "Detected in all" "Early spermatids: 1282.6;Late spermatids: 460.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049798, HPA053510" Enhanced Enhanced "Nucleoli,Nucleoli rim,Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Nuclear speckles" "Nucleoli, Nucleoli rim" "HPA049798: AB_2680888, HPA053510: AB_2682174" "unprognostic (5.80e-3)" "unprognostic (2.25e-1)" "unprognostic (1.35e-2)" "unprognostic (7.39e-2)" "unprognostic (2.06e-1)" "unprognostic (1.91e-1)" "unprognostic (6.47e-3)" "unprognostic (9.57e-2)" "unprognostic (7.21e-3)" "unprognostic (2.77e-3)" "unprognostic (4.83e-2)" "unprognostic (1.50e-2)" "prognostic favorable (7.08e-4)" "unprognostic (2.09e-1)" "unprognostic (8.23e-2)" "unprognostic (3.71e-1)" "unprognostic (4.25e-2)" 20.9 21.0 9.5 16.3 10.7 23.6 22.5 26.9 14.9 23.7 38.3 26.9 19.7 25.7 25.1 20.2 27.7 18.7 24.7 10.8 8.1 24.3 43.3 24.2 18.2 5.5 5.1 26.1 37.4 33.2 24.3 23.0 6.8 23.6 31.2 41.1 31.4 23.6 30.2 21.4 21.2 28.2 4.4 15.7 21.6 173.6 9.0 20.0 32.2 25.1 23.6 22.1 19.5 13.1 39.5 75.4 64.7 54.8 50.8 48.6 68.3 58.6 54.2 85.2 74.7 55.3 63.2 55.1 41.9 61.4 46.3 44.4 46.8 55.7 115.9 43.4 34.7 26.7 51.6 42.5 51.2 57.3 34.3 39.2 65.2 68.2 66.9 53.3 56.7 47.2 54.2 21.0 75.8 86.3 52.8 28.1 39.9 60.8 64.1 46.1 83.9 23.1 54.3 68.2 45.6 37.0 75.2 75.4 37.3 54.3 75.3 36.3 39.2 101.3 65.1 43.1 59.2 29.3 30.0 61.7 49.0 27.1 48.0 19.1 20.7 29.4 18.9 25.3 20.4 16.8 18.0 20.8 22.1 15.4 17.2 16.9 3.8 25.9 29.6 12.5 17.2 17.4 9.5 10.7 26.9 14.9 10.8 8.1 5.5 5.1 6.8 4.4 9.0 13.1 25.2 121.8 57.0 38.2 18.1 22.7 24.5 25.2 21.1 61.2 27.0 24.9 22.6 28.6 37.6 20.2 77.2 49.2 25.4 28.4 35.2 25.6 1282.6 53.0 46.6 28.7 31.8 17.1 88.8 23.0 27.4 30.5 20.9 34.3 45.6 51.8 24.3 38.1 20.3 65.6 65.5 31.4 34.6 14.9 16.3 460.1 39.4 19.6 5.4 34.7 20.0 33.6 18.6 64.3 62.9 22.0 16.4 47.4 18.6 26.0 27.4 32.4 53.0 78.9 13.1 46.6 35.4 217.9 81.5 23.0 19.7 40.6 20.1 39.2 32.8 16.3 ZC3H7A "FLJ20318, HSPC055, ZC3H7, ZC3HDC7" ENSG00000122299 "Zinc finger CCCH-type containing 7A" Q8IWR0 16 11750586-11797258 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040808, HPA059849" Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA040808: AB_10794150, HPA059849: AB_2684141" "unprognostic (2.82e-1)" "unprognostic (1.15e-1)" "unprognostic (1.45e-1)" "unprognostic (2.07e-1)" "unprognostic (5.64e-2)" "unprognostic (2.07e-2)" "unprognostic (5.75e-2)" "unprognostic (1.16e-2)" "unprognostic (4.96e-2)" "unprognostic (9.16e-2)" "unprognostic (1.44e-1)" "unprognostic (2.27e-2)" "unprognostic (7.27e-3)" "unprognostic (6.00e-2)" "unprognostic (1.05e-2)" "unprognostic (1.50e-2)" "unprognostic (3.55e-2)" 22.3 17.8 12.1 21.8 13.4 38.0 21.1 18.7 12.8 19.7 26.8 19.1 17.7 22.4 18.0 12.8 18.7 18.9 19.7 11.9 12.8 22.8 21.3 23.6 29.3 13.1 12.5 26.6 26.2 23.4 14.7 26.4 13.4 24.2 19.7 30.3 30.0 25.5 32.8 15.4 18.8 22.8 12.4 23.9 18.7 10.3 13.9 28.2 25.7 21.8 27.6 18.4 15.9 16.6 33.5 16.9 58.2 31.8 40.0 39.4 23.3 52.4 52.2 38.9 47.7 18.9 28.5 46.7 32.2 62.7 25.0 21.1 33.1 50.9 56.0 36.9 37.5 20.1 35.5 31.8 56.6 46.5 42.4 44.7 27.7 36.7 68.7 45.4 49.5 41.8 33.5 40.8 57.1 26.2 35.3 23.6 34.2 23.2 15.2 51.0 32.6 33.3 36.0 25.6 44.3 35.2 42.5 40.5 52.4 34.3 29.6 30.2 47.2 45.1 27.6 61.9 35.8 32.5 26.2 68.5 33.3 34.3 118.7 16.6 12.9 20.4 14.0 17.8 19.8 15.5 18.1 15.4 12.8 16.5 21.1 15.0 16.0 22.3 32.2 10.2 24.2 9.4 12.1 13.4 18.7 12.8 11.9 12.8 13.1 12.5 13.4 12.4 13.9 16.6 39.4 64.1 36.4 36.9 46.2 15.0 15.2 9.6 27.3 29.4 21.2 23.7 44.3 17.2 29.0 14.7 54.2 14.9 40.5 16.4 15.6 18.5 3.2 30.9 48.7 32.7 20.9 22.5 29.4 22.7 15.4 31.1 27.5 33.9 18.3 31.3 32.9 18.5 14.5 53.8 35.3 25.1 18.3 36.3 26.2 5.3 32.6 39.3 19.6 30.9 40.2 25.6 22.6 65.9 32.7 22.3 16.9 35.7 45.2 18.0 20.3 16.4 29.5 52.4 19.7 42.2 37.1 17.2 9.0 18.0 15.8 7.5 40.3 28.9 18.5 16.0 ZDHHC6 "FLJ21952, ZNF376" ENSG00000023041 "Zinc finger DHHC-type palmitoyltransferase 6" Q9H6R6 10 112424428-112446917 "Enzymes, Metabolic proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014357 Approved NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 32: U-937 - Innate immune response" "Cluster 29: Early spermatids - Spermatogenesis" "HPA014357: AB_2304658" "unprognostic (1.21e-1)" "unprognostic (1.00e-1)" "unprognostic (6.31e-2)" "unprognostic (2.51e-2)" "unprognostic (1.80e-1)" "unprognostic (2.07e-1)" "unprognostic (3.29e-2)" "unprognostic (6.24e-2)" "unprognostic (5.21e-1)" "unprognostic (3.54e-2)" "unprognostic (1.56e-1)" "unprognostic (7.14e-3)" "unprognostic (3.00e-2)" "unprognostic (9.30e-2)" "unprognostic (8.87e-2)" "unprognostic (7.64e-2)" "unprognostic (1.22e-2)" 19.5 19.9 15.2 24.6 16.0 21.8 22.7 16.7 18.9 21.2 20.2 24.5 44.6 24.0 33.2 23.7 19.3 23.2 17.0 15.4 16.1 59.3 29.5 20.0 30.6 15.5 15.7 25.7 21.3 21.4 15.4 25.9 15.6 22.4 29.9 21.3 23.9 20.6 14.9 20.5 45.8 17.8 15.9 24.8 25.9 13.6 16.9 25.0 26.2 18.1 30.6 23.9 20.8 17.9 51.7 39.4 40.3 50.2 38.2 28.8 28.5 49.3 46.7 38.2 45.3 37.7 89.6 28.4 22.1 30.2 43.0 60.0 33.8 31.5 44.3 67.0 41.4 29.4 46.4 47.3 24.7 67.9 49.5 21.9 20.7 41.9 48.9 58.7 48.6 42.0 32.4 46.1 41.7 43.3 38.1 75.6 23.6 57.0 32.1 31.4 51.1 26.6 45.3 28.1 15.0 20.9 25.5 40.1 49.1 31.4 22.4 49.2 34.8 43.7 27.6 29.5 47.3 25.7 31.7 37.5 38.7 118.0 29.0 10.4 17.4 21.6 14.7 16.2 18.9 16.7 16.7 18.5 16.6 14.0 14.1 15.9 11.3 16.0 13.7 13.6 23.9 15.9 15.2 16.0 16.7 18.9 15.4 16.1 15.5 15.7 15.6 15.9 16.9 17.9 21.0 22.4 20.1 11.8 35.9 20.3 31.9 23.2 23.9 11.0 21.9 16.1 14.3 31.5 27.4 35.0 8.4 34.8 25.7 31.3 60.7 35.8 72.4 14.9 15.5 18.7 11.4 26.1 15.0 29.8 46.9 17.9 16.3 23.8 23.5 17.8 19.2 21.2 34.4 15.2 15.7 22.7 10.2 20.2 35.9 17.7 16.1 28.6 12.4 12.2 22.2 21.0 23.7 15.1 14.4 31.2 27.9 19.5 23.7 25.7 66.9 39.7 13.4 15.5 6.6 13.9 18.2 11.7 12.5 27.6 22.3 36.5 33.0 10.9 28.5 47.7 ZDHHC9 "CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380" ENSG00000188706 "Zinc finger DHHC-type palmitoyltransferase 9" Q9Y397 X 129803288-129843909 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Acyltransferase, Transferase" "Disease variant, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Adipocytes: 66.0;Oligodendrocytes: 118.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA031814 Uncertain Supported "Endoplasmic reticulum,Golgi apparatus,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 50: Fibroblasts - ECM organization" "Endoplasmic reticulum, Golgi apparatus" Cytosol "HPA031814: AB_10610700" "prognostic unfavorable (9.77e-5)" "prognostic unfavorable (4.64e-5)" "unprognostic (2.83e-2)" "unprognostic (7.53e-3)" "unprognostic (2.68e-1)" "prognostic unfavorable (2.45e-4)" "unprognostic (4.01e-3)" "unprognostic (1.02e-1)" "unprognostic (4.04e-1)" "unprognostic (3.49e-2)" "unprognostic (9.70e-3)" "unprognostic (4.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.05e-2)" "unprognostic (1.31e-1)" "unprognostic (1.17e-2)" "unprognostic (4.11e-2)" 28.2 12.0 39.2 10.2 66.6 5.4 24.3 46.5 52.5 19.1 23.3 22.0 31.6 11.8 11.7 15.6 12.1 15.3 15.5 39.2 49.0 37.1 40.1 26.7 3.3 60.5 58.2 11.2 25.9 25.2 11.4 17.2 52.5 18.8 24.9 6.0 21.1 11.3 13.4 35.3 34.0 15.3 44.8 3.9 19.5 4.1 57.8 3.6 13.8 11.3 6.6 23.8 14.5 78.6 45.9 23.8 33.2 67.5 112.4 87.7 27.0 44.3 50.6 20.9 26.0 37.6 58.4 1.6 73.7 47.6 54.0 30.4 38.0 44.6 30.0 2.6 23.7 9.2 24.0 50.1 44.4 6.1 15.7 96.0 71.1 34.0 50.1 36.5 39.9 15.0 10.1 17.6 34.0 40.0 8.8 11.4 18.0 102.3 40.4 8.2 21.4 27.1 30.1 25.2 26.3 22.0 12.7 64.7 20.5 38.9 27.6 10.1 32.8 21.1 7.3 50.0 36.3 16.5 12.7 5.5 37.9 25.1 10.8 0.0 2.2 1.8 3.0 2.0 3.7 2.7 3.6 2.9 2.4 1.5 4.5 2.6 0.0 2.5 5.2 5.1 1.8 2.1 39.2 66.6 46.5 52.5 39.2 49.0 60.5 58.2 52.5 44.8 57.8 78.6 66.0 22.4 28.6 4.6 2.8 18.6 12.4 12.8 13.1 9.1 16.8 15.1 4.6 17.2 15.9 46.0 2.1 5.6 2.7 20.1 3.9 18.6 1.8 23.8 16.9 16.6 18.0 4.2 10.5 19.8 19.1 32.7 18.3 59.7 2.5 11.5 7.9 43.7 4.9 1.7 11.8 23.2 10.2 3.5 12.2 2.0 12.2 3.9 10.6 7.5 0.3 1.5 1.0 9.5 118.2 33.5 14.6 7.5 7.7 39.1 51.0 25.8 7.2 2.8 0.0 9.5 11.1 8.4 8.7 16.9 19.2 10.3 5.1 7.5 27.2 22.1 ZFAND4 "ANUBL1, FLJ40185" ENSG00000172671 "Zinc finger AN1-type containing 4" Q86XD8 10 45615500-45672780 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "testis: 37.4" "Group enriched" "Detected in many" 6 "Early spermatids: 414.6;Late spermatids: 689.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "Daudi: 34.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA057543, HPA074103" Enhanced Approved "Golgi apparatus" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 83: Testis - Spermatogenesis" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 25: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA057543: AB_2683461, HPA074103: " "unprognostic (1.57e-1)" "unprognostic (1.53e-2)" "unprognostic (6.90e-2)" "unprognostic (3.57e-2)" "unprognostic (2.27e-2)" "unprognostic (5.31e-2)" "unprognostic (1.62e-1)" "unprognostic (1.46e-3)" "unprognostic (2.55e-1)" "unprognostic (3.16e-1)" "unprognostic (8.85e-5)" "unprognostic (3.23e-1)" "unprognostic (9.15e-3)" "unprognostic (1.18e-1)" "unprognostic (6.19e-2)" "unprognostic (1.28e-1)" "unprognostic (4.07e-3)" 2.2 3.3 1.8 2.0 1.9 2.2 3.0 4.0 2.1 2.6 1.9 2.1 2.1 2.4 1.5 1.6 2.7 1.4 2.5 1.5 2.4 2.1 3.8 2.2 4.9 2.3 2.4 2.4 2.4 1.4 3.0 1.2 2.3 2.6 2.2 2.2 2.3 1.7 2.2 3.2 2.0 1.8 2.1 2.5 1.9 37.4 2.3 3.2 3.4 1.6 4.7 2.1 2.2 2.4 1.0 0.7 1.4 2.1 3.2 2.5 0.0 1.4 2.4 1.3 1.4 0.0 1.0 34.6 1.7 0.9 1.9 0.3 1.1 0.9 1.6 5.6 1.7 1.0 1.1 0.8 2.4 0.0 6.8 2.2 1.7 0.5 1.3 1.0 1.2 4.5 0.9 5.8 1.5 0.1 3.3 0.7 1.4 1.1 0.9 0.5 1.1 0.0 1.1 0.9 2.7 1.8 1.1 1.3 1.1 1.5 2.9 1.9 1.1 0.5 2.5 2.1 1.7 4.6 8.2 0.0 1.0 3.4 0.6 0.3 0.2 0.0 0.4 0.1 0.5 0.4 0.3 0.3 0.1 0.3 0.3 0.4 0.0 0.7 0.4 0.1 0.3 0.1 1.8 1.9 4.0 2.1 1.5 2.4 2.3 2.4 2.3 2.1 2.3 2.4 2.5 6.4 3.1 22.5 7.6 0.8 3.3 1.0 5.7 7.9 4.0 2.2 3.9 4.3 0.7 1.8 27.1 0.3 7.1 3.7 1.9 1.1 414.6 6.5 3.4 2.8 1.8 5.7 3.3 1.8 0.4 3.1 4.6 1.8 2.5 3.0 3.3 5.6 2.2 3.3 23.2 2.5 0.0 2.5 1.0 689.8 6.5 2.3 3.6 13.1 2.2 4.1 1.0 47.3 39.7 1.3 0.5 3.0 10.3 3.9 1.6 3.7 8.9 8.7 6.6 4.5 2.2 86.3 13.5 3.2 2.3 0.1 7.0 4.0 2.7 1.9 ZFHX3 "ATBF1, C16orf47, FLJ26184, ZNF927" ENSG00000140836 "Zinc finger homeobox 3" Q15911 16 72782885-73891871 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Myogenesis, Transcription, Transcription regulation" "Activator, DNA-binding, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 47 "brain: 501.8" "Cell type enhanced" "Detected in all" "Microglial cells: 285.8;Smooth muscle cells: 177.3" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 7 "cerebral cortex: 501.8" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA059353 Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 10: Brain - Neuronal signaling" "Cluster 20: HeLa - Mitochondria" "Cluster 48: Smooth muscle cells - ECM organization" Nucleoplasm "HPA059353: AB_2683987" "prognostic unfavorable (1.55e-4)" "unprognostic (3.57e-2)" "unprognostic (1.68e-1)" "unprognostic (2.03e-2)" "unprognostic (2.81e-2)" "unprognostic (3.12e-1)" "unprognostic (4.24e-2)" "unprognostic (6.36e-2)" "unprognostic (9.94e-3)" "unprognostic (2.85e-1)" "unprognostic (1.06e-1)" "unprognostic (4.16e-2)" "prognostic favorable (1.37e-5)" "unprognostic (6.76e-2)" "unprognostic (1.10e-1)" "unprognostic (2.11e-1)" "unprognostic (2.15e-2)" 6.0 4.3 5.9 1.9 5.8 0.9 3.6 2.8 501.8 5.2 7.1 6.0 1.5 4.7 4.0 2.0 3.6 4.2 3.5 68.3 12.1 3.2 3.1 4.3 1.2 72.3 13.7 2.8 4.0 9.7 3.9 6.2 49.5 6.9 2.6 4.5 4.0 6.4 9.9 2.6 2.6 4.1 11.3 3.1 3.6 1.8 12.5 1.3 7.4 10.7 0.7 6.8 3.5 56.5 5.0 9.2 14.7 12.3 5.3 6.7 15.1 3.9 4.3 2.5 2.8 10.6 2.9 2.3 5.5 7.5 3.4 3.5 9.4 4.7 3.4 9.3 2.3 0.4 13.1 15.1 4.9 1.6 3.5 2.5 2.8 7.3 6.5 2.3 4.7 1.0 1.1 0.6 6.3 10.9 0.5 3.1 2.4 2.7 1.5 7.0 4.0 0.8 4.0 8.8 10.9 3.9 6.9 2.1 4.8 6.7 3.0 0.7 10.3 6.0 7.0 6.5 4.9 4.7 1.7 1.6 2.9 1.4 4.7 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.2 0.0 0.0 5.9 5.8 2.8 501.8 68.3 12.1 72.3 13.7 49.5 11.3 12.5 56.5 13.6 70.5 26.7 109.7 8.6 17.0 55.6 13.1 37.0 122.0 24.5 20.6 23.7 47.1 34.8 47.8 22.9 47.4 5.2 11.0 5.9 23.0 2.6 94.6 33.1 40.3 26.9 7.4 22.0 23.4 19.4 68.8 25.5 154.6 21.0 20.7 44.6 37.5 67.0 23.5 8.7 23.2 22.4 84.2 142.6 2.8 10.5 72.9 21.4 285.8 40.8 13.9 3.1 83.9 18.5 20.7 22.4 19.9 2.2 77.5 6.9 7.4 29.3 34.1 124.9 153.7 177.3 3.7 16.8 29.5 17.2 62.1 7.7 12.4 31.0 43.8 ZFR "SPG71, ZFR1" ENSG00000056097 "Zinc finger RNA binding protein" Q96KR1 5 32354350-32444740 "Predicted intracellular proteins" "Developmental protein, DNA-binding, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016666 Supported Approved Nucleoplasm NA NA 8100 "Cluster 27: Non-specific - Gene expression" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 10: Non-specific - Unknown function" Nucleoplasm "HPA016666: AB_1859060" "unprognostic (7.45e-3)" "unprognostic (8.46e-2)" "unprognostic (4.07e-3)" "unprognostic (4.92e-2)" "unprognostic (1.14e-1)" "unprognostic (1.76e-2)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.38e-1)" "unprognostic (1.47e-2)" "unprognostic (6.42e-2)" "unprognostic (1.58e-1)" "unprognostic (3.66e-2)" "unprognostic (1.16e-1)" "unprognostic (1.47e-2)" "unprognostic (5.46e-2)" "unprognostic (1.16e-1)" "unprognostic (2.07e-1)" 26.6 28.3 32.2 21.8 36.4 30.9 26.8 32.5 37.6 26.6 23.9 22.1 18.5 27.9 21.7 26.0 27.9 23.6 34.4 34.4 32.2 29.5 24.9 19.5 26.7 31.8 32.2 38.4 26.0 31.3 14.2 35.5 32.2 26.2 22.5 36.7 27.7 24.7 42.4 16.1 21.0 27.4 33.0 22.6 21.2 30.2 32.6 31.6 34.1 41.3 26.3 28.7 17.3 36.8 45.1 65.8 75.4 47.2 81.4 59.3 65.8 68.0 57.3 70.5 50.3 65.9 39.0 65.7 43.2 66.8 92.0 34.4 99.0 48.1 98.4 62.4 55.3 80.5 66.9 65.3 71.2 83.7 63.6 56.7 59.1 74.7 135.8 63.9 53.9 31.9 82.0 53.9 73.1 34.0 73.7 35.4 55.5 47.3 48.7 59.2 101.3 36.1 52.7 73.1 41.9 44.2 101.1 58.2 60.8 53.1 36.1 102.0 61.4 69.5 65.0 51.9 57.4 26.7 50.3 72.6 51.4 66.2 86.2 35.3 15.5 19.8 15.6 24.2 18.1 16.6 14.9 16.1 17.3 13.1 14.2 14.3 10.1 22.9 24.9 9.1 15.1 13.2 32.2 36.4 32.5 37.6 34.4 32.2 31.8 32.2 32.2 33.0 32.6 36.8 48.0 51.3 55.4 80.0 55.1 26.0 70.6 47.0 61.5 61.2 39.4 34.9 108.7 34.3 63.7 31.3 22.9 40.1 51.4 28.3 49.0 51.7 53.1 47.7 62.1 51.6 39.5 36.6 109.5 35.9 31.3 66.0 34.1 48.6 76.5 50.4 40.4 35.8 32.7 77.4 98.5 26.1 52.9 35.8 31.3 35.6 53.1 47.3 30.2 74.0 53.9 70.8 52.5 117.6 171.4 44.9 39.6 60.9 52.3 69.8 28.7 45.6 56.3 55.4 39.5 81.2 70.9 118.5 71.8 53.1 24.6 55.5 50.1 65.3 34.1 55.7 ZHX1 ENSG00000165156 "Zinc fingers and homeoboxes 1" Q9UKY1 8 123248451-123275541 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 146.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055357 Supported Nucleoplasm No No "Cluster 27: Non-specific - Gene expression" "Cluster 15: Liver - Metabolism" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 62: Horizontal cells - Visual perception" Nucleoplasm "HPA055357: AB_2682793" "unprognostic (4.36e-3)" "unprognostic (6.73e-2)" "unprognostic (1.38e-1)" "prognostic unfavorable (6.09e-4)" "unprognostic (8.73e-3)" "unprognostic (5.61e-2)" "unprognostic (9.22e-2)" "unprognostic (1.51e-1)" "unprognostic (2.01e-1)" "unprognostic (6.00e-2)" "unprognostic (7.97e-2)" "unprognostic (1.44e-1)" "unprognostic (2.07e-2)" "unprognostic (6.63e-2)" "unprognostic (1.51e-1)" "unprognostic (1.30e-2)" "unprognostic (1.76e-2)" 28.2 14.8 24.5 12.1 24.3 13.5 18.7 27.0 28.1 20.8 21.3 15.6 18.4 17.4 15.2 37.0 18.5 15.1 15.2 23.3 31.9 22.9 39.5 14.4 12.6 25.4 27.7 20.8 17.2 22.8 12.7 14.3 26.5 17.9 14.8 35.0 17.4 18.6 15.5 27.8 19.3 19.2 23.1 15.8 14.8 10.1 24.1 19.8 37.7 19.4 15.0 19.8 17.9 29.4 29.7 13.2 18.0 21.3 34.3 28.3 11.6 35.3 19.6 25.6 29.6 23.5 12.4 44.7 46.1 42.8 11.4 19.6 51.3 32.5 32.4 89.5 26.5 72.6 29.1 14.2 23.3 26.9 33.3 21.4 36.9 35.1 30.0 21.9 20.5 21.2 86.0 34.1 38.3 89.7 62.0 12.1 4.8 62.1 27.7 31.3 16.2 32.0 22.9 66.0 86.3 32.1 40.3 113.6 14.1 10.5 45.4 30.6 19.3 40.1 53.4 32.6 23.8 32.1 95.1 49.6 27.2 49.7 11.2 1.5 3.6 3.6 3.8 6.4 4.8 3.3 4.8 3.5 4.9 3.9 4.5 4.8 1.3 6.5 14.0 2.7 5.7 2.9 24.5 24.3 27.0 28.1 23.3 31.9 25.4 27.7 26.5 23.1 24.1 29.4 35.0 25.6 25.7 0.0 15.7 37.1 28.0 19.7 47.3 46.3 28.8 27.1 30.7 25.8 26.8 20.2 47.9 10.4 22.8 33.5 31.3 16.6 10.9 13.0 52.5 30.8 43.3 19.8 0.0 22.3 6.6 33.0 19.4 13.8 28.5 19.1 28.9 71.5 15.0 146.4 0.0 23.1 14.2 24.2 19.0 21.7 46.6 19.4 26.6 0.0 20.5 46.3 27.8 0.0 0.0 16.7 25.8 64.3 15.3 21.2 35.8 33.2 21.4 34.3 39.5 34.4 38.0 38.5 27.6 84.4 62.5 9.6 20.0 27.0 22.8 29.2 ZKSCAN8 "LD5-1, ZNF192, ZSCAN40" ENSG00000198315 "Zinc finger with KRAB and SCAN domains 8" Q15776 6 28141883-28159460 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003483 Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoplasm Cytosol "HPA003483: AB_1080686" "unprognostic (2.02e-1)" "unprognostic (1.45e-1)" "unprognostic (3.94e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (2.75e-3)" "unprognostic (4.19e-2)" "unprognostic (2.24e-3)" "unprognostic (5.34e-2)" "unprognostic (9.80e-3)" "unprognostic (4.68e-3)" "unprognostic (2.63e-2)" "unprognostic (2.29e-1)" "unprognostic (1.22e-2)" "unprognostic (4.30e-2)" "unprognostic (1.66e-1)" "unprognostic (1.28e-1)" "unprognostic (6.33e-3)" 11.0 7.7 4.5 8.1 6.2 14.8 11.5 8.9 7.2 11.2 7.4 11.8 6.6 15.9 13.3 5.6 11.1 7.6 7.6 4.5 5.6 7.7 7.3 9.2 10.5 5.5 5.1 17.6 9.9 12.9 8.4 9.4 6.1 10.3 8.4 17.6 9.0 11.6 8.1 7.9 10.7 10.7 5.0 10.8 9.2 9.1 5.2 13.1 10.6 8.9 10.9 10.2 7.9 9.2 9.0 5.6 26.1 25.4 15.8 14.9 8.2 9.7 18.3 12.6 15.7 6.3 5.3 19.4 15.7 9.4 10.5 7.4 16.7 6.2 17.9 11.2 14.1 17.7 11.7 13.6 14.4 21.8 12.7 15.4 10.4 12.9 19.2 21.5 12.5 16.9 27.9 7.1 12.9 4.4 15.5 18.2 9.5 2.1 6.4 17.0 16.5 15.2 8.6 10.9 19.5 24.7 11.6 5.3 11.9 14.3 5.9 11.7 10.9 18.1 10.5 6.1 13.2 17.3 13.2 15.6 5.1 14.8 9.9 2.2 0.5 0.6 1.0 1.2 1.1 0.5 0.6 0.4 0.4 1.7 1.0 0.8 0.1 1.1 2.1 0.7 0.6 0.6 4.5 6.2 8.9 7.2 4.5 5.6 5.5 5.1 6.1 5.0 5.2 9.2 6.9 3.2 9.3 11.8 9.8 4.8 2.6 3.8 14.8 9.5 8.5 5.1 8.0 7.2 5.0 7.3 6.2 4.2 11.0 2.0 0.0 3.1 3.7 5.9 10.0 8.8 7.2 9.4 11.1 2.9 2.0 9.5 4.6 7.4 5.1 12.7 8.6 10.2 4.1 6.7 12.5 4.6 4.1 11.1 6.8 5.2 9.0 6.0 1.8 15.9 5.9 6.5 4.1 26.7 17.1 3.0 2.4 9.1 9.0 4.3 2.3 3.5 6.1 9.2 0.0 9.9 7.3 11.9 8.6 8.5 2.8 2.3 7.1 7.4 3.7 1.9 ZMYM3 "DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261" ENSG00000147130 "Zinc finger MYM-type containing 3" Q14202 X 71239624-71255146 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Granulosa cells: 38.8;Theca cells: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003211, HPA075255" Approved Enhanced Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 35: Non-specific - Unknown function" "Cluster 12: NES - Nervous system development" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA003211: AB_1080661, HPA075255: AB_2732287" "unprognostic (2.17e-1)" "unprognostic (1.73e-1)" "unprognostic (1.31e-1)" "unprognostic (7.69e-3)" "unprognostic (2.03e-1)" "unprognostic (1.68e-1)" "prognostic unfavorable (5.18e-4)" "unprognostic (5.03e-2)" "unprognostic (9.10e-2)" "unprognostic (2.33e-2)" "unprognostic (4.07e-2)" "unprognostic (1.17e-1)" "unprognostic (2.93e-1)" "unprognostic (2.73e-1)" "unprognostic (5.50e-2)" "unprognostic (4.42e-2)" "unprognostic (1.30e-3)" 10.0 29.2 19.5 8.6 18.9 7.1 10.2 10.7 18.2 17.3 9.5 15.5 7.1 15.9 18.6 9.9 19.2 9.9 9.6 17.8 20.4 13.2 13.6 11.0 12.1 12.8 14.4 37.1 10.8 11.6 18.1 7.9 14.2 15.5 7.8 13.3 11.6 17.1 10.8 11.4 12.0 14.6 13.0 15.5 12.2 20.5 25.9 16.0 15.8 5.7 10.9 13.3 13.3 13.7 15.4 27.9 66.2 35.2 18.8 18.9 16.7 14.0 20.8 29.7 27.8 31.1 22.9 39.0 34.1 25.3 26.8 14.2 57.1 21.2 22.3 13.1 30.6 33.9 25.6 27.9 8.7 31.9 20.3 22.3 12.1 21.6 13.4 52.8 25.2 30.8 39.7 20.9 22.0 25.5 38.6 40.6 65.9 19.0 24.2 47.7 20.3 28.7 22.0 18.6 31.5 21.7 23.8 14.7 13.7 47.8 21.7 20.7 19.5 14.6 26.7 21.5 12.8 18.9 12.1 32.9 17.6 42.9 16.4 6.1 5.2 4.3 4.2 4.8 4.8 7.1 4.8 3.9 4.8 6.6 4.0 4.0 0.3 4.9 4.2 10.1 4.8 4.0 19.5 18.9 10.7 18.2 17.8 20.4 12.8 14.4 14.2 13.0 25.9 13.7 5.6 12.8 11.9 14.7 6.9 3.8 2.7 12.2 6.8 12.9 9.2 10.0 10.6 7.2 15.0 31.3 10.4 8.5 4.7 3.3 1.9 6.7 1.1 12.0 8.5 7.5 4.8 7.6 15.8 8.9 7.0 7.0 6.6 9.4 2.5 38.8 8.9 15.3 9.8 13.5 17.3 9.2 6.1 11.9 6.7 4.0 13.7 6.6 3.6 6.5 11.2 9.5 7.2 7.1 12.3 5.5 8.8 23.3 4.9 1.9 4.5 15.1 12.0 7.7 6.6 5.3 9.9 1.5 4.0 9.3 3.8 4.2 5.2 40.0 7.1 2.0 ZMYM4 "KIAA0425, MYM, ZNF198L3, ZNF262" ENSG00000146463 "Zinc finger MYM-type containing 4" Q5VZL5 1 35268709-35422058 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Excitatory neurons: 127.9;Inhibitory neurons: 136.5;Oligodendrocyte precursor cells: 174.4;Oligodendrocytes: 132.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051301, HPA054802" Approved Approved Nucleoplasm,Nucleoli,Cytosol No No "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 1: K-562 - Erythropoiesis" "Cluster 68: Oligodendrocytes - Mixed function" Nucleoplasm "Nucleoli, Cytosol" "HPA051301: AB_2681431, HPA054802: AB_2682605" "unprognostic (8.95e-2)" "unprognostic (6.80e-2)" "unprognostic (1.51e-2)" "unprognostic (1.76e-2)" "unprognostic (1.06e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (9.75e-9)" "unprognostic (9.76e-2)" "unprognostic (4.35e-3)" "unprognostic (4.44e-2)" "unprognostic (6.70e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (8.10e-4)" "unprognostic (1.18e-1)" "unprognostic (2.04e-1)" "unprognostic (9.18e-2)" "unprognostic (2.21e-1)" 12.1 11.4 13.3 12.5 14.3 13.6 17.2 23.9 15.2 17.2 12.0 11.8 8.9 16.3 15.5 12.7 14.8 13.5 11.2 11.8 14.9 13.3 12.8 12.1 14.4 12.8 13.3 21.7 13.9 18.1 9.3 17.2 14.0 15.0 11.5 24.6 12.2 13.6 14.9 10.9 9.2 13.7 13.8 14.8 13.7 34.2 14.0 20.9 18.4 15.3 17.0 14.6 9.9 16.0 28.1 22.6 67.7 35.0 19.2 41.4 24.9 32.7 49.1 39.1 50.7 24.6 27.6 52.0 19.6 41.3 19.1 17.8 47.3 24.4 56.2 29.5 27.8 63.5 25.0 21.4 35.5 54.7 28.1 31.3 21.1 38.3 35.9 32.4 44.0 28.5 70.0 14.1 47.9 17.4 47.4 32.0 56.3 15.0 19.9 52.4 43.4 26.1 28.7 37.2 39.1 37.5 39.1 29.4 45.7 42.3 23.2 41.4 53.7 36.4 37.8 16.3 35.9 15.3 29.9 40.0 26.2 41.4 35.7 1.8 3.6 2.7 3.1 5.1 2.9 3.2 2.8 2.7 3.5 2.4 2.7 2.6 0.7 6.6 7.1 7.0 2.4 1.9 13.3 14.3 23.9 15.2 11.8 14.9 12.8 13.3 14.0 13.8 14.0 16.0 33.6 12.8 21.9 94.3 17.4 11.5 16.6 14.4 17.1 30.7 31.8 29.1 32.0 25.8 20.8 27.6 31.3 14.7 20.6 6.6 5.9 22.7 59.8 25.0 45.1 22.8 22.3 22.5 127.9 23.7 12.5 27.0 21.9 33.7 14.5 49.1 18.5 16.1 13.1 23.5 136.5 14.7 14.2 23.1 12.5 91.9 26.4 21.4 5.4 109.6 27.5 22.5 26.8 174.4 132.6 19.9 8.1 23.0 13.9 22.7 5.5 11.8 21.6 33.0 19.7 33.4 29.0 34.4 13.3 13.8 11.4 14.1 13.9 45.5 14.0 22.7 ZNF146 OZF ENSG00000167635 "Zinc finger protein 146" Q15072 19 36214602-36238771 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Oligodendrocytes: 121.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003358 Supported Supported Nucleoli NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 52: Non-specific - Ribosome" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 32: Non-specific - Translation" Nucleoli "HPA003358: AB_1080674" "unprognostic (1.01e-1)" "unprognostic (1.93e-1)" "unprognostic (5.35e-3)" "unprognostic (2.11e-3)" "unprognostic (1.82e-2)" "unprognostic (1.15e-1)" "unprognostic (1.42e-3)" "unprognostic (2.87e-2)" "unprognostic (1.35e-2)" "unprognostic (1.27e-1)" "unprognostic (3.95e-3)" "unprognostic (2.53e-2)" "unprognostic (1.72e-2)" "unprognostic (7.84e-2)" "unprognostic (1.17e-1)" "unprognostic (2.51e-2)" "unprognostic (1.92e-1)" 25.9 21.1 22.6 25.6 30.4 12.5 41.6 26.6 33.9 33.7 20.5 26.8 23.1 37.0 21.9 24.7 28.1 22.4 23.7 21.5 26.4 29.2 32.4 23.4 35.3 28.4 30.7 40.5 22.8 33.4 28.2 32.4 30.9 30.5 31.5 31.2 24.4 26.4 46.3 27.0 21.8 32.6 24.0 27.0 25.2 12.1 27.9 39.6 33.9 46.4 37.5 34.4 23.2 36.2 70.2 96.0 79.8 77.1 57.8 64.5 42.5 60.2 55.4 57.1 56.2 43.5 49.6 67.7 94.6 56.0 37.4 31.8 102.6 70.5 102.3 105.5 57.2 113.0 37.4 52.7 67.4 180.1 74.9 52.8 106.5 55.1 156.0 60.0 71.7 72.6 122.2 72.3 69.4 45.9 84.1 42.2 108.1 122.2 57.7 96.1 80.3 58.2 69.4 67.7 100.7 63.5 74.7 93.0 66.1 81.6 41.5 90.9 55.0 64.0 76.8 50.6 107.1 50.2 63.7 95.2 44.9 88.0 83.1 7.9 11.2 8.7 15.8 13.8 22.7 19.1 18.1 16.0 13.6 17.4 23.2 21.4 2.6 14.9 22.4 6.9 16.8 14.9 22.6 30.4 26.6 33.9 21.5 26.4 28.4 30.7 30.9 24.0 27.9 36.2 21.4 44.8 29.0 21.5 29.7 23.6 30.8 20.5 22.8 10.8 26.7 22.1 45.4 21.5 28.4 20.2 10.4 34.3 26.3 11.6 35.2 27.7 18.3 16.7 35.5 22.8 14.5 25.0 29.2 18.0 48.7 26.9 16.3 23.6 20.8 28.5 20.3 20.8 18.9 11.8 33.4 24.6 14.2 17.8 14.0 20.9 25.1 15.5 10.6 19.7 18.8 9.0 28.8 37.2 121.1 25.0 13.7 19.2 18.6 38.1 9.0 21.2 23.7 10.3 6.6 30.2 29.6 13.0 10.7 24.5 29.8 23.5 29.9 20.0 26.4 29.6 ZNF181 "HHZ181, MGC44316" ENSG00000197841 "Zinc finger protein 181" Q2M3W8 19 34734155-34745378 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA043701, HPA062305" Uncertain Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 54: Non-specific - Microtubule organization" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 50: Fibroblasts - ECM organization" Nucleoplasm "HPA043701: AB_10960859, HPA062305: AB_2684743" "unprognostic (2.00e-1)" "unprognostic (1.01e-1)" "unprognostic (1.16e-1)" "unprognostic (1.06e-4)" "unprognostic (1.06e-1)" "unprognostic (4.83e-3)" "unprognostic (5.60e-2)" "unprognostic (2.28e-2)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.01e-1)" "prognostic favorable (1.05e-4)" "unprognostic (1.06e-1)" "unprognostic (6.52e-2)" "unprognostic (2.60e-1)" "unprognostic (1.13e-1)" "unprognostic (9.34e-2)" "prognostic favorable (5.45e-4)" 7.5 8.9 10.4 5.9 12.5 3.6 10.4 13.8 13.2 8.8 10.3 9.4 9.7 9.0 6.3 6.5 9.0 7.2 13.8 10.0 11.2 9.2 14.6 8.1 7.8 11.6 11.3 18.2 11.8 13.2 6.8 5.5 11.1 8.5 7.0 17.7 8.0 10.6 22.8 5.1 8.8 8.1 11.2 9.8 7.6 7.1 10.8 8.8 10.5 23.7 9.1 7.8 5.8 14.1 4.4 7.0 8.5 11.2 13.4 10.5 2.7 5.3 9.4 5.7 6.5 5.0 4.6 6.8 14.8 8.2 7.6 4.1 5.9 5.8 4.3 14.5 6.0 12.9 9.1 7.0 15.8 7.6 4.3 8.1 9.2 4.0 7.8 14.4 5.5 15.0 10.6 0.1 11.4 3.0 15.1 5.4 5.4 10.0 5.7 10.3 10.7 8.9 7.5 5.1 5.9 10.8 11.6 3.2 12.4 7.0 6.7 12.1 7.2 14.6 7.3 3.6 5.8 10.2 16.4 5.7 5.8 2.0 7.5 3.0 4.1 6.6 8.3 5.6 8.5 8.8 11.0 11.3 6.0 15.2 17.1 12.3 0.7 10.9 16.1 6.6 7.6 6.3 10.4 12.5 13.8 13.2 10.0 11.2 11.6 11.3 11.1 11.2 10.8 14.1 11.5 16.0 5.3 8.5 5.7 1.7 3.7 4.0 3.4 15.9 6.5 9.0 40.8 2.8 9.4 5.5 4.2 3.6 3.1 5.3 17.6 6.3 3.3 4.6 7.3 8.9 4.2 1.7 6.8 4.9 1.0 11.2 5.6 4.0 2.5 13.1 7.5 8.5 3.8 13.5 7.8 6.5 4.1 5.4 2.0 2.5 9.3 3.3 5.4 2.8 3.0 16.1 15.5 8.0 11.7 2.6 4.6 12.0 2.6 2.7 6.9 8.0 14.5 15.5 0.0 22.3 14.6 18.9 8.9 3.2 0.9 1.1 6.2 13.1 4.4 1.5 ZNF256 BMZF-3 ENSG00000152454 "Zinc finger protein 256" Q9Y2P7 19 57940833-57947706 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatogonia: 8.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 32.8" HPA055390 Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA055390: AB_2682803" "unprognostic (2.47e-2)" "unprognostic (3.43e-2)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (2.95e-2)" "unprognostic (1.42e-1)" "unprognostic (3.03e-1)" "unprognostic (3.38e-1)" "unprognostic (3.49e-3)" "unprognostic (2.32e-2)" "unprognostic (4.73e-3)" "unprognostic (2.83e-2)" "unprognostic (6.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-1)" "unprognostic (1.27e-1)" "unprognostic (3.28e-3)" 3.5 2.5 2.3 2.3 2.6 10.8 5.6 5.6 3.3 2.9 2.4 3.3 2.3 3.5 4.4 2.7 3.9 1.9 6.0 2.5 1.9 3.1 1.8 3.2 4.9 1.6 1.8 5.5 2.1 4.4 2.8 4.6 1.6 3.8 2.9 9.1 3.3 4.0 3.6 7.1 3.5 3.5 1.6 4.6 2.6 4.3 1.7 5.4 3.9 4.2 5.3 3.1 2.8 2.3 3.9 1.3 9.6 9.7 2.0 3.3 8.3 3.3 3.5 5.2 3.5 0.8 2.1 0.0 2.9 4.3 8.0 0.5 2.2 7.4 8.5 0.0 32.8 9.5 0.0 2.6 3.7 0.0 7.4 6.5 2.0 3.8 0.0 5.4 3.2 9.1 0.7 0.0 5.3 0.9 13.2 0.0 11.6 0.4 8.2 4.2 12.0 5.9 3.8 16.8 4.8 6.9 0.0 3.0 2.4 11.8 7.2 3.0 1.3 10.7 6.3 0.0 6.5 4.4 4.7 16.9 0.3 0.0 4.7 1.3 1.0 1.3 3.3 3.4 6.1 4.7 5.6 5.0 4.2 5.6 5.4 6.4 0.5 3.9 3.6 2.0 4.9 2.2 2.3 2.6 5.6 3.3 2.5 1.9 1.6 1.8 1.6 1.6 1.7 2.3 2.4 0.0 0.0 2.0 4.0 2.7 4.8 3.5 2.2 4.5 2.4 1.4 3.2 1.5 1.7 1.8 0.0 3.1 2.2 0.4 3.9 3.5 0.2 1.2 1.1 2.7 1.2 5.2 1.6 0.8 1.7 2.0 1.1 1.3 0.0 2.2 0.7 0.7 1.4 1.7 1.4 0.9 8.2 0.8 1.0 0.3 1.8 0.8 0.0 1.0 1.7 3.8 1.0 3.5 0.6 0.8 0.3 0.4 0.3 2.7 0.8 0.9 3.4 7.2 0.0 2.6 2.1 4.9 8.7 1.6 3.4 2.6 3.1 2.3 1.2 3.7 ZNF266 HZF1 ENSG00000174652 "Zinc finger protein 266" Q14584 19 9412461-9435571 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 74.2" "Low region specificity" "Detected in all" "HPA026836, HPA054110" Uncertain Supported "Nucleoplasm,Vesicles,Rods & Rings" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 51: Non-specific - Unknown function" "Cluster 24: NB-4 - Immune response" "Cluster 52: Non-specific - Transcription" Vesicles "Nucleoplasm, Rods & Rings" "HPA026836: AB_2672018, HPA054110: AB_2682383" "unprognostic (2.50e-2)" "prognostic favorable (1.41e-4)" "unprognostic (2.27e-2)" "unprognostic (1.04e-1)" "unprognostic (7.60e-2)" "prognostic favorable (3.94e-6)" "unprognostic (1.72e-2)" "prognostic favorable (4.47e-4)" "unprognostic (4.59e-2)" "unprognostic (9.00e-3)" "prognostic favorable (3.03e-5)" "unprognostic (2.92e-3)" "prognostic unfavorable (1.82e-4)" "unprognostic (7.76e-2)" "unprognostic (1.08e-1)" "unprognostic (3.56e-2)" "prognostic favorable (9.15e-5)" 21.0 17.6 8.7 12.7 9.1 17.5 22.8 10.5 10.7 26.3 10.1 22.8 10.2 20.6 53.3 17.5 21.7 9.7 15.3 8.4 8.9 16.3 15.4 21.8 23.8 8.9 8.9 24.2 15.1 15.7 20.1 15.0 9.0 31.5 15.9 12.6 19.0 14.6 11.4 25.1 29.4 14.0 8.8 44.1 19.4 16.7 9.1 27.6 26.3 8.6 27.9 20.0 20.3 9.9 21.5 5.4 13.0 26.6 10.8 15.3 10.3 19.4 18.9 19.1 27.5 10.1 7.1 22.5 12.6 10.7 7.4 6.3 19.3 10.8 22.1 6.8 29.6 27.1 21.8 13.9 9.2 16.9 17.3 16.4 16.0 9.6 14.3 15.5 14.2 25.7 18.0 0.0 16.7 2.1 25.8 74.2 16.6 9.9 16.5 9.6 16.4 16.9 13.6 22.2 13.0 19.5 10.5 11.0 14.0 14.0 8.8 14.2 13.7 16.6 6.9 23.1 11.8 32.1 55.6 28.0 4.5 14.8 11.3 4.0 3.5 4.9 9.6 4.1 6.8 4.8 5.7 7.4 2.9 5.3 7.5 8.1 2.0 11.1 5.4 2.7 7.5 4.8 8.7 9.1 10.5 10.7 8.4 8.9 8.9 8.9 9.0 8.8 9.1 9.9 8.8 0.0 14.3 10.4 15.3 4.0 5.9 5.3 11.4 8.0 9.0 8.8 5.5 4.3 8.7 3.7 12.5 4.8 22.4 7.2 3.9 5.5 0.7 5.0 5.4 7.5 9.5 14.3 12.5 3.7 3.3 6.6 11.2 6.5 12.0 12.9 10.8 3.1 4.8 8.4 12.0 7.1 6.1 11.4 7.2 1.4 6.2 9.1 5.4 14.0 11.3 4.2 20.6 14.1 15.1 4.7 5.2 4.5 10.5 5.6 7.6 1.4 6.6 9.5 6.6 7.2 6.2 5.5 8.7 6.4 4.7 4.7 17.1 6.5 7.4 6.4 ZNF268 HZF3 ENSG00000090612 "Zinc finger protein 268" Q14587 12 133181409-133214832 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001794 Approved Supported Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 30: Epithelial cell lines - Translation" "Cluster 52: Non-specific - Transcription" Cytosol "HPA001794: AB_2666437" "unprognostic (7.65e-2)" "unprognostic (2.78e-1)" "unprognostic (1.21e-1)" "unprognostic (4.64e-2)" "unprognostic (3.09e-1)" "unprognostic (2.81e-1)" "unprognostic (1.16e-1)" "unprognostic (1.94e-1)" "unprognostic (4.91e-3)" "unprognostic (2.21e-1)" "unprognostic (7.63e-3)" "unprognostic (2.57e-2)" "unprognostic (6.59e-3)" "unprognostic (5.69e-2)" "unprognostic (2.30e-1)" "unprognostic (8.79e-2)" "unprognostic (1.53e-3)" 5.6 6.6 2.8 4.0 3.9 3.6 9.5 5.0 3.9 7.4 4.9 5.5 4.4 7.5 7.4 6.5 8.7 4.3 4.4 2.7 3.3 9.3 12.8 5.6 6.2 3.4 3.5 9.7 5.3 13.1 3.9 9.5 3.3 8.1 5.4 12.0 5.6 6.9 2.4 5.1 5.2 5.8 3.2 6.0 7.1 5.8 3.2 7.3 10.7 4.9 7.1 6.3 3.7 4.2 6.9 10.1 21.4 19.0 9.0 11.5 14.6 10.2 10.8 9.3 7.4 10.6 4.6 5.9 15.5 10.3 9.4 6.3 10.5 12.8 11.8 0.2 8.5 14.6 5.3 13.4 9.6 14.1 12.6 16.9 12.6 11.1 17.4 12.5 10.8 5.6 11.2 7.8 15.9 8.2 5.7 6.4 15.8 8.7 0.6 5.7 6.6 7.3 5.3 15.9 15.3 12.9 20.9 7.0 9.1 18.2 17.0 12.0 11.6 10.6 13.2 3.7 9.3 2.8 4.2 12.9 5.9 7.3 11.3 1.9 5.1 6.0 8.2 5.0 5.5 9.6 9.3 10.4 7.6 7.2 14.2 10.2 1.6 10.8 8.6 6.0 5.2 5.0 2.8 3.9 5.0 3.9 2.7 3.3 3.4 3.5 3.3 3.2 3.2 4.2 8.0 19.2 22.3 6.8 10.0 1.8 5.6 5.7 5.2 24.3 10.0 8.4 8.4 12.8 13.6 7.3 20.9 14.9 3.2 2.8 5.9 8.8 15.5 7.1 9.0 9.5 3.6 15.8 8.4 6.4 9.4 9.7 4.6 7.5 2.5 19.1 14.6 11.0 9.8 21.9 10.0 6.9 4.1 6.7 3.0 4.3 10.5 7.7 5.4 10.3 5.5 15.8 8.2 11.6 12.9 7.7 7.6 11.3 5.2 6.3 5.5 11.5 7.1 19.1 6.6 17.4 8.8 14.9 17.3 6.4 2.8 8.6 7.5 12.4 6.9 4.4 ZNF3 "A8-51, FLJ20216, HF.12, KOX25, PP838, Zfp113" ENSG00000166526 "Zinc finger protein 3" P17036 7 100064033-100082548 "Predicted intracellular proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003719 Supported Supported Approved Nucleoplasm No No "Cluster 27: Non-specific - Gene expression" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 49: Ciliated cells - Cilium organization" Nucleoplasm "HPA003719: AB_1080701" "unprognostic (5.92e-2)" "unprognostic (3.82e-2)" "unprognostic (1.00e-1)" "unprognostic (1.01e-1)" "unprognostic (3.19e-2)" "unprognostic (2.76e-2)" "unprognostic (1.10e-1)" "prognostic favorable (5.73e-4)" "prognostic unfavorable (1.59e-4)" "unprognostic (2.65e-1)" "unprognostic (2.50e-3)" "unprognostic (7.54e-2)" "unprognostic (3.71e-2)" "unprognostic (8.22e-3)" "unprognostic (1.24e-1)" "unprognostic (3.41e-2)" "prognostic favorable (2.20e-4)" 13.3 11.1 18.5 9.9 21.1 27.1 19.8 20.4 20.6 17.7 20.0 16.9 20.3 21.3 22.2 13.5 36.5 11.9 11.8 18.7 19.0 15.1 18.6 12.3 12.9 21.3 21.0 21.7 16.0 19.2 13.0 11.7 21.4 14.9 18.4 14.9 14.3 15.7 18.3 13.9 21.0 14.2 20.3 13.9 16.6 8.8 19.9 18.6 18.5 19.5 15.5 14.3 13.8 26.1 13.2 14.1 39.1 54.9 18.8 14.5 23.1 16.8 18.5 23.8 20.4 18.4 19.0 19.2 28.8 15.7 19.6 17.2 29.3 18.2 19.8 20.1 23.7 15.5 20.8 26.6 22.4 28.7 13.6 18.5 21.5 16.8 37.3 26.4 21.4 27.6 44.9 29.3 22.0 36.1 67.3 28.9 54.9 24.2 25.7 27.7 31.4 49.0 22.8 25.9 40.9 60.5 20.1 57.2 26.1 37.1 16.5 27.1 17.5 29.5 21.8 22.0 22.0 39.9 47.3 38.1 14.8 24.6 29.3 13.1 10.2 19.5 14.2 9.8 16.6 13.4 11.8 14.7 10.5 15.5 13.6 14.9 3.9 18.6 14.5 11.8 12.7 10.1 18.5 21.1 20.4 20.6 18.7 19.0 21.3 21.0 21.4 20.3 19.9 26.1 13.5 12.8 31.9 8.1 16.9 7.6 10.0 8.1 12.0 18.7 15.1 12.2 10.5 14.3 13.2 3.7 16.7 12.5 12.6 17.0 7.9 19.3 2.7 42.3 16.1 17.4 26.3 26.1 5.8 11.1 7.6 16.4 15.8 13.0 15.2 28.5 14.6 14.5 6.6 18.5 6.2 20.0 10.2 12.6 5.9 1.8 15.2 7.8 3.6 2.8 11.5 16.5 30.9 9.0 20.4 16.1 18.1 15.1 11.6 12.7 32.5 13.5 32.1 19.5 6.6 9.3 12.1 16.2 17.0 9.9 8.9 10.4 11.1 14.0 20.1 8.2 ZNF304 ENSG00000131845 "Zinc finger protein 304" Q9HCX3 19 57351271-57359898 "Predicted intracellular proteins, Transcription factors" "Angiogenesis, Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050531 Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 35: Glandular cells - Unknown function" "Nuclear speckles" Cytosol "HPA050531: AB_2681160" "unprognostic (4.44e-1)" "unprognostic (1.73e-3)" "unprognostic (5.63e-2)" "unprognostic (1.50e-1)" "unprognostic (1.07e-1)" "unprognostic (9.72e-2)" "unprognostic (2.86e-1)" "unprognostic (1.60e-1)" "prognostic unfavorable (4.95e-4)" "unprognostic (1.54e-1)" "unprognostic (1.28e-3)" "unprognostic (5.97e-2)" "prognostic favorable (1.52e-7)" "unprognostic (1.01e-1)" "unprognostic (4.33e-2)" "unprognostic (4.31e-1)" "unprognostic (9.00e-3)" 4.4 6.3 4.2 3.5 4.4 4.3 6.5 6.7 6.0 4.3 3.5 4.9 2.6 5.0 7.4 5.2 5.2 4.3 6.2 4.8 4.4 4.5 3.5 5.3 5.2 3.0 3.6 6.7 2.5 10.0 5.0 5.5 3.2 5.5 3.1 5.3 4.7 6.2 5.0 6.1 3.8 5.1 3.4 6.8 3.9 4.4 4.3 7.5 7.0 5.3 7.3 4.2 3.0 4.1 6.4 3.1 7.6 9.6 6.2 5.9 4.8 6.4 9.7 7.1 16.0 0.0 3.0 5.3 3.9 7.4 3.7 2.3 4.4 8.4 10.6 1.7 20.5 8.4 8.9 4.5 4.4 4.7 5.1 7.1 11.0 7.0 9.7 7.6 4.5 11.8 2.6 0.0 7.6 1.7 10.0 2.7 5.1 0.0 9.9 6.3 12.3 6.7 5.0 13.7 6.0 6.4 6.7 5.1 4.4 6.9 6.2 6.6 5.2 9.9 5.9 3.1 6.8 8.1 7.7 7.8 6.3 0.1 5.3 2.5 1.3 1.1 1.4 1.0 2.6 2.3 2.4 2.0 1.8 1.8 1.9 2.1 0.1 2.8 2.8 0.9 2.0 1.7 4.2 4.4 6.7 6.0 4.8 4.4 3.0 3.6 3.2 3.4 4.3 4.1 5.0 0.0 0.5 4.2 3.2 6.4 0.8 1.3 4.6 4.9 6.9 5.1 4.4 7.2 4.6 0.0 0.0 1.7 2.9 1.0 1.9 1.7 1.2 3.2 1.8 4.1 0.0 0.0 8.2 1.0 0.8 1.9 1.5 4.0 0.0 5.2 10.4 2.7 1.6 3.3 6.4 1.4 4.1 2.1 2.8 1.1 1.8 1.6 3.6 2.8 0.6 1.4 1.0 3.0 2.8 0.9 0.5 2.2 1.6 1.4 0.8 1.6 6.2 2.2 0.0 2.2 2.8 2.2 4.2 5.4 5.5 1.1 2.1 5.0 1.9 1.2 ZNF322 "bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489" ENSG00000181315 "Zinc finger protein 322" Q6U7Q0 6 26634383-26659752 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043161, HPA046692" Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm "Centrosome, Cytosol" "HPA043161: AB_2678346, HPA046692: AB_2679755" "unprognostic (1.01e-2)" "unprognostic (2.81e-1)" "unprognostic (5.20e-2)" "unprognostic (3.39e-3)" "prognostic favorable (1.28e-4)" "unprognostic (1.21e-1)" "unprognostic (9.35e-2)" "prognostic favorable (8.57e-4)" "unprognostic (5.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.53e-1)" "unprognostic (2.50e-1)" "unprognostic (1.73e-1)" "unprognostic (1.08e-1)" "unprognostic (3.55e-1)" "unprognostic (3.24e-2)" "unprognostic (5.71e-2)" 7.8 12.0 11.0 7.8 11.9 1.3 12.8 12.1 12.4 15.4 10.9 8.8 9.3 15.5 13.3 8.6 11.4 9.8 7.7 10.2 12.0 11.8 9.3 9.9 9.9 11.8 11.5 17.9 8.2 17.7 7.1 11.2 12.4 14.9 10.9 14.3 8.7 13.9 6.6 6.0 8.1 10.5 12.0 11.7 9.1 11.1 11.6 10.1 15.3 12.8 9.7 10.8 7.4 15.0 9.3 6.8 26.2 31.0 17.3 22.5 9.7 12.3 16.1 16.6 20.1 13.3 5.5 11.0 28.5 10.6 20.8 11.5 19.7 7.4 20.8 17.3 18.0 19.5 8.7 13.2 19.5 0.0 17.3 14.1 27.0 10.7 12.3 20.8 14.4 13.5 23.3 11.7 18.3 5.2 14.1 16.9 7.8 8.5 8.4 15.4 18.6 16.0 10.1 14.5 21.3 22.7 14.5 13.6 25.9 12.8 12.5 12.8 14.4 27.8 11.0 11.4 12.4 12.2 25.8 10.8 5.8 2.9 28.4 3.3 8.4 10.8 10.5 7.2 7.6 11.2 5.3 6.9 6.9 9.0 6.1 9.1 8.0 17.8 11.9 7.8 4.5 5.1 11.0 11.9 12.1 12.4 10.2 12.0 11.8 11.5 12.4 12.0 11.6 15.0 24.8 6.4 10.5 3.9 18.0 4.0 17.3 4.8 14.8 32.1 23.9 31.2 5.8 12.8 11.1 9.2 8.4 12.5 16.1 9.9 35.2 17.7 4.1 14.2 32.6 20.1 19.7 7.2 5.3 10.2 11.3 21.9 10.2 15.7 13.3 30.0 18.2 7.6 13.3 47.1 7.0 14.1 8.2 8.9 5.3 3.7 30.1 11.7 8.8 6.5 12.7 26.7 10.3 11.1 10.3 16.1 12.8 26.4 11.8 26.4 10.2 13.3 8.1 13.9 32.9 20.6 22.2 26.0 15.7 12.0 6.5 9.6 9.1 37.7 10.0 24.9 ZNF326 "FLJ20403, ZAN75, Zfp326, ZIRD" ENSG00000162664 "Zinc finger protein 326" Q5BKZ1 1 89995110-90035533 "Predicted intracellular proteins" "mRNA processing, mRNA splicing, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 52.6" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 373.2;Rod photoreceptor cells: 458.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028450, HPA028461, HPA028466" Supported Enhanced "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 79: Retina - Phototransduction" "Cluster 20: HeLa - Mitochondria" "Cluster 46: Photoreceptor cells - Phototransduction" Nucleoplasm "Golgi apparatus, Vesicles" "HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677" "prognostic favorable (9.46e-4)" "unprognostic (2.45e-1)" "unprognostic (7.25e-3)" "unprognostic (1.09e-1)" "unprognostic (5.28e-3)" "unprognostic (1.67e-2)" "unprognostic (8.61e-3)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (3.17e-2)" "unprognostic (3.66e-2)" "unprognostic (1.33e-2)" "unprognostic (2.62e-2)" "unprognostic (8.59e-2)" "unprognostic (1.33e-1)" "unprognostic (2.29e-1)" "prognostic favorable (2.84e-4)" 11.0 9.5 5.9 5.5 7.2 21.0 11.1 8.9 6.7 13.5 6.8 12.8 8.8 12.5 7.4 15.3 11.0 5.3 10.4 7.1 5.2 12.2 12.8 8.5 6.9 7.3 6.5 17.2 17.0 4.5 10.3 6.2 7.3 9.3 8.5 52.6 13.4 3.9 9.8 10.2 12.6 5.0 6.7 8.0 10.3 6.9 5.8 5.3 10.9 2.4 6.0 9.6 12.4 10.2 9.2 6.9 17.9 7.1 6.1 4.3 16.4 11.1 4.5 6.6 5.0 7.2 8.1 13.3 5.7 5.6 6.3 9.5 10.8 7.2 8.8 5.9 7.2 10.6 14.3 7.0 2.4 12.6 6.1 4.3 4.3 6.8 5.7 8.5 4.6 7.8 11.7 5.8 7.1 4.0 13.3 9.6 11.2 6.1 8.0 11.1 11.1 3.0 6.2 15.5 11.3 10.9 10.1 10.6 5.0 10.2 7.8 4.2 8.0 9.3 7.7 8.3 8.4 7.2 3.8 8.8 2.7 10.1 5.3 1.0 1.1 1.2 0.9 1.4 0.8 0.9 0.8 0.9 0.7 1.5 0.8 1.0 0.8 2.0 1.5 1.7 0.6 0.4 5.9 7.2 8.9 6.7 7.1 5.2 7.3 6.5 7.3 6.7 5.8 10.2 43.0 22.4 50.9 48.0 40.5 65.1 61.5 43.3 37.0 140.8 35.3 39.0 39.2 28.6 43.4 23.9 373.2 46.4 46.7 81.6 19.6 54.2 5.1 45.0 50.3 43.5 70.3 66.9 29.1 54.8 85.3 35.6 35.2 48.9 51.8 68.4 29.6 35.1 26.1 69.0 35.1 47.8 38.7 19.4 38.2 7.3 43.2 34.0 39.2 28.1 40.9 57.0 28.8 58.8 61.3 47.7 70.6 33.8 33.0 53.8 61.0 19.6 44.6 458.4 26.3 45.0 53.6 58.5 35.8 53.2 45.3 49.4 31.6 71.0 50.0 82.0 ZNF331 "RITA, ZNF361, ZNF463" ENSG00000130844 "Zinc finger protein 331" Q9NQX6 19 53519527-53580269 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "B-cells: 284.5;dendritic cells: 298.4;granulocytes: 241.9;Langerhans cells: 245.5;Macrophages: 241.4;T-cells: 303.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEK 293: 79.7;RT4: 63.4" "Low region specificity" "Detected in all" HPA063157 Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 7: Non-specific - Mitochondria" Nucleoplasm "HPA063157: AB_2684951" "unprognostic (2.19e-1)" "unprognostic (1.79e-1)" "unprognostic (5.18e-2)" "unprognostic (1.55e-2)" "unprognostic (4.24e-1)" "unprognostic (8.16e-2)" "unprognostic (7.62e-3)" "unprognostic (3.25e-2)" "unprognostic (1.84e-2)" "unprognostic (4.40e-2)" "unprognostic (5.68e-3)" "unprognostic (2.69e-1)" "unprognostic (4.73e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (7.43e-4)" "unprognostic (6.74e-2)" 52.6 124.7 14.3 18.5 13.5 46.3 19.2 55.9 25.1 22.6 23.6 14.8 4.8 20.2 10.7 7.5 46.6 22.6 39.0 13.7 21.2 13.7 12.3 43.4 10.3 24.1 23.0 119.4 21.0 17.0 74.7 54.5 17.8 24.3 8.4 41.2 11.0 22.4 18.8 14.4 10.8 14.2 11.6 10.6 15.3 20.0 22.6 12.2 16.6 9.3 8.7 28.8 16.5 14.7 0.2 11.3 22.5 26.0 15.0 10.7 38.3 16.2 13.7 12.0 21.4 11.8 5.7 7.9 4.2 9.4 5.4 6.6 16.4 12.1 21.4 0.1 79.7 11.8 18.8 7.5 10.9 6.8 15.4 12.4 6.9 13.2 4.8 6.2 5.6 13.9 0.5 3.0 11.4 7.6 16.5 15.1 9.5 0.2 15.5 20.2 13.5 9.6 5.9 63.4 14.3 15.7 7.1 18.8 4.5 43.2 4.1 6.7 5.6 17.0 15.1 10.0 11.1 37.7 28.2 17.8 0.2 1.0 13.9 0.8 5.7 8.2 9.6 4.7 15.2 8.9 10.5 9.7 4.3 10.3 15.6 10.2 0.7 6.1 9.8 4.8 11.7 5.9 14.3 13.5 55.9 25.1 13.7 21.2 24.1 23.0 17.8 11.6 22.6 14.7 37.4 19.2 56.2 13.1 284.5 44.7 21.1 10.9 95.6 56.2 28.6 44.7 20.5 35.8 15.2 77.3 29.2 38.2 298.4 1.6 9.8 4.0 125.7 51.0 18.9 36.8 23.4 7.4 36.3 4.0 33.7 96.7 52.5 79.3 241.9 14.5 13.6 3.8 62.1 30.3 39.9 4.8 14.2 46.8 245.5 84.8 24.2 241.4 46.2 15.0 5.9 33.8 11.3 17.6 24.9 2.4 2.7 19.5 141.7 15.9 3.9 4.4 12.4 38.3 0.0 44.0 151.4 39.2 23.5 15.8 50.6 44.5 303.9 14.0 5.2 12.3 ZNF354C KID3 ENSG00000177932 "Zinc finger protein 354C" Q86Y25 5 179060373-179083977 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Horizontal cells: 16.8;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 16.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 17.8" "Low region specificity" "Detected in all" "HPA030904, HPA068570" Uncertain Supported Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 21: Non-specific - Transcription" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "HPA030904: AB_10603842, HPA068570: " "unprognostic (1.55e-1)" "unprognostic (1.78e-1)" "unprognostic (1.82e-1)" "unprognostic (6.56e-4)" "unprognostic (4.76e-1)" "unprognostic (2.40e-3)" "unprognostic (2.61e-2)" "unprognostic (2.83e-2)" "unprognostic (1.01e-3)" "unprognostic (1.58e-1)" "unprognostic (1.11e-1)" "unprognostic (5.57e-2)" "unprognostic (1.62e-1)" "unprognostic (2.46e-2)" "unprognostic (1.61e-1)" "unprognostic (4.00e-2)" "unprognostic (2.83e-1)" 3.2 2.2 2.7 2.4 3.7 0.6 4.0 6.1 2.9 3.6 1.8 3.1 1.2 5.1 1.8 2.0 3.6 2.6 2.8 2.3 2.6 2.1 1.4 2.6 3.4 3.0 3.5 7.0 2.0 3.1 1.2 3.2 3.2 3.5 1.6 6.4 2.1 3.3 2.2 1.9 2.0 3.8 2.9 3.3 2.0 2.2 3.4 4.4 4.7 4.3 3.4 2.5 2.3 4.4 1.0 1.4 11.1 17.8 5.6 9.0 0.0 5.0 4.3 5.4 6.1 0.0 2.2 0.0 5.9 5.4 9.0 3.4 0.0 1.7 10.2 0.0 0.1 0.0 0.5 0.0 5.3 0.0 2.4 6.8 1.6 5.4 0.0 1.7 2.6 0.0 0.1 0.0 6.5 0.6 10.6 0.0 7.7 0.8 0.0 0.0 0.0 0.0 2.0 0.4 6.7 11.2 7.8 0.1 5.2 4.7 4.6 4.2 3.3 0.0 7.1 4.7 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.2 0.1 0.1 0.5 0.2 0.5 0.3 0.7 0.5 0.2 0.3 0.7 0.6 0.0 0.3 0.6 0.0 0.5 0.3 2.7 3.7 6.1 2.9 2.3 2.6 3.0 3.5 3.2 2.9 3.4 4.4 6.4 3.2 3.1 10.4 2.6 0.9 0.6 1.4 2.8 10.5 1.7 3.0 6.1 4.3 2.3 0.0 0.0 2.2 2.2 0.1 0.0 1.3 0.4 1.3 5.5 4.3 0.0 2.1 8.0 0.9 1.4 5.1 0.5 1.3 1.3 7.4 4.6 0.9 1.7 16.8 2.5 0.5 2.0 1.6 2.2 0.4 3.1 1.7 1.8 4.7 0.6 5.4 1.0 17.6 16.2 0.7 0.1 5.7 0.7 0.6 0.2 0.6 1.3 5.0 6.6 7.0 3.9 2.3 1.3 2.2 0.9 0.5 2.2 4.3 0.7 0.3 ZNF384 "CAGH1A, CIZ, NMP4, NP, TNRC1" ENSG00000126746 "Zinc finger protein 384" Q8TF68 12 6666477-6689572 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA004051 Supported Approved Nucleoplasm NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 59: Non-specific - Transcription" Nucleoplasm "HPA004051: AB_1859228" "unprognostic (1.90e-1)" "unprognostic (5.11e-3)" "unprognostic (1.76e-1)" "unprognostic (6.16e-2)" "unprognostic (1.79e-1)" "unprognostic (3.04e-2)" "unprognostic (1.87e-2)" "unprognostic (9.94e-2)" "unprognostic (1.35e-2)" "unprognostic (2.57e-2)" "unprognostic (3.51e-2)" "unprognostic (4.25e-1)" "unprognostic (1.24e-2)" "unprognostic (1.01e-1)" "unprognostic (2.22e-1)" "unprognostic (2.06e-1)" "unprognostic (8.13e-2)" 31.4 33.2 21.9 36.2 23.2 59.9 30.7 26.9 26.4 39.8 22.9 35.1 35.1 40.6 25.1 27.9 35.8 26.1 25.9 22.5 23.8 28.9 26.3 28.6 36.0 23.5 22.3 46.3 29.8 34.7 32.6 32.5 22.3 31.9 32.7 30.2 29.9 30.0 36.7 32.1 36.8 37.8 20.8 40.2 30.9 31.7 22.8 46.7 38.4 32.3 37.6 36.7 30.8 25.4 35.4 66.2 79.9 53.7 55.2 38.9 107.1 50.0 46.4 47.3 50.3 73.3 73.6 82.9 18.5 56.4 68.5 46.6 59.8 45.9 53.6 150.8 54.0 94.9 93.0 38.6 38.9 91.2 67.5 43.0 43.6 58.3 90.1 88.9 41.5 57.4 50.6 27.9 52.4 54.8 82.6 58.3 155.0 64.1 28.7 81.0 85.4 32.2 41.9 93.6 24.8 80.4 51.8 68.4 44.1 133.5 18.0 74.5 51.9 51.6 71.4 40.9 59.6 38.5 39.6 149.9 51.0 32.4 60.0 3.7 8.5 15.4 16.4 9.8 13.4 9.7 10.7 13.4 11.5 8.0 10.2 11.6 14.4 17.0 15.3 7.6 14.5 8.3 21.9 23.2 26.9 26.4 22.5 23.8 23.5 22.3 22.3 20.8 22.8 25.4 19.2 0.0 8.7 17.3 12.5 7.9 2.6 4.4 12.0 6.0 11.1 11.9 2.6 10.0 4.7 1.8 10.4 6.7 17.9 16.5 0.0 4.6 4.3 10.2 12.9 10.7 3.6 8.0 10.3 5.0 6.8 8.2 12.8 13.5 5.7 14.7 8.9 8.3 7.0 0.0 10.4 11.8 2.0 16.6 6.0 2.7 8.4 8.6 5.4 6.5 9.9 6.1 7.2 9.0 11.8 6.8 14.4 8.6 11.4 4.8 10.6 4.3 5.6 7.8 0.0 9.3 9.3 7.1 6.5 10.7 9.8 7.3 13.2 9.0 13.4 4.6 ZNF441 FLJ38637 ENSG00000197044 "Zinc finger protein 441" Q8N8Z8 19 11767000-11784078 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Rod photoreceptor cells: 19.0;Sertoli cells: 19.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA063338 Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" "Nuclear speckles" "HPA063338: AB_2684989" "unprognostic (1.97e-1)" "unprognostic (1.96e-1)" "unprognostic (2.51e-1)" "unprognostic (1.04e-1)" "unprognostic (1.18e-1)" "unprognostic (6.42e-4)" "unprognostic (2.60e-2)" "unprognostic (1.92e-3)" "unprognostic (1.17e-1)" "unprognostic (3.91e-2)" "unprognostic (2.37e-3)" "unprognostic (1.30e-2)" "unprognostic (1.33e-3)" "unprognostic (1.80e-1)" "unprognostic (1.75e-1)" "unprognostic (1.68e-2)" "unprognostic (2.70e-3)" 3.3 2.9 3.4 3.0 3.9 0.9 5.9 6.9 4.0 3.6 2.3 3.4 2.3 4.6 6.1 1.7 3.9 2.1 3.8 3.6 3.3 6.4 4.4 3.5 4.9 2.7 3.1 6.4 3.4 7.2 7.1 3.2 3.0 4.5 3.2 7.1 3.8 4.9 3.6 3.1 4.2 3.2 3.1 4.6 3.2 2.7 3.0 3.6 7.1 2.7 4.4 3.9 2.5 3.9 2.1 0.0 2.5 2.1 3.0 3.2 2.7 5.0 2.8 3.7 3.6 2.3 0.7 4.4 2.6 3.2 1.8 1.5 1.6 3.0 4.2 0.0 1.8 2.0 1.7 3.7 2.7 0.0 3.6 3.9 3.3 2.6 2.0 2.5 2.1 1.8 3.3 0.0 5.8 0.0 4.7 1.3 0.4 0.9 3.6 1.7 5.0 1.3 3.0 3.4 1.9 3.0 3.3 1.0 1.8 2.4 3.3 4.5 1.0 8.0 1.9 7.0 3.4 4.4 6.9 1.9 0.4 0.0 3.2 0.0 0.3 0.8 1.0 0.3 0.7 1.4 1.1 1.5 0.6 1.6 1.4 1.6 0.5 0.9 1.6 0.4 0.8 0.6 3.4 3.9 6.9 4.0 3.6 3.3 2.7 3.1 3.0 3.1 3.0 3.9 5.6 16.0 8.7 8.5 9.5 0.4 0.8 1.2 0.6 11.7 2.7 2.3 14.5 0.0 4.5 11.0 14.6 2.1 5.1 1.9 3.9 1.7 0.2 2.5 3.8 5.3 0.0 1.7 12.3 1.2 0.6 3.6 1.1 1.8 2.5 6.4 3.6 1.9 0.8 6.7 9.5 1.6 2.0 0.8 1.2 0.8 2.5 2.2 3.6 2.8 1.8 7.0 8.2 4.0 4.2 1.1 1.5 7.2 1.9 0.9 1.5 3.0 0.9 19.0 19.7 6.7 6.2 7.6 6.0 1.4 0.0 0.8 3.4 4.9 0.8 0.4 ZNF449 "FLJ23614, ZSCAN19" ENSG00000173275 "Zinc finger protein 449" Q6P9G9 X 135344796-135363413 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 15.8;Inhibitory neurons: 12.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018079 Uncertain Approved Nucleoplasm,Cytosol "Intracellular and membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 29: Non-specific - Vesicular transport" "Cluster 23: AN3-CA - Transcription regulation" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" "Nucleoplasm, Cytosol" "HPA018079: AB_1859277" "unprognostic (5.51e-3)" "unprognostic (1.64e-1)" "unprognostic (6.94e-2)" "unprognostic (2.74e-1)" "unprognostic (1.30e-1)" "unprognostic (2.20e-1)" "unprognostic (3.74e-2)" "unprognostic (1.42e-2)" "unprognostic (1.66e-2)" "unprognostic (4.86e-2)" "unprognostic (2.69e-1)" "unprognostic (5.31e-2)" "unprognostic (1.34e-3)" "unprognostic (1.28e-1)" "unprognostic (2.54e-1)" "unprognostic (9.61e-2)" "unprognostic (4.22e-2)" 7.3 10.3 2.9 4.4 3.2 1.4 6.1 2.6 4.0 5.6 2.7 5.5 3.2 6.4 5.3 3.6 4.4 5.3 5.3 3.2 3.4 3.8 3.5 5.0 3.9 3.2 2.9 4.5 8.3 5.8 4.2 6.8 3.1 5.6 3.4 4.9 4.8 4.3 5.2 3.6 3.7 4.8 2.8 6.1 4.9 2.8 3.8 2.8 7.0 5.5 3.4 4.5 4.7 3.1 2.7 3.8 7.7 6.3 6.8 13.5 3.7 5.1 3.9 3.2 7.8 1.3 3.6 1.7 6.4 4.0 4.3 3.1 5.4 2.3 5.1 2.3 4.6 2.2 4.3 2.0 5.2 1.8 3.2 5.3 6.6 2.7 7.9 4.5 6.2 4.2 2.2 1.8 9.2 1.5 2.3 2.0 2.7 2.6 4.2 1.9 5.1 2.5 4.7 1.6 1.8 4.5 1.2 3.7 3.8 4.9 2.7 2.0 6.1 7.4 2.7 5.0 4.6 1.4 1.8 1.3 2.9 3.0 4.8 0.7 1.2 1.7 1.2 1.5 2.4 0.7 1.1 1.7 1.1 0.4 1.1 1.1 0.3 2.6 3.3 0.7 1.1 1.0 2.9 3.2 2.6 4.0 3.2 3.4 3.2 2.9 3.1 2.8 3.8 3.1 6.7 0.0 2.2 7.8 2.4 0.9 0.9 1.1 1.2 6.0 2.5 2.5 10.2 1.5 1.3 1.8 0.0 2.5 1.3 0.8 0.0 1.7 0.3 1.2 3.4 6.4 3.0 0.8 15.8 0.6 2.1 3.7 3.1 1.1 1.3 6.4 6.8 0.6 4.2 10.1 12.5 0.8 0.0 3.2 1.9 0.5 5.3 2.4 3.6 8.4 5.0 3.9 0.0 9.5 7.2 1.2 1.4 4.1 1.1 1.1 0.6 0.6 2.2 2.8 0.0 2.4 4.0 2.8 2.3 1.0 2.3 1.2 1.9 11.5 0.6 0.6 ZNF480 MGC32104 ENSG00000198464 "Zinc finger protein 480" Q8WV37 19 52297169-52325922 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" Activator "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA042218 Uncertain Supported Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 63: NK-cells & T-cells - Immune response" Nucleoplasm Cytosol "HPA042218: AB_10794791" "unprognostic (1.50e-2)" "unprognostic (1.43e-1)" "unprognostic (1.56e-1)" "unprognostic (1.35e-1)" "unprognostic (3.01e-2)" "unprognostic (5.22e-2)" "unprognostic (2.01e-2)" "unprognostic (1.29e-1)" "prognostic unfavorable (1.65e-4)" "unprognostic (4.22e-2)" "unprognostic (7.81e-3)" "unprognostic (4.97e-2)" "prognostic favorable (2.03e-4)" "unprognostic (3.05e-1)" "unprognostic (1.11e-2)" "unprognostic (2.54e-1)" "unprognostic (1.82e-3)" 7.6 7.3 4.8 10.4 5.9 9.5 6.6 7.7 6.9 7.5 5.3 10.4 9.8 6.0 3.3 6.5 5.6 4.5 11.1 4.8 6.0 8.7 8.6 6.2 12.6 6.0 5.1 6.9 4.5 7.4 5.9 5.7 6.0 6.2 10.1 10.4 7.2 5.2 10.8 5.5 8.2 6.0 4.2 9.8 9.1 3.3 5.9 15.2 7.2 14.9 15.5 11.1 5.4 8.3 7.2 28.4 18.2 21.2 21.1 19.7 14.1 18.3 26.7 12.8 14.9 12.9 10.0 36.0 11.2 15.1 23.4 15.3 19.9 18.5 18.5 0.3 33.1 37.0 15.2 12.5 20.3 52.7 29.0 18.1 23.4 17.8 20.7 26.7 18.8 31.0 27.0 12.0 29.0 11.7 48.3 10.5 13.7 23.7 22.8 24.5 19.5 30.0 18.8 51.0 17.2 15.0 26.6 18.9 7.4 37.3 15.7 38.1 32.4 12.7 15.8 7.3 28.6 28.4 56.9 74.3 5.7 28.2 23.1 10.1 9.6 11.2 12.6 9.4 14.5 19.7 12.8 15.1 11.9 19.1 12.0 16.3 3.6 17.8 11.4 19.3 15.9 7.8 4.8 5.9 7.7 6.9 4.8 6.0 6.0 5.1 6.0 4.2 5.9 8.3 13.1 35.3 11.8 8.5 20.1 5.5 15.3 22.1 5.7 4.7 6.7 6.1 43.0 8.6 18.2 3.7 2.1 8.7 17.8 11.7 17.6 18.6 2.5 12.7 11.9 17.0 12.6 14.9 1.7 27.6 16.8 11.1 9.7 14.1 12.6 15.4 14.3 15.4 17.6 6.7 4.7 18.0 20.3 15.8 14.3 2.4 9.0 12.3 7.2 6.5 19.0 6.1 26.8 9.5 10.2 36.3 11.8 8.2 9.2 25.4 13.5 24.2 16.8 7.4 0.0 10.6 12.0 1.9 6.1 10.5 8.4 14.8 19.7 12.1 16.1 22.6 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96754553-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Excitatory neurons: 21.5;Inhibitory neurons: 22.7;Oligodendrocytes: 20.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 77: Retina - Visual perception" "Cluster 31: RH-30 & LHCN-M2 - Muscle contraction" "Cluster 52: Non-specific - Transcription" "Nucleoplasm, Plasma membrane" "HPA049139: AB_2680651" "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 3.6 3.8 4.8 3.3 4.7 2.3 4.8 8.3 6.1 5.2 2.4 3.9 2.6 4.7 3.5 2.7 4.0 2.7 3.6 4.9 5.2 3.8 3.8 3.3 4.3 3.6 4.2 5.7 5.1 5.0 4.6 3.1 3.7 4.3 3.3 11.7 3.3 4.3 4.3 3.4 2.9 4.1 4.0 4.2 3.4 3.3 5.2 5.5 4.7 4.8 4.7 3.7 3.2 5.2 4.2 4.3 8.1 7.2 6.7 6.3 4.0 3.7 6.5 6.1 6.4 3.7 2.7 5.7 2.2 3.7 5.8 8.7 3.2 3.3 5.8 6.5 3.7 6.0 7.0 2.5 3.5 3.5 5.2 4.3 5.8 4.5 6.9 6.5 5.3 8.2 6.8 4.5 7.8 3.9 9.3 5.2 6.6 5.9 3.6 5.6 14.4 2.4 4.3 3.2 9.9 7.8 7.0 3.9 3.8 5.4 3.1 6.2 4.1 4.4 4.5 5.6 5.9 8.8 9.8 3.5 2.7 2.0 4.6 0.4 0.2 0.6 0.7 0.3 1.2 0.9 1.2 0.9 0.2 1.0 1.3 0.9 0.1 1.4 0.8 0.3 0.8 0.4 4.8 4.7 8.3 6.1 4.9 5.2 3.6 4.2 3.7 4.0 5.2 5.2 5.5 3.2 3.2 13.4 4.5 1.7 1.6 1.7 0.6 11.0 2.6 2.5 5.1 1.5 2.9 3.7 2.1 2.2 3.2 1.4 1.9 2.2 5.7 3.5 6.3 4.2 1.2 4.0 21.5 2.6 1.4 5.7 2.0 4.0 1.3 5.7 3.6 1.3 2.0 16.8 22.7 2.1 2.0 2.5 0.5 6.9 5.9 2.2 5.4 10.3 2.0 4.5 8.2 18.1 20.5 1.8 2.8 4.1 3.1 2.0 1.0 1.9 3.2 6.5 6.6 4.6 3.3 3.6 5.6 1.8 1.4 0.8 4.6 4.3 1.5 1.1 ZNF526 "KIAA1951, MGC4267" ENSG00000167625 "Zinc finger protein 526" Q8TF50 19 42220312-42228201 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 2: 33.3;granulocytes: 25.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023070, HPA056609" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 59: Non-specific - Translation" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 11: Alveolar cells - Smell perception" "Nucleoplasm, Golgi apparatus, Vesicles" "HPA023070: AB_2671057, HPA056609: AB_2683189" "unprognostic (2.04e-1)" "unprognostic (3.15e-1)" "unprognostic (2.42e-1)" "unprognostic (3.95e-3)" "unprognostic (1.46e-1)" "unprognostic (5.86e-2)" "unprognostic (9.09e-3)" "unprognostic (1.79e-1)" "unprognostic (8.84e-2)" "unprognostic (8.62e-3)" "unprognostic (1.28e-2)" "unprognostic (2.14e-1)" "unprognostic (1.59e-1)" "unprognostic (1.98e-1)" "unprognostic (1.35e-1)" "unprognostic (2.81e-1)" "unprognostic (2.30e-1)" 3.4 2.5 2.1 2.8 2.3 3.8 3.1 4.3 2.6 3.9 2.0 3.3 3.3 3.6 2.3 3.1 3.5 1.9 2.8 2.0 2.1 2.3 2.8 2.6 4.0 2.4 2.2 4.5 3.5 3.9 3.0 3.0 2.3 3.3 2.1 2.0 4.6 3.3 5.1 5.2 3.1 2.4 1.6 3.6 3.1 3.5 2.4 4.2 2.8 4.0 3.6 3.5 3.4 3.4 7.8 24.8 7.1 6.4 8.0 7.7 6.2 8.9 8.2 9.2 10.1 13.0 5.5 12.6 6.3 9.5 4.2 5.7 7.7 9.7 5.7 7.5 9.2 12.6 12.0 12.5 7.5 8.1 7.8 7.6 7.7 9.2 9.6 5.7 5.8 6.7 12.3 7.8 5.9 10.8 8.2 5.2 4.7 6.8 8.7 9.4 8.7 5.7 4.2 14.0 7.3 6.4 10.2 10.1 7.2 5.4 4.1 14.4 7.8 11.3 7.7 4.8 11.2 9.3 5.9 8.5 7.5 7.8 9.5 1.8 3.6 1.4 4.5 3.6 6.9 4.7 3.5 4.1 2.8 4.4 4.2 5.3 0.7 3.4 5.3 4.2 3.9 3.3 2.1 2.3 4.3 2.6 2.0 2.1 2.4 2.2 2.3 1.6 2.4 3.4 3.0 22.4 33.3 2.0 6.9 5.5 4.4 2.8 4.0 7.4 3.1 2.4 3.2 0.0 17.1 3.7 14.6 8.0 3.2 5.7 3.9 4.1 5.8 1.7 4.0 7.1 13.8 9.5 1.4 3.0 8.3 7.4 4.6 2.3 25.2 4.9 3.6 2.6 4.6 6.7 1.5 4.2 2.0 6.8 1.8 6.3 7.2 7.0 0.0 1.9 5.8 4.1 11.3 1.0 1.4 2.9 2.8 3.0 6.1 4.6 7.8 2.8 9.2 9.6 0.0 5.7 3.6 9.9 10.1 1.9 5.1 10.3 6.7 3.7 5.7 2.6 ZNF555 MGC26707 ENSG00000186300 "Zinc finger protein 555" Q8NEP9 19 2841437-2860471 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 81.6;Late spermatids: 62.6;Spermatocytes: 27.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA053956, HPA055430" Uncertain NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA053956: AB_2682321, HPA055430: AB_2682814" "unprognostic (9.64e-3)" "unprognostic (4.39e-3)" "unprognostic (7.98e-2)" "unprognostic (2.08e-3)" "unprognostic (4.30e-2)" "unprognostic (3.22e-2)" "unprognostic (1.30e-1)" "unprognostic (6.11e-4)" "unprognostic (1.29e-1)" "unprognostic (3.85e-1)" "unprognostic (1.99e-3)" "unprognostic (5.73e-2)" "unprognostic (1.06e-7)" "unprognostic (2.44e-2)" "unprognostic (5.06e-2)" "unprognostic (1.86e-1)" "unprognostic (9.66e-2)" 2.3 1.9 1.3 1.5 2.0 2.8 4.0 3.1 2.4 3.0 1.0 2.5 1.4 3.7 3.0 3.3 3.2 1.3 3.0 1.4 1.7 3.0 2.3 2.2 2.4 2.4 1.8 5.9 2.7 3.3 1.9 3.9 2.3 2.9 1.8 5.5 2.3 3.4 2.7 2.0 1.7 2.2 1.7 2.8 2.2 5.7 1.9 2.5 4.0 4.7 3.0 2.7 2.4 2.9 2.5 1.2 5.7 4.9 4.6 7.6 2.9 2.2 6.0 5.6 5.6 3.1 2.0 3.1 1.8 3.9 4.3 2.0 4.9 3.1 5.2 0.0 2.3 2.3 1.5 4.0 5.5 0.0 4.0 5.0 4.7 3.0 7.4 6.2 5.6 4.0 5.0 1.7 6.4 0.9 1.9 2.4 3.4 1.5 2.9 4.1 6.0 1.3 6.7 2.5 1.3 4.5 3.2 3.4 5.6 6.6 2.5 4.2 3.8 3.2 1.8 4.7 3.0 1.0 4.7 0.0 3.3 6.4 3.1 5.2 4.7 8.0 3.2 5.6 4.7 3.0 3.6 4.4 6.9 2.1 3.2 2.6 0.5 2.6 9.6 9.6 4.0 3.3 1.3 2.0 3.1 2.4 1.4 1.7 2.4 1.8 2.3 1.7 1.9 2.9 2.4 0.0 1.1 13.1 2.0 0.6 1.7 1.4 1.8 13.2 2.8 2.5 5.7 1.5 1.0 1.8 18.8 1.9 2.6 0.4 3.9 2.8 81.6 2.4 4.1 2.2 1.2 3.4 8.9 2.0 1.2 3.2 1.5 3.3 0.0 6.2 3.9 0.9 2.1 11.8 11.7 1.3 0.0 1.9 3.8 62.6 5.9 2.7 0.0 1.9 2.9 6.8 1.0 8.5 11.5 1.8 1.5 3.8 5.8 1.7 0.5 2.3 2.3 13.0 0.0 4.7 2.5 27.2 11.3 1.6 1.7 1.6 1.8 4.3 1.0 1.1 ZNF574 FLJ22059 ENSG00000105732 "Zinc finger protein 574" Q6ZN55 19 42068477-42081552 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 40.9;Spermatocytes: 35.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023196, HPA057274" Approved Supported Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 71: Testis - DNA repair" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Nucleoplasm Vesicles "HPA023196: AB_2671105, HPA057274: AB_2683392" "unprognostic (3.90e-1)" "unprognostic (3.68e-2)" "unprognostic (3.39e-2)" "unprognostic (7.84e-2)" "unprognostic (1.66e-1)" "unprognostic (2.11e-2)" "unprognostic (9.49e-2)" "unprognostic (2.84e-2)" "unprognostic (5.24e-2)" "unprognostic (1.55e-3)" "unprognostic (6.36e-3)" "unprognostic (2.11e-1)" "unprognostic (2.10e-2)" "unprognostic (6.48e-2)" "unprognostic (3.51e-2)" "unprognostic (2.97e-1)" "unprognostic (1.09e-3)" 8.1 5.4 6.8 4.6 6.1 11.1 7.9 9.5 7.7 8.4 4.3 9.5 6.7 10.3 2.7 9.6 8.8 5.1 6.8 6.2 6.2 5.5 5.4 5.6 6.5 6.9 5.8 9.6 7.9 6.1 6.5 5.0 5.8 7.5 2.8 4.1 8.1 6.7 9.3 12.8 7.5 3.7 5.6 8.4 7.2 27.1 6.3 6.3 6.0 6.4 4.2 8.2 7.5 6.3 15.0 41.1 9.0 11.4 8.1 8.0 9.7 11.0 9.6 14.2 13.6 16.2 10.1 21.4 9.7 9.1 7.5 8.9 10.4 14.1 5.6 11.4 17.6 20.5 10.1 14.0 8.6 12.6 13.5 9.5 13.9 13.2 11.1 8.7 7.9 11.8 17.1 13.3 10.1 31.2 15.2 10.9 16.1 13.5 16.2 20.7 8.6 9.3 7.4 19.7 14.9 12.8 11.3 24.0 7.3 6.2 11.0 20.5 9.5 19.2 14.9 5.8 16.4 14.3 9.3 15.7 10.6 11.9 11.0 12.3 10.5 16.7 16.2 7.8 17.6 17.3 12.1 17.8 12.5 12.8 12.6 11.9 13.3 10.9 11.2 11.1 10.3 12.9 6.8 6.1 9.5 7.7 6.2 6.2 6.9 5.8 5.8 5.6 6.3 6.3 6.0 0.0 3.3 1.3 11.3 29.3 15.1 6.1 40.9 7.5 11.0 7.6 4.3 4.3 6.0 1.8 2.1 7.9 6.3 5.8 1.9 6.9 25.3 6.1 5.7 7.6 3.5 8.6 1.4 5.1 6.7 6.6 7.7 5.7 12.7 5.4 6.8 3.1 5.1 3.3 1.7 7.6 6.1 2.5 11.0 15.7 5.6 3.0 8.8 1.0 7.5 3.9 4.1 1.5 0.9 4.3 8.5 8.6 8.1 10.6 6.4 4.3 5.2 9.8 6.6 8.8 8.0 35.5 20.5 22.1 22.7 4.8 10.6 3.8 7.9 9.6 ZNF584 FLJ39899 ENSG00000171574 "Zinc finger protein 584" Q8IVC4 19 58401504-58418327 "Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "HEK 293: 49.8" "Low region specificity" "Detected in all" "HPA043408, HPA048075" Uncertain Approved "Nuclear speckles" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 54: Cardiomyocytes - Muscle contraction" "Nuclear speckles" "HPA043408: AB_2678466, HPA048075: AB_2680251" "unprognostic (6.06e-2)" "unprognostic (3.27e-3)" "unprognostic (3.76e-3)" "unprognostic (8.15e-3)" "unprognostic (5.50e-2)" "unprognostic (1.16e-2)" "unprognostic (1.23e-1)" "unprognostic (1.04e-2)" "unprognostic (6.33e-2)" "unprognostic (2.17e-1)" "unprognostic (1.01e-3)" "unprognostic (1.90e-3)" "unprognostic (1.66e-1)" "unprognostic (1.53e-1)" "unprognostic (1.80e-1)" "unprognostic (3.27e-1)" "unprognostic (1.36e-2)" 5.7 6.7 4.6 2.9 4.5 1.8 5.0 5.4 5.5 5.6 6.0 6.6 3.5 6.9 3.8 5.8 6.8 2.3 8.9 5.1 4.3 5.3 6.6 4.3 2.5 5.3 4.6 6.1 4.9 8.4 6.7 2.7 4.6 5.0 2.6 5.1 4.7 5.7 9.8 9.0 3.5 5.1 4.0 3.3 5.6 4.7 4.5 3.2 4.7 10.9 3.4 6.1 5.0 4.1 11.7 16.7 11.2 14.7 10.8 10.7 4.5 8.9 15.8 5.4 6.7 2.7 3.5 5.8 7.0 14.7 14.2 6.5 12.1 14.6 6.1 7.5 49.8 15.7 9.6 3.5 18.3 17.3 4.3 11.1 10.4 16.5 22.8 11.9 10.9 9.5 15.8 5.4 8.9 8.3 14.4 5.4 2.8 7.6 23.2 10.4 8.4 9.0 7.6 13.7 9.0 9.5 19.5 5.6 7.4 2.9 3.7 8.6 7.0 21.2 6.5 8.9 14.3 5.0 9.5 1.3 15.2 6.0 7.1 0.0 2.2 0.8 3.2 2.1 5.2 2.1 4.3 4.5 3.4 3.3 2.3 3.6 0.7 3.2 3.5 2.9 5.1 2.7 4.6 4.5 5.4 5.5 5.1 4.3 5.3 4.6 4.6 4.0 4.5 4.1 4.2 3.2 3.9 1.0 2.3 11.2 3.2 5.6 6.2 4.1 4.8 4.3 12.8 5.7 2.1 9.2 4.2 1.0 5.9 1.6 13.7 5.6 9.6 8.1 6.1 4.6 6.7 9.5 2.0 5.1 1.5 5.6 3.6 1.8 2.5 5.5 6.8 4.7 2.6 3.3 2.2 2.3 4.1 2.4 3.3 7.8 5.3 2.1 1.8 0.0 1.3 6.1 2.1 0.5 1.6 4.9 2.8 6.4 2.6 4.2 2.1 5.5 10.2 9.2 6.6 4.4 6.3 8.1 3.7 4.3 15.9 0.4 4.0 12.3 3.2 2.0 ZNF599 FLJ30663 ENSG00000153896 "Zinc finger protein 599" Q96NL3 19 34758073-34773229 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal tubular cells: 33.2;Early spermatids: 81.4;Late spermatids: 30.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014701 Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 29: Early spermatids - Spermatogenesis" "Plasma membrane, Cytosol" Nucleoplasm "HPA014701: AB_1859371" "unprognostic (3.52e-3)" "unprognostic (1.42e-3)" "unprognostic (1.99e-2)" "unprognostic (9.35e-3)" "unprognostic (9.20e-2)" "unprognostic (5.16e-3)" "unprognostic (3.95e-3)" "unprognostic (1.72e-2)" "unprognostic (1.70e-2)" "unprognostic (7.35e-3)" "unprognostic (1.77e-3)" "unprognostic (5.03e-2)" "unprognostic (4.42e-2)" "unprognostic (1.16e-1)" "unprognostic (1.00e-1)" "unprognostic (2.71e-2)" "unprognostic (8.12e-3)" 4.4 5.9 5.8 2.3 6.7 1.2 5.6 6.8 6.0 8.1 8.1 6.3 2.5 7.6 11.9 3.9 8.6 2.4 4.7 5.5 6.4 9.5 4.7 4.7 3.3 6.4 6.6 7.4 4.8 9.8 11.0 3.1 6.3 9.5 2.8 4.7 5.9 4.8 3.6 4.4 4.3 3.6 6.2 5.0 4.8 14.0 6.6 4.2 11.1 5.0 2.7 6.0 6.1 7.3 4.8 2.4 4.6 3.4 5.2 6.9 2.6 1.7 4.5 4.1 4.7 2.0 3.1 0.5 4.3 3.1 3.8 2.3 3.4 2.3 4.9 0.5 4.2 3.6 4.9 5.7 4.1 0.8 3.5 6.5 3.1 1.9 2.0 6.7 4.7 8.3 6.2 0.4 6.0 1.9 9.1 3.8 2.0 6.5 0.1 4.6 4.5 3.0 5.1 1.1 5.8 8.4 5.6 1.0 3.2 3.0 2.8 0.4 2.6 3.2 4.4 3.0 1.9 5.1 5.6 0.4 2.5 0.1 3.8 1.9 0.6 3.5 3.4 1.4 2.3 1.0 3.5 1.9 1.0 2.2 3.5 3.2 0.3 3.5 3.2 2.2 2.8 1.6 5.8 6.7 6.8 6.0 5.5 6.4 6.4 6.6 6.3 6.2 6.6 7.3 5.8 0.0 3.7 5.2 2.5 3.1 7.6 5.5 6.8 4.2 10.2 11.2 4.4 1.5 8.3 18.4 2.1 7.9 5.2 1.1 33.2 4.6 81.4 25.4 6.4 5.3 1.2 3.8 0.7 2.3 4.5 8.3 1.5 4.1 0.0 6.6 5.0 4.0 3.8 0.0 3.5 3.3 4.1 1.0 1.9 30.8 10.2 1.2 5.4 0.0 0.9 14.4 4.1 9.5 8.1 3.1 0.9 4.9 4.8 5.5 2.9 15.3 22.7 2.7 6.6 5.7 5.7 26.2 7.5 4.8 1.6 1.9 3.9 7.2 3.2 6.0 ZNF613 FLJ13590 ENSG00000176024 "Zinc finger protein 613" Q6PF04 19 51927147-51948759 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "prostate: 19.4" "Low cell type specificity" "Detected in many" "Cancer enhanced" "Detected in all" "prostate cancer: 10.1" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026833 Uncertain Approved Nucleoplasm,Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 1: Thyroid gland - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm Vesicles "HPA026833: AB_1859377" "unprognostic (1.10e-1)" "unprognostic (2.57e-1)" "unprognostic (9.27e-2)" "unprognostic (2.84e-1)" "unprognostic (9.31e-3)" "unprognostic (1.79e-1)" "unprognostic (2.25e-2)" "unprognostic (1.08e-1)" "unprognostic (1.33e-2)" "unprognostic (1.91e-1)" "unprognostic (2.73e-1)" "unprognostic (5.30e-2)" "unprognostic (5.30e-3)" "unprognostic (1.12e-1)" "unprognostic (1.79e-1)" "unprognostic (4.78e-3)" "prognostic favorable (1.92e-6)" 3.2 3.2 3.4 2.6 3.8 1.4 7.0 4.6 4.2 3.1 3.2 5.2 2.2 3.5 3.8 3.4 3.2 2.8 3.5 3.5 5.1 4.9 2.9 3.8 4.2 4.0 4.2 3.8 2.5 6.0 3.2 6.6 3.9 19.4 5.0 7.2 2.9 4.0 2.7 3.6 2.9 4.1 3.5 4.3 2.8 2.8 4.0 5.6 4.3 3.5 4.2 3.6 2.8 4.2 2.9 3.8 6.2 6.3 5.5 5.7 1.5 5.0 7.8 6.4 8.1 1.3 3.5 2.7 2.6 6.1 5.8 3.2 6.3 6.1 6.9 0.1 8.2 5.4 2.8 3.7 5.5 0.3 7.2 4.6 7.1 6.2 5.0 7.7 7.1 6.2 2.5 0.0 6.6 0.5 8.9 4.1 4.5 1.3 5.9 4.7 7.0 2.8 6.5 9.9 4.2 4.0 8.0 5.8 4.6 9.8 6.3 6.4 4.6 2.7 5.3 2.2 5.3 5.5 0.0 4.9 0.1 0.0 8.5 5.7 5.2 10.5 7.1 5.3 6.5 6.0 7.4 8.3 7.0 9.0 7.6 9.9 5.4 7.7 9.4 3.5 7.7 5.4 3.4 3.8 4.6 4.2 3.5 5.1 4.0 4.2 3.9 3.5 4.0 4.2 2.0 3.2 2.6 2.0 0.9 0.5 0.6 0.8 0.6 2.4 1.6 1.0 4.6 1.5 2.7 3.7 0.0 6.1 1.5 1.9 3.9 2.5 2.3 1.2 1.2 3.0 1.2 0.0 2.4 2.2 1.7 1.2 1.5 1.6 1.3 4.9 3.3 1.5 3.2 0.0 2.0 3.7 6.1 1.6 1.5 1.2 1.2 1.2 0.0 4.7 3.0 2.3 3.1 4.5 4.6 1.8 2.1 1.5 0.5 1.6 1.0 1.4 0.5 4.0 0.0 1.6 1.5 1.9 2.1 1.5 0.6 7.1 1.4 2.3 2.1 0.7 ZNF616 MGC45556 ENSG00000204611 "Zinc finger protein 616" Q08AN1 19 52113091-52139938 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA062639, HPA071539" Approved Approved Centrosome NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 89: Fibroblasts - ECM organization" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 43: Cardiomyocytes - Nuclear processes" Centrosome "HPA062639: AB_2684815, HPA071539: AB_2686414" "unprognostic (5.98e-3)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (3.02e-1)" "unprognostic (2.11e-2)" "unprognostic (3.05e-1)" "unprognostic (2.58e-2)" "unprognostic (1.03e-1)" "unprognostic (3.78e-2)" "unprognostic (4.78e-3)" "unprognostic (1.97e-1)" "unprognostic (1.19e-2)" "unprognostic (2.87e-2)" "unprognostic (3.71e-2)" "unprognostic (2.60e-1)" "unprognostic (3.01e-2)" "unprognostic (1.32e-3)" 5.4 11.6 3.6 4.1 3.8 2.4 6.2 8.3 4.1 6.1 3.1 4.9 4.1 6.8 5.7 4.2 6.8 4.4 3.8 3.4 4.5 6.0 5.9 5.2 5.4 2.9 3.3 10.9 5.5 7.7 2.6 6.8 3.2 6.9 5.6 9.5 4.6 5.1 4.1 5.7 4.3 5.9 1.7 5.9 5.4 4.0 3.4 7.2 7.8 4.9 5.3 3.7 3.7 4.6 5.4 4.9 13.8 11.4 16.0 14.8 0.2 6.9 7.9 6.0 9.4 5.9 4.4 7.2 4.7 6.5 3.2 3.4 12.4 7.8 9.7 5.3 20.0 13.6 14.0 12.3 10.4 12.9 8.3 10.5 10.6 5.9 19.3 11.0 8.3 8.8 15.4 3.8 10.2 4.0 11.7 7.0 15.1 4.2 12.4 11.1 20.3 10.9 4.6 14.5 16.2 9.3 12.3 4.9 3.8 12.3 7.6 4.3 8.2 5.3 6.4 6.2 7.5 6.9 11.1 10.4 4.8 7.9 10.9 3.8 2.9 3.4 4.9 1.7 4.4 3.2 4.5 3.9 3.0 3.4 4.0 3.6 3.9 13.2 10.5 3.7 3.2 2.1 3.6 3.8 8.3 4.1 3.4 4.5 2.9 3.3 3.2 1.7 3.4 4.6 2.4 6.4 3.2 1.6 2.5 4.1 3.9 1.4 5.2 3.6 3.0 2.2 3.1 7.2 1.8 7.3 4.2 3.2 3.0 3.6 5.9 3.5 0.0 2.8 4.3 2.7 1.2 1.7 3.1 1.8 4.3 4.2 4.1 2.0 0.0 4.0 2.9 2.6 3.2 6.7 3.0 4.0 2.0 1.9 3.2 0.6 6.5 2.7 1.8 5.6 3.1 3.6 8.2 6.0 5.6 2.0 1.5 2.6 1.5 3.2 3.6 3.1 3.7 8.1 0.0 2.4 3.6 4.5 4.2 2.7 2.6 1.9 2.9 2.7 2.9 4.5 ZNF689 "FLJ90415, TIPUH1" ENSG00000156853 "Zinc finger protein 689" Q96CS4 16 30602558-30624012 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 19.5" "Cell type enhanced" "Detected in many" "Early spermatids: 53.0;Late spermatids: 52.0;Spermatocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054095, HPA055385" Approved Approved "Nucleoplasm,Nucleoli fibrillar center" No No "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 14: REH - Unknown function" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nucleoli fibrillar center" "HPA054095: AB_2682377, HPA055385: AB_2682801" "unprognostic (5.62e-2)" "unprognostic (2.36e-2)" "unprognostic (2.77e-3)" "unprognostic (2.73e-2)" "unprognostic (7.73e-2)" "unprognostic (3.74e-2)" "unprognostic (1.57e-1)" "unprognostic (8.38e-2)" "unprognostic (5.83e-3)" "unprognostic (2.26e-1)" "prognostic favorable (9.89e-4)" "unprognostic (3.21e-1)" "unprognostic (1.58e-3)" "unprognostic (3.93e-2)" "unprognostic (5.23e-1)" "unprognostic (1.84e-1)" "unprognostic (3.69e-2)" 3.5 3.5 3.4 3.5 3.5 6.6 10.2 3.4 3.7 4.3 2.4 4.5 4.8 5.4 2.7 2.3 4.1 2.9 3.7 3.3 3.4 3.2 4.3 3.5 4.1 3.4 3.3 5.4 4.8 7.1 3.5 3.2 3.1 3.6 3.1 2.8 3.4 4.7 5.1 2.6 4.3 4.1 3.3 4.7 3.8 19.5 3.4 5.9 3.9 5.5 4.0 4.2 3.0 3.6 4.6 8.1 11.1 11.6 4.7 4.6 5.5 5.6 8.2 9.0 8.7 9.5 3.5 13.2 8.6 5.0 6.5 3.5 14.0 6.1 7.1 10.9 23.6 11.2 7.1 14.7 5.0 11.1 8.2 4.4 5.7 6.2 6.1 4.9 6.4 12.0 13.4 7.4 5.8 6.9 20.6 10.4 12.6 3.6 8.2 25.7 10.7 11.9 3.8 4.5 13.8 8.4 4.1 7.4 6.4 5.5 7.7 9.6 5.0 11.6 4.9 5.6 7.8 13.6 16.8 15.7 4.2 12.0 11.5 0.1 6.2 2.5 5.1 9.3 3.7 3.8 4.2 5.2 8.9 2.9 3.6 3.5 0.4 8.8 10.3 3.2 4.5 4.4 3.4 3.5 3.4 3.7 3.3 3.4 3.4 3.3 3.1 3.3 3.4 3.6 10.5 3.2 2.0 1.3 8.4 1.7 4.9 2.6 1.8 10.0 25.4 20.7 4.7 11.5 1.2 1.8 6.2 4.3 10.2 5.9 0.0 6.2 53.0 2.3 5.7 8.6 6.0 6.1 2.4 6.9 3.2 6.3 3.6 3.3 14.0 8.0 8.6 6.9 5.1 10.1 2.7 6.5 6.1 8.6 4.3 52.0 8.1 6.6 0.0 3.7 6.9 5.8 8.2 2.0 3.0 5.2 4.8 10.5 6.6 5.5 7.9 4.3 1.5 6.1 0.0 11.5 5.8 87.7 8.9 2.1 1.0 0.8 8.8 6.6 6.6 3.0 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 72: Non-specific - Transcription" "Cluster 5: NTERA-2 - Transcription" "Cluster 52: Non-specific - Transcription" "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavorable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favorable (4.11e-4)" 7.1 5.4 6.6 5.3 6.5 3.0 7.4 6.6 7.4 10.8 5.0 7.7 4.0 8.9 3.6 6.0 10.1 3.0 5.4 6.2 6.6 9.9 3.4 6.2 7.3 7.1 6.6 11.7 7.1 2.9 7.1 2.9 6.7 9.4 3.8 2.9 5.8 4.0 6.4 7.0 9.2 4.5 6.1 12.8 6.6 6.6 6.8 4.0 8.3 3.3 6.4 8.1 7.8 8.0 3.5 3.5 5.7 4.1 3.7 6.9 5.3 2.1 1.1 5.0 2.2 5.6 6.5 11.9 5.5 3.5 1.1 2.3 4.0 4.3 2.2 3.3 3.5 7.6 8.7 1.1 8.5 5.1 9.2 7.4 8.7 4.5 5.5 3.1 3.4 4.2 6.2 6.0 4.2 7.6 7.6 7.8 12.8 8.1 4.7 1.6 0.5 10.6 5.6 5.8 4.5 9.5 8.5 4.0 6.0 3.0 4.4 10.1 5.0 4.0 0.9 2.1 4.9 9.1 6.2 0.1 5.6 1.8 8.7 0.1 0.4 0.1 1.0 0.7 0.8 0.7 0.6 0.6 0.4 1.3 0.8 0.7 0.1 0.5 1.7 0.9 0.4 0.4 6.6 6.5 6.6 7.4 6.2 6.6 7.1 6.6 6.7 6.1 6.8 8.0 6.7 3.2 2.7 5.5 6.1 2.5 2.5 4.6 1.8 13.3 7.5 7.6 2.2 7.2 3.2 0.0 10.4 3.0 6.1 3.4 3.9 2.1 5.3 3.2 7.9 4.3 3.6 1.7 5.7 2.7 2.0 7.0 7.1 6.2 0.0 6.4 5.0 6.6 4.2 6.7 6.3 4.7 4.1 7.9 4.6 5.0 8.7 3.9 5.4 11.2 5.2 3.8 8.2 4.0 8.5 3.0 1.6 5.7 3.9 4.0 3.0 1.1 5.5 8.8 13.1 7.4 5.0 16.3 6.9 3.6 3.0 1.1 5.0 6.9 4.3 2.4 ZNF813 FLJ16542 ENSG00000198346 "Zinc finger protein 813" Q6ZN06 19 53467733-53496255 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Hepatic stellate cells: 13.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 18.1" HPA056406 Uncertain Approved Vesicles NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 68: Epididymis - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 40: Granulosa cells - Unknown function" Vesicles "HPA056406: AB_2683119" "unprognostic (1.20e-1)" "unprognostic (3.43e-2)" "unprognostic (1.17e-1)" "unprognostic (3.98e-3)" "unprognostic (2.28e-1)" "unprognostic (3.61e-3)" "unprognostic (1.48e-2)" "unprognostic (1.84e-3)" "unprognostic (3.39e-3)" "unprognostic (1.74e-1)" "unprognostic (3.75e-2)" "unprognostic (3.61e-2)" "unprognostic (1.25e-3)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (6.56e-2)" 1.2 1.1 0.9 1.5 1.3 1.4 2.2 1.1 1.1 1.1 1.4 1.8 1.8 1.3 3.9 1.2 1.8 1.4 0.7 1.0 1.2 1.3 0.7 1.4 2.2 1.4 1.4 1.8 1.3 2.4 0.6 3.6 1.3 4.9 1.7 0.6 1.2 1.1 0.4 2.0 1.7 1.0 1.0 1.9 1.9 1.6 1.3 2.2 1.9 0.5 2.1 1.4 1.2 1.8 0.9 0.8 2.6 4.3 2.2 2.6 6.0 2.4 2.4 1.6 2.3 4.6 2.7 6.9 2.3 2.3 3.0 1.4 6.3 2.7 3.0 0.0 9.9 6.9 1.8 5.2 1.1 0.0 7.1 2.2 2.2 1.8 1.3 0.9 1.4 4.9 3.8 0.1 2.6 1.3 9.2 3.8 3.3 0.8 2.4 5.6 5.7 3.4 1.5 18.1 1.1 2.5 0.0 4.5 1.6 5.6 1.8 3.4 2.3 0.9 3.1 0.1 2.3 3.6 5.5 7.5 0.0 0.0 4.7 1.8 1.1 0.8 1.7 1.6 1.7 1.6 1.6 1.9 1.2 2.4 3.0 2.3 0.5 3.6 3.0 1.1 1.3 1.4 0.9 1.3 1.1 1.1 1.0 1.2 1.4 1.4 1.3 1.0 1.3 1.8 3.4 6.4 1.8 0.3 4.4 1.8 3.1 1.4 4.6 0.7 1.9 1.8 1.9 5.7 2.6 0.0 0.0 5.0 4.3 2.5 1.9 2.2 1.7 2.6 3.2 4.0 0.0 3.4 0.3 1.2 10.1 4.1 3.6 2.6 0.0 7.0 13.6 1.2 2.8 3.3 1.0 3.2 2.0 3.0 1.7 0.9 2.5 2.6 3.6 1.0 3.7 1.1 3.1 2.0 2.8 1.5 3.4 2.2 1.5 5.0 1.2 0.8 2.0 0.6 0.0 4.0 3.4 0.9 4.1 2.2 1.6 8.9 2.8 2.6 3.9 2.3 ZSCAN2 "FLJ20595, ZFP29, ZNF854" ENSG00000176371 "Zinc finger and SCAN domain containing 2" Q7Z7L9 15 84600986-84627796 "Predicted intracellular proteins, Transcription factors" "Differentiation, Spermatogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 18.0;Proximal tubular cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007296, HPA024331" Supported Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 22: Non-specific - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 67: Proximal tubular cells - Tubular reabsorption" Nucleoplasm Cytosol "HPA007296: , HPA024331: AB_1859497" "unprognostic (4.05e-1)" "unprognostic (2.08e-1)" "unprognostic (9.49e-2)" "unprognostic (6.76e-2)" "unprognostic (7.84e-2)" "unprognostic (2.47e-2)" "unprognostic (3.58e-2)" "unprognostic (1.73e-1)" "unprognostic (1.06e-1)" "unprognostic (1.95e-1)" "prognostic favorable (3.52e-4)" "unprognostic (4.24e-1)" "prognostic favorable (7.46e-4)" "unprognostic (2.42e-2)" "unprognostic (3.53e-3)" "unprognostic (2.98e-1)" "prognostic favorable (4.16e-5)" 7.6 5.8 3.0 4.2 3.9 8.7 7.2 4.8 3.6 6.7 2.3 4.5 3.1 6.4 2.3 2.3 4.0 3.5 6.0 3.2 4.1 7.5 8.8 3.0 4.1 3.2 3.3 6.0 16.6 4.1 4.1 2.1 3.8 5.2 2.9 6.2 6.8 3.0 8.2 2.6 4.4 3.3 2.8 5.9 8.1 11.8 3.7 10.1 4.1 3.1 3.1 4.6 3.5 4.8 2.2 13.4 9.0 14.6 5.7 3.5 8.5 2.5 6.2 5.3 6.4 10.4 5.2 4.9 6.9 3.5 9.8 5.6 6.9 5.0 4.6 10.4 13.0 6.2 8.4 22.0 4.9 3.9 4.4 5.6 4.9 7.0 6.6 7.0 15.5 24.0 8.4 3.9 5.6 6.7 16.8 9.6 16.9 4.5 7.9 16.8 5.6 9.2 5.3 16.7 13.5 23.1 7.6 4.1 11.7 14.5 9.1 9.8 10.8 6.3 12.4 3.2 3.3 6.3 9.5 16.8 4.3 8.7 3.7 6.4 5.8 5.0 5.7 6.4 2.8 3.9 5.2 4.3 6.6 3.5 3.8 4.3 3.1 5.6 8.4 5.9 7.8 3.9 3.0 3.9 4.8 3.6 3.2 4.1 3.2 3.3 3.8 2.8 3.7 4.8 9.1 0.0 2.0 1.6 3.9 0.9 1.2 2.6 2.2 3.1 3.5 3.2 2.5 4.3 1.7 7.3 2.1 1.6 2.5 1.3 5.9 6.9 18.0 5.7 3.3 3.0 3.0 3.0 1.6 8.6 5.1 2.3 4.6 6.9 1.3 8.0 1.1 7.5 3.6 0.0 1.6 3.2 4.1 2.8 2.3 12.3 0.9 2.9 1.8 1.0 5.5 2.3 2.1 4.0 2.5 9.9 4.2 1.5 11.1 2.6 1.9 22.6 1.8 3.1 6.6 2.3 3.9 7.1 8.2 0.9 0.4 1.4 3.7 3.6 2.6 1.5 ZSCAN32 "FLJ20417, ZNF434" ENSG00000140987 "Zinc finger and SCAN domain containing 32" Q9NX65 16 3382081-3401065 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Alveolar cells type 1: 19.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005758 Uncertain Approved Nucleoplasm,Cytosol NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 20: Retina & Lymphoid tissues - Unknown function" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 51: Myeloid cells - Hemostasis" Nucleoplasm Cytosol "HPA005758: AB_1080720" "unprognostic (5.05e-2)" "unprognostic (2.64e-1)" "unprognostic (1.46e-2)" "unprognostic (6.04e-2)" "unprognostic (2.84e-2)" "unprognostic (2.38e-3)" "unprognostic (7.72e-2)" "unprognostic (9.40e-2)" "unprognostic (2.19e-1)" "unprognostic (4.73e-2)" "unprognostic (3.20e-1)" "unprognostic (1.54e-2)" "unprognostic (1.13e-3)" "unprognostic (6.04e-2)" "unprognostic (1.74e-1)" "unprognostic (1.18e-3)" "unprognostic (9.71e-2)" 4.8 5.9 8.9 5.6 9.4 3.6 5.9 8.6 10.9 6.2 10.0 6.6 7.8 6.0 4.4 4.9 6.9 5.0 5.3 8.6 10.1 5.9 5.5 6.0 8.6 9.6 9.6 8.2 7.4 7.6 8.4 5.4 9.5 6.5 5.7 11.6 4.9 7.0 4.6 6.1 5.4 5.5 8.8 6.9 5.9 7.4 9.6 10.1 7.2 3.3 9.1 6.1 5.2 11.4 6.0 10.1 12.7 15.3 10.1 10.0 9.5 7.1 12.6 10.3 9.9 5.2 8.8 19.4 7.5 10.6 6.8 6.4 10.6 10.6 12.0 13.0 7.6 16.7 9.1 7.1 12.7 11.9 12.1 10.0 17.1 10.2 17.3 11.2 10.6 21.3 16.5 7.5 13.5 7.5 16.4 8.1 13.8 10.6 5.1 16.0 13.1 18.6 8.9 6.4 11.2 8.6 14.4 8.8 7.8 8.1 10.1 14.7 12.8 8.9 8.4 7.3 8.6 12.4 14.8 25.1 2.5 9.4 13.6 4.1 5.4 7.3 9.7 4.2 8.3 8.3 6.7 6.2 4.9 6.7 9.3 9.0 6.0 15.0 13.1 5.0 9.5 6.2 8.9 9.4 8.6 10.9 8.6 10.1 9.6 9.6 9.5 8.8 9.6 11.4 3.9 19.2 5.3 3.3 5.1 2.3 2.2 1.7 1.8 4.6 3.0 3.4 0.9 5.7 6.2 1.8 8.4 4.9 3.6 2.7 11.7 5.6 1.6 3.5 3.8 3.9 0.0 6.1 4.8 6.2 2.7 2.8 1.5 2.2 5.1 4.6 2.5 3.4 3.0 8.4 4.4 3.3 2.0 5.1 1.8 1.4 4.4 5.1 1.8 9.4 6.2 6.0 9.2 8.0 7.7 5.8 3.2 5.3 3.6 3.9 3.1 3.7 1.7 4.2 0.0 4.1 2.9 15.9 15.9 2.9 2.8 2.6 5.6 6.5 3.1 1.5 ZSWIM3 "C20orf164, dJ337O18.7, PPP1R174" ENSG00000132801 "Zinc finger SWIM-type containing 3" Q96MP5 20 45857614-45879122 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Excitatory neurons: 7.6;Inhibitory neurons: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055692, HPA060508" Uncertain Approved "Nucleoli fibrillar center,Vesicles,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 34: Non-specific - Transcription" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 59: Non-specific - Transcription" Vesicles "Nucleoli fibrillar center, Cytosol" "HPA055692: AB_2682887, HPA060508: AB_2684297" "prognostic unfavorable (9.32e-5)" "unprognostic (8.53e-2)" "unprognostic (3.55e-1)" "prognostic unfavorable (4.21e-4)" "unprognostic (4.61e-2)" "unprognostic (1.09e-3)" "unprognostic (1.77e-3)" "unprognostic (4.49e-2)" "unprognostic (2.20e-1)" "unprognostic (1.36e-2)" "unprognostic (2.72e-3)" "unprognostic (9.28e-2)" "unprognostic (4.74e-2)" "unprognostic (5.55e-2)" "unprognostic (1.76e-1)" "unprognostic (4.69e-2)" "unprognostic (4.13e-2)" 1.3 2.9 2.3 2.0 2.2 0.7 1.8 2.8 2.5 1.8 1.4 2.3 2.4 1.9 2.8 1.8 2.1 1.5 2.0 2.1 2.3 1.8 2.3 1.9 3.4 2.0 2.1 2.7 1.5 2.2 1.9 1.7 2.1 1.9 2.3 3.3 1.8 1.6 1.4 2.2 2.4 1.7 2.0 3.2 1.8 3.2 2.2 3.5 1.9 2.4 3.9 1.6 1.4 2.1 1.7 1.4 4.1 2.4 4.9 3.5 2.4 2.6 3.1 4.7 4.6 5.9 2.6 5.3 8.8 2.2 2.3 2.8 5.9 2.8 3.5 3.3 2.5 5.1 2.6 3.8 5.9 2.9 6.7 3.2 3.1 3.6 2.2 5.0 4.1 4.6 4.8 2.5 3.6 8.5 4.0 5.8 1.6 3.9 5.6 3.9 3.8 4.0 1.3 1.0 5.4 2.7 4.2 4.8 3.3 3.1 2.3 7.6 4.1 4.7 1.5 1.8 1.6 5.4 3.0 3.4 4.0 3.4 1.5 1.0 1.1 1.6 1.3 1.5 2.8 2.1 1.5 2.0 1.9 1.8 1.4 1.9 0.8 1.7 4.8 1.1 2.4 1.1 2.3 2.2 2.8 2.5 2.1 2.3 2.0 2.1 2.1 2.0 2.2 2.1 1.6 3.2 1.1 4.6 4.1 0.4 0.3 0.7 0.6 4.4 1.1 1.0 1.3 0.0 0.5 1.8 0.0 1.3 1.4 2.8 0.0 1.2 0.5 0.6 1.2 1.8 2.4 0.8 7.6 1.4 0.6 1.4 1.5 1.0 0.0 5.2 2.2 0.8 1.0 0.0 9.2 1.1 0.0 1.3 1.4 0.7 0.3 1.1 0.0 6.5 0.6 2.8 0.0 7.1 7.0 0.6 0.3 1.2 2.6 0.2 2.0 1.2 0.5 4.3 0.0 1.3 1.2 2.4 4.3 1.3 0.3 0.8 3.1 4.7 0.9 0.4 ZW10 KNTC1AP ENSG00000086827 "Zw10 kinetochore protein" O43264 11 113733187-113773735 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 44.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011565, HPA051253, HPA055410" Enhanced Supported "Endoplasmic reticulum,Cytosol" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Endoplasmic reticulum, Cytosol" "CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809" "unprognostic (4.33e-3)" "unprognostic (6.65e-2)" "prognostic favorable (2.70e-4)" "unprognostic (3.12e-1)" "unprognostic (5.51e-2)" "unprognostic (6.52e-2)" "prognostic unfavorable (8.57e-4)" "unprognostic (7.44e-2)" "unprognostic (8.01e-3)" "unprognostic (5.91e-2)" "unprognostic (1.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.57e-3)" "unprognostic (6.00e-2)" "unprognostic (8.73e-2)" "unprognostic (2.95e-1)" "unprognostic (1.17e-3)" 6.9 6.0 3.5 8.1 4.1 9.2 10.9 5.0 4.8 8.1 3.7 8.3 7.2 7.6 7.3 9.6 6.1 5.9 5.6 3.8 3.8 8.8 13.0 6.4 9.4 4.2 4.7 6.9 9.1 7.2 5.1 7.7 4.6 7.9 10.0 6.8 8.3 7.3 13.4 13.7 7.1 8.7 3.8 7.0 7.3 13.5 4.2 12.1 6.7 12.0 12.0 8.5 7.5 5.7 25.0 14.4 30.2 22.1 18.4 20.0 17.4 26.1 21.4 32.2 32.5 38.1 46.1 29.0 34.5 25.8 28.1 34.2 36.7 31.6 46.0 19.1 15.1 30.9 12.0 23.5 20.6 31.7 18.8 16.5 20.8 34.1 27.4 14.2 33.5 31.7 36.3 11.8 33.8 12.2 29.3 20.9 21.7 29.8 29.0 27.0 34.4 32.7 21.2 22.2 13.3 15.7 29.1 24.2 11.8 24.2 44.9 17.4 21.1 28.8 44.2 14.4 28.8 6.1 10.6 30.6 9.9 38.1 33.0 8.5 7.4 7.4 6.3 10.4 8.5 5.9 5.9 5.6 9.5 5.1 5.4 6.8 1.9 6.2 9.2 3.0 5.6 5.6 3.5 4.1 5.0 4.8 3.8 3.8 4.2 4.7 4.6 3.8 4.2 5.7 5.6 0.0 4.8 11.1 5.8 12.1 7.6 7.5 8.0 2.9 5.9 5.0 6.8 7.2 7.3 0.0 0.0 9.2 3.9 3.9 9.8 10.1 10.7 7.7 7.1 6.9 3.6 10.7 12.5 11.8 10.0 6.5 8.2 12.7 3.8 7.8 3.9 8.1 9.2 3.3 11.1 4.6 4.1 6.0 5.4 7.3 5.0 6.1 3.6 10.3 8.0 7.6 3.1 12.1 18.7 8.4 3.8 5.7 10.4 5.6 5.3 7.2 4.8 4.9 19.7 7.0 7.0 44.4 17.5 9.4 12.5 10.5 5.9 6.9 6.4 5.8 ZWILCH "FLJ10036, KNTC1AP" ENSG00000174442 "Zwilch kinetochore protein" Q9H900 15 66504959-66550130 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 53.9" "Cell type enhanced" "Detected in many" "Early spermatids: 97.3;Late spermatids: 74.5;Spermatocytes: 167.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "unprognostic (1.10e-1)" "unprognostic (9.99e-2)" "unprognostic (9.44e-2)" "unprognostic (1.02e-1)" "unprognostic (3.79e-1)" "unprognostic (4.83e-3)" "unprognostic (3.32e-2)" "unprognostic (1.31e-2)" "unprognostic (2.17e-2)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.90e-5)" "prognostic unfavorable (7.34e-4)" "prognostic unfavorable (2.58e-4)" "unprognostic (2.81e-2)" "unprognostic (4.37e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-1)" 3.8 2.2 2.9 8.4 2.7 10.3 6.7 2.3 2.8 4.9 4.1 8.7 5.5 6.2 6.3 6.7 4.0 5.9 2.6 3.0 2.7 4.7 5.4 5.2 11.6 3.3 2.1 6.0 3.2 2.6 2.4 7.3 2.9 4.6 9.9 3.8 3.4 3.7 3.3 7.9 5.5 6.2 3.0 5.5 5.5 53.9 3.1 14.1 3.9 3.1 14.1 5.5 4.1 3.8 38.1 48.5 58.0 51.5 13.6 24.0 31.3 58.8 35.6 69.4 76.5 39.4 32.2 81.6 26.3 38.6 57.7 92.6 156.4 42.2 83.9 41.7 31.9 59.5 63.9 31.3 4.9 41.4 32.0 9.9 10.7 71.2 51.8 21.4 44.8 34.3 57.4 43.2 54.7 38.2 36.7 25.2 111.7 75.2 31.0 41.9 72.1 59.6 24.9 42.6 34.5 37.5 32.1 41.4 50.6 66.1 32.9 27.6 30.0 63.2 68.7 37.6 87.2 21.6 92.6 85.0 42.9 94.5 53.5 4.0 2.1 3.6 4.3 4.2 3.7 4.3 4.3 4.1 2.1 4.1 2.8 4.0 2.5 5.0 5.4 2.2 4.5 2.2 2.9 2.7 2.3 2.8 3.0 2.7 3.3 2.1 2.9 3.0 3.1 3.8 6.1 3.2 4.6 1.3 7.5 11.1 6.4 8.4 4.0 5.1 5.8 4.2 1.5 5.7 8.7 1.8 0.0 14.1 7.0 5.3 3.9 8.2 97.3 5.9 6.6 6.5 4.8 31.5 5.2 6.5 25.1 6.7 10.7 7.8 15.2 9.6 3.9 4.7 12.5 0.0 4.3 10.3 12.2 4.1 8.4 74.5 7.5 7.4 5.4 2.8 7.4 1.5 7.2 2.5 2.7 8.1 2.1 5.3 15.0 4.6 2.0 2.8 5.2 3.7 26.3 3.1 6.4 167.9 43.1 11.2 8.5 12.9 8.3 4.8 10.1 6.9